Citrus Sinensis ID: 042958
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP24 | 1120 | Probable leucine-rich rep | yes | no | 0.986 | 0.947 | 0.472 | 0.0 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.843 | 0.867 | 0.453 | 0.0 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.978 | 0.842 | 0.369 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.934 | 0.912 | 0.375 | 1e-174 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.986 | 0.846 | 0.351 | 1e-172 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.946 | 0.922 | 0.363 | 1e-166 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.927 | 0.887 | 0.349 | 1e-161 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.894 | 0.843 | 0.359 | 1e-156 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.978 | 0.882 | 0.350 | 1e-148 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.828 | 0.785 | 0.364 | 1e-148 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/1095 (47%), Positives = 690/1095 (63%), Gaps = 34/1095 (3%)
Query: 1 MEEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTS-PC-AWVGIHCNRGGRVNSINLTSI 58
+ EA+ALL+WK++ N S LSSW + T TS C +W G+ CN G + +NLT+
Sbjct: 31 IAEANALLKWKSTF---TNSSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNT 87
Query: 59 GLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIG 118
G++G DF F S +LAY+DL N L G IPPQ GN+S+L Y DLS+N G I P +G
Sbjct: 88 GIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLG 147
Query: 119 HLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178
+L L L L +N L IP E+G + S+ LAL N L IP SLGNL NL L+LY+
Sbjct: 148 NLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYE 207
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG 238
N L+ IP E GN+ S++ L+L NK +GSIP +LGNL NL LYL+ N L IP E+G
Sbjct: 208 NYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIG 267
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
N+ S++ L+L NKL+GSIP SLGNL NL L L++N L+G IP + GN+ S+ L L
Sbjct: 268 NMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSN 327
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
NKL G IP SLGNL NL LY++ N L+G IP E+GN+ S+ +L L+ NKL+GSIP S G
Sbjct: 328 NKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L NL LYLY N L IP ELGN+ S+ L L NKL+GS+P S GN T L +L L
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRV 447
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
N LSG+IP N L+TL L N +G P ++ L + L N L G IP +
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLR 507
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
+ +S+ NK +G I ++ G +L + +N I S L L +
Sbjct: 508 DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSN 567
Query: 539 NKLSGSIP------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
N ++G+IP L LDLS+N++ GE+P +G L L +L L NQLSG++ L
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
L LE LDLSSN S+ IP++F + +KLH +NLS N+F IP +L +L L++LDLSH
Sbjct: 628 FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSH 686
Query: 653 NFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
N L IPSQ+ +QSL+ L+LSHN+L GLIP+ FE M L +DIS N+L+GP+P++
Sbjct: 687 NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPT 746
Query: 713 FRDAPIEALQGNKGLCGDV--KGLPSCKTLKS-NKQALRKIWVVVVFPLLGIVALLISLI 769
FR A +AL+ N GLC ++ + L C+ LK K +W++V P+LG++ +L S+
Sbjct: 747 FRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SIC 803
Query: 770 GLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQG 829
F + R LQ +++ T +S+ + +GK Y++II +TN+FD H IG GG
Sbjct: 804 ANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYS 863
Query: 830 SVYKAELASGEIVAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886
VY+A L I+AVK+ H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH
Sbjct: 864 KVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHR 922
Query: 887 RH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDI 935
RH SL +L+N+ AK L WT+R+NV+KG++ ALSYMH+D PIVHRDI
Sbjct: 923 RHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDI 982
Query: 936 SSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSF 995
SS N+LLD D A +SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSF
Sbjct: 983 SSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSF 1042
Query: 996 GVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISC 1055
GVL LE+I GKHP D +SS+SSS ++L + D R+ P ++KL+ +VE+A+ C
Sbjct: 1043 GVLILELIIGKHPGDLVSSLSSSP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLC 1101
Query: 1056 LDENPESRPTMPKVS 1070
L NPESRPTM +S
Sbjct: 1102 LQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 749 bits (1933), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/940 (45%), Positives = 578/940 (61%), Gaps = 33/940 (3%)
Query: 157 LEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNL 216
ED SL NL+ +D L N S +I +G L L N+ G IP LG+L
Sbjct: 109 FEDFPFSSLPNLTFVD---LSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDL 165
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
+NL TL+L N L SIPSE+G L ++ +++ N L+G IP S GNLT L LYL+ NS
Sbjct: 166 SNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINS 225
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
LSGSIPSE GNL +L L L N L G IP S GNL N+ L + N LSG IP EIGN+
Sbjct: 226 LSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNM 285
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK 396
+L L L NKL+G IP +LG + LA L+LY N L SIP ELG + S+ L + NK
Sbjct: 286 TALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENK 345
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNL 456
L+G +P S G LT L L L DN LSG IP N L+ L L N +G +P ++
Sbjct: 346 LTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRG 405
Query: 457 TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNS 516
L+ L L DN G +P + + +S+ + N SG I ++ G L + L NN+
Sbjct: 406 GKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNN 465
Query: 517 LFDSIPSELGNLRSLSMLSFAYNKLSGSIP------HSLGVLDLSSNHIVGEIPTELGKL 570
+ + + L + N ++G+IP L LDLSSN I GE+P + +
Sbjct: 466 FHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNI 525
Query: 571 NFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
N + KL L N+LSG++ + L LE+LDLSSNR S+ IP + NL +L+Y+NLS N
Sbjct: 526 NRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRND 585
Query: 631 FSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKM 690
+ IP L +L L LDLS+N L I SQ +Q+LE L+LSHN+L G IP F+ M
Sbjct: 586 LDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDM 645
Query: 691 HGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDV---KGLPSCKTLKSNK-QA 746
L +D+S+N LQGPIP++ AFR+AP +A +GNK LCG V +GL C S K
Sbjct: 646 LALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHK 705
Query: 747 LRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQ--TQQSSPGNTRGLLSVLTFEGK 804
R + + ++ P++G + +L G+F F++R ++ T S G T LS+ +F+GK
Sbjct: 706 DRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGET---LSIFSFDGK 762
Query: 805 IVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT---FQQEF 861
+ Y+EII+AT +FD ++ IG GG G VYKA+L + I+AVKK + ++ +QEF
Sbjct: 763 VRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEF 821
Query: 862 LNEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMN 910
LNE++ALTEIRHRN+VK +GFCSH R+ SL +L N+ AK L W +R+N
Sbjct: 822 LNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRIN 881
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970
V+KG++ ALSYMH+D P IVHRDISS N+LL D EA +SDFG AK LKPDSSNW+ +A
Sbjct: 882 VVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVA 941
Query: 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030
GTYGYVAPELAY MKVTEKCDVYSFGVL LEVIKG+HP D +S++SSS + ++L +
Sbjct: 942 GTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSIS 1001
Query: 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVS 1070
D RLP P+ ++++++ I++VA+ CL +P++RPTM +S
Sbjct: 1002 DHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 648 bits (1672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/1213 (36%), Positives = 620/1213 (51%), Gaps = 161/1213 (13%)
Query: 3 EAHALLRWKTSL-QNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGG--RVNSINLTSIG 59
+ LL K SL N L W +N+ C+W G+ C+ G RV ++NLT +G
Sbjct: 26 DLQTLLEVKKSLVTNPQEDDPLRQWNSDNINY---CSWTGVTCDNTGLFRVIALNLTGLG 82
Query: 60 LKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGH 119
L G + + F F +L +LDL N L G IP + N++ L+ L L SN G IP ++G
Sbjct: 83 LTGSISPW-FGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGS 141
Query: 120 LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L +++L++ +N+L G IP +G L +L LAL S L IP LG L + +L L DN
Sbjct: 142 LVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDN 201
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
L IP+E GN L++ + N +G+IP LG L NL L L NNSL IPS+LG
Sbjct: 202 YLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGE 261
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
+ L LSL N+L G IP SL +L NL TL L N+L+G IP EF N+ L L L N
Sbjct: 262 MSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANN 321
Query: 300 KLNGIIPHSL-GNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIP---- 354
L+G +P S+ N TNL L + LSG IP E+ +SL L LS N L+GSIP
Sbjct: 322 HLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALF 381
Query: 355 --------------------PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
PS+ L+NL L LY N+L +P E+ LR L +L L
Sbjct: 382 ELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYE 441
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
N+ SG IP +GN T+L +D++ N G IP G L+ L+ L L N+L G +P SLG
Sbjct: 442 NRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLG 501
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYL-- 512
N L+ L L DN LSGSIP G L+ + L L NN L G++P SL +L NL + L
Sbjct: 502 NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSH 561
Query: 513 ---------------------YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG- 550
NN D IP ELGN ++L L N+L+G IP +LG
Sbjct: 562 NRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGK 621
Query: 551 -----VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSN 605
+LD+SSN + G IP +L L + L N LSG + P LG L+QL L LSSN
Sbjct: 622 IRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSN 681
Query: 606 R------------------------LSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEE 641
+ L+ SIP+ GNL L+ LNL NQFS +P + +
Sbjct: 682 QFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGK 741
Query: 642 LIHLSELDLSHNFLREAIPSQICIMQSLEN-LNLSHNSLVGLIPSCFEKMHGLLRIDISY 700
L L EL LS N L IP +I +Q L++ L+LS+N+ G IPS + L +D+S+
Sbjct: 742 LSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSH 801
Query: 701 NELQGPIPNSIA----------------------FRDAPIEALQGNKGLCGDVKGLPSCK 738
N+L G +P S+ F P ++ GN GLCG L C
Sbjct: 802 NQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSP--LSRCN 859
Query: 739 TLKSN--KQAL--RKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNT-- 792
++SN +Q L R + ++ L + L+I +I LFFK QR + + S T
Sbjct: 860 RVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK-QRHDFFKKVGHGSTAYTSS 918
Query: 793 --------RGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAV 844
+ L + I +E+I+ AT++ +E IG GG G VYKAEL +GE VAV
Sbjct: 919 SSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAV 978
Query: 845 KKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN-------- 896
KK ++ + F EVK L IRHR++VK G+CS L +++
Sbjct: 979 KKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIW 1036
Query: 897 ----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN 946
K L W R+ + G++ + Y+H+DC PPIVHRDI S NVLLD +
Sbjct: 1037 DWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNM 1096
Query: 947 EAHVSDFGIAKFLKP------DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 1000
EAH+ DFG+AK L DS+ W A +YGY+APE AY++K TEK DVYS G++ +
Sbjct: 1097 EAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1154
Query: 1001 EVIKGKHPRD--FISSMSS---SSLNLNI---ALDEMLDPRLPTPSCIVQDKLISIVEVA 1052
E++ GK P D F + M +L + A D+++DP+L +D ++E+A
Sbjct: 1155 EIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIA 1214
Query: 1053 ISCLDENPESRPT 1065
+ C +P+ RP+
Sbjct: 1215 LQCTKTSPQERPS 1227
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 612 bits (1578), Expect = e-174, Method: Compositional matrix adjust.
Identities = 418/1114 (37%), Positives = 574/1114 (51%), Gaps = 109/1114 (9%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLK 61
EE LL +K L N +NG L+SW N ++PC W GI C V S++L + L
Sbjct: 26 EEGRVLLEFKAFL-NDSNG-YLASW---NQLDSNPCNWTGIACTHLRTVTSVDLNGMNLS 80
Query: 62 GMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLS 121
G L L L++ N + G IP + L+ LDL +N F G IP ++ +
Sbjct: 81 GTLSPL-ICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMII 139
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181
LK L L EN L GSIP +IG LSSL L +YSN L +IPPS+ L L + N
Sbjct: 140 TLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGF 199
Query: 182 SDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLR 241
S IPSE SL +L L N GS+P L L NL L L N L IP +GN+
Sbjct: 200 SGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNIS 259
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301
L +L+L N +GSIP +G LT + LYLY N L+G IP E GNL + ++ N+L
Sbjct: 260 RLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQL 319
Query: 302 NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLS 361
G IP G++ NL L++ N L G IP E+G L L L LS N+L+G+IP L +L
Sbjct: 320 TGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
YL LFD N+L G IP +G +N + LD+ NSL
Sbjct: 380 -----YLVDLQLFD-------------------NQLEGKIPPLIGFYSNFSVLDMSANSL 415
Query: 422 SGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLR 481
SG IP+ F ++L LSLG NKLSG+IP L +L L L DN L+GS+P E+ NL+
Sbjct: 416 SGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQ 475
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKL 541
+++ L L+ N LSG+I LG L NL L L NN+ IP E+GNL + + + N+L
Sbjct: 476 NLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQL 535
Query: 542 SGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLA 595
+G IP LG LDLS N G I ELG+L +L L L+ N+L+G++ G L
Sbjct: 536 TGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLT 595
Query: 596 QLEHLDLSSNRLSNSIPKSFGNLVKLHY-LNLSNNQFSRGIPIKLEELIHLSELDLSHNF 654
+L L L N LS +IP G L L LN+S+N S IP L L L L L+ N
Sbjct: 596 RLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNK 655
Query: 655 LREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFR 714
L IP+ I + SL N+S+N+LV G +P++ F+
Sbjct: 656 LSGEIPASIGNLMSLLICNISNNNLV------------------------GTVPDTAVFQ 691
Query: 715 DAPIEALQGNKGLCGDVKGLPSCKTL-------------KSNKQALRKIWVVVVFPLLGI 761
GN GLC + C+ L S +Q + I +V+ +
Sbjct: 692 RMDSSNFAGNHGLCNSQRS--HCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSV--- 746
Query: 762 VALLISLIGLFFKFQRRNNDLQT--QQSSPGNTRGLLSVLTFEGK-IVYEEIIRATNDFD 818
LI+ +GL + +RR Q+ P ++ F K Y+ ++ AT +F
Sbjct: 747 --FLITFLGLCWTIKRREPAFVALEDQTKP----DVMDSYYFPKKGFTYQGLVDATRNFS 800
Query: 819 DEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
++ +G+G G+VYKAE++ GE++AVKK +S G + F E+ L +IRHRNIVK
Sbjct: 801 EDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAEISTLGKIRHRNIVK 859
Query: 879 FYGFCSHV-----------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
YGFC H + SL L L W R + G ++ L Y+H+DC
Sbjct: 860 LYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCR 919
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-SSNWTELAGTYGYVAPELAYTMKV 986
P IVHRDI S N+LLD +AHV DFG+AK + S + + +AG+YGY+APE AYTMKV
Sbjct: 920 PQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKV 979
Query: 987 TEKCDVYSFGVLALEVIKGKHPR-------DFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
TEKCD+YSFGV+ LE+I GK P D ++ + S N+ I EM D RL T
Sbjct: 980 TEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDK 1038
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
++ ++++A+ C +P SRPTM +V ++
Sbjct: 1039 RTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 606 bits (1563), Expect = e-172, Method: Compositional matrix adjust.
Identities = 428/1217 (35%), Positives = 615/1217 (50%), Gaps = 157/1217 (12%)
Query: 2 EEAHALLRWKTS-LQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGR-VNSINLTSIG 59
++ LL K S + N +L W N S C W G+ C GGR + +NL+ +G
Sbjct: 28 DDLQTLLELKNSFITNPKEEDVLRDW---NSGSPSYCNWTGVTC--GGREIIGLNLSGLG 82
Query: 60 LKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSS-NLFFGTIPPEIG 118
L G + S F +L ++DL N+L G IP + N+S NL G IP ++G
Sbjct: 83 LTGSISP-SIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLG 141
Query: 119 HLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178
L LK+L+L +N+LNG+IP G L +L LAL S L LIP G L L TL L D
Sbjct: 142 SLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQD 201
Query: 179 NSLSDSIPSEFGN------------------------LRSLSMLSLGYNKFSGSIPHSLG 214
N L IP+E GN L++L L+LG N FSG IP LG
Sbjct: 202 NELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLG 261
Query: 215 N------------------------LTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
+ L NL TL L +N+L I E + L L L
Sbjct: 262 DLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAK 321
Query: 251 NKLSGSIPHSL-GNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309
N+LSGS+P ++ N T+L L+L E LSG IP+E N +SL +L+L N L G IP SL
Sbjct: 322 NRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSL 381
Query: 310 GNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
L L LY++NNSL G++ S I NL +L L N L G +P +G+L L +YLY
Sbjct: 382 FQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLY 441
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF 429
N +P E+GN L + N+LSG IP S+G L +L L L +N L G+IP+
Sbjct: 442 ENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASL 501
Query: 430 GNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489
GN ++ + L N+LSGSIP S G LT L+ +Y+NSL G++P + NL++++ + +
Sbjct: 502 GNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFS 561
Query: 490 NNKLSGS-----------------------IPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
+NK +GS IP LG +NL L L N IP G
Sbjct: 562 SNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFG 621
Query: 527 NLRSLSMLSFAYNKLSGSIPHSLGV------------------------------LDLSS 556
+ LS+L + N LSG IP LG+ L LSS
Sbjct: 622 KISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSS 681
Query: 557 NHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFG 616
N VG +PTE+ L ++ L L N L+G + ++G+L L L+L N+LS +P + G
Sbjct: 682 NKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIG 741
Query: 617 NLVKLHYLNLSNNQFSRGIPIKLEELIHL-SELDLSHNFLREAIPSQICIMQSLENLNLS 675
L KL L LS N + IP+++ +L L S LDLS+N IPS I + LE+L+LS
Sbjct: 742 KLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLS 801
Query: 676 HNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLP 735
HN LVG +P M L +++SYN L+G + + A +A GN GLCG L
Sbjct: 802 HNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQA--DAFVGNAGLCGSP--LS 857
Query: 736 SCKTLKS-NKQALRKIWVVVVFPL--LGIVALLISLIGLFFK-----FQR-RNNDLQTQQ 786
C S N+++L VV++ + L +AL++ +I LFFK F++ R +
Sbjct: 858 HCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSS 917
Query: 787 SSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKK 846
+S + L S + I +++I+ AT+ ++E IG GG G VYKAEL +GE +AVKK
Sbjct: 918 NSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKK 977
Query: 847 FHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL------------ 894
++ + F EVK L IRHR++VK G+CS L +++
Sbjct: 978 IL--WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDW 1035
Query: 895 ----SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950
N + LGW R+ + G++ + Y+H DC PPIVHRDI S NVLLD + EAH+
Sbjct: 1036 LHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHL 1095
Query: 951 SDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006
DFG+AK L + TE AG+YGY+APE AY++K TEK DVYS G++ +E++ GK
Sbjct: 1096 GDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGK 1155
Query: 1007 HPRDFISSMSSSSLNL----------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCL 1056
P + + + + + A ++++D L + ++ ++E+A+ C
Sbjct: 1156 MPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCT 1215
Query: 1057 DENPESRPTMPKVSQLL 1073
P+ RP+ + S+ L
Sbjct: 1216 KSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1514), Expect = e-166, Method: Compositional matrix adjust.
Identities = 401/1103 (36%), Positives = 571/1103 (51%), Gaps = 86/1103 (7%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNR---GGRVNSINLTSIG 59
E LL K+ + L +W N+ + PC W G+ C+ V S+NL+S+
Sbjct: 30 EGQYLLEIKSKFVDAKQN--LRNWNSND---SVPCGWTGVMCSNYSSDPEVLSLNLSSMV 84
Query: 60 LKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGH 119
L G L S HL LDL +N L G IP +IGN S L+ L L++N F G IP EIG
Sbjct: 85 LSGKLSP-SIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGK 143
Query: 120 LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L L+ L ++ N+++GS+P EIG L SL+ L YSN + +P S+GNL L + N
Sbjct: 144 LVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQN 203
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
+S S+PSE G SL ML L N+ SG +P +G L L+ + L N IP E+ N
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
SL L+L N+L G IP LG+L +L LYLY N L+G+IP E GNL ++ N
Sbjct: 264 CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323
Query: 300 KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGY 359
L G IP LGN+ L LY+ N L+G+IP E+ L++LS L LS N L+G IP Y
Sbjct: 324 ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383
Query: 360 LSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN 419
L L L L+ NSL +IP +LG L +L + N LSG IP L +N+ L+L N
Sbjct: 384 LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443
Query: 420 SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGN 479
+LSG+IP+ ++L L L N L G P +L N+ A+ L N GSIP E+GN
Sbjct: 444 NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503
Query: 480 LRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN 539
++ L L +N +G +P+ +G LS L L + +N L +PSE+ N + L
Sbjct: 504 CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQR------ 557
Query: 540 KLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEH 599
LD+ N+ G +P+E+G L L L L+ N LSG + LG+L++L
Sbjct: 558 ------------LDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTE 605
Query: 600 LDLSSNRLSNSIPKSFGNLVKLHY-LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
L + N + SIP+ G+L L LNLS N+ + IP +L L+ L L L++N L
Sbjct: 606 LQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGE 665
Query: 659 IPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPI 718
IPS + SL N S+NSL G IP R+ +
Sbjct: 666 IPSSFANLSSLLGYNFSYNSLTGPIP---------------------------LLRNISM 698
Query: 719 EALQGNKGLCG--------DVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLIG 770
+ GN+GLCG PS T K KI + + G+ +LI+LI
Sbjct: 699 SSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIV 758
Query: 771 LFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGS 830
+ R Q P + EG +++++ AT++FD+ +G+G G+
Sbjct: 759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGT 817
Query: 831 VYKAELASGEIVAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV-- 886
VYKA L +G +AVKK S G F E+ L IRHRNIVK +GFC+H
Sbjct: 818 VYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGS 877
Query: 887 ---------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937
+ SL IL + + +L W++R + G + L+Y+H+DC P I HRDI S
Sbjct: 878 NLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935
Query: 938 KNVLLDFDNEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 996
N+LLD EAHV DFG+AK + P S + + +AG+YGY+APE AYTMKVTEK D+YS+G
Sbjct: 936 NNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995
Query: 997 VLALEVIKGKHPRDFISS------MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050
V+ LE++ GK P I S + + +LD RL + ++++++
Sbjct: 996 VVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLK 1055
Query: 1051 VAISCLDENPESRPTMPKVSQLL 1073
+A+ C +P +RP+M +V +L
Sbjct: 1056 IALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 570 bits (1470), Expect = e-161, Method: Compositional matrix adjust.
Identities = 384/1099 (34%), Positives = 568/1099 (51%), Gaps = 102/1099 (9%)
Query: 23 LSSWTLNNVTKTSPCAWVGIHCNRGGR--------VNSINLTSIGLKGMLHDFSFSSFPH 74
L +W N +PC W+G++C+ G V S++L+S+ L G++ S +
Sbjct: 55 LHNW---NGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSP-SIGGLVN 110
Query: 75 LAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLN 134
L YL+L +N L G+IP +IGN S+L+ + L++N F G+IP EI LS L++ + N+L+
Sbjct: 111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170
Query: 135 GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRS 194
G +P EIG L +L L Y+N L +P SLGNL+ L T N S +IP+E G +
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254
L +L L N SG +P +G L L + L N IP ++GNL SL L+L N L
Sbjct: 231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314
G IP +GN+ +L LYLY+N L+G+IP E G L + ++ N L+G IP L ++
Sbjct: 291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350
Query: 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF 374
L LY+ N L+G IP+E+ LR+L+ L LS N L+G IPP L+++ L L+ NSL
Sbjct: 351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS 434
IP LG L ++ N+LSG IP + +NL L+L N + G+IP +S
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494
L L + N+L+G P L L NL A+ L N SG +P EIG + + L L N+ S
Sbjct: 471 LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFS 530
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP------HS 548
++P + LSNLV + +NSL IPSE+ N + L L + N GS+P H
Sbjct: 531 SNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQ 590
Query: 549 LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLE-HLDLSSNRL 607
L +L LS N G IP +G L L +L + N SG + P+LG L+ L+ ++LS N
Sbjct: 591 LEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDF 650
Query: 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQ 667
S IP GNL L YL+L+NN S IP E L
Sbjct: 651 SGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENL------------------------S 686
Query: 668 SLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGL 727
SL N S+N+L G +P++ F++ + + GNKGL
Sbjct: 687 SLLGCNFSYNNLT------------------------GQLPHTQIFQNMTLTSFLGNKGL 722
Query: 728 CG--------DVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRN 779
CG P +LK+ +I ++V + GI LLI+++ F +
Sbjct: 723 CGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEP 782
Query: 780 NDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASG 839
P + + E + ++I+ AT F D + +G+G G+VYKA + SG
Sbjct: 783 TAPYVHDKEPFFQESDIYFVPKE-RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSG 841
Query: 840 EIVAVKKFH----SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV--------- 886
+ +AVKK F E+ L +IRHRNIV+ Y FC H
Sbjct: 842 KTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLY 901
Query: 887 ----RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL 942
R SL +L + + + W R + G ++ L+Y+H+DC P I+HRDI S N+L+
Sbjct: 902 EYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILI 960
Query: 943 DFDNEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 1001
D + EAHV DFG+AK + P S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE
Sbjct: 961 DENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLE 1020
Query: 1002 VIKGKHPRD------FISSMSSSSLNLNIALDEMLDPRL-PTPSCIVQDKLISIVEVAIS 1054
++ GK P +++ + + + + E+LDP L ++ + +I++ ++A+
Sbjct: 1021 LLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVL 1080
Query: 1055 CLDENPESRPTMPKVSQLL 1073
C +P RPTM +V +L
Sbjct: 1081 CTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 553 bits (1426), Expect = e-156, Method: Compositional matrix adjust.
Identities = 390/1086 (35%), Positives = 554/1086 (51%), Gaps = 124/1086 (11%)
Query: 30 NVTKTSPCA-WVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGN 88
N +PC W I C+ G + I++ S+ L QL +
Sbjct: 62 NSIDNTPCNNWTFITCSSQGFITDIDIESVPL-----------------------QL--S 96
Query: 89 IPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148
+P + L+ L +S GT+P +G LK L L N L G IP+ + +L +L
Sbjct: 97 LPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLE 156
Query: 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNK-FSG 207
L L SN L IPP + S L +L L+DN L+ SIP+E G L L ++ +G NK SG
Sbjct: 157 TLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISG 216
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
IP +G+ +NL L L S+ ++PS LG L+ L LS+ +SG IP LGN + L
Sbjct: 217 QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276
Query: 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327
L+LYENSLSGSIP E G L L L L N L G IP +GN +NL + + N LSG
Sbjct: 277 VDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSG 336
Query: 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
SIPS IG L L +S NK SGSIP ++ S+L L L N + IPSELG L L
Sbjct: 337 SIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKL 396
Query: 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447
++ N+L GSIP L + T+L LDL NSL+G+IPS LR+L+ L L N LSG
Sbjct: 397 TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSG 456
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
IP +GN ++L L L N ++G IP IG+L+ I+ L ++N+L G +P +G+ S L
Sbjct: 457 FIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSEL 516
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTEL 567
++ L NNSL S+P+ + +L L +L + N+ SG IP S L
Sbjct: 517 QMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPAS------------------L 558
Query: 568 GKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY-LNL 626
G+L L KLIL++N SG + LG + L+ LDL SN LS IP G++ L LNL
Sbjct: 559 GRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNL 618
Query: 627 SNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSC 686
S+N+ + IP K+ L LS LDLSHN L + + ++EN
Sbjct: 619 SSNRLTGKIPSKIASLNKLSILDLSHNMLE----GDLAPLANIEN--------------- 659
Query: 687 FEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSC--------- 737
L+ ++ISYN G +P++ FR + L+GNK LC + SC
Sbjct: 660 ------LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD--SCFLTYRKGNG 711
Query: 738 --------KTLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSP 789
+T K I + VV +LG VA++ + RRN D + S
Sbjct: 712 LGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRA---------RRNID-NERDSEL 761
Query: 790 GNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHS 849
G T + ++IIR + + IGKG G VY+A++ +GE++AVKK
Sbjct: 762 GETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWP 818
Query: 850 PL------PGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI---------- 893
+ + F EVK L IRH+NIV+F G C + L M
Sbjct: 819 AMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS 878
Query: 894 LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953
L + L W R ++ G + L+Y+H+DC PPIVHRDI + N+L+ D E +++DF
Sbjct: 879 LLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADF 938
Query: 954 GIAKFLKPDSSNWTE--LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011
G+AK + +AG+YGY+APE Y+MK+TEK DVYS+GV+ LEV+ GK P D
Sbjct: 939 GLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDP 998
Query: 1012 ISSMS---SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPK 1068
+ N E+LD L + + D+++ ++ A+ C++ +P+ RPTM
Sbjct: 999 TVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKD 1058
Query: 1069 VSQLLK 1074
V+ +LK
Sbjct: 1059 VAAMLK 1064
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 415/1185 (35%), Positives = 593/1185 (50%), Gaps = 133/1185 (11%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKG 62
E +L+ +K SL+N SLLS + N + S C WVG+ C G RVNS++L S+ L+G
Sbjct: 26 ETTSLISFKRSLENP---SLLS--SWNVSSSASHCDWVGVTCLLG-RVNSLSLPSLSLRG 79
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSY 122
+ SS +L L L NQ G IPP+I N+ L+ LDLS N G +P + L
Sbjct: 80 QIPK-EISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQ 138
Query: 123 LKTLQLFENQLNGSIPYEIG-RLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181
L L L +N +GS+P L +L+ L + +N L IPP +G LSNL L++ NS
Sbjct: 139 LLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSF 198
Query: 182 SDSIPSEFGN------------------------LRSLSMLSLGYNKFSGSIPHSLGNLT 217
S IPSE GN L+ L+ L L YN SIP S G L
Sbjct: 199 SGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELH 258
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
NL+ L L + L IP ELGN +SL L L +N LSG +P L + L T N L
Sbjct: 259 NLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIP-LLTFSAERNQL 317
Query: 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337
SGS+PS G + L L L N+ +G IPH + + L L + +N LSGSIP E+
Sbjct: 318 SGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSG 377
Query: 338 SLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397
SL + LSGN LSG+I S+L L L +N + SIP +L L L L L N
Sbjct: 378 SLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDSNNF 436
Query: 398 SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT 457
+G IP SL TNL N L G +P+E GN SL L L N+L+G IP +G LT
Sbjct: 437 TGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLT 496
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
+L L L N G IP E+G+ S++ L L +N L G IP + L+ L L L N+L
Sbjct: 497 SLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNL 556
Query: 518 FDSIPS------------ELGNLRSLSMLSFAYNKLSGSIPHSLGV------LDLSSNHI 559
SIPS +L L+ + +YN+LSG IP LG + LS+NH+
Sbjct: 557 SGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHL 616
Query: 560 VGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLV 619
GEIP L +L L L L+ N L+G + ++G+ +L+ L+L++N+L+ IP+SFG L
Sbjct: 617 SGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLG 676
Query: 620 KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
L LNL+ N+ +P L L L+ +DLS N L + S++ M+ L L + N
Sbjct: 677 SLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKF 736
Query: 680 VGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA------------------------FRD 715
G IPS + L +D+S N L G IP I +D
Sbjct: 737 TGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQD 796
Query: 716 APIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLI------ 769
L GNK LCG V G CK LR W + +LG ++ +
Sbjct: 797 PSKALLSGNKELCGRVVG-SDCKI---EGTKLRSAWGIAGL-MLGFTIIVFVFVFSLRRW 851
Query: 770 GLFFKFQRRNNDLQTQQS-------------SPGNTRGLLSV--LTFEG---KIVYEEII 811
+ + ++R++ + ++S S +R LS+ FE K+ +I+
Sbjct: 852 AMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIV 911
Query: 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
AT+ F ++ IG GG G+VYKA L + VAVKK + +EF+ E++ L ++
Sbjct: 912 EATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE---AKTQGNREFMAEMETLGKV 968
Query: 872 RHRNIVKFYGFCSH-----------VRHSLAMILSNNAAAKD-LGWTRRMNVIKGISDAL 919
+H N+V G+CS V SL L N + L W++R+ + G + L
Sbjct: 969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW-TELAGTYGYVAP 978
+++H+ P I+HRDI + N+LLD D E V+DFG+A+ + S+ T +AGT+GY+ P
Sbjct: 1029 AFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPP 1088
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPR--DFISS-------MSSSSLNLNIALDEM 1029
E + + T K DVYSFGV+ LE++ GK P DF S + +N A+D +
Sbjct: 1089 EYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVD-V 1147
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+DP L S +++ + ++++A+ CL E P RP M V + LK
Sbjct: 1148 IDPLL--VSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 359/986 (36%), Positives = 523/986 (53%), Gaps = 95/986 (9%)
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221
PP++ + ++L L + + +L+ +I SE G+ L ++ L N G IP SLG L NL
Sbjct: 99 PPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQE 158
Query: 222 LYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS-LSGS 280
L L++N L IP ELG+ SL L + N LS ++P LG ++ L ++ NS LSG
Sbjct: 159 LCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGK 218
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLS 340
IP E GN R+L +L L K++G +P SLG L+ L +L +++ LSG IP E+GN L
Sbjct: 219 IPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELI 278
Query: 341 NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400
NL L N LSG++P LG L NL + L+ N+L IP E+G ++SL+ + L N SG+
Sbjct: 279 NLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGT 338
Query: 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLD 460
IP S GNL+NL L L N+++GSIPS N L + N++SG IP +G L L+
Sbjct: 339 IPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELN 398
Query: 461 ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
+ N L G+IP E+ +++ L L+ N L+GS+P L L NL L L +N++
Sbjct: 399 IFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGV 458
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPHSLGVL------DLSSNHIVGEIPTELGKLNFLI 574
IP E+GN SL L N+++G IP +G L DLS N++ G +P E+ L
Sbjct: 459 IPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQ 518
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
L L+ N L G L L SL +L+ LD+SSN L+ IP S G+L+ L+ L LS N F+
Sbjct: 519 MLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGE 578
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLE-NLNLSHNSLVGLIP--------- 684
IP L +L LDLS N + IP ++ +Q L+ LNLS NSL G IP
Sbjct: 579 IPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRL 638
Query: 685 --------------SCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGD 730
S + L+ ++IS+N G +P+S FR ++GN GLC
Sbjct: 639 SVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS- 697
Query: 731 VKGLPSCKTLKSNKQALRK--------------IWVVVVFPLLGIVALLISLIGLFFKFQ 776
KG SC S++ ++ I V V +LG++A++ + +
Sbjct: 698 -KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRA-----KQMI 751
Query: 777 RRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAEL 836
R +ND +T ++ L F + V + ++ + IGKG G VYKAE+
Sbjct: 752 RDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEG-------NVIGKGCSGIVYKAEM 804
Query: 837 ASGEIVAVKKFHS---PLPGEMT----FQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889
+ E++AVKK P E T + F EVK L IRH+NIV+F G C +
Sbjct: 805 PNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTR 864
Query: 890 LAM-----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSK 938
L M +L + LGW R +I G + L+Y+H+DC PPIVHRDI +
Sbjct: 865 LLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKAN 924
Query: 939 NVLLDFDNEAHVSDFGIAKFLK----PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYS 994
N+L+ D E ++ DFG+AK + SSN +AG+YGY+APE Y+MK+TEK DVYS
Sbjct: 925 NILIGPDFEPYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYS 982
Query: 995 FGVLALEVIKGKHPRD-------FISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047
+GV+ LEV+ GK P D I ++ + +D+ L R P V++ ++
Sbjct: 983 YGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQV-IDQGLQAR---PESEVEE-MMQ 1037
Query: 1048 IVEVAISCLDENPESRPTMPKVSQLL 1073
+ VA+ C++ PE RPTM V+ +L
Sbjct: 1038 TLGVALLCINPIPEDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | ||||||
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.981 | 0.939 | 0.480 | 0.0 | |
| 356577797 | 1204 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.882 | 0.456 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.828 | 0.894 | 0.543 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.842 | 0.872 | 0.533 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.843 | 0.878 | 0.537 | 0.0 | |
| 15219699 | 1120 | putative leucine-rich repeat receptor-li | 0.986 | 0.947 | 0.472 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.843 | 0.878 | 0.536 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.841 | 0.872 | 0.527 | 0.0 | |
| 357439013 | 1131 | Receptor protein kinase-like protein [Me | 0.988 | 0.939 | 0.455 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.823 | 0.820 | 0.524 | 0.0 |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 927 bits (2395), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/1104 (48%), Positives = 694/1104 (62%), Gaps = 49/1104 (4%)
Query: 1 MEEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSP----CAWVGIHCNRGGRVNSINLT 56
+ EA+ALL+WK++ N ++ S LSSW N T+P +W G+ CN G + +NLT
Sbjct: 31 IAEANALLKWKSTFTNQSHSSKLSSWV--NDANTNPSFSCTSWYGVFCNSRGSIEKLNLT 88
Query: 57 SIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116
++G DF FSS P+LA +DL N+ G IPPQ GN+S+L Y DLS+N IPP
Sbjct: 89 DNAIEGTFQDFPFSSLPNLASIDLSMNRFSGTIPPQFGNLSKLIYFDLSTNHLTREIPPS 148
Query: 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176
+G+L L L L N L G IP ++G + S+ YL L N L IP SLGNL NL L+L
Sbjct: 149 LGNLKNLTVLDLHHNYLTGVIPPDLGNMESMTYLELSHNKLTGSIPSSLGNLKNLTVLYL 208
Query: 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE 236
Y N L+ IP E GN+ S+ L L NK +GSIP SLGNL NL LYLH+N L IP E
Sbjct: 209 YQNYLTGVIPPELGNMESMIDLELSTNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPE 268
Query: 237 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
LGN+ S+ L L NKL+GSIP SLGNL NL LYLY+N L+G IP E GN+ S++ L+L
Sbjct: 269 LGNMESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLYKNYLTGVIPPELGNMESMTYLDL 328
Query: 297 GYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS 356
NKL G IP SLGNL NL LY+H+N L+G IP E+GNL S+ +L LS NKL+GSIP S
Sbjct: 329 SENKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNLESMIDLELSDNKLTGSIPSS 388
Query: 357 LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDL 416
LG L NL LYL+ N L IP ELGN+ S+ L+L N L+GSIP S GN T L +L L
Sbjct: 389 LGNLKNLTVLYLHHNYLTGVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYL 448
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476
DN LSG+IP N L+ L L N +G +P ++ L L N L G IP
Sbjct: 449 RDNHLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKS 508
Query: 477 IGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSF 536
+ + +S+ NK G+I ++ G +L + L +N I S L L
Sbjct: 509 LRDCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIM 568
Query: 537 AYNKLSGSIP------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590
+ N ++G+IP LG LDLS+N++ GE+P +G L L KL+L N+LSG++
Sbjct: 569 SNNNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTG 628
Query: 591 LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650
L L LE LDLSSNR S+ IP++F + +KLH +NLS N F IP L +L L+ LDL
Sbjct: 629 LSFLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIP-GLTKLTQLTHLDL 687
Query: 651 SHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNS 710
SHN L IPSQ+ +QSL+ LNLSHN+L G IP+ FE M L IDIS N+L+GP+P++
Sbjct: 688 SHNQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDN 747
Query: 711 IAFRDAPIEALQGNKGLCGDV--KGLPSCKTL-KSNKQALRKIWVVVVFPLLGIVALLIS 767
AF++A +AL+GN+GLC ++ + L SC+ K K +W++V P+LG + +L
Sbjct: 748 PAFQNATSDALEGNRGLCSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVILSI 805
Query: 768 LIGLFFKFQR-------RNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDE 820
G F + R RN D +T ++ +S+ + +GK Y++II +TN+FD
Sbjct: 806 CAGAFTYYIRKRKPHNGRNTDSETGEN--------MSIFSVDGKFKYQDIIESTNEFDQR 857
Query: 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIV 877
+ IG GG VYKA L IVAVK+ H + E++ +QEFLNEV+ALTEIRHRN+V
Sbjct: 858 YLIGSGGYSKVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVV 916
Query: 878 KFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
K +GFCSH RH SL +L+N AK L WT+R+N++KG++ ALSYMH+D
Sbjct: 917 KLFGFCSHRRHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDR 976
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 986
PIVHRDISS N+LLD D A +SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKV
Sbjct: 977 STPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKV 1036
Query: 987 TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046
TEKCDVYSFGVL LEVI GKHP D ++S+SSS ++L + D R+ P ++KLI
Sbjct: 1037 TEKCDVYSFGVLILEVIMGKHPGDLVASLSSSP-GETLSLRSISDERILEPRGQNREKLI 1095
Query: 1047 SIVEVAISCLDENPESRPTMPKVS 1070
+VEVA+SCL +P+SRPTM +S
Sbjct: 1096 KMVEVALSCLQADPQSRPTMLSIS 1119
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 534/1169 (45%), Positives = 716/1169 (61%), Gaps = 107/1169 (9%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKG 62
EA+ALL+WK+SL N + SL SSW+ NN PC W+GI C+ V++INLT++GL+G
Sbjct: 36 EANALLKWKSSLDNQSRASL-SSWSGNN-----PCIWLGIACDEFNSVSNINLTNVGLRG 89
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSY 122
L + +FS P++ L++ HN L G IPPQIG++S+L LDLS N G IP IG+LS
Sbjct: 90 TLQNLNFSLLPNILTLNMSHNSLNGTIPPQIGSLSKLARLDLSDNFLSGEIPSTIGNLSN 149
Query: 123 LKTLQLFE------------------------NQLNGSIPYEIGRLSSLNYLALYSNYLE 158
L L ++ N+L+GSIP+ IG LS L+ L++YSN L
Sbjct: 150 LYYLSFYDNSLSGAIPSSIGNLVNLDSMILHKNKLSGSIPFIIGNLSKLSVLSIYSNELT 209
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTN 218
IP S+GNL N+D+L LY+N LS SIP GNL LS L + N+ +G IP S+GNL N
Sbjct: 210 GPIPTSIGNLVNMDSLLLYENKLSGSIPFTIGNLSKLSGLYISLNELTGPIPASIGNLVN 269
Query: 219 LATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS 278
L + L N L SIP +GNL LS LS+ N+L+G IP S+GNL NL ++ L++N LS
Sbjct: 270 LEAMRLFKNKLSGSIPFNIGNLSKLSKLSIHSNELTGPIPASIGNLVNLDSMILHKNKLS 329
Query: 279 GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338
GSIP GNL S+L++ +N+L G IP S+GNL +L +L + N LSGSIP IGNL
Sbjct: 330 GSIPFIIGNLSKFSVLSISFNELTGPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSK 389
Query: 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
LS L +S N+L+G IP S+G L NL + L+ N L SIP +GNL LS LS+ N+L+
Sbjct: 390 LSGLYISLNELTGPIPASIGNLVNLEAMRLFKNKLSGSIPFTIGNLSKLSKLSIHSNELT 449
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
G IP S+GNL +L +L L +N LSGSIP GNL LS LS+ N+L+GSIP ++GNL+N
Sbjct: 450 GPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSKLSVLSISLNELTGSIPSTIGNLSN 509
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ------------------- 499
+ L+ N L G IP E+ L ++ +L L +N G +PQ
Sbjct: 510 VRELFFIGNELGGKIPIEMSMLTALESLQLADNNFIGHLPQNICIGGTLKNFTAGDNNFI 569
Query: 500 -----------------------------SLGNLSNLVILYLYNNSLFDSIPSELGNLRS 530
+ G L NL + L +N+ + + G RS
Sbjct: 570 GPIPVSLKNCSSLIRVRLQRNQLTGDITDAFGVLPNLDYIELSDNNFYGQLSPNWGKFRS 629
Query: 531 LSMLSFAYNKLSGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS 584
L+ L + N LSG IP L L LSSNH+ G IP +L L L L L N L+
Sbjct: 630 LTSLRISNNNLSGVIPPELAGATKLQRLQLSSNHLTGNIPHDLCNLP-LFDLSLDNNNLT 688
Query: 585 GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIH 644
G + ++ S+ +L+ L L SN+LS IPK GNL+ L ++LS N F IP +L +L
Sbjct: 689 GNVPKEIASMQKLQILKLGSNKLSGLIPKQLGNLLNLWNMSLSQNNFQGNIPSELGKLKS 748
Query: 645 LSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L+ LDL N LR IPS ++SLE LNLSHN+L G + S F+ M L IDISYN+ +
Sbjct: 749 LTSLDLGGNSLRGTIPSMFGELKSLETLNLSHNNLSGNL-SSFDDMTSLTSIDISYNQFE 807
Query: 705 GPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTL--KSNKQALRKIWVVVVFPLLGIV 762
GP+PN +AF +A IEAL+ NKGLCG+V GL C T KS+ +K+ +V++ LGI+
Sbjct: 808 GPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMRKKVMIVILPLTLGIL 867
Query: 763 ALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHC 822
L + G+++ + + + + Q +S T + ++ +F+GK+V+E II AT DFDD+H
Sbjct: 868 ILALFAFGVWYHLCQTSTNKEDQATSI-QTPNIFAIWSFDGKMVFENIIEATEDFDDKHL 926
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
IG GGQG VYKA L +G++VAVKK HS GEM + F E++ALTEIRHRNIVK YGF
Sbjct: 927 IGVGGQGCVYKAVLPTGQVVAVKKLHSVPNGEMLNLKAFTCEIQALTEIRHRNIVKLYGF 986
Query: 883 CSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
CSH + S + L ++ A W +R+NV+K +++AL YMH++C P IV
Sbjct: 987 CSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDVANALCYMHHECSPRIV 1046
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCD 991
HRDISSKNVLLD + AHVSDFG AKFL PDSSNWT GT+GY APELAYTM+V EKCD
Sbjct: 1047 HRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGYAAPELAYTMEVNEKCD 1106
Query: 992 VYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA--LDEM-----LDPRLPTPSCIVQDK 1044
VYSFGVLA E++ GKHP D ISS+ SS + +A LD M LDPRLP P+ + +
Sbjct: 1107 VYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMALMDKLDPRLPHPTKPIGKE 1166
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ SI ++A++CL E+P SRPTM +V+ L
Sbjct: 1167 VASIAKIAMACLTESPRSRPTMEQVANEL 1195
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/916 (54%), Positives = 620/916 (67%), Gaps = 25/916 (2%)
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG 238
N+LS IP + G L L L L N+FSG IP +G LTNL L+L N L SIP E+G
Sbjct: 81 NNLSGPIPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIG 140
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
L SL L+L N+L GSIP SLGNL+NLA LYLYEN LS SIP E GNL +L +
Sbjct: 141 QLASLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDT 200
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
N L G IP + GNL L LY+ NN LSG IP EIGNL+SL L L N LSG IP SLG
Sbjct: 201 NNLIGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLG 260
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
LS L L+LY+N L IP E+GNL+SL L L N+L+GSIP SLGNLTNL TL L D
Sbjct: 261 DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRD 320
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
N LSG IP E G L L L + N+L GS+P + +L+ + DN LSG IP +
Sbjct: 321 NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLK 380
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
N ++++ N+L+G+I + +G+ NL + + NS + G L L A+
Sbjct: 381 NCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAW 440
Query: 539 NKLSGSIPHSLGV------LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
N ++GSIP G+ LDLSSNH+ GEIP ++G + L KLIL NQLSG + P+LG
Sbjct: 441 NNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELG 500
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
SLA L +LDLS+NRL+ SIP+ G+ + L+YLNLSNN+ S GIP+++ +L HLS+LDLSH
Sbjct: 501 SLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSH 560
Query: 653 NFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
N L IP QI +QSLENLNLSHN+L G IP FE+M GL +DISYN+LQGPIPNS A
Sbjct: 561 NLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKA 620
Query: 713 FRDAPIEALQGNKGLCGDVKGLPSCKTLKS-NKQALR---KIWVVVVFPLLGIVALLISL 768
FRDA IEAL+GNKGLCG+VK L CK ++Q ++ K+ +++FPLLG + LL +
Sbjct: 621 FRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 680
Query: 769 IGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQ 828
IG+F RR + ++ N L S+ TF+G+ +YEEII+AT DFD +CIGKGG
Sbjct: 681 IGIFLIAARRERTPEIKEGEVQND--LFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGH 738
Query: 829 GSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888
GSVYKAEL S IVAVKK H P EM Q++FLNE++ALTEI+HRNIVK GFCSH RH
Sbjct: 739 GSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRH 797
Query: 889 -----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937
SLA ILS A K LGW R+N+IKG++ AL+YMH+DC PPIVHRDISS
Sbjct: 798 KFLVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISS 856
Query: 938 KNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 997
N+LLD EAH+SDFG AK LK DSSN + LAGT+GY+APELAYTMKVTEK DV+SFGV
Sbjct: 857 NNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGV 916
Query: 998 LALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLD 1057
+ALEVIKG+HP D I S+S S NIAL++MLDPRLP + + ++I+I++ A CL
Sbjct: 917 IALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLK 976
Query: 1058 ENPESRPTMPKVSQLL 1073
NP+SRPTM VSQ+L
Sbjct: 977 ANPQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/931 (53%), Positives = 623/931 (66%), Gaps = 25/931 (2%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S + NL + + N+LS IP + G L L L L N+FSG IP +G LTNL L+
Sbjct: 108 SFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLH 167
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L N L SIP E+G L SL L+L N+L GSIP SLGNL+NLA+LYLYEN LSGSIP
Sbjct: 168 LVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 227
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
E GNL +L + N L G IP + GNL L LY+ NNSLSG IP EIGNL+SL L
Sbjct: 228 EMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELS 287
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
L N LSG IP SL LS L L+LY+N L IP E+GNL+SL L L N+L+GSIP
Sbjct: 288 LYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPT 347
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
SLGNLTNL L L DN LSG IP E G L L L + N+L GS+P + +L
Sbjct: 348 SLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFA 407
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
+ DN LSG IP + N R+++ N+L+G+I + +G+ NL + L N +
Sbjct: 408 VSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSH 467
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHSLGV------LDLSSNHIVGEIPTELGKLNFLIKLI 577
G L L A N ++GSIP G+ LDLSSNH+VGEIP ++G L L+ LI
Sbjct: 468 NWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLI 527
Query: 578 LAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPI 637
L NQLSG + P+LGSL+ LE+LDLS+NRL+ SIP+ G+ + LHYLNLSNN+ S GIP+
Sbjct: 528 LNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPV 587
Query: 638 KLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRID 697
++ +L HLS+LDLSHN L IP QI +QSLE L+LSHN+L G IP FE M L +D
Sbjct: 588 QMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVD 647
Query: 698 ISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCK-TLKSNKQALR---KIWVV 753
ISYN+LQGPIP+S AFR+A IE L+GNK LCG+VKGL CK ++Q ++ K+ +
Sbjct: 648 ISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFI 707
Query: 754 VVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRA 813
++FPLLG + LL + IG+F +RR + ++ N L S+ F+G+ +YEEII+A
Sbjct: 708 IIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQND--LFSISNFDGRTMYEEIIKA 765
Query: 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
T DFD +CIGKGG GSVYKAEL S IVAVKK H P EM Q++FLNE++ALTEI+H
Sbjct: 766 TKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKH 824
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
RNIVK GFCSH RH SLA ILS A K LGW R+N+IKG++ AL+YM
Sbjct: 825 RNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYM 883
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+DC PPIVHRD+SS N+LLD EAH+SDFG AK LK DSSN + LAGT+GY+APELAY
Sbjct: 884 HHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAY 943
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
TMKVTEK DV+SFGV+ALEVIKG+HP D I S+S S NIAL++MLDPRLP + +
Sbjct: 944 TMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDE 1003
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
++I+I++ AI CL NP+SRPTM VSQ+L
Sbjct: 1004 GEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2289), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/927 (53%), Positives = 623/927 (67%), Gaps = 20/927 (2%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S + NL + N LS IP + G L L L L N+FSG IP +G LTNL L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L N L SIP E+G L+SL LSL NKL GSIP SLGNL+NL LYL EN LSG IP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
E GNL L L L N L G IP +LGNL +L L ++NN LSG IP+EIGNL+ L NL
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
LS N LSG IP SLG LS L +L L+ N L IP E+GNLRSL L + N+L+GSIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
SLGNL NL L L DN LS SIP E G L L L + N+LSG +P + +L+
Sbjct: 345 SLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
++DN L G IP + N S++ L N+L+G+I ++ G NL + L NN + +
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFLIKLI 577
G L L A N ++GSIP G VL+LSSNH+VGEIP +LG ++ L KLI
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLI 524
Query: 578 LAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPI 637
L N+LSG + P+LGSLA L +LDLS NRL+ SIP+ GN + L+YLNLSNN+ S GIP+
Sbjct: 525 LNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPV 584
Query: 638 KLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRID 697
++ +L HLS LDLSHN L IPSQI +QSLE LNLSHN+L G+IP FE MHGL ++D
Sbjct: 585 QMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVD 644
Query: 698 ISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFP 757
ISYN+LQG IPNS AF++ IE LQGNKGLCG VKGL C+ +S + K +++F
Sbjct: 645 ISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCEN-RSATKGTHKAVFIIIFS 703
Query: 758 LLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDF 817
LLG + +L + IG+ Q R N + +++ T L S+ TF+G+ YE II AT DF
Sbjct: 704 LLGALLILSAFIGISLISQGRRNA-KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDF 762
Query: 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
D +CIG+GG GSVYKAEL SG IVAVKK H +M Q++F+NE++ALTEI+HRNIV
Sbjct: 763 DPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIV 821
Query: 878 KFYGFCSHVRHS-----------LAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
K GFCSH RHS L ILS AK++GW R+N+IKG++ ALSY+H+DC
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDC 881
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 986
PPIVHRDISS NVLLD EAHVSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 987 TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046
TEKCDVYSFGVLALEV++G+HP D ISS+S+S N+ L ++LDPRLP P+ + +++
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVM 1001
Query: 1047 SIVEVAISCLDENPESRPTMPKVSQLL 1073
S++++A +CL+ +P+SRPTM VSQ+L
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219699|ref|NP_174809.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] gi|75175345|sp|Q9LP24.1|Y1571_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At1g35710; Flags: Precursor gi|8778966|gb|AAF79881.1|AC021198_1 Contains similarity to receptor protein kinase-like protein from Arabidopsis thaliana gb|AL161513. It contains a eukaryotic protein kinase domain PF|00069. EST gb|AI997574 comes from this gene [Arabidopsis thaliana] gi|332193703|gb|AEE31824.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2281), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/1095 (47%), Positives = 690/1095 (63%), Gaps = 34/1095 (3%)
Query: 1 MEEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTS-PC-AWVGIHCNRGGRVNSINLTSI 58
+ EA+ALL+WK++ N S LSSW + T TS C +W G+ CN G + +NLT+
Sbjct: 31 IAEANALLKWKSTF---TNSSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNT 87
Query: 59 GLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIG 118
G++G DF F S +LAY+DL N L G IPPQ GN+S+L Y DLS+N G I P +G
Sbjct: 88 GIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLG 147
Query: 119 HLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178
+L L L L +N L IP E+G + S+ LAL N L IP SLGNL NL L+LY+
Sbjct: 148 NLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYE 207
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG 238
N L+ IP E GN+ S++ L+L NK +GSIP +LGNL NL LYL+ N L IP E+G
Sbjct: 208 NYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIG 267
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
N+ S++ L+L NKL+GSIP SLGNL NL L L++N L+G IP + GN+ S+ L L
Sbjct: 268 NMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSN 327
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
NKL G IP SLGNL NL LY++ N L+G IP E+GN+ S+ +L L+ NKL+GSIP S G
Sbjct: 328 NKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L NL LYLY N L IP ELGN+ S+ L L NKL+GS+P S GN T L +L L
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRV 447
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
N LSG+IP N L+TL L N +G P ++ L + L N L G IP +
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLR 507
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
+ +S+ NK +G I ++ G +L + +N I S L L +
Sbjct: 508 DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSN 567
Query: 539 NKLSGSIP------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
N ++G+IP L LDLS+N++ GE+P +G L L +L L NQLSG++ L
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
L LE LDLSSN S+ IP++F + +KLH +NLS N+F IP +L +L L++LDLSH
Sbjct: 628 FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSH 686
Query: 653 NFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
N L IPSQ+ +QSL+ L+LSHN+L GLIP+ FE M L +DIS N+L+GP+P++
Sbjct: 687 NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPT 746
Query: 713 FRDAPIEALQGNKGLCGDV--KGLPSCKTLKS-NKQALRKIWVVVVFPLLGIVALLISLI 769
FR A +AL+ N GLC ++ + L C+ LK K +W++V P+LG++ +L S+
Sbjct: 747 FRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SIC 803
Query: 770 GLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQG 829
F + R LQ +++ T +S+ + +GK Y++II +TN+FD H IG GG
Sbjct: 804 ANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYS 863
Query: 830 SVYKAELASGEIVAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886
VY+A L I+AVK+ H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH
Sbjct: 864 KVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHR 922
Query: 887 RH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDI 935
RH SL +L+N+ AK L WT+R+NV+KG++ ALSYMH+D PIVHRDI
Sbjct: 923 RHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDI 982
Query: 936 SSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSF 995
SS N+LLD D A +SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSF
Sbjct: 983 SSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSF 1042
Query: 996 GVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISC 1055
GVL LE+I GKHP D +SS+SSS ++L + D R+ P ++KL+ +VE+A+ C
Sbjct: 1043 GVLILELIIGKHPGDLVSSLSSSP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLC 1101
Query: 1056 LDENPESRPTMPKVS 1070
L NPESRPTM +S
Sbjct: 1102 LQANPESRPTMLSIS 1116
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2277), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/927 (53%), Positives = 620/927 (66%), Gaps = 20/927 (2%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S + NL + N LS IP + G L L L L N+FSG IP +G LTNL L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L N L SIP E+G L+SL LSL NKL G+IP SLGNL+NL LYL EN LSG IP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
E GNL L L L N L G IP +LGNL +L L ++NN LSG IP+EIGNL+ L NL
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
LS N LSG IP SLG LS L +L L+ N L IP E+GNLRSL L + N+L+GSIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
LGNL NL L L DN LS SIP E G L L L + N+LSG +P + +L+
Sbjct: 345 LLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
++DN L G IP + N S++ L N+L+G+I ++ G NL + L NN + +
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFLIKLI 577
G L L A N ++GSIP G VL+LSSNH+VGEIP +LG ++ L KLI
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLI 524
Query: 578 LAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPI 637
L N+LSG + P+LGSLA L +LDLS NRL+ SIP+ GN + L+YLNLSNN+ S GIP+
Sbjct: 525 LNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPV 584
Query: 638 KLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRID 697
++ +L HLS LDLSHN L IPSQI +QSLE LNLSHN+L G+IP FE MHGL ++D
Sbjct: 585 QMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVD 644
Query: 698 ISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFP 757
ISYN+LQG IPNS AF++ IE LQGNKGLCG VKGL C+ +S + K +++F
Sbjct: 645 ISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCEN-RSATKGTHKAVFIIIFS 703
Query: 758 LLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDF 817
LLG + +L + IG+ Q R N + +++ T L S+ TF+G+ YE II AT DF
Sbjct: 704 LLGALLILSAFIGISLISQGRRNA-KMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDF 762
Query: 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
D +CIG+GG GSVYKAEL SG IVAVKK H +M Q++F+NE++ALTEI+HRNIV
Sbjct: 763 DPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIV 821
Query: 878 KFYGFCSHVRHS-----------LAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
K GFCSH RHS L ILS AK++GW R+N+IKG+S ALSY+H+DC
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDC 881
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 986
PPIVHRDISS NVLLD EAHVSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 987 TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046
TEKCDVYSFGVLALEV++G+HP D ISS+S S N+ L ++LDPRLP P+ + ++
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVT 1001
Query: 1047 SIVEVAISCLDENPESRPTMPKVSQLL 1073
S++++A +CL+ +P+SRPTM VSQ+L
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/931 (52%), Positives = 626/931 (67%), Gaps = 26/931 (2%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S + NL + + N+LS IP + G L L L L N+FSG IP +G LTNL L+
Sbjct: 108 SFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLDLSINQFSGGIPPEIGLLTNLEVLH 167
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L N L SIP E+G L SL L+L N+L GSIP SLGNL+NLA+LYLYEN LSGSIP
Sbjct: 168 LVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 227
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
E GNL +L L N L G IP + GNL +L LY+ NNSLSG IP EIGNL+SL L
Sbjct: 228 EMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLYLFNNSLSGPIPPEIGNLKSLQGLS 287
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
L GN LSG IP SL LS L L+LY+N L IP E+GNL+SL L L N+L+GSIP
Sbjct: 288 LYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPT 347
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
SLGNLTNL L L DN LSG P E G L L L + N+L GS+P + +L+
Sbjct: 348 SLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFT 407
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
+ DN LSG IP + N R+++ N+L+G++ + +G+ NL + L N +
Sbjct: 408 VSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSH 467
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHSLGV------LDLSSNHIVGEIPTELGKLNFLIKLI 577
G L L A N ++GSIP G+ LDLSSNH+VGEIP ++G L L+ LI
Sbjct: 468 NWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLI 527
Query: 578 LAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPI 637
L NQLSG + P+LGSL+ LE+LDLS+NRL+ SIP+ G+ + LHYLNLSNN+ S GIP+
Sbjct: 528 LNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPV 587
Query: 638 KLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRID 697
++ +L HLS+LDLSHN L IP+QI ++SLE L+LSHN+L G IP FE M L +D
Sbjct: 588 QMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVD 647
Query: 698 ISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCK-TLKSNKQALR---KIWVV 753
ISYN+LQGPIP+S AFR+A IE L+GNK LCG+VKGL CK ++Q ++ K+ +
Sbjct: 648 ISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFI 707
Query: 754 VVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRA 813
++FPLLG + LL + IG+F +RR + ++ N LLS+ TF+G+ +YEEII+A
Sbjct: 708 IIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNN--LLSISTFDGRAMYEEIIKA 765
Query: 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
T DFD +CIGKGG GSVYKAEL SG IVAVKK H P +M Q++FLN+V+A+TEI+H
Sbjct: 766 TKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKH 824
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
RNIV+ GFCS+ RH SLA ILS A K LGW R+ +IKG++ ALSYM
Sbjct: 825 RNIVRLLGFCSYPRHSFLVYEYLERGSLATILSREEAKK-LGWATRVKIIKGVAHALSYM 883
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+DC PPIVHRDISS N+LLD EAH+S+ G AK LK DSSN ++LAGT GYVAPE AY
Sbjct: 884 HHDCSPPIVHRDISSNNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAY 943
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
TMKVTEK DVYSFGV+ALEVIKG+HP D I S+S S NI L +MLDPRLP + +
Sbjct: 944 TMKVTEKTDVYSFGVIALEVIKGRHPGDQILSISVSP-EKNIVLKDMLDPRLPPLTPQDE 1002
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
++++I+++A +CL+ NP+SRPTM +SQ+L
Sbjct: 1003 GEVVAIIKLATACLNANPQSRPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439013|ref|XP_003589783.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355478831|gb|AES60034.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 878 bits (2269), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/1097 (45%), Positives = 692/1097 (63%), Gaps = 34/1097 (3%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCA-WVGIHCN-RGGRVNSINLTSIGL 60
EA ALL+WK SL NH+N +LLSSW NN PC+ W GI C+ + +N +NLT IGL
Sbjct: 36 EADALLKWKASLDNHSN-ALLSSWIGNN-----PCSSWEGITCDYKSKSINKVNLTDIGL 89
Query: 61 KGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHL 120
KG L +FSS + L L +N LYG +P IG +S LK LDLS N GTIP IG+L
Sbjct: 90 KGTLQSLNFSSLTKIHTLVLTNNFLYGVVPHHIGEMSSLKTLDLSVNNLSGTIPNSIGNL 149
Query: 121 SYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
S + L L N L G IP+EI +L SL +L++ +N L IP +GNL NL+ L + N+
Sbjct: 150 SKISYLDLSFNYLTGIIPFEITQLVSLYFLSMATNQLIGHIPREIGNLVNLERLDIQLNN 209
Query: 181 LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNL 240
L+ S+P E G L L+ L L N SG+IP ++GNL+NL LYL+ N L SIPSE+GNL
Sbjct: 210 LTGSVPQEIGFLTKLAELDLSANYLSGTIPSTIGNLSNLHWLYLYQNHLMGSIPSEVGNL 269
Query: 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK 300
SL + L N LSG IP S+GNL NL ++ L N LSG IP G L +L ++L NK
Sbjct: 270 YSLFTIQLLGNHLSGPIPSSIGNLVNLNSIRLDHNDLSGEIPISIGKLVNLDTIDLSDNK 329
Query: 301 LNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
++G +P ++GNLT L LY+ +N+L+G IP IGNL +L + LS NKLS IP ++G L
Sbjct: 330 ISGPLPSTIGNLTKLTVLYLSSNALTGQIPPSIGNLVNLDTIDLSENKLSRPIPSTVGNL 389
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420
+ ++ L L+SN+L +P +GN+ +L + L NKLSG IP ++GNLT L +L L+ NS
Sbjct: 390 TKVSILSLHSNALTGQLPPSIGNMVNLDTIYLSENKLSGPIPSTIGNLTKLNSLSLFSNS 449
Query: 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480
L+G+IP N+ +L +L L N +G +P ++ L +N +G IP +
Sbjct: 450 LTGNIPKVMNNIANLESLQLASNNFTGHLPLNICAGRKLTKFSASNNQFTGPIPKSLKKC 509
Query: 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK 540
S+ + L N+++ +I + G NL + L +N+ + I G ++L+ L + N
Sbjct: 510 SSLIRVRLQQNQITDNITDAFGVYPNLDYMELSDNNFYGHISPNWGKCKNLTSLQISNNN 569
Query: 541 LSGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSL 594
L+GSIP LG L+LSSNH+ G+IP ELG L+ LIKL ++ N L G++ ++ SL
Sbjct: 570 LTGSIPQELGGATQLQELNLSSNHLTGKIPEELGNLSLLIKLSISNNNLLGEVPVQIASL 629
Query: 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNF 654
L L+L N LS IP+ G L +L +LNLS N+F IP++ ++L + +LDLS N
Sbjct: 630 QALTALELEKNNLSGFIPRRLGRLSELIHLNLSQNKFEGNIPVEFDQLKVIEDLDLSENV 689
Query: 655 LREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFR 714
+ IPS + + L+ LNLSHN+L G IP + +M L +DISYN+L+GPIP+ AF+
Sbjct: 690 MSGTIPSMLGQLNHLQTLNLSHNNLSGTIPLSYGEMLSLTIVDISYNQLEGPIPSITAFQ 749
Query: 715 DAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLI--GLF 772
APIEAL+ NKGLCG+V GL C T N + + ++V+ L + LL++ G+
Sbjct: 750 KAPIEALRNNKGLCGNVSGLVCCSTSGGNFHSHKTSNILVLVLPLTLGTLLLAFFAYGIS 809
Query: 773 FKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVY 832
+ F + ++ + + T L ++ +F+GK+VYE II AT DFD++H IG GG GSVY
Sbjct: 810 YLFCQTSSTKEDNHAEEFQTENLFAIWSFDGKMVYETIIEATEDFDNKHLIGVGGHGSVY 869
Query: 833 KAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892
KAEL +G++VAVKK HS EM+ + F NE+ AL EIRHRNIVK YGFCSH HS +
Sbjct: 870 KAELPTGQVVAVKKLHSLQNEEMSNLKAFTNEIHALKEIRHRNIVKLYGFCSHRLHSFLV 929
Query: 893 -----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVL 941
IL +N A + W RR+NVIK I++AL Y+H+DC PPIVHRDISSKNV+
Sbjct: 930 YEFLEKGSMDNILKDNEQAAEFDWNRRVNVIKDIANALCYLHHDCSPPIVHRDISSKNVI 989
Query: 942 LDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 1001
LD + AHVSDFG +KFL P+SSN T AGT+GY APELAYTM+V EKCDVYSFG+L LE
Sbjct: 990 LDLEYVAHVSDFGTSKFLNPNSSNMTSFAGTFGYAAPELAYTMEVNEKCDVYSFGILTLE 1049
Query: 1002 VIKGKHPRDFISSM--SSSSLNLNIALDEM-----LDPRLPTPSCIVQDKLISIVEVAIS 1054
++ GKHP D ++S+ S +++ LD M LD RLP P+ + ++ S+V +A++
Sbjct: 1050 ILFGKHPGDVVTSLWKQPSQSVIDVTLDTMPLIERLDQRLPHPTNTIVQEVASVVRIAVA 1109
Query: 1055 CLDENPESRPTMPKVSQ 1071
CL E+ SRPTM V +
Sbjct: 1110 CLAESLRSRPTMEHVCK 1126
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2218), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/931 (52%), Positives = 608/931 (65%), Gaps = 46/931 (4%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S + NL + + N+LS IP + G L L L L N+FSG IP +G LTNL L+
Sbjct: 136 SFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLDLSTNQFSGGIPPEIGLLTNLEVLH 195
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L L+L N+L GSIP SLGNL+NLA+LYLYEN LSGSIP
Sbjct: 196 L---------------------LALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 234
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
E GNL +L + N L G+IP + GNL L TLY+ NN LSG IP EIGNL SL +
Sbjct: 235 EMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQGIS 294
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
L N LSG IP SLG LS L L+LY+N L IP E+GNL+SL L L N+L+GSIP
Sbjct: 295 LYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSIPT 354
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
SLGNLTNL L L DN LSG P E G L L L + N+LSGS+P + +L
Sbjct: 355 SLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVRFT 414
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
+ DN LSG IP + N R+++ N+L+G+I + +G+ NL + L N +
Sbjct: 415 VSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGELSH 474
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHSLGV------LDLSSNHIVGEIPTELGKLNFLIKLI 577
G L L A N ++GSIP G+ LDLSSNH+VGEIP ++G L L++L
Sbjct: 475 NWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLELK 534
Query: 578 LAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPI 637
L NQLSG + P+LGSL L HLDLS+NRL+ SI ++ G + LHYLNLSNN+ S IP
Sbjct: 535 LNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRIPA 594
Query: 638 KLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRID 697
++ +L HLS+LDLSHN L IP QI ++SLENLNLSHN+L G IP FE+M GL ID
Sbjct: 595 QMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSDID 654
Query: 698 ISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLK-SNKQALR---KIWVV 753
ISYN+LQGPIPNS AFRDA IE L+GNK LCG+VKGL CK + +Q ++ KI +
Sbjct: 655 ISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFI 714
Query: 754 VVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRA 813
+VFPLLG + LL + IG+F +R + ++ N L S+ TF+G+ +YEEII+A
Sbjct: 715 IVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQND--LFSISTFDGRAMYEEIIKA 772
Query: 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
T DFD +CIGKGG GSVYKAEL+SG IVAVKK ++ +M Q++F NEV+ALTEI+H
Sbjct: 773 TKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYAS-DIDMANQRDFFNEVRALTEIKH 831
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
RNIVK GFCSH RH SLA +LS A K LGW R+N+IKG++ ALSYM
Sbjct: 832 RNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEAKK-LGWATRINIIKGVAHALSYM 890
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+DC PPIVHRDISS N+LLD E H+SDFG AK LK DSSN + LAGT+GYVAPE AY
Sbjct: 891 HHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAY 950
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
TMKVTEK DVYSFGV+ LEVIKG+HP D I S+S S NI L++MLDPRLP + +
Sbjct: 951 TMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLDPRLPPLTAQDE 1010
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
++ISI+ +A +CL NPESRPTM +SQ+L
Sbjct: 1011 GEVISIINLATACLSVNPESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1075 | ||||||
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.909 | 0.873 | 0.417 | 2.1e-194 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.826 | 0.849 | 0.421 | 5.4e-182 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.753 | 0.648 | 0.362 | 2.4e-166 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.746 | 0.713 | 0.344 | 8e-155 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.931 | 0.908 | 0.361 | 3.4e-148 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.747 | 0.674 | 0.338 | 4.2e-145 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.896 | 0.875 | 0.365 | 6.6e-145 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.584 | 0.553 | 0.389 | 2.4e-140 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.881 | 0.830 | 0.351 | 5.4e-134 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.962 | 0.826 | 0.327 | 5.7e-130 |
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1883 (667.9 bits), Expect = 2.1e-194, P = 2.1e-194
Identities = 425/1019 (41%), Positives = 584/1019 (57%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
F + L Y DL N L G I P +GN+ L L L N IP E+G++ + L L
Sbjct: 122 FGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLAL 181
Query: 129 FENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
+N+L GSIP +G +IPP LGN+ ++ L L N L+ SIPS
Sbjct: 182 SQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPST 241
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
GNL++L +L L N +G IP +GN+ ++ L L N L SIPS LGNL++L++LSL
Sbjct: 242 LGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSL 301
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308
N L+G IP LGN+ ++ L L N L+GSIPS GNL++L++L L N L G+IP
Sbjct: 302 FQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPE 361
Query: 309 LGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPPSLGYLSNLATLYL 368
LGN+ ++ L ++NN L+GSIPS IP LG + ++ L L
Sbjct: 362 LGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDL 421
Query: 369 YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428
N L S+P GN L L L N LSG+IP + N ++L TL L N+ +G P
Sbjct: 422 SQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPET 481
Query: 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488
R L +SL YN L G IP SL + +L N +G I G ++ +
Sbjct: 482 VCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDF 541
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHS 548
++NK G I + L L + NN++ +IP+E+ N+ L L
Sbjct: 542 SHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVEL-------------- 587
Query: 549 LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLS 608
DLS+N++ GE+P +G L L +L L NQLSG++ L L LE LDLSSN S
Sbjct: 588 ----DLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFS 643
Query: 609 NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQX 668
+ IP++F + +KLH +NLS N+F IP +L +L L++LDLSHN L IPSQ+ +Q
Sbjct: 644 SEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQS 702
Query: 669 XXXXXXXXXXXVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLC 728
GLIP+ FE M L +DIS N+L+GP+P++ FR A +AL+ N GLC
Sbjct: 703 LDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLC 762
Query: 729 GDV--KGLPSCKTLKS-NKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQ 785
++ + L C+ LK K +W++V P+LG++ +L S+ F + R LQ
Sbjct: 763 SNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SICANTFTYCIRKRKLQNG 819
Query: 786 QSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVK 845
+++ T +S+ + +GK Y++II +TN+FD H IG GG VY+A L I+AVK
Sbjct: 820 RNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVK 878
Query: 846 KFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-----------SLA 891
+ H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH RH SL
Sbjct: 879 RLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLN 938
Query: 892 MILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951
+L+N+ AK L WT+R+NV+KG++ ALSYMH+D PIVHRDISS N+LLD D A +S
Sbjct: 939 KLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKIS 998
Query: 952 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011
DFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSFGVL LE+I GKHP D
Sbjct: 999 DFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDL 1058
Query: 1012 IXXXXXXXLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVS 1070
+ ++L + D R+ P ++KL+ +VE+A+ CL NPESRPTM +S
Sbjct: 1059 VSSLSSSPGEA-LSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1766 (626.7 bits), Expect = 5.4e-182, P = 5.4e-182
Identities = 392/930 (42%), Positives = 539/930 (57%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
I P G S L+ L N L IP E G+L +L L L NK +GSIP +G LT +
Sbjct: 134 ISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVT 193
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ +++N L IPS GNL L L L N LSGSIP +GNL NL L L N+L+G
Sbjct: 194 EIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGK 253
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXX 340
IPS FGNL+++++LN+ N+L+G IP +GN+T L TL +H N L+G IPS +
Sbjct: 254 IPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLA 313
Query: 341 XXXXXXXXXXXXIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400
IPP LG + ++ L + N L +P G L +L L L N+LSG
Sbjct: 314 VLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGP 373
Query: 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLD 460
IP + N T L L L N+ +G +P L L+L N G +P SL + +L
Sbjct: 374 IPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLI 433
Query: 461 ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
+ NS SG I G +++ + L+NN G + + LV L NNS+ +
Sbjct: 434 RVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGA 493
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQ 580
IP E+ N+ LS L DLSSN I GE+P + +N + KL L
Sbjct: 494 IPPEIWNMTQLSQL------------------DLSSNRITGELPESISNINRISKLQLNG 535
Query: 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLE 640
N+LSG++ + L LE+LDLSSNR S+ IP + NL +L+Y+NLS N + IP L
Sbjct: 536 NRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLT 595
Query: 641 ELIHLSELDLSHNFLREAIPSQICIMQXXXXXXXXXXXXVGLIPSCFEKMHGLLRIDISY 700
+L L LDLS+N L I SQ +Q G IP F+ M L +D+S+
Sbjct: 596 KLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSH 655
Query: 701 NELQGPIPNSIAFRDAPIEALQGNKGLCGDV---KGLPSCKTLKSNKQAL-RKIWVVVVF 756
N LQGPIP++ AFR+AP +A +GNK LCG V +GL C S K R + + ++
Sbjct: 656 NNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILV 715
Query: 757 PLLGIVALLISLIGLFFKFQRRNNDLQ--TQQSSPGNTRGLLSVLTFEGKIVYEEIIRAT 814
P++G + +L G+F F++R ++ T S G T LS+ +F+GK+ Y+EII+AT
Sbjct: 716 PIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGET---LSIFSFDGKVRYQEIIKAT 772
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT---FQQEFLNEVKALTEI 871
+FD ++ IG GG G VYKA+L + I+AVKK + ++ +QEFLNE++ALTEI
Sbjct: 773 GEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEI 831
Query: 872 RHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALS 920
RHRN+VK +GFCSH R+ SL +L N+ AK L W +R+NV+KG++ ALS
Sbjct: 832 RHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALS 891
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
YMH+D P IVHRDISS N+LL D EA +SDFG AK LKPDSSNW+ +AGTYGYVAPEL
Sbjct: 892 YMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPEL 951
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIXXXXXXXLNLNIALDEMLDPRLPTPSCI 1040
AY MKVTEKCDVYSFGVL LEVIKG+HP D + + ++L + D RLP P+
Sbjct: 952 AYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE 1011
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVS 1070
++++++ I++VA+ CL +P++RPTM +S
Sbjct: 1012 IKEEVLEILKVALLCLHSDPQARPTMLSIS 1041
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 2.4e-166, Sum P(2) = 2.4e-166
Identities = 304/838 (36%), Positives = 433/838 (51%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
L L N L G IP ++GN S L + N+ GTIP E+G L L+ L L N L G I
Sbjct: 196 LILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEI 255
Query: 138 PYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM 197
P ++G + LIP SL +L NL TL L N+L+ IP EF N+ L
Sbjct: 256 PSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLD 315
Query: 198 LSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256
L L N SGS+P S+ N TNL L L L IP EL +SL L L N L+GS
Sbjct: 316 LVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGS 375
Query: 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLA 316
IP +L L L LYL+ N+L G++ NL +L L L +N L G +P + L L
Sbjct: 376 IPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLE 435
Query: 317 TLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPPSLGYLSNLATLYLYSNSLFDS 376
L+++ N SG IP EI IPPS+G L L L+L N L
Sbjct: 436 VLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGG 495
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLS 436
+P+ LGN L++L L N+LSGSIP S G L L L LY+NSL G++P +LR+L+
Sbjct: 496 LPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLT 555
Query: 437 TLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS 496
++L +N+L+G+I H L ++ + + +N IP E+GN +++ L L N+L+G
Sbjct: 556 RINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGK 614
Query: 497 IPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP------HSLG 550
IP +LG + L +L + +N+L +IP +L + L+ + N LSG IP LG
Sbjct: 615 IPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLG 674
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
L LSSN V +PTEL L+ L L N L+G + ++G+L L L+L N+ S S
Sbjct: 675 ELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGS 734
Query: 611 IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHL-SELDLSHNFLREAIPSQICIMQXX 669
+P++ G L KL+ L LS N + IP+++ +L L S LDLS+N IPS I +
Sbjct: 735 LPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKL 794
Query: 670 XXXXXXXXXXVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCG 729
G +P M L +++S+N L G + F P ++ GN GLCG
Sbjct: 795 ETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCG 852
Query: 730 DVKGLPSCKTLKSN-KQ---ALRKIWVVVVFPLLGIVALLISLIGLFFK-----FQRRNN 780
L C ++SN KQ + R + ++ L + L+I +I LFFK F++ +
Sbjct: 853 SP--LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGH 910
Query: 781 DLQTQQSSPGNTRGLLSVLTFEGK----IVYEEIIRATNDFDDEHCIGKGGQGSVYKAEL 836
SS +++ L G I +E+I+ AT++ +E IG GG G VYKAEL
Sbjct: 911 GSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAEL 970
Query: 837 ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894
+GE VAVKK ++ + F EVK L IRHR++VK G+CS L +++
Sbjct: 971 ENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLI 1026
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 8.0e-155, Sum P(2) = 8.0e-155
Identities = 283/822 (34%), Positives = 402/822 (48%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLI 161
LDLSS G + P IG L L L L N L G IP EIG I
Sbjct: 90 LDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSI 149
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221
P + LS L + ++ +N LS +P E G+L +L L N +G +P SLGNL L T
Sbjct: 150 PVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTT 209
Query: 222 LYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSI 281
N +IP+E+G +L +L L N +SG +P +G L L + L++N SG I
Sbjct: 210 FRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFI 269
Query: 282 PSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXX 341
P + GNL SL L L N L G IP +GN+ +L LY++ N L+G+IP E+
Sbjct: 270 PKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVME 329
Query: 342 XXXXXXXXXXXIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 401
IP L +S L LYL+ N L IP+EL LR+L+ L L N L+G I
Sbjct: 330 IDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPI 389
Query: 402 PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDA 461
P NLT++ L L+ NSLSG IP G L + N+LSG IP + +NL
Sbjct: 390 PPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLIL 449
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
L L N + G+IP + +S+ L + N+L+G P L L NL + L N +
Sbjct: 450 LNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPL 509
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVL------DLSSNHIVGEIPTELGKLNFLIK 575
P E+G + L L A N+ S ++P+ + L ++SSN + G IP+E+ L +
Sbjct: 510 PPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQR 569
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGI 635
L L++N G L P+LGSL QLE L LS NR S +IP + GNL L L + N FS I
Sbjct: 570 LDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSI 629
Query: 636 PIKLEELIHLS-ELDLSHNFLREAIPSQICIMQXXXXXXXXXXXXVGLIPSCFEKMHGLL 694
P +L L L ++LS+N IP +I + G IP+ FE + LL
Sbjct: 630 PPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLL 689
Query: 695 RIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCG------DVK--GLPSCKTLKSNKQA 746
+ SYN L G +P++ F++ + + GNKGLCG D P +LK+
Sbjct: 690 GCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSAR 749
Query: 747 LRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIV 806
+I ++V + GI LLI+++ F + P + + E +
Sbjct: 750 RGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-RFT 808
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT----FQQEFL 862
++I+ AT F D + +G+G G+VYKA + SG+ +AVKK S G F
Sbjct: 809 VKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFR 868
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLG 904
E+ L +IRHRNIV+ Y FC H + ++L + LG
Sbjct: 869 AEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLG 910
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1447 (514.4 bits), Expect = 3.4e-148, P = 3.4e-148
Identities = 379/1049 (36%), Positives = 533/1049 (50%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFF 110
NS + G G++ ++SS P + L+L L G + P IG + LK LDLS N
Sbjct: 52 NSNDSVPCGWTGVMCS-NYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLS 110
Query: 111 GTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSN 170
G IP EIG+ S L+ L+L NQ +G IP EIG+ +P +GNL +
Sbjct: 111 GKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLS 170
Query: 171 LDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230
L L Y N++S +P GNL+ L+ G N SGS+P +G +L L L N L
Sbjct: 171 LSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLS 230
Query: 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRS 290
+P E+G L+ LS + L N+ SG IP + N T+L TL LY+N L G IP E G+L+S
Sbjct: 231 GELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQS 290
Query: 291 LSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXX 350
L L L N LNG IP +GNL+ + N+L+G IP E+
Sbjct: 291 LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLT 350
Query: 351 XXIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410
IP L L NL+ L L N+L IP LR L ML L N LSG+IP LG ++
Sbjct: 351 GTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSD 410
Query: 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
L LD+ DN LSG IPS ++ L+LG N LSG+IP + L L L N+L
Sbjct: 411 LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLV 470
Query: 471 GSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS 530
G P + +++ + L N+ GSIP+ +GN S L L L +N +P E+G
Sbjct: 471 GRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIG---- 526
Query: 531 LSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590
MLS LG L++SSN + GE+P+E+ L +L + N SG L +
Sbjct: 527 --MLS------------QLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSE 572
Query: 591 LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLS-ELD 649
+GSL QLE L LS+N LS +IP + GNL +L L + N F+ IP +L L L L+
Sbjct: 573 VGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALN 632
Query: 650 LSHNFLREAIPSQICIMQXXXXXXXXXXXXVGLIPSCFEKMHGLLRIDISYNELQGPIP- 708
LS+N L IP ++ + G IPS F + LL + SYN L GPIP
Sbjct: 633 LSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL 692
Query: 709 -NSIAFRD-APIEALQGNK-GLCGDVKGL-PSCKTLKSNKQALRKIWVVVVFPLLGIVAL 764
+I+ E L G C + PS T K KI + + G+ +
Sbjct: 693 LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLM 752
Query: 765 LISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIG 824
LI+LI + R Q P + EG +++++ AT++FD+ +G
Sbjct: 753 LIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVG 811
Query: 825 KGGQGSVYKAELASGEIVAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G+VYKA L +G +AVKK S G F E+ L IRHRNIVK +GF
Sbjct: 812 RGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGF 871
Query: 883 CSHV-----------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
C+H + SL IL + + +L W++R + G + L+Y+H+DC P I
Sbjct: 872 CNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIF 929
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
HRDI S N+LLD EAHV DFG+AK + P S + + +AG+YGY+APE AYTMKVTEK
Sbjct: 930 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKS 989
Query: 991 DVYSFGVLALEVIKGKHPRDFIXXXXXXX--LNLNIALDEM----LDPRLPTPSCIVQDK 1044
D+YS+GV+ LE++ GK P I + I D + LD RL +
Sbjct: 990 DIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSH 1049
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLL 1073
+++++++A+ C +P +RP+M +V +L
Sbjct: 1050 MLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 4.2e-145, Sum P(2) = 4.2e-145
Identities = 298/880 (33%), Positives = 427/880 (48%)
Query: 53 INLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGT 112
++L+ G L F S P L+ LD+ +N L G IPP+IG +S L L + N F G
Sbjct: 142 LDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQ 201
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLD 172
IP EIG++S LK NG +P EI + + IP S G L NL
Sbjct: 202 IPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLS 261
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
L+L L IP E GN +SL L L +N SG +P L + L T N L S
Sbjct: 262 ILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIP-LLTFSAERNQLSGS 320
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
+PS +G + L L L N+ SG IPH + + L L L N LSGSIP E SL
Sbjct: 321 LPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLE 380
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXX 352
++L N L+G I ++L L + NN ++GSIP ++
Sbjct: 381 AIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDSNNFTGE- 439
Query: 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 412
IP SL +NL N L +P+E+GN SL L L N+L+G IP +G LT+L+
Sbjct: 440 IPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLS 499
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
L+L N G IP E G+ SL+TL LG N L G IP + L L L L N+LSGS
Sbjct: 500 VLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGS 559
Query: 473 IPG---------EIGNLRSISN---LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
IP E+ +L + + L+ N+LSG IP+ LG LV + L NN L
Sbjct: 560 IPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGE 619
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPHSLGV------LDLSSNHIVGEIPTELGKLNFLI 574
IP+ L L +L++L + N L+GSIP +G L+L++N + G IP G L L+
Sbjct: 620 IPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLV 679
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
KL L +N+L G + LG+L +L H+DLS N LS + + KL L + N+F+
Sbjct: 680 KLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGE 739
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICIMQXXXXXXXXXXXXVGLIPSCFEKMHGLL 694
IP +L L L LD+S N L IP++IC GL P+ L
Sbjct: 740 IPSELGNLTQLEYLDVSENLLSGEIPTKIC----------------GL-PN-------LE 775
Query: 695 RIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVV 754
++++ N L+G +P+ +D L GNK LCG V G CK ++ K LR W +
Sbjct: 776 FLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVG-SDCK-IEGTK--LRSAWGIA 831
Query: 755 VFPLLGIVALLISLI------GLFFKFQRRNNDLQTQQS-------------SPGNTRGL 795
+LG ++ + + + ++R++ + ++S S +R
Sbjct: 832 GL-MLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREP 890
Query: 796 LSV--LTFEG---KIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSP 850
LS+ FE K+ +I+ AT+ F ++ IG GG G+VYKA L + VAVKK
Sbjct: 891 LSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE- 949
Query: 851 LPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890
+ +EF+ E++ L +++H N+V G+CS L
Sbjct: 950 --AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKL 987
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1416 (503.5 bits), Expect = 6.6e-145, P = 6.6e-145
Identities = 378/1033 (36%), Positives = 532/1033 (51%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
+DL L G + P I + L+ L++S+N G IP ++ L+ L L N+ +G I
Sbjct: 72 VDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVI 131
Query: 138 PYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM 197
P ++ IP +GNLS+L L +Y N+L+ IP LR L +
Sbjct: 132 PIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRI 191
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257
+ G N FSG IP + +L L L N L S+P +L L++L+ L L N+LSG I
Sbjct: 192 IRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEI 251
Query: 258 PHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLAT 317
P S+GN++ L L L+EN +GSIP E G L + L L N+L G IP +GNL + A
Sbjct: 252 PPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAE 311
Query: 318 LYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPPSLGYLSNLATLYLYSNSLFDSI 377
+ N L+G IP E IP LG L+ L L L N L +I
Sbjct: 312 IDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTI 371
Query: 378 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLST 437
P EL L L L L N+L G IP +G +N + LD+ NSLSG IP+ F ++L
Sbjct: 372 PQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLIL 431
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
LSLG NKLSG+IP L +L L L DN L+GS+P E+ NL++++ L L+ N LSG+I
Sbjct: 432 LSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNI 491
Query: 498 PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGV------ 551
LG L NL L L NN+ IP E+GNL + + + N+L+G IP LG
Sbjct: 492 SADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQR 551
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI 611
LDLS N G I ELG+L +L L L+ N+L+G++ G L +L L L N LS +I
Sbjct: 552 LDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENI 611
Query: 612 PKSFGNLVKLHY-LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQXXX 670
P G L L LN+S+N S IP L L L L L+ N L IP+ I
Sbjct: 612 PVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASI------- 664
Query: 671 XXXXXXXXXVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGD 730
G + S LL +IS N L G +P++ F+ GN GLC
Sbjct: 665 ----------GNLMS-------LLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNS 707
Query: 731 VKG-----LPSCKTLKS---NKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDL 782
+ +P + + N +KI + ++G V LI+ +GL + +RR
Sbjct: 708 QRSHCQPLVPHSDSKLNWLINGSQRQKILTITCI-VIGSV-FLITFLGLCWTIKRREPAF 765
Query: 783 QT--QQSSPGNTRGLLSVLTFEGK-IVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASG 839
Q+ P ++ F K Y+ ++ AT +F ++ +G+G G+VYKAE++ G
Sbjct: 766 VALEDQTKPD----VMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGG 821
Query: 840 EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI--LSNN 897
E++AVKK +S G + F E+ L +IRHRNIVK YGFC H +L + +S
Sbjct: 822 EVIAVKKLNSRGEGASS-DNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880
Query: 898 AAAKDL--G-------WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEA 948
+ + L G W R + G ++ L Y+H+DC P IVHRDI S N+LLD +A
Sbjct: 881 SLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQA 940
Query: 949 HVSDFGIAKFLKPD-SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 1007
HV DFG+AK + S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE+I GK
Sbjct: 941 HVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKP 1000
Query: 1008 P-------RDFIXXXXXXXLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENP 1060
P D + N+ I EM D RL T ++ ++++A+ C +P
Sbjct: 1001 PVQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSP 1059
Query: 1061 ESRPTMPKVSQLL 1073
SRPTM +V ++
Sbjct: 1060 ASRPTMREVVAMI 1072
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 2.4e-140, Sum P(2) = 2.4e-140
Identities = 251/644 (38%), Positives = 345/644 (53%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGR--VNSINLTSIGL 60
E AL+ W S N S+ S W N + + PC W I C+ V IN+ S+ L
Sbjct: 39 EVSALISWLHS-SNSPPPSVFSGW---NPSDSDPCQWPYITCSSSDNKLVTEINVVSVQL 94
Query: 61 KGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHL 120
+ + SSF L L + + L G I +IG+ S L +DLSSN G IP +G L
Sbjct: 95 -ALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKL 153
Query: 121 SYLKTLQLFENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLDTLHLYDNS 180
L+ L L N L G IP E+G + +P LG +S L+++ NS
Sbjct: 154 KNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNS 213
Query: 181 -LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
LS IP E GN R+L +L L K SGS+P SLG L+ L +L +++ L IP ELGN
Sbjct: 214 ELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGN 273
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
L L L N LSG++P LG L NL + L++N+L G IP E G ++SL+ ++L N
Sbjct: 274 CSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMN 333
Query: 300 KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPPSLGY 359
+G IP S GNL+NL L + +N+++GSIPS + IPP +G
Sbjct: 334 YFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGL 393
Query: 360 LSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN 419
L L + N L +IP EL ++L L L N L+GS+P L L NL L L N
Sbjct: 394 LKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISN 453
Query: 420 SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGN 479
++SG IP E GN SL L L N+++G IP +G L NL L L +N+LSG +P EI N
Sbjct: 454 AISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISN 513
Query: 480 LRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN 539
R + L L+NN L G +P SL +L+ L +L + +N L IP LG+L SL+ L + N
Sbjct: 514 CRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKN 573
Query: 540 KLSGSIPHSLG------VLDLSSNHIVGEIPTELGKLNFL-IKLILAQNQLSGQLSPKLG 592
+G IP SLG +LDLSSN+I G IP EL + L I L L+ N L G + ++
Sbjct: 574 SFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERIS 633
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIP 636
+L +L LD+S N LS + + L L LN+S+N+FS +P
Sbjct: 634 ALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLP 676
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 353/1004 (35%), Positives = 507/1004 (50%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLI 161
+D+ S ++P + L+ L + L G++P +G I
Sbjct: 86 IDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDI 145
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221
P SL L NL+TL L N L+ IP + L L L N +GSIP LG L+ L
Sbjct: 146 PWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEV 205
Query: 222 LYLHNNS-LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ + N + IPSE+G+ +L++L L +SG++P SLG L L TL +Y +SG
Sbjct: 206 IRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGE 265
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIXXXXXXX 340
IPS+ GN L L L N L+G IP +G LT L L++ NSL G IP EI
Sbjct: 266 IPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLK 325
Query: 341 XXXXXXXXXXXXIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400
IP S+G LS L + N SIP+ + N SL L L N++SG
Sbjct: 326 MIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGL 385
Query: 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLD 460
IP LG LT L + N L GSIP + L L L N L+G+IP L L NL
Sbjct: 386 IPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLT 445
Query: 461 ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
L L NSLSG IP EIGN S+ L L N+++G IP +G+L + L +N L
Sbjct: 446 KLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGK 505
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPH------SLGVLDLSSNHIVGEIPTELGKLNFLI 574
+P E+G+ L M+ + N L GS+P+ L VLD+S+N G+IP LG+L L
Sbjct: 506 VPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLN 565
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY-LNLSNNQFSR 633
KLIL++N SG + LG + L+ LDL SN LS IP G++ L LNLS+N+ +
Sbjct: 566 KLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTG 625
Query: 634 GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQXXXXXXXXXXXXVGLIPSCFEKMHGL 693
IP K+ L LS LDLSHN L E + + ++ G +P + L
Sbjct: 626 KIPSKIASLNKLSILDLSHNML-EGDLAPLANIENLVSLNISYNSFSGYLPD-----NKL 679
Query: 694 LRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRKIWVV 753
R +S +L+G + +D+ + GL GD G S +T K I +
Sbjct: 680 FR-QLSPQDLEGNKKLCSSTQDSCFLTYRKGNGL-GD-DGDAS-RTRKLRLTLALLITLT 735
Query: 754 VVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVY--EEII 811
VV +LG VA++ + RRN D + + S G T F+ K+ + ++II
Sbjct: 736 VVLMILGAVAVIRA---------RRNIDNE-RDSELGETYKW-QFTPFQ-KLNFSVDQII 783
Query: 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG----EMT--FQQEFLNEV 865
R + + IGKG G VY+A++ +GE++AVKK + E T + F EV
Sbjct: 784 RC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEV 840
Query: 866 KALTEIRHRNIVKFYGFCSHVRHSLAMI----------LSNNAAAKDLGWTRRMNVIKGI 915
K L IRH+NIV+F G C + L M L + L W R ++ G
Sbjct: 841 KTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGA 900
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL-KPDSSNWTE-LAGTY 973
+ L+Y+H+DC PPIVHRDI + N+L+ D E +++DFG+AK + + D + +AG+Y
Sbjct: 901 AQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSY 960
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIXXXXXXXLNL---NIALDEML 1030
GY+APE Y+MK+TEK DVYS+GV+ LEV+ GK P D ++ N E+L
Sbjct: 961 GYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVL 1020
Query: 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
D L + + D+++ ++ A+ C++ +P+ RPTM V+ +LK
Sbjct: 1021 DSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 361/1102 (32%), Positives = 528/1102 (47%)
Query: 16 NHNNGSLLSSW-TLNNVTKTS--PCAWVGIHCNRGGRV---NSINLTSIGLKGMLHDFSF 69
N NG++ ++ L N+ + C G+ +R GR+ ++ L L+G +
Sbjct: 154 NELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPI-PAEI 212
Query: 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLF 129
+ LA N+L G++P ++ + L+ L+L N F G IP ++G L ++ L L
Sbjct: 213 GNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLI 272
Query: 130 ENQLNGSIPYEIGRXXXXXXXXXXXXXXEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEF 189
NQL G IP + +I ++ L+ L L N LS S+P
Sbjct: 273 GNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTI 332
Query: 190 -GNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
N SL L L + SG IP + N +L L L NN+L IP L L L+ L L
Sbjct: 333 CSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYL 392
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308
N L G++ S+ NLTNL LY N+L G +P E G L L ++ L N+ +G +P
Sbjct: 393 NNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVE 452
Query: 309 LGNLTNLATLYIHNNSLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPPSLGYLSNLATLYL 368
+GN T L + + N LSG IPS I IP SLG + + L
Sbjct: 453 IGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDL 512
Query: 369 YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428
N L SIPS G L +L + + N L G++P SL NL NL ++ N +GSI
Sbjct: 513 ADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPL 572
Query: 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488
G+ LS + N G IP LG TNLD L L N +G IP G + +S L +
Sbjct: 573 CGSSSYLS-FDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDI 631
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHS 548
+ N LSG IP LG L + L NN L IP+ LG L L L + NK GS+P
Sbjct: 632 SRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE 691
Query: 549 L----GVLDL--SSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
+ +L L N + G IP E+G L L L L +NQLSG L +G L++L L L
Sbjct: 692 IFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRL 751
Query: 603 SSNRLSNSIPKSFGNLVKLHY-LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPS 661
S N L+ IP G L L L+LS N F+ IP + L L LDLSHN L +P
Sbjct: 752 SRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPG 811
Query: 662 QICIMQXXXXXXXXXXXXVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEAL 721
QI M+ +G + + + G L+ S + + N+ +P+
Sbjct: 812 QIGDMKS-----------LGYLNLSYNNLEGKLKKQFSRWQADAFVGNA-GLCGSPLSHC 859
Query: 722 QGNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNND 781
N+ + + L S KT+ A+ + + + L+ I+ LF K + N+
Sbjct: 860 --NRAGSKNQRSL-SPKTVVIIS-AISSLAAIALMVLV-IILFFKQNHDLFKKVRGGNSA 914
Query: 782 LQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEI 841
+ SS + L S + I +++I+ AT+ ++E IG GG G VYKAEL +GE
Sbjct: 915 FSSNSSS--SQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGET 972
Query: 842 VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL------- 894
+AVKK ++ + F EVK L IRHR++VK G+CS L +++
Sbjct: 973 IAVKKIL--WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANG 1030
Query: 895 --------SNNAAAKD-LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945
+ N K+ LGW R+ + G++ + Y+H DC PPIVHRDI S NVLLD +
Sbjct: 1031 SVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSN 1090
Query: 946 NEAHVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 1001
EAH+ DFG+AK L + TE AG+YGY+APE AY++K TEK DVYS G++ +E
Sbjct: 1091 IEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1150
Query: 1002 VIKGKHPRDFIXXXXXXXLN-LNIALD---------EMLDPRLPTPSCIVQDKLISIVEV 1051
++ GK P + + + + LD +++D L + ++ ++E+
Sbjct: 1151 IVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEI 1210
Query: 1052 AISCLDENPESRPTMPKVSQLL 1073
A+ C P+ RP+ + S+ L
Sbjct: 1211 ALQCTKSYPQERPSSRQASEYL 1232
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LP24 | Y1571_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4721 | 0.9869 | 0.9473 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.1__3648__AT1G35710.1 | annotation not avaliable (1123 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1075 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-141 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-107 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 2e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.003 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.003 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.003 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.004 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 450 bits (1158), Expect = e-141
Identities = 328/1009 (32%), Positives = 481/1009 (47%), Gaps = 155/1009 (15%)
Query: 95 NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLS-SLNYLALY 153
N SR+ +DLS G I I L Y++T+ L NQL+G IP +I S SL YL
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL--- 123
Query: 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL 213
NLSN N F+GSIP
Sbjct: 124 -------------NLSN--------------------------------NNFTGSIPR-- 136
Query: 214 GNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLY 273
G++ NL TL L NN L IP+++G+ SL +L LG N L G IP+SL NLT+L L L
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196
Query: 274 ENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333
N L G IP E G ++SL + LGYN +LSG IP EI
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYN------------------------NLSGEIPYEI 232
Query: 334 GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393
G L SL++L L N L+G IP SLG L NL L+LY N
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN---------------------- 270
Query: 394 YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL 453
KLSG IP S+ +L L +LDL DNSLSG IP L++L L L N +G IP +L
Sbjct: 271 --KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 454 GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLY 513
+L L L L+ N SG IP +G +++ L L+ N L+G IP+ L + NL L L+
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 514 NNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHS------LGVLDLSSNHIVGEIPTEL 567
+NSL IP LG RSL + N SG +P + LD+S+N++ G I +
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 568 GKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLS 627
+ L L LA+N+ G L GS +LE+LDLS N+ S ++P+ G+L +L L LS
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLS 507
Query: 628 NNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCF 687
N+ S IP +L L LDLSHN L IP+ M L L+LS N L G IP
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
Query: 688 EKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVK--GLPSCKTLKSNKQ 745
+ L++++IS+N L G +P++ AF A+ GN LCG GLP CK ++
Sbjct: 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS 627
Query: 746 ALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKI 805
W + L + L + G F R N +L+ ++ G I
Sbjct: 628 W----WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683
Query: 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEI-VAVKKFH--SPLPGEMTFQQEFL 862
+I+ + +E+ I +G +G+ YK + + VK+ + + +P
Sbjct: 684 TINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---------S 731
Query: 863 NEVKALTEIRHRNIVKFYGFC-----SHVRH------SLAMILSNNAAAKDLGWTRRMNV 911
+E+ + +++H NIVK G C +++ H +L+ +L N L W RR +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKI 785
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
GI+ AL ++H C P +V ++S + +++D +E H+ + L D+ + A
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA- 843
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------NIA 1025
YVAPE T +TEK D+Y FG++ +E++ GK P D + S + +
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900
Query: 1026 LDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
LD +DP + + Q++++ ++ +A+ C +P +RP V + L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 358 bits (919), Expect = e-107
Identities = 238/601 (39%), Positives = 321/601 (53%), Gaps = 41/601 (6%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLK 61
EE LL +K+S+ + LS+W + C W GI CN RV SI+L+ +
Sbjct: 29 EELELLLSFKSSINDPLK--YLSNWNSSADV----CLWQGITCNNSSRVVSIDLSGKNIS 82
Query: 62 GMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNIS-RLKYLDLSSNLFFGTIPPEIGHL 120
G + F P++ ++L +NQL G IP I S L+YL+LS+N F G+IP G +
Sbjct: 83 GKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSI 139
Query: 121 SYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
L+TL L N L+G IP +IG SSL L L N L IP SL NL++L+ L L N
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 181 LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNL 240
L IP E G ++SL + LGYN SG IP+ +G LT+L L L N+L IPS LGNL
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK 300
++L L L NKLSG IP S+ +L L +L L +NSLSG IP L++L +L+L N
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319
Query: 301 LNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
G IP +L +L L L + +N SG IP +G +L+ L LS N L+G IP L
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420
NL L L+SNSL IP LG RSL + L N SG +P L + LD+ +N+
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480
L G I S ++ SL LSL NK G +P S G+
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS------------------------- 474
Query: 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK 540
+ + NL L+ N+ SG++P+ LG+LS L+ L L N L IP EL + + L L ++N+
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 541 LSGSIPHS------LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSL 594
LSG IP S L LDLS N + GEIP LG + L+++ ++ N L G L L
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 595 A 595
A
Sbjct: 595 A 595
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 33/269 (12%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
++ +G+G G VY A + +G++VA+K ++ L E+K L +++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58
Query: 876 IVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
IV+ Y L +L R ++ I AL Y+H+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFY--LRQILSALEYLHS 115
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
IVHRD+ +N+LLD D ++DFG+A+ L P T GT Y+APE+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGK 171
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC--IVQ 1042
+ D++S GV+ E++ GK P F L ++ P+ P P +
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071
+ ++ L ++PE R T + Q
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 75/271 (27%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
++ +G G G+VYKA +G+IVAVK + Q E++ L + H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 876 IVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
IV+ H L LS L + I L Y+H+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYT 983
+ I+HRD+ +N+LLD + ++DFG+AK L SS+ T GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
K DV+S GV+ E++ GK P F + L+ + +L P L
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--F---SGENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ CL+++P RPT ++L+
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAE---EILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+GG G+VY A +G+ VA+K + +E L E++ L ++ H NIVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 882 FCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
H SL +L N L + ++ I + L Y+H++ I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 931 VHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 988
+HRD+ +N+LLD DN + ++DFG++K L D S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 989 KCDVYSFGVLALEVIKGKHPRDFISSM 1015
K D++S GV+ E+ + K D I M
Sbjct: 174 KSDIWSLGVILYELPELK---DLIRKM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 39/274 (14%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
F+ IGKGG G VYKA +G+ VA+K +++ +NE++ L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKIINEIQILKKCKHP 57
Query: 875 NIVKFYGFCSHVRHS---LAMILSNNAAAKDL--GWTRRMN------VIKGISDALSYMH 923
NIVK+YG S+++ + M + + KDL + + V K + L Y+H
Sbjct: 58 NIVKYYG--SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
++ I+HRDI + N+LL D E + DFG++ L D+ + GT ++APE+
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVING 171
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD---PRLPTPSCI 1040
K D++S G+ A+E+ +GK P + M AL ++ P L P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------ALFKIATNGPPGLRNPE-K 222
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
D+ ++ CL +NPE RPT QLLK
Sbjct: 223 WSDEFKDFLK---KCLQKNPEKRPT---AEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 47/276 (17%)
Query: 821 HCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFL-NEVKALTEIRHRNIVK 878
+G+G GSVY A + +GE++AVK L G+ + E L E++ L+ ++H NIV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 879 FYGFCSHVRH-------------SLAMILSNNAAAKDLGWTRRMNVIKG----ISDALSY 921
+YG SL+ +L + VI+ I + L+Y
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAY 116
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPE 979
+H++ IVHRDI N+L+D D ++DFG AK L + + GT ++APE
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT-PS 1038
+ + D++S G +E+ GK P + + + I P +P S
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALYKIGSSG-EPPEIPEHLS 230
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+D L CL +P+ RPT +LL+
Sbjct: 231 EEAKDFL-------RKCLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 53/278 (19%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G+G G VYK L VAVK + +EFL E + + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 878 KFYGFCSHVRHSLAMIL---SN--------NAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
K G C+ L +++ K+L + ++ I+ + Y+ +
Sbjct: 65 KLLGVCTE-EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----------WTELAGTYGYV 976
+HRD++++N L+ + +SDFG+++ L D W
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM--------- 171
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
APE K T K DV+SFGVL E+ G+ P MS++ + + L
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYLKKGYRLPKPPN 228
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
P + ++ + C E+PE RPT ++ ++L
Sbjct: 229 CPP--------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 56/279 (20%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G+G G VYK +L VAVK + +EFL E + + ++ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 878 KFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
K G C+ L ++ L N L + ++ I+ + Y+ +
Sbjct: 65 KLLGVCTE-EEPLYIVMEYMEGGDLLSYLRKNR--PKLSLSDLLSFALQIARGMEYLESK 121
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----------WTELAGTYGY 975
+HRD++++N L+ + +SDFG+++ L D W
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-------- 170
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
APE K T K DV+SFGVL E+ G+ P MS+ + + L
Sbjct: 171 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLKNGYRLPQPP 226
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
P + ++ + C E+PE RPT ++ ++L
Sbjct: 227 NCPP--------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 61/275 (22%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G+G G VYK L + VAVK E ++EFL E + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64
Query: 878 KFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
+ G C+ L ++ L + L +M I+ + Y+ +
Sbjct: 65 RLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM--ALQIAKGMEYLESK 121
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV-----APEL 980
F VHRD++++N L+ + +SDFG+++ + D G + APE
Sbjct: 122 NF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPES 175
Query: 981 AYTMKVTEKCDVYSFGVLALEVI-------KGKHPRDFISSMSSSSLNLNIALDEMLD-- 1031
K T K DV+SFGVL E+ G + + E+L+
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL---------------ELLEDG 220
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTM 1066
RLP P ++ + E+ + C +PE RPT
Sbjct: 221 YRLPRP----ENCPDELYELMLQCWAYDPEDRPTF 251
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 74/293 (25%)
Query: 823 IGKGGQGSVYKAEL----ASGEIVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHRNI 876
+G+G G VYK +L VAVK L + + ++ +FL E + + ++ H N+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 877 VKFYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGISDA 918
V+ G C+ L ++L + L ++ I+
Sbjct: 59 VRLLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-----------WT 967
+ Y+ + VHRD++++N L+ D +SDFG+++ + D W
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
APE T K DV+SFGVL E+ G P ++
Sbjct: 175 ---------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP------------GLSN 213
Query: 1027 DEMLDP-----RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+E+L+ RLP P D+L ++ SC +PE RPT ++ + L+
Sbjct: 214 EEVLEYLRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 27/270 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+D + +G+G G VYK +G+I A+KK H + G+ F+++ L E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58
Query: 874 RNIVKFYG-FCSHVRHSLAMILSN-----NAAAKDLGWTRRMNVIKGIS----DALSYMH 923
+VK YG F S+ + + + K + + I+ L Y+H
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV--LAYIARQILKGLDYLH 116
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
I+HRDI N+L++ E ++DFGI+K L+ GT Y++PE
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
+ D++S G+ LE GK P F+ S L A+ P P+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAI--CDGPPPSLPAEEFSP 230
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + +CL ++P+ RP+ ++LL
Sbjct: 231 EFRDFIS---ACLQKDPKKRPS---AAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE----FLNEVKALTEI 871
+ + IG+G G VYKA + A+G+ VA+KK M +++ +NE+ + +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKK--------MRLRKQNKELIINEILIMKDC 72
Query: 872 RHRNIVKFYGFCSHVRHSLAMI---LSNNAAAKDLGWTR-RMN------VIKGISDALSY 921
+H NIV +Y V L ++ + + + RMN V + + L Y
Sbjct: 73 KHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H+ ++HRDI S N+LL D ++DFG A L + S + GT ++APE+
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
K D++S G++ +E+ +G+ P + L + P L P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPY-----LREPPLRALFLITTKGIPPLKNPE-KW 242
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + CL ++PE RP+ +LL+
Sbjct: 243 SPEFKDFLN---KCLVKDPEKRPS---AEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 58/283 (20%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVK 878
IGKG G+V K + G+I+ K+ G MT + Q+ ++EV L E++H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 879 FYG---------------FCSHVRHSLAMILSNNAAAKDLGWTRRMN----------VIK 913
+Y +C LA ++ ++ ++
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEG--GDLAQLIQK---------CKKERKYIEEEFIWRILT 112
Query: 914 GISDALSYMHN--DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
+ AL HN D ++HRD+ N+ LD +N + DFG+AK L DSS G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031
T Y++PE M EK D++S G L E+ P F + + L L + E
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--F---TARNQLQLASKIKEGKF 227
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
R+P +L +++ S L+ +P+ RP+ +LL+
Sbjct: 228 RRIPY---RYSSELNEVIK---SMLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 39/268 (14%)
Query: 822 CIGKGGQGSVYKAE-LASGEIVAVKKF--HSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
IG+G G VYK L +G+ VA+K+ + + + E+ L ++H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63
Query: 879 FYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+ G SL I+ + + + L+Y+H
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 987
++HRDI + N+L D ++DFG+A L S + + GT ++APE+ +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SCIVQDKLI 1046
D++S G +E++ G P ++ M++ I D+ P LP S ++D L
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAAL---FRIVQDDH--PPLPEGISPELKDFL- 231
Query: 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ C ++P RPT QLLK
Sbjct: 232 ------MQCFQKDPNLRPT---AKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 76/280 (27%), Positives = 119/280 (42%), Gaps = 45/280 (16%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
++ IGKG G VY + G++ +K+ E +++ LNEVK L ++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG-------------------I 915
NI+K+Y S I+ A DL IK +
Sbjct: 60 NIIKYYE--SFEEKGKLCIVMEYADGGDL-----SQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
AL Y+H+ I+HRDI +N+ L + + DFGI+K L + GT Y
Sbjct: 113 CLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
++PEL K D++S G + E+ KHP F + L L I + P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FEGE-NLLELALKI----LKGQYPP 222
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLKI 1075
PS +L ++V S L ++PE RP+ ++Q+L+
Sbjct: 223 IPSQ-YSSELRNLVS---SLLQKDPEERPS---IAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 40/271 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
IGKG G VYK L VAVK S LP ++ +++FL E + L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 883 CSHVRHSLAMILSNNAAAKDLGWTRR-------MNVIKGISDA---LSYMHNDCFPPIVH 932
C + + +++ L + R+ +++ DA + Y+ + +H
Sbjct: 61 CVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTE 988
RD++++N L+ +N +SDFG+++ + + +T G + APE + T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 989 KCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTP-SCIVQDK 1044
+ DV+S+G+L E G P MS N E ++ R+P P C +
Sbjct: 175 ESDVWSYGILLWETFSLGDTP---YPGMS------NQQTRERIESGYRMPAPQLCPEE-- 223
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLKI 1075
I + + C +PE+RP+ ++ L+I
Sbjct: 224 ---IYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 81/287 (28%), Positives = 126/287 (43%), Gaps = 69/287 (24%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ-------QEFLNEVKALTEIRHR 874
IG G G VY A L +GE++AVK E+ Q +E +E+K L ++H
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 875 NIVKFYG-------------FCSHVRHSLAMILSNNAAAKDLGWTRRMNVI----KGISD 917
N+VK+YG +CS +L +L + G +VI + +
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCS--GGTLEELL-------EHGRILDEHVIRVYTLQLLE 110
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE----LAGTY 973
L+Y+H+ IVHRDI N+ LD + + DFG A LK +++ E LAGT
Sbjct: 111 GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 974 GYVAPELAYTMKVTEK---CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA--LDE 1028
Y+APE+ K D++S G + LE+ GK P + + I +
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIMFHVGA 221
Query: 1029 MLDPRLPTPSCIVQDKLISIVEVAIS-CLDENPESRPTMPKVSQLLK 1074
P +P +L + + CL+ +P+ RPT S+LL+
Sbjct: 222 GHKPPIPDS-----LQLSPEGKDFLDRCLESDPKKRPT---ASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQE------FLNEVKALTEIRHRN 875
IG G GSVY A SGE++AVK+ P + ++ E+ L E++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 876 IVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
IV++ G H S+A +L+N A ++ T N ++ I L+Y+HN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT------ELAGTYGYVAP 978
I+HRDI N+L+D +SDFGI+K L+ +S + L G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
E+ T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 65/286 (22%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ IGKG G V + G+ VAVK L + T Q FL E +T +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHP 60
Query: 875 NIVKFYGFCSHVRHSLAMILSN---NAAAKDLGWTRRMNVIKG---------ISDALSYM 922
N+V+ G ++ + I++ + D +R VI + + + Y+
Sbjct: 61 NLVQLLGVV--LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSS----NWTELAGTYGYV 976
F VHRD++++NVL+ D A VSDFG+AK DS WT
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVI---KGKHPRDFISSMSSSSLNLNIALDEMLDP- 1032
APE K + K DV+SFG+L E+ + +PR I L +++
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPHV 212
Query: 1033 ----RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
R+ P C + + +V C + +P RPT ++ + L
Sbjct: 213 EKGYRMEAPEGCPPE-----VYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 40/275 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKF---HSPLPGEMTFQQEFLNEVKALTE 870
F CIGKG G VYKA + + ++VA+K + E+ Q+ E++ L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQ---EIQFLSQ 55
Query: 871 IRHRNIVKFYGFCSHVRHS-LAMILS--NNAAAKDLGWTRRMN------VIKGISDALSY 921
R I K+YG S ++ S L +I+ + DL +++ +++ + L Y
Sbjct: 56 CRSPYITKYYG--SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEY 113
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H + +HRDI + N+LL + + ++DFG++ L S GT ++APE+
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
EK D++S G+ A+E+ KG+ P + M L L P+ PS +
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VL--FLIPKNNPPS--L 218
Query: 1042 QDKLIS--IVEVAISCLDENPESRPTMPKVSQLLK 1074
+ S + CL+++P+ RP+ +LLK
Sbjct: 219 EGNKFSKPFKDFVSLCLNKDPKERPS---AKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 39/267 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ + VA+K G M+ + +F+ E K + ++ H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMS-EDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 883 CSHVRHSLAMILSNNAAAKDLGWTRRM----------NVIKGISDALSYMHNDCFPPIVH 932
C+ R + ++ A L + R ++ + +A+ Y+ ++ F +H
Sbjct: 68 CTKQR-PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IH 123
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEK 989
RD++++N L+ DN VSDFG+A+++ D +T GT + PE+ + + K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 990 CDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS- 1047
DV+SFGVL EV +GK P + S N + RL P KL
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRP------KLAPT 228
Query: 1048 -IVEVAISCLDENPESRPTMPKVSQLL 1073
+ + SC E PE RP K+ L
Sbjct: 229 EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 36/265 (13%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRH 873
DF+ + IGKG G V+K A + A+K+ S + ++E ++E + L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE--REEAIDEARVLAKLDS 58
Query: 874 RNIVKFYG-------------FCSH-VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
I+++Y + + H L + +D W + ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
+++H+ I+HRDI S N+ LD + + D G+AK L +++ + GT Y++PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
L EK DV++ GV+ E GKHP D + + +L L I + P S
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILKI-----IRGVFPPVSQ 223
Query: 1040 IVQDKLISIVEVAISCLDENPESRP 1064
+ +L +++ CL ++ RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG G VY A L + E VA+K+ L T E EV+A+++ H N+VK+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYY- 65
Query: 882 FCSHV-RHSLAMILSNNAAAKDLGWTRRMN------------VIKGISDALSYMHNDCFP 928
S V L +++ + L + V+K + L Y+H++
Sbjct: 66 -TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW----TELAGTYGYVAPELAYTM 984
+HRDI + N+LL D ++DFG++ L GT ++APE+ +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 985 K-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
K D++SFG+ A+E+ G P M L L P L T
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-----PPSLETG---ADY 233
Query: 1044 KLISIV--EVAISCLDENPESRPTMPKVSQLLK 1074
K S ++ CL ++P RPT +LLK
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPT---AEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 46/278 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
FD +G+G GSVYKA +G++VA+K P+ ++ QE + E+ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAA---KDLGWTRRMN----------VIKGISDALS 920
IVK+YG S+ +++ I+ A D+ + N ++ L
Sbjct: 58 PYIVKYYG--SYFKNTDLWIVMEYCGAGSVSDI--MKITNKTLTEEEIAAILYQTLKGLE 113
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+H++ +HRDI + N+LL+ + +A ++DFG++ L + + GT ++APE+
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ K D++S G+ A+E+ +GK P I M A+ + P P P+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AI--FMIPNKPPPTLS 220
Query: 1041 VQDK----LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+K V+ CL ++PE RP+ QLL+
Sbjct: 221 DPEKWSPEFNDFVK---KCLVKDPEERPS---AIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-20
Identities = 75/264 (28%), Positives = 128/264 (48%), Gaps = 35/264 (13%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 873
F D IG G G+VY A ++ + E+VA+KK G+ + + Q+ + EV+ L ++RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 874 RNIVKFYGFCSHVRHS--LAMILSNNAAA-------KDLGWTRRMNVIKGISDALSYMHN 924
N +++ G C H+ L M +A+ K L + G L+Y+H+
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
+HRDI + N+LL ++DFG A + P +S GT ++APE+ M
Sbjct: 134 HE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAM 186
Query: 985 ---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
+ K DV+S G+ +E+ + K P + +M++ S +IA ++ P L +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND--SPTLSSNDW-- 239
Query: 1042 QDKLISIVEVAISCLDENPESRPT 1065
D + V+ SCL + P+ RP+
Sbjct: 240 SDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.1 bits (227), Expect = 1e-19
Identities = 68/267 (25%), Positives = 113/267 (42%), Gaps = 28/267 (10%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFYG 881
+G+G G VY A ++VA+K L + + FL E++ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 882 FCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
F SL +L L + + ++ I AL Y+H+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 931 VHRDISSKNVLLDFD-NEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELAYT 983
+HRDI +N+LLD D + DFG+AK L S + GT GY+APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 984 M---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-NIALDEMLDPRLPTPSC 1039
+ + D++S G+ E++ G P + + S++S L I P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTM 1066
+ + ++ L ++P++R +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
IGKG G V + + ++ A+K + E + LNE + L E+ H +V Y
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 881 GFCSHVRHSLAMILSNNAAAKDL--GWTRRMNVIKG--------------ISDALSYMHN 924
F ++ +++ DL G R ++ + I AL Y+H+
Sbjct: 68 SFQD--EENMYLVV-------DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
I+HRDI N+LLD H++DF IA + PD+ T +GT GY+APE+
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQ 174
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS 1018
+ D +S GV A E ++GK P S
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 58/279 (20%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEF---LNEVKALTEI 871
D++ IG G G VYKA ++A+GE+VA+K ++ +F E+ L E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQEISMLKEC 57
Query: 872 RHRNIVKFYGFCSHVRH-------------SLAMILSNNAAA---KDLGWTRRMNVIKGI 915
RH NIV ++G S++R SL I + + R +KG
Sbjct: 58 RHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG- 113
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
L+Y+H +HRDI N+LL D + ++DFG++ L + GT +
Sbjct: 114 ---LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 976 VAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
+APE+A KCD+++ G+ A+E+ + + P +L+ L
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM----------FDLHPMRALFLIS 217
Query: 1033 RLPTPSCIVQDK------LISIVEVAISCLDENPESRPT 1065
+ P ++DK ++ CL ++P+ RPT
Sbjct: 218 KSNFPPPKLKDKEKWSPVFHDFIKK---CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 29/268 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+D + +G G G V K +G+I+AVK L Q++ L E+ L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNS 58
Query: 874 RNIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISD------------ALS 920
IV FYG F ++ S+ M + + + V I + L+
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKI----LKEVQGRIPERILGKIAVAVLKGLT 114
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+H I+HRD+ N+L++ + + DFG++ L + GT Y+APE
Sbjct: 115 YLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPER 170
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ K D++S G+ +E+ G+ P + L + PRL PS
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSGK 228
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPK 1068
V + CL ++P RP+ +
Sbjct: 229 FSPDFQDFVNL---CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 43/273 (15%)
Query: 823 IGKGGQGSV----YKAELASGEIVAVKKFHSPLPGEM-TFQQEFLNEVKALTEIRHRNIV 877
+G G GSV Y + VAVK + ++EFL E + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 878 KFYGFCSHVRHSLAMILSNNAAAKD-LGWTRRMNVIK------GISDALSYMHNDCFPPI 930
+ G C L M L+ L R + V ++ ++Y+ + F
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF--- 116
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYTMK 985
VHRD++++NVLL ++A +SDFG+++ L S + A T G + APE K
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECINYGK 174
Query: 986 VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS-CIV 1041
+ K DV+S+GV E G P M + + ML+ RLP P C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGAEVI------AMLESGERLPRPEECP- 224
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
I + +SC PE RPT ++ +
Sbjct: 225 ----QEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 28/201 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 876
IG+G G+VY A ++A+G+ VA+K +M QQ+ +NE+ + E +H NI
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 877 VKF---YGFCSHVRHSLAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMHNDCF 927
V + Y + + M + D+ M+ V + AL ++H++
Sbjct: 79 VNYLDSYLVGDEL--WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 987
++HRDI S N+LL D ++DFG + P+ S + + GT ++APE+
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 988 EKCDVYSFGVLALEVIKGKHP 1008
K D++S G++A+E+++G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKK---FHSPLPGEMT---FQQEFLNEVK 866
+F E IGKG VYKA L G +VA+KK F EM +Q+ L E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF------EMMDAKARQDCLKEID 54
Query: 867 ALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRM----------------- 909
L ++ H N++K+ S + ++ I+ A A DL RM
Sbjct: 55 LLKQLDHPNVIKYLA--SFIENNELNIVLELADAGDL---SRMIKHFKKQKRLIPERTIW 109
Query: 910 NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
+ AL +MH+ I+HRDI NV + + D G+ +F ++ L
Sbjct: 110 KYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
GT Y++PE + K D++S G L E+ + P + M+ SL I +
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEKCDY 225
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P P+ ++L +V C++ +PE RP + V Q+ K
Sbjct: 226 ----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 36/245 (14%)
Query: 842 VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR--HSLAMILSNNAA 899
VA+K G M+ + EF+ E K + ++ H +V+ YG C+ R + + +SN
Sbjct: 31 VAIKMIKE---GSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 900 AKDLGWTRR-------MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952
L + + + K + + ++Y+ + F +HRD++++N L+D VSD
Sbjct: 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSD 143
Query: 953 FGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008
FG+++++ D +T G+ + PE+ K + K DV++FGVL EV GK P
Sbjct: 144 FGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
Query: 1009 RDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPK 1068
+ + N RL P + +K+ +I+ SC E E RPT
Sbjct: 202 YERFN-------NSETVEKVSQGLRLYRPH-LASEKVYAIM---YSCWHEKAEERPTF-- 248
Query: 1069 VSQLL 1073
QLL
Sbjct: 249 -QQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 75/276 (27%), Positives = 132/276 (47%), Gaps = 36/276 (13%)
Query: 820 EHCIGKGGQGSVYKAEL--ASGEIVAVKK--FHSPLPGEMTFQQE-----FLNEVKALTE 870
EH +G G G VYK ++A+K+ H+P G+ +++ ++EV + E
Sbjct: 6 EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 871 -IRHRNIVKFY-GFCSHVRHSLAMILSNNAAAKDLGWT-----------RRMNVIKGISD 917
+RH NIV++Y F + R + M L A + + R N+ +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
AL Y+H + IVHRD++ N++L D++ ++DFG+AK K S T + GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
PE+ EK DV++FG + ++ P + ++M S + + A+ E P P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVEAVYE------PLP 234
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + + ++ SCL + E+RP + +VS ++
Sbjct: 235 EGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 38/263 (14%)
Query: 823 IGKGGQGSVYKAELAS--GEI--VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G G V + E ++ G++ VAVK S ++ +FL E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 879 FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG------------ISDALSYMHNDC 926
YG V M+++ A L R + + I++ + Y+ +
Sbjct: 61 LYGV---VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYT 983
F +HRD++++N+LL D++ + DFG+ + L + ++ L + + APE T
Sbjct: 118 F---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 984 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
+ DV+ FGV E+ G+ P + S L +D+ + RL P Q
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILK---KIDKEGE-RLERPEACPQ 228
Query: 1043 DKLISIVEVAISCLDENPESRPT 1065
D I V + C NP RPT
Sbjct: 229 D----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 76/270 (28%), Positives = 135/270 (50%), Gaps = 39/270 (14%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 876
IG+G G+VY A ++A+G+ VA++ +M QQ+ +NE+ + E ++ NI
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAK--DLGWTRRMN------VIKGISDALSYMHNDCFP 928
V + V L +++ A D+ M+ V + AL ++H++
Sbjct: 80 VNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
++HRDI S N+LL D ++DFG + P+ S + + GT ++APE+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 989 KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048
K D++S G++A+E+I+G+ P +++ +L L IA + P L P +KL +I
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP--YLNENPLRALYL-IATNGT--PELQNP-----EKLSAI 245
Query: 1049 VEVAIS-CLDENPESRPTMPKV--SQLLKI 1075
++ CLD + E R + ++ Q LKI
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 65/268 (24%), Positives = 123/268 (45%), Gaps = 34/268 (12%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
R +F E +G G G V++ + VA+K S ++ QQ+F EV+AL +
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRL 59
Query: 872 RHRNIVKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
RH++++ + CS + + + + L +++ +++ ++Y
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD--SSNWTELAGTYGYVAPE 979
+ +HRD++++N+L+ D V+DFG+A+ +K D S+ ++ Y + APE
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPE 174
Query: 980 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDE-MLDPRLPTP 1037
A + K DV+SFG+L E+ G+ P +N + D+ R+P P
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYP--------GMNNHEVYDQITAGYRMPCP 226
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPT 1065
+ Q I ++ + C PE RP+
Sbjct: 227 AKCPQ----EIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 64/264 (24%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ + + VA+K + G M+ +++F+ E K + ++ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMS-EEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 883 CSHVR--HSLAMILSN----NAAAKDLGWTRR---MNVIKGISDALSYMHNDCFPPIVHR 933
C+ + + + + N N + G + +++ + + + + Y+ + F +HR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF---IHR 124
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEKC 990
D++++N L+ VSDFG+ +++ D +T +G + PE+ K + K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 991 DVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049
DV+SFGVL EV +GK P F + + + + P+L + +++
Sbjct: 183 DVWSFGVLMWEVFTEGKMP--FEKKSNYEVVEMISRGFRLYRPKLAS---------MTVY 231
Query: 1050 EVAISCLDENPESRPTMPKVSQLL 1073
EV SC E PE RPT ++ + +
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQ--EFL-NEVKALTEI 871
D+ IG+G G V A + ++G VAVKK ++ QQ E L NEV + +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73
Query: 872 RHRNIVKFYGFCSH-VRHSLAMILS--NNAAAKDLGWTRRMN------VIKGISDALSYM 922
+H NIV+ Y S+ V L +++ A D+ RMN V + ALS++
Sbjct: 74 QHPNIVEMYS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H ++HRDI S ++LL D +SDFG + + L GT ++APE+
Sbjct: 132 HAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ + D++S G++ +E++ G+ P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 68/266 (25%), Positives = 108/266 (40%), Gaps = 46/266 (17%)
Query: 823 IGKGGQGSVYKA----ELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G G G+VYK E +I VA+K + +E L+E + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHVV 72
Query: 878 KFYGFCSHVRHSLAMIL----------SNNAAAKD----LGWTRRMNVIKGISDALSYMH 923
+ G C + L L N+ L W + I+ +SY+
Sbjct: 73 RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELA 981
+VHRD++++NVL+ ++DFG+AK L D + G ++A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 982 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS-C 1039
T K DV+S+GV E++ G P + I ++ L RLP P C
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-------GERLPQPPIC 236
Query: 1040 IVQDKLISIVEVAISCLDENPESRPT 1065
I + V + C + ESRPT
Sbjct: 237 T-----IDVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK--- 878
IG+G G VYKA + +GEIVA+KK + L E+K L E+ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 879 -------FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
Y + L ++ + L + + + + L++ H+ I+
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKC 990
HRD+ +N+L++ + ++DFG+A+ +T T Y APEL K +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 991 DVYSFGVLALEVIKGK 1006
D++S G + E++ +
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G V+KA + +GE VA+KK E + L E+KAL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 882 FCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
H + L+ +L + + ++ + ++YMH + I+
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN---GIM 121
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAY-TMKVTEK 989
HRD+ N+L+ D ++DFG+A+ + ++ T Y APEL Y K
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 990 CDVYSFGVLALEVIKG 1005
D+++ G + E++ G
Sbjct: 182 VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-R 872
+DF IG+G +V A E + + A+K + + E + LT +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 873 HRNIVKFYGFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSY 921
H I+K Y + +L +L + D TR I AL Y
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR--FYAAEILLALEY 117
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA----------- 970
+H+ I+HRD+ +N+LLD D ++DFG AK L P+SS +
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 971 ---------GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
GT YV+PEL + D+++ G + +++ GK P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 67/259 (25%), Positives = 126/259 (48%), Gaps = 38/259 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V++ + VAVK PG M ++FL E + + ++RH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 883 CSH----------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
C+ +++ SL L A + L + +++ ++ ++Y+ + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 990
HRD++++NVL+ +N V+DFG+A+ +K D E A + APE A + + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 991 DVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTP-SCIVQDKLI 1046
DV+SFG+L E++ G+ P M+ N + + +D R+P P C +
Sbjct: 186 DVWSFGILLTEIVTYGRMP---YPGMT------NAEVLQQVDQGYRMPCPPGCPKE---- 232
Query: 1047 SIVEVAISCLDENPESRPT 1065
+ ++ + C E+P+ RPT
Sbjct: 233 -LYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 39/274 (14%)
Query: 820 EHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 874
+ IG G G V++ L VA+K PG Q Q+FL+E + + H
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK---PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 875 NIVKFYGFCSHVRHSLAMILS----NNAAAK-------DLGWTRRMNVIKGISDALSYMH 923
NI++ G + + AMI++ N A K + + + +++GI+ + Y+
Sbjct: 67 NIIRLEGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-SSNWTELAGTYG--YVAPEL 980
+ + VHRD++++N+L++ + E VSDFG+++ L+ D +T G + APE
Sbjct: 125 DMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 981 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
K T DV+SFG++ EV+ G+ P S+ + A+++ RLP P
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP-----YWDMSNHEVMKAINDGF--RLPAP-- 232
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
D ++ ++ + C ++ RP + LL
Sbjct: 233 --MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 65/265 (24%), Positives = 121/265 (45%), Gaps = 50/265 (18%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ VAVK PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 883 CS----------HVRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
CS ++ SL L + K L + +++ I++ ++Y+ + + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRNY---I 125
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----------WTELAGTYGYVAPELA 981
HRD++++N+L+ + ++DFG+A+ ++ D WT APE A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEAA 176
Query: 982 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ T K DV+SFG+L E++ G+ P M++ + + R+P P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP---YPGMTNREVLEQV----ERGYRMPRPPNC 229
Query: 1041 VQDKLISIVEVAISCLDENPESRPT 1065
+ + ++ + C D++PE RPT
Sbjct: 230 PE----ELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 50/279 (17%)
Query: 820 EHCIGKGGQGSVYKAEL---ASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
E IG G G V + L EI VA+K + + + +FL E + + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTEASIMGQFDHPN 66
Query: 876 IVKFYGFCSHVRHSLAMI----LSNNAAAK-------DLGWTRRMNVIKGISDALSYMHN 924
I++ G + R MI + N + K + + +++GI+ + Y+
Sbjct: 67 IIRLEGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG--YVAPE-LA 981
+ VHRD++++N+L++ + VSDFG+++ L+ + +T G + APE +A
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 982 YTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSMSSSSLNLNIALDEMLDPRL 1034
Y K T DV+SFG++ EV+ G+ P +D I ++ RL
Sbjct: 182 YR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------------GYRL 227
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
P P D ++ ++ + C ++ RPT ++ L
Sbjct: 228 PPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 35/264 (13%)
Query: 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 873
F H IG G G+VY A + + E+VAVKK G+ T + Q+ + EVK L +++H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 874 RNIVKFYGFCSHVRHSLAMILSNN-AAAKDLGWTRR--------MNVIKGISDALSYMHN 924
N +++ G C H+ +++ +A DL + + G L+Y+H+
Sbjct: 81 PNTIEYKG-CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
++HRDI + N+LL + ++DFG A P +S GT ++APE+ M
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAM 192
Query: 985 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
+ K DV+S G+ +E+ + K P + +M++ S +IA ++ +P+
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND-------SPTLQS 242
Query: 1042 QDKLISIVEVAISCLDENPESRPT 1065
+ S CL + P+ RP
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 65/286 (22%), Positives = 123/286 (43%), Gaps = 53/286 (18%)
Query: 823 IGKGGQGSVYKAELASG------EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ E E+VAVK + +++F E + LT +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--RKDFEREAELLTNFQHENI 70
Query: 877 VKFYGFC-----------------------SHVRHSLAMILSNNAAAKDLGWTRRMNVIK 913
VKFYG C SH A + S ++ +L ++ + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD-AAFLKSPDSPMGELTLSQLLQIAV 129
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT- 972
I+ + Y+ + F VHRD++++N L+ +D + DFG+++ + ++++ + G
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHT 184
Query: 973 ---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDE 1028
++ PE K T + DV+SFGV+ E+ GK P +S+ + I
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYGLSNEEVIECITQGR 241
Query: 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+L PS + ++ + C +P+ R + + + L+
Sbjct: 242 LLQRPRTCPS--------EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-17
Identities = 47/112 (41%), Positives = 63/112 (56%), Gaps = 5/112 (4%)
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI 449
L L L G IP+ + L +L +++L NS+ G+IP G++ SL L L YN +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 450 PHSLGNLTNLDALYLYDNSLSGSIPGEIGNL---RSISNLALNNNKLSGSIP 498
P SLG LT+L L L NSLSG +P +G R+ N +N L G IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT-DNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 35/264 (13%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 873
F D IG G G+VY A ++ + E+VA+KK G+ + + Q+ + EV+ L ++RH
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 874 RNIVKFYGFCSHVRHSLAMILSNN-AAAKDLGWTRR--------MNVIKGISDALSYMHN 924
N +++ G C H+ +++ +A DL + V G L+Y+H+
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
++HRD+ + N+LL + DFG A + P + GT ++APE+ M
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186
Query: 985 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
+ K DV+S G+ +E+ + K P + +M++ S +IA +E P L +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPALQSGHW-- 239
Query: 1042 QDKLISIVEVAISCLDENPESRPT 1065
+ + V+ SCL + P+ RPT
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-17
Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 31/262 (11%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F D IG G G+VY A ++ + E+VA+KK Q+ + EVK L I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 876 IVKFYGFCSHVRHSLAMILSNN-AAAKDLGWTRR--------MNVIKGISDALSYMHNDC 926
+++ G C H+ +++ +A DL + + G L+Y+H+
Sbjct: 87 SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH- 144
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 986
++HRDI + N+LL + ++DFG A P +S GT ++APE+ M
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDE 198
Query: 987 TE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
+ K DV+S G+ +E+ + K P + +M++ S +IA +E P L + D
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPTLQSNEW--SD 251
Query: 1044 KLISIVEVAISCLDENPESRPT 1065
+ V+ SCL + P+ RPT
Sbjct: 252 YFRNFVD---SCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 46/113 (40%), Positives = 61/113 (53%), Gaps = 24/113 (21%)
Query: 318 LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSI 377
L + N L G IP++I LR L ++ LSGN + G+IPPS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS--------------------- 461
Query: 378 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG 430
LG++ SL +L L YN +GSIP SLG LT+L L+L NSLSG +P+ G
Sbjct: 462 ---LGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 75/282 (26%), Positives = 116/282 (41%), Gaps = 60/282 (21%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKF-HSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V +GE VAVK HS GE + +F E++ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68
Query: 877 VKFYGFC-SHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
VK+ G C SL +I L + +L R + I + Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLG 126
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV------- 976
+ +HRD++++N+L++ ++ +SDFG+AK L D Y YV
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGESP 175
Query: 977 ----APELAYTMKVTEKCDVYSFGVLALEVI----KGKHPRDFISSMSSSSLNLNIALD- 1027
APE T K + DV+SFGV E+ + P M + I
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 1028 -EMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
E+L RLP P SC + + ++ C + P+ RP+
Sbjct: 236 LELLKEGERLPRPPSCPDE-----VYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK--KFHSPLPGEM-TFQQEFLNEVKALTEIRHRNIVK 878
+G G S Y+A ++ +G ++AVK + E + E++ + + H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 879 FYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
G H S++ +LS A K+ +N + + LSY+H +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 928 PPIVHRDISSKNVLLDFDNE-AHVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAY 982
I+HRD+ N+L+D + ++DFG A L + E L GT ++APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
+ CDV+S G + +E+ K P + + S+ L L + P +
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWN--AEKHSNHLALIFKIASATTAP-SIPEHLSP 238
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ +V + CL+ PE R P +LLK
Sbjct: 239 G----LRDVTLRCLELQPEDR---PPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 26/200 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 876
IG+G G+VY A ++A+G+ VA+K +M QQ+ +NE+ + E ++ NI
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAK--DLGWTRRMN------VIKGISDALSYMHNDCFP 928
V + V L +++ A D+ M+ V + AL ++H++
Sbjct: 79 VNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
++HRDI S N+LL D ++DFG + P+ S + + GT ++APE+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 989 KCDVYSFGVLALEVIKGKHP 1008
K D++S G++A+E+++G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 48/273 (17%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH---RNIVK 878
IG+G G+VY+ + +G +VA+K + P + + EV L+++R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV--SDIQREVALLSQLRQSQPPNITK 66
Query: 879 FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN------------VIKGISDALSYMHNDC 926
+YG L +I+ G R + +I+ + AL Y+H
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEG----GSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV- 120
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 981
++HRDI + N+L+ + DFG+A L +SS + GT ++APE+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
Y K D++S G+ E+ G P + + + L + + PRL
Sbjct: 179 YDTKA----DIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLEDNG--- 226
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
KL+ E +CLDE P+ R + +LLK
Sbjct: 227 YSKLLR--EFVAACLDEEPKERLS---AEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 74/292 (25%), Positives = 116/292 (39%), Gaps = 55/292 (18%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
N ++ +G+G G V K A+GEIVA+KKF E ++ L EVK L ++RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRH 59
Query: 874 RNIVKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
NIV V +L +L + R I + A++Y H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH 117
Query: 924 -NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPEL- 980
++ I+HRDI +N+L+ + DFG A+ L+ +S T+ T Y APEL
Sbjct: 118 SHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 981 ----AYTMKVTEKCDVYSFGVLALEVIKGK--HPRD---------------FISSM---- 1015
Y V DV++ G + E++ G+ P D S
Sbjct: 174 VGDTNYGKPV----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 1016 SSSSLNLNIALDEML--DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065
SS+ +A E + V + ++ +CL +P+ R T
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK---ACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 35/257 (13%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
IG G G V+ VA+K G M+ +++F+ E + + ++ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 883 CSHVRHSLAMILS--NNAAAKDLGWTRR--------MNVIKGISDALSYMHNDCFPPIVH 932
C+ R + ++ + D +R + + + + ++Y+ + +H
Sbjct: 68 CTE-RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IH 123
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEK 989
RD++++N L+ + VSDFG+ +F+ D +T GT + +PE+ K + K
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 990 CDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048
DV+SFGVL EV +GK P + S+ S +N + PRL + S+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGF-RLYKPRLASQ---------SV 230
Query: 1049 VEVAISCLDENPESRPT 1065
E+ C E PE RP+
Sbjct: 231 YELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 46/276 (16%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLN---EVKALTEIRHRNIVKF 879
+GKG G+VY G+++AVK+ + ++E+ EV L ++H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 880 YGFCSHVR-----------HSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
G C S++ IL+ + + + K I D ++Y+HN+C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE------LAGTYGYVAPELAY 982
+VHRDI NV+L + + DFG A+ L + T + GT ++APE+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
K D++S G E+ GK P ++SM + I L PRLP
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPD------ 232
Query: 1043 DKLISIVEVAI----SCLDENPESRPTMPKVSQLLK 1074
S AI SCL + RP+ QLL+
Sbjct: 233 ----SFSAAAIDFVTSCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 41/269 (15%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIR------HR 874
IGKG G VY A + +GE++AVK+ P + VKAL +EI H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRM------NVIKGISD----ALSYMHN 924
NIV++ GF L++ L +G R +++ ++ L+Y+H+
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEY-VPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP--DSSNWTELAGTYGYVAPEL-- 980
I+HRD+ + N+L+D D +SDFGI+K D+ + G+ ++APE+
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+Y+ + K D++S G + LE+ G+ P S A+ ++ + R P I
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPW--------SDEEAIAAMFKLGNKRSAPP--I 233
Query: 1041 VQDKLISIVEVAISCLDE----NPESRPT 1065
D +++ VA+ L+ NP++RPT
Sbjct: 234 PPDVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 33/262 (12%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
IG+G G+V + E +G+ VAVK + Q FL E +T++ H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA-----QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 883 CSHVRHSLAMILSNNAAAKDLGWTR---RMNVIK------GISDALSYMHNDCFPPIVHR 933
H + M L + + TR ++VI+ +++ + Y+ + +VHR
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
D++++N+L+ D A VSDFG+A+ + + ++L + APE K + K DV+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKSDVW 181
Query: 994 SFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052
S+GVL EV G+ P MS + + ++P P+ + +
Sbjct: 182 SYGVLLWEVFSYGRAP---YPKMSLKEVKECVEKGYRMEPPEGCPA--------DVYVLM 230
Query: 1053 ISCLDENPESRPTMPKVSQLLK 1074
SC + P+ RP+ K+ + L+
Sbjct: 231 TSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 44/280 (15%)
Query: 820 EHCIGKGGQGSVYKAEL---ASGEI-VAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 873
E IG G G V + L EI VA+K L T +Q +FL+E + + H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKT----LKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN-----------VIKGISDALSYM 922
NI+ G + R MI++ L R N +++GI+ + Y+
Sbjct: 65 PNIIHLEGVVTKSRP--VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVA 977
+ VHRD++++N+L++ + VSDFG+++FL+ D+S+ T + G + A
Sbjct: 123 SEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036
PE K T DV+S+G++ EV+ G+ P MS+ + +N A+++ D RLP
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDV-IN-AIEQ--DYRLPP 232
Query: 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPK-VSQLLKI 1075
P D ++ ++ + C ++ +RP + VS L K+
Sbjct: 233 P----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 50/290 (17%)
Query: 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
T F+ IG+G G VYKA +G++VA+K E ++E N ++ +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-YNILRKYSN- 61
Query: 872 RHRNIVKFYG-------FCSHVRHSLAMILSNNAAAKDL-----GWTRRMN------VIK 913
H NI FYG + + L M L + DL +R+ +++
Sbjct: 62 -HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS--DFGIAKFLKPDSSNWTELAG 971
L+Y+H + ++HRDI +N+LL A V DFG++ L G
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILL--TKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175
Query: 972 TYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026
T ++APE+ + + + DV+S G+ A+E+ GK P + M AL
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------AL 227
Query: 1027 DEMLDPRLPTPSCIVQDKLIS--IVEVAISCLDENPESRPTMPKVSQLLK 1074
PR P P+ + + S + CL +N E RP M +LL+
Sbjct: 228 --FKIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFM---EELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 7e-16
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G VYKA +GE+VA+KK + F + E+K L ++RH NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 882 FC-SHVRHSLAMIL---SNNAAAKDL-GWTRRMNV------IKGIS----DALSYMHNDC 926
S + S+ M+ + DL G V IK + L Y+H++
Sbjct: 66 IVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-NWTELAGTYGYVAPEL----- 980
I+HRDI N+L++ D ++DFG+A+ +S ++T T Y PEL
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGK 1006
Y +V D++S G + E+ GK
Sbjct: 178 RYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKG G V+K + + ++VA+K L ++ E+ L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 882 FCSHVRHS-LAMILSNNAAAKDLGWTRR--------MNVIKGISDALSYMHNDCFPPIVH 932
S+++ + L +I+ L R ++K I L Y+H++ +H
Sbjct: 70 --SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIH 124
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDV 992
RDI + NVLL + ++DFG+A L GT ++APE+ K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 993 YSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052
+S G+ A+E+ KG+ P S M + I P+ P+ + + E
Sbjct: 185 WSLGITAIELAKGEPPN---SDMHPMRVLFLI-------PKNNPPT-LTGEFSKPFKEFI 233
Query: 1053 ISCLDENPESRPTMPKVSQLLK 1074
+CL+++P RPT +LLK
Sbjct: 234 DACLNKDPSFRPT---AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-16
Identities = 110/348 (31%), Positives = 153/348 (43%), Gaps = 43/348 (12%)
Query: 82 HNQLYGNIPPQIGNI-----SRLKYLDLSSNLFFG--TIPPEIGHLSYLKTLQLFENQLN 134
N+L N+ + SRL LDL S + +L L +L L N+L
Sbjct: 47 VNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLR 106
Query: 135 GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRS 194
+I E+ L++L L L +N + D+ P SNL L L DN + +PS NL +
Sbjct: 107 SNIS-ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPN 164
Query: 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254
L L L +N S +P L NL+NL L L N + D +P E+ L +L L L N +
Sbjct: 165 LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII 222
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314
+ S NL++LS L L NKL +P S+GNL+N
Sbjct: 223 -------------------------ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSN 256
Query: 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF 374
L TL + NN + S S +G+L +L L LSGN LS ++P L L L N L
Sbjct: 257 LETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLL 311
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
EL L ++ N S P +L L +L L DN+L
Sbjct: 312 TLKALELKLNSILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 878
IG+G G V A E SG VAVK ++ QQ NEV + + +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 879 FYGFCSHVRHSLAMILS--NNAAAKDLGWTRRMN------VIKGISDALSYMHNDCFPPI 930
Y V L +++ A D+ R+N V + + AL Y+H+ +
Sbjct: 83 MYK-SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GV 138
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
+HRDI S ++LL D +SDFG + D L GT ++APE+ +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 991 DVYSFGVLALEVIKGKHP 1008
D++S G++ +E++ G+ P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 42/268 (15%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHRNIVKF 879
+GKG GSVYK + L+ + A+K+ G M+ ++ + +NE++ L + H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL---GSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 880 Y-------GFCSHVRHS----LAMILSNNAAAK-----DLGWTRRMNVIKGISDALSYMH 923
C + ++ L+ +S + W + +++G L +H
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALH 120
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
I+HRD+ S N+LL ++ + D GI+K LK + + T++ GT Y+APE+
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKG 175
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
+ K D++S G L E+ P + S L + + P +P I
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKY--PPIPP---IYSQ 227
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071
L + + S L P+ RP K+
Sbjct: 228 DLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 23/194 (11%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IGKG G V + G VAVK + Q FL E +T++RH N+V+
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQL 64
Query: 880 YGFCSHVRHSLAMILSNNAAAK--DLGWTRRMNVIKG---------ISDALSYMHNDCFP 928
G + L ++ A D +R +V+ G + +A+ Y+ + F
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF- 123
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
VHRD++++NVL+ DN A VSDFG+ K SS + APE K +
Sbjct: 124 --VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 989 KCDVYSFGVLALEV 1002
K DV+SFG+L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK-FY 880
+GKG G V + +G++ A+K + + L E L+ I H IVK Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 881 GFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
F L ++L + R I AL Y+H+
Sbjct: 61 AF--QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLHSL---G 113
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMK 985
I++RD+ +N+LLD D ++DFG+AK L + S GT Y+APE+ Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 986 VTEKCDVYSFGVLALEVIKGKHP 1008
V D +S GVL E++ GK P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 59/290 (20%)
Query: 817 FDDEHCI-----GKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLN 863
F++ H GKG GSV EL +GE+VAVKK ++F
Sbjct: 1 FEERHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFER 54
Query: 864 EVKALTEIRHRNIVKFYGFC-SHVRHSLAMI------------LSNNAAAKDLGWTRRMN 910
E++ L ++H NIVK+ G C S R +L ++ L + D R++
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLL 111
Query: 911 VIKG-ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
+ I + Y+ + + VHRD++++N+L++ +N + DFG+ K L D +
Sbjct: 112 LYASQICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168
Query: 970 ----AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSMSSSSL 1020
+ + Y APE K + DV+SFGV+ E+ K P +F+ M +
Sbjct: 169 EPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227
Query: 1021 NLNIA--LDEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
I L E+L RLP P C + I + C + +P RP+
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAE-----IYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-15
Identities = 39/89 (43%), Positives = 56/89 (62%)
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII 305
L L L G IP+ + L +L ++ L NS+ G+IP G++ SL +L+L YN NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 306 PHSLGNLTNLATLYIHNNSLSGSIPSEIG 334
P SLG LT+L L ++ NSLSG +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 35/266 (13%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ VAVK PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMS-PESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 883 CS---------HVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHR 933
S ++ + + + L +++ ++ ++Y+ + +HR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHR 126
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEKC 990
D+ S N+L+ ++DFG+A+ + + + +T G + APE A + T K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 991 DVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEM-LDPRLPTPSCIVQDKLISI 1048
DV+SFG+L E++ KG+ P +N L+++ R+P P QD IS+
Sbjct: 185 DVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPISL 232
Query: 1049 VEVAISCLDENPESRPTMPKVSQLLK 1074
E+ + C ++PE RPT + L+
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 22/198 (11%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 878
IG+G G V A + +SG++VAVKK ++ QQ NEV + + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 879 FYGFCSHVRHSLAMILS--NNAAAKDLGWTRRMN------VIKGISDALSYMHNDCFPPI 930
Y V L +++ A D+ RMN V + ALS +H +
Sbjct: 82 MYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GV 137
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
+HRDI S ++LL D +SDFG + + L GT ++APEL + +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 991 DVYSFGVLALEVIKGKHP 1008
D++S G++ +E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 43/272 (15%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+GKG G V+K L VAVK LP E+ + FL+E + L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60
Query: 883 CSHVRHSLAMILSNNAAAKDLGWTRRM-------NVIKGISDALSYMHNDCFPPIVHRDI 935
C+ R + +++ L + R+ ++K DA + M +HRD+
Sbjct: 61 CTQ-RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 936 SSKNVLLDFDNEAHVSDFGIAK----------FLKPDSSNWTELAGTYGYVAPELAYTMK 985
+++N L+ +N +SDFG+++ LK WT APE +
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------APEALNYGR 170
Query: 986 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQD 1043
+ + DV+S+G+L E F + N E ++ R+ P D
Sbjct: 171 YSSESDVWSYGILLWET--------FSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD 222
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLKI 1075
+ +V C D PE+RP ++ + L
Sbjct: 223 ----VYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 3e-15
Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 16/195 (8%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G+V+ A ++A+G+ VA+K+ + + ++ +NE+ + E+++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 882 FCSHVRHSLAMILSNNAAAK--DLGWTRRMN------VIKGISDALSYMHNDCFPPIVHR 933
V L +++ A D+ M+ V + AL ++H + ++HR
Sbjct: 84 -SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHR 139
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
DI S NVLL D ++DFG + P+ S + + GT ++APE+ K D++
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 994 SFGVLALEVIKGKHP 1008
S G++A+E+++G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 27/199 (13%)
Query: 820 EHCIGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+H +G G G VY+ VAVK L + +EFL E + EI+H N+V+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 879 FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN-----------VIKGISDALSYMHNDCF 927
G C+ +I L + R N + IS A+ Y+ F
Sbjct: 67 LLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE-LAYT 983
+HRD++++N L+ ++ V+DFG+++ + D+ +T AG + APE LAY
Sbjct: 126 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 180
Query: 984 MKVTEKCDVYSFGVLALEV 1002
K + K DV++FGVL E+
Sbjct: 181 -KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-15
Identities = 40/89 (44%), Positives = 57/89 (64%)
Query: 414 LDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSI 473
L L + L G IP++ LR L +++L N + G+IP SLG++T+L+ L L NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 474 PGEIGNLRSISNLALNNNKLSGSIPQSLG 502
P +G L S+ L LN N LSG +P +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 34/205 (16%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
+G+G G VYKA + +GEIVA+KK E L E+ L E++H NIVK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-GIPSTALREISLLKELKHPNIVKLL 64
Query: 881 GFCSHVR----------HSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHNDC 926
R L L L N+IK I L+Y H+
Sbjct: 65 DVIHTERKLYLVFEYCDMDLKKYLDKRP--GPL----SPNLIKSIMYQLLRGLAYCHSHR 118
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 981
I+HRD+ +N+L++ D ++DFG+A+ +T T Y APE+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGK 1006
Y+ V D++S G + E+I GK
Sbjct: 176 YSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-15
Identities = 39/82 (47%), Positives = 52/82 (63%)
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
L G IP++ LR L +NL N + G IP SLG++T+L L + NS +GSIP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 337 RSLSNLGLSGNKLSGSIPPSLG 358
SL L L+GN LSG +P +LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 878
IG+G G V A E +G+ VAVKK ++ QQ NEV + + H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 879 FY-GFCSHVRHSLAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMHNDCFPPIV 931
Y + + M A D+ RMN V + ALSY+HN ++
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCD 991
HRDI S ++LL D +SDFG + + L GT ++APE+ + + D
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 992 VYSFGVLALEVIKGKHP 1008
++S G++ +E+I G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 34/275 (12%)
Query: 824 GKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
G G+ S+Y + A +GE+VAVK + T + E+ L + H NIVK+
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIVKYK 72
Query: 881 GFCSHV-RHSLAMI--------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
G CS L +I L + L + + + I + ++Y+H+ + +
Sbjct: 73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY---I 129
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMKVT 987
HRD++++NVLLD D + DFG+AK + P+ + + + A E K +
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENKFS 188
Query: 988 EKCDVYSFGVLALEVI-----KGKHPRDFISSMSSSSLNLN-IALDEMLD--PRLPTPSC 1039
DV+SFGV E++ K P+ F + + + L E+L+ RLP P
Sbjct: 189 YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKN 248
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
Q+ + + +C + + RPT + +LK
Sbjct: 249 CPQE----VYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-14
Identities = 39/92 (42%), Positives = 57/92 (61%)
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518
+D L L + L G IP +I LR + ++ L+ N + G+IP SLG++++L +L L NS
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 519 DSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550
SIP LG L SL +L+ N LSG +P +LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 49/274 (17%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G V+ L A VAVK LP ++ + +FL E + L + H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 882 FCSHVRHSLAMILSNNAAAKDLGWTR----RMNV---IKGISDA---LSYMHNDCFPPIV 931
C+ + + +++ L + R R+ V I+ + +A + Y+ + +
Sbjct: 61 VCTQ-KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG-----------YVAPEL 980
HRD++++N L+ N +SDFG+++ E G Y + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 981 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
+ + + DV+SFG+L E G P +S+ + A+++ + RLP P
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGV--RLPCPE- 219
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ D + ++E C + +P RP+ V Q L
Sbjct: 220 LCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 43/272 (15%)
Query: 823 IGKGGQGSVYKAE------LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G G G VYKA+ A+ +I+ ++ E+ ++F+ E+ L+E +H NI
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-----EEEL---EDFMVEIDILSECKHPNI 64
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAKD---LGWTRRMN------VIKGISDALSYMHNDCF 927
V Y + +I + A D L R + V + + +AL+++H+
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH-- 122
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY--TMK 985
++HRD+ + N+LL D + ++DFG++ K GT ++APE+ T K
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 986 VTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
K D++S G+ +E+ + + P ++ + L I E P L PS
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPH---HELNPMRVLLKILKSE--PPTLDQPSKWSS 236
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
S + SCL ++P+ RPT ++LLK
Sbjct: 237 ----SFNDFLKSCLVKDPDDRPT---AAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 59/197 (29%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKGG G V ++ A+G++ A KK + +Q LNE K L ++ R IV Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 881 GFCSHVRHSLAMILSN---------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
F + L M L N N R + I L ++H IV
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCD 991
+RD+ +NVLLD +SD G+A L AGT GY+APE+ D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 992 VYSFGVLALEVIKGKHP 1008
++ G E+I G+ P
Sbjct: 177 WFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 51/275 (18%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKF 879
+G G GSVY+ L G+ AVK+ G+ + ++ E+ L++++H NIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 880 YG----------FCSHVRH-SLAMILSNNAAAKD---LGWTRRMNVIKGISDALSYMHND 925
G F V SLA +L + + +TR+ I L Y+H+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR 121
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 980
VHRDI N+L+D + ++DFG+AK + + S G+ ++APE+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
Y + D++S G LE+ GK P S + + I + L P +P
Sbjct: 178 GYGLAA----DIWSLGCTVLEMATGKPP---WSQLEGVAAVFKIGRSKEL-PPIP----- 224
Query: 1041 VQDKLISIVEVAIS-CLDENPESRPTMPKVSQLLK 1074
D L + I CL +P RPT ++LL+
Sbjct: 225 --DHLSDEAKDFILKCLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-14
Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 624 LNLSNNQFSRG-IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGL 682
L L +NQ RG IP + +L HL ++LS N +R IP + + SLE L+LS+NS G
Sbjct: 423 LGL-DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 683 IPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEA----LQGNKGLCGDVKGLPSCK 738
IP ++ L ++++ N L G +P ++ R + N GLCG + GL +C
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR--LLHRASFNFTDNAGLCG-IPGLRAC- 537
Query: 739 TLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQ 786
+ KI + VA L +I ++RR N L+ Q+
Sbjct: 538 --GPHLSVGAKIGIA----FGVSVAFLFLVICAMCWWKRRQNILRAQR 579
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
D + +G G G V+ + S A+K P + +Q NE + L E+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTR---RMNVIKG------ISDALSYMHND 925
I++ + + H + L M++ + + R R + G I AL Y+H+
Sbjct: 62 FIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
IV+RD+ +N+LLD + ++DFG AK L+ WT L GT Y+APE+ +
Sbjct: 121 ---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVIQSKG 174
Query: 986 VTEKCDVYSFGVLALEVIKGKHP 1008
+ D ++ G+L E++ G P
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 45/271 (16%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G+G G V+ VA+K PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 883 CSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVH 932
S + SL L K L + +++ I+ ++Y+ + VH
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VH 125
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEK 989
RD+ + N+L+ + V+DFG+A+ + + + +T G + APE A + T K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 990 CDVYSFGVLALEV-IKGKHPRDFISSMSSSSLNLNIALDEMLDP-----RLPTPSCIVQD 1043
DV+SFG+L E+ KG+ P + + E+LD R+P P +
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVNR------------EVLDQVERGYRMPCPPECPE- 230
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
S+ ++ C + PE RPT + L+
Sbjct: 231 ---SLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 66/268 (24%), Positives = 121/268 (45%), Gaps = 39/268 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G+G G V+ VA+K PG M + FL E + + ++RH +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 883 CSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVH 932
S + SL L K L + +++ I+D ++Y+ + +H
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IH 125
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEK 989
RD+ + N+L+ + ++DFG+A+ + + + +T G + APE A + T K
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 990 CDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQDKLI 1046
DV+SFG+L E++ KG+ P + +N + E ++ R+P P +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGM---------VNREVLEQVERGYRMPCPQGCPE---- 230
Query: 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074
S+ E+ C ++P+ RPT + L+
Sbjct: 231 SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-14
Identities = 37/78 (47%), Positives = 51/78 (65%)
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLS 436
IP+++ LR L ++L N + G+IP SLG++T+L LDL NS +GSIP G L SL
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 437 TLSLGYNKLSGSIPHSLG 454
L+L N LSG +P +LG
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 48/223 (21%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-------FLN 863
R+ +F+ + IG+G G VY+A + SGEIVA+KK + E L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKK--------VRMDNERDGIPISSLR 55
Query: 864 EVKALTEIRHRNIVKF---------------YGFCSHVRHSLAMILSNNAAAKDLGWTRR 908
E+ L +RH NIV+ +C LA +L N
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPT------PFS 106
Query: 909 MNVIKGIS----DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964
+ +K + L Y+H + I+HRD+ N+LL ++DFG+A+ +
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163
Query: 965 NWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 1006
T T Y APEL T D+++ G + E++ K
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-14
Identities = 39/89 (43%), Positives = 53/89 (59%)
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257
L L G IP+ + L +L ++ L NS+ +IP LG++ SL +L L YN +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 258 PHSLGNLTNLATLYLYENSLSGSIPSEFG 286
P SLG LT+L L L NSLSG +P+ G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 43/272 (15%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G G VYKA+ +G + A K + E+ ++++ E++ L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 882 FCSHVRHSLAMILSNNAAAKD---LGWTRRMN------VIKGISDALSYMHNDCFPPIVH 932
MI A D L R + + + + +AL Y+H+ I+H
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133
Query: 933 RDISSKNVLLDFDNEAHVSDFGI-AKFLKP----DSSNWTELAGTYGYVAPELAY--TMK 985
RD+ + NVLL D + ++DFG+ AK +K DS GT ++APE+ TMK
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMCETMK 188
Query: 986 VTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
T K D++S G+ +E+ + + P ++ M + L IA E P L PS
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTLSQPSKWSM 243
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + + LD++PE+RP+ +QLL+
Sbjct: 244 E----FRDFLKTALDKHPETRPS---AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 43/221 (19%)
Query: 823 IGKGGQGSVYKAELAS------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ AE + +VAVK P + +++F E + LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69
Query: 877 VKFYGFC----------SHVRHS-----------LAMILSNN---AAAKDLGWTRRMNVI 912
VKFYG C +++H AMIL + A +LG ++ +++
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG- 971
I+ + Y+ + F VHRD++++N L+ + + DFG+++ + S+++ + G
Sbjct: 130 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184
Query: 972 ---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008
++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 40/89 (44%), Positives = 55/89 (61%)
Query: 222 LYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSI 281
L L N L IP+++ LR L ++L N + G+IP SLG++T+L L L NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 282 PSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310
P G L SL +LNL N L+G +P +LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 31/262 (11%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKG G VYK + + E+VA+K L ++ E+ L++ I ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 882 FCSHVRHS---LAMILSNNAAAKDL------GWTRRMNVIKGISDALSYMHNDCFPPIVH 932
S+++ + + M +A DL T +++ I L Y+H++ +H
Sbjct: 70 --SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDV 992
RDI + NVLL + ++DFG+A L GT ++APE+ K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 993 YSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052
+S G+ A+E+ KG+ P + M L P+ P+ Q E
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVL----------FLIPKNSPPTLEGQYSK-PFKEFV 233
Query: 1053 ISCLDENPESRPTMPKVSQLLK 1074
+CL+++P RPT +LLK
Sbjct: 234 EACLNKDPRFRPT---AKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+F E IG+G VY+A L G VA+KK + + + + E+ L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLG-----WTRRMNVIK---------GISDALS 920
N++K+Y S + + I+ A A DL + ++ +I + AL
Sbjct: 63 NVIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
+MH+ ++HRDI NV + + D G+ +F ++ L GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSC 1039
+ K D++S G L E+ + P + M+ SL I E D P P PS
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI---EQCDYP--PLPSD 231
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++L +V + C++ +PE RP + V + K
Sbjct: 232 HYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 66/268 (24%), Positives = 112/268 (41%), Gaps = 47/268 (17%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFL-NEVKALTEIRHRNIVK 878
+G+G G VY ++ +G +AVK+ P E + L E++ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 879 FYGFCSHVRHSLAMI------------------LSNNAAAKDLGWTRRMNVIKGISDALS 920
+YG C +L++ L+ K +TR+ I + +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQ------ILEGVE 118
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVA 977
Y+H++ IVHRDI N+L D + DFG +K L+ S+ T + GT +++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
PE+ K DV+S G +E++ K P +M++ IA +P+LP
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQPT-NPQLP-- 229
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPT 1065
EN + RP+
Sbjct: 230 ----SHVSPDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 70/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKG G V+K + + ++VA+K L ++ E+ L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 882 -FCSHVRHSLAMILSNNAAAKDL------GWTRRMNVIKGISDALSYMHNDCFPPIVHRD 934
+ + + M +A DL T+ +++ I L Y+H++ +HRD
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRD 126
Query: 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYS 994
I + NVLL E ++DFG+A L GT ++APE+ K D++S
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186
Query: 995 FGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAIS 1054
G+ A+E+ KG+ P + M + L +P PT L VE +
Sbjct: 187 LGITAIELAKGEPPHSELHPMKV------LFLIPKNNP--PTLEGNYSKPLKEFVE---A 235
Query: 1055 CLDENPESRPTMPKVSQLLK 1074
CL++ P RPT +LLK
Sbjct: 236 CLNKEPSFRPT---AKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 58/292 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV---- 877
+G+G G V K + +G+IVA+KKF +M ++ + E++ L ++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-KKIAMREIRMLKQLRHENLVNLIE 67
Query: 878 ------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRM--NVIKGISDALSYMHNDCFPP 929
+ Y V H++ L D R+ +++GI + HN
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI--EFCHSHN----- 120
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTE 988
I+HRDI +N+L+ + DFG A+ L +T+ T Y APEL K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 989 KCDVYSFGVLALEVIKGK--HPRD---------------FISS----MSSSSLNLNIALD 1027
D+++ G L E++ G+ P D I + L + L
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 1028 EM-----LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
E+ L+ R P S +V D +A CL +P+ RP+ SQLL
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLD-------LAKQCLRIDPDDRPS---SSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 862 LNEVKALTEIRHRNIVKFYG-FCSHVRHSLAMILSNN-------AAAKDLGWTRRM--NV 911
LNE+ L+ ++H NI+ +Y F + M +N K + M
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
+ I A+SY+H I+HRDI + N+ L + DFGI+K L + S + G
Sbjct: 107 LFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG 163
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031
T Y++PEL +K K D+++ G + E++ K D +++ LNL + + +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-----ATNPLNLVVKI--VQG 216
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
P S + LIS+V S L ++PE RPT +V
Sbjct: 217 NYTPVVSVYSSE-LISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-13
Identities = 104/296 (35%), Positives = 143/296 (48%), Gaps = 21/296 (7%)
Query: 360 LSNLATLYLYSNSLFDS--IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLY 417
LS L +L L S S S L NL L L L N+L +I L LTNL +LDL
Sbjct: 66 LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLD 124
Query: 418 DNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477
+N+++ P +L L L NK+ S+P L NL NL L L N LS +P +
Sbjct: 125 NNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182
Query: 478 GNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFA 537
NL +++NL L+ NK+S +P + LS L L L NNS+ + S L NL++LS L +
Sbjct: 183 SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 538 YNKLSGSI-----PHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
NKL +L LDLS+N I + LG L L +L L+ N LS + L
Sbjct: 241 NNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS--NALPLI 296
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSEL 648
+L L L + L+ + +KL+ + L+NN S G E L L L
Sbjct: 297 ALLLLLLELLLNLLLTLKALE-----LKLNSILLNNNILSNGETSSPEALSILESL 347
|
Length = 394 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 40/211 (18%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKG G V A + +GE VA+KK + ++ L E+K L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVE--- 63
Query: 882 FCSHVRHSLAMILSNNAAAKD------LGWTRRMNVIKGISD---------------ALS 920
++H M+ + KD L + VIK D AL
Sbjct: 64 ----IKH--IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK--FLK-PDSSNWTELAGTYGYVA 977
Y+H + HRD+ KN+L + D + + DFG+A+ F P + WT+ T Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 978 PEL--AYTMKVTEKCDVYSFGVLALEVIKGK 1006
PEL ++ K T D++S G + EV+ GK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 38/89 (42%), Positives = 54/89 (60%)
Query: 150 LALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSI 209
L L + L IP + L +L +++L NS+ +IP G++ SL +L L YN F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 210 PHSLGNLTNLATLYLHNNSLFDSIPSELG 238
P SLG LT+L L L+ NSL +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 34/265 (12%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ + VAVK PG M+ Q FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 69
Query: 883 CSH-----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
+ + SL L ++ K + + ++ I++ ++Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 990
HRD+ + NVL+ ++DFG+A+ ++ + E A + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 991 DVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SCIVQDKLISI 1048
DV+SFG+L E++ GK P MS+S ++ AL R+P +C + +
Sbjct: 186 DVWSFGILLYEIVTYGKIP---YPGMSNS--DVMSALQRGY--RMPRMENCPDE-----L 233
Query: 1049 VEVAISCLDENPESRPTMPKVSQLL 1073
++ +C E E RPT + +L
Sbjct: 234 YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 72/281 (25%), Positives = 124/281 (44%), Gaps = 51/281 (18%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGE--MTFQQEFLNEVKALTEIR 872
DF+ IG G G VYKA + +GE+ A+K PGE QQE + + + +
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEII----MMKDCK 64
Query: 873 HRNIVKFYGFCSHVRHS---LAMILSNNAAAKD-------LGWTRRMNVIKGISDALSYM 922
H NIV ++G S++R + M + +D L ++ V + L Y+
Sbjct: 65 HSNIVAYFG--SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYL 122
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+ +HRDI N+LL + ++DFG++ + + GT ++APE+A
Sbjct: 123 HSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 983 TMK---VTEKCDVYSFGVLALEVIKGK------HPRDFISSMSSSSLNLNIALDEMLDPR 1033
+ + CD+++ G+ A+E+ + + HP + M+ S+ P+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---------PPK 230
Query: 1034 LPTPSCIVQDKLI---SIVEVAISCLDENPESRPTMPKVSQ 1071
L +DK+ S L +NP+ RPT K+ Q
Sbjct: 231 L-------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 51/287 (17%)
Query: 809 EIIRAT--NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEV 865
+I+R +D++ +G G G VYKA L +GE+ AVK + + Q+ E+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EI 57
Query: 866 KALTEIRHRNIVKFYG-FCSHVRHSLAMILSNNAAAKD-------LGWTRRMNVIKGISD 917
+ E +H NIV ++G + S + + M + +D L + V +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
L+Y+H+ +HRDI N+LL + + ++DFG+A + + GT ++A
Sbjct: 118 GLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174
Query: 978 PELAYTMK---VTEKCDVYSFGVLALEVIKGK------HPRDFISSMSSSSLNLNIALDE 1028
PE+A K + CD+++ G+ A+E+ + + HP + MS S+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ------- 227
Query: 1029 MLDPRLPTPSCIVQDKLI------SIVEVAISCLDENPESRPTMPKV 1069
P+L +DK + V+++ L +NP+ RPT ++
Sbjct: 228 --PPKL-------KDKTKWSSTFHNFVKIS---LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F +GKGG G V ++ A+G++ A KK + + LNE + L ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 876 IVKF-YGFCSHVRHSLAMILSNNAAAK-------DLGWTRRMNVIKG--ISDALSYMHND 925
+V Y + + L + L N K + G+ V I L +H +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
IV+RD+ +N+LLD +SD G+A + P+ GT GY+APE+ +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNER 177
Query: 986 VTEKCDVYSFGVLALEVIKGKHP 1008
T D ++ G L E+I G+ P
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 37/92 (40%), Positives = 56/92 (60%)
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494
+ L L L G IP+ + L +L ++ L NS+ G+IP +G++ S+ L L+ N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
GSIP+SLG L++L IL L NSL +P+ LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 37/89 (41%), Positives = 53/89 (59%)
Query: 294 LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSI 353
L L L G IP+ + L +L ++ + NS+ G+IP +G++ SL L LS N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 354 PPSLGYLSNLATLYLYSNSLFDSIPSELG 382
P SLG L++L L L NSL +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 51/285 (17%)
Query: 817 FDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F+ +G G G VYK + +G++ A+K E +QE +N +K + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRN 64
Query: 876 IVKFYGFCSHVRHS---------LAMILSNNAAAKDLGWTRRMNVIKG---------ISD 917
I +YG + ++ + L M + DL + N +K I
Sbjct: 65 IATYYG--AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
LS++H ++HRDI +NVLL + E + DFG++ L GT ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 978 PELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
PE+ + + K D++S G+ A+E+ +G P + M + L P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----------FLIP 229
Query: 1033 RLPTP---SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
R P P S K S +E SCL +N RPT QL+K
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPT---TEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 823 IGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G GG G V ++ S A+K E Q+ +E + L E H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 882 FCSHVRHSLAMILSNNAAAKDLGWTRRMNV----------IKGISDALSYMHNDCFPPIV 931
++ + M++ +L R I + A Y+HN I+
Sbjct: 61 TFKDKKY-IYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GII 115
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKVT 987
+RD+ +N+LLD + + DFG AK LK WT GT YVAPE+ Y V
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSV- 173
Query: 988 EKCDVYSFGVLALEVIKGKHP 1008
D +S G+L E++ G+ P
Sbjct: 174 ---DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 40/92 (43%), Positives = 54/92 (58%)
Query: 171 LDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230
+D L L + L IP++ LR L ++L N G+IP SLG++T+L L L NS
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 262
SIP LG L SL +L+L N LSG +P +LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 42/220 (19%)
Query: 823 IGKGGQGSVYKAELAS------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ AE + +VAVK + +Q+F E + LT ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 877 VKFYGFCS----------HVRHS-----------LAMIL--SNNAAAKDLGWTRRMNVIK 913
V+FYG C+ ++RH A IL + A L + + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG-- 971
I+ + Y+ + F VHRD++++N L+ + DFG+++ + S+++ + G
Sbjct: 130 QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184
Query: 972 --TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008
++ PE K T + D++SFGV+ E+ GK P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKGG G V ++ A+G++ A KK + + + + E + L ++ R IV Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 881 GFCSHVRHSLAMILSN---------NAAAKDLGWT--RRMNVIKGISDALSYMHNDCFPP 929
F + L M + N N ++ G+ R I L ++H
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 989
I++RD+ +NVLLD D +SD G+A LK S AGT G++APEL +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 990 CDVYSFGVLALEVIKGKHP 1008
D ++ GV E+I + P
Sbjct: 178 VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 43/291 (14%)
Query: 808 EEIIRATNDFDDEHCIGKGGQGSVYK-AELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
E + T+ ++ IGKG G VYK G + AVK + + E+ N ++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-NILQ 73
Query: 867 ALTEIRHRNIVKFYGF------CSHVRHSLAMILSNNAAAKDL--GWTRRMN-------- 910
+L H N+VKFYG + L + L N + +L G
Sbjct: 74 SLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 911 -VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
++ G L ++HN+ I+HRD+ N+LL + + DFG++ L
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 970 AGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024
GT ++APE+ Y +CDV+S G+ A+E+ G P + M I
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHPVKTLFKI 245
Query: 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAIS-CLDENPESRPTMPKVSQLLK 1074
PR P P+ + +K IS CL ++ E+RP+ V+ LL+
Sbjct: 246 -------PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+F E IG+G VY+A L + VA+KK + +Q+ + E+ L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLG-----WTRRMNVIK---------GISDALS 920
N++K+ S + + I+ A A DL + ++ +I + A+
Sbjct: 63 NVIKYLD--SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
+MH+ ++HRDI NV + + D G+ +F ++ L GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSC 1039
+ K D++S G L E+ + P + M+ SL I E D P LPT
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKI---EQCDYPPLPTEH- 232
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+KL +V + C+ +P+ RP + V Q+ K
Sbjct: 233 -YSEKLRELVSM---CIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 28/204 (13%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G+G GSV K L + ++ K + P Q++ L E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPYIVKYYGA 67
Query: 883 CSHVRHSLAMILSNNAAAKDLGWT-RRM-------------NVIKGISDALSYMHNDCFP 928
S I L +++ + + + LSY+H+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR--- 124
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE----LAYTM 984
I+HRDI N+LL + + DFG++ L +S GT Y+APE Y++
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKPYSI 182
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
DV+S G+ LEV + + P
Sbjct: 183 ----TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-12
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 35/141 (24%)
Query: 36 PCA-----WVGIHC---NRGGR--VNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQL 85
PC W G C + G+ ++ + L + GL+G + + S HL ++L N +
Sbjct: 396 PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSI 454
Query: 86 YGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLS 145
GNIPP +G+I+ L+ LDLS N NGSIP +G+L+
Sbjct: 455 RGNIPPSLGSITSLEVLDLS------------------------YNSFNGSIPESLGQLT 490
Query: 146 SLNYLALYSNYLEDLIPPSLG 166
SL L L N L +P +LG
Sbjct: 491 SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 483 ISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
I L L+N L G IP + L +L + L NS+ +IP LG++ SL +L +YN +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 543 GSIPHSLG------VLDLSSNHIVGEIPTELG 568
GSIP SLG +L+L+ N + G +P LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 30/260 (11%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G GSV K + + +G ++A K H + + + +++ L E++ + E R IV FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 882 -FCSHVRHSLAMIL----SNNAAAKDLGWTRRM---NVIKGISDALSYMHNDCFPPIVHR 933
F + + M S + K G + + + L+Y++N I+HR
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
DI N+L++ + + DFG++ L ++ GT Y++PE K T K DV+
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 994 SFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-------PRLPTPSCIVQDKLI 1046
S G+ +E+ GK P F + + + + ++L PRLP
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDD-PMGILDLLQQIVQEPPPRLP------SSDFP 239
Query: 1047 SIVEVAIS-CLDENPESRPT 1065
+ + CL ++P RPT
Sbjct: 240 EDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-12
Identities = 37/86 (43%), Positives = 52/86 (60%), Gaps = 1/86 (1%)
Query: 130 ENQ-LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
+NQ L G IP +I +L L + L N + IPPSLG++++L+ L L NS + SIP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLG 214
G L SL +L+L N SG +P +LG
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 21/194 (10%)
Query: 823 IGKGGQGSVYKA---ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+G G G+V K S + VAVK + + + E L E + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 880 YGFCSHVRHSLAMILS-----NNAAAKDLGWTRR--MNVIKGISDALSYMHNDCFPPIVH 932
G C L M L+ N K+ T + ++ +S + Y+ F VH
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF---VH 118
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYTMKVT 987
RD++++NVLL + A +SDFG++K L D + + A T+G + APE K +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYYKFS 176
Query: 988 EKCDVYSFGVLALE 1001
K DV+SFGVL E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 64/265 (24%), Positives = 115/265 (43%), Gaps = 34/265 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G G+VYK + GE V + K + G EF++E + + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLVR 73
Query: 879 FYGFCSHVRHSLAMILSNNAA--------AKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
G C L L + ++G +N I+ + Y+ +
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RL 130
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTMKVTE 988
VHRD++++NVL+ N ++DFG+A+ L+ D + G ++A E + K T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 989 KCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQDKL 1045
+ DV+S+GV E++ G P D I + + ++L+ RLP P
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGERLPQPPICT---- 237
Query: 1046 ISIVEVAISCLDENPESRPTMPKVS 1070
I + V + C + +SRP +++
Sbjct: 238 IDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 7e-12
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 29/203 (14%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 876
+G+G VYKA +G IVA+KK GE ++ +N E+K L E++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 877 VKFYG-FCSHVRHSLAMILSNNAAAKDL-GWTRRMNVIKGISD----------ALSYMHN 924
+ F +L DL + +++ +D L Y+H+
Sbjct: 65 IGLLDVFGHKSNINLVFEF----METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-T 983
+ I+HRD+ N+L+ D ++DFG+A+ + T T Y APEL +
Sbjct: 121 -NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177
Query: 984 MKVTEKCDVYSFGVLALEVIKGK 1006
D++S G + E++
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVK 878
IG+G G+VYKA +L +G VA+KK PL E L E+ K L H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 879 FYGFC---------------SHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
C HV LA LS L ++++ + + ++H
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
+ IVHRD+ +N+L+ D + ++DFG+A+ + + T + T Y APE
Sbjct: 125 SHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 51/285 (17%)
Query: 817 FDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F+ +G G G VYK + +G++ A+K E + E +N +K + HRN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INMLKKYSH--HRN 74
Query: 876 IVKFYGFCSHVRHS---------LAMILSNNAAAKDLGWTRRMNVIKG---------ISD 917
I +YG + ++ S L M + DL + N +K I
Sbjct: 75 IATYYG--AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
L+++H ++HRDI +NVLL + E + DFG++ L GT ++A
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 978 PELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
PE+ + + + D++S G+ A+E+ +G P + M + L P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----------FLIP 239
Query: 1033 RLPTP---SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
R P P S K I +E CL +N SRP+ QLLK
Sbjct: 240 RNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPS---TEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 77/291 (26%), Positives = 114/291 (39%), Gaps = 64/291 (21%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR- 872
ND ++ IG G G VYK +G ++AVK+ T +E + L ++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------RTGNKEENKRI--LMDLDV 66
Query: 873 ----HR--NIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWTRRMN----------VIKGI 915
H IVK YG F + + M L + K L +R+ + I
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLL---KRIQGPIPEDILGKMTVAI 123
Query: 916 SDALSYM---HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972
AL Y+ H ++HRD+ N+LLD + DFGI+ L DS T AG
Sbjct: 124 VKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGC 177
Query: 973 YGYVAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHP-----RDFISSMSSSSLNLN 1023
Y+APE K DV+S G+ +E+ G+ P +F + + L
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKILQEE 235
Query: 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P LP D S V+ CL ++ R PK +LL+
Sbjct: 236 P-------PSLPPNEGFSPD-FCSFVD---LCLTKDHRKR---PKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 42/207 (20%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKF----HSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
IG+G G V+K +G+IVA+KKF P+ ++ L E++ L +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63
Query: 878 KF-------------YGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH- 923
+ +C H ++ L N ++ +I A+++ H
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDH---TVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCHK 118
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 980
++C +HRD+ +N+L+ + + DFG A+ L ++T+ T Y APEL
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 981 --AYTMKVTEKCDVYSFGVLALEVIKG 1005
Y V DV++ G + E++ G
Sbjct: 175 DTQYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI 611
L L + + G IP ++ KL L + L+ N + G + P LGS+ LE LDLS N + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 612 PKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHN 653
P+S G L L LNL+ N S +P L L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 51/285 (17%)
Query: 814 TNDFDDEHCIGKGGQGSVYKAELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
++ + +GKG G VY A S ++ +A+K+ + + Q E+ + ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK 63
Query: 873 HRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
HRNIV++ G S SL+ +L + + K I + L Y
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 922 MHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFL---KPDSSNWTELAGTYGYVA 977
+H++ IVHRDI NVL++ + +SDFG +K L P + +T GT Y+A
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMA 177
Query: 978 PELAYTMKVTEK--------CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
PE V +K D++S G +E+ GK P FI + + + ++
Sbjct: 178 PE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGEPQAAMFKVGMFKI 229
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +P I + C + +P+ R + LL+
Sbjct: 230 -HPEIPESLSAEAKNFI------LRCFEPDPDKRAS---AHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 2e-11
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DF+ +G G G V SG+ A+K ++ + LNE + L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRM-----NVIK----GISDALSYMHN 924
+V YG +L +++ + R+ V + + AL Y+H+
Sbjct: 61 PFLVNLYGSFQDDS-NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 980
IV+RD+ +N+LLD D ++DFG AK +K + +T L GT Y+APE+
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTPEYLAPEIILSK 173
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y V D ++ G+L E++ G P
Sbjct: 174 GYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
R + FD IG+G G VYKA + +GE+VA+KK E F + E+K L +
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQ 62
Query: 871 IRHRNIVK--------------------FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN 910
+ HRNIV FY ++ H L +L + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIKS 120
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTEL 969
+K + + L+Y H F +HRDI N+LL+ + ++DFG+A+ + S +T
Sbjct: 121 FMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 970 AGTYGYVAPEL 980
T Y PEL
Sbjct: 178 VITLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 823 IGKGGQGSVYKAELAS-GEIVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK- 878
I KG G V+ A+ S G+I A+K K + + Q L E L++ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQ-VLTERDILSQAQSPYVVKL 58
Query: 879 FYGFCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+Y F + +L ++ L N + D R I I AL Y+H++
Sbjct: 59 YYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--IYIAEIVLALEYLHSN-- 112
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF--------LKPDSSNWTELAGTYGYVAPE 979
I+HRD+ N+L+D + ++DFG++K L D + GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ ++ D +S G + E + G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 16/219 (7%)
Query: 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKGG G V ++ +G++ A KK + + ++ L E + L ++ IV Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 881 GFCSHVRHSLAMILSN---------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
F S L M L N N + L R ++ I+ + ++H+ IV
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCD 991
+RD+ +NVLLD +SD G+A L D T+ AGT GY+APE+ + D
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176
Query: 992 VYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIALDEM 1029
++ G E++ G+ P +D ++ L DE+
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 823 IGKGGQGSVYKA----ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G G+V+K E S +I K G TFQ E + + A+ + H IV+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIVR 73
Query: 879 FYGFCSHVRHSLAMILSNNAAAKD--------LGWTRRMNVIKGISDALSYMHNDCFPPI 930
G C L LS + D L R +N I+ + Y+ +
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---M 130
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTE 988
VHR+++++N+LL D+ ++DFG+A L PD ++E ++A E + T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 989 KCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQDKL 1045
+ DV+S+GV E++ G P + + + D +L+ RL P Q
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEP--------YAGMRPHEVPD-LLEKGERLAQP----QICT 237
Query: 1046 ISIVEVAISC--LDENPESRPTMPKVS 1070
I + V + C +DEN RPT +++
Sbjct: 238 IDVYMVMVKCWMIDEN--VRPTFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV-- 877
I +G G VY+A + +GEIVA+K K G F L E+ L +++H NIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTV 69
Query: 878 ----------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
K Y +V H L ++ + + ++ + ++++H++
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKV 986
I+HRD+ + N+LL+ + DFG+A+ +T+L T Y APEL +
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 987 TEKCDVYSFGVLALEVIKGK 1006
+ D++S G + E++ K
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G G+VYKA L + I+AVK PL + Q++ ++E++ L + I+ FYG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 882 -FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDA----LSYMHNDCFPPIVHRDIS 936
F R S+ + + D+ +V+ I+ A L+Y+ + I+HRD+
Sbjct: 67 AFFVENRISICTEFMDGGSL-DVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVK 122
Query: 937 SKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 996
N+L++ + + DFG++ L +S GT Y+APE + DV+S G
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLG 180
Query: 997 VLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD---PRLPTPSCIVQDKLISIVEVAI 1053
+ +E+ G+ P I S + L + L ++D P LP V V
Sbjct: 181 ISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLP-----VGQFSEKFVHFIT 234
Query: 1054 SCLDENPESRPT 1065
C+ + P+ RP
Sbjct: 235 QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 81/261 (31%), Positives = 118/261 (45%), Gaps = 13/261 (4%)
Query: 466 DNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS-- 523
++ +P + L S+ L+ + S ++L NL L L L N L +I
Sbjct: 55 SSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISELL 113
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPHS---LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQ 580
EL NL SL + + + I L LDLS N I +P+ L L L L L+
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSF 172
Query: 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLE 640
N LS L L +L+ L +LDLS N++S +P L L L+LSNN + L
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIE-LLSSLS 229
Query: 641 ELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISY 700
L +LS L+LS+N L E +P I + +LE L+LS+N + S + L +D+S
Sbjct: 230 NLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSG 286
Query: 701 NELQGPIPNSIAFRDAPIEAL 721
N L +P L
Sbjct: 287 NSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 45/295 (15%)
Query: 805 IVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLN 863
I+++ ++ ++ IGKG G V+K +G AVK + + E+ N
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-N 66
Query: 864 EVKALTEIRHRNIVKFYG--FCSHVRHS----LAMILSNNAAAKDL--GWTRR---MN-- 910
+KAL++ H N+VKFYG + V++ L + L N + DL G+ +R M
Sbjct: 67 ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 911 ----VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966
++ L ++H + +HRD+ N+LL + + DFG++ L
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 967 TELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021
GT ++APE+ +CDV+S G+ A+E+ G P + M
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236
Query: 1022 LNIALDEMLDPRLPTPSCIVQDKLIS--IVEVAISCLDENPESRPTMPKVSQLLK 1074
AL ++ PR P P+ + Q +L S + CL ++ E RPT VS LL+
Sbjct: 237 ---ALFKI--PRNPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F +GKGG G V ++ A+G++ A K+ + + LNE + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 876 IVKFYGFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+V + + +L ++L+ N R + I L +H
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
+ V+RD+ +N+LLD +SD G+A + P+ + GT GY+APE+
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
+ T D + G L E+I+G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/226 (27%), Positives = 92/226 (40%), Gaps = 52/226 (23%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
D D IG+G G+V K SG I+AVK+ S + Q+ L ++ + +R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVV--MRS 59
Query: 874 RN---IVKFYG---------------------FCSHVRHSLAMILSNNAAAKDLGWTRRM 909
+ IVKFYG F +V L ++ K
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK-------- 111
Query: 910 NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
+ AL+Y+ + I+HRD+ N+LLD + + DFGI+ L DS T
Sbjct: 112 -IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRD 167
Query: 970 AGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
AG Y+APE Y + + DV+S G+ EV GK P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 69/308 (22%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL---------ASGEIVAVKKFHSPLPGEMTFQQ 859
EI + F +E +G+G G VYK EL S I +K+ P QQ
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQ 53
Query: 860 EFLNEVKALTEIRHRNIVKFYG-------------FCSH-------VRHS----LAMILS 895
EF E + +++++H NIV G + +H VR+S +
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 896 NNAAAKDLGWTRRMNVIKGISDALSYM--HNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953
+ L + +++ I+ + Y+ H+ VHRD++++N L+ +SDF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168
Query: 954 GIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008
G+++ + S+++ + ++ PE K T + D++SFGV+ E+ G P
Sbjct: 169 GLSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
Query: 1009 RDFISSMSSSSLNLNIALDEMLDPR--LPTPSCIVQDKLISIVEVAISCLDENPESRPTM 1066
S N + EM+ R LP P D + + I C +E P RP
Sbjct: 227 YYGFS---------NQEVIEMIRSRQLLPCPE----DCPARVYALMIECWNEIPARRPRF 273
Query: 1067 PKVSQLLK 1074
+ L+
Sbjct: 274 KDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 827 GQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
G+G K EL +GE VAVK G + E++ L + H NIVK
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVK 70
Query: 879 FYGFCSH-------------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
+ G C+ SL L N +L +++ I + Y+ +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSR 128
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAY 982
+ VHRD++++NVL++ +++ + DFG+ K ++ D +T +L + APE
Sbjct: 129 QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 983 TMKVTEKCDVYSFGVLALEVI 1003
K DV+SFGV E++
Sbjct: 186 QSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 58/285 (20%)
Query: 823 IGKGGQGSVYKA-----ELASGE-IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ A E GE +V VK + Q EF E+ ++ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70
Query: 877 VKFYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGISDA 918
V+ G C MIL L +++ + I+
Sbjct: 71 VRLLGLCRE-AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG---Y 975
+ ++ N F VHRD++++N L+ E VS ++K +S + +L +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------RDFISSMSSSSLNLNIALDE 1028
+APE + K DV+SFGVL EV +G+ P + ++ + + L L +
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG- 243
Query: 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
PS + ++ C NP+ RP+ ++ L
Sbjct: 244 -------CPS--------RLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 34/89 (38%), Positives = 50/89 (56%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLI 161
L L + G IP +I L +L+++ L N + G+IP +G ++SL L L N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFG 190
P SLG L++L L+L NSLS +P+ G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 48/276 (17%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFY 880
+G+G G V K + +G I+AVK+ + + Q+ L ++ V FY
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 881 G---------FCSHVRH-SLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHNDC 926
G C V SL D G T +++ I+ AL Y+H+
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKK---VYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL------ 980
++HRD+ NVL++ + + + DFGI+ +L DS T AG Y+APE
Sbjct: 124 --SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPELN 180
Query: 981 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
Y + K DV+S G+ +E+ G+ P D S + L ++E P+LP
Sbjct: 181 QKGYDV----KSDVWSLGITMIELATGRFPYD---SWKTPFQQLKQVVEEP-SPQLPAEK 232
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + CL +N + RP P +LL+
Sbjct: 233 FSPE-----FQDFVNKCLKKNYKERPNYP---ELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 33/271 (12%)
Query: 810 IIRATNDFDDEHCIGKGGQGSVYKA-ELASGE----IVAVKKFHSPLPGEMTFQQEFLNE 864
I++ T +F +G G G+VYK + GE VA+K+ + +E L+E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDE 59
Query: 865 VKALTEIRHRNIVKFYGFC--SHVR-----HSLAMILSNNAAAKD-LGWTRRMNVIKGIS 916
+ + + ++ + G C S V+ +L KD +G +N I+
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--G 974
++Y+ +VHRD++++NVL+ ++DFG+AK L D + G
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
++A E T + DV+S+GV E++ G P D I + SS+ R
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER 229
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRP 1064
LP P I + + + C + +SRP
Sbjct: 230 LPQPPICT----IDVYMIMVKCWMIDADSRP 256
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 823 IGKGGQGSVYKA--ELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+G G G V K ++ +I VA+K + E + + E + E + + ++ + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 880 YGFCSHVRHSLAM-ILSNNAAAKDLGWTRRM----NVIK---GISDALSYMHNDCFPPIV 931
G C L M + S K L + NV++ +S + Y+ F V
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF---V 117
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYTMKV 986
HRD++++NVLL + A +SDFG++K L D S + A + G + APE K
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFRKF 175
Query: 987 TEKCDVYSFGVLALEVIK-GKHP 1008
+ + DV+S+G+ E G+ P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 817 FDDEHCIGKGGQGSV-YKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+ D +G G G+V + +G VA+KK + P E+ F + E++ L ++H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHEN 75
Query: 876 IV----------------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
++ FY + L ++ + ++D R ++ + L
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED----RIQFLVYQMLKGL 131
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG---TYGYV 976
Y+H I+HRD+ N+ ++ D E + DFG+A+ + DS E+ G T Y
Sbjct: 132 KYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDS----EMTGYVVTRWYR 182
Query: 977 APELAYT-MKVTEKCDVYSFGVLALEVIKGK 1006
APE+ M T+ D++S G + E++ GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 62/292 (21%), Positives = 129/292 (44%), Gaps = 67/292 (22%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ AE +VAVK +++F E + LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69
Query: 877 VKFYGFC----------SHVRHS-----------LAMILSNNAAAKDLGWTRRMNVIKGI 915
VKFYG C +++H A++++ +L ++ +++ + I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG---- 971
+ + Y+ + F VHRD++++N L+ + + DFG+++ + S+++ + G
Sbjct: 130 AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 184
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML 1030
++ PE K T + DV+S GV+ E+ GK P +S+ +E++
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------NEVI 232
Query: 1031 DPRLPTPSCIVQDKLIS--------IVEVAISCLDENPESRPTMPKVSQLLK 1074
+ CI Q +++ + ++ + C P R + ++ LL+
Sbjct: 233 E-------CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 821 HCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK- 878
+G G GSV A + +GE VA+KK P E+ F + E+ L ++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGL 79
Query: 879 ---------------FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
FY +++ L I+ + + + + ++ + L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIH 134
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
+ I+HRD+ N+ ++ D E + DFG+A+ + + + T Y APE+
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVILN 188
Query: 984 -MKVTEKCDVYSFGVLALEVIKGK 1006
M + D++S G + E++ GK
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 864 EVKALTEIRHRNIVKF--------------YGFCS--HVRHSLAMILSNNAAAKDLGWTR 907
E + L++++H NIV + GFC + H L K L +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-----KEQKGKLLPENQ 103
Query: 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967
+ I+ AL Y+H I+HRD+ ++NV L N V D GIA+ L+ +
Sbjct: 104 VVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027
L GT Y++PEL K DV++ G E+ KH + ++ ++N +
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSLVY 212
Query: 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+++ +LP + +D + E+ + L + PE RP++ +
Sbjct: 213 RIIEGKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 63/278 (22%), Positives = 120/278 (43%), Gaps = 33/278 (11%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
EI R + + + +G G G V+ A VAVK PG M+ + FL E +
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVM 55
Query: 869 TEIRHRNIVKFYGFCSHV----------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDA 918
++H +VK + + + SL L ++ +K + ++ I++
Sbjct: 56 KTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEG 114
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVA 977
++++ + +HRD+ + N+L+ ++DFG+A+ ++ + E A + A
Sbjct: 115 MAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036
PE T K DV+SFG+L +E++ G+ P MS+ + + + PR
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGYRM-PR--P 225
Query: 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+C + + + + C PE RPT + +L
Sbjct: 226 ENCPEE-----LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 68/274 (24%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 820 EHCIGKGGQGSVYKAEL---ASGEI-VAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIRHR 874
E IG G G V L EI VA+K + G Q+ +FL+E + + H
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA---GYTEKQRRDFLSEASIMGQFDHP 65
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN-----------VIKGISDALSYMH 923
NI+ G + + MI++ L R + +++GI+ + Y+
Sbjct: 66 NIIHLEGVVT--KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-SSNWTELAGTYG--YVAPEL 980
+ + VHRD++++N+L++ + VSDFG+++ L+ D + +T G + APE
Sbjct: 124 DMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 981 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
K T DV+S+G++ EV+ G+ P S+ ++ A++E RLP P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQDVIKAIEEGY--RLPAP-- 231
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
D ++ ++ + C ++ RP ++ +L
Sbjct: 232 --MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 48/228 (21%)
Query: 817 FDDEHCIGKGGQGSVYKA---ELASGEIVAVKKFHSPLPGEMT-FQQEFLNEVKALTEIR 872
++ E CIG+G G VYKA G+ A+KKF + T Q E+ L E++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-KEQYTGISQSACREIALLRELK 60
Query: 873 HRNIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWT-------------RRM--NVIKGIS 916
H N+V F H S+ ++ + A DL M +++ I
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLF--DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAG- 971
+ + Y+H++ ++HRD+ N+L+ + + D G+A+ +L
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 972 --TYGYVAPELA-----YTMKVTEKCDVYSFG-----VLALEVI-KGK 1006
T Y APEL YT + D+++ G +L LE I KG+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 25/203 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVK 878
IG G G+VYKA + SG VA+K E + EV K L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ-TNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 879 FYGFCS---------------HVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
C+ HV L L L ++++ L ++H
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
+C IVHRD+ +N+L+ + ++DFG+A+ + T + T Y APE+
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQ 181
Query: 984 MKVTEKCDVYSFGVLALEVIKGK 1006
D++S G + E+ + K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 29/181 (16%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G V+KA + +IVA+KK E F L E+K L ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 78
Query: 882 FCSH------------------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
C H LA +LSN L +++ +K + + L Y+H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYYIH 136
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL----KPDSSNWTELAGTYGYVAPE 979
I+HRD+ + N+L+ D ++DFG+A+ + +T T Y PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 980 L 980
L
Sbjct: 194 L 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
N F+ +G+G G V K + EIVA+KKF E ++ L E+K L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59
Query: 874 RNIV----------KFYGFCSHVRHSLAMILSN--NAAAKDLGWTRRMNVIKGISDALSY 921
NIV K Y +V ++ +L N + + +IK A+ +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK----AIHW 115
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-SNWTELAGTYGYVAPEL 980
H + IVHRDI +N+L+ ++ + DFG A+ L S +N+TE T Y +PEL
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGK 1006
+ D++S G + E+ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+GKGG G V ++ A+G++ A KK + + LNE + L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 882 FCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
+ + +L ++L+ N R + + L + + I
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
V+RD+ +N+LLD +SD G+A + P+ GT GY+APE+ K T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 991 DVYSFGVLALEVIKGKHP 1008
D + G L E+I+G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
IG+G G +Y A+ S V K + ++ EV L +++H NIV F+
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA- 66
Query: 883 CSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG--------------ISDALSYMHNDCFP 928
S + I+ DL +R+N +G IS L ++H+
Sbjct: 67 -SFQENGRLFIVMEYCDGGDL--MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--- 120
Query: 929 PIVHRDISSKNVLLDFDNE-AHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYT 983
I+HRDI S+N+ L + A + DFGIA+ L ++ ELA GT Y++PE+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSPEICQN 176
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHP 1008
K D++S G + E+ KHP
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 879
+G+G G VY ++ +G +A K+ P E + + L E++ L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 880 YGFC--SHVRHSLAMILS--NNAAAKD-------LGWTRRMNVIKGISDALSYMHNDCFP 928
YG C +L + + + KD L + + I + +SY+H++
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYTMK 985
IVHRDI N+L D + DFG +K L+ + T + GT +++PE+
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 986 VTEKCDVYSFGVLALEVIKGKHP 1008
K DV+S G +E++ K P
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 76/271 (28%), Positives = 117/271 (43%), Gaps = 53/271 (19%)
Query: 823 IGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
IGKG G VY L + AVK + ++ ++FL E + + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 879 FYGFCSHVRHSLAMIL---------------SNNAAAKDL-GWTRRMNVIKGISDALSYM 922
G C S ++L ++N KDL G+ + V KG + Y+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKG----MEYL 114
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK------FLKPDSSNWTELAGTYGYV 976
+ F VHRD++++N +LD V+DFG+A+ + + +L ++
Sbjct: 115 ASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWM 169
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
A E T K T K DV+SFGVL E++ +G P + S +I + + RL
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRRLL 222
Query: 1036 TPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
P C D L EV +SC PE RPT
Sbjct: 223 QPEYC--PDPL---YEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK---- 878
+G G G VYKA+ ++A K E ++++ E+ L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70
Query: 879 FY---------GFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
FY FC+ M+ + L + V K +AL+Y+H +
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE- 988
I+HRD+ + N+L D + ++DFG++ GT ++APE+ +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 989 ----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
K DV+S G+ +E+ + + P ++ M + L IA E P L PS +
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTLAQPSRWSSE- 237
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ CL++N ++R T +QLL+
Sbjct: 238 ---FKDFLKKCLEKNVDARWT---TTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 822 CIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
CIG+G G VY+ S E VAVK + + ++FL E + + H +IV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70
Query: 878 KFYGFCSHVRHSLAMILSNNAAAKDLG--------WTRRMNVIK---GISDALSYMHNDC 926
K G + + M L A +L ++I +S AL+Y+ +
Sbjct: 71 KLIGVITENPVWIVMEL---APLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTM 984
F VHRDI+++NVL+ + + DFG++++L+ D S + G ++APE
Sbjct: 128 F---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 985 KVTEKCDVYSFGVLALEVIK-GKHP 1008
+ T DV+ FGV E++ G P
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-10
Identities = 56/194 (28%), Positives = 83/194 (42%), Gaps = 34/194 (17%)
Query: 838 SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY--GFC---------SHV 886
+G VA+K + P E + F E + H NIV G +V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 887 R-HSLAMILSNNAA--AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL- 942
+L +L+ + A A + G R M + DAL+ HN IVHRD+ +N+++
Sbjct: 62 PGRTLREVLAADGALPAGETG--RLM---LQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 943 --DFDNEAHVSDFGIAKFLKPDSSNW--------TELAGTYGYVAPELAYTMKVTEKCDV 992
A V DFGI L P + TE+ GT Y APE VT D+
Sbjct: 114 QTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 993 YSFGVLALEVIKGK 1006
Y++G++ LE + G+
Sbjct: 173 YAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
TN + D +G G G V A + +G+ VA+KK P + ++ + E+K L +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 873 HRNIVKF-----------YGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
H NI+ Y + L +L++ K +++G L Y
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRG----LKY 123
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H+ +VHRD+ N+L++ + + + DFG+A + T T Y APE+
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIM 177
Query: 982 YT-MKVTEKCDVYSFGVLALEVIKGK 1006
T K + D++S G + E+++GK
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 879
+G+G G VY + +G +AVK+ P E + + L E++ L + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 880 YGFCSHVRH---SLAMILSNNAAAKDL---------GWTRRMNVIKGISDALSYMHNDCF 927
YG S+ M + KD TR+ + I + +SY+H++
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSYLHSNM- 126
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP---DSSNWTELAGTYGYVAPELAYTM 984
IVHRDI N+L D + DFG +K L+ + + GT +++PE+
Sbjct: 127 --IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017
K D++S G +E++ K P +M++
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
IS AL+Y+H I++RD+ NVLLD + ++D+G+ K L+P + + GT
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE-MLDP 1032
Y+APE+ D ++ GVL E++ G+ P D + S + N L + +L+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
Query: 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESR 1063
++ P + + V S L+++P+ R
Sbjct: 221 QIRIPRSLS----VKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+GKGG G V ++ A+G++ A KK + + LNE + L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 882 FCSHVRHSLAMILS--NNAAAK----DLG-----WTRRMNVIKGISDALSYMHNDCFPPI 930
+ + +L ++L+ N K ++G R + I+ L +H + I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
V+RD+ +N+LLD +SD G+A + P+ GT GY+APE+ + T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFSP 182
Query: 991 DVYSFGVLALEVIKGKHP 1008
D + G L E+I+GK P
Sbjct: 183 DWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 71/275 (25%), Positives = 115/275 (41%), Gaps = 52/275 (18%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+GKG GSVYK +G +A+K+ L E F Q + E+ L + IV FYG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQ-IIMELDILHKAVSPYIVDFYG 66
Query: 882 FCSHVRHSLAMIL--------------SNNAAAKDLGWTRRMN--VIKGISDALSYMHND 925
+ ++ M + RR+ V+KG+ L HN
Sbjct: 67 -AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK-FLKEEHN- 123
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE------ 979
I+HRD+ NVL++ + + + DFG++ L + T + G Y+APE
Sbjct: 124 ----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNI-GCQSYMAPERIKSGG 177
Query: 980 ----LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
YT+ + DV+S G+ LE+ G++P + ++ A+ + P LP
Sbjct: 178 PNQNPTYTV----QSDVWSLGLSILEMALGRYP--YPPETYANIFAQLSAIVDGDPPTLP 231
Query: 1036 TP-SCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ S QD CL++ P RPT ++
Sbjct: 232 SGYSDDAQD-------FVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
L ++H I++RD+ NVLLD D ++DFG+ K + GT Y+A
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
PE+ K E D +SFGVL E++ G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 46/211 (21%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVK----KFHSPLPGEMTFQQEFLN--EVKALTEI-RH 873
+G G GSVY A +GE+VA+K KF+S +E +N EVK+L ++ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLREVKSLRKLNEH 57
Query: 874 RNIVKFYGFCSHV---RHSLAMI---LSNN-------AAAKDLGWTRRMNVIKGISDALS 920
NIVK V L + + N K + ++I I L+
Sbjct: 58 PNIVKLK----EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
++H F HRD+ +N+L+ ++DFG+A+ ++ +T+ T Y APE+
Sbjct: 114 HIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEI 169
Query: 981 -----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
+Y+ V D+++ G + E+ +
Sbjct: 170 LLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFH-SPLPGEMTFQQEF----------LNEVKALTE 870
+G+G G V KA +G+IVA+KK + ++T ++ L E+K + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 871 IRHRNIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMH 923
I+H NI+ + +L M + + K + R+ ++ I + L+ +H
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH 136
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA-KFLKPDSS-------------NWTEL 969
+ +HRD+S N+ ++ ++DFG+A ++ P S T
Sbjct: 137 K-WY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 970 AGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 1006
T Y APEL K D++S G + E++ GK
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 60/263 (22%), Positives = 113/263 (42%), Gaps = 29/263 (11%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
+G G G V+ VA+K G M+ + FL E + +++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 883 CSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVH 932
+ SL L K L + +++ I++ ++++ + +H
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---IH 125
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKCD 991
RD+ + N+L+ ++DFG+A+ ++ + E A + APE T K D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 992 VYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEV 1051
V+SFG+L E++ + R M++ + N L+ R+P P ++ + E+
Sbjct: 186 VWSFGILLTEIV--TYGRIPYPGMTNPEVIQN--LERGY--RMPRPDNCPEE----LYEL 235
Query: 1052 AISCLDENPESRPTMPKVSQLLK 1074
C E PE RPT + +L+
Sbjct: 236 MRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-09
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 41/214 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKGG G VY A + VA+KK L ++ FL E K ++ H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 882 FCSHVR-----------HSLAMILSN----NAAAKDLGWTRR----MNVIKGISDALSYM 922
CS ++L +L + + +K+L +++ I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD---------------SSNWT 967
H+ ++HRD+ N+LL E + D+G A F K + S+ T
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 968 ---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998
++ GT Y+APE + +E D+Y+ GV+
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 29/246 (11%)
Query: 842 VAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNAAA 900
VAVK + ++ ++E+K ++ + H NIV G C+ ++++
Sbjct: 68 VAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTI--GGPILVITEYCCY 123
Query: 901 KDL-GWTRR-MNVIKGISDALSY-------MHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951
DL + RR + D LS+ M +HRD++++NVLL +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC 183
Query: 952 DFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKH 1007
DFG+A+ + D SN+ ++APE + T + DV+S+G+L E+ G +
Sbjct: 184 DFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242
Query: 1008 PRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMP 1067
P + + S L M P I ++ +C D +P RPT
Sbjct: 243 PYPGM-PVDSKFYKLIKEGYRMAQPEHAPA---------EIYDIMKTCWDADPLKRPTFK 292
Query: 1068 KVSQLL 1073
++ QL+
Sbjct: 293 QIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 57/299 (19%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
DF+ +G G G V K SG I+A K H L + + + + E+K L E
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59
Query: 875 NIVKFYG-FCSHVRHSLAM----ILSNNAAAKDLGWTRRM--NVIKGIS----DALSYMH 923
IV FYG F S S+ M S + K G R+ N++ IS L+Y+
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLR 116
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
I+HRD+ N+L++ E + DFG++ L +N GT Y++PE
Sbjct: 117 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQG 172
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFISSMSSSSLNLN--- 1023
T + D++S G+ +E+ G++P + + S ++ +
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
Query: 1024 ----IALDEMLD-------PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
+A+ E+LD P+L PS D+ V+ CL +NP+ R + ++++
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVD---KCLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGE-MTFQQEF--LNEVKALTEIRHRNIVK 878
+G+G G V+ A ++V +K+ +P E MT + NE + L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 879 FY-GFCSHVRHSLAMILSNNAAAKDLGWTRR---------MNVIKGISDALSYMHNDCFP 928
+Y F + M + + R ++ I AL ++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 929 PIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 987
I+HRD+ ++N+LLD + DFGI+K L S +T + GT Y++PEL
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYN 179
Query: 988 EKCDVYSFGVLALEV 1002
+K D+++ G + E+
Sbjct: 180 QKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 64/235 (27%)
Query: 818 DDEHCIGKGGQGS---VYKA-ELASGEIVAVKKF--HSPLPGEMTFQQEFLNEVKALTEI 871
D +GK G+G+ VYKA ++ +G +VA+KK H+ G F L E+K L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKL 64
Query: 872 RHRNIVK------------------FYGFCSHVRHSLAMILSNN------AAAKDLGWTR 907
+H N+V Y ++ H L+ +L N + K
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK------ 118
Query: 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW- 966
+ + + ++Y+H + I+HRDI + N+L+D ++DFG+A+ N
Sbjct: 119 --CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 967 ----------TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 1006
T L T Y PEL YT V D++ G + E+ +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 44/270 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
DF +G+GG G V+ A+ +GEIVA+K+ L ++ + L E LT +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 874 RNIVK-FYGFCSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
+VK Y F LAM +L+N + R + + +A+ +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE-DHARFY--MAEMFEAVDAL 117
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAP 978
H +HRD+ +N L+D ++DFG+ S A G+ Y+AP
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYMAP 167
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN---LNIA-LDEMLD-PR 1033
E+ D +S G + E + G P S S+ N N+ E L P
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPP------FSGSTPNETWENLKYWKETLQRPV 221
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESR 1063
P + D+ ++ +++ P R
Sbjct: 222 YDDPRFNLSDEAWDLIT---KLIND-PSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 37/216 (17%)
Query: 862 LNEVKALTEIRHRNIVK-----FYGFCS-----HVRHSLAMILSNNAAAKDLGWTRRMNV 911
L E L + H ++++ G + H L L+ + + + + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI--DQALII 162
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
K I + L Y+H I+HRD+ ++N+ ++ ++ + D G A+F + + LAG
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAG 218
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031
T APE+ K K D++S G++ E++ I D
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS---------------TIFEDPPST 263
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMP 1067
P SC L+ I IS L +PE P P
Sbjct: 264 PEEYVKSC--HSHLLKI----ISTLKVHPEEFPRDP 293
|
Length = 357 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 42/263 (15%)
Query: 823 IGKGGQGSVYKA-ELASGE----IVAVKKFH---SPLPGEMTFQQEFLNEVKALTEIRHR 874
+G G G+VYK + GE VA+K SP +E L+E + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSP 69
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKD--------LGWTRRMNVIKGISDALSYMHNDC 926
+ + G C L L D +G +N I+ +SY+
Sbjct: 70 YVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELAYTM 984
+VHRD++++NVL+ N ++DFG+A+ L D + + G ++A E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 985 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIV 1041
+ T + DV+S+GV E++ G P D I + + ++L+ RLP P
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGERLPQPPICT 237
Query: 1042 QDKLISIVEVAISCLDENPESRP 1064
D + + + C + E RP
Sbjct: 238 ID----VYMIMVKCWMIDSECRP 256
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 978
L ++H+ I++RD+ NV+LD D ++DFG+ K + + GT Y+AP
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
E+ +K T D +SFGVL E++ G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGE-MTFQQEFLNEVKALTEIRH 873
+ + IG+G G V A +G VA+KK P E TF Q L E+K L +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFKH 62
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG--ISD------------AL 919
NI+ +R ++ ++L T +IK +S+ L
Sbjct: 63 ENIIGILDI---IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---WTELAGTYGYV 976
Y+H+ ++HRD+ N+LL+ + + + DFG+A+ P+ + TE T Y
Sbjct: 120 KYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 977 APELAYTMK-VTEKCDVYSFGVLALEVIK------GKHPRD 1010
APE+ K T+ D++S G + E++ GK
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKF-HSPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 879
+G+G G VY + +G +AVK+ P E + + L E++ L +RH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 880 YGFC--SHVRHSLAMILS--NNAAAKDL---------GWTRRMNVIKGISDALSYMHNDC 926
YG C L++ + + KD TRR + I +SY+H++
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT--RQILQGVSYLHSNM 126
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAYT 983
IVHRDI N+L D + DFG +K ++ + T + GT +++PE+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP---TPSC 1039
K DV+S +E++ K P +M++ IA + P LP + +C
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIA-TQPTKPMLPDGVSDAC 238
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 9e-09
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 823 IGKGGQGSVYKAELA-SGEIVAVKK----FHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G G G V A +G VA+KK F S + + T++ E++ L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-----ELRLLKHMDHENVI 77
Query: 878 KFYG-FC--SHVRHSLAMILSNNAAAKDLGW---TRRMN------VIKGISDALSYMHND 925
F S + + L + DL ++++ ++ I L Y+H+
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS- 136
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-M 984
I+HRD+ N+ ++ D E + DFG+A + T T Y APE+ M
Sbjct: 137 --AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWM 191
Query: 985 KVTEKCDVYSFGVLALEVIKGK 1006
+ D++S G + E++ GK
Sbjct: 192 HYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIR 872
DF+ +G G G V A+ +GE A+K K L +M Q E L E+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELS 76
Query: 873 HRNIVKFY-GFCSHVRHSLAMILSNNAAAKDLGWTRRM-----NVIKGISD----ALSYM 922
H IV F R + +L + R+ +V K A Y+
Sbjct: 77 HPFIVNMMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+ I++RD+ +N+LLD V+DFG AK K +T L GT Y+APE+
Sbjct: 135 HSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEYLAPEVIQ 188
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ + D ++ GVL E I G P
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 36/115 (31%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 978
L ++H+ IV+RD+ N+LLD D ++DFG+ K + GT Y+AP
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
E+ K D +SFGVL E++ G+ P L +I +D PR
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 14/224 (6%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKG G V E A+G A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 881 GFCSHVRHSLAMILSNNAA-----AKDLGWTRRMNVIKG--ISDALSYMHNDCFPPIVHR 933
F +H R M +N +++ ++ G I AL Y+H++ +V+R
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYR 120
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
D+ +N++LD D ++DFG+ K D + GT Y+APE+ D +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 994 SFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
GV+ E++ G+ P F + L I ++E+ PR +P
Sbjct: 181 GLGVVMYEMMCGRLP--FYNQDHEKLFEL-ILMEEIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 15/192 (7%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G VYKA +GE+VA+KK E + E+ L E+ H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 882 FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDAL--SYMHN------DCFP-PIVH 932
H + L ++ +DL + + GI L SY+ C ++H
Sbjct: 67 VI-HTENKLYLVFE--FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCD 991
RD+ +N+L++ + ++DFG+A+ +T T Y APE+ K + D
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 183
Query: 992 VYSFGVLALEVI 1003
++S G + E++
Sbjct: 184 IWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
+HRD++++N+LL +N + DFG+A+ + PD ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 989 KCDVYSFGVLALEVIK-GKHP-------RDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ DV+SFGVL E+ G P +F + + M P TP
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATP--- 304
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
I + ++C +P+ RPT + ++L
Sbjct: 305 ------EIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 37/104 (35%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 541 LSGSIP------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSL 594
L G IP L ++LS N I G IP LG + L L L+ N +G + LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLH--YLNLSNNQFSRGIP 636
L L+L+ N LS +P + G + LH N ++N GIP
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKG G V E A+G A+K + + E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 881 GFCSHVRHSLAMILSNNAA-----AKDLGWTRRMNVIKG--ISDALSYMHNDCFPPIVHR 933
F +H R M +N +++ +T G I AL Y+H+ +V+R
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYR 119
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
DI +N++LD D ++DFG+ K D + GT Y+APE+ D +
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 994 SFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
GV+ E++ G+ P + L I ++E+ PR +P
Sbjct: 180 GLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSP 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 53/217 (24%)
Query: 823 IGKGGQGSVYK---AELASGEI---VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G VY+ + GE VA+K + M + EFLNE + E ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAKDL-GWTRR-------------------MNVIKGIS 916
V+ G S + +++ A DL + R + + I+
Sbjct: 72 VRLLGVVSTGQP--TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK------FLKPDSS-----N 965
D ++Y+ F VHRD++++N ++ D + DFG+ + + +
Sbjct: 130 DGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 1002
W +APE T K DV+SFGV+ E+
Sbjct: 187 W---------MAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 29/168 (17%)
Query: 858 QQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG--- 914
++E EV L+ ++H NIV++ S + I+ + DL +++N +G
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQE--SFEENGNLYIVMDYCEGGDL--YKKINAQRGVLF 98
Query: 915 -----------ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
I AL ++H+ I+HRDI S+N+ L D + DFGIA+ L
Sbjct: 99 PEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---- 151
Query: 964 SNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 1007
++ ELA GT Y++PE+ K D+++ G + E+ KH
Sbjct: 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 47/211 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIRHR 874
IG+G G VYKA + +GEIVA+KK + + E + E+ L E+ H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK--------IRLETEDEGVPSTAIREISLLKELNHP 58
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN----------VIKG----ISDALS 920
NIV+ H + L ++ DL + M+ +IK + ++
Sbjct: 59 NIVRLLDVV-HSENKLYLVFE----FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y H+ ++HRD+ +N+L+D + ++DFG+A+ +T T Y APE+
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 170
Query: 981 -----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
Y+ V D++S G + E++ +
Sbjct: 171 LLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DF+ +G G G V K + SG I+A K H L + + + + E++ L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 874 RNIVKFYG-FCSHVRHSLAMI-LSNNAAAKDLGWTRRM--NVIKGISDA----LSYMHND 925
IV FYG F S S+ M + + + L +R+ ++ +S A L+Y+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
I+HRD+ N+L++ E + DFG++ L +N GT Y++PE
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTH 178
Query: 986 VTEKCDVYSFGVLALEVIKGKHP 1008
+ + D++S G+ +E+ G++P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 27/153 (17%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
+HRD++++N+LL +N + DFG+A+ + PD + ++APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 989 KCDVYSFGVLALEVIK-GKHP-------RDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ DV+SFGVL E+ G P +F + + M P TP
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------RMRAPEYATP--- 303
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
I + + C NPE RPT ++ ++L
Sbjct: 304 ------EIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 5/100 (5%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I AL+++H I++RD+ NVLLD D ++D+G+ K L P + T GT
Sbjct: 105 ICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTP 160
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013
Y+APE+ + D ++ GVL E++ G+ P D I+
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 21/198 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G GSV A + +G VAVKK P + ++ + E++ L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 882 FCSHVR------------HSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
+ R H + L+N + L +I I L Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 140
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTE 988
I+HRD+ N+ ++ D E + DFG+A+ + + + T Y APE+ M +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYNQ 197
Query: 989 KCDVYSFGVLALEVIKGK 1006
D++S G + E++ G+
Sbjct: 198 TVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 33/204 (16%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR-----NI 876
I KG GSVY A+ ++G+ A+K +M + + N VKA I +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTN-VKAERAIMMIQGESPYV 59
Query: 877 VK-FYGFCSHVRHSLAMILSNN----AAAKDLG-----WTRRMNVIKGISDALSYMHNDC 926
K +Y F S L M N + K LG W + I + + +H
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR- 116
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTM 984
I+HRDI +N+L+D ++DFG+++ GT Y+APE +
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGV 168
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
+ D +S G + E + G P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 12/195 (6%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 880
+GKG G V E ASG+ A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 881 GFCSHVRHSLAMILSNNAA-----AKDLGWTRRMNVIKG--ISDALSYMHNDCFPPIVHR 933
F + R M N +++ ++ G I AL Y+H+ IV+R
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYR 119
Query: 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 993
D+ +N++LD D ++DFG+ K D++ GT Y+APE+ D +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179
Query: 994 SFGVLALEVIKGKHP 1008
GV+ E++ G+ P
Sbjct: 180 GLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 28/79 (35%), Positives = 41/79 (51%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 989
++HRDI SKN+ L + + + DFG A+ L + GT YV PE+ M K
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180
Query: 990 CDVYSFGVLALEVIKGKHP 1008
D++S G + E+ KHP
Sbjct: 181 SDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 5/108 (4%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
IS AL+++H I++RD+ NVLLD + ++D+G+ K ++P + T GT
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021
Y+APE+ D ++ GVL E++ G+ P D + + N
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 76/312 (24%), Positives = 111/312 (35%), Gaps = 66/312 (21%)
Query: 414 LDLYDNSLSGS----IPSEFGNLRSLSTLSLGYNKLS------GSIPHSLGNLTNLDALY 463
L L N+L + S SL L L N+ S+ L L L
Sbjct: 28 LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELD 87
Query: 464 LYDNSLSGSIPGEIGNLRSIS---NLALNNNKLSGSIPQSLG-----NLSNLVILYLYNN 515
L DN+L G + +L S L LNNN L + L L L L N
Sbjct: 88 LSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRN 147
Query: 516 SLF----DSIPSELGNLRSLSMLSFAYNKLSGS-IPH---------SLGVLDLSSNHIVG 561
L +++ L R L L+ A N + + I +L VLDL++N +
Sbjct: 148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL-- 205
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI-----PKSFG 616
T+ G + L+ L SL LE L+L N L+++
Sbjct: 206 ---TDEG---------------ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS 247
Query: 617 NLVKLHYLNLSNNQFSRGIPIKLEELIH----LSELDLSHNFL-----REAIPSQICIMQ 667
+ L L+LS N + L E++ L ELDL N + S +
Sbjct: 248 PNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGN 307
Query: 668 SLENLNLSHNSL 679
LE+L + +S
Sbjct: 308 ELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 72/288 (25%), Positives = 108/288 (37%), Gaps = 60/288 (20%)
Query: 823 IGKGGQGSVYKAELASGEIVA---VKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
IG G G V E G A VK+ S P E Q FL EV+ E+ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 879 FYGFCSHVRHSL------------AMILSNNAAAKDLGWTR---RM--NVIKGISDALSY 921
G C L + SN + RM V G L +
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG----LLW 115
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA------KFLKPDSSNWTELAGTYGY 975
+H F +H D++ +N L D + D+G+A + + L +
Sbjct: 116 LHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----W 168
Query: 976 VAPELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALD 1027
+APEL T+K +++S GV E+ P +S + + +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP---YPDLSDEQVLKQVVRE 225
Query: 1028 EMLDPRLPTPSCIVQDKLIS-IVEVAISC-LDENPESRPTMPKVSQLL 1073
+ D +LP P + K EV C LD PE+RPT +V +LL
Sbjct: 226 Q--DIKLPKPQ--LDLKYSDRWYEVMQFCWLD--PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 46/263 (17%)
Query: 842 VAVKKFHSPLPGE-MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL------ 894
VAVK P +++FL EVK L+ + NI + G C+ L MI+
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENG 104
Query: 895 --------------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNV 940
+K L ++ + + I+ + Y+ + F VHRD++++N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNC 161
Query: 941 LLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP------ELAYTMKVTEKCDVYS 994
L+ + ++DFG+++ L SS++ + G P E K T K DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLY--SSDYYRVQGR--APLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 995 FGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR---LPTPSCIVQDKLISIVEV 1051
FGV E++ + + ++ + N D R LP P +D I E+
Sbjct: 218 FGVTLWEILTLCREQPY-EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYEL 272
Query: 1052 AISCLDENPESRPTMPKVSQLLK 1074
+ C + E RPT ++ L+
Sbjct: 273 MLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 21/197 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG G QG V A + G VAVKK P + T + E+ L + H+NI+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLN 87
Query: 882 FCSHVRH-------SLAMILSNNAAAK----DLGWTRRMNVIKGISDALSYMHNDCFPPI 930
+ + L M L + + +L R ++ + + ++H+ I
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGI 144
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTE 988
+HRD+ N+++ D + DFG+A+ +N+ T T Y APE+ M E
Sbjct: 145 IHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKE 201
Query: 989 KCDVYSFGVLALEVIKG 1005
D++S G + E++KG
Sbjct: 202 NVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
AL ++H+ I++RD+ +N+LLD + ++DFG++K GT Y+A
Sbjct: 110 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
PE+ T+ D +SFGVL E++ G P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYK-AELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DF+ +G G G V+K + SG I+A K H L + + + + E++ L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 874 RNIVKFYG-FCSHVRHSLAMILSNNAA------------AKDLGWTRRMNVIKGISDALS 920
IV FYG F S S+ M + + + LG + VIKG L+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-IAVIKG----LT 117
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+ I+HRD+ N+L++ E + DFG++ L +N GT Y++PE
Sbjct: 118 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ + D++S G+ +E+ G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
IS L ++H I++RD+ NV+LD + ++DFG+ K D GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 1010
Y+APE+ + D +++GVL E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-08
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 60/220 (27%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKK----FHSPLPGEMTFQQEFLNEVKALTEIR-HRNI 876
+GKG G V+KA + + E+VA+KK F + + TF+ E+ L E+ H NI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-----EIMFLQELGDHPNI 69
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAKDLGW------TRRMNVIK-GISD------------ 917
VK L +I + N KD+ T VI+ I +
Sbjct: 70 VKL----------LNVIKAEND--KDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL 117
Query: 918 -ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW-----TELAG 971
AL Y+H+ ++HRD+ N+LL+ D ++DFG+A+ L N T+
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 972 TYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
T Y APE+ YT V D++S G + E++ GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 51/230 (22%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE---LASGE---IVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
N+ + IG+G G V++A L E +VAVK +M Q +F E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 62
Query: 869 TEIRHRNIVKFYGFCS--------------------------HVRHSLAMILSNNAAAK- 901
E H NIVK G C+ + SL+ S+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 902 ---DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI--- 955
L T ++ + K ++ ++Y+ F VHRD++++N L+ + ++DFG+
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 956 ---AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 1002
A + K ++ + ++ PE + + T + DV+++GV+ E+
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-07
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 49/213 (23%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKK----FHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
IG G G V A + SG+ VA+KK F P T + L E+K L +H NI
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-----TLAKRTLRELKILRHFKHDNI 66
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAK------DLGWTRRMNVIKG---------------I 915
+ ++ A K DL + ++I +
Sbjct: 67 IAI----------RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL--KPD--SSNWTELAG 971
L Y+H+ ++HRD+ N+L++ D E + DFG+A+ L P TE
Sbjct: 117 LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 972 TYGYVAPELAYTM-KVTEKCDVYSFGVLALEVI 1003
T Y APEL ++ + T D++S G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
I L ++H I++RD+ NVLLD + ++DFG+ K + GT
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
Y+APE+ D ++ GVL E++ G+ P + L +I DE+ PR
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILEDEVRYPRW 218
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESR 1063
+ + SI++ S L +NPE R
Sbjct: 219 ------LSKEAKSILK---SFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-- 879
+G G GSV A + + VAVKK P + ++ + E++ L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81
Query: 880 -YGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIK--GISD------------ALSYMHN 924
+ + + + + L N DL N++K +SD L Y+H+
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLN-----NIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT- 983
I+HRD+ NV ++ D E + DFG+A + T T Y APE+
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNW 190
Query: 984 MKVTEKCDVYSFGVLALEVIKGK 1006
M + D++S G + E++KGK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I+ L ++H+ I++RD+ NV+LD + ++DFG+ K + + T GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 1010
Y+APE+ + D ++FGVL E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 54/285 (18%)
Query: 823 IGKGGQGSVYKAEL------ASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+G G G VY+ SG I VAVK + ++EFL E ++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 876 IVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG----------------ISDAL 919
IVK G C + +I+ L + R V + ++
Sbjct: 61 IVKLLGVCL-LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 920 SYMHNDCFPPIVHRDISSKNVLL-----DFDNEAHVSDFGIAKFLKPDSSNWTELAGT-- 972
Y+ F +HRD++++N L+ D D + DFG+A+ + S++ G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGL 174
Query: 973 --YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029
++APE K T + DV+SFGVL E++ G+ P ++ N +
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVT 227
Query: 1030 LDPRL-PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
RL +C DK+ ++ +C ++P RPT ++ ++L
Sbjct: 228 AGGRLQKPENC--PDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 17/128 (13%)
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA---KFLKPDSSNWTELAGTYGY 975
L +MHN +V+RD+ N+LLD +SD G+A KP +S GT+GY
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 161
Query: 976 VAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-----SLNLNIALDEM 1029
+APE L + D +S G + ++++G P + +L + + L +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 1030 LDPRLPTP 1037
P L +
Sbjct: 222 FSPELRSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
I+ AL ++H+ I++RD+ NVLLD + ++DFG+ K + + GT
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ M D ++ GVL E++ G P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 15/143 (10%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVT 987
++HRDI S N+LL + + DFG +K S+ GT YVAPE+ +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL-PTPSCIVQDKLI 1046
+K D++S GVL E++ K P D N+ + + L R P P I +
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPPSISPE--- 272
Query: 1047 SIVEVAISCLDENPESRPTMPKV 1069
+ E+ + L +P+ RP+ K+
Sbjct: 273 -MQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 26/79 (32%), Positives = 41/79 (51%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 989
+++RD+ +N+LLD+ + DFG+ K D GT Y+APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 990 CDVYSFGVLALEVIKGKHP 1008
D ++ GVL E++ G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELAYTM----- 984
VHRDI NVLLD + ++DFG L D + + +A GT Y++PE+ M
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
+ +CD +S GV E++ G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
++ AL ++H +++RD+ N+LLD + ++DFG+ K + T GT
Sbjct: 105 VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ ++ D ++ GVL E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 48/212 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIRHR 874
IG+G G VYKA + + E +A+KK + +QE + E+ L E++H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK--------IRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN----------VIKG----ISDALS 920
NIV+ H L ++ DL + M+ +IK I ++
Sbjct: 62 NIVRLQDVV-HSEKRLYLVFE----YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 921 YMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
Y H+ ++HRD+ +N+L+D N ++DFG+A+ +T T Y APE
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 980 L-----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
+ Y+ V D++S G + E++ K
Sbjct: 174 ILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELAYTM----- 984
VHRDI NVLLD + ++DFG + D + + +A GT Y++PE+ M
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
K +CD +S GV E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 26/81 (32%), Positives = 43/81 (53%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 989
I++RD+ NV+LD + ++DFG+ K D GT Y+APE+ +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 990 CDVYSFGVLALEVIKGKHPRD 1010
D ++FGVL E++ G+ P +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 34/85 (40%), Positives = 47/85 (55%), Gaps = 7/85 (8%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL-AGTYGYVAPELAYTMKVTEK 989
VHRDI +NVL+D ++DFG A L + ++L GT Y+APE+ TM K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 990 ------CDVYSFGVLALEVIKGKHP 1008
CD +S GV+A E+I G+ P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 36/128 (28%), Positives = 59/128 (46%), Gaps = 17/128 (13%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA---KFLKPDSSNWTELAGTYG 974
L +MHN +V+RD+ N+LLD +SD G+A KP +S GT+G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 160
Query: 975 YVAPE-LAYTMKVTEKCDVYSFGVLALEVIKG-----KHPRDFISSMSSSSLNLNIALDE 1028
Y+APE L D +S G + ++++G +H + +L +N+ L +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD 220
Query: 1029 MLDPRLPT 1036
P L +
Sbjct: 221 SFSPELKS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 823 IGKGGQGSVYKAE------LASGEIVAVKKF-HSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+G+G G V KA A VAVK + E+ ++ L+E L ++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL---RDLLSEFNLLKQVNHPH 64
Query: 876 IVKFYGFC-------------------SHVRHS-------LAMILSNNAAAKDLGWTRRM 909
++K YG C S +R S L + N++ D R +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 910 NVIK------GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
+ IS + Y+ +VHRD++++NVL+ + +SDFG+++ + +
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 964 SNWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 1003
S G ++A E + T + DV+SFGVL E++
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 57/226 (25%), Positives = 79/226 (34%), Gaps = 51/226 (22%)
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDL 554
S+ Q L L L L +N+L L +L S SL L L
Sbjct: 71 QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSS---------------SLQELKL 115
Query: 555 SSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN----S 610
++N L L K G LE L L NRL +
Sbjct: 116 NNN------GLGDRGLRLLAK---------GLKDLPP----ALEKLVLGRNRLEGASCEA 156
Query: 611 IPKSFGNLVKLHYLNLSNNQFS-RGIPIKLEELIHLSEL---DLSHNFLREAIPSQICI- 665
+ K+ L LNL+NN GI E L L DL++N L + S +
Sbjct: 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216
Query: 666 ---MQSLENLNLSHNSL-----VGLIPSCFEKMHGLLRIDISYNEL 703
++SLE LNL N+L L + LL + +S N++
Sbjct: 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-07
Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 29/262 (11%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG G G+VYK +G + A+K + E T +++ E++ L ++ H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 882 FCSHVRHSLAMI-------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRD 934
H ++ L A + +V + I ++Y+H IVHRD
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---DVARQILSGIAYLHRR---HIVHRD 193
Query: 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-----LAYTMKVTEK 989
I N+L++ ++DFG+++ L GT Y++PE L +
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA 253
Query: 990 CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049
D++S GV LE G+ P +SL I M P P + +
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MSQP--PEAPATASREFRHFI 308
Query: 1050 EVAISCLDENPESRPTMPKVSQ 1071
CL P R + ++ Q
Sbjct: 309 SC---CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 65/223 (29%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQE--FLNEVKALTEIRHR 874
+G G G VY+ A VAVK LP + Q E FL E +++ H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKT----LPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 875 NIVKFYGFC-------------------SHVRH---------SLAMILSNNAAAKDLGWT 906
NIV+ G S +R SL M KDL
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM--------KDL--- 118
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDFGIAKFLKPDS 963
+ + ++ Y+ + F +HRDI+++N LL A ++DFG+A+ +
Sbjct: 119 --LFCARDVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--R 171
Query: 964 SNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEV 1002
+++ G ++ PE T K DV+SFGVL E+
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 26/202 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE----FLNEVKALTEIRHRNIV 877
+GKG G V E A+G+ A+K L E+ ++ L E + L RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 878 KF-YGFCSHVRHSLAMILSNNAAAKDLGW-TRRMNVIKG---------ISDALSYMHNDC 926
Y F +H R M +N +L + R V I AL Y+H+
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC- 114
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 986
+V+RD+ +N++LD D ++DFG+ K D + GT Y+APE+
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 987 TEKCDVYSFGVLALEVIKGKHP 1008
D + GV+ E++ G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELAYTM----- 984
VHRDI N+L+D + ++DFG L D + + +A GT Y++PE+ M
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP 1008
K +CD +S GV E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYV 976
AL ++H IV+RDI +N+LLD + ++DFG++K FL + GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 977 APELAYTMKVTEKC-DVYSFGVLALEVIKGKHP 1008
APE+ K D +S G+L E++ G P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-06
Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 19/100 (19%)
Query: 918 ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS---NWTELAGT 972
L Y+H N ++HRD+ N+L++ + + + DFG+A+ + PD TE T
Sbjct: 115 GLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 973 YGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKH 1007
Y APEL YT + D++S G + E++ K
Sbjct: 170 RWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
AL ++H IV+RD+ +N+LLD + DFG++K D+ GT Y+A
Sbjct: 108 ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164
Query: 978 PELAYTMK-VTEKCDVYSFGVLALEVIKGKHP 1008
PE+ K T+ D +S GVL E+ G P
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 864 EVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRM-----------NVI 912
E + L+++ H IVKF+ S + I++ +DL V
Sbjct: 52 EAQLLSKLDHPAIVKFHA--SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109
Query: 913 KGISDAL---SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
+ L YMH I+HRD+ +KN+ L +N + DFG+++ L T
Sbjct: 110 EWFIQLLLGVHYMHQR---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTF 165
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
GT Y++PE K D++S G + E+ H + + L++ + + E
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEG 220
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065
P LP +L SI++ S L+++P RP+
Sbjct: 221 PTPSLPE---TYSRQLNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 27/153 (17%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
+HRD++++N+LL +N + DFG+A+ + PD + ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 989 KCDVYSFGVLALEVIK-GKHP-------RDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ DV+SFGVL E+ G P +F + + M P TP
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTP--- 309
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + + C P RPT ++ + L
Sbjct: 310 ------EMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 75/306 (24%), Positives = 129/306 (42%), Gaps = 65/306 (21%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL---ASGE---IVAVKKFHSPLPGEMTFQQEFL 862
EI +T F +E +G+ G VYK L A GE VA+K E ++EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFK 56
Query: 863 NEVKALTEIRHRNIVKFYG-------------FCSHVRHSLAMILSNNAAAKDLGWTRR- 908
+E + ++H NIV G +CSH L L + D+G T
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH--SDLHEFLVMRSPHSDVGSTDDD 114
Query: 909 ------------MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGI 955
++++ I+ + ++ + +VH+D++++NVL+ FD +SD G+
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV-FDKLNVKISDLGL 170
Query: 956 AKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD 1010
F + ++++ +L G +++PE K + D++S+GV+ EV G P
Sbjct: 171 --FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 1011 FISSMSSSSLNLNIALDEMLDPR--LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPK 1068
S N + EM+ R LP P D + + + C +E P RP
Sbjct: 229 GYS---------NQDVIEMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 1069 VSQLLK 1074
+ L+
Sbjct: 276 IHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 802 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEI--VAVKKFHSPLPGEMTFQQ 859
+ K+ YE DF+ +G G G V A + + VA+K+F +
Sbjct: 24 KNKMKYE-------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 860 EFLNEVKALTEIRHRNIVKFYGFC---SHVRHSLAMILS---------NNAAAKDLGWTR 907
+E K L I H V YG S++ L ++ N D+G
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136
Query: 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967
++ I + L ++ IV+RD+ +N+LLD D ++DFG AK + D+ +T
Sbjct: 137 AAQIVL-IFEYLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT 187
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
L GT Y+APE+ + + D ++ G+ E++ G P
Sbjct: 188 -LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 29/202 (14%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +VYK +GEIVA+K+ H L E + E+ + E++H NIV+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 882 FCSHVRHSLAMILS-------------NNAAAKDLGWTRRM--NVIKGISDALSYMHNDC 926
H + L ++ A D + ++KGI+ + H +
Sbjct: 66 VI-HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHEN- 119
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMK 985
++HRD+ +N+L++ E ++DFG+A+ F P ++ E+ T Y AP++ +
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 986 V-TEKCDVYSFGVLALEVIKGK 1006
+ D++S G + E+I G+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 49/282 (17%)
Query: 823 IGKGGQGSVYKAELASGEI-------VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+G+G G VY+ +A G + VA+K + M + EFLNE + E +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70
Query: 876 IVKFYGFCSHVRHSLAMI------------------LSNNAAAKDLGWTRRMNVIKGISD 917
+V+ G S + +L ++ + NN + + + I+D
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT----Y 973
++Y++ + F VHRD++++N ++ D + DFG+ + + +++ G
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP 1032
+++PE T DV+SFGV+ E+ + P MS+ + + +LD
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGMSNEQVLRFVMEGGLLDK 242
Query: 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P D L ++ + C NP+ RP+ ++ +K
Sbjct: 243 PDNCP-----DMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKV-- 986
I++RDI +N+LLD + ++DFG++K FL + GT Y+APE+
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 987 TEKCDVYSFGVLALEVIKGKHP 1008
+ D +S GVL E++ G P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-06
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL 349
+L L+L N+L I + L NL L + N+L+ P L SL +L LSGN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 32/206 (15%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
IG+G G V A + E VA+KK + + ++ L E+K L + H N++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70
Query: 881 GFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIK---GISD------------ALSYMHND 925
+ ++ +L T +I+ +SD L Y+H+
Sbjct: 71 DI---MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS- 126
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 980
++HRD+ N+LL+ + + + DFG+A+ TE T Y APEL
Sbjct: 127 --ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGK 1006
YT + DV+S G + E++ K
Sbjct: 185 EYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 46/281 (16%)
Query: 823 IGKGGQGSVYKAEL----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+GKG GSV +A+L S + VAVK + + + EFL E + E H N++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65
Query: 879 FYGFCSHVRHS----LAMILSNNAAAKDLGWTRRMNVIK----------------GISDA 918
G R + M++ DL M+ I I+
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT----YG 974
+ Y+ + F +HRD++++N +L+ + V+DFG++K K S ++
Sbjct: 126 MEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCASKLPVK 180
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
++A E T DV++FGV E++ +G+ P + +S N I + + P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLIKGNRLKQP- 237
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P C L + E+ C P+ RP+ + L+
Sbjct: 238 ---PDC-----LEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 15/148 (10%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVT 987
VHRD++++NVLL + DFG+A+ + D SN+ T+ ++APE + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317
Query: 988 EKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046
DV+S+G+L E+ G P + + S+ I R+ P Q+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTP--YPGMIVDSTFYNKIKSGY----RMAKPDHATQE--- 368
Query: 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ + C + PE RP+ +S +++
Sbjct: 369 -VYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 23/152 (15%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVT 987
+HRD++++N+LL + DFG+A+ ++ D SN+ ++APE + T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYT 294
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSS---SLNLNIALDEMLDP--RLPTPSCIVQ 1042
+ DV+S+G+L E I S+ SS + ++ +M+ R+ +P C
Sbjct: 295 FESDVWSYGILLWE----------IFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + ++ SC D +P RPT ++ QL++
Sbjct: 345 E----MYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYV 976
AL ++H I++RDI +N+LLD + ++DFG++K F + + GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 977 APELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 1008
AP++ + D +S GVL E++ G P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G+V+KA + EIVA+K+ E L E+ L E++H+NIV+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYD 66
Query: 882 FCSHVRHSLAMILSNNAAAKDL-------GWTRRMNVIKGIS----DALSYMHNDCFPPI 930
H L ++ +DL ++K L++ H+ +
Sbjct: 67 VL-HSDKKLTLVFEY--CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKV-TE 988
+HRD+ +N+L++ + E ++DFG+A+ F P E+ T Y P++ + K+ +
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179
Query: 989 KCDVYSFGVLALEVIKGKHP 1008
D++S G + E+ P
Sbjct: 180 SIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-06
Identities = 16/44 (36%), Positives = 28/44 (63%), Gaps = 4/44 (9%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCN 45
++ ALL +K+SL +G+ LSSW ++ + PC+W G+ C+
Sbjct: 3 DDRDALLAFKSSLNGDPSGA-LSSWNPSS---SDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 40/266 (15%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882
I + Q S+YK + + V ++ F G NE+K L I NI+K YGF
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 883 CSHV---------------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+ R L +L KDL + ++++ L ++
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTM-- 984
P +++++S + L+ + + + G+ K L P N + Y + ++ +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SCIVQD 1043
+ T K D+YS GV+ E+ GK P + +++ L +N L P CIV
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV-- 255
Query: 1044 KLISIVEVAISCLDENPESRPTMPKV 1069
+C + RP + ++
Sbjct: 256 ---------EACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 32/148 (21%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT------YGYVAPELAYT 983
+HRD++++NVL+ D+ ++DFG+A+ D + T ++APE +
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFD 208
Query: 984 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-----PRLPTP 1037
T + DV+SFGVL E+ G P I ++E+ R+ P
Sbjct: 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYP------------GIPVEELFKLLKEGYRMEKP 256
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPT 1065
Q+ + + C E P RPT
Sbjct: 257 QNCTQE----LYHLMRDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 45/211 (21%)
Query: 863 NEVKALTEIRHRNIVKF----------YGFCSHVRHSLAMILSNNAAA-KD---LGWTRR 908
NE+ AL + H NI+K Y L + + A KD L TR
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271
Query: 909 MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA-KFLKPDSSNWT 967
++K + A+ Y+H+ ++HRDI +N+ L+ D + + DFG A F K +
Sbjct: 272 --IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-------------GKHPRDFISS 1014
GT +PE+ E D++S G++ L+++ GK I S
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045
+S + D P P C + D +
Sbjct: 387 LS------------VCDEEFPDPPCKLFDYI 405
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKV 986
+HRD++++NVLL A + DFG+A+ + DS N+ + G ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYV-VKGNARLPVKWMAPESIFDCVY 291
Query: 987 TEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045
T + DV+S+G+L E+ GK P I ++S + +M P P ++
Sbjct: 292 TVQSDVWSYGILLWEIFSLGKSPYPGIL-VNSKFYKMVKRGYQMSRPDFAPP------EI 344
Query: 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074
SI++ C + P RPT ++SQL++
Sbjct: 345 YSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 8e-06
Identities = 55/240 (22%), Positives = 88/240 (36%), Gaps = 47/240 (19%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DF+ IG+G G V+ + +G++ A+K + E L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 874 RNIVK-FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNV---------IKGISDALSYMH 923
IVK +Y F H L +++ + R +V I + AL +H
Sbjct: 61 PWIVKLYYSF-QDEEH-LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-------------------FLKPDSS 964
F +HRDI N+L+D D ++DFG+ K F
Sbjct: 119 KLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 965 NWTEL----------AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 1014
+ GT Y+APE+ +CD +S GV+ E++ G P F S
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP--FYSD 233
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 60/220 (27%), Positives = 82/220 (37%), Gaps = 37/220 (16%)
Query: 377 IPSELGNLRSLSMLSLGYNKLS------GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG 430
+ S L SL L L N+ S+ L L LDL DN+L
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 431 NLRSLSTL---SLGYNKLSGSI-PHSLGNLT----NLDALYLYDNSLSG----SIPGEIG 478
+L S+L L N L L L+ L L N L G ++ +
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162
Query: 479 NLRSISNLALNNNKLSG----SIPQSLGNLSNLVILYLYNNSLFD---SIPSE-LGNLRS 530
R + L L NN + ++ + L NL +L L NN L D S +E L +L+S
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222
Query: 531 LSMLSFAYNKLSG-----------SIPHSLGVLDLSSNHI 559
L +L+ N L+ S SL L LS N I
Sbjct: 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 9e-06
Identities = 23/58 (39%), Positives = 29/58 (50%)
Query: 596 QLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
L+ LDLS+NRL+ +F L L L+LS N + P L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 11/112 (9%)
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL-----KPDSSNWT 967
+ + +AL+Y+H I+HRD+ ++N+ LD A + DFG A L P W
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW- 247
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS 1019
+GT +PEL K D++S G++ E+ SSSS
Sbjct: 248 --SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 24/239 (10%)
Query: 823 IGKGGQGSV---YKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IG G QG V Y A L VA+KK P + T + E+ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISL 81
Query: 880 YGFCS---------HVRHSLAMILSN--NAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
+ V + ++ +N +L R ++ + + ++H+
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---A 138
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
I+HRD+ N+++ D + DFG+A+ S T T Y APE+ M E
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 989 KCDVYSFGVLALEVIKGK--HP-RDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
D++S G + E+++ K P RD+I + L E + PT V+++
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 62/282 (21%), Positives = 119/282 (42%), Gaps = 49/282 (17%)
Query: 823 IGKGGQGSVYKA---ELASGEI---VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G VY+ ++ GE VAVK + + + EFLNE + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 71
Query: 877 VKFYGFCSHVRHSLAMIL-----------------SNNAAAKDLGWTRRMNVIKG-ISDA 918
V+ G S + +L ++ + N + + M + I+D
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT----YG 974
++Y++ F VHRD++++N ++ D + DFG+ + + +++ G
Sbjct: 132 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 186
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALD-EMLDP 1032
++APE T D++SFGV+ E+ + P +S+ L +D LD
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----LKFVMDGGYLDQ 242
Query: 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +++ ++ + C NP+ RPT ++ LLK
Sbjct: 243 PDNCP-----ERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 20/237 (8%)
Query: 823 IGKGGQGSVYKAELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG G QG V A A E VA+KK P + T + E+ + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 882 FCSHVRH---------SLAMILSN--NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
+ + + ++ +N +L R ++ + + ++H+ I
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 147
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
+HRD+ N+++ D + DFG+A+ + Y Y APE+ M E
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV 206
Query: 991 DVYSFGVLALEVIKGK--HP-RDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
D++S G + E+IKG P D I + L E + PT V+++
Sbjct: 207 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 10/78 (12%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG------YVAPELAYTM 984
+HRD++++NVL+ DN ++DFG+A+ D N T ++APE +
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDR 211
Query: 985 KVTEKCDVYSFGVLALEV 1002
T + DV+SFGVL E+
Sbjct: 212 VYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-05
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301
+L L L N+L+ + L NL L L N+L+ P F L SL L+L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 25/78 (32%), Positives = 45/78 (57%), Gaps = 10/78 (12%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK------FLKPDSSNWTELAGTYGYVAPELAYTM 984
+HRD++++NVL+ DN ++DFG+A+ + K S+ + ++APE +
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVK----WMAPEALFDR 211
Query: 985 KVTEKCDVYSFGVLALEV 1002
T + DV+SFG+L E+
Sbjct: 212 VYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 72/293 (24%)
Query: 823 IGKGGQGSVYKAELASGEI----VAVKKF------HSPLPGEMTFQQEFLNEVKALTEIR 872
+G+G GSV + +L+ + VAVK +S + +EFL+E + +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-------EEFLSEAACMKDFD 59
Query: 873 HRNIVKFYGFCSHVR--------------------HSLAMILSNNAAAKDLGWTRRMNVI 912
H N++K G C HS + + L + +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972
I+ + Y+ N F +HRD++++N +L D V+DFG++K +G
Sbjct: 120 VDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGD 167
Query: 973 Y-----------GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSL 1020
Y ++A E T K DV++FGV E+ +G+ P + +
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227
Query: 1021 NLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ RL P +D L + ++ SC +P+ RPT K+ ++L
Sbjct: 228 LRH-------GNRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 48/223 (21%)
Query: 816 DFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT 869
D E IG+G G V +A + + I +K+F S ++F E++ L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLC 57
Query: 870 EI-RHRNIVKFYGFCSH-------------------VRHSLAMILSNNAAAKDLGWTRRM 909
++ H NI+ G C + +R S ++ ++ A AK+ G +
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTL 116
Query: 910 N---VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966
+++ SD + M +HRD++++NVL+ + + ++DFG+++
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEE 170
Query: 967 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVI 1003
+ T G ++A E L Y++ T K DV+SFGVL E++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/188 (23%), Positives = 83/188 (44%), Gaps = 35/188 (18%)
Query: 841 IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS----------- 889
+VAVK + + T + +FL E+K ++ +++ NI++ G C V
Sbjct: 46 LVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVC--VSDDPLCMITEYMEN 101
Query: 890 --LAMILSNN------AAAKDLGWTRRMNVI---KGISDALSYMHNDCFPPIVHRDISSK 938
L LS A ++ N++ I+ + Y+ + F VHRD++++
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATR 158
Query: 939 NVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYS 994
N L+ ++DFG+++ L S ++ + G ++A E K T DV++
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 995 FGVLALEV 1002
FGV E+
Sbjct: 217 FGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I+ AL Y+H+ IV+RD+ +N+LLD ++DFG+ K ++ + + T GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTP 160
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ + D + G + E++ G P
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
I+ AL Y+H+ IV+RD+ +N+LLD ++DFG+ K S T GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ D + G + E++ G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 23/150 (15%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYV 976
L Y+H + IV+RD+ N+LLD + ++DFG+ K + T GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP--RDFISSMSSSSLNLNIALDEMLDPR- 1033
APE+ T D + GVL E++ G+ P D + S +N DE+ PR
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRF 223
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESR 1063
L + + +L L NPE R
Sbjct: 224 LSREAISIMRRL----------LRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 24/200 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV---- 877
IG+G G VYK +G+IVA+KK E + E+ L E++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQD 66
Query: 878 ------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
+ Y + L L + + + + + I + + H+ ++
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKV 986
HRD+ +N+L+D ++DFG+A+ +T T Y APE+ Y+ V
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 987 TEKCDVYSFGVLALEVIKGK 1006
D++S G + E+ K
Sbjct: 184 ----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
NL +L L N L+ F L +L +L+L N L I P + L +L +L + N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 51/274 (18%)
Query: 823 IGKGGQGSVYKAELASGEI---VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+G+G GSV + +L + VAVK + + ++FL+E + E H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 880 YGFC----------------SHVRHS--LAMILSNNAAAKDLGWTRRMNV--IKGISDAL 919
G C ++H + +L + +M V + I+ +
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA-KFLKPDSSNWTELAGT-YGYVA 977
Y+ + F +HRD++++N +L+ + V+DFG++ K D +A ++A
Sbjct: 126 EYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 978 PELAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSMSSSSLNLNIALDEMLD----- 1031
E T K DV+SFGV E+ +G+ P + + E+ D
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYDYLRQG 230
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065
RL P D L + + SC NP+ RP+
Sbjct: 231 NRLKQPP----DCLDGLYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 25/78 (32%), Positives = 45/78 (57%), Gaps = 10/78 (12%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK------FLKPDSSNWTELAGTYGYVAPELAYTM 984
+HRD++++NVL+ DN ++DFG+A+ + K ++ + ++APE +
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDR 217
Query: 985 KVTEKCDVYSFGVLALEV 1002
T + DV+SFGVL E+
Sbjct: 218 IYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 26/78 (33%), Positives = 44/78 (56%), Gaps = 10/78 (12%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG------YVAPELAYTM 984
+HRD++++NVL+ +N ++DFG+A+ D +N T ++APE +
Sbjct: 159 IHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDR 214
Query: 985 KVTEKCDVYSFGVLALEV 1002
T + DV+SFGVL E+
Sbjct: 215 VYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 63/291 (21%), Positives = 120/291 (41%), Gaps = 60/291 (20%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEI---VAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
ND + IG+G G V KA + + A+K+ ++F E++ L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKL 64
Query: 872 -RHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIK----------------- 913
H NI+ G C H R L + + L + R+ V++
Sbjct: 65 GHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 914 --------GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965
++ + Y+ F +HRD++++N+L+ + A ++DFG+++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQ 174
Query: 966 WTELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSS 1018
+ T G ++A E L Y++ T DV+S+GVL E++ G P M+ +
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCA 230
Query: 1019 SLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
L + L+ L +C D++ ++ C E P RP+ ++
Sbjct: 231 ELYEKLPQGYRLEKPL---NC--DDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 27/201 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-- 879
IG G QG V A + +G+ VA+KK P ++ + E+ + + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82
Query: 880 --------------YGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
Y + +L ++ DL R ++ + + ++H+
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHS- 136
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
I+HRD+ N+++ D + DFG+A+ S T T Y APE+ M
Sbjct: 137 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMG 193
Query: 986 VTEKCDVYSFGVLALEVIKGK 1006
E D++S G + E+I+G
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 817 FDDEHC-IGKGGQGSVYKAELASGEI---VAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
F+ E C +G+G G VYKA+ G+ A+K+ E+ L E++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-----TGISMSACREIALLRELK 56
Query: 873 HRNIVKFYG-FCSH-----------VRHSLAMIL----SNNAAAKDLGWTRRM--NVIKG 914
H N++ F SH H L I+ ++ A K + R M +++
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFD----NEAHVSDFGIAKF----LKPDSSNW 966
I D + Y+H + ++HRD+ N+L+ + ++D G A+ LKP ++
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-LADL 172
Query: 967 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVI 1003
+ T+ Y APEL + T+ D+++ G + E++
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 27/110 (24%), Positives = 55/110 (50%), Gaps = 4/110 (3%)
Query: 898 AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957
AA +++ + + + + A+ Y+H + I+HRDI ++N+ ++ + + DFG A
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 958 F-LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006
F + +++ + AGT APEL D++S G++ E+
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-05
Identities = 82/347 (23%), Positives = 121/347 (34%), Gaps = 88/347 (25%)
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIP-----HSLGNL- 216
P L +NL+TL L D S +PS L L L + + +P SL L
Sbjct: 651 PDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLN 710
Query: 217 --------------TNLATLYLHNNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGS---- 256
TN++ L L ++ + PS L NL L + + KL
Sbjct: 711 LSGCSRLKSFPDISTNISWLDLDETAIEE-FPSNLRLENLDELILCEMKSEKLWERVQPL 769
Query: 257 ------IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310
+ S L L+L + +PS NL L L +
Sbjct: 770 TPLMTMLSPS------LTRLFLSDIPSLVELPSSIQNLHKLEHLE-------------IE 810
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYS 370
N NL TL P+ I NL SL +L LSG + P +N++ L L S
Sbjct: 811 NCINLETL-----------PTGI-NLESLESLDLSGCSRLRTFP---DISTNISDLNL-S 854
Query: 371 NSLFDSIPSELGNLRSLSMLSL-GYNKLSGSIPHSLGNLTNLATLDLYD---------NS 420
+ + +P + +LS L + G N L + + L +L T+D D N
Sbjct: 855 RTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVSLN-ISKLKHLETVDFSDCGALTEASWNG 913
Query: 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
+ N+ S KL ++ + N NLD L
Sbjct: 914 SPSEVAMATDNIHS---------KLPSTVCINFINCFNLDQEALLQQ 951
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 13/137 (9%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 990
+HR S N+LL +D + G F P+ S ++APE+ TEK
Sbjct: 33 LHRQAKSGNILLTWD--GLLKLDGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKA 85
Query: 991 DVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL--ISI 1048
D+YS G+ E + + P + +S+ L I L+ M P ++ S
Sbjct: 86 DIYSLGITLYEALDYELPYNEERELSAI---LEILLNGM-PADDPRDRSNLEGVSAARSF 141
Query: 1049 VEVAISCLDENPESRPT 1065
+ C P+ R
Sbjct: 142 EDFMRLCASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-05
Identities = 21/60 (35%), Positives = 30/60 (50%)
Query: 410 NLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469
NL +LDL +N L+ F L +L L L N L+ P + L +L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 40/218 (18%)
Query: 817 FDDEHC-IGKGGQGSVYKAELASG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
F+ E C +G+G G VYKA+ G A+K+ E+ L E++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-----TGISMSACREIALLRELK 56
Query: 873 HRNIVKFYG-FCSH-----------VRHSLAMIL----SNNAAAKDLGWTRRM--NVIKG 914
H N++ F SH H L I+ ++ A K + R M +++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFD----NEAHVSDFGIAKF----LKPDSSNW 966
I D + Y+H + ++HRD+ N+L+ + ++D G A+ LKP ++
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-LADL 172
Query: 967 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVI 1003
+ T+ Y APEL + T+ D+++ G + E++
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-05
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 33/165 (20%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TELAGTYG 974
AL +H+ ++HRD+ S N+ L + DFG +K DS + + GT
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPY 236
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSMSSSSLNLNIALDE 1028
Y+APEL + ++K D++S GV+ E++ KG R+ + + +
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------- 289
Query: 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
P P C V + ++++ +S +NP RPT QLL
Sbjct: 290 ------PFP-CPVSSGMKALLDPLLS---KNPALRPT---TQQLL 321
|
Length = 478 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 9e-05
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445
+L L L N+L+ + L NL LDL N+L+ P F L SL +L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 44/195 (22%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +VYK +G++VA+K + F + E L ++H NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIVLLHD 70
Query: 882 FCSHVRHSLAMILS------NNAAAKDLGWTRRMNV---IKGISDALSYMHNDCFPPIVH 932
H + +L + + G NV + + L+Y+H I+H
Sbjct: 71 II-HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILH 126
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCD 991
RD+ +N+L+ + E ++DFG+A+ S ++ T Y P+ L + D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 992 VYSFGVLALEVIKGK 1006
++ G + +E+++G+
Sbjct: 187 IWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 32/207 (15%)
Query: 823 IGKGGQGSVYKAE--LASGEIVAVKKFHSPLPGE-MTFQQEFLNEVKALTEIR---HRNI 876
IG+G G V+KA G VA+K+ E M + EV L + H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNV 66
Query: 877 VKFYGFCS---------------HVRHSLAMILSNNAAAKDLGWTRRM--NVIKGISDAL 919
V+ + C+ HV L L + G +++ + L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGL 123
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
++H+ +VHRD+ +N+L+ + ++DFG+A+ + T + T Y APE
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPE 179
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGK 1006
+ D++S G + E+ + K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 74/278 (26%), Positives = 117/278 (42%), Gaps = 19/278 (6%)
Query: 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYN 395
L L N+ L G+K IP L +NL TL L S +PS + L L L +
Sbjct: 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691
Query: 396 KLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455
+ +P + NL +L L+L S S P N+ S L L + P +L
Sbjct: 692 ENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNI---SWLDLDETAIE-EFPSNL-R 745
Query: 456 LTNLDALYLYDNSLSGSIPGEIGNLR--------SISNLALNNNKLSGSIPQSLGNLSNL 507
L NLD L L + S + + L S++ L L++ +P S+ NL L
Sbjct: 746 LENLDELILCEMK-SEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL 804
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH-SLGVLDLSSNHI-VGEIPT 565
L + N +++P+ + NL SL L + + P S + DL+ + + E+P
Sbjct: 805 EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPW 863
Query: 566 ELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
+ K + L L + ++S + L LE +D S
Sbjct: 864 WIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFS 901
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)
Query: 822 CIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
C + K + + +VAVKK + + + E+ +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNILPYV- 65
Query: 882 FCSHVRHSLAMI--LSNNAAAKDLGWTRRMN---------VIKGISDALSYMHNDCFPPI 930
V L ++ L + +DL T ++K + +AL Y+H+ F
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF--- 122
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK------------FLKPDSS----NWTELAGTYG 974
+HR + + ++LL D + +S + P SS W
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL------- 175
Query: 975 YVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHP 1008
+PE+ EK D+YS G+ A E+ G P
Sbjct: 176 --SPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 35/134 (26%), Positives = 55/134 (41%), Gaps = 46/134 (34%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI---------AKFLKP------D 962
A+ +H F +HRDI N+L+D D ++DFG+ +K+ + D
Sbjct: 113 AIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 963 S----SNWTE------------------------LAGTYGYVAPELAYTMKVTEKCDVYS 994
S W+E L GT Y+APE+ T+ CD +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 995 FGVLALEVIKGKHP 1008
GV+ E++ G+ P
Sbjct: 230 VGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-NWTELAGTYGYVA 977
L Y+H+ I+HRDI N+L++ + + DFG+A+ +PD S + T+ T Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 978 PELA-----YTMKVTEKCDVYSFGVLALEVIKGK 1006
PE+ YT V D++S G + E++ +
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 17/194 (8%)
Query: 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +VYK + +G++VA+K L E + E L ++H NIV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 882 FCSHVRHSLAMILSN------NAAAKDLGWTRRMNV---IKGISDALSYMHNDCFPPIVH 932
H + +L ++ K G NV + + LSY+H I+H
Sbjct: 71 II-HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILH 126
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC-D 991
RD+ +N+L+ E ++DFG+A+ S ++ T Y P++ C D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 992 VYSFGVLALEVIKG 1005
++ G + +E+I+G
Sbjct: 187 MWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 19/60 (31%), Positives = 29/60 (48%)
Query: 170 NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL 229
NL +L L +N L+ F L +L +L L N + P + L +L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-04
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 58/270 (21%)
Query: 484 SNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL-GNLRSLSMLSFAYNKLS 542
+ L L L+ +IP + + L L NN L S+P L GN+++L S +
Sbjct: 181 TELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQGNIKTLYANSNQLTSIP 236
Query: 543 GSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
++P ++ ++LS N I E+P L + L L L N++S L L +L +L +
Sbjct: 237 ATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLPE--ELRYLSV 290
Query: 603 SSNRLSNSIPKSF-GNLVKLHYLNLSNNQFSRGIPIKLEELI---------------HLS 646
N + ++P + L+ + S +P L+ L L
Sbjct: 291 YDNSIR-TLPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALTSLPASLPPELQ 349
Query: 647 ELDLSHN---FLREAIPSQICIMQSLENLNLSHNSLVGL---IPSCFEKMHGLLRIDISY 700
LD+S N L E +P ++ L++S N+L L +P+ + M S
Sbjct: 350 VLDVSKNQITVLPETLPP------TITTLDVSRNALTNLPENLPAALQIMQA------SR 397
Query: 701 NEL------------QGPIPNSIAFRDAPI 718
N L +GP P I P
Sbjct: 398 NNLVRLPESLPHFRGEGPQPTRIIVEYNPF 427
|
Length = 754 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
I+ AL Y+H+ I++RD+ +N+LLD ++DFG+ K S + GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ D + G + E++ G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 823 IGKGGQGSVYKAELASG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IG G G V E+ SG V VK+ + Q +FL E + ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 880 YGFCSHVRHSLAMI-----------LSNNAAAK----DLGWTRRMNVIKGISDALSYMHN 924
G C+ V L ++ L + A+ D +RM I+ L ++H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHK 118
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-------FLKPDSSNWTELAGTYGYVA 977
+ F +H D++ +N LL D + D+G++ ++ PD W L ++A
Sbjct: 119 NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIA 170
Query: 978 PELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029
PEL + T++ +V+S GV E+ + G P +S + + ++
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
PRL P + D+ EV C + PE RP+ +V LL
Sbjct: 231 PKPRLKLP---LSDRW---YEVMQFCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 26/75 (34%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVT 987
VHRD++++NVL+ + DFG+A+ + D SN+ T+ ++APE + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFNNLYT 319
Query: 988 EKCDVYSFGVLALEV 1002
DV+SFG+L E+
Sbjct: 320 TLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
++ A+ Y+H+ I++RD+ +N+LLD ++DFG+ K ++P+ + T GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ D + G + E++ G P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 46/195 (23%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 823 IGKGGQGSVYKAELASGE-IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +V+K E +VA+K+ L E + EV L +++H NIV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 882 FCSHVRHSLAMILSN-----NAAAKDLGWTRRMNVIK----GISDALSYMHNDCFPPIVH 932
H SL ++ D G M+ +K I L+Y H ++H
Sbjct: 72 IV-HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLH 127
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCD 991
RD+ +N+L++ E ++DFG+A+ + ++ T Y P+ L + + + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 992 VYSFGVLALEVIKGK 1006
++ G + E+ G+
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 4e-04
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 644 HLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL 703
+L LDLS+N L + +L+ L+LS N+L + P F + L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 53/260 (20%), Positives = 108/260 (41%), Gaps = 40/260 (15%)
Query: 841 IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL------ 894
+VAVK + +FL E+K ++ ++ NI++ C L MI
Sbjct: 48 LVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-TSDPLCMITEYMENG 104
Query: 895 --------------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNV 940
+ A + ++ + + I+ + Y+ + F VHRD++++N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNC 161
Query: 941 LLDFDNEAHVSDFGIAKFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFG 996
L+ + ++DFG+++ L S ++ + G +++ E K T DV++FG
Sbjct: 162 LVGKNYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219
Query: 997 VLALEVIKGKHPRDFISSMSSSSLNLNIA---LDEMLDPRLPTPSCIVQDKLISIVEVAI 1053
V E++ + + S +S + N D+ LP P+ S+ ++ +
Sbjct: 220 VTLWEILTLCKEQPY-SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD----SLYKLML 274
Query: 1054 SCLDENPESRPTMPKVSQLL 1073
SC N + RP+ ++ L
Sbjct: 275 SCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-04
Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 5/86 (5%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGY 975
A+ Y+H + I+HRDI ++NVL++ + + DFG A F + S +AGT
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALE 1001
APE+ T D++S G++ E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 30/125 (24%), Positives = 51/125 (40%), Gaps = 47/125 (37%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGI---------AKF------LKPDSSNWT-------- 967
+HRDI N+L+D D ++DFG+ +K+ ++ DS +++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 968 ------------------------ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 1003
L GT Y+APE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 1004 KGKHP 1008
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 858 QQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDL-GWTRR-------- 908
++ FL E L + H NIV+ G + R + MI++ + L + R+
Sbjct: 50 RRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQLVAG 107
Query: 909 --MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN- 965
M ++ G++ + Y+ + VH+ +++ VL++ D +S F L+ D S
Sbjct: 108 QLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEA 161
Query: 966 -WTELAGTYG--YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008
+T ++G + APE + DV+SFG++ EV+ G+ P
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 823 IGKGGQG---SVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIV- 877
+G+G G S AE + E VA+KK + ++ ++ L E+K L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNITC 66
Query: 878 -------------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+ Y + + L I+ + + L + I I L Y+H+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS 123
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSNWTELAGTYGYVAPEL 980
++HRD+ N+L++ D E + DFG+A+ + + TE T Y APE+
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 981 AYTMK-VTEKCDVYSFGVLALEVIKGK 1006
+ + T+ DV+S G + E++ K
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 7e-04
Identities = 19/60 (31%), Positives = 29/60 (48%)
Query: 434 SLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
+L +L L N+L+ + L NL L L N+L+ P L S+ +L L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 146 SLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKF 205
+L L L +N L + + L NL L L N+L+ P F L SL L L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 17/195 (8%)
Query: 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +VYK + +VA+K+ L E + EV L +++H NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 882 FCSHVRHSLAMILSN-----NAAAKDLGWTRRMNVIK----GISDALSYMHNDCFPPIVH 932
H SL ++ D G + M+ +K + L+Y H ++H
Sbjct: 72 II-HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLH 127
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCD 991
RD+ +N+L++ E ++DFG+A+ + ++ T Y P+ L + + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 992 VYSFGVLALEVIKGK 1006
++ G + E+ G+
Sbjct: 188 MWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 47/125 (37%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGI---------AKF------LKPDSSN----WTE--- 968
+HRDI N+L+D D ++DFG+ +K+ ++ DS W +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 969 -------------------------LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 1003
L GT Y+APE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 1004 KGKHP 1008
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 33/113 (29%), Positives = 45/113 (39%), Gaps = 35/113 (30%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLK--------------PDS------------- 963
+HRDI N+LLD +SDFG+ LK P S
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 964 ----SNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
N +LA GT Y+APE+ + CD +S GV+ E++ G P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYG 974
IS AL ++H I++RD+ +N+LLD ++DFG+ K + + GT
Sbjct: 109 ISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ + D +S G L +++ G P
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 64/248 (25%), Positives = 86/248 (34%), Gaps = 43/248 (17%)
Query: 168 LSNLDTLHLYDNSLSDS----IPSEFGNLRSLSMLSLGYN------KFSGSIPHSLGNLT 217
L L L L N+L + + S SL L L N + S+ L
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 218 NLATLYLHNNSLFDSIPSELGNLR---SLSMLSLGYNKLSGSI-PHSLGNLT----NLAT 269
L L L +N+L L +L SL L L N L L L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 270 LYLYENSLSG----SIPSEFGNLRSLSMLNLGYNKLN--GI--IPHSLGNLTNLATLYIH 321
L L N L G ++ R L LNL N + GI + L NL L ++
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 322 NNS--------LSGSIPSEIGNLRSLSNLGLSGNKLSGSI-----PPSLGYLSNLATLYL 368
NN L+ ++ S L+SL L L N L+ + L +L TL L
Sbjct: 202 NNGLTDEGASALAETLAS----LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 369 YSNSLFDS 376
N + D
Sbjct: 258 SCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 21/59 (35%), Positives = 30/59 (50%)
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
L L L+ N+L+ L L+ LDLS N L++ P++F L L L+LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 50/259 (19%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
+IP + + TL L NN L S+P L GN+++L S N+L+ SIP +L +
Sbjct: 192 TIPACIPE--QITTLILDNNELK-SLPENLQGNIKTLYANS---NQLT-SIPATLPDTIQ 244
Query: 267 LATLYLYE-NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
L + L +PS +L L+L +NK++ +P +L L L +++NS+
Sbjct: 245 EMELSINRITELPERLPS------ALQSLDLFHNKISC-LPENLPE--ELRYLSVYDNSI 295
Query: 326 SG---SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSN---SLFDSIPS 379
+PS I +L SN S L ++PP L TL N SL S+P
Sbjct: 296 RTLPAHLPSGITHLNVQSN---SLTALPETLPP------GLKTLEAGENALTSLPASLPP 346
Query: 380 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL-RSLSTL 438
EL L + N+++ +P +L + TLD+ N+L+ ++P NL +L +
Sbjct: 347 ELQV------LDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPE---NLPAALQIM 393
Query: 439 SLGYN---KLSGSIPHSLG 454
N +L S+PH G
Sbjct: 394 QASRNNLVRLPESLPHFRG 412
|
Length = 754 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYV 976
AL +H+ F +HRD+ N+LLD ++DFG + + + A GT Y+
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210
Query: 977 APELAYTMKVT----EKCDVYSFGVLALEVIKGKHP 1008
+PE+ + +CD +S GV E++ G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYV 976
AL +H+ F +HRD+ N+LLD ++DFG + + + A GT Y+
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 977 APELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 1008
+PE+ + +CD +S GV E++ G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 65/259 (25%), Positives = 96/259 (37%), Gaps = 78/259 (30%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKA----LT 869
+DF+ IG+G G V + +G I A+KK EM ++E + V+A L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEM-LEKEQVAHVRAERDILA 56
Query: 870 EIRHRNIVK-FYGFCSHVRHSLAM----------------ILSNNAAAKDLGWTRRMNVI 912
E + +VK +Y F L M + R +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--------RFYIA 108
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK------------ 960
+ I A+ +H + +HRDI N+LLD +SDFG+ LK
Sbjct: 109 ETIL-AIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 961 -------------PDSS-----NWTE----LA----GTYGYVAPELAYTMKVTEKCDVYS 994
P SS W LA GT Y+APE+ ++CD +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 995 FGVLALEVIKGKHPRDFIS 1013
GV+ E++ G P F S
Sbjct: 225 LGVIMYEMLVGYPP--FCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
NL +L L NN L L +L +L L N L+ P + L +L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 37/221 (16%)
Query: 820 EHCIGKGGQGSVYKAELASGEIV---AVKKFHS---------PLPGEMTFQQEFLNEVKA 867
+ IG GG G VY+ + AS + AV K + L + + + K
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 868 LTEIRHRNIVKFYGFCSHVRHSL--------AMILSNNAAAKDLGWTRR---MNVIKGIS 916
+ I H I K+YG S R + ++ + K + + N++K +
Sbjct: 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDML 136
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL---------KPDSSNWT 967
L Y+H I H DI +N+++D +N ++ D+GIA + +
Sbjct: 137 TTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH 193
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
GT Y + VT + D+ S G L+ K P
Sbjct: 194 R--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL---AGTYGYVAPELAYTMK- 985
++HRD+ N+LLD ++DFG +K D + GT Y++PE+ +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 986 ---VTEKCDVYSFGVLALEVIKGKHP 1008
+CD +S GV E++ G P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
NL +L L +N L L +L +L L N L+ P + L +L +LDL N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 35/113 (30%)
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKP---------------------------DS 963
+HRDI N+LLD +SDFG+ LK +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 964 SNWT----ELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
W +LA GT Y+APE+ + CD +S GV+ E++ G P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 48/216 (22%)
Query: 823 IGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRN 875
IG+G G V KA + I +K++ S ++F E++ L ++ H N
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPN 57
Query: 876 IVKFYGFCSH-------------------VRHSLAMILSNNAAAKDLGWTRRMN---VIK 913
I+ G C H +R S ++ ++ A A ++ ++
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLH 116
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY 973
+D M +HRD++++N+L+ + A ++DFG+++ + T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTM 170
Query: 974 G-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVI 1003
G ++A E L Y++ T DV+S+GVL E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 32/116 (27%), Positives = 48/116 (41%), Gaps = 31/116 (26%)
Query: 905 WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964
W M V AL +H + IV RD++ N+LLD ++ F
Sbjct: 90 WAAEMVV------ALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS---------- 130
Query: 965 NWTELAGTYG-------YVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-----HP 1008
W+E+ + Y APE+ + TE CD +S G + E++ GK HP
Sbjct: 131 RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 53/212 (25%)
Query: 823 IGKGGQGS---VYKA-ELASGEIVAVKK----FHSPLPGEMTFQQEFLNEVKALTEIR-- 872
+GK G+G+ V KA +G+ A+K F S L +V L EI+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS------------LEQVNNLREIQAL 51
Query: 873 -----HRNIVKFYGFCSHV----RHSLAMIL-----SNNAAAKD----LGWTRRMNVIKG 914
H NI++ + LA++ + K L R + +
Sbjct: 52 RRLSPHPNILRL---IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ 108
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK--FLKPDSSNWTELAGT 972
+ +L +MH + I HRDI +N+L+ D ++DFG + + KP +TE T
Sbjct: 109 LLKSLDHMHRN---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP---YTEYIST 161
Query: 973 YGYVAPELAYTMKV-TEKCDVYSFGVLALEVI 1003
Y APE T K D+++ G + E++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 41/229 (17%)
Query: 857 FQQEFLNEVKALTEIRHRNIVKFYGFC----------SHVRH-SLAMILSNNAAAKDLGW 905
+ + F ++++ H+++V YG C +V+ SL L N ++ W
Sbjct: 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101
Query: 906 TRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH--------VSDFGIAK 957
++ V K ++ AL ++ + + H ++ +KNVLL + + +SD GI+
Sbjct: 102 --KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156
Query: 958 FLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 1016
+ P L +V PE + ++ D +SFG E+ G D S
Sbjct: 157 TVLPKEI----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG---DKPLSAL 209
Query: 1017 SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065
S L D +LP P K + + C+D P+ RP+
Sbjct: 210 DSQKKLQFYEDRH---QLPAP------KWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.004
Identities = 20/68 (29%), Positives = 27/68 (39%), Gaps = 12/68 (17%)
Query: 817 FDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEF-----LNEVKALTE 870
++ IG G G V A +G VA+KK F L E+K L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLRH 55
Query: 871 IRHRNIVK 878
+RH NI+
Sbjct: 56 LRHENIIG 63
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 67/256 (26%), Positives = 108/256 (42%), Gaps = 39/256 (15%)
Query: 774 KFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATN-DFDDEHCIGKGGQGSVY 832
KF+ + L ++ S N G E K++ +I R+ N + + IG G G VY
Sbjct: 27 KFEMNDKKLDEEERSHNNNAGEDED---EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVY 83
Query: 833 KAE-LASGEIVAVKK-FHSPLPGEMTFQQEFLNEVKALTEIRHRNIV--KFYGFCSHVRH 888
+A + + E VA+KK P Q E+ + + H NI+ K Y + +
Sbjct: 84 EAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135
Query: 889 SLAMILSN-------NAAAKDLGWTRRMN------VIKGIS----DALSYMHNDCFPPIV 931
+ I N K + R N ++K S AL+Y+H+ I
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---IC 192
Query: 932 HRDISSKNVLLDFDNEA-HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEK 989
HRD+ +N+L+D + + DFG AK L + + + + Y APEL T
Sbjct: 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YRAPELMLGATNYTTH 251
Query: 990 CDVYSFGVLALEVIKG 1005
D++S G + E+I G
Sbjct: 252 IDLWSLGCIIAEMILG 267
|
Length = 440 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1075 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.68 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.51 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.51 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.38 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.35 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.34 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.3 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.03 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.91 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.89 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.87 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.72 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.71 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.66 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.65 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.4 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.35 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.35 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.19 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.19 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.18 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-109 Score=1072.70 Aligned_cols=903 Identities=36% Similarity=0.583 Sum_probs=563.6
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEcc
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLW 81 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~ 81 (1075)
+|++||++||+++.++ . +.+.+|+. .+.+|.|.||+|+..++|+.++++++++.|.+++. +..+++|++|||+
T Consensus 29 ~~~~~l~~~~~~~~~~-~-~~~~~w~~----~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~-~~~l~~L~~L~Ls 101 (968)
T PLN00113 29 EELELLLSFKSSINDP-L-KYLSNWNS----SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA-IFRLPYIQTINLS 101 (968)
T ss_pred HHHHHHHHHHHhCCCC-c-ccCCCCCC----CCCCCcCcceecCCCCcEEEEEecCCCccccCChH-HhCCCCCCEEECC
Confidence 6899999999999654 3 46789962 23359999999987788888877776666665443 5566666666666
Q ss_pred CCCccCCCCcccc-ccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCC
Q 042958 82 HNQLYGNIPPQIG-NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL 160 (1075)
Q Consensus 82 ~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 160 (1075)
+|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p---------------------- 157 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP---------------------- 157 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCC----------------------
Confidence 6666555555443 455555555555555444442 223334444443333333222
Q ss_pred CCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCC
Q 042958 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNL 240 (1075)
Q Consensus 161 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (1075)
..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+ |..++.+
T Consensus 158 --~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~------------------------p~~l~~l 211 (968)
T PLN00113 158 --NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI------------------------PRELGQM 211 (968)
T ss_pred --hHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcC------------------------ChHHcCc
Confidence 22444444555555555554444444444444444444444444444 4444444
Q ss_pred CCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceec
Q 042958 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYI 320 (1075)
Q Consensus 241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 320 (1075)
++|++|+|++|.+++.+|..++++++|++|++++|.+++.+|..|+++++|+.|++++|++.+..|..+.++++|++|++
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred ccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeecccccccc
Q 042958 321 HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400 (1075)
Q Consensus 321 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 400 (1075)
++|.+.+.+|..+.++++|+.|++++|.+.+.+|.. +..+++|+.|++++|++.+.
T Consensus 292 s~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~------------------------~~~l~~L~~L~L~~n~l~~~ 347 (968)
T PLN00113 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA------------------------LTSLPRLQVLQLWSNKFSGE 347 (968)
T ss_pred cCCeeccCCChhHcCCCCCcEEECCCCccCCcCChh------------------------HhcCCCCCEEECcCCCCcCc
Confidence 444444444444444444444444444444333333 34444444444444444444
Q ss_pred CChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCc
Q 042958 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480 (1075)
Q Consensus 401 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 480 (1075)
+|..++.+++|+.|++++|++++..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..|..+
T Consensus 348 ~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l 427 (968)
T PLN00113 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427 (968)
T ss_pred CChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcC
Confidence 44445555555555555555555555555555555555666666655566666666666666666666666666666666
Q ss_pred CCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccc
Q 042958 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIV 560 (1075)
Q Consensus 481 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~ 560 (1075)
+.|+.|++++|.+++.+|..+..+++|+.|+|++|++.+.+|..+
T Consensus 428 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~----------------------------------- 472 (968)
T PLN00113 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF----------------------------------- 472 (968)
T ss_pred CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-----------------------------------
Confidence 777777777777766666666566666666666665543222111
Q ss_pred cccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcc
Q 042958 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLE 640 (1075)
Q Consensus 561 ~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 640 (1075)
..++|+.|||++|++++.+|..|..+++|++|+|++|++++.+|..+.
T Consensus 473 --------------------------------~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 520 (968)
T PLN00113 473 --------------------------------GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS 520 (968)
T ss_pred --------------------------------ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHc
Confidence 123567777777777777777777788888888888888888888888
Q ss_pred cccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccccccEEeecCCccCCCCCCCcccccccccc
Q 042958 641 ELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEA 720 (1075)
Q Consensus 641 ~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~~~~~p~~~~~~~~~~~~ 720 (1075)
.+.+|++|+|++|.+++.+|..+..+++|+.|++++|+++|.+|..+..++.|+.+|+++|++.|.+|...+|..+...+
T Consensus 521 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~ 600 (968)
T PLN00113 521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600 (968)
T ss_pred CccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhh
Confidence 88888888888888888888888888888888999999988999999999999999999999999999988888888888
Q ss_pred ccCCccccCCCC--CCCcccccccccccceeEEEEEehhHHHHHHHHHHHHHHHhhhheecccccccCCCCCCcccccee
Q 042958 721 LQGNKGLCGDVK--GLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLSV 798 (1075)
Q Consensus 721 ~~~n~~lcg~~~--~l~~c~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~ 798 (1075)
+.+|+.+||..+ +.++|.... +. ..+.++++++++++++++++++++++++||++. +.++.+..........
T Consensus 601 ~~~n~~lc~~~~~~~~~~c~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 674 (968)
T PLN00113 601 VAGNIDLCGGDTTSGLPPCKRVR----KT-PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL-ELKRVENEDGTWELQF 674 (968)
T ss_pred hcCCccccCCccccCCCCCcccc----cc-ceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcc-cccccccccccccccc
Confidence 999999999653 356775321 11 122233333333333333322233333332221 1111111110000000
Q ss_pred ec--ccccccHHHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc
Q 042958 799 LT--FEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875 (1075)
Q Consensus 799 ~~--~~~~~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 875 (1075)
.. ....+.++++ ...|+..+.||+|+||.||+|.. .+|+.||||++..... ....|++.+++++|||
T Consensus 675 ~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~Hpn 744 (968)
T PLN00113 675 FDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPN 744 (968)
T ss_pred cccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCC
Confidence 00 0112233333 34677888999999999999976 5799999999864321 1234688899999999
Q ss_pred eeeEEEEeeccccchhheecCcccc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCce
Q 042958 876 IVKFYGFCSHVRHSLAMILSNNAAA------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH 949 (1075)
Q Consensus 876 iv~l~~~~~~~~~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 949 (1075)
||+++|+|.+....+ +++++...+ ..++|.++.+++.|||+|++|||..+.++|+||||||+||+++.++.++
T Consensus 745 Iv~~~~~~~~~~~~~-lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~ 823 (968)
T PLN00113 745 IVKLIGLCRSEKGAY-LIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823 (968)
T ss_pred cceEEEEEEcCCCCE-EEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceE
Confidence 999999998765432 333322211 3479999999999999999999977666999999999999999999888
Q ss_pred EeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc--hh----hhh
Q 042958 950 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS--SL----NLN 1023 (1075)
Q Consensus 950 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~----~~~ 1023 (1075)
+. ||.+...... ....+++.|+|||++.+..++.++|||||||++|||+||+.||+........ .. ...
T Consensus 824 ~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 824 LR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred EE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 76 6665443221 2236789999999999999999999999999999999999998643221110 00 001
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+.++.+........++..++.+++.+||+.||++||||+||++.|+
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 112334455443333344566778999999999999999999999999885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-61 Score=623.94 Aligned_cols=496 Identities=41% Similarity=0.598 Sum_probs=326.7
Q ss_pred CceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEE
Q 042958 48 GRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127 (1075)
Q Consensus 48 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 127 (1075)
.++..|+|+++.+.|.++...+..+++|++|||++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 46788999999999999887667999999999999999999985 6799999999999999999999999999999999
Q ss_pred ccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecccccc
Q 042958 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSG 207 (1075)
Q Consensus 128 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 207 (1075)
|++|.+.+.+|.. ++++++|++|+|++|.+++.+|..|+++++|++|+|++|++++
T Consensus 171 L~~n~l~~~~p~~------------------------~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 171 LGGNVLVGKIPNS------------------------LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CccCcccccCChh------------------------hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 9999998777655 6778889999999999999999999999999999999999998
Q ss_pred ccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCC
Q 042958 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN 287 (1075)
Q Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 287 (1075)
.+|..++++++|++|++++|.+++.+|..++.+++|++|++++|++.+.+|..+.++++|++|++++|.+++.+|..+.+
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 306 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence 88888888888888888888888888888888888888888888887777777777777777777777776666666666
Q ss_pred CccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceee
Q 042958 288 LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367 (1075)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~ 367 (1075)
+++|+.|++++|.+.+..|..+..+++|+.|++++|.+.+..|..++.+++|+.|++++|+
T Consensus 307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~------------------- 367 (968)
T PLN00113 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN------------------- 367 (968)
T ss_pred CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCe-------------------
Confidence 6666666666666666555555555555555555555554444444444444444444444
Q ss_pred ccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccccccccc
Q 042958 368 LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447 (1075)
Q Consensus 368 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 447 (1075)
+.+.+|..+..+.+|+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++
T Consensus 368 -----l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 442 (968)
T PLN00113 368 -----LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442 (968)
T ss_pred -----eEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccC
Confidence 433444444444445555555555555555555555555555555555555455555555555555555555554
Q ss_pred CCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccC
Q 042958 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGN 527 (1075)
Q Consensus 448 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 527 (1075)
.+|..+..+++|+.|+|++|++.+.+|.. ++ .++|+.|++++|++++.+|..+.+
T Consensus 443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~------------------------~~-~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 443 RINSRKWDMPSLQMLSLARNKFFGGLPDS------------------------FG-SKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred ccChhhccCCCCcEEECcCceeeeecCcc------------------------cc-cccceEEECcCCccCCccChhhhh
Confidence 44444444444444444444444443332 21 234455555555444333333322
Q ss_pred ccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcc
Q 042958 528 LRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL 607 (1075)
Q Consensus 528 l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 607 (1075)
+++|+.|++++|++ ++.+|..+..+++|++|+|++|.+
T Consensus 498 l~~L~~L~Ls~N~l------------------------------------------~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 498 LSELMQLKLSENKL------------------------------------------SGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred hhccCEEECcCCcc------------------------------------------eeeCChHHcCccCCCEEECCCCcc
Confidence 22222222211111 112223334445555666666666
Q ss_pred cCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchh
Q 042958 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP 660 (1075)
Q Consensus 608 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 660 (1075)
++.+|..|+.+++|+.|+|++|++++.+|..+..+..|+.|++++|++.+.+|
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 65555555555555555555555555555555555555555555555555444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=402.89 Aligned_cols=269 Identities=40% Similarity=0.677 Sum_probs=219.3
Q ss_pred cccccHHHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEE
Q 042958 802 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881 (1075)
Q Consensus 802 ~~~~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 881 (1075)
...+++.|+..||++|...+.||+|+||.||+|...+|+.||||++....... .++|..|++++.+++|||+|+++|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence 44689999999999999999999999999999999999999999886543221 356999999999999999999999
Q ss_pred Eeecccc-chhhe-ecCc--------cccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 882 FCSHVRH-SLAMI-LSNN--------AAAK-DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 882 ~~~~~~~-~l~~~-~~~~--------~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
||.+.+. .+.++ +... .... .++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998773 32222 2111 1112 7899999999999999999999999889999999999999999999999
Q ss_pred eccccccccCCCCCceecc-ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc------cc-hhhh
Q 042958 951 SDFGIAKFLKPDSSNWTEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS------SS-SLNL 1022 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~------~~-~~~~ 1022 (1075)
+|||+|+............ .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+...... +. ....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999997655312222222 89999999999999999999999999999999999999887543111 11 1112
Q ss_pred hhhhhhccCCCCCCCCcCcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPRLPTPSCIVQ-DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+++|+++... .+.. .+...+..++.+|++.+|++||+|.||+++|+
T Consensus 299 ~~~~~eiiD~~l~~~-~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEG-EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred CcchhheeCCCccCC-CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 226788899987632 2232 67778999999999999999999999999874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=377.98 Aligned_cols=468 Identities=34% Similarity=0.488 Sum_probs=272.2
Q ss_pred CcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEcc
Q 042958 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLG 297 (1075)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 297 (1075)
.|+.+.+++|.++. +-+.+.++..|.+|++++|++. ..|.+++.+..++.|+.++|+++ .+|..+..+.+|+.|+++
T Consensus 46 ~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 34444444444432 2223444444444444444444 33444444444444444444444 344444444444444444
Q ss_pred CCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCC
Q 042958 298 YNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSI 377 (1075)
Q Consensus 298 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 377 (1075)
+|.+. ..|+.++.+..|+.++..+|+++ ..|..+..+.+|..|++.+|++... |+..-.++.|++|+..+|-+ +.+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L-~tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLL-ETL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhh-hcC
Confidence 44444 33444444444444444444444 3444444444444444444444422 22222244444555444444 344
Q ss_pred ccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccc
Q 042958 378 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT 457 (1075)
Q Consensus 378 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 457 (1075)
|..++.+.+|+-|+|..|+|. ..| .|.++..|++|+++.|+|.....+...++++|..|||.+|++. ..|+.++.+.
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 444455555555555555553 333 4444445555555555554222222224555555555555554 4455555555
Q ss_pred ccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCC--Cccceee-------ccCCC---------CCC
Q 042958 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL--SNLVILY-------LYNNS---------LFD 519 (1075)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~-------L~~N~---------l~~ 519 (1075)
+|++||+++|.|+ .+|.+++++ .|+.|-+.+|++..+-.+.+..= .-|++|. ++.-. ..+
T Consensus 276 sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~ 353 (565)
T KOG0472|consen 276 SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE 353 (565)
T ss_pred hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence 5555555555555 344445555 45555555555432111111000 0011110 00000 000
Q ss_pred CCCccccCccccccccccccccccccCC---------cccccccCCCccccccchhhhhhhHhH-HHhhccccccccccc
Q 042958 520 SIPSELGNLRSLSMLSFAYNKLSGSIPH---------SLGVLDLSSNHIVGEIPTELGKLNFLI-KLILAQNQLSGQLSP 589 (1075)
Q Consensus 520 ~~~~~l~~l~~L~~L~l~~N~l~~~~p~---------~l~~L~Ls~N~l~~~~p~~~~~~~~l~-~L~l~~n~l~~~~~~ 589 (1075)
..| ....+...++|+++.-+++ .+|. -+...++++|++. ++|..+..+..++ .+.+++|.+. .+|.
T Consensus 354 ~~~-~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~ 429 (565)
T KOG0472|consen 354 SFP-DIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPL 429 (565)
T ss_pred ccc-chhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchH
Confidence 011 1234455566666666665 3443 1567889999998 8899888887665 4555555555 7788
Q ss_pred ccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhcccccc
Q 042958 590 KLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSL 669 (1075)
Q Consensus 590 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L 669 (1075)
.++.+++|+.|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++..+.|+.+.+|..|
T Consensus 430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL 507 (565)
T KOG0472|consen 430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL 507 (565)
T ss_pred HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence 8999999999999999997 89999999999999999999996 699999999999999999999999888889999999
Q ss_pred ceeecCCCccccCChhhhcccccccEEeecCCccC
Q 042958 670 ENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704 (1075)
Q Consensus 670 ~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~~ 704 (1075)
..|||.+|.|. .||+.+++|.+|+.|++++|+|+
T Consensus 508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999999998 67899999999999999999987
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=384.01 Aligned_cols=483 Identities=33% Similarity=0.442 Sum_probs=344.5
Q ss_pred CCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEe
Q 042958 168 LSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247 (1075)
Q Consensus 168 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 247 (1075)
-..|+.|.+++|.++...+ .+.++..|.+|++++|+++ ..|.+++.+..++.++.++|++. .+|+.++.+.+|..|+
T Consensus 44 qv~l~~lils~N~l~~l~~-dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLEVLRE-DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchhhccH-hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 3456677777777764443 3677777788888888877 66777777777888888888776 5677777778888888
Q ss_pred ccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 248 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
.++|.+. .+|+.++.+-.|+.|+..+|+++ ..|.++..+.+|..+++.+|+++...|..+. ++.|++|+...|.+.
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~- 196 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE- 196 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-
Confidence 8888877 66777777777888888888887 4677777777778888888887755444444 777888887777777
Q ss_pred CCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCcccc-CCCcccceeeeccccccccCChhhc
Q 042958 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLG 406 (1075)
Q Consensus 328 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~ 406 (1075)
.+|..++.+.+|+.|++.+|++. ..| .|..+..|++|+++.|++ ..+|.+. .++.++..|||..|++. ..|+.+.
T Consensus 197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i-~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQI-EMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHH-HhhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 57777777888888888888877 455 777777777777777777 4455443 47777777777777775 6777777
Q ss_pred cCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccc--cccccccc--cCCccccCCCccccCcCC
Q 042958 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNL--TNLDALYL--YDNSLSGSIPGEIGNLRS 482 (1075)
Q Consensus 407 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~L--~~N~l~~~~p~~~~~l~~ 482 (1075)
-+.+|++||+|+|.|+ ..|.+++++ .|+.|-+.+|.+..+--+.+.+= .-|++|.= ..-.++..-- +.
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~---~~--- 344 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEG---GT--- 344 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcc---cc---
Confidence 7777777777777777 355567777 77777777777753211111110 11233321 1111110000 00
Q ss_pred CCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccc---cccccccccccccccCCcc-------ccc
Q 042958 483 ISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS---LSMLSFAYNKLSGSIPHSL-------GVL 552 (1075)
Q Consensus 483 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~---L~~L~l~~N~l~~~~p~~l-------~~L 552 (1075)
-..-++ .. ........+.+.+.|++++-+++. +|.+...... ...++++.|++. .+|+.+ +.+
T Consensus 345 e~~~t~----~~-~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 345 ETAMTL----PS-ESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL 417 (565)
T ss_pred cccCCC----CC-Ccccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence 000000 00 111123335566677777766653 4444433333 566777777775 455543 346
Q ss_pred ccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccc
Q 042958 553 DLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632 (1075)
Q Consensus 553 ~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 632 (1075)
++++|.++ .+|..++.+++++.|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+.+--++|++.
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence 77777776 89999999999999999999998 78899999999999999999997 89999888888998888889998
Q ss_pred cccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccc
Q 042958 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 633 ~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~ 680 (1075)
...|..+.++.+|++|||.+|.+.. +|..+++|.+|++|++++|++.
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq~-IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQQ-IPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchhh-CChhhccccceeEEEecCCccC
Confidence 8888889999999999999999985 8889999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=373.05 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=207.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.+|...+.||+|+|+.||+++. .+|+.||+|++.+.......+++.+.+|+++.++++|||||+++++|++....+.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999965 889999999998766566667889999999999999999999999999877654433
Q ss_pred -ec-------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 -LS-------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 -~~-------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+. .....+.+++.+.+.+..||+.|+.|||+. +|+|||||..|++++++.++||+|||+|..+..+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 21 123467899999999999999999999999 9999999999999999999999999999999988777
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
..+.+|||.|+|||++....++..+||||+|||||.|+.|++||+. ....+....+.......|. ..+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~~Y~~P~----~ls 242 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLNEYSMPS----HLS 242 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhcCccccc----ccC
Confidence 8889999999999999999999999999999999999999999972 2233344444444444332 344
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..++|.+++++||.+|||+++|++
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 46889999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.00 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--chhh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--SLAM 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~l~~ 892 (1075)
+.+..+.||+|..|+|||+.++ +++.+|+|++... .+...++++.+|++++++.+||+||.+||.|..... .+.|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3455688999999999999765 7999999999543 445567899999999999999999999999987663 3444
Q ss_pred eecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 893 ILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 893 ~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.+++.+ ..+.+++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||||||.++.+... .
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I 233 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence 443332 2345788888999999999999999732 9999999999999999999999999999987654 4
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
..+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||.... .........+..+.+...|.... ...+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS 308 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPPPRLPE--GEFS 308 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCCCCCCc--ccCC
Confidence 567899999999999999999999999999999999999999987541 11223344455666543332211 1366
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++..++..|+++||.+|||++|+++
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 77999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=373.11 Aligned_cols=245 Identities=28% Similarity=0.523 Sum_probs=195.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--chhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--SLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~l~~ 892 (1075)
.+....+.+|+|+||+||+|.++....||||++......... .++|.+|+.+|.+++|||||+++|+|..... .+++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 334445669999999999999994444999999876544444 7899999999999999999999999998763 2333
Q ss_pred eecCc--------c-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCCCCeeeCCCC-CceEeccccccccCC
Q 042958 893 ILSNN--------A-AAKDLGWTRRMNVIKGISDALSYMHNDCFPP-IVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~~~~--------~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~ 961 (1075)
.+... . ....+++..+++||.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 22211 1 256799999999999999999999999 7 99999999999999998 999999999987664
Q ss_pred CCCceeccccccCccCccccc--cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc-CCCCCCCC
Q 042958 962 DSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML-DPRLPTPS 1038 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1038 (1075)
.....+...||+.|||||++. ...|+.|+||||||+++|||+||+.||........ ...... ..+...+.
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-------~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-------ASAVVVGGLRPPIPK 269 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcCCCCCCCc
Confidence 434445578999999999999 56899999999999999999999999985543211 111111 12222221
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++..+..++..||+.||++||++.|++..|+
T Consensus 270 ----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 270 ----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred ----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 24556999999999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=374.34 Aligned_cols=366 Identities=26% Similarity=0.274 Sum_probs=283.4
Q ss_pred CceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCC
Q 042958 99 LKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178 (1075)
Q Consensus 99 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 178 (1075)
-+.||+|+|.++..-+..|-++++|++++|.+|.++ .+|.......+|+.|+|.+|.|..+..+.++.++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 345777777776666666777777777777777776 5666555566677777777777777777777788888888888
Q ss_pred CCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccC
Q 042958 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP 258 (1075)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 258 (1075)
|.|+.+.-..|..-.++++|+|++|.|+..-.+.|..+.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.--
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 88877766677766778888888888887777788888888888888888887666777788888888888888874335
Q ss_pred CCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccc
Q 042958 259 HSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338 (1075)
Q Consensus 259 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 338 (1075)
-.|.++++|+.|.|..|.++..-..+|..+.++++|+|+.|++...-..++.+|+.|+.|+||+|.|..+.++.+.-.++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 67888888888888888888766778888888888888888888777778888888888888888888888888888888
Q ss_pred cccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCCh---hhccCCCCCeEE
Q 042958 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH---SLGNLTNLATLD 415 (1075)
Q Consensus 339 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~ 415 (1075)
|++|+|++|+|+...+++|..+..|++|.|++|.+...-...|..+++|+.|||++|.++..+.+ .|.++++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 88888888888877777788888888888888888666666777888888888888888765543 566778888888
Q ss_pred eeccccccccccccccccccceecccccccccCCCCCCccccccccccccC
Q 042958 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466 (1075)
Q Consensus 416 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 466 (1075)
|.+|+|..+.-.+|.++..|++|||.+|.|..+-|++|..+ +|+.|.+..
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 88888876666778888888888888888877777788777 777776554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=368.89 Aligned_cols=365 Identities=27% Similarity=0.270 Sum_probs=224.9
Q ss_pred CCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccC
Q 042958 171 LDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250 (1075)
Q Consensus 171 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 250 (1075)
-+.||+++|.++.+-+..|.++++|+++++.+|.++ .+|.......+|+.|+|.+|.|+.+-.+.++.++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 345666666666666666666666666666666665 5555544455566666666666655555566666666666666
Q ss_pred CCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCC
Q 042958 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIP 330 (1075)
Q Consensus 251 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 330 (1075)
|.|+.+.-.+|..-.++++|+|++|.|+..-...|..+.+|..|.|+.|+++..++.+|.+|++|+.|+|..|+|.-..-
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 66664444455555566666666666665555566666666666666666665555666666666666666666653334
Q ss_pred cccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCC
Q 042958 331 SEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410 (1075)
Q Consensus 331 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 410 (1075)
-.|.++++|+.|.|..|++...-...|..+.++++|+|..|++......++.+++.|+.|+||+|.|..+.+++....++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 45666666666666666666555556666666666666666665555556666666666666666666666666666666
Q ss_pred CCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCc---cccCcCCCCEEe
Q 042958 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPG---EIGNLRSISNLA 487 (1075)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~ 487 (1075)
|++|+|++|+|+...++.|..+..|++|+|++|+|...-..+|..+.+|+.|+|++|.|+..+.. .|..+++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 66666666666666666666666666666666666655555666666666666666666654432 355566666666
Q ss_pred CCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccccccccc
Q 042958 488 LNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFA 537 (1075)
Q Consensus 488 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~ 537 (1075)
|.+|+++.+.-..|.++.+|++|||.+|.|..+-|+.|..+ .|+.|-+.
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 66666665555556666666666666666666666666665 55555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.37 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=200.9
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCc----hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGE----MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
..+.|.+.+.+|+|+||.|-+| ..++|+.||||++.+..... ......+.+|+++|++++|||||++.+++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3467788899999999999999 66789999999998754332 122344679999999999999999999998876
Q ss_pred cchhheecCccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEecccc
Q 042958 888 HSLAMILSNNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDFGI 955 (1075)
Q Consensus 888 ~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGl 955 (1075)
.. +|+++...+ .+.+.+.....+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~-YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SS-YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ce-EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 64 333433333 33456666788999999999999999 99999999999999766 6799999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCCC---CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
|+..+ ..+.+.+.+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||..... .....+++..+
T Consensus 326 AK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl~eQI~~G 397 (475)
T KOG0615|consen 326 AKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSLKEQILKG 397 (475)
T ss_pred hhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccHHHHHhcC
Confidence 99887 5567888999999999999986653 3478999999999999999999974322 12234556666
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++......+.+.+.+..++|.+|+..||++|||++|+++
T Consensus 398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 666655677888889999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=333.01 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=195.2
Q ss_pred cCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEe-eccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC-SHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~l~~ 892 (1075)
.+|++.++||+|.||+|||+ ...+|..||.|.+.-.. -+...+++...|+.++++++|||||+++++- .+....+..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34677789999999999999 66789999999987433 3344578899999999999999999999843 333332333
Q ss_pred eecC-------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 893 ILSN-------------NAAAKDLGWTRRMNVIKGISDALSYMHNDCF-PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 893 ~~~~-------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+++. ..+...+++...++++.|+++||.++|.... ..|.||||||.||+++++|.+|++|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 3222 2345668999999999999999999999422 1399999999999999999999999999999
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
+........+.+|||.||+||.+.+.+|++||||||+||++|||+.-+.||.+.. ......++.....+.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qgd~~~-- 247 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQGDYPP-- 247 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcCCCCC--
Confidence 9887777788999999999999999999999999999999999999999997532 112223333333332
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKV 1069 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1069 (1075)
.....++.++.+++..|+..||+.||+.-.+
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 1235677889999999999999999984333
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=369.33 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=196.3
Q ss_pred cCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.+....+.||+|+||+||+|+.. +.+.||||.++.. .+.+.+++|.+|+++++.++|||||+++|+|...+.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 44555688999999999999653 3457999999875 444568999999999999999999999999988766
Q ss_pred chhheecCc------------------cccCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC
Q 042958 889 SLAMILSNN------------------AAAKD----LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN 946 (1075)
Q Consensus 889 ~l~~~~~~~------------------~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 946 (1075)
.++++.+.. ..+.+ ++..+.+.||.|||.|++||-++ .+|||||..+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 544332110 12333 88999999999999999999999 899999999999999999
Q ss_pred CceEeccccccccCCCCC-cee-ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhh
Q 042958 947 EAHVSDFGIAKFLKPDSS-NWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 947 ~~kl~DfGla~~~~~~~~-~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1075)
.+||+|||+++..-..++ ... ...-+++|||||.|..++|+.+||||||||||||+++ |+.||.+... +
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~ 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------Q 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------H
Confidence 999999999997543322 211 2234689999999999999999999999999999998 9999976544 2
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.++.+.++++- ..++.++.+++++|..||+..|++||+++||-..|+
T Consensus 713 EVIe~i~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 713 EVIECIRAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred HHHHHHHcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 334444455442 234566778999999999999999999999988774
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.34 Aligned_cols=239 Identities=27% Similarity=0.453 Sum_probs=191.0
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~~~~~ 895 (1075)
++..+.||+|.||+||.|.++....||+|.++.... ..++|.+|+++|++++|++||+++|+|..++. .+.+.+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 344578999999999999999777999999976422 24789999999999999999999999988662 2222221
Q ss_pred Cc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 896 NN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 896 ~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.. ..+..+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+...++....
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 11 2456678888999999999999999999 99999999999999999999999999999655443322
Q ss_pred e-ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc-cCCCCCCCCcCcHH
Q 042958 967 T-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM-LDPRLPTPSCIVQD 1043 (1075)
Q Consensus 967 ~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1043 (1075)
+ ...-++.|.|||.+...+++.|||||||||+||||+| |+.||......+ .++.+ ...+++.|..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyRlp~P~~---- 428 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYRLPRPEG---- 428 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCcCCCCCC----
Confidence 2 2334679999999999999999999999999999998 999987443311 11111 2345665543
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
++..+.++|..||+.+|++|||++.+...++
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 4556999999999999999999998887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=333.39 Aligned_cols=237 Identities=26% Similarity=0.345 Sum_probs=195.1
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.++||+|+||+||.++. ++++.+|+|++++...-+....+....|..++.+++||.||+++-.|++.+..+.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 357899999999999999999954 5799999999988766555557889999999999999999999988877655433
Q ss_pred heecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+ +... .....+++.+..-++..|+.||.|||+. +|||||+||+|||+|++|+++|+|||+++.....
T Consensus 103 V-ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 V-LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred E-EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 2 2222 2245678888888999999999999999 9999999999999999999999999999976666
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....+.+||+.|||||++.+..|+.++|+||+|+++|||++|.+||.... .....+.+...+.+.+...
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k~~~~p~~-- 248 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGKLPLPPGY-- 248 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCcCCCCCcc--
Confidence 666777899999999999999999999999999999999999999997432 2333444444443333222
Q ss_pred HHHHHHHHHHHHccCCCCCCCC
Q 042958 1043 DKLISIVEVAISCLDENPESRP 1064 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RP 1064 (1075)
...+..+++.+.+++||++|-
T Consensus 249 -ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 -LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCHHHHHHHHHHhccCHHHhc
Confidence 223588999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=322.03 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=195.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+...++|+|+||.|||++.+ +|+.||||++.... .+....+-.++|++++++++|||+|.++++|...+....++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56788889999999999999665 69999999997643 34555677899999999999999999998886654432221
Q ss_pred -ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 -LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 -~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+.+. .....++.+...++.+|++.|+.|+|++ +++||||||+||+++.++.+|+||||+|+.+..+...
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 1111 1233467888899999999999999999 9999999999999999999999999999999877788
Q ss_pred eeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh------hhhhhhhccC-------
Q 042958 966 WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN------LNIALDEMLD------- 1031 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~------~~~~~~~~~~------- 1031 (1075)
++..+.|.+|+|||.+.+ ..|...+||||.||++.||++|.+-|.+.++.+.-... ..-...+++.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 889999999999998887 78999999999999999999999998765554311100 0000111111
Q ss_pred CCCCCCCc------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSC------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
-++|.+.. ........+.++++.|++.||.+|++.+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 12222211 11223456889999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.99 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=195.3
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
+++.+..+++.+...||+|.||+||+|.|. | .||||++.......+ +.+.|+.|+..+++-+|.||+-|+|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 445555566777899999999999999887 3 589999987765544 6789999999999999999999999998877
Q ss_pred cchhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 888 HSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 888 ~~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
..++..+.+. .....+...+...||.|||+|+.|||.+ +|||||||..||++.+++++||+|||++..-
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 6322222111 1224467778889999999999999999 9999999999999999999999999998642
Q ss_pred C--CCCCceeccccccCccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 960 K--PDSSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 960 ~--~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
. ..........|...|||||+++.+ +|++.+||||||+|+|||++|..||. +...+ +...+.-...-.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d------qIifmVGrG~l~ 611 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD------QIIFMVGRGYLM 611 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh------heEEEecccccC
Confidence 2 222334456788999999999754 58999999999999999999999997 22211 111111111112
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+........+..++.+++..||..++++||.+.+|+..|+
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 2222233455668999999999999999999999999664
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=372.64 Aligned_cols=506 Identities=30% Similarity=0.360 Sum_probs=352.5
Q ss_pred EccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccc
Q 042958 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 127 ~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
|++..++. .||..+..-..|+.|+++.|.+...+-+...+.-+|+.|++++|+++ ..|..+..+.+|+.|+++.|-|.
T Consensus 4 d~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~ 81 (1081)
T KOG0618|consen 4 DASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR 81 (1081)
T ss_pred ccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence 33333333 33433333333555555555544433334445556999999999987 56777888999999999999998
Q ss_pred cccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccC
Q 042958 207 GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFG 286 (1075)
Q Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 286 (1075)
..|.+..++.+|++|.|.+|.++ ..|..+..+++|++||+|+|++. .+|..+..++.++.+..++|..... ++
T Consensus 82 -~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg 154 (1081)
T KOG0618|consen 82 -SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LG 154 (1081)
T ss_pred -hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hc
Confidence 77888999999999999999986 68999999999999999999998 7899999999999999999933322 22
Q ss_pred CCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCccee
Q 042958 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366 (1075)
Q Consensus 287 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 366 (1075)
... ++.+++..|.+.+.++..+..++. .|+|..|.+. -..+..+.+|+.|....|++... --..++|+.|
T Consensus 155 ~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L 224 (1081)
T KOG0618|consen 155 QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISGPSLTAL 224 (1081)
T ss_pred ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecCcchhee
Confidence 222 888999999999888888888777 7999999987 23567788999999999998732 2234789999
Q ss_pred eccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccc
Q 042958 367 YLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLS 446 (1075)
Q Consensus 367 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 446 (1075)
+.++|.+....+. ..-.+|+++++++|+++ .+|.++..+.+|+.|+..+|+++ ..|..+....+|+.|++.+|.+.
T Consensus 225 ~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~ 300 (1081)
T KOG0618|consen 225 YADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE 300 (1081)
T ss_pred eeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh
Confidence 9999999744332 23367999999999998 56699999999999999999997 67888888999999999999998
Q ss_pred cCCCCCCccccccccccccCCccccCCCccccCcCC-CCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccc
Q 042958 447 GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRS-ISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL 525 (1075)
Q Consensus 447 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 525 (1075)
.+|....+++.|++|+|..|+|....+..+..+.. |..|+.+.|++....-..=..++.|+.|++.+|.+++..-+.+
T Consensus 301 -yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l 379 (1081)
T KOG0618|consen 301 -YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVL 379 (1081)
T ss_pred -hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhh
Confidence 67888888999999999999998544444444433 6777778888764332222346678888888888888777777
Q ss_pred cCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCC
Q 042958 526 GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSN 605 (1075)
Q Consensus 526 ~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N 605 (1075)
.+...|+.|+|+||+|. ..+...+.++..|+.|+|++|+|+ .+|..+..++.|++|...+|
T Consensus 380 ~~~~hLKVLhLsyNrL~------------------~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN 440 (1081)
T KOG0618|consen 380 VNFKHLKVLHLSYNRLN------------------SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSN 440 (1081)
T ss_pred ccccceeeeeecccccc------------------cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCC
Confidence 77777777777777664 233344555555555555555555 34455555555555555555
Q ss_pred cccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCC
Q 042958 606 RLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHN 677 (1075)
Q Consensus 606 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N 677 (1075)
+|. ..| ++..++.|+.+|+|.|+|+...-.....-++|+.|||++|.-....-..+-.++++...+++-|
T Consensus 441 ~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 441 QLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 554 344 4455555555555555554321111111144555555555432222333333344444444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.88 Aligned_cols=194 Identities=28% Similarity=0.470 Sum_probs=163.7
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
...+|...+.||+|+||+||+|+++ ++..||||.+..... ....++.+..|+.+++.++|||||++++++..++..+.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3467888889999999999999665 689999999976543 23346778999999999999999999999987765432
Q ss_pred h-eecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC------CCceEecccccc
Q 042958 892 M-ILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD------NEAHVSDFGIAK 957 (1075)
Q Consensus 892 ~-~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~DfGla~ 957 (1075)
+ .+...+ ..+.+++...+.++.|+|.|+++||++ +||||||||.|||++.. -.+||+|||+|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 2 222211 134678888999999999999999999 99999999999999875 358999999999
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 1011 (1075)
.+.+. ....+.+|++-|||||+++.++|+.|+|+||+|+++||+++|+.||+.
T Consensus 164 ~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98743 445668999999999999999999999999999999999999999983
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=336.97 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=201.6
Q ss_pred cCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|.+.+.||+|.||.|||| +..+.+.||+|.+.+....+.+ .+.+.+|++++++++|||||.++++|+...+.+.+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57888899999999999999 5557999999999876655443 577999999999999999999999998877764443
Q ss_pred ec-------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 894 LS-------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 894 ~~-------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.+ .......++++..+.+++++..||.|||+. +|.|||+||.||+++..+.+|+||||+|+.+.......
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 21 123456689999999999999999999999 99999999999999999999999999999998877777
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
+...|||.|||||...++.|+..+|.||+||++||+++|++||... ......+.+.....+.| ...+.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v~~p----~~~S~ 225 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPVKPP----STASS 225 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCCCCc----ccccH
Confidence 8889999999999999999999999999999999999999998521 11222333333333322 35566
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..++...+.+||.+|.|..+++.
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhc
Confidence 7999999999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.95 Aligned_cols=245 Identities=26% Similarity=0.376 Sum_probs=199.9
Q ss_pred HHHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 888 (1075)
.+...+|..++.||+|+|++||+| +..+++.||||++.+...-.+...+.+..|-.+|.+| +||.|++++-.|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 344578999999999999999999 5568999999999765544444567788999999999 9999999998887744
Q ss_pred chhheecCcccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 SLAMILSNNAAA---------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.+++.++....+ +.+++...+.+|.+|+.|++|||++ |||||||||+|||+|+||++||+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 455555444433 4466777788999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC-----------c--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhh
Q 042958 960 KPDSS-----------N--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026 (1075)
Q Consensus 960 ~~~~~-----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1075)
.+... . ....+||..|.+||++.....++.+|+|+|||++|+|+.|++||... +.....
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--------NeyliF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--------NEYLIF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--------cHHHHH
Confidence 65321 1 14578999999999999999999999999999999999999999743 233445
Q ss_pred hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+++++-.+..+.... ..+.+++++.+..||.+|+|++||.+
T Consensus 297 qkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 555555554443333 45899999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=303.41 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=194.6
Q ss_pred cCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|...+++|+|.||.||+| +..+|+.||||+++.....+. ......+|++.++.++|+||+.++++|.+.+..-.++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46777889999999999999 567899999999987643322 2356789999999999999999999997765432222
Q ss_pred ec-C-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LS-N-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~-~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.+ . ......++-.+...++.++.+|++|+|++ .|+||||||.|+|++++|.+||+|||+|+.+.+....
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 11 1 12345678889999999999999999999 9999999999999999999999999999999987776
Q ss_pred eeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh--------hhh-----hhhhccC
Q 042958 966 WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------LNI-----ALDEMLD 1031 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------~~~-----~~~~~~~ 1031 (1075)
.+..+.|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+.++.+.-... .+. .+..+..
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 6667899999999988765 5899999999999999999999877654443210000 000 0000000
Q ss_pred -CCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1032 -PRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1032 -~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...|.+ ......+..+..+++.+++..||.+|+|+.|+++.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011111 11333445567999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=350.44 Aligned_cols=241 Identities=25% Similarity=0.468 Sum_probs=195.2
Q ss_pred CCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch--
Q 042958 817 FDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL-- 890 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l-- 890 (1075)
..+.++||.|.||+||+|+++- ...||||.++.. ..+.++.+|+.|+.+|.++.||||+++.|+....+...
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3456899999999999997752 357999999875 34456789999999999999999999999987654431
Q ss_pred hheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 891 AMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 891 ~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
..+++.. ...+.+++.+...+.++||.|++||.+. ++|||||.++|||++.+..+||+|||+++.+.++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 1222221 1234588899999999999999999999 99999999999999999999999999999887665
Q ss_pred C-ceecccc--ccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhcc-CCCCCCCC
Q 042958 964 S-NWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML-DPRLPTPS 1038 (1075)
Q Consensus 964 ~-~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1038 (1075)
. .+++..| +++|.|||.+..++++.+|||||||+||||.|+ |..||...+. ++.+..+. +-++|.|
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~gyRLPpP- 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQGYRLPPP- 856 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhccCCCCC-
Confidence 3 3444444 479999999999999999999999999999997 9999874433 12222222 3466665
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+++..+.++|..||++|-.+||+++||+..|+
T Consensus 857 ---mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD 889 (996)
T KOG0196|consen 857 ---MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD 889 (996)
T ss_pred ---CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence 466778999999999999999999999998874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=368.73 Aligned_cols=506 Identities=34% Similarity=0.418 Sum_probs=362.2
Q ss_pred EEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccc
Q 042958 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYL 157 (1075)
Q Consensus 78 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 157 (1075)
+|.+..++. .||..+-.-..++.|+++.|.+....-+.+.+.-+|+.|||++|+++ ..|..+..+++|+.|.++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 567777776 78888877777999999999876322233344445999999999998 7899999999999999999999
Q ss_pred cCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccc
Q 042958 158 EDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSEL 237 (1075)
Q Consensus 158 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (1075)
..++ ...+++.+|++|.|.+|.+. ..|..+..+.+|++|++++|++. .+|..+..++.+..+..++|..... +
T Consensus 81 ~~vp-~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----l 153 (1081)
T KOG0618|consen 81 RSVP-SSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----L 153 (1081)
T ss_pred hhCc-hhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----h
Confidence 8764 67888899999999998887 57788899999999999999997 7888888889999999998832222 2
Q ss_pred cCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccc
Q 042958 238 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLAT 317 (1075)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 317 (1075)
+... ++.+++..|.+.+.++..+..++. .|+|.+|.+. . ..+..+.+|+.|....|++.... ...++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 2222 788888888888888877777665 6888888887 2 34667778888888888877432 22367888
Q ss_pred eecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccc
Q 042958 318 LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397 (1075)
Q Consensus 318 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 397 (1075)
|+.++|.++...+. ..-.+|+++++++|+++ .+|++++.+.+|+.+...+|++ ..+|..+....+|+.|++.+|++
T Consensus 224 L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL-VALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhH-HhhHHHHhhhhhHHHHHhhhhhh
Confidence 88888887733222 22356777777777777 3557777777777777777777 55666666677777777777777
Q ss_pred cccCChhhccCCCCCeEEeeccccccccccccccccc-cceecccccccccCCCCCCccccccccccccCCccccCCCcc
Q 042958 398 SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS-LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476 (1075)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 476 (1075)
. -+|.....++.|++|+|..|+|...++..|.-+.. |..|+.+.|++. ..| .++
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp-~~~---------------------- 354 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLP-SYE---------------------- 354 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccc-ccc----------------------
Confidence 5 55556666677777777777776333323333322 555555555554 222 111
Q ss_pred ccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCC
Q 042958 477 IGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSS 556 (1075)
Q Consensus 477 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~ 556 (1075)
=.....|+.|++.+|.|+...-+.+.+...|++|+|++|++.......+.++..|++|++|+|+++
T Consensus 355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-------------- 420 (1081)
T KOG0618|consen 355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-------------- 420 (1081)
T ss_pred chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh--------------
Confidence 112334555555566665555556666777777777777765444445667777777777777665
Q ss_pred CccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccC-cccccccccccceEEEcccccccccc
Q 042958 557 NHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQFSRGI 635 (1075)
Q Consensus 557 N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~ 635 (1075)
.+|.++..+..|+.|....|++. ..| .+..+++|+.+|+|.|.|+. .+|..... ++|++|||++|.-...-
T Consensus 421 -----~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d 492 (1081)
T KOG0618|consen 421 -----TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFD 492 (1081)
T ss_pred -----hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccc
Confidence 67889999999999999999998 556 79999999999999999986 44444443 89999999999743334
Q ss_pred chhcccccccceeeeccc
Q 042958 636 PIKLEELIHLSELDLSHN 653 (1075)
Q Consensus 636 p~~~~~l~~L~~L~ls~N 653 (1075)
-..|..+.++...++.-|
T Consensus 493 ~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 493 HKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhHHhhhhhheecccC
Confidence 456667777777777666
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.40 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=194.1
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc-ccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV-RHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l~ 891 (1075)
.+.|+..++||+|.||.||+| +..+|+.||+|++...... .....-..+||.+|+++.||||+++.+...+. ...++
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456777788999999999999 6678999999999765432 33356678999999999999999999988776 33444
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++++.. .+..++..++..+++|++.||+|+|.+ +|+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 4443322 244689999999999999999999999 9999999999999999999999999999988766
Q ss_pred CC-ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchh--------hhhh----hhh-
Q 042958 963 SS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL--------NLNI----ALD- 1027 (1075)
Q Consensus 963 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~--------~~~~----~~~- 1027 (1075)
.. .++..+.|.+|+|||.+.|. .|+.++|+||.|||+.||+.|++.|.+-...+.... .... .+.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 54 47888999999999988865 699999999999999999999999875433211000 0000 000
Q ss_pred -hccCCCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 -EMLDPRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 -~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+... +.....+....+++..++..||.+|.||.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01111111000 011122456789999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=325.43 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=198.4
Q ss_pred HHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 889 (1075)
...++|...++||.|.||.||+| ...+|+.||||+++..... ++ .-.=.+|+..++++. |||||++.+++.+.+..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34577888999999999999999 5568999999999875433 22 233468999999998 99999999999887643
Q ss_pred hhheecC---------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSN---------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+..+++. ......+++..++.|++||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 3333221 12377899999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeccccccCccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc-------------chhhhhhhh
Q 042958 961 PDSSNWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS-------------SSLNLNIAL 1026 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-------------~~~~~~~~~ 1026 (1075)
. ...++..+.|.+|+|||++ +.+-|+.+.|+||+|||++|+.+-++-|.+.+..+. ........+
T Consensus 162 S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 S-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred c-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 4 3557788999999999976 466789999999999999999999988876544321 111111222
Q ss_pred hhccCCCCCCCCc-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1027 DEMLDPRLPTPSC-----IVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+.-+++.... .....+.+..+++.+|++.||++||||+|.++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 3333333333211 122356789999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.69 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=185.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~ 891 (1075)
..++...+.||+|+||.||++... +|+..|||.+...... ..+.+.+|+.+|++++|||||+++|....... .+.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345677899999999999999554 5999999998765211 15678999999999999999999997444333 334
Q ss_pred heecCccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccccccccC
Q 042958 892 MILSNNAA----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 892 ~~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~ 960 (1075)
.++++..+ +..+++...++++.||++||+|||++ +||||||||+|||++. ++.+||+|||.++...
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 44443321 12689999999999999999999999 9999999999999999 7999999999998766
Q ss_pred CC---CCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 961 PD---SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 961 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
.. ........||+.|||||++..+ ...+++||||+||++.||+||+.||... .... ............|
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~----~~~~~ig~~~~~P- 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEA----EALLLIGREDSLP- 242 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchH----HHHHHHhccCCCC-
Confidence 31 1223457899999999999853 3446999999999999999999998742 0000 1111111111122
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+...+.+..+++.+|+++||++||||+|+++-
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1223345568999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.93 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=192.4
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|+..+.||.|..++||+| ....++.||||++........ .+.+.+|+..|+.++||||++++..|...+..+.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3578999999999999999999 456789999999987654432 6889999999999999999999998877665544
Q ss_pred heecC-cc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSN-NA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~-~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.-.. .+ -...+.+..+..|.+++++||.|||++ |.||||||+.|||++.+|.+||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 33111 11 022377888889999999999999999 999999999999999999999999999877665
Q ss_pred CCCce----eccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 962 DSSNW----TELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 962 ~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
..... ...+||+.|||||++.. ..|+.|+||||||++..|+.+|+.||...++...-....+...........
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~- 257 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL- 257 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC-
Confidence 54322 44689999999999543 469999999999999999999999998666543211111111000000000
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.+........+.+++..|+++||++|||++++++
T Consensus 258 -~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 -DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11112234457999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.95 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=196.8
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
...|+...+||+|+.|.||.| +..+++.||||++....... ++-+..|+.+|+..+|+|||.+++.|...+..+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 357788889999999999999 56689999999997654332 46688999999999999999999977665544333
Q ss_pred e-ecCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 893 I-LSNNA------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 893 ~-~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+ +.+.+ ....+++.++..|++++++||+|||.. +|+|||||.+|||++.+|.+||+|||++..+......
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 2 22221 123467889999999999999999999 9999999999999999999999999999999888778
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
..+.+||++|||||+.....|++|+||||+|++++||+.|.+||-...+...-. .+..--.+++. .....+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-----LIa~ng~P~lk----~~~klS 496 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPKLK----NPEKLS 496 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-----HHhhcCCCCcC----CccccC
Confidence 888999999999999999999999999999999999999999986433221111 11111112222 233455
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+|+.+|++.||++||++.|+++
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 67999999999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.73 Aligned_cols=242 Identities=25% Similarity=0.416 Sum_probs=194.9
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
...|+..+.||+|.||.||+| +..+++.||+|++...... ...+++.+|+.++.+.+++||.++||.+......+..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 456777899999999999999 6668999999999876433 3467889999999999999999999988765543332
Q ss_pred e-ecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 I-LSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~-~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+ +...+ .+..+.+....-|..++..|+.|+|.+ +.+|||||+.||++.++|.+|++|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 2 22211 123346666677899999999999999 999999999999999999999999999998877666
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
...+.+||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....++. ..-.+....| |. .....
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------vlflIpk~~P-P~-L~~~~ 235 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------VLFLIPKSAP-PR-LDGDF 235 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------EEEeccCCCC-Cc-ccccc
Confidence 6678999999999999999899999999999999999999999987554421 1111122222 11 22356
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+..+.+++..|+.+||+.||+|.++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 677999999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.72 Aligned_cols=232 Identities=30% Similarity=0.504 Sum_probs=188.2
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
...+.+|.|+-|.||.|+++ ++.||||+++. .-+.+|+-|++++||||+.|.|+|.... .+++++++.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsP-cyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSP-CYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCc-eeEEeeecc
Confidence 44578999999999999998 89999998742 2246899999999999999999997643 333443332
Q ss_pred c---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 898 A---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 898 ~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
. .+..+.-.....|.++||.|+.|||.+ .|||||||+-|||++.+..+||+|||-++....- +..-.
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS 270 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS 270 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence 2 245567777789999999999999999 9999999999999999999999999999876644 44455
Q ss_pred cccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 969 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
++||..|||||+++..+.++|+||||||||||||+||..||...+............+ .++-| ..++..+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL------~LpvP----stcP~Gf 340 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL------HLPVP----STCPDGF 340 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc------cccCc----ccCchHH
Confidence 8999999999999999999999999999999999999999986655433322222111 22332 3445568
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhhhcC
Q 042958 1049 VEVAISCLDENPESRPTMPKVSQLLKI 1075 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs~~evl~~L~i 1075 (1075)
.-++++||+..|..||++.+++.-|+|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 999999999999999999999998876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=351.96 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=192.3
Q ss_pred hcCCCCCceecccCceEEEEEEEC--CCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--SGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
....+..+.||+|+||.||+|... +|. .||||.+... .+.+...+|.+|..+|+.++|||||+++|+|.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345556788999999999999664 343 4899988764 44556789999999999999999999999998844
Q ss_pred cchhheecCcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEe
Q 042958 888 HSLAMILSNNA----------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 888 ~~l~~~~~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
..+. ++++.. +...++..+...++.|||+|+.||++. ++|||||.++|+|+++...+||+
T Consensus 769 ~~~i-~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 PPLI-LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CcEE-EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 4322 222211 134577888899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCcee-cc-ccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhh
Q 042958 952 DFGIAKFLKPDSSNWT-EL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 952 DfGla~~~~~~~~~~~-~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
|||+|+.+...+.... .. .-..+|||||++..+.++.|+|||||||++||++| |..||...+. .+.....
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~ 917 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDV 917 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHH
Confidence 9999996544333222 12 23579999999999999999999999999999998 9999864332 1222234
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+++.|..++. .++++|.+||+.+|++||++..+++.++
T Consensus 918 ~~ggRL~~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 918 LEGGRLDPPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred HhCCccCCCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 44557777654444 5899999999999999999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=335.83 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=186.9
Q ss_pred HhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.+ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 457899999999999999999953 235789999987532 223356789999999999 89999999998876
Q ss_pred cccchhheecCccc------------------------------------------------------------------
Q 042958 886 VRHSLAMILSNNAA------------------------------------------------------------------ 899 (1075)
Q Consensus 886 ~~~~l~~~~~~~~~------------------------------------------------------------------ 899 (1075)
....+.+++++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54433222211110
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccc
Q 042958 900 -----AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGT 972 (1075)
Q Consensus 900 -----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt 972 (1075)
...+++.+..+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13477888899999999999999999 9999999999999999999999999999865433221 1233456
Q ss_pred cCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHH
Q 042958 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEV 1051 (1075)
Q Consensus 973 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1051 (1075)
+.|+|||++.+..++.++||||||+++|||++ |+.||........ ....+.+...... ....+..+.++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~l~~l 309 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRA---PENATPEIYRI 309 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------HHHHHhcCCCCCC---CCCCCHHHHHH
Confidence 78999999999899999999999999999997 9999875332110 0111111111110 11234468999
Q ss_pred HHHccCCCCCCCCCHHHHHhhhc
Q 042958 1052 AISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1052 i~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+||+.||++|||+.||++.|+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=327.02 Aligned_cols=245 Identities=21% Similarity=0.349 Sum_probs=197.7
Q ss_pred HHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCC-c-hhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPG-E-MTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVR 887 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 887 (1075)
.....|...+.||+|+||+||.| ...+|+.||+|++...... . ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999 4457899999977653211 1 123456778999999998 999999999998877
Q ss_pred cchhheecCccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEecccccc
Q 042958 888 HSLAMILSNNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAK 957 (1075)
Q Consensus 888 ~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~ 957 (1075)
. +++++++..+ ...+.+.+..+++.|++.|++|+|++ +|+||||||+||+++.+ +++||+|||++.
T Consensus 94 ~-~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 K-IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred e-EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 6 4444444333 35678888999999999999999999 99999999999999999 999999999999
Q ss_pred ccCCCCCceeccccccCccCccccccCC-CC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
..........+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+... .......+....+.
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKGEFK 241 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcCCcc
Confidence 8753445667789999999999999987 86 78999999999999999999998522 12222334444444
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.|.... +.++..++.+|+..||.+|+|+.||++
T Consensus 242 ~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 IPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 443221 556999999999999999999999973
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.81 Aligned_cols=230 Identities=24% Similarity=0.337 Sum_probs=193.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+...-...+.+....|..+++.+.||+++++++.|.+.+. +.++
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~-lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN-LYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe-EEEE
Confidence 56888899999999999999665 688999999988766666677889999999999999999999998887554 4455
Q ss_pred ecCcccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNAAA---------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++...++ ++++....+-+|.||+.|++|||+. .|++||+||+|||+|.+|.+||+|||.|+.....
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 5444443 4566677788999999999999999 9999999999999999999999999999987643
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
.-+.+|||.|+|||.+...++..++|.|||||++|||+.|..||..... -...+++...++..|.....
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~fP~~fs~-- 266 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKFPSYFSS-- 266 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccCCcccCH--
Confidence 4568999999999999999999999999999999999999999974333 23445666666665544333
Q ss_pred HHHHHHHHHHccCCCCCCC
Q 042958 1045 LISIVEVAISCLDENPESR 1063 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~R 1063 (1075)
++.+++...++.|-.+|
T Consensus 267 --~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 --DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHHHHHHHHhhhhHhh
Confidence 48999999999999888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=328.67 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=190.5
Q ss_pred HhcCCCCCceecccCceEEEEEEECC--C---CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELAS--G---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.-++....++||+|+||.||+|+++. + ..||||..+...........+|..|+++|+.++|||||++||++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455566899999999999996543 3 238999988644345667899999999999999999999999998765
Q ss_pred cchhh-eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 888 HSLAM-ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 888 ~~l~~-~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
..+.+ .+...+ ....++..++.+++.++|.||+|||+. +++||||.++|+|++.++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 54333 332221 123589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc-c-CCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM-L-DPRLP 1035 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~-~~~~~ 1035 (1075)
............-+.+|+|||.+....|++++|||||||++||+++ |..||...... .....+ . ..+.+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMP 383 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCC
Confidence 4311111112235689999999999999999999999999999998 89998754332 111222 1 12222
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+. ..+..+..++.+||..||++||+|.++.+.++
T Consensus 384 ~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 384 IPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 222 34456899999999999999999999999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.97 Aligned_cols=337 Identities=30% Similarity=0.430 Sum_probs=224.7
Q ss_pred CccCcEEEccCCCCC-CCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCccee
Q 042958 288 LRSLSMLNLGYNKLN-GIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366 (1075)
Q Consensus 288 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 366 (1075)
++-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 344556677777777 456777777777888877777777 67788888888888888888877 566677788888888
Q ss_pred eccccccCCC-CccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccccccc
Q 042958 367 YLYSNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445 (1075)
Q Consensus 367 ~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 445 (1075)
.+..|++... +|..+..+..|+.||||+|++. ..|..+..-+++-.|+||+|+|..++...|.++..|-.||||+|++
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 8888887544 6777788888888888888886 7788888888888888888888866666778888888888888888
Q ss_pred ccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc-CCCcccccCCCccceeeccCCCCCCCCCcc
Q 042958 446 SGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS-GSIPQSLGNLSNLVILYLYNNSLFDSIPSE 524 (1075)
Q Consensus 446 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 524 (1075)
. .+|..+.+|..|+.|.|++|.+...--..+..+++|+.|++++.+=+ ..+|.++..+.+|..+|||.|.+. .+|+.
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 7 66777788888888888888776544455566777777787776532 346777777777777777777773 56677
Q ss_pred ccCcccccccccccccccc-----ccCCcccccccCCCccccccchhhhhhhHhHHHhhccccccc-ccccccCcccccc
Q 042958 525 LGNLRSLSMLSFAYNKLSG-----SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG-QLSPKLGSLAQLE 598 (1075)
Q Consensus 525 l~~l~~L~~L~l~~N~l~~-----~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~ 598 (1075)
+.++++|+.|+||+|+|+. ..-..+++|+||+|+++ .+|.++++++.|++|.+.+|+++- -+|..++.+.+|+
T Consensus 241 ly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Le 319 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLE 319 (1255)
T ss_pred HhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhH
Confidence 7777777777777776652 01123444444444444 444444444444444444444441 1333344444444
Q ss_pred eeecCCCcccCcccccccccccceEEEcccccc
Q 042958 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631 (1075)
Q Consensus 599 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 631 (1075)
.+..++|.+. ..|+.+..+.+|+.|.|++|++
T Consensus 320 vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 320 VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRL 351 (1255)
T ss_pred HHHhhccccc-cCchhhhhhHHHHHhcccccce
Confidence 4444444443 3444444444444444444443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=317.38 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=196.0
Q ss_pred hcCCCCCceecccCceEEEEEEECC---CC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS---GE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~---g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.+..+..++||+|-||.||+|.+.+ |+ .||||+.+..- ..+..+.|..|..+|+.++||||++++|+|.+...
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~ 465 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPM 465 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccce
Confidence 3445566899999999999995532 33 58999988643 23346889999999999999999999999998887
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.|.+...+ ....++......+++||+.||+|||+. .+|||||..+|||+.....+|++|||+++.+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 7777665432 234567777788999999999999999 99999999999999999999999999999988
Q ss_pred CCCCce-eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhcc-CCCCCCC
Q 042958 961 PDSSNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML-DPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1037 (1075)
.+.... +...-++.|||||.+.-++++.++|||.|||+|||++. |..||.+....+.. ..+. ..++|.|
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------~~iEnGeRlP~P 614 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------GHIENGERLPCP 614 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------EEecCCCCCCCC
Confidence 665432 22334679999999999999999999999999999996 99999865543221 1111 2345544
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+++.++.++.+||++||.+||.+.|+...|.
T Consensus 615 ----~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 615 ----PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ----CCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 345567999999999999999999999988763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=325.47 Aligned_cols=240 Identities=21% Similarity=0.293 Sum_probs=199.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
...++|...++||+|.||+|+.|..+ +++.+|||++++...-..+..+..+.|.+++... +||.++.++..|+..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999665 6899999999987666666678889999998888 599999999998887665
Q ss_pred hhheecC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 LAMILSN-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 l~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+.++.+- ....+.++..+..-+|..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||+++.-...
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 4333221 12245678888999999999999999999 9999999999999999999999999999976655
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....+.+||+.|||||++.++.|+.++|.|||||+||||+.|+.||.+.+. .+..+.++......| .
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~FdsI~~d~~~yP----~ 589 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFDSIVNDEVRYP----R 589 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCCCCC----C
Confidence 5667789999999999999999999999999999999999999999974332 334445544444433 3
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1043 DKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
..+.+.+.++++++.++|++|--+
T Consensus 590 ~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cccHHHHHHHHHHhccCcccccCC
Confidence 345568999999999999999866
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.78 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=183.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC--CcCceeeEEEEeeccccc---
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI--RHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~--- 889 (1075)
...+..+++|+|.||.||||.+. ++.||||++.. +..+.|..|.++++.. +|+||++|+++-......
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 44555678999999999999987 69999999853 2356788888887765 899999999987554421
Q ss_pred --hhheecCc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 890 --LAMILSNN------AAAKDLGWTRRMNVIKGISDALSYMHNDCF------PPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 890 --l~~~~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~------~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
++..++.. -....++|....+|+..+++||+|||+... |+|+|||||++|||+..|+++.|+|||+
T Consensus 283 ywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 12222221 235668999999999999999999998643 7899999999999999999999999999
Q ss_pred ccccCCCCC--ceeccccccCccCccccccCCC------CcccchHhHHHHHHHHHhCCCCCCc--cCcc----------
Q 042958 956 AKFLKPDSS--NWTELAGTYGYVAPELAYTMKV------TEKCDVYSFGVLALEVIKGKHPRDF--ISSM---------- 1015 (1075)
Q Consensus 956 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~s~G~vl~elltg~~p~~~--~~~~---------- 1015 (1075)
|..+.+... .....+||.+|||||++.+..- -.+.||||+|.|+|||++.-.-++. .+..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 998876543 2334789999999999987531 2368999999999999985543321 1110
Q ss_pred -ccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1016 -SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1016 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
............+-..|.++...... .....+.+.+..||..||+.|.|+.-|.+.+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 01111111222233334444332222 4456799999999999999999999887754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.97 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=197.3
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
+-++|++++.||+|-||.||.|+. +++-.||+|++.+..........++.+|+++-+.++||||+++|+||.+....+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 347899999999999999999955 5688999999977655555556789999999999999999999999987654332
Q ss_pred heecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 892 MILSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 892 ~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
. +++. .....++......++.|+|.|+.|+|.. +|+||||||+|+|++.++..|++|||.+....
T Consensus 100 i-lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 I-LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred E-EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 2 2222 1345577778889999999999999999 99999999999999999999999999998644
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.....+.+||..|.|||...+..++.++|+|++|++.||++.|.+||.... ..+..+++...++..|.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p~-- 243 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFPS-- 243 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCCc--
Confidence 455677899999999999999999999999999999999999999997322 22233344434444332
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+..++|.+|+.++|.+|.+..||++
T Consensus 244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 --TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 23345899999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.99 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=191.9
Q ss_pred HHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCC-------c----hhHHHHHHHHHHHHhcCCcCceeeE
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPG-------E----MTFQQEFLNEVKALTEIRHRNIVKF 879 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~----~~~~~~~~~E~~~l~~l~h~niv~l 879 (1075)
..-++|++.+.||+|.||.|-+|+ ..+++.||||++.+.... . ....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 445789999999999999999994 457999999998653210 0 1113578899999999999999999
Q ss_pred EEEeeccccc-hhheecCcc--------ccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCce
Q 042958 880 YGFCSHVRHS-LAMILSNNA--------AAKD-LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH 949 (1075)
Q Consensus 880 ~~~~~~~~~~-l~~~~~~~~--------~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 949 (1075)
+++-.++... +++++++.. .... ++..+.++++.++..||+|||.+ +||||||||+|+|++++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 9988665432 333332221 1223 88999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCC-----CCceeccccccCccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCccCccccchh
Q 042958 950 VSDFGIAKFLKPD-----SSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 950 l~DfGla~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 1020 (1075)
|+|||.+...... .......+|||.|+|||...+.. .+.+.||||+||++|.++.|+.||-...
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------- 323 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------- 323 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-------
Confidence 9999999876322 22234478999999999887632 3568899999999999999999986321
Q ss_pred hhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1021 NLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....++++...+..|. ..+....+.+++++++.+||++|.+..||..
T Consensus 324 -~~~l~~KIvn~pL~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 -ELELFDKIVNDPLEFPE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred -HHHHHHHHhcCcccCCC--cccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 23345566665554442 2345567999999999999999999999864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.64 Aligned_cols=365 Identities=30% Similarity=0.447 Sum_probs=282.0
Q ss_pred cCCcceeeccccccc-CCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCce
Q 042958 144 LSSLNYLALYSNYLE-DLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222 (1075)
Q Consensus 144 l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 222 (1075)
|+-.+-.|+++|.++ +..|.....+++++.|.|.+.++. .+|+.++.+.+|++|.+++|++. .+...++.++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 334456678888887 566777788888888888888886 47777888888888888888887 566677788888888
Q ss_pred eccccCCCC-CCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCC
Q 042958 223 YLHNNSLFD-SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301 (1075)
Q Consensus 223 ~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 301 (1075)
.+.+|++.. -+|..+..+..|++||||+|+++ ..|..+...+++-.|+|++|+|..++...|.+++.|-+||||+|++
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 888887742 36777778888888888888888 7788888888888888888888854445667788888888888888
Q ss_pred CCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCccc-ccCCCcCCCCCCcceeeccccccCCCCccc
Q 042958 302 NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS-GSIPPSLGYLSNLATLYLYSNSLFDSIPSE 380 (1075)
Q Consensus 302 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 380 (1075)
. .+|.....+.+|++|+|++|.+....-..+..+++|+.|.+++.+-+ ..+|.++..+.+|..+|++.|.+ ..+|+.
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L-p~vPec 240 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL-PIVPEC 240 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC-CcchHH
Confidence 7 45667778888888888888876555555666777888888876533 35777888888888888888887 567888
Q ss_pred cCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccc-cCCCCCCcccccc
Q 042958 381 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLS-GSIPHSLGNLTNL 459 (1075)
Q Consensus 381 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L 459 (1075)
+.++++|+.|+||+|+|+ .+.-..+.+.+|++|+||.|+++ ..|+++..+++|+.|++.+|+++ .-+|..+++|.+|
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 888888888888888886 55556667778888888888887 67788888888888888888876 2367788888888
Q ss_pred ccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCC
Q 042958 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517 (1075)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 517 (1075)
+++..++|.+. .+|+.++.+..|+.|.|+.|++. .+|+.+.-++.|+.|||.+|.=
T Consensus 319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 88888888887 77888888888888888888876 5788888888888888887754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=314.68 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=184.6
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec--ccc-chhheecC
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--VRH-SLAMILSN 896 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~-~l~~~~~~ 896 (1075)
...||+|++|.||+|.. +|+.||||++...........+.|.+|+.++++++||||++++|++.+ .+. .+.++++.
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 499999999986544444446788999999999999999999999876 222 22222222
Q ss_pred cc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 897 NA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 897 ~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. ....++|..+.+++.|++.|+.|||+.. +++||||||+||+++.++.+||+|||+++.+.... .
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---F 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---c
Confidence 11 2346789999999999999999999842 77899999999999999999999999998654321 2
Q ss_pred ccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc--CCCCCCCCcCcHH
Q 042958 968 ELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML--DPRLPTPSCIVQD 1043 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 1043 (1075)
...|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+. ..+.+.+ ..
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~----~~ 246 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNSLKLP----LD 246 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCCCCCC----Cc
Confidence 3468899999999876 67899999999999999999999999743221 1111111 1122211 13
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+..+.+++.+||+.||++|||++||++.|+
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 4556999999999999999999999999886
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.25 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=191.6
Q ss_pred HHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 888 (1075)
.....|...+.||+|+||.|+.| ...+|+.||||++..+... ....++..+|+++++.++|+||+.+.+.+..+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456666788999999999999 5568999999999765433 3345778899999999999999999998865211
Q ss_pred ----chhheecC------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 889 ----SLAMILSN------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 889 ----~l~~~~~~------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
++++.+.+ ...+..++......+.+|+++||+|+|+. +|+|||+||+|++++++..+||+|||+|+.
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 11111211 12345588899999999999999999999 999999999999999999999999999998
Q ss_pred cCCC--CCceeccccccCccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh---------------
Q 042958 959 LKPD--SSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL--------------- 1020 (1075)
Q Consensus 959 ~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~--------------- 1020 (1075)
..+. ...++..+.|.+|+|||.+. ...|+.+.||||.||++.||++|+.-|.+.+....-..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 8642 34467788999999999764 56799999999999999999999999876543321000
Q ss_pred hhhhhhhhccC--CCCCC-C-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1021 NLNIALDEMLD--PRLPT-P-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1021 ~~~~~~~~~~~--~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........++. +..+. + ....+...+...+++.+|+..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000111111 11111 1 1122344567899999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.36 Aligned_cols=254 Identities=22% Similarity=0.260 Sum_probs=189.9
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---S 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~ 889 (1075)
.++|+..+.|++|+||.||+| +.++++.||+|+++.....+ -..-.-.+|+.++.+.+|||||.+-++...... +
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 456788899999999999999 55689999999998654222 222346799999999999999999887654332 2
Q ss_pred hhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 LAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++|.+.+. ...+++...+..-++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.++.+
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 22221111 2246788889999999999999999999 8999999999999999999999999999999988
Q ss_pred CCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccch----------------hhhhhh
Q 042958 963 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS----------------LNLNIA 1025 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~----------------~~~~~~ 1025 (1075)
...++..+.|.+|+|||.+.+. .|+.+.|+||+|||+.|++++++-|.+.+..+... ...--.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 8888889999999999988775 58999999999999999999998887544332100 000000
Q ss_pred hhhccCCCCCCCC--cCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 LDEMLDPRLPTPS--CIVQD--KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~~~~~~~~~~~~~--~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+..+... ..... -...-.+++...+..||++|.||+|.++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0001111111000 00001 1245778999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.59 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=190.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh-
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM- 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~- 892 (1075)
.....+.++||+|-||+|..+....+..||||+++... ....+.+|.+|+++|.+++|||||+++|+|..++....+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34556678999999999999988878999999998653 344468999999999999999999999999876654222
Q ss_pred -eecCccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 -ILSNNAA--------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 -~~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++...- .....-....+|+.|||.|++||.+. .+||||+.++|+|+|.++++||+|||+++-+-..+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 2222110 11123445578999999999999999 99999999999999999999999999999655443
Q ss_pred Cce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCccCccccchhhhhhhhhhccCCC-CCCCC
Q 042958 964 SNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSMSSSSLNLNIALDEMLDPR-LPTPS 1038 (1075)
Q Consensus 964 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1038 (1075)
... ...+-+++|||||.+.-++++.++|||+||+++||+++ ...||...... +..+...++.+.. .....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhhhcCCCCcceec
Confidence 321 22345789999999999999999999999999999885 78898644332 2222222333221 11111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
..+.-++..+++++..||..|-++||+++++...|
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 12334556799999999999999999999998765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.63 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=198.0
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.-|..++.||+|+-|.|..|++ .+|+.+|||++.+...........+++|+-+|+-+.||||+++|++++...+.+..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4567788999999999999955 589999999998764444445677899999999999999999999998876655444
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.+..+ ..+.+.+.+..+++.||..|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-. ++.-
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gkl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKL 167 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-CCcc
Confidence 32222 245678888999999999999999999 99999999999999999999999999998644 3445
Q ss_pred eeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
..+.+|++.|.|||+++|.+|. .++||||.|||+|.++||+.||++. +....+.++..+.+..|. ..
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~MPs----~I 235 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEMPS----NI 235 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccCCC----cC
Confidence 5678999999999999999985 7899999999999999999999832 223334444445444432 33
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.+..+++.+|+..||+.|.|++||.+
T Consensus 236 s~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 236 SSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CHHHHHHHHHHhccCccccccHHHHhh
Confidence 446899999999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=316.57 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=185.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.............+.+|++++++++|++|+++++++.+.+..+.++.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999954 5799999999865432223334567899999999999999999998876554322221
Q ss_pred -cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 -SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 -~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
... .....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence 111 1123578899999999999999999999 9999999999999999999999999999875432 2
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||..|+|||++.+..++.++||||+||++|||++|+.||......... ............. .....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~----~~~~~ 228 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVKEDQEE----YSEKF 228 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhhccccc----CCccC
Confidence 234457899999999999999999999999999999999999999743321100 1111111111111 12233
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
+..+.+++.+||+.||++||+ ++|+++
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 456899999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=320.47 Aligned_cols=235 Identities=21% Similarity=0.269 Sum_probs=182.9
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc-
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA- 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~- 898 (1075)
+.||+|+||.||+|.. .+|+.||+|++.............+.+|+.++++++||||+++++++......+ ++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~-lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC-FVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE-EEEeCCCC
Confidence 4699999999999955 579999999987543223334567889999999999999999999887755432 2222211
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
....+++.+...++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccccee
Confidence 234578889999999999999999999 999999999999999999999999999986543334445567
Q ss_pred cccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHH
Q 042958 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 971 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1050 (1075)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ....++.+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~----~~~~~~~~ 224 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPR----TLSPEAKS 224 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHHHHH
Confidence 99999999999999999999999999999999999999863221 1111222222222221 23446899
Q ss_pred HHHHccCCCCCCCC-----CHHHHHh
Q 042958 1051 VAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
++.+||+.||++|| ++.|+++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 99999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.20 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=182.8
Q ss_pred cCCCCCceecccCceEEEEEEECC-----------------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCcee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELAS-----------------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 877 (1075)
.+|++.+.||+|+||.||+|...+ +..||+|.+.... ......+|.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 578888999999999999996532 3479999987542 233457899999999999999999
Q ss_pred eEEEEeeccccchhheecCcc----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 042958 878 KFYGFCSHVRHSLAMILSNNA----------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929 (1075)
Q Consensus 878 ~l~~~~~~~~~~l~~~~~~~~----------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 929 (1075)
++++++......+ ++++... ....++|.+..+++.||+.|++|||+. +
T Consensus 83 ~~~~~~~~~~~~~-lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 83 RLLGVCVDEDPLC-MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred EEEEEEecCCceE-EEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999987654322 2211110 112467888999999999999999999 9
Q ss_pred eEEecCCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh--C
Q 042958 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--G 1005 (1075)
Q Consensus 930 ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g 1005 (1075)
|+||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999866443221 122345788999999988889999999999999999987 5
Q ss_pred CCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1006 KHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1006 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..||.......... ....................++..+.+++.+||+.||++|||++||.+.|+
T Consensus 239 ~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIE----NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHH----HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 56765432211100 000000000000000011123346899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.55 Aligned_cols=243 Identities=24% Similarity=0.294 Sum_probs=190.6
Q ss_pred HhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|+...+||+|+||+||.|+ ..+|+.+|+|++++...-...+.+.+..|..+|....+|.||+++-.|++.+..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY- 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY- 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE-
Confidence 45899999999999999999995 4579999999999876666677888999999999999999999998888765543
Q ss_pred heecCccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC-
Q 042958 892 MILSNNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP- 961 (1075)
Q Consensus 892 ~~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~- 961 (1075)
.++++..+ .+.|+....+.++.+.+-|++.+|+. |+|||||||+|+|+|..|++||+|||++..+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 33333222 35678888899999999999999999 999999999999999999999999999953321
Q ss_pred ----------------------CCCc----e--------------------eccccccCccCccccccCCCCcccchHhH
Q 042958 962 ----------------------DSSN----W--------------------TELAGTYGYVAPELAYTMKVTEKCDVYSF 995 (1075)
Q Consensus 962 ----------------------~~~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 995 (1075)
+... . ...+|||.|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 12469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC--CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 042958 996 GVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR--LPTPSCIVQDKLISIVEVAISCLDENPESRPT---MPKVS 1070 (1075)
Q Consensus 996 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 1070 (1075)
|||||||+.|.+||....+. .....++..+ +..|. ..+...+..++|.+|+. ||++|-- ++||.
T Consensus 375 G~ImyEmLvGyPPF~s~tp~--------~T~rkI~nwr~~l~fP~--~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ--------ETYRKIVNWRETLKFPE--EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhhhccCCC--cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999999754332 2222222222 22221 12233578999999999 9999985 55554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=282.04 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=190.2
Q ss_pred HHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 888 (1075)
...++|++.+.+|+|+|..||.+ ...+++.||+|++.-.. .+..+...+|++..++++||||+++++++.....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 44678999999999999999999 46789999999987543 3446788999999999999999999987744322
Q ss_pred --chhheecC-------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 889 --SLAMILSN-------------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 889 --~l~~~~~~-------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
..+..+.+ ...+..+++.+.++|+.+|++||++||+. .|+++||||||.||++.+++.+++.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 11111111 12355789999999999999999999998 347999999999999999999999999
Q ss_pred ccccccCCCCC---------ceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh
Q 042958 954 GIAKFLKPDSS---------NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021 (1075)
Q Consensus 954 Gla~~~~~~~~---------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 1021 (1075)
|.++...-.-. .......|..|+|||.+. +...++++||||+||++|+||.|..||+..-.. -...
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl- 251 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL- 251 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE-
Confidence 99976542211 122345789999999886 345689999999999999999999999743221 0000
Q ss_pred hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.-.+..+.+..|.. ..++..+.++++.|++.||.+||++.|++..++
T Consensus 252 ----aLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 252 ----ALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred ----EEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 11122223322221 125667999999999999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=296.49 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=182.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc----
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS---- 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 889 (1075)
-.|+..+++|.|+||.||+|... +++.||||+...... .--+|+++|+.+.|||||++.-+|......
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 34666789999999999999654 579999999864332 223799999999999999999887654332
Q ss_pred hhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEeccccc
Q 042958 890 LAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 956 (1075)
+..++++. ..+..++.....-+++||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 11112111 1244556666677899999999999998 99999999999999987 89999999999
Q ss_pred cccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhhhh-
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIALD- 1027 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~~~- 1027 (1075)
+.+.+.... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+...... .+.+.
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 998876555 556789999999988765 69999999999999999999999998655432111000 00011
Q ss_pred ------hccCCCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 ------EMLDPRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ------~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+...+.+.... .......++..+++.++++++|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112221111 123345567999999999999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=321.73 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=182.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++|+||+++++++......+ ++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ-VL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE-EE
Confidence 45566788999999999999654 78999999986532 3334578999999999999999999999987655433 22
Q ss_pred ecCccc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 894 LSNNAA-----AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 894 ~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
+++... .....+.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.+.........
T Consensus 151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 151 LEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred EecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence 222211 22346777788999999999999999 9999999999999999999999999999876544333445
Q ss_pred cccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 969 LAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
..||..|+|||++.. ...+.++|||||||++|||++|+.||.......... ..........+ .....
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~---~~~~~ 299 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS-----LMCAICMSQPP---EAPAT 299 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH-----HHHHHhccCCC---CCCCc
Confidence 679999999998743 234568999999999999999999997322111111 11111111111 11123
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...++.+++.+||+.||++|||++|+++.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34569999999999999999999999863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=316.26 Aligned_cols=233 Identities=23% Similarity=0.284 Sum_probs=179.7
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc----
Q 042958 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN---- 897 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~---- 897 (1075)
||+|+||.||+|... +++.||+|++.............+.+|+.++++++||||+++++++......+. +++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l-v~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL-VLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE-EEcCCCCCc
Confidence 699999999999654 688999999865322233345678899999999999999999998876554322 22211
Q ss_pred -----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccc
Q 042958 898 -----AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972 (1075)
Q Consensus 898 -----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt 972 (1075)
.....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.............||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCC
Confidence 1234578899999999999999999999 99999999999999999999999999998654443344456799
Q ss_pred cCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHH
Q 042958 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052 (1075)
Q Consensus 973 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1052 (1075)
+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+ ......+.+++
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~~~li 224 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPLRFP----DGFDRDAKDLL 224 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCCCC----CcCCHHHHHHH
Confidence 999999999999999999999999999999999999964321 111222222222222 22344689999
Q ss_pred HHccCCCCCCCCC---HHHHHh
Q 042958 1053 ISCLDENPESRPT---MPKVSQ 1071 (1075)
Q Consensus 1053 ~~cl~~dP~~RPs---~~evl~ 1071 (1075)
.+||+.||++||+ +.|+++
T Consensus 225 ~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=320.65 Aligned_cols=241 Identities=28% Similarity=0.478 Sum_probs=192.5
Q ss_pred CCCCceecccCceEEEEEEE-CCC----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASG----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
....++||+|+||+||+|.+ ..| -+||+|++...... ....++.+|+..|.+++|||+++++|+|......++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHH
Confidence 34568899999999999954 334 36999998765433 335789999999999999999999999988764433
Q ss_pred heecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 892 MILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 892 ~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
..+... .....+.-+..+.|.+|||+||.|||++ ++|||||.++|||+.+...+||.|||+|+...++.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 332221 1345577788899999999999999999 99999999999999999999999999999988776
Q ss_pred Cceecccc--ccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 964 SNWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 964 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
..+....| .+.|||-|.+....|+.++|||||||++||++| |..|++..+..+.... ++. ..+++.|.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-----le~--geRLsqPp-- 923 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-----LEK--GERLSQPP-- 923 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-----Hhc--cccCCCCC--
Confidence 66554444 679999999999999999999999999999998 9999986654332211 111 12355543
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
-+..+++-++.+||..|+..||+++++...+
T Consensus 924 --iCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 924 --ICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred --CccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 3444589999999999999999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.72 Aligned_cols=238 Identities=24% Similarity=0.296 Sum_probs=185.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++||||+++++++.+.... .++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFL-YML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeE-EEE
Confidence 46888999999999999999654 7999999998653322333456788999999999999999999888765433 222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++.. ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 22211 234578888899999999999999999 9999999999999999999999999999876432
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.......+. ..
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~ 221 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKLEFPR----HL 221 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcCCCc----cC
Confidence 2235789999999999998999999999999999999999999864322 1112222222222221 22
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
...+.+++.+|++.||.+||+ ++|+++
T Consensus 222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 346899999999999999995 888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.20 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=202.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|...+++|+|+||.++.++++ ++..||+|.+......+.. ++...+|+.++++++|||||.+.+.|...+..+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 367888999999999999999554 6789999999876655544 45788999999999999999999999887775555
Q ss_pred eecCccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 893 ILSNNAA-----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++.+..+ +..+++++..+|+.|++.|+.|||+. .|+|||||+.||+++.++.+|++|||+|+.+.+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 5443322 35578888999999999999999988 999999999999999999999999999999998
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
+.....+.+||+.||+||.+.+.+|..|+||||+||++|||++-+.+|...+. .....++......+ ..
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~P---lp 227 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYSP---LP 227 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCCC---CC
Confidence 87677788999999999999999999999999999999999999999974332 22223333333211 22
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..++.++..+++.|+..+|..||++.|++..
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3455679999999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=318.17 Aligned_cols=238 Identities=25% Similarity=0.279 Sum_probs=186.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+.++++++||||+++++++...+..+. +
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l-v 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF-L 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE-E
Confidence 57888899999999999999664 689999999865332233345678999999999999999999999877654332 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 22211 234578888889999999999999999 99999999999999999999999999998764322
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.......+.. .
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~p~~----~ 238 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGRLKFPNW----F 238 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCcCCCCC----C
Confidence 235789999999999999999999999999999999999999864322 11122233333332222 2
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
...+.+++.+||+.||++||+ ++|+++
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 335889999999999999997 677764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=312.83 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=184.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++....... ....+.+|+.+++.++||||+++++++......+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 478999999999999999999665 78999999987543222 234677899999999999999999998776543222
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 -~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 -FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred -EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 2211 1124578888999999999999999999 99999999999999999999999999997654333
Q ss_pred CceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhh--------------hh
Q 042958 964 SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL--------------DE 1028 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------------~~ 1028 (1075)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||................. ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 33445678999999998865 4578899999999999999999999975432111000000000 00
Q ss_pred ccCCCCC--CCCcCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPRLP--TPSCIV-----QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~~~--~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+. .+.... ......+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 000000 011245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=295.80 Aligned_cols=240 Identities=22% Similarity=0.352 Sum_probs=197.9
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|++.+.+|+|.||.|-+| .+..|+.||||.+++....+++..-.+.+|+++|+.++||||+.++++|+..+....
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi- 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI- 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE-
Confidence 356777788999999999999 557899999999998877777767789999999999999999999999987655332
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++++. .....+++.+.+.++.||..|+.|+|.+ +|+|||||.+|||+|.++++||+|||++-.+.. .
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-K 206 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc-c
Confidence 22222 2345688899999999999999999999 999999999999999999999999999987764 3
Q ss_pred CceeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....+++|++-|.+||.+.+.+|. +.+|-||+||++|.+..|..|||+.+. ...+.++..+.+..|..
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaYrEP~~--- 275 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAYREPET--- 275 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcccccCCCC---
Confidence 456778999999999999999984 889999999999999999999985332 22334444444433321
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+....-+|++|+..+|++|.|+.||..
T Consensus 276 --PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 276 --PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred --CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 123567999999999999999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=321.06 Aligned_cols=246 Identities=19% Similarity=0.292 Sum_probs=181.7
Q ss_pred hcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|++.+.||+|+||.||+|. ..+++.||+|+.. .+.+.+|++++++++||||+++++++......+.+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 3679999999999999999994 4578999999743 24567899999999999999999988765543222
Q ss_pred eecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-C
Q 042958 893 ILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-S 964 (1075)
Q Consensus 893 ~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~ 964 (1075)
+.... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+...... .
T Consensus 162 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 21111 1234578899999999999999999999 99999999999999999999999999997543222 2
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc---hh------------------hhh
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS---SL------------------NLN 1023 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---~~------------------~~~ 1023 (1075)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .. ...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 233467999999999999989999999999999999999999886422111000 00 000
Q ss_pred hhhh----hccC--CCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALD----EMLD--PRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~----~~~~--~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.... .... ...+... ......+.++.+++.+|++.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000 0000000 011123557899999999999999999999985
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=314.61 Aligned_cols=235 Identities=22% Similarity=0.263 Sum_probs=183.0
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc-
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA- 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~- 898 (1075)
+.||+|+||.||++.. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..+. ++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l-v~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF-VMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEE-EEeCCCC
Confidence 4699999999999955 4799999999875433333445678899999999999999999998876554322 222211
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
....+++.+...++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccccc
Confidence 134578899999999999999999999 999999999999999999999999999986543333344567
Q ss_pred cccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHH
Q 042958 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 971 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1050 (1075)
||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+ ...+.++.+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~~~~~p----~~~~~~~~~ 224 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEDIKFP----RTLSADAKS 224 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccCCccCC----CCCCHHHHH
Confidence 999999999999989999999999999999999999999643211 11112221222222 123446899
Q ss_pred HHHHccCCCCCCCC-----CHHHHHh
Q 042958 1051 VAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
++.+|+++||++|| ++.|+++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 99999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.39 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=188.9
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc-eeeEEEEeecccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFYGFCSHVRH--- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~--- 888 (1075)
...|+..++||+|+||+||+| ...+|+.||+|+++..... +-......+|+.++++++|+| ||++++++...+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 345666778999999999999 4568999999999865432 123456789999999999999 9999999977653
Q ss_pred --chhheecCc---------ccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 889 --SLAMILSNN---------AAA---KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 889 --~l~~~~~~~---------~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
.+.++++.. ... ..++-.....++.|+++|++|+|++ +|+||||||.||+++++|.+||+|||
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 332222211 001 3456678899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccch--------hhhhhh
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS--------LNLNIA 1025 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~--------~~~~~~ 1025 (1075)
+|+...-+...++..++|..|+|||++.+. .|+...||||+||+++||++++.-|.+....+... .....+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999777666667788999999999998876 68999999999999999999998887554321000 000000
Q ss_pred -----hhhc--cCCCCCCCCcCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1026 -----LDEM--LDPRLPTPSCIVQ---DKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1026 -----~~~~--~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.... ..+..+.+..... .......+++.+|++.+|.+|.|++.+++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 0011110111111 111368899999999999999999998863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=314.68 Aligned_cols=235 Identities=21% Similarity=0.269 Sum_probs=182.3
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc-
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA- 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~- 898 (1075)
+.||+|+||.||++.. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..+ +++++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~-lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC-FVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE-EEEeCCCC
Confidence 4699999999999955 579999999987543223334567788999999999999999999887655432 2222211
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
....+++...+.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccccc
Confidence 234578999999999999999999999 999999999999999999999999999886444333444567
Q ss_pred cccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHH
Q 042958 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 971 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1050 (1075)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+. ..+..+.+
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~~~~p~----~~~~~~~~ 224 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPR----TLSPEAKS 224 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCC----CCCHHHHH
Confidence 99999999999999999999999999999999999999863321 1111222222222221 23346899
Q ss_pred HHHHccCCCCCCCC-----CHHHHHh
Q 042958 1051 VAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
++.+||++||++|| ++.|+++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 99999999999998 8888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.39 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=183.8
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC--CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI--RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~l 890 (1075)
...+.+..+.||+|.||+||+|+|+ |+.||||++.... ++.+.+|.++++.. +|+||+.|++.-..++..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3467788899999999999999999 9999999996531 25566777777765 9999999998776555442
Q ss_pred hhe---ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 891 AMI---LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHND-----CFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 891 ~~~---~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
..+ -.+.+ ....++....++++..+|.||+|||.+ ..|.|.|||||+.||++..++.+.|+|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 221 11221 234567788899999999999999965 34899999999999999999999999999
Q ss_pred cccccCCCCC----ceeccccccCccCccccccCC----C--CcccchHhHHHHHHHHHh----C------CCCCCccCc
Q 042958 955 IAKFLKPDSS----NWTELAGTYGYVAPELAYTMK----V--TEKCDVYSFGVLALEVIK----G------KHPRDFISS 1014 (1075)
Q Consensus 955 la~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~s~G~vl~ellt----g------~~p~~~~~~ 1014 (1075)
+|........ .....+||-+|||||++...- + -..+||||||.|+||+.. | +.||.+.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9988765532 234578999999999986532 2 235899999999999985 2 356654322
Q ss_pred cc-cchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1015 MS-SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1015 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
.+ ..+........+-..|..+..+ ...+....+.++|+.||..+|..|-|+--+.+.|
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 21 1111111111111122222222 2345677899999999999999999998887765
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=280.03 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=197.7
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCC-----CchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLP-----GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
.-..|...+.+|+|..++|.++ ...+|..+|+|++..... ......++-.+|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777889999999999988 455789999998854321 1223455677899999999 89999999999987
Q ss_pred cccchhheec--------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 886 VRHSLAMILS--------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 886 ~~~~l~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
+...+.++-. +......+++.+.++|+.|+.+|++|||.. .|||||+||+|||+|++.++||+|||+|+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 6655444311 112344578889999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCceeccccccCccCcccccc------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
.+.+. ...+..+|||+|.|||.+.. ..|+..+|+|+.||+||.++.|.+||..- ..-..+..+..
T Consensus 172 ~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlMLR~Ime 242 (411)
T KOG0599|consen 172 QLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLMLRMIME 242 (411)
T ss_pred ccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHHHHHHHh
Confidence 88754 55677899999999998863 35788999999999999999999998511 11122344455
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+++......+.+.+....+++.+|++.||.+|.|++|++.
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 5555555567788889999999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=310.44 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=180.6
Q ss_pred cCCCCCceecccCceEEEEEEE-C-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeecc---
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-A-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHV--- 886 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~--- 886 (1075)
.+|++.+.||+|+||.||+|.. . +|+.||+|++......+ .....+.+|+.+++.+ +||||++++++|...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 3688999999999999999965 3 46889999987543222 2234556677776665 699999999988532
Q ss_pred -ccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 887 -RHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 887 -~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
...+.++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 80 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 122222222211 123478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh-------hh--
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI-------AL-- 1026 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~-------~~-- 1026 (1075)
++..... .......|++.|+|||++.+..++.++||||+||++|||++|+.||............... ..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9876533 2334457899999999998888999999999999999999999999754322110000000 00
Q ss_pred -----hhccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 -----DEMLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..........+ .....+.+..+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.45 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=182.2
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----ch
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----SL 890 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~l 890 (1075)
+|++.+.||+|+||.||+|.. .+|+.||||++...... ......+.+|++++++++||||+++++++..... .+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 478889999999999999954 57999999998643222 2224578899999999999999999998754321 12
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++++... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 22222211 234578999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC---ceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-----------------
Q 042958 963 SS---NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL----------------- 1020 (1075)
Q Consensus 963 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~----------------- 1020 (1075)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 21 1234578999999999865 5789999999999999999999999964332110000
Q ss_pred --hhhhhhhhccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1021 --NLNIALDEMLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1021 --~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........+.. ..+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 237 NEKARRYLSSMRK-KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhHHHHHHhhcc-cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000011111 11100 0001122346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.91 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=191.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+++.||||.+.............+.+|+++++.++||||+++++++......+..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999965 478999999886543344455677899999999999999999999887654432221
Q ss_pred e-cCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 894 L-SNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 ~-~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
. ... .....+++.....++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 1 111 1123467888899999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........+++.|+|||++.+..++.++||||+|+++|||++|+.||...... .......+.....+. ...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCDYPP--LPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCCCCC--CCh
Confidence 433334456889999999998888999999999999999999999998532211 011111111111111 112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.+|++||++.||++.++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 234567999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=319.87 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=185.2
Q ss_pred HHHhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
....++|++.+.||+|+||.||+|.. .++..||||++..... ....+.+.+|+++++.+ +|||||+++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34456899999999999999999853 2345799999975432 23356788999999999 899999999988
Q ss_pred eccccchhheecCc------------------------------------------------------------------
Q 042958 884 SHVRHSLAMILSNN------------------------------------------------------------------ 897 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~------------------------------------------------------------------ 897 (1075)
......+.+ ++..
T Consensus 112 ~~~~~~~lv-~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 THGGPVLVI-TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred cCCCCeEEe-HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 765432111 1100
Q ss_pred -------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 898 -------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 898 -------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.....+++.+.++++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0112478888999999999999999999 999999999999999999999999999986543322
Q ss_pred c--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 965 N--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 965 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||........ ........... ..+.
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~--~~~~--- 338 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQM--SRPD--- 338 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCc--cCCC---
Confidence 1 112335678999999998899999999999999999997 9999864322110 00111111111 1111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++|||+.||++.|+
T Consensus 339 -~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 339 -FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 12346999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=310.25 Aligned_cols=245 Identities=24% Similarity=0.441 Sum_probs=186.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
..+|+..+.||+|+||.||+|.+. +|+ .||+|++... ......+++..|+.+++.++||||++++|+|.....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCc
Confidence 356899999999999999999653 344 3899998643 223345789999999999999999999999977544
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+.+...+ ....+++...++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 3333222211 133578888999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCcee--ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||+...... ....... ....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~--~~~~~~~ 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK--GERLPQP 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhC--CCCCCCC
Confidence 4433222 2234678999999999999999999999999999998 999987432211 0111111 1122222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. .+...+.+++.+||+.||.+||++.|++..+.
T Consensus 234 ~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 234 P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2 22346899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=284.89 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=193.9
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++.|++.+.||+|.|+.||+. ...+|+.+|+|.+........ ..+++.+|+++-+.++|||||++.+.+......+.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3567788889999999999999 556899999998865433322 35789999999999999999999987765443332
Q ss_pred heecCcccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEecccccccc
Q 042958 892 MILSNNAAA---------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDFGIAKFL 959 (1075)
Q Consensus 892 ~~~~~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~ 959 (1075)
++ +...++ ..+++...-..+.||++|+.|.|.+ +|||||+||+|+++-.. .-+|++|||+|..+
T Consensus 88 vF-e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VF-DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EE-ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 22 222211 1234445566889999999999999 99999999999999643 36999999999998
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
. +...+...+|||+|||||+.+..+|+..+|||+-||++|-++.|..||.+.+ .....+.+.......+..
T Consensus 164 ~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 164 N-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred C-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccCCCCc
Confidence 8 5556677899999999999999999999999999999999999999997422 223345555555554444
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++....++..+++++|+..||.+|.|+.|.++
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 56667778999999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.49 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=183.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|.. .+++.||+|+++..... .....+.+|++++++++||||+++++++...+.. .++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL-TLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE-EEE
Confidence 5788999999999999999955 47899999998654322 1235678999999999999999999998765432 222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 2211 1133468888999999999999999999 999999999999999999999999999986544333
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh----------------hhhhhh
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN----------------LNIALD 1027 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------------~~~~~~ 1027 (1075)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3445578999999998865 56889999999999999999999998643221100000 000000
Q ss_pred hccCCCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..... .........+..+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111110000 0001112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.61 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=185.5
Q ss_pred hcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 886 (1075)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+..|+.++.++ +|+||++++++|...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 45789999999999999999943 235789999987532 222346788999999999 899999999988655
Q ss_pred ccchhheecCcc--------------------------------------------------------------------
Q 042958 887 RHSLAMILSNNA-------------------------------------------------------------------- 898 (1075)
Q Consensus 887 ~~~l~~~~~~~~-------------------------------------------------------------------- 898 (1075)
+..+..++++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 433222221110
Q ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccC
Q 042958 899 --AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYG 974 (1075)
Q Consensus 899 --~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~ 974 (1075)
....++|..+.+++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++.+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 013678999999999999999999999 9999999999999999999999999999876433221 223455678
Q ss_pred ccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHH
Q 042958 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAI 1053 (1075)
Q Consensus 975 y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1053 (1075)
|+|||++.+..++.++||||+||++|||++ |+.||......+. ............ .+ ......+.+++.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~----~~~~~~~~~l~~ 310 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRRLKEGTRMR--AP----EYATPEIYSIML 310 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHHHhccCCCC--CC----ccCCHHHHHHHH
Confidence 999999999999999999999999999998 9999864322110 001111111111 11 123346899999
Q ss_pred HccCCCCCCCCCHHHHHhhhc
Q 042958 1054 SCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1054 ~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+||+.+|++||++.||++.|+
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HHccCChhhCcCHHHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=318.68 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=184.5
Q ss_pred HhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
..++|++.+.||+|+||.||+|+. .++..||||+++.... ....+.+.+|+++++.+ +||||++++++|..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 345788999999999999999953 2466899999865322 22356788999999999 89999999999876
Q ss_pred cccchhheecCc--------------------------------------------------------------------
Q 042958 886 VRHSLAMILSNN-------------------------------------------------------------------- 897 (1075)
Q Consensus 886 ~~~~l~~~~~~~-------------------------------------------------------------------- 897 (1075)
....+.++ +..
T Consensus 111 ~~~~~lv~-E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 111 GGPTLVIT-EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred CCcceeee-hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 54432111 100
Q ss_pred ----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 898 ----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 898 ----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.....++|..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0112478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... .....++..|+|||++.+..++.++||||||+++|||++ |..||........ ......... +...+.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~ 340 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK----FYKMIKEGY--RMLSPE 340 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH----HHHHHHhCc--cCCCCC
Confidence 3221 112334678999999999999999999999999999998 8889864322110 001111110 111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++||||+||++.|+
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 12346899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=308.98 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=187.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|+.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..+ ++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLY-LV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEE-EE
Confidence 46889999999999999999665 6889999998754322 233567889999999999999999999887655432 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 22111 124578889999999999999999999 999999999999999999999999999987653322
Q ss_pred -ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhhhhh-ccCC---
Q 042958 965 -NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIALDE-MLDP--- 1032 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~-~~~~--- 1032 (1075)
......|++.|+|||++.+..++.++||||+||++|||++|+.||............. ...... ..++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2334578999999999998889999999999999999999999997433211000000 000000 0000
Q ss_pred --CCCCC---C----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 --RLPTP---S----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 --~~~~~---~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.. . ......+..+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0 001123456999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=311.71 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=181.1
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHH---hcCCcCceeeEEEEeeccccchhh
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL---TEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
|++.+.||+|+||.||+|.. .+|+.||||+++..........+.+..|++++ +.++||||+++++++......+ +
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~-l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC-F 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE-E
Confidence 56778999999999999965 47899999998753222222345666676654 5678999999999987665433 2
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 222211 134689999999999999999999999 999999999999999999999999999876544333
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+. ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~p~----~~ 224 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVRYPR----FL 224 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC----CC
Confidence 444567999999999999999999999999999999999999999643221 111222222222221 22
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+..+.+++.+|++.||.+|| ++.|+++
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 34588999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.57 Aligned_cols=244 Identities=24% Similarity=0.405 Sum_probs=186.5
Q ss_pred cCCCCCceecccCceEEEEEEECC-C-----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELAS-G-----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+|.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468888999999999999996542 2 579999986442 33445779999999999999999999998876543
Q ss_pred chhhe-ecCc-----------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 889 SLAMI-LSNN-----------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 889 ~l~~~-~~~~-----------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
.+.++ +... .....+++.+.+.++.|++.|++|||+. +++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 22111 1100 0014578888999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLN 1021 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 1021 (1075)
++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986543321 1233456788999999988889999999999999999998 99998643221
Q ss_pred hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+.....+. .....+.++.+++.+||+.||.+||+++||++.|+
T Consensus 234 --~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 234 --EVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 1111221111111 12344567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=312.86 Aligned_cols=238 Identities=22% Similarity=0.316 Sum_probs=179.3
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|.. .+++.||+|++...........+.+..|+.++.++ +||||+++++++......+. +++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l-v~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF-VIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEE-EEeCCC
Confidence 4699999999999965 46889999998765333344456788899988877 89999999998876554322 222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 156 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccc
Confidence 234578889999999999999999999 99999999999999999999999999998644333334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-hhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-LNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
.||+.|+|||++.+..++.++||||||+++|||++|+.||+........... .......+.......+ ...+..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 232 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKA 232 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 7999999999999999999999999999999999999999643222111111 1111122222222222 2234468
Q ss_pred HHHHHHccCCCCCCCCCH
Q 042958 1049 VEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs~ 1066 (1075)
.+++.+|++.||++||++
T Consensus 233 ~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 233 ASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHhcCCHHHcCCC
Confidence 899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=313.63 Aligned_cols=235 Identities=21% Similarity=0.265 Sum_probs=182.1
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc-
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA- 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~- 898 (1075)
+.||+|+||.||+|.. .+|+.||+|++.............+..|+++++.++||||+++++++......+. +++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~l-v~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF-VMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEE-EEeCCCC
Confidence 4699999999999954 5799999999875433333345677889999999999999999998876554322 222211
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccc
Confidence 23457899999999999999999997 6 99999999999999999999999999998654433344456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ....++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~~~~~~~ 224 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPR----TLSPEAK 224 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcCCCCCCC----CCCHHHH
Confidence 799999999999999999999999999999999999999963221 1111122222222221 2334689
Q ss_pred HHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1050 EVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+++.+|++.||++|+ +++|+++
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 999999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=314.69 Aligned_cols=247 Identities=19% Similarity=0.236 Sum_probs=188.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +++.||||++...........+.+..|+++++.++||||+++++++......+. +
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l-v 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL-A 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE-E
Confidence 36888999999999999999665 689999999875432333345678899999999999999999999877554322 2
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 2211 1234578889999999999999999999 999999999999999999999999999986543
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... ..........+.... .....
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~---~~~~~ 229 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-LKYWKETLQRPVYDD---PRFNL 229 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-HHhccccccCCCCCc---ccccc
Confidence 23345789999999999999999999999999999999999999974332111000 000000001111110 01123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+.++.+++.+|+..+|++||+++|+++.
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 4568999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=313.58 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=185.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-C-CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-S-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|..+ + +..||+|++...........+.+.+|+++++.++||||+++++++.+....+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~- 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY- 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE-
Confidence 457888999999999999999654 3 3689999986533223334567889999999999999999999997765432
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 2222211 234578888899999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+..
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~--- 250 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGIIYFPKF--- 250 (340)
T ss_pred ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCCCCC---
Confidence 23457999999999999988999999999999999999999999743221 1112222222222221
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
.+..+.+++.+|++.||++|+ +++|+++
T Consensus 251 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 251 -LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 233588999999999999995 8998875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.49 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=185.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|.++ .+..||+|+++... .....+.+.+|+..+++++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 356888899999999999999653 46789999987643 223356799999999999999999999998765443
Q ss_pred hhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 890 LAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 890 l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.++++... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 82 -~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 82 -MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred -EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 22222211 124678999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCC
Q 042958 960 KPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPT 1036 (1075)
Q Consensus 960 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1036 (1075)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ..+.+.+. ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 229 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFRLPA 229 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCC
Confidence 322111 112334678999999999999999999999999999885 999986432211 11111111 1122
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+ ...+..+.+++.+||+++|++||+++|+.+.|+
T Consensus 230 ~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 230 P----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred C----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 2 234456999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=312.39 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=183.6
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|.. .+++.||||+++..........+.+..|..+++.+ +||||+++++++......+ ++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~-lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF-FVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE-EEEeCCC
Confidence 4699999999999965 46899999999764333334456788999999998 7999999999987655432 2222111
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF 156 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccc
Confidence 234688999999999999999999999 99999999999999999999999999997543333334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-hhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-LNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||+........... .....+.+.......+. ..+..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~~~~~ 232 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC----CCCHHH
Confidence 7999999999999999999999999999999999999999743322111110 11112222222222222 223458
Q ss_pred HHHHHHccCCCCCCCCC------HHHHHh
Q 042958 1049 VEVAISCLDENPESRPT------MPKVSQ 1071 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs------~~evl~ 1071 (1075)
.+++.+|++.||.+||+ ++|+++
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 99999999999999997 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.02 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=191.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+++.||||.+......+....+++.+|+.+++.++||||+++++++...+..+..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999964 579999999886543334445578899999999999999999999887654332221
Q ss_pred -ecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 894 -LSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 -~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+... .....+++...+.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 1111 1234578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........++..|+|||++.+..++.++||||||+++|||++|+.||...... .............+. ...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPP--LPS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCC--CCc
Confidence 443334456889999999999888999999999999999999999998632211 001111111111111 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||||.+|++.++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 234557999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=304.85 Aligned_cols=238 Identities=24% Similarity=0.287 Sum_probs=180.9
Q ss_pred ecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe-ecCc---
Q 042958 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI-LSNN--- 897 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~-~~~~--- 897 (1075)
||+|+||+||++.. .+|+.||+|++...........+.+..|+++++.++||||+++.+++......+.++ +...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999955 478999999986543222233456788999999999999999998887654432221 1111
Q ss_pred --------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 898 --------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
.....+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+..+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 1234578999999999999999999999 99999999999999999999999999998765544444456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||||+++|||++|+.||........ .............. .....+..+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRILNDSVT----YPDKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHhhcccCCC----CcccCCHHHH
Confidence 789999999999999999999999999999999999999974322110 11111122222111 1223445689
Q ss_pred HHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1050 EVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+++.+|++.||++|| +++|+++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 999999999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=308.68 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=186.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|..||+|.+.... .....+.+.+|++++++++||||+++++++...+..+ +
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-I 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE-E
Confidence 468999999999999999999654 78899999987542 2334578999999999999999999999987655432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.....++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 222211 1245788888999999999999999852 6999999999999999999999999999865432
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh---------------------
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------------- 1022 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------------- 1022 (1075)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2234578999999999999999999999999999999999999996322110000000
Q ss_pred -----------------hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1023 -----------------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1023 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
......+.....+. ........++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0011234579999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.64 Aligned_cols=235 Identities=23% Similarity=0.318 Sum_probs=180.8
Q ss_pred ceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 821 HCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
+.||+|+||.||+++. .+++.||||++..... ........+..|+++++.++||||+++++++...+..+ ++++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~-lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLY-LILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEE-EEEe
Confidence 6799999999999964 3588999999864321 11222456788999999999999999999987765432 2222
Q ss_pred Ccc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 896 NNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 896 ~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
... ....+.+.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 221 234467788888999999999999999 99999999999999999999999999997654433334
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+. ..+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~~~~~~----~~~~ 225 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLNLPP----YLTP 225 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCH
Confidence 456799999999999988899999999999999999999999974322 1122233333332222 2234
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
.+.+++.+|+++||++|| +++++++
T Consensus 226 ~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 589999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=314.10 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=186.6
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--- 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 888 (1075)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 357899999999999999999955 5689999999875432 22335678899999999999999999998865432
Q ss_pred --chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 --SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 --~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++.... ...+++.+...++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 12222222211 23467888889999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh--------------hhhhhh
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL--------------NLNIAL 1026 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~--------------~~~~~~ 1026 (1075)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........... ......
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 32 223345789999999999999999999999999999999999999974332110000 000000
Q ss_pred hhccC--CCCC--------------CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLD--PRLP--------------TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~--~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..... +..+ ............+.+++.+|++.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000 000011112346899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.53 Aligned_cols=243 Identities=20% Similarity=0.315 Sum_probs=184.6
Q ss_pred CCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
+|++.+.||+|+||.||+|... +++.||+|++.... .....+.+..|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4666788999999999999653 25789999987542 223456789999999999999999999988765442
Q ss_pred hhheecC------------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 890 LAMILSN------------------------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 890 l~~~~~~------------------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
...+... ......+++..+.+++.|+++||+|+|+. +|+||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 2111100 01123478888999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1075)
+.+||+|||+++........ .....+++.|+|||++.+..++.++||||+|+++|||++ |..||.....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 99999999998866433221 123345789999999988889999999999999999998 8888764322
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+.+....... ...+.+..+.+++.+||+.+|++||+++||++.|+
T Consensus 233 ~~~~~~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 QDVIEMIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11222222222211 12234456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=307.47 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=194.4
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
++++-...+.+..++||.|.||.||.|.|+ ..-.||||.++.. ....++|+.|+.+|+.++|||+|+++|+|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 455555667888899999999999999876 3668999999753 33478999999999999999999999999876
Q ss_pred ccchhhe--ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 887 RHSLAMI--LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 887 ~~~l~~~--~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
..++.+- +.+.. ....++-...+.+|.||+.|++||..+ .+|||||.++|+|+.++..+||+|||++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 5543332 11111 122234445578999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcee-ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 957 KFLKPDSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 957 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
+.+..+..... ...-.+.|.|||.+....++.|+|||+|||++||+.| |-.||.+++... .+..++.- .++
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkg--yRM 485 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKG--YRM 485 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhcc--ccc
Confidence 99876543221 1223689999999999999999999999999999998 888987654322 22222221 223
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..| +.+++.++++|+.||+..|.+||+++|+-+.+|
T Consensus 486 ~~P----eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 486 DGP----EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cCC----CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 332 345667999999999999999999999988775
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.17 Aligned_cols=240 Identities=24% Similarity=0.424 Sum_probs=185.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
++|++.+.||+|+||.||+|+++++..+|+|.+..... ..+.+..|++++++++||||+++++++......+.+ +
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv-~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV-T 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE-E
Confidence 45788899999999999999988888999998764321 136788999999999999999999998765543222 2
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+.. .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 111 1123578999999999999999999999 999999999999999999999999999986543322
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCc
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIV 1041 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1041 (1075)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+... +...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~--- 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRLYRPK--- 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC---
Confidence 1 122335668999999998889999999999999999999 89998643221 111111111 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 225 -~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.60 Aligned_cols=235 Identities=21% Similarity=0.301 Sum_probs=181.2
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|+.. +++.||||++...........+.+..|.++++.+ +||||+++++++...+..+. +++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~l-v~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFF-VMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEE-EEeCCC
Confidence 46999999999999654 6889999998754322233345677899988866 89999999999877654322 222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccc
Confidence 234578888999999999999999999 99999999999999999999999999998654444444456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....+.+.......+. ..+.++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~~~~~~~ 224 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDVLYPV----WLSKEAV 224 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHHHH
Confidence 799999999999998999999999999999999999999974332 1112222222222221 1234688
Q ss_pred HHHHHccCCCCCCCC-------CHHHHHh
Q 042958 1050 EVAISCLDENPESRP-------TMPKVSQ 1071 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RP-------s~~evl~ 1071 (1075)
+++.+|+++||++|| +++++++
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=308.57 Aligned_cols=230 Identities=23% Similarity=0.331 Sum_probs=177.5
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCc-
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNN- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~- 897 (1075)
+.||+|+||.||+|..+ +++.||||++...........+.+..|..++... +||||+++++++...+..+. ++++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~i-v~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFF-VMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEE-EEcCCC
Confidence 46999999999999654 6899999998653222223356677888888876 79999999998876554322 22221
Q ss_pred --------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 898 --------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccc
Confidence 1234578889999999999999999999 99999999999999999999999999988654333344456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ..+.++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~~~ 224 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPT----WLSQDAV 224 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCCCCCC----CCCHHHH
Confidence 799999999999998999999999999999999999999974322 1112222222222221 2234689
Q ss_pred HHHHHccCCCCCCCCCH
Q 042958 1050 EVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~ 1066 (1075)
+++.+|++.||++||++
T Consensus 225 ~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 225 DILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHcccCHHHCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=302.64 Aligned_cols=237 Identities=31% Similarity=0.525 Sum_probs=176.9
Q ss_pred CceecccCceEEEEEEEC-----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 820 EHCIGKGGQGSVYKAELA-----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.+.||.|+||.||+|.+. .+..|+||+++.. ......+.|.+|++.+++++||||++++|+|...+.. .+++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~-~lv~ 80 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL-FLVM 80 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE-EEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccc-cccc
Confidence 468999999999999776 3568999999643 3333468899999999999999999999999854432 2222
Q ss_pred cCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 895 SNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 895 ~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+.. .....+++.++.+|+.||++||.|||+. +++|+||+++||+++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 211 1135789999999999999999999999 99999999999999999999999999998763222
Q ss_pred Cc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 964 SN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 964 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .........|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+.+..... .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~---~ 226 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLP---I 226 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETT---S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccce---e
Confidence 21 223456789999999999889999999999999999999 7889764322 11112222221111 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
....+..+.+++.+||+.||++||||.|+++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 122344589999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=319.27 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=188.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCC-CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEE-eecc---c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASG-EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGF-CSHV---R 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~---~ 887 (1075)
..++++.++|.+|||+.||.|....+ ..||+|++... ++...+.+.+|+++|+.++ |||||.+++. .... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45567779999999999999966554 99999998754 5566788999999999995 9999999993 2211 1
Q ss_pred cc----hhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 888 HS----LAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 888 ~~----l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
.. +.|.+... .....|++.++++|++|+++|+++||.. .|+|||||||-+|||++.+++.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 11 12222221 1123488999999999999999999987 4589999999999999999999999999
Q ss_pred cccccCCCCCce---------eccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh
Q 042958 955 IAKFLKPDSSNW---------TELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 955 la~~~~~~~~~~---------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 1022 (1075)
.|.......... -....|+.|+|||++. +...++|+|||++||+||-++....||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 997544332111 1234789999999874 66789999999999999999999999974322
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
-.+++.++..|. ...++..+.+||+.||+.||.+||++.||++.+
T Consensus 264 ----laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 264 ----LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 234444444442 246777899999999999999999999998865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=307.44 Aligned_cols=235 Identities=20% Similarity=0.278 Sum_probs=179.8
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcC-ceeeEEEEeeccccchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR-NIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~l~~~ 893 (1075)
+|++.+.||+|+||.||+|... +++.||||++...........+.+..|++++..++|+ +|+++++++...+.. +++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~-~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL-YFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEE-EEE
Confidence 5788899999999999999654 6789999998754322233356788899999999765 588888887665433 222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 22211 234578899999999999999999999 999999999999999999999999999875433333
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~ 224 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK----SL 224 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CC
Confidence 44456799999999999999999999999999999999999999974322 1112222222222221 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCH
Q 042958 1045 LISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
+..+.+++.+|+++||.+|+++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCC
Confidence 3468899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.39 Aligned_cols=245 Identities=26% Similarity=0.454 Sum_probs=191.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
+...+|++.+.||+|+||.||+|...+++.||+|.+.... .....++..|+.+++.++||||+++++++......+.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 3456789999999999999999988879999999987532 2234678899999999999999999999876654332
Q ss_pred heecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++.... .....+++.++++++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..+..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 221111 1234678999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSC 1039 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1039 (1075)
.........++..|+|||...+..++.++||||||+++|+|++ |+.||...... .....+... +.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-- 226 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPCP-- 226 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCCC--
Confidence 3332333446778999999988889999999999999999998 89998643321 111111111 11211
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|||++|+.+.|+
T Consensus 227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 227 --AKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 233456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.33 Aligned_cols=238 Identities=28% Similarity=0.413 Sum_probs=193.0
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc-ccchhhee
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV-RHSLAMIL 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l~~~~ 894 (1075)
|.+.+++|+|+||.||+|.+ .+|+.||||.+... ...+++..|+.+|++.+.|+||++||.|... +..++|.+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 45668899999999999944 57999999998543 2267899999999999999999999966543 44444444
Q ss_pred cCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
...+ ..+++.+.++..+....++||+|||.. .-+|||||+.|||++.+|.+|++|||.|..+.+.-...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 3332 256788899999999999999999998 78999999999999999999999999998776555556
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
.+..||+.|||||++..-.|..++||||+|++..||..|++||.++.+.... -++..+.|+....+..-+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------EeccCCCCCCCCChHhhhh
Confidence 6789999999999999999999999999999999999999999876654321 1222222222233444566
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++.++++.|+.+.|++|.|+.++++
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 8999999999999999999999876
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=306.01 Aligned_cols=234 Identities=24% Similarity=0.319 Sum_probs=176.3
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|.. .+++.||||+++..........+.+..|..++... +||||+++++++...... .++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~-~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL-FFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE-EEEEcCCC
Confidence 4699999999999965 46889999998754322223344566677777654 899999999988765543 22222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 156 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccc
Confidence 234578888899999999999999999 99999999999999999999999999998654443444556
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+ .....++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~----~~~~~~~~ 224 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRPHFP----RWISKEAK 224 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCC----CCCCHHHH
Confidence 7999999999999989999999999999999999999999743221 11112222221111 12334588
Q ss_pred HHHHHccCCCCCCCCCHH-HHH
Q 042958 1050 EVAISCLDENPESRPTMP-KVS 1070 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~-evl 1070 (1075)
+++.+||+.||++||++. +++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=301.42 Aligned_cols=244 Identities=23% Similarity=0.423 Sum_probs=187.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|.+.+.||+|+||.||+|... +++.||||.+..... .+..+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 356888899999999999999653 357899999875432 234578999999999999999999999987764
Q ss_pred cchhheecCc-----------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 888 HSLAMILSNN-----------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 888 ~~l~~~~~~~-----------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
..+.+ ++.. .....+++.+...++.|++.|+.|||+. +++||||||+||+++.
T Consensus 82 ~~~lv-~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 82 PPIMV-FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred CeEEE-EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 43222 2111 1123478889999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLN 1021 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 1021 (1075)
++.+|++|||+++....... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------ 231 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------ 231 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------
Confidence 99999999999986543321 1123345788999999999999999999999999999998 99998643221
Q ss_pred hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.+.....+.+ ....+..+.+++.+||++||++||+++||++.|+
T Consensus 232 --~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 --EVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11122222222211 1223456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=307.30 Aligned_cols=235 Identities=20% Similarity=0.284 Sum_probs=181.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+|++.+.||+|+||.||+|... +++.||||++...........+.+..|..++... +|++|+++++++...+..+ ++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~-lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY-FV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE-EE
Confidence 5788899999999999999654 6889999998754322333345677788888877 5899999999887655432 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 22211 234578889999999999999999999 999999999999999999999999999986543333
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+. ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~~ 224 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK----SM 224 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----cC
Confidence 44456799999999999999999999999999999999999999974322 1112222222222221 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCH
Q 042958 1045 LISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
+.++.+++.+|+++||++|+++
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCC
Confidence 4468999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=295.02 Aligned_cols=238 Identities=26% Similarity=0.408 Sum_probs=181.1
Q ss_pred eecccCceEEEEEEE---CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 822 CIGKGGQGSVYKAEL---ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.||+|+||.||+|.+ .++..||+|+++... ......+++..|+.+++.++||||+++++++......+.+.+....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCC
Confidence 589999999999954 357899999986543 2334567899999999999999999999998654433222221111
Q ss_pred -------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce---ec
Q 042958 899 -------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TE 968 (1075)
Q Consensus 899 -------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~---~~ 968 (1075)
....+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 224578899999999999999999999 99999999999999999999999999998765443221 12
Q ss_pred cccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 969 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
..++..|+|||.+....++.++||||||+++|||++ |+.||....... ......... ..+.+ ...+.+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~~~~--~~~~~----~~~~~~ 226 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIESGE--RMECP----QRCPPE 226 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCCC--CCCCC----CCCCHH
Confidence 234578999999988889999999999999999998 999987432211 111111111 11111 123456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1048 IVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+++.+||++||++||++++|++.|+
T Consensus 227 l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 227 MYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred HHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=312.76 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=186.6
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 888 (1075)
...++|+..+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 3457899999999999999999954 46899999998764322 2335678899999999999999999998864332
Q ss_pred ---chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 ---SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ---~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
..+++++.... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 11122211111 23467888899999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh--------------hhhh
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------------LNIA 1025 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------------~~~~ 1025 (1075)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ ....
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 432 2223457899999999999999999999999999999999999999743321100000 0000
Q ss_pred hhhccCC----------------CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 LDEMLDP----------------RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+... ..+............+.+++.+|++.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 000000011122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=298.65 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=182.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
++|++.+.||+|+||.||+|.+. +|+ .||+|++... .......++..|+..++++.||||+++++++......
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccE
Confidence 57888899999999999999653 454 4788887533 2223346788899999999999999999998654332
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.+..... .....+++.....++.||+.|++|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 22221111 1234578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
... ......++..|+|||++.+..++.++||||||+++||+++ |+.||........ ....... ...+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~ 234 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----PDLLEKG--ERLAQPQ 234 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHCC--CcCCCCC
Confidence 322 1233456789999999998889999999999999999998 9999864322110 0111110 1111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+...+.+++.+||..||++|||+.|+++.|+
T Consensus 235 ----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 235 ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred ----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 12335788999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=303.45 Aligned_cols=247 Identities=25% Similarity=0.331 Sum_probs=202.7
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l 890 (1075)
..+.|+..+.||+|.||.||++..+ +|+.+|+|.+.+.........+.+.+|+.+|+++. |||||.++++|+.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999655 59999999998765544444678999999999997 999999999998766432
Q ss_pred -hheecCccc-----cC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC----CCceEecccccccc
Q 042958 891 -AMILSNNAA-----AK-DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD----NEAHVSDFGIAKFL 959 (1075)
Q Consensus 891 -~~~~~~~~~-----~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~~ 959 (1075)
.+.+...+. .. .+++.....++.|++.|+.|||+. +|+|||+||+|+++... +.+|++|||+|...
T Consensus 113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 222222111 11 288889999999999999999998 99999999999999644 47999999999998
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
.. .......+||+.|+|||++....|+.++||||+||++|.|++|..||...... .....+....+.....
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDFDFTSE 260 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCCCCCCC
Confidence 87 55677889999999999999999999999999999999999999999754322 2223444455544455
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+...+..+.+++..|+..||.+|+|+.++++
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 66777888999999999999999999999986
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=293.82 Aligned_cols=241 Identities=23% Similarity=0.394 Sum_probs=185.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
++|++.+.||+|+||.||+|+..++..||+|.+..... ..+++.+|+.++++++||||+++++++......+ .++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE-EEE
Confidence 45778899999999999999887777899999864322 1367899999999999999999999987655432 222
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+.. .....+++.++++++.||+.|++|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 211 1123689999999999999999999999 999999999999999999999999999986654322
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
. .....++..|+|||+..+..++.++||||||+++|||++ |+.||....... ....+........ ..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~---~~ 224 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYR---PH 224 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCC---CC
Confidence 1 112335678999999988889999999999999999998 999986433211 1111111111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++||++.++++.++
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.73 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=184.7
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||++.. .+++.||||++.............+.+|+.++++++||||+++++++......+..+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999965 4789999999865332222334567889999999999999999998876554322211
Q ss_pred -cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 -SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 -~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
... .....+++.....++.|++.|+.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 111 1124578999999999999999999999 99999999999999999999999999998754322
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ........+...... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~----~~~~~ 228 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQEE----YSEKF 228 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcccc----cCccc
Confidence 2234578999999999998889999999999999999999999997432211 000111111111111 12234
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+..+.+++.+||+.||++|| +++++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 45689999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=295.14 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=192.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||+|.++.....+....+.+.+|++++++++|+|++++++++.........+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999665 89999999887543334444678999999999999999999999887654332221
Q ss_pred e-cC-----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 894 L-SN-----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 ~-~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
. .. ......+++.++..++.|+++|++|||+. +|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 1 11 11234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.......+.. ..
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--~~ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEKCDYPPL--PA 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhcCCCCCC--Ch
Confidence 433334456889999999999888999999999999999999999998532210 0111111111111111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||..+|++|||+.+|+++|+
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 234456899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=296.96 Aligned_cols=242 Identities=22% Similarity=0.365 Sum_probs=187.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII- 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE-
Confidence 46788899999999999999988888899999976422 2256889999999999999999999988765543222
Q ss_pred ecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++.. .....+++.+++.++.|+++|++|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 2111 1234578889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 963 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 963 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ........ ...+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~--- 226 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQRG--YRMPRM--- 226 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHcC--CCCCCC---
Confidence 221 122345678999999988889999999999999999998 999986322111 11111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.++.+++.+||+.+|++||+++++.+.|+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 227 -ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 123346899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=323.55 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=188.3
Q ss_pred HHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 888 (1075)
...++|++.+.||+|+||+||+|. ..+|+.||||++...... ......+.+|+..+..++|+|++++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445799999999999999999995 457999999998754332 3345678899999999999999998876643221
Q ss_pred -----chhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 889 -----SLAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 889 -----~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
.+.+++++.. ....+++.....++.|++.||+|+|+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 1122222211 124578888899999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC--CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh
Q 042958 951 SDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 951 ~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
+|||+++.+.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999998765332 123346799999999999999999999999999999999999999964321 111122
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
........ .....+.++.+++.+||+.||++||++.|+++.
T Consensus 257 ~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22221111 112234569999999999999999999999763
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=299.79 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=185.1
Q ss_pred HhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
+.++|+..+.||+|+||.||+|... ++..||||++.... ......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 5678999999999999999998643 35679999986432 223356789999999999999999999998765
Q ss_pred ccchhheecCcc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 887 RHSLAMILSNNA-------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 887 ~~~l~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
...+.+ ++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 82 ~~~~lv-~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 82 QPTLVI-MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCeEEE-EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 443222 11110 012357788899999999999999998 9999999999999999999
Q ss_pred ceEeccccccccCCCCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhh
Q 042958 948 AHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1075)
++++|||+++......... ....+++.|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~ 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------Q 229 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence 9999999998654332211 12345778999999998889999999999999999999 78888643221 1
Q ss_pred hhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.......+.. ....+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111112221111 1123346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=294.56 Aligned_cols=243 Identities=21% Similarity=0.378 Sum_probs=187.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++||||+++++++......+.+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEE
Confidence 467888999999999999999888899999999875332 2467889999999999999999999875433222221
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 1111 1234578899999999999999999998 999999999999999999999999999987653222
Q ss_pred -ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 965 -NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......++..|+|||++.+..++.++||||||+++||+++ |+.||....... ........ .+.+.+ .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~----~ 226 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERG--YRMPRP----D 226 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHHHcC--CCCCCC----C
Confidence 1223345678999999988889999999999999999999 999986432211 11111111 111111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.+|++||+++++.+.|+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 23346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=314.43 Aligned_cols=244 Identities=20% Similarity=0.246 Sum_probs=181.0
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+++.||||++...........+.+.+|++++++++||||+++++++.+....+ +++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~-lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLY-FVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEE-EEE
Confidence 578889999999999999954 578999999987543333344567899999999999999999999998765432 222
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
+... ....+++.....++.||+.||+|||+. +|+||||||+||+++.++++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 2221 134577888888999999999999999 999999999999999999999999999764311000
Q ss_pred ----------------------------------------------ceeccccccCccCccccccCCCCcccchHhHHHH
Q 042958 965 ----------------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998 (1075)
Q Consensus 965 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~v 998 (1075)
.....+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123469999999999998899999999999999
Q ss_pred HHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHh
Q 042958 999 ALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAIS--CLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 999 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 1071 (1075)
+|||++|+.||........ .............+.. ...+.++.+++.+ |+..+|..||+++|+++
T Consensus 238 l~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET----QLKVINWENTLHIPPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH----HHHHHccccccCCCCC----CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999974322110 0000000001112211 1233457888887 55667777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=304.63 Aligned_cols=184 Identities=20% Similarity=0.337 Sum_probs=145.8
Q ss_pred CceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-hhheec
Q 042958 820 EHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-LAMILS 895 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l~~~~~ 895 (1075)
.++||+|+||.||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++...... +.++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999754 567899999864321 24577899999999999999999987543221 111111
Q ss_pred Cc-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee----CCCCCceEeccc
Q 042958 896 NN-----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL----DFDNEAHVSDFG 954 (1075)
Q Consensus 896 ~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG 954 (1075)
.. .....+++.....++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 11 1123478888999999999999999999 99999999999999 456789999999
Q ss_pred cccccCCCCC---ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCc
Q 042958 955 IAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 1011 (1075)
Q Consensus 955 la~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~ 1011 (1075)
+++.+..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9987654322 23346789999999998764 588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=306.08 Aligned_cols=235 Identities=22% Similarity=0.286 Sum_probs=181.0
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|... +++.||||+++............+..|.++++.+ +||||+++++++...+..+ ++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~-lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF-FVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE-EEEcCCC
Confidence 46999999999999654 6889999998754322233346677899998888 7999999999887655432 2222221
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF 156 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccce
Confidence 234688999999999999999999999 99999999999999999999999999997643333333445
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+ ...+..+.
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~~~----~~~~~~~~ 224 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVRYP----RWLSKEAK 224 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCC----CcCCHHHH
Confidence 7899999999999999999999999999999999999999743321 11122222222222 12334689
Q ss_pred HHHHHccCCCCCCCCCH-----HHHHh
Q 042958 1050 EVAISCLDENPESRPTM-----PKVSQ 1071 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~-----~evl~ 1071 (1075)
+++.+||+.||++||++ .++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=270.35 Aligned_cols=239 Identities=24% Similarity=0.360 Sum_probs=184.4
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc-hhhe
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS-LAMI 893 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-l~~~ 893 (1075)
.+....+|.|..|.||+++.+ +|...|||.+.... ..+..++++..++++..- .+|+||+.+|||...... +.|.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344567999999999999665 68999999998653 344457788888886665 489999999999765443 3333
Q ss_pred ecC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 894 LSN-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 894 ~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
+.. ....+++++.-.-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||.+.++-+. ...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kAh 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KAH 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-ccc
Confidence 221 112445777777789999999999999885 9999999999999999999999999999887644 334
Q ss_pred eccccccCccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC---CCCCCCCcC
Q 042958 967 TELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD---PRLPTPSCI 1040 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 1040 (1075)
+..+|-+.|||||.+... +|+.++||||||+.++|+.||+.||...... .+.+-.+.+ +.++.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP~L~~---- 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPPLLPG---- 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCCCCCc----
Confidence 556889999999998643 6889999999999999999999999743221 111222222 33332
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....++.+.+++..|+++|+.+||...++++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2235677999999999999999999999876
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=316.08 Aligned_cols=243 Identities=22% Similarity=0.291 Sum_probs=187.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||||++.............+..|+++++.++||||+++++++.+....+. +
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l-v 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL-V 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE-E
Confidence 46888999999999999999654 799999999875432232345678999999999999999999998876554322 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS- 963 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 963 (1075)
++... ....+++...+.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 22211 124678899999999999999999998 99999999999999999999999999998765433
Q ss_pred ----------------------------CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcc
Q 042958 964 ----------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM 1015 (1075)
Q Consensus 964 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 1015 (1075)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1223456899999999999999999999999999999999999999743321
Q ss_pred ccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHhh
Q 042958 1016 SSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT-MPKVSQL 1072 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1072 (1075)
.....+.. .....+.. ...+..+.+++.+|+. ||.+||+ ++|+++.
T Consensus 237 --------~~~~~i~~~~~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 --------ETYNKIINWKESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --------HHHHHHhccCCcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111 11111111 1134568999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=295.00 Aligned_cols=243 Identities=25% Similarity=0.423 Sum_probs=186.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|+..+.||+|+||.||+|.+. +...||||++.... ......+|.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 357889999999999999999764 24579999987543 233456789999999999999999999988765443
Q ss_pred hhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 890 LAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 890 l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+. +++.. .....+++.++++++.|++.|++|||+. +|+||||||+||++++++.++++|||+++..
T Consensus 81 ~i-v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MI-ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EE-EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 22 22211 1123678999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCCcee--ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCC
Q 042958 960 KPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLP 1035 (1075)
Q Consensus 960 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1035 (1075)
........ ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence 53222222 2234678999999998899999999999999999998 99998532211 111111111 112
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ ...+..+.+++.+||+.+|++||+++||++.|+
T Consensus 229 ~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 229 PP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=298.16 Aligned_cols=238 Identities=28% Similarity=0.421 Sum_probs=187.2
Q ss_pred CCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-hhhee
Q 042958 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-LAMIL 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l~~~~ 894 (1075)
|+..+.||.|+||.||.| +.++.+.||||++........+...++..|++++.+++|||++.+-|+|...... ++|.+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455577999999999999 5568899999999776555555668899999999999999999999988654443 33333
Q ss_pred cCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 895 SNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 895 ~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.-.. ..+++...++..|..+.+.||+|||++ +.||||||+.|||+++.|.+|++|||.|..+.+. .
T Consensus 108 ClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----n 180 (948)
T KOG0577|consen 108 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----N 180 (948)
T ss_pred HhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----h
Confidence 3222 245678888899999999999999999 9999999999999999999999999999887654 4
Q ss_pred ccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 968 ELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
.++|||+|||||++. .+.|+-|+||||+|++-.|+...++|.--...+. .-.-+..--.|-++ ..+-
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-----ALYHIAQNesPtLq-----s~eW 250 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNESPTLQ-----SNEW 250 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-----HHHHHHhcCCCCCC-----Cchh
Confidence 579999999999885 4579999999999999999999999964221111 00011111112222 2344
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+..+..|+..|+++-|.+|||.+++++
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 456999999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=326.99 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=184.2
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.++||+|+||.||+|.. .+|+.||||++...........+++.+|++++++++||||+++++++.+.+..+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV- 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT- 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE-
Confidence 5788999999999999999965 46899999998765444444567899999999999999999999998765543222
Q ss_pred ecCcc--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 894 LSNNA--------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 894 ~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
++... .....++...++++.||++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 11110 112345677789999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC------------------CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcc
Q 042958 954 GIAKFLKPDS------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM 1015 (1075)
Q Consensus 954 Gla~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 1015 (1075)
|+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762111 0112246899999999999999999999999999999999999999642221
Q ss_pred ccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHhhh
Q 042958 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRP-TMPKVSQLL 1073 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L 1073 (1075)
... . ......+.... ...+.+..+.+++.+|++.||++|| +++++.+.|
T Consensus 238 ki~---~---~~~i~~P~~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 238 KIS---Y---RDVILSPIEVA---PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhh---h---hhhccChhhcc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 100 0 01111111000 1123345689999999999999997 556666554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=302.13 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=187.8
Q ss_pred CCCceecccCceEEEEEEEC--CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 818 DDEHCIGKGGQGSVYKAELA--SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
...+.||+|+||.|++|.|+ .|+ .||||.++...... ...+|.+|+.+|.+++|||++++||+..+....+++.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 34578999999999999775 344 58999998754332 4689999999999999999999999988754444443
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+... .....|-......++.|||.|+.||..+ +.||||+..+|+++-....+||+|||+.+-+..+..
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 3221 2234456666778999999999999999 999999999999999999999999999998876655
Q ss_pred ceec---cccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc-cCCCCCCCCc
Q 042958 965 NWTE---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM-LDPRLPTPSC 1039 (1075)
Q Consensus 965 ~~~~---~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1039 (1075)
.+.. ..-.+.|.|||.+...+++.++|||+|||++|||+| |..||-+..... .++.+ ...+++.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------IL~~iD~~erLpRP-- 337 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------ILKNIDAGERLPRP-- 337 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------HHHhccccccCCCC--
Confidence 4432 234678999999999999999999999999999998 889987554322 12222 12344444
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..++.+++++++.||...|.+|||+..+.+.
T Consensus 338 --k~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 338 --KYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred --CCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 3455679999999999999999999999743
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=309.56 Aligned_cols=231 Identities=23% Similarity=0.277 Sum_probs=179.2
Q ss_pred ceecccCceEEEEEEE----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.||+|+||.||++.. .+|+.||+|++...... ......+..|++++++++||||+++++++......+ ++++.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY-LILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE-EEEcC
Confidence 5799999999999854 36899999998753221 122356778999999999999999999987755433 22222
Q ss_pred cc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 897 NA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 897 ~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. ....+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 21 134578999999999999999999999 999999999999999999999999999987654434445
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+. ..+..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~~~~p~----~~~~~ 224 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAKLGMPQ----FLSPE 224 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHH
Confidence 56799999999999988899999999999999999999999974322 1112222222222221 22345
Q ss_pred HHHHHHHccCCCCCCCCCHHH
Q 042958 1048 IVEVAISCLDENPESRPTMPK 1068 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~~e 1068 (1075)
+.+++.+||++||++||++.+
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCC
Confidence 889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=284.44 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=197.6
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEE
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 880 (1075)
..|+....++++....+.+|.||.||.|.|. +.+.|.||.++.. .+..+...+..|...+..+.|||+..+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 3556666788888899999999999999554 3456778888754 3445577899999999999999999999
Q ss_pred EEeeccccchhhe------------ec-----CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 881 GFCSHVRHSLAMI------------LS-----NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 881 ~~~~~~~~~l~~~------------~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
+++.+......+. +. +....+.++..+...++.|++.|++|||++ +|||.||.++|+++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 9987654332221 11 223345567788889999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 1020 (1075)
+..++|++|=.+++.+.+.+... ...-.+..||+||.+....|+.++|||||||+||||+| |+.||..+++.+..
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-- 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-- 508 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--
Confidence 99999999999999888765432 23345789999999999999999999999999999998 99999766553322
Q ss_pred hhhhhhhhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1021 NLNIALDEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1021 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
....| .++..|. .++.++..++..||+.+|++||+++|++.-|
T Consensus 509 ------~ylkdGyRlaQP~----NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 509 ------HYLKDGYRLAQPF----NCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred ------HHHhccceecCCC----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 12222 2344433 3455699999999999999999999998765
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=298.21 Aligned_cols=242 Identities=20% Similarity=0.349 Sum_probs=184.1
Q ss_pred cCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......++.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4678889999999999999964 356789999987532 233456789999999999999999999988765443
Q ss_pred hhheecCcc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 890 LAMILSNNA--------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 890 l~~~~~~~~--------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
+.. ++... ....+++.+...++.|++.|++|||+. +++||||||+||+++
T Consensus 83 ~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 83 CML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred EEE-EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 221 11110 023467888899999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 1020 (1075)
.++.+|++|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~----- 233 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ----- 233 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999999987643321 1223345678999999988889999999999999999998 99998643211
Q ss_pred hhhhhhhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1021 NLNIALDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+...... .+.+ ...+..+.+++.+||++||++||++.+|.+.|+
T Consensus 234 ---~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 234 ---EVIEMVRKRQLLPCS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred ---HHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 1111111111 1111 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=314.08 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=183.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+++++.++||||+++++++.+....+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv- 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI- 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE-
Confidence 4788999999999999999965 47899999998753222233456788999999999999999999998876543322
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 2221 1234578999999999999999999999 999999999999999999999999999875432110
Q ss_pred --------------------------------------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCC
Q 042958 965 --------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006 (1075)
Q Consensus 965 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~ 1006 (1075)
.....+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 001246899999999999999999999999999999999999
Q ss_pred CCCCccCccccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHh
Q 042958 1007 HPRDFISSMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT---MPKVSQ 1071 (1075)
Q Consensus 1007 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1071 (1075)
.||....... ....+.. ..+..+. ....+..+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~~~--------~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE--------TYRKIINWKETLQFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH--------HHHHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997433211 1111111 1111111 11223468899999996 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=297.76 Aligned_cols=245 Identities=24% Similarity=0.426 Sum_probs=185.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|+..+.||+|+||.||+|++ .+|+ .||+|++.... .....+++.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCc
Confidence 46788889999999999999964 3555 48999986542 23345778999999999999999999999876443
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+..... .....+++...+.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 322221111 1134588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
...... ....++..|+|||...+..++.++||||||+++||+++ |..||+...... ........ ...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~ 233 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPDLLEKG--ERLPQP 233 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCC--CcCCCC
Confidence 433221 12234678999999998899999999999999999998 999986432211 11111111 111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 234 ----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 234 ----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred ----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 123456899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=306.61 Aligned_cols=231 Identities=23% Similarity=0.290 Sum_probs=174.1
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHH-HHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||+||+|.. .+|+.||+|++............++..|.. +++.++||||+++++++...+..+ ++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~-lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY-FVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE-EEEcCCC
Confidence 4699999999999965 479999999986532222222344555554 567899999999999887655432 2222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccc
Confidence 234578888899999999999999999 99999999999999999999999999997644333334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.......+. ..+..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~~~ 224 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKPLRLKP----NISVSAR 224 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHHHH
Confidence 799999999999999999999999999999999999999864321 1112222222222211 2244689
Q ss_pred HHHHHccCCCCCCCCCHH
Q 042958 1050 EVAISCLDENPESRPTMP 1067 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~ 1067 (1075)
+++.+|++.||++||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHhhcCHHhCCCCC
Confidence 999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=311.20 Aligned_cols=241 Identities=22% Similarity=0.265 Sum_probs=179.3
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||+||+|.. .+++.||||++......+......+..|+.++.+++||||+++++++.+....+ ++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~-lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY-LI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE-EE
Confidence 4788999999999999999955 468999999986533223334567889999999999999999999987755432 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 22211 235678899999999999999999999 999999999999999999999999999976532110
Q ss_pred -----------------------------------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 042958 965 -----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 1009 (1075)
Q Consensus 965 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 1009 (1075)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012347999999999999999999999999999999999999999
Q ss_pred CccCccccchhhhhhhhhhccC----CCCCCCCcCcHHHHHHHHHHHHHccC--CCCCCCCCHHHHHh
Q 042958 1010 DFISSMSSSSLNLNIALDEMLD----PRLPTPSCIVQDKLISIVEVAISCLD--ENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~ 1071 (1075)
....... ....+.. ..++... ....++.+++.+++. .++..||+++||++
T Consensus 237 ~~~~~~~--------~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQE--------TYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHH--------HHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 7432211 1111111 1112111 122346777776443 34446789999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=298.92 Aligned_cols=243 Identities=22% Similarity=0.396 Sum_probs=185.4
Q ss_pred hcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
..+|.+.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 46788899999999999999964 23566999988643 2233567999999999999999999999987654
Q ss_pred cchhheecCc----------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 888 HSLAMILSNN----------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 888 ~~l~~~~~~~----------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
..+.++ +.. .....+++.++++++.|++.||+|||+. +++||||||+||+++.+
T Consensus 81 ~~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 81 PLIMVF-EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred ccEEEE-EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 432222 111 1122489999999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1075)
+.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------- 229 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------- 229 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 99999999999865433211 122345778999999998899999999999999999998 89998643221
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.+........ ....+.++.+++.+||+.||.+|||+.||.+.|+
T Consensus 230 -~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 230 -EVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred -HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 11122222221111 1123346999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=294.17 Aligned_cols=244 Identities=23% Similarity=0.432 Sum_probs=187.1
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|...+++.||+|.++.... ..+++.+|++++++++||||+++++++...+..+.+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 3467888999999999999999877788999999865321 246788999999999999999999998766543222
Q ss_pred eecC-c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSN-N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~-~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+-.. . ..+..+++..+.+++.|++.|+.|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 2111 0 1124588999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 963 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 963 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
... ......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ........ ...+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~--- 226 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-----VLQQVDQG--YRMPCP--- 226 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcC--CCCCCC---
Confidence 211 111223458999999999899999999999999999999 999986432110 00111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+|++.+|++||+++++.+.|+
T Consensus 227 -~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 227 -PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred -CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 223456999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=296.50 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=192.6
Q ss_pred HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
.....|++.++||+||.+.||++...+.+.||+|++.... .+.....-|..|+..|.++ .|.+||++++|-.. +.++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceE
Confidence 3457789999999999999999988888999999876543 3445578899999999999 69999999999876 5556
Q ss_pred hheecCccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMILSNNAA----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+|+++.... .....| .++.+.+|++.|+.++|.+ ||||.||||.|+++- .|.+||+|||.|..+.
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 666654321 223345 6778899999999999999 999999999999985 6899999999999888
Q ss_pred CCCCc--eeccccccCccCccccccCC-----------CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 961 PDSSN--WTELAGTYGYVAPELAYTMK-----------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 961 ~~~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
.+... ....+||+.||+||.+.... .++++||||+||++|+|+.|+.||..+.. ....+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~ 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLH 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHH
Confidence 77654 34578999999999886432 56789999999999999999999974322 334556
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+.++....+..... ...++.++++.|++.||++||+..|+++
T Consensus 584 aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 666663321111111 1123899999999999999999999986
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=303.70 Aligned_cols=234 Identities=23% Similarity=0.280 Sum_probs=176.6
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|..+ +|+.||+|+++..........+.+..|..++... +||||+++++++...+..+ ++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~-lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF-FVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE-EEECCCC
Confidence 46999999999999654 6899999998753221122245567788887754 8999999999987765432 2222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceecc
Confidence 134578888899999999999999999 99999999999999999999999999987543333344556
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.......+. ....++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~ 224 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPR----WITKESK 224 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC----CCCHHHH
Confidence 7999999999999999999999999999999999999999643221 111111111111111 1234588
Q ss_pred HHHHHccCCCCCCCCCHH-HHH
Q 042958 1050 EVAISCLDENPESRPTMP-KVS 1070 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~-evl 1070 (1075)
+++.+|++.||++||++. ++.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=293.24 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=187.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.++++++|++++++++++......+.+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEE
Confidence 3578889999999999999998888889999998753322 357899999999999999999999886543332222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.... .....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 1111 1133578999999999999999999999 999999999999999999999999999987654322
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCc
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIV 1041 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1041 (1075)
. .....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ...+.+... ..+. .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~----~ 225 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMPC----P 225 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCC----C
Confidence 1 122335668999999988889999999999999999999 89998643221 111111111 1111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+|++++|++|||++++.+.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 233456999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=310.26 Aligned_cols=247 Identities=22% Similarity=0.367 Sum_probs=185.0
Q ss_pred HhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 885 (1075)
..++|++.+.||+|+||.||+|... .+..||||++.... .....+.+.+|+++++++. ||||++++++|..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3578889999999999999999642 23469999986542 2333578999999999995 9999999999876
Q ss_pred cccchhhe-ecCc-------------------------------------------------------------------
Q 042958 886 VRHSLAMI-LSNN------------------------------------------------------------------- 897 (1075)
Q Consensus 886 ~~~~l~~~-~~~~------------------------------------------------------------------- 897 (1075)
....+.++ +...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 54322211 1000
Q ss_pred ------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCee
Q 042958 898 ------------------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVL 941 (1075)
Q Consensus 898 ------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nil 941 (1075)
.....+++.++.+++.|+++|++|||+. +|+||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 0012477888899999999999999999 9999999999999
Q ss_pred eCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccc
Q 042958 942 LDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSS 1018 (1075)
Q Consensus 942 l~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 1018 (1075)
++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 99999999999999986543322 1223456788999999998889999999999999999997 9999864321100
Q ss_pred hhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1019 SLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ .+.+.+ ...+..+.+++.+||+.||++||++.+|.++|+
T Consensus 349 ---~~~~~~~~--~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 349 ---FYNKIKSG--YRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred ---HHHHHhcC--CCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 00011111 111111 233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=303.17 Aligned_cols=234 Identities=22% Similarity=0.300 Sum_probs=176.5
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|... +++.||||+++..........+.+..|..+++.. +||||+++++++.+.+..+ ++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~-lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF-FVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE-EEEeCCC
Confidence 46999999999999654 6889999998753221122235566788888764 9999999999987765432 2222221
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeee
Confidence 134578889999999999999999999 99999999999999999999999999997643333334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+. ....++.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~----~~~~~~~ 224 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPCYPR----WLTREAK 224 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc----cCCHHHH
Confidence 7999999999999989999999999999999999999999643211 111111111111111 1234588
Q ss_pred HHHHHccCCCCCCCCCHH-HHH
Q 042958 1050 EVAISCLDENPESRPTMP-KVS 1070 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~-evl 1070 (1075)
+++.+||++||++||++. ++.
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHH
Confidence 999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=312.65 Aligned_cols=245 Identities=20% Similarity=0.251 Sum_probs=185.3
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+..|+.+++.++||||+++++++.+....+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~- 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY- 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE-
Confidence 356889999999999999999965 468999999986432222233456789999999999999999999887655432
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++++... ....++......++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 2222211 123467788888999999999999999 99999999999999999999999999998765432
Q ss_pred C-ceeccccccCccCccccccC----CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC--CCC
Q 042958 964 S-NWTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR--LPT 1036 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1036 (1075)
. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+.... +..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~ 268 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNSLTF 268 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCcCCC
Confidence 2 22345799999999988654 3788999999999999999999999743321 1112222211 111
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1071 (1075)
+ .....+.++.+++.+|++.+|++ ||+++|+++
T Consensus 269 ~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 269 P--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1 11123456899999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=299.19 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=188.3
Q ss_pred HhcCCCCCceecccCceEEEEEEECC-----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELAS-----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
..++|++.+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35788889999999999999997654 688999998643 23344677899999999999999999999887643
Q ss_pred cchhheecC------------cc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 888 HSLAMILSN------------NA-----AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 888 ~~l~~~~~~------------~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
.....+... .. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 322222111 11 114588999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhh
Q 042958 951 SDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
+|||+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....... ......
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~ 233 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAAYLK 233 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH
Confidence 999999876543221 122345678999999998889999999999999999999 999987432211 111111
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ....+.+ ...+.++.+++.+||+.||++|||+.||++.|+
T Consensus 234 ~--~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 234 D--GYRLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred c--CCCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1 1111111 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=303.74 Aligned_cols=251 Identities=17% Similarity=0.245 Sum_probs=183.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|+.+ +++.||+|++....... ....+.+|++++++++||||+++++++...+..+.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv- 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV- 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE-
Confidence 57888999999999999999654 68899999987543222 234677899999999999999999998765543222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 2211 1133478888999999999999999999 999999999999999999999999999986544433
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhhh------hhcc
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIAL------DEML 1030 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~~------~~~~ 1030 (1075)
......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+...... .... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 3444568899999998865 457899999999999999999999996433211100000 0000 0000
Q ss_pred CCCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+...+... ......+.++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00011000 001123446889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=295.04 Aligned_cols=242 Identities=25% Similarity=0.379 Sum_probs=181.3
Q ss_pred CCCCceecccCceEEEEEEECC-CC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-----
Q 042958 817 FDDEHCIGKGGQGSVYKAELAS-GE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----- 888 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 888 (1075)
|.+.+.||+|+||.||+|...+ ++ .||+|.++.... .....+.+..|+++++.++||||++++++|.....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999997653 33 699998875432 23345788999999999999999999998753221
Q ss_pred chhheecCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 889 SLAMILSNN---------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 889 ~l~~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
...++++.. .....+++.....++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 111111111 1123478999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhcc
Q 042958 954 GIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 954 Gla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
|+++.+...... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||....... ..+.+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------IYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHH
Confidence 999876543221 122345678999999999999999999999999999999 888986432211 111111
Q ss_pred CC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1031 DP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1031 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ..+.+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 229 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 229 QGNRLKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred cCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 11111 123345899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=291.57 Aligned_cols=237 Identities=23% Similarity=0.379 Sum_probs=179.2
Q ss_pred eecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc-
Q 042958 822 CIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN- 897 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~- 897 (1075)
.||+|+||.||+|.+. ++..||+|++.... .....+++.+|+.++++++||||+++++++......+.+.+...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCC
Confidence 3899999999999653 35679999986542 23345679999999999999999999999865433333322211
Q ss_pred -------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee---
Q 042958 898 -------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT--- 967 (1075)
Q Consensus 898 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~--- 967 (1075)
.....+++.++++++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...........
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 1234578999999999999999999999 999999999999999999999999999986554332211
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
...++..|+|||++.+..++.++||||||+++||+++ |+.||....... ........ .+... ....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~----~~~~~~ 225 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VMSFIEQG--KRLDC----PAECPP 225 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHHHCC--CCCCC----CCCCCH
Confidence 1223578999999988889999999999999999996 999986433211 00111111 11111 122345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
++.+++.+||+.||++||++.+|.+.|+
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 6899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=297.55 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=184.5
Q ss_pred CCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-ch
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SL 890 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l 890 (1075)
|+..+.||+|+||+||++.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++..... .+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37889999999999987642 4678999999875421 2235678899999999999999999998865432 22
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.++++... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 23322211 123588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc-----h-hhhhhhhhhccCCC
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-----S-LNLNIALDEMLDPR 1033 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-----~-~~~~~~~~~~~~~~ 1033 (1075)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... . ........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 221 12234567799999998888999999999999999999999998643211000 0 00000111111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+ .....+..+.+++.+||+.||++|||+++|++.|+
T Consensus 241 ~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 241 MRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred CCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 1110 11233457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=312.72 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=184.1
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----ch
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----SL 890 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~l 890 (1075)
+|+..+.||+|+||.||+|.. .+|+.||||++..... .....+++.+|+++++.++||||+++++++..... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478889999999999999965 5799999999865322 22335678899999999999999999999876541 11
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++++.. .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 2222111 1235688999999999999999999999 9999999999999999999999999999865433
Q ss_pred CC-ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------------hhhh
Q 042958 963 SS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------NIAL 1026 (1075)
Q Consensus 963 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------~~~~ 1026 (1075)
.. ......+++.|+|||++.+. .++.++||||+||++|||++|+.||............. ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 22 23345678999999998774 47899999999999999999999997543221000000 0000
Q ss_pred hhccCCC-CCCC-----CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPR-LPTP-----SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+... ...+ .........++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000 0000 0011122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=294.84 Aligned_cols=247 Identities=22% Similarity=0.323 Sum_probs=186.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+++.+|++++++++||||+++++++...+.... +
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l-v 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI-C 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE-E
Confidence 4678889999999999999954 578999999986542 23345679999999999999999999999877554322 2
Q ss_pred ecCccc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 894 LSNNAA-----AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 894 ~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
++.... ...+++.....++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++...... ....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~ 152 (279)
T cd06619 78 TEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT 152 (279)
T ss_pred EecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence 222211 23467888899999999999999999 9999999999999999999999999999865432 2234
Q ss_pred cccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 969 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
..|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ..........+...+.. .....+.++
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVL--PVGQFSEKF 229 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCC--CCCcCCHHH
Confidence 578999999999999899999999999999999999999986432211110 00111111111111110 011233468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1049 VEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.+++.+|++.+|++||+++|+++.
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=310.03 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=185.9
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--- 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 888 (1075)
..++|+..+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 457899999999999999999954 46899999998754322 2334678899999999999999999998754331
Q ss_pred --chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 --SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 --~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 12222222211 22467888899999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------------hhhh
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------NIAL 1026 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------~~~~ 1026 (1075)
.. .......+|+.|+|||++.+..++.++||||+||++|||++|+.||............. ....
T Consensus 178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 178 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 32 22234578999999999999999999999999999999999999997433211000000 0000
Q ss_pred hhccCCC----------------CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPR----------------LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+ .+............+.+++.+|++.||.+|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 00000011112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=291.54 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=188.9
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|++|.||+|.. .+++.||+|.+...... ....+++.+|++++++++|||++++++++......+..+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477789999999999999965 46899999998654322 3345789999999999999999999999876544322221
Q ss_pred cC-c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SN-N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~-~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.. . .....+++.++++++.|++.|+.|||+. +++||||||+||+++.++.++++|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 11 1 1134678899999999999999999999 999999999999999999999999999987765444
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ............+.. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~---~~~~ 225 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPV---SQMY 225 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCC---cccc
Confidence 34455788999999999998899999999999999999999999864331 111111222222111 1134
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+.+++.+||+.+|++||++.|+++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 4569999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=311.05 Aligned_cols=247 Identities=19% Similarity=0.247 Sum_probs=184.4
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++......+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999664 68899999986432222233456889999999999999999999987655432
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++++... ....+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|......
T Consensus 120 -lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 -MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred -EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 2222211 123467888899999999999999999 9999999999999999999999999999876533
Q ss_pred CC-ceeccccccCccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC--CC
Q 042958 963 SS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR--LP 1035 (1075)
Q Consensus 963 ~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1035 (1075)
.. ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+.... +.
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~ 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHKNSLN 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCcccC
Confidence 22 223567999999999987543 778999999999999999999999743221 1122222211 11
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHhh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQL 1072 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1072 (1075)
.+ .....+..+.+++..|+..++.+ ||+++|+++.
T Consensus 268 ~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 FP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 11223446888999999855543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=303.05 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=179.8
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|.. .+++.||+|++...........+.+..|+.++.++ +||+|+++++++......+ ++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~-lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF-LVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE-EEEeCCC
Confidence 4699999999999965 46889999999764433334456788999999888 6999999999887655432 2222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF 156 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecc
Confidence 134688999999999999999999999 99999999999999999999999999998644333344556
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... .......+.......+. ..+..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~p~----~~~~~~~ 231 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQVILEKPIRIPR----FLSVKAS 231 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHHHHhCCCCCCC----CCCHHHH
Confidence 799999999999999999999999999999999999999964332111100 01111222222222221 2234588
Q ss_pred HHHHHccCCCCCCCCCHH
Q 042958 1050 EVAISCLDENPESRPTMP 1067 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~ 1067 (1075)
+++.+|+++||++||++.
T Consensus 232 ~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 232 HVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHhccCHHHcCCCC
Confidence 999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=302.78 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=184.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||++++++|...+..+ +
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-I 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE-E
Confidence 478999999999999999999665 68899999886542 2234567999999999999999999999998755432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++++.. ....+++.....++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 222211 1235778888899999999999999742 7999999999999999999999999999765432
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh---------h------------
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN---------L------------ 1022 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~------------ 1022 (1075)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 123356899999999999988999999999999999999999998643211000000 0
Q ss_pred ---------------hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 ---------------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+.....+ .........++.+++.+||++||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPP--KLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCc--cCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000000000 0000112346899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=316.58 Aligned_cols=247 Identities=23% Similarity=0.239 Sum_probs=178.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----- 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 887 (1075)
..+|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 46799999999999999999965 468999999885321 23457999999999999999998764321
Q ss_pred --cchhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEec
Q 042958 888 --HSLAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSD 952 (1075)
Q Consensus 888 --~~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~D 952 (1075)
..+.++++.. .....+++...+.++.||+.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 1121222211 1235678888999999999999999999 999999999999999765 799999
Q ss_pred cccccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------h
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------I 1024 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~ 1024 (1075)
||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.............. .
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998765432 22345789999999988764 689999999999999999999999975332111000000 0
Q ss_pred hhh----hccCCCCCCCCc------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALD----EMLDPRLPTPSC------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~----~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... ...+..++.... .....+.++.+++.+||++||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000001111000 01112356899999999999999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.95 Aligned_cols=242 Identities=24% Similarity=0.391 Sum_probs=185.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
..+|++.++||+|+||.||+|...++..||+|++..... ..+++.+|++++++++||||+++++++......+.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEE
Confidence 356889999999999999999877677899999875322 2357899999999999999999999875543322222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+... .....+++..+..++.|+++||+|+|+. +++||||||+||+++.++.+||+|||.++.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 1111 1123478899999999999999999999 999999999999999999999999999987654332
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCc
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIV 1041 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1041 (1075)
. .....++..|+|||+..+..++.++||||||+++||+++ |+.||...... ......... ..+ ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~----~~ 225 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMP----CP 225 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCCC----Cc
Confidence 1 123346678999999988889999999999999999999 88888633211 111111111 111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+.+..+.+++.+|+++||++||+++++.+.|+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 234557899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=292.59 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=184.3
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.+|++.+.||+|+||.||+|.. ++++.||+|++... ....+++.+|++++++++||||+++++++......+.++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4577889999999999999954 46889999998643 122467889999999999999999999987654432221
Q ss_pred -ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 -LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 -~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+... .....+++..++.++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 1111 1123578999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cce-eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 964 SNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 964 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
... ....++..|+|||++.+..++.++||||||+++|||++ |..||....... ......... +... .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~~~~--~~~~----~ 227 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKGY--RMER----P 227 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCC--CCCC----C
Confidence 211 11234568999999999999999999999999999998 999986432111 111111111 1111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 223456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=304.34 Aligned_cols=186 Identities=25% Similarity=0.353 Sum_probs=156.8
Q ss_pred CCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-c-----CceeeEEEEeecccc
Q 042958 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-H-----RNIVKFYGFCSHVRH 888 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 888 (1075)
+|.+.+.||+|+||.|.+| +.++++.||||+++.. .....+-..|+.+|..++ | -|+|++++||....+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 8899999999999999999 7778999999999853 445667788999999996 4 379999999988777
Q ss_pred chhheec---------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC--CceEecccccc
Q 042958 889 SLAMILS---------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN--EAHVSDFGIAK 957 (1075)
Q Consensus 889 ~l~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfGla~ 957 (1075)
.+.++.. ....-..++....+.|+.||+.||.+||+. +|||+||||+|||+...+ .+||+|||.|+
T Consensus 263 lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 6443310 112234588999999999999999999999 999999999999997654 79999999999
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 1011 (1075)
+....-. ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+
T Consensus 340 ~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 8654322 56778999999999999999999999999999999999776653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=297.20 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=184.9
Q ss_pred hcCCCCCceecccCceEEEEEEECC-----------------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS-----------------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 876 (1075)
..+|++.+.||+|+||.||+|.... +..||+|++.... .....+++.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 4678999999999999999985532 3468999987542 22346789999999999999999
Q ss_pred eeEEEEeeccccchhheecCcc--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 042958 877 VKFYGFCSHVRHSLAMILSNNA--------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDIS 936 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 936 (1075)
+++++++...+..+.++ +... ....+++...+.++.|++.|++|||+. +|+|||||
T Consensus 82 ~~~~~~~~~~~~~~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTVDPPLCMIM-EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred eEEEEEEecCCCcEEEE-ecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99999987754332222 1110 112578999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCcc
Q 042958 937 SKNVLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFI 1012 (1075)
Q Consensus 937 ~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~ 1012 (1075)
|+||+++.++.++++|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999986543322 1223456778999999988889999999999999999998 66777532
Q ss_pred CccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1013 SSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..... .......................+.++.+++.+||+.||++|||+.||++.|+
T Consensus 238 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQV----IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHH----HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21110 00000110000100000011123356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=297.92 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=184.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVR-- 887 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-- 887 (1075)
.+++.|+..+.||+|+||.||+|.. .+++.||+|++..... ...++..|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3567788889999999999999965 4689999999865321 235788999999998 7999999999986532
Q ss_pred ---cchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 888 ---HSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 888 ---~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
..+.++++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 11222222211 134578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
|++..............|+..|+|||++. +..++.++||||+||++|||++|+.||......... .....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~ 230 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR 230 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhc
Confidence 99987654433444567899999999886 345788999999999999999999998643321100 00011
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...... .....+..+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 001111 11123346899999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=290.77 Aligned_cols=241 Identities=27% Similarity=0.443 Sum_probs=184.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.+|++.+.||+|+||.||+|..+++..+|+|.+..... ....+.+|++++++++||||+++++++......+ +++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF-IVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE-EEE
Confidence 45788899999999999999887788899999864322 1357888999999999999999999887655432 222
Q ss_pred cCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 2111 123578999999999999999999999 999999999999999999999999999986543221
Q ss_pred ce-eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 965 NW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 965 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.. ....++..|+|||.+.+..++.++||||||+++||+++ |+.||+.....+. ........ ....+ .
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~----~ 224 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----VESVSAGY--RLYRP----K 224 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHHHcCC--cCCCC----C
Confidence 11 11223457999999998899999999999999999999 8999874332111 11111111 11111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 23456999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=317.57 Aligned_cols=238 Identities=21% Similarity=0.214 Sum_probs=183.9
Q ss_pred CCCCCceecccCceEEEEEEE-CC-CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-AS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.|.+.+.||+|+||.||+|.. .+ ++.||+|.+... .......+..|+.+++.++|||||+++++|...+..+.+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv- 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI- 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE-
Confidence 488889999999999999954 34 678899876432 233346778899999999999999999999776543322
Q ss_pred ecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 894 LSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 894 ~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++... ....+++.+...++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 22211 123477888899999999999999999 99999999999999999999999999998765
Q ss_pred CCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 961 PDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 961 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...............
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~- 291 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPF- 291 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC-
Confidence 4322 23345699999999999999999999999999999999999999864221 111222222222111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||++||++||+++|++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123346899999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=313.09 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=181.0
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|++++++++||||+++++++.+....+ ++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~-lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY-LI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE-EE
Confidence 4788899999999999999954 579999999986532223334567889999999999999999999998765432 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 22221 134577888889999999999999999 999999999999999999999999999964321100
Q ss_pred -----------------------------------------------ceeccccccCccCccccccCCCCcccchHhHHH
Q 042958 965 -----------------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 997 (1075)
Q Consensus 965 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 997 (1075)
.....+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCccccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHhh
Q 042958 998 LALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESR---PTMPKVSQL 1072 (1075)
Q Consensus 998 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 1072 (1075)
++|||++|+.||....... ....+.. ..+..+. ....+.++.+++.+|+. +|.+| +++.|+++.
T Consensus 237 il~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999996432211 1111111 1111111 11233468899999997 66665 599998763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=312.75 Aligned_cols=247 Identities=19% Similarity=0.244 Sum_probs=179.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
...|.+.+.||+|+||.||+|... +++.||||... ...+.+|++++++++|+|||++++++...+..+.+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346889999999999999999654 68899999642 13456899999999999999999988765543322
Q ss_pred eecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+.... .....++|.+++.|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 21111 1123589999999999999999999999 999999999999999999999999999987643322
Q ss_pred --ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh---hhhhhhhhcc--CCCC---
Q 042958 965 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL---NLNIALDEML--DPRL--- 1034 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~--~~~~--- 1034 (1075)
......||..|+|||++.+..++.++|||||||++|||++|..|+........... .....+.... ...+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 12235699999999999999999999999999999999998876432211100000 0000000000 0000
Q ss_pred ------------------CC-CCcCcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1035 ------------------PT-PSCIVQ---DKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1035 ------------------~~-~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+. ....+. .....+.+++.+|++.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000 122368899999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=309.20 Aligned_cols=240 Identities=22% Similarity=0.272 Sum_probs=184.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||+|+++..........+.+.+|+.+++.++||||+++++++...... +++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~-~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL-YLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeE-EEE
Confidence 4688899999999999999955 47999999998764333334456788999999999999999999988765443 222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 22211 124678889999999999999999999 99999999999999999999999999998765443
Q ss_pred Cc-eeccccccCccCccccc------cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC----C
Q 042958 964 SN-WTELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD----P 1032 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~ 1032 (1075)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+.. .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~ 228 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRFL 228 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCcc
Confidence 32 23357899999999986 4567889999999999999999999996432211 1111111 1
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++.. ...+..+.+++.+|++ +|++|||++++++
T Consensus 229 ~~~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11211 1233468899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=303.00 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=187.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
-|.+...+|.|+||.||+|..+ ++-..|-|++... +.+..++|.-|+++++...||+||++++.|+..+..+.++.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3455677999999999999554 4556777887543 33346789999999999999999999987666555444443
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+..+ -+..+...++.-+++|++.||.|||+. .|||||||+.|||++-+|.++++|||.+.........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 3222 245689999999999999999999999 9999999999999999999999999998765444445
Q ss_pred eeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 966 WTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
...+.|||+|||||+.. ..+|+.++||||||+++.||..+.+|......+. .-..+..--.+.+..|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----VllKiaKSePPTLlqP--- 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPPTLLQP--- 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----HHHHHhhcCCCcccCc---
Confidence 66789999999999864 5689999999999999999999999986443321 1111222222333333
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..-...+.+++++|+.++|..||+++++++
T Consensus 259 -S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 -SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 233446999999999999999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=319.64 Aligned_cols=253 Identities=17% Similarity=0.242 Sum_probs=179.7
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc------CceeeEEE
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH------RNIVKFYG 881 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~ 881 (1075)
++....++|++.+.||+|+||.||+|.. .+++.||||+++... ....++..|+++++.++| .+++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3444568899999999999999999955 468899999986421 123445667777766654 45889999
Q ss_pred EeeccccchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCC------
Q 042958 882 FCSHVRHSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDN------ 946 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~------ 946 (1075)
++......++++++..+ ....+++.....|+.||+.||+|||+ . +||||||||+||+++.++
T Consensus 199 ~~~~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 199 YFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EEEcCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 88765444333333221 23458889999999999999999997 5 899999999999998765
Q ss_pred ----------CceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc
Q 042958 947 ----------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 1016 (1075)
Q Consensus 947 ----------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 1016 (1075)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999886432 22345679999999999999999999999999999999999999997543221
Q ss_pred cchhhhh---------------hhhhhccCC--CCC---CC----------CcCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1017 SSSLNLN---------------IALDEMLDP--RLP---TP----------SCIVQDKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1017 ~~~~~~~---------------~~~~~~~~~--~~~---~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
....... .....+.+. .+. .+ ..........+.+|+.+|++.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 0000000 000000000 000 00 00000113457899999999999999999
Q ss_pred HHHHh
Q 042958 1067 PKVSQ 1071 (1075)
Q Consensus 1067 ~evl~ 1071 (1075)
+|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=304.53 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=182.0
Q ss_pred CCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
+|++.+.||+|+||.||+++. .+++.||+|++..... ......+.+..|+.+++.+ +||+|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999854 3688999999864321 1222345688999999999 599999999988765443
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+ ++++... ....+++.+...++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~-lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 H-LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred E-EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 2 2222211 234578899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC-ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 961 PDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 961 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .....+.....+.+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~~~~~~~~~~~~~~- 231 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS----EVSRRILKCDPPFP- 231 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH----HHHHHHhcCCCCCC-
Confidence 3322 23345799999999998865 47889999999999999999999996433211111 11111221111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
...+..+.+++.+|++.||++|| +++|+++
T Consensus 232 ---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 232 ---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 12334689999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.46 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=182.5
Q ss_pred CCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
+|++.+.||+|+||.||+|... ....||+|.+.... .....+++.+|+.+++.++||||++++++|......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999999542 23578999886542 223356789999999999999999999988765443
Q ss_pred hhheecCc---------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 042958 890 LAMILSNN---------------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDIS 936 (1075)
Q Consensus 890 l~~~~~~~---------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 936 (1075)
+.++ +.. .....+++...+.++.|++.|++|||+. +++|||||
T Consensus 79 ~lv~-e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 79 LLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred EEEE-EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 2221 111 1123478899999999999999999999 99999999
Q ss_pred CCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccC
Q 042958 937 SKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFIS 1013 (1075)
Q Consensus 937 ~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~ 1013 (1075)
|+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865433221 122345678999999988889999999999999999998 999986432
Q ss_pred ccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1014 SMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... ......... +.+.+ ...+..+.+++.+||+.+|++||+++|+++.|+
T Consensus 235 ~~~-----~~~~~~~~~--~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 235 PER-----LFNLLKTGY--RMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHH-----HHHHHhCCC--CCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 211 011111111 11111 223346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=303.70 Aligned_cols=231 Identities=22% Similarity=0.290 Sum_probs=173.7
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHH-HHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|+. .+|+.||+|++.............+..|.. +++.++||||+++++++.+.+..+. +++...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~l-v~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYF-VLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEE-EEcCCC
Confidence 4699999999999966 468999999986532222222345555554 5788999999999998876554322 222211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+...+...++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccc
Confidence 134567888888999999999999999 99999999999999999999999999998643333334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.......+ ......+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~----~~~~~~~~ 224 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKPLQLP----GGKTVAAC 224 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCCCCCC----CCCCHHHH
Confidence 789999999999998999999999999999999999999964321 111222222222222 12334689
Q ss_pred HHHHHccCCCCCCCCCHH
Q 042958 1050 EVAISCLDENPESRPTMP 1067 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~ 1067 (1075)
+++.+|++.||.+||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=305.88 Aligned_cols=231 Identities=23% Similarity=0.282 Sum_probs=174.9
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHH-HHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|.. .+|+.||+|++............++..|.. +++.++||||+++++++...+..+.+ ++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv-~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV-LDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE-EcCCC
Confidence 4699999999999955 579999999986532222223345556655 46778999999999988765543322 22211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccc
Confidence 234678889999999999999999999 99999999999999999999999999997644333344456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+. ..+..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~ 224 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKPLVLRP----GASLTAW 224 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCCccCCC----CCCHHHH
Confidence 7999999999999999999999999999999999999999643211 111222222221111 2334588
Q ss_pred HHHHHccCCCCCCCCCHH
Q 042958 1050 EVAISCLDENPESRPTMP 1067 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~ 1067 (1075)
+++.+|+++||.+||++.
T Consensus 225 ~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 225 SILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHhccCHHhcCCCC
Confidence 999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=294.95 Aligned_cols=237 Identities=24% Similarity=0.293 Sum_probs=177.4
Q ss_pred ecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc---
Q 042958 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA--- 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~--- 898 (1075)
||+|+||.||++.. .+|+.||+|++.............+..|++++++++||||+++++++......+ ++++...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~-lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLC-LVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEE-EEEecCCCCC
Confidence 69999999999965 469999999986432222222345667999999999999999999887655432 2222111
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... .......
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 123478888899999999999999999 9999999999999999999999999999876533 2233457
Q ss_pred cccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHH
Q 042958 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 971 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1050 (1075)
|+..|+|||++.+..++.++||||+||++|||++|+.||........ ................ ....+.++.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDEVKFE---HQNFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccccccc---cccCCHHHHH
Confidence 89999999999988899999999999999999999999864321110 1111112222222111 1123456899
Q ss_pred HHHHccCCCCCCCCCHHHHHh
Q 042958 1051 VAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++.+||++||++||+++|+++
T Consensus 229 li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHhccCHhhCCCCccchh
Confidence 999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=307.15 Aligned_cols=254 Identities=20% Similarity=0.311 Sum_probs=183.5
Q ss_pred HHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
....++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|++++++++||||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34567899999999999999999954 5789999999875432 222345678999999999999999999877543211
Q ss_pred -----hhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 890 -----LAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 890 -----l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
.++.+... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 11111111 1234588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhh----
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIA---- 1025 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~---- 1025 (1075)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||............. ...
T Consensus 167 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred ecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75432 234578999999999876 468899999999999999999999996432211000000 000
Q ss_pred ----hhhccC--CCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 ----LDEMLD--PRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ----~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...... +..+.. ..........+.+++.+|++.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000 0000112235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=298.04 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=178.2
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeeccc----
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHVR---- 887 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~---- 887 (1075)
+|++.+.||+|+||.||+|.. .+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 478889999999999999955 478999999987543222 1123455677776665 7999999999876432
Q ss_pred cchhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 888 HSLAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 888 ~~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
..+.++++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 1122222211 1123478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hhh-h--
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IAL-D-- 1027 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~~-~-- 1027 (1075)
...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||.............. ... .
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 765322 22345688999999999988999999999999999999999999864322110000000 000 0
Q ss_pred ----hccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 ----EMLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ----~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+ ..........+.+++.+|+++||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 0011123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=292.40 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=185.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++......+ +
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~-i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW-I 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE-E
Confidence 35799999999999999999965 5789999999864321 22456889999999999999999999987654432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.++..++.|+++|+.|||+. +|+|||+||+||+++.++.+||+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 222211 234578889999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC-Cc
Q 042958 964 SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SC 1039 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1039 (1075)
.......|+..|+|||.+. ...++.++||||+|+++|||++|+.||......... ..+....+..+ ..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 232 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSKSNFQPPKLK 232 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eeeecCCCCCCCCc
Confidence 3334456889999999874 345788999999999999999999998533221100 01111111111 00
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
.....+..+.+++.+||+.||++|||++++++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112345799999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.69 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=187.4
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|++|.||++.. .+++.||+|++...... ....+.+..|++++++++|+|++++++++...+..+.+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 478889999999999999954 46889999998654322 2335678899999999999999999988764443332222
Q ss_pred cCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 895 SNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 895 ~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+... ....+++.++.+++.|++.|++|||+. +++||||||+||+++.++.++|+|||++..+....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 2111 134578999999999999999999999 99999999999999999999999999998775444
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......+++.|+|||+..+..++.++||||+|+++||+++|+.||+..... ...........+. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~ 225 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIEGKLPP---MPKD 225 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCC---Cccc
Confidence 4444567889999999999999999999999999999999999998632211 1111111222211 1223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+.+++.+||+.||++||++.|+++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4457999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=290.20 Aligned_cols=241 Identities=23% Similarity=0.412 Sum_probs=185.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
++|.+.+.||+|+||.||+|....+..||+|++.... ...+.+.+|++++++++|||++++++++......+.+..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEc
Confidence 5688889999999999999988777789999876432 124678899999999999999999998765433222211
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 111 1123478899999999999999999999 9999999999999999999999999999876443221
Q ss_pred -eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCcH
Q 042958 966 -WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIVQ 1042 (1075)
Q Consensus 966 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1042 (1075)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||....... ....+... ..+. ..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~~ 226 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGYRMPC----PQ 226 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC----Cc
Confidence 122345678999999998889999999999999999999 899986432211 11111111 1111 12
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||++||++||++++|.+.|+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 34557999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=301.71 Aligned_cols=235 Identities=26% Similarity=0.390 Sum_probs=183.7
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCccc
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAA 899 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~~ 899 (1075)
-++|+|.||+||-|+. .+...+|||.+..... ...+-+..|+..-++++|+|||+++|.|.+.+ ++.++++...+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCC
Confidence 3699999999999954 5667899999865322 22456889999999999999999999987755 44444443332
Q ss_pred c----------CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEeccccccccCCCCCce
Q 042958 900 A----------KDL--GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 900 ~----------~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
+ +++ .+...-.+.+||++||.|||+. .|||||||.+||+++ ..|.+||+|||-++.+..-....
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 2 233 4556667889999999999999 999999999999996 57899999999999887666667
Q ss_pred eccccccCccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 967 TELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
.+..||..|||||++..+ .|..++|||||||++.||.||++||.........-. .-.+.... +..+.+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-----kVGmyKvH----P~iPeel 804 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-----KVGMYKVH----PPIPEEL 804 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-----hhcceecC----CCCcHHH
Confidence 778999999999999754 588999999999999999999999975443221110 01111111 2245677
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.+...+|.+|+.+||.+||++.++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 788999999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.27 Aligned_cols=237 Identities=24% Similarity=0.405 Sum_probs=179.7
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc--
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN-- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~-- 897 (1075)
+.||+|+||.||+|.. .+++.||+|.+.... ..+....+.+|++++++++||||++++++|......+.+ ++..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv-~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV-MELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE-EeeccC
Confidence 3699999999999965 479999999876432 233457799999999999999999999998765543222 2211
Q ss_pred --------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce--e
Q 042958 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--T 967 (1075)
Q Consensus 898 --------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~ 967 (1075)
.....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++.......... .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 1133578999999999999999999999 99999999999999999999999999997654321111 1
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....+..|+|||.+.+..++.++||||+|+++|||++ |..||....... ........ ...+. ....+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~--~~~~~----~~~~~~ 223 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQG--VRLPC----PELCPD 223 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcC--CCCCC----cccCCH
Confidence 1123467999999998889999999999999999998 888886332211 11111111 11111 122345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+.+++.+|++++|++|||+.||.++|+
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 6899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=304.97 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=183.7
Q ss_pred hcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 886 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46799999999999999999953 3578999999875432 22346788999999999 789999999988655
Q ss_pred ccchhheecCcc--------------------------------------------------------------------
Q 042958 887 RHSLAMILSNNA-------------------------------------------------------------------- 898 (1075)
Q Consensus 887 ~~~l~~~~~~~~-------------------------------------------------------------------- 898 (1075)
+..+.+++++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 443322221110
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc--eec
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTE 968 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~ 968 (1075)
....+++.++.+++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012367888899999999999999999 9999999999999999999999999999875433221 122
Q ss_pred cccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 969 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
..++..|+|||.+.+..++.++||||||+++|||++ |..||........ ........ ...+.+.. ...+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~--~~~~~~~~----~~~~ 310 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEG--TRMRAPDY----TTPE 310 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhcc--CCCCCCCC----CCHH
Confidence 345678999999988889999999999999999997 9999864322110 00111111 11111111 2235
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1048 IVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+++..||+.||++|||+.||++.|+
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=292.01 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=183.7
Q ss_pred CCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 817 FDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
|++.+.||+|+||.||+|... .+..||+|+++..... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999654 2478999998754322 2335678999999999999999999998865443
Q ss_pred -chhheecCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 889 -SLAMILSNN---------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 889 -~l~~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
...+++++. .....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 111111111 1123578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc
Q 042958 953 FGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 953 fGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
||.++.+...... .....++..|+|||++.+..++.++||||||+++|||++ |..||....... ..+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHH
Confidence 9999876543322 112235678999999988889999999999999999999 889986433211 11122
Q ss_pred cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....... .....+..+.+++.+||+.||++|||+.||++.|+
T Consensus 229 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 229 RHGNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HcCCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2111111 11233456999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.09 Aligned_cols=241 Identities=21% Similarity=0.292 Sum_probs=186.7
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|+||.||++.. .+++.||+|.++.... ....+.+..|+.+++.++||||+++++++......+..+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 477889999999999999955 4789999999865422 2235678899999999999999999999876654432221
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
... .....+++...+.++.|+++|+.|||+. +|+|+||||+||+++.++.++++|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 111 1233578888999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||+..... ............. .....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~---~~~~~ 224 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQGSYKP---LPSHY 224 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhcCCCCC---CCccc
Confidence 334567889999999999888999999999999999999999999742211 1111111111111 11223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+..+.+++.+||+.||++||++.|++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 4468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=296.08 Aligned_cols=242 Identities=24% Similarity=0.440 Sum_probs=185.1
Q ss_pred cCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.+|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 45777899999999999999542 3567999998643 22334678999999999999999999999876554
Q ss_pred chhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 889 SLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 889 ~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
.+.++ +... ....+++..+++++.|++.|++|||++ +|+||||||+||+++
T Consensus 82 ~~lv~-e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 LIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred eEEEE-ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 32221 1110 123478999999999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 1020 (1075)
.++.++|+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 232 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----- 232 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999986544321 1223456788999999999999999999999999999998 99998643221
Q ss_pred hhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1021 NLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.+.....+.. ....+..+.+++.+||++||++||+++||+++|+
T Consensus 233 ---~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 233 ---EVIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred ---HHHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 11122222222111 1123456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=304.41 Aligned_cols=232 Identities=22% Similarity=0.245 Sum_probs=172.9
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHH-HHHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 821 HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEV-KALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
+.||+|+||.||+|... +++.||+|++.............+..|. .+++.++||||+++++++...+..+. +++...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~l-v~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF-VLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEE-EEeCCC
Confidence 46999999999999654 6789999998643211122223444444 45678899999999998876554322 222221
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+...+...++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccc
Confidence 123467778888999999999999999 99999999999999999999999999998654433444556
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+ ...+..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~----~~~~~~~~ 224 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLK----PNITNSAR 224 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCcCCC----CCCCHHHH
Confidence 7999999999999999999999999999999999999999643221 11112222222111 12334689
Q ss_pred HHHHHccCCCCCCCCCHHH
Q 042958 1050 EVAISCLDENPESRPTMPK 1068 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~e 1068 (1075)
+++.+|+++||.+||++.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHcccCHHHCCCCCC
Confidence 9999999999999998874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=289.95 Aligned_cols=239 Identities=27% Similarity=0.417 Sum_probs=187.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +++.||+|.+.... ..+++.+|++++++++||||+++++++......+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~- 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV- 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE-
Confidence 67889999999999999999766 48899999986431 157899999999999999999999998776443222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++...+.++.|+++|+.|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 22111 245679999999999999999999999 99999999999999999999999999998766544
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......++..|+|||++.+..++.++||||||+++|||++|+.||......... ............ ....
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~----~~~~ 224 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FMIPNKPPPTLS----DPEK 224 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hhhccCCCCCCC----chhh
Confidence 3334456889999999999889999999999999999999999998743221100 000000011111 1223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.+++.+||+.||++|||+.||++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3456899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=295.74 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=182.5
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee-
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL- 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~- 894 (1075)
|+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|+++++.++|+||+++.+++...+..+..+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999955 5789999999865433333334567889999999999999999988876554322221
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++.....++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ES 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cc
Confidence 111 1123588999999999999999999999 9999999999999999999999999999765432 22
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....|+..|+|||++.+..++.++|+||+|+++|||++|+.||........ .............. ......
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~ 229 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEV----YSAKFS 229 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccc----cCccCC
Confidence 2345789999999999988999999999999999999999999964322110 01111111111111 112234
Q ss_pred HHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
..+.+++..|++.||++||+ ++|+++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 46889999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.35 Aligned_cols=235 Identities=21% Similarity=0.290 Sum_probs=179.4
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+|+..+.||+|+||.||+|.. .+|+.||+|++...........+.+..|..+++.+. |++|+++++++...+.. .++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~-~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL-YFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEE-EEE
Confidence 477789999999999999965 478999999987532222233456788999988885 57788888887665433 222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 22221 224688999999999999999999999 999999999999999999999999999986544333
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~----~~ 224 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK----SL 224 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----cC
Confidence 34456799999999999998999999999999999999999999974322 1112222222222221 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCH
Q 042958 1045 LISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
+.++.+++.+|+++||.+|++.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCC
Confidence 3468899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=299.97 Aligned_cols=184 Identities=20% Similarity=0.345 Sum_probs=145.5
Q ss_pred CceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chhheec
Q 042958 820 EHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLAMILS 895 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~~~~~ 895 (1075)
..+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++..... .+.++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 357999999999999764 457899999864321 2467789999999999999999998854322 2212111
Q ss_pred Cc-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee----CCCCCceEeccc
Q 042958 896 NN-----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL----DFDNEAHVSDFG 954 (1075)
Q Consensus 896 ~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfG 954 (1075)
.. .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 11 1123478888999999999999999999 99999999999999 566789999999
Q ss_pred cccccCCCCC---ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCc
Q 042958 955 IAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 1011 (1075)
Q Consensus 955 la~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~ 1011 (1075)
+++....... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9987654322 22345689999999998764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=294.44 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=187.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......+.+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 35788889999999999999964 57899999998654322 246788999999999999999999988765443222
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 96 -~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 -MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred -ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 21111 123478889999999999999999999 999999999999999999999999999887654433
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ........... .......
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~--~~~~~~~ 242 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPE--LQNPEKL 242 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------HHHHhcCCCCC--CCCcccc
Confidence 33445788999999999988899999999999999999999999964332110 00111111110 0112234
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+.+++.+||.+||++||++.|+++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 4568999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=310.89 Aligned_cols=241 Identities=20% Similarity=0.258 Sum_probs=178.4
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+....+ +++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~-lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY-FVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEE-EEE
Confidence 578889999999999999955 578999999986533223344567899999999999999999999988755432 222
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC--
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-- 963 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-- 963 (1075)
+... ....+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 2211 124567888888999999999999999 99999999999999999999999999975331100
Q ss_pred ---------------------------------------------CceeccccccCccCccccccCCCCcccchHhHHHH
Q 042958 964 ---------------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998 (1075)
Q Consensus 964 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~v 998 (1075)
......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCccCccccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHh
Q 042958 999 ALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT---MPKVSQ 1071 (1075)
Q Consensus 999 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1071 (1075)
+|||++|+.||....... ....+.. .....+. ....+.+..+++.+++ .+|++|++ ++|+++
T Consensus 238 l~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE--------TQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHH--------HHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999997432211 1111111 1111111 1122345777777765 59999997 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.20 Aligned_cols=251 Identities=20% Similarity=0.232 Sum_probs=183.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++......+..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4788899999999999999664 7999999998654322 2234678899999999999999999999876554322221
Q ss_pred cC----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SN----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.. ......+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 11 11225688999999999999999999999 999999999999999999999999999986654433
Q ss_pred ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh----------------hhhhh
Q 042958 965 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL----------------NIALD 1027 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------------~~~~~ 1027 (1075)
......+++.|+|||++.+. .++.++||||+|+++|||++|+.||............. .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 33445678999999987654 47889999999999999999999987432211000000 00000
Q ss_pred hccCCCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.... ..... .......+.++.+++.+||+.||++|||+.||++
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFP-KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhcc-ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000 0001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=293.75 Aligned_cols=242 Identities=25% Similarity=0.424 Sum_probs=184.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
..+|+..++||+|+||.||+|... ++..||+|.+... .....+.+.+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 356788899999999999999532 4668999987643 2334568999999999999999999999887654
Q ss_pred cchhheecCcc------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 888 HSLAMILSNNA------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 888 ~~l~~~~~~~~------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
..+.. ++... ....+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 81 ~~~lv-~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 81 PLLMV-FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred ceEEE-EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 43222 11110 013478999999999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 1020 (1075)
+++.+||+|||+++.+...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 232 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---- 232 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----
Confidence 9999999999999765432211 122335678999999999999999999999999999998 899985322211
Q ss_pred hhhhhhhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1021 NLNIALDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......... ...+ ...+..+.+++.+||+.||.+||+++||.+.|+
T Consensus 233 ----~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 ----AIECITQGRELERP----RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HHHHHHcCccCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 1111 123446899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=290.10 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=185.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCc--hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGE--MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
++|+..+.||+|++|.||+|.. .++++||+|.+....... ....+.+.+|++++++++||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~- 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS- 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE-
Confidence 5688999999999999999954 578999999986543221 223457889999999999999999999987765332
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+++... ....+++....+++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 2222111 134567888899999999999999999 9999999999999999999999999999765432
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
... .....++..|+|||++.+..++.++||||+|+++||+++|+.||....... ........... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~--~~ 227 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTN--PQ 227 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccCCC--CC
Confidence 211 123467889999999999889999999999999999999999986432211 01111111110 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
........+.+++.+||..+|++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 122334468999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=292.02 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=182.1
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++......+..+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 566788999999999999654 5788999988543 233456788999999999999999999988765543222211
Q ss_pred Cc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 896 NN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 896 ~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.. .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++..........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 10 1134588999999999999999999999 99999999999999999999999999997654433333
Q ss_pred eccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 967 TELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
....++..|+|||++. +..++.++||||+||++|||++|+.||....... ..........+....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~---- 231 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPPTLAQP---- 231 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHhhcCCCCCCCc----
Confidence 4457899999999874 4457789999999999999999999986433211 0001111111111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+||+.||.+||+++++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223456999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=294.16 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=183.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-----------------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-----------------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 876 (1075)
.++|++.+.||+|+||.||++... ++..||+|++.... ......++.+|+++++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 356899999999999999998532 23469999987542 23345789999999999999999
Q ss_pred eeEEEEeeccccchhheecCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 042958 877 VKFYGFCSHVRHSLAMILSNN--------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDIS 936 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 936 (1075)
+++++++...+..+.+ ++.. .....+++.+..+++.|++.|++|||+. +++|||||
T Consensus 82 ~~~~~~~~~~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 82 IRLLAVCITSDPLCMI-TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred ceEEEEEecCCccEEE-EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 9999998765443222 1111 0112467888999999999999999999 99999999
Q ss_pred CCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCcc
Q 042958 937 SKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFI 1012 (1075)
Q Consensus 937 ~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~ 1012 (1075)
|+||+++.++.++++|||+++.+...... .....+++.|+|||+..+..++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999866443221 122334678999999888889999999999999999998 77887643
Q ss_pred Cccccchhhhhhhhhhc-cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1013 SSMSSSSLNLNIALDEM-LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......... ....... .....+.+ ..++..+.+++.+||+.||++||++.||.+.|+
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENT-GEFFRDQGRQVYLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHHHHHH-HHHHhhccccccCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 221111100 0000000 01111111 123356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=295.87 Aligned_cols=253 Identities=20% Similarity=0.232 Sum_probs=176.8
Q ss_pred hcCCCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhH--------HHHHHHHHHHHhcCCcCceeeEEE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTF--------QQEFLNEVKALTEIRHRNIVKFYG 881 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~ 881 (1075)
..+|.+.+.||+|+||.||+|...+ +..+|+|+........... ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999997653 4566777643321110000 011233445566779999999998
Q ss_pred Eeeccccch---hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 882 FCSHVRHSL---AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 882 ~~~~~~~~l---~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
++....... .+.+... ......++.....++.|+++|++|||+. +|+||||||+||+++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 765433211 1111110 1112356777889999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc-chhhh
Q 042958 951 SDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS-SSLNL 1022 (1075)
Q Consensus 951 ~DfGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-~~~~~ 1022 (1075)
+|||+|+.+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999987643221 11234699999999999999999999999999999999999999975532111 11011
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......+..++...+ ..+..+.+++..||..+|++||+++++++.++
T Consensus 248 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFIKRLHEGKIKIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhhhhhhccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111122222222211 22456999999999999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=291.40 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=186.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 467888999999999999999653 24689999986432 2233567889999999999999999999987654
Q ss_pred cchhheecCcc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCc
Q 042958 888 HSLAMILSNNA-------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEA 948 (1075)
Q Consensus 888 ~~l~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 948 (1075)
..+.+ ++... ....++|.+++.++.|++.|+.|||+. +|+||||||+||+++.++.+
T Consensus 83 ~~~~v-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 83 PTLVV-MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CcEEE-EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 43222 22111 122467889999999999999999999 99999999999999999999
Q ss_pred eEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhh
Q 042958 949 HVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIA 1025 (1075)
Q Consensus 949 kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 1025 (1075)
||+|||+++.+..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------V 230 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------H
Confidence 9999999986544321 1223456789999999988889999999999999999998 999986332211 1
Q ss_pred hhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1026 LDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1026 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ ...+. ..+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111211 11111 22456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=287.85 Aligned_cols=238 Identities=26% Similarity=0.417 Sum_probs=180.0
Q ss_pred ceecccCceEEEEEEEC-C---CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAELA-S---GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
++||+|+||.||+|... . +..||+|.+...... ...+++..|+++++.+.||||+++++++......+.+....
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCC
Confidence 46999999999999543 2 368999998754322 34578999999999999999999999886544332222211
Q ss_pred cc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec-
Q 042958 897 NA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE- 968 (1075)
Q Consensus 897 ~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~- 968 (1075)
.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++...........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 11 223578999999999999999999999 9999999999999999999999999999876544332211
Q ss_pred --cccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 969 --LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 969 --~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
..++..|+|||...+..++.++||||||+++|||++ |+.||........ ....... ...+. ....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~-----~~~~~~~--~~~~~----~~~~~ 224 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-----IAMLESG--ERLPR----PEECP 224 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHHHHcC--CcCCC----CCCCC
Confidence 123467999999998899999999999999999998 9999874332111 1111111 11111 12234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.+++.+||..+|++||++.||++.|+
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 56899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=307.47 Aligned_cols=251 Identities=18% Similarity=0.237 Sum_probs=185.9
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
.++....++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999664 6889999998643222223345688999999999999999999988765
Q ss_pred ccchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 887 RHSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 887 ~~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
... .++++... ....++...+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 116 ~~~-~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYL-YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred CEE-EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 443 22222211 123467788888999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ceeccccccCccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC-
Q 042958 959 LKPDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP- 1032 (1075)
Q Consensus 959 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1032 (1075)
...... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+...
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~ 263 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHK 263 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC
Confidence 654322 223567999999999987543 788999999999999999999999743221 111222211
Q ss_pred -CCCCCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHhh
Q 042958 1033 -RLPTPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQL 1072 (1075)
Q Consensus 1033 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1072 (1075)
.+..+ .....+..+.+++.+|+..++.+ ||+++|+++.
T Consensus 264 ~~~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSLTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CcccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111 11234456889999999844433 7899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=294.23 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=182.3
Q ss_pred hcCCCCCceecccCceEEEEEEECC---------------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS---------------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 878 (1075)
..+|++.+.||+|+||.||++.... ...||+|++.... .......|.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 3578899999999999999985432 2358999987542 2334567999999999999999999
Q ss_pred EEEEeeccccchhheecCcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 042958 879 FYGFCSHVRHSLAMILSNNA---------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937 (1075)
Q Consensus 879 l~~~~~~~~~~l~~~~~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 937 (1075)
+++++......+ ++++... ....+++.++++++.|+++|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~-lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 82 LLGVCVSDDPLC-MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred EEEEEcCCCccE-EEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 999987654432 2222111 012368889999999999999999999 999999999
Q ss_pred CCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCccC
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS 1013 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~ 1013 (1075)
+||+++.++.+||+|||++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999999865433211 122345678999999988889999999999999999998 566775432
Q ss_pred ccccchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1014 SMSSSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...... ...+.... ............+..+.+++.+||+.||++||++++|++.|+
T Consensus 238 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIE-----NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHH-----HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 211100 00000000 000000011123346999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=297.33 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=185.0
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|+..+.||+|+||+||++... +++.||+|++........ .......|+.++++++||||+++++++......+.++-.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 556789999999999999665 567899999986532222 223445699999999999999999999875544322211
Q ss_pred -Cc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 896 -NN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 896 -~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. .....+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||.+..+........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 11 1246688999999999999999999999 999999999999999999999999999987543444555
Q ss_pred ccccccCccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 968 ELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
...++..|+|||++. +..++.++||||+|+++|+|++|+.||........ ........................
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-----LEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-----HHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhh-----hhhhhhcccccccccccccchhHH
Confidence 677899999999998 88899999999999999999999999975411111 111111111000000000111125
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+.+++.+|++.||++||++.|+++
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 7999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=287.29 Aligned_cols=239 Identities=23% Similarity=0.367 Sum_probs=192.7
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.-|...+.||+|.|..|-.|++ -+|+.||||++.+....+.. ..++.+|++.|+-++|||||++|++.......+ .+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly-Li 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY-LI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEE-EE
Confidence 4577778899999999999954 48999999999876654433 567889999999999999999999875544322 22
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEeccccccccCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~ 962 (1075)
++-.. ....+.+.-..+++.||+.|+.|.|+. .||||||||+||.+- .-|-+|+.|||++-.+.+.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 22111 233467788899999999999999999 899999999998764 5678999999999887754
Q ss_pred CCceeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
....+.+|+..|-|||.+.+..|+ +++||||+||++|-+++|+.||+...+ .+.+-.++|=++..|
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND--------SETLTmImDCKYtvP---- 239 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND--------SETLTMIMDCKYTVP---- 239 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc--------hhhhhhhhcccccCc----
Confidence 455678999999999999998887 688999999999999999999974332 334455556555543
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.++.++|..|+..||++|.+.+||+.
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 455667999999999999999999999874
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=311.61 Aligned_cols=243 Identities=20% Similarity=0.237 Sum_probs=179.2
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|+||.||+|+. .+++.||||++...........+.+.+|++++++++||||+++++++.+.+..+ +++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~-lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY-FVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE-EEE
Confidence 688899999999999999954 468999999986432222233467889999999999999999999987755432 222
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC--
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-- 963 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-- 963 (1075)
+... ....++......++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 2221 134467788888999999999999999 99999999999999999999999999975331000
Q ss_pred -----------------------------------------CceeccccccCccCccccccCCCCcccchHhHHHHHHHH
Q 042958 964 -----------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 1002 (1075)
Q Consensus 964 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~el 1002 (1075)
.......||+.|+|||++.+..++.++||||+||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 001134699999999999999999999999999999999
Q ss_pred HhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHh
Q 042958 1003 IKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRP---TMPKVSQ 1071 (1075)
Q Consensus 1003 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 1071 (1075)
++|+.||......... ...... ......+ .....+..+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 238 l~G~~Pf~~~~~~~~~-----~~i~~~-~~~~~~~--~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 238 LVGQPPFLADTPAETQ-----LKVINW-ETTLHIP--SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhCCCCCCCCCHHHHH-----HHHhcc-CccccCC--CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999743321110 001100 0111111 11123345778888876 5999999 8898875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=285.12 Aligned_cols=237 Identities=24% Similarity=0.387 Sum_probs=181.3
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc---
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN--- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~--- 897 (1075)
++||+|+||.||+|...++..||+|++.... .......+.+|++++++++||||+++++++......+. +++..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l-v~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI-VMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE-EEECCCCC
Confidence 3689999999999988889999999987543 22334578899999999999999999999876554322 22211
Q ss_pred -------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce-ecc
Q 042958 898 -------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW-TEL 969 (1075)
Q Consensus 898 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~ 969 (1075)
.....+++..++.++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++.......... ...
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 1133578999999999999999999999 99999999999999999999999999997644322111 122
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
.++..|+|||+..+..++.++||||||+++||+++ |..||....... ......... +... ....+..+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~--~~~~----~~~~~~~~ 223 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGY--RMSC----PQKCPDDV 223 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCC--CCCC----CCCCCHHH
Confidence 34578999999998889999999999999999998 999986432211 111111111 1111 11234569
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1049 VEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+++.+|++.+|++||++.|+++.|+
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=293.21 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=183.5
Q ss_pred cCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH- 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 888 (1075)
..|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4688889999999999999964 35889999998643 23345688999999999999999999998754332
Q ss_pred chhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 889 SLAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 889 ~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
.+.++++.. .....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 222222211 1123578999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce---eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccch-------hhhhhhhhh
Q 042958 959 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS-------LNLNIALDE 1028 (1075)
Q Consensus 959 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~ 1028 (1075)
........ ....++..|+|||+..+..++.++||||||+++|||++|..|+.......... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 65433221 11223456999999998889999999999999999999887754221110000 000000111
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........+ .....+..+.+++.+||+.+|++||||+||++.|+
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 238 LLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 111111100 11223456999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=306.81 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=182.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
..+|.+.+.||+|+||.||++... +++.||+|.+... ..+.+|++++++++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 457999999999999999999543 4678999987542 23468999999999999999999887654332
Q ss_pred hheecC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 891 AMILSN-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 891 ~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
.++... ......+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 163 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 221110 12345689999999999999999999999 99999999999999999999999999998665432
Q ss_pred Cc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh--------------------
Q 042958 964 SN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------------------- 1021 (1075)
Q Consensus 964 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------------------- 1021 (1075)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 23457999999999999999999999999999999999999998643321100000
Q ss_pred -hhhhhhhcc---CCCCCCCCc-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 -LNIALDEML---DPRLPTPSC-IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 -~~~~~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......... .+....+.. .......++.+++.+|+..||++|||+.|++.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 000110000 00122346889999999999999999999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=293.68 Aligned_cols=245 Identities=26% Similarity=0.438 Sum_probs=183.6
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......++.+|+.+++.++||||++++|+|.....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCc
Confidence 46778889999999999999965 3454 57889876432 22334578899999999999999999999876443
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+.+... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 322222111 1123578889999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....... ....... ....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~--~~~~~~~ 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPDLLEK--GERLPQP 233 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHC--CCCCCCC
Confidence 43221 122345678999999998899999999999999999997 999986432111 0111111 1112221
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. .+...+.+++..||..+|++||+++|+++.|+
T Consensus 234 ~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 234 P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 22346899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=296.01 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=186.5
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
....++|+..+.||+|+||.||+|... ....||+|++..... .....++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344567888999999999999999653 236799999875422 22346788999999999 899999999998
Q ss_pred eccccchhheecCc-------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 042958 884 SHVRHSLAMILSNN-------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSK 938 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 938 (1075)
......+.+ ++.. .....+++..+++++.|++.|++|||+. +|+||||||+
T Consensus 86 ~~~~~~~li-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 86 TQEGPLYVV-VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred cCCCCeEEE-EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 765443221 1110 2245688999999999999999999999 9999999999
Q ss_pred CeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCcc
Q 042958 939 NVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSM 1015 (1075)
Q Consensus 939 Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 1015 (1075)
||+++.++.+|++|||.++.+...... .....++..|+|||+..+..++.++|||||||++||+++ |..||......
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999999876543221 122234678999999988899999999999999999997 99998633211
Q ss_pred ccchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1016 SSSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ........ ....+ ......+.+++.+||+.||++||||.|+++.|+
T Consensus 242 ~--------~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 242 E--------LFKLLKEGYRMEKP----QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred H--------HHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 1 11111111 11111 123346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=293.25 Aligned_cols=242 Identities=24% Similarity=0.394 Sum_probs=187.2
Q ss_pred cCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.+|+..+.||.|+||.||+|. ..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++......+.++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 468889999999999999995 46799999999865322 23467889999999999999999999987655433222
Q ss_pred ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 894 LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 894 ~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 1111 1123578999999999999999999999 99999999999999999999999999988765443333
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....++..|+|||.+.+..++.++|||||||++|++++|+.||........ .........+.... ....+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~ 243 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGTPELQN----PEKLSP 243 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCcccCC----cccCCH
Confidence 445688999999999988899999999999999999999999974332110 00011111111111 122344
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+.+++.+||..||++||++.++++
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 6889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.41 Aligned_cols=245 Identities=21% Similarity=0.379 Sum_probs=186.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|+..+.||+|+||.||+|... ++..||+|++.... .....+++.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467899999999999999999653 46789999987542 2334567999999999999999999999987655
Q ss_pred cchhheec-Cc-----------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 042958 888 HSLAMILS-NN-----------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937 (1075)
Q Consensus 888 ~~l~~~~~-~~-----------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 937 (1075)
..+.++.. .. .....+++.+++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 43222211 00 0112467888999999999999999999 999999999
Q ss_pred CCeeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCc
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 1014 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 1014 (1075)
+||+++.++.++++|||.+..+..... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543321 1122334678999999998899999999999999999997 8888753322
Q ss_pred cccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. .....+.+...... ....+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 239 ~--------~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 E--------EVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H--------HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11222222222111 1123456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=305.33 Aligned_cols=185 Identities=21% Similarity=0.317 Sum_probs=150.8
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
....+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 34567999999999999999999664 5789999985422 2346899999999999999999987765443
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.++.... .....+++..++.|+.||+.||.|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 134 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 134 MVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 2221111 1245688999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 1009 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 1009 (1075)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2233457899999999999999999999999999999999855543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=287.02 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=183.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+|++++++++...+.....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 357888899999999999999776 8889999986431 2467899999999999999999999875544333333
Q ss_pred ecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++... ....+++....+++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 22211 123478899999999999999999999 9999999999999999999999999998865432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..........+. ..
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~------~~ 221 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMD------AP 221 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhcCCCCC------CC
Confidence 2 22344678999999998889999999999999999997 999986322110 001111111111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 233456999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.19 Aligned_cols=241 Identities=23% Similarity=0.368 Sum_probs=184.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++......+.+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM- 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE-
Confidence 67888999999999999999664 5899999998643 233457788999999999999999999988765533222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 22111 134578999999999999999999999 99999999999999999999999999987654433
Q ss_pred CceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 964 SNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.......++..|+|||++. ...++.++|||||||++|||++|+.||...... ...........+. .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~-~ 235 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPT-L 235 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCcc-C
Confidence 3334456889999999885 345678999999999999999999998643221 1111111111110 0
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+.++.+++.+||+.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111233446899999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=293.52 Aligned_cols=244 Identities=22% Similarity=0.276 Sum_probs=183.5
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+++.||||.+...........+.+..|+.++++++|++++++++++...+..+..+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367778999999999999954 5789999999865433333334567889999999999999999998876554322221
Q ss_pred cC-c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SN-N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~-~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.. . .....+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.++++|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 11 1 1123478889999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||......... .......... +. ......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----~~~~~~~~~~-~~--~~~~~~ 228 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----EEVERLVKEV-QE--EYSEKF 228 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----HHHHhhhhhh-hh--hcCccC
Confidence 223457899999999999999999999999999999999999999743221100 0111111100 00 011223
Q ss_pred HHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
...+.+++.+||+.||++||| ++|+++
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 446899999999999999999 888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=303.53 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=184.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEee
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCS 884 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 884 (1075)
...++|.+.+.||+|+||.||+|++. .++.||||++...... ...+.+..|++++.++. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44457888899999999999999753 3468999999764322 23457889999999997 999999999987
Q ss_pred ccccchhheecCc-------------------------------------------------------------------
Q 042958 885 HVRHSLAMILSNN------------------------------------------------------------------- 897 (1075)
Q Consensus 885 ~~~~~l~~~~~~~------------------------------------------------------------------- 897 (1075)
.....+ ++++..
T Consensus 112 ~~~~~~-iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 KGGPIY-IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred cCCCcE-EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 654321 111100
Q ss_pred ----------------------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 042958 898 ----------------------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937 (1075)
Q Consensus 898 ----------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 937 (1075)
.....+++.+..+++.|++.|++|||+. +|+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 0112367888899999999999999998 999999999
Q ss_pred CCeeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCc
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 1014 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 1014 (1075)
+||+++.++.+|++|||+++.+..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986543221 1123456788999999998889999999999999999998 8999864322
Q ss_pred cccchhhhhhhhhhccCC--CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1015 MSSSSLNLNIALDEMLDP--RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ .....+.. +.+.+ ...+..+.+++.+||+++|.+||+++||++.|+
T Consensus 348 ~~--------~~~~~~~~~~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 348 NE--------QFYNAIKRGYRMAKP----AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred hH--------HHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11 01111111 11111 123456999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=293.68 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=179.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||.||+|..+ ++. .+|+|.++... .....+.+.+|+++++++ +||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57889999999999999999664 343 47888876432 223356789999999999 7999999999886644321
Q ss_pred hheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 891 AMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 891 ~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
++++... ....+++..+.+++.|++.|++|||+. +|+||||||+||+++++
T Consensus 80 -lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 80 -IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred -EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 1111110 113478899999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1075)
+.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |+.||.......
T Consensus 156 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------- 226 (297)
T cd05089 156 LASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------- 226 (297)
T ss_pred CeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence 999999999986432111 1111233567999999988889999999999999999997 999986432211
Q ss_pred hhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ ....+ ...+..+.+++.+||+.+|.+||+++|+++.|+
T Consensus 227 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 227 LYEKLPQGYRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 11111 123346899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=314.62 Aligned_cols=244 Identities=27% Similarity=0.467 Sum_probs=183.7
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc--
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-- 889 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-- 889 (1075)
-..+|+..+.||+||||.||+++.+ ||+.||||++.... .......+.+|+..+++++|||||+++..+.+....
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3456777788999999999999665 89999999998764 334457789999999999999999998755321100
Q ss_pred ---------------------hhhe--------------------------------e------------cCc-------
Q 042958 890 ---------------------LAMI--------------------------------L------------SNN------- 897 (1075)
Q Consensus 890 ---------------------l~~~--------------------------------~------------~~~------- 897 (1075)
..+. . +++
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0000 0 000
Q ss_pred --cc--------------------cCC------------------------------C--CHHHHHHHHHHHHHHHHHHH
Q 042958 898 --AA--------------------AKD------------------------------L--GWTRRMNVIKGISDALSYMH 923 (1075)
Q Consensus 898 --~~--------------------~~~------------------------------l--~~~~~~~i~~~i~~~L~~LH 923 (1075)
.+ ..+ + .-...++++.+|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 000 0 01233678999999999999
Q ss_pred hCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC------------------CCCCceeccccccCccCccccccCC
Q 042958 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK------------------PDSSNWTELAGTYGYVAPELAYTMK 985 (1075)
Q Consensus 924 ~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~ 985 (1075)
+. |||||||||.||++|++..+||+|||+|+... .+....+..+||.-|+|||.+.+..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998722 0112345678999999999987654
Q ss_pred ---CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCC
Q 042958 986 ---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPES 1062 (1075)
Q Consensus 986 ---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1062 (1075)
|+.|+|+||+|+|++||+. ||. ........+....++.+|.+........+.=.++|.+++++||.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~-------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFG-------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCC-------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999999986 443 122233455666677777765555566667789999999999999
Q ss_pred CCCHHHHHh
Q 042958 1063 RPTMPKVSQ 1071 (1075)
Q Consensus 1063 RPs~~evl~ 1071 (1075)
||||.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999985
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=288.26 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=182.8
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
++.+++.+.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 345566777778999999999999964 46888999987643 22335688999999999999999999999877554
Q ss_pred chhheecCcc----------ccCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEecccc
Q 042958 889 SLAMILSNNA----------AAKDL--GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGI 955 (1075)
Q Consensus 889 ~l~~~~~~~~----------~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGl 955 (1075)
.+.+ ++... ....+ ++..+..++.||++|++|||+. +|+||||||+||+++. ++.++|+|||.
T Consensus 80 ~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 80 FKIF-MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEE-EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 3222 22111 11234 6777888999999999999999 9999999999999986 67999999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
+..............+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------~~~~~~~~ 229 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------FKVGMFKI 229 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH------hhhhhhcc
Confidence 987654333334456889999999986543 7889999999999999999999986432211000 00000001
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+ ........++.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CC---CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11 112233456899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=299.70 Aligned_cols=238 Identities=23% Similarity=0.381 Sum_probs=178.7
Q ss_pred CCCceecccCceEEEEE-EECCCCEEE---EEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 818 DDEHCIGKGGQGSVYKA-ELASGEIVA---VKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~-~~~~g~~va---vK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
....+||+|+|-+|||| +-.+|..|| ||.-... ......++|..|+.+|+.|+|||||++|.++.+.......+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~--q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT--QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh--cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 34467999999999999 555688777 3322111 22334588999999999999999999999998765532222
Q ss_pred ec----------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEeccccccccCCC
Q 042958 894 LS----------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~~~~ 962 (1075)
.. +...-+.++....++|+.||++||.|||++ .|+|+|||||-+||+++.+ |.+||+|+|+|......
T Consensus 121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 11 112234567778889999999999999998 6799999999999999865 79999999999987643
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....+|||.|||||+.. ..|.+.+||||||++|+||.|+.+||...... -...+++..+.-|.. ...
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~s--l~k 267 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAA--LSK 267 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHH--hhc
Confidence 334479999999999877 67999999999999999999999998643321 111222222222211 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
-..+++.++|.+|+.. .++|||+.|+++
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1234699999999999 999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=287.80 Aligned_cols=242 Identities=23% Similarity=0.429 Sum_probs=184.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-C---CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-S---GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
.+|++.+.||+|+||.||+|... + +..||+|.++... .....+.+..|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56788899999999999999653 2 3479999986542 2233568999999999999999999999987655432
Q ss_pred hheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+..+.
T Consensus 82 -lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 -IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred -EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 2222221 124578899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcee---ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCC
Q 042958 961 PDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLP 1035 (1075)
Q Consensus 961 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1035 (1075)
....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ....+.+. +.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 229 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRLP 229 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCcCC
Confidence 4332211 1223568999999998889999999999999999986 999986432211 11111111 112
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ ...+..+.+++.+|++++|.+||+|.++++.|+
T Consensus 230 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 230 AP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CC----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 11 123446899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=291.02 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=183.2
Q ss_pred HhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
.+++|++.+.||+|+||.||+|... .+..||+|.+.... .......|..|+.++++++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3567889999999999999999664 35789999876432 223346789999999999999999999988765
Q ss_pred ccchhheecCcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---C
Q 042958 887 RHSLAMILSNNA----------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---E 947 (1075)
Q Consensus 887 ~~~l~~~~~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~ 947 (1075)
...+.+ ++... ....++|.++.+++.||+.|++|||+. +++||||||+||+++.++ .
T Consensus 82 ~~~~lv-~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 82 LPRFIL-LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCcEEE-EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 443222 11110 112588999999999999999999999 999999999999998765 5
Q ss_pred ceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhh
Q 042958 948 AHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1075)
+|++|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------- 229 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------- 229 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence 999999999876432211 112233568999999998899999999999999999997 999986432211
Q ss_pred hhhhcc-CCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEML-DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+. ..+...+ ...+..+.+++.+|++.+|++||++.||++.|+
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 VMEFVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 011111 1111111 223456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=292.22 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=183.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34678999999999999999999543 24589999886432 22334568899999999999999999998876
Q ss_pred cccchhheecCcc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC
Q 042958 886 VRHSLAMILSNNA-------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN 946 (1075)
Q Consensus 886 ~~~~l~~~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 946 (1075)
.... +++++... .....++....+++.|++.|+.|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~ 156 (288)
T cd05061 81 GQPT-LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF 156 (288)
T ss_pred CCCc-EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence 5433 22222111 112345677888999999999999999 999999999999999999
Q ss_pred CceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhh
Q 042958 947 EAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 947 ~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1075)
.+|++|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~ 228 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------E 228 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 9999999999865433221 122345678999999998889999999999999999998 7888863221 1
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......+...... ....+..+.+++.+|++.||++|||+.|+++.|+
T Consensus 229 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 229 QVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11122222211111 1122356999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=287.13 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=188.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~~~ 893 (1075)
+|++.+.||.|+||.||+|.. .+|+.||+|++..... .....+++..|++++++++||||+++++++..... .+.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 478889999999999999954 5789999999865432 23345678899999999999999999998764332 22222
Q ss_pred ecCc-------------cccCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 894 LSNN-------------AAAKDLGWTRRMNVIKGISDALSYMH-----NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 894 ~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
++.. .....+++...+.++.|+++|++||| +. +++|+||+|+||+++.++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 2211 11356889999999999999999999 66 999999999999999999999999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
+..............+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ...+.+.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCCCC
Confidence 988765443344557899999999999888999999999999999999999998743211 111122222221
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
. .....+..+.+++.+|++.+|++||+++||++.
T Consensus 229 ~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 122344579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=285.77 Aligned_cols=238 Identities=26% Similarity=0.367 Sum_probs=174.9
Q ss_pred ceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.+++.++||||+++++++...+.....+++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999653 2457999987542 22334568889999999999999999999886544332333222
Q ss_pred cc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC--
Q 042958 897 NA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-- 964 (1075)
Q Consensus 897 ~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-- 964 (1075)
.. ......+.....++.|+++|++|||+. +++||||||+||+++.++.+||+|||+++.+.....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 11 123357778889999999999999999 999999999999999999999999999986543211
Q ss_pred --ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhC-CCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 965 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
......++..|+|||+..+..++.++||||||+++|||++| ..||...... ...........+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~ 224 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLLQGRRLLQ---P 224 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhcCCCCCC---C
Confidence 11223456789999999888999999999999999999995 5555432211 11111111111111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 122346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=323.50 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=184.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-c
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-S 889 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~ 889 (1075)
...++|++.+.||+|+||.||+|.. .+++.||+|.+...... ......|..|+.++++++|||||+++++|..... .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4457899999999999999999955 46788999998754322 2345778999999999999999999998865432 2
Q ss_pred hhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEecCCCCCeeeCCC-------
Q 042958 890 LAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCF----PPIVHRDISSKNVLLDFD------- 945 (1075)
Q Consensus 890 l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlk~~Nill~~~------- 945 (1075)
++++++... ....+++...+.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 222222211 12468899999999999999999998521 269999999999999643
Q ss_pred ----------CCceEeccccccccCCCCCceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccC
Q 042958 946 ----------NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013 (1075)
Q Consensus 946 ----------~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 1013 (1075)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998764332 2234578999999998854 458899999999999999999999996432
Q ss_pred ccccchhhhhhhhhhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1014 SMSSSSLNLNIALDEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... .....+.. +.++. ...+.++.+++..||+.+|.+||++.|+++
T Consensus 248 ~~~-------qli~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS-------QLISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH-------HHHHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 11111111 11111 123456999999999999999999999984
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=290.49 Aligned_cols=241 Identities=26% Similarity=0.410 Sum_probs=187.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++.+....+ ++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW-II 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE-EE
Confidence 36788899999999999999654 68999999986542 2233567889999999999999999999887654332 22
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.+... ....+++.....++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 22111 123689999999999999999999999 9999999999999999999999999999887654344
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||........ .........+..+. ...+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~ 224 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLIPKNNPPSLEG-----NKFS 224 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHhhhcCCCCCcc-----cccC
Confidence 4456788899999999988899999999999999999999999964332110 00111111111111 1134
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+++.+||..||++|||++|+++
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 56899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=294.83 Aligned_cols=251 Identities=16% Similarity=0.216 Sum_probs=183.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++++++||||+++++++......+. +
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l-v 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL-V 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE-E
Confidence 57888999999999999999654 68999999986543222 23567789999999999999999999876554322 2
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 2211 1234578888999999999999999999 999999999999999999999999999986544333
Q ss_pred ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-------hhhhhh------hcc
Q 042958 965 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------LNIALD------EML 1030 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------~~~~~~------~~~ 1030 (1075)
......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||......+..... ...... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 33445678999999987654 5788999999999999999999999743321100000 000000 000
Q ss_pred CCCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+... ......+..+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111000 001123446889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=292.67 Aligned_cols=244 Identities=27% Similarity=0.350 Sum_probs=182.5
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+|+..+.||+|+||.||++.. .+++.||+|++...... .....+.+|+.++.++. ||||+++++++......+..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 455667899999999999955 46899999998754322 34567889999999996 999999999887654432211
Q ss_pred -ecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 894 -LSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 -~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+... .....+++....+++.|++.|++|||+.. +++||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 1110 12356888999999999999999999742 899999999999999999999999999976543
Q ss_pred CCCceeccccccCccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC-C
Q 042958 962 DSSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT-P 1037 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1037 (1075)
... .....|+..|+|||++.+. .++.++||||+|+++|||++|+.||..... ......+......+. +
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPPILS 232 (288)
T ss_pred CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCCcCC
Confidence 322 2334688899999998766 688999999999999999999999864321 011111211111111 1
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.++.+++.+||+.||++|||++||++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111234567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=295.50 Aligned_cols=242 Identities=23% Similarity=0.378 Sum_probs=180.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.+... ......+++.+|++++.++ +||||+++++++...+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 467888899999999999999654 454 4577776542 2233456788999999999 899999999998765543
Q ss_pred hhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 890 LAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 890 l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
+.. ++... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.
T Consensus 84 ~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 84 YLA-IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred eEE-EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 222 21110 123578899999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1075)
++.+||+|||++...... .......++..|+|||++.+..++.++||||||+++|||+| |+.||......+
T Consensus 160 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------- 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------- 231 (303)
T ss_pred CCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------
Confidence 999999999998643211 11112234668999999988889999999999999999998 999986332211
Q ss_pred hhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ ....+ ...+..+.+++.+||+.+|++||+++++++.++
T Consensus 232 -~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 232 -LYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred -HHHHHhcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 11111 123346899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=287.46 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=181.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCC--CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 890 (1075)
.+|+..+.||+|+||.||+|.. .++..||+|++..... ......+.+.+|+.++++++||||+++++++.... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999955 5689999998865322 22233467889999999999999999999886532 222
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.++++... ....+++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 22222211 234578888999999999999999998 999999999999999999999999999986543
Q ss_pred CC---CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.. .......++..|+|||++.+..++.++||||+|+++||+++|+.||....... ...........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~---- 230 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIATQPTNPQL---- 230 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHhcCCCCCCC----
Confidence 21 12233568899999999999889999999999999999999999986432111 00000001111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.+++ .||..+|++||+|+||++
T Consensus 231 --~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 --PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 122334567777 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=287.34 Aligned_cols=241 Identities=29% Similarity=0.454 Sum_probs=184.4
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch------hHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM------TFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
+|.+...||+|+||.||+|.. .+++.||+|.+........ ...+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999954 4689999998875433221 233578899999999999999999999877554
Q ss_pred chhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 SLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.+.+ ++... ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.++..
T Consensus 81 ~~lv-~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIF-LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEE-EEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 3322 22211 124578888899999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 960 KPDSS------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 960 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
..... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... ..........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~ 231 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AIFKIGENASPE 231 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HHHHHhccCCCc
Confidence 53211 1123457889999999998889999999999999999999999997432211 001111111112
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+ ...+..+.+++.+||+.||++||++.||++
T Consensus 232 ~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 232 IP------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CC------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 223456899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.40 Aligned_cols=230 Identities=20% Similarity=0.354 Sum_probs=171.5
Q ss_pred ceecccCceEEEEEEECC-------------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 821 HCIGKGGQGSVYKAELAS-------------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
+.||+|+||.||+|...+ ...||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999996532 235889987643 2233467889999999999999999999987654
Q ss_pred cchhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC-------ceE
Q 042958 888 HSLAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE-------AHV 950 (1075)
Q Consensus 888 ~~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl 950 (1075)
..+. +++.. .....+++..+.+++.||++|++|||+. +|+||||||+||+++.++. +++
T Consensus 78 ~~~l-v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ENIM-VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCEE-EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 4322 22111 1234588999999999999999999999 9999999999999987664 899
Q ss_pred eccccccccCCCCCceeccccccCccCccccc-cCCCCcccchHhHHHHHHHHH-hCCCCCCccCccccchhhhhhhhhh
Q 042958 951 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
+|||.+...... ....++..|+|||++. +..++.++||||||+++|||+ +|+.||......+ ...
T Consensus 154 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~~ 220 (262)
T cd05077 154 SDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KER 220 (262)
T ss_pred CCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HHH
Confidence 999998765422 2345788999999886 466899999999999999998 5888875322111 011
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......... .....++.+++.+||+.||++||++.||++.+.
T Consensus 221 ~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYEGQCMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHhcCccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111111111 112346899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.34 Aligned_cols=241 Identities=20% Similarity=0.295 Sum_probs=186.8
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||++.. .+|+.||+|++...... ....+++.+|+.++++++||||+++++++......+.++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 478889999999999999954 57899999998654322 2234678999999999999999999999876654432221
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
... .....+++.+.++++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 111 1123468889999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|++.|+|||+..+..++.++||||||+++|++++|+.||..... ............+. .....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~ 225 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPP---VSSHY 225 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCC---CcccC
Confidence 33345688899999999988899999999999999999999999863211 11122222222211 11233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..++.+++.+||+.+|.+||++.||++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=284.50 Aligned_cols=238 Identities=26% Similarity=0.398 Sum_probs=184.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++......+. +
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~-v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI-V 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE-E
Confidence 457888999999999999999776 89999999875422 35789999999999999999999999876433222 2
Q ss_pred ecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 21111 112589999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.. ....+..|+|||++.+..++.++||||||+++||+++ |+.||....... ........ ..... .
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~----~ 221 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEKG--YRMEA----P 221 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhcC--CCCCC----c
Confidence 11 2345678999999988889999999999999999997 999986332111 11111110 11111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||..+|++|||++|++++|+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 223456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=293.59 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=184.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEE
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGF 882 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 882 (1075)
...++|++.+.||+|+||.||+|+.. ++..||+|.+.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34567888999999999999999641 34579999986432 223356789999999999 89999999998
Q ss_pred eeccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 042958 883 CSHVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~ 937 (1075)
+......+. +++... ....+++.++..++.||++|++|||+. +|+||||||
T Consensus 90 ~~~~~~~~l-v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 90 CTQDGPLYV-IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred EecCCceEE-EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 876543322 111110 123578889999999999999999999 999999999
Q ss_pred CCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCc
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 1014 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 1014 (1075)
+||+++.++.+||+|||.++.+...... .....+++.|+|||++.+..++.++||||||+++||+++ |..||.....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999876543222 122345678999999998889999999999999999998 7888764322
Q ss_pred cccchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1015 MSSSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ ........ .... ....+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 246 ~~--------~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 246 EE--------LFKLLKEGHRMDK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred HH--------HHHHHHcCCcCCC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 11 11111111 1111 1233456999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.04 Aligned_cols=242 Identities=27% Similarity=0.413 Sum_probs=187.4
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++||||+++++++......+ .+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~-l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW-IV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE-EE
Confidence 6788899999999999999965 46889999998754322 3578899999999999999999999887654432 22
Q ss_pred ecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.. .....+++.+...++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 2211 1125688899999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeccccccCccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC-Cc
Q 042958 964 SNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SC 1039 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1039 (1075)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ........+..+ ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 227 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--------LFLISKSNFPPPKLK 227 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhccCCCcccc
Confidence 333445788899999998776 789999999999999999999999864332110 000111101110 11
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.++.+++.+||+.+|.+|||+.||++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12344567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=293.28 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=185.3
Q ss_pred HhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
..++|...+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 346788999999999999999953 2355799999875422 23356789999999999 79999999999876
Q ss_pred cccchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 886 VRHSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 886 ~~~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
.+..+.. ++... ....+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||
T Consensus 111 ~~~~~lv-~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEE-EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 5543222 22111 122378999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC
Q 042958 955 IAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 955 la~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
+++........ .....++..|+|||++.+..++.++||||+|+++|||++ |+.||....... .......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~ 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIK 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHH
Confidence 99866543221 122345678999999998889999999999999999998 999986432211 0111111
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...... .....+..+.+++.+|++++|++|||+.||++.|+
T Consensus 259 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 259 EGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred cCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 111110 01122346999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=292.33 Aligned_cols=242 Identities=23% Similarity=0.367 Sum_probs=187.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......+.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 46889999999999999999964 5799999999865322 2246788999999999999999999998765543322
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+........
T Consensus 95 -~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 95 -MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred -ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 22111 123578889999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......+++.|+|||...+..++.++||||||+++|++++|+.||......... ........+ +.......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--------~~~~~~~~~-~~~~~~~~ 241 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATNGTP-ELQNPERL 241 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--------eeeccCCCC-CCCCcccc
Confidence 334457889999999999888999999999999999999999999643221100 000000000 00111223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.+++.+||+.+|++||+++||++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 446889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.89 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=189.6
Q ss_pred CCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||.++ ..+++.||+|++...... ....+++.+|++++++++|+||+++++++.+....+..+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 47888999999999999994 456899999998654322 2335678899999999999999999999877554322211
Q ss_pred -cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 -SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 -~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
... .....+++.++..++.|+++|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 111 1134578899999999999999999999 999999999999999999999999999987655443
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......+++.|+|||+..+..++.++||||||+++|||++|+.||+.... ......+.....+.. ....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~ 225 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPV---VSVY 225 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC---cccc
Confidence 34456789999999999888899999999999999999999999864221 111222222222211 1233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
+..+.+++.+||+.+|.+||+++|+++.+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 45689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=289.32 Aligned_cols=251 Identities=21% Similarity=0.359 Sum_probs=185.5
Q ss_pred cCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH- 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 888 (1075)
..|++.+.||+|+||.||+|.. .++..||+|.++... .....+.+.+|+++++.++|||++++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578889999999999999963 357899999986542 23345689999999999999999999999876532
Q ss_pred chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 889 SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 889 ~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
...++++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 2222222211 123578999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc-------cchhhhhhhhhh
Q 042958 959 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-------SSSLNLNIALDE 1028 (1075)
Q Consensus 959 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-------~~~~~~~~~~~~ 1028 (1075)
+...... .....++..|+|||++.+..++.++||||||+++||+++++.|........ ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543321 123456778999999988889999999999999999999877643211000 000000111111
Q ss_pred ccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.... ..+. ....+..+.+++.+||+.+|++|||++|+++.++
T Consensus 239 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 239 LEEGKRLPR----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHcCccCCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 1111 1111 1234457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=285.92 Aligned_cols=244 Identities=25% Similarity=0.472 Sum_probs=184.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCC---EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGE---IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
..+|+..+.||+|+||.||+|... ++. .||+|.+.... .....+.+..|++++++++|||++++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 346788899999999999999664 333 79999986532 233356799999999999999999999998766543
Q ss_pred hhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+.++.... .....+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 32221111 1134578999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCce-e--ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCC
Q 042958 961 PDSSNW-T--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLP 1035 (1075)
Q Consensus 961 ~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1035 (1075)
...... . ....+..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~~ 230 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRLP 230 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCCC
Confidence 332211 1 1123457999999998889999999999999999997 99998643221 111111111 112
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ .+.+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 231 AP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 233456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=290.42 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=187.3
Q ss_pred cHHHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 806 ~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
.++++.++.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +||||+++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 3455667889999999999999999999955 468899999875421 1235678899999999 699999999987
Q ss_pred ecc----ccchhheecCc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC
Q 042958 884 SHV----RHSLAMILSNN-------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN 946 (1075)
Q Consensus 884 ~~~----~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 946 (1075)
... +..+..++++. .....+++..+..++.|+++|+.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 432 11122222211 1234577888899999999999999999 999999999999999999
Q ss_pred CceEeccccccccCCCCCceeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh
Q 042958 947 EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021 (1075)
Q Consensus 947 ~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 1021 (1075)
.+|++|||.++.+...........|++.|+|||++.. ..++.++||||+||++|||++|+.||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--- 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--- 238 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---
Confidence 9999999999876544333344578999999998753 44788999999999999999999998643221100
Q ss_pred hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
........+....+ ......+.+++.+||+.||++|||+.||++..
T Consensus 239 --~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --FKIPRNPPPTLHQP----ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --hhccccCCCcccCC----CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00001111111111 11234589999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=290.56 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=187.3
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
..++..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....++.+|+.+++++ +|||++++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 345556788999999999999999999965 578999999986431 1246678899999999 8999999999986
Q ss_pred cccc----chhheecCc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 885 HVRH----SLAMILSNN-------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 885 ~~~~----~l~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
..+. ....++++. .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 5432 122222211 1235678999999999999999999999 9999999999999999999
Q ss_pred ceEeccccccccCCCCCceeccccccCccCccccccC-----CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh
Q 042958 948 AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 1022 (1075)
+||+|||.+..............|+..|+|||++... .++.++|||||||++|||++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 9999999998765433333345688999999987643 368899999999999999999999864322110
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.........+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKIPRNPPPTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhcCCCCCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00011111111111 1223346999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=291.09 Aligned_cols=252 Identities=21% Similarity=0.372 Sum_probs=186.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|..+ +|+.||+|++...... ....+.+.+|+.++++++||||+++++++......+.++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46888899999999999999665 6899999998653222 223456889999999999999999999987755432222
Q ss_pred -ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 -LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 -~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 1111 1234589999999999999999999998 9999999999999999999999999999877654433
Q ss_pred eeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhh-------hhccC------
Q 042958 966 WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL-------DEMLD------ 1031 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~------ 1031 (1075)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... ...... .+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcccccccc
Confidence 444567889999999876 457899999999999999999999997433211100 000000 00000
Q ss_pred -CCCCCCCc------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 -PRLPTPSC------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 -~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.+.. .....+..+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00111100 01123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=288.28 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=182.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++......+ ++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~-lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW-IC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE-EE
Confidence 4677778899999999999954 578999999986542 122356788999999999999999999887654432 22
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.+.+.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 2211 1234678899999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 965 NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
......|+..|+|||++. ...++.++||||+||++|||++|+.||.......... .........+.... .
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~----~ 234 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQPPKLKD----K 234 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCCCCcccc----c
Confidence 344567899999999874 4558899999999999999999999985332211000 00000111111111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+|++.+|++||++++|++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 122346889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=293.50 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=182.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......++..|+.+++.+ +||||++++++|.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 367899999999999999999642 23579999987542 222346788999999999 8999999999987
Q ss_pred ccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
.....+. +++... ....+++.++.+++.|++.||+|||+. +++||||||+|
T Consensus 95 ~~~~~~l-v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 95 QDGPLYV-IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred cCCceEE-EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 6554322 222111 113478999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
|+++.++.+||+|||.++......... ....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999998654322111 11234568999999998889999999999999999998 888886322110
Q ss_pred cchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ ..... ....+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 251 -----~~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 251 -----LFKLLKEG--HRMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred -----HHHHHHcC--CCCCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 00011111 11111 1223456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=292.34 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=182.2
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|++++++++||||+++++++.+....+.+.-
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 477889999999999999965 47999999998654322 2224567889999999999999999998876544322211
Q ss_pred cCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
... .....+++...+.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 111 1234578999999999999999999999 99999999999999999999999999998765443334
Q ss_pred eccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-----------hhhhhccCC-C
Q 042958 967 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-----------IALDEMLDP-R 1033 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~-~ 1033 (1075)
....++..|+|||++.+.. ++.++||||+|+++|||++|+.|+.............. .......+. .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 4456789999999887654 68999999999999999999998642221110000000 000000000 0
Q ss_pred CCCCC------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPS------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+... ......+.++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 001123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.38 Aligned_cols=243 Identities=21% Similarity=0.373 Sum_probs=185.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++++......+.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEE
Confidence 4678899999999999999998777888999988642 223467899999999999999999999887632222211
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.... .....+++.+++.++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 1111 1133468888999999999999999998 999999999999999999999999999976543222
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
. .....++..|+|||++.+..++.++|+||||+++|++++ |+.||....... ........ ...+. ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~----~~ 226 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERG--YRMPR----PE 226 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCC--CCCCC----cc
Confidence 1 122345678999999998889999999999999999998 999986432211 01111111 11111 12
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+++|++||++.++.+.|+
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 33456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=284.95 Aligned_cols=236 Identities=28% Similarity=0.453 Sum_probs=184.6
Q ss_pred ceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|++.++.++|+||+++++++...... .++++.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~-~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL-YLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCce-EEEEEe
Confidence 469999999999996653 7899999987653322 467899999999999999999999998774332 222221
Q ss_pred c---------cc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 897 N---------AA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 897 ~---------~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
. .. ...+++.++++++.|+++|++|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 1 11 36689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCC
Q 042958 959 LKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRL 1034 (1075)
Q Consensus 959 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1034 (1075)
..... .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||....... ..+.... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~ 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYRL 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence 76543 12233457889999999988889999999999999999999 699987542211 1111111 111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ....+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 1223457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=289.35 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=184.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
..|+..+.||+|+||.||+|... +|+.||+|++...........+++.+|+++++.++||||++++++|......+.++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999654 68999999986543334444567899999999999999999999998755432221
Q ss_pred ec-Cc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LS-NN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~-~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
-. .. .....+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 11 10 1234588999999999999999999999 9999999999999999999999999999765432
Q ss_pred eeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 966 WTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....+++.|+|||++. ...++.++||||||+++|||++|+.||....... ..........+ .....
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~--~~~~~ 237 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSP--TLSSN 237 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHhcCCCC--CCCch
Confidence 2346788999999874 4568889999999999999999999986432211 00111111111 11122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+..+.+++.+||+.||++||++.+|++.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 345579999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=285.12 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=185.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
..+|++.+.||+|+||.||+|... +|+ .||+|....... .....++.+|+..+++++||||++++++|.....
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLSSQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCce
Confidence 357888899999999999999653 343 589998865432 3345788999999999999999999999987333
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+..... .....+++....+++.|+++|++|||+. +++||||||+||+++.++.+||+|||.++...
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 322222111 1133578999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCcee--ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCC
Q 042958 961 PDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPT 1036 (1075)
Q Consensus 961 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1036 (1075)
....... ...++..|+|||.+....++.++||||||+++||+++ |+.||+.....+ ....+... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERLPQ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCCCCC
Confidence 4332221 1223568999999988889999999999999999998 999987433211 11111111 1222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+. .+...+.+++.+||..||.+||++.++++.|+
T Consensus 233 ~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 233 PP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 21 23346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=285.44 Aligned_cols=239 Identities=25% Similarity=0.446 Sum_probs=180.8
Q ss_pred ceecccCceEEEEEEECC--C--CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAELAS--G--EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.||+|++|.||+|.+.+ + ..||||.+...... ...+.+..|+..+++++||||+++++++......+.+.+..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecC
Confidence 468999999999996643 3 36999998765432 45678999999999999999999999887622111111111
Q ss_pred c--------ccc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce-
Q 042958 897 N--------AAA-KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW- 966 (1075)
Q Consensus 897 ~--------~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 966 (1075)
. ... ..+++...+.++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.+.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 1 011 4678999999999999999999999 99999999999999999999999999998775433221
Q ss_pred --eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 967 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 967 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...... .....+.+ ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~-~~~~~~~~----~~ 225 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-----LKKIDK-EGERLERP----EA 225 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHh-cCCcCCCC----cc
Confidence 12456789999999998899999999999999999998 9999864322110 001111 11111111 22
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+..+.+++.+||+.+|++||+++||++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 3456999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=293.33 Aligned_cols=243 Identities=22% Similarity=0.374 Sum_probs=182.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......++..|+++++++ +||||++++++|.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 467888999999999999999642 24579999987532 223356788999999999 6999999999987
Q ss_pred ccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
.....+.+ +++.. ....+++.+..+++.|++.|++|||+. +++||||||+|
T Consensus 89 ~~~~~~lv-~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 89 QEGPLYVI-VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred cCCceEEE-EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 65432221 11110 123578999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
|+++.++.+|++|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876532221 112234567999999998889999999999999999999 888986432211
Q ss_pred cchhhhhhhhhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......... ...+ ...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 245 --------~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 245 --------LFKLLREGHRMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred --------HHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111111 1111 123346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.84 Aligned_cols=242 Identities=24% Similarity=0.464 Sum_probs=187.0
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++...... .+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI-YI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce-EE
Confidence 3578899999999999999999888788999999874322 246789999999999999999999988764332 22
Q ss_pred eecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 893 ILSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+++.. .....+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 22111 1124578999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCC
Q 042958 962 DSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPS 1038 (1075)
Q Consensus 962 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1038 (1075)
... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... .....+.. ...+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~- 226 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRP- 226 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC-
Confidence 211 1112234568999999998889999999999999999998 99998532211 11111111 111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+|++.+|++||+++|+.+.|+
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 227 ---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 122446999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=304.41 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=179.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|.. .+++.||+|++...........+.+..|+.++..++||+|+++++++.+.+..+. +
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l-v 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL-I 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE-E
Confidence 4688889999999999999965 4689999999865322233345678899999999999999999998877654322 2
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 2221 1234578888999999999999999999 999999999999999999999999999875432110
Q ss_pred -----------------------------------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 042958 965 -----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 1009 (1075)
Q Consensus 965 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 1009 (1075)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 011346999999999999999999999999999999999999999
Q ss_pred CccCccccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHh
Q 042958 1010 DFISSMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT---MPKVSQ 1071 (1075)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1071 (1075)
....... ....+.. .....+.. ...+.++.+++.+++. ||++|++ ++|+++
T Consensus 237 ~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQE--------TYRKVMNWKETLVFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHH--------HHHHHHcCCCceecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 7433211 1111111 11111111 1123357788888764 9999995 566653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=284.58 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=172.4
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 821 HCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+....+ +++++.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL-LVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcE-EEEECC
Confidence 35899999999999654 346799998865432 223457889999999999999999999987654432 222221
Q ss_pred cc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 898 AA--------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 898 ~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
.. ....++..+.+++.|+++|++|||+. +++||||||+||+++.++++|++|||.++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 11 12345667788999999999999999 99999999999999999999999999997644332
Q ss_pred Cc--eeccccccCccCccccccC-------CCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 964 SN--WTELAGTYGYVAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 964 ~~--~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
.. .....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.... .... ...+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~ 229 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TVRE-QQLK 229 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hhhc-ccCC
Confidence 21 1234567889999988642 35789999999999999996 9999964322111000 0000 1111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+.+. ........+.+++..|| .+|++|||++||++.|+
T Consensus 230 ~~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 11122345888999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=282.16 Aligned_cols=240 Identities=25% Similarity=0.419 Sum_probs=184.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.+|++.+.||+|+||.||+|...+++.+|+|.+...... ..++.+|++++++++|||++++++++......+.+ +
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v-~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV-F 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE-E
Confidence 467788999999999999998777889999998654322 35788999999999999999999998765543222 2
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+.. .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 211 1123578999999999999999999999 999999999999999999999999999986543321
Q ss_pred c-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCc
Q 042958 965 N-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIV 1041 (1075)
Q Consensus 965 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1041 (1075)
. .....++.+|+|||+..+..++.++||||+|+++|||++ |+.||...... ...+..... +...+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKPR--- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCCCC---
Confidence 1 122335678999999998889999999999999999998 99998632211 111111111 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.+|++|||++||++.|.
T Consensus 225 -~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12346999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=282.64 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=184.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCC---chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG---EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
+|+..+.||+|+||+||+|...+|+.+|||.+...... .....+.+.+|++++++++|+||+++++++.+....+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888999999988653221 122345688999999999999999999999776443222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.....++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 -~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 -MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred -EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 22111 124578888899999999999999999 99999999999999999999999999987653211
Q ss_pred ------CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 964 ------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 964 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.......|+..|+|||++.+..++.++||||+|+++|||++|+.||...+.... .. ...... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~-~~~~~~-~~~~~- 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----MF-YIGAHR-GLMPR- 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----HH-Hhhhcc-CCCCC-
Confidence 112335688999999999998899999999999999999999999964322110 00 000000 01111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........+.+++.+||+.+|++||++.|+++
T Consensus 230 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 --LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11223456899999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=291.34 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=182.8
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|++|.||+|.. .+|+.||||++...... ....+.+.+|++++++++||||+++++++.+....+..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 478889999999999999965 47899999998754322 2234678899999999999999999999876554322221
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++.....++.|+++|++|||+. +++||||+|+||+++.++.+|++|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 111 1234578999999999999999999999 9999999999999999999999999999876544333
Q ss_pred eeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------------hhhhhc--
Q 042958 966 WTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------------IALDEM-- 1029 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------------~~~~~~-- 1029 (1075)
.....+++.|+|||+..+.. ++.++||||||+++|||+||+.||.............. ......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 34456788999999887654 58899999999999999999999864322110000000 000000
Q ss_pred cCCCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 LDPRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..... ..........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 0000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=300.43 Aligned_cols=234 Identities=22% Similarity=0.227 Sum_probs=172.3
Q ss_pred ecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeeccccchhheecCcc
Q 042958 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
||+|+||.||+|.. .+|+.||||++.............+..|..++... +||||+++++++......+.+ +++..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv-~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV-TDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE-EcCCC
Confidence 69999999999965 46999999998643222222234455677776655 699999999988776543322 22211
Q ss_pred ---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 899 ---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 899 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
....+++.+...++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++............
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCc
Confidence 234578899999999999999999999 99999999999999999999999999997654433344456
Q ss_pred ccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 970 AGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
.||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.......+.. .....+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~---~~~~~~ 225 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKVRFPKN---VLSDEG 225 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCc---cCCHHH
Confidence 799999999998764 478999999999999999999999864221 11112222222211111 123458
Q ss_pred HHHHHHccCCCCCCCC----CHHHHHh
Q 042958 1049 VEVAISCLDENPESRP----TMPKVSQ 1071 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RP----s~~evl~ 1071 (1075)
.+++.+||++||++|| ++.|+++
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 8999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=283.34 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=185.3
Q ss_pred hcCCCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcE
Confidence 3568888999999999999996543 3468999886542 233457899999999999999999999998765443
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.+..... .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 33222111 1123578999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCC
Q 042958 962 DSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPS 1038 (1075)
Q Consensus 962 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1038 (1075)
.... .....++..|+|||.+....++.++||||||+++||+++ |+.||....... ....+.. .+.+.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~- 230 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGERLPMP- 230 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCcCCCC-
Confidence 3221 112234568999999988889999999999999999996 999986433211 1111111 111221
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+|+..+|.+|||+.|+++.|+
T Consensus 231 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 231 ---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 223456999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=289.82 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=186.6
Q ss_pred cHHHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 806 ~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
...++..+...|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 4455556678899999999999999999965 568999999875431 2246788999999999 799999999988
Q ss_pred ecc-----ccchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 884 SHV-----RHSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 884 ~~~-----~~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
... ...++++++... ....+++..+..++.|+++|++|||+. +++||||+|+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 532 122222222211 123467888899999999999999999 9999999999999999999
Q ss_pred ceEeccccccccCCCCCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh
Q 042958 948 AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 1022 (1075)
++|+|||++..............|+..|+|||.+. +..++.++||||+|+++|||++|+.||........
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----- 234 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----- 234 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----
Confidence 99999999886543333334467899999999875 34578899999999999999999999864322110
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........ .+.......+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ---~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ---LFLIPRNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hhhHhhCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00111111 011111234457999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=285.63 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=187.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
..|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++......+.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII- 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE-
Confidence 4577778899999999999965 4689999999865322 23357889999999999999999999998765443222
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
++... ....+++.+...++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 22111 134578888899999999999999999 9999999999999999999999999999876544333
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....++..|+|||++.+..++.++||||||+++|||++|+.||........ .... .... +.......+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~-~~~~--~~~~~~~~~ 226 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFLI-PKNN--PPTLTGEFS 226 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhhh-hcCC--CCCCchhhh
Confidence 3445678899999999988899999999999999999999999864322110 0111 1111 112234566
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+.+++.+||+.+|++||+++|+++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 789999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=287.90 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=182.6
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
++++|++.+.||+|+||.||+|.. .+|+.||+|++....... ....+.+|+.+++.++|+||+++++++......+.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 457899999999999999999954 578999999986543222 23467789999999999999999999876544322
Q ss_pred heecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++.. .....+.+.+...++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 -v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 -VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred -EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 22111 1123467888889999999999999999 9999999999999999999999999999865443
Q ss_pred CCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh------------------h
Q 042958 963 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------------------N 1023 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------------------~ 1023 (1075)
........++..|+|||++.+. .++.++||||+|+++|||++|+.||+........-... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 3333445678999999998754 57889999999999999999999997443210000000 0
Q ss_pred hhhhhccCCCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLDPRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...........+... .........+.+++.+|++.||++|||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 000012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=286.95 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=185.7
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~~ 892 (1075)
++|+..+.||.|++|.||+|.. .+++.||+|.+..... .....++.+|++++++++||||++++++|..... .+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3577889999999999999966 4689999999875422 2345778999999999999999999998865432 2222
Q ss_pred eecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 893 ILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 893 ~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+++... ....+++.....++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 222111 134467888889999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||+.....................+.++....
T Consensus 156 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 43221 2345788999999999889999999999999999999999999754221111111111111111111111111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+..+.+++.+||+.+|.+|||+.||++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11223557899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=290.22 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=187.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|.. .+|+.||+|++.... .....+.+.+|+++++.++||||+++++++......+..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC- 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE-
Confidence 5677889999999999999955 468999999876532 233457899999999999999999999999876543222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++.. ....+++.....++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 22111 1345788999999999999999999742 89999999999999999999999999987543221
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccch---hhhhhhhhhccCCCCCCCCcCc
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS---LNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.....|+..|+|||++.+..++.++|||||||++||+++|+.||+......... .........+.....+.. ..
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 235 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--PS 235 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--Cc
Confidence 224578999999999988889999999999999999999999997543321100 001111222222111111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+..+.+++.+||++||++|||++||++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 2244579999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=288.55 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=184.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......++.+|++++++++||||++++++|...+..+. +
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l-v 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI-C 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE-E
Confidence 4688999999999999999965 468899999886532 23345678899999999999999999999876554332 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++.. ....+++.....++.|+++||+|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 22211 2345788888999999999999999732 8999999999999999999999999998765432
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh----------------------
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL---------------------- 1022 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------------------- 1022 (1075)
......++..|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2234578899999999988889999999999999999999999986322111000000
Q ss_pred ------hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1023 ------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1023 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
....+....... +.........++.+++.+||+.||++|||++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 000011234568999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=290.27 Aligned_cols=239 Identities=26% Similarity=0.384 Sum_probs=184.1
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|++++++++||||+++++++......+.+ +
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv-~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII-M 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE-E
Confidence 455667899999999999954 468899999986442 223356789999999999999999999988765443222 2
Q ss_pred cCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
+... ....+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++..........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 1111 234578899999999999999999999 99999999999999999999999999998765443333
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....++..|+|||++.+..++.++||||||+++|||++|+.|+........ .........+. .....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~---~~~~~~~ 227 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--------LFLIPKNSPPT---LEGQYSK 227 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--------HhhhhcCCCCC---CCcccCH
Confidence 345688899999999998899999999999999999999999863322110 01111111111 1123445
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+.+++.+||+.+|++||+|.||++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 6899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=286.73 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=185.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|++++++++||||+++++++......+ +
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW-I 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE-E
Confidence 356888899999999999999664 6899999998643 3334567899999999999999999999987655432 2
Q ss_pred eecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++... ....+++.....++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 222111 134588999999999999999999999 9999999999999999999999999998765544
Q ss_pred CCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 963 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
........+++.|+|||++. +..++.++||||+|+++|||++|+.||........ .........+.+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~- 230 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILKSEPPTLDQ- 230 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhcCCCCCcCC-
Confidence 33344557899999999874 34567899999999999999999999864322110 00111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||+.+|.+||++.+|++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 231 ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ---cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1223446899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=285.39 Aligned_cols=242 Identities=26% Similarity=0.407 Sum_probs=181.3
Q ss_pred CCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 817 FDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
|++.+.||+|+||.||+|... +++.||||++...... ....+++.+|++++++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567789999999999999643 4688999998754322 23356788999999999999999999988653211
Q ss_pred -hhh-eecCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 890 -LAM-ILSNN---------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 890 -l~~-~~~~~---------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
..+ ++... .....+++....+++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 111 11100 0112468888999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc
Q 042958 953 FGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 953 fGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
||.++....... ......+++.|++||.+.+..++.++||||||+++|||++ |+.||....... ....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHHH
Confidence 999987643321 1122345678999999998889999999999999999999 888886332211 11111
Q ss_pred cCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1030 LDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1030 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... ....+ ...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 229 ~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 229 IKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred HcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 11111 123346999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=286.18 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=186.5
Q ss_pred cCCCCCceecccCceEEEEEEEC-----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
+.|+..+.||+|+||.||+|.+. +++.||||++...... ...++|.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46778899999999999999653 4789999998754332 3457899999999999999999999988763321
Q ss_pred -hhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 890 -LAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 890 -l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
...+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 12222111 1122488999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee---ccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc------hhhhhhhhhhc
Q 042958 959 LKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS------SLNLNIALDEM 1029 (1075)
Q Consensus 959 ~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~------~~~~~~~~~~~ 1029 (1075)
......... ...++..|+|||+..+..++.++||||||+++|||++|+.|+......... .........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 764322211 224456799999998889999999999999999999999997643221100 00001111111
Q ss_pred cC--CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1030 LD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1030 ~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. .+.+.+ ..++.++.+++.+||+.+|++||||.||+++|+
T Consensus 239 ~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 239 LKEGERLPRP----PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHcCCcCCCC----ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 11 111211 223356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=280.35 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=181.2
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc---
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN--- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~--- 897 (1075)
++||+|+||.||+|...+++.||+|++...... ...+.+..|+++++++.||||+++++++......+.++....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999997766999999998764332 345789999999999999999999999877654332221110
Q ss_pred ------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce--ecc
Q 042958 898 ------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TEL 969 (1075)
Q Consensus 898 ------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~~~ 969 (1075)
.....+++.....++.+++.|++|||+. +++||||||+||+++.++.+||+|||.+.......... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 1133578888899999999999999999 99999999999999999999999999998654221111 112
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1048 (1075)
..+..|+|||.+.+..++.++||||+|+++|||++ |..||....... ........ ...+. ....+..+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~~~--~~~~~----~~~~~~~~ 224 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESG--YRMPA----PQLCPEEI 224 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHhcC--CCCCC----CccCCHHH
Confidence 33567999999988889999999999999999999 888885432211 11111111 11111 12334579
Q ss_pred HHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1049 VEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1049 ~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+++.+||+.+|++|||+.||++.|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=283.29 Aligned_cols=243 Identities=27% Similarity=0.485 Sum_probs=183.7
Q ss_pred cCCCCCceecccCceEEEEEEEC-CC---CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
.+|++.+.||+|+||.||+|... ++ ..||||.+.... .....++|..|+.+++.++||||+++++++......+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 34778899999999999999654 33 369999986542 3344678999999999999999999999987655432
Q ss_pred hheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+ ++... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..+.
T Consensus 82 lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 II-TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EE-EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 22 21111 134578999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCc--eec-cc--cccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 961 PDSSN--WTE-LA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 961 ~~~~~--~~~-~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
..... ... .. .+..|+|||++.+..++.++||||+|+++||+++ |..||....... ....... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----~~~~i~~--~~~~ 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VINAIEQ--DYRL 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHc--CCcC
Confidence 43221 111 11 2357999999998899999999999999999986 999986432211 1111111 1122
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+ .+.+..+.+++.+||+++|.+||++++|++.|+
T Consensus 231 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 231 PPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred CCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 222 233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=289.72 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=183.4
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|.....||+|+||.||++.. .++..||||++.... ....+.+.+|+.+++.++||||+++++++...+..+.. ++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv-~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV-ME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE-Ee
Confidence 33346799999999999965 468999999986432 23356788999999999999999999988765443222 22
Q ss_pred Ccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 896 NNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 896 ~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
... ....+++.+...++.||+.|++|||+. +|+||||||+||+++.++.++|+|||++...........
T Consensus 100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 111 123578899999999999999999999 999999999999999999999999999976654433334
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
...|+..|+|||+..+..++.++||||||+++|||++|+.||....... .............+. .......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~ 247 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDNLPPRVKD----SHKVSSV 247 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCcccc----ccccCHH
Confidence 4578999999999988889999999999999999999999986432211 011111122222221 1123446
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1048 IVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+.+++.+||..||.+|||++|+++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 8899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.99 Aligned_cols=249 Identities=19% Similarity=0.247 Sum_probs=176.3
Q ss_pred CCceeccc--CceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee-
Q 042958 819 DEHCIGKG--GQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL- 894 (1075)
Q Consensus 819 ~~~~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~- 894 (1075)
+.++||+| +|++||++.. .+|+.||+|++...... ....+.+.+|+++++.++||||++++++|...+..+.++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 35679999 6889999954 57999999998754322 2335677889999999999999999999977654432221
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++..+++++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 111 0123478999999999999999999999 9999999999999999999999999876543221110
Q ss_pred -------eeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc------
Q 042958 966 -------WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML------ 1030 (1075)
Q Consensus 966 -------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 1030 (1075)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 112346778999999876 45889999999999999999999999743221100000000000000
Q ss_pred -------------CCCC----------C-----CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 -------------DPRL----------P-----TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 -------------~~~~----------~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+... + ............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0 000011233457899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=282.84 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=186.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||.|+||.||+|.. .++..||+|++....... ..+.+.+|++.++.++|+||+++++.+...+..+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4788999999999999999965 468899999986543222 4578999999999999999999999887655433222
Q ss_pred ecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.... .....+++.....++.|++.|++|||+. +++||||+|+||++++++.++++|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 1110 1124578899999999999999999999 9999999999999999999999999999876654
Q ss_pred CCc----eeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 963 SSN----WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 963 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
... .....|+..|+|||++... .++.++||||||+++|||++|+.||.......... .... ...+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~ 230 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM----LTLQ-NDPPSLETG 230 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH----HHhc-CCCCCcCCc
Confidence 322 1334688999999998776 78999999999999999999999997443221100 0000 011111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+..+.+++.+||+.||++||+++|+++
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 -ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001234567899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=283.02 Aligned_cols=237 Identities=26% Similarity=0.437 Sum_probs=182.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.+|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++......+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEEC
Confidence 4688899999999999999975 58889999986431 24678899999999999999999999876543322221
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++..+.+++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 111 1123478889999999999999999998 9999999999999999999999999998764322
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ........ .+... ....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~----~~~~ 222 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECVEKG--YRMEP----PEGC 222 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHhCC--CCCCC----CCcC
Confidence 122334578999999988889999999999999999997 999986432211 11111111 11111 1233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+..+.+++.+||+.+|++||+++++++.|+
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=290.82 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=185.5
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++||||+++++++......+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV- 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE-
Confidence 46888899999999999999765 68999999986543322 3456788999999999999999999998765443222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.++..++.||++|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 2111 1123478999999999999999999999 999999999999999999999999999987655444
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh------hhhh----------h
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------NIAL----------D 1027 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------~~~~----------~ 1027 (1075)
......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+...... .... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 4445568899999998875 347889999999999999999999986432211000000 0000 0
Q ss_pred hccCCCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+...... ......+..+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00011110000 001123456999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=291.18 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=181.4
Q ss_pred CCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 819 DEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 819 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
....||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++......+.. ++..
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv-~e~~ 100 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL-MEFL 100 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE-EecC
Confidence 345799999999999955 4789999999864322 2346788999999999999999999988765443222 2211
Q ss_pred c--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 898 A--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 898 ~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
. ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.............
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 1 134578999999999999999999999 99999999999999999999999999997665444334456
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.|+..|+|||++.+..++.++||||||+++|||++|+.||........ ............. ........+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~l~ 248 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLK----NAHKISPVLR 248 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhccCCCCcc----ccCCCCHHHH
Confidence 789999999999988899999999999999999999999863322110 0011111111111 1112334589
Q ss_pred HHHHHccCCCCCCCCCHHHHHh
Q 042958 1050 EVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+++.+||+.+|++||+++|+++
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 249 DFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhh
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=285.66 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=186.3
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc-
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~- 888 (1075)
.++++|++.+.||+|+||.||+|... +++.||+|++.... ...+++.+|+.+++++ +|+||+++++++.....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 35689999999999999999999664 68899999986532 1246789999999999 79999999999876442
Q ss_pred ----chhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEe
Q 042958 889 ----SLAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 889 ----~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
.+.++++... ....+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.+|++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 1222222211 135678899999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhh
Q 042958 952 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026 (1075)
Q Consensus 952 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 1026 (1075)
|||.+..............|+..|+|||++.. ..++.++||||+|+++|||++|+.||....... ..
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~ 227 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------AL 227 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HH
Confidence 99999876544444445678999999998753 346789999999999999999999986332211 11
Q ss_pred hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..... ............+.+++.+||..||++|||++|+++
T Consensus 228 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 FKIPRNPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhhccCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111 111111224457899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=293.77 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=182.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
..+|++.+.||+|+||.||+|... .+..||+|.+.... .....+++.+|+++++++ +||||++++++|.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 456889999999999999999542 12368999887432 223357889999999999 8999999999987
Q ss_pred ccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
.....+.+ ++... ....++|.++.+++.|++.|++|||+. +++||||||+|
T Consensus 89 ~~~~~~lv-~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 89 QDGPLYVL-VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred cCCceEEE-EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 65433221 11110 123478899999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
|+++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999866533221 112234567999999999899999999999999999998 88888643211
Q ss_pred cchhhhhhhhhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+.... ...+ ...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 244 -------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 244 -------ELFKLLKEGHRMDKP----ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred -------HHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111111111 1111 123346899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.78 Aligned_cols=244 Identities=20% Similarity=0.253 Sum_probs=191.4
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch-hh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL-AM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l-~~ 892 (1075)
+.|+..+.||.|.-|+||.++.+ ++..+|+|++.+..........+...|.+||+.+.||.++.+|+.++...... +|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 44566788999999999999776 45899999998766555556677889999999999999999999988765432 22
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC--
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP-- 961 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~-- 961 (1075)
.+... ..+..++....+-+|..|+-||+|||.. |||+|||||+|||+.++|++-++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 22221 2245678888899999999999999999 999999999999999999999999999753321
Q ss_pred -------------------------------CCC-----------------------ceeccccccCccCccccccCCCC
Q 042958 962 -------------------------------DSS-----------------------NWTELAGTYGYVAPELAYTMKVT 987 (1075)
Q Consensus 962 -------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~ 987 (1075)
... .....+||-.|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 01124689999999999999999
Q ss_pred cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC--
Q 042958 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT-- 1065 (1075)
Q Consensus 988 ~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-- 1065 (1075)
.++|+|+|||++|||+.|..||.+... ...+..++...+..+.. ...+..+.++|++.+.+||.+|.-
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~--------~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN--------KETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc--------hhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhccc
Confidence 999999999999999999999975443 23344444443333321 245567999999999999999998
Q ss_pred --HHHHHh
Q 042958 1066 --MPKVSQ 1071 (1075)
Q Consensus 1066 --~~evl~ 1071 (1075)
++||.+
T Consensus 384 rGA~eIK~ 391 (459)
T KOG0610|consen 384 RGAAEIKR 391 (459)
T ss_pred cchHHhhc
Confidence 777754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.91 Aligned_cols=240 Identities=25% Similarity=0.322 Sum_probs=171.0
Q ss_pred eecccCceEEEEEEECC---CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 822 CIGKGGQGSVYKAELAS---GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|++.++.++||||+++++++......+. +++...
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~l-v~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL-VLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEE-EEEeCC
Confidence 58999999999996543 3578888876432 23335678899999999999999999999876554322 221111
Q ss_pred --------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 899 --------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 899 --------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.....++.....++.|++.|++|||+. +|+||||||+||+++.++++||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 012245677789999999999999999 999999999999999999999999999876443221
Q ss_pred c--eeccccccCccCcccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 965 N--WTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 965 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
. .....+++.|+|||+... ..++.++||||+|+++|||++ |+.||........ ...........+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~~~~~~~~~~~~ 230 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQDIKL 230 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-----HHHHhhccCccC
Confidence 1 123345678999998643 356789999999999999999 7888864322110 000011111122
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+ ......+..+.+++..|| .||++|||++||++.|.
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 221 112234456788999999 59999999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.98 Aligned_cols=244 Identities=21% Similarity=0.257 Sum_probs=178.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|+.+++.++|+||+++++++......+ ++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~-lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY-LV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE-EE
Confidence 47889999999999999999654 68999999986422222233466889999999999999999999887665432 22
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 22211 134578888899999999999999999 99999999999999999999999999997665433
Q ss_pred Cc-eeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC--CCCC
Q 042958 964 SN-WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD--PRLP 1035 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1035 (1075)
.. .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ ....+.. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCccc
Confidence 22 223468999999999863 457889999999999999999999996432211 1111111 1111
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCC--CCCCHHHHHh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPE--SRPTMPKVSQ 1071 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~ 1071 (1075)
.+. .....+..+.+++.+|+..+++ .||+++|+++
T Consensus 229 ~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 229 FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 111 1112344688899987755433 4789998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=283.07 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=185.5
Q ss_pred CCCCCceecccCceEEEEEEECC--CCEEEEEEccCCCC-------CchhHHHHHHHHHHHHhc-CCcCceeeEEEEeec
Q 042958 816 DFDDEHCIGKGGQGSVYKAELAS--GEIVAVKKFHSPLP-------GEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSH 885 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 885 (1075)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999997654 78899998754221 122234567789988875 799999999999877
Q ss_pred cccchhheec-C-----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 886 VRHSLAMILS-N-----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 886 ~~~~l~~~~~-~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
....+..+.. . ......+++..+++++.|++.|+.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 5544332211 1 012345788899999999999999999631 8999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||...... ..........
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhcc
Confidence 9998765443 334567889999999999888999999999999999999999998632211 1111111121
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..... ....+..+.+++.+||+.||++||++.||..+++
T Consensus 230 ~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110 1123456999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=268.72 Aligned_cols=237 Identities=24% Similarity=0.290 Sum_probs=186.3
Q ss_pred HhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc-ccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV-RHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 890 (1075)
..++|...+++|+|.||.|-.++ ..+|+.+|+|++++...-..+....-..|-++++.-+||.+..+--.|+.. +.++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 35788999999999999999994 558999999999987766666677888999999999999988774434332 2223
Q ss_pred hheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 891 AMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 891 ~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+|.+... .....+++.+.+-+...|..||.|||+. +||.||+|.+|.++|.||++||+|||+++.--...
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 3322211 1234567777788899999999999999 99999999999999999999999999999766667
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....+.+|||.|.|||++....|..++|.|.+|||||||++|+.||...+. ....+-+....+..|. .
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~ed~kFPr----~ 390 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILMEDLKFPR----T 390 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhhhccCCc----c
Confidence 778889999999999999999999999999999999999999999963221 1111222222222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCC
Q 042958 1044 KLISIVEVAISCLDENPESRP 1064 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RP 1064 (1075)
..++...++...+.+||++|.
T Consensus 391 ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhc
Confidence 233578899999999999996
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=290.34 Aligned_cols=244 Identities=21% Similarity=0.259 Sum_probs=187.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++++......+.++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999654 58999999997654333334567899999999999999999999887655432222
Q ss_pred ecC-c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSN-N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~-~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
... . .....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 111 1 1234678899999999999999999999 99999999999999999999999999987653221
Q ss_pred Cc-----------------------------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCc
Q 042958 964 SN-----------------------------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 1014 (1075)
Q Consensus 964 ~~-----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 1014 (1075)
.. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 1123678899999999988899999999999999999999999864322
Q ss_pred cccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHh
Q 042958 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT----MPKVSQ 1071 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 1071 (1075)
. .....+.......+. ....+..+.+++.+||+.||++||+ ++|+++
T Consensus 238 ~--------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D--------ETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H--------HHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 112222222222211 1114557999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.09 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=186.5
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ....+++.+|++++++++||||+++++++......+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36778889999999999999665 689999999876432 244578899999999999999999999887654432222
Q ss_pred ecCcc---------c-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNA---------A-AKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~---------~-~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+... . ...++.....+++.|+++|++|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 79 -e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 79 -EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred -EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 1111 1 1567888889999999999999999 7 9999999999999999999999999998765432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
... ...++..|+|||+..+..++.++||||+|+++|+|++|+.||.......... ....+.......+.. ...
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~ 227 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---FELLQYIVNEPPPRL--PSG 227 (265)
T ss_pred Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH---HHHHHHHhcCCCCCC--Chh
Confidence 221 2678889999999999899999999999999999999999986432211111 111222222211111 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||..||++|||+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 14556999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=280.12 Aligned_cols=244 Identities=21% Similarity=0.320 Sum_probs=182.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCC--CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 890 (1075)
.+|++.+.||+|+||.||+|.. .+|+.||||.+..... ......+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999965 5689999998754321 22233567889999999999999999999886543 222
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
..+++... ....+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 22222211 123467888899999999999999999 999999999999999999999999999986543
Q ss_pred CC---CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.. .......++..|+|||++.+..++.++||||||+++|||++|+.||....... ........+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 228 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTNP--- 228 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCCC---
Confidence 21 12233568889999999988889999999999999999999999986432111 001111111111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.........+.+++.+|+. +|++||+++||++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1123344568899999995 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=287.82 Aligned_cols=251 Identities=18% Similarity=0.288 Sum_probs=180.3
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|++|.||+|..+ +++.||||.+....... ....+.+|++++++++||||+++++++......+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV- 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE-
Confidence 67888999999999999999654 78999999986543221 124567899999999999999999998765543222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 22111 123578888999999999999999999 999999999999999999999999999876433222
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------hhhh------hhc
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------NIAL------DEM 1029 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------~~~~------~~~ 1029 (1075)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||............. .... ...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 2233456889999998875 457899999999999999999999996433110000000 0000 000
Q ss_pred cCCCCCC--CCc---C--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 LDPRLPT--PSC---I--VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~--~~~---~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....... +.. . .......+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000 0 0011146789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=285.50 Aligned_cols=238 Identities=24% Similarity=0.305 Sum_probs=186.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++......+. +
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~-v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL-V 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE-E
Confidence 46888899999999999999654 689999999865433333445678999999999999999999999877654322 2
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 2221 1235678899999999999999999998 9999999999999999999999999999876543
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ....+.......+.+. ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~----~~ 221 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPS----FF 221 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCc----cC
Confidence 2345688999999999888889999999999999999999999864331 1111222222222222 22
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
...+.+++.+||+.||.+|| +++|+++
T Consensus 222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 34689999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=285.83 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=183.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++||||+++++++......+.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46888899999999999999665 79999999886532 2233467899999999999999999999877654432221
Q ss_pred -ecC----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 -LSN----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 -~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+.. ......+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 111 111236899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CCceeccccccCccCccccccCC------CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 963 SSNWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....... .......+.....+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~ 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSAIVDGDPPT 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHHHhhcCCCC
Confidence 223346788999999886543 4789999999999999999999986432111 111122222222111
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+...++.+++.+||+.+|++||+++|+++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 230 ---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 12235567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=278.90 Aligned_cols=243 Identities=28% Similarity=0.427 Sum_probs=185.7
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+..|+.++++++|+||+++++++......+.+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~- 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM- 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE-
Confidence 478889999999999999965 47899999998765432 345678999999999999999999999876654332222
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+.. .....+++..++.++.|+++|+.|||+. +|+|+||+|+||+++.++.+||+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 111 1123478889999999999999999999 9999999999999999999999999999876544332
Q ss_pred e----eccccccCccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 966 W----TELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 966 ~----~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
. ....++..|+|||++.+.. ++.++||||||+++||+++|+.||....... ...........+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~-- 229 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGAGHKPPIPD-- 229 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhcCCCCCCCc--
Confidence 2 2356788999999988766 8899999999999999999999996432111 0001111111112221
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.+++.+||+.+|.+|||+.|+++
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 --SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1122456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.26 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=183.7
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~~ 892 (1075)
++|+..+.||+|+||.||+|... +++.||+|.++..... ......+.+|+.++++++||||+++++++...+ ...+.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 57888899999999999999665 6899999998754322 222346778999999999999999999887652 22222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++...+.++.||+.||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 222111 123588999999999999999999999 99999999999999999999999999998776543
Q ss_pred CceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------------hhhhhc
Q 042958 964 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------------IALDEM 1029 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------------~~~~~~ 1029 (1075)
.......+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||.............. ......
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 3344456788999999887654 68899999999999999999999874332110000000 000000
Q ss_pred cCCCCCCC-----CcCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 LDPRLPTP-----SCIVQD--KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~~-----~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........ ...... ....+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 000011 2456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=288.54 Aligned_cols=253 Identities=22% Similarity=0.263 Sum_probs=183.9
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC--chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
+|+..+.||+|+||.||+|.. .+|+.||||++...... .......+..|++++++++|+||+++++++......+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l- 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL- 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE-
Confidence 477788999999999999965 46899999998764332 12234567789999999999999999999877443322
Q ss_pred eecCcc--------cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA--------AA-KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~--------~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... .. ..+++..+..++.||++||.|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 221111 11 2689999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------h------hhhhc
Q 042958 964 SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------I------ALDEM 1029 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~------~~~~~ 1029 (1075)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.............. . .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 44444567888999998865 4578999999999999999999877764332110000000 0 00000
Q ss_pred cCCCCCCC---CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1030 LDPRLPTP---SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1030 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.......+ ..........+.+++.+||+.||++|||++||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 00112234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=309.94 Aligned_cols=256 Identities=18% Similarity=0.203 Sum_probs=173.0
Q ss_pred HhcCCCCCceecccCceEEEEEEEC--CCCEEEEEEc--------------cCCCCCchhHHHHHHHHHHHHhcCCcCce
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA--SGEIVAVKKF--------------HSPLPGEMTFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~--------------~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 876 (1075)
..++|++.+.||+|+||+||++..+ +++.+++|.+ .+...........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998543 2322332211 11111122334668899999999999999
Q ss_pred eeEEEEeeccccchhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 877 VKFYGFCSHVRHSLAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
+++++++...+..+.+..... .........+..+++.|++.||+|||+. +|+||||||+||+++.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999877655433211110 0011223456678999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCC-CCccCccccchhhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNL 1022 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~ 1022 (1075)
++.+||+|||+++.+...... .....||..|+|||++.+..++.++|||||||++|||++|+.+ +.............
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999999999877543322 2345799999999999999999999999999999999998754 33211110000000
Q ss_pred h---------------hhhhhccC-CCCCCCCcCc------HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 N---------------IALDEMLD-PRLPTPSCIV------QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ~---------------~~~~~~~~-~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. .....++. .......... ......+.+++.+|++.||++|||+.|+++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000000 0000000000 011235678899999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=286.15 Aligned_cols=240 Identities=28% Similarity=0.386 Sum_probs=183.5
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|+..+.||+|+||.||+|.. .+++.||+|++.............+..|++++++++|||++++++++......+.++-
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366778899999999999965 4689999999875433334445678999999999999999999999877554332221
Q ss_pred cCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
... .....+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 111 1234578999999999999999999999 9999999999999999999999999998754432
Q ss_pred eccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 967 TELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....+++.|+|||++. ...++.++||||||+++|||++|+.||...... .....+.....+.. ....
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--~~~~ 248 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPTL--QSNE 248 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhccCCCC--CCcc
Confidence 2346888999999874 456889999999999999999999998643211 11111111111111 1123
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.+..+.+++.+||+.+|.+||++.||++.
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 34568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=290.68 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=183.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~ 891 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++|+||+++++++..... .+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 46899999999999999999965 469999999986533221 223456789999999999999999999875432 222
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+++... ....+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 2222211 125588999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh-------hhhhcc----
Q 042958 963 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI-------ALDEML---- 1030 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~---- 1030 (1075)
........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............... ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 333344456788999998865 45789999999999999999999998643321110000000 000000
Q ss_pred --CCCCCC-CCcC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 --DPRLPT-PSCI----VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 --~~~~~~-~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+. +... .......+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0000 0112456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=286.50 Aligned_cols=251 Identities=21% Similarity=0.253 Sum_probs=182.0
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|++.+.||.|++|.||+|.. .+|+.||+|++...... ....+.+.+|+++++.++|||++++++++......+..+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 66788999999999999965 47999999998754322 22345688899999999999999999998765443222211
Q ss_pred Cc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 896 NN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 896 ~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.. .....+++..+++++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 10 1113578999999999999999999999 99999999999999999999999999998665433333
Q ss_pred eccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-----------------hhhhh
Q 042958 967 TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-----------------IALDE 1028 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-----------------~~~~~ 1028 (1075)
....++..|+|||++.+. .++.++||||||+++|||++|+.||.............. .....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 444678899999987664 468899999999999999999999864332110000000 00000
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
................+..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000111223356889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=281.24 Aligned_cols=230 Identities=19% Similarity=0.338 Sum_probs=169.5
Q ss_pred eecccCceEEEEEEECC-------------------------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce
Q 042958 822 CIGKGGQGSVYKAELAS-------------------------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 876 (1075)
.||+|+||.||+|.+.. ...||+|++... ......++.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 59999999999996421 135889988542 22334678899999999999999
Q ss_pred eeEEEEeeccccchhhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-
Q 042958 877 VKFYGFCSHVRHSLAMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN- 946 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~- 946 (1075)
++++++|......+.++ +... .....+++..+.+++.||++||+|||+. +|+||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999997655432221 1111 1234578999999999999999999999 999999999999998654
Q ss_pred ------CceEeccccccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHH-hCCCCCCccCccccc
Q 042958 947 ------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSS 1018 (1075)
Q Consensus 947 ------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~ 1018 (1075)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999988654322 22357788999998865 56889999999999999995 69999864322110
Q ss_pred hhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1019 SLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..........+.. ....+.+++.+||+.+|++||||+||++.|.
T Consensus 231 --------~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --------ERFYEKKHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --------HHHHHhccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0111111111111 1235899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=283.33 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=177.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHH-HhcCCcCceeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
++|++.+.||+|+||.||+|... +|+.||+|++....... ...++..|+.. ++..+||||+++++++......+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46888999999999999999654 79999999987543222 23455556664 6667999999999998765443221
Q ss_pred e-ecC----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 893 I-LSN----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~-~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+ +.. ......+++...+.++.||+.|++|||+++ +++||||||+||+++.++.+||+|||.+..+..
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 1 111 112346789999999999999999999853 899999999999999999999999999987643
Q ss_pred CCCceeccccccCccCcccccc----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 962 DSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.. ......++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||...... ..... .......+..+
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~~-- 229 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLK-QVVEEPSPQLP-- 229 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHH-HHHhcCCCCCC--
Confidence 21 2233467889999998865 45688999999999999999999998632110 00000 01111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.++.+++.+||+.+|++||+++|+++
T Consensus 230 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 ---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123456999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.48 Aligned_cols=241 Identities=25% Similarity=0.280 Sum_probs=184.9
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-h
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-L 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l 890 (1075)
..+.|+..++||+|+||.||-++. .+|+-+|.|.+.+.......-....+.|..++.+++.+.||.+--.|+..+.. +
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999999854 47999999987654433333345678899999999999999986555544432 2
Q ss_pred hheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++-+++. -+...+++.+.+-+|.+|+-||+|||++ +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 2222211 1234688999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.. ..+..+||.+|||||++.+..|+...|.||+||++|||+.|+.||..... ....+.++.. -...+..+.
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~eEvdrr---~~~~~~ey~ 410 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKREEVDRR---TLEDPEEYS 410 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhHHHHHHH---Hhcchhhcc
Confidence 43 34556999999999999999999999999999999999999999963221 1111111111 112223344
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC
Q 042958 1042 QDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
...+.+..++.+..+++||++|--
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhcc
Confidence 556667899999999999999964
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=282.79 Aligned_cols=241 Identities=26% Similarity=0.420 Sum_probs=184.5
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC---cCceeeEEEEeeccccchh
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~l~ 891 (1075)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|+.++++++ |||++++++++......+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477788999999999999965 5789999999865422 223467889999999996 9999999998876543322
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++++.. ....+++.....++.|+++|+.|||+. +++||||+|+||+++.++.++++|||.+..+....
T Consensus 80 -v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 -IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred -EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 222111 124678999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.......|+..|+|||++.+. .++.++||||||+++|+|++|+.||......... ........+.++ ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~-----~~ 225 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-----MLIPKSKPPRLE-----DN 225 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----hccccCCCCCCC-----cc
Confidence 444455789999999988654 4689999999999999999999999743321110 000111111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+.++.+++.+||+.||++||++.|+++.
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 144569999999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=280.92 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=183.0
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|...+.||+|++|.||+|.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++......+..+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 355567999999999999964 57899999988543 22234668899999999999999999998876544322221
Q ss_pred cCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 895 SNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 895 ~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
... .....+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+...........
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 110 0124578889999999999999999999 999999999999999999999999999876554433334
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
...|++.|+|||...+..++.++||||||+++|||++|+.||........ .........+.... ....+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~ 244 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKN----LHKVSPR 244 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-----HHHHHhcCCCCCcc----cccCCHH
Confidence 45689999999999888899999999999999999999999864322111 01111111111111 1123456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1048 IVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.+++.+||+.+|++||++.|+++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=284.36 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=186.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|+.++++++||||+++++++...+..+.+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36888899999999999999954 578999999985432 22346788999999999999999999998765543322
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+ +... ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 95 ~-e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 95 M-EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred E-ecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 2 2111 123568889999999999999999999 999999999999999999999999999876655444
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......+++.|+|||.+.+..++.++||||||+++||+++|+.||.......... .....+... .......
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~--~~~~~~~ 241 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPE--LQNPEKL 241 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCCCCC--CCCcccc
Confidence 4444578899999999988889999999999999999999999996432211000 000011100 1112233
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+.+++.+||+.+|++||+++|+++.
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4568999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=292.09 Aligned_cols=244 Identities=21% Similarity=0.243 Sum_probs=180.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+++.. +++.||+|++.............+..|+.++..++|++|+++++++...+..+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv- 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV- 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE-
Confidence 47889999999999999999654 6889999998643222223345688899999999999999999998765543222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 22111 134578888899999999999999999 99999999999999999999999999998765443
Q ss_pred Cc-eeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC--CCCC
Q 042958 964 SN-WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD--PRLP 1035 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1035 (1075)
.. .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+.. .+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEERFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCccc
Confidence 22 233569999999998875 46788999999999999999999999643221 11111111 1111
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQ 1071 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1071 (1075)
.+. ...+.+.++.+++.+|+..++++ |++++++++
T Consensus 229 ~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111 11223456889999999866544 468888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=269.38 Aligned_cols=242 Identities=27% Similarity=0.341 Sum_probs=181.8
Q ss_pred CCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhc-CCcCceeeEEEEeeccccc-hhheec
Q 042958 819 DEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSHVRHS-LAMILS 895 (1075)
Q Consensus 819 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~-l~~~~~ 895 (1075)
....||.|+||+|+|-.+ .+|+..|||+++.... ...++++..|.+...+ -++||||+++|.+...+.. .+|.+.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 346699999999999955 4799999999987654 2235778888877544 4899999999987665544 333332
Q ss_pred C-----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 896 N-----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 896 ~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+ ......+++.-.-+|+.....||.||-+.. .|+|||+||+|||+|..|.+|+||||.+..+...-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 2 123455677767778888899999999875 89999999999999999999999999998765432
Q ss_pred ceeccccccCccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC--CCcC
Q 042958 965 NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT--PSCI 1040 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1040 (1075)
..+.-+|-..|||||.+... .|+.+|||||+|++|||+.||+.||+...+ .-+.+..++.+..|. ....
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCCeecCccc
Confidence 22334678899999988643 489999999999999999999999874332 122233333333222 1222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+....+..++..|+.+|-.+||..+++.++
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 23466789999999999999999999998764
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=281.43 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=182.2
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC-------chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG-------EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... .....+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999954 57999999987542211 1112356889999999999999999999987654
Q ss_pred cchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 888 HSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 888 ~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
..+ .+++.. .....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.++.
T Consensus 82 ~~~-lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLS-IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceE-EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 332 222211 1224678899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC--ceeccccccCccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 959 LKPDSS--NWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 959 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
...... ......++..|+|||.+.... ++.++||||+|+++||+++|+.||........ .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~ 233 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----MFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH----HHHhhccccCCcC
Confidence 543221 122346788999999987654 78999999999999999999999863222110 0000000011111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+.....+.+..+.+++.+||++||++||+++||++.
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 --PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111222345679999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=279.97 Aligned_cols=235 Identities=23% Similarity=0.383 Sum_probs=174.3
Q ss_pred ceecccCceEEEEEEEC-CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhheecC
Q 042958 821 HCIGKGGQGSVYKAELA-SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.||+|+||.||+|... ++. .+|+|.++... .....+.+..|+++++++ +||||+++++++......+ +.++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~-lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCce-EEEEe
Confidence 36899999999999664 444 46888876432 223356788999999999 8999999999987654332 22211
Q ss_pred cc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEe
Q 042958 897 NA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 897 ~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
.. ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence 10 123478999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhcc
Q 042958 952 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 952 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 155 dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~ 225 (270)
T cd05047 155 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLP 225 (270)
T ss_pred CCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHh
Confidence 99998632211 11112234567999999988889999999999999999997 99998643211 1111111
Q ss_pred CC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1031 DP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1031 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ....+ .....++.+++.+||+.+|.+|||++|+++.|+
T Consensus 226 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 226 QGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCCCCC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 11 11111 122346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=280.52 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=185.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+-|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++......+..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 3467788999999999999965 478999999876432 2233567899999999999999999999987655433222
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+... ....+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 82 -e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 -EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred -EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 1111 234578999999999999999999999 9999999999999999999999999999776543333
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....++..|+|||++.+..++.++||||||+++|+|++|..||....... ....+.....+. .....+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~---~~~~~~ 226 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPPT---LEGNYS 226 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCCCC---CCcccC
Confidence 344568889999999988889999999999999999999999986432111 111111111111 122334
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+++.+||+.+|.+||++.|+++
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 56899999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=276.53 Aligned_cols=241 Identities=26% Similarity=0.410 Sum_probs=182.2
Q ss_pred CCCCceecccCceEEEEEEECC-----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 817 FDDEHCIGKGGQGSVYKAELAS-----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
|++.+.||+|+||.||+|...+ +..||+|++..... ....+.+..|++.++.++|+||+++++++...+..+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567889999999999996653 38899999865422 2245789999999999999999999999877543322
Q ss_pred heecCc--------cccC-C-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNN--------AAAK-D-LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~--------~~~~-~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++.... .... . +++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 221111 0111 2 89999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcee-ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 962 DSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 962 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
...... ...+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ...+..........
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-- 225 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--------EVLEYLKKGYRLPK-- 225 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhcCCCCCC--
Confidence 422111 2336789999999988889999999999999999998 88887642211 11111111111111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
....+.++.+++.+|+..||++|||+.|+++.|
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112345699999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=291.59 Aligned_cols=244 Identities=20% Similarity=0.253 Sum_probs=179.5
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||++..+ +++.||+|++.+...........+..|+.++..++|++|+++++++......+. +
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l-v 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL-V 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE-E
Confidence 47888999999999999999665 578899999864222222234568899999999999999999998876654322 2
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++.. ....+++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 22111 134578888899999999999999999 99999999999999999999999999997654332
Q ss_pred Cc-eeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC--CCC
Q 042958 964 SN-WTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP--RLP 1035 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1035 (1075)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+... +.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~~ 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERFQ 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCcccc
Confidence 22 23457999999999886 3457889999999999999999999997432211 11111111 111
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQ 1071 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1071 (1075)
.+. .....+.++.+++.+|+..++++ |++++|+++
T Consensus 229 ~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 229 FPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred CCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 111 11223456889999988654444 689998875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=286.42 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=187.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|++++++++|+||+++++++...+..+ ++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY-LV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEE-EE
Confidence 36888899999999999999665 689999999865432 2233578899999999999999999999987654332 22
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.+...++.||+.|++|||+. +++||||+|+||+++.++.+||+|||.+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 2111 1123478899999999999999999999 999999999999999999999999999987665433
Q ss_pred -ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh------hhhhhc--cCC--
Q 042958 965 -NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN------IALDEM--LDP-- 1032 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~------~~~~~~--~~~-- 1032 (1075)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||.............. ...... .++
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 33445678899999999887 789999999999999999999999864322110000000 000000 000
Q ss_pred ---CCCCCC-------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1033 ---RLPTPS-------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1033 ---~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.++... ......+.++.+++++||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 0111125679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=281.50 Aligned_cols=245 Identities=22% Similarity=0.413 Sum_probs=184.3
Q ss_pred cCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.... .....+++.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 57888899999999999999753 34679999886432 22345789999999999999999999999876443
Q ss_pred chhhe-ecC----------ccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEe
Q 042958 889 SLAMI-LSN----------NAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 889 ~l~~~-~~~----------~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
.+..+ +.. ... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 22211 111 110 11589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCC-CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc
Q 042958 952 DFGIAKFLKPDS-SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 952 DfGla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHH
Confidence 999987543222 22333456788999999988889999999999999999998 888885332211 11111
Q ss_pred cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......+ .....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~~~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111 11123346999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=278.57 Aligned_cols=245 Identities=25% Similarity=0.411 Sum_probs=191.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|++|.||+|... +++.||||++...... ...+.+..|++.+++++|+|++++++++......+..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888899999999999999665 6999999998764322 34678999999999999999999999987764432222
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.... .....+++..+.+++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 1111 123567889999999999999999999 8 999999999999999999999999999987765444
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH-
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD- 1043 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1043 (1075)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+.....+. ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~ 227 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----FFELMQAICDGPPPS---LPAEE 227 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-----HHHHHHHHhcCCCCC---CCccc
Confidence 4345568899999999998889999999999999999999999987543211 111122222221111 1112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.+..+.+++.+||+.+|++||++.|+++.
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 44579999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=286.57 Aligned_cols=247 Identities=20% Similarity=0.229 Sum_probs=182.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++++......+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999654 68899999986543222334567889999999999999999999887655332222
Q ss_pred -ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 894 -LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 894 -~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
.... .....+++.....++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 1111 1234578888999999999999999999 999999999999999999999999999874211100
Q ss_pred --------------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc
Q 042958 965 --------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 965 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
......++..|+|||++.+..++.++|+||||+++||+++|+.||..... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 01123578899999999888899999999999999999999999863221 11111111
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
......+.. ....+..+.+++.+||+.||++||++.++.+.+
T Consensus 230 ~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 230 SDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred hcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 111111111 112344689999999999999999965555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=281.63 Aligned_cols=236 Identities=24% Similarity=0.417 Sum_probs=177.6
Q ss_pred ceecccCceEEEEEEECC-------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 821 HCIGKGGQGSVYKAELAS-------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.||+|+||.||+|+..+ ++.||+|.+.... ......++.+|+.+++.++||||++++++|......+..
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v- 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII- 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE-
Confidence 368999999999996542 2579999886432 123356789999999999999999999998765443222
Q ss_pred ecCcc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-----CceEec
Q 042958 894 LSNNA----------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-----EAHVSD 952 (1075)
Q Consensus 894 ~~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~D 952 (1075)
++... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 11110 123468899999999999999999998 999999999999999887 899999
Q ss_pred cccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhc
Q 042958 953 FGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 953 fGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~ 226 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHV 226 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHH
Confidence 999976543321 1122345688999999999999999999999999999998 999986332211 11111
Q ss_pred cC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1030 LD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1030 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ..... ....+..+.+++.+||+++|.+||++++|++.|+
T Consensus 227 ~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGGRLQK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCCccCC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 11111 1234557899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=278.68 Aligned_cols=230 Identities=23% Similarity=0.390 Sum_probs=171.9
Q ss_pred ceecccCceEEEEEEECC-C----------CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 821 HCIGKGGQGSVYKAELAS-G----------EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
+.||+|+||.||+|...+ + ..|++|.+.... .. ...+.+|+.++++++||||+++++++......
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcE
Confidence 468999999999997653 3 257888765432 11 57889999999999999999999998763222
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-------CceEeccc
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-------EAHVSDFG 954 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~DfG 954 (1075)
+.+.+... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 22211111 1122578999999999999999999999 999999999999999888 79999999
Q ss_pred cccccCCCCCceeccccccCccCccccccC--CCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
++..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||......... .... ..
T Consensus 154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-----~~~~--~~ 222 (259)
T cd05037 154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-----RFYQ--DQ 222 (259)
T ss_pred ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-----HHHh--cC
Confidence 9986543 2234567789999998876 78899999999999999999 57777543211100 0000 11
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.+. ...+.+++.+||..+|.+|||+.||++.|+
T Consensus 223 ~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 146899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=278.68 Aligned_cols=241 Identities=23% Similarity=0.351 Sum_probs=184.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCC--CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+..+.+.+|+++++.++|+||+++++++......+.+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999665 799999998865332 1233457899999999999999999999998765543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+ +... ....+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~-e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 L-ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred E-EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 2 1111 133478899999999999999999999 99999999999999999999999999998754432
Q ss_pred CceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......++..|+|||.+.... ++.++|+||||+++|++++|+.||....... ....... ....+. ...
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~--~~~~~~---~~~ 225 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-----AVFKIGR--SKELPP---IPD 225 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-----HHHHHHh--cccCCC---cCC
Confidence 234456889999999987766 8999999999999999999999986432111 0000011 011111 112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.+++.+||+.+|.+||++.|+++
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 23456899999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=290.57 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=185.2
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--- 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 888 (1075)
..++|+..+.||+|+||.||+|.. .+|+.||+|++..... ......++.+|+.++++++||||+++++++.....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 457899999999999999999954 4799999999865432 22334567889999999999999999998864331
Q ss_pred --chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 --SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 --~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
..+++++.... ...+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 11222222111 12378888899999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh--------------hhhhhh
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL--------------NLNIAL 1026 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~--------------~~~~~~ 1026 (1075)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+....... ......
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4322 2334678899999999999999999999999999999999999864321100000 000000
Q ss_pred hhccCCCC----------------CCCC-cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPRL----------------PTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~~----------------~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+. +... ......+..+.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 0000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=293.85 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=182.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46899999999999999999954 579999999986422 22234678899999999999999999988765432
Q ss_pred chhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 SLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 ~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
..+++++.. .....+++...+.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 111111111 1234688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCC---ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-------hhhhhhhcc
Q 042958 962 DSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------LNIALDEML 1030 (1075)
Q Consensus 962 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~ 1030 (1075)
... ......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 322 1223568899999998654 46889999999999999999999999643211000000 000000000
Q ss_pred CC-------CCCCCCc-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1031 DP-------RLPTPSC-----IVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1031 ~~-------~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.. ..+.... .....+.++.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000 001224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=278.82 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=185.9
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCc---hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
+|+..+.||+|+||.||+|.. .+++.||+|++....... ....+.+..|++++++++|+||+++++++.+.+....
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999954 679999999986543221 2235678999999999999999999999877665433
Q ss_pred heecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCC
Q 042958 892 MILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 962 (1075)
++.... .....+++.....++.|++.|+.|||+. +++|+||+|+||+++.++ .+||+|||.+..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 322111 1134578899999999999999999999 999999999999998876 5999999999876543
Q ss_pred CC----ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 963 SS----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 963 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.. ......++..|+|||.+.+..++.++||||+|+++|++++|+.||......... .......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~--~~~ 230 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-----ALIFKIASAT--TAP 230 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----HHHHHHhccC--CCC
Confidence 21 112346788999999998888999999999999999999999998633221110 0111110000 011
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........++.+++.+|++.+|.+||++.|+++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 122344567999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=279.36 Aligned_cols=240 Identities=22% Similarity=0.309 Sum_probs=167.9
Q ss_pred eecccCceEEEEEEECCC---CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 822 CIGKGGQGSVYKAELASG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.||+|+||.||+|...++ ..+++|.+.... .....+.+.+|+..++.++||||++++++|...... .+.++...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY-LLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc-EEEEecCC
Confidence 599999999999965433 346677665432 223357899999999999999999999998765432 22222111
Q ss_pred c-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC--
Q 042958 899 A-------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-- 963 (1075)
Q Consensus 899 ~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-- 963 (1075)
. .....+.....++.||++||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 1 12345566678999999999999999 99999999999999999999999999986432221
Q ss_pred CceeccccccCccCcccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 964 SNWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||.....................++..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 12234567889999998753 245789999999999999997 5678753322111110000111111112211
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......+.+++..|| .+|++||+++||++.|.
T Consensus 236 ------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 ------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 123346888999999 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=285.54 Aligned_cols=253 Identities=19% Similarity=0.247 Sum_probs=181.7
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc----
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---- 888 (1075)
++|+..+.||+|+||.||+|... +|+.||||+....... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46888999999999999999654 7899999987654322 22345788899999999 46999999998865443
Q ss_pred chhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccc
Q 042958 889 SLAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFG 954 (1075)
Q Consensus 889 ~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfG 954 (1075)
..+++++... ....+++...+.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 1111111110 124578999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh---hhhhc-
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI---ALDEM- 1029 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~- 1029 (1075)
.++.+...........+++.|+|||++.+ ..++.++||||||+++|||++|..||............... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 99876544333344467889999998765 45789999999999999999999998643322110000000 00000
Q ss_pred ------c----CCCCCC--CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 ------L----DPRLPT--PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ------~----~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. .+.... ...........+.+++.+||++||.+||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 00001123456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=277.37 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=183.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...+..+ +++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~-lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM-IVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEE-EEE
Confidence 478889999999999999954 47899999998754332 233578999999999999999999999876544332 222
Q ss_pred cCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCC
Q 042958 895 SNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 895 ~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 962 (1075)
+... ....+++..+.+++.|+++|++|||+. +++||||+|+||+++.++ .+|++|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 2111 134578999999999999999999999 999999999999998654 5899999999876543
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+...... ............ ...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~---~~~ 223 (256)
T cd08220 156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--------LVLKIMSGTFAP---ISD 223 (256)
T ss_pred cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--------HHHHHHhcCCCC---CCC
Confidence 22 233568889999999998889999999999999999999999986432211 111111111111 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 23446899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=279.84 Aligned_cols=230 Identities=21% Similarity=0.384 Sum_probs=170.6
Q ss_pred ceecccCceEEEEEEEC-C-------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 821 HCIGKGGQGSVYKAELA-S-------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~-~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
+.||+|+||.||+|... . ...||+|.+... .....+++..|+.+++.++||||+++++++......+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l- 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM- 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE-
Confidence 36999999999999553 2 234888887532 23335678899999999999999999999876544322
Q ss_pred eecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC--------ceEeccc
Q 042958 893 ILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE--------AHVSDFG 954 (1075)
Q Consensus 893 ~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~DfG 954 (1075)
+++.. .....+++..+.+++.||+.|++|||+. +|+||||||+||+++.++. ++++|||
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 22211 1123578999999999999999999999 9999999999999988765 5999999
Q ss_pred cccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCC-CCCCccCccccchhhhhhhhhhccCC
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK-HPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
.+...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .|+....... .......
T Consensus 154 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~~ 220 (258)
T cd05078 154 ISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFYED 220 (258)
T ss_pred cccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHHHc
Confidence 98765432 23467889999999886 45789999999999999999985 5554322111 0011111
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+...+. ....++.+++.+||+.||++|||++|+++.|+
T Consensus 221 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111 12245899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=261.39 Aligned_cols=254 Identities=19% Similarity=0.311 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
++|....++ +.+|+|+|+.|..+ ...+|..||||++.+. ....+.++.+|++++.+. .|+||+.+++||+
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 455555543 56999999999988 6788999999999875 234578899999999998 6999999999999
Q ss_pred ccccchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEecc
Q 042958 885 HVRHSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDF 953 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Df 953 (1075)
+.+.++.++....+ ....+++.+..++.++|+.||+|||.+ ||.|||+||+|||-.... -+|||||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 88776655543332 234578888899999999999999999 999999999999998765 4899999
Q ss_pred ccccccCCC-------CCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCc-------
Q 042958 954 GIAKFLKPD-------SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISS------- 1014 (1075)
Q Consensus 954 Gla~~~~~~-------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~------- 1014 (1075)
.++.-+.-. .....+.+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||.+.=.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887644322 12234578999999999763 33588999999999999999999999964221
Q ss_pred cccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+......+...+.+-++++..|...+.+.+.+..+++...+..||.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 122233345556777778888887788889999999999999999999999998875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=291.16 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=184.9
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc-c
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH-S 889 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~ 889 (1075)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ......+.+|+.+++++ +||||++++++|...+. .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3567888899999999999999654 6899999988643222 22345677899999999 99999999999865432 2
Q ss_pred hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+.++++... ....+.|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 84 IYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 222222211 122678899999999999999999999 9999999999999999999999999999866543
Q ss_pred CC-----ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh---------------
Q 042958 963 SS-----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------------- 1021 (1075)
Q Consensus 963 ~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------------- 1021 (1075)
.. ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 2233568899999998765 45788999999999999999999998643321100000
Q ss_pred ----hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1022 ----LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1022 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.......................+..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001111111111111234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=282.92 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=181.7
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|... +++.||||++..... .....++..|+.++.+. .||||++++++|......+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3467888999999999999999776 489999999875422 22345667788777666 5999999999987655432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.. ++... ....+++..+..++.|++.|++|||+.. +|+||||+|+||+++.++.+||+|||++..+..
T Consensus 91 ~v-~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 IC-MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EE-eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 22 21111 1346889999999999999999999732 899999999999999999999999999986643
Q ss_pred CCCceeccccccCccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ............+..
T Consensus 168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 239 (296)
T cd06618 168 SKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPSL 239 (296)
T ss_pred CCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCCC
Confidence 322 23345788999999987654 788999999999999999999998632110 111112222211111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
. .......++.+++.+||+.||++||+++++++.
T Consensus 240 ~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 111234568999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=279.43 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=184.3
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||+|... +|..||+|.+....... ...+.+.+|+++++.++|+||+++++++......+.++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778899999999999999654 68999999986532221 234678899999999999999999998876544322221
Q ss_pred cCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCCC
Q 042958 895 SNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 895 ~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 963 (1075)
... .....+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 110 1123478999999999999999999999 999999999999999886 46999999998766543
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||...... ...........+.. ...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---~~~ 225 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQGYFAPI---SPN 225 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcccCCCC---CCC
Confidence 3334456889999999998888999999999999999999999998633211 11112222221111 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.+.++.+++.+||+.+|++|||++||++.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 33468999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=280.69 Aligned_cols=243 Identities=25% Similarity=0.392 Sum_probs=187.8
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++.|+..+.+|+|+||.||+|... +++.||+|++..... ..+.+..|++.++.++|+||+++++++......+.
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888899999999999999665 789999999875432 35678899999999999999999998876544322
Q ss_pred heecCcc---------cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNNA---------AA-KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~~---------~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.+ +... .. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 v~-e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 93 VM-EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EE-eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 22 1111 11 2789999999999999999999998 999999999999999999999999999876654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||........ .........+. ....
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~-~~~~ 239 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--------LFLITTKGIPP-LKNP 239 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcCCCC-Ccch
Confidence 43333445678899999999888899999999999999999999999864322110 11111111111 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+..+.+++.+||+.+|.+||++.||++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2234569999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=284.52 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=180.8
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|+..+.||+|++|.||+|... +|+.||+|++...... ....+.+.+|++++++++||||+++++++......+.++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888999999999999999654 7899999998654322 223467889999999999999999999997755433222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccccccccCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~ 962 (1075)
+... ....+++.....++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||++......
T Consensus 81 -e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 -EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred -ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 2111 112246777788999999999999999 9999999999999985 457999999999866544
Q ss_pred CCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh---hhhhhc---------
Q 042958 963 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN---IALDEM--------- 1029 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~--------- 1029 (1075)
........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.............. ......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 3333445678899999988764 578899999999999999999999864322110000000 000000
Q ss_pred ---cCCCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 ---LDPRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ---~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..+.. .......+..+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 0001122346889999999999999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=290.95 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=184.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|.+.+.||+|+||.||+|.. .+++.||||.+....... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45788999999999999999954 579999999987543222 224567789999999999999999998764421
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
..+++++.. .....+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 112222211 1235688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccch---------------hhhhh
Q 042958 961 PDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS---------------LNLNI 1024 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~---------------~~~~~ 1024 (1075)
..........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 44333344567889999998764 468899999999999999999999986432110000 00000
Q ss_pred hhhhccC--CCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1025 ALDEMLD--PRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1025 ~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
....... +..+.+ .......+..+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000 000000 00112345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=287.55 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=181.8
Q ss_pred CCCCCceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLA 891 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~ 891 (1075)
+|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.++++++||||+++++++.... ..+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999654 48999999987643222333467788999999999999999999998762 2222
Q ss_pred heecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC----CCCceEeccc
Q 042958 892 MILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF----DNEAHVSDFG 954 (1075)
Q Consensus 892 ~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~DfG 954 (1075)
++++... ....++....+.++.|++.|++|||+. +|+||||||+||+++. ++.+|++|||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 2222111 113577888899999999999999999 9999999999999999 8999999999
Q ss_pred cccccCCCCC---ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCcccc-chhhhhhhhh--
Q 042958 955 IAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS-SSLNLNIALD-- 1027 (1075)
Q Consensus 955 la~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~-- 1027 (1075)
+++....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987654322 12334678899999987764 578999999999999999999999974432210 0000000000
Q ss_pred --------------------------hccCCCCCCCCcCc------HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 --------------------------EMLDPRLPTPSCIV------QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 --------------------------~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+. .... ......+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 0000 023346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=311.16 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=187.3
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh-
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA- 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~- 891 (1075)
+-+++....||.|.||.||-| ...+|+..|+|-++..... ....+...+|+.++..++|||+|+++|+-.+.+..+.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 356777889999999999999 6778999999988765433 4445778999999999999999999998877554322
Q ss_pred heecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 892 MILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 892 ~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
|.+...+ .+.-.++.....+..|++.|++|||++ |||||||||.||+++.+|-+|++|||.|+.+.++..
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 2222221 122234445566889999999999999 999999999999999999999999999998876643
Q ss_pred c----eeccccccCccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 965 N----WTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 965 ~----~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
. .....||+-|||||++.+.. ...++||||+|||+.||+||+.||...+..... +..+-.+.-|.
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI-------My~V~~gh~Pq- 1461 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI-------MYHVAAGHKPQ- 1461 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-------HhHHhccCCCC-
Confidence 2 23568999999999998654 567899999999999999999999744432111 11111112111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+...+.+-.+++.+|+..||++|-++.|+++
T Consensus 1462 --~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 --IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 22335667889999999999999999988876
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=271.04 Aligned_cols=240 Identities=30% Similarity=0.465 Sum_probs=185.8
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++.++.++||+|+++++++......+..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4778899999999999999665 789999999875432 345789999999999999999999998876543322211
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 111 1124689999999999999999999998 999999999999999999999999999987665432
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ........+..+.. ...+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~ 224 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKIATNGPPGLRNP----EKWS 224 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHHhcCCCCcCcc----cccC
Confidence 34457889999999998888999999999999999999999998743221100 00111111111111 1124
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 56999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=282.72 Aligned_cols=238 Identities=27% Similarity=0.384 Sum_probs=180.8
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|...+.||+|+||.||+|.. .+|+.||+|++...........+.+..|+++++.++|||++++++++.+....+.++..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999965 46899999998754434444456788999999999999999999998776543322211
Q ss_pred Cc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 896 NN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 896 ~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. .....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++..... ..
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 11 1234588999999999999999999999 999999999999999999999999999865322 23
Q ss_pred ccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 968 ELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
...|+..|+|||++. ...++.++||||||+++|||++|+.||........ .........+.. .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~--~~~~~ 245 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTL--QSNEW 245 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHHhcCCCCC--Ccccc
Confidence 456888999999874 45688899999999999999999999864322110 011111111110 11123
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+..+.+++.+||+++|.+||++.|+++
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 345899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=282.19 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=184.7
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc--
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-- 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 888 (1075)
.+.++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ......+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999665 6899999998754322 2224567889999999999999999998876441
Q ss_pred -------chhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 889 -------SLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 889 -------~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
.+.++++... ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 1222222211 123578999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh------
Q 042958 953 FGIAKFLKPDSS-NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI------ 1024 (1075)
Q Consensus 953 fGla~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~------ 1024 (1075)
||.+........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...............
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999987654332 2233456788999998765 35788999999999999999999998743321100000000
Q ss_pred -hhhhccC--------CCCC--CC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 -ALDEMLD--------PRLP--TP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 -~~~~~~~--------~~~~--~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.. .... .. .......+..+.+++.+||+.||.+||+++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 0000 00 0001112456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=290.19 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=181.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
..+|...+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+++++.++||||+++++++......
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 47899999999999999999965 57999999998754322 22345688999999999999999999988654321
Q ss_pred --hhheecCc------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 --LAMILSNN------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 --l~~~~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+....... .....+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 11111111 0123678999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hh--------
Q 042958 962 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IA-------- 1025 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~-------- 1025 (1075)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 233467889999998876 4588999999999999999999999974332110000000 00
Q ss_pred hhhccC--CCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 LDEMLD--PRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...... +..+... .........+.+++.+||+.||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 0000000 000122346889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=277.70 Aligned_cols=243 Identities=25% Similarity=0.318 Sum_probs=186.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||.|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++......+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999654 699999999876443333446789999999999999999999988766544322221
Q ss_pred cC-c-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SN-N-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~-~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.. . .....+++.....++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.+....... ..
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 11 1 1124688899999999999999999999 99999999999999999999999999998765432 23
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ...............+ ...+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~ 227 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQETADVLYP----ATWST 227 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhccccccCc----ccCcH
Confidence 34568889999999998889999999999999999999999987443210 0011111111111111 22345
Q ss_pred HHHHHHHHccCCCCCCCCCH--HHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTM--PKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~--~evl~ 1071 (1075)
.+.+++.+||+.||.+||++ +|+++
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhc
Confidence 79999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=282.19 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=183.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|++|.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++...+..+..+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788899999999999999764 6899999998754322 224567789999999999999999999887654322211
Q ss_pred -cC---------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 895 -SN---------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 895 -~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.. ......+++..+.+++.|+++|++|||+. +++||||||+||++++++.++++|||.+........
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 11 11124578999999999999999999999 999999999999999999999999999986554333
Q ss_pred ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhhhhhcc-----C
Q 042958 965 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIALDEML-----D 1031 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~-----~ 1031 (1075)
......++..|+|||++.+. .++.++||||+|+++||+++|+.||......+...... ....+.+. .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 33345678899999987654 56889999999999999999999987443211000000 00000000 0
Q ss_pred CCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+... ......+..+.+++.+|++.||.+||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=277.93 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=181.0
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeecccc----
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---- 888 (1075)
|++.+.||+|+||.||+|..+ +++.||+|++......+ .....+.+|+.+++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567789999999999999776 58999999997543322 2235566788777666 59999999999876543
Q ss_pred chhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 889 SLAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 889 ~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
.+.++++.. .....+++.+++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+..
T Consensus 80 ~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 80 KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 122222111 1123589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhc---------
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM--------- 1029 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 1029 (1075)
+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ....+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL----DKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH----HHHHHHcCCCChHhcC
Confidence 654322 23345788999999999989999999999999999999999998743321100 0000000
Q ss_pred ---------cCCCC-CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 ---------LDPRL-PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ---------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..... ........+....+.+++.+||+.||++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0001112234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=283.30 Aligned_cols=241 Identities=27% Similarity=0.382 Sum_probs=181.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..+.||+|+||.||+|.. .+++.||+|.+...........+++.+|+++++.++|+|++++++++......+.++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466678899999999999965 468899999986533233334567889999999999999999999987754432222
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.... .....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 1111 1234578899999999999999999999 9999999999999999999999999998765432
Q ss_pred eeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 966 WTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ..........+.. ...
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~--~~~ 237 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPAL--QSG 237 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcCCCCc--Ccc
Confidence 2346788999999874 3467889999999999999999999986332111 0011111111110 112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.....+.+++.+||+.+|++||++++|++.
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 344568999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=287.47 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=186.6
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
..++...+++|+..+.||+|+||.||+|. ..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45666788999999999999999999995 457999999998754322 2234668889999999999999999998754
Q ss_pred cccc-----hhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 886 VRHS-----LAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 886 ~~~~-----l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
.... ...+.+.. .....+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~df 164 (345)
T cd07877 88 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 164 (345)
T ss_pred cccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecc
Confidence 3211 11111111 1124588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-------hhhh
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------LNIA 1025 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------~~~~ 1025 (1075)
|+++.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ ....
T Consensus 165 g~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 165 GLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99986432 2233567889999998766 46788999999999999999999998533221100000 0000
Q ss_pred hh--------hccC--CCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 LD--------EMLD--PRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~~--------~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. .+.. +..+... ........++.+++.+|++.||.+||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00 0000 0001000 000112446889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=280.35 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=183.6
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++++++......+.+ +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v-~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV-M 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE-e
Confidence 478889999999999999965 478999999987643222 2356789999999999999999999998775443222 2
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
+... ....+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++++|||.+........
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 1111 124578999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh----------------hhh
Q 042958 965 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI----------------ALD 1027 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~----------------~~~ 1027 (1075)
......++..|+|||++.+. .++.++||||+|+++|||++|+.||............... ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 23345688999999988654 4689999999999999999998887533221100000000 000
Q ss_pred hccCCCCCC-C-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPT-P-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.... + .....+....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0 0001123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=288.41 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=184.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc---cc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR---HS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~ 889 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 47899999999999999999954 57999999998754322 223467788999999999999999998775432 11
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.++++.. .....+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 83 VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 22222211 1234589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCc----eeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh---------------
Q 042958 962 DSSN----WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------------- 1021 (1075)
Q Consensus 962 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------------- 1021 (1075)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 3221 223468899999998765 45889999999999999999999999643321100000
Q ss_pred hhhhhhhcc---CCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 LNIALDEML---DPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 ~~~~~~~~~---~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......... ....+.+ .......+..+.+++.+|++.||++||+++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000 0000000 0001223567999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=274.57 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=183.7
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCC--CCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-ch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPL--PGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l 890 (1075)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... .........+.+|++++++++||||+++++++.+... .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999954 569999999875321 1223345678999999999999999999998865432 22
Q ss_pred hheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.++++.. .....+++....+++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 2222221 1124578888999999999999999999 999999999999999999999999999986543
Q ss_pred CC---CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.. .......++..|+|||++.+..++.++||||||+++||+++|+.||...... ....+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~--~~ 228 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQPT--KP 228 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCCC--CC
Confidence 21 1223456889999999999888999999999999999999999998643211 11111111100 01
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+......+.+++.+||+ +|.+||++.++++.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1223344569999999999 57999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.85 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=180.9
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc--
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN-- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~-- 897 (1075)
..||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++|+|++++++++...+..+..+....
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 5799999999999966 47899999987542 22335678999999999999999999998876554332221111
Q ss_pred -----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccc
Q 042958 898 -----AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972 (1075)
Q Consensus 898 -----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt 972 (1075)
.....+++.....++.|++.|++|||+. +++||||+|+||++++++.++++|||++..............++
T Consensus 103 ~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 103 ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 1123578899999999999999999999 99999999999999999999999999987665443333445688
Q ss_pred cCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHH
Q 042958 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052 (1075)
Q Consensus 973 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1052 (1075)
+.|+|||++.+..++.++||||+|+++|||++|+.||........ ...........+.. ....+..+.+++
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~l~~li 250 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPKLKN----LHKVSPSLKGFL 250 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhhCCcccCC----cccCCHHHHHHH
Confidence 999999999888899999999999999999999999864222110 01111111111111 122344688999
Q ss_pred HHccCCCCCCCCCHHHHHh
Q 042958 1053 ISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1053 ~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+||+.||.+||++.|+++
T Consensus 251 ~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 251 DRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHhCCcccCcCHHHHhc
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=277.92 Aligned_cols=236 Identities=25% Similarity=0.297 Sum_probs=177.0
Q ss_pred ecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc---
Q 042958 823 IGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA--- 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~--- 898 (1075)
||+|+||+||+|.. .+|+.||+|.+...........+.+..|+++++.++||||+++++++...+..+ +++++..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLC-LVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEE-EEEecCCCCc
Confidence 69999999999954 479999999986533222233456778999999999999999999887655432 2222111
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccc
Q 042958 899 --------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
....+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+...... .......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 123588999999999999999999999 9999999999999999999999999999866432 2233456
Q ss_pred cccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHH
Q 042958 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 971 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1050 (1075)
++..|+|||++.+..++.++||||+|+++|+|++|+.||......... ............. .....+..+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRRTLEMAVE----YPDKFSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HHHHhcccccccc----CCccCCHHHHH
Confidence 788999999998888999999999999999999999998643321110 0111111111111 12223456899
Q ss_pred HHHHccCCCCCCCC-----CHHHHHh
Q 042958 1051 VAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
++.+||+.||.+|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=272.21 Aligned_cols=234 Identities=25% Similarity=0.308 Sum_probs=181.1
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc---
Q 042958 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA--- 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~--- 898 (1075)
||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+....+. +++...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l-v~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM-LMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE-EEecCCCCc
Confidence 699999999999664 589999999876543334456789999999999999999999998876554332 222211
Q ss_pred ------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccc
Q 042958 899 ------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972 (1075)
Q Consensus 899 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt 972 (1075)
....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 155 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGT 155 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCC
Confidence 134578889999999999999999998 99999999999999999999999999998765432 22334688
Q ss_pred cCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC--CCCCCCCcCcHHHHHHHHH
Q 042958 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVE 1050 (1075)
Q Consensus 973 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~ 1050 (1075)
..|+|||.+.+..++.++|+||+|+++|||++|+.||...... .......+.. .....+ ...+..+.+
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 225 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNGKLEFP----NYIDKAAKD 225 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCCCCCCC----cccCHHHHH
Confidence 9999999998888999999999999999999999998743310 1111222221 111111 122456999
Q ss_pred HHHHccCCCCCCCCC-----HHHHHh
Q 042958 1051 VAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
++.+||+.+|++||+ ++|+++
T Consensus 226 ~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 226 LIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999 788765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=284.51 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=185.4
Q ss_pred HHHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
...+++|+..+.||+|+||.||+|. ..+++.||||++...... ....+.+..|++++++++||||+++++++......
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4567889999999999999999995 458999999988654322 22346788999999999999999999988664433
Q ss_pred hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+++++... ....+++.....++.|+++|++|||+. +|+||||+|+||+++.++.+|++|||.+......
T Consensus 85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 323322221 134567888889999999999999999 9999999999999999999999999999764332
Q ss_pred CCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-------hhhhhhhccC---
Q 042958 963 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------LNIALDEMLD--- 1031 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~--- 1031 (1075)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ .........+
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 233467889999998765 56899999999999999999999998643221000000 0000000000
Q ss_pred ----CCCCC----C-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1032 ----PRLPT----P-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1032 ----~~~~~----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+. + ..........+.+++.+|++.+|++|||++|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0 00011234579999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=281.78 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=180.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||++++++|......
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 45789999999999999999965 47999999988654322 22234567899999999999999999988654321
Q ss_pred ----hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 890 ----LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 890 ----l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
..++++... ....+++.+.+.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 122222111 123578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc----eeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------h
Q 042958 957 KFLKPDSSN----WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------I 1024 (1075)
Q Consensus 957 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~ 1024 (1075)
..+...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.............. .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866443221 2234578899999987664 468899999999999999999999864332110000000 0
Q ss_pred ------hhhhccCCCCCCCCc-C------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ------ALDEMLDPRLPTPSC-I------VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ------~~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..........+.... . .......+.+++.+||+.||.+|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000000000 0 0001235779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=304.40 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=187.4
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC----C----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEE
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA----S----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYG 881 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 881 (1075)
+...++..+.+.+|+|+||.|++|... . ...||||+++..... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 334445566679999999999999542 1 457999999876443 4578999999999999 6999999999
Q ss_pred EeeccccchhheecCc------------c-----------cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 042958 882 FCSHVRHSLAMILSNN------------A-----------AA--KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDIS 936 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~------------~-----------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 936 (1075)
+|...+.. ..+.++. . .. ..++..+.+.++.|||.|++||++. ++||||+.
T Consensus 370 ~~t~~~~~-~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPL-YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eeccCCce-EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 99873322 2221110 1 01 2388899999999999999999999 99999999
Q ss_pred CCCeeeCCCCCceEeccccccccCCCCCce-ecccc--ccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcc
Q 042958 937 SKNVLLDFDNEAHVSDFGIAKFLKPDSSNW-TELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 1012 (1075)
Q Consensus 937 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~ 1012 (1075)
++||+++++..+||+|||+|+...+..... ....+ +..|||||.+....|+.++|||||||++||++| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999765543322 22232 457999999999999999999999999999998 99998642
Q ss_pred CccccchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1013 SSMSSSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... ....+...++ ++..|. .+..+++++|+.||+.+|++||++.|+++.++
T Consensus 526 ~~~-------~~l~~~l~~G~r~~~P~----~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 526 PPT-------EELLEFLKEGNRMEQPE----HCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred CcH-------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 211 0112222222 233332 23446999999999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=277.64 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=182.6
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchhhee
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLAMIL 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~~~~ 894 (1075)
|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+.+|+++++.++|||++++++++.... ....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567789999999999999665 58999999997653 22333467889999999999999999999987761 2222222
Q ss_pred cCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 895 SNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 895 ~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
+... ....+++..++.++.|+++|++|||+. +++|+||+|+||++++++.+|++|||.+........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 2111 124688999999999999999999999 999999999999999999999999999987654432
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hhhh---hc----
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IALD---EM---- 1029 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~~~---~~---- 1029 (1075)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+............. .... ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233456889999997765 4578999999999999999999999864332110000000 0000 00
Q ss_pred -cCCCCCCCC---cCcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1030 -LDPRLPTPS---CIVQD-KLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1030 -~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.......+. ..... ++..+.+++.+||+.+|.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00001 25578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=271.65 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=187.3
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|||++++++++......+.+ +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v-~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII-L 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE-E
Confidence 4778899999999999999554 6889999999765432 23457899999999999999999999988765433222 2
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+.. .....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 111 1125689999999999999999999999 9999999999999999999999999999887655443
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||....... ..........+..+ ...+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~------~~~~ 224 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALFRIVQDDHPPLP------EGIS 224 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhccCCCCCC------CCCC
Confidence 445678899999999988888999999999999999999999986433211 00011111111111 1223
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+++.+|++.+|++|||+.|++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 225 PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 46899999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=277.42 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=178.4
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccc-cchhhe
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVR-HSLAMI 893 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~l~~~ 893 (1075)
|++.+.||+|+||.||+|.. .+++.||+|+++....... .....+|+..++++. |+|++++++++.+.. ..+.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56778999999999999954 4789999999875432221 234457888999885 999999999988652 222222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++.......
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 79 FELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 22211 124689999999999999999999999 9999999999999999 9999999999987654322
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhhhhh-----ccC
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIALDE-----MLD 1031 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~~~~-----~~~ 1031 (1075)
.....++..|+|||+..+ ..++.++||||+||++|||++|+.||......+...... ...... ..+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 233567889999997654 557889999999999999999999996433211000000 000000 000
Q ss_pred CCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+... ......+..+.+++.+||+++|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0111000 001234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=271.18 Aligned_cols=240 Identities=25% Similarity=0.387 Sum_probs=187.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|+..+.||+|+||.||++... +++.||+|++...... ....+++.+|+++++.++|||++++++.+......+.. +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv-~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV-M 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE-E
Confidence 4778899999999999999654 6899999998764332 23457789999999999999999999988765333222 2
Q ss_pred cCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 895 SNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 895 ~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+... ....+++.+...++.++++|+.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 1111 136688999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........|++.|+|||...+..++.++||||+|+++|+|++|+.||+..... ...........+.. .
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---~ 224 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPI---P 224 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCC---C
Confidence 443334457889999999998888999999999999999999999998643211 11111112111111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+.+++.+||..+|++|||+.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 123346899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=285.11 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=181.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|++.+.||+|+||.||+|... +++.||||++......+. ....+.+|++++++++||||+++++++......
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 478999999999999999999654 689999998865432221 134567899999999999999999877543321
Q ss_pred ----hhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 890 ----LAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 890 ----l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
+.++++.. .....+++.++..++.|+++||+|||+. +|+||||||+||++++++.+|++|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 12221111 1234689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-----------eeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-
Q 042958 957 KFLKPDSSN-----------WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN- 1023 (1075)
Q Consensus 957 ~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~- 1023 (1075)
+........ .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865433211 1233567889999987654 578999999999999999999999864332110000000
Q ss_pred ------------hhhhh----ccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ------------IALDE----MLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ------------~~~~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..... ......+.. ..........+.+++.+|++.||++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 000011100 0000112246889999999999999999999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=273.32 Aligned_cols=237 Identities=20% Similarity=0.236 Sum_probs=172.6
Q ss_pred ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHH-hcCCcCceeeEEEEeeccccchhheecCc-
Q 042958 821 HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIRHRNIVKFYGFCSHVRHSLAMILSNN- 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~l~~~~~~~- 897 (1075)
+.||+|+||.||+|.. .+|+.||||++.............+..|..++ ...+|+|++++++++...+..+.. ++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv-~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV-MEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE-EeccC
Confidence 4699999999999965 46899999998654322222233445555544 455899999999998765443222 2211
Q ss_pred --------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecc
Q 042958 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969 (1075)
Q Consensus 898 --------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 969 (1075)
.....+++..+.+++.|++.||.|||+. +++||||+|+||+++.++.+|++|||+++.... ....
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~ 153 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKF 153 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cccC
Confidence 1224578899999999999999999999 999999999999999999999999999876432 2234
Q ss_pred ccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 970 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
.++..|+|||...+..++.++||||+|+++|||++|..||....... ............+.......+..+.
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcccCCCCcccccCCHHHH
Confidence 67889999999988888999999999999999999999986432211 1111111111111111223445699
Q ss_pred HHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1050 EVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
+++.+||+.+|++||++.++.+.+
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHH
Confidence 999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=269.24 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=188.5
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchhhe
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLAMI 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~~~ 893 (1075)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++++.... ..+.++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4777899999999999999665 7999999998765322 334678999999999999999999999987752 122222
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 2211 1123789999999999999999999998 999999999999999999999999999987765433
Q ss_pred --ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcCc
Q 042958 965 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCIV 1041 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1041 (1075)
......++..|+|||...+..++.++||||||+++|++++|+.||...... ......... ...+. ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~---~~ 226 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGEPPE---IP 226 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCCCcC---CC
Confidence 134457889999999998888999999999999999999999999754311 111111111 11111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 233557999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=271.99 Aligned_cols=239 Identities=24% Similarity=0.308 Sum_probs=186.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
+|++.+.||+|+||.||++.. .+++.+|+|++....... ....++.+|++++++++|+||+++++++......+.++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~- 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM- 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe-
Confidence 477889999999999999954 478999999987543222 33567889999999999999999998877654332222
Q ss_pred cCc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 895 SNN-------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 895 ~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.. .....+++...+.++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 111 1124578889999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. ......+++.|+|||...+..++.++|+||+|+++||+++|+.||....... ..........+. ..
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~---~~ 222 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYPP---IP 222 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCCC---Cc
Confidence 4 2233567889999999999889999999999999999999999986433211 111111222221 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.....++.+++.+|++.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2455679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=275.40 Aligned_cols=236 Identities=21% Similarity=0.216 Sum_probs=170.3
Q ss_pred eecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHH---hcCCcCceeeEEEEeeccccchhheecCc
Q 042958 822 CIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL---TEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
.||+|+||.||+|.. .+++.||+|.+.............+..|..++ ...+||+|+.+++++...+..+.+ +++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv-~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI-LDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE-EecC
Confidence 489999999999965 46899999988654332222223344454433 334799999999988765443222 2211
Q ss_pred ---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 898 ---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 898 ---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
.....+++.....++.|++.|++|||+. +|+||||||+||++++++.++++|||++....... ...
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 154 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHA 154 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccC
Confidence 1234589999999999999999999999 99999999999999999999999999997654322 223
Q ss_pred cccccCccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 969 LAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
..|+..|+|||.+. +..++.++||||+||++|||++|+.||.......... ... ........+ ....+.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~-~~~~~~~~~------~~~~~~~ 225 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDR-MTLTVNVEL------PDSFSPE 225 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHH-HhhcCCcCC------ccccCHH
Confidence 46899999999886 4568899999999999999999999997433211110 000 000111111 2233456
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHhh
Q 042958 1048 IVEVAISCLDENPESRP-----TMPKVSQL 1072 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RP-----s~~evl~~ 1072 (1075)
+.+++.+|++.||++|| +++|+++.
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 226 LKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 89999999999999999 59998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=259.15 Aligned_cols=195 Identities=23% Similarity=0.356 Sum_probs=154.6
Q ss_pred HhcCCCCCceecccCceEEEEE-EECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
....|+....||+|.||.||+| ..++ ...+|+|+++........ ....-+|+..++.++||||+.+..++...+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3467889999999999999999 3332 236999999765433222 245678999999999999999987776533
Q ss_pred cchhhee-------------cCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC----CCceE
Q 042958 888 HSLAMIL-------------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD----NEAHV 950 (1075)
Q Consensus 888 ~~l~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl 950 (1075)
..+.+.+ +.......++-.....|..||+.|+.|||+. =|+|||+||.||++..+ |.+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 3322222 2223346678888899999999999999999 79999999999999988 89999
Q ss_pred eccccccccCCCCCc---eeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCc
Q 042958 951 SDFGIAKFLKPDSSN---WTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDF 1011 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~ 1011 (1075)
+|||+|+.+...-.. ....+.|+.|+|||.+.+.+ |+++.||||.||++.||+|-++-|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999988765332 34567899999999988764 89999999999999999998877653
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=276.01 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=185.2
Q ss_pred CCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|+..+.||+|++|.||+|.. .+|+.+|+|++...... ......+..|++++++++|+||+++++++......+.++..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56778999999999999965 47899999998754332 23356788999999999999999999988765433222111
Q ss_pred Cc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 896 NN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 896 ~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. .....+++.++..++.|+++|++|||+. +|+|+||||+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 10 1124678999999999999999999999 999999999999999999999999999987765543334
Q ss_pred ccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hhhhhccC--------
Q 042958 968 ELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IALDEMLD-------- 1031 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~-------- 1031 (1075)
...++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+....... ........
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 45678899999998776 789999999999999999999999864332111000000 00000000
Q ss_pred -CC--CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 -PR--LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 -~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+. ...........+.++.+++.+||++||.+||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00000112234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=285.34 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=185.8
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----cch
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----HSL 890 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~l 890 (1075)
+|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4788899999999999999664 589999999875432 2233567899999999999999999999887654 112
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++++.. .....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 2222211 1223688999999999999999999999 9999999999999999999999999999876654
Q ss_pred C---CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh---------------h
Q 042958 963 S---SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL---------------N 1023 (1075)
Q Consensus 963 ~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------------~ 1023 (1075)
. .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||............. .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 123445678899999999887 78999999999999999999999986433211000000 0
Q ss_pred hhhhhccC---CCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLD---PRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........ ...+.+ .......+..+.+++.+||+.+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 000000 0001123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=274.78 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=179.6
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc---
Q 042958 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA--- 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~--- 898 (1075)
||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++||||+++++.+......+.++ +...
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~-e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVM-EYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEE-ecCCCCc
Confidence 689999999999765 59999999987544333345678899999999999999999998876544332222 2111
Q ss_pred ------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC--------
Q 042958 899 ------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-------- 964 (1075)
Q Consensus 899 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-------- 964 (1075)
....+++..+.+++.|+++||+|||+. +++||||+|+||+++.++.++++|||++........
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 123678999999999999999999999 999999999999999999999999999876543321
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......++..|+|||...+..++.++||||||+++||+++|+.||...... .............+... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~--~~ 226 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKIEWPEDV--EV 226 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCcCCCccc--cC
Confidence 223456788999999998888999999999999999999999998643211 11112221222211111 12
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
+..+.+++.+||+.+|++|||+.+|.+.|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 45689999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=275.25 Aligned_cols=236 Identities=22% Similarity=0.297 Sum_probs=192.1
Q ss_pred CceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC--
Q 042958 820 EHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN-- 896 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~-- 896 (1075)
.+++|.|.||+||-|.+ ++|+.||||++.+...... ...++..|+.+++.++||.||.+.-.|+..+..++++...
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47899999999999955 5899999999987654433 3578999999999999999999998887766544333111
Q ss_pred -------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEeccccccccCCCCCce
Q 042958 897 -------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 897 -------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~~ 966 (1075)
.....+++......++.||+.||.|||.. +|||+|+||+|||+.... ++|+||||.|+.++. .+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksFR 723 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSFR 723 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hhhh
Confidence 12355678888888999999999999999 999999999999997543 799999999998874 4556
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
...+||+.|.|||+++...|...-|+||.||++|.-++|..||...++ .-+++-+..+..|...+.+...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----------hhHHhhccccccCCCchhhcCH
Confidence 778999999999999999999999999999999999999999974322 1233334445555556777888
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHH
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVS 1070 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl 1070 (1075)
...++|...++..-.+|-|.++-+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhc
Confidence 899999999999999998887654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=283.32 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=184.6
Q ss_pred HHHHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
+....++|++.+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 33456789999999999999999995 45799999999865332 22334678899999999999999999998865432
Q ss_pred c-----hhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 889 S-----LAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 889 ~-----l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
. +.+++... .....+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 1 11111111 1134688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhh---
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIA--- 1025 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~--- 1025 (1075)
...... .....+++.|+|||++.+ ..++.++|+||+|+++|++++|+.||............. ...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 166 RQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 865432 233467889999998876 457899999999999999999999997432210000000 000
Q ss_pred -----hhhccC--CCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 -----LDEMLD--PRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 -----~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...... +..... ..........+.+++.+|++.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000 0001123346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=254.10 Aligned_cols=243 Identities=22% Similarity=0.267 Sum_probs=190.7
Q ss_pred HhcCCCCC-ceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc---
Q 042958 813 ATNDFDDE-HCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV--- 886 (1075)
Q Consensus 813 ~~~~~~~~-~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 886 (1075)
.+++|++. ++||-|-.|.|..+ ...+|+.+|+|++... ....+|++.--.. .|||||.++++|...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 46677664 57999999999999 4458999999998642 3445677764333 799999999988643
Q ss_pred ccchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEec
Q 042958 887 RHSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSD 952 (1075)
Q Consensus 887 ~~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~D 952 (1075)
...+.++++... +...+++.+.-.|+.||+.|+.|||+. .|.||||||+|+|.+.. ..+|++|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 334444443322 234478888899999999999999999 99999999999999754 4699999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
||+|+.-... ....+.+-|+.|.|||++...+|+...|+||+||+||-|++|.+||......... ......+...
T Consensus 208 fGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----pgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKRRIRTG 282 (400)
T ss_pred cccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----hhHHhHhhcc
Confidence 9999975532 3455678899999999999999999999999999999999999999754442221 1222344455
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..|...+.+.+.+..++|+.++..+|.+|.|+.|+++
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 555566677888899999999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=278.29 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=189.7
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-h
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-L 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l 890 (1075)
....|.+...||+|.|+.|..|++ .+|..||||.+.+..... ...+.+.+|+++|+.+.|||||+++.+....... +
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 346788889999999999999955 479999999998765443 3345689999999999999999999988754433 2
Q ss_pred hheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 891 AMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 891 ~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.+... .............++.|+.+|++|+|++ .|||||||++||+++.+..+||+|||++.++.. .
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY-G 208 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc-c
Confidence 2222211 1223344567778899999999999999 999999999999999999999999999998873 3
Q ss_pred CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....+.+|++.|.|||++.+..| .+++|+||+|+++|.++.|..||++..- ...-+..+..++..+...
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~rIp~~m-- 278 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYRIPFYM-- 278 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeeccccee--
Confidence 44567899999999999999887 4899999999999999999999984321 111122233333333222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..++.+++++++..+|.+|++++++.+
T Consensus 279 --s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 --SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --echhHHHHHHhhccCccccCCHHHhhh
Confidence 224789999999999999999999976
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=280.28 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=178.2
Q ss_pred CCCCCceecccCceEEEEEEEC-C--CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccc---c
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-S--GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVR---H 888 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---~ 888 (1075)
+|++.+.||+|+||.||+|... + +..||+|++..... .....+.+.+|+++++++ +||||+++++++.... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4777889999999999999654 4 78999999864322 222346788999999999 5999999998754321 1
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
....+++.. .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 111111111 1245678999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC----ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-------hhhhhhhh
Q 042958 961 PDSS----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-------NLNIALDE 1028 (1075)
Q Consensus 961 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~ 1028 (1075)
.... ......|+..|+|||+..+ ..++.++||||+|+++|++++|+.||........... ........
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3221 1233568999999998765 4688999999999999999999999864331100000 00000000
Q ss_pred ccC----------CCCCC--CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLD----------PRLPT--PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~----------~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.. ...+. ...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000 00011112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=274.17 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=186.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~ 892 (1075)
++|...+.||+|+||.||+|... +|+.||+|++...........+.+..|++++++++ ||||+++++++......+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l- 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF- 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE-
Confidence 46888899999999999999654 79999999987643333344577889999999998 9999999998766543322
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++.. .....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 22211 1233689999999999999999999999 99999999999999999999999999998665432
Q ss_pred C--------------------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh
Q 042958 964 S--------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 964 ~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 1023 (1075)
. ......++..|+|||...+..++.++||||+|+++|++++|+.||..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------Y 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------H
Confidence 1 12234578899999999888899999999999999999999999874321 1
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHh
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTM----PKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 1071 (1075)
.............+. ..+..+.+++.+||+.+|.+||++ +|+++
T Consensus 229 ~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111222222222221 224468999999999999999999 88775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=281.27 Aligned_cols=252 Identities=22% Similarity=0.238 Sum_probs=177.9
Q ss_pred cCCC-CCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch-----------hHHHHHHHHHHHHhcCCcCceeeEEE
Q 042958 815 NDFD-DEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM-----------TFQQEFLNEVKALTEIRHRNIVKFYG 881 (1075)
Q Consensus 815 ~~~~-~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 881 (1075)
++|. +.+.||+|+||.||+|.. .+++.||||++........ .....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 457799999999999954 4799999999865422210 01125778999999999999999999
Q ss_pred EeeccccchhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 882 FCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
++...+..+. +++.. .....+++.....++.|+++|++|||+. +++||||+|+||+++.++.+|++||
T Consensus 88 ~~~~~~~~~l-v~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINL-VMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEE-EEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 9876554322 22111 1223578888899999999999999999 9999999999999999999999999
Q ss_pred ccccccCC--------------CCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccc
Q 042958 954 GIAKFLKP--------------DSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS 1018 (1075)
Q Consensus 954 Gla~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 1018 (1075)
|.+..... .........++..|+|||++.+. .++.++||||+|+++|||++|+.||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99986651 11112233567889999998764 4689999999999999999999998644321100
Q ss_pred hhhhhhhhhhccCC----------------CCCC-CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1019 SLNLNIALDEMLDP----------------RLPT-PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1019 ~~~~~~~~~~~~~~----------------~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... ........+. ..+. ..........++.+++.+|++.||++|||++|++.
T Consensus 244 ~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRI-FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH-HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000 0000000000 0000 00001122456889999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=276.79 Aligned_cols=248 Identities=17% Similarity=0.191 Sum_probs=173.8
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc--
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN-- 897 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~-- 897 (1075)
.+.+|.|+++.||++.. +++.||||++..... .....+.+..|++++++++||||+++++++......+..+....
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34455556666666544 699999999876422 22345789999999999999999999998876554332221111
Q ss_pred --------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-----
Q 042958 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS----- 964 (1075)
Q Consensus 898 --------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~----- 964 (1075)
.....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+..+.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 1123477888899999999999999999 999999999999999999999999999876543221
Q ss_pred --ceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh------------
Q 042958 965 --NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE------------ 1028 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------------ 1028 (1075)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 1123456788999999876 357899999999999999999999997433211000000000000
Q ss_pred --------ccCCC--CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1029 --------MLDPR--LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1029 --------~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..++. .............++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000111222345678899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=275.41 Aligned_cols=245 Identities=21% Similarity=0.249 Sum_probs=173.0
Q ss_pred ceeccc--CceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec-C
Q 042958 821 HCIGKG--GQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS-N 896 (1075)
Q Consensus 821 ~~lG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~-~ 896 (1075)
..||+| +||+||+|.. .+|+.||+|++....... ...+.+.+|+.+++.++||||++++++|...+..+..+.. .
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999965 479999999987543222 3357889999999999999999999999876543222111 1
Q ss_pred c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce-
Q 042958 897 N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW- 966 (1075)
Q Consensus 897 ~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 966 (1075)
. .....+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 0 0123478888889999999999999999 99999999999999999999999998654332221111
Q ss_pred ------eccccccCccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------------hhh
Q 042958 967 ------TELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------------NIA 1025 (1075)
Q Consensus 967 ------~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------------~~~ 1025 (1075)
....++..|+|||++.+. .++.++||||+|+++|||++|+.||............. ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 112345679999998763 47899999999999999999999996432110000000 000
Q ss_pred hh------------------------hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 LD------------------------EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. .+....+. ..........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00000000 0112345668999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=272.89 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=183.1
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|+..+.||+|+||.||+|... +++.||+|++.... ......+.+..|+.++++++|+|++++++++......+ ++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~-~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY-LVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE-EEec
Confidence 566788999999999999655 59999999987653 22233467889999999999999999999887653322 2222
Q ss_pred Cccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 896 NNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 896 ~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.... ...+++..+.+++.|+++|++|||+. +|+||||+|+||+++.++.+||+|||.++.........
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 1111 13688999999999999999999999 99999999999999999999999999998765544334
Q ss_pred eccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------hhh---hhhc--cCCC
Q 042958 967 TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIA---LDEM--LDPR 1033 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-------~~~---~~~~--~~~~ 1033 (1075)
....++..|+|||.+.+. .++.++||||||+++||+++|+.||............. ... .... .+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 445567889999998766 78999999999999999999999986432211000000 000 0000 0111
Q ss_pred CCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++... .........+.+++.+||..||++||++.||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 11100 001122457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=267.02 Aligned_cols=235 Identities=21% Similarity=0.230 Sum_probs=170.6
Q ss_pred eecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHH---HHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 822 CIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
.||+|+||.||+|.. .+++.||+|.+.............+..|. ..++...||+|+++++++...+..+.+ +++.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v-~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE-EecC
Confidence 489999999999954 56899999988654322222122333443 344455899999999988765543222 2111
Q ss_pred ---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 898 ---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 898 ---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
.....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++....... ...
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 154 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHA 154 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcC
Confidence 1234589999999999999999999999 99999999999999999999999999997654322 233
Q ss_pred cccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 969 LAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
..|+..|+|||++.++ .++.++||||+|+++|||++|+.||........... . .........++ ...+..
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~~~~~------~~~s~~ 225 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D-RMTLTMAVELP------DSFSPE 225 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--H-HHhhccCCCCC------CcCCHH
Confidence 5789999999998754 688999999999999999999999975422111110 0 00111111111 122456
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1048 IVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+.+++.+|+..+|.+|| ++.|+++
T Consensus 226 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 99999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=281.86 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=178.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
..+|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 36788899999999999999955 5789999999865432 3346788999999999999999999876543221
Q ss_pred ----------hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEe
Q 042958 890 ----------LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVS 951 (1075)
Q Consensus 890 ----------l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~ 951 (1075)
..++++... ....+++...+.++.||++|++|||+. +|+||||||+||+++. ++.+|++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 112222111 123578899999999999999999999 9999999999999985 5578999
Q ss_pred ccccccccCCCCC---ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh------
Q 042958 952 DFGIAKFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN------ 1021 (1075)
Q Consensus 952 DfGla~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~------ 1021 (1075)
|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543211 1123457889999997654 56788999999999999999999999643221100000
Q ss_pred -----hhh---hh-hhc----cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 -----LNI---AL-DEM----LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 -----~~~---~~-~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... .. ... ...+.+. .........++.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPL-RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCH-HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00 000 0000000 0001123356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=271.50 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=182.4
Q ss_pred CCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
+|++.+.||+|+||.||+|.. .+++.||||+++.... ......+.+..|++++.++ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477789999999999999954 3578999999864321 1222346788999999999 699999999887665443
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+ ++++... ....+++.....++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++...
T Consensus 81 ~-lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 H-LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred E-EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 2 2222111 134578888999999999999999998 99999999999999999999999999998755
Q ss_pred CCCCc-eeccccccCccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSN-WTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... .....|+..|+|||...+.. .+.++||||||+++|||++|+.||......... ......+.....+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~ 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ----SEISRRILKSKPPFP 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH----HHHHHHHHccCCCCC
Confidence 43322 22346889999999987665 788999999999999999999998632211111 111112222222222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......+.+++.+||+.||++|||+.+|.+.|+
T Consensus 233 ----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 233 ----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 123346899999999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=268.08 Aligned_cols=241 Identities=21% Similarity=0.277 Sum_probs=179.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCC--chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
+|.+.+.||+|+||.||++... .+..+++|..+..... ......++..|+.++++++||||+++++++.+....+.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999554 3555666665432211 112234577899999999999999999887665443222
Q ss_pred ee-cC-----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 893 IL-SN-----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~-~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+. .. ......+++.+++.++.|+++|+.|||+. +++|+||+|+||+++. +.+|++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 11 11 11235688999999999999999999999 9999999999999975 679999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
..........|++.|+|||...+..++.++|+||||+++|+|++|+.||..... ............+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~ 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVEGPTPS---L 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCC---C
Confidence 544444455688999999999888899999999999999999999999863221 11111121121111 1
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.++.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 2344567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=263.09 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=181.0
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC-c---
Q 042958 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN-N--- 897 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~-~--- 897 (1075)
||+|+||.||++... +++.||+|++...........+.+..|++++++++||||+++++++......+.++-.. .
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999664 68999999987654444445678999999999999999999998876654332222111 1
Q ss_pred ----cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecccccc
Q 042958 898 ----AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY 973 (1075)
Q Consensus 898 ----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~ 973 (1075)
.....+++.....++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+..............++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 1233578999999999999999999998 999999999999999999999999999987654433344557888
Q ss_pred CccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHH
Q 042958 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAI 1053 (1075)
Q Consensus 974 ~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1053 (1075)
.|+|||...+...+.++|+||||+++||+++|+.||...+. ......+.....+.+.. .+..+.+++.
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~l~~~i~ 225 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEF----LSPEARDLIS 225 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCHHHHHHHH
Confidence 99999999888889999999999999999999999864322 11122222222222222 2346899999
Q ss_pred HccCCCCCCCCCH---HHHHh
Q 042958 1054 SCLDENPESRPTM---PKVSQ 1071 (1075)
Q Consensus 1054 ~cl~~dP~~RPs~---~evl~ 1071 (1075)
+||..||++||++ +++.+
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=251.65 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=190.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
-.+|...++||+|+|.+|..++++ +.+.+|+|++++....+.+..+-+..|-.+..+- +||.+|.+..+|......+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999654 6889999999886655554455666777777666 79999999887765443322
Q ss_pred he--------ecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 892 MI--------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 892 ~~--------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++ +........++++..+.+...|.-||.|||++ ||+.||+|..||++|.+|++|++|+|+++.--.+.
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 22 11223345678888888999999999999999 99999999999999999999999999999866666
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....+.+|||.|+|||.+++..|...+|.|++||+|+|||.|+.||+................+.++......|. .
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----s 481 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----S 481 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----e
Confidence 777889999999999999999999999999999999999999999996553322222222233344444444332 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCC
Q 042958 1044 KLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
.+.....+++.-+++||++|.-
T Consensus 482 lsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcC
Confidence 3345678899999999999863
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=262.93 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=190.3
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCch----hHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEM----TFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
..++|-..+.+|+|+|++||+| ++...+.||||+-.....+.. .+.+...+|.++-+.+.||.||++|+|+.-+.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3466777889999999999999 777789999998654332222 23455778999999999999999999998887
Q ss_pred cchhheecCccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC---CCCCceEecccc
Q 042958 888 HSLAMILSNNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD---FDNEAHVSDFGI 955 (1075)
Q Consensus 888 ~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGl 955 (1075)
+.++.++++..+ ...+++.+.+.|+.||..||.||.+. .|+|||-||||.|||+- ..|.+||+|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 777766655433 34467888899999999999999987 46999999999999994 457899999999
Q ss_pred ccccCCCCCc-------eeccccccCccCccccccC----CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh
Q 042958 956 AKFLKPDSSN-------WTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 956 a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1075)
++.+..+... ....+||.+|.+||.+.-+ +.+.|+||||+||++|+.+.|+.||...... .......
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhhh
Confidence 9999876543 2356899999999977533 4678999999999999999999999743221 1111111
Q ss_pred hhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+-....-.+|..+ ....+...+|++|+++.-++|....|+..
T Consensus 698 TIlkAtEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 TILKATEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred chhcceeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 12222222333322 22345789999999999999988877653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-29 Score=229.63 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=181.6
Q ss_pred CCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe-
Q 042958 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI- 893 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~- 893 (1075)
+|...++||+|.||+||+|+ +.+++.||+|+++.....+ .......+|+-+++.++|+|||+++++.........++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999994 5579999999987654332 23567789999999999999999998765443321111
Q ss_pred ec-------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 894 LS-------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 894 ~~-------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
.. .....+.++.+..+.++.|+++|+.+.|++ .|.|||+||.|.+++.+|++|++|||+|+.++-+-..+
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 11 123456788888999999999999999999 99999999999999999999999999999887766666
Q ss_pred eccccccCccCccccccCC-CCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhh--------hh---hccC--
Q 042958 967 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIA--------LD---EMLD-- 1031 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~--------~~---~~~~-- 1031 (1075)
...+.|..|++|.++.+.+ |+...|+||.||++.|+.. |++-|.+.+-.+ .-...... .. ..-|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccCCCCc
Confidence 7778899999999998875 7889999999999999997 555554322111 00000000 00 0000
Q ss_pred --CCCCCCCcCcHHH----HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 --PRLPTPSCIVQDK----LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 --~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.++.. ..+... ...=++++.+.+.-+|.+|.++++.++
T Consensus 238 ~yp~ypat-tswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPAT-TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCcccc-chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 000000 011111 123457888889999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=267.26 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=179.1
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhhee
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
|++.+.||+|+||.||+|... +++.||||++...... .......+|+..+++++ |||++++++++......+..+-
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567789999999999999765 5889999998654322 11234567999999998 9999999998876443322211
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....+++.++..++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred cCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 111 0123679999999999999999999999 99999999999999999999999999998765332 2
Q ss_pred eeccccccCccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-------------hhhhhhhhccC
Q 042958 966 WTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-------------NLNIALDEMLD 1031 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-------------~~~~~~~~~~~ 1031 (1075)
.....++..|+|||++. +..++.++|+||||+++|||++|+.||........... ...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23456788999999875 44578999999999999999999999864322110000 00000000111
Q ss_pred CCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1032 PRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1032 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+... .........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1111000 0001113569999999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=280.92 Aligned_cols=252 Identities=20% Similarity=0.335 Sum_probs=182.0
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--- 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 888 (1075)
..++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4578999999999999999999664 6889999998654322 2234667889999999999999999887654432
Q ss_pred --chhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 --SLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 --~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
...++.+..+ ....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+...
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 1122221111 124588999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hhhh----
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IALD---- 1027 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~~~---- 1027 (1075)
... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||.............. ....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 233467889999998765 3678999999999999999999999864322110000000 0000
Q ss_pred ----hccCC--CCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 ----EMLDP--RLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ----~~~~~--~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+... ....+ .......+..+.+++.+|++.||++|||+.||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00000 0000112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=269.96 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=179.3
Q ss_pred CCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ......+++..|+++++++ +|++|+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999965 3689999999865322 1222346788999999999 699999999888765432
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+ ++++... ....+++.+...++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++....
T Consensus 81 ~-lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 H-LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred E-EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 2 2221111 234577888888999999999999999 99999999999999999999999999998754
Q ss_pred CCCC-ceeccccccCccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSS-NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||........ .............+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSEPPYP 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhccCCCCC
Confidence 4322 22235688999999998753 467899999999999999999999864322111 1111112211111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
......+.+++.+||+.||++|| +++++++
T Consensus 233 ----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 233 ----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 22345689999999999999997 6777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=276.76 Aligned_cols=241 Identities=27% Similarity=0.409 Sum_probs=178.4
Q ss_pred CCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----c----
Q 042958 818 DDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----H---- 888 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~---- 888 (1075)
...+.||+|+||.||+|+ ..+|+.||||.++... ....++...+|++++++++|+|||+++++-.+.. .
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 445779999999999997 5589999999998754 2233577889999999999999999988655433 1
Q ss_pred ---------chhheecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee--CCCC--CceEecccc
Q 042958 889 ---------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL--DFDN--EAHVSDFGI 955 (1075)
Q Consensus 889 ---------~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~--~~kl~DfGl 955 (1075)
.+.-++........++..+.+.+..+++.||.|||++ +|+||||||.||++ .++| --||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 1222233344556689999999999999999999999 99999999999988 3445 479999999
Q ss_pred ccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccc-hhh------------
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-SLN------------ 1021 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~------------ 1021 (1075)
|+.+.++ +.....+||..|.+||.... +.|+.-+|.|||||++||.+||..||......... ...
T Consensus 171 Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 171 ARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred cccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9988755 46788999999999999884 77889999999999999999999999755443210 000
Q ss_pred ----hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCC
Q 042958 1022 ----LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRP 1064 (1075)
Q Consensus 1022 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1064 (1075)
......-.....+|.+..........+...+..++.-+|++|-
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0000011111233444333344445566677777777777776
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=261.08 Aligned_cols=237 Identities=21% Similarity=0.288 Sum_probs=183.4
Q ss_pred HhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
...+|....+||+|+||.|..|+ ..+.+.+|||++++...-..+..+--+.|-++++-- +-|.++++...|+..+..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL- 425 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL- 425 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe-
Confidence 34678889999999999999994 446788999999876543333334456677777766 567788887766554332
Q ss_pred hheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.++++. .+-+.+.+....-+|..||-||-+||++ +|+.||||.+||++|.+|++||+|||+++.---
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 2222222 2233456666778999999999999999 999999999999999999999999999987555
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
+.....+.+|||.|+|||.+..++|+.++|.|||||++|||+.|++||++.+. .+....+.+.....|
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~ehnvsyP---- 570 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIMEHNVSYP---- 570 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHccCcCc----
Confidence 56667789999999999999999999999999999999999999999985443 334455555555443
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC
Q 042958 1042 QDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
...+.+..++.+..+.+.|.+|.-
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccC
Confidence 344456788888999999999863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=261.19 Aligned_cols=240 Identities=20% Similarity=0.288 Sum_probs=175.4
Q ss_pred HHHHHHhcCCCCCcee--cccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 808 EEIIRATNDFDDEHCI--GKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~l--G~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... . |+.....+ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEEE
Confidence 3344455677777776 9999999999954 578999999986432111 1 22222212 799999999998
Q ss_pred eccccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEecc
Q 042958 884 SHVRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDF 953 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Df 953 (1075)
...+..+ ++++.. .....+++.+...++.|+++|+.|||+. +++||||||+||+++.++ .++++||
T Consensus 79 ~~~~~~~-iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 79 TTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred ecCCeeE-EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 7755432 222211 1234789999999999999999999999 999999999999999998 9999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|.+...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||........ .... ........
T Consensus 155 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~-~~~~~~~~ 226 (267)
T PHA03390 155 GLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL---DLES-LLKRQQKK 226 (267)
T ss_pred ccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh---hHHH-HHHhhccc
Confidence 999865432 234688999999999998999999999999999999999999973322111 0111 11111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPT-MPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1071 (1075)
.+ .....+..+.+++.+|++.+|.+||+ ++|+++
T Consensus 227 ~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11 12234557999999999999999996 698875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=270.95 Aligned_cols=231 Identities=21% Similarity=0.246 Sum_probs=176.6
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
++.|.....+|.|+|+.|-++ ...+++..+||++.+.. .+-.+|+.++... +|||++++.+.+.+..+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 567777788999999999888 44578999999997652 2233566555555 79999999999987655433
Q ss_pred heecCcccc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee-CCCCCceEeccccccccCCC
Q 042958 892 MILSNNAAA--------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~DfGla~~~~~~ 962 (1075)
+. +...++ .......+..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||.++.....
T Consensus 394 v~-e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VM-ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ee-hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 32 111111 1122256667999999999999998 99999999999999 68999999999999876654
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....+-|..|.|||+.....|++++|+||+|++||+|++|+.||..-+.. ......+..++.. .
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s------~ 533 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS------E 533 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc------c
Confidence 33446688999999999999999999999999999999999999743331 1122222222221 3
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+....+++.+|++.||.+||+|+|+..
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 45567999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=292.65 Aligned_cols=140 Identities=21% Similarity=0.307 Sum_probs=115.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++.............+..|+.+++.++||||+++++++......+ +
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~-l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY-L 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE-E
Confidence 367888999999999999999665 78999999987654444445678899999999999999999998887655432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
++++.. ....+++...++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 222221 123467888899999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=248.10 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=178.6
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
...|....+||+|.||+||+|+. ++|+.||+|+...... .+.......+|++++..++|+|++.+++.|.....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34566678899999999999955 4688899987643221 11223456799999999999999999998853211
Q ss_pred ---chhheec--Cc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 889 ---SLAMILS--NN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 889 ---~l~~~~~--~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
.+++++. +. .....++..++.+++.++..||.|+|+. .|+|||+||.|++++.++.+|++|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 1222211 11 1234578889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC----CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccc---------------
Q 042958 957 KFLKPDS----SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMS--------------- 1016 (1075)
Q Consensus 957 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--------------- 1016 (1075)
+.+.... ..++..+.|..|++||.+.+. .|+++.|||..||++.||+|+.+-+.+.....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7665332 235567789999999987764 68999999999999999999998876433211
Q ss_pred -cchhhhhhhhhhccCCCCCCCC-cCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1017 -SSSLNLNIALDEMLDPRLPTPS-CIVQDK------LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1017 -~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+...+.....+.+.-+.++... ....+. ..+..+++.+++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0000000001111001011100 000011 125778999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=264.92 Aligned_cols=236 Identities=23% Similarity=0.342 Sum_probs=186.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCC-EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGE-IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++.+...+|-|+||.|-.+...... .+|+|.+++...-+..+.+.+..|-.+|...+.|.||++|-.|.+... ++|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky-vYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY-VYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh-hhhh
Confidence 44556678999999999998766433 489999988766677778899999999999999999999988876544 3343
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. ...+.++......++..+.+|++|||++ +||+|||||+|.++|.+|.+|+.|||+|+.+.....
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 3322 2234456666677899999999999999 999999999999999999999999999999886544
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
. -+.+||+.|.|||.+.+..++.++|.||+|+++||+++|.+||...+++........ .++.+-.|+ ..
T Consensus 576 T-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-Gid~i~~Pr---------~I 644 (732)
T KOG0614|consen 576 T-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-GIDKIEFPR---------RI 644 (732)
T ss_pred e-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh-hhhhhhccc---------cc
Confidence 4 457999999999999999999999999999999999999999987665543322111 122222221 22
Q ss_pred HHHHHHHHHHccCCCCCCCCC
Q 042958 1045 LISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs 1065 (1075)
.....+++++.+..+|.+|--
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhc
Confidence 334778999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=230.79 Aligned_cols=195 Identities=25% Similarity=0.389 Sum_probs=153.4
Q ss_pred HHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 888 (1075)
....++......||+|+||.|-+-++ .+|+..|+|++...... +..++..+|+.+..+- .+|.+|.++|.+.+...
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 33445555567899999999988855 47999999999865432 2356778888875554 89999999996654433
Q ss_pred -chhheecC----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 889 -SLAMILSN----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 889 -~l~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
...|.... ...+..+++.-.-+||..|.+||.|||++. .|+|||+||+|||++.+|++|+||||.+.
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 23332221 234667888888999999999999999985 89999999999999999999999999998
Q ss_pred ccCCCCCceeccccccCccCcccccc----CCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
.+.+.-. .+.-+|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.||+
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 7764322 222467788999998863 368999999999999999999999987
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=268.82 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=194.6
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
++.....++.|++.+.||+|.+|.||++ ..++|+.+|+|+....... .++++.|.++++.. .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3444455788899999999999999999 4557999999998754322 46778899999888 7999999999885
Q ss_pred ccc------cchhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCce
Q 042958 885 HVR------HSLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH 949 (1075)
Q Consensus 885 ~~~------~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 949 (1075)
... ..++|.+...+ .+..+.|..+..|...+++|+.|||.. .++|||||-.|||++.++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 432 23444443332 256688999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCceeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh
Q 042958 950 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 950 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1075)
++|||.+......-....+.+||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-+..+..
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------- 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------- 235 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence 9999999887665556667899999999999863 346788999999999999999999976433321
Q ss_pred hhhhccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1025 ALDEMLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.-+.-++-|+| ...+..-..++.++|..|+.+|.++||++.++++.
T Consensus 236 --aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 --ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111222222 22244556689999999999999999999998763
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-29 Score=260.49 Aligned_cols=403 Identities=27% Similarity=0.314 Sum_probs=256.0
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccc-ccccCCCCCCCCCCCCCCEEEc
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS-NYLEDLIPPSLGNLSNLDTLHL 176 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L 176 (1075)
.-++++|..|.|+...|.+|+.+++|+.||||+|+|+.+-|.+|.++++|..|.+.+ |+|+++....|.+|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 345666666666655566677777777777777777777777777777777777766 7777777777888888888888
Q ss_pred CCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC------------CCCcccccCCCCCC
Q 042958 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF------------DSIPSELGNLRSLS 244 (1075)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L~ 244 (1075)
.-|++.-+..++|..+++|..|.+.+|.+..+-..+|..+..++.+.+..|.+. ...|..++..+-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 888887777777888888888888888887444447777888888888777721 22344455555555
Q ss_pred eEeccCCCCCCccCCCCccc-ccccccccccccCcCCCC-cccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccc
Q 042958 245 MLSLGYNKLSGSIPHSLGNL-TNLATLYLYENSLSGSIP-SEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322 (1075)
Q Consensus 245 ~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 322 (1075)
-..+.++++..+-+..|... ..+..=..+.+...++-| ..|..+++|+.|+|++|+|+.+-+.+|.++..+++|+|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 55666666664444444322 222222222333333444 4688888888888888888888888888888888888888
Q ss_pred ccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCC-ccccCCCcccceeeeccccccccC
Q 042958 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSI-PSELGNLRSLSMLSLGYNKLSGSI 401 (1075)
Q Consensus 323 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 401 (1075)
|+|..+....|.++..|+.|+|.+|+|+...|..|..+.+|.+|.|-.|.+.-.- -.+++. . |..+...|..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~--W-----lr~~~~~~~~ 380 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE--W-----LRKKSVVGNP 380 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH--H-----HhhCCCCCCC
Confidence 8888777778888888888888888888888888888888888888887762110 001110 0 1111111221
Q ss_pred ChhhccCCCCCeEEeecccccc---cccccc---------ccccccceecccccccccCCCCCCccccccccccccCCcc
Q 042958 402 PHSLGNLTNLATLDLYDNSLSG---SIPSEF---------GNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469 (1075)
Q Consensus 402 ~~~~~~l~~L~~L~L~~N~l~~---~~~~~~---------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 469 (1075)
|- +.-..++.+.++++.+.. ..|++. ..++-+.+..=-.|+....+|..+. ..-.+||+.+|.+
T Consensus 381 ~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~ 456 (498)
T KOG4237|consen 381 RC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAI 456 (498)
T ss_pred CC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchh
Confidence 11 111234444444443321 111111 1233344433333444345555443 2456777777777
Q ss_pred ccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCC
Q 042958 470 SGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515 (1075)
Q Consensus 470 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 515 (1075)
+ .+|.+ .+++| .+|+++|+++......|.++++|..|-|+.|
T Consensus 457 ~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 457 T-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred c-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 7 56665 55666 7777777777555566666666666666654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-28 Score=253.28 Aligned_cols=257 Identities=19% Similarity=0.289 Sum_probs=185.7
Q ss_pred ccHHHHHHHhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-c-C----cee
Q 042958 805 IVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-H-R----NIV 877 (1075)
Q Consensus 805 ~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv 877 (1075)
+.++.--..+.+|.+...+|+|.||.|.++ +..++..||||+++.- ..+.+..+-|+++++++. + | -+|
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 333333344789999999999999999999 5556899999999743 334567788999999993 2 2 277
Q ss_pred eEEEEeeccccchhhe-ecC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC----
Q 042958 878 KFYGFCSHVRHSLAMI-LSN--------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---- 944 (1075)
Q Consensus 878 ~l~~~~~~~~~~l~~~-~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---- 944 (1075)
.+.+||...++...++ +.+ ...-.+++....+.|++|++++++|||+. +++|-||||+||++..
T Consensus 155 ~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 8878776655542222 111 12345678899999999999999999999 9999999999999942
Q ss_pred ----------------CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 042958 945 ----------------DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008 (1075)
Q Consensus 945 ----------------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 1008 (1075)
...+||+|||.|++-... ....+.|..|+|||++.+-+++.++||||+||+++|+.+|..-
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 235899999999875433 3567889999999999999999999999999999999999998
Q ss_pred CCccCccccc-----------hhhhhhh-hhhcc-CCCCC-----------------CC----CcCcHHHHHHHHHHHHH
Q 042958 1009 RDFISSMSSS-----------SLNLNIA-LDEML-DPRLP-----------------TP----SCIVQDKLISIVEVAIS 1054 (1075)
Q Consensus 1009 ~~~~~~~~~~-----------~~~~~~~-~~~~~-~~~~~-----------------~~----~~~~~~~~~~l~~li~~ 1054 (1075)
|+.-+..+.- ....... .+++. ..++. .+ ......+..++.+++++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8644422100 0000000 00000 00000 00 01223455689999999
Q ss_pred ccCCCCCCCCCHHHHHh
Q 042958 1055 CLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1055 cl~~dP~~RPs~~evl~ 1071 (1075)
|+..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=256.64 Aligned_cols=421 Identities=26% Similarity=0.286 Sum_probs=254.7
Q ss_pred EEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccC-CC
Q 042958 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY-NK 252 (1075)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~ 252 (1075)
.+-++-.++ .+|..+. +.-..++|..|+|+.+.|.+|+.+++|+.|+|++|.|+.+-|.+|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344444444 2443332 3456777888888877777888888888888888888777778888877776665544 78
Q ss_pred CCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcc
Q 042958 253 LSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE 332 (1075)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 332 (1075)
|+....+.|+++..|+.|.+.-|++..+..++|..+++|..|.+-+|.+..+...+|..+..++.+.+..|.+..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence 876666677788888888888888877667778888888888888888775555577778888888777777321
Q ss_pred cccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCC-Ccccc-eeeeccccccccCC-hhhccCC
Q 042958 333 IGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN-LRSLS-MLSLGYNKLSGSIP-HSLGNLT 409 (1075)
Q Consensus 333 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~-~L~Ls~N~l~~~~~-~~~~~l~ 409 (1075)
..+++.+.... ...|..++...-.....+.++++..+.+..|.. ++++. .+....+.. ++-| ..|..++
T Consensus 203 dCnL~wla~~~-------a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d-~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 203 DCNLPWLADDL-------AMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPD-SICPAKCFKKLP 274 (498)
T ss_pred ccccchhhhHH-------hhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcC-CcChHHHHhhcc
Confidence 11122111110 012223333333444444555554443333322 12222 122222222 2333 4577777
Q ss_pred CCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCC
Q 042958 410 NLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489 (1075)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 489 (1075)
+|+.|+|++|+|+++.+.+|.++..+++|.|..|+|...-...|.++..|+.|+|++|+|+...|+.|..+.+|.+|.|-
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~ 354 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL 354 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence 77777777777777777777777777777777777765555667777777777777777777777777777777777777
Q ss_pred CCcccCC-Ccccc---------------cCCCccceeeccCCCCCC---CCCccccCccccccccccccccccccCCc--
Q 042958 490 NNKLSGS-IPQSL---------------GNLSNLVILYLYNNSLFD---SIPSELGNLRSLSMLSFAYNKLSGSIPHS-- 548 (1075)
Q Consensus 490 ~N~l~~~-~~~~~---------------~~l~~L~~L~L~~N~l~~---~~~~~l~~l~~L~~L~l~~N~l~~~~p~~-- 548 (1075)
.|++..- --.++ +.-..++.+.++++.+.+ ..|++.+..+ ++..|+.
T Consensus 355 ~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP~~c~ 422 (498)
T KOG4237|consen 355 SNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCPPPCT 422 (498)
T ss_pred cCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCC------------CCCCCCCcc
Confidence 7765421 00011 111234444555444322 1222222111 1123332
Q ss_pred -c-cccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEc
Q 042958 549 -L-GVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626 (1075)
Q Consensus 549 -l-~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 626 (1075)
+ ++..-|++.+. .+|..+- ...++|.+.+|+++ .+|.. .+..| .+|||+|+|+..-.-.|.++++|.+|-|
T Consensus 423 c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlil 495 (498)
T KOG4237|consen 423 CLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLIL 495 (498)
T ss_pred hhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEE
Confidence 1 23344555554 3333322 23567888888888 44554 56777 8899999998666678889999999988
Q ss_pred ccc
Q 042958 627 SNN 629 (1075)
Q Consensus 627 s~N 629 (1075)
|+|
T Consensus 496 syn 498 (498)
T KOG4237|consen 496 SYN 498 (498)
T ss_pred ecC
Confidence 886
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=238.26 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=181.4
Q ss_pred CCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe--
Q 042958 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI-- 893 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~-- 893 (1075)
.+..+.||-|+||.||.+ +-++|+.||+|++.... ......+.+.+|++++..++|.||+..++.-......+...
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344578999999999999 45689999999986543 22334578899999999999999999887654433221111
Q ss_pred -----ec-----CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 -----LS-----NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 -----~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+. -......++-....-+.+||++||+|||+. +|.||||||.|.+++.+..+||||||+|+....+.
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 10 112345577777888999999999999999 99999999999999999999999999999866554
Q ss_pred C-ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccch---------------hhhhhhh
Q 042958 964 S-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS---------------LNLNIAL 1026 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~---------------~~~~~~~ 1026 (1075)
. .++..+.|..|+|||.+.+. .|+.+.||||.||++.|++..+.-|....+.+... ...+...
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 3 46667889999999999876 58999999999999999999888876443332100 0011111
Q ss_pred hhccCCCCCCCC-------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1027 DEMLDPRLPTPS-------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1027 ~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
..+.......|. ....+...+...+..+++..||++|.+.++.+..
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 111111111110 1111223356678888999999999998887643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=277.02 Aligned_cols=247 Identities=22% Similarity=0.237 Sum_probs=188.0
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
++.-..++|.+.++||+|+||.|..++++ +++.||+|++.+...-......-|..|..+|..-..+=|+.+.-.|.+.+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44455689999999999999999999664 78999999997632222222456889999999888888999876666654
Q ss_pred cchhheecCcccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 888 HSLAMILSNNAAA---------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 888 ~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+ +++++.++.++ ..++....+.++..|.-||.-+|+. |+|||||||+|||+|..|++|++|||.+-.
T Consensus 149 ~-LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 Y-LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred c-eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence 4 44444443332 2477888888999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc-eeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 959 LKPDSSN-WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 959 ~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
+..++.. ....+|||.|++||++.. +.|++..|.||+||++|||+.|..||...+- ......+++-
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~KIm~h 296 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYGKIMNH 296 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHHHHhch
Confidence 8866553 455789999999998862 5688999999999999999999999973222 1222233322
Q ss_pred --CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 042958 1033 --RLPTPSCIVQDKLISIVEVAISCLDENPESRPT---MPKVS 1070 (1075)
Q Consensus 1033 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 1070 (1075)
.+..| ...+.+.+..++|.+.+. +|+.|.. ++|+.
T Consensus 297 k~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 297 KESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 22222 123356678899988876 6788877 66664
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=246.72 Aligned_cols=210 Identities=19% Similarity=0.200 Sum_probs=158.3
Q ss_pred cCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc------
Q 042958 826 GGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA------ 898 (1075)
Q Consensus 826 G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~------ 898 (1075)
|.||.||++. ..+++.||+|++.... .+..|...+....||||+++++++......+ ++++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVF-LVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEE-EEEecCCCCCHHH
Confidence 8999999994 4578999999986531 2334555556667999999999887654432 2222111
Q ss_pred ---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCc
Q 042958 899 ---AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975 (1075)
Q Consensus 899 ---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y 975 (1075)
....+++.....++.|+++|++|+|+. +|+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y 148 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY 148 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence 123478899999999999999999999 9999999999999999999999999988765432 2233457789
Q ss_pred cCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHc
Q 042958 976 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISC 1055 (1075)
Q Consensus 976 ~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1055 (1075)
+|||...+..++.++||||+|+++|||++|+.|++..... .........+ ......+.+++.+|
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~~li~~~ 212 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP------EWVSEEARSLLQQL 212 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc------ccCCHHHHHHHHHH
Confidence 9999998888999999999999999999999887532110 0000001111 12334689999999
Q ss_pred cCCCCCCCCCH
Q 042958 1056 LDENPESRPTM 1066 (1075)
Q Consensus 1056 l~~dP~~RPs~ 1066 (1075)
++.||++||++
T Consensus 213 l~~dp~~R~~~ 223 (237)
T cd05576 213 LQFNPTERLGA 223 (237)
T ss_pred ccCCHHHhcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=272.18 Aligned_cols=253 Identities=19% Similarity=0.202 Sum_probs=148.7
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-C----CCEEEEEEccCCCCCchhHHHHHHHH-----HHHHhcC-------CcCc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-S----GEIVAVKKFHSPLPGEMTFQQEFLNE-----VKALTEI-------RHRN 875 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~E-----~~~l~~l-------~h~n 875 (1075)
..++|+..+.||+|+||.||+|... + +..||||++......+....+.+... ......+ ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 5678999999999999999999664 4 78999998764321111111111000 0000000 0111
Q ss_pred eeeEEEEeeccccchhheecCc-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 042958 876 IVKFYGFCSHVRHSLAMILSNN-----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSK 938 (1075)
Q Consensus 876 iv~l~~~~~~~~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 938 (1075)
+.-++.|+... .+..++... .............++.|++.||+|||+. +|+||||||+
T Consensus 210 ~~LV~ey~~~g--sL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~ 284 (566)
T PLN03225 210 YWLVWRYEGES--TLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ 284 (566)
T ss_pred eEEEEEecCCC--cHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence 22223332211 111111100 0001112334567999999999999999 9999999999
Q ss_pred CeeeCC-CCCceEeccccccccCCCC-CceeccccccCccCccccccC----------------------CCCcccchHh
Q 042958 939 NVLLDF-DNEAHVSDFGIAKFLKPDS-SNWTELAGTYGYVAPELAYTM----------------------KVTEKCDVYS 994 (1075)
Q Consensus 939 Nill~~-~~~~kl~DfGla~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~s 994 (1075)
|||++. ++.+||+|||+|+.+.... .......+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 5799999999998654332 223456789999999965322 2345679999
Q ss_pred HHHHHHHHHhCCCCCCccCcc-----ccchhhhhhhhhhccCCCCCCC----CcCcHHHHHHHHHHHHHccCCCCCCCCC
Q 042958 995 FGVLALEVIKGKHPRDFISSM-----SSSSLNLNIALDEMLDPRLPTP----SCIVQDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 995 ~G~vl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
+||++|||+++..|++..... ....... ........+..... ............+++.+|+++||++|||
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcH-HHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999999999987775421000 0000000 00111111111000 0000011123558999999999999999
Q ss_pred HHHHHh
Q 042958 1066 MPKVSQ 1071 (1075)
Q Consensus 1066 ~~evl~ 1071 (1075)
++|+++
T Consensus 444 a~e~L~ 449 (566)
T PLN03225 444 AKAALA 449 (566)
T ss_pred HHHHhC
Confidence 999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=243.97 Aligned_cols=231 Identities=27% Similarity=0.410 Sum_probs=174.8
Q ss_pred CceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe-ecCc-------
Q 042958 827 GQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI-LSNN------- 897 (1075)
Q Consensus 827 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~-~~~~------- 897 (1075)
+||.||+|... +|+.||+|++........ .+.+.+|++.+++++|+||+++++++.........+ ....
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999776 589999999876433221 578999999999999999999999887643322221 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccC
Q 042958 898 AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977 (1075)
Q Consensus 898 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~a 977 (1075)
.....+++..+..++.++++|+.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|+|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ 154 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMA 154 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCC
Confidence 0112278899999999999999999999 99999999999999999999999999998765432 3344568889999
Q ss_pred ccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccC
Q 042958 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLD 1057 (1075)
Q Consensus 978 PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1057 (1075)
||...+..++.++||||+|+++|++++|..||...... ....+........... .....+.++.+++.+|+.
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~ 226 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLV 226 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHcc
Confidence 99998888999999999999999999999998642111 1111112111111110 000133469999999999
Q ss_pred CCCCCCCCHHHHHh
Q 042958 1058 ENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1058 ~dP~~RPs~~evl~ 1071 (1075)
.+|++||++.|+++
T Consensus 227 ~~p~~Rp~~~~~~~ 240 (244)
T smart00220 227 KDPEKRLTAEEALQ 240 (244)
T ss_pred CCchhccCHHHHhh
Confidence 99999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-27 Score=266.00 Aligned_cols=233 Identities=25% Similarity=0.401 Sum_probs=167.6
Q ss_pred CCCCceecccCceE-EEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhhe-
Q 042958 817 FDDEHCIGKGGQGS-VYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMI- 893 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~- 893 (1075)
|...+++|.|+.|+ ||+|... |+.||||++-.. ...-..+|+..++.- .|||||++++.-.+....+..+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44456799999875 6899887 899999998532 234567899999888 7999999987665544432211
Q ss_pred ---------ecCc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---C--CCceEeccccccc
Q 042958 894 ---------LSNN-AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---D--NEAHVSDFGIAKF 958 (1075)
Q Consensus 894 ---------~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~kl~DfGla~~ 958 (1075)
.+.. .......-...+.+..|+++|++|||+. +||||||||.|||++. + .+++|+|||+++.
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 1111 0000011133467889999999999998 9999999999999986 3 3799999999999
Q ss_pred cCCCCCce---eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 959 LKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 959 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
+..+.... ....||.+|+|||++....-+.++||||+|||+|+.++ |.+||...-.. + ..++....
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------~---~NIl~~~~ 730 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------Q---ANILTGNY 730 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-------h---hhhhcCcc
Confidence 88765433 34679999999999999888899999999999999998 59999732111 0 11111110
Q ss_pred CCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.-. -....++ +..++|.+|+++||..||+|.+|+.
T Consensus 731 ~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 0011112 6889999999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=238.58 Aligned_cols=124 Identities=23% Similarity=0.421 Sum_probs=99.6
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-----c---CceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----H---RNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~ 884 (1075)
..+|.+.++||.|.|++||.| +..+.+.||+|+.+. ...+.+....||++|++++ | .+||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 467889999999999999999 666789999999874 3445677889999999983 2 47999999997
Q ss_pred cccc---chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 885 HVRH---SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 885 ~~~~---~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
..+. .++|+++..+ .-+.++.....+|++||+.||.|||++| +|||.||||+|||+.
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 6432 2444433221 2234678888999999999999999998 999999999999994
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=255.17 Aligned_cols=254 Identities=16% Similarity=0.193 Sum_probs=164.3
Q ss_pred HhcCCCCCceecccCceEEEEEEE-----------------CCCCEEEEEEccCCCCCch-----------hHHHHHHHH
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-----------------ASGEIVAVKKFHSPLPGEM-----------TFQQEFLNE 864 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E 864 (1075)
..++|++.++||+|+||.||+|.. ..++.||||++........ ...+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 2356899999865322110 011224457
Q ss_pred HHHHhcCCcCce-----eeEEEEeecc---------ccchhheecCc-------------------------------cc
Q 042958 865 VKALTEIRHRNI-----VKFYGFCSHV---------RHSLAMILSNN-------------------------------AA 899 (1075)
Q Consensus 865 ~~~l~~l~h~ni-----v~l~~~~~~~---------~~~l~~~~~~~-------------------------------~~ 899 (1075)
+.++.+++|.++ +++++||... ...+++.+... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 6677776432 11111111000 01
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc-eeccccccCccCc
Q 042958 900 AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAP 978 (1075)
Q Consensus 900 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~gt~~y~aP 978 (1075)
...++|..+..++.|+++|+.|+|+. +|+||||||+||+++.++.+||+|||+++.+...... .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778889999999999999999 9999999999999999999999999999765433211 1123347899999
Q ss_pred cccccCC----------------------CCcccchHhHHHHHHHHHhCCC-CCCccCccccchhhhhhh---hhhccCC
Q 042958 979 ELAYTMK----------------------VTEKCDVYSFGVLALEVIKGKH-PRDFISSMSSSSLNLNIA---LDEMLDP 1032 (1075)
Q Consensus 979 E~~~~~~----------------------~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~~~~~~~~~~---~~~~~~~ 1032 (1075)
|.+.... ...+.||||+||++|||++|.. |+................ .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875322 1234699999999999999885 665322111100000000 1111111
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENP---ESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 1071 (1075)
.... ...........+++.+++.++| .+|+|++|+++
T Consensus 460 ~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111 1122334568899999999766 68999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=217.55 Aligned_cols=249 Identities=18% Similarity=0.281 Sum_probs=180.9
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+++|+|-|++||.| ...+.+.++||+++.- ..+.+.+|+.++..+. ||||+++++...++....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3578899999999999999999 5667899999998642 2578899999999995 999999999887765442
Q ss_pred hheecCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCC
Q 042958 891 AMILSNNAA-------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~ 962 (1075)
.....+.-. -..++...++..+.+++.||.|+|+. ||.|||+||.|+++|... .++++|+|+|.++.+.
T Consensus 110 paLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 222222111 12355667788999999999999999 999999999999999765 7999999999998865
Q ss_pred CCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCc-cc----cchh---------------h
Q 042958 963 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISS-MS----SSSL---------------N 1021 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~-~~----~~~~---------------~ 1021 (1075)
. .+.-.+.+..|.-||.+... .|+..-|+|||||++.+|+..+.||-.-.+ .+ .... .
T Consensus 187 ~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 K-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred c-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3 34455678889999987654 578899999999999999999999742211 10 0000 0
Q ss_pred hhhhhhhccCCCCCCCC------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 LNIALDEMLDPRLPTPS------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..-....++......+. +...-..++..+++.+.+..|-.+|||++|.+.
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00001111111000000 000112357889999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=243.64 Aligned_cols=204 Identities=23% Similarity=0.311 Sum_probs=161.2
Q ss_pred HHHHHHHh---cCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEE
Q 042958 807 YEEIIRAT---NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882 (1075)
Q Consensus 807 ~~e~~~~~---~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 882 (1075)
|..+.++. .-|...+.||-|+||+|..+ +.++...||.|.+++...-...+...++.|..||+.-..+-||++|-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 33444443 45777889999999999999 555678899999987554455566788999999999999999999977
Q ss_pred eeccccchhheecCcccc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 883 CSHVRHSLAMILSNNAAA---------KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
|.+.+. +++++.+..++ +.+.+...+.++..++.|+++.|.. |+|||||||+|||||.+|++||+||
T Consensus 698 FQDkdn-LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 698 FQDKDN-LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred eccCCc-eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence 776544 44444444333 3355666677888999999999999 9999999999999999999999999
Q ss_pred ccccccC---------CCCC----------c-----------------------eeccccccCccCccccccCCCCcccc
Q 042958 954 GIAKFLK---------PDSS----------N-----------------------WTELAGTYGYVAPELAYTMKVTEKCD 991 (1075)
Q Consensus 954 Gla~~~~---------~~~~----------~-----------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 991 (1075)
|++.-+. ..+. . ....+||+.|+|||++....|+...|
T Consensus 774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd 853 (1034)
T KOG0608|consen 774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD 853 (1034)
T ss_pred cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence 9985332 1000 0 01246999999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCccCc
Q 042958 992 VYSFGVLALEVIKGKHPRDFISS 1014 (1075)
Q Consensus 992 v~s~G~vl~elltg~~p~~~~~~ 1014 (1075)
.||.|||||||+.|+.||.....
T Consensus 854 wws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCC
Confidence 99999999999999999975444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=224.82 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=182.4
Q ss_pred cCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc----
Q 042958 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS---- 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 889 (1075)
.+|.-...+|.|+- .|..| +.-.+++||+|+...+... ....++..+|...+..+.|+|+++++.++...+..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 45666677888888 66666 4446899999998877444 33346677999999999999999999988654322
Q ss_pred ---hhheecCccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 ---LAMILSNNAA----AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 ---l~~~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+.+.+..... ...++..+...+.+|++.|++|||+. +|+||||||+||++..+..+||.|||+|+....+
T Consensus 95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 2222222111 13456777889999999999999999 9999999999999999999999999999875543
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc----------hh----hhh-----
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS----------SL----NLN----- 1023 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~----------~~----~~~----- 1023 (1075)
-..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+....+.. .. +..
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 2455678899999999999999999999999999999999999887643222100 00 000
Q ss_pred ----------hhh-hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ----------IAL-DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ----------~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... +-+-|..++.......-......+++.+|+..||++|.+++++++
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 001111112211112223446889999999999999999999975
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-24 Score=273.05 Aligned_cols=363 Identities=23% Similarity=0.326 Sum_probs=235.9
Q ss_pred ceeEEEeccccccc-ccCCcccCCCCCccEEEccCCC------ccCCCCccccccC-CCceeecccCcccccCCCCCCCC
Q 042958 49 RVNSINLTSIGLKG-MLHDFSFSSFPHLAYLDLWHNQ------LYGNIPPQIGNIS-RLKYLDLSSNLFFGTIPPEIGHL 120 (1075)
Q Consensus 49 ~v~~l~l~~~~l~g-~~~~~~~~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l 120 (1075)
.|..+.+.-..... .++...|.++++|++|.+..+. +...+|..+..++ +|+.|++.++.+. .+|..+ ..
T Consensus 533 ~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~ 610 (1153)
T PLN03210 533 KVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RP 610 (1153)
T ss_pred eeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-Cc
Confidence 45554443322221 2444568888999999887653 3345777777765 5888888888876 777777 56
Q ss_pred CCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEee
Q 042958 121 SYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSL 200 (1075)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 200 (1075)
.+|++|+|++|++. .+|..+..+++|++|+|+++.....+| .++.+++|++|+|++|.....+|..++++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 88888888888877 567777777778888877765444444 3667777777777777655566777777777777777
Q ss_pred eccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCC
Q 042958 201 GYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280 (1075)
Q Consensus 201 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 280 (1075)
++|.....+|..+ ++++|+.|++++|.....+|.. .++|+.|++++|.+. .+|..+ .+++|++|++.++....
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~- 761 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK- 761 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-
Confidence 7764433555544 5667777777766544444432 345666666666665 344433 34555555555432211
Q ss_pred CCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCC
Q 042958 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360 (1075)
Q Consensus 281 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l 360 (1075)
++. .+....+..+...++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ .+
T Consensus 762 l~~----------------~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L 824 (1153)
T PLN03210 762 LWE----------------RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NL 824 (1153)
T ss_pred ccc----------------cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Cc
Confidence 110 1111112222334567777777776666677777777777777777765433566555 57
Q ss_pred CCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeec-cccccccccccccccccceec
Q 042958 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD-NSLSGSIPSEFGNLRSLSTLS 439 (1075)
Q Consensus 361 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 439 (1075)
++|+.|++++|.....+|.. ..+|++|+|++|.+. .+|.++..+++|+.|+|++ |+++ .+|..+..+++|+.|+
T Consensus 825 ~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~ 899 (1153)
T PLN03210 825 ESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVD 899 (1153)
T ss_pred cccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeee
Confidence 77888888887655555543 357888888888886 6788888889999999988 4555 4666778888888888
Q ss_pred ccccc
Q 042958 440 LGYNK 444 (1075)
Q Consensus 440 L~~N~ 444 (1075)
+++|.
T Consensus 900 l~~C~ 904 (1153)
T PLN03210 900 FSDCG 904 (1153)
T ss_pred cCCCc
Confidence 88773
|
syringae 6; Provisional |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=241.62 Aligned_cols=195 Identities=22% Similarity=0.321 Sum_probs=157.5
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHH-----HHHHHHHHHHhcCC---cCceeeEEE
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQ-----QEFLNEVKALTEIR---HRNIVKFYG 881 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~niv~l~~ 881 (1075)
.....+|+..+.+|+|+||.|+.|.++ +...|+||.+.+.+.-...+. -.+-.|+++|+.++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344567899999999999999999665 567899999876543211111 12567999999997 999999999
Q ss_pred EeeccccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 882 FCSHVRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
+|++.+.++...-... .-...+++.+...|++||+.|++|||+. +|||||||-+||.++.+|-+|++|
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 9998765433321111 1234467888889999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCC
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
||.|..... ......+||..|.|||++.+.+|- ..-|||++|+++|.++....||.
T Consensus 714 fgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999987543 446678999999999999999885 56799999999999999988874
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=271.22 Aligned_cols=306 Identities=25% Similarity=0.289 Sum_probs=145.5
Q ss_pred cCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccC
Q 042958 219 LATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298 (1075)
Q Consensus 219 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 298 (1075)
|+.|++.++.+. .+|..| ...+|+.|++++|++. .++..+..+++|+.|+|+++.....+| .+..+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecC
Confidence 444444444443 233333 2344444444444444 334444444444444444433222333 244444444444444
Q ss_pred CCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCc
Q 042958 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIP 378 (1075)
Q Consensus 299 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 378 (1075)
|.....+|..+..+++|+.|++++|.....+|..+ ++++|+.|++++|.....+|.. ..+|++|++++|.+ ..+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i-~~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAI-EEFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcc-cccc
Confidence 43333444444444445555544433222333332 3444555555544332233321 23444555555554 2333
Q ss_pred cccCCCcccceeeeccccc-------cccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCC
Q 042958 379 SELGNLRSLSMLSLGYNKL-------SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451 (1075)
Q Consensus 379 ~~~~~l~~L~~L~Ls~N~l-------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (1075)
..+ .+++|++|++.++.. ....+..+...++|+.|+|++|.....+|..++++++|+.|+|++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 332 344444444444221 111111222234566666666655445566666666666666666543334554
Q ss_pred CCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccc
Q 042958 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531 (1075)
Q Consensus 452 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 531 (1075)
.+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++|.-...+|..+..+++|
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L 895 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895 (1153)
T ss_pred CC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence 44 4566666666665443344432 245666666666665 456666666666666666633333455556666666
Q ss_pred cccccccc
Q 042958 532 SMLSFAYN 539 (1075)
Q Consensus 532 ~~L~l~~N 539 (1075)
+.++++++
T Consensus 896 ~~L~l~~C 903 (1153)
T PLN03210 896 ETVDFSDC 903 (1153)
T ss_pred CeeecCCC
Confidence 66666655
|
syringae 6; Provisional |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=237.48 Aligned_cols=263 Identities=18% Similarity=0.191 Sum_probs=192.8
Q ss_pred cccccccHHHHHHHhcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC------
Q 042958 800 TFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR------ 872 (1075)
Q Consensus 800 ~~~~~~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------ 872 (1075)
..++.+.+.=-+....+|.+....|+|-|++|.+|. ..-|..||||++... +...+.-+.|+++|+++.
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchh
Confidence 455666665555667899999999999999999994 445889999999753 334567789999999994
Q ss_pred cCceeeEEEEeeccccchhhe----------ecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee
Q 042958 873 HRNIVKFYGFCSHVRHSLAMI----------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL 942 (1075)
Q Consensus 873 h~niv~l~~~~~~~~~~l~~~----------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill 942 (1075)
--|+++++..|.+..+...++ +..++....+.......++.|+.-||.+|-.. +|+|.||||.|||+
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV 569 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence 247888887776665543332 33345556677888889999999999999998 99999999999999
Q ss_pred CCCC-CceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccch--
Q 042958 943 DFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS-- 1019 (1075)
Q Consensus 943 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-- 1019 (1075)
++.. .+||||||.|.+...+. .+.+..+..|.|||.+.|-.|+...|+||+||++||+.||+.-|.+...-....
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 9765 68999999998876442 333456778999999999999999999999999999999998775322110000
Q ss_pred ---------------------hh--------------hhh--hhhhccCC---------CCCCCCcCcHHHHHHHHHHHH
Q 042958 1020 ---------------------LN--------------LNI--ALDEMLDP---------RLPTPSCIVQDKLISIVEVAI 1053 (1075)
Q Consensus 1020 ---------------------~~--------------~~~--~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~ 1053 (1075)
.+ ... .....+.| ..+...........++.+++.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 00 000 00000001 000011223445678999999
Q ss_pred HccCCCCCCCCCHHHHHh
Q 042958 1054 SCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1054 ~cl~~dP~~RPs~~evl~ 1071 (1075)
+|+..||++|.|..|.++
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-25 Score=216.65 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=175.3
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..+.|++.+.+|+|.||.+-.++++ +.+.+|+|.+..+. ...++|.+|...--.+ .|.||+.-|++.......+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3467889999999999999999776 57789999987653 2367888888776666 6899999887554433333
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee-CCC-CCceEeccccccccC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFD-NEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-~~~-~~~kl~DfGla~~~~ 960 (1075)
....+.. -....+.+....+++.|+++|+.|||++ .+||||||.+|||+ +.| .++|+||||..+..+
T Consensus 98 vF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 3222221 1234467788899999999999999999 99999999999998 334 389999999988644
Q ss_pred CCCCceeccccccCccCccccccC-----CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
.. -...--+-.|.|||..... ...+.+|||.||+++|.++||+.||+- .......+...........++.|
T Consensus 175 ~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 TT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccCccCc
Confidence 21 1222335578999976432 356789999999999999999999983 22233333223333333344444
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.. .......+.++.++-+.++|++|-...++.++
T Consensus 251 ~~---F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 KK---FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hh---hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 32 33344568888999999999999666665554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=215.53 Aligned_cols=202 Identities=31% Similarity=0.563 Sum_probs=166.1
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc---
Q 042958 823 IGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA--- 898 (1075)
Q Consensus 823 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~--- 898 (1075)
||+|.+|.||++... +++.+++|++....... ..+.+.+|++.++.++|++++++++++......... ++...
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~-~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV-MEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEE-EecCCCCc
Confidence 689999999999765 48999999987543221 347899999999999999999999988764322211 11111
Q ss_pred -----cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccccccccCCCCCceeccc
Q 042958 899 -----AA--KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGIAKFLKPDSSNWTELA 970 (1075)
Q Consensus 899 -----~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 970 (1075)
.. ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+..............
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 01 3578899999999999999999999 9999999999999999 89999999999987654432234456
Q ss_pred cccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHH
Q 042958 971 GTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049 (1075)
Q Consensus 971 gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1049 (1075)
+...|++||..... .++.++|+|++|++++++ ..+.
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~~ 191 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PELK 191 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHHH
Confidence 78899999998877 788999999999999999 2488
Q ss_pred HHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1050 EVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1050 ~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
+++.+|++.+|++||++.++++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-24 Score=238.22 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=186.9
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-hh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-LA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l~ 891 (1075)
.++|.....+|.|.||.|||| +..+++.+|||+++.....+ .+-..+|+-+++.-+|||||.++|.+...+.. ..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 467888999999999999999 55689999999998754332 45667899999999999999999977554433 33
Q ss_pred heecCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 892 MILSNNAA-------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 892 ~~~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
|.+...+. ..++++.++..+.+...+|++|||+. +-+|||||-.||+++..|.+|++|||.+..+...-.
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 33333322 34578888899999999999999999 889999999999999999999999999988776666
Q ss_pred ceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC-CcC
Q 042958 965 NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SCI 1040 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1040 (1075)
......||++|||||+.. .+.|...+|||+.|+...|+-.-+.|--..... ..+.-+....+..+ ...
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMTKSGFQPPTLKD 239 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhhccCCCCCcccC
Confidence 677889999999999763 556889999999999999998888773322211 11111111111111 112
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...-...+-++++.|+.++|++||+++.++.
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2233456889999999999999999987654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=246.20 Aligned_cols=266 Identities=29% Similarity=0.404 Sum_probs=153.5
Q ss_pred CcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccc
Q 042958 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441 (1075)
Q Consensus 362 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 441 (1075)
.-..|++++|.++ .+|..+. .+|+.|++++|+++ .+|. ..++|++|+|++|+|+.+ |.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 3456777777774 4565554 36777777777776 3443 246677777777777643 332 3566677777
Q ss_pred ccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCC
Q 042958 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521 (1075)
Q Consensus 442 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 521 (1075)
+|.|+ .+|..+ ++|+.|++++|+++ .+|.. .++|+.|+|++|+|++ +|... .+|+.|++++|++++ +
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-c
Confidence 77766 344332 34566666777666 34432 3456666666666663 33221 245555666665542 2
Q ss_pred CccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceee
Q 042958 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLD 601 (1075)
Q Consensus 522 ~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 601 (1075)
|. +|.+|+.|+|++|+|++ +|.. ..+|..|++++|+|++ +|.. ..+|+.|+
T Consensus 338 P~---------------------lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~Ld 388 (788)
T PRK15387 338 PT---------------------LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELI 388 (788)
T ss_pred cc---------------------cccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEE
Confidence 32 23445556666666653 3322 1234555666666663 3332 24577777
Q ss_pred cCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCcccc
Q 042958 602 LSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681 (1075)
Q Consensus 602 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~ 681 (1075)
|++|+|+ .+|..+ ++|+.|++++|+|++ +|... .+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++
T Consensus 389 Ls~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 389 VSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred ecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCc
Confidence 7777776 355432 456777777777764 44322 34566777777776 366666667777777777777776
Q ss_pred CChhhhcc
Q 042958 682 LIPSCFEK 689 (1075)
Q Consensus 682 ~~p~~~~~ 689 (1075)
.+|..+..
T Consensus 460 ~~~~~L~~ 467 (788)
T PRK15387 460 RTLQALRE 467 (788)
T ss_pred hHHHHHHH
Confidence 66665543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=239.09 Aligned_cols=224 Identities=28% Similarity=0.361 Sum_probs=104.2
Q ss_pred CCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceec
Q 042958 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYI 320 (1075)
Q Consensus 241 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 320 (1075)
++|++|+|++|+++ .+|.. .++|+.|++++|.++. +|..+ .+|+.|++++|+++.+ |.. +++|+.|++
T Consensus 242 ~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~L-P~~---p~~L~~LdL 309 (788)
T PRK15387 242 PELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLTH-LPALP---SGLCKLWIFGNQLTSL-PVL---PPGLQELSV 309 (788)
T ss_pred CCCcEEEecCCccC-cccCc---ccccceeeccCCchhh-hhhch---hhcCEEECcCCccccc-ccc---ccccceeEC
Confidence 34444444444444 22321 1244444444444442 22211 3344455555555432 221 234555555
Q ss_pred ccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeecccccccc
Q 042958 321 HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400 (1075)
Q Consensus 321 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 400 (1075)
++|++++ +|... .+|+.|++++|++++ +|.. ..+|++|+|++|+|.+ +|.. ..+|+.|++++|+|+.
T Consensus 310 S~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~- 376 (788)
T PRK15387 310 SDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS- 376 (788)
T ss_pred CCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-
Confidence 5555553 22211 234455555555542 3321 1345555555555532 3321 1344555555555552
Q ss_pred CChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCc
Q 042958 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480 (1075)
Q Consensus 401 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 480 (1075)
+|.. ..+|+.|++++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|++++|+|+ .+|..+..+
T Consensus 377 LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L 444 (788)
T PRK15387 377 LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHL 444 (788)
T ss_pred Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhc
Confidence 3332 2345666666666653 3322 234556666666665 244322 24555666666665 455555556
Q ss_pred CCCCEEeCCCCcccCCCcccc
Q 042958 481 RSISNLALNNNKLSGSIPQSL 501 (1075)
Q Consensus 481 ~~L~~L~L~~N~l~~~~~~~~ 501 (1075)
++|+.|+|++|+|++..++.+
T Consensus 445 ~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 445 SSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred cCCCeEECCCCCCCchHHHHH
Confidence 666666666666655544444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=204.53 Aligned_cols=155 Identities=23% Similarity=0.279 Sum_probs=117.7
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCcc
Q 042958 900 AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979 (1075)
Q Consensus 900 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE 979 (1075)
+..+++.+++.|+.||++||+|||+. + ||+||+++.++.+|+ ||.++...... ..||+.|||||
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~~~y~aPE 74 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVDPYFMAPE 74 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----CCCcccccChH
Confidence 34689999999999999999999999 5 999999999999999 99998765422 26889999999
Q ss_pred ccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH--HHHHHHHHccC
Q 042958 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI--SIVEVAISCLD 1057 (1075)
Q Consensus 980 ~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~ 1057 (1075)
++.+..++.++|||||||++|||++|+.||......... ......... ...+........... .+.+++.+||+
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 150 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI---LEILLNGMP-ADDPRDRSNLESVSAARSFADFMRVCAS 150 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH---HHHHHHHhc-cCCccccccHHHHHhhhhHHHHHHHHHh
Confidence 999999999999999999999999999998643321110 111111111 111111111222222 59999999999
Q ss_pred CCCCCCCCHHHHHhhhc
Q 042958 1058 ENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1058 ~dP~~RPs~~evl~~L~ 1074 (1075)
.||++||++.|+++.+.
T Consensus 151 ~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 151 RLPQRREAANHYLAHCR 167 (176)
T ss_pred cccccccCHHHHHHHHH
Confidence 99999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=208.58 Aligned_cols=189 Identities=31% Similarity=0.505 Sum_probs=153.2
Q ss_pred CCCCceecccCceEEEEEEECC-CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 817 FDDEHCIGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++.........+..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5667899999999999997764 899999998764322 2467899999999999999999999988764433222211
Q ss_pred Ccc--------ccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-Cc
Q 042958 896 NNA--------AAKD-LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-SN 965 (1075)
Q Consensus 896 ~~~--------~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-~~ 965 (1075)
... .... +++.....++.++++++.|||+. +++|+|++|+||+++.++.++++|||.+....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 111 1122 78889999999999999999999 99999999999999999999999999998776542 12
Q ss_pred eeccccccCccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 966 WTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
.....++..|++||.. ....++.++|||++|+++|||++|+.||+
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2345678899999998 66678889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=215.10 Aligned_cols=194 Identities=27% Similarity=0.379 Sum_probs=150.9
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEE
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGF 882 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 882 (1075)
+.+....+.|...++||+|.|++||+|... ..+.||+|.+..... ...+..|++++..+ .+.||+++.++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhh
Confidence 344555678999999999999999999433 467899999865432 35788999999999 68999999987
Q ss_pred eeccccchhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEecccc
Q 042958 883 CSHVRHSLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGI 955 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGl 955 (1075)
+...+....+ +.+... -..++..+...+...+..||.|+|.. |||||||||+|++++.. +.-.|+|||+
T Consensus 104 ~rnnd~v~iv-lp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 104 FRNNDQVAIV-LPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred hccCCeeEEE-ecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 7665544333 222221 23467888899999999999999999 99999999999999854 5789999999
Q ss_pred ccccCCCC---------------------------------C-----------ceeccccccCccCccccccC-CCCccc
Q 042958 956 AKFLKPDS---------------------------------S-----------NWTELAGTYGYVAPELAYTM-KVTEKC 990 (1075)
Q Consensus 956 a~~~~~~~---------------------------------~-----------~~~~~~gt~~y~aPE~~~~~-~~~~~~ 990 (1075)
|....... . .....+||++|+|||++... ..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221100 0 00124699999999987654 568899
Q ss_pred chHhHHHHHHHHHhCCCCCC
Q 042958 991 DVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 991 Dv~s~G~vl~elltg~~p~~ 1010 (1075)
||||.||++.-+++++.||-
T Consensus 260 Diws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ceeeccceeehhhccccccc
Confidence 99999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=252.16 Aligned_cols=156 Identities=18% Similarity=0.228 Sum_probs=113.3
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-------------------CCCceEeccccccccC
Q 042958 900 AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-------------------DNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 900 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------------------~~~~kl~DfGla~~~~ 960 (1075)
...+++.+++.++.||++||+|||++ +|+||||||+|||++. ++.+|++|||+++...
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~ 150 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE 150 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence 34589999999999999999999999 9999999999999954 4456777777775422
Q ss_pred CCC----------------CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh
Q 042958 961 PDS----------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 961 ~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1075)
... .......||+.|||||++.+..++.++|||||||++|||++|..|+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~------~~~~ 224 (793)
T PLN00181 151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR------TMSS 224 (793)
T ss_pred cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH------HHHH
Confidence 100 001123578899999999999999999999999999999999888642110 0000
Q ss_pred hhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.. .........++.+||++||.+||+|.||++
T Consensus 225 ~~~~~~~~~~-------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 225 LRHRVLPPQI-------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhhcChhh-------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011111110 112234668889999999999999999986
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=227.33 Aligned_cols=280 Identities=25% Similarity=0.394 Sum_probs=186.4
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
+.+.|+++++.++ .+|..+. +.|+.|+|++|+++ .+|..+. ++|++|++++|.++.+ |..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEECc
Confidence 4567777777776 4565553 46777777777777 4555443 4677777777777754 33332 367888888
Q ss_pred CCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCcc
Q 042958 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257 (1075)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 257 (1075)
+|++. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 88877 3454443 46888888888887 4566554 478888888888874 454433 468888888888884 4
Q ss_pred CCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccc
Q 042958 258 PHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337 (1075)
Q Consensus 258 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 337 (1075)
|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+. ++|++|+|++|.++. +|..+. .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~ 388 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTN-LPENLP--A 388 (754)
T ss_pred Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCC-CCHhHH--H
Confidence 54443 578888888888885 565553 688899999998874 555443 688899999999884 555554 3
Q ss_pred ccccccccCCcccccCCCcC----CCCCCcceeeccccccCCCCccccCCCcccceeeeccccccc-cCChhhccCCCCC
Q 042958 338 SLSNLGLSGNKLSGSIPPSL----GYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLA 412 (1075)
Q Consensus 338 ~L~~L~l~~N~l~~~~~~~l----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~ 412 (1075)
+|+.|++++|+++ .+|..+ ..++++..|++.+|.+.. ..+.+|+.| ++.+.+.| .++...+.+.+++
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~ 460 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVR 460 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccccccccc
Confidence 6888999999988 455443 445788999999998852 344555555 34444433 3333444444444
Q ss_pred eEE
Q 042958 413 TLD 415 (1075)
Q Consensus 413 ~L~ 415 (1075)
...
T Consensus 461 ~~~ 463 (754)
T PRK15370 461 VTR 463 (754)
T ss_pred ccc
Confidence 433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=227.32 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=138.3
Q ss_pred ccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccc
Q 042958 194 SLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLY 273 (1075)
Q Consensus 194 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 273 (1075)
+...|+++++.++ .+|..+. ++|+.|+|++|+++. +|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4677888888887 5665553 468888888888874 455443 47888888888887 4555443 357777777
Q ss_pred cccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccC
Q 042958 274 ENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSI 353 (1075)
Q Consensus 274 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 353 (1075)
+|.++ .+|..+. .+|+.|++++|+++. +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 77777 4555443 467777777777763 444442 366666777666663 333332 345566666666552 3
Q ss_pred CCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccccccccccccc
Q 042958 354 PPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLR 433 (1075)
Q Consensus 354 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 433 (1075)
|..+. ++|+.|++++|.+ ++ +|..+. ++|+.|++++|+|+ .+|..+. +
T Consensus 320 P~~l~--~sL~~L~Ls~N~L------------------------t~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~ 367 (754)
T PRK15370 320 PETLP--PGLKTLEAGENAL------------------------TS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P 367 (754)
T ss_pred Ccccc--ccceeccccCCcc------------------------cc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence 33221 3445555555544 32 232221 34555555555554 2333221 3
Q ss_pred ccceecccccccccCCCCCCccccccccccccCCccccCCCccc----cCcCCCCEEeCCCCccc
Q 042958 434 SLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI----GNLRSISNLALNNNKLS 494 (1075)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~ 494 (1075)
+|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ +.++.+..|++.+|+|+
T Consensus 368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 4555555555555 2333332 24556666666665 334332 23355666666666665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=181.92 Aligned_cols=246 Identities=17% Similarity=0.250 Sum_probs=181.1
Q ss_pred hcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
.-.|.++++||+|+||+++.| .+-++++||||.-.... + ..++..|.+..+.+ ..++|..++-|-....+...
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--E---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--C---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 457999999999999999999 56689999999854332 1 35778899998888 56888888754444333222
Q ss_pred he-ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-----CceEeccccccc
Q 042958 892 MI-LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-----EAHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~-~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~DfGla~~ 958 (1075)
++ +-.. -.+..++..+...+|.|++.-++|+|++ ..|.|||||+|+||...+ .+.++|||+|+.
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 21 1111 1356688888899999999999999999 999999999999998655 489999999998
Q ss_pred cCCCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 959 LKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 959 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
+.++.+. .....||.+||+-....+.+-+.+.|+-|+|-|+++.+.|..||.+..... .....+++-+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeKIGe 253 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEKIGE 253 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHHhcc
Confidence 8765432 345679999999999999999999999999999999999999998765432 1222333333
Q ss_pred CCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1032 PRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1032 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.+-..+ .......+.++..-+.-.-..+=++-|..+-+.+.
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~L 295 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKL 295 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 332222 11222344566777776667777787877655443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=200.93 Aligned_cols=165 Identities=20% Similarity=0.225 Sum_probs=120.5
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC--CCCEEEEEEccCCCC--CchhHHHHHHHHHHHHhcCCcCceee-EEEEeec
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA--SGEIVAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVK-FYGFCSH 885 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 885 (1075)
....++|+..+.||+|+||+||+|..+ +++.||||+...... ......+.|.+|++++++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999654 578889998753211 12234567999999999999999985 4432
Q ss_pred cccchhheecCccccCCCCH---HHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCeeeCCCCCceEeccccccccCC
Q 042958 886 VRHSLAMILSNNAAAKDLGW---TRRMNVIKGISDALSYMHNDCFPPIVHRDI-SSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 886 ~~~~l~~~~~~~~~~~~l~~---~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
....+.+ +... +..+.. .....++.|+++||+|||+. +|+|||| ||+||+++.++.+||+|||+|+.+..
T Consensus 91 ~~~~LVm--E~~~-G~~L~~~~~~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 GKDGLVR--GWTE-GVPLHLARPHGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CCcEEEE--EccC-CCCHHHhCccchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 1222222 2211 122211 11257889999999999999 9999999 99999999999999999999997765
Q ss_pred CCCc--------eeccccccCccCccccccC
Q 042958 962 DSSN--------WTELAGTYGYVAPELAYTM 984 (1075)
Q Consensus 962 ~~~~--------~~~~~gt~~y~aPE~~~~~ 984 (1075)
.... .....+++.|+|||++...
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 4321 1345678899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=195.20 Aligned_cols=245 Identities=20% Similarity=0.227 Sum_probs=173.1
Q ss_pred CCCCCceecccCceEEEEEEECC--CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc----CceeeEEEEee-cccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAELAS--GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH----RNIVKFYGFCS-HVRH 888 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~-~~~~ 888 (1075)
+|.+.+.||+|+||.||.+.... ...+|+|......... ...+..|+.++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 79999999999999999996543 3578999876532221 1257778888888863 58888888773 3322
Q ss_pred chh-heecC--------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-----CCceEeccc
Q 042958 889 SLA-MILSN--------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-----NEAHVSDFG 954 (1075)
Q Consensus 889 ~l~-~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfG 954 (1075)
.+. |.+.. ......++..+..+|+.|++.||+++|+. |++||||||.|+.+... ..+.+.|||
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 222 21111 11146789999999999999999999999 99999999999999865 368999999
Q ss_pred ccc--ccCCCCCc--------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh
Q 042958 955 IAK--FLKPDSSN--------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 955 la~--~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1075)
+|+ .+...... .....||.+|.+++...+...+.+.|+||++.++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 43222211 12345999999999999999999999999999999999999999654432211111111
Q ss_pred hhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
........ .....+..+.++...+-..+..++|....+.+.+
T Consensus 253 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 253 PRKLLTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred hhhhcccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 11111111 0111223466777777778999999999887765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=183.24 Aligned_cols=238 Identities=18% Similarity=0.277 Sum_probs=168.3
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh--eec-
Q 042958 819 DEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM--ILS- 895 (1075)
Q Consensus 819 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~--~~~- 895 (1075)
...+|.+...|+.|+|+++ |..+++|++...... ....++|..|.-.++-+.||||++++|.|..+.....+ ++.
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3456889999999999998 555666777543322 22346789999999999999999999999876543221 111
Q ss_pred -------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceec
Q 042958 896 -------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968 (1075)
Q Consensus 896 -------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 968 (1075)
....+...+..+..++|.++|+|++|||+.. |-|-.--+.++.|++|++.+++|+ .+-+++.... ..
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe----~g 345 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----VG 345 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeec----cc
Confidence 1122344677889999999999999999973 233344688999999999998875 1222221111 11
Q ss_pred cccccCccCccccccCCCC---cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 969 LAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 969 ~~gt~~y~aPE~~~~~~~~---~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
..-.+.||+||.++..+.+ .++|+|||++++||+-|...||...++.+..-...-+.+ +... ++..+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl------rv~i----ppgis 415 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL------RVHI----PPGIS 415 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc------cccC----CCCcc
Confidence 2346789999999876544 578999999999999999999987666543221111111 1111 22344
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.+++.-|+..||.+||.++.|+-.||
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 56899999999999999999999988775
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=174.06 Aligned_cols=249 Identities=19% Similarity=0.294 Sum_probs=179.8
Q ss_pred HhcCCCCCceecccCceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc-CceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~l 890 (1075)
...+|...++||.|+||.+|.| ...+|+.||||+-..... ..++..|.++...+++ ..|..+..|..+.....
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 3578999999999999999999 667899999998654322 2567789999998865 55666665555443322
Q ss_pred -hheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEecccccccc
Q 042958 891 -AMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDFGIAKFL 959 (1075)
Q Consensus 891 -~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~ 959 (1075)
+|-+-... ....++..+.+-.|-|+..-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+.+
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 22221111 234567778888999999999999999 89999999999999744 46899999999987
Q ss_pred CCCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 960 KPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 960 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
.+..+. .+...||.+|.+-....+...+.+.|+-|+|.++...-.|..||++...... ....+.+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI~Ek 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKISEK 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHHHHh
Confidence 654322 2346799999998888888889999999999999999999999987654221 1122233333
Q ss_pred CCCCCC-cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1033 RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1033 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+...+. ......+.++.-.+.-|-..-=++-|...-+.+.+.
T Consensus 240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 332221 111223456777888888888888888877766654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-19 Score=207.21 Aligned_cols=238 Identities=20% Similarity=0.221 Sum_probs=164.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh--
Q 042958 816 DFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM-- 892 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~-- 892 (1075)
+|...+.+|.+.|=+|.+|+.+.|. |+||++.+... .......+-..|++ ...++|||++++.-+-...+..+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777889999999999999888787 88999876532 12222233334444 5566999999987654333322111
Q ss_pred e----ecCc-cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC-CCC--C
Q 042958 893 I----LSNN-AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK-PDS--S 964 (1075)
Q Consensus 893 ~----~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~-~~~--~ 964 (1075)
+ +++. .....+...+.+.||.|++.|+...|+. +|+|||||.+|||++.-..+.|+||..-+... +++ .
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 1 1121 2223345667788999999999999999 99999999999999999999999998765321 111 1
Q ss_pred ce----eccccccCccCccccccC----------C-CCcccchHhHHHHHHHHHh-CCCCCCccCccccc---hhhhhhh
Q 042958 965 NW----TELAGTYGYVAPELAYTM----------K-VTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSS---SLNLNIA 1025 (1075)
Q Consensus 965 ~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~---~~~~~~~ 1025 (1075)
.+ .+...-..|.|||.+... . .+++-||||+||++.|+++ |++||...+-.... ..+.+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 22 222334579999987542 1 4678899999999999998 89998732211111 1122222
Q ss_pred hhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1026 LDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
++++-|. .+++++..|++.||.+|-++++.++.
T Consensus 259 Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 3333222 38899999999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-19 Score=210.63 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=172.7
Q ss_pred CCCceecccCceEEEEEE-ECCCCEEEEEEccC---CCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh-
Q 042958 818 DDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHS---PLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM- 892 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~- 892 (1075)
...+++|.|++|.|+.+. ....+.++.|.+.. ....+......+..|..+-..++|||++..+..+.+.......
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999888773 33445455554432 2222333333477888889999999987765544332222111
Q ss_pred eec------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC--
Q 042958 893 ILS------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-- 964 (1075)
Q Consensus 893 ~~~------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-- 964 (1075)
.+. .......+...++-.++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+.....+..
T Consensus 401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 111 111223577788888999999999999999 999999999999999999999999999986654433
Q ss_pred --ceeccccccCccCccccccCCCCc-ccchHhHHHHHHHHHhCCCCCCccCccccc-hhhhhhhhhhccCCCCCCCCcC
Q 042958 965 --NWTELAGTYGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSSS-SLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.....+|+-.|+|||.+.+..|++ ..||||.|++++.|.+|+.||......+.. .......... ....+...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~----~~~~~~~~ 553 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN----IFEGPNRL 553 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc----cccChHHH
Confidence 234577999999999999999975 579999999999999999999744332211 0000000000 11112223
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.....++.++++.||++|.|+++|++
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 3445567889999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=181.44 Aligned_cols=225 Identities=21% Similarity=0.246 Sum_probs=143.0
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc----------CceeeEEEEee-
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH----------RNIVKFYGFCS- 884 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~- 884 (1075)
+...+.||.|+++.||.++.. +|+.+|||++...........+++.+|.-....+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999664 699999999877665555567788888876666432 12222222111
Q ss_pred --------cccc--chh----heecCc----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 042958 885 --------HVRH--SLA----MILSNN----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRD 934 (1075)
Q Consensus 885 --------~~~~--~l~----~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 934 (1075)
...+ .+. ..+... .....+....++.+..|+.+.+++||+. |+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1100 000 001000 0011234455677889999999999999 999999
Q ss_pred CCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCcccccc--------CCCCcccchHhHHHHHHHHHhCC
Q 042958 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--------MKVTEKCDVYSFGVLALEVIKGK 1006 (1075)
Q Consensus 935 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~elltg~ 1006 (1075)
|+|+|++++++|.++++||+.....+. .......+..|.+||.... ..++.+.|.|++|+++|.|++|+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999998876442 2222345678999997644 24788999999999999999999
Q ss_pred CCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCC
Q 042958 1007 HPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESR 1063 (1075)
Q Consensus 1007 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1063 (1075)
.||+.......... .+ ..+. +.+..+..+|..+++++|.+|
T Consensus 248 lPf~~~~~~~~~~~------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99985432211111 01 1122 566679999999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-17 Score=185.70 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=180.1
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcC-ceeeEEEEeeccccc-hhhee
Q 042958 817 FDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR-NIVKFYGFCSHVRHS-LAMIL 894 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~-l~~~~ 894 (1075)
|...+.+|.|+||.||++... ..+|+|.+.............+.+|+.+++.+.|+ +++++.+++...... +.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999766 88999998776544433467899999999999988 799999988554431 11111
Q ss_pred cCc-------ccc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCCC
Q 042958 895 SNN-------AAA---KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 895 ~~~-------~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 963 (1075)
... ... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 110 011 2577888899999999999999999 999999999999999998 79999999998655443
Q ss_pred C------ceeccccccCccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 964 S------NWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 964 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||........ .............+..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA-TSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc-HHHHHHHHHhcCCccc
Confidence 2 2356789999999999987 5788899999999999999999999764432100 0001111111111101
Q ss_pred CCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.... .........+.+++..|+..+|..|.++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1000 000112246889999999999999999887654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-20 Score=172.21 Aligned_cols=177 Identities=35% Similarity=0.623 Sum_probs=102.1
Q ss_pred ccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEE
Q 042958 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLD 415 (1075)
Q Consensus 336 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 415 (1075)
+..++.|.||+|+++ .+|+.+..+.+|+.|++++|++ +.+|..+..++.|+.|+++-|++. +.|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqi-e~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQI-EELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchh-hhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 445555666666665 4555555556666666666665 445555566666666666666664 5566666666666666
Q ss_pred eecccccc-ccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc
Q 042958 416 LYDNSLSG-SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 416 L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
|++|++.. ..|+.|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.+..|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 66665543 34556666666666666666665 55666666666666666666665 45666666666666666666665
Q ss_pred CCCcccccCCCc---cceeeccCCCCC
Q 042958 495 GSIPQSLGNLSN---LVILYLYNNSLF 518 (1075)
Q Consensus 495 ~~~~~~~~~l~~---L~~L~L~~N~l~ 518 (1075)
.+|+.++++.- =+.+.+.+|.+.
T Consensus 187 -vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 -VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred -ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 44444444321 233444445443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=9e-20 Score=205.37 Aligned_cols=113 Identities=24% Similarity=0.312 Sum_probs=71.9
Q ss_pred cCcccccceeecCCCcccCc----ccccccccccceEEEccccccccccchhccc-----ccccceeeeccccccC----
Q 042958 591 LGSLAQLEHLDLSSNRLSNS----IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEE-----LIHLSELDLSHNFLRE---- 657 (1075)
Q Consensus 591 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~---- 657 (1075)
+..++.|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+.. ...|+.|++++|.++.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~ 268 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAK 268 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHH
Confidence 33446777777777777642 3344556677788888887776533333322 3677888888887762
Q ss_pred chhhhhccccccceeecCCCccccC----Chhhhccc-ccccEEeecCCcc
Q 042958 658 AIPSQICIMQSLENLNLSHNSLVGL----IPSCFEKM-HGLLRIDISYNEL 703 (1075)
Q Consensus 658 ~~~~~~~~~~~L~~L~ls~N~l~~~----~p~~~~~~-~~l~~l~~s~N~~ 703 (1075)
.+...+..+++|+.+++++|.++.. ....+... +.|+++|+.+|.+
T Consensus 269 ~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 269 DLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 3344555667788888888888744 44444444 5677777777753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-19 Score=203.96 Aligned_cols=260 Identities=28% Similarity=0.314 Sum_probs=137.0
Q ss_pred CCCcccceeeecccccccc----CChhhccCCCCCeEEeecccccc------ccccccccccccceecccccccccCCCC
Q 042958 382 GNLRSLSMLSLGYNKLSGS----IPHSLGNLTNLATLDLYDNSLSG------SIPSEFGNLRSLSTLSLGYNKLSGSIPH 451 (1075)
Q Consensus 382 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (1075)
..+..|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..+++|+.|++++|.+.+..+.
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 3334444444444444221 22333344445555555444431 1223344445555555555555433333
Q ss_pred CCccccc---cccccccCCcccc----CCCccccCc-CCCCEEeCCCCcccCC----CcccccCCCccceeeccCCCCCC
Q 042958 452 SLGNLTN---LDALYLYDNSLSG----SIPGEIGNL-RSISNLALNNNKLSGS----IPQSLGNLSNLVILYLYNNSLFD 519 (1075)
Q Consensus 452 ~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 519 (1075)
.+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 3333333 5555555555542 112223334 5566666666665532 22334445556666666665543
Q ss_pred CC----CccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCccc
Q 042958 520 SI----PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLA 595 (1075)
Q Consensus 520 ~~----~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~ 595 (1075)
.. +..+..+++ |++|++++|.+++.... .+...+..++
T Consensus 180 ~~~~~l~~~l~~~~~------------------L~~L~L~~n~i~~~~~~--------------------~l~~~~~~~~ 221 (319)
T cd00116 180 AGIRALAEGLKANCN------------------LEVLDLNNNGLTDEGAS--------------------ALAETLASLK 221 (319)
T ss_pred HHHHHHHHHHHhCCC------------------CCEEeccCCccChHHHH--------------------HHHHHhcccC
Confidence 11 111112222 33444444444321111 1223355678
Q ss_pred ccceeecCCCcccCcccccccc-----cccceEEEcccccccc----ccchhcccccccceeeeccccccCc----hhhh
Q 042958 596 QLEHLDLSSNRLSNSIPKSFGN-----LVKLHYLNLSNNQFSR----GIPIKLEELIHLSELDLSHNFLREA----IPSQ 662 (1075)
Q Consensus 596 ~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~~~~ 662 (1075)
+|++|++++|.+++.....+.. .+.|++|++++|.++. .+...+..+++|+.+++++|.++.. ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 8999999999988633333322 3789999999999872 3445667778899999999999965 3434
Q ss_pred hccc-cccceeecCCCcc
Q 042958 663 ICIM-QSLENLNLSHNSL 679 (1075)
Q Consensus 663 ~~~~-~~L~~L~ls~N~l 679 (1075)
+-.. +.|+.|++.+|++
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 4344 6799999999874
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-19 Score=167.63 Aligned_cols=155 Identities=34% Similarity=0.593 Sum_probs=104.1
Q ss_pred CCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccce
Q 042958 358 GYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLST 437 (1075)
Q Consensus 358 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 437 (1075)
..+...+.|.|++|++ ..+|..++.+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl-~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKL-TVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCce-eecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 3455666777777777 455666677777777777777775 56667777777777777777775 66777777777777
Q ss_pred eccccccccc-CCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCC
Q 042958 438 LSLGYNKLSG-SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNS 516 (1075)
Q Consensus 438 L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 516 (1075)
|||++|.+.. .+|..|..++.|+.|||++|.+. .+|..++++++|+.|.+..|.+- ..|..++.++.|+.|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 7777777653 45666777777777777777776 56666666666666666666664 455555555555555555555
Q ss_pred C
Q 042958 517 L 517 (1075)
Q Consensus 517 l 517 (1075)
+
T Consensus 185 l 185 (264)
T KOG0617|consen 185 L 185 (264)
T ss_pred e
Confidence 5
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-17 Score=171.86 Aligned_cols=158 Identities=22% Similarity=0.311 Sum_probs=110.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC--CCC--CceEeccccccccCC------CCCceecccc
Q 042958 902 DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD--FDN--EAHVSDFGIAKFLKP------DSSNWTELAG 971 (1075)
Q Consensus 902 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~DfGla~~~~~------~~~~~~~~~g 971 (1075)
..+...+.-|..|+++|+.|||++ +|.|||+|++||++. .|+ .+.|+|||.+---.. ..+......|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG 413 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG 413 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence 345566677899999999999999 999999999999994 333 578999998743221 1123344668
Q ss_pred ccCccCccccccCCC------CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 972 TYGYVAPELAYTMKV------TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 972 t~~y~aPE~~~~~~~------~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
....||||+....+- -.|+|.|+.|.+.||+++...||..-..... ....+....+|.. ...++
T Consensus 414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------~~r~Yqe~qLPal---p~~vp 483 (598)
T KOG4158|consen 414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------DTRTYQESQLPAL---PSRVP 483 (598)
T ss_pred cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------chhhhhhhhCCCC---cccCC
Confidence 889999998764321 2578999999999999999999974211100 0111222223321 23345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+.+.+++...+++||.+|++..-....
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhH
Confidence 568999999999999999997654443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-17 Score=186.94 Aligned_cols=218 Identities=23% Similarity=0.275 Sum_probs=163.4
Q ss_pred eecccCceEEEEEE----ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhheecC
Q 042958 822 CIGKGGQGSVYKAE----LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
.+|+|+||.|+.++ .+.|..+|.|+.++......... ....|..++...+ ||.+|++.-.++.... +..++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~k-l~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGK-LYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccc-hhHhhhh
Confidence 37999999999762 34577899998877654433322 5667888888886 9999999765554333 3333222
Q ss_pred cc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 897 NA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 897 ~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
.. ....+.+.....+...++-|++++|+. +|+|||+|++||+++.+|.+++.|||+++..-+....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 22 223345556667778889999999999 9999999999999999999999999999876544322
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1075)
+||..|||||++. ....++|.||||++++||+||..||.. +....+...++.. +......
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~----p~~l~~~ 213 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEM----PRELSAE 213 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCC----chhhhHH
Confidence 8999999999988 578899999999999999999999973 2223333334433 3455566
Q ss_pred HHHHHHHccCCCCCCCCCH
Q 042958 1048 IVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1048 l~~li~~cl~~dP~~RPs~ 1066 (1075)
..+++..+..++|..|--.
T Consensus 214 a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 214 ARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHhhCHHHHhcc
Confidence 8888889999999988754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=159.02 Aligned_cols=185 Identities=11% Similarity=0.025 Sum_probs=127.8
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEccCCCCCch-hHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhheec
Q 042958 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM-TFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
.+...+++|+||+||.+.- .+.+++.+.+........ .....+.+|++++++++ |+++++++++. +..+.+.+-
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---GRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---CEEEEEeee
Confidence 4567899999999998865 588888777754321111 11225889999999994 58899998862 122222111
Q ss_pred Ccc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCeeeCCCCCceEeccccccccCCCCCc-----ee-
Q 042958 896 NNA-AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDI-SSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-----WT- 967 (1075)
Q Consensus 896 ~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~DfGla~~~~~~~~~-----~~- 967 (1075)
... -..... .....++.|++++++++|+. +|+|||| ||+||+++.++.++|+|||+|......... ..
T Consensus 81 ~G~~L~~~~~-~~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 81 AGAAMYQRPP-RGDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred cCccHHhhhh-hhhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 111 000111 12245788999999999999 9999999 799999999999999999999865543321 00
Q ss_pred -------ccccccCccCccccccC-CCC-cccchHhHHHHHHHHHhCCCCCC
Q 042958 968 -------ELAGTYGYVAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 968 -------~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
-...++.|++|+...-- ..+ .+.+.++-|.-+|.++|++.|+.
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 12257778888754322 233 56799999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-17 Score=168.07 Aligned_cols=180 Identities=12% Similarity=0.155 Sum_probs=126.5
Q ss_pred cHHHHH--HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHH------HHHHHHHHhcCCcCcee
Q 042958 806 VYEEII--RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQE------FLNEVKALTEIRHRNIV 877 (1075)
Q Consensus 806 ~~~e~~--~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv 877 (1075)
.|.++. ....+|+..+.+|.|+||.||.++. ++..+|||.+.......+...+. +.+|+..+.++.|++|.
T Consensus 20 ~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~ 98 (232)
T PRK10359 20 KYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA 98 (232)
T ss_pred cHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence 344443 3368999999999999999999866 47789999997655444433333 68999999999999999
Q ss_pred eEEEEeecccc-------chhheecCccccCCCC-HH-HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCc
Q 042958 878 KFYGFCSHVRH-------SLAMILSNNAAAKDLG-WT-RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEA 948 (1075)
Q Consensus 878 ~l~~~~~~~~~-------~l~~~~~~~~~~~~l~-~~-~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~ 948 (1075)
.+.+++..... ...++++...+ ..+. +. .......+++.++..+|+. +++|||++|+||+++.++ +
T Consensus 99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G-~tL~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 99 SLNDFYLLAERKTLRYAHTYIMLIEYIEG-VELNDMPEISEDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cceEeeeecccccccccCCeEEEEEEECC-ccHHHhhhccHHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 99988654321 11222222221 1111 00 0123567999999999999 999999999999999988 9
Q ss_pred eEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHH
Q 042958 949 HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 1003 (1075)
Q Consensus 949 kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 1003 (1075)
+++|||..+....+... ..+.....+..++|+|++|+.+....
T Consensus 174 ~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988755322111 11334445667899999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-16 Score=162.37 Aligned_cols=136 Identities=19% Similarity=0.232 Sum_probs=97.5
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchh-----------------------HHHHHHHHHHHHhcCCcCce
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT-----------------------FQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni 876 (1075)
...||+|+||.||+|...+|+.||||+++........ .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999998754221111 01223459999999987776
Q ss_pred eeEEEEeeccccchhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCCeeeCCCCCc
Q 042958 877 VKFYGFCSHVRHSLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYM-HNDCFPPIVHRDISSKNVLLDFDNEA 948 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~~~~~ 948 (1075)
.....+... ...+.|.+... .....++..+..+++.|++.|+.|+ |+. +|+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcE
Confidence 433322221 22222222211 1124577888899999999999999 687 999999999999998 5789
Q ss_pred eEeccccccccC
Q 042958 949 HVSDFGIAKFLK 960 (1075)
Q Consensus 949 kl~DfGla~~~~ 960 (1075)
+++|||+|....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.4e-17 Score=179.76 Aligned_cols=142 Identities=24% Similarity=0.452 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC------CceeccccccCccCccccc
Q 042958 909 MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS------SNWTELAGTYGYVAPELAY 982 (1075)
Q Consensus 909 ~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~------~~~~~~~gt~~y~aPE~~~ 982 (1075)
..++.|++.|++| + +.+|||+||.||++..+..+||.|||+........ ...+...||..||+||.+.
T Consensus 362 ~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~ 435 (516)
T KOG1033|consen 362 LDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR 435 (516)
T ss_pred HHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence 4588899999999 5 88999999999999999999999999998766544 2345568999999999999
Q ss_pred cCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCC
Q 042958 983 TMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPE 1061 (1075)
Q Consensus 983 ~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1061 (1075)
+..|+.|+||||+|++++|++. -..+++ .......+.+..+|+. .. ...+.=+.++.+++.+.|.
T Consensus 436 g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d~r~g~ip~~--~~-~d~p~e~~ll~~lls~~p~ 501 (516)
T KOG1033|consen 436 GQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTDIRDGIIPPE--FL-QDYPEEYTLLQQLLSPSPE 501 (516)
T ss_pred hhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhhhhcCCCChH--Hh-hcCcHHHHHHHHhcCCCcc
Confidence 9999999999999999999998 444433 1223445555555521 11 1112345799999999999
Q ss_pred CCCCHHHHH
Q 042958 1062 SRPTMPKVS 1070 (1075)
Q Consensus 1062 ~RPs~~evl 1070 (1075)
+||++.++.
T Consensus 502 ~RP~~~~~~ 510 (516)
T KOG1033|consen 502 ERPSAIEVA 510 (516)
T ss_pred cCchHHHHh
Confidence 999776654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=157.79 Aligned_cols=137 Identities=19% Similarity=0.219 Sum_probs=100.0
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCch-----------------------hHHHHHHHHHHHHhcCCcCce
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM-----------------------TFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~ni 876 (1075)
...||+|+||.||+|...+|+.||||+++....... .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999777899999999876422100 001234678999999999887
Q ss_pred eeEEEEeeccccchhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCc
Q 042958 877 VKFYGFCSHVRHSLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEA 948 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~ 948 (1075)
.....+.... ..+.+.+.... ....++..+..+++.|++.++.++|+ . +|+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~~-~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKK-NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecC-CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCE
Confidence 5433332222 22222222111 12235667888999999999999999 8 999999999999999 8999
Q ss_pred eEeccccccccCC
Q 042958 949 HVSDFGIAKFLKP 961 (1075)
Q Consensus 949 kl~DfGla~~~~~ 961 (1075)
+++|||+++....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.6e-16 Score=174.44 Aligned_cols=200 Identities=24% Similarity=0.393 Sum_probs=142.0
Q ss_pred HhcCCcCceeeEEEEeeccccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEecCCC
Q 042958 868 LTEIRHRNIVKFYGFCSHVRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI-VHRDISS 937 (1075)
Q Consensus 868 l~~l~h~niv~l~~~~~~~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dlk~ 937 (1075)
|+.+.|.|+.+++|.+.+....+.++-... .....++|.-...++++|+.|++|+|.. +| +|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 456789999999999988744433321111 1244578888899999999999999998 55 9999999
Q ss_pred CCeeeCCCCCceEeccccccccCC--CCCceeccccccCccCccccccCC-------CCcccchHhHHHHHHHHHhCCCC
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLKP--DSSNWTELAGTYGYVAPELAYTMK-------VTEKCDVYSFGVLALEVIKGKHP 1008 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~G~vl~elltg~~p 1008 (1075)
+|+++|....+|++|||+...... .........-..-|.|||.++... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999987643 111122223456799999987641 46779999999999999999999
Q ss_pred CCccCccccchhhhhhhhhhccC-CC-CCCCCcC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1009 RDFISSMSSSSLNLNIALDEMLD-PR-LPTPSCI-VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
|+......... +....+.+ .. ...|.-. ..+....+..++..||..+|.+||++++|...++
T Consensus 158 ~~~~~~~~~~~----eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 158 FDLRNLVEDPD----EIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred cccccccCChH----HHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 98543322221 11111111 11 1111111 1133446999999999999999999999988765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.8e-16 Score=182.18 Aligned_cols=207 Identities=23% Similarity=0.312 Sum_probs=141.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|...+.|..|+||.||..+++ +.+.+|+|+ .+. .-+.+- ++.....|.+| |=|. .
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq--------~lilRn--ilt~a~npfvv---gDc~-------t 140 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ--------NLILRN--ILTFAGNPFVV---GDCA-------T 140 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-ccc--------chhhhc--cccccCCccee---chhh-------h
Confidence 468888999999999999999776 567888854 221 111111 34444556655 1111 1
Q ss_pred eecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC--------
Q 042958 893 ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-------- 964 (1075)
Q Consensus 893 ~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~-------- 964 (1075)
.+ .....++.. .+.|++|+|+. +|+|||+||+|.+++.-|++|+.|||+++.......
T Consensus 141 ll---k~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 141 LL---KNIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hc---ccCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 11 111122222 27899999999 999999999999999999999999999875432110
Q ss_pred -------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 965 -------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 965 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.....+||+.|+|||++..+.|...+|+|++|+++||.+-|..||......+ .+..++......+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--------lfg~visd~i~wp 278 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LFGQVISDDIEWP 278 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--------HHhhhhhhhcccc
Confidence 0234689999999999999999999999999999999999999997543211 1111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCC
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRP 1064 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RP 1064 (1075)
.. ......+..+++.+.++.+|.+|-
T Consensus 279 E~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 11 222334688999999999999986
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.3e-15 Score=179.75 Aligned_cols=240 Identities=20% Similarity=0.201 Sum_probs=162.7
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC---cCceeeEEEEeec
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSH 885 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 885 (1075)
+.....+.|.+.+.+|+|+||+||+|...+|+.||+|+-+.+...+--...+ ++.+|+ -+-|+.+...+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHcc
Confidence 4445567888999999999999999988889999999987765554332233 333333 1222222221111
Q ss_pred cccc-hhhee-------cCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-------CCCceE
Q 042958 886 VRHS-LAMIL-------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-------DNEAHV 950 (1075)
Q Consensus 886 ~~~~-l~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~~kl 950 (1075)
.+.. +...+ ......+.++|.-.+.++.|+++.+++||.. +|||+||||+|+++.. ..-++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 1111 11111 1112566789999999999999999999999 9999999999999953 235999
Q ss_pred eccccccccC--CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh
Q 042958 951 SDFGIAKFLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 951 ~DfGla~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
+|||-+..+. ++.......++|-.+-.+|+..|+.++..+|.|.++.+++-|+.|+.-- ...+ ...
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g-----------~~~ 910 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNG-----------SSW 910 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCC-----------cce
Confidence 9999997654 4445677788999999999999999999999999999999999998552 0000 000
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+...++. ....+ .+.++...+++.|...=|...++...++
T Consensus 911 ~~~~~~~R--y~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~ 951 (974)
T KOG1166|consen 911 MVKTNFPR--YWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELE 951 (974)
T ss_pred eccccchh--hhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHH
Confidence 11111111 11122 2556666777766666666666665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.4e-15 Score=176.36 Aligned_cols=148 Identities=32% Similarity=0.532 Sum_probs=103.4
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCccceEEeCCC-----CceeEEEecccccccccCCcccCCCCCcc
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRG-----GRVNSINLTSIGLKGMLHDFSFSSFPHLA 76 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~w~gv~C~~~-----~~v~~l~l~~~~l~g~~~~~~~~~l~~L~ 76 (1075)
+|.+||++||+++.++ . ..+|.++.. ....|.|.||.|+.. .+|+.|+|+++++.|.+++. ++.+++|+
T Consensus 372 ~~~~aL~~~k~~~~~~-~---~~~W~g~~C-~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~-i~~L~~L~ 445 (623)
T PLN03150 372 EEVSALQTLKSSLGLP-L---RFGWNGDPC-VPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND-ISKLRHLQ 445 (623)
T ss_pred hHHHHHHHHHHhcCCc-c---cCCCCCCCC-CCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH-HhCCCCCC
Confidence 5889999999999654 2 247963110 000137999999632 24777777777777777765 77777777
Q ss_pred EEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCcccccc-CCcceeecccc
Q 042958 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRL-SSLNYLALYSN 155 (1075)
Q Consensus 77 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~L~~n 155 (1075)
.|+|++|.+.|.+|+.++.+++|++|+|++|.++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.+|
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 77777777777777777777777777777777777777777777777777777777777777765542 23444444444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.2e-14 Score=143.80 Aligned_cols=131 Identities=15% Similarity=0.173 Sum_probs=92.2
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-----CcCceeeEEEEeecccc--c
Q 042958 817 FDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-----RHRNIVKFYGFCSHVRH--S 889 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~--~ 889 (1075)
....+.||+|+||.||. .-.++.. +||++..... ...+.+.+|+++++.+ .||||++++|++.+... .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34457899999999996 3234444 7998865322 2346799999999999 57999999999987642 2
Q ss_pred hh-heecCcc-cc---------CCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEecCCCCCeeeCCC----CCceEecc
Q 042958 890 LA-MILSNNA-AA---------KDLGWTRRMNVIKGISDAL-SYMHNDCFPPIVHRDISSKNVLLDFD----NEAHVSDF 953 (1075)
Q Consensus 890 l~-~~~~~~~-~~---------~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Df 953 (1075)
+. .+++..+ .+ ..+++. ..++.+++.++ +|||++ +|+||||||+||+++.. +.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 22 2233211 11 123333 35577888777 999999 99999999999999743 37999995
Q ss_pred cccc
Q 042958 954 GIAK 957 (1075)
Q Consensus 954 Gla~ 957 (1075)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 4443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.9e-14 Score=149.04 Aligned_cols=140 Identities=19% Similarity=0.201 Sum_probs=100.1
Q ss_pred hcCCCCCceecccCceEEEEEE--ECCCCEEEEEEccCCCCCc---------------------hhHHHHHHHHHHHHhc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAE--LASGEIVAVKKFHSPLPGE---------------------MTFQQEFLNEVKALTE 870 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~ 870 (1075)
..-|++.+.||+|+||.||+|. ..+|+.||||+++...... ......+..|+..+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999997 5689999999987532110 0012346789999999
Q ss_pred CCcC--ceeeEEEEeeccccchhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCCCCe
Q 042958 871 IRHR--NIVKFYGFCSHVRHSLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP-IVHRDISSKNV 940 (1075)
Q Consensus 871 l~h~--niv~l~~~~~~~~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~Ni 940 (1075)
+.+. .+.+++++. ...+.+.+.... ........+...++.|++.|+.+||+. + |+||||||+||
T Consensus 107 L~~~~i~~p~~~~~~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 107 LYEAGVPVPKPIAWR---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred HHhcCCCCCeeeEec---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 9753 344555432 222222221110 112234445678999999999999999 8 99999999999
Q ss_pred eeCCCCCceEeccccccccC
Q 042958 941 LLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 941 ll~~~~~~kl~DfGla~~~~ 960 (1075)
+++ +++++++|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999988644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.2e-14 Score=145.98 Aligned_cols=147 Identities=19% Similarity=0.168 Sum_probs=103.4
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCch-------------------hHHHHHHHHHHHH
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM-------------------TFQQEFLNEVKAL 868 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l 868 (1075)
.++......|...+.||+|+||.||+|...+|+.||||++........ .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 345555556888899999999999999888899999998764321100 0112367889999
Q ss_pred hcCCcC--ceeeEEEEeeccccchhheecCccccCCCCH-HHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 869 TEIRHR--NIVKFYGFCSHVRHSLAMILSNNAAAKDLGW-TRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 869 ~~l~h~--niv~l~~~~~~~~~~l~~~~~~~~~~~~l~~-~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
..+.|+ .++..++.+ ...+.+.+.....-..+.. .....++.+++.++.++|+. +|+||||||+||+++++
T Consensus 88 ~~l~~~~i~v~~~~~~~---~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 88 KALYEEGFPVPKPIDWN---RHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred HHHHHcCCCCCceeecC---CceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 998777 455555432 2222222211111111111 34567899999999999998 99999999999999999
Q ss_pred CCceEeccccccccC
Q 042958 946 NEAHVSDFGIAKFLK 960 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~ 960 (1075)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.6e-14 Score=169.66 Aligned_cols=120 Identities=33% Similarity=0.488 Sum_probs=83.4
Q ss_pred ccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecC
Q 042958 596 QLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLS 675 (1075)
Q Consensus 596 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls 675 (1075)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|||++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCccccCChhhhcccc-cccEEeecCCccCCCCCCCccccccccccccCCccccCCCCCCCcccc
Q 042958 676 HNSLVGLIPSCFEKMH-GLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKT 739 (1075)
Q Consensus 676 ~N~l~~~~p~~~~~~~-~l~~l~~s~N~~~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~l~~c~~ 739 (1075)
+|.++|.+|..+..+. .+.. ..+.+|+.+||.+ +++.|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~-----------------------l~~~~N~~lc~~p-~l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRAS-----------------------FNFTDNAGLCGIP-GLRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCce-----------------------EEecCCccccCCC-CCCCCcc
Confidence 7777777776665431 1222 2466777788743 4567753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.5e-13 Score=135.41 Aligned_cols=135 Identities=24% Similarity=0.266 Sum_probs=89.1
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHH---------------------HHHHHHHHhcCCcCc--e
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQE---------------------FLNEVKALTEIRHRN--I 876 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~n--i 876 (1075)
.+.||+|+||.||+|...+|+.||||++............. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999987789999999986543221111111 135566666654432 4
Q ss_pred eeEEEEeeccccchhheecCc-----cccCCCCH-HHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCce
Q 042958 877 VKFYGFCSHVRHSLAMILSNN-----AAAKDLGW-TRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAH 949 (1075)
Q Consensus 877 v~l~~~~~~~~~~l~~~~~~~-----~~~~~l~~-~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~k 949 (1075)
.+.+++. ...+.+.+... ........ .+..+++.+++.++.++|. . +|+||||||+||+++ ++.++
T Consensus 82 ~~~~~~~---~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 82 PKPIDLN---RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CceEecC---CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEE
Confidence 4444321 11111111111 00011111 5667899999999999999 7 999999999999999 99999
Q ss_pred EeccccccccCC
Q 042958 950 VSDFGIAKFLKP 961 (1075)
Q Consensus 950 l~DfGla~~~~~ 961 (1075)
++|||.+.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-14 Score=155.58 Aligned_cols=175 Identities=35% Similarity=0.499 Sum_probs=92.2
Q ss_pred ccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccccee
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 390 (1075)
.+.--...+|+.|++. .+|..+..+..|+.+.|.+|.+. .+|..+..+..|+.|+|+.|++ ...|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nql-S~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQL-SHLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchh-hcCChhhhcCc-ceeE
Confidence 3444455566666666 55666666666666666666665 4555555555555555555555 34444444443 4555
Q ss_pred eeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccc
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 470 (1075)
-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|..++.| .|..||++.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 55555553 44555554455555555555554 34444555555555555555554 333344432 2444555555555
Q ss_pred cCCCccccCcCCCCEEeCCCCccc
Q 042958 471 GSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 471 ~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
.+|-.|.+++.|++|-|.+|+|.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC
Confidence 44555555555555555555554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.38 E-value=2e-12 Score=154.86 Aligned_cols=139 Identities=19% Similarity=0.292 Sum_probs=99.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEc-cCCCCC----chhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKF-HSPLPG----EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
...|...+.||+|+||.||+|.+... .+++|+. .+.... .....+++.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44556788999999999999987644 3444432 221111 11224568899999999999999887776665333
Q ss_pred chhheecCccccCCCCH--HHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 SLAMILSNNAAAKDLGW--TRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l~~~~~~~~~~~~l~~--~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
. .+++++. .+..+.. ..+..++.++++++.|||+. +++|||+||+||++ .++.++|+|||+++..
T Consensus 411 ~-~lv~E~~-~g~~L~~~l~~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 K-TIVMEYI-GGKDLKDVLEGNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred C-EEEEEec-CCCcHHHHHHHHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 2 2222222 2333322 23678999999999999999 99999999999999 6789999999999763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=134.00 Aligned_cols=131 Identities=18% Similarity=0.298 Sum_probs=91.4
Q ss_pred eecccCceEEEEEEECCCCEEEEEEccCCCCCc-----hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 822 CIGKGGQGSVYKAELASGEIVAVKKFHSPLPGE-----MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
.||+|+||.||+|.+ +|..|++|+........ .....++.+|++++..++|+++.....++...... .++++.
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~-~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK-TIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC-EEEEEE
Confidence 389999999999985 47889999865432111 11235678899999999888654443333332221 122222
Q ss_pred ccccCCCCHHHHH---HHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 897 NAAAKDLGWTRRM---NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 897 ~~~~~~l~~~~~~---~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
. .+..+...... .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.++..
T Consensus 79 ~-~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 I-EGKPLKDVIEEGNDELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred E-CCccHHHHHhhcHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 1 12222211111 7899999999999999 999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5e-14 Score=154.62 Aligned_cols=172 Identities=36% Similarity=0.502 Sum_probs=88.4
Q ss_pred cccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccccccccccc
Q 042958 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS 345 (1075)
Q Consensus 266 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 345 (1075)
--...||+.|++. .+|..+..+-.|+.+.|..|.+. .+|.+++++..|++|+|+.|+++ ..|..++.|+ |+.|.++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3344555555555 45555555555555555555555 44555555555555555555555 4444444443 4555555
Q ss_pred CCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccccc
Q 042958 346 GNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI 425 (1075)
Q Consensus 346 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 425 (1075)
+|+++ .+|..++....|..|+.+.|.+ ..+|..++++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei-~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEI-QSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhh-hhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence 55555 4455555555555555555555 344445555555555555555554 334444433 3455555555554 34
Q ss_pred ccccccccccceecccccccc
Q 042958 426 PSEFGNLRSLSTLSLGYNKLS 446 (1075)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~ 446 (1075)
|-.|.+|+.|++|.|.+|.+.
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred chhhhhhhhheeeeeccCCCC
Confidence 445555555555555555554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.2e-12 Score=132.73 Aligned_cols=130 Identities=16% Similarity=0.306 Sum_probs=96.0
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCch-----hHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
+.||+|++|.||+|.. +|..|++|+......... .....+.+|++++..++|+++.....++......+ ++++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~-lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI-IVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE-EEEE
Confidence 5799999999999987 588899998654322111 12346788999999999998877666654433222 1221
Q ss_pred CccccCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 896 NNAAAKDL-------GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 896 ~~~~~~~l-------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
... +..+ .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~-G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIE-GEPLKDLINSNGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeC-CcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 111 1111 12 5678999999999999999 999999999999999 78999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.6e-13 Score=160.03 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=173.0
Q ss_pred hcCCCCCceecccCceEEEEEEE--CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccch
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL--ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l 890 (1075)
...|...+.||+|+|+.|-.+.. .....+|+|.+.... .+.........|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 34567778899999999988844 335567777776553 23334456667888877776 999999999877655543
Q ss_pred hheecCc---------c-ccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCCeeeCCCC-CceEeccccccc
Q 042958 891 AMILSNN---------A-AAKDLGWTRRMNVIKGISDALSYMH-NDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~~---------~-~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~ 958 (1075)
...-... . .....+......+..|+..|+.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 3321100 0 1112344455678899999999999 77 999999999999999999 999999999987
Q ss_pred cCC-CCC--ceecccc-ccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 959 LKP-DSS--NWTELAG-TYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 959 ~~~-~~~--~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
+.. ... .....+| ++.|+|||...+.. ..+..|+||.|+++..+++|..||+......... ..+...+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------~~~~~~~ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------SSWKSNK 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------eeecccc
Confidence 766 332 2344678 99999999988754 4677899999999999999999998654432111 1111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+........++..+++..+|..|.+.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001112233345778888999999999999887653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.3e-12 Score=149.38 Aligned_cols=195 Identities=41% Similarity=0.571 Sum_probs=88.6
Q ss_pred ceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccc-cccccccccccCcCCCCcccCCCccCcEEEccCC
Q 042958 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLT-NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299 (1075)
Q Consensus 221 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 299 (1075)
.+.+..|.+.. ....+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 34444444421 1222333455555555555555 3444444442 5555555555555 23344555555555555555
Q ss_pred CCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCcc
Q 042958 300 KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS 379 (1075)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 379 (1075)
++.. +|...+.+++|+.|++++|++. .+|........|++|.+++|.+. ..+..+..+.++..+.+.+|++. ..+.
T Consensus 174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 5552 2333334455555555555555 34433333444555555555322 23334444444444444444442 1233
Q ss_pred ccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccc
Q 042958 380 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS 424 (1075)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 424 (1075)
.+..+.++++|++++|+++.... ++.+.+++.|++++|.+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence 34444444444444444432211 44444444444444444433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.8e-12 Score=150.20 Aligned_cols=198 Identities=43% Similarity=0.621 Sum_probs=119.8
Q ss_pred eEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCc-cCcEEEccCCCCCCCcCCCCCccccccceecccc
Q 042958 245 MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLR-SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323 (1075)
Q Consensus 245 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 323 (1075)
.++++.|.+... ...+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 567777776422 223444466777777777777 3444455553 6777777777776 34455666777777777777
Q ss_pred cccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCCh
Q 042958 324 SLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403 (1075)
Q Consensus 324 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 403 (1075)
+++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|.+ ...+..+.++.++..+.+++|++. ..+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~-~~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI-IELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc-eecchhhhhcccccccccCCceee-eccc
Confidence 776 44444446666777777777776 4555544555566666666643 234455566666666666666664 3355
Q ss_pred hhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCC
Q 042958 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451 (1075)
Q Consensus 404 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (1075)
.++.++++++|++++|.++.+.+ ++.+.+|+.|++++|.+....|.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 56666666666666666664332 56666666666666666644443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-11 Score=122.75 Aligned_cols=133 Identities=14% Similarity=0.125 Sum_probs=103.0
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc--CceeeEEEEeeccccchhheecC
Q 042958 819 DEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 819 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
+.+.+|+|.++.||++... +..+++|....... ...+..|+.+++.++| .++++++++....+. ..++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGW-SYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-cEEEEEe
Confidence 3567999999999999876 47899999865422 3578899999999976 588998887765432 2222222
Q ss_pred c--cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 897 N--AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 897 ~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
. .....++......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 75 ~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 2 1122235677888999999999999997545799999999999999989999999998875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.2e-11 Score=127.97 Aligned_cols=136 Identities=15% Similarity=0.208 Sum_probs=94.0
Q ss_pred Cceec-ccCceEEEEEEECCCCEEEEEEccCCCC----------CchhHHHHHHHHHHHHhcCCcCce--eeEEEEeecc
Q 042958 820 EHCIG-KGGQGSVYKAELASGEIVAVKKFHSPLP----------GEMTFQQEFLNEVKALTEIRHRNI--VKFYGFCSHV 886 (1075)
Q Consensus 820 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 886 (1075)
...|| .|+.|+||+++.. +..+|||++..... ........+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999776 78899998854210 111234568899999999998874 6777765433
Q ss_pred ccchh---heecCccccCCCCHH-----HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 887 RHSLA---MILSNNAAAKDLGWT-----RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 887 ~~~l~---~~~~~~~~~~~l~~~-----~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
..... ++++...+...+... .....+.+++.++.+||+. ||+||||||.||+++.++.++|+|||.++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 22211 222212211111100 0123467899999999999 999999999999999999999999998875
Q ss_pred c
Q 042958 959 L 959 (1075)
Q Consensus 959 ~ 959 (1075)
.
T Consensus 192 ~ 192 (239)
T PRK01723 192 R 192 (239)
T ss_pred C
Confidence 3
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.4e-13 Score=137.57 Aligned_cols=250 Identities=21% Similarity=0.273 Sum_probs=120.7
Q ss_pred cCCCCCccEEEccCCCccC----CCCccccccCCCceeecccC---cccccCCCC-------CCCCCCCcEEEccCcccC
Q 042958 69 FSSFPHLAYLDLWHNQLYG----NIPPQIGNISRLKYLDLSSN---LFFGTIPPE-------IGHLSYLKTLQLFENQLN 134 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n---~l~~~~p~~-------l~~l~~L~~L~Ls~n~l~ 134 (1075)
+..+..+++++||+|.|.. .|.+.+.+.++|+..++|+- +...++|+. +-..++|++||||.|.|.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 3446778888999988853 46677778888888888763 222344433 345567888888888877
Q ss_pred CCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCc
Q 042958 135 GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG 214 (1075)
Q Consensus 135 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 214 (1075)
...+..+..+ +..++.|++|.|.+|.+.-.-...++. .|..|. .|+ ..+
T Consensus 106 ~~g~~~l~~l--------------------l~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~ 154 (382)
T KOG1909|consen 106 PKGIRGLEEL--------------------LSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAA 154 (382)
T ss_pred ccchHHHHHH--------------------HHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccC
Confidence 5555443221 233444455555555443211111110 111111 000 011
Q ss_pred CCCCcCceeccccCCCCC----CcccccCCCCCCeEeccCCCCCC----ccCCCCcccccccccccccccCcCC----CC
Q 042958 215 NLTNLATLYLHNNSLFDS----IPSELGNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLYLYENSLSGS----IP 282 (1075)
Q Consensus 215 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~----~~ 282 (1075)
.-++|+.+...+|++... +...|...+.|+.+.++.|.+.. .+...|..+++|+.|||.+|.++.. +.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 122344444444444221 11223333444444444444431 1112344445555555555544421 12
Q ss_pred cccCCCccCcEEEccCCCCCCCcCCCC-----CccccccceecccccccCC----CCcccccccccccccccCCcc
Q 042958 283 SEFGNLRSLSMLNLGYNKLNGIIPHSL-----GNLTNLATLYIHNNSLSGS----IPSEIGNLRSLSNLGLSGNKL 349 (1075)
Q Consensus 283 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 349 (1075)
..+..+++|+.|++++|.+......+| ...++|++|.|.+|.|+.. +...+...+.|+.|+|++|.+
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 334445555555555555554332222 1245566666666666521 122233456677777777766
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.1e-12 Score=126.62 Aligned_cols=132 Identities=27% Similarity=0.272 Sum_probs=82.8
Q ss_pred cCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccc
Q 042958 381 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLD 460 (1075)
Q Consensus 381 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 460 (1075)
+...+.|+++|||+|.|+ .+.++..-++.++.|++|+|.|+.+ +.++.+++|+.||||+|.++ .+..+-.+|-+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 334456777777777775 5556666667777777777777643 23666777777777777776 3445555566677
Q ss_pred cccccCCccccCCCccccCcCCCCEEeCCCCcccCCC-cccccCCCccceeeccCCCCC
Q 042958 461 ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI-PQSLGNLSNLVILYLYNNSLF 518 (1075)
Q Consensus 461 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 518 (1075)
.|.|++|.|.. -..++++-+|..||+++|+|.... -+.+++++-|+.+.|.+|++.
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 77777777652 234566666777777777765321 234566666666666666654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=125.75 Aligned_cols=133 Identities=29% Similarity=0.331 Sum_probs=91.6
Q ss_pred ccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccc
Q 042958 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 268 (1075)
Q Consensus 189 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 268 (1075)
+.....|++||||+|.|+ .+..+..-.+.++.|++++|.+..+ ..+..+++|+.||||+|.++ .+..+-..+.+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 444566777788888777 5666666677778888888877643 23677777888888888777 4444555666777
Q ss_pred ccccccccCcCCCCcccCCCccCcEEEccCCCCCCCc-CCCCCccccccceecccccccC
Q 042958 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII-PHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 269 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
+|.|++|.+... +.++.+-+|..||+++|+|.... -..+++++.|+.+.|.+|.+.+
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 777877777632 45666777777788877776432 2456777777777777777763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.9e-12 Score=135.03 Aligned_cols=170 Identities=25% Similarity=0.269 Sum_probs=92.2
Q ss_pred CCCEEeCCCCcccCCCcc----cccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCC
Q 042958 482 SISNLALNNNKLSGSIPQ----SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN 557 (1075)
Q Consensus 482 ~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N 557 (1075)
+|+.|+||.|-|.-.-++ .+..++.|+.|+|.||.+.-..-..++ ..|..|. .|+.. .-|+.|++++..+|
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk~-~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKKA-ASKPKLRVFICGRN 167 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhcc-CCCcceEEEEeecc
Confidence 444444444444322222 234567777777777766321111221 1222222 33322 23567888888888
Q ss_pred ccccccchh----hhhhhHhHHHhhccccccc----ccccccCcccccceeecCCCcccC----cccccccccccceEEE
Q 042958 558 HIVGEIPTE----LGKLNFLIKLILAQNQLSG----QLSPKLGSLAQLEHLDLSSNRLSN----SIPKSFGNLVKLHYLN 625 (1075)
Q Consensus 558 ~l~~~~p~~----~~~~~~l~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ 625 (1075)
++....... +...+.|..+.+.+|.+.. .+...|..+++|+.|||.+|.|+. .+...++.+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 886543333 3334556666777776652 123346677777777777777763 3345566667777777
Q ss_pred ccccccccccchhcc-----cccccceeeecccccc
Q 042958 626 LSNNQFSRGIPIKLE-----ELIHLSELDLSHNFLR 656 (1075)
Q Consensus 626 Ls~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~ 656 (1075)
++++.++......+. ..++|++|.|.+|.++
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 777776654433331 2445555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-11 Score=142.31 Aligned_cols=151 Identities=33% Similarity=0.422 Sum_probs=83.9
Q ss_pred CccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccccc
Q 042958 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 270 (1075)
Q Consensus 191 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 270 (1075)
.+..++.+++..|.+. .+-..+..+++|+.|++.+|+|... ...+..+++|++|++++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 3445555556666665 2333455566666666666666532 22255666666666666666643 234455556666
Q ss_pred ccccccCcCCCCcccCCCccCcEEEccCCCCCCCcC-CCCCccccccceecccccccCCCCcccccccccccccccCCcc
Q 042958 271 YLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP-HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL 349 (1075)
Q Consensus 271 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 349 (1075)
++++|.++.+ ..+..+..|+.+++++|++..+.+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence 6666666632 344446666666666666664433 1 3555666666666666652 22333344444455555555
Q ss_pred c
Q 042958 350 S 350 (1075)
Q Consensus 350 ~ 350 (1075)
+
T Consensus 221 ~ 221 (414)
T KOG0531|consen 221 S 221 (414)
T ss_pred e
Confidence 4
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-11 Score=141.41 Aligned_cols=219 Identities=33% Similarity=0.469 Sum_probs=132.7
Q ss_pred cccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCE
Q 042958 94 GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDT 173 (1075)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (1075)
..+..++.+.+..|.+. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|.|+.+.+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 45667777777777776 333457777888888888888773 33335667777777777777777643 666677777
Q ss_pred EEcCCCCCCCCCCccccCccccceEeeeccccccccCCC-CcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCC
Q 042958 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHS-LGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252 (1075)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 252 (1075)
|++++|.|+.. ..+..++.|+.+++++|++...-+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 77777777643 235557777777777777763332 1 4566677777777777643 2334455555555677777
Q ss_pred CCCccCCCCccccc--ccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccccccc
Q 042958 253 LSGSIPHSLGNLTN--LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326 (1075)
Q Consensus 253 l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 326 (1075)
++..- .+..+.. |+.+++++|.+.. .+..+..+..+..|++.+|++... ..+.....+..+....|.+.
T Consensus 220 i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 220 ISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 66321 1222222 6666777666662 224455555666666666665533 22333444555555555543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-10 Score=131.33 Aligned_cols=240 Identities=25% Similarity=0.279 Sum_probs=162.9
Q ss_pred CCCCCceecc--cCceEEEEEEE---CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGK--GGQGSVYKAEL---ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
.|.....+|. |.+|.||.+.. .++..+|+|+-+.+...... ...=.+|+...+.+ .|++.++.+..+...+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence 4556678999 99999999955 47899999986665443222 22334666666666 589999977666554443
Q ss_pred hhhee-cCc-------cccCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEeccccc
Q 042958 890 LAMIL-SNN-------AAAKDLGWTRRMNVIKGISD----ALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~-~~~-------~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 956 (1075)
+.... ... .....++....+.+..+..+ |+.++|.. .++|-|+||.||+...+ ...+++|||+.
T Consensus 194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence 32221 110 11222444555666667777 99999999 99999999999999999 88999999999
Q ss_pred cccCCCCCc-----eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 957 KFLKPDSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 957 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
..+.+..-. .....|...|++||...+ .++.++|+|++|.+..+..++..+...--...+... ..
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---------r~ 340 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---------RQ 340 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---------cc
Confidence 888765421 122357788999998765 488899999999999999998766431100011110 00
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... +.++......++..++..+++.+|..|++++++..
T Consensus 341 ~~i--p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 GYI--PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccC--chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011 11111222334666899999999999999998765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-10 Score=113.49 Aligned_cols=124 Identities=31% Similarity=0.316 Sum_probs=50.2
Q ss_pred hHhHHHhhcccccccccccccC-cccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceee
Q 042958 571 NFLIKLILAQNQLSGQLSPKLG-SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELD 649 (1075)
Q Consensus 571 ~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 649 (1075)
..+++|+|.+|+|+.. +.++ .+.+|+.||||+|.|+. ++ .+..+++|++|++++|+|+...+.....+++|++|+
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 3567777777777743 3455 57889999999999973 43 477788999999999999864332224688899999
Q ss_pred eccccccCchh-hhhccccccceeecCCCccccCCh---hhhcccccccEEee
Q 042958 650 LSHNFLREAIP-SQICIMQSLENLNLSHNSLVGLIP---SCFEKMHGLLRIDI 698 (1075)
Q Consensus 650 ls~N~l~~~~~-~~~~~~~~L~~L~ls~N~l~~~~p---~~~~~~~~l~~l~~ 698 (1075)
|++|+|...-. ..+..+++|+.|++.+|++....- .-+..+|+|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 99999976332 456678889999999999874421 23677888888874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.1e-11 Score=129.25 Aligned_cols=158 Identities=26% Similarity=0.185 Sum_probs=66.3
Q ss_pred CCcceeecccccccCCCC-CCCCCCCCCCEEEcCCCCCCCC--CCccccCccccceEeeeccccccccCCCC-cCCCCcC
Q 042958 145 SSLNYLALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSLSDS--IPSEFGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLA 220 (1075)
Q Consensus 145 ~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~ 220 (1075)
++|+...|+++.+..... .....+++++.|||++|-+... +......+++|+.|+|+.|++.....+.. ..+++|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 334444444444333221 2344555566666666555432 12223445556666666665542111111 1234455
Q ss_pred ceeccccCCCCC-CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCC-CcccCCCccCcEEEccC
Q 042958 221 TLYLHNNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSI-PSEFGNLRSLSMLNLGY 298 (1075)
Q Consensus 221 ~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~ 298 (1075)
.|.|+.|.++.. +......+++|+.|+|.+|.....-......+..|++|+|++|++-... -...+.++.|+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 555555555421 1112233455555555555322222222333344555555555444211 02333444444444444
Q ss_pred CCCC
Q 042958 299 NKLN 302 (1075)
Q Consensus 299 N~l~ 302 (1075)
+.+.
T Consensus 281 tgi~ 284 (505)
T KOG3207|consen 281 TGIA 284 (505)
T ss_pred cCcc
Confidence 4444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=123.55 Aligned_cols=137 Identities=19% Similarity=0.221 Sum_probs=85.1
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCch---------------------------hHH----------HHHHH
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM---------------------------TFQ----------QEFLN 863 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------------------~~~----------~~~~~ 863 (1075)
+.||.|++|.||+|++++|+.||||+.+....... ... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864321100 000 02445
Q ss_pred HHHHHhcCC----cCceeeEEEEeec--cccchhheecCccccCCCCHH-----HHHHHHHHHHH-HHHHHHhCCCCCeE
Q 042958 864 EVKALTEIR----HRNIVKFYGFCSH--VRHSLAMILSNNAAAKDLGWT-----RRMNVIKGISD-ALSYMHNDCFPPIV 931 (1075)
Q Consensus 864 E~~~l~~l~----h~niv~l~~~~~~--~~~~l~~~~~~~~~~~~l~~~-----~~~~i~~~i~~-~L~~LH~~~~~~iv 931 (1075)
|++.+.+++ |.+-+.+-.++.+ ....+.+.+.....-..+... .+.+++.+++. .+..+|.. |++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~---g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD---GFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---Cce
Confidence 555555552 2222222222211 122233322222111111000 23467777776 47888988 999
Q ss_pred EecCCCCCeeeCCCCCceEeccccccccC
Q 042958 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 932 H~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
|+|++|.||+++.+++++++|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-11 Score=128.06 Aligned_cols=210 Identities=24% Similarity=0.227 Sum_probs=111.0
Q ss_pred CCCCCCCEEEcCCCCCCCCCC-ccccCccccceEeeecccccccc--CCCCcCCCCcCceeccccCCCCCCccc-ccCCC
Q 042958 166 GNLSNLDTLHLYDNSLSDSIP-SEFGNLRSLSMLSLGYNKFSGSI--PHSLGNLTNLATLYLHNNSLFDSIPSE-LGNLR 241 (1075)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~ 241 (1075)
+++.+|+...|.++.+..... .....|++++.||||.|-+.... -.....+++|+.|+|+.|++....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 356778888888887763322 34566778888888888776322 233455677777777777765322211 12455
Q ss_pred CCCeEeccCCCCCC-ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCc-CCCCCcccccccee
Q 042958 242 SLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII-PHSLGNLTNLATLY 319 (1075)
Q Consensus 242 ~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ 319 (1075)
+|+.|.|+.|.++- .+...+..+++|+.|+|..|...........-+..|+.|||++|.+.... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 66666666666652 11222334455666666666422222223333455555666655554221 02334455555555
Q ss_pred cccccccCCCCcccccccccccccccCCcccccCCCc-----CCCCCCcceeeccccccCCCC-ccccCCCcccceeeec
Q 042958 320 IHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS-----LGYLSNLATLYLYSNSLFDSI-PSELGNLRSLSMLSLG 393 (1075)
Q Consensus 320 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-----l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls 393 (1075)
++.+.|..+. .|+. ....++|++|++..|++.+.. -..+..+++|+.|...
T Consensus 278 ls~tgi~si~-----------------------~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 278 LSSTGIASIA-----------------------EPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred ccccCcchhc-----------------------CCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 5555554221 1111 233455666666666663221 1234445666666766
Q ss_pred ccccc
Q 042958 394 YNKLS 398 (1075)
Q Consensus 394 ~N~l~ 398 (1075)
.|.++
T Consensus 335 ~n~ln 339 (505)
T KOG3207|consen 335 LNYLN 339 (505)
T ss_pred ccccc
Confidence 77765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.8e-10 Score=113.79 Aligned_cols=66 Identities=33% Similarity=0.338 Sum_probs=17.8
Q ss_pred CCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccC-CCCcCCCCcCceeccccCCC
Q 042958 165 LGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIP-HSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 165 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 230 (1075)
+..+++|++|++++|+|+.+.+.....+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++
T Consensus 60 l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp ----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 4445555555555555554322111245555555555555542111 22334444555555555443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.5e-10 Score=136.46 Aligned_cols=131 Identities=29% Similarity=0.376 Sum_probs=82.9
Q ss_pred CCCCCccEEEccCCCccCCCCccccccCCCceeecccCc--ccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCc
Q 042958 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNL--FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSL 147 (1075)
Q Consensus 70 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 147 (1075)
.+....++..+-+|.+. .++....+ ++|+.|-+..|. +....+..|..++.|++|||++|.=.+.+|..++.|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34456677777777765 44433332 367788887775 442333446778888888888876666777777777777
Q ss_pred ceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecc
Q 042958 148 NYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203 (1075)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (1075)
++|++++..+.. .|..+.+|+.|.+|++..+.-...+|.....+++|++|.+..-
T Consensus 598 ryL~L~~t~I~~-LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 598 RYLDLSDTGISH-LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred hcccccCCCccc-cchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 777777777663 3555666666666666666544444555555666666655543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=116.50 Aligned_cols=161 Identities=19% Similarity=0.240 Sum_probs=113.9
Q ss_pred EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCccccCCC-------CHHH
Q 042958 835 ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDL-------GWTR 907 (1075)
Q Consensus 835 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~~~~~l-------~~~~ 907 (1075)
+..++.+|.|...+.... ...+...+.++.++.++||||+++++.+...+..+. .-+ ...++ +...
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~yl-vTE---rV~Pl~~~lk~l~~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYL-VTE---RVRPLETVLKELGKEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEE-Eee---ccccHHHHHHHhHHHH
Confidence 556789999988875432 334667788999999999999999998776553211 111 11112 2223
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCccccccCCCC
Q 042958 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 987 (1075)
Q Consensus 908 ~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 987 (1075)
..-.+.||+.||.|||+.| +++|++|.-..|++++.|+.||++|-++..............--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 3446789999999999776 899999999999999999999999988865443222111222223566777654333
Q ss_pred cccchHhHHHHHHHHHhCC
Q 042958 988 EKCDVYSFGVLALEVIKGK 1006 (1075)
Q Consensus 988 ~~~Dv~s~G~vl~elltg~ 1006 (1075)
-..|.|-||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.5e-10 Score=135.61 Aligned_cols=299 Identities=29% Similarity=0.285 Sum_probs=162.3
Q ss_pred CccccceEeeeccccccccCCCCcCCCCcCceeccccC--CCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccc
Q 042958 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS--LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 268 (1075)
Q Consensus 191 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 268 (1075)
+....+...+-+|.+. .++.... +++|++|-+..|. +....++.|..++.|++|||++|.--+.+|..++.+-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3356777778788776 4444333 3478888888886 4444445577788888888888877778888888888888
Q ss_pred ccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccccccc--CCCCcccccccccccccccC
Q 042958 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS--GSIPSEIGNLRSLSNLGLSG 346 (1075)
Q Consensus 269 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~ 346 (1075)
+|++++..++ .+|..++++..|.+|++..+.-...+|.....+++|++|.+-.-... ...-..+..+.+|+.+....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 8888888888 67888888888888888887765556667777888888887665422 11222233344444444322
Q ss_pred CcccccCCCcCCCCCCcc----eeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccc
Q 042958 347 NKLSGSIPPSLGYLSNLA----TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422 (1075)
Q Consensus 347 N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 422 (1075)
... .+-..+..+..|. .+.+..+.. ...+..+..+.+|+.|.+.++.+.............+.
T Consensus 678 ~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~---------- 744 (889)
T KOG4658|consen 678 SSV--LLLEDLLGMTRLRSLLQSLSIEGCSK-RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL---------- 744 (889)
T ss_pred chh--HhHhhhhhhHHHHHHhHhhhhccccc-ceeecccccccCcceEEEEcCCCchhhcccccccchhh----------
Confidence 221 0111112222222 122111111 22333344444445555544444322221111110000
Q ss_pred cccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCC-Ccccc
Q 042958 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS-IPQSL 501 (1075)
Q Consensus 423 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~ 501 (1075)
.++++..+.+.++..- ..+.+..-.++|+.|++.++.....+.+....+..++.+-+..+.+.+. .-...
T Consensus 745 --------~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l 815 (889)
T KOG4658|consen 745 --------CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSL 815 (889)
T ss_pred --------hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecC
Confidence 0122222222222111 1122222336677777776666555555555555565555666666554 34445
Q ss_pred cCCCccceeeccC
Q 042958 502 GNLSNLVILYLYN 514 (1075)
Q Consensus 502 ~~l~~L~~L~L~~ 514 (1075)
+.++++..+.++.
T Consensus 816 ~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 816 GGLPQLYWLPLSF 828 (889)
T ss_pred CCCceeEecccCc
Confidence 5555555555444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.9e-09 Score=105.30 Aligned_cols=128 Identities=20% Similarity=0.149 Sum_probs=87.4
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce-eeEEEEeeccccchhheecCccc
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI-VKFYGFCSHVRHSLAMILSNNAA 899 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~l~~~~~~~~~ 899 (1075)
+.++.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.++ .+++++.... ..+. ++...
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~-~~lv--~e~i~- 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDPET-GVLI--TEFIE- 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeCCC-CeEE--EEecC-
Confidence 56899999999999876 78899999754321 12346788999988865554 4555554322 2222 22211
Q ss_pred cCCCCH--HHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 900 AKDLGW--TRRMNVIKGISDALSYMHNDC--FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 900 ~~~l~~--~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+..+.. .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 122221 122456789999999999983 12369999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.9e-09 Score=110.12 Aligned_cols=188 Identities=21% Similarity=0.289 Sum_probs=118.9
Q ss_pred HhcCCcCceeeEEEEeecccc----chhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 042958 868 LTEIRHRNIVKFYGFCSHVRH----SLAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930 (1075)
Q Consensus 868 l~~l~h~niv~l~~~~~~~~~----~l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 930 (1075)
+-++-|.|+|++..|+.+... ...++.++.. ....+....-.+|..||..||.|||+. .|+|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 344568999999998865433 1222222211 122344445568999999999999986 6799
Q ss_pred EEecCCCCCeeeCCCCCceEeccccccccCCCC-----CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhC
Q 042958 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-----SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 1005 (1075)
Q Consensus 931 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg 1005 (1075)
+|+++..+-|++..+|-+|+.--.-. ...+.. .......+-++|.|||+-.....+.++|||+||....||.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999988887421111 111100 011123456899999998877788899999999999999887
Q ss_pred CCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1006 KHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1006 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..--... ......+......+...-. . .=+.++.+|++..|..||+|.+++.
T Consensus 279 Eiq~tns----eS~~~~ee~ia~~i~~len-----~-----lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNS----ESKVEVEENIANVIIGLEN-----G-----LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCC----cceeehhhhhhhheeeccC-----c-----cccCcCcccccCCCCCCcchhhhhc
Confidence 6441100 0111111111111111000 0 1235788999999999999998763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2e-07 Score=100.11 Aligned_cols=244 Identities=19% Similarity=0.290 Sum_probs=152.3
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceee----------------EE
Q 042958 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVK----------------FY 880 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----------------l~ 880 (1075)
...+.+|+|+.+.+|-...- +.. +-|++..+...... + -+..|... .||-+-. .+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~a---q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQA---Q---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCchHHH---H---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45678999999999976222 222 44777765443221 1 12222332 3443222 23
Q ss_pred EEeec---cccchhheecCc---cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 881 GFCSH---VRHSLAMILSNN---AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 881 ~~~~~---~~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
|+... ....+.+++... .......|.-.++++..+|.|.+-||.. |.+-+|+.++|+|+.+++.+.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 33211 111222333222 1223468999999999999999999999 89999999999999999999999855
Q ss_pred cccccCCCCCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhC-CCCCCccCccccchhhhhhhh--
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSSSSLNLNIAL-- 1026 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~-- 1026 (1075)
.-... .++..+...+|...|.+||.-. +...+...|-|.+|+++++++.| ++||.++........-.+..+
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 43322 3455667788999999999643 44567789999999999999975 999986543321111111010
Q ss_pred ------hhccCCCCCCCCcC-cHHHHHHHHHHHHHccCC--CCCCCCCHHHHHhhh
Q 042958 1027 ------DEMLDPRLPTPSCI-VQDKLISIVEVAISCLDE--NPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1027 ------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L 1073 (1075)
.+...+..+.|... ..--++.+..+..+|+.. .+.-|||++-.+..|
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 11111222222222 222345688888899864 367899998877655
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.5e-09 Score=84.38 Aligned_cols=61 Identities=46% Similarity=0.589 Sum_probs=39.1
Q ss_pred cccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccc
Q 042958 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFL 655 (1075)
Q Consensus 595 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 655 (1075)
++|++|++++|+|+...+..|..+++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666644445666666666666666666666666666666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.7e-09 Score=84.30 Aligned_cols=58 Identities=41% Similarity=0.583 Sum_probs=25.4
Q ss_pred CCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCc
Q 042958 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468 (1075)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 468 (1075)
|++|++++|+|+.+.++.|.++++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333444444444444444444443334444444444444444443
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-08 Score=115.90 Aligned_cols=239 Identities=20% Similarity=0.179 Sum_probs=157.6
Q ss_pred HHhcCCCCCceecccCceEEEEEEE--CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL--ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 888 (1075)
....+|..+..||.|.|+.||+... .++..|++|..........+. ..-..|+.+...+ .|.++++++..+...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 3456888899999999999999844 467889999887665443332 2234566665555 57788876654443333
Q ss_pred ch-hheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEecccccccc
Q 042958 889 SL-AMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l-~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~~ 959 (1075)
.+ ...+... .....++...++++..|++.|+.++|+. .++|+|+||+||++..+ +..++.|||.+..+
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 22 1111111 1122356667788999999999999998 99999999999999886 78899999998642
Q ss_pred CCCCCceeccccccCc-cCccccccCCCCcccchHhHHHHHHHHHhCCCCCC-ccCccccchhhhhhhhhhccCCCCCCC
Q 042958 960 KPDSSNWTELAGTYGY-VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD-FISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.-. .......+..| .+|+......+..+.|+||||.-+.|.++|..--. +.. ...+.....+..
T Consensus 418 ~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------~~~i~~~~~p~~ 483 (524)
T KOG0601|consen 418 AFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------SLTIRSGDTPNL 483 (524)
T ss_pred cee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------ceeeecccccCC
Confidence 211 11111223333 35666667788899999999999999999875421 100 111111222221
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
. ....++..+.+.+..+|+..||.+.+....
T Consensus 484 ~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 484 P----GLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred C----chHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 1 111457778888999999999999887654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-07 Score=107.80 Aligned_cols=143 Identities=17% Similarity=0.240 Sum_probs=80.7
Q ss_pred hcCCCCCceecccCceEEEEEEECC-CCEEEEEEccCCCCCc---------------------------h----hHHHH-
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGE---------------------------M----TFQQE- 860 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---------------------------~----~~~~~- 860 (1075)
...|+. +.+|.|++|.||+|++++ |+.||||+.+...... . +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999887 9999999987432100 0 11122
Q ss_pred -----HHHHHHHHhcCC----cCceeeEEEEeec--cccchhheecCccccCCCCHH-----HHHHHHHHHHHH-HHHHH
Q 042958 861 -----FLNEVKALTEIR----HRNIVKFYGFCSH--VRHSLAMILSNNAAAKDLGWT-----RRMNVIKGISDA-LSYMH 923 (1075)
Q Consensus 861 -----~~~E~~~l~~l~----h~niv~l~~~~~~--~~~~l~~~~~~~~~~~~l~~~-----~~~~i~~~i~~~-L~~LH 923 (1075)
|.+|+..+.+++ +...+.+-.++.+ ....+.|.+.....-.++... .+..++...+++ +..+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 344444444442 3322322222211 122222222221111111000 012233333322 33445
Q ss_pred hCCCCCeEEecCCCCCeeeCCCC----CceEeccccccccC
Q 042958 924 NDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIAKFLK 960 (1075)
Q Consensus 924 ~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla~~~~ 960 (1075)
.. |++|+|+||.||+++.++ ++++.|||++..+.
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 56 999999999999999988 99999999998664
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-08 Score=74.38 Aligned_cols=41 Identities=39% Similarity=0.947 Sum_probs=28.4
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCccceEEeC
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCN 45 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~w~gv~C~ 45 (1075)
+|++||++||+++.+++. +.+.+|+... .+.+|.|.||+|+
T Consensus 3 ~d~~aLl~~k~~l~~~~~-~~l~~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 3 QDRQALLAFKKSLNNDPS-GVLSSWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHCTT-SC--CCCTT--TT----S-CCCSTTEEE-
T ss_pred HHHHHHHHHHHhcccccC-cccccCCCcC--CCCCeeeccEEeC
Confidence 589999999999987654 6899998321 1345999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.1e-07 Score=94.04 Aligned_cols=135 Identities=19% Similarity=0.230 Sum_probs=91.7
Q ss_pred CceecccCceEEEEEEECC-------CCEEEEEEccCCCCC----------c---------hhHHHHHH----HHHHHHh
Q 042958 820 EHCIGKGGQGSVYKAELAS-------GEIVAVKKFHSPLPG----------E---------MTFQQEFL----NEVKALT 869 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~----------~---------~~~~~~~~----~E~~~l~ 869 (1075)
...||.|--+.||.|...+ +..+|||+.+..... + ....+.+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999995442 479999987532100 0 11123333 8999999
Q ss_pred cCCc--CceeeEEEEeeccccchhheecCcc-----c--cCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCC
Q 042958 870 EIRH--RNIVKFYGFCSHVRHSLAMILSNNA-----A--AKDLGWTRRMNVIKGISDALSYM-HNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 870 ~l~h--~niv~l~~~~~~~~~~l~~~~~~~~-----~--~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~N 939 (1075)
++.. -++.+.+++ .++.+.|.+-... . ...++..+...+..+++.++.++ |+. ++||||++++|
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 9843 456666654 2344443332211 0 11233445567889999999999 788 99999999999
Q ss_pred eeeCCCCCceEeccccccccCC
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~ 961 (1075)
|+++ ++.++++|||.|.....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEE-CCcEEEEECCCceeCCC
Confidence 9997 57899999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.5e-09 Score=121.01 Aligned_cols=126 Identities=35% Similarity=0.362 Sum_probs=101.2
Q ss_pred ccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccc
Q 042958 549 LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628 (1075)
Q Consensus 549 l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 628 (1075)
|...+.++|.++ ....++.-++.++.|+|++|+++..- .+..+++|.+||||+|++. .+|..=..-..|..|++++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecc
Confidence 556777788777 66778888899999999999999553 7889999999999999998 5664332233499999999
Q ss_pred cccccccchhcccccccceeeeccccccCchh-hhhccccccceeecCCCccc
Q 042958 629 NQFSRGIPIKLEELIHLSELDLSHNFLREAIP-SQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 629 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~~~~L~~L~ls~N~l~ 680 (1075)
|.++.. ..+++|.+|+-||||+|-|.+.-. ..++.+.+|+.|+|.+|++-
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999752 357889999999999999987332 34566778999999999994
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.9e-10 Score=126.61 Aligned_cols=127 Identities=32% Similarity=0.442 Sum_probs=93.7
Q ss_pred cccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCC-CCcccccccccc
Q 042958 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLY 271 (1075)
Q Consensus 193 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~ 271 (1075)
-.|...+.++|.+. ....++.-++.|+.|+|++|+++.. ..+..+++|++|||++|.+. .+|. ....+ +|..|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 35777888888887 6777888888889999999988754 37788888999999999888 4443 23334 388888
Q ss_pred cccccCcCCCCcccCCCccCcEEEccCCCCCCCcC-CCCCccccccceeccccccc
Q 042958 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP-HSLGNLTNLATLYIHNNSLS 326 (1075)
Q Consensus 272 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 326 (1075)
+++|.++.. ..+.++.+|+.||+++|-|.+.-. ..+..|..|+.|+|.+|.+-
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 888888742 356778888888888888774321 23455677888888888775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-08 Score=118.82 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=152.6
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec-cccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-VRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 890 (1075)
..+.+.+.+-+..|+++.++-+.-. .|...++|.......-.....+....+-.+.-..++|-++...--+.. ....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4566777788899999999988433 455555554432211111112223333333333455666654433111 11112
Q ss_pred hheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC--
Q 042958 891 AMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP-- 961 (1075)
Q Consensus 891 ~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~-- 961 (1075)
.+.+.... .....+..-.+.....+..+.+|||.. .+.|||++|.|.+...++..+++|||......-
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 22211110 011122233345566778899999998 799999999999999999999999984322110
Q ss_pred -------------------CC----------CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 042958 962 -------------------DS----------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 1012 (1075)
Q Consensus 962 -------------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 1012 (1075)
.. .......||+.|.|||...+.....++|+|++|++++|.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00 0012245899999999999999999999999999999999999999743
Q ss_pred CccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 042958 1013 SSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMP 1067 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1067 (1075)
.. +...+.+.....+.+. ..........+++...+..+|.+|-.|.
T Consensus 1039 tp--------q~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TP--------QQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ch--------hhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence 32 2333444444444432 2334455678888888999999998775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.8e-08 Score=113.87 Aligned_cols=150 Identities=19% Similarity=0.322 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc----ee-----ccccccCccCcccccc
Q 042958 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----WT-----ELAGTYGYVAPELAYT 983 (1075)
Q Consensus 913 ~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~----~~-----~~~gt~~y~aPE~~~~ 983 (1075)
.+++.|+.|+|... ++||++|.|++|.+++.+..|++.|+.+.....+... ++ .......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999984 9999999999999999999999999998765542211 11 1234568999999999
Q ss_pred CCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCC
Q 042958 984 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPES 1062 (1075)
Q Consensus 984 ~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1062 (1075)
...+.++|+||+|+++|-+.. |+.-+.............. ..+... ..+....+.++.+=+.+++..++.-
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-----~~~~~~---~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-----LLNAGA---FGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-----cccccc---ccccccCcHHHHHHHHHHhcCCccc
Confidence 888999999999999999995 4444433222111111000 000000 0111233456889999999999999
Q ss_pred CCCHHHHHhh
Q 042958 1063 RPTMPKVSQL 1072 (1075)
Q Consensus 1063 RPs~~evl~~ 1072 (1075)
||++.++...
T Consensus 256 rp~~~~l~~~ 265 (700)
T KOG2137|consen 256 RPTLDLLLSI 265 (700)
T ss_pred Ccchhhhhcc
Confidence 9988877653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.5e-06 Score=91.97 Aligned_cols=136 Identities=16% Similarity=0.236 Sum_probs=97.1
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcC--ceeeEEEEeeccc--cchhheecC
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR--NIVKFYGFCSHVR--HSLAMILSN 896 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~--~~l~~~~~~ 896 (1075)
+.++.|..+.||+++..+|+.+++|........ ....++..|+++++.+++. .+.+++.+..... ....++++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998876789999997653221 1235788999999999763 4577777766532 111122221
Q ss_pred ccc---c-----CCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 042958 897 NAA---A-----KDLGWTRRMNVIKGISDALSYMHNDC------------------------------------------ 926 (1075)
Q Consensus 897 ~~~---~-----~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------ 926 (1075)
..+ . ..++..++..++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 111 1 23566778889999999999999531
Q ss_pred -----------CCCeEEecCCCCCeeeCC--CCCceEeccccccc
Q 042958 927 -----------FPPIVHRDISSKNVLLDF--DNEAHVSDFGIAKF 958 (1075)
Q Consensus 927 -----------~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~ 958 (1075)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 136799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=6e-07 Score=87.09 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=84.8
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcc-CCC----CCchhHHHHHHHHHHHHhcCCcCcee--eEEEEeeccccchhhe
Q 042958 821 HCIGKGGQGSVYKAELASGEIVAVKKFH-SPL----PGEMTFQQEFLNEVKALTEIRHRNIV--KFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~-~~~----~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~~~~~l~~~ 893 (1075)
..+++|+-+.+|.+.+. |.++++|.-. +.. ....-......+|++++.+++--.|. .++++.... ..+.|.
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEEE
Confidence 35789999999999876 5556666432 211 11122334577899999988654443 344433322 122222
Q ss_pred ecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 894 LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 894 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
.-+...-++.-+..+..++..|-+-+.-||.. +|+|+|+.++||.+..+. +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhcchHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 22222111112222456788888889999999 999999999999998655 99999999975
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.2e-08 Score=100.25 Aligned_cols=186 Identities=26% Similarity=0.280 Sum_probs=96.9
Q ss_pred CCCccEEEccCCCccC--CCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCC-CCccccccCCcc
Q 042958 72 FPHLAYLDLWHNQLYG--NIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGS-IPYEIGRLSSLN 148 (1075)
Q Consensus 72 l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~ 148 (1075)
.++++.|||.+|.|+. .|..-+.+|++|++|+|+.|.+...|-..=..+++|++|-|.+..+.-. ....+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4667777777777754 5556666777777777777777644322114556777777777666521 112233344444
Q ss_pred eeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCc--cccCccccceEeeeccccccccCCCCcCCCCcCceeccc
Q 042958 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS--EFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHN 226 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 226 (1075)
+|.++.|. ++.+.+.+|.++...+. .+..++.+..+.++-|++...+ +++..+.+..
T Consensus 150 elHmS~N~--------------~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~e 208 (418)
T KOG2982|consen 150 ELHMSDNS--------------LRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF-------PNVNSVFVCE 208 (418)
T ss_pred hhhhccch--------------hhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc-------ccchheeeec
Confidence 44444442 22233333333322211 1223334444445555554333 3555566666
Q ss_pred cCCCCCC-cccccCCCCCCeEeccCCCCCCcc-CCCCcccccccccccccccCc
Q 042958 227 NSLFDSI-PSELGNLRSLSMLSLGYNKLSGSI-PHSLGNLTNLATLYLYENSLS 278 (1075)
Q Consensus 227 N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~ 278 (1075)
|.+...- -+.+..++.+..|+|+.|++.+.- -+.+.++++|..|.+++|.+.
T Consensus 209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 6554321 223444555556666666665311 234555566666666666655
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.1e-06 Score=82.78 Aligned_cols=136 Identities=19% Similarity=0.292 Sum_probs=88.2
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcc-----CCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEe-eccccchhh
Q 042958 819 DEHCIGKGGQGSVYKAELASGEIVAVKKFH-----SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC-SHVRHSLAM 892 (1075)
Q Consensus 819 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~l~~ 892 (1075)
....+-+|+-+.|+++.+. |+.+.||.-. .+.....-..++..+|++.+.+.+--.|....-++ ....+.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4577899999999999887 8887777432 22222223355678899999888543332222122 222333333
Q ss_pred eecCc-cccC--------CCCHH-HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEeccccccc
Q 042958 893 ILSNN-AAAK--------DLGWT-RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDFGIAKF 958 (1075)
Q Consensus 893 ~~~~~-~~~~--------~l~~~-~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~ 958 (1075)
.+.+. .... +-... ....++.+|-+.+.-||.. .++|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 32221 1111 11112 2257888999999999999 999999999999997766 458999999864
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=8e-08 Score=98.25 Aligned_cols=186 Identities=29% Similarity=0.318 Sum_probs=91.7
Q ss_pred cccccccccccccCcC--CCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCC-Ccccccccccc
Q 042958 264 LTNLATLYLYENSLSG--SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSI-PSEIGNLRSLS 340 (1075)
Q Consensus 264 l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~ 340 (1075)
.+.++++||.+|.|+. .+...+.++|.|+.|+|+.|.+...+...-..+.+|++|.|.+..+...- ...+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3456666666666652 22334456666777777777666332211134556677766666665322 22344566666
Q ss_pred cccccCCcccccCCCcCCCCCCcceeeccccccCCCCcc--ccCCCcccceeeeccccccccCChhhccCCCCCeEEeec
Q 042958 341 NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS--ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418 (1075)
Q Consensus 341 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 418 (1075)
.|++|.|.+. .+.+..|.+...-|. .+..++.+..+.++-|++... ++++..+.+..
T Consensus 150 elHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e 208 (418)
T KOG2982|consen 150 ELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCE 208 (418)
T ss_pred hhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeec
Confidence 6666666432 222333333221111 111222333333444444322 24566666666
Q ss_pred ccccccc-ccccccccccceecccccccccC-CCCCCccccccccccccCCccc
Q 042958 419 NSLSGSI-PSEFGNLRSLSTLSLGYNKLSGS-IPHSLGNLTNLDALYLYDNSLS 470 (1075)
Q Consensus 419 N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 470 (1075)
|.+...- ...+..++.+.-|+|+.|+|... .-+.+.+++.|..|.+++|.+.
T Consensus 209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 6555322 22444555666666666666421 1234445555555556665554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.5e-08 Score=88.16 Aligned_cols=59 Identities=29% Similarity=0.388 Sum_probs=27.0
Q ss_pred ccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc
Q 042958 434 SLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 434 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.++..|+..+|.+.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 4444444444444 33444444444444444444444 33444444444444444444443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.8e-05 Score=87.86 Aligned_cols=205 Identities=18% Similarity=0.197 Sum_probs=135.8
Q ss_pred CceEEEEE-EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---chhh----------
Q 042958 827 GQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---SLAM---------- 892 (1075)
Q Consensus 827 ~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~l~~---------- 892 (1075)
.-.+.||+ ...||..|++|+++....... ..-..-+++++++.|+|||++.+++..... .++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34578999 455899999999954332221 122356788999999999999776652111 1111
Q ss_pred ----eec-----------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 893 ----ILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 893 ----~~~-----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
++. +...+...++...|.++.|++.||.++|+. |...+-+.+++|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 111 112234467888899999999999999999 99999999999999999999999999887
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
....+.. |-+. --.+-|.=.+|.+++.+.||..--..-+. ......+.
T Consensus 442 vl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~------~~~s~~~~--------- 489 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS------TQSSHLTR--------- 489 (655)
T ss_pred eecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc------hHHHHHHH---------
Confidence 7665431 0011 12356999999999999999654110000 00000111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
....++.++++++.-.....+++ -+..+++.+
T Consensus 490 --I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 --ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 12344556777877777777776 567766654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.4e-06 Score=82.26 Aligned_cols=124 Identities=25% Similarity=0.299 Sum_probs=77.6
Q ss_pred EEEEEEECCCCEEEEEEccCCCC-----------------------CchhHHHHHHHHHHHHhcCCcC--ceeeEEEEee
Q 042958 830 SVYKAELASGEIVAVKKFHSPLP-----------------------GEMTFQQEFLNEVKALTEIRHR--NIVKFYGFCS 884 (1075)
Q Consensus 830 ~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 884 (1075)
.||.|...+|..+|||..+.... ..........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998753211 1111234577899999999765 466666553
Q ss_pred ccccchhheecC--ccccCC-----CCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 885 HVRHSLAMILSN--NAAAKD-----LGWTRRMNVIKGISDALSYM-HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 885 ~~~~~l~~~~~~--~~~~~~-----l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
++.+.|.+-. ...... ++......++.++++.+..+ |.. +++|+|+.+.||+++++ .+.++|||.+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred --CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcc
Confidence 3333333222 111111 11234567788888866664 677 99999999999999987 9999999988
Q ss_pred cccC
Q 042958 957 KFLK 960 (1075)
Q Consensus 957 ~~~~ 960 (1075)
....
T Consensus 154 v~~~ 157 (188)
T PF01163_consen 154 VDSS 157 (188)
T ss_dssp EETT
T ss_pred eecC
Confidence 7654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.3e-06 Score=83.76 Aligned_cols=138 Identities=23% Similarity=0.205 Sum_probs=93.9
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEccCCC-----------------CCch--hHHHHHHHHHHHHhcCCcC--c
Q 042958 817 FDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPL-----------------PGEM--TFQQEFLNEVKALTEIRHR--N 875 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-----------------~~~~--~~~~~~~~E~~~l~~l~h~--n 875 (1075)
+.++..||.|--+.||.|....|.++|||.=+... ..++ ..+....+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34567899999999999988889999999532211 0111 1233467899999999654 6
Q ss_pred eeeEEEEeeccccchhheecCccccCCCC--HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 876 IVKFYGFCSHVRHSLAMILSNNAAAKDLG--WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 876 iv~l~~~~~~~~~~l~~~~~~~~~~~~l~--~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
|.+.+++- ++...|.+-+......+. ....-.+...|++-+...-.. ||||+|+.+-||++++||.+.++||
T Consensus 173 VP~P~~~n---RHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDw 246 (304)
T COG0478 173 VPKPIAWN---RHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDW 246 (304)
T ss_pred CCCccccc---cceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeC
Confidence 77776653 444444433332222222 444445566666665555566 9999999999999999999999999
Q ss_pred ccccccC
Q 042958 954 GIAKFLK 960 (1075)
Q Consensus 954 Gla~~~~ 960 (1075)
--+....
T Consensus 247 PQ~v~~~ 253 (304)
T COG0478 247 PQAVPIS 253 (304)
T ss_pred cccccCC
Confidence 7665433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.1e-08 Score=86.79 Aligned_cols=109 Identities=28% Similarity=0.400 Sum_probs=68.9
Q ss_pred cceeeccccccCCCCccc---cCCCcccceeeeccccccccCChhhc-cCCCCCeEEeecccccccccccccccccccee
Q 042958 363 LATLYLYSNSLFDSIPSE---LGNLRSLSMLSLGYNKLSGSIPHSLG-NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTL 438 (1075)
Q Consensus 363 L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 438 (1075)
+-.++|++|++ ..+++. +.....|+..+|++|.+. ..|..|. ..+.++.|+|++|.|. .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 34456666665 333333 333445566677777776 3444443 3456777777777776 455567777777777
Q ss_pred cccccccccCCCCCCccccccccccccCCccccCCCcc
Q 042958 439 SLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476 (1075)
Q Consensus 439 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 476 (1075)
+++.|.+. ..|..+..|.+|..|+..+|.+. .+|..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD 141 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence 77777777 55666666777777777777776 44443
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.4e-07 Score=95.25 Aligned_cols=187 Identities=20% Similarity=0.235 Sum_probs=101.7
Q ss_pred CCCCccEEEccCCCccC----CCCccccccCCCceeecccCcc---cccCC-------CCCCCCCCCcEEEccCcccCCC
Q 042958 71 SFPHLAYLDLWHNQLYG----NIPPQIGNISRLKYLDLSSNLF---FGTIP-------PEIGHLSYLKTLQLFENQLNGS 136 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l---~~~~p-------~~l~~l~~L~~L~Ls~n~l~~~ 136 (1075)
.+..++.+|||+|.|.. .+...+.+-.+|+..++|+-.. ...+| ..+.+++.|+..+||.|.|+..
T Consensus 28 ~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~ 107 (388)
T COG5238 28 MMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSE 107 (388)
T ss_pred hhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcc
Confidence 35667788888888854 3455566667777777776322 11222 3445677777777777777766
Q ss_pred CCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccc-------------cCccccceEeeecc
Q 042958 137 IPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEF-------------GNLRSLSMLSLGYN 203 (1075)
Q Consensus 137 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L~~L~Ls~N 203 (1075)
.|..+.. .+++-+.|++|.|++|.+.-....-+ .+-|.|++.....|
T Consensus 108 ~~e~L~d--------------------~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrN 167 (388)
T COG5238 108 FPEELGD--------------------LISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN 167 (388)
T ss_pred cchHHHH--------------------HHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence 6655332 24455666666666666542211111 23355666666666
Q ss_pred ccccccCCC-----CcCCCCcCceeccccCCCCCC-----cccccCCCCCCeEeccCCCCCCc----cCCCCcccccccc
Q 042958 204 KFSGSIPHS-----LGNLTNLATLYLHNNSLFDSI-----PSELGNLRSLSMLSLGYNKLSGS----IPHSLGNLTNLAT 269 (1075)
Q Consensus 204 ~l~~~~~~~-----l~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~ 269 (1075)
++. ..+.. +..-.+|+++.+..|.|.-.- -..+..+.+|++|||..|-++-. +..++...+.|++
T Consensus 168 Rle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 168 RLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred hhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 665 22211 122245666666666653110 01123456667777776666521 1223334445566
Q ss_pred cccccccCc
Q 042958 270 LYLYENSLS 278 (1075)
Q Consensus 270 L~L~~n~l~ 278 (1075)
|.+..|-++
T Consensus 247 L~lnDClls 255 (388)
T COG5238 247 LRLNDCLLS 255 (388)
T ss_pred ccccchhhc
Confidence 666666555
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1075 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-56 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-56 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-18 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-17 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 9e-17 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-16 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-16 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-16 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 9e-16 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-15 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 5e-15 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-11 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-09 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 7e-09 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 1e-09 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 7e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-09 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-09 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 7e-09 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-08 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 8e-08 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 7e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 4e-06 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 3e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 9e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-06 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 1e-05 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 9e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 1h6u_A | 308 | Internalin H: Crystal Structure Of Fused N-Terminal | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 2e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-05 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-05 | ||
| 3p72_A | 269 | Structure Of Platelet Glycoprotein 1b Alpha With A | 7e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 1u0n_D | 265 | The Ternary Von Willebrand Factor A1-Glycoprotein I | 8e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 9e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-05 | ||
| 1m0z_A | 290 | Crystal Structure Of The Von Willebrand Factor Bind | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 1m10_B | 290 | Crystal Structure Of The Complex Of Glycoprotein Ib | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 1e-04 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 1e-04 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 2e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 5e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 1sq0_B | 288 | Crystal Structure Of The Complex Of The Wild-Type V | 2e-04 | ||
| 3pmh_G | 290 | Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-04 | ||
| 1ook_G | 290 | Crystal Structure Of The Complex Of Platelet Recept | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 1gwb_B | 281 | Structure Of Glycoprotein 1b Length = 281 | 3e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 1p9a_G | 290 | Crystal Structure Of N-terminal Domain Of Human Pla | 3e-04 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-04 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 2r9u_A | 174 | Crystal Structure Of Lamprey Variable Lymphocyte Re | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1H6U|A Chain A, Internalin H: Crystal Structure Of Fused N-Terminal Domains Length = 308 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288 | Back alignment and structure |
|
| >pdb|3PMH|G Chain G, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OOK|G Chain G, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1GWB|B Chain B, Structure Of Glycoprotein 1b Length = 281 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor 2913 Ectodomain Length = 174 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 687 bits (1775), Expect = 0.0
Identities = 237/762 (31%), Positives = 356/762 (46%), Gaps = 33/762 (4%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLK 61
E H L+ +K L + N LL W+ + +PC + G+ C +V SI+L+S L
Sbjct: 12 REIHQLISFKDVLPDKN---LLPDWS----SNKNPCTFDGVTCRDD-KVTSIDLSSKPLN 63
Query: 62 GMLHDF--SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPP--EI 117
S S L L L ++ + G++ + L LDLS N G + +
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 118 GHLSYLKTLQLFENQLNGSIPYEIG-RLSSLNYLALYSNYLEDLIPPSL---GNLSNLDT 173
G S LK L + N L+ G +L+SL L L +N + L
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233
L + N +S + +L L + N FS IP LG+ + L L + N L
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239
Query: 234 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLS 292
+ L +L++ N+ G IP L +L L L EN +G IP G +L+
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGLSGNKLSG 351
L+L N G +P G+ + L +L + +N+ SG +P + + +R L L LS N+ SG
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 352 SIPPSLGYLS-NLATLYLYSNSLFDSIPSELGN--LRSLSMLSLGYNKLSGSIPHSLGNL 408
+P SL LS +L TL L SN+ I L +L L L N +G IP +L N
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
+ L +L L N LSG+IPS G+L L L L N L G IP L + L+ L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 469 LSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNL 528
L+G IP + N +++ ++L+NN+L+G IP+ +G L NL IL L NNS +IP+ELG+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 529 RSLSMLSFAYNKLSGSIPHSLGVL--DLSSNHIVGEIPTELGKLNFLIKLILAQN--QLS 584
RSL L N +G+IP ++ +++N I G+ + + A N +
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 585 GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIH 644
G S +L L+ +++S +F N + +L++S N S IP ++ + +
Sbjct: 598 GIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY 657
Query: 645 LSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L L+L HN + +IP ++ ++ L L+LS N L G IP + L ID+S N L
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 705 GPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQA 746
GPIP F P N GLCG LP C ++ A
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPSNADGYA 757
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 415 bits (1070), Expect = e-132
Identities = 152/648 (23%), Positives = 239/648 (36%), Gaps = 41/648 (6%)
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181
+ +L +P ++ +++ L L N L L + S L +L + N++
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 182 SDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLR 241
S P L L +L+L +N+ S + TNL L+L +NS+ + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFG--NLRSLSMLNLGYN 299
+L L L +N LS + + L NL L L N + E SL L L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 300 KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG---NLRSLSNLGLSGNKLSGSIPPS 356
++ P + L L+++N L S+ ++ S+ NL LS ++LS + +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 357 LGYL--SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414
L +NL L L N+L L L L YN + HSL L N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 415 DLYDN---------SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465
+L + SL F L+ L L++ N + G + L NL L L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 466 DNSLSGSIPGEIG----NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
++ S + L L NK+S + L +L +L L N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 522 P-SELGNLRSLSMLSFAYNKLSGSIPHSLG------VLDLSSNHI--VGEIPTELGKLNF 572
E L ++ + +YNK +S L L + V P+ L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLS--------NSIPKSFGNLVKLHYL 624
L L L+ N ++ L L +LE LDL N L+ L LH L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 625 NLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIP 684
NL +N F ++L L +DL N L S SL++LNL N + +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 685 SCFEK-MHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLCGDV 731
F L +D+ +N + F + E L
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-122
Identities = 149/634 (23%), Positives = 221/634 (34%), Gaps = 43/634 (6%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYL 123
L +F+ + L LD+ N + P + LK L+L N + L
Sbjct: 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
L L N + + +L L L N L + L NL L L +N +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 184 SIPSEFG--NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG--- 238
E SL L L N+ P + L L+L+N L S+ +L
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNL--TNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
S+ LSL ++LS + + L TNL L L N+L+ F L L L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 297 GYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS 356
YN + + HSL L N+ L + + + +S L S
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASLPKIDDFS 324
Query: 357 LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG----NLTNLA 412
+L L L + N + + L +L LSL + S + + L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIP-HSLGNLTNLDALYLYDNSLSG 471
L+L N +S F L L L LG N++ + L N+ +YL N
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 472 SIPGEIGNLRSISNLALNNNKLSG--SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLR 529
+ S+ L L L S P L NL IL L NN++ + L L
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 530 SLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSP 589
L +L +N L+ L + G L L+ L L L N
Sbjct: 505 KLEILDLQHNNLA----------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 590 KLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEE-LIHLSEL 648
L +L+ +DL N L+ F N V L LNL N + +L+EL
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 649 DLSHNFLREAIPSQICIMQSLENLNLSHNSLVGL 682
D+ N S I + +N +H ++ L
Sbjct: 615 DMRFNPFDCTCES---IAWFVNWINETHTNIPEL 645
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-106
Identities = 119/517 (23%), Positives = 205/517 (39%), Gaps = 32/517 (6%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
+ + L +P +L ++++L+L +N+L + + L +L + N+
Sbjct: 4 VSHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
+S P L L +LNL +N+L+ + + TNL L++ +NS+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG--NLRSLSMLSLGY 394
++L L LS N LS + + L NL L L +N + EL SL L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG---NLRSLSTLSLGYNKLSGSIPH 451
N++ P + L L L + L S+ + S+ LSL ++LS +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 452 SLGNL--TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVI 509
+ L TNL L L N+L+ L + L N + SL L N+
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 510 LYLYNN---------SLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH------SLGVLDL 554
L L + SL L+ L L+ N + G + +L L L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 555 SSNHIVGEIPTELG----KLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
S++ T + L L L +N++S S L LE LDL N +
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 611 IPKS-FGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLR--EAIPSQICIMQ 667
+ + L + + LS N++ + + L L L L+ ++ PS ++
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 668 SLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+L L+LS+N++ + E + L +D+ +N L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = 1e-91
Identities = 111/477 (23%), Positives = 191/477 (40%), Gaps = 30/477 (6%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+ L+ +P + ++++LNL +N+L + + + L +L + N+
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNL 384
+S P L L L L N+LS + + +NL L+L SNS+ +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG--NLRSLSTLSLGY 442
++L L L +N LS + + L NL L L +N + E SL L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG---NLRSISNLALNNNKLSGSIPQ 499
N++ P + L L+L + L S+ ++ SI NL+L+N++LS +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 500 SLGNL--SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG------- 550
+ L +NL +L L N+L L L YN + HSL
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 551 --------VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
+S + L L L + N + G S L L++L L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 603 SSNRLSNS--IPKSFGNLV--KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
S++ S ++F +L LH LNL+ N+ S+ L HL LDL N + +
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 659 IPSQ-ICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFR 714
+ Q ++++ + LS+N + L + F + L R+ + L+ + F+
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-119
Identities = 100/651 (15%), Positives = 196/651 (30%), Gaps = 82/651 (12%)
Query: 3 EAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKG 62
+ AL +L N W+ W + + G
Sbjct: 31 DYLALKEIWDALNGKN-------WSQQGFGTQPGANWN-------------FNKELDMWG 70
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFG----TIPPEIG 118
S +S + L L G +P IG ++ L+ L L S+ P I
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 119 HLSYLKTLQLFENQLNGSIPYEIGRL--SSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176
+ Q + R S L + S+ + I S +
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190
Query: 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE 236
N+++ + L L +G + F N + + +
Sbjct: 191 LSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLK 244
Query: 237 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
NL+ L+ + + +P L L + + + N
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS----------------G 288
Query: 297 GYNKLNGIIPHSLGNLTNLATLYIHNNSL-SGSIPSEIGNLRSLSNLGLSGNKLSGSIPP 355
K + + +YI N+L + + + + ++ L L N+L G P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLP 347
Query: 356 SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATL 414
+ G LA+L L N + + + G + LS +NKL +++ ++ +
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAI 407
Query: 415 DLYDNSLSG-------SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
D N + + ++S+++L N++S + L ++ L N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 468 SLSG-------SIPGEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNNSLFD 519
L+ N ++++ L NKL+ L LV + L NS
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-S 526
Query: 520 SIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILA 579
P++ N +L D N + E P + L +L +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQ------------RDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 580 QNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
N + ++ K+ + LD+ N + ++ L ++
Sbjct: 575 SNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-119
Identities = 92/577 (15%), Positives = 187/577 (32%), Gaps = 66/577 (11%)
Query: 140 EIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS----DSIPSEFGNLRSL 195
+ + L+L +P ++G L+ L+ L L + P S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 196 SMLSLGYNKFSGSIPHSLG--NLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL 253
+ + + ++L ++++ SI + + N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 254 SGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLT 313
+ + ++ LT L Y+ + E N Y + NL
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLK 249
Query: 314 NLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL--------SGSIPPSLGYLSNLAT 365
+L + ++N +P+ + L + + ++ N+ +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 366 LYLYSNSLFD-SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS 424
+Y+ N+L + + L ++ L ML YN+L G +P + G+ LA+L+L N ++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368
Query: 425 IPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTNLDALYLYDNSLSG-------SIPGE 476
+ G + LS +NKL +++ + A+ N + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 477 IGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL-------FDSIPSELGNLR 529
++S++ L+NN++S + S L + L N L N
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 530 SLSMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQ 582
L+ + +NKL+ L +DLS N + PT+ + L +
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ- 546
Query: 583 LSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEEL 642
D NR P+ L L + +N + K+
Sbjct: 547 -----------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--T 586
Query: 643 IHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
++S LD+ N S +C L ++
Sbjct: 587 PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-113
Identities = 90/573 (15%), Positives = 174/573 (30%), Gaps = 64/573 (11%)
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSG----SIPHSLGNLTNL 219
SL + + L L S +P G L L +L+LG + P + +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 220 ATLYLHNNSLFDSIPSELGNLR--SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
+ L + + SI S + N++
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337
+ + L L +G + N + + NL+
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLK 249
Query: 338 SLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD--------SIPSELGNLRSLSM 389
L+++ + +P L L + + + N ++ + +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 390 LSLGYNKL-SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGS 448
+ +GYN L + + SL + L L+ N L G +P FG+ L++L+L YN+++
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368
Query: 449 IPHSLGNLTNLDALYLYDNSLSG-SIPGEIGNLRSISNLALNNNKLSG-------SIPQS 500
+ G ++ L N L + ++ +S + + N++ + +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 501 LGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIV 560
N+ + L NN + LS ++ N L+ IP + +
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKN----------SL 477
Query: 561 GEIPTELGKLNFLIKLILAQNQLSG-QLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLV 619
+ L + L N+L+ + +L L +DLS N S P N
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSS 536
Query: 620 KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
L + N D N P I + SL L + N +
Sbjct: 537 TLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 680 VGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
+ + +DI N + +
Sbjct: 579 RKVNEKITPN---ISVLDIKDNPNISIDLSYVC 608
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-105
Identities = 129/609 (21%), Positives = 220/609 (36%), Gaps = 52/609 (8%)
Query: 89 IPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148
IP + K LDLS N L+ L L ++ LS L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKF-SG 207
L L N ++ L + LS+L L + +L+ G+L++L L++ +N S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSM----LSLGYNKLSGSIPHSLGN 263
+P NLTNL L L +N + ++L L + + L L N ++ P +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 264 LTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNG---IIPHSLGNLTNLATLY 319
+ L L L N S ++ L L + L + + L L L
Sbjct: 200 I-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 320 IHNNSLS------GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSL 373
I L+ I L ++S+ L + Y L L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316
Query: 374 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS--GSIPSEFGN 431
+ L+ S+ L + G S +L +L LDL N LS G
Sbjct: 317 -----GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 432 LRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNN 490
SL L L +N + + + L L+ L ++L + +LR++ L +++
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 491 NKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNKLSGSIPHSL 549
+ LS+L +L + NS ++ + LR+L+
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT----------------- 473
Query: 550 GVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN 609
LDLS + PT L+ L L ++ N + L L+ LD S N +
Sbjct: 474 -FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
Query: 610 SIPKSFGNLVK-LHYLNLSNNQFSRGIPIK--LEELIHLSELDLSHNFLREAIPSQICIM 666
S + + L +LNL+ N F+ + L+ + +L + + A PS
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK-QG 591
Query: 667 QSLENLNLS 675
+ +LN++
Sbjct: 592 MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-105
Identities = 134/597 (22%), Positives = 207/597 (34%), Gaps = 51/597 (8%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
IP + S L L N L L S + L L L + + +L L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 196 SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL-S 254
S L L N + L++L L +L +G+L++L L++ +N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSM----LNLGYNKLNGIIPHSLG 310
+P NLTNL L L N + ++ L + + L+L N +N I P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 311 NLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
+ L L + NN S ++ I L L L +
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN------------------ 239
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGS---IPHSLGNLTNLATLDLYDNSLSGSIP 426
+L S L L +L++ L I LTN+++ L ++
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
Query: 427 SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNL 486
F L L K L +L L S G +L S+ L
Sbjct: 300 --FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFL 352
Query: 487 ALNNNKLS--GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGS 544
L+ N LS G QS ++L L L N + ++ S L L L F ++ L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 545 IPHS-------LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQ 596
S L LD+S H L+ L L +A N P L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLR 656
L LDLS +L P +F +L L LN+S+N F + L L LD S N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 657 EAIPSQIC-IMQSLENLNLSHNSLVGLIPSC--FEKMHGLLRIDISYNELQGPIPNS 710
+ ++ SL LNL+ N + + ++ + ++ P+
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-102
Identities = 114/573 (19%), Positives = 195/573 (34%), Gaps = 37/573 (6%)
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222
P + + N+ T + + IP S L L +N +S + L L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIP 282
L + +L LS L L N + + L++L L E +L+
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 283 SEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSN 341
G+L++L LN+ +N + +P NLTNL L + +N + +++ L +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 342 ----LGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNK 396
L LS N ++ I P L L L +N ++ + L L + L +
Sbjct: 178 LNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 397 LSGS------IPHSLGNLTNLATLDLYDNSLSGS---IPSEFGNLRSLSTLSLGYNKLSG 447
+L L NL + L I F L ++S+ SL +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
S L L + ++ +L+ L G S +L +L
Sbjct: 297 VKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSL 349
Query: 508 VILYLYNNSL--FDSIPSELGNLRSLSMLSFAYNKLSGSIP-----HSLGVLDLSSNHIV 560
L L N L SL L ++N + L LD +++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 409
Query: 561 GEIPTE-LGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI-PKSFGNL 618
L LI L ++ + L+ LE L ++ N + P F L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 619 VKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNS 678
L +L+LS Q + P L L L++SHN + SL+ L+ S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 679 LVGLIPSCFEKMHGLLR-IDISYNELQGPIPNS 710
++ + L ++++ N+ +
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = 7e-99
Identities = 118/568 (20%), Positives = 206/568 (36%), Gaps = 38/568 (6%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYL 123
L +SF SFP L LDL ++ ++S L L L+ N LS L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSLS 182
+ L E L + IG L +L L + N ++ +P NL+NL+ L L N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 183 DSIPSEFGNLRSLSM----LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-L 237
++ L + + L L N + P + + L L L NN ++ +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCI 221
Query: 238 GNLRSLSMLSLGYNKLSGSI---PHSLGNLTNLATLYLYENSLS------GSIPSEFGNL 288
L L + L + L L L + E L+ I F L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 289 RSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNK 348
++S +L + + S L + N ++ +L+ L+ G
Sbjct: 282 TNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG- 338
Query: 349 LSGSIPPSLGYLSNLATLYLYSNSL--FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
S L +L L L N L SL L L +N + + +
Sbjct: 339 ----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393
Query: 407 NLTNLATLDLYDNSLSGSIP-SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465
L L LD ++L S F +LR+L L + + + L++L+ L +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 466 DNSLSGSI-PGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE 524
NS + P LR+++ L L+ +L P + +LS+L +L + +N+ F
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 525 LGNLRSLSMLSFAYNKLSGSIPHSLG-------VLDLSSNHIVGEIPTE--LGKLNFLIK 575
L SL +L ++ N + S L L+L+ N + L + +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLS 603
L++ ++ + + L+++
Sbjct: 574 LLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 2e-95
Identities = 116/518 (22%), Positives = 187/518 (36%), Gaps = 28/518 (5%)
Query: 215 NLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE 274
+ N+ + N F IP L S L L +N L +S + L L L
Sbjct: 6 VVPNITYQCMELN--FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 275 NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334
+ + +L LS L L N + + + L++L L +L+ IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 335 NLRSLSNLGLSGNKL-SGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSM---- 389
+L++L L ++ N + S +P L+NL L L SN + ++L L + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGS 448
L L N ++ P + + L L L +N S ++ L L L +
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 449 ------IPHSLGNLTNLDALYLYDNSLSGS---IPGEIGNLRSISNLALNNNKLSGSIPQ 499
+L L NL L I L ++S+ +L + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 500 SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP-HSLGVLDLSSNH 558
S L L N +L +L+ L+ S + SL LDLS N
Sbjct: 301 S--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 559 I--VGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS-F 615
+ G L L L+ N + +S L QLEHLD + L S F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 616 GNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQI-CIMQSLENLNL 674
+L L YL++S+ L L L ++ N +E I +++L L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 675 SHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
S L L P+ F + L +++S+N
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-61
Identities = 76/418 (18%), Positives = 139/418 (33%), Gaps = 36/418 (8%)
Query: 49 RVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNI---PPQIGNISRLKYLDLS 105
R++ + L + + L L + + L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
L+YL + I L++++ +L S +E +
Sbjct: 261 EF-----------RLAYL-------DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L L + + +L+ L+ S G S +L +L L L
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN-----KGGNAFSEVDLPSLEFLDLS 355
Query: 226 NNSL--FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIP- 282
N L SL L L +N + + + L L L ++L
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 283 SEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSN 341
S F +LR+L L++ + L++L L + NS + +I LR+L+
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 342 LGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 401
L LS +L P + LS+L L + N+ F L SL +L N + S
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 402 PHSLGNL-TNLATLDLYDNSLSGSIPSE--FGNLRSLSTLSLGYNKLSGSIPHSLGNL 456
L + ++LA L+L N + + + ++ L + ++ + P +
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-53
Identities = 72/347 (20%), Positives = 124/347 (35%), Gaps = 15/347 (4%)
Query: 50 VNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLF 109
+ L + F+ +++ L + ++L+L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNC-K 315
Query: 110 FGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYL--EDLIPPSLGN 167
FG P L LK L G + L SL +L L N L + S
Sbjct: 316 FGQFPT--LKLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 168 LSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHS-LGNLTNLATLYLHN 226
++L L L N + ++ S F L L L ++ S +L NL L + +
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 227 NSLFDSIPSELGNLRSLSMLSLGYNKLSGSI-PHSLGNLTNLATLYLYENSLSGSIPSEF 285
+ L SL +L + N + P L NL L L + L P+ F
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL-RSLSNLGL 344
+L SL +LN+ +N + L +L L N + S E+ + SL+ L L
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 345 SGNKLSGSIPPS--LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSM 389
+ N + + L ++ + L + + + PS+ + LS+
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-24
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 4/164 (2%)
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
+ +IP L L L+ N L S S +L+ LDLS +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 611 IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLE 670
++ +L L L L+ N L L +L L I +++L+
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 671 NLNLSHNSLVGL-IPSCFEKMHGLLRIDISYNELQGPIPNSIAF 713
LN++HN + +P F + L +D+S N++Q +
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 335 bits (860), Expect = e-103
Identities = 121/538 (22%), Positives = 205/538 (38%), Gaps = 24/538 (4%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
IP +L ++ + L N L + F L +L+ L L + + + L
Sbjct: 27 IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
TL L N L + L ++L L +S L N L +LYL N +S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH--NNSLSGSIPSEIGNLRS 338
+ L +L+ N ++ + + +L L ++ N ++ I +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203
Query: 339 LSNLGLSGNKLSGSIPPSLGY--LSNLATLYLYSNSLFDSIPSELGNLRSLSM--LSLGY 394
+L G + I L + +L D P+ L +S+ ++L
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
+ ++ + L LDL LS +PS L +L L L NK S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 455 NLTNLDALYLYDNSLSGSI-PGEIGNLRSISNLALNNNKL--SGSIPQSLGNLSNLVILY 511
N +L L + N+ + G + NL ++ L L+++ + S L NLS+L L
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 512 LYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGEIP 564
L N L +L A+ +L H L VL+LS + +
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 565 TELGKLNFLIKLILAQNQLSG---QLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
L L L L N Q + L +L +LE L LS LS+ +F +L +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
++++LS+N+ + L L + L+L+ N + +PS + I+ +NL N L
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-101
Identities = 123/563 (21%), Positives = 195/563 (34%), Gaps = 29/563 (5%)
Query: 100 KYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED 159
K + + IP + + + L+ N L RL +L +L L +
Sbjct: 15 KTYNCENL-GLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 160 LIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL 219
+ + + LDTL L N L + ++L L S L N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 220 ATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS- 278
+LYL +N + + L +L N + + +L L L N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 279 GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN--LTNLATLYIHNNSLSGSIPSEIGNL 336
I + LN G + +I L N + +L + P+ L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 337 RSLS--NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
+S ++ L + + S L L L + L +PS L L +L L L
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKL--SGSIPH 451
NK S N +L L + N+ + + NL +L L L ++ + S
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS-LGNLSNLVIL 510
L NL++L +L L N + L L +L QS NL L +L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 511 YLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKL 570
L ++ L S L +L L+ N L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR------------- 477
Query: 571 NFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
L L+L+ LS SL + H+DLS NRL++S ++ +L + YLNL++N
Sbjct: 478 --LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534
Query: 631 FSRGIPIKLEELIHLSELDLSHN 653
S +P L L ++L N
Sbjct: 535 ISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-100
Identities = 119/552 (21%), Positives = 199/552 (36%), Gaps = 25/552 (4%)
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
T + + L+ IP S L +N + L NL L L ++
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
+ L L L N L +L L L+ + +S N ++L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSN--LGLSGNKLS 350
L LG N ++ I L L NN++ ++ +L+ +N L L+GN ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN--LRSLSMLSLGYNKLSGSIPHSLGNL 408
I P + +L I L N ++SL + + P L
Sbjct: 193 -GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 409 --TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
++ +++L + + F L L L LS +P L L+ L L L
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSI-PQSLGNLSNLVILYLYNNSL--FDSIPS 523
N N S+++L++ N + L NL NL L L ++ + D
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 524 ELGNLRSLSMLSFAYNKLSGSIPH------SLGVLDLSSNHIVG-EIPTELGKLNFLIKL 576
+L NL L L+ +YN+ L +LDL+ + + + L+ L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 577 ILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI---PKSFGNLVKLHYLNLSNNQFSR 633
L+ + L L L+HL+L N S L +L L LS S
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 634 GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGL 693
L ++ +DLSHN L + + ++ + LNL+ N + ++PS +
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549
Query: 694 LRIDISYNELQG 705
I++ N L
Sbjct: 550 RTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = 2e-99
Identities = 127/586 (21%), Positives = 209/586 (35%), Gaps = 22/586 (3%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYL 123
L++ + L+ N L + L +LDL+ + L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
TL L N L + +L +L + + L N L++L+L N +S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 184 SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF-DSIPSELGNLRS 242
+ L +L N + +L L L+ N I +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 243 LSMLSLGYNKLSGSIPHSLGN--LTNLATLYLYENSLSGSIPSEFGNLRSLSM--LNLGY 298
L+ G + I L N + +L + P+ F L +S+ +NL
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
+ I ++ + L L + LS +PS + L +L L LS NK S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 359 YLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNKL--SGSIPHSLGNLTNLATLD 415
+L L + N+ + + L NL +L L L ++ + S L NL++L +L+
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHS-LGNLTNLDALYLYDNSLSGSIP 474
L N F L L L + +L S NL L L L + L S
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 475 GEIGNLRSISNLALNNNKLSGSIPQ---SLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531
L ++ +L L N Q SL L L IL L L +L+ +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 532 SMLSFAYNKLSGSIPHSLG-----VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ 586
+ + ++N+L+ S +L L+L+SNHI +P+ L L+ + L QN L
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC- 561
Query: 587 LSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
+ LE + +L ++ N L + LS+ S
Sbjct: 562 -TCSNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 8e-79
Identities = 101/501 (20%), Positives = 156/501 (31%), Gaps = 53/501 (10%)
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
T N L + IP L S L +N L + L NL L L +
Sbjct: 16 TYNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLS 340
F + L L L N L + +L L L+ +S + N ++L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 341 NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS-G 399
+L L N +S P L L +N++ ++ +L+ + LSL N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGN--LRSLSTLSLGYNKLSGSIPHSLGNL- 456
I + +L+ I N ++SL + P L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 457 -TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515
+++++ L + + L L LS +P L LS L L L N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 516 SLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIK 575
+ N SL+ L + N E+ T
Sbjct: 312 KFENLCQISASNFPSLT------------------HLSIKGNTKRLELGTGC-------- 345
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS--IPKSFGNLVKLHYLNLSNNQFSR 633
L +L L LDLS + + S NL L LNLS N+
Sbjct: 346 ---------------LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
Query: 634 GIPIKLEELIHLSELDLSHNFLREAIP-SQICIMQSLENLNLSHNSLVGLIPSCFEKMHG 692
+E L LDL+ L+ S + L+ LNLSH+ L F+ +
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 693 LLRIDISYNELQGPIPNSIAF 713
L +++ N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNS 471
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-26
Identities = 41/202 (20%), Positives = 75/202 (37%), Gaps = 2/202 (0%)
Query: 539 NKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLE 598
N++ G++P+S L+ S N + T +L L L L + Q+ S +L+
Sbjct: 25 NEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
L L++N L + L +L S I L L L L N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 659 IPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGL--LRIDISYNELQGPIPNSIAFRDA 716
+ + L+ L+ +N++ L + L ++++ N++ G P +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 717 PIEALQGNKGLCGDVKGLPSCK 738
G + L KGL +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNST 226
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 331 bits (849), Expect = 1e-98
Identities = 107/629 (17%), Positives = 194/629 (30%), Gaps = 100/629 (15%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
LD+W +Q + N R+ L L+ G +P IG L+ LK L + S
Sbjct: 308 LDMWGDQ----PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 138 PYEIGRLSSLNYLALYSNYLEDLIPP-SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196
+ + + + L L+ L ++++ + E ++ S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDS 421
Query: 197 MLSLGYNKFSG------SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
+SL + I ++ LT L +Y N+ + + Y
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDY 476
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI------ 304
K + S NL +L + LY +P +L L LN+ N+
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 305 ---IPHSLGNLTNLATLYIHNNSLSGSIPS-EIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
+ + Y+ N+L S + + L L NK+ + G
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTN 594
Query: 361 SNLATLYLYSNSLFDSIPSELG-NLRSLSMLSLGYNKLSGSIPH--SLGNLTNLATLDLY 417
L L L N + + IP + + L +NKL IP+ + ++ + ++D
Sbjct: 595 VKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652
Query: 418 DNSLSGSIPSEFG-----NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
N + + + ST++L YN++ + + + L +N ++ S
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-S 711
Query: 473 IPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL--GNLRS 530
IP + N L + L N L S+ + L
Sbjct: 712 IPENSL----------------KPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPY 754
Query: 531 LSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590
LS + +YN S PT+ + L +
Sbjct: 755 LSNMDVSYNCFS-------------------SFPTQPLNSSQLKAFGIRHQ--------- 786
Query: 591 LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650
D NR+ P L L + +N + KL L LD+
Sbjct: 787 ---------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDI 834
Query: 651 SHNFLREAIPSQICIMQSLENLNLSHNSL 679
+ N + +C L ++
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = 2e-97
Identities = 104/649 (16%), Positives = 198/649 (30%), Gaps = 100/649 (15%)
Query: 10 WKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSF 69
W+ NN +W N W
Sbjct: 286 WRYYSGTINNTIHSLNWNFNK----ELDMWGDQPGV----------------------DL 319
Query: 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLF 129
+ + L L G +P IG ++ LK L ++ + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 130 ENQLNGSIPYEIGR-LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
++++ LN L + + P + + + L D + +
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNL---- 433
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
N+ + I ++ LT L +Y N+ + +
Sbjct: 434 -------------TNRIT-FISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANS 474
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI---- 304
Y K + S NL +L + LY +P +L L LN+ N+
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534
Query: 305 -----IPHSLGNLTNLATLYIHNNSLSGSIPS-EIGNLRSLSNLGLSGNKLSGSIPPSLG 358
+ + Y+ N+L S + + L L NK+ + G
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFG 592
Query: 359 YLSNLATLYLYSNSLFDSIPSELG-NLRSLSMLSLGYNKLSGSIPH--SLGNLTNLATLD 415
L L L N + + IP + + L +NKL IP+ + ++ + ++D
Sbjct: 593 TNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD 650
Query: 416 LYDNSLSGSIPSEFG-----NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
N + + + ST++L YN++ + + + L +N ++
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
Query: 471 -------GSIPGEIGNLRSISNLALNNNKLSGSIPQSL--GNLSNLVILYLYNNSLFDSI 521
G N ++ + L NKL+ S+ L L + + N S
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSF 768
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQN 581
P++ N L + D N I+ + PT + LI+L + N
Sbjct: 769 PTQPLNSSQLKAFGIRHQ------------RDAEGNRILRQWPTGITTCPSLIQLQIGSN 816
Query: 582 QLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
+ + KL QL LD++ N + S ++ L ++
Sbjct: 817 DIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = 1e-94
Identities = 99/613 (16%), Positives = 198/613 (32%), Gaps = 77/613 (12%)
Query: 131 NQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFG 190
+ ++ + L+L + +P ++G L+ L L +S + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 191 NLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLG 249
+ M ++ L L L +++ + E+ ++ S +SL
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 250 YNKLSG------SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303
++ I ++ LT L +Y + + + N Y K
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYE 481
Query: 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
S NL +L + ++N +P + +L L +L ++ N+ +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ--------- 532
Query: 364 ATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLDLYDNSLS 422
+ + + + + + +GYN L SL + L LD N +
Sbjct: 533 ------LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG-NLTNLDALYLYDNSLSGSIP--GEIGN 479
FG L+ L L YN++ IP ++ L N L IP +
Sbjct: 587 --HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
Query: 480 LRSISNLALNNNKLSG-----SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSML 534
+ + ++ + NK+ S N + L N + +S +
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTI 702
Query: 535 SFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG-QLSPKLGS 593
+ N ++ SIP + + L + L N+L+ + +
Sbjct: 703 ILSNNLMT-SIPEN----------SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATT 751
Query: 594 LAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
L L ++D+S N S S P N +L + + D N
Sbjct: 752 LPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------------------RDAEGN 792
Query: 654 FLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL-QGPIPNSIA 712
+ P+ I SL L + N + + +++ L DI+ N + +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYIL---DIADNPNISIDVTSVCP 849
Query: 713 FRDAPIEALQGNK 725
+ +A + L +K
Sbjct: 850 YIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 3e-90
Identities = 102/671 (15%), Positives = 223/671 (33%), Gaps = 76/671 (11%)
Query: 99 LKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLE 158
LK + ++ + + +P ++ + YS
Sbjct: 173 LKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAY---TTYSQSGI 229
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSD-------------SIPSEFGNLRSLSMLSLGYNKF 205
++ ++ + DN L+ I L ++
Sbjct: 230 KRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRY 288
Query: 206 SGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLT 265
++ + N + D +L N ++ LSL G +P ++G LT
Sbjct: 289 YSGTINNTIHSLNWNFN-KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG------NLTNLATLY 319
L L +S + S + M +++ NL++L
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 320 IHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS 379
I+ N I + + +G N+++ I ++ L+ L +Y ++ +
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPF-----T 461
Query: 380 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLS 439
+ Y K + S NL +L ++LY+ +P +L L +L+
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 440 LGYNKLSG---------SIPHSLGNLTNLDALYLYDNSLSG-SIPGEIGNLRSISNLALN 489
+ N+ + + Y+ N+L + + + L
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG-NLRSLSMLSFAYNKLSGSIP-- 546
+NK+ ++ G L L L N + + IP + + L F++NKL IP
Sbjct: 582 HNKV--RHLEAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637
Query: 547 ------HSLGVLDLSSNHIVG---EIPTELGKLNF--LIKLILAQNQLSGQLSPKLGSLA 595
+ +G +D S N I I + + L+ N++ + + +
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 596 QLEHLDLSSNRLSN-------SIPKSFGNLVKLHYLNLSNNQFSRGIP--IKLEELIHLS 646
+ + LS+N +++ ++ N L ++L N+ + + + L +LS
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 647 ELDLSHNFLREAIPSQICIMQSLENLNLSH------NSLVGLIPSCFEKMHGLLRIDISY 700
+D+S+N P+Q L+ + H N ++ P+ L+++ I
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 701 NELQGPIPNSI 711
N+++ + +
Sbjct: 816 NDIRK-VDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-29
Identities = 42/318 (13%), Positives = 97/318 (30%), Gaps = 19/318 (5%)
Query: 408 LTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
LT A + + + I L + ++ + N + D
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD- 309
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGN 527
++ N ++ L+L G +P ++G L+ L +L +S S
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 528 LRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQL 587
+ M +++ + + + L + L I ++
Sbjct: 370 ELTPDMSEERKHRIR-----------MHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
Query: 588 SPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSE 647
SL + +NR++ I K+ L KL + +N+ F+ + +
Sbjct: 419 KDSRISLKDT-QIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWED 471
Query: 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPI 707
+ + E ++ L ++ L + + +P + L ++I+ N
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531
Query: 708 PNSIAFRDAPIEALQGNK 725
+ + G K
Sbjct: 532 QLKADWTRLADDEDTGPK 549
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 4e-93
Identities = 91/299 (30%), Positives = 141/299 (47%), Gaps = 11/299 (3%)
Query: 184 SIPSEFGNLRSLS----MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF--DSIPSEL 237
I + GN +LS + G + + + L L +L IPS L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 238 GNLRSLSMLSL-GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
NL L+ L + G N L G IP ++ LT L LY+ ++SG+IP +++L L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 297 GYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSN-LGLSGNKLSGSIPP 355
YN L+G +P S+ +L NL + N +SG+IP G+ L + +S N+L+G IPP
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 356 SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLD 415
+ L NLA + L N L G+ ++ + L N L+ + +G NL LD
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP 474
L +N + G++P L+ L +L++ +N L G IP GNL D +N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 3e-86
Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 27/303 (8%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLI 161
D + + G + + L L L P I
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------I 68
Query: 162 PPSLGNLSNLDTLHLYD-NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
P SL NL L+ L++ N+L IP L L L + + SG+IP L + L
Sbjct: 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLAT-LYLYENSLSG 279
TL N+L ++P + +L +L ++ N++SG+IP S G+ + L T + + N L+G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
IP F NL +L+ ++L N L G G+ N +++ NSL+ + +G ++L
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNL 246
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
+ L L N++ G++P L L L +L + N+L IP GNL+ + + NK
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLC 305
Query: 400 SIP 402
P
Sbjct: 306 GSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-84
Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 14/305 (4%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGG---RVNSINLTSI 58
++ ALL+ K L N LSSW T W+G+ C+ RVN+++L+ +
Sbjct: 6 QDKQALLQIKKDLGNPTT---LSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 59 GLKGMLH-DFSFSSFPHLAYLDLWH-NQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116
L S ++ P+L +L + N L G IPP I +++L YL ++ G IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDT-LH 175
+ + L TL N L+G++P I L +L + N + IP S G+ S L T +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235
+ N L+ IP F NL +L+ + L N G G+ N ++L NSL +
Sbjct: 181 ISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLN 295
+G ++L+ L L N++ G++P L L L +L + N+L G IP GNL+ +
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297
Query: 296 LGYNK 300
NK
Sbjct: 298 YANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-83
Identities = 93/313 (29%), Positives = 146/313 (46%), Gaps = 35/313 (11%)
Query: 305 IPHSLGNLTNLA----TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
I LGN T L+ T N + G + ++NL LSG L P
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP------ 67
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSL-GYNKLSGSIPHSLGNLTNLATLDLYDN 419
IPS L NL L+ L + G N L G IP ++ LT L L +
Sbjct: 68 ----------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 420 SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGN 479
++SG+IP +++L TL YN LSG++P S+ +L NL + N +SG+IP G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 480 LRSISN-LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
+ + ++ N+L+G IP + NL NL + L N L G+ ++ + A
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 539 NKLSGSIP-----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGS 593
N L+ + +L LDL +N I G +P L +L FL L ++ N L G++ P+ G+
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGN 289
Query: 594 LAQLEHLDLSSNR 606
L + + ++N+
Sbjct: 290 LQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 267 bits (686), Expect = 8e-82
Identities = 91/369 (24%), Positives = 145/369 (39%), Gaps = 76/369 (20%)
Query: 376 SIPSELGNLRSLS----MLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS--IPSEF 429
I +LGN +LS G + + + LDL +L IPS
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 430 GNLRSLSTLSL-GYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488
NL L+ L + G N L G IP ++ LT L LY+ ++SG+IP + ++++ L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHS 548
+ N LSG++P S+ +L NLV + N + +IP G+ L
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT--------------- 177
Query: 549 LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLS 608
+ +S N + G+IP LN L +DLS N L
Sbjct: 178 --SMTISRNRLTGKIPPTFANLN-------------------------LAFVDLSRNMLE 210
Query: 609 NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQS 668
FG+ ++L+ N + + K+ +L+ LDL +N + +P + ++
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 669 LENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKGLC 728
L +LN+S +N L G IP + + A NK LC
Sbjct: 270 LHSLNVS------------------------FNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
Query: 729 GDVKGLPSC 737
G LP+C
Sbjct: 306 G--SPLPAC 312
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 8e-91
Identities = 135/587 (22%), Positives = 210/587 (35%), Gaps = 49/587 (8%)
Query: 111 GTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSN 170
G++ P I + + T Q + +L+ +P +I SS + L N L+ L S N S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 171 LDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230
L L L + + L LS L L N P S LT+L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 231 DSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLR 289
+G L +L L++ +N + +P NLTNL + L N + ++ LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 290 SLSM----LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGL 344
L++ N ++ I + + L L + N S +I + NL L L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSM--LSLGYNKLSGSIP 402
+ +L PS + L +++ L Y
Sbjct: 237 ILGEFKD------------------ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
Query: 403 HSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDAL 462
L N++ + L S+ + +LS+ +L L L +L
Sbjct: 279 VKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT-- 334
Query: 463 YLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL--SNLVILYLYNNSLFDS 520
L N SI + L S+S L L+ N LS S S +L ++L L L N
Sbjct: 335 -LTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-I 390
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGEIPTELGKLNFL 573
+ + L L L F ++ L L LD+S + + L L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 574 IKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
L +A N + L LDLS +L F L +L LN+S+N
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
+L LS LD S N + + +SL NL++NS+
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 1e-89
Identities = 125/566 (22%), Positives = 203/566 (35%), Gaps = 45/566 (7%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
+ P + + N+ T D LS +P + + S + L +N +S N + L
Sbjct: 4 LNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
L L + L LS L L N + P S LT+L L E L+
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
G L +L LN+ +N ++ +P NLTNL + + N + +++ LR
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 340 SN----LGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSL-- 392
L +S N + I L L L N +I L NL L + L
Sbjct: 180 PQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 393 ----GYNKLSGSIPHSLGNLTNLATLDLYD--NSLSGSIPSEFGNLRSLSTLSLGYNKLS 446
L P + L ++ + + +F L ++S +SL +
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 447 GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSN 506
+ +L + L ++ L+S++ L NK SI L +
Sbjct: 299 Y--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT---LTMNKG--SISFKKVALPS 351
Query: 507 LVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE 566
L L L N+L S +L + SL LDLS N + +
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTN----------------SLRHLDLSFNGAI-IMSAN 394
Query: 567 LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLN 625
L L L + L SL +L +LD+S F L L+ L
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454
Query: 626 LSNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIP 684
++ N F +L+ LDLS L + + L+ LN+SHN+L+ L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 685 SCFEKMHGLLRIDISYNELQGPIPNS 710
S + +++ L +D S+N ++
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 4e-89
Identities = 125/573 (21%), Positives = 193/573 (33%), Gaps = 48/573 (8%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
+L +P I S K +DLS N + S L+ L L ++
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 138 PYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM 197
L L+ L L N ++ P S L++L+ L + L+ G L +L
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 198 LSLGYNKFSG-SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSM----LSLGYNK 252
L++ +N +P NLTNL + L N + ++L LR L + N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 253 LSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGN 311
+ I L L L N S +I NL L + L +
Sbjct: 193 ID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD-------- 243
Query: 312 LTNLATLYIHNNSLSGSIPSEIGNLRSLS--NLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
+L PS + L ++ L+ L+N++ + L
Sbjct: 244 ----------ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF 429
S+ ++ LS+ +L +L L +L L N SI +
Sbjct: 294 GVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKK 346
Query: 430 GNLRSLSTLSLGYNKLSGSIPHSLGNL--TNLDALYLYDNSLSGSIPGEIGNLRSISNLA 487
L SLS L L N LS S S +L +L L L N + L + +L
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD 405
Query: 488 LNNNKLSGSIPQS-LGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP 546
++ L S +L L+ L + + L SL+ L A N +
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 547 H-------SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEH 599
+L LDLS + L+ L L ++ N L S L L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 600 LDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
LD S NR+ S L + NL+NN +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 8e-80
Identities = 116/520 (22%), Positives = 190/520 (36%), Gaps = 33/520 (6%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYL 123
L +SFS+F L +LDL ++ + L L L+ N P L+ L
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSLS 182
+ L E +L + IG+L +L L + N++ +P NL+NL + L N +
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 183 DSIPSEFGNLRSLSM----LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-L 237
++ LR L + N I L L L N +I L
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCL 225
Query: 238 GNLRSLSMLSL------GYNKLSGSIPHSLGNLTNLAT--LYLYENSLSGSIPSEFGNLR 289
NL L + L L P + L ++ L + +F L
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285
Query: 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL 349
++S ++L + + + +L I L P+ +L L +L L+ NK
Sbjct: 286 NVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG 340
Query: 350 SGSIPPSLGYLSNLATLYLYSNSL--FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 407
SI L +L+ L L N+L SL L L +N + +
Sbjct: 341 --SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 408 LTNLATLDLYDNSLSGSIP-SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L L LD ++L S F +L L L + Y LT+L+ L +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 467 NSLSGSIPGEI-GNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL 525
NS + + N +++ L L+ +L L L +L + +N+L S
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 526 GNLRSLSMLSFAYNKLSG------SIPHSLGVLDLSSNHI 559
L SLS L ++N++ P SL +L++N +
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-76
Identities = 109/520 (20%), Positives = 173/520 (33%), Gaps = 43/520 (8%)
Query: 207 GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
GS+ + + N+ T + L +P ++ + S + L +N L +S N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKL-SKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 267 LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326
L L L + + L LS L L N + P S LT+L L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 327 GSIPSEIGNLRSLSNLGLSGNKLSG-SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLR 385
IG L +L L ++ N + +P L+NL + L N + ++L LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 386 SLSM----LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSL 440
L + N + I L L L N S +I NL L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 441 GYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSIS--NLALNNNKLSGSIP 498
+ +L P + L ++ L
Sbjct: 237 ILGEFKDE------------------RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
Query: 499 QSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG---VLDLS 555
L+N+ + L S+ ++ LS +L L L L+
Sbjct: 279 VKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLT 336
Query: 556 SNHIVGEIPTELGKLNFLIKLILAQNQLS--GQLSPKLGSLAQLEHLDLSSNRLSNSIPK 613
N I + L L L L++N LS G S L HLDLS N +
Sbjct: 337 MNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSA 393
Query: 614 SFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIPSQICIMQSLENL 672
+F L +L +L+ ++ R L L LD+S+ + + SL L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453
Query: 673 NLSHNSLVGLIPSC-FEKMHGLLRIDISYNELQGPIPNSI 711
++ NS S F L +D+S +L+
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-62
Identities = 94/497 (18%), Positives = 162/497 (32%), Gaps = 39/497 (7%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLK----YLDLSS 106
+N+ + FS+ +L ++DL +N + + + LD+S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 107 NLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGR-LSSLNYLALYSNYLEDLIPPSL 165
N I + L L L N + +I + L+ L+ L +D
Sbjct: 191 N-PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE----- 244
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM--LSLGYNKFSGSIPHSLGNLTNLATLY 223
+L PS L +++ L Y L N++ +
Sbjct: 245 -------------RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L S+ ++ LS+ +L +L L +L L N SI
Sbjct: 292 LAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISF 344
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNL--TNLATLYIHNNSLSGSIPSEIGNLRSLSN 341
+ L SLS L+L N L+ S +L +L L + N + + L L +
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403
Query: 342 LGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400
L + L S L L L + + L SL+ L + N +
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 401 IPHS-LGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
+ N TNL LDL L F L L L++ +N L L +L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD 519
L N + S +S++ L NN ++ I + L + + ++
Sbjct: 524 STLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQ 582
Query: 520 SIPSELGNLRSLSMLSF 536
+ + + +L F
Sbjct: 583 MTCATPVEMNTSLVLDF 599
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-51
Identities = 75/382 (19%), Positives = 134/382 (35%), Gaps = 30/382 (7%)
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410
GS+ P + + N+ T L +P ++ + S + L +N L +S N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKL-SKVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
L LDL + + L LS L L N + P S LT+L+ L + L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 471 GSIPGEIGNLRSISNLALNNNKLSG-SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLR 529
IG L ++ L + +N + +P NL+NLV + L N + ++L LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 530 SLSM----LSFAYNKLSGSIPH-----SLGVLDLSSNHIVGEIP-TELGKLNFLIKLILA 579
L + N + L L L N I T L L L L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 580 QNQLSGQLSPKLGSLA--------QLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
+ + + ++ + ++ L+ + F L + ++L+
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 632 SRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMH 691
+ + L + L++ + L++L L+ N I +
Sbjct: 298 KY--LEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKG--SISFKKVALP 350
Query: 692 GLLRIDISYNELQGPIPNSIAF 713
L +D+S N L S +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSD 372
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 65/324 (20%), Positives = 105/324 (32%), Gaps = 51/324 (15%)
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
GS+ + + N+ T D LS +P + + S + L +N L +S N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518
L L L + L +SNL L N + P S L++L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 519 DSIPSELGNLRSLSMLSFAYNKLSGSIPH-------SLGVLDLSSNHIVGEIPTELGKLN 571
+G L +L L+ A+N + +L +DLS N+I +L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 572 FLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
++ LD+S N + ++F + KLH L L N
Sbjct: 178 ENPQV--------------------NLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFN 216
Query: 632 SRGIP-IKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKM 690
S I L+ L L L + +L PS E +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFK------------------DERNLEIFEPSIMEGL 258
Query: 691 HGLLRIDISYNELQGPIPNSIAFR 714
+ + + + F
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFH 282
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 18/113 (15%), Positives = 34/113 (30%), Gaps = 1/113 (0%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
F + L L++ HN L + L LD S N + L
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
L N + I L + + +E + + ++ L +++
Sbjct: 552 LTNNSVA-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNST 603
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-80
Identities = 87/290 (30%), Positives = 150/290 (51%), Gaps = 26/290 (8%)
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
E+ A+++F +++ +G+GG G VYK LA G +VAVK+ + +F EV+
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQFQTEVE 79
Query: 867 ALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKD-LGWTRRMNVIKG 914
++ HRN+++ GFC S+A L ++ L W +R + G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTELAGTY 973
+ L+Y+H+ C P I+HRD+ + N+LLD + EA V DFG+AK + ++ T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL---------NI 1024
G++APE T K +EK DV+ +GV+ LE+I G+ D + + L
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L+ ++D L +++ +++VA+ C +P RP M +V ++L+
Sbjct: 260 KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-77
Identities = 129/483 (26%), Positives = 204/483 (42%), Gaps = 36/483 (7%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F+ ++ L + + ++ ++ L + +L+ L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
NQL P + L+ L + + +N + D+ P L NL+NL L L++N ++D P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
NL +L+ L L N S +L LT+L L N + L NL +L L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERL 182
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
+ NK+S L LTNL +L N +S P G L +L L+L N+L I
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT 238
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366
L +LTNL L + NN +S P + L L+ L L N++S P L L+ L L
Sbjct: 239 --LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 367 YLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIP 426
L N L D P + NL++L+ L+L +N +S P + +LT L L Y+N +S
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346
Query: 427 SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNL 486
S NL +++ LS G+N++S P L NLT + L L D + + + P SI N
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNT 403
Query: 487 ALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP 546
N P ++ + + + N + SG++
Sbjct: 404 VKNVTGAL-IAPATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
Query: 547 HSL 549
L
Sbjct: 462 QPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 2e-74
Identities = 133/468 (28%), Positives = 207/468 (44%), Gaps = 36/468 (7%)
Query: 75 LAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLN 134
L + + I ++ L T+ L + TLQ +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 135 GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRS 194
+ L++L + +N L D+ P L NL+ L + + +N ++D P NL +
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113
Query: 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254
L+ L+L N+ + P L NLTNL L L +N++ S S L L SL LS G N+++
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVT 168
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314
P L NLT L L + N +S S L +L L N+++ I P LG LTN
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF 374
L L ++ N L + +L +L++L L+ N++S P L L+ L L L +N +
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS 434
+ P L L +L+ L L N+L P + NL NL L LY N++S P +L
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494
L L NK+S SL NLTN++ L N +S P + NL I+ L LN+ +
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
+ N+S + +L P+ + + S + +N S
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 1e-72
Identities = 133/543 (24%), Positives = 210/543 (38%), Gaps = 82/543 (15%)
Query: 142 GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLG 201
G L S + + L+ L +++D++ +L ++ L
Sbjct: 1 GPLGSATIT--QDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQAD 54
Query: 202 YNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL 261
+ L NL + NN L D P L NL L + + N+++ P L
Sbjct: 55 RLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 262 GNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH 321
NLTNL L L+ N ++ P NL +L+ L L N ++ I L LT+L L
Sbjct: 109 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG 164
Query: 322 NNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSEL 381
N + NL +L L +S NK+S L L+NL +L +N + D P L
Sbjct: 165 NQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--L 217
Query: 382 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
G L +L LSL N+L +L +LTNL LDL +N +S P L L+ L LG
Sbjct: 218 GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273
Query: 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL 501
N++S P L LT L L L +N L P I NL++++ L L N +S P +
Sbjct: 274 ANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327
Query: 502 GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVG 561
+L+ L L+ YNN + S S L NL +++ LS +N++S P
Sbjct: 328 SSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--------------- 370
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
L +L ++ L L+ +N+ N+
Sbjct: 371 -----------------------------LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681
+ + P + + +E D++ N + + G
Sbjct: 402 NTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSG 458
Query: 682 LIP 684
+
Sbjct: 459 TVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-64
Identities = 121/491 (24%), Positives = 192/491 (39%), Gaps = 77/491 (15%)
Query: 220 ATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
+ + + L LG ++ ++ +L + TL +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 59
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
L +L+ +N N+L I P L NLT L + ++NN ++ P + NL +L
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
+ L L N+++ P L L+NL L L SN++ S S L L SL LS G N+++
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTD 169
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
P L NLT L LD+ N +S S L +L +L N++S P LG LTNL
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD 519
D L L N L G + +L ++++L L NN++S P L L+ L L L N + +
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279
Query: 520 SIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILA 579
P L L +L+ L N+L P
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISP--------------------------------- 304
Query: 580 QNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL 639
+ +L L +L L N +S+ P +L KL L NN+ S L
Sbjct: 305 -----------ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSL 349
Query: 640 EELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDIS 699
L +++ L HN + + P + + + L L+ + + + +
Sbjct: 350 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNV 407
Query: 700 YNELQGPIPNS 710
L P S
Sbjct: 408 TGALIAPATIS 418
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 9e-71
Identities = 123/536 (22%), Positives = 190/536 (35%), Gaps = 46/536 (8%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
IP + S L L N L L S + L L L + + +L L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 196 SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL-S 254
S L L N + L++L L +L +G+L++L L++ +N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSM----LNLGYNKLNGIIPHSLG 310
+P NLTNL L L N + ++ L + + L+L N +N I P +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 311 NLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGLSGNKLSGS---IPPSLGYLSNLATL 366
+ L L + NN S ++ I L L L + L L L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 367 YLYSNSL------FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420
+ L D I L ++S SL + S L+L +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCK 315
Query: 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS--GSIPGEIG 478
P L+SL L+ NK + S +L +L+ L L N LS G
Sbjct: 316 FG-QFP--TLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
S+ L L+ N + ++ + L L L ++ NL+ +S S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS-----------NLKQMSEFSVFL 418
Query: 539 NKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQL 597
+ +L LD+S H L+ L L +A N P L L
Sbjct: 419 S------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
LDLS +L P +F +L L LN+++NQ + L L ++ L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-70
Identities = 122/570 (21%), Positives = 200/570 (35%), Gaps = 46/570 (8%)
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222
P + + N+ T + + IP S L L +N +S + L L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIP 282
L + +L LS L L N + + L++L L E +L+
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 283 SEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSN 341
G+L++L LN+ +N + +P NLTNL L + +N + +++ L +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 342 ----LGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSL---- 392
L LS N ++ I P L L L +N ++ + L L + L
Sbjct: 178 LNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 393 --GYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS---IPSEFGNLRSLSTLSLGYNKLSG 447
L +L L NL + L I F L ++S+ SL +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
S L L + ++ +L+ L +NK + S +L +L
Sbjct: 297 VKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNAF--SEVDLPSL 349
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTEL 567
L L N L S + + SL LDLS N ++ + +
Sbjct: 350 EFLDLSRN-----------GLSFKGCCSQSDFGTT-----SLKYLDLSFNGVI-TMSSNF 392
Query: 568 GKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626
L L L + L SL L +LD+S + F L L L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 627 SNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPS 685
+ N F EL +L+ LDLS L + P+ + SL+ LN++ N L +
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 686 CFEKMHGLLRIDISYNELQGPIPNSIAFRD 715
F+++ L +I + N P
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-69
Identities = 116/573 (20%), Positives = 196/573 (34%), Gaps = 73/573 (12%)
Query: 79 DLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIP 138
Y IP + K LDLS N L+ L L ++
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 139 YEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSML 198
LS L+ L L N ++ L + LS+L L + +L+ G+L++L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 199 SLGYNKF-SGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSM----LSLGYNKL 253
++ +N S +P NLTNL L L +N + ++L L + + L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 254 SGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNL------GYNKLNGIIP 306
+ I L L L N S ++ L L + L L
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 307 HSLGNLTNLATLYIHNNSLSGS---IPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
+L L NL L I L ++S+ L + Y
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGW 306
Query: 364 ATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS- 422
L L + +L +L+ L+ NK + S +L +L LDL N LS
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSF 361
Query: 423 -GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNL 480
G SL L L +N + ++ + L L+ L ++L + +L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYN 539
R++ L +++ + LS+L +L + NS ++ + LR+L+ L +
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 540 KLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEH 599
+L + + SL+ L+
Sbjct: 481 QLE-QLSPTA-----------------------------------------FNSLSSLQV 498
Query: 600 LDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
L+++SN+L + F L L + L N +
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-16
Identities = 40/148 (27%), Positives = 61/148 (41%), Gaps = 6/148 (4%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQI--GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLK 124
+F L +LD H+ L + ++ L YLD+S I LS L+
Sbjct: 391 NFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHT-HTRVAFNGIFNGLSSLE 448
Query: 125 TLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
L++ N + +I L +L +L L LE L P + +LS+L L++ N L
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508
Query: 184 SIPSEFGNLRSLSMLSLGYNKFSGSIPH 211
F L SL + L N + S P
Sbjct: 509 VPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 7e-70
Identities = 91/319 (28%), Positives = 139/319 (43%), Gaps = 49/319 (15%)
Query: 787 SSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKK 846
S V ++ ++ ATN+FD + IG G G VYK L G VA+K+
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 847 FHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL-----SNN-- 897
+ Q +EF E++ L+ RH ++V GFC MIL N
Sbjct: 71 RTP-----ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE---MILIYKYMENGNL 122
Query: 898 --------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH 949
+ W +R+ + G + L Y+H I+HRD+ S N+LLD +
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 950 VSDFGIAKFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006
++DFGI+K + T + GT GY+ PE ++TEK DVYSFGV+ EV+ +
Sbjct: 180 ITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 1007 HPRDFISSMSSSSLNLNIA-----------LDEMLDPRLPTPSCIVQDKLISIVEVAISC 1055
S +N+A L++++DP L I + L + A+ C
Sbjct: 239 SAIV----QSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKC 292
Query: 1056 LDENPESRPTMPKVSQLLK 1074
L + E RP+M V L+
Sbjct: 293 LALSSEDRPSMGDVLWKLE 311
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 6e-69
Identities = 123/556 (22%), Positives = 215/556 (38%), Gaps = 37/556 (6%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGY 202
L++ L L NY+ + S L L L L +I E F NL +L +L LG
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 203 NKFSGSIPHSLGNLTNLATLYLHNNSLFDSI--PSELGNLRSLSMLSLGYNKLSG-SIPH 259
+K P + L +L L L+ L D++ NL++L+ L L N++ +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 260 SLGNLTNLATLYLYENSLSGSIPSEFGNLR--SLSMLNLGYNKLNGIIPHSLGNLTN-LA 316
S G L +L ++ N + E L+ +LS +L N L + G N
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
+ + +SG N ++ G N +S S SL ++ +++ D
Sbjct: 203 NMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 377 IPSELGNLR--SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS 434
+ L S+ L L + + L +L L+L N ++ F L +
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494
L L+L YN L + L + + L N ++ L + L L +N L+
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP----HSLG 550
++ + ++ ++L N L ++P + + L L
Sbjct: 376 -----TIHFIPSIPDIFLSGNKL-VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQ 429
Query: 551 VLDLSSNHIVGEIPTEL-GKLNFLIKLILAQNQLSGQLSPKL-----GSLAQLEHLDLSS 604
+L L+ N + + L +L L +N L +L L+ L+ L L+
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
Query: 605 NRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQIC 664
N L++ P F +L L L+L++N+ + L +L LD+S N L P
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPD--- 544
Query: 665 IMQSLENLNLSHNSLV 680
+ SL L+++HN +
Sbjct: 545 VFVSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 7e-61
Identities = 117/529 (22%), Positives = 200/529 (37%), Gaps = 38/529 (7%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
+ SF L L+L I + N+ L+ LDL S+ + P+ L
Sbjct: 39 VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLF 97
Query: 122 YLKTLQLFENQLNGSI--PYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYD 178
+L L+L+ L+ ++ L +L L L N + L + PS G L++L ++
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 179 NSLSDSIPSEFGNLR--SLSMLSLGYNKFSGSIPHSLGNLTN-LATLYLHNNSLFDSIPS 235
N + E L+ +LS SL N + G N + L +
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV------ 211
Query: 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLR--SLSM 293
GN ++ + N +S S SL ++ +++ + F L S+
Sbjct: 212 -SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 294 LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSI 353
L+L + + + L +L L + N ++ L +L L LS N L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 354 PPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLAT 413
+ L +A + L N + L L L L N L+ ++ + ++
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPD 385
Query: 414 LDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTNLDALYLYDNSLSG- 471
+ L N L ++P + + + L N+L I + L + +L L L N S
Sbjct: 386 IFLSGNKLV-TLPKIN---LTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441
Query: 472 SIPGEIGNLRSISNLALNNNKLSGSIPQSL-----GNLSNLVILYLYNNSLFDSIPSELG 526
S S+ L L N L + L LS+L +LYL +N L P
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 527 NLRSLSMLSFAYNKLS----GSIPHSLGVLDLSSNHIVGEIPTELGKLN 571
+L +L LS N+L+ +P +L +LD+S N ++ P L+
Sbjct: 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLS 550
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-52
Identities = 116/491 (23%), Positives = 192/491 (39%), Gaps = 46/491 (9%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQ--IGNISRLKYLDLSSNLFFG-TIPPEIGHL 120
LH +F HL L L+ L + N+ L LDLS N + P G L
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 121 SYLKTLQLFENQLNGSIPYEIGRLS--SLNYLALYSNYLEDLIPPSLGNLSN------LD 172
+ LK++ NQ+ +E+ L +L++ +L +N L + G N L+
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 173 TLHLYDNSLSDSIPSEFGN------------LRSLSMLSLGYNKFSGSIPHSLGNL--TN 218
L + N + I F N + G++ ++ L ++
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267
Query: 219 LATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS 278
+ L L + +F L+ L +L+L YNK++ + L NL L L N L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 279 GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338
S F L ++ ++L N + I + L L TL + +N+L + I + S
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPS 382
Query: 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD-SIPSELGNLRSLSMLSLGYNKL 397
+ ++ LSGNKL +L ++L N L + I L + L +L L N+
Sbjct: 383 IPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 398 SG-SIPHSLGNLTNLATLDLYDNSLSGSIPSE-----FGNLRSLSTLSLGYNKLSGSIPH 451
S S + +L L L +N L + +E F L L L L +N L+ P
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILY 511
+LT L L L N L+ + ++ L ++ N+L P +LS +L
Sbjct: 499 VFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVSLS---VLD 553
Query: 512 LYNNSLFDSIP 522
+ +N
Sbjct: 554 ITHNKFICECE 564
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-45
Identities = 89/442 (20%), Positives = 155/442 (35%), Gaps = 63/442 (14%)
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328
+ +L+ +P L + L L +N + + S L L L + + +
Sbjct: 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 329 IPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
I E NL +L L L +K+ + P L L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDA-----------------------FQGLFHL 99
Query: 388 SMLSLGYNKLSGSI--PHSLGNLTNLATLDLYDNSLSG-SIPSEFGNLRSLSTLSLGYNK 444
L L + LS ++ NL L LDL N + + FG L SL ++ N+
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 445 LSGSIPHSLGNLT--NLDALYLYDNSLSGSIPGEIGN-LRSISNLALNNNKLSGSIPQSL 501
+ H L L L L NSL + + G + N+ L +SG
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG------ 213
Query: 502 GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVG 561
N + I ++N++ S L + F ++ + ++ L SS
Sbjct: 214 -NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS----- 267
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
+ L L+ + S +L L+ L+L+ N+++ ++F L L
Sbjct: 268 -----------VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681
LNLS N L ++ +DL N + ++ L+ L+L N+L
Sbjct: 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-- 374
Query: 682 LIPSCFEKMHGLLRIDISYNEL 703
+ + + I +S N+L
Sbjct: 375 ---TTIHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-44
Identities = 82/370 (22%), Positives = 138/370 (37%), Gaps = 14/370 (3%)
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI-P 402
L+ +P L + L L N + S L L +L LG +I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 403 HSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI--PHSLGNLTNLD 460
+ NL NL LDL + + P F L L L L + LS ++ NL L
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 461 ALYLYDNSLSG-SIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS--NLVILYLYNNSL 517
L L N + + G L S+ ++ ++N++ L L L L NSL
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186
Query: 518 FDSIPSELGN-LRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKL 576
+ + + G + + +SG+ + SN I L + ++
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD-ITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 577 ILAQNQLSGQLSPKLGSLAQ--LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
+ + LA+ + HLDLS + + + F L L LNL+ N+ ++
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI 305
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLL 694
L +L L+LS+N L E S + + ++L N + + F+ + L
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365
Query: 695 RIDISYNELQ 704
+D+ N L
Sbjct: 366 TLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-44
Identities = 105/522 (20%), Positives = 197/522 (37%), Gaps = 40/522 (7%)
Query: 49 RVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNIS--RLKYLDLSS 106
+ ++L+ ++ + SF L +D NQ++ ++ + L + L++
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 107 NLFFGTIPPEIGH-LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
N + + + G ++ + + L ++G+ +++ +SN + SL
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGN-------GWTVDITGNFSNAISKSQAFSL 236
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLR--SLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
++ +++ D + F L S+ L L + L +L L
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
L N + L +L +L+L YN L + L +A + L +N ++
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
F L L L+L N L ++ + ++ +++ N L ++P + + +
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIH 407
Query: 344 LSGNKLSG-SIPPSLGYLSNLATLYLYSNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGS 400
LS N+L I L + +L L L N S + SL L LG N L +
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 401 IPHSL-----GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455
L L++L L L N L+ P F +L +L LSL N+L+ + L
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-- 524
Query: 456 LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIP----QSLGNLSNLVILY 511
NL+ L + N L P +L + + +NK + N +N+ I
Sbjct: 525 PANLEILDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFINWLNHTNVTIAG 581
Query: 512 LYNNSLFDSIPSELGN-LRSLSMLSFAYNKLSGSIPHSLGVL 552
+ S G L SLS ++ S+ SL ++
Sbjct: 582 PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIV 623
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 49/226 (21%), Positives = 75/226 (33%), Gaps = 21/226 (9%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLF 109
N I+L+ L+ + + PHL L L N+ Q L+ L L N+
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
Query: 110 FGTIPPEI-----GHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPS 164
E+ LS+L+ L L N LN P L++L L+L SN L L
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL--SH 521
Query: 165 LGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY-------------NKFSGSIPH 211
+NL+ L + N L P F +L L + + N + +I
Sbjct: 522 NDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAG 581
Query: 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257
++ + SLF L L +
Sbjct: 582 PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVT 627
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-68
Identities = 116/521 (22%), Positives = 185/521 (35%), Gaps = 71/521 (13%)
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLD 172
I P ++L+ + L +P E + S + E PP G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
L D R L L S S+P +L +L NSL
Sbjct: 62 VSRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSL-TE 105
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
+P +L+SL + + LS P L L + N L +P E N L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS 352
++++ N L +P +L + NN L +P E+ NL L+ + N L
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-K 209
Query: 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 412
+P +L ++ +N L EL NL L+ + N L ++P +L
Sbjct: 210 LPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA-- 261
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
L++ DN L+ +P +L L ++ LS P NL L N + S
Sbjct: 262 -LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-S 311
Query: 473 IPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLS 532
+ +L L ++NNKL +P L L N L +P NL+ L
Sbjct: 312 LCDLPPSLEE---LNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVPELPQNLKQLH 363
Query: 533 MLSFAYNKLSGSIPHSLGVL-DLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL 591
+ YN L P + DL N + E+P L +L + N L +
Sbjct: 364 V---EYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIP 415
Query: 592 GSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
S +E L ++S R+ + + KL ++
Sbjct: 416 ES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 6e-62
Identities = 113/518 (21%), Positives = 193/518 (37%), Gaps = 70/518 (13%)
Query: 186 PSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSM 245
P N L + + +P N+ + Y + + P G R +++
Sbjct: 5 PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII 305
L L L LS S+P +L S L N L +
Sbjct: 63 SRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-EL 106
Query: 306 PHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLAT 365
P +L +L + +LS P L LG+S N+L P L S L
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKL--PELQNSSFLKI 157
Query: 366 LYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI 425
+ + +NSL +P +L ++ G N+L +P L NL L + +NSL +
Sbjct: 158 IDVDNNSL-KKLPDLPPSLEF---IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KL 210
Query: 426 PSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISN 485
P +L ++ G N L L NL L +Y +N L ++P +L +
Sbjct: 211 PDLPLSLE---SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA--- 261
Query: 486 LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSI 545
L + +N L+ +P+ +L+ L + + L NL L+ S L
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNASSNEIRSLCDLP 316
Query: 546 PHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSN 605
P SL L++S+N ++ E+P +L +LI + N L+ ++ + L+ L + N
Sbjct: 317 P-SLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQN---LKQLHVEYN 367
Query: 606 RLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICI 665
L P ++ L + +P E +L +L + N LRE P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAE-----VP---ELPQNLKQLHVETNPLRE-FPDIP-- 415
Query: 666 MQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL 703
+S+E+L ++ +V E L ++
Sbjct: 416 -ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-58
Identities = 100/488 (20%), Positives = 162/488 (33%), Gaps = 76/488 (15%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGN-------------ISRLKYLDLSSNLFFGTIP 114
+ ++ N PP G + L+L++ ++P
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL-GLSSLP 87
Query: 115 PEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTL 174
H L++L N L +P L SL L DL P L+ L
Sbjct: 88 ELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYL 136
Query: 175 HLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP 234
+ +N L +P E N L ++ + N +P +L + NN L
Sbjct: 137 GVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQL--EEL 188
Query: 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSML 294
EL NL L+ + N L +P +L ++ N L E NL L+ +
Sbjct: 189 PELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNIL--EELPELQNLPFLTTI 242
Query: 295 NLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIP 354
N L +P +L L + +N L+ +P +L L + LS P
Sbjct: 243 YADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
Query: 355 PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414
NL L SN + S+ +L L++ NKL +P L L
Sbjct: 298 -------NLYYLNASSNEI-RSLCDLPPSLEE---LNVSNNKLI-ELPALPPRLER---L 342
Query: 415 DLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP 474
N L+ +P NL+ L + YN L P ++ +L NS +P
Sbjct: 343 IASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVP 392
Query: 475 GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSML 534
NL+ L + N L P ++ + L + + + D L
Sbjct: 393 ELPQNLKQ---LHVETNPLR-EFPDIPESVED---LRMNSERVVDPYEFAHETTDKLEDD 445
Query: 535 SFAYNKLS 542
F ++
Sbjct: 446 VFEHHHHH 453
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-68
Identities = 101/372 (27%), Positives = 168/372 (45%), Gaps = 27/372 (7%)
Query: 99 LKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLE 158
L P L+ L + + + L S+ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTN 218
+ + L+NL+ L+L N ++D P NL L+ L +G NK + +L NLTN
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 219 LATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS 278
L LYL+ +++ D P L NL + L+LG N + L N+T L L + E+ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 279 GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338
P NL L L+L YN++ I P L +LT+L + N ++ P + N+
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
L++L + NK++ P L LS L L + +N + S + + +L L ML++G N++S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS 278
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
L NL+ L +L L +N L G L +L+TL L N ++ P L +L+
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334
Query: 459 LDALYLYDNSLS 470
+D+ + +
Sbjct: 335 MDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 3e-66
Identities = 93/356 (26%), Positives = 158/356 (44%), Gaps = 25/356 (7%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F + L + + + + L ++ I +L+ L+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYL 71
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
L NQ+ P + L L L + +N + D+ +L NL+NL L+L ++++SD P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP 127
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
NL + L+LG N + L N+T L L + + + D P + NL L L
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
SL YN++ P L +LT+L Y N ++ P N+ L+ L +G NK+ + P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366
L NL+ L L I N +S + + +L L L + N++S L LS L +L
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 367 YLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
+L +N L + +G L +L+ L L N ++ P L +L+ + + D + +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-64
Identities = 104/371 (28%), Positives = 173/371 (46%), Gaps = 29/371 (7%)
Query: 291 LSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS 350
+ L +N I P +L + S++ + L S++ L ++G K++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410
SI + YL+NL L L N + D P L NL L+ L +G NK++ +L NLTN
Sbjct: 58 -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
L L L ++++S P NL + +L+LG N + L N+T L+ L + ++ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 471 GSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS 530
P I NL + +L+LN N++ P L +L++L Y N + D P + N+
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 531 LSMLSFAYNKLSGSIP----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ 586
L+ L NK++ P L L++ +N I + L L L + NQ+S
Sbjct: 223 LNSLKIGNNKITDLSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD- 279
Query: 587 LSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLS 646
+S L +L+QL L L++N+L N + G L L L LS N + P L L +
Sbjct: 280 ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMD 336
Query: 647 ELDLSHNFLRE 657
D ++ +++
Sbjct: 337 SADFANQVIKK 347
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 191 bits (489), Expect = 3e-54
Identities = 78/350 (22%), Positives = 140/350 (40%), Gaps = 27/350 (7%)
Query: 363 LATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
ATL + P +L L ++ + L ++ L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRS 482
L +L L+L N+++ P L NL L LY+ N ++ + NL +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 483 ISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
+ L LN + +S P L NL+ + L L N S S L N+ L+ L+ +K+
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 543 GSIP----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLE 598
P L L L+ N I P L L L NQ++ + ++ +L
Sbjct: 169 DVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLN 224
Query: 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
L + +N++++ P NL +L +L + NQ S +++L L L++ N + +
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD- 279
Query: 659 IPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIP 708
S + + L +L L++N L + L + +S N + P
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 28/161 (17%), Positives = 62/161 (38%), Gaps = 12/161 (7%)
Query: 549 LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLS 608
L I +I L I+ +L + ++ L + L ++ +++
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 609 NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQS 668
+ + L L YLNL+ NQ + P L L+ L+ L + N + S + + +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 669 LENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPN 709
L L L+ +++ + P + + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-65
Identities = 60/343 (17%), Positives = 112/343 (32%), Gaps = 27/343 (7%)
Query: 207 GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
GS H + + LY ++ L + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 267 LATLYLYENSLSGSIPSEFGNLRS--LSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+L + + L L L P L++L + I
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNL 384
L +P + L L L+ N L ++P S+ L+ L L + + +P L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNK 444
L NL +L L + S+P+ NL++L +L + +
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL 504
LS ++ ++ +L L+ L L + + P G + L L + ++P + L
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH 547
+ L L L +PS + L + ++ + + H
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-61
Identities = 60/351 (17%), Positives = 112/351 (31%), Gaps = 29/351 (8%)
Query: 110 FGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLS 169
G+ H S + L + + + + N +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 170 NLDTLHLYDNSLSDSIPSEFGNLRS--LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227
N +L + + L L P L++L + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN 287
L +P + L L+L N L ++P S+ +L L L + +P +
Sbjct: 115 GL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 288 LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGN 347
+ L NL +L + + S+P+ I NL++L +L + +
Sbjct: 173 TDA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 348 KLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSL-GYNKLSGSIPHSLG 406
LS ++ P++ +L L L L + + P G L L L + L ++P +
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH 274
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT 457
LT L LDL +PS L + + + + + H
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-61
Identities = 56/320 (17%), Positives = 99/320 (30%), Gaps = 21/320 (6%)
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221
+ S + L+ ++ + N N
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQI 60
Query: 222 LYLHNNSLFDSIPSELGNLRS--LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
+L + L + L L L P L++L + + L
Sbjct: 61 ETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN---- 335
+P L L L N L +P S+ +L L L I +P + +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 336 -----LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390
L +L +L L + S+P S+ L NL +L + ++ L ++ + +L L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEEL 234
Query: 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIP 450
L + P G L L L D S ++P + L L L L +P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 451 HSLGNLTNLDALYLYDNSLS 470
+ L + + + +
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-58
Identities = 61/390 (15%), Positives = 114/390 (29%), Gaps = 69/390 (17%)
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314
GS H + + LY ++ + + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 315 LATLYIHNNSLSGSIPSEIGNLRS--LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNS 372
+L + + + L L L P LS+L + + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 373 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL 432
L +P + L L+L N L ++P S+ +L L L + +P +
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
L NL +L L + S+P I NL+++ +L + N+
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVL 552
LS ++ ++ +L L L L + + P G L L
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK------------------RL 258
Query: 553 DLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIP 612
L + +P ++ +L QLE LDL + +P
Sbjct: 259 ILKDCSNLLTLPLDIHRLT------------------------QLEKLDLRGCVNLSRLP 294
Query: 613 KSFGNLVKLHYLNLSNNQFSRGIPIKLEEL 642
L + + + ++ +
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-56
Identities = 62/336 (18%), Positives = 104/336 (30%), Gaps = 21/336 (6%)
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410
GS + S LY ++ L + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 411 LATLDLYDNSLSGSIPSEFGNLRS--LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
+L + + L L L P L++L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 469 LSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNL 528
L +P + + L L N L ++P S+ +L+ L L + +P L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 529 RSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLS 588
+ +L L L I +P + L L L + + LS L
Sbjct: 174 DASGEHQGL---------VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 589 PKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSEL 648
P + L +LE LDL + P FG L L L + +P+ + L L +L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 649 DLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIP 684
DL +PS I + + + + + L
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 57/324 (17%), Positives = 101/324 (31%), Gaps = 21/324 (6%)
Query: 75 LAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLN 134
L + + R D + + + + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK 69
Query: 135 GSIPYEIGRLSSLN--YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNL 192
+ + + L L S L P LS+L + + L +P
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN---------LRSL 243
L L+L N ++P S+ +L L L + +P L + L +L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 244 SMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303
L L + + S+P S+ NL NL +L + + LS ++ +L L L+L
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
P G L L + + S ++P +I L L L L G +P + L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 364 ATLYLYSNSLFDSIPSELGNLRSL 387
+ + + +
Sbjct: 304 CIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-46
Identities = 56/321 (17%), Positives = 97/321 (30%), Gaps = 33/321 (10%)
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
GS H + + L ++ + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSIS--NLALNNNKLSGSIPQSLGNLSNLVILYLYNNS 516
+L + + + L L + L P LS+L + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 517 LFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG------VLDLSSNHIVGEIPTELGKL 570
L +P + L L+ A N L ++P S+ L + + + E+P L
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 571 NFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
S + L L+ L L + S+P S NL L L + N+
Sbjct: 174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217
Query: 631 FSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKM 690
+ + L L ELDL P L+ L L S + +P ++
Sbjct: 218 L-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 691 HGLLRIDISYNELQGPIPNSI 711
L ++D+ +P+ I
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLI 297
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 46/247 (18%), Positives = 87/247 (35%), Gaps = 21/247 (8%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
HL ++ + L +P + + L+ L L+ N +P I L+ L+ L
Sbjct: 99 QAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLRELS 156
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS 187
+ +P + + L NL +L L + S+P+
Sbjct: 157 IRACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 188 EFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
NL++L L + + S ++ ++ +L L L L + + P G L L
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259
Query: 248 L-GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
L + L ++P + LT L L L +PS L + ++ + + +
Sbjct: 260 LKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 307 HSLGNLT 313
H
Sbjct: 319 HRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 33/227 (14%), Positives = 59/227 (25%), Gaps = 52/227 (22%)
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHS--LGVL 552
GS + S LY ++ L + + +S +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 553 DLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIP 612
+ + L + L+L S L P
Sbjct: 62 TRTGRALK-ATADLLEDA----------------------TQPGRVALELRSVPLP-QFP 97
Query: 613 KSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENL 672
L L ++ + +P +++ L L L+ N LR +P+ I + L L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLREL 155
Query: 673 NLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIE 719
++ EL +P +A DA E
Sbjct: 156 SIRAC-----------------------PELTE-LPEPLASTDASGE 178
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 5e-64
Identities = 112/515 (21%), Positives = 191/515 (37%), Gaps = 44/515 (8%)
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ S SIPS L ++ L L +NK++ L NL L L + ++
Sbjct: 9 VCDGRSRSF-TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG-SIPSEIGNLRSL 339
F +L SL L+L N L+ + G L++L L + N + S NL +L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 340 SNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
L + + I L++L L + + SL + L ++R + L+L ++ +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
+ L+++ L+L D +L+ S S + + S S L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518
L L + + + N ++ + L++ LF
Sbjct: 246 LLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 519 DSIPSELGNLRSLSMLSFAYNKLSGSIPH-------SLGVLDLSSNHIVGEI---PTELG 568
+ + L + ++ +K+ +P SL LDLS N +V E G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 569 KLNFLIKLILAQNQLS--GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626
L L+L+QN L + L +L L LD+S N +P S K+ +LNL
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 627 SNNQFS---RGIPIKLEELI--------------HLSELDLSHNFLREAIPSQICIMQSL 669
S+ IP LE L L EL +S N L+ +P + L
Sbjct: 418 SSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPD-ASLFPVL 475
Query: 670 ENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ +S N L + F+++ L +I + N
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 6e-63
Identities = 107/561 (19%), Positives = 195/561 (34%), Gaps = 68/561 (12%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
D +IP + + +K LDLS N ++ + L+ L L +++N
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 138 PYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLS 196
L SL +L L N+L L G LS+L L+L N + S F NL +L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 197 MLSLGYNKFSGSIP-HSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255
L +G + I LT+L L + SL + L ++R + L+L ++ +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
+ L+++ L L + +L+ S S + + + + S L L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 316 ATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD 375
+ + + + + ++ + L++ LF
Sbjct: 247 LRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI---PSEFGNL 432
+ + L + +++ +K+ +L +L LDL +N + + G
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 433 RSLSTLSLGYNKLS--GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
SL TL L N L L L NL +L + N+
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-------------------- 400
Query: 491 NKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550
+P S + L L + + + IP +L
Sbjct: 401 -----PMPDSCQWPEKMRFLNLSSTGI---------------------RVVKTCIPQTLE 434
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
VLD+S+N++ L +L +L +++N+L P L + +S N+L +
Sbjct: 435 VLDVSNNNL-DSFSLFLPRLQ---ELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSV 488
Query: 611 IPKSFGNLVKLHYLNLSNNQF 631
F L L + L N +
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-57
Identities = 103/502 (20%), Positives = 171/502 (34%), Gaps = 37/502 (7%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFE 130
+ LDL N++ + + L+ L L S+ TI + L L+ L L +
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSD 83
Query: 131 NQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYDNSLSDSIPSE- 188
N L+ G LSSL YL L N + L SL NL+NL TL + + I
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
F L SL+ L + SL ++ ++ L LH + + L S+ L L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSG----------SIPSEFGNLRSLSMLNLGY 298
L+ L + + S + L + +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 299 NKLNGIIPHSLG--------NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS 350
N L P + L+I L + + L + + + +K+
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSI---PSELGNLRSLSMLSLGYNKLS--GSIPHSL 405
+L +L L L N + + + G SL L L N L L
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 406 GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465
L NL +LD+ N+ +P + L+L + + L+ L +
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVS 439
Query: 466 DNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL 525
+N+L S + L+ L ++ NKL ++P + L+++ + N L
Sbjct: 440 NNNLD-SFSLFLPRLQE---LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIF 493
Query: 526 GNLRSLSMLSFAYNKLSGSIPH 547
L SL + N S P
Sbjct: 494 DRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-44
Identities = 70/425 (16%), Positives = 141/425 (33%), Gaps = 24/425 (5%)
Query: 52 SINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQ-IGNISRLKYLDLSSNLFF 110
+NL + + F + +L L + + + + I ++ L L++ +
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
Query: 111 GTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSN 170
+ + + L L ++ + LSS+ YL L L L
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221
Query: 171 LDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230
+ S F L L L ++ + T + +
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESD 275
Query: 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRS 290
++ L + L + L + + + + + S +L+S
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 291 LSMLNLGYNKLNGIIPHS---LGNLTNLATLYIHNNSLSGSIPSEIG---NLRSLSNLGL 344
L L+L N + + G +L TL + N L S+ L++L++L +
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDI 394
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404
S N +P S + + L L S + + + + ++L +L + N L S
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLD-SFSL- 448
Query: 405 LGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464
L L L + N L ++P + L + + N+L LT+L ++L
Sbjct: 449 --FLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 465 YDNSL 469
+ N
Sbjct: 505 HTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-44
Identities = 71/405 (17%), Positives = 133/405 (32%), Gaps = 21/405 (5%)
Query: 52 SINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFG 111
++ + ++ + F+ L L++ L + +I + +L L +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 112 TIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNL 171
+ LS ++ L+L + L + + + + L S L L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 172 DTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD 231
L + + F + + ++ + L++ LF
Sbjct: 247 LRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSI---PSEFGNL 288
+ + L + +++ +K+ +L +L L L EN + + G
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 289 RSLSMLNLGYNKLNGI--IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
SL L L N L + L L NL +L I N+ +P + L LS
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSS 419
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
+ + L L + +N+L DS L L+ L + NKL ++P +
Sbjct: 420 TGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFLPRLQE---LYISRNKLK-TLPDA-S 470
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451
L + + N L F L SL + L N S P
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 15/259 (5%)
Query: 49 RVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNL 108
+N + + ++ + + L + L+ ++ + ++K + + ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 109 FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYE---IGRLSSLNYLALYSNYLEDL--IPP 163
F HL L+ L L EN + G SL L L N+L +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
L L NL +L + N+ +P + L+L + L L
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLD 437
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
+ NN+L DS L L+ L + NKL ++P + L + + N L
Sbjct: 438 VSNNNL-DSFSLFLPRLQE---LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDG 491
Query: 284 EFGNLRSLSMLNLGYNKLN 302
F L SL + L N +
Sbjct: 492 IFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 5/167 (2%)
Query: 548 SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL 607
+ GV D S IP+ L + L L+ N+++ L + A L+ L L S+R+
Sbjct: 6 ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICI-M 666
+ +F +L L +L+LS+N S L L L+L N + + + +
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 667 QSLENLNLSH-NSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
+L+ L + + + + F + L ++I L+ S+
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-63
Identities = 86/300 (28%), Positives = 138/300 (46%), Gaps = 46/300 (15%)
Query: 807 YEEIIRATNDFDDEHC------IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQ-- 858
+ E+ TN+FD+ +G+GG G VYK + + VAVKK + + T +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT-TEELK 74
Query: 859 QEFLNEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTR 907
Q+F E+K + + +H N+V+ GF S SL LS L W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW- 966
R + +G ++ ++++H + +HRDI S N+LLD A +SDFG+A+ +
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190
Query: 967 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-- 1022
+ + GT Y+APE A ++T K D+YSFGV+ LE+I G D L
Sbjct: 191 MTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLD 245
Query: 1023 --------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+++ +D ++ + ++ VA CL E RP + KV QLL+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 4e-60
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 51/309 (16%)
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
E + + +G G V+KA+L E VAVK F P+ + ++Q E+ EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF--PIQDKQSWQNEY--EVY 70
Query: 867 ALTEIRHRNIVKFYGFCS---------------HVRHSLAMILSNNAAAKDLGWTRRMNV 911
+L ++H NI++F G H + SL+ L N + W ++
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126
Query: 912 IKGISDALSYMHNDCF-------PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964
+ ++ L+Y+H D P I HRDI SKNVLL + A ++DFG+A + S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 965 NW--TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS- 1016
GT Y+APE+ + + D+Y+ G++ E+ D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 1017 ---SSSLNLNIALDEM--------LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065
+ + +L++M P L + + E C D + E+R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 1066 MPKVSQLLK 1074
V + +
Sbjct: 306 AGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-57
Identities = 65/270 (24%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ + E +G+G G V KA+ + VA+K+ S + ++ F+ E++ L+ + H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHP 61
Query: 875 NIVKFYGFCSH---------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
NIVK YG C + SL +L M+ S ++Y+H+
Sbjct: 62 NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 926 CFPPIVHRDISSKNVLLDFDNE-AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
++HRD+ N+LL + DFG A ++ ++ T G+ ++APE+
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGS 178
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
+EKCDV+S+G++ EVI + P F + + + A+ R P +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKP--F-DEIGGPAFRIMWAVHNGT--RPPLIKNL-PKP 232
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ S++ C ++P RP+M ++ +++
Sbjct: 233 IESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-56
Identities = 74/473 (15%), Positives = 145/473 (30%), Gaps = 30/473 (6%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
+I N + ++SL ++ S + ++ L L N LS L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327
L L N L + +L +L L+L N + L ++ TL+ NN++S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD-SIPSELGNLRS 386
+ + N+ L+ NK++ G S + L L N + + + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 387 LSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLS 446
L L+L YN + + + L TLDL N L+ + EF + ++ +SL NKL
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 447 GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSN 506
I +L NL+ L N ++ + + Q+ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 507 LVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE 566
+ + D L +L +L + + E
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRK-------------EHALLSGQGSET-ERLECE 331
Query: 567 LGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626
++ + Q + L+ L + +L
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 627 SNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
E+ + + + Q ++ + ++ +
Sbjct: 392 QAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-56
Identities = 71/490 (14%), Positives = 145/490 (29%), Gaps = 28/490 (5%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203
+ + + L+ + + N+ L L N LS ++ L +L+L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 263
L +L+ L TL L+NN + EL S+ L N +S +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSR 118
Query: 264 LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHN 322
+YL N ++ + G + L+L N+++ + + L L +
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N + + ++ L L LS NKL+ + P + + + L +N L I L
Sbjct: 179 NFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALR 234
Query: 383 NLRSLSMLSLGYNKLS-GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
++L L N G++ + T+ ++ + G
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYG 292
Query: 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGS----IPGEIGNLRSISNLALNNNKLSGSI 497
L L S GS + E N + + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 498 PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN------KLSGSIPHSLGV 551
Q + L +L + + + L + +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL 412
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI 611
+ + + + + N + + Q++ + DL+ + ++
Sbjct: 413 RAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATL 472
Query: 612 PKSFGNLVKL 621
+ L
Sbjct: 473 QELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-54
Identities = 75/457 (16%), Positives = 149/457 (32%), Gaps = 30/457 (6%)
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
N + + D+SL ++ S + ++ L L N S L T L L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEF 285
+N L +L +L +L L L N + L ++ TL+ N++S +
Sbjct: 67 SNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS- 117
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG-SIPSEIGNLRSLSNLGL 344
+ + L NK+ + G + + L + N + + + +L +L L
Sbjct: 118 -RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404
N + + + + L TL L SN L + E + ++ +SL NKL I +
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 405 LGNLTNLATLDLYDNSLS-GSIPSEFGNLRSLSTLSLGYNK-LSGSIPHSLGNLTNLDAL 462
L NL DL N G++ F + + T++ K L+G T
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 463 YLYDNSLSGSIPGEIGNLRSISN--LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
L + L+ + L+ ++ + N + +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTV 351
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPHSLG--------VLDLSSNHIVGEIPTELGKLNF 572
I ++ L L + + + + E L
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQL 411
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN 609
L ++ ++ + + + D+ ++ +
Sbjct: 412 LRAIVKRYEEMYVE--QQSVQNNAIRDWDMYQHKETQ 446
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-54
Identities = 65/433 (15%), Positives = 130/433 (30%), Gaps = 22/433 (5%)
Query: 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176
+ + K ++ ++ L ++ ++ L L N L + L + L+ L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE 236
N L + + +L +L L L N L ++ TL+ NN++ +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCS 117
Query: 237 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG-SIPSEFGNLRSLSMLN 295
+ + L NK++ G + + L L N + + + +L LN
Sbjct: 118 --RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 296 LGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPP 355
L YN + + L TL + +N L+ + E + ++ + L NKL I
Sbjct: 176 LQYNFIYDVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 356 SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLD 415
+L + NL L N ++ + ++ + + T
Sbjct: 232 ALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGS----IPHSLGNLTNLDALYLYDNSLSG 471
L +L GS + N +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 472 SIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD--SIPSELGNLR 529
I ++ L L + + L + E L+
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410
Query: 530 SLSMLSFAYNKLS 542
L + Y ++
Sbjct: 411 LLRAIVKRYEEMY 423
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-53
Identities = 69/456 (15%), Positives = 129/456 (28%), Gaps = 22/456 (4%)
Query: 93 IGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152
N +R K ++ + + +K L L N L+ ++ + L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHS 212
SN L + L +LS L TL L +N + E S+ L N S +
Sbjct: 66 SSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS-- 115
Query: 213 LGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLY 271
+YL NN + + G + L L N++ + + L L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPS 331
L N + + + L L+L NKL + + + + + NN L I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 332 EIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLS 391
+ ++L + L GN + N + ++ ++
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 392 LGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS----IPSEFGNLRSLSTLSLGYNKLSG 447
G L L + S GS + E N + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
I L +L + + + + S L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPL 409
Query: 508 VIL-YLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
+L + + + ++ +K +
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-51
Identities = 59/432 (13%), Positives = 119/432 (27%), Gaps = 54/432 (12%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
+I N + + + L + + N+ L + N LS +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
L LS N L L LS L TL L +N + EL S+ L N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTN 458
+ + L +N ++ + G + L L N++ + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518
L+ L L N + + G++ + L L++NKL+ + + + + + L NN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 519 DSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLIL 578
I L ++L N +
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-------------------FSKNQRVQTV 267
Query: 579 AQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK 638
A+ + + + L+ L
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK---------------- 311
Query: 639 LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDI 698
+ L + + + ++ +I + + ++
Sbjct: 312 ---RKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367
Query: 699 SYNELQGPIPNS 710
L + N
Sbjct: 368 KKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 2e-50
Identities = 75/469 (15%), Positives = 148/469 (31%), Gaps = 23/469 (4%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
+ + + L + + +K LDLS N ++ + L+ L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
N L ++ + LS+L L L +NY++ L +++TLH +N++S S
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSR 118
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD-SIPSELGNLRSLSMLS 247
++ + L NK + G + + L L N + + + +L L+
Sbjct: 119 GQGKKN---IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307
L YN + + + L TL L N L+ + EF + ++ ++L NKL +I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 308 SLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367
+L NL + N ++ ++ + + + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 368 LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS----IPHSLGNLTNLATLDLYDNSLSG 423
+ D L +L GS + N +D
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
I ++ TL L + + LD + +
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPL 409
Query: 484 SNL-ALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531
L A+ + Q + + +Y + + E L+ L
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE-TQLAEENARLKKL 457
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-37
Identities = 53/279 (18%), Positives = 102/279 (36%), Gaps = 11/279 (3%)
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
+I N + D+SL ++ + ++ L L+ N LS L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG-SIPHSLGVLDLSSNHIVGEIPTE 566
+L L +N L +L +L +L L N + + S+ L ++N+I +
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI-SRVSCS 117
Query: 567 LGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN-SIPKSFGNLVKLHYLN 625
+ LA N+++ G +++++LDL N + + + + L +LN
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 626 LSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPS 685
L N + L LDLS N L + + + ++L +N LV I
Sbjct: 176 LQYNFIYD-VK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEK 231
Query: 686 CFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGN 724
L D+ N ++ ++ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 24/271 (8%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
D + + IG G G+V++AE G VAVK EFL EV + +RH
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHP 94
Query: 875 NIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
NIV F G + + SL +L + A + L RR+++ ++ ++Y+H
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
N PPIVHR++ S N+L+D V DFG+++ + AGT ++APE+
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
EK DVYSFGV+ E+ + P + +++ + + + RL P +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP--W-GNLNPAQVVAAVGFKCK---RLEIPRNL-NP 266
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ +I+E C P RP+ + LL+
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 79/281 (28%), Positives = 123/281 (43%), Gaps = 35/281 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGEMTFQ----QEFLNEVKALT 869
N+ + E IGKGG G V+K L +VA+K T QEF EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 870 EIRHRNIVKFYGFCSH---------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALS 920
+ H NIVK YG + L L + A + W+ ++ ++ I+ +
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIE 136
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNE-----AHVSDFGIAKFLKPDSSNWTELAGTYGY 975
YM N PPIVHRD+ S N+ L +E A V+DFG+++ S + L G + +
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSV--SGLLGNFQW 192
Query: 976 VAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
+APE A TEK D YSF ++ ++ G+ P D S +N+ R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----R 248
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +L +++E C +P+ RP + + L
Sbjct: 249 PTIPEDC-PPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 3e-53
Identities = 87/384 (22%), Positives = 156/384 (40%), Gaps = 51/384 (13%)
Query: 168 LSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227
+ L++ ++ L+ ++P ++ L + N + S+P L L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN 287
L S+P L LS+ S L + L L+++ N L+ S+P
Sbjct: 92 QL-TSLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPPG 142
Query: 288 LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGN 347
L+ L++ N+L +P L L+ +NN L+ S+P L+ LS +S N
Sbjct: 143 LQE---LSVSDNQLAS-LPALPSELCK---LWAYNNQLT-SLPMLPSGLQELS---VSDN 191
Query: 348 KLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 407
+L+ S+P L L+ Y+N L S+P+ L+ L + N+L+ S+P
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRL-TSLPALPSGLKE---LIVSGNRLT-SLPVLPSE 242
Query: 408 LTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
L L + N L+ S+P L S LS+ N+L+ +P SL +L++ + L N
Sbjct: 243 LKE---LMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 468 SLSGSIPGEIGNLRSISNLALNNNK---LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE 524
LS + + S + + S P+ L +L + P++
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 525 ----LGNLRSLSMLSFAYNKLSGS 544
G + S ++LS +
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-52
Identities = 89/385 (23%), Positives = 151/385 (39%), Gaps = 51/385 (13%)
Query: 143 RLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY 202
+ L + + L L P L ++ TL + DN+L+ S+P+ LR+ L +
Sbjct: 38 LNNGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSG 90
Query: 203 NKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 262
N+ + S+P L L+ L P+ L L + N+L+ S+P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPVLPP 141
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L L + +N L+ S+P+ L L N N+L +P L L + +
Sbjct: 142 GLQE---LSVSDNQLA-SLPALPSELCKLWAYN---NQLTS-LPMLPSGLQ---ELSVSD 190
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N L+ S+P+ L L N+L+ S+P L L + N L S+P
Sbjct: 191 NQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPS---GLKELIVSGNRL-TSLPVLPS 241
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
L+ L + N+L+ S+P L +L +Y N L+ +P +L S +T++L
Sbjct: 242 ELKE---LMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 443 NKLSGSIPHSLGNLTNLDALY---LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIP- 498
N LS +L +T+ + + S P E L + L + P
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
Query: 499 ---QSLGNLSNLVILYLYNNSLFDS 520
G N L+ + L ++
Sbjct: 354 DRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-51
Identities = 87/369 (23%), Positives = 145/369 (39%), Gaps = 46/369 (12%)
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS 182
L + E+ L ++P + + + L + N L L P L L+ + N L+
Sbjct: 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PALPPELRTLE---VSGNQLT 94
Query: 183 DSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRS 242
S+P L LS+ S + L L++ N L S+P L+
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLPVLPPGLQE 145
Query: 243 LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302
LS + N+L+ S+P L L + Y N L+ S+P L+ L ++ N+L
Sbjct: 146 LS---VSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSGLQEL---SVSDNQLA 194
Query: 303 GIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSN 362
+P L L + +NN L+ S+P+ L+ L +SGN+L+ S+P
Sbjct: 195 -SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPS---E 242
Query: 363 LATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
L L + N L S+P L SLS + N+L+ +P SL +L++ T++L N LS
Sbjct: 243 LKELMVSGNRL-TSLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRS 482
+ S S + + + L + L + GE
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADR 355
Query: 483 ISNLALNNN 491
+N
Sbjct: 356 WHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 5e-51
Identities = 91/386 (23%), Positives = 148/386 (38%), Gaps = 57/386 (14%)
Query: 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156
+ L++ + T+P + +++ TL + +N L S+P L +L + N
Sbjct: 40 NGNAVLNVGES-GLTTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 157 LEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNL 216
L L P L L L L L + N+ + S+P L
Sbjct: 93 LTSL-PVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPGL 143
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
L + +N L S+P+ L L + N+L+ S+P L L + +N
Sbjct: 144 QE---LSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPSGLQ---ELSVSDNQ 192
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
L+ S+P+ L L N N+L +P L L + N L+ S+P L
Sbjct: 193 LA-SLPTLPSELYKLWAYN---NRLTS-LPALPSGLK---ELIVSGNRLT-SLPVLPSEL 243
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK 396
+ L +SGN+L+ S+P L +L +Y N L +P L +L S + ++L N
Sbjct: 244 KELM---VSGNRLT-SLPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNP 295
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLS------GSIPSEFGNLRSLSTLSLGYNKLSGSIP 450
LS +L +T+ Y + S P E L + L + P
Sbjct: 296 LSERTLQALREITS---APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352
Query: 451 ----HSLGNLTNLDALYLYDNSLSGS 472
H G N DA L+ + LS +
Sbjct: 353 ADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 5e-50
Identities = 75/339 (22%), Positives = 129/339 (38%), Gaps = 38/339 (11%)
Query: 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYN 395
+ L + + L+ ++P L +++ TL + N+L S+P+ LR+L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPPELRTLE---VSGN 91
Query: 396 KLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455
+L+ S+P L L+ L L L + N+L+ S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPPG 142
Query: 456 LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515
L L + DN L+ S+P L L NN+L+ S+P L L + +N
Sbjct: 143 LQELS---VSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQEL---SVSDN 191
Query: 516 SLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIK 575
L S+P+ L L + L L L +S N + +P +L +
Sbjct: 192 QL-ASLPTLPSELYKLWAYNNRLTSLPALPS-GLKELIVSGNRL-TSLPVLPSELK---E 245
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGI 635
L+++ N+L+ L L L + N+L+ +P+S +L +NL N S
Sbjct: 246 LMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 300
Query: 636 PIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNL 674
L E+ A S ++L
Sbjct: 301 LQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-45
Identities = 82/382 (21%), Positives = 135/382 (35%), Gaps = 55/382 (14%)
Query: 54 NLTSIGLKGM-LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGT 112
+ + L H+ L + N L ++P L+ L++S N +
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTLVIPDNNL-TSLPALPPE---LRTLEVSGNQL-TS 95
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLD 172
+P L L L S L L ++ N L L P L L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTSL-PVLPPGLQELS 147
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
+ DN L+ S+P+ L L + N+ + S+P L L + +N L S
Sbjct: 148 ---VSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQ---ELSVSDNQL-AS 195
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
+P+ L L + N+L+ S+P L L + N L+ S+P L+
Sbjct: 196 LPTLPSELYKLWAYN---NRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPSELKE-- 245
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS 352
L + N+L +P L +L ++ N L+ +P + +L S + + L GN LS
Sbjct: 246 -LMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-E 298
Query: 353 IPPSLGYLSNLATLYLYSNSL------FDSIPSELGNLRSLSMLSLGYNKLSGSIP---- 402
+ + YS + S P E L + L + P
Sbjct: 299 RTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
Query: 403 HSLGNLTNLATLDLYDNSLSGS 424
H G N L+ + LS +
Sbjct: 357 HMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-43
Identities = 75/310 (24%), Positives = 129/310 (41%), Gaps = 44/310 (14%)
Query: 384 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYN 443
++L++G + L+ ++P L ++ TL + DN+L+ S+P+ LR+L + N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 444 KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGN 503
+L+ S+P L L L P L L + N+L+ S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPVLPPG 142
Query: 504 LSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG---VLDLSSNHIV 560
L L + +N L S+P+ L L + N+L+ S+P L +S N +
Sbjct: 143 LQEL---SVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELSVSDNQLA 194
Query: 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620
+PT +L KL N+L+ L L + L +S NRL+ S+P L +
Sbjct: 195 -SLPTLPSEL---YKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELKE 245
Query: 621 LHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
L +S N+ + +P L L + N L +P + + S +NL N L
Sbjct: 246 L---MVSGNRLTS-LP---MLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLS 297
Query: 681 GLIPSCFEKM 690
++
Sbjct: 298 ERTLQALREI 307
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 40/189 (21%), Positives = 71/189 (37%), Gaps = 32/189 (16%)
Query: 537 AYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQ 596
K+ + + VL++ + + +P L + L++ N L+ L +
Sbjct: 30 VVQKMRACLNNGNAVLNVGESGL-TTLPDCLPAH--ITTLVIPDNNLT-SLPA---LPPE 82
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELI------------- 643
L L++S N+L+ S+P L++L + +P L +L
Sbjct: 83 LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-LPSGLCKLWIFGNQLTSLPVLP 140
Query: 644 -HLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNE 702
L EL +S N L +P+ L L +N L L P GL + +S N+
Sbjct: 141 PGLQELSVSDNQLAS-LPALPS---ELCKLWAYNNQLTSL-PMLPS---GLQELSVSDNQ 192
Query: 703 LQGPIPNSI 711
L +P
Sbjct: 193 LAS-LPTLP 200
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-53
Identities = 81/423 (19%), Positives = 153/423 (36%), Gaps = 46/423 (10%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
+ I + + + + + +E L++ + ++ + L L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
+ ++ L+L D + + F ++ L +G+N PH N+ L L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE- 284
N L S+P N L TL + N+L I +
Sbjct: 126 RNDL-SSLP-----------------------RGIFHNTPKLTTLSMSNNNLE-RIEDDT 160
Query: 285 FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGL 344
F SL L L N+L + L + +L + N L S + ++ L
Sbjct: 161 FQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDA 212
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404
S N ++ + + L L L N+L D + L N L + L YN+L + H
Sbjct: 213 SHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 405 LGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464
+ L L + +N L ++ + +L L L +N L + + L+ LYL
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE 524
NS+ ++ + ++ NL L++N + ++L N+ + + I +
Sbjct: 326 DHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQ 380
Query: 525 LGN 527
L +
Sbjct: 381 LEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-49
Identities = 94/379 (24%), Positives = 155/379 (40%), Gaps = 17/379 (4%)
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 411
I +L Y +++ + E L + +++ + + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 412 ATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSG 471
L+L D + F ++ L +G+N + PH N+ L L L N LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 472 SIPGEI-GNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS 530
S+P I N ++ L+++NN L + ++L L L +N L + L + S
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPS 187
Query: 531 LSMLSFAYNKLSG-SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSP 589
L + +YN LS +IP ++ LD S N I + + L L L N L+ +
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 242
Query: 590 KLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELD 649
L + L +DLS N L + F + +L L +SNN+ + + + + L LD
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301
Query: 650 LSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPN 709
LSHN L + LENL L HNS+V L S H L + +S+N+
Sbjct: 302 LSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD-CNSL 356
Query: 710 SIAFRDAPIEALQGNKGLC 728
FR+ A+ C
Sbjct: 357 RALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-48
Identities = 76/358 (21%), Positives = 135/358 (37%), Gaps = 24/358 (6%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
I +L +++ + E L + +++ + + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327
L L + + F ++ L +G+N + + PH N+ L L + N LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 328 SIPSEI-GNLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSELGNLR 385
S+P I N L+ L +S N L I ++L L L SN L + L +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIP 186
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445
SL ++ YN LS +L + LD NS++ + L+ L L +N L
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238
Query: 446 SGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS 505
+ L N L + L N L + ++ + L ++NN+L ++ +
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 506 NLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP----HSLGVLDLSSNHI 559
L +L L +N L + L L +N + ++ H+L L LS N
Sbjct: 296 TLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-47
Identities = 76/409 (18%), Positives = 150/409 (36%), Gaps = 43/409 (10%)
Query: 225 HNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE 284
+ I S L + + L N + +++ +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64
Query: 285 FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLG 343
+ R + +LNL ++ I ++ + LY+ N++ +P + N+ L+ L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123
Query: 344 LSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSI 401
L N LS S+P + L TL + +N+L + I + SL L L N+L+ +
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 402 PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDA 461
L + +L ++ N L S ++ L +N ++ + + L
Sbjct: 181 D--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 230
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
L L N+L+ + N + + L+ N+L + + L LY+ NN L ++
Sbjct: 231 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VAL 287
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQN 581
+ +L +L ++N L + + + L L L N
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-------------------HVERNQPQFDRLENLYLDHN 328
Query: 582 QLSGQLSPKLGSLAQLEHLDLSSNRLS-NSIPKSFGNLVKLHYLNLSNN 629
+ + KL + L++L LS N NS+ F N+ + + +
Sbjct: 329 SIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-45
Identities = 81/369 (21%), Positives = 132/369 (35%), Gaps = 46/369 (12%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEIGHLSY 122
L SF + L+L Q+ I ++ L + N +PP +
Sbjct: 60 LPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNA-IRYLPPHV----- 112
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS 182
F+N + L L L N L L N L TL + +N+L
Sbjct: 113 ------FQN------------VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 183 DSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRS 242
F SL L L N+ + + L + +L + N L S L +
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIA 206
Query: 243 LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302
+ L +N ++ + + L L L N+L+ N L ++L YN+L
Sbjct: 207 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE 261
Query: 303 GIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSN 362
I+ H + L LYI NN L ++ + +L L LS N L + +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 363 LATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
L LYL NS+ ++ L +L L+L +N + +L N+A + D
Sbjct: 320 LENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQH 374
Query: 423 GSIPSEFGN 431
I + +
Sbjct: 375 CKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-44
Identities = 72/392 (18%), Positives = 135/392 (34%), Gaps = 49/392 (12%)
Query: 250 YNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFG-----NLRSLSMLNLGYNKLNGI 304
YN + + Y+ + + L + ++ + + +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 305 IPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPS-LGYLSN 362
L + + L +++ + I + ++ L + N + +PP +
Sbjct: 61 PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118
Query: 363 LATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
L L L N L S+P + N L+ LS+ N L + T+L L L N L
Sbjct: 119 LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177
Query: 422 SGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLR 481
+ + + SL ++ YN LS +L ++ L NS++ + G +
Sbjct: 178 T-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NV 226
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNK 540
++ L L +N L+ L N LV + L N L + I ++ L L + N+
Sbjct: 227 ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNR 283
Query: 541 LSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHL 600
L + + L L L+ N L + +LE+L
Sbjct: 284 LV-------------------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323
Query: 601 DLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
L N + ++ L L LS+N +
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-52
Identities = 102/550 (18%), Positives = 197/550 (35%), Gaps = 36/550 (6%)
Query: 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156
+ +Y + I + + + + + +E L++ + ++
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 157 LEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNL 216
+ L L + ++ L+L D + + F ++ L +G+N PH N+
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 217 TNLATLYLHNNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYEN 275
L L L N L S+P + N L+ LS+ N L + T+L L L N
Sbjct: 123 PLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 276 SLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335
L+ + + SL N+ YN L+ +L + L +NS++ + +
Sbjct: 182 RLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV-- 230
Query: 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGY 394
L+ L L N L+ L L + L N L + I ++ L L +
Sbjct: 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISN 287
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
N+L ++ + L LDL N L + L L L +N + ++ L
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LS 342
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGN----------L 504
L L L N + + R+++ A+++ I L +
Sbjct: 343 THHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIP 564
+ ++ Y+ S+ + + G + ++ + LS I GV + + E+
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQS-LSHYITQQGGVPLQGNEQLEAEVN 459
Query: 565 TELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSS-NRLSNSIPKSFGNLVKLHY 623
++ L + Q QL L ++ + + L R S+++ K F +L +
Sbjct: 460 ELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQA 519
Query: 624 LNLSNNQFSR 633
L Q R
Sbjct: 520 FKLRETQARR 529
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-44
Identities = 103/590 (17%), Positives = 184/590 (31%), Gaps = 63/590 (10%)
Query: 50 VNSINLTSIGLKG----MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDL 104
+ N + K L SF + L+L Q+ I ++ L +
Sbjct: 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYM 106
Query: 105 SSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPS 164
N +PP + + L L L N L L
Sbjct: 107 GFNA-IRYLPPHVFQ-----------------------NVPLLTVLVLERNDLSSLPRGI 142
Query: 165 LGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYL 224
N L TL + +N+L F SL L L N+ + + L + +L +
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANV 199
Query: 225 HNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE 284
N L S L ++ L +N ++ + + L L L N+L+
Sbjct: 200 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW- 249
Query: 285 FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGL 344
N L ++L YN+L I+ H + L LYI NN L ++ + +L L L
Sbjct: 250 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404
S N L + + L LYL NS+ ++ L +L L+L +N + +
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNSLRA 364
Query: 405 LGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464
L N+A + D I + + G P+ L + +
Sbjct: 365 L--FRNVARPAVDDADQHCKIDYQLEH---------GLCCKESDKPYLDRLLQYIALTSV 413
Query: 465 YDN-SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLV-ILYLYNNSLFDSIP 522
+ + + S+ +L+ + G Q L V L L +
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQI 473
Query: 523 SELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFL--IKLILAQ 580
+ L+ L + L + N + + + A
Sbjct: 474 QQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEAD 533
Query: 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
+ + ++A + LD + + ++ K+ L N+
Sbjct: 534 AKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNR 583
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 61/306 (19%), Positives = 110/306 (35%), Gaps = 33/306 (10%)
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
I +L + + + E L + ++ + + L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD 519
+ L L D + +I L + N + P N+ L +L L N
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN---- 133
Query: 520 SIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE-LGKLNFLIKLIL 578
+L SL F L L +S+N++ I + L L L
Sbjct: 134 -------DLSSLPRGIFHNT-------PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 178
Query: 579 AQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK 638
+ N+L+ L + L H ++S N LS + + + L+ S+N + ++
Sbjct: 179 SSNRLT---HVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VR 227
Query: 639 LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDI 698
+ L+ L L HN L + + + L ++LS+N L ++ F KM L R+ I
Sbjct: 228 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285
Query: 699 SYNELQ 704
S N L
Sbjct: 286 SNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 10/95 (10%), Positives = 35/95 (36%)
Query: 609 NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQS 668
I + + +++ + L + + ++ +R+ + + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 669 LENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL 703
+E LNL+ + + F H + ++ + +N +
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-52
Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT-FQQEFLNEVKALTEIRH 873
+ E IG GG G VY+A G+ VAVK +++ + E K ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
NI+ G C + L +LS K + +N I+ ++Y+
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAH--------VSDFGIAKFLKPDSSNWTELAGTYG 974
H++ PI+HRD+ S N+L+ E ++DFG+A+ + AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
++APE+ ++ DV+S+GVL E++ G+ P I ++ + L L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------AL 233
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P PS + ++E C + +P SRP+ + L
Sbjct: 234 PIPSTC-PEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-50
Identities = 59/330 (17%), Positives = 115/330 (34%), Gaps = 17/330 (5%)
Query: 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291
+I N + + + L ++ + N+ L L N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 292 SMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351
+LNL N L + L +L+ L TL ++NN + E+ S+ L + N +S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTN 410
+ S +YL +N + + G + L L N++ + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
L L+L N + + + L TL L NKL+ + + + + L +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 471 GSIPGEIGNLRSISNLALNNNKLS-GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLR 529
I + +++ + L N G++ + + E +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 530 SLSMLSFAYNKLSGSIPHSLGVLDLSSNHI 559
+L Y P + ++ L +H
Sbjct: 287 TLGHYGA-YCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-50
Identities = 65/316 (20%), Positives = 115/316 (36%), Gaps = 19/316 (6%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
I N + + D+SL ++ S + ++ L L N S L T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
L L +N L +L +L +L L L N + L ++ TL+ N++S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG-SIPSEIGNLRSL 339
+ + + L NK+ + G + + L + N + + + +L
Sbjct: 114 VSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
+L L N + + + + L TL L SN L + E + ++ +SL NKL
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 400 SIPHSLGNLTNLATLDLYDNSLS-GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
I +L NL DL N G++ F + + T++ K +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECT 284
Query: 459 LDALYLYDNSLSGSIP 474
+ L Y +P
Sbjct: 285 VPTLGHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-49
Identities = 56/330 (16%), Positives = 106/330 (32%), Gaps = 15/330 (4%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
+I N + + + L + + N+ L + N LS +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
L LS N L L LS L TL L +N + EL S+ L N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTN 458
+ + L +N ++ + G + L L N++ + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518
L+ L L N + + G++ + L L++NKL+ + + + + + L NN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 519 DSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLIL 578
I L ++L N + + + +L N +
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 579 AQNQLSGQLSPKLGSLAQLEHLDLSSNRLS 608
L + + L +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-49
Identities = 66/357 (18%), Positives = 122/357 (34%), Gaps = 44/357 (12%)
Query: 184 SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSL 243
+I N + + + ++ + N+ L L N L ++L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 244 SMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303
+L+L N L + +L +L L+L N +
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
L ++ TL+ NN++S + + N+ L+ NK++ G S +
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 364 ATLYLYSNSLFD-SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
L L N + + + +L L+L YN + + + L TLDL N L+
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS-GSIPGEIGNLR 481
+ EF + ++ +SL NKL I +L NL+ L N G++ +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG-NLRSLSMLSFA 537
+ +A K + + L Y + +P+ L +L
Sbjct: 263 RVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 56/330 (16%), Positives = 104/330 (31%), Gaps = 16/330 (4%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
+I + + + L+ + + N+ L L N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 196 SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255
+L+L N L +L+ L TL L+NN + EL S+ L N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTN 314
+ +YL N ++ + G + L+L N+++ + +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF 374
L L + N + + ++ L L LS NKL+ + P + + + L +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS 434
I L ++L L N N + ++
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464
+ G L L +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-47
Identities = 59/330 (17%), Positives = 116/330 (35%), Gaps = 18/330 (5%)
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLD 172
I + + K ++ ++ L ++ ++ L L N L + L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
L+L N L + + +L +L L L N L ++ TL+ NN++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG-SIPSEFGNLRSL 291
+ + + L NK++ G + + L L N + + + +L
Sbjct: 114 VSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 292 SMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351
LNL YN + + L TL + +N L+ + E + ++ + L NKL
Sbjct: 172 EHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 411
I +L + NL L N ++ + ++ + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTV 285
Query: 412 ATLDLYDNSLSGSIPSEFG-NLRSLSTLSL 440
TL Y +P+ F L +L
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 59/313 (18%), Positives = 111/313 (35%), Gaps = 32/313 (10%)
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
+I N + + + L ++ + N+ LDL N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 436 STLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
L+L N L L +L+ L L L +N + E+ SI L NN +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 496 SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP--------H 547
+ +YL NN + + G + L N++ ++
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
Query: 548 SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL 607
+L L+L N I ++ ++ L L L+ N+L+ + P+ S A + + L +N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQ 667
I K+ L + +L N F L + + ++ + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 668 SLENLNLSHNSLV 680
+ +L
Sbjct: 277 GQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 60/326 (18%), Positives = 117/326 (35%), Gaps = 18/326 (5%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
+ + + L + + +K LDLS N ++ + L+ L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
N L ++ LS+L L L +NY++ L +++TLH +N++S +
Sbjct: 66 SSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD-SIPSELGNLRSLSMLS 247
+ + L NK + G + + L L N + + + +L L+
Sbjct: 118 --RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307
L YN + + + L TL L N L+ + EF + ++ ++L NKL +I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 308 SLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367
+L NL + N ++ ++ + + + TL
Sbjct: 232 ALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLG 289
Query: 368 LYSNSLFDSIPSELG-NLRSLSMLSL 392
Y + +P+ L +L
Sbjct: 290 HYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 56/282 (19%), Positives = 95/282 (33%), Gaps = 33/282 (11%)
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
+I N + + L ++ + N+ L L N LS ++ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 484 SNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543
L L++N L L +LS L L L NN + EL S+ L A N +S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
+ + LA N+++ G +++++LDL
Sbjct: 113 ------------------RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 604 SNRLSN-SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQ 662
N + + + + L +LNL N + L LDLS N L + +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLAF-MGPE 209
Query: 663 ICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ ++L +N LV I L D+ N
Sbjct: 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 38/189 (20%), Positives = 72/189 (38%), Gaps = 10/189 (5%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYG-NIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLS 121
ML D + YLDL N++ N + L++L+L N F + ++ +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN-FIYDVKGQV-VFA 191
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181
LKTL L N+L + E + + +++L +N L I +L NL+ L N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249
Query: 182 S-DSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG-N 239
++ F + + ++ K + + TL + + +P+
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 240 LRSLSMLSL 248
L +L
Sbjct: 307 LIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 22/137 (16%), Positives = 51/137 (37%), Gaps = 20/137 (14%)
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
+ + + ++ + L ++ + + L+LS N S+ L L L+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 653 NFLREAIP-----------------SQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLR 695
N L E + ++ + S+E L+ ++N++ + S + G
Sbjct: 68 NVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ---GKKN 124
Query: 696 IDISYNELQGPIPNSIA 712
I ++ N++
Sbjct: 125 IYLANNKITMLRDLDEG 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 6e-50
Identities = 74/325 (22%), Positives = 135/325 (41%), Gaps = 9/325 (2%)
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
+ + ++P +L LG N+ + +L L L+ N +
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
P NL +L L L N+L L+NL L + EN + + F +L +L
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSG 351
L +G N L I + L +L L + +L+ SIP+E +L L L L ++
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA 190
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTN 410
S L L L + D++ +L+ LS+ + L+ ++P+ ++ +L
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249
Query: 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470
L L+L N +S S L L + L +L+ P++ L L L + N L+
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 471 GSIPGEI-GNLRSISNLALNNNKLS 494
++ + ++ ++ L L++N L+
Sbjct: 310 -TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 79/309 (25%), Positives = 132/309 (42%), Gaps = 14/309 (4%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLF 129
LDL N++ + + L+ L+L+ N+ + P +L L+TL L
Sbjct: 31 PTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLR 88
Query: 130 ENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
N+L IP + LS+L L + N + L+ +L NL +L + DN L I
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146
Query: 189 -FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
F L SL L+L + +L +L L L L + ++ L L +L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIP 306
+ + ++ + NL +L + +L+ ++P +L L LNL YN ++ I
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLA 364
L L L + + L+ + L L L +SGN+L+ ++ S+ + NL
Sbjct: 266 SMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLE 323
Query: 365 TLYLYSNSL 373
TL L SN L
Sbjct: 324 TLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-46
Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 14/323 (4%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
F +P I + + L L +N++ E L L L N + + P +
Sbjct: 19 HRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 166 GNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYL 224
NL NL TL L N L IP F L +L+ L + NK + + +L NL +L +
Sbjct: 77 NNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 225 HNNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
+N L I L SL L+L L+ +L +L L L L +++
Sbjct: 136 GDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNL 342
F L L +L + + + + NL +L I + +L+ ++P + +L L L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 343 GLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGS 400
LS N +S +I L L L + L L + L L +L++ N+L+ +
Sbjct: 254 NLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-T 310
Query: 401 IPHSL-GNLTNLATLDLYDNSLS 422
+ S+ ++ NL TL L N L+
Sbjct: 311 LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-44
Identities = 73/346 (21%), Positives = 124/346 (35%), Gaps = 39/346 (11%)
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ H ++P + +L LG N++ + +L L L EN +S
Sbjct: 15 AVLCHRKRF-VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSL 339
P F NL +L L L N+L I L+NL L I N + + + +L +L
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL 130
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
+L + N L I L SL L+L L+
Sbjct: 131 KSLEVGDNDLV-YISHRA-----------------------FSGLNSLEQLTLEKCNLTS 166
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
+L +L L L L +++ F L L L + + ++ + NL
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD 519
+L + +L+ + +L + L L+ N +S L L L + L L
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-A 285
Query: 520 SIPSE-LGNLRSLSMLSFAYNKLSGSIPH-------SLGVLDLSSN 557
+ L L +L+ + N+L+ ++ +L L L SN
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-44
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 12/293 (4%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
L+ F+SFPHL L+L N + + P N+ L+ L L SN IP + LS
Sbjct: 47 LNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLS 104
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
L L + EN++ + + L +L L + N L + + L++L+ L L +
Sbjct: 105 NLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163
Query: 181 LSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
L+ SIP+E +L L +L L + + +S L L L + + D++
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 240 LRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
+L+ LS+ + L+ ++P+ ++ +L L L L N +S S L L + L
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLS 350
+L + P++ L L L + N L+ ++ + ++ +L L L N L+
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-43
Identities = 78/341 (22%), Positives = 132/341 (38%), Gaps = 23/341 (6%)
Query: 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS 424
+ + ++P + +L LG N++ + +L L+L +N +S
Sbjct: 15 AVLCHRKRF-VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 425 IPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSI 483
P F NL +L TL L N+L L+NL L + +N + + + +L ++
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL 130
Query: 484 SNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543
+L + +N L ++ L++L L L NL S+ + ++
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC-----------NLTSIPTEALSHL---- 175
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
H L VL L +I +L L L ++ ++P L L ++
Sbjct: 176 ---HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQI 663
L+ + +LV L +LNLS N S L EL+ L E+ L L P
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 664 CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ L LN+S N L L S F + L + + N L
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-43
Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 13/321 (4%)
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
+ ++P + + L L N + E + L L L N +S P
Sbjct: 18 CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG 74
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDAL 462
+ NL NL TL L N L IP F L +L+ L + NK+ + + +L NL +L
Sbjct: 75 AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 463 YLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIP 522
+ DN L L S+ L L L+ ++L +L L++L L + ++
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 523 SELGNLRSLSMLSFAYNKLSGSIP------HSLGVLDLSSNHIVGEIPTE-LGKLNFLIK 575
L L +L ++ ++ +L L ++ ++ +P + L +L
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGI 635
L L+ N +S L L +L+ + L +L+ P +F L L LN+S NQ +
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312
Query: 636 PIKLEELIHLSELDLSHNFLR 656
+ +L L L N L
Sbjct: 313 ESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 56/264 (21%), Positives = 98/264 (37%), Gaps = 15/264 (5%)
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
+ + ++P I L L N++ + +L L L N +
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGEIPTELGKLNFLI 574
P NL +L L N+L IP +L LD+S N IV + L L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 575 KLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR 633
L + N L +S + L LE L L L++ ++ +L L L L + +
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190
Query: 634 GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGL 693
+ L L L++SH + + +L +L+++H +L + + L
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
Query: 694 LRIDISYNELQGPIPNSIAFRDAP 717
+++SYN + I S +
Sbjct: 251 RFLNLSYNPIST-IEGS-MLHELL 272
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 8e-49
Identities = 48/276 (17%), Positives = 102/276 (36%), Gaps = 35/276 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ + + G ++K G + VK + +F E L H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHP 67
Query: 875 NIVKFYGFCSH-------------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
N++ G C SL +L + ++ + ++ +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAF 126
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 980
+H P I ++S++V++D D A +S + + +VAPE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEAL 180
Query: 981 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
D++SF VL E++ + P F + +S+ + + +AL+ + R P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP--F-ADLSNMEIGMKVALEGL---RPTIPP 234
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
I + +++ C++E+P RP + +L+
Sbjct: 235 GISP-HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 66/317 (20%), Positives = 115/317 (36%), Gaps = 56/317 (17%)
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
E ++ IG+G G+VYK L VAVK F +Q F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF------ANRQNFINEKN 57
Query: 867 --ALTEIRHRNIVKFYGFCSHV----RHSLAMI--------LSNNAAAKDLGWTRRMNVI 912
+ + H NI +F V R ++ L + W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA 117
Query: 913 KGISDALSYMHND------CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966
++ L+Y+H + P I HRD++S+NVL+ D +SDFG++ L +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 967 --------TELAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011
GT Y+APE L ++ D+Y+ G++ E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 1012 ISSMS------SSSLNLNIALDEMLDP------RLPTPSCIVQDK--LISIVEVAISCLD 1057
S+ + + + ++M R P ++ + S+ E C D
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 1058 ENPESRPTMPKVSQLLK 1074
++ E+R T + +
Sbjct: 298 QDAEARLTAQXAEERMA 314
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-47
Identities = 94/490 (19%), Positives = 179/490 (36%), Gaps = 37/490 (7%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
L + N + + S++ +L L +L + +N++ L L L N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335
L I +L L+L +N + + I GN++ L L + L S I +
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYN 395
L L + G P L + T L+ + + ++ ++ +L +
Sbjct: 138 LNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 396 KLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH-SLG 454
+ + + + L N ++ S + + ++ + S+
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
N+ L D SG+ +L+++S + ++ SN+ I
Sbjct: 256 NVKLQGQLDFRDFDYSGT------SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
+ R + ML S LD S+N + + G L L
Sbjct: 310 S-----------GTRMVHMLCP-------SKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 575 KLILAQNQLS--GQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQF 631
LIL NQL +++ + L+ LD+S N +S K L LN+S+N
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 632 SRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMH 691
+ I L + LDL N + ++IP Q+ +++L+ LN++ N L + F+++
Sbjct: 412 TDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468
Query: 692 GLLRIDISYN 701
L +I + N
Sbjct: 469 SLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 5e-46
Identities = 88/471 (18%), Positives = 170/471 (36%), Gaps = 37/471 (7%)
Query: 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFEN 131
L++ N + I ++S+L+ L +S N + + L+ L L N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQELEYLDLSHN 79
Query: 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYDNSLSDSIPSEFG 190
+L I +L +L L N + L GN+S L L L L S
Sbjct: 80 KLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
+L +L + + L + T LH + + ++ ++ +L
Sbjct: 137 HLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 251 NKLSG-----------SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL---RSLSMLNL 296
+ + SI L L+ L L + + L ++ ++
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 297 GYNKLNGII-----PHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351
KL G + +S +L L+ + ++ +++ + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG---NL 408
+S L +N L D++ G+L L L L N+L + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373
Query: 409 TNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
+L LD+ NS+S +SL +L++ N L+ +I L + L L+ N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNNSL 517
+ SIP ++ L ++ L + +N+L S+P L++L ++L+ N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-46
Identities = 96/545 (17%), Positives = 187/545 (34%), Gaps = 84/545 (15%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLI 161
+D S N +P ++ L + +N ++ +I LS L L + N ++ L
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHS--LGNLTNL 219
L+ L L N L I +L L L +N F ++P GN++ L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 220 ATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
L L L S + +L +L + L + T L+ +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTN 175
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
++ ++ NL + + + L + S SI +++ L
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCV-------------LEDNKCSYFLSILAKLQTNPKL 222
Query: 340 SNLGLSGNKLSGSIPPSLG---YLSNLATLYLYSNSL-----FDSIPSELGNLRSLSMLS 391
SNL L+ + + + + + + + + + L F +L++LS+
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282
Query: 392 LGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451
+ + + +N+ + + + L N L+ ++
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIG---NLRSISNLALNNNKLSGSIPQSL-GNLSNL 507
+ G+LT L+ L L N L + ++S+ L ++ N +S + +L
Sbjct: 343 NCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTEL 567
+ L + +N L D+I +P + VLDL SN I
Sbjct: 402 LSLNMSSNILTDTIF--------------------RCLPPRIKVLDLHSNKIK------- 434
Query: 568 GKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNL 626
+ ++ L L+ L+++SN+L S+P F L L + L
Sbjct: 435 ------------------SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL 475
Query: 627 SNNQF 631
N +
Sbjct: 476 HTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-45
Identities = 95/492 (19%), Positives = 181/492 (36%), Gaps = 30/492 (6%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI 137
+D N L ++P + + L++S N +I LS L+ L + N++
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 138 PYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLS 196
L YL L N L + S NL L L N+ I EFGN+ L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLK 118
Query: 197 MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256
L L S + +L L + + + + L+ + SL +
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNK 176
Query: 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLA 316
H + +++ L +++ + + + L N + + T +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
+ I ++ S+SN+ L G S L L+ + S+
Sbjct: 237 FIRILQLVWHTTVWY-----FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLS 436
++++ + + ++ LD +N L+ ++ G+L L
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 437 TLSLGYNKLSGSIPHSLG---NLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNK 492
TL L N+L + + +L L + NS+S +S+ +L +++N
Sbjct: 352 TLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH----- 547
L+ +I + L + +L L++N + SIP ++ L +L L+ A N+L S+P
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDR 466
Query: 548 --SLGVLDLSSN 557
SL + L +N
Sbjct: 467 LTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-38
Identities = 89/430 (20%), Positives = 145/430 (33%), Gaps = 61/430 (14%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPP--EIGHLS 121
L F L YLDL HN+L I LK+LDLS N F +P E G++S
Sbjct: 60 LDISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAF-DALPICKEFGNMS 115
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181
LK L L L S I L+ L + L + +T L+
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFP 173
Query: 182 SDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG--------------------------- 214
++ ++ ++ +L + + +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 215 -----------NLTNLATLYLHNNSL-----FDSIPSELGNLRSLSMLSLGYNKLSGSIP 258
T + + N L F +L++LS+ + +
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 259 HSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATL 318
+ +N+ + + L+ N L + + G+LT L TL
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 319 YIHNNSLSGSIPSEIG---NLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLF 374
+ N L + ++SL L +S N +S + +L +L + SN L
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLR 433
D+I L + +L L NK+ SIP + L L L++ N L S+P F L
Sbjct: 413 DTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLT 468
Query: 434 SLSTLSLGYN 443
SL + L N
Sbjct: 469 SLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 59/371 (15%), Positives = 123/371 (33%), Gaps = 26/371 (7%)
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
S N L +P L L + N + + S++ +L L +L + +N++
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHS--LGNLTNLDA 461
L LDL N L I +L L L +N ++P GN++ L
Sbjct: 64 VFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKF 119
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
L L L S I +L L + + L + L+ +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQN 581
+ ++ ++ + + + + + LS I +L L L L
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS-------ILAKLQTNPKLSNLTLNNI 230
Query: 582 QLSGQLSPKLGSLA---QLEHLDLSSNRL-----SNSIPKSFGNLVKLHYLNLSNNQFSR 633
+ + ++ L + + +S+ +L S +L L + ++ F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 634 GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGL 693
E +++ + + + R + +L+ S+N L + + L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 694 LRIDISYNELQ 704
+ + N+L+
Sbjct: 351 ETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-31
Identities = 74/399 (18%), Positives = 133/399 (33%), Gaps = 12/399 (3%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
+ N L +P ++ + + L +S N +S + LS L L + N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL-SGSIPSEFGNLRSL 435
S + L L L +NKL I NL LDL N+ + I EFGN+ L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 436 STLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
L L L S + +L L + + + L+ + +L+ +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTN 175
Query: 496 SIPQSLGNLSNLVILYL-YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDL 554
+ ++S + L +N ++ S+ KLS +++
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 555 SSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS 614
S I+ + + + L SL L + S+
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 615 FGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNL 674
+ ++ N + + + ++ LD S+N L + + + LE L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 675 SHNSLVGL--IPSCFEKMHGLLRIDISYNELQGPIPNSI 711
N L L I +M L ++DIS N +
Sbjct: 356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 65/326 (19%), Positives = 116/326 (35%), Gaps = 17/326 (5%)
Query: 13 SLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFS-FSS 71
LQ+ N SL + N V N L L + +
Sbjct: 159 GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQT 218
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNI---SRLKYLDLSSNLFFGTIPPEIGHLS-----YL 123
P L+ L L + + N +I + + + Y +S+ G + S L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
Q+ + Y S++N + + +S L +N L+D
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 184 SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG---NLTNLATLYLHNNSL-FDSIPSELGN 239
++ G+L L L L N+ + + +L L + NS+ +D +
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
+SL L++ N L+ +I L + L L+ N + SIP + L +L LN+ N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454
Query: 300 KLNGIIPHSLGNLTNLATLYIHNNSL 325
+L + LT+L +++H N
Sbjct: 455 QLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 42/191 (21%), Positives = 76/191 (39%), Gaps = 14/191 (7%)
Query: 551 VLDLSSN---HIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL 607
++D S N H+ ++ + LN ++QN +S + + SL++L L +S NR+
Sbjct: 4 LVDRSKNGLIHVPKDLSQKTTILN------ISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE-AIPSQICIM 666
F +L YL+LS+N+ + I ++L LDLS N I + M
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 667 QSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQGNKG 726
L+ L LS L ++ ++ + E G + +D E+L
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNI-SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 727 LCGDVKGLPSC 737
+ +
Sbjct: 174 TNKEFHFILDV 184
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 49/295 (16%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
C+GKG G V++ GE VAVK F S E ++ +E E+ +RH NI+ F
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRET--ELYNTVMLRHENILGF 67
Query: 880 YGFCSHVRH---------------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
RH SL L L + ++ I+ L+++H
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHI 123
Query: 925 DCF-----PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS----NWTELAGTYGY 975
+ F P I HRD+ SKN+L+ + + ++D G+A ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 976 VAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS---SSSLNLNIAL 1026
+APE+ ++ D+++FG++ EV + + + + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 1027 DEMLDP------RLPTPSCIVQDK-LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++M R P+ D L S+ ++ C +NP +R T ++ + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 808 EEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
I R +D +GKG G K +GE++ +K+ E T Q+ FL EVK
Sbjct: 4 HRIFRP-SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVK 59
Query: 867 ALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGI 915
+ + H N++KF G + +L I+ + W++R++ K I
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDI 117
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL--------------KP 961
+ ++Y+H+ I+HRD++S N L+ + V+DFG+A+ + KP
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021
D + G ++APE+ EK DV+SFG++ E+I +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-----T 229
Query: 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ L+ P S + + C D +PE RP+ K+ L+
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-46
Identities = 91/380 (23%), Positives = 146/380 (38%), Gaps = 37/380 (9%)
Query: 145 SSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYN 203
+ +NY+ L N + +L S L +L L + + I + F L SL +L L YN
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDS-IPSEL-GNLRSLSMLSLGYNKLSGSIPHSL 261
+F + L NL L L +L + + L SL ML L N + P S
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 262 -GNLTNLATLYLYENSLSGSIPSEFGNLRS--LSMLNLGYNKLNGIIPHSLG-------- 310
N+ L L N + + N + ++L L L + + LG
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNL-------------GLSGNKLSGSIPPSL 357
T++ TL + N S+ + + + + +
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 358 GYL--SNLATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414
L S + T L + +F ++ + + L L+L N+++ ++ LT+L L
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 415 DLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPH-SLGNLTNLDALYLYDNSLSGS 472
+L N L SI S F NL L L L YN + ++ S L NL L L N L S
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 473 IPGEI-GNLRSISNLALNNN 491
+P I L S+ + L+ N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-42
Identities = 90/410 (21%), Positives = 150/410 (36%), Gaps = 36/410 (8%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRS 338
+P ++ + +L N + + S L +L L + + I + L S
Sbjct: 24 QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 339 LSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDS-IPSEL-GNLRSLSMLSLGYN 395
L L L N+ + L+NL L L +L + + L SL ML L N
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 396 KLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
+ P S N+ LDL N + + N + L
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL-------------- 185
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L+++ + + L G SI+ L L+ N S+ + + +
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 515 NSLFDSIPSELG--NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNF 572
S ++ S G N + +F G + DLS + I + +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTF-----KGLEASGVKTCDLSKSKIFALLKSVFSHFTD 300
Query: 573 LIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
L +L LAQN+++ ++ L L L+LS N L + + F NL KL L+LS N
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 632 SRGIPIKL-EELIHLSELDLSHNFLREAIPSQI-CIMQSLENLNLSHNSL 679
+ + L +L EL L N L+ ++P I + SL+ + L N
Sbjct: 360 RA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-41
Identities = 85/395 (21%), Positives = 142/395 (35%), Gaps = 49/395 (12%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
L++ SFS L +L + I +S L L L N F + L+
Sbjct: 45 LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ-FLQLETGAFNGLA 103
Query: 122 YLKTLQLFENQLNGS-IPYEI-GRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYD 178
L+ L L + L+G+ + L+SL L L N ++ + P S N+ L L
Sbjct: 104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG 238
N + + N + L L+++ ++ L
Sbjct: 164 NKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPF 209
Query: 239 NLRSLSMLSLGYNKLSGSIP---HSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLN 295
S++ L L N S+ T + +L L + GS +
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS--------------S 255
Query: 296 LGYNKLNGIIPHSLGNL--TNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGS 352
G+ + L + + T + + + ++ + + L L L+ N+++
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-K 313
Query: 353 IPP-SLGYLSNLATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLT 409
I + L++L L L N L SI S + NL L +L L YN + ++ S L
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP 371
Query: 410 NLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
NL L L N L S+P F L SL + L N
Sbjct: 372 NLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 68/340 (20%), Positives = 120/340 (35%), Gaps = 31/340 (9%)
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNK 444
++ + L N ++ S L +L L + + I + F L SL L L YN+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSL-SGSIPGEI-GNLRSISNLALNNNKLSGSIPQSL- 501
+ L NL+ L L +L + G L S+ L L +N + P S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 502 GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVG 561
N+ +L L N + SI +L + F +L S+ + D++ +
Sbjct: 151 LNMRRFHVLDLTFNKV-KSICE--EDLLNFQGKHFTLLRL-----SSITLQDMNEYWLGW 202
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHL-------------DLSSNRLS 608
E K + L L+ N ++ + +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 609 NSIPKSFGNLV--KLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPSQICI 665
+ +F L + +LS ++ + + L +L L+ N + I
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFW 320
Query: 666 -MQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ L LNLS N L + FE + L +D+SYN ++
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 55/255 (21%), Positives = 89/255 (34%), Gaps = 45/255 (17%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFF 110
++ + G + + LDL N + + FF
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK----------------ESMAKRFF 233
Query: 111 GTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNL-- 168
I + +++L L + GS + +D + L
Sbjct: 234 DAIA-----GTKIQSLILSNSYNMGS--------------SFGHTNFKDPDNFTFKGLEA 274
Query: 169 SNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227
S + T L + + ++ F + L L+L N+ + ++ LT+L L L N
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333
Query: 228 SLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYENSLSGSIPSE- 284
L SI S + NL L +L L YN + ++ S L NL L L N L S+P
Sbjct: 334 FL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
Query: 285 FGNLRSLSMLNLGYN 299
F L SL + L N
Sbjct: 391 FDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-16
Identities = 34/189 (17%), Positives = 59/189 (31%), Gaps = 4/189 (2%)
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDL 602
+P + +DLS N I T +L L L + Q + L+ L L L
Sbjct: 27 ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQF-SRGIPIKL-EELIHLSELDLSHNFLREAIP 660
N+ +F L L L L+ + + L L L L N +++ P
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 661 SQI-CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIE 719
+ M+ L+L+ N + + G + + + N
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 720 ALQGNKGLC 728
N +
Sbjct: 207 NPFKNTSIT 215
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-45
Identities = 76/334 (22%), Positives = 124/334 (37%), Gaps = 59/334 (17%)
Query: 781 DLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGE 840
DL Q S G+ GL +V I + IGKG G V+ + GE
Sbjct: 13 DLIEQSQSSGSGSGL-------PLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGE 61
Query: 841 IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS---------------H 885
VAVK F + E ++ +E E+ +RH NI+ F H
Sbjct: 62 KVAVKVFFTT--EEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117
Query: 886 VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF-----PPIVHRDISSKNV 940
SL L + L + + L ++H + F P I HRD+ SKN+
Sbjct: 118 ENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 941 LLDFDNEAHVSDFGIAKFLKPDSSNW----TELAGTYGYVAPEL------AYTMKVTEKC 990
L+ + ++D G+A D++ GT Y+ PE+ +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 991 DVYSFGVLALEVIKGKHPRDFISSM---SSSSLNLNIALDEMLDP------RLPTPSCIV 1041
D+YSFG++ EV + + + + + ++M + R P+
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293
Query: 1042 QDK-LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
D+ L + ++ C NP SR T +V + L
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
IG G G+VYK + G+ VAVK + P Q F NEV L + RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 80
Query: 875 NIVKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
NI+ F G+ + SL L + + +++ + + + Y+H
Sbjct: 81 NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA 138
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK--PDSSNWTELAGTYGYVAPEL-- 980
I+HRD+ S N+ L DN + DFG+A S + +L+G+ ++APE+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 981 -AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
+ + + DVY+FG++ E++ G+ P S++++ + + L P L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVRS 252
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ ++ CL + + RP+ P++ ++
Sbjct: 253 NCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 67/334 (20%), Positives = 125/334 (37%), Gaps = 59/334 (17%)
Query: 781 DLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGE 840
DL ++ G+ GL +V I R + IGKG G V++ + GE
Sbjct: 18 DLIYDMTTSGSGSGL-------PLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGE 66
Query: 841 IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS---------------H 885
VAVK F S E ++ +E E+ +RH NI+ F + H
Sbjct: 67 EVAVKIFSSRE--ERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 886 VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF-----PPIVHRDISSKNV 940
SL L+ + + + + L+++H + P I HRD+ SKN+
Sbjct: 123 EHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178
Query: 941 LLDFDNEAHVSDFGIAKFLKPDSS----NWTELAGTYGYVAPEL------AYTMKVTEKC 990
L+ + ++D G+A + GT Y+APE+ + ++
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238
Query: 991 DVYSFGVLALEVIKGKHPRDFISSMS---SSSLNLNIALDEMLDP------RLPTPSCIV 1041
D+Y+ G++ E+ + + + +++EM R P+
Sbjct: 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298
Query: 1042 QDKLIS-IVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + + ++ C N +R T ++ + L
Sbjct: 299 SCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 57/285 (20%), Positives = 104/285 (36%), Gaps = 44/285 (15%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ IGKG G VY GE VA++ E + F EV A + RH
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLK-AFKREVMAYRQTRHE 89
Query: 875 NIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
N+V F G C H +L ++ + L + + + I + Y+H
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-----FLKPDSSNWTELAGTYGYVAP 978
I+H+D+ SKNV D + + ++DFG+ G ++AP
Sbjct: 148 A---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 979 EL---------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
E+ + ++ DV++ G + E+ + P + + ++ +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKTQPAEAIIWQMGTGM- 259
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + ++ I+ C E RPT K+ +L+
Sbjct: 260 ---KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-43
Identities = 76/456 (16%), Positives = 155/456 (33%), Gaps = 42/456 (9%)
Query: 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQ 132
+ A ++ ++ L LD ++ T I L+ L L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN 75
Query: 133 LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNL 192
+ ++ + + ++L YLA SN L +L + L+ L L+ N L+ +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK---LDVSQN 126
Query: 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252
L+ L+ N + I + + T L L H N + + L+ L +NK
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 253 LSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL 312
++ + L L N+++ + L+ L+ NKL I + L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNS 372
T L N L+ + + L L+ L L I L + + L
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 373 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL 432
+ ++ + L +L ++ + L L L L + L+ + +
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
L +LS + S+G + L+ + + ++P E S++ +
Sbjct: 339 TKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLL 395
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNL 528
P ++ V N ++++ ++ +
Sbjct: 396 DQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAV 431
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-40
Identities = 83/453 (18%), Positives = 147/453 (32%), Gaps = 48/453 (10%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS 228
N + + + L +L+ L + + + + LT L L +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 229 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL 288
+ ++ L +L+ L+ NKL+ ++ + LT L L N L+ +
Sbjct: 76 I-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 289 RSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNK 348
L+ LN N L I + + T L L H N + + L+ L S NK
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 349 LSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL 408
++ + L L +N++ + L L+ L NKL+ I + L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
T L D N L+ + L L+TL L I L + T L
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCR 286
Query: 469 LSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNL 528
+ ++ + + L ++ + L LV LYL N L + + +
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-TELD--VSHN 338
Query: 529 RSLSMLSFAYNKLSGSIP-----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQL 583
L LS + +L + + L + I +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 584 SG---QLSPKLGSLAQLEHLDLSSNRLSNSIPK 613
G + P G + ++ LS P
Sbjct: 398 FGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-39
Identities = 72/402 (17%), Positives = 138/402 (34%), Gaps = 44/402 (10%)
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
N S + I S L L +L HN+S++ + I L L+ L +
Sbjct: 19 NFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
N ++ ++ L +NL L SN L ++ + L L+ L+ NKL+ +
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L L+ N+L+ I + L+ L NK + + T L L
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
N ++ ++ + ++ L + N ++ + L L L +N L I +
Sbjct: 180 NKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-TEID--VT 230
Query: 527 NLRSLSMLSFAYNKLS---GSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQL 583
L L+ + N L+ S L L + E+ + +
Sbjct: 231 PLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGC 285
Query: 584 SGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELI 643
+ QL LD + ++ KL YL L+N + + + +
Sbjct: 286 RKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTE---LDVSHNT 339
Query: 644 HLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPS 685
L L + +++ S + + +L N + + +
Sbjct: 340 KLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKE 379
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-36
Identities = 73/436 (16%), Positives = 130/436 (29%), Gaps = 42/436 (9%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
L L N + + + + L YL SN + + L+ L L
Sbjct: 60 IEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNK-LTNLD--VTPLTKLTYLNC 113
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
N+L + + + L YL N L ++ + + + L L + N +
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD-- 165
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
L+ L +NK + + L L N++ + L L+ L
Sbjct: 166 VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDC 219
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308
NKL+ I + LT L N L+ + L L+ L+ L I
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---D 270
Query: 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYL 368
L + T L + ++ + L L ++ + L L LYL
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYL 325
Query: 369 YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428
+ L + + + L LS + S+G + L +
Sbjct: 326 NNTEL-TELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKET 380
Query: 429 FGNLRSLSTLSLGYNKLSG---SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISN 485
N +S G +I G + + + +LS P S +
Sbjct: 381 LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440
Query: 486 LALNNNKLSGSIPQSL 501
+ PQ +
Sbjct: 441 AIVGTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-33
Identities = 67/414 (16%), Positives = 138/414 (33%), Gaps = 40/414 (9%)
Query: 54 NLTSIGLKG-MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGT 112
LT + + S +L YL N+L N+ + +++L YL+ +N
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNK-LTK 120
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLD 172
+ + L L N L ++ + L L + N + + + L
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLT 173
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
TL N +++ + + L+ L+ N + + L L L +N L
Sbjct: 174 TLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-TE 226
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLS 292
I + L L+ N L+ + + L+ L TL+ + L + L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS 352
I + + T L L ++ + + L L L+ +L+
Sbjct: 282 AEG-----CRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-E 332
Query: 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 412
+ + + + L +L + + D S +G + +L+ + +L N +
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
Query: 413 TLDLYDNSLSG---SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463
+ G +I G + +T ++ + LS P T+ +
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAI 442
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 67/391 (17%), Positives = 131/391 (33%), Gaps = 57/391 (14%)
Query: 314 NLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSL 373
N A+ + + L +L++L + ++ + + L+ L L SN++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNI 76
Query: 374 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLR 433
++ L +L+ L+ NKL+ ++ + LT L L+ N L+ +
Sbjct: 77 -TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 434 SLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
L+ L+ N L+ I + + T L L + N + + ++ L + NK+
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 494 SGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLD 553
+ + L L N++ + L L+ L + NKL+ I
Sbjct: 183 TEL---DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID------- 228
Query: 554 LSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK 613
+ L L + N L+ + +L++L L L
Sbjct: 229 -------------VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLEI--- 269
Query: 614 SFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLN 673
+ +L Y + + + + L LD + E SQ L L
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGITELDLSQ---NPKLVYLY 324
Query: 674 LSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L++ L L L + +Q
Sbjct: 325 LNNTELTEL---DVSHNTKLKSLSCVNAHIQ 352
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 71/311 (22%), Positives = 129/311 (41%), Gaps = 24/311 (7%)
Query: 146 SLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKF 205
L + LE +P L + L L +N +++ +F NL++L L L NK
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 206 SGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLT 265
S P + L L LYL N L +P ++ ++L L + N+++ L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 266 NLATLYLYENSL-SGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
+ + L N L S I + F ++ LS + + + I G +L L++ N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI---PQGLPPSLTELHLDGN 202
Query: 324 SLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSEL 381
++ + + L +L+ LGLS N +S ++ SL +L L+L +N L +P L
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL-VKVPGGL 259
Query: 382 GNLRSLSMLSLGYNKLSG------SIPHSLGNLTNLATLDLYDNSLS-GSIPSE-FGNLR 433
+ + + ++ L N +S P + + + L+ N + I F +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 434 SLSTLSLGYNK 444
+ + LG K
Sbjct: 320 VRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 69/311 (22%), Positives = 133/311 (42%), Gaps = 24/311 (7%)
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301
L ++ L +P L + A L L N ++ +F NL++L L L NK+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 302 NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPP-SLGYL 360
+ I P + L L LY+ N L +P ++ ++L L + N+++ + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 361 SNLATLYLYSNSLFDS-IPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
+ + + L +N L S I + ++ LS + + ++ +IP L +L L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 419 NSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477
N ++ + + L +L+ L L +N +S SL N +L L+L +N L +PG +
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 478 GNLRSISNLALNNNKLSG------SIPQSLGNLSNLVILYLYNNSL-FDSIPSEL-GNLR 529
+ + I + L+NN +S P ++ + L++N + + I +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 530 SLSMLSFAYNK 540
+ + K
Sbjct: 320 VRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 78/309 (25%), Positives = 125/309 (40%), Gaps = 22/309 (7%)
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
+L + + L + +P +L ++L L NK++ NL NL TL L N +
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNL 336
S P F L L L L N+L + L L +H N ++ + + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKEL---PEKMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 337 RSLSNLGLSGNKL-SGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
+ + L N L S I + + L+ + + ++ +IP L SL+ L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDG 201
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
NK++ SL L NLA L L NS+S N L L L NKL +P L
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 455 NLTNLDALYLYDNSLSG------SIPGEIGNLRSISNLALNNNKLSGSI--PQSLGNLSN 506
+ + +YL++N++S PG S S ++L +N + P + +
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 507 LVILYLYNN 515
+ L N
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 62/303 (20%), Positives = 129/303 (42%), Gaps = 23/303 (7%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
S+L +P ++ L L N++ + L +L+ L L +N + + P +
Sbjct: 39 SDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 96
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L L+ L+L N L +P + ++L L + N+ + L + + L
Sbjct: 97 APLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 226 NNSLFDS-IPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
N L S I + ++ LS + + ++ +IP L +L L+L N ++ + +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDA 209
Query: 284 E-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNL 342
L +L+ L L +N ++ + SL N +L L+++NN L +P + + + + +
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268
Query: 343 GLSGNKLSGSIPPS-------LGYLSNLATLYLYSNSL-FDSIPSEL-GNLRSLSMLSLG 393
L N +S +I + ++ + + L+SN + + I + + + LG
Sbjct: 269 YLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327
Query: 394 YNK 396
K
Sbjct: 328 NYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 23/290 (7%)
Query: 72 FPHLAYLDLWHNQLYGNIPP-QIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLF 129
P A LDL +N++ I N+ L L L +N I P L L+ L L
Sbjct: 51 PPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLS 108
Query: 130 ENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDS-IPSE 188
+NQL +P ++ +L L ++ N + + L+ + + L N L S I +
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 189 -FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-LGNLRSLSML 246
F ++ LS + + + +IP L +L L+L N + + + L L +L+ L
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKL 221
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI-- 304
L +N +S SL N +L L+L N L +P + + + ++ L N ++ I
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 305 ----IPHSLGNLTNLATLYIHNNSLS-GSIPSEI-GNLRSLSNLGLSGNK 348
P + + + + +N + I + + + L K
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 80/346 (23%), Positives = 132/346 (38%), Gaps = 52/346 (15%)
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
+L + + L +P + ++L+L NK+ I NL NL TL + NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 326 SGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGN 383
S I L L L LS N+L +P + L L ++ N + +
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 384 LRSLSMLSLGYNKLSGSI--PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
L + ++ LG N L S + + L+ + + D +++ +IP G SL+ L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL 501
NK++ SL L NL L L NS+S G + N + L LNNNKL +P L
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 502 GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHI-V 560
+ + ++YL+NN N+ ++ F + S + L SN +
Sbjct: 260 ADHKYIQVVYLHNN-----------NISAIGSNDFCPPGYNTKKA-SYSGVSLFSNPVQY 307
Query: 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNR 606
EI + + L + +
Sbjct: 308 WEIQPST-----------------------FRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 72/329 (21%), Positives = 130/329 (39%), Gaps = 44/329 (13%)
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445
L ++ L +P L + A LDL +N ++ +F NL++L TL L NK+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 446 SGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS 505
S P + L L+ LYL N L +P ++ +++ L ++ N+++ L+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 506 NLVILYLYNNSLFDS-IPSE-LGNLRSLSMLSFAYNKLSG---SIPHSLGVLDLSSNHIV 560
++++ L N L S I + ++ LS + A ++ +P SL L L N I
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKI- 204
Query: 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620
++ L L L L LS N +S S N
Sbjct: 205 TKVDAAS-----------------------LKGLNNLAKLGLSFNSISAVDNGSLANTPH 241
Query: 621 LHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE------AIPSQICIMQSLENLNL 674
L L+L+NN+ + +P L + ++ + L +N + P S ++L
Sbjct: 242 LRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300
Query: 675 SHNSL--VGLIPSCFEKMHGLLRIDISYN 701
N + + PS F ++ + +
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 51/253 (20%), Positives = 92/253 (36%), Gaps = 29/253 (11%)
Query: 54 NLTSIGLKG-MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSN-LFF 110
L + L L + L L + N++ + + ++++ ++L +N L
Sbjct: 101 KLERLYLSKNQLKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 111 GTIPPEI-GHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLS 169
I + L +++ + + +IP + SL L L N + + SL L+
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 216
Query: 170 NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL 229
NL L L NS+S N L L L NK +P L + + +YLHNN++
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 230 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS-GSIPSE-FGN 287
+I S P + + + L+ N + I F
Sbjct: 276 -SAIGSN-----------------DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
Query: 288 LRSLSMLNLGYNK 300
+ + + LG K
Sbjct: 318 VYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 55/253 (21%), Positives = 97/253 (38%), Gaps = 37/253 (14%)
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
+L + D L +P ++ + L L NNK++ NL NL L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 518 FDSIPSELGNLRSLSMLSFAYNKLS---GSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
P L L L + N+L +P +L L + N I ++ +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT-KVRKSV------- 140
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI--PKSFGNLVKLHYLNLSNNQFS 632
L Q+ ++L +N L +S +F + KL Y+ +++ +
Sbjct: 141 ----------------FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKMH 691
IP L L+EL L N + + + + + +L L LS NS+ +
Sbjct: 185 T-IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240
Query: 692 GLLRIDISYNELQ 704
L + ++ N+L
Sbjct: 241 HLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLR 656
LDL +N+++ F NL LH L L NN+ S+ P L+ L L LS N L+
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 657 EAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDA 716
E +P ++ ++L+ L + N + + S F ++ ++ +++ N L+ + AF+
Sbjct: 114 E-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 717 P 717
Sbjct: 171 K 171
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 95/503 (18%), Positives = 182/503 (36%), Gaps = 45/503 (8%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
+P ++ L+L N + +L P + LS L L L N + S+ F +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP--SELGNLRSLSMLSLGYNK 252
L L + +N+ +I + +L L L N D +P E GNL L+ L L K
Sbjct: 102 LEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAK 157
Query: 253 LSGSIPHSLGNL-TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN 311
+ +L + L L + G + ++L+L ++ + +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMS 216
Query: 312 LTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSN 371
+ L L + N L+ + S G + ++ L ++ T + S
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT---------LQHIETTWKCSV 267
Query: 372 SLFDSIPSELGNLRSLSMLSLGYNKL--SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF 429
LF + L++ +L + +S L +L + + S + +
Sbjct: 268 KLFQFF--WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 430 GNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489
++ L + + ++ L N + S+ L+ + L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSL 549
N L + + N+ L + SL+ L+ + + S+
Sbjct: 386 RNGLK-NFFKVALMTKNMSSLETLDV--------------SLNSLNSHAYDRTCAWAESI 430
Query: 550 GVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN 609
VL+LSSN + G + L + L L N++ + + L L+ L+++SN+L
Sbjct: 431 LVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL-K 486
Query: 610 SIPK-SFGNLVKLHYLNLSNNQF 631
S+P F L L Y+ L +N +
Sbjct: 487 SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-39
Identities = 95/430 (22%), Positives = 165/430 (38%), Gaps = 39/430 (9%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPP--EIGHLS 121
L F L YLD+ HN+L NI ++ L++LDLS N F +P E G+L+
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFND-FDVLPVCKEFGNLT 146
Query: 122 YLKTLQLFENQLNGSIPYEIGRLS-SLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
L L L + + L S L L S +++ SL N LHL +
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHP 205
Query: 181 LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLT-------NLATLYLHNNSLFDSI 233
S ++ +L L L K + L L + L +
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 234 PSELGNL---RSLSMLSLGYNKLSGSIP-----HSLGNLTNLATLYLYENSLSGSIPSEF 285
+L R + L++ ++ I +S L +L ++ S + +
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS 345
+++ L + I + ++ L N + S+ L+ L L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 346 GNKLSGSIPPSLGYLSNLATLYLYSNSL-------FDSIPSELGNLRSLSMLSLGYNKLS 398
N L + N+++L SL +D + ++ L+L N L+
Sbjct: 386 RNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV---LNLSSNMLT 441
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH-SLGNLT 457
GS+ L + LDL++N + SIP + +L++L L++ N+L S+P LT
Sbjct: 442 GSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497
Query: 458 NLDALYLYDN 467
+L ++L+DN
Sbjct: 498 SLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-39
Identities = 97/464 (20%), Positives = 174/464 (37%), Gaps = 35/464 (7%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
L L +NS+S + L L +L L +N++ + H +L L + +N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS--LGYLSNLATLYLYSNSLFDSIPSELG 382
L +I + SL +L LS N +P G L+ L L L + +
Sbjct: 112 LQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 383 NLR-SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
+L S +L L + G SL N L L + S ++ +L L L
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 442 YNKLSGSIPHSLGN----------LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNN 491
KL+ L L N+ ++ + R + L + N
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 492 KLSGSIPQ-----SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG--- 543
++ I + S L +L+I ++ N S + +++ + +
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 544 ---SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS--GQLSPKLGSLAQLE 598
P S L+ + N + L L LIL +N L +++ +++ LE
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
Query: 599 HLDLSSNRLSNSIPKS-FGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE 657
LD+S N L++ + LNLS+N + + L + LDL +N +
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-M 463
Query: 658 AIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
+IP + +Q+L+ LN++ N L + F+++ L I + N
Sbjct: 464 SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 95/469 (20%), Positives = 167/469 (35%), Gaps = 55/469 (11%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQ 127
S L L L HN++ ++ + L+ L
Sbjct: 72 ISFLSELRVLRLSHNRI-------------------------RSLDFHVFLFNQDLEYLD 106
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYDNSLSDSIP 186
+ N+L +I ++SL +L L N + L GNL+ L L L
Sbjct: 107 VSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDL 163
Query: 187 SEFGNLR-SLSMLSLGYNKFSGSIPHSLGNL-TNLATLYLHNNSLFDSIPS-ELGNLRSL 243
+L S +L L G SL T + L H NSLF + + L L
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 244 SMLSLGYNKLSGSIPHSL-------GNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
+ ++ N + + L N+ ++ +F R + LN+
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 297 GYNKLNGIIP-----HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351
+ I +S L +L ++ N S + ++ LS +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 411
S+ L N DS+ L+ L L L N L + N+
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 412 ATLDLYDNSL----SGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467
++L+ D SL S + S+ L+L N L+GS+ L + L L++N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNN 460
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
+ SIP ++ +L+++ L + +N+L S+P L++L ++L++N
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 77/443 (17%), Positives = 154/443 (34%), Gaps = 21/443 (4%)
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328
+ +L+ +P L+L N ++ + + L+ L L + +N + S
Sbjct: 35 MVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 329 IPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIP--SELGNLR 385
+ + + L L +S N+L +I +++L L L N D +P E GNL
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF-DVLPVCKEFGNLT 146
Query: 386 SLSMLSLGYNKLSGSIPHSLGNL-TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNK 444
L+ L L K + +L + LDL + G + + L L ++
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHP 205
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL 504
S ++ L L L + L+ + S ++ ++
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIP 564
S + + + + + NL + S + SL + + + +
Sbjct: 266 SVKLFQFFWPRPVEYL---NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 565 TELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYL 624
+ +L+ + S + L+ + N ++S+ + L +L L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 625 NLSNNQFSR--GIPIKLEELIHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSLVG 681
L N + + + + L LD+S N L + C +S+ LNLS N L G
Sbjct: 383 ILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 682 LIPSCFEKMHGLLRIDISYNELQ 704
+ C + +D+ N +
Sbjct: 443 SVFRCL--PPKVKVLDLHNNRIM 463
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 70/311 (22%), Positives = 121/311 (38%), Gaps = 25/311 (8%)
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301
L ++ L ++P + + L L N +S +F L+ L L L NK+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 302 NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPP-SLGYL 360
+ I + L L LYI N L IP + SL L + N++ +P L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 361 SNLATLYLYSNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN 419
N+ + + N L +S + L+ L + KL+ IP L L L L N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 420 SLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
+ +I E L L LG+N++ SL L L L+L +N LS +P +
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
Query: 479 NLRSISNLALNNNKLSGSIPQS-------LGNLSNLVILYLYNNSL-FDSIPSEL-GNLR 529
+L+ + + L+ N ++ + + + + L+NN + + + +
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 530 SLSMLSFAYNK 540
+ F K
Sbjct: 321 DRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 66/302 (21%), Positives = 114/302 (37%), Gaps = 22/302 (7%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
S+L +P EI L L N ++ + L L L L +N + + +
Sbjct: 41 SDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF 98
Query: 166 GNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L L L++ N L IP SL L + N+ L N+ + +
Sbjct: 99 SPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 226 NNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE 284
N L +S + L+ L + KL+ IP L L L+L N + +I E
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELE 211
Query: 285 -FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
L L LG+N++ I SL L L L++ NN LS +P+ + +L+ L +
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270
Query: 344 LSGNKLSGSIPPS-------LGYLSNLATLYLYSNSL-FDSIPSEL-GNLRSLSMLSLGY 394
L N ++ + + + + L++N + + + + + G
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329
Query: 395 NK 396
K
Sbjct: 330 YK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 24/296 (8%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
+P + + L L +N +S+ +F L+ L L L NK S + L L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL-SG 279
LY+ N L IP L SL L + N++ L N+ + + N L +
Sbjct: 106 KLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRS 338
+ L+ L + KL GI L L++ +N + +I E
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLTGI---PKDLPETLNELHLDHNKIQ-AIELEDLLRYSK 218
Query: 339 LSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397
L LGL N++ I SL +L L L+L +N L +P+ L +L+ L ++ L N +
Sbjct: 219 LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNI 276
Query: 398 SGSIP-------HSLGNLTNLATLDLYDNSLSGSI--PSEFGNLRSLSTLSLGYNK 444
+ + + L++N + P+ F + + G K
Sbjct: 277 T-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 72/328 (21%), Positives = 121/328 (36%), Gaps = 43/328 (13%)
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445
L ++ L ++P + + LDL +N +S +F L+ L L L NK+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 446 SGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS 505
S + L L LY+ N L IP + S+ L +++N++ L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 506 NLVILYLYNNSLFDS-IPSELGNLRSLSMLSFAYNKLSG---SIPHSLGVLDLSSNHIVG 561
N+ + + N L +S + L+ L + KL+G +P +L L L N I
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ- 206
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
I E L ++L L L N++ S L L
Sbjct: 207 AIELED-----------------------LLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQ------SLENLNLS 675
L+L NN+ SR +P L +L L + L N + + + C + ++L
Sbjct: 244 RELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 676 HN--SLVGLIPSCFEKMHGLLRIDISYN 701
+N + P+ F + L I
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 73/370 (19%), Positives = 127/370 (34%), Gaps = 77/370 (20%)
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
+L + + L ++P E ++L+L N ++ + L +L L + NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 326 SGSIPSEIGNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNL 384
S I + L L LY+ N L IP L
Sbjct: 91 S-------------------------KIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--P 122
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL-SGSIPSEFGNLRSLSTLSLGYN 443
SL L + N++ L N+ +++ N L + + L+ L +
Sbjct: 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 444 KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNKLSGSIPQSLG 502
KL+ IP L L+ L+L N + +I E + L L +N++ SL
Sbjct: 183 KLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGE 562
L L L+L NN L +P+ L +L+ L V+ L +N+I
Sbjct: 239 FLPTLRELHLDNNKL-SRVPAGLPDLKLLQ------------------VVYLHTNNI--- 276
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI--PKSFGNLVK 620
T++G +F A + L +N + P +F +
Sbjct: 277 --TKVGVNDF-------------CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 621 LHYLNLSNNQ 630
+ N +
Sbjct: 322 RLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 26/275 (9%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEIGHLS 121
L F HL L L +N++ I + + +L+ L +S N IPP + S
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNH-LVEIPPNL--PS 123
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDN 179
L L++ +N++ +P + L ++N + + N LE+ P + L+ L + +
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIP-HSLGNLTNLATLYLHNNSLFDSIPSE-L 237
L+ IP +L+ L L +NK +I L + L L L +N + I + L
Sbjct: 183 KLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI-RMIENGSL 237
Query: 238 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-------FGNLRS 290
L +L L L NKLS +P L +L L +YL+ N+++ +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295
Query: 291 LSMLNLGYNKL--NGIIPHSLGNLTNLATLYIHNN 323
+ ++L N + + P + +T+ + N
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 63/254 (24%), Positives = 98/254 (38%), Gaps = 40/254 (15%)
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
+L + D L ++P EI + L L NN +S L +L L L NN +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 518 FDSIPSE-LGNLRSLSMLSFAYNKLS---GSIPHSLGVLDLSSNHIVGEIPTELGKLNFL 573
I + LR L L + N L ++P SL L + N I ++ K F
Sbjct: 91 -SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRI-----RKVPKGVF- 143
Query: 574 IKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI--PKSFGNLVKLHYLNLSNNQF 631
L + +++ N L NS P +F L KL+YL +S +
Sbjct: 144 ------------------SGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184
Query: 632 SRGIPIKLEELIHLSELDLSHNFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKM 690
+ IP L L+EL L HN ++ I + + L L L HN + + +
Sbjct: 185 TG-IPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 691 HGLLRIDISYNELQ 704
L + + N+L
Sbjct: 241 PTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 32/119 (26%), Positives = 48/119 (40%), Gaps = 3/119 (2%)
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLR 656
LDL +N +S F L L+ L L NN+ S+ L L +L +S N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 657 EAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRD 715
E IP + SL L + N + + F + + I++ N L+ AF
Sbjct: 116 E-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-39
Identities = 71/257 (27%), Positives = 106/257 (41%), Gaps = 14/257 (5%)
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
+ + L +P + + L+L N + + +L +L L L NS+
Sbjct: 55 QFSKVVCTRRGL-SEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 278 SGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GN 335
I F L SL+ L L N L I + L+ L L++ NN + SIPS
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 336 LRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
+ SL L L K I + L NL L L ++ +P+ L L L L +
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMPN-LTPLVGLEELEMSG 227
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHS- 452
N P S L++L L + ++ +S I F L SL L+L +N LS S+PH
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 453 LGNLTNLDALYLYDNSL 469
L L L+L+ N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 72/257 (28%), Positives = 110/257 (42%), Gaps = 14/257 (5%)
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
+ + LS +P + LNL N + I + +L +L L + NS+
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 326 SGSIPSEI-GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSE-LG 382
I L SL+ L L N L+ IP + YLS L L+L +N + +SIPS
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFN 168
Query: 383 NLRSLSMLSLG-YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
+ SL L LG KL + L NL L+L ++ +P+ L L L +
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226
Query: 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS- 500
N P S L++L L++ ++ +S L S+ L L +N LS S+P
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 501 LGNLSNLVILYLYNNSL 517
L LV L+L++N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 74/259 (28%), Positives = 109/259 (42%), Gaps = 14/259 (5%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFE 130
+ + L +P I S +YL+L N I + HL +L+ LQL
Sbjct: 53 SNQFSKVVCTRRGL-SEVPQGIP--SNTRYLNLMEN-NIQMIQADTFRHLHHLEVLQLGR 108
Query: 131 NQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE- 188
N + I L+SLN L L+ N+L + + LS L L L +N + SIPS
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 189 FGNLRSLSMLSLG-YNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
F + SL L LG K + L NL L L ++ +P+ L L L L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMPN-LTPLVGLEELE 224
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIP 306
+ N P S L++L L++ + +S I F L SL LNL +N L+ +
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPH 283
Query: 307 HSLGNLTNLATLYIHNNSL 325
L L L++H+N
Sbjct: 284 DLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-31
Identities = 65/297 (21%), Positives = 102/297 (34%), Gaps = 48/297 (16%)
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNK 444
S + LS +P + +N L+L +N++ F +L L L LG N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL 504
+ + L +L+ L L+DN L+ G L + L L NN + + +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 505 SNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEI 563
+L+ L L + I L +L L+ + +P+
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN---------------- 213
Query: 564 PTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY 623
L L LE L++S N P SF L L
Sbjct: 214 ---------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 624 LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
L + N+Q S + L L EL+L+HN L ++ L L+L HN
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 63/220 (28%), Positives = 92/220 (41%), Gaps = 13/220 (5%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
+ +F HL L L N + I ++ L L+L N IP +LS
Sbjct: 90 IQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNW-LTVIPSGAFEYLS 147
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYS-NYLEDLIPPSLGNLSNLDTLHLYDN 179
L+ L L N + SIP R+ SL L L LE + + L NL L+L
Sbjct: 148 KLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-LG 238
++ +P+ L L L + N F P S L++L L++ N+ + I
Sbjct: 207 NIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFD 263
Query: 239 NLRSLSMLSLGYNKLSGSIPHS-LGNLTNLATLYLYENSL 277
L SL L+L +N LS S+PH L L L+L+ N
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 56/273 (20%), Positives = 98/273 (35%), Gaps = 48/273 (17%)
Query: 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
S + LS +P + +N L L +N++ +L + L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVL 552
+ + L++L L L++N L + +F Y L L
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDN-----------WLTVIPSGAFEYL-------SKLREL 152
Query: 553 DLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSS-NRLSNSI 611
L +N I IP+ + L LDL +L
Sbjct: 153 WLRNNPIE-SIPSYA-----------------------FNRVPSLMRLDLGELKKLEYIS 188
Query: 612 PKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLEN 671
+F L L YLNL +P L L+ L EL++S N E P + SL+
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 672 LNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L + ++ + + + F+ + L+ +++++N L
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 9/171 (5%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHL 120
++ +F L L L +N + +IP + L LDL I L
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 121 SYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS 180
LK L L + +P + L L L + N+ ++ P S LS+L L + ++
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 181 LSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHS-LGNLTNLATLYLHNNSL 229
+S I F L SL L+L +N S S+PH L L L+LH+N
Sbjct: 254 VS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-39
Identities = 70/345 (20%), Positives = 122/345 (35%), Gaps = 37/345 (10%)
Query: 184 SIPSEFGNLRSLSMLSLGYNKFSG---SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNL 240
SI N SLS S YN SG + A + N + L +
Sbjct: 2 SIMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK 300
S L L LS S+P +L + L + +N+L S+P +L L + N+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNR 111
Query: 301 LNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
L+ +P +L +L + NN L+ +P L ++ N+L+ +P
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPT-- 160
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLAT----LDL 416
+L L + +N L +P +L +L + N L S+P +
Sbjct: 161 -SLEVLSVRNNQL-TFLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476
+N ++ IP +L T+ L N LS I SL T + S S +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 477 IGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
R +++ + + + + + N+ +
Sbjct: 274 NTLHRPLADAVTAW--FPENKQSDVSQIWHAFEHEEHANTFSAFL 316
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-38
Identities = 82/429 (19%), Positives = 146/429 (34%), Gaps = 43/429 (10%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGI---IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
SI N SLS N YN ++G + A + N + +
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK 396
S L L+ LS S+P +L + L + N+L S+P +L L N+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLD---ACDNR 111
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNL 456
LS ++P +L +L D+ +N L+ +P L ++ N+L+ +P +L
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPTSL 162
Query: 457 TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL----VILYL 512
L + +N L+ +P +L + L ++ N L S+P + +
Sbjct: 163 EVLS---VRNNQLT-FLPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNF 572
N + IP + +L + N LS I SL ++ I +
Sbjct: 215 RENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
+ ++ S +N+ L + + F
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSAR-NTSGFR 332
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQIC------IMQSLENLNLSHNSLVGLIPSC 686
+ LE+L +EL +F A ++ C +L L H + GL +
Sbjct: 333 EQVAAWLEKLSASAELRQQ-SFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDND 391
Query: 687 FEKMHGLLR 695
+ L R
Sbjct: 392 TGALLSLGR 400
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 68/395 (17%), Positives = 130/395 (32%), Gaps = 43/395 (10%)
Query: 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQL 133
A N+ + I++ L L+ ++P + + L++ +N L
Sbjct: 38 KQALPGENRNEAVSLLK--ECLINQFSELQLNRL-NLSSLPDNLP--PQITVLEITQNAL 92
Query: 134 NGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLR 193
S+P L L+ N L L P +L +LD + +N L+ +P L
Sbjct: 93 -ISLPELPASLEYLD---ACDNRLSTL-PELPASLKHLD---VDNNQLT-MLPELPALLE 143
Query: 194 SLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL 253
++ N+ + +P +L L + NN L +P +L +L + N L
Sbjct: 144 YIN---ADNNQLT-MLPELPTSLE---VLSVRNNQL-TFLPELPESLEALD---VSTNLL 192
Query: 254 SGSIPHSLGNLTNLAT----LYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309
S+P + EN ++ IP +L + L N L+ I SL
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 310 GNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
T + S S + N + + + + +
Sbjct: 251 SQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEH 308
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF 429
+N+ + L + S S +++ L L+ A L +++
Sbjct: 309 ANTFS-AFLDRLSDTVSARNTSGFREQVA----AWLEKLSASAELRQQSFAVAADATESC 363
Query: 430 GNLRSLSTLSLGYNKL-----SGSIPHSLGNLTNL 459
+ +L+ +L L G + G L +L
Sbjct: 364 EDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 60/374 (16%), Positives = 124/374 (33%), Gaps = 41/374 (10%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131
+ L L L ++P + ++ L+++ N ++P L+ L +N
Sbjct: 58 INQFSELQLNRLNL-SSLPDNLP--PQITVLEITQNA-LISLPELPAS---LEYLDACDN 110
Query: 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGN 191
+L+ ++P L L+ + +N L L P L ++ +N L+ +P +
Sbjct: 111 RLS-TLPELPASLKHLD---VDNNQLTML-PELPALLEYIN---ADNNQLT-MLPELPTS 161
Query: 192 LRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLS----MLS 247
L LS+ N+ + +P +L L + N L +S+P+
Sbjct: 162 LEV---LSVRNNQLT-FLPELPESLE---ALDVSTNLL-ESLPAVPVRNHHSEETEIFFR 213
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307
N+++ IP ++ +L T+ L +N LS I + + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 308 SLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367
N + + S++ + N S + L +
Sbjct: 273 Q--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTS 329
Query: 368 LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL-----S 422
+ + + L L + + L ++ S + L +L L
Sbjct: 330 GFRE----QVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASE 385
Query: 423 GSIPSEFGNLRSLS 436
G ++ G L SL
Sbjct: 386 GLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 65/295 (22%), Positives = 102/295 (34%), Gaps = 53/295 (17%)
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSG---SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480
SI N SLS S YN +SG + N + +
Sbjct: 2 SIMLPINNNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLI 58
Query: 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK 540
S L LN LS S+P +L + +L + N+L S+P +L L
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYL--------- 105
Query: 541 LSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHL 600
D N + +P L L + NQL+ L A LE++
Sbjct: 106 ------------DACDNRLS-TLPELPASLK---HLDVDNNQLT-MLPE---LPALLEYI 145
Query: 601 DLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP 660
+ +N+L+ +P+ +L L++ NNQ + +P E L LD+S N L +P
Sbjct: 146 NADNNQLT-MLPELPTSL---EVLSVRNNQLTF-LP---ELPESLEALDVSTNLLES-LP 196
Query: 661 SQICIMQSLEN----LNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSI 711
+ E N + + P + I + N L I S+
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-21
Identities = 57/328 (17%), Positives = 103/328 (31%), Gaps = 34/328 (10%)
Query: 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLF 129
L YLD N+L +P + LK+LD+ +N +P L+ +
Sbjct: 97 ELPASLEYLDACDNRL-STLPELPAS---LKHLDVDNNQ-LTMLPELPAL---LEYINAD 148
Query: 130 ENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEF 189
NQL +P L L+ + +N L L P +L LD + N L S+P+
Sbjct: 149 NNQLT-MLPELPTSLEVLS---VRNNQLTFL-PELPESLEALD---VSTNLLE-SLPAVP 199
Query: 190 GNLRSLS----MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSM 245
N+ + IP ++ +L T+ L +N L I L +
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII 305
S S N + + S+ + N + +
Sbjct: 259 YHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL 316
Query: 306 PHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG-----YL 360
L + + + + + + + L + + L ++ S
Sbjct: 317 -DRLSDTVS----ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTW 371
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLS 388
+NL L + ++ G L SL
Sbjct: 372 NNLRKTLLVHQASEGLFDNDTGALLSLG 399
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 72/257 (28%), Positives = 114/257 (44%), Gaps = 14/257 (5%)
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
+ + +L +P + + +L+L N++ +S +L +L L L N +
Sbjct: 44 QFSKVICVRKNL-REVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 278 SGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GN 335
+I F L +L+ L L N+L I + L+ L L++ NN + SIPS
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 336 LRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
+ SL L L K I + LSNL L L +L IP+ L L L L L
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDELDLSG 216
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHS- 452
N LS P S L +L L + + + I F NL+SL ++L +N L+ +PH
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 453 LGNLTNLDALYLYDNSL 469
L +L+ ++L+ N
Sbjct: 275 FTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 69/280 (24%), Positives = 108/280 (38%), Gaps = 34/280 (12%)
Query: 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK 300
S + L +P + TN L L+EN + + F +LR L +L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 301 LNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSL-G 358
+ I + L NL TL + +N L+ +IP+ L L L L N + SIP
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
+ +L L L I + L+NL L+L
Sbjct: 158 RIPSLRRLDLGELKRLSYIS-----------------------EGAFEGLSNLRYLNLAM 194
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
+L IP+ L L L L N LS P S L +L L++ + +
Sbjct: 195 CNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
Query: 479 NLRSISNLALNNNKLSGSIPQS-LGNLSNLVILYLYNNSL 517
NL+S+ + L +N L+ +P L +L ++L++N
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 74/259 (28%), Positives = 112/259 (43%), Gaps = 14/259 (5%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFE 130
+ + L +P I + + L+L N I HL +L+ LQL
Sbjct: 42 SNQFSKVICVRKNL-REVPDGIS--TNTRLLNLHEN-QIQIIKVNSFKHLRHLEILQLSR 97
Query: 131 NQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE- 188
N + +I L++LN L L+ N L + + LS L L L +N + SIPS
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
Query: 189 FGNLRSLSMLSLG-YNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
F + SL L LG + S + L+NL L L +L IP+ L L L L
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDELD 213
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIP 306
L N LS P S L +L L++ ++ + I F NL+SL +NL +N L +
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPH 272
Query: 307 HSLGNLTNLATLYIHNNSL 325
L +L +++H+N
Sbjct: 273 DLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 13/220 (5%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
+ SF HL L L N + I ++ L L+L N TIP +LS
Sbjct: 79 IKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNR-LTTIPNGAFVYLS 136
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYS-NYLEDLIPPSLGNLSNLDTLHLYDN 179
LK L L N + SIP R+ SL L L L + + LSNL L+L
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-LG 238
+L IP+ L L L L N S P S L +L L++ + + I
Sbjct: 196 NLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFD 252
Query: 239 NLRSLSMLSLGYNKLSGSIPHS-LGNLTNLATLYLYENSL 277
NL+SL ++L +N L+ +PH L +L ++L+ N
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 78/300 (26%), Positives = 114/300 (38%), Gaps = 54/300 (18%)
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNK 444
S + L +P + TN L+L++N + + F +LR L L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL 504
+ + L NL+ L L+DN L+ +IP + L
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIP-----------------------NGAFVYL 135
Query: 505 SNLVILYLYNNSLFDSIPSE----LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIV 560
S L L+L NN + +SIPS + +LR L + +LS I
Sbjct: 136 SKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGE--LKRLS-YIS-------------- 177
Query: 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620
L+ L L LA L P L L +L+ LDLS N LS P SF L+
Sbjct: 178 ---EGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 621 LHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
L L + +Q + L L E++L+HN L + LE ++L HN
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 28/282 (9%)
Query: 426 PSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISN 485
PS S + L +P + TN L L++N + +LR +
Sbjct: 36 PSVCSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 486 LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSI 545
L L+ N + + L+NL L L++N L ++ +F Y
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDN-----------RLTTIPNGAFVY------- 134
Query: 546 PHSLGVLDLSSNHIVGEIPTEL-GKLNFLIKLILAQ-NQLSGQLSPK-LGSLAQLEHLDL 602
L L L +N I IP+ ++ L +L L + +LS +S L+ L +L+L
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNL 192
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQ 662
+ L IP + L+KL L+LS N S P + L+HL +L + + ++ +
Sbjct: 193 AMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250
Query: 663 ICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+QSL +NL+HN+L L F +H L RI + +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 5/106 (4%)
Query: 612 PKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLEN 671
P + + +P + + L+L N ++ + ++ LE
Sbjct: 36 PSVCSCSNQFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEI 92
Query: 672 LNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAP 717
L LS N + + F + L +++ N L IPN AF
Sbjct: 93 LQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNG-AFVYLS 136
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 60/245 (24%), Positives = 97/245 (39%), Gaps = 12/245 (4%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS--DSIPSEFGNLR 193
S+P I SS L L SN L+ L L+ L L L N LS
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 194 SLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE--LGNLRSLSMLSLGYN 251
SL L L +N ++ + L L L +++L + +LR+L L + +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHT 136
Query: 252 KLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLG 310
+ L++L L + NS + + F LR+L+ L+L +L + P +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL--GYLSNLATLYL 368
+L++L L + +N+ L SL L S N + + + S+LA L L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 369 YSNSL 373
N
Sbjct: 256 TQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 13/260 (5%)
Query: 170 NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL 229
+ + L+ S+P+ S + L L NK LT L L L +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 230 -FDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE--F 285
F S+ SL L L +N + ++ + L L L ++L + F
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGL 344
+LR+L L++ + L++L L + NS + +I LR+L+ L L
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 345 SGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
S +L + P + LS+L L + N+ F L SL +L N + S
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 404 SLGNL-TNLATLDLYDNSLS 422
L + ++LA L+L N +
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 61/274 (22%), Positives = 101/274 (36%), Gaps = 29/274 (10%)
Query: 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS-- 422
+ S L S+P+ + S + L L NKL LT L L L N LS
Sbjct: 11 EIRCNSKGL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLR 481
G SL L L +N + ++ + L L+ L ++L + +LR
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKL 541
++ L +++ + LS+L +L + NS ++ L
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--DIFTELR--------- 175
Query: 542 SGSIPHSLGVLDLSSNHIVGEIPTE-LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEH 599
+L LDLS + ++ L+ L L ++ N L L L+
Sbjct: 176 ------NLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQV 227
Query: 600 LDLSSNRLSNSIPKSFGNLVK-LHYLNLSNNQFS 632
LD S N + S + + L +LNL+ N F+
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSL-F 374
+ ++ L+ S+P+ I S + L L NKL S+P L+ L L L SN L F
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 375 DSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE--FGN 431
S+ SL L L +N + ++ + L L LD ++L + F +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124
Query: 432 LRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNN 490
LR+L L + + + L++L+ L + NS + +I LR+++ L L+
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 491 NKLSGSIPQ-SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS------- 542
+L + + +LS+L +L + +N+ F L SL +L ++ N +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243
Query: 543 GSIPHSLGVLDLSSN 557
P SL L+L+ N
Sbjct: 244 QHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 10/238 (4%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNL--FFGTIPPEIGHLSYLKTLQL 128
L+L N+L ++P + +++L L LSSN F G + LK L L
Sbjct: 27 PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYDNSLSDSIPS 187
N + ++ L L +L + L+ + S+ +L NL L + +
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144
Query: 188 EFGNLRSLSMLSLGYNKFSGSI-PHSLGNLTNLATLYLHNNSLFDSIPSE-LGNLRSLSM 245
F L SL +L + N F + P L NL L L L + + +L SL +
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQV 203
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL-RSLSMLNLGYNKLN 302
L++ +N L +L L N + S E + SL+ LNL N
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 69/273 (25%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS-- 470
+ L+ S+P+ S + L L NKL LT L L L N LS
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 471 GSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS 530
G S+ L L+ N + ++ + L L L +++L + E S
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMS-EFSVFLS 124
Query: 531 LSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE-LGKLNFLIKLILAQNQLSGQLSP 589
L +L LD+S H L+ L L +A N P
Sbjct: 125 L---------------RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 590 K-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSEL 648
L L LDLS +L P +F +L L LN+S+N F + L L L
Sbjct: 169 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 649 DLSHNFLREAIPSQI--CIMQSLENLNLSHNSL 679
D S N + Q SL LNL+ N
Sbjct: 229 DYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 63/246 (25%), Positives = 97/246 (39%), Gaps = 24/246 (9%)
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521
+ L+ S+P I S + L L +NKL L+ L L L +N
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN------ 62
Query: 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQN 581
L S + + SL LDLS N ++ + + L L L +
Sbjct: 63 -----GLSFKGCCSQSDFGTT-----SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111
Query: 582 QLSGQLSPK--LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK- 638
L Q+S SL L +LD+S + F L L L ++ N F
Sbjct: 112 NLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
Query: 639 LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDI 698
EL +L+ LDLS L + P+ + SL+ LN+SHN+ L ++ ++ L +D
Sbjct: 171 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230
Query: 699 SYNELQ 704
S N +
Sbjct: 231 SLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 45/210 (21%), Positives = 73/210 (34%), Gaps = 16/210 (7%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFF 110
N ++ S L YLDL N + + + +L++LD +
Sbjct: 62 NGLSFKGCC------SQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK 114
Query: 111 GTIPPEI-GHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSN-YLEDLIPPSLGN 167
+ L L L + I LSSL L + N + E+ +P
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 168 LSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHN 226
L NL L L L + F +L SL +L++ +N F L +L L
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 227 NSLFDSIPSEL--GNLRSLSMLSLGYNKLS 254
N + + + SL+ L+L N +
Sbjct: 233 NHI-MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 40/164 (24%), Positives = 65/164 (39%), Gaps = 9/164 (5%)
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNS 610
+ +S + +PT + + +L L N+L L L QL L LSSN LS
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 611 --IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICI-MQ 667
+S L YL+LS N + L L LD H+ L++ + + ++
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 668 SLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSI 711
+L L++SH F + L + ++ N Q I
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 21/276 (7%)
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
SIP L + +L L N ++ S+ +L L L N +N I S +L +L
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 316 ATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPS--LGYLSNLATLYLYSNS 372
L + N LS ++ S L SL+ L L GN ++ + +L+ L L + +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 373 LFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FG 430
F I + L L L + + L P SL ++ N++ L L+ +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 431 NLRSLSTLSLGYNKLSG----SIPH----SLGNLTNLDALYLYDNSLSGSIPGEIGNLRS 482
S+ L L L + SL + + D SL + + +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 483 ISNLALNNNKLSGSIPQS-LGNLSNLVILYLYNNSL 517
+ L + N+L S+P L++L ++L+ N
Sbjct: 279 LLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 60/283 (21%), Positives = 99/283 (34%), Gaps = 27/283 (9%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS 228
+ +L L +N ++ S+ +L L L N + S +L +L L L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 229 LFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHS--LGNLTNLATLYLYENSLSGSIPSE- 284
L ++ S L SL+ L+L N ++ + +LT L L + I +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 285 FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLG 343
F L L L + + L P SL ++ N++ L +H + S+ L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
L L L S +S L + + + L +
Sbjct: 229 LRDTDLDTFHFSEL------------STGETNS----LIKKFTFRNVKITDESLF-QVMK 271
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKL 445
L ++ L L+ N L S+P F L SL + L N
Sbjct: 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 31/293 (10%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
SIP + ++ L L +N + + L NL L L N ++ +I + F +L S
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 195 LSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIP--SELGNLRSLSMLSLGYN 251
L L L YN S ++ S L++L L L N ++ S +L L +L +G
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVGNM 159
Query: 252 KLSGSIPH-SLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSL 309
I LT L L + + L S + +++++S L L + ++ +
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218
Query: 310 GNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
+++ L + + L ++LS SL + +
Sbjct: 219 DVTSSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS-LGNLTNLATLDLYDNSL 421
SLF + L + L L N+L S+P LT+L + L+ N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 7e-35
Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 20/284 (7%)
Query: 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIP 282
+ SL +SIPS L ++ L L N+++ L NL L L N ++ +I
Sbjct: 37 KGSSGSL-NSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 283 SE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLS 340
+ F +L SL L+L YN L+ + L++L L + N + + +L L
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152
Query: 341 NLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNKLS 398
L + I L+ L L + ++ L S + L +++++S L L +
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSE--------FGNLRSLSTLSLGYNKLSGSIP 450
+ + +++ L+L D L SE + + + L +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 451 HSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNKL 493
L ++ L L N L S+P I L S+ + L+ N
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 60/297 (20%), Positives = 102/297 (34%), Gaps = 32/297 (10%)
Query: 415 DLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP 474
SL+ SIPS G ++ +L L N+++ L NL AL L N ++
Sbjct: 37 KGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 475 GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIP--SELGNLRSLS 532
+L S+ +L L+ N LS LS+L L L N ++ S +L L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQ 152
Query: 533 MLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
+L I L FL +L + + L L
Sbjct: 153 ILRVGNMDTFTKIQR--KDFA---------------GLTFLEELEIDASDLQSYEPKSLK 195
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNN--------QFSRGIPIKLEELIH 644
S+ + HL L + + + L L + + S G L +
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 645 LSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
+ ++ L + + + + L L S N L + F+++ L +I + N
Sbjct: 256 FRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 48/253 (18%), Positives = 88/253 (34%), Gaps = 17/253 (6%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHL 120
+ + +L L L N + I ++ L++LDLS N + L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPL 123
Query: 121 SYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPP-SLGNLSNLDTLHLYD 178
S L L L N + L+ L L + + I L+ L+ L +
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL----FDSIP 234
+ L P +++++S L L + + + +++ L L + L F +
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 235 S----ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLR 289
+ L + + + L + L ++ L L N L S+P F L
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT 301
Query: 290 SLSMLNLGYNKLN 302
SL + L N +
Sbjct: 302 SLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 67/337 (19%), Positives = 118/337 (35%), Gaps = 48/337 (14%)
Query: 349 LSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL 408
S + S SL +SIPS L ++ L L N+++ L
Sbjct: 19 KEESSNQASLSCDRNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNNRITYISNSDLQRC 75
Query: 409 TNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYD 466
NL L L N ++ +I + F +L SL L L YN LS ++ S L++L L L
Sbjct: 76 VNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 467 NSLSGSIPGEI-GNLRSISNLALNNNKLSGSIP-QSLGNLSNLVILYLYNNSLFDSIPSE 524
N + +L + L + N I + L+ L L + + L S +
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPK 192
Query: 525 -LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQL 583
L +++++S L + + +D + + L L L
Sbjct: 193 SLKSIQNVSHLILHMKQHI-LLLE--IFVD---------------VTSSVECLELRDTDL 234
Query: 584 SGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELI 643
+ LS S + +++ + + L ++
Sbjct: 235 DT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQIS 277
Query: 644 HLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSL 679
L EL+ S N L+ ++P I + SL+ + L N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 4/163 (2%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLS 603
+ ++ LDLS+N I ++L + L L+L N ++ + SL LEHLDLS
Sbjct: 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS 108
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPSQ 662
N LSN F L L +LNL N + L L L L + + I +
Sbjct: 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 663 I-CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ LE L + + L P + + + + + +
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 58/301 (19%), Positives = 121/301 (40%), Gaps = 61/301 (20%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
R DF+ C+G+GG G V++A+ A+K+ LP +++ + EVKAL +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59
Query: 871 IRHRNIVKFYG-------------------------FCSHVRHSLAMILSNNAAAKDLGW 905
+ H IV+++ C + +L ++ ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR--KENLKDWMNGRCTIEERER 117
Query: 906 TRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK----- 960
+ +++ I++A+ ++H+ ++HRD+ N+ D+ V DFG+ +
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 961 -------PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013
P + T GT Y++PE + + K D++S G++ E++ +P F +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FST 229
Query: 1014 SMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
M ++ + P L T + ++ L +P RP ++
Sbjct: 230 QMERVRTLTDVRNLKF--PPLFTQKYPCEYVMVQ------DMLSPSPMERPE---AINII 278
Query: 1074 K 1074
+
Sbjct: 279 E 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 49/276 (17%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IG+G +VYK + + VA + L +Q F E + L ++H NIV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE--RQRFKEEAEMLKGLQHPNIVRF 90
Query: 880 YGFCSHVRH---------------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
Y +L L K + + + I L ++H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH- 146
Query: 925 DCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
PPI+HRD+ N+ + + D G+A + + + GT ++APE+ Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YE 203
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS-----SSLNLNIALDEMLDPRLPTPS 1038
K E DVY+FG+ LE+ ++P + + +S + D++ P
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------ 257
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ I+E C+ +N + R + + LL
Sbjct: 258 -----EVKEIIE---GCIRQNKDERYS---IKDLLN 282
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 11/219 (5%)
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
++P + ++L+ N +S + F R+L++L L N L I + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 316 ATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSL 373
L + +N+ S+ L L L L L + P L+ L LYL N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 374 FDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGN 431
++P + +L +L+ L L N++S + L +L L L+ N ++ + F +
Sbjct: 142 -QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
Query: 432 LRSLSTLSLGYNKLSGSIPHS-LGNLTNLDALYLYDNSL 469
L L TL L N LS ++P L L L L L DN
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 9/224 (4%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSL 165
+P I + + + L N+++ +L L L+SN L + +
Sbjct: 19 PQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 166 GNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLY 223
L+ L+ L L DN+ S+ F L L L L + L L LY
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135
Query: 224 LHNNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIP 282
L +N+L ++P + +L +L+ L L N++S + L +L L L++N ++ +
Sbjct: 136 LQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH 193
Query: 283 SE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
F +L L L L N L+ + +L L L L +++N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 14/229 (6%)
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328
T + L ++P + + L N+++ + S NL L++H+N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-R 70
Query: 329 IPSEI-GNLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSE-LGNLR 385
I + L L L LS N S+ P+ L L TL+L L + L
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129
Query: 386 SLSMLSLGYNKLSGSIP-HSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
+L L L N L ++P + +L NL L L+ N +S S+P F L SL L L N
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN 187
Query: 444 KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNN 491
+++ PH+ +L L LYL+ N+LS ++P E LR++ L LN+N
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 10/227 (4%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
T L ++P I + + L GN++S S NL L+L+SN L
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRS 434
+ L L L L N S+ + L L TL L L + F L +
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130
Query: 435 LSTLSLGYNKLSGSIP-HSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
L L L N L ++P + +L NL L+L+ N +S L S+ L L+ N++
Sbjct: 131 LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 494 SGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYN 539
+ P + +L L+ LYL+ N+L ++P+E L LR+L L N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/194 (32%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHL 120
+ SF + +L L L N L I ++ L+ LDLS N ++ P L
Sbjct: 46 HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 121 SYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L TL L L + + L++L YL L N L+ L + +L NL L L+ N
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 180 SLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-L 237
+S S+P F L SL L L N+ + PH+ +L L TLYL N+L ++P+E L
Sbjct: 164 RIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEAL 221
Query: 238 GNLRSLSMLSLGYN 251
LR+L L L N
Sbjct: 222 APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/250 (22%), Positives = 88/250 (35%), Gaps = 24/250 (9%)
Query: 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
T S L ++P + ++L+ N +S R+++ L L++N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNKLSGSIPHSLGV 551
L+ + L+ L L L +N+ S+ L L L L + L
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL-- 124
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNS 610
L L L L N L L L L HL L NR+S+
Sbjct: 125 ---------------FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSV 168
Query: 611 IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLE 670
++F L L L L N+ + P +L L L L N L + +++L+
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228
Query: 671 NLNLSHNSLV 680
L L+ N V
Sbjct: 229 YLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/222 (22%), Positives = 81/222 (36%), Gaps = 14/222 (6%)
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP-- 546
L ++P + + ++L+ N + + R+L++L N L+ I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 547 -----HSLGVLDLSSNHIVGEIPTE-LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEH 599
L LDLS N + + L L L L + L +L P LA L++
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 600 LDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAI 659
L L N L +F +L L +L L N+ S L L L L N +
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 660 PSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
P + L L L N+L L + L + ++ N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 34/144 (23%), Positives = 56/144 (38%), Gaps = 3/144 (2%)
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
+P + ++ L N++S + + L L L SN L+ +F L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 622 HYLNLSNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
L+LS+N R + L L L L L+E P + +L+ L L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 681 GLIPSCFEKMHGLLRIDISYNELQ 704
L F + L + + N +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 57/291 (19%), Positives = 113/291 (38%), Gaps = 59/291 (20%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQ-QEFLNEVKALT 869
R DF + IG GG G V+KA+ G+ +K + + ++ EVKAL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59
Query: 870 EIRHRNIVKFYGFCSHVRHSLAMILSNNAAAK--------------DLG-WTRR------ 908
++ H NIV + G + N++ +K L W +
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 909 -----MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
+ + + I+ + Y+H+ +++RD+ N+ L + + DFG+ LK D
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN 1023
GT Y++PE + ++ D+Y+ G++ E++ + +S +
Sbjct: 177 KRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTD 230
Query: 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + ++++ L + PE RP S++L+
Sbjct: 231 L-------RDGIISDIFDKK-EKTLLQ---KLLSKKPEDRPN---TSEILR 267
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 71/279 (25%), Positives = 114/279 (40%), Gaps = 36/279 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTF--QQEFLNEVKALTEI 871
D++ + IG G G K + G+I+ K+ G MT +Q ++EV L E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLREL 62
Query: 872 RHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLG-----WTRR---------MNVIKGISD 917
+H NIV++Y ++ I+ DL T+ + V+ ++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 918 ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
AL H +D ++HRD+ NV LD + DFG+A+ L D+S GT Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
++PE M EK D++S G L E+ P F + S L I
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKI----REGKFRR 235
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P + L I+ L+ RP+ V ++L+
Sbjct: 236 IPYRYSDE-LNEIIT---RMLNLKDYHRPS---VEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 871
+F E IG+G VY+A L G VA+KK + M + + + E+ L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89
Query: 872 RHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRR-MNVIKGISDAL 919
H N++K+Y L+ ++ + K L R + AL
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
+MH+ ++HRDI NV + + D G+ +F ++ L GT Y++PE
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS-SMSSSSLNLNIALDEMLDPRLPTPS 1038
+ K D++S G L E+ + P F M+ SL I P PS
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKI----EQCDYPPLPS 260
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLKI 1075
++L +V C++ +PE RP V+ + +
Sbjct: 261 DHYSEELRQLVN---MCINPDPEKRPD---VTYVYDV 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 32/258 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY- 880
+G GG +VY AE VA+K P + + F EV +++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 881 -GFCSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
+ L M + ++ L +N I D + + H+
Sbjct: 79 VDE-EDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYTMKV 986
IVHRDI +N+L+D + + DFGIAK L ++ T+ + GT Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 987 TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046
E D+YS G++ E++ G+ P + +++S IA+ + D + + +D
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 1047 SIVEVAISCLDENPESRP 1064
S+ V + +++ +R
Sbjct: 243 SLSNVILRATEKDKANRY 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 48/283 (16%)
Query: 816 DFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHR 874
F + +G G +G++ + VAVK+ EV+ L E H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78
Query: 875 NIVKFYGFCSHVRHS-LAM----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
N+++++ + +A+ + + A L + +++ + L+++H
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHLH 135
Query: 924 NDCFPPIVHRDISSKNVLLDFDNE-----AHVSDFGIAKFLKPDSS---NWTELAGTYGY 975
+ IVHRD+ N+L+ N A +SDFG+ K L + + GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 976 VAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLD 1031
+APE+ T D++S G + VI +G HP ++ L +LD
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD--CL 250
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
I ++ LI + +P+ RP+ +LK
Sbjct: 251 HPEKHEDVIARE-LIE------KMIAMDPQKRPSA---KHVLK 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 41/277 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 871
+ IG+G G + G +K+ + M+ + +E EV L +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANM 80
Query: 872 RHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG--------------ISD 917
+H NIV++ S + I+ + DL +R+N KG I
Sbjct: 81 KHPNIVQYRE--SFEENGSLYIVMDYCEGGDLF--KRINAQKGVLFQEDQILDWFVQICL 136
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
AL ++H+ I+HRDI S+N+ L D + DFGIA+ L GT Y++
Sbjct: 137 ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
PE+ K D+++ G + E+ KH F + S +L L I P +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLKIISGSF--PPVSL- 247
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L S+V NP RP+ V+ +L+
Sbjct: 248 --HYSYDLRSLVS---QLFKRNPRDRPS---VNSILE 276
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/261 (25%), Positives = 107/261 (40%), Gaps = 33/261 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY- 880
+G GG V+ A L VAVK + L + +F F E + + H IV Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 881 ----GFCSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
+ + M I+ + R + VI AL++ H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN- 135
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYT 983
I+HRD+ N+++ N V DFGIA+ + ++ T+ + GT Y++PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
V + DVYS G + EV+ G+ P S +S +A + + PS +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVRED-PIPPSARHEG 245
Query: 1044 KLISIVEVAISCLDENPESRP 1064
+ V + L +NPE+R
Sbjct: 246 LSADLDAVVLKALAKNPENRY 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 32/257 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+GG G VY+AE IVA+K L + F+ E + ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 882 F-CSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
F + + M +L L R + +++ I AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYTMKVT 987
HRD+ +N+L+ D+ A++ DFGIA T+L GT Y+APE T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047
+ D+Y+ + E + G P + L++ + +P PS + ++
Sbjct: 214 YRADIYALTCVLYECLTGSPP--YQGD------QLSVMGAHINQA-IPRPSTVRPGIPVA 264
Query: 1048 IVEVAISCLDENPESRP 1064
V + +NPE R
Sbjct: 265 FDAVIARGMAKNPEDRY 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 73/316 (23%), Positives = 127/316 (40%), Gaps = 43/316 (13%)
Query: 776 QRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATN---DFDDEHCIGKGGQGSVY 832
++ + + G+++ F+ + ++ + D IG+G G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAAL--RMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 833 KA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-- 889
A E SG VAVK L + ++ NEV + + +H N+V+ Y S++
Sbjct: 63 LAREKHSGRQVAVKMM--DLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEEL 117
Query: 890 -LAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMHNDCFPPIVHRDISSKNVLL 942
+ M A D+ R+N V + + AL+Y+H ++HRDI S ++LL
Sbjct: 118 WVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174
Query: 943 DFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 1002
D +SDFG + D L GT ++APE+ + D++S G++ +E+
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 1003 IKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK----LISIVEVAISCLDE 1058
+ G+ P S + A+ P P K L +E L
Sbjct: 235 VDGEPPYFSDSPVQ--------AM--KRLRDSPPPKLKNSHKVSPVLRDFLER---MLVR 281
Query: 1059 NPESRPTMPKVSQLLK 1074
+P+ R T +LL
Sbjct: 282 DPQERAT---AQELLD 294
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 20/279 (7%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203
L++ +A + + D + +L + TL + ++ L +L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 263
+ + + L NLT + L L N L S + L+S+ L L +++ P L
Sbjct: 74 QIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 264 LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
L+NL LYL N ++ +I S L +L L++G +++ + P L NL+ L TL +N
Sbjct: 128 LSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183
Query: 324 SLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383
+S S + +L +L + L N++S + P L SNL + L + ++ + N
Sbjct: 184 KISDI--SPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 384 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
L +++ P ++ + A+ +L N S
Sbjct: 240 LVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 20/284 (7%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F + + + + + + ++ + L T + +L+ L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGL 68
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
+L +NQ+ + + L+ + L L N L+++ + L ++ TL L ++D P
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
L +L +L L N+ + +I L LTNL L + N + D + L NL L+ L
Sbjct: 125 --LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTL 178
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
NK+S I L +L NL ++L N +S S N +L ++ L +
Sbjct: 179 KADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPV 234
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS 350
NL + S + P+ I + + ++ L+ N S
Sbjct: 235 FYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 19/270 (7%)
Query: 95 NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS 154
++ + + T L + TL F + +I + L++L L L
Sbjct: 17 ALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 155 NYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG 214
N + DL P L NL+ + L L N L + S L+S+ L L + + P L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 215 NLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE 274
L+NL LYL N + + S L L +L LS+G ++S P L NL+ L TL +
Sbjct: 127 GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 275 NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334
N +S S +L +L ++L N+++ + P L N +NL + + N +++
Sbjct: 183 NKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 335 NLRSLSNL-GLSGNKLSGSIPPSLGYLSNL 363
NL + + G SG ++ + G ++
Sbjct: 239 NLVVPNVVKGPSGAPIAPATISDNGTYASP 268
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 66/299 (22%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 357 LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDL 416
L+N + +++ D +L ++ LS ++ +I + L NL L+L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476
DN ++ + NL ++ L L N L ++ ++ L ++ L L ++ P
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP-- 124
Query: 477 IGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSF 536
+ L ++ L L+ N+++ +I L L+NL L + N + D + L NL L+ L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKA 180
Query: 537 AYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQ 596
NK+S D+S L L LI++ L NQ+S +SP L + +
Sbjct: 181 DDNKIS----------DISP----------LASLPNLIEVHLKNNQIS-DVSP-LANTSN 218
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFL 655
L + L++ ++N NLV + + P + + + +L+ N
Sbjct: 219 LFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 20/262 (7%)
Query: 453 LGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYL 512
L N + ++++ ++ +L I+ L+ ++ +I + L+NL+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP----HSLGVLDLSSNHIVGEIPTELG 568
+N + D + L NL ++ L + N L S+ LDL+S I P L
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 569 KLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628
L+ L L L NQ++ +SP L L L++L + + ++S+ P NL KL L +
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 629 NQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFE 688
N+ S P L L +L E+ L +N + + P + +L + L++ ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 689 KMHGLLRIDISYNELQGPIPNS 710
+ + P S
Sbjct: 239 NLVVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 16/236 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
+L L+L NQ+ ++ P + N++++ L+LS N I L +KTL L
Sbjct: 59 VQYLNNLIGLELKDNQI-TDLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDL 114
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
Q+ P + LS+L L L N + ++ P L L+NL L + + +SD +
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL--TP 168
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
NL L+ L NK S I L +L NL ++L NN + D S L N +L +++L
Sbjct: 169 LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTL 224
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304
++ NL + + P+ + + + NL +N + I
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTSFI 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ IG+G G+VY A ++A+G+ VA+++ L + + +NE+ + E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKE-LIINEILVMRENK 75
Query: 873 HRNIVKFYGFCSHVRHS---LAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMH 923
+ NIV + S++ + M + D+ M+ V + AL ++H
Sbjct: 76 NPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
++ ++HRDI S N+LL D ++DFG + P+ S + + GT ++APE+
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
K D++S G++A+E+I+G+ P + + AL L TP +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------AL--YLIATNGTPELQNPE 240
Query: 1044 K----LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
K + CL+ + E R + +LL+
Sbjct: 241 KLSAIFRDFLNR---CLEMDVEKRGS---AKELLQ 269
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 39/273 (14%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
F IGKG G V+K + + ++VA+K L ++ E+ L++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 875 NIVKFYGFCSHVRHS---LAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMHND 925
+ K+YG S+++ + + M +A DL ++ +++ I L Y+H++
Sbjct: 81 YVTKYYG--SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
+HRDI + NVLL E ++DFG+A L GT ++APE+
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 986 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK- 1044
K D++S G+ A+E+ +G+ P + M L L P+ P+ ++
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMK--------VL--FLIPKNNPPT--LEGNY 243
Query: 1045 ---LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L VE CL++ P RPT +LLK
Sbjct: 244 SKPLKEFVEA---CLNKEPSFRPT---AKELLK 270
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 60/302 (19%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
R +DF++ +G+G G V KA A+KK + L+EV L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58
Query: 871 IRHRNIVKFYGFCSHVRHSLAMILSNNAAAK-----------DL-GWTRRMN-------- 910
+ H+ +V++Y R+ + + + + L N
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 911 --VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE 968
+ + I +ALSY+H+ I+HRD+ N+ +D + DFG+AK +
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 969 LA--------------GTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013
+ GT YVA E L T EK D+YS G++ E+I F +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FST 230
Query: 1014 SMSSSSLNLNIALDEM-LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072
M ++ + + P V+ K+I +D +P RP L
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG---ARTL 281
Query: 1073 LK 1074
L
Sbjct: 282 LN 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 65/315 (20%), Positives = 114/315 (36%), Gaps = 44/315 (13%)
Query: 778 RNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKA-EL 836
+ + Q+ P +LT + K V E + + +G+G G V++ +
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 837 ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-------- 888
+G AVK ++ + + E+ A + IV YG
Sbjct: 81 QTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 889 ---SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945
SL ++ + R + + + L Y+H I+H D+ + NVLL D
Sbjct: 133 EGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186
Query: 946 -NEAHVSDFGIAKFLKPDSSNWTE-----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 999
+ A + DFG A L+PD + + GT ++APE+ K D++S +
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 1000 LEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDEN 1059
L ++ G HP L L IA + P P ++ L +
Sbjct: 247 LHMLNGCHPWTQYFRG---PLCLKIASEPP--PIREIPPSCAPL-TAQAIQ---EGLRKE 297
Query: 1060 PESRPTMPKVSQLLK 1074
P R + +L +
Sbjct: 298 PVHRAS---AMELRR 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 54/287 (18%), Positives = 97/287 (33%), Gaps = 52/287 (18%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ +G+GG V E L G A+K+ E ++E E H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHP 86
Query: 875 NIVKFYG-----------------FCSHVRHSLAMILSNNAAAKDLGWTRR--MNVIKGI 915
NI++ F R +L + K T + ++ GI
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFK--RGTLWNEI-ERLKDKGNFLTEDQILWLLLGI 143
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA----- 970
L +H HRD+ N+LL + + + D G +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 971 ----GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022
T Y APEL ++ + + E+ DV+S G + ++ G+ P +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVA 257
Query: 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+++ P+ P S + L++ S + +P RP +P +
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQ-LLN------SMMTVDPHQRPHIPLL 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 71/297 (23%), Positives = 114/297 (38%), Gaps = 22/297 (7%)
Query: 147 LNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS 206
+ S ++ + P + +L S++D++ L S+ + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 207 GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
S+ + L N+ L+L+ N L D L NL++L L L NK+ + SL +L
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110
Query: 267 LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326
L +L L N +S I +L L L LG NK+ I L LT L TL + +N +S
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 166
Query: 327 GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRS 386
I + L L NL LS N +S + L L NL L L+S + + NL
Sbjct: 167 -DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 387 LSMLSLGYNKLSG----SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLS 439
+ + L S L + N +S ++ +
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 279
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 65/299 (21%), Positives = 107/299 (35%), Gaps = 43/299 (14%)
Query: 219 LATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS 278
+ + + P +L ++ ++ L ++ + + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 279 GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338
S+ L +++ L L NKL I P L NL NL L++ N + + S + +L+
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
L +L L N +S I L +L L +LYL +N + D + L L L LSL N++S
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458
I L LT L L L N +S L L+ L N
Sbjct: 167 -DIV-PLAGLTKLQNLYLSKNHIS-----------DLRALA---------------GLKN 198
Query: 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS-LGNLSNLVILYLYNNS 516
LD L L+ NL + + + L S G+ + +
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-26
Identities = 61/315 (19%), Positives = 112/315 (35%), Gaps = 62/315 (19%)
Query: 363 LATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
+ S + P +L ++ ++ L ++ + ++ +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 423 GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRS 482
S+ L +++ L L NKL+ I L NL NL L+L +N + + + +L+
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110
Query: 483 ISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
+ +L+L +N +S I L +L L LYL NN + D + L L L LS N++S
Sbjct: 111 LKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 543 GSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
D+ L L +L++L L
Sbjct: 167 ----------DIVP----------------------------------LAGLTKLQNLYL 182
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQ 662
S N +S+ ++ L L L L + + L+ + + + L P
Sbjct: 183 SKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 238
Query: 663 ICIMQSLENLNLSHN 677
I E N+ +
Sbjct: 239 ISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 68/311 (21%), Positives = 113/311 (36%), Gaps = 44/311 (14%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F +F +L + + ++ + + +++ +I +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS--------DIKSVQ----- 59
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
I L ++ L L N L D+ P L NL NL L L +N + D
Sbjct: 60 -------------GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS 104
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
+L+ L LSL +N S I L +L L +LYL NN + D + L L L L
Sbjct: 105 --LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 158
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
SL N++S I L LT L LYL +N +S + L++L +L L +
Sbjct: 159 SLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPI 214
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366
+ NL T+ + SL P I + + + + ++
Sbjct: 215 NHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP--EFTNEVSFIFYQPVT 270
Query: 367 YLYSNSLFDSI 377
+ + F
Sbjct: 271 IGKAKARFHGR 281
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-23
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 34/258 (13%)
Query: 453 LGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYL 512
L S++ ++ L SI + NN+ + S+ Q + L N+ L+L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNF 572
N L D L NL++L L NK+ DLSS L L
Sbjct: 73 NGNKLTDI--KPLTNLKNLGWLFLDENKIK----------DLSS----------LKDLKK 110
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
L L L N +S ++ L L QLE L L +N++++ L KL L+L +NQ S
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHG 692
+P L L L L LS N + + + +++L+ L L + + +
Sbjct: 167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 693 LLRIDISYNELQGPIPNS 710
+ + L P S
Sbjct: 223 PNTVKNTDGSLVTPEIIS 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 58/282 (20%), Positives = 93/282 (32%), Gaps = 50/282 (17%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
F +G G G V+K G + AVK+ SP G + L EV + +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEK 112
Query: 871 I-RHRNIVKFYG-------------FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS 916
+ +H V+ C SL L + ++
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGP---SLQQHCEAWG--ASLPEAQVWGYLRDTL 167
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
AL+++H+ +VH D+ N+ L + DFG+ L + + G Y+
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYM 223
Query: 977 APEL---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
APEL +Y DV+S G+ LEV L L P
Sbjct: 224 APELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGW--QQLRQGY-----LPPE 272
Query: 1034 LPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
S ++ ++ L+ +P+ R T LL
Sbjct: 273 FTAGLSSELRS-VLV------MMLEPDPKLRAT---AEALLA 304
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 53/290 (18%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKA 867
+ D IG+G G V+ L + VAVK LP ++ + +FL E +
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARI 165
Query: 868 LTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGIS 916
L + H NIV+ G C+ + L L + ++ +
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAA 223
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----------- 965
+ Y+ + C +HRD++++N L+ N +SDFG+++
Sbjct: 224 AGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNI 1024
WT APE + + + DV+SFG+L E G P ++S+ +
Sbjct: 281 WT---------APEALNYGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFV 328
Query: 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
RLP P ++ + C P RP+ + Q L+
Sbjct: 329 EKGG----RLPCPELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 42/274 (15%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
FD +G+G GSVYKA +G+IVA+K+ P+ ++ QE + E+ + + +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85
Query: 876 IVKFYGFCSHVRHS---LAMILSNNAAAKDL--GWTRRMN------VIKGISDALSYMHN 924
+VK+YG S+ +++ + M + D+ + + +++ L Y+H
Sbjct: 86 VVKYYG--SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
+HRDI + N+LL+ + A ++DFG+A L + + GT ++APE+ +
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
D++S G+ A+E+ +GK P I M A+ + P P P+ +
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AI--FMIPTNPPPTFRKPEL 250
Query: 1045 ----LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
V+ CL ++PE R T +QLL+
Sbjct: 251 WSDNFTDFVKQ---CLVKSPEQRAT---ATQLLQ 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 62/292 (21%), Positives = 124/292 (42%), Gaps = 48/292 (16%)
Query: 807 YEEIIRATN---DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFL 862
YE + R + ++ +G G G VYKA +G + A K E + +++
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYI 64
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRHS---LAMILSNNAAAKDL--GWTRRMN------V 911
E++ L H IVK G ++ + + A + R + V
Sbjct: 65 VEIEILATCDHPYIVKLLG--AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
+ + +AL+++H+ I+HRD+ + NVL+ + + ++DFG++ G
Sbjct: 123 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 972 TYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026
T ++APE+ + + K D++S G+ +E+ + + P ++ M L
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VL 231
Query: 1027 DEMLDPRLPTPSCIVQDK----LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + P+ + K +++ LD+NPE+RP+ +QLL+
Sbjct: 232 --LKIAKSDPPTLLTPSKWSVEFRDFLKI---ALDKNPETRPS---AAQLLE 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 75/303 (24%), Positives = 130/303 (42%), Gaps = 58/303 (19%)
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
+E+ ++ N E +G G G+V G VAVK+ F L E+K
Sbjct: 9 FEQSLK--NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIK 60
Query: 867 ALTEI-RHRNIVKFYGFCSHVRHS-LAM----------ILSNNAAAKDLGWTRRM---NV 911
LTE H N++++Y + R +A+ + S N + ++L + ++
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH-------------VSDFGIAKF 958
++ I+ ++++H+ I+HRD+ +N+L+ + +SDFG+ K
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 959 LKPDSSNWT----ELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KGK 1006
L S++ +GT G+ APEL ++T D++S G + ++ KGK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 1007 HPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTM 1066
HP S S+ + +LDEM + D LIS +D +P RPT
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPTA 290
Query: 1067 PKV 1069
KV
Sbjct: 291 MKV 293
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 35/295 (11%), Positives = 73/295 (24%), Gaps = 62/295 (21%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+ G + V+ ++ E A+K F + + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 882 FCSHVRHSLAMILSNN-----------------------AAAKDLG-------------- 904
+ S A+ + + AA+ DL
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 905 ---WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961
+ + + + + +VH + N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---WK 243
Query: 962 DSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS 1019
+ + Y E A T T + + G+ V P + +
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG-LVTPGIKG 302
Query: 1020 LNLNIALDEMLDPRLPTPSCI-----VQDKLISIVEVAISCLDENPESRPTMPKV 1069
+L L SC V+ LI L+ + R +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRRLLPLEA 350
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 27/287 (9%)
Query: 220 ATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
+ + +L ++ ++ L ++ + + +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
S+ L +++ L L NKL I P L NL NL L++ N + + S + +L+ L
Sbjct: 60 SV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKL 114
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
+L L N +S I L +L L +LYL +N + D + L L L LSL N++S
Sbjct: 115 KSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS- 169
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
I L LT L L L N +S + L++L L L + + NL
Sbjct: 170 DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLA-LNNNKLSGSIPQSLGNLS 505
+ + D SL IS+ + +P+ +S
Sbjct: 227 NTVKNTDGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 20/271 (7%)
Query: 152 LYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH 211
++ + + +L S++D++ L S+ + + S+
Sbjct: 9 TVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ- 62
Query: 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLY 271
+ L N+ L+L+ N L D L NL++L L L NK+ + SL +L L +L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS 118
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPS 331
L N +S I +L L L LG NK+ I L LT L TL + +N +S I
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-V 172
Query: 332 EIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLS 391
+ L L NL LS N +S + L L NL L L+S + + NL + +
Sbjct: 173 PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 392 LGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
L P + + + ++ +
Sbjct: 231 NTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 18/243 (7%)
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
+ I + S++ ++ L S+ + + + + S+ +
Sbjct: 12 TPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQ 65
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
YL N+ L+L N L D L NL++L L L NK+ + SL +L L +L L
Sbjct: 66 YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
N +S I +L L +L LG NK++ L LT LD L L DN +S I +
Sbjct: 122 NGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LA 175
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
L + NL L+ N +S + ++L L NL +L L++ + + NL + +
Sbjct: 176 GLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 539 NKL 541
L
Sbjct: 234 GSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 18/256 (7%)
Query: 143 RLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY 202
+ L + D + L+++D + ++ + L +++ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 203 NKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 262
NK + I L NL NL L+L N + D S L +L+ L LSL +N +S I L
Sbjct: 78 NKLT-DIK-PLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
+L L +LYL N + + + L L L+L N+++ I+P L LT L LY+
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N +S + + L++L L L + L T+ SL P +
Sbjct: 188 NHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIIS 243
Query: 383 NLRSLSMLSLGYNKLS 398
+ ++ ++
Sbjct: 244 DDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 42/284 (14%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
FS +F +L + + ++ + + +++ +I + ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS--------DIKSVQGIQYL 67
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
++ L L N L D+ P L NL NL L L +N + D
Sbjct: 68 P------------------NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-- 105
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
S +L+ L LSL +N S I L +L L +LYL NN + D + L L L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
SL N++S I L LT L LYL +N +S + L++L +L L +
Sbjct: 162 SLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPI 217
Query: 307 HSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS 350
+ NL T+ + SL P I + + +
Sbjct: 218 NHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 364 ATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSG 423
+ + +L ++ ++ L ++ + ++ +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
S+ L +++ L L NKL+ I L NL NL L+L +N + + + +L+ +
Sbjct: 60 SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKL 114
Query: 484 SNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543
+L+L +N +S I L +L L LYL NN + D + L L L LS N++S
Sbjct: 115 KSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS- 169
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
D+ L L L L L++N +S L L L L+ L+L
Sbjct: 170 ---------DIVP----------LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELF 208
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFL 655
S N NLV + + ++ P + + + ++ +
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLP 258
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 18/232 (7%)
Query: 453 LGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYL 512
L S++ ++ L SI + NN+ + S+ Q + L N+ L+L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP----HSLGVLDLSSNHIVGEIPTELG 568
N L D L NL++L L NK+ L L L N I L
Sbjct: 76 NGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI--SDINGLV 131
Query: 569 KLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628
L L L L N+++ ++ L L +L+ L L N++S+ +P L KL L LS
Sbjct: 132 HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 629 NQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
N S L L +L L+L + + + + SLV
Sbjct: 188 NHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 16/223 (7%)
Query: 230 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNL 288
F IP L S L L +N L +S + L L L + +I + +L
Sbjct: 19 FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSL 75
Query: 289 RSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGN 347
LS L L N + + + L++L L +L+ S+ + G+L++L L ++ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 348 KLSGSIPPSL-GYLSNLATLYLYSNSLFDSIPSE----LGNLRSLSM-LSLGYNKLSGSI 401
+ P L+NL L L SN + SI L + L++ L L N ++ I
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 402 PHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
L L L N L S+P F L SL + L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+ L L N L F + L +L+L ++ I + +L++L+TL + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 325 LSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFDSIPSE-- 380
+ S+ L SL L L+ S+ G+L L L + N + S
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFKLPEY 144
Query: 381 LGNLRSLSMLSLGYNKLSGSIPH----SLGNLTNLA-TLDLYDNSLSGSIPSE-FGNLRS 434
NL +L L L NK+ SI L + L +LDL N ++ I F +R
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR- 201
Query: 435 LSTLSLGYNKLSGSIPH-SLGNLTNLDALYLYDN 467
L L+L N+L S+P LT+L ++L+ N
Sbjct: 202 LKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/210 (29%), Positives = 85/210 (40%), Gaps = 18/210 (8%)
Query: 77 YLDLWHNQLYGNIPP-QIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLN 134
LDL N L ++ + L+ LDLS TI LS+L TL L N +
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 135 GSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE--FGN 191
S+ LSSL L L L +G+L L L++ N + S F N
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147
Query: 192 LRSLSMLSLGYNKFSGSIPH----SLGNLTNLA-TLYLHNNSLFDSIPSELGNLRSLSML 246
L +L L L NK SI L + L +L L N + + I L L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKEL 205
Query: 247 SLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
+L N+L S+P LT+L ++L+ N
Sbjct: 206 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 26/227 (11%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDN 467
+ LDL N L F + L L L ++ +I +L++L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 468 SLSGSIPGEI-GNLRSISNLALNNNKLSGSIP-QSLGNLSNLVILYLYNNSLFDSIPSE- 524
+ S+ L S+ L L+ S+ +G+L L L + +N + S
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI-QSFKLPE 143
Query: 525 -LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFL-IKLILAQNQ 582
NL +L L + NK+ SI L L ++ L + L L+ N
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYC--TDLR------------VLHQMPLLNLSLDLSLNP 188
Query: 583 LSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNN 629
++ + P +L+ L L +N+L + F L L + L N
Sbjct: 189 MN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 26/226 (11%)
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL-GNLRSLSMLSFAYNK 540
S NL L+ N L S + L +L L + +I +L LS L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 541 LSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHL 600
+ S+ + L L KL+ + L+ + +G L L+ L
Sbjct: 88 IQ-SLAL--------------GAFSGLSSLQ---KLVAVETNLASLENFPIGHLKTLKEL 129
Query: 601 DLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQF---SRGIPIKLEELIHLS-ELDLSHNFL 655
+++ N + + +P+ F NL L +L+LS+N+ L ++ L+ LDLS N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 656 REAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
I L+ L L N L + F+++ L +I + N
Sbjct: 190 NF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 7/166 (4%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLS 603
+P S LDLS N + L L L++ ++ + SL+ L L L+
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQI 663
N + + +F L L L + + L L EL+++HN ++ +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 664 CI-MQSLENLNLSHNSLVGLIPSCFEKMHGL----LRIDISYNELQ 704
+ +LE+L+LS N + + + +H + L +D+S N +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-28
Identities = 57/265 (21%), Positives = 94/265 (35%), Gaps = 56/265 (21%)
Query: 820 EHCIGKGGQGSVYKAE--LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+ CI GG G +Y A +G V +K G+ Q + E + L E+ H +IV
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 878 KFYGFCSHVRH----------------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
+ + F H SL + L + + I ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H+ +V+ D+ +N++L + + + D G + L GT G+ APE+
Sbjct: 198 LHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEIV 249
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM--LDPRLPTPSC 1039
T T D+Y+ G + R+ +D + DP L T
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRN------------GRYVDGLPEDDPVLKTYD- 295
Query: 1040 IVQDKLISIVEVAISCLDENPESRP 1064
S + +D +P R
Sbjct: 296 -------SYGRLLRRAIDPDPRQRF 313
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 11/210 (5%)
Query: 188 EFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
E + S ++ + ++P L + L+L N L+ + L L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307
L +L+ + G L L TL L N L S+P L +L++L++ +N+L +
Sbjct: 62 LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 308 SLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLAT 365
+L L L LY+ N L ++P + L L L+ N L+ +P L L NL T
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176
Query: 366 LYLYSNSLFDSIPSELGNLRSLSMLSLGYN 395
L L NSL +IP L L N
Sbjct: 177 LLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/182 (30%), Positives = 69/182 (37%), Gaps = 8/182 (4%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131
L L N LY + +RL L+L T G L L TL L N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHN 87
Query: 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FG 190
QL S+P L +L L + N L L +L L L L+L N L ++P
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 191 NLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLG 249
L LSL N + +P L L NL TL L NSL +IP L L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLH 203
Query: 250 YN 251
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 29/225 (12%)
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
+ + ++ +L+ ++P + + L L N L +L T L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL- 525
L+ + G L + L L++N+L S+P L L +L + N L S+P
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGAL 120
Query: 526 GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG 585
L L L N+L ++P G+L L KL LA N L+
Sbjct: 121 RGLGELQELYLKGNELK-TLPP--GLLT---------------PTPKLEKLSLANNNLT- 161
Query: 586 QLSPKL-GSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNN 629
+L L L L+ L L N L +IPK F L + L N
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 52/225 (23%), Positives = 80/225 (35%), Gaps = 29/225 (12%)
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
+ + + +L+ ++P ++ + + L L+ N L +L + L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
L + L LG LDLS N + +P L L
Sbjct: 65 AEL-TKLQ--------------VDGTLP-----VLGTLDLSHNQLQ-SLPLLGQTLPALT 103
Query: 575 KLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR 633
L ++ N+L+ L L +L+ L L N L P KL L+L+NN +
Sbjct: 104 VLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162
Query: 634 GIPIKL-EELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHN 677
+P L L +L L L N L IP L L N
Sbjct: 163 -LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 28/204 (13%)
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGE 562
+++ + + +L ++P +P +L LS N +
Sbjct: 8 KVASHLEVNCDKRNL-TALPP--------------------DLPKDTTILHLSENLLYTF 46
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLH 622
L L +L L + +L G+L L LDLS N+L S+P L L
Sbjct: 47 SLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT 103
Query: 623 YLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPSQICI-MQSLENLNLSHNSLV 680
L++S N+ + +P+ L L EL L N L+ +P + LE L+L++N+L
Sbjct: 104 VLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
Query: 681 GLIPSCFEKMHGLLRIDISYNELQ 704
L + L + + N L
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 46/137 (33%), Positives = 63/137 (45%), Gaps = 6/137 (4%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQ 127
+ P L LDL HNQL ++P + L LD+S N ++P L L+ L
Sbjct: 73 DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELY 130
Query: 128 LFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
L N+L ++P + L L+L +N L +L L L NLDTL L +NSL +IP
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 187 SEFGNLRSLSMLSLGYN 203
F L L N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI- 871
F+ +G G G VYK + +G++ A+K + G+ ++E E+ L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78
Query: 872 RHRNIVKFYGFCSHVRHS---------LAMILSNNAAAKDL---GWTRRMN------VIK 913
HRNI +YG + ++ + L M + DL + + +
Sbjct: 79 HHRNIATYYG--AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTY 973
I LS++H ++HRDI +NVLL + E + DFG++ L GT
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 974 GYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028
++APE+ + + K D++S G+ A+E+ +G P + M AL
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------AL-- 243
Query: 1029 MLDPRLPTPSCIVQDKLIS--IVEVAISCLDENPESRPTMPKVSQLLK 1074
L PR P P ++ K S SCL +N RP QL+K
Sbjct: 244 FLIPRNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPAT---EQLMK 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 37/270 (13%)
Query: 822 CIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
+GKG G VY +L++ +A+K+ Q E+ ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85
Query: 881 GFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
G S SL+ +L + K I + L Y+H++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 930 IVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE--LAYTMKV 986
IVHRDI NVL++ + +SDFG +K L + GT Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 987 TEKCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIALDEMLDPRLPTP-SCIVQDK 1044
+ D++S G +E+ GK P + ++ + + + + P +P S +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFK-VHPEIPESMSAEAKAF 258
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + C + +P+ R + LL
Sbjct: 259 I-------LKCFEPDPDKRAC---ANDLLV 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 46/277 (16%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F D IG G G+VY A ++ + E+VA+KK Q+ + EV+ L ++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 876 IVKFYGFCSHVRHSLAMI----LSNNAAAKDLGWTRRMN------VIKGISDALSYMHND 925
+++ G ++R A + +A+ + + V G L+Y+H+
Sbjct: 116 TIQYRG--CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
++HRD+ + N+LL + DFG A + P +S GT ++APE+ M
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMD 226
Query: 986 VTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
+ K DV+S G+ +E+ + K P +++MS AL + +P+ +Q
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------AL--YHIAQNESPA--LQ 274
Query: 1043 DK-----LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ V+ CL + P+ RPT LLK
Sbjct: 275 SGHWSEYFRNFVDS---CLQKIPQDRPT---SEVLLK 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 63/298 (21%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+D++ + IG G V A E VA+K+ L T E L E++A+++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 874 RNIVKFYGFCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMN------VIKGIS 916
NIV +Y V+ L ++ + + AK + ++ +++ +
Sbjct: 73 PNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA------ 970
+ L Y+H + +HRD+ + N+LL D ++DFG++ FL + T
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKTFV 187
Query: 971 GTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA 1025
GT ++APE+ Y K D++SFG+ A+E+ G P M
Sbjct: 188 GTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPMK--------V 235
Query: 1026 LDEMLDPRLPTPSCIVQDKLISIVE---------VAISCLDENPESRPTMPKVSQLLK 1074
L ML + PS + +++ ++ CL ++PE RPT ++LL+
Sbjct: 236 L--MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPT---AAELLR 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/299 (19%), Positives = 107/299 (35%), Gaps = 63/299 (21%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
R T +F + IG G GSV+K + G I A+K+ PL G +Q L EV A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66
Query: 871 I-RHRNIVKFYG-------------FCSHVRHSLA-MILSNNAAAKDLGWTRRMNVIKGI 915
+ +H ++V+++ +C+ SLA I N +++ +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNG--GSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS-------------------DFGIA 956
L Y+H+ +VH DI N+ + + + + D G
Sbjct: 125 GRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 957 KFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM 1015
+ S+ G ++A E L K D+++ + + +
Sbjct: 182 TRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
I + PR+ P + Q+ +++ + +PE RP+ L+K
Sbjct: 238 ------HEIRQGRL--PRI--PQVLSQE-FTELLK---VMIHPDPERRPS---AMALVK 279
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 29/184 (15%), Positives = 71/184 (38%), Gaps = 10/184 (5%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203
+ L + ++ + +++L + L + +++D + ++ L++
Sbjct: 22 FKAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 263
+ P + L+NL L + + L L SL++L + ++ SI +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 264 LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
L + ++ L N I L L LN+ ++ ++ + + L LY +
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 324 SLSG 327
++ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 32/185 (17%), Positives = 75/185 (40%), Gaps = 10/185 (5%)
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
++ LG + I + + +L + + N +++ + + I ++ +L ++
Sbjct: 21 TFKAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
+ P + LSNL L + + L L SL++L + ++ SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L + ++DL N I L L +L++ ++ + + + L+ LY +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 467 NSLSG 471
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 29/185 (15%), Positives = 67/185 (36%), Gaps = 10/185 (5%)
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
++ LG + + + + +L + L +++ + + ++ L +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
P + L+NL L I ++ + L SL+ L +S + SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L + ++ L N I L L L L++ ++ + + + L L +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 419 NSLSG 423
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 30/185 (16%), Positives = 71/185 (38%), Gaps = 10/185 (5%)
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYS 370
+ +S + + SL+ + L+ ++ + + Y N+ L + +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 371 NSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG 430
+ + + L +L L + ++ +L LT+L LD+ ++ SI ++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
L ++++ L YN I L L L +L + + + I + ++ L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 491 NKLSG 495
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 27/181 (14%), Positives = 68/181 (37%), Gaps = 10/181 (5%)
Query: 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
++ LG + + + + +L + L N ++ D + + ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310
+ P + L+NL L + ++ L SL++L++ ++ + I +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYS 370
L + ++ + N I + L L +L + + + + L LY +S
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 371 N 371
Sbjct: 191 Q 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 34/185 (18%), Positives = 71/185 (38%), Gaps = 10/185 (5%)
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L ++S + + SL+ + L + + + N+ L I+N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
+ + I L +L L + G ++ P+L L++L L + ++ DSI +++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
L ++ + L YN I L L L +L++ + + + L+ L
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 443 NKLSG 447
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 26/181 (14%), Positives = 69/181 (38%), Gaps = 10/181 (5%)
Query: 335 NLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
++ N L + + + +++L + L + ++ D + + ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454
+ P + L+NL L + ++ L SL+ L + ++ SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L ++++ L N I + L + +L + + + + + L LY ++
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 515 N 515
Sbjct: 191 Q 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 27/181 (14%), Positives = 66/181 (36%), Gaps = 12/181 (6%)
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
++ LG + + + + +L + L + +++ + + ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLG 502
+ P + L+NL+ L + ++ + L S++ L ++++ SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP----HSLGVLDLSSNH 558
L + + L N I L L L L+ ++ + L L S
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQT 192
Query: 559 I 559
I
Sbjct: 193 I 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 34/163 (20%), Positives = 64/163 (39%), Gaps = 7/163 (4%)
Query: 93 IGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152
++ L Y+ L++ T I + +K L + P I LS+L L +
Sbjct: 40 EAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHS 212
+ P+L L++L L + ++ DSI ++ L ++ + L YN I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-P 154
Query: 213 LGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255
L L L +L + + + D + + L+ L + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-18
Identities = 29/203 (14%), Positives = 73/203 (35%), Gaps = 28/203 (13%)
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGE 562
+ L +S + +++ +L + L++ ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYI---------------------TLANINV--T 57
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLH 622
T + + + L + + +P + L+ LE L + +++ + L L
Sbjct: 58 DLTGIEYAHNIKDLTINNIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 623 YLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGL 682
L++S++ I K+ L ++ +DLS+N I + + L++LN+ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174
Query: 683 IPSCFEKMHGLLRIDISYNELQG 705
E L ++ + G
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 28/139 (20%), Positives = 50/139 (35%), Gaps = 5/139 (3%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
++ L + + N P I +S L+ L + P + L+ L L +
Sbjct: 62 IEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
+ + SI +I L +N + L N I P L L L +L++ + + D
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG-- 176
Query: 189 FGNLRSLSMLSLGYNKFSG 207
+ L+ L G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 18/120 (15%), Positives = 42/120 (35%), Gaps = 7/120 (5%)
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
+ + L + + + + L Y+ L+N + +E ++ +L +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 653 NFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
P I + +LE L + + + L +DIS++ I I
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 61/289 (21%), Positives = 101/289 (34%), Gaps = 53/289 (18%)
Query: 820 EHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIV 877
+ +GG VY+A+ + SG A+K+ S E + + EV + ++ H NIV
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 878 KFYGFCSHVRH------------------SLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
+F S + L L + L + + A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA--------- 970
+MH PPI+HRD+ +N+LL + DFG A +
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 971 ---GTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024
T Y PE+ + EK D+++ G + + +HP + L I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------DGAKLRI 261
Query: 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ P T + LI + L NPE R ++ +V L
Sbjct: 262 VNGKYSIPPHDTQYTVFHS-LIR------AMLQVNPEERLSIAEVVHQL 303
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 50/280 (17%), Positives = 88/280 (31%), Gaps = 39/280 (13%)
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
+ + + IPS+L R+ L KL + +L + + +N +
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 278 SGSIPSE-FGNLRSLSMLNL-GYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-G 334
I ++ F NL L + + N L I P + NL NL L I N + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125
Query: 335 NLRSLSNLGLSGNKLSGSIPPSL--GYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLS 391
+ L + N +I + G L+L N + I + + +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNL 184
Query: 392 LGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451
N L + LD+ + S+P +
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP-----------------------SY 220
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNN 491
L NL L A Y+ +P + L ++ +L
Sbjct: 221 GLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 52/280 (18%), Positives = 85/280 (30%), Gaps = 39/280 (13%)
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
+ E+ ++ IPS+ R+ L KL I + +L + I N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 326 SGSIPSEI-GNLRSLSNLGLS-GNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSEL- 381
I +++ NL L + + N L I P L NL L + + + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124
Query: 382 GNLRSLSMLSLGYNKLSGSIPH-SLGNLT-NLATLDLYDNSLSGSIPSEFGNLRSLSTLS 439
+ +L + N +I S L+ L L N + S F +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184
Query: 440 LGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ 499
N L + L + + S+P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP-----------------------SY 220
Query: 500 SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN 539
L NL L YN +P+ L L +L S Y
Sbjct: 221 GLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 58/331 (17%), Positives = 107/331 (32%), Gaps = 60/331 (18%)
Query: 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
+ + + IPS+L R+ L KL + +L +++ N +
Sbjct: 10 SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 422 SGSIPSE-FGNLRSLSTLSL-GYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGN 479
I ++ F NL L + + N L P + NL NL L + +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT-----------G 115
Query: 480 LRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN 539
++ + ++ + V+L + +N N+ ++ SF
Sbjct: 116 IKHLPDVHKIH-------------SLQKVLLDIQDNI----------NIHTIERNSFV-- 150
Query: 540 KLSGSIPHSLGVLDLSSNHIVGEIPTE-LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQL 597
+ +L L+ N I EI + N L +L +
Sbjct: 151 ----GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGP 204
Query: 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE 657
LD+S R+ + NL KL + N + +P LE+L+ L E L++
Sbjct: 205 VILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTY----- 255
Query: 658 AIPSQICIMQSLENLNLSHNSLVGLIPSCFE 688
PS C + + + E
Sbjct: 256 --PSHCCAFANWRRQISELHPICNKSILRQE 284
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 14/248 (5%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPS- 164
IP ++ L+ +L L + + N + ++I
Sbjct: 17 QESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 165 LGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATL 222
NL L + + + I E F NL +L L + +P + L
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 223 YLHNNSLFDSIPSEL--GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ +N +I G +L L N + I +S N T L L L +N+
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192
Query: 281 IPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
+P++ F +L++ +++ + + L NL L +N +P+ + L +L
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVAL 248
Query: 340 SNLGLSGN 347
L+
Sbjct: 249 MEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-22
Identities = 42/255 (16%), Positives = 84/255 (32%), Gaps = 19/255 (7%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNGS 136
+++ IP + L I L+ +++ +N +
Sbjct: 14 FLCQESKV-TEIPSDLP--RNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 137 IPYEI-GRLSSLNYLAL-YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLR 193
I ++ L L+ + + +N L + P + NL NL L + + + +P +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128
Query: 194 SLSMLSLGYNKFSGSIPH-SLGNLT-NLATLYLHNNSLFDSIPSE-LGNLRSLSMLSLGY 250
+L + N +I S L+ L+L+ N + I + + +
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDN 187
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSL 309
N L + L + + S+PS NL+ L + K +P +L
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TL 242
Query: 310 GNLTNLATLYIHNNS 324
L L + S
Sbjct: 243 EKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-22
Identities = 49/254 (19%), Positives = 88/254 (34%), Gaps = 36/254 (14%)
Query: 54 NLTSIGLKG----MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNL 108
N + ++ +FS F L +++ N + I + N+ +L + +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 109 FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNL 168
I PE F+N L +L YL + + ++ L +
Sbjct: 91 NLLYINPEA-----------FQN------------LPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 169 SNLDTLHLYDNSLSDSIPSE-FGNLRSLSM-LSLGYNKFSGSIPHSLGNLTNLATLYLHN 226
L + DN +I F L S+ L L N I +S N T L L L +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186
Query: 227 NSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEF 285
N+ + +P++ +L + ++ + L NL L Y +P+
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-L 242
Query: 286 GNLRSLSMLNLGYN 299
L +L +L Y
Sbjct: 243 EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 43/252 (17%), Positives = 77/252 (30%), Gaps = 31/252 (12%)
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
+ ++ ++ IP ++ R+ L KL + +L + + N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 518 FDSIP----SELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFL 573
+ I S L L + + N L I L L
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEK--ANNLL-YINPEA-----------------FQNLPNL 106
Query: 574 IKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIP-KSFGNL-VKLHYLNLSNNQF 631
L+++ + Q LD+ N ++I SF L + L L+ N
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 632 SRGIPIKLEELIHLSELDLSHNFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKM 690
I L EL+LS N E +P+ + L++S + L E +
Sbjct: 167 QE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225
Query: 691 HGLLRIDISYNE 702
L +
Sbjct: 226 KKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 18/183 (9%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLF 109
+ NL I + +F + P+L YL + + + ++P + + LD+ N+
Sbjct: 88 KANNLLYI------NPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 110 FGTIPPEI--GHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS-NYLEDLIPPSLG 166
TI G L L +N + I + L+ L L N LE+L
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 167 NLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
S L + + S+PS NL+ L S K +P +L L L L
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLT 254
Query: 226 NNS 228
S
Sbjct: 255 YPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 27/212 (12%)
Query: 510 LYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGE 562
+ + IPS+L R+ L F KL I L +++S N ++
Sbjct: 14 FLCQESKV-TEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 563 IPTE----LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGN 617
I + L KL+ + I N L ++P+ +L L++L +S+ + + +
Sbjct: 70 IEADVFSNLPKLHEI--RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 618 LVKLHYLNLSNNQFSRGIP----IKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLN 673
++ L++ +N I + L L L+ N ++E I + L+ LN
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFE--SVILWLNKNGIQE-IHNSAFNGTQLDELN 183
Query: 674 LSH-NSLVGLIPSCFEKMHGLLRIDISYNELQ 704
LS N+L L F G + +DIS +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 67/207 (32%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+ L L N LS F L L +L L NKL + L NL TL++ +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 325 LSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383
L ++P + L +L+ L L N+L S+PP +FDS
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPP----------------RVFDS------- 131
Query: 384 LRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLG 441
L L+ LSLGYN+L S+P + LT+L L LY+N L +P F L L TL L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLD 189
Query: 442 YNKLSGSIPH-SLGNLTNLDALYLYDN 467
N+L +P + +L L L L +N
Sbjct: 190 NNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/193 (33%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
+IP I + L L SN L L + L+ L L+L DN L ++P+ F L++
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 195 LSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSEL-GNLRSLSMLSLGYNK 252
L L + NK ++P + L NLA L L N L S+P + +L L+ LSLGYN+
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNE 144
Query: 253 LSGSIPHSL-GNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLG 310
L S+P + LT+L L LY N L +P F L L L L N+L + +
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 311 NLTNLATLYIHNN 323
+L L L + N
Sbjct: 203 SLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 71/207 (34%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 314 NLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNS 372
N ++ + L+ +IPS I L L NKLS S+P L+ L LYL N
Sbjct: 17 NKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK 72
Query: 373 LFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-F 429
L ++P+ + L++L L + NKL ++P + L NLA L L N L S+P F
Sbjct: 73 L-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129
Query: 430 GNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488
+L L+ LSLGYN+L S+P + LT+L L LY+N L G L + L L
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNN 515
+NN+L + +L L +L L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 49/164 (29%), Positives = 71/164 (43%), Gaps = 10/164 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTL 126
F L L L N+L +P I + L+ L ++ N +P + L L L
Sbjct: 57 FHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNK-LQALPIGVFDQLVNLAEL 114
Query: 127 QLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSI 185
+L NQL S+P + L+ L YL+L N L+ L L++L L LY+N L +
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RV 172
Query: 186 PSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
P F L L L L N+ +P + +L L L L N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 62/249 (24%), Positives = 90/249 (36%), Gaps = 74/249 (29%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDN 467
+ LDL N LS F L L L L NKL ++P + L NL+ L++ DN
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 468 SLSGSIPGEI-GNLRSISNLALNNNKLSGSIPQSL-GNLSNLVILYLYNNSLFDSIPSEL 525
L ++P + L +++ L L+ N+L S+P + +L+ L L L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY----------- 142
Query: 526 GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG 585
N+L S+P GV D
Sbjct: 143 -------------NELQ-SLPK--GVFD-------------------------------- 154
Query: 586 QLSPKLGSLAQLEHLDLSSNRLSNSIPKS-FGNLVKLHYLNLSNNQFSRGIPIKLEELIH 644
L L+ L L +N+L +P+ F L +L L L NNQ R + L
Sbjct: 155 -------KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 645 LSELDLSHN 653
L L L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLS 603
IP LDL SN + +L L L L N+L L + L LE L ++
Sbjct: 35 IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93
Query: 604 SNRLSNSIPKS-FGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPS 661
N+L ++P F LV L L L NQ +P ++ + L L+ L L +N L+ ++P
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 662 QICI-MQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ + SL+ L L +N L + F+K+ L + + N+L+
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 53/248 (21%)
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
N +++ L+ +IP I L L +NKLS ++ L+ L +LYL +N L
Sbjct: 17 NKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 518 FDSIPSEL-GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKL 576
++P+ + L++L L NKL ++P GV D +L L +L
Sbjct: 74 -QTLPAGIFKELKNLETLWVTDNKLQ-ALPI--GVFD---------------QLVNLAEL 114
Query: 577 ILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQFSRG 634
L +NQL L P++ SL +L +L L N L S+PK F L L L L NNQ
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-- 170
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKMHGL 693
+P + L+ L L +N L + F+ + L
Sbjct: 171 -----------------------RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 694 LRIDISYN 701
+ + N
Sbjct: 208 KMLQLQEN 215
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 47/279 (16%)
Query: 822 CIGKGGQGSVYKAELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRN--IVK 878
IG GG V++ +I A+K + + + NE+ L +++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT--LDSYRNEIAYLNKLQQHSDKIIR 92
Query: 879 FYGFCSHVRH----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
Y + ++ L L K + R + K + +A+ +H
Sbjct: 93 LYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL------ 980
IVH D+ N L+ D + DFGIA ++PD+++ GT Y+ PE
Sbjct: 148 -IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 981 -----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
K++ K DV+S G + + GK P F ++ S I
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEFPD 263
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +QD ++ CL +P+ R ++P +LL
Sbjct: 264 IPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 292
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 76/274 (27%), Positives = 114/274 (41%), Gaps = 46/274 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
DF+ +GKG G+VY A E S I+A+K + + + EV+ + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 874 RNIVKFYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGI 915
NI++ YG+ H + +IL A I +
Sbjct: 69 PNILRLYGYF-HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------YITEL 118
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
++ALSY H+ ++HRDI +N+LL E ++DFG + P S L GT Y
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDY 173
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
+ PE+ EK D++S GVL E + GK P F ++ + I+ E P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--FEAN-TYQETYKRISRVEFTFPDFV 230
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
T LIS L NP RP + +V
Sbjct: 231 TEGAR---DLIS------RLLKHNPSQRPMLREV 255
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 71/282 (25%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIR 872
D D IG+G GSV K SG+I+AVK+ + Q++ L ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 873 HRNIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWTRRMN-----------VIKGISDALS 920
IV+FYG + M L + + K + + + AL+
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE- 979
++ + I+HRDI N+LLD + DFGI+ L DS T AG Y+APE
Sbjct: 140 HLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPER 196
Query: 980 ---LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD---PR 1033
A + DV+S G+ E+ G+ P +S+ L +++ P+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDPPQ 249
Query: 1034 LPTPSCIV-QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L I+ V CL ++ RP +LLK
Sbjct: 250 LSNSEEREFSPSFINFVN---LCLTKDESKRPK---YKELLK 285
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 53/276 (19%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IGKG G V + G VAVK Q FL E +T++RH N+V+
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 79
Query: 880 YGFCSHVRHSLAMI--------LSN---NAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
G + L ++ L + + LG + + +A+ Y+ + F
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELAY 982
VHRD++++NVL+ DN A VSDFG+ K WT APE
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALR 187
Query: 983 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS- 1038
K + K DV+SFG+L E+ G+ P I + ++ ++ P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEKGYKMDAPDG 238
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
C ++ EV +C + RP+ ++ + L+
Sbjct: 239 C-----PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-25
Identities = 58/276 (21%), Positives = 105/276 (38%), Gaps = 66/276 (23%)
Query: 823 IGKGGQGSVYKAEL----ASGEI-VAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHRNI 876
+G G G+VYK +I VA+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 877 VKFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+ G C ++ +I + + ++G +N I+ ++Y+ +
Sbjct: 80 CRLLGICL--TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED 135
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-----------NWTELAGTY 973
VHRD++++NVL+ ++DFG+AK L + W
Sbjct: 136 RRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ 186
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
A E T + DV+S+GV E++ G P D I + +L+
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEK 234
Query: 1033 --RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
RLP P C I + + C + +SRP
Sbjct: 235 GERLPQPPIC-----TIDVYMIMRKCWMIDADSRPK 265
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 59/291 (20%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
I ++ IG G G V+ + + VA+K G M+ +++F+ E + +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMS-EEDFIEEAEVM 57
Query: 869 TEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISD 917
++ H +V+ YG C L+ L + + + +
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCE 115
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------WT 967
++Y+ C +HRD++++N L+ + VSDFG+ +F+ D S+ W
Sbjct: 116 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
+PE+ + + K DV+SFGVL EV +GK P + S N +
Sbjct: 173 ---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEV 214
Query: 1027 DEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
E + RL P + ++ C E PE RP ++ + L
Sbjct: 215 VEDISTGFRLYKPRLA-----STHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 59/289 (20%), Positives = 100/289 (34%), Gaps = 32/289 (11%)
Query: 406 GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHS---LGNLTNLDAL 462
G + L D ++ SL L++ ++ I + ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 463 YLYDNSLSGSIPGEIGNL--RSISNLALNNNKLSG--SIPQSLGNLS--NLVILYLYNNS 516
L + ++G+ P + ++ L L N + + L L +L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 517 LFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKL 576
+ ++ +LS L + N G + P + L L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL-----------CPLKFPTLQVLALR 209
Query: 577 ILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQFS--- 632
SG S + QL+ LDLS N L ++ S +L+ LNLS
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681
+G+P KL LDLS+N L PS + + NL+L N +
Sbjct: 270 KGLPAKLS------VLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 63/276 (22%), Positives = 97/276 (35%), Gaps = 22/276 (7%)
Query: 142 GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS---EFGNLRSLSML 198
G S L + + +L L + + I + L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 199 SLGYNKFSGSIPHSLGNLT--NLATLYLHNNSL--FDSIPSELGNL--RSLSMLSLGYNK 252
+L + +G+ P L T +L L L N S D+ +EL L +LS+
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 253 LSGSIPHSLGNLTNLATLYLYENSLSGSI-------PSEFGNLRSLSMLNLGYNKLNGII 305
+ L+TL L +N G P +F L+ L++ N G +G+
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 306 PHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLA 364
L L + +NSL + + L++L LS L +P L + L+
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLS 277
Query: 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 400
L L N L D PS L + LSL N S
Sbjct: 278 VLDLSYNRL-DRNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 7e-22
Identities = 56/293 (19%), Positives = 95/293 (32%), Gaps = 32/293 (10%)
Query: 214 GNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS---LGNLTNLATL 270
G + L + +++ SL L++ ++ I + ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 271 YLYENSLSGSIPSEFG-----NLRSLSMLNLGYNKLNGIIPHSLGNL-TNLATLYIHNNS 324
L ++G+ P +L L++ N+ + + + L L L I
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNL 384
++ +LS L LS N G P + L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISA-----------------LCPLKFPTL 203
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
+ L++ + G SG L LDL NSL + + L++L+L +
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263
Query: 444 KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS 496
L +P L L L L N L P L + NL+L N S
Sbjct: 264 GLK-QVPKGL--PAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 60/328 (18%), Positives = 102/328 (31%), Gaps = 43/328 (13%)
Query: 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNI 96
C + + N + + L G S L +D + + ++
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGR----SLEYLLKRVDTEADLGQFTDIIKSLSL 70
Query: 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156
RL + +S L+ L L ++ G+ P + +
Sbjct: 71 KRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT----------- 119
Query: 157 LEDLIPPSLGNLSNLDTLHLYDNSLS--DSIPSEFGNL--RSLSMLSLGYNKFSGSIPHS 212
+L+ L+L + S + D+ +E L +LS+
Sbjct: 120 -----------GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 213 LGNLTNLATLYLHNNSLFDSI-------PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLT 265
+ L+TL L +N P + L+ L++ + G SG
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 266 NLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
L L L NSL + + L+ LNL + L + G L+ L + N
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNR 285
Query: 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGS 352
L PS L + NL L GN S
Sbjct: 286 LD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 55/263 (20%), Positives = 80/263 (30%), Gaps = 26/263 (9%)
Query: 454 GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS---LGNLSNLVIL 510
G + L D +I S+ L + ++ I + +S L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 511 YLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKL 570
L N + + P L + +S D + + L L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVS------WATRDAWLAELQQWLKPGLKVL 154
Query: 571 NFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS----FGNLVKLHYLNL 626
+ +AQ ++ L LDLS N L L L
Sbjct: 155 S------IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 627 SNNQF---SRGIPIKLEELIHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSLVGL 682
N S + L LDLSHN LR+A + C L +LNLS L +
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV 268
Query: 683 IPSCFEKMHGLLRIDISYNELQG 705
K L +D+SYN L
Sbjct: 269 PKGLPAK---LSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 69/353 (19%), Positives = 105/353 (29%), Gaps = 87/353 (24%)
Query: 275 NSLSGSIPSEFGNLRSLSMLNLGYN-KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPS-- 331
N L + +G RSL L + + + + +L L + + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 332 -EIGNLRSLSNLGLSGNKLSGSIPPSLG--YLSNLATLYLYSNSL--FDSIPSELGNL-- 384
+ + L L L +++G+ PP L +L L L + S D+ +EL
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI-------PSEFGNLRSLST 437
L +LS+ + L+TLDL DN G P +F L+ L+
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
+ G SG L L L NSL +
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG----------------------- 245
Query: 498 PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN 557
S S L L L L ++ +P L VLDLS N
Sbjct: 246 APSCDWPSQLNSLNLSFTGL---------------------KQVPKGLPAKLSVLDLSYN 284
Query: 558 HIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
+ +P L Q+ +L L N +S
Sbjct: 285 RL--------------------------DRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 27/170 (15%), Positives = 51/170 (30%), Gaps = 9/170 (5%)
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS---FGNL 618
++ G + L + + L+ L + + R+ + I +
Sbjct: 35 DVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGI 94
Query: 619 VKLHYLNLSNNQFSRGIPIKLEELIH--LSELDLSHN----FLREAIPSQICIMQSLENL 672
L L L N + + P L E L+ L+L + Q + L+ L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 673 NLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIAFRDAPIEALQ 722
+++ + L +D+S N G A LQ
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 49/280 (17%)
Query: 822 CIGKGGQGSVYKAELASGEIVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIV 877
IG GG V++ +I A+K + + NE+ L +++ I+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 72
Query: 878 KFYGFCSHVRH----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+ Y + ++ L L K + R + K + +A+ +H
Sbjct: 73 RLYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL----- 980
IVH D+ N L+ D + DFGIA ++PD+++ GT Y+ PE
Sbjct: 129 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 981 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
K++ K DV+S G + + GK P F ++ S I
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEFP 243
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +QD ++ CL +P+ R ++P +LL
Sbjct: 244 DIPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 273
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 41/265 (15%)
Query: 823 IGKGGQGSVYKAELASGEI----VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G G V + E + VAVK + + +F+ EV A+ + HRN+++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 879 FYGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
YG SL L + +++ + Y+ + F
Sbjct: 86 LYGVVLTPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRF- 142
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 985
+HRD++++N+LL + + DFG+ + L + ++ + + APE T
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 986 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP---RLPTP-SCI 1040
+ D + FGV E+ G+ P ++ I +D RLP P C
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQIL--HKIDKEGERLPRPEDC- 250
Query: 1041 VQDKLISIVEVAISCLDENPESRPT 1065
I V + C PE RPT
Sbjct: 251 ----PQDIYNVMVQCWAHKPEDRPT 271
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 41/272 (15%)
Query: 820 EHCIGKGGQGSVYKAELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+H +G G G VY+ + VAVK M +EFL E + EI+H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 280
Query: 879 FYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
G C+ +L L +++ + + IS A+ Y+ F
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 984
+HR+++++N L+ ++ V+DFG+++ + D+ +T AG + APE
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 394
Query: 985 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIV 1041
K + K DV++FGVL E+ G P I + E+L+ R+ P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKDYRMERPEGCP 445
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + E+ +C NP RP+ ++ Q
Sbjct: 446 E----KVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 39/270 (14%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
E +G+G G V+ VA+K PG M+ + FL E + + ++RH +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 244
Query: 880 YGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
Y S + SL L K L + +++ I+ ++Y+ +
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY-- 301
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKV 986
VHRD+ + N+L+ + V+DFG+A+ ++ + +T G + APE A +
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRF 358
Query: 987 TEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQD 1043
T K DV+SFG+L E+ KG+ P + N + + ++ R+P P +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP----PE 405
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLL 1073
S+ ++ C + PE RPT + L
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-25
Identities = 36/297 (12%), Positives = 80/297 (26%), Gaps = 71/297 (23%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 872
+G+ + +A +GE V + ++ EV L +R
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 873 -------------HRNIVKFYGFCSHVRHSLAM-------------------ILSNNAAA 900
K R + +LS+++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 901 KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960
K L R+ + + L+ +H+ +VH + +++LD ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260
Query: 961 PDSSNWTELAGTYG---YVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFI 1012
+S + + + A + +T D ++ G+ + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N- 317
Query: 1013 SSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ + +P P V+ L+ L E R +
Sbjct: 318 ---TDDAALGGSEWIFRSCKNIPQP---VRA-LLE------GFLRYPKEDRLLPLQA 361
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 64/274 (23%), Positives = 101/274 (36%), Gaps = 63/274 (22%)
Query: 823 IGKGGQGSVYKAEL--ASGEI-VAVKKFHSPLPGEM--TFQQEFLNEVKALTEIRHRNIV 877
+G G G+V K VAVK + E L E + ++ + IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 878 KFYGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+ G C L L N + + + ++ +S + Y+ F
Sbjct: 82 RMIGICEAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTELAGTYGY 975
VHRD++++NVLL + A +SDFG++K L+ D + W
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-------- 187
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP-- 1032
APE K + K DV+SFGVL E G+ P M + ML+
Sbjct: 188 -APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMK------GSEVTAMLEKGE 237
Query: 1033 RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
R+ P C + ++ C + E+RP
Sbjct: 238 RMGCPAGC-----PREMYDLMNLCWTYDVENRPG 266
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 53/276 (19%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
IGKG G V + G VAVK Q FL E +T++RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 251
Query: 880 YGFCSHVRHSLAMI---LSN--------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
G + L ++ ++ + LG + + +A+ Y+ + F
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELAY 982
VHRD++++NVL+ DN A VSDFG+ K WT APE
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALR 359
Query: 983 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS- 1038
K + K DV+SFG+L E+ G+ P I + ++ ++ P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------LKDVVPRVEKGYKMDAPDG 410
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
C ++ +V +C + +RPT ++ + L+
Sbjct: 411 C-----PPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 59/291 (20%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
E+ R + +G G G V + VAVK G M+ + EF E + +
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS-EDEFFQEAQTM 57
Query: 869 TEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISD 917
++ H +VKFYG CS L L ++ K L ++ + + + +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCE 115
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------WT 967
++++ + F +HRD++++N L+D D VSDFG+ +++ D S W+
Sbjct: 116 GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
APE+ + K + K DV++FG+L EV GK P D + N +
Sbjct: 173 ---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---------NSEV 214
Query: 1027 DEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ RL P D + I+ SC E PE RPT ++ ++
Sbjct: 215 VLKVSQGHRLYRPHLA--SDTIYQIM---YSCWHELPEKRPTFQQLLSSIE 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 42/281 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIR 872
+D + +G+G G V K + SG+I+AVK+ Q+ L ++ ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVD 64
Query: 873 HRNIVKFYG-FCSHVRHSLAMILSNNAAAKDLGWTRRMN----------VIKGISDALSY 921
V FYG + M L + + K + I AL +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-- 979
+H+ ++HRD+ NVL++ + + DFGI+ +L D AG Y+APE
Sbjct: 125 LHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 980 ------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
Y++ K D++S G+ +E+ + P + S + + + P+
Sbjct: 182 NPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVEEP--SPQ 233
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
LP + + CL +N + RPT +L++
Sbjct: 234 LPADKF--SAEFVDFTS---QCLKKNSKERPT---YPELMQ 266
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+GKG GSV +GE+VAVKK ++F E++ L ++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 878 KFYGFCSH-VRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
K+ G C R +L +I L + + + + + I + Y+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTELAGT 972
+ +HRD++++N+L++ +N + DFG+ K L D W
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----- 184
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL-------NIA 1025
APE K + DV+SFGV+ E+ + +
Sbjct: 185 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 1026 LDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
L E+L RLP P C I + C + N RP+
Sbjct: 241 LIELLKNNGRLPRPDGC-----PDEIYMIMTECWNNNVNQRPS 278
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 59/284 (20%)
Query: 820 EHCIGKGGQGSVYKAEL--ASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+ +G G GSV + +I VA+K +E + E + + ++ + I
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYI 72
Query: 877 VKFYGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
V+ G C L L +++ + ++ +S + Y+
Sbjct: 73 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTELAGTYG 974
F VHRD++++NVLL + A +SDFG++K L D S W
Sbjct: 131 F---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY------- 180
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP- 1032
APE K + + DV+S+GV E + G+ P M + ++
Sbjct: 181 --APECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKKMK------GPEVMAFIEQG 229
Query: 1033 -RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
R+ P C + + C E RP V Q ++
Sbjct: 230 KRMECPPEC-----PPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 41/271 (15%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
E +G G G V+ A VAVK PG M+ + FL E + ++H +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS-VEAFLAEANVMKTLQHDKLVKL 248
Query: 880 YGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
+ + + SL L ++ + ++ I++ ++++ +
Sbjct: 249 HAVVTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV---APELAYTMKV 986
+HRD+ + N+L+ ++DFG+A+ ++ + +T G + APE
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSF 362
Query: 987 TEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS-CIVQ 1042
T K DV+SFG+L +E++ G+ P +S N + L+ R+P P C
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMS---------NPEVIRALERGYRMPRPENC--- 410
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + + C PE RPT + +L
Sbjct: 411 --PEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 49/280 (17%)
Query: 822 CIGKGGQGSVYKAELASGEIVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIV 877
IG GG V++ +I A+K + + NE+ L +++ I+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 119
Query: 878 KFYGFCSHVRH----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+ Y + ++ L L K + R + K + +A+ +H
Sbjct: 120 RLYDYEITDQYIYMVMECGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPEL----- 980
IVH D+ N L+ D + DFGIA ++PD+++ + G Y+ PE
Sbjct: 176 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 981 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
K++ K DV+S G + + GK P F ++ S I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHEIEFP 290
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P +QD ++ CL +P+ R ++P +LL
Sbjct: 291 DIPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 320
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 59/291 (20%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKA 867
E+ R D +H +G G G VY+ + VAVK M +EFL E
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAV 62
Query: 868 LTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGIS 916
+ EI+H N+V+ G C+ +L L +++ + + IS
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------W 966
A+ Y+ F +HRD++++N L+ ++ V+DFG+++ + D + W
Sbjct: 122 SAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIA 1025
T APE K + K DV++FGVL E+ G P I
Sbjct: 179 T---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQ 220
Query: 1026 LDEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ E+L+ R+ P C + E+ +C NP RP+ ++ Q
Sbjct: 221 VYELLEKDYRMERPEGC-----PEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 56/259 (21%), Positives = 109/259 (42%), Gaps = 26/259 (10%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+GKGG ++ + + E+ A K L + +++ E+ + H+++V F+G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 882 FCSHVRHSLAMIL---SNNAAAKDLGWTRRMN------VIKGISDALSYMHNDCFPPIVH 932
+ ++L + + + + ++ I Y+H + ++H
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIH 164
Query: 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDV 992
RD+ N+ L+ D E + DFG+A ++ D L GT Y+APE+ + + DV
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 993 YSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052
+S G + ++ GK P F +S + I +E P+ P LI
Sbjct: 225 WSIGCIMYTLLVGKPP--FETSCLKETYL-RIKKNEYSIPKHINPVAA---SLIQ----- 273
Query: 1053 ISCLDENPESRPTMPKVSQ 1071
L +P +RPT+ ++
Sbjct: 274 -KMLQTDPTARPTINELLN 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 39/270 (14%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
E +G+G G V+ VA+K PG M+ + FL E + + ++RH +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 327
Query: 880 YGFCSH-----VRH-----SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
Y S V SL L K L + +++ I+ ++Y+ +
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY-- 384
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKV 986
VHRD+ + N+L+ + V+DFG+A+ ++ + +T G + APE A +
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRF 441
Query: 987 TEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPSCIVQD 1043
T K DV+SFG+L E+ KG+ P + N + + ++ R+P P +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP----PE 488
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLL 1073
S+ ++ C + PE RPT + L
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 62/286 (21%)
Query: 820 EHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+GKG GSV +GE+VAVKK ++F E++ L ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102
Query: 875 NIVKFYGFCSH-VRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSY 921
NIVK+ G C R +L +I L + + + + + I + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEY 160
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTEL 969
+ + +HRD++++N+L++ +N + DFG+ K L D W
Sbjct: 161 LGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------- 1022
APE K + DV+SFGV+ E+ + +
Sbjct: 216 -------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 1023 NIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
L E+L RLP P C I + C + N RP+
Sbjct: 269 VFHLIELLKNNGRLPRPDGC-----PDEIYMIMTECWNNNVNQRPS 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 55/270 (20%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+G G G V+ VAVK G M+ FL E + +++H+ +V+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS-PDAFLAEANLMKQLQHQRLVRL 73
Query: 880 YGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
Y + + + SL L + K L + +++ I++ ++++ +
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------WTELAGTYGYVAPE 979
+HRD+ + N+L+ ++DFG+A+ ++ + WT APE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APE 180
Query: 980 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPT 1036
T K DV+SFG+L E++ G+ P ++ N + + L+ R+
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVR 231
Query: 1037 P-SCIVQDKLISIVEVAISCLDENPESRPT 1065
P +C ++L ++ C E PE RPT
Sbjct: 232 PDNC--PEELYQLM---RLCWKERPEDRPT 256
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/266 (20%), Positives = 109/266 (40%), Gaps = 26/266 (9%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ +GKGG ++ + + E+ A K L + +++ E+ + H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 875 NIVKFYGFCSHVRHSLAMIL---SNNAAAKDLGWTRRMN------VIKGISDALSYMHND 925
++V F+G + ++L + + + + ++ I Y+H +
Sbjct: 76 HVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
++HRD+ N+ L+ D E + DFG+A ++ D L GT Y+APE+
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 986 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045
+ + DV+S G + ++ GK P + + L I +E P+ P L
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIPKHINPVAA---SL 245
Query: 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071
I L +P +RPT+ ++
Sbjct: 246 IQ------KMLQTDPTARPTINELLN 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 59/293 (20%), Positives = 104/293 (35%), Gaps = 60/293 (20%)
Query: 820 EHCIGKGGQGSVYKAELA-----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+G+G G V +GE VAVK P G + E++ L + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH-IADLKKEIEILRNLYHE 83
Query: 875 NIVKFYGFCSHVRHSLAMI-------------LSNNAAAKDLGWTRRMNVIKGISDALSY 921
NIVK+ G C+ + + L N + +++ I + Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDY 141
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTEL 969
+ + + VHRD++++NVL++ +++ + DFG+ K ++ D W
Sbjct: 142 LGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLN-----LN 1023
APE K DV+SFGV E++ ++
Sbjct: 197 -------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 1024 IALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
L L RLP P C + ++ C + P +R + + +
Sbjct: 250 TRLVNTLKEGKRLPCPPNC-----PDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 58/320 (18%), Positives = 103/320 (32%), Gaps = 69/320 (21%)
Query: 814 TNDFDDEHCIGKGGQ--GSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFL-NEVKALT 869
++ IGKG + +V A +GE V V++ L FL E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 870 EIRHRNIVKFYGFCSHVRHS---LAMILSNNAAAKDL---GWTRRMN------VIKGISD 917
H NIV + + + + + +AKDL + MN +++G+
Sbjct: 82 LFNHPNIVPYRA--TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL-------KPDSSNWTELA 970
AL Y+H+ VHR + + ++L+ D + ++S + +
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 971 GTYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGK------HP-------------- 1008
+++PE+ K D+YS G+ A E+ G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 1009 ------------RDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV--EVAIS 1054
S ++S + P + S
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 1055 CLDENPESRPTMPKVSQLLK 1074
CL NP++RP+ S LL
Sbjct: 317 CLQRNPDARPS---ASTLLN 333
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 59/282 (20%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
EI D +G G G V + VA+K G M+ + EF+ E K +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS-EDEFIEEAKVM 73
Query: 869 TEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISD 917
+ H +V+ YG C+ R L L + + + K + +
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCE 131
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------WT 967
A+ Y+ + F +HRD++++N L++ VSDFG+++++ D S W+
Sbjct: 132 AMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
PE+ K + K D+++FGVL E+ GK P + + N
Sbjct: 189 ---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---------NSET 230
Query: 1027 DEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
E + RL P + + SC E + RPT
Sbjct: 231 AEHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPT 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 60/306 (19%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DF+ +G G G V+K SG ++A K H L + + + + E++ L E
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90
Query: 874 RNIVKFYG-------------FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALS 920
IV FYG SL +L A + V + L+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMD--GGSLDQVLKK---AGRIPEQILGKVSIAVIKGLT 145
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+ I+HRD+ N+L++ E + DFG++ L DS + GT Y++PE
Sbjct: 146 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPER 201
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP--- 1037
+ + D++S G+ +E+ G++P + + + +
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 1038 --------------------SCIVQDKLISIVEVAIS---------CLDENPESRPTMPK 1068
IV + + S CL +NP R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-- 319
Query: 1069 VSQLLK 1074
QL+
Sbjct: 320 -KQLMV 324
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 45/191 (23%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G G V++ E A+G + K ++P P + + NE+ + ++ H ++ +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHD 115
Query: 882 FCSHVRHSLAMI--------LSNNAAAKDLGWTRR--MNVIKGISDALSYMHNDCFPPIV 931
++ + +I L + AA+D + +N ++ + L +MH IV
Sbjct: 116 AFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 171
Query: 932 HRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 988
H DI +N++ + + V DFG+A L PD T + APE + V
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGF 229
Query: 989 KCDVYSFGVLA 999
D+++ GVL
Sbjct: 230 YTDMWAIGVLG 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 63/293 (21%), Positives = 105/293 (35%), Gaps = 61/293 (20%)
Query: 820 EHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+GKG GSV +G +VAVK+ Q++F E++ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSD 84
Query: 875 NIVKFYGFCSHVRHSLAMI-------------LSNNAAAKDLGWTRRMNVIKGISDALSY 921
IVK+ G + L + A L +R + I + Y
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEY 142
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS------------NWTEL 969
+ + VHRD++++N+L++ + ++DFG+AK L D W
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNL--NIAL 1026
APE + + DV+SFGV+ E+ + AL
Sbjct: 198 -------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 1027 DEMLDP-----RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+L+ RLP P C + E+ C +P+ RP+ + L
Sbjct: 251 SRLLELLEEGQRLPAPPAC-----PAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 49/203 (24%), Positives = 79/203 (38%), Gaps = 39/203 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G G G V A E + + VA++ KF E E++ L ++ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 877 VKFYGFCSHVRHSLAM-----------ILSNN----AAAKDLGWTRRMNVIKGISDALSY 921
+K F + + + ++ N A K + A+ Y
Sbjct: 203 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQMLLAVQY 254
Query: 922 MHNDCFPPIVHRDISSKNVLLD-FDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAP 978
+H + I+HRD+ +NVLL + + + +DFG +K L S L GT Y+AP
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAP 310
Query: 979 E-LAYTMKV--TEKCDVYSFGVL 998
E L D +S GV+
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 39/202 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G G G V A E + + VA+K KF E E++ L ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 877 VKFYGFCSHVRHSLAM-----------ILSNN----AAAKDLGWTRRMNVIKGISDALSY 921
+K F + + + ++ N A K + A+ Y
Sbjct: 78 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQMLLAVQY 129
Query: 922 MHNDCFPPIVHRDISSKNVLLD-FDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAP 978
+H + I+HRD+ +NVLL + + + +DFG +K L S L GT Y+AP
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAP 185
Query: 979 E-LAYTMKV--TEKCDVYSFGV 997
E L D +S GV
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGV 207
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 54/278 (19%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+DFD +GKG G+VY A E + I+A+K + + + E++ + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 874 RNIVKFYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGI 915
NI++ Y + H R + ++L +A ++ +
Sbjct: 74 PNILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT---------FMEEL 123
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
+DAL Y H ++HRDI +N+L+ + E ++DFG + P T + GT Y
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDY 178
Query: 976 VAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031
+ PE+ + KV D++ GVL E + G P F S S + + I ++
Sbjct: 179 LPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP--FDSP-SHTETHRRIVNVDLKF 231
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
P + LIS L +P R + V
Sbjct: 232 PPFLSDGSK---DLIS------KLLRYHPPQRLPLKGV 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 38/196 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G V+ + +G++ A+K NE+ L +I+H NIV
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 882 -FCSHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+ S + L M L + A+ VI+ + A+ Y+H
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---------VIQQVLSAVKYLHE 124
Query: 925 DCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+ IVHRD+ +N+L + + + +DFG++K + + GT GYVAPE+
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVL 179
Query: 982 YTMKVTEKCDVYSFGV 997
++ D +S GV
Sbjct: 180 AQKPYSKAVDCWSIGV 195
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 3e-23
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 802 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAEL--ASGEI-VAVKKFHSPLPGEMTFQ 858
E K + R D +G G GSV + +I VA+K
Sbjct: 324 ELKDKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--T 380
Query: 859 QEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKD--------LGWTRRMN 910
+E + E + + ++ + IV+ G C L M ++ + +
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970
++ +S + Y+ F VHR+++++NVLL + A +SDFG++K L D S +T +
Sbjct: 441 LLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 971 GT---YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
+ APE K + + DV+S+GV E + G+ P M +
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMK------GPEV 548
Query: 1027 DEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ R+ P C + + C E RP V Q ++
Sbjct: 549 MAFIEQGKRMECPPEC-----PPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/291 (20%), Positives = 107/291 (36%), Gaps = 62/291 (21%)
Query: 823 IGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 877
+G+G G V +GE+VAVK G + + E+ L + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH-RSGWKQEIDILRTLYHEHII 96
Query: 878 KFYGFCSHVRHSLAMIL--------------SNNAAAKDLGWTRRMNVIKGISDALSYMH 923
K+ G C + ++ ++ L + + I + ++Y+H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTELAG 971
+ +HRD++++NVLLD D + DFG+AK + W
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---- 204
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLN-----LNIA 1025
APE K DV+SFGV E++ + + +
Sbjct: 205 -----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 1026 LDEMLDP--RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L E+L+ RLP P + + + +C + RPT + +LK
Sbjct: 260 LTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLIPILK 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 54/306 (17%), Positives = 111/306 (36%), Gaps = 72/306 (23%)
Query: 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAEL-------ASGEI-VAVKKFHSPLPGEMTF 857
V+ +I D +G+G ++K E V +K +
Sbjct: 1 VFHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNY 55
Query: 858 QQEFLNEVKALTEIRHRNIVKFYGFCSH----------VRH-SLAMILSNNAAAKDLGWT 906
+ F ++++ H+++V YG C V+ SL L N ++ W
Sbjct: 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW- 114
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH--------VSDFGIAKF 958
++ V K ++ A+ ++ + +H ++ +KN+LL + + +SD GI+
Sbjct: 115 -KLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 959 LKPDSS-----NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 1011
+ P W PE + + D +SFG E+ G P
Sbjct: 171 VLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--- 218
Query: 1012 ISSMSSSSLNLNIALDEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPK 1068
+S++ + + + +LP P + + + +C+D P+ RP+
Sbjct: 219 LSALD------SQRKLQFYEDRHQLPAPKAA-------ELANLINNCMDYEPDHRPSFRA 265
Query: 1069 VSQLLK 1074
+ + L
Sbjct: 266 IIRDLN 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 41/280 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIR 872
ND ++ +G G G V+K +G ++AVK+ G + L ++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHD 82
Query: 873 HRNIVKFYGFCSHVRHSLAMIL-----SNNAAAKDLGWTRRMNVIKGIS----DALSYMH 923
IV+ +G + + + K + ++ ++ AL Y+
Sbjct: 83 CPYIVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
++HRD+ N+LLD + + DFGI+ L D AG Y+APE
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERIDP 198
Query: 984 MKVTE-----KCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIALDEMLD---PRL 1034
T+ + DV+S G+ +E+ G+ P ++ + L ++L P L
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--------VLTKVLQEEPPLL 250
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P S V+ CL ++ RP ++LL+
Sbjct: 251 PGHMGF-SGDFQSFVK---DCLTKDHRKRPK---YNKLLE 283
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 62/274 (22%)
Query: 823 IGKGGQGSVYKAELA----SGEI-VAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHRNI 876
+G G G+VYK +I VA+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 877 VKFYGFCS---------HVRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
+ G C + L + + ++G +N I+ ++Y+ +
Sbjct: 80 CRLLGICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-----------NWTELAGTYGY 975
VHRD++++NVL+ ++DFG+AK L + W
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-------- 186
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP-- 1032
A E T + DV+S+GV E++ G P D I + +L+
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGE 236
Query: 1033 RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
RLP P C I + + + C + +SRP
Sbjct: 237 RLPQPPIC-----TIDVYMIMVKCWMIDADSRPK 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 64/268 (23%), Positives = 112/268 (41%), Gaps = 27/268 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKK-FHSPLPGEMTFQQEFLNEVKALTEIR 872
DF + +GKG VY+A + +G VA+K + Q+ NEVK +++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 873 HRNIVKFYG-FCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMH 923
H +I++ Y F L + + +N K + + I + Y+H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
+ I+HRD++ N+LL + ++DFG+A LK L GT Y++PE+A
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
+ DV+S G + ++ G+ P D + + + + L + P + +D
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFD---TDTVKNTLNKVVLADYEMPSFLSIEA--KD 241
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071
LI L NP R ++ V
Sbjct: 242 -LIH------QLLRRNPADRLSLSSVLD 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 67/297 (22%), Positives = 122/297 (41%), Gaps = 65/297 (21%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL---ASGEI-VAVKKFHSPLPGEMTFQQ-EFLN 863
EI + E IG G G V L ++ VA+K G Q+ +FL+
Sbjct: 45 EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLS 99
Query: 864 EVKALTEIRHRNIVKFYGFCSH----------VRH-SLAMILSNNAAAKDLGWTRRMNVI 912
E + + H NI++ G + + + SL L + + + ++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGML 157
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------- 965
+G+ + Y+ + + VHRD++++NVL+D + VSDFG+++ L+ D
Sbjct: 158 RGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 966 -----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSS 1019
WT APE + DV+SFGV+ EV+ G+ P +M+
Sbjct: 215 KIPIRWT---------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMT--- 259
Query: 1020 LNLNIALDEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
N + ++ RLP P C ++ ++ + C ++ RP ++ +L
Sbjct: 260 ---NRDVISSVEEGYRLPAPMGC-----PHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-23
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 44/200 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
+GKG G V K + + + AVK + + + L EV+ L ++ H NI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87
Query: 881 GFC-SHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDALSYMH 923
+ L S + AA+ +IK + ++YMH
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFSGITYMH 138
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
IVHRD+ +N+LL+ + + DFG++ + ++ + GT Y+APE+
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV 194
Query: 981 ---AYTMKVTEKCDVYSFGV 997
Y EKCDV+S GV
Sbjct: 195 LRGTY----DEKCDVWSAGV 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 45/200 (22%), Positives = 81/200 (40%), Gaps = 42/200 (21%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+GKG V + ++ +G+ A ++ Q+ E + ++H NIV+ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 882 FC-SHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
H L L S A+ I+ I +A+ + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---------CIQQILEAVLHCHQ 128
Query: 925 DCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 980
+VHR++ +N+LL A V +DFG+A ++ + W AGT GY++PE+
Sbjct: 129 MG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 981 ---AYTMKVTEKCDVYSFGV 997
Y + D+++ GV
Sbjct: 186 RKDPY----GKPVDLWACGV 201
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 60/276 (21%)
Query: 820 EHCIGKGGQGSVYKAEL----ASGEI-VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+G G G+V+K S +I V +K G +FQ + + A+ + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQ-AVTDHMLAIGSLDHA 75
Query: 875 NIVKFYGFCSH---------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+IV+ G C + SL + + LG +N I+ + Y+
Sbjct: 76 HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE 133
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-----------NWTELAGTY 973
VHR+++++NVLL ++ V+DFG+A L PD W
Sbjct: 134 HGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM------ 184
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
A E + K T + DV+S+GV E++ G P + + ++L+
Sbjct: 185 ---ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR---------LAEVPDLLEK 232
Query: 1033 --RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
RL P C I + V + C + RPT
Sbjct: 233 GERLAQPQIC-----TIDVYMVMVKCWMIDENIRPT 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-22
Identities = 59/297 (19%), Positives = 98/297 (32%), Gaps = 69/297 (23%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G GG G V + +GE VA+K+ L + ++ + E++ + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79
Query: 882 -------------------FCSH-------VRHSLAMILSNNAAAKDLGWTRRMNVIKGI 915
+C + L ++ I
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT---------LLSDI 130
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWTELAGT 972
S AL Y+H + I+HRD+ +N++L + + D G AK L GT
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGT 186
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFISSM 1015
Y+APEL K T D +SFG LA E I G P + +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 1016 SSSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
+ P L ++ + + L + R T P+
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPN 297
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 49/225 (21%)
Query: 810 IIRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVK----------KFHSPLPGE 854
+ + + +G G G V E A+K ++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 855 MTFQQEFLNEVKALTEIRHRNIVKFYG-FCSHVRHSLAM----------------ILSNN 897
F +E NE+ L + H NI+K + F L
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 898 AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAH--VSDFG 954
AA ++K I + Y+H IVHRDI +N+LL + ++ + + DFG
Sbjct: 147 DAAN---------IMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 999
++ F D + GT Y+APE K EKCDV+S GV+
Sbjct: 195 LSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 29/257 (11%), Positives = 61/257 (23%), Gaps = 52/257 (20%)
Query: 820 EHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
G ++A A VA+ QE L+ L+ I + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 879 FYGFCSH----------VR-HSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF 927
+R SL + + ++ ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 987
+ V + D + ++ +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPD-------AN 180
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047
+ D+ G ++ + P + S L + + P+ I +D
Sbjct: 181 PQDDIRGIGASLYALLVNRWP--LPEAGVRSGLA---PAERDTAGQPIEPADIDRDIPFQ 235
Query: 1048 IVEVAISCLDENPESRP 1064
I VA + + R
Sbjct: 236 ISAVAARSVQGDGGIRS 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 51/299 (17%), Positives = 104/299 (34%), Gaps = 67/299 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +V++ +G++ A+K F++ + E + L ++ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 882 ---------------FCSH-------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
FC S A L + V++ + +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI---------VLRDVVGGM 125
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAGTYGY 975
+++ + IVHR+I N++ + ++DFG A+ L+ D + L GT Y
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEY 181
Query: 976 VAPEL--------AYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIAL 1026
+ P++ + K D++S GV G P R F + + I
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 1027 DEMLDP----------------RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ +P + + + + V + L+ + E +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 41/210 (19%)
Query: 814 TNDFDDE----HCIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKA 867
+ F D +GKG V + +G A K + L Q+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARI 58
Query: 868 LTEIRHRNIVKFYGFC-SHVRHSLAMIL----------------SNNAAAKDLGWTRRMN 910
+++H NIV+ + H L L S A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------- 109
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLKPDSSNWT 967
I+ I ++++Y H++ IVHR++ +N+LL A V +DFG+A + + W
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGV 997
AGT GY++PE+ ++ D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 31/202 (15%)
Query: 816 DFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+G G G V+K E A+G +A K + + ++E NE+ + ++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146
Query: 875 NIVKFYG-FCSHVRHSLAM-----------ILSNNAAAKDLGWTRR--MNVIKGISDALS 920
N+++ Y F S L M I+ + T + +K I + +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRII-----DESYNLTELDTILFMKQICEGIR 201
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAP 978
+MH I+H D+ +N+L + + DFG+A+ KP GT ++AP
Sbjct: 202 HMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAP 257
Query: 979 E-LAYTMKVTEKCDVYSFGVLA 999
E + Y V+ D++S GV+A
Sbjct: 258 EVVNYD-FVSFPTDMWSVGVIA 278
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 50/235 (21%), Positives = 86/235 (36%), Gaps = 17/235 (7%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+ + IPS S L L L I H+ NL N++ +Y+ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 325 LSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSE-- 380
+ S NL ++++ + + I P L L L L +++ L P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTK 125
Query: 381 LGNLRSLSMLSLGYNKLSGSIP-HSLGNLTN-LATLDLYDNSLSGSIPSEFGNLRSLSTL 438
+ + +L + N SIP ++ L N TL LY+N + S+ N L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 439 SLGYNKLSGSIPHSL--GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNN 491
L NK I G + L + S++ ++P + L + L N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 13/212 (6%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGY 202
S L L +L + + NL N+ +++ + + S F NL ++ + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 203 NKFSGSIPHS-LGNLTNLATLYLHNNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGSIP- 258
+ I L L L L + N L P + + +L + N SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 259 HSLGNLTN-LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK-LNGIIPHSLGNL-TNL 315
++ L N TL LY N + S+ N L + L NK L I + G + +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 316 ATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGN 347
+ L + S++ ++PS+ L L L
Sbjct: 208 SLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 43/272 (15%), Positives = 79/272 (29%), Gaps = 48/272 (17%)
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420
+ + IPS S L L L H+ NL N++ + + +
Sbjct: 11 HQEEDFRVTCKDI-QRIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 421 LSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHS-LGNLTNLDALYLYDNSLSGSIPGEIG 478
+ S F NL ++ + + + I L L L L +++ L P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
+ + IL + +N SIP +F
Sbjct: 126 ----------------------VYSTDIFFILEITDNPYMTSIPVN----------AFQ- 152
Query: 539 NKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL--GSLAQ 596
+ + L L +N + L + L +N+ + G +
Sbjct: 153 -----GLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628
LD+S ++ K +L +L N
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 42/247 (17%), Positives = 93/247 (37%), Gaps = 38/247 (15%)
Query: 40 VGIHCNRGGRVNSI--NLTSIGLKG----MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI 93
+ C R+ S+ + ++ L + +FS+ P+++ + + + +
Sbjct: 16 FRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS 75
Query: 94 -GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152
N+S++ ++++ + I P+ + L L +L +
Sbjct: 76 FYNLSKVTHIEIRNTRNLTYIDPDA-----------LKE------------LPLLKFLGI 112
Query: 153 YSNYLEDLIPPS-LGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSM-LSLGYNKFSGSI 209
++ L+ + + + L + DN SIP F L + ++ L L N F+ S+
Sbjct: 113 FNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SV 171
Query: 210 PHSLGNLTNLATLYLHNNSLFDSIPSEL--GNLRSLSMLSLGYNKLSGSIPH-SLGNLTN 266
N T L +YL+ N I + G S+L + ++ ++P L +L
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKE 230
Query: 267 LATLYLY 273
L +
Sbjct: 231 LIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 44/244 (18%), Positives = 74/244 (30%), Gaps = 28/244 (11%)
Query: 457 TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNS 516
+ + + IP S L L L + NL N+ +Y+ +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 517 LFDSIPSEL-GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIK 575
+ S NL ++ + + I P L +L L
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYID-----------------PDALKELPLLKF 109
Query: 576 LILAQNQLSG-QLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVK-LHYLNLSNNQFS 632
L + L K+ S L+++ N SIP +F L L L NN F+
Sbjct: 110 LGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
Query: 633 RGIPIKLEELIHLSELDLSHNFLREAIPSQIC--IMQSLENLNLSHNSLVGLIPSCFEKM 690
+ L + L+ N I + L++S S+ L E +
Sbjct: 170 S-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
Query: 691 HGLL 694
L+
Sbjct: 229 KELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 18/125 (14%), Positives = 42/125 (33%), Gaps = 4/125 (3%)
Query: 594 LAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSH 652
+ L L L +F NL + + +S + + + L ++ +++ +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 653 NFLREAIPSQICI-MQSLENLNLSHNSLVGLIP-SCFEKMHGLLRIDISYNELQGPIPNS 710
I + L+ L + + L + ++I+ N IP +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 711 IAFRD 715
AF+
Sbjct: 150 -AFQG 153
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 42/225 (18%)
Query: 810 IIRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLN 863
I + +G G G V + + A+K + + + L
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS--NSKLLE 85
Query: 864 EVKALTEIRHRNIVKFYGFCSHVRH-SLAM----------------ILSNNAAAKDLGWT 906
EV L + H NI+K Y F R+ L M + AA
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV----- 140
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDS 963
+IK + ++Y+H IVHRD+ +N+LL+ + + DFG++ +
Sbjct: 141 ----IIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
E GT Y+APE+ K EKCDV+S GV+ ++ G P
Sbjct: 194 K-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 44/205 (21%), Positives = 84/205 (40%), Gaps = 23/205 (11%)
Query: 808 EEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
+ + D +E +G G G V++ E A+G A K +P + ++ E++
Sbjct: 152 HDHVLDHYDIHEE--LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQ 206
Query: 867 ALTEIRHRNIVKFYGFCSHVRHSLAMI--------LSNNAAAKDLGWTRR--MNVIKGIS 916
++ +RH +V + + + MI L A + + + ++ +
Sbjct: 207 TMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYG 974
L +MH + VH D+ +N++ + DFG+ L P + GT
Sbjct: 266 KGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAE 321
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLA 999
+ APE+A V D++S GVL+
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 6e-22
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 24/191 (12%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G G V++ E +S + K + + T Q E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 882 FCSHVRHSLAMI--------LSNNAAAKDLGWTRR--MNVIKGISDALSYMHNDCFPPIV 931
L MI + R ++ + + +AL ++H+ I
Sbjct: 69 SFES-MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 932 HRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 988
H DI +N++ + + +FG A+ LKP N+ L Y APE + + V+
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDV-VST 182
Query: 989 KCDVYSFGVLA 999
D++S G L
Sbjct: 183 ATDMWSLGTLV 193
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 98/472 (20%), Positives = 163/472 (34%), Gaps = 78/472 (16%)
Query: 241 RSLSMLSLGYNKLS-GSIPHSLGNLTNLATLYLYENSLS----GSIPSEFGNLRSLSMLN 295
+ L + +LS L L + L + L+ I S +L+ LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 296 LGYNKLNGIIPHSLGNL-----TNLATLYIHNNSLS----GSIPSEIGNLRSLSNLGLSG 346
L N+L + H + + L + N L+ G + S + L +L L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 347 NKLSGSIPPSLGYL-----SNLATLYLYSNSLFD----SIPSELGNLRSLSMLSLGYNKL 397
N L + L L L L SL + S L L++ N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 398 SGS----IPHSLGNLT-NLATLDLYDNSLS----GSIPSEFGNLRSLSTLSLGYNKLSGS 448
+ + + L + L L L ++ + + SL L+LG NKL
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 449 -----IPHSLGNLTNLDALYLYDNSLS----GSIPGEIGNLRSISNLALNNNKLSGSIPQ 499
P L + L L++++ ++ G + + S+ L+L N+L +
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 500 SLGNL-----SNLVILYLYNNSLFD----SIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550
L L L++ + S S L R L L + N+L + G
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA-----G 357
Query: 551 VLDLSSNHIVGEIPTELGKLNF-LIKLILAQNQLSGQ----LSPKLGSLAQLEHLDLSSN 605
V +L LG+ L L LA +S L+ L + L LDLS+N
Sbjct: 358 VRELCQ---------GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408
Query: 606 RLSNSIPKSFGNLVK-----LHYLNLSNNQFSRGIPIKLEELI----HLSEL 648
L ++ V+ L L L + +S + +L+ L L +
Sbjct: 409 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-21
Identities = 80/421 (19%), Positives = 142/421 (33%), Gaps = 67/421 (15%)
Query: 337 RSLSNLGLSGNKLS-GSIPPSLGYLSNLATLYLYSNSLFD----SIPSELGNLRSLSMLS 391
+ +L + +LS L L + L L + I S L +L+ L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 392 LGYNKLSGSIPHSLGNL-----TNLATLDLYDNSLS----GSIPSEFGNLRSLSTLSLGY 442
L N+L H + + L L + L+ G + S L +L L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 443 NKLSGSIPHSLG-----NLTNLDALYLYDNSLSGSIPGEIG----NLRSISNLALNNNKL 493
N L + L L+ L L SLS + + L ++NN +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 494 SGSIPQSLG-----NLSNLVILYLYNNSLFD----SIPSELGNLRSLSMLSFAYNKLSGS 544
+ + + L + L L L + + + + + SL L+ NKL
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ----LSPKLGSLAQLEHL 600
G+ +L L + L L + + ++ + L L + L+ L
Sbjct: 243 -----GMAELCP--------GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 601 DLSSNRLSNSIPKSFGNLVK-----LHYLNLSNNQFS----RGIPIKLEELIHLSELDLS 651
L+ N L + + + L L + + F+ L + L EL +S
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349
Query: 652 HNFLREAIPSQICIM-----QSLENLNLSHNSL----VGLIPSCFEKMHGLLRIDISYNE 702
+N L +A ++C L L L+ + + + H L +D+S N
Sbjct: 350 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409
Query: 703 L 703
L
Sbjct: 410 L 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 93/471 (19%), Positives = 155/471 (32%), Gaps = 92/471 (19%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS 228
++ +L + LSD+ L L + L +
Sbjct: 3 LDIQSLDIQCEELSDA-----------------------RWAELLPLLQQCQVVRLDDCG 39
Query: 229 LFD----SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL-----TNLATLYLYENSLS- 278
L + I S L +L+ L+L N+L H + + L L L+
Sbjct: 40 LTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 99
Query: 279 ---GSIPSEFGNLRSLSMLNLGYNKLNG-----IIPHSLGNLTNLATLYIHNNSLS---- 326
G + S L +L L+L N L + L L L + SLS
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159
Query: 327 GSIPSEIGNLRSLSNLGLSGNKLSGS----IPPSLGY-LSNLATLYLYSNSLFD----SI 377
+ S + L +S N ++ + + L L L L S + +
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 378 PSELGNLRSLSMLSLGYNKLSGS-----IPHSLGNLTNLATLDLYDNSLS----GSIPSE 428
+ + SL L+LG NKL P L + L TL +++ ++ G +
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNL-----TNLDALYLYDNSLSG----SIPGEIGN 479
SL LSL N+L L L++L++ S + +
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 480 LRSISNLALNNNKLSGSIPQSLG-----NLSNLVILYLYNNSLFD----SIPSELGNLRS 530
R + L ++NN+L + + L S L +L+L + + D S+ + L S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 531 LSMLSFAYNKLSGS----------IPHS-LGVLDLSSNHIVGEIPTELGKL 570
L L + N L + P L L L + E+ L L
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 93/455 (20%), Positives = 147/455 (32%), Gaps = 78/455 (17%)
Query: 75 LAYLDLWHNQL-YGNIPPQIGNISRLKYLDLSSN----LFFGTIPPEIGHLSYLKTLQLF 129
+ LD+ +L + + + + + L I + L L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 130 ENQLNGSIPYEIGRL-----SSLNYLALYSNYLED----LIPPSLGNLSNLDTLHLYDNS 180
N+L + + + + L+L + L ++ +L L L LHL DN
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 181 LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD----SIPSE 236
L D+ L+ L L L L L SL + S
Sbjct: 125 LGDA------GLQLLCEGLLDPQ-------------CRLEKLQLEYCSLSAASCEPLASV 165
Query: 237 LGNLRSLSMLSLGYNKLSGS----IPHSLGNLT-NLATLYLYENSLS----GSIPSEFGN 287
L L++ N ++ + + L + L L L ++ + +
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 288 LRSLSMLNLGYNKL-----NGIIPHSLGNLTNLATLYIHNNSLS----GSIPSEIGNLRS 338
SL L LG NKL + P L + L TL+I ++ G + + S
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 339 LSNLGLSGNKLSGSIPPSLG-----YLSNLATLYLYSNSLFD----SIPSELGNLRSLSM 389
L L L+GN+L L L +L++ S S S L R L
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345
Query: 390 LSLGYNKLSGSIPHSLG-----NLTNLATLDLYDNSLS----GSIPSEFGNLRSLSTLSL 440
L + N+L + L + L L L D +S S+ + SL L L
Sbjct: 346 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 405
Query: 441 GYNKLSGSIPHSLG-----NLTNLDALYLYDNSLS 470
N L + L L+ L LYD S
Sbjct: 406 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 91/428 (21%), Positives = 146/428 (34%), Gaps = 75/428 (17%)
Query: 49 RVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNI-----SRLKYLD 103
R++ LT K + + P LA L+L N+L + +++ L
Sbjct: 34 RLDDCGLTEARCKDIS--SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 91
Query: 104 LSSNLF----FGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED 159
L + G + + L L+ L L +N L + L L E
Sbjct: 92 LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD---------AGLQLLC------EG 136
Query: 160 LIPPSLGNLSNLDTLHLYDNSLSD----SIPSEFGNLRSLSMLSLGYNKFSGS----IPH 211
L+ P L+ L L SLS + S L++ N + + +
Sbjct: 137 LLDPQ----CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 192
Query: 212 SLGNLT-NLATLYLHNNSLFD----SIPSELGNLRSLSMLSLGYNKLSGS-----IPHSL 261
L + L L L + + + + + SL L+LG NKL P L
Sbjct: 193 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252
Query: 262 GNLTNLATLYLYENSLS----GSIPSEFGNLRSLSMLNLGYNKL-----NGIIPHSLGNL 312
+ L TL+++E ++ G + SL L+L N+L + L
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 313 TNLATLYIHNNSLSG----SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG-----YLSNL 363
L +L++ + S + S + R L L +S N+L + L S L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 364 ATLYLYSNSLFD----SIPSELGNLRSLSMLSLGYNKLSGSIPHSLG-----NLTNLATL 414
L+L + D S+ + L SL L L N L + L L L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 432
Query: 415 DLYDNSLS 422
LYD S
Sbjct: 433 VLYDIYWS 440
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 42/204 (20%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G V K + +G+ A K K ++E EV L EIRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 879 FYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGISDALS 920
+ + + + +IL + + A +K I D +
Sbjct: 73 LHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGVH 122
Query: 921 YMHNDCFPPIVHRDISSKNVLL-DFDNEAH---VSDFGIAKFLKPDSSNWTELAGTYGYV 976
Y+H+ I H D+ +N++L D + + DFGIA ++ + + + GT +V
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFV 178
Query: 977 APE-LAYTMKVTEKCDVYSFGVLA 999
APE + Y + + D++S GV+
Sbjct: 179 APEIVNYE-PLGLEADMWSIGVIT 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-22
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 38/197 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
+GKG G V K + + + AVK + + + L EV+ L ++ H NI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87
Query: 881 GFC-SHVRHSLAM-----------ILSNN-----AAAKDLGWTRRMNVIKGISDALSYMH 923
+ I+ AA+ +IK + ++YMH
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFSGITYMH 138
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
IVHRD+ +N+LL+ + + DFG++ + ++ + GT Y+APE+
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV 194
Query: 981 AYTMKVTEKCDVYSFGV 997
EKCDV+S GV
Sbjct: 195 -LRGTYDEKCDVWSAGV 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 810 IIRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNE 864
+ +T F D + +GKG G V + +G+ AVK + T ++ L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 865 VKALTEIRHRNIVKFYGFC-SHVRHSLAM----------------ILSNNAAAKDLGWTR 907
V+ L ++ H NI+K Y F L S AA+
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 908 RMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFLKPDSS 964
+I+ + ++YMH + IVHRD+ +N+LL D + DFG++ +
Sbjct: 131 ---IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ GT Y+APE+ EKCDV+S GV+ ++ G P
Sbjct: 185 -MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGSIP-HSLGNL 264
++P SL + A L L +N+L + +E L +L L L +N L+ I + +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 265 TNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
NL L L N L ++ F +L++L +L L N + + ++ ++ L LY+ N
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 324 SLSGSIPSEI----GNLRSLSNLGLSGNKLSGSIPPSLGYLSNL--ATLYLYSNSL 373
+S P E+ L L L LS NKL L L LYL++N L
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 9e-21
Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGSIP 402
S +L ++P SL S A L L N+L + +E L +L L L +N L+ I
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 403 -HSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIP-HSLGNLTNL 459
+ + NL LDL N L ++ F +L++L L L N + + ++ ++ L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQL 138
Query: 460 DALYLYDNSLSGSIPGEI----GNLRSISNLALNNNKLSGSIPQSLGNLSNLV--ILYLY 513
LYL N +S P E+ L + L L++NKL L L V LYL+
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 514 NNSL 517
NN L
Sbjct: 198 NNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 16/168 (9%)
Query: 313 TNLATLYIHNNSLSGSIPSEI--GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLY 369
+ A L + +N+LS + +E L +L +L LS N L+ I + + NL L L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 370 SNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLDLYDNSLSGSIPS 427
SN L ++ +L++L +L L N + + ++ ++ L L L N +S P
Sbjct: 97 SNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 428 E----FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL--DALYLYDNSL 469
E L L L L NKL L L + LYL++N L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 49/182 (26%), Positives = 73/182 (40%), Gaps = 16/182 (8%)
Query: 106 SNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEI--GRLSSLNYLALYSNYLEDLIPP 163
S +P + SY L L N L + E RL++L+ L L N+L +
Sbjct: 26 SKQQLPNVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSE 82
Query: 164 SLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIP-HSLGNLTNLAT 221
+ + NL L L N L ++ F +L++L +L L N + ++ ++ L
Sbjct: 83 AFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK 140
Query: 222 LYLHNNSLFDSIPSE----LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL--ATLYLYEN 275
LYL N + P E L L +L L NKL L L LYL+ N
Sbjct: 141 LYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
Query: 276 SL 277
L
Sbjct: 200 PL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTE--LGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLD 601
+P +LDLS N++ + E +L L L+L+ N L+ +S + + L +LD
Sbjct: 37 LPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 602 LSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIP 660
LSSN L F +L L L L NN + E++ L +L LS N + P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISR-FP 152
Query: 661 SQI----CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDIS 699
++ + L L+LS N L L + +K+ ++ +
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSE--FGNLRSLSTLSLGYNKLSGSIP-HSLGNL 456
++P SL + A LDL N+LS + +E L +L +L L +N L+ I + +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 457 TNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYN 514
NL L L N L ++ + +L+++ L L NN + + + + +++ L LYL
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 515 NSLFDSIPSE----LGNLRSLSMLSFAYNKLSGSIPHS 548
N + P E L L +L + NKL +P +
Sbjct: 146 NQI-SRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 47/168 (27%), Positives = 70/168 (41%), Gaps = 14/168 (8%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQI--GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQL 128
+ A LDL HN L + + ++ L L LS N I E + L+ L L
Sbjct: 38 PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDL 95
Query: 129 FENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS 187
N L+ ++ + L +L L LY+N++ + + +++ L L+L N +S P
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 188 E----FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL--ATLYLHNNSL 229
E L L +L L NK L L LYLHNN L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 5/113 (4%)
Query: 595 AQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSH 652
+ LDLS N LS + + L LH L LS+N + I + + +L LDLS
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSS 97
Query: 653 NFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
N L + + +Q+LE L L +N +V + + FE M L ++ +S N++
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 54 NLTSIGLKG----MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNL 108
NL S+ L + +F P+L YLDL N L + + ++ L+ L L +N
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNH 123
Query: 109 FFGTIPPEI-GHLSYLKTLQLFENQLNGSIPYEI----GRLSSLNYLALYSNYLEDLIPP 163
+ ++ L+ L L +NQ++ P E+ +L L L L SN L+ L
Sbjct: 124 -IVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLT 181
Query: 164 SLGNLSNL--DTLHLYDNSL 181
L L + L+L++N L
Sbjct: 182 DLQKLPAWVKNGLYLHNNPL 201
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 64/277 (23%)
Query: 820 EHCIGKGGQGSVYKAELASGEI----VAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 874
+G+G G VY+ + + VAVK ++F++E + + H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 875 NIVKFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYM 922
+IVK G +I L N L + I A++Y+
Sbjct: 74 HIVKLIGIIE--EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYL 129
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN----------WTELAGT 972
+ VHRDI+ +N+L+ + DFG++++++ + W
Sbjct: 130 ESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLD 1031
+PE + T DV+ F V E++ GK P + N + +L+
Sbjct: 182 ----SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF---WLE------NKDVIGVLE 228
Query: 1032 P--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
RLP P C + + C D +P RP
Sbjct: 229 KGDRLPKPDLC-----PPVLYTLMTRCWDYDPSDRPR 260
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 18/238 (7%)
Query: 152 LYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH 211
+ + P L+N +L S++D L + + + S+
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLA- 57
Query: 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLY 271
+ TNL L+L +N + D P L +L L LS+ N+L ++ + L+ L+
Sbjct: 58 GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLF 112
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPS 331
L N L +L++L +L++ NKL I+ LG L+ L L +H N ++ +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-G 166
Query: 332 EIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIP-SELGNLRSLS 388
+ L+ ++ + L+G K L T+ S G+
Sbjct: 167 GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 15/209 (7%)
Query: 213 LGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYL 272
L N L S+ D L + + + + S+ + TNL L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 273 YENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE 332
N +S + S +L L L++ N+L + + L+ L++ NN L
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDS 123
Query: 333 IGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSL 392
+ +L++L L + NKL SI LG+LS L L L+ N + + L L+ ++ + L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179
Query: 393 GYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
K L T+ D
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 46/238 (19%), Positives = 85/238 (35%), Gaps = 18/238 (7%)
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
+ P L + +LG ++ + L+ + +++ S+ +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
+L L+L +N+++ + P L +LT L L ++ N L L L
Sbjct: 58 GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF--- 112
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
L N+L SL +L NL L + +N L LG L L +L L N+++ +
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NTG- 166
Query: 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHS-LGNLTNLD 460
L L + +DL L +T+ + S G+ +
Sbjct: 167 GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 20/223 (8%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203
L++ L + DL+ LS + + ++++ + +L L L +N
Sbjct: 18 LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN 73
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 263
+ S + L +LT L L ++ N L + L L L N+L SL +
Sbjct: 74 QIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRD--TDSLIH 126
Query: 264 LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
L NL L + N L SI G L L +L+L N++ L L + + +
Sbjct: 127 LKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182
Query: 324 SLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366
L + + + I P Y+SN +
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRW---ISPY--YISNGGSY 220
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 44/211 (20%), Positives = 82/211 (38%), Gaps = 15/211 (7%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F + +L + ++ +S ++ + ++ + + LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSV-TDLVS-QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
L NQ++ P + L+ L L++ N L++L + + L L L +N L D
Sbjct: 69 HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--T 121
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
+L++L +LS+ NK SI LG L+ L L LH N + + L L+ ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWI 177
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
L K L T+ +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 39/229 (17%), Positives = 88/229 (38%), Gaps = 19/229 (8%)
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
L + +LG ++ + L+ + ++++ S+ G + ++ L L++
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSH 72
Query: 491 NKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP---- 546
N++S + L +L+ L L + N L + L L + N+L +
Sbjct: 73 NQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL---DNNELRDTDSLIHL 127
Query: 547 HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNR 606
+L +L + +N + I LG L+ L L L N+++ L L ++ +DL+ +
Sbjct: 128 KNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQK 183
Query: 607 LSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFL 655
N K L + + + ++ P + + +
Sbjct: 184 CVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 19/227 (8%)
Query: 488 LNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG---- 543
++ P L+N V L S+ D L + + + +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAGM 59
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
+L L LS N I ++ + L L L +L + +N+L L+ A L L L
Sbjct: 60 QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLD 114
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQI 663
+N L + S +L L L++ NN+ + L L L LDL N + +
Sbjct: 115 NNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNT--GGL 168
Query: 664 CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNS 710
++ + ++L+ V +++ + P S
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 37/177 (20%), Positives = 70/177 (39%), Gaps = 12/177 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
F +L L L HNQ+ ++ P + ++++L+ L ++ N I L L L
Sbjct: 59 MQFFTNLKELHLSHNQI-SDLSP-LKDLTKLEELSVNRNRL--KNLNGIPSAC-LSRLFL 113
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
N+L + + L +L L++ +N L+ + LG LS L+ L L+ N +++
Sbjct: 114 DNNELRDTDS--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN--TGG 167
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP-SELGNLRSLS 244
L+ ++ + L K L T+ + S G+
Sbjct: 168 LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNS 372
+ S++ ++ L S+ + + + + + YL N+ L L N
Sbjct: 19 AETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNK 74
Query: 373 L-----FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIP 426
L L +L+ L L N+L S+P+ + LTNL L L +N L S+P
Sbjct: 75 LHDISALKE-------LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLP 125
Query: 427 SE-FGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSI 483
F L +L+ L+L +N+L S+P + LTNL L L N L S+P G L +
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQL 183
Query: 484 SNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
+L L N+L S+P L++L ++L++N
Sbjct: 184 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 40/232 (17%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS--GSIPHSLGNLTNLATLYLYE 274
L S+ ++ L S+ + + + I + L N+ L L
Sbjct: 19 AETIKANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGG 72
Query: 275 NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334
N L I + L +L+ L L N+L + LTNL L + N L S+P +
Sbjct: 73 NKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF 129
Query: 335 N-LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393
+ L +L+ L L+ N+L S+P +FD L +L+ L L
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPK----------------GVFDK-------LTNLTELDLS 165
Query: 394 YNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
YN+L S+P + LT L L LY N L S+P F L SL + L N
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
P + L ++ L+++ + ++ + S+ + L ++
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI-KSVQG-IQYLPNV 65
Query: 388 SMLSLGYNKLSGSIPHSLG---NLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
L+LG NKL + LTNL L L N L S+P+ F L +L L L N
Sbjct: 66 RYLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 444 KLSGSIPHSLGN-LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL- 501
+L S+P + + LTNL L L N L G L +++ L L+ N+L S+P+ +
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVF 177
Query: 502 GNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSML 534
L+ L L LY N L S+P L SL +
Sbjct: 178 DKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 36/212 (16%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+ + + + ++ + I + ++YL L N + L+ L L
Sbjct: 36 TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL--HDISALKELTNLTYLI 91
Query: 128 LFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
L NQL S+P + +L++L L L N L+ L L+NL L+L N L S+P
Sbjct: 92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149
Query: 187 SE-FGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELGNLRSLS 244
F L +L+ L L YN+ S+P + LT L L L+ N L
Sbjct: 150 KGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL--------------- 193
Query: 245 MLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
S+P LT+L ++L++N
Sbjct: 194 ----------KSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 38/202 (18%)
Query: 510 LYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGK 569
L S+ ++ L S+ + + + S+ + +
Sbjct: 24 ANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIK-----SVQGIQ---------YLPNVRY 67
Query: 570 LNFLIKLILAQNQLSGQLSPKLG---SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626
L L N+L + L L +L L+ N+L + F L L L L
Sbjct: 68 LA------LGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116
Query: 627 SNNQFSR---GIPIKLEELIHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSLVGL 682
NQ G+ KL L+ L+L+HN L +++P + + +L L+LS+N L L
Sbjct: 117 VENQLQSLPDGVFDKLTN---LTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSL 172
Query: 683 IPSCFEKMHGLLRIDISYNELQ 704
F+K+ L + + N+L+
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLK 194
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 49/220 (22%)
Query: 808 EEIIRATNDFDDE----HCIGKGGQGSVYKA-ELASGEIVAVKKFH-SPLPGEMTFQQEF 861
E ++ A+ F D +GKG V + +G A K + L Q+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKL 75
Query: 862 LNEVKALTEIRHRNIVKFYG-FCSHVRHSLAMIL----------------SNNAAAKDLG 904
E + +++H NIV+ + H L L S A+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---- 131
Query: 905 WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLKP 961
+ I+ I ++++Y H++ IVHR++ +N+LL A V +DFG+A +
Sbjct: 132 -----HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 962 DSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGV 997
+ W AGT GY++PE+ Y ++ D+++ GV
Sbjct: 184 SEA-WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGV 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 70/292 (23%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL----ASGEI-VAVKKFHSPLPGEMTFQQ-EFL 862
EI + + IG G G VYK L E+ VA+K G Q+ +FL
Sbjct: 40 EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFL 94
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRHSLAMI-------------LSNNAAAKDLGWTRRM 909
E + + H NI++ G S ++ MI L + + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKD--GEFSVLQLV 150
Query: 910 NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---- 965
+++GI+ + Y+ N + VHRD++++N+L++ + VSDFG+++ L+ D
Sbjct: 151 GMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 966 --------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS 1016
WT APE K T DV+SFG++ EV+ G+ P +S
Sbjct: 208 SGGKIPIRWT---------APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW---ELS 255
Query: 1017 SSSLNLNIALDEMLDP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
N + + ++ RLPTP C +I ++ + C + RP
Sbjct: 256 ------NHEVMKAINDGFRLPTPMDC-----PSAIYQLMMQCWQQERARRPK 296
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 42/204 (20%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G V K E ++G A K K + +++ EV L EI+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 879 FYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGISDALS 920
+ + + + +IL + A +K I + +
Sbjct: 79 LHEVYEN-KTDVILILELVAGGELFDFLAEKESLTEEEAT---------EFLKQILNGVY 128
Query: 921 YMHNDCFPPIVHRDISSKNVLL----DFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
Y+H+ I H D+ +N++L + DFG+A + + + + GT +V
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFV 184
Query: 977 APE-LAYTMKVTEKCDVYSFGVLA 999
APE + Y + + D++S GV+
Sbjct: 185 APEIVNYE-PLGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 47/220 (21%)
Query: 812 RATNDFDDE----HCIGKGGQGSVYKA-ELASGEIVAVK-----KFHSPLPGEMTFQQEF 861
A +F + IG+G V + A+G AVK ++
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 862 LNEVKALTEIR-HRNIVKFYGFC-SHVRHSLAM-----------ILSN-----NAAAKDL 903
E L ++ H +I+ S L +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS-- 204
Query: 904 GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
+++ + +A+S++H + IVHRD+ +N+LLD + + +SDFG + L+P
Sbjct: 205 -------IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 964 SNWTELAGTYGYVAPE-LAYTMKVTEK-----CDVYSFGV 997
EL GT GY+APE L +M T D+++ GV
Sbjct: 255 K-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 51/299 (17%), Positives = 104/299 (34%), Gaps = 67/299 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +V++ +G++ A+K F++ + E + L ++ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 882 ---------------FCSH-------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
FC S A L + V++ + +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI---------VLRDVVGGM 125
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAGTYGY 975
+++ + IVHR+I N++ + ++DFG A+ L+ D + L GT Y
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEY 181
Query: 976 VAPEL--------AYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIAL 1026
+ P++ + K D++S GV G P R F + + I
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 1027 DEMLDP----------------RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ +P + + + + V + L+ + E +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 42/204 (20%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G V K E ++G A K K S ++E EV L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 879 FYGFCSHVRHSLAMIL------------------SNNAAAKDLGWTRRMNVIKGISDALS 920
+ + R + +IL S A + IK I D ++
Sbjct: 80 LHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGVN 129
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAGTYGYV 976
Y+H I H D+ +N++L N + DFG+A ++ + + GT +V
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFV 185
Query: 977 APE-LAYTMKVTEKCDVYSFGVLA 999
APE + Y + + D++S GV+
Sbjct: 186 APEIVNYE-PLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 40/203 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+G G V K E ++G A K K S ++E EV L ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 879 FYG-FCSHVRHSLAM----------------ILSNNAAAKDLGWTRRMNVIKGISDALSY 921
+ + + L + LS A + IK I D ++Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGVNY 130
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAGTYGYVA 977
+H I H D+ +N++L N + DFG+A ++ + + GT +VA
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVA 186
Query: 978 PE-LAYTMKVTEKCDVYSFGVLA 999
PE + Y + + D++S GV+
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 64/277 (23%)
Query: 820 EHCIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 874
CIG+G G V++ S E VA+K ++FL E + + H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76
Query: 875 NIVKFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKGISDALSYM 922
+IVK G + + + +I L L + +S AL+Y+
Sbjct: 77 HIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYL 132
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----SSN------WTELAGT 972
+ F VHRDI+++NVL+ ++ + DFG++++++ +S W
Sbjct: 133 ESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLD 1031
APE + T DV+ FGV E++ G P + N + ++
Sbjct: 185 ----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ---GVK------NNDVIGRIE 231
Query: 1032 P--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
RLP P +C ++ + C +P RP
Sbjct: 232 NGERLPMPPNC-----PPTLYSLMTKCWAYDPSRRPR 263
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 47/221 (21%), Positives = 85/221 (38%), Gaps = 48/221 (21%)
Query: 812 RATNDFDDE----HCIGKGGQGSVYKA-ELASGEIVAVKKF------HSPLPGEMTFQQE 860
+T+ F + +G+G V + + + AVK ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 861 FLNEVKALTEI-RHRNIVKFYGFC-SHVRHSLAM-----------I-----LSNNAAAKD 902
L EV L ++ H NI++ ++ L + LS K
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128
Query: 903 LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962
+++ + + + +H IVHRD+ +N+LLD D ++DFG + L P
Sbjct: 129 --------IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 963 SSNWTELAGTYGYVAPE-LAYTMKV-----TEKCDVYSFGV 997
E+ GT Y+APE + +M ++ D++S GV
Sbjct: 178 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 63/278 (22%)
Query: 820 EHCIGKGGQGSVYKAEL---ASGEI-VAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIRHR 874
+ +G G G V L + EI VA+K G Q+ +FL E + + H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHP 106
Query: 875 NIVKFYGFCSH----------VRH-SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
NI++ G + + + SL L + + + +++GI+ + Y+
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS 164
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN------------WTELAG 971
+ + VHRD++++N+L++ + VSDFG+ + L+ D WT
Sbjct: 165 DMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEML 1030
+PE K T DV+S+G++ EV+ G+ P MS N + + +
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---YWEMS------NQDVIKAV 263
Query: 1031 DP--RLPTP-SCIVQDKLISIVEVAISCLDENPESRPT 1065
D RLP P C ++ ++ + C ++ +RP
Sbjct: 264 DEGYRLPPPMDC-----PAALYQLMLDCWQKDRNNRPK 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 35/205 (17%), Positives = 82/205 (40%), Gaps = 33/205 (16%)
Query: 882 FCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVL 941
C + +L ++ + +D +++ I++A+ ++H+ ++HRD+ N+
Sbjct: 142 LCR--KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIF 196
Query: 942 LDFDNEAHVSDFGIAKFLKPDSS------------NWTELAGTYGYVAPELAYTMKVTEK 989
D+ V DFG+ + D T GT Y++PE + + K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 990 CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIV 1049
D++S G++ E++ + F + M + ++ + + P + +V
Sbjct: 257 VDIFSLGLILFELL---YS--FSTQM-----ERVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 1050 EVAISCLDENPESRPTMPKVSQLLK 1074
+ L +P RP + +++
Sbjct: 307 Q---DMLSPSPTERPE---ATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 22/78 (28%), Positives = 39/78 (50%), Gaps = 3/78 (3%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
R DF+ C+G+GG G V++A+ A+K+ LP +++ + EVKAL +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 60
Query: 871 IRHRNIVKFYGFCSHVRH 888
+ H IV+++
Sbjct: 61 LEHPGIVRYFNAWLETPP 78
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 54/242 (22%), Positives = 87/242 (35%), Gaps = 52/242 (21%)
Query: 788 SPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVK- 845
SPG + G +L + + + + IGKG V + +G+ AVK
Sbjct: 2 SPGISGGGGGILDMADD---DVLFEDVYELCEV--IGKGPFSVVRRCINRETGQQFAVKI 56
Query: 846 ----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS---HV------------ 886
KF S ++ E ++H +IV+ S +
Sbjct: 57 VDVAKFTSS---PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL 113
Query: 887 ------RHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH-NDCFPPIVHRDISSKN 939
R + S A+ + ++ I +AL Y H N+ I+HRD+
Sbjct: 114 CFEIVKRADAGFVYSEAVAS---------HYMRQILEALRYCHDNN----IIHRDVKPHC 160
Query: 940 VLL-DFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 996
VLL +N A V FG+A L GT ++APE+ + DV+ G
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 997 VL 998
V+
Sbjct: 221 VI 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 6e-21
Identities = 35/233 (15%), Positives = 67/233 (28%), Gaps = 38/233 (16%)
Query: 808 EEIIRATNDFDDEHCIGKGGQGSVYKAE------LASGEIVAVKKFHSPLPGEMTFQQEF 861
E + H +G+G VY+A + + +K P E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114
Query: 862 LNEVKALTEIRHRNIVKFYG-FCSHVRHSLAMILSN------------NAAAKDLGWTRR 908
++ L +KFY L L + N K +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 909 MNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH-----------VSDFGIAK 957
++ + + +H+ I+H DI N +L + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 958 FLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+K P + +T T G+ E+ + D + ++ G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 7e-21
Identities = 36/300 (12%), Positives = 84/300 (28%), Gaps = 76/300 (25%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 872
+G+ + +A + +GE V + ++ EV L +R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 873 ----------------HRNIVKFYGFCSHVRHS----------------LAMILSNNAAA 900
+ +++ + ++LS+++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 901 KDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960
K L R+ + + L+ +H+ +VH + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 961 PDSSNWTELAGTYGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPR 1009
+ + G+ PEL +T D ++ G++ + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 1010 DFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ + +P P V+ L+ L E R +
Sbjct: 313 -I----TKDAALGGSEWIFRSCKNIPQP---VRA-LLE------GFLRYPKEDRLLPLQA 357
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 807 YEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFL 862
++ I F + +G G G V+ E +SG +K K S +P E
Sbjct: 16 FQGTIDDLFIFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IE 68
Query: 863 NEVKALTEIRHRNIVKFYGFC-SHVRHSLAM-----------ILSNNAAAKDLGWTRRMN 910
E++ L + H NI+K + + + M I+S A K L
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWT 967
++K + +AL+Y H+ +VH+D+ +N+L + + DFG+A+ K D T
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-ST 184
Query: 968 ELAGTYGYVAPE-LAYTMKVTEKCDVYSFGV 997
AGT Y+APE VT KCD++S GV
Sbjct: 185 NAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 52/243 (21%), Positives = 96/243 (39%), Gaps = 39/243 (16%)
Query: 776 QRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKA- 834
N Q+ S + + L + I ++ F+ E +G+G VY+
Sbjct: 14 GTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK 73
Query: 835 ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC-SHVRHSLAMI 893
+ + + A+K + ++ E+ L + H NI+K + SL +
Sbjct: 74 QKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 894 L----------------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISS 937
L S AA +K I +A++Y+H + IVHRD+
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAAD---------AVKQILEAVAYLHENG---IVHRDLKP 176
Query: 938 KNVLL-DFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYS 994
+N+L +A + +DFG++K ++ + GT GY APE+ + D++S
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 995 FGV 997
G+
Sbjct: 236 VGI 238
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 66/293 (22%), Positives = 108/293 (36%), Gaps = 73/293 (24%)
Query: 820 EHCIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 873
IG+G G VY L + AVK L + +FL E + + H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 874 RNIVKFYGFCSHVRHSLAMIL---------------SNNAAAKDLGWTRRMNVIKGISDA 918
N++ G C S ++L ++N KDL + ++
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 140
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL-------KPDSSN------ 965
+ Y+ + F VHRD++++N +LD V+DFG+A+ + + +
Sbjct: 141 MKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNI 1024
W A E T K T K DV+SFGVL E++ +G P ++
Sbjct: 198 WM---------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------TF 239
Query: 1025 ALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ L RL P C + EV + C E RP+ ++ +
Sbjct: 240 DITVYLLQGRRLLQPEYC-----PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 65/285 (22%), Positives = 108/285 (37%), Gaps = 57/285 (20%)
Query: 820 EHCIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 873
IG+G G VY L + AVK L + +FL E + + H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 874 RNIVKFYGFCSHVRHSLAMIL---------------SNNAAAKDLGWTRRMNVIKGISDA 918
N++ G C S ++L ++N KDL + ++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 204
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV-- 976
+ ++ + F VHRD++++N +LD V+DFG+A+ + + T +
Sbjct: 205 MKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPV 260
Query: 977 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
A E T K T K DV+SFGVL E++ +G P ++ + L
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---------TFDITVYLLQ 311
Query: 1033 --RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
RL P C + EV + C E RP+ ++ +
Sbjct: 312 GRRLLQPEYC-----PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 53/285 (18%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQEFLNE 864
I + IGKG G VY E A+K + + FL E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQ-VEAFLRE 72
Query: 865 VKALTEIRHRNIVKFYGFCSHVRHSLAMIL---------------SNNAAAKDLGWTRRM 909
+ + H N++ G ++L N KDL +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----I 127
Query: 910 NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
+ ++ + Y+ F VHRD++++N +LD V+DFG+A+ + D ++
Sbjct: 128 SFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQ 183
Query: 970 AGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLN 1023
+ + A E T + T K DV+SFGVL E++ +G P I
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---------P 234
Query: 1024 IALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPT 1065
L L RLP P C S+ +V C + +P RPT
Sbjct: 235 FDLTHFLAQGRRLPQPEYC-----PDSLYQVMQQCWEADPAVRPT 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 50/236 (21%), Positives = 77/236 (32%), Gaps = 62/236 (26%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKF 879
IG+G G V A E + I A+K + ++ + + EV+ + ++ H NI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 880 YG-------------FCS------------HVRHSLAMILSNNAAAKDLGWTRRM----- 909
Y C +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 910 ------------------NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV- 950
N+++ I AL Y+HN I HRDI +N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 951 -SDFGIAKFLKP----DSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLA 999
DFG++K + T AGT +VAPE+ KCD +S GVL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 47/199 (23%), Positives = 76/199 (38%), Gaps = 44/199 (22%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G V A + + A KK + F E++ + + H NI++ Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKY---FVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 882 FC-SHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDALSYMHN 924
+ L M L + AA+ ++K + A++Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------IMKDVLSAVAYCHK 124
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 980
+ HRD+ +N L D+ + DFG+A KP GT YV+P++
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVL 180
Query: 981 --AYTMKVTEKCDVYSFGV 997
Y +CD +S GV
Sbjct: 181 EGLY----GPECDEWSAGV 195
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 49/203 (24%), Positives = 76/203 (37%), Gaps = 50/203 (24%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIR-HRN 875
+G+G K S + AVK + E+ AL H N
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67
Query: 876 IVKFYGFC-SHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDA 918
IVK + + L M L S A+ +++ + A
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------IMRKLVSA 118
Query: 919 LSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGY 975
+S+MH+ +VHRD+ +N+L D ++ + DFG A+ PD+ T Y
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 976 VAPELAYTMKVTEKCDVYSFGVL 998
APEL E CD++S GV+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVI 198
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 54/300 (18%), Positives = 100/300 (33%), Gaps = 51/300 (17%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVK--------------KFHSPLPGEMTFQQE 860
ND+ + +G + E + A+K K ++ + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 861 FLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL-----------------SNNAAAKDL 903
F NE++ +T+I++ + G + +I + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 904 GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
+IK + ++ SY+HN I HRD+ N+L+D + +SDFG ++++ D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDK 205
Query: 964 SNWTELAGTYGYVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021
GTY ++ PE K D++S G+ + P F +S L
Sbjct: 206 KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--FSLKISLVELF 262
Query: 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVA---------ISC-LDENPESRPTMPKVSQ 1071
NI + P S + L +NP R T +
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 46/226 (20%), Positives = 79/226 (34%), Gaps = 46/226 (20%)
Query: 800 TFEGKIVYEEIIRATNDFDDE----HCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGE 854
T + +++ R + F D IG G + A+ AVK
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------ 56
Query: 855 MTFQQEFLNEVKAL-TEIRHRNIVKFYGFC-SHVRHSLAMIL----------------SN 896
+++ E++ L +H NI+ + L S
Sbjct: 57 -KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 897 NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH----VSD 952
A+ V+ I+ + Y+H +VHRD+ N+L ++ + D
Sbjct: 116 REASA---------VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163
Query: 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998
FG AK L+ ++ T +VAPE+ CD++S GVL
Sbjct: 164 FGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 59/182 (32%), Positives = 78/182 (42%), Gaps = 30/182 (16%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
+ L L L+ + F L L+ LNL YN+L + +LT L TL + NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 325 LSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383
L+ S+P + +L L L L GN+L S+P + FD
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV----------------FDR------- 129
Query: 384 LRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIP-SEFGNLRSLSTLSLG 441
L L L L N+L SIP LTNL TL L N L S+P F L L T++L
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLF 187
Query: 442 YN 443
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLYLYEN 275
+ L L + L + L L+ L+L YN+L ++ + +LT L TL L N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 276 SLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI- 333
L+ S+P F +L L L LG N+L + LT L L ++ N L SIP+
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 334 GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSN 371
L +L L LS N+L S+P + L L T+ L+ N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 55/169 (32%), Positives = 74/169 (43%), Gaps = 12/169 (7%)
Query: 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSEL-GNLRS 386
S+PS I L L L+ + L+ L L L N L ++ + + +L
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTE 84
Query: 387 LSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNK 444
L L L N+L+ S+P + +LT L L L N L S+PS F L L L L N+
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142
Query: 445 LSGSIPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
L SIP LTNL L L N L S+P G L + + L N
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 53/156 (33%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
+ L L L L+ L +L L N L+ L +L+ L TL L +N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 184 SIPSE-FGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSEL-GNL 240
S+P F +L L L LG N+ S+P + LT L L L+ N L SIP+ L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154
Query: 241 RSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
+L LSL N+L S+PH + L L T+ L+ N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 52/150 (34%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGS 448
L L L+ + LT L L+L N L ++ + F +L L TL L N+L+ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 449 IPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSL-GNLS 505
+P + +LT LD LYL N L S+P G L + L LN N+L SIP L+
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 506 NLVILYLYNNSLFDSIP-SELGNLRSLSML 534
NL L L N L S+P L L +
Sbjct: 156 NLQTLSLSTNQL-QSVPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNGS 136
LDL L +++L +L+L N T+ + L+ L TL L NQL S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQ-LQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 137 IPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
+P + L+ L+ L L N L+ L L+ L L L N L SIP+ F L +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 195 LSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
L LSL N+ S+PH + L L T+ L N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 53/177 (29%), Positives = 73/177 (41%), Gaps = 30/177 (16%)
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGI 304
L L L+ + LT L L L N L ++ + F +L L L L N+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 305 IPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
+LT L LY+ N L S+PS + L L L L+ N+L SIP
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIP--------- 147
Query: 364 ATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLDLYDN 419
FD L +L LSL N+L S+PH + L L T+ L+ N
Sbjct: 148 -------AGAFDK-------LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 52/156 (33%), Positives = 67/156 (42%), Gaps = 8/156 (5%)
Query: 100 KYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLE 158
+ LDL S L+ L L L NQL ++ + L+ L L L +N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSL-GNL 216
L +L+ LD L+L N L S+PS F L L L L N+ SIP L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 217 TNLATLYLHNNSLFDSIP-SELGNLRSLSMLSLGYN 251
TNL TL L N L S+P L L ++L N
Sbjct: 155 TNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 457 TNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL-GNLSNLVILYLYNN 515
+ + L L L+ L ++ L L+ N+L ++ + +L+ L L L NN
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 516 SLFDSIPSEL-GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
L S+P + +L L L N+L S+P GV D +L L
Sbjct: 94 QL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFD---------------RLTKLK 134
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQF 631
+L L NQL + L L+ L LS+N+L S+P +F L KL + L NQF
Sbjct: 135 ELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 4/159 (2%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSS 604
IP LDL S + L L L L NQL + L +L L L++
Sbjct: 33 IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92
Query: 605 NRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPSQI 663
N+L++ F +L +L L L NQ +P + + L L EL L+ N L+ +IP+
Sbjct: 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 664 C-IMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
+ +L+ L+LS N L + F+++ L I + N
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR- 633
KL L L+ L +L L+L N+L F +L +L L L+NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 634 --GIPIKLEELIHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSLVGLIPSCFEKM 690
G+ L + L +L L N L +++PS + + L+ L L+ N L + F+K+
Sbjct: 99 PLGVFDHLTQ---LDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154
Query: 691 HGLLRIDISYNELQ 704
L + +S N+LQ
Sbjct: 155 TNLQTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTL 126
F L L L NQL ++P + +++LK L L++N +IP L+ L+TL
Sbjct: 103 FDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQ-LQSIPAGAFDKLTNLQTL 160
Query: 127 QLFENQLNGSIPYEI-GRLSSLNYLALYSN 155
L NQL S+P+ RL L + L+ N
Sbjct: 161 SLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 86/426 (20%), Positives = 151/426 (35%), Gaps = 89/426 (20%)
Query: 695 RIDISYNELQGPIPNSIA-FRDAPIEALQGNKGLCGDVKGLPSCKTLKSNKQALRK---I 750
ISY +G P +A F ++ +Q + D KG+ K + + +
Sbjct: 247 EEGISYLTDKGANPTHLADFNQ--VQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSL 304
Query: 751 WVVVVFPLL--GIVALLI----SLIGLFFKFQRRNNDLQTQ------QSSPGNTRGLLSV 798
+ L G L+ S I K R + Q +T +
Sbjct: 305 TIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSET 364
Query: 799 LTFEGKIVYEEIIRATNDFDDE---------HCIGKGGQGSVYKAELASGE----IVAVK 845
+ I E+ + D E CIG+G G V++ S E VA+K
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 846 KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI------------ 893
+ + +++FL E + + H +IVK G + + + +I
Sbjct: 425 TCKNCTSDSV--REKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSF 480
Query: 894 LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953
L L + +S AL+Y+ + F VHRDI+++NVL+ ++ + DF
Sbjct: 481 LQVRK--FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDF 535
Query: 954 GIAKFLKPDS----------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 1003
G++++++ + W APE + T DV+ FGV E++
Sbjct: 536 GLSRYMEDSTYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMWEIL 586
Query: 1004 -KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDEN 1059
G P + N + ++ RLP P C ++ + C +
Sbjct: 587 MHGVKPFQGVK---------NNDVIGRIENGERLPMPPNC-----PPTLYSLMTKCWAYD 632
Query: 1060 PESRPT 1065
P RP
Sbjct: 633 PSRRPR 638
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 41/212 (19%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 810 IIRATNDFDD-----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLN 863
++ +F++ +G+G V + ++G+ A K G+ + E L+
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILH 77
Query: 864 EVKALTEIRHR-NIVKFYGFCSHVRHSLAMI--------LSNNAAAKDLGW-TRR--MNV 911
E+ L + ++ + + + +I + + + + + +
Sbjct: 78 EIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL 136
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH---VSDFGIAKFLKPDSSNWTE 968
IK I + + Y+H + IVH D+ +N+LL + DFG+++ + E
Sbjct: 137 IKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LRE 192
Query: 969 LAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 999
+ GT Y+APE L Y +T D+++ G++A
Sbjct: 193 IMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 89.0 bits (220), Expect = 2e-18
Identities = 50/211 (23%), Positives = 76/211 (36%), Gaps = 10/211 (4%)
Query: 474 PGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSM 533
+ + L+ K + + L + L L N +I + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 534 LSFA---YNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590
++ L P LD + + E + + L LA L+ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH- 458
Query: 591 LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650
L L + HLDLS NRL ++P + L L L S+N + + L L EL L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515
Query: 651 SHNFLRE-AIPSQICIMQSLENLNLSHNSLV 680
+N L++ A + L LNL NSL
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 87.9 bits (217), Expect = 5e-18
Identities = 57/282 (20%), Positives = 94/282 (33%), Gaps = 21/282 (7%)
Query: 210 PHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL----GNLT 265
P +++ L SL D +P + S L P
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 266 NLATLYLYENSLSGSIPSEFGNLRSLSML---NLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L L + + SE + + L L N ++ +L L +
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
++L P L L + L N + +++ L+L L ++ L
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVL------KMEYADVRVLHLAHKDL--TVLCHLE 460
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
L ++ L L +N+L ++P +L L L L DN+L ++ NL L L L
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCN 517
Query: 443 NKLSG-SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
N+L + L + L L L NSL G L +
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 1e-16
Identities = 42/224 (18%), Positives = 78/224 (34%), Gaps = 11/224 (4%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQL 128
++ L +L + + ++ + L+ L+ + TI I + L L
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLY 400
Query: 129 FENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188
+ L + YL + +++ LHL L+
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCH 458
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248
L ++ L L +N+ ++P +L L L L +N+L +++ + NL L L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL-ENVD-GVANLPRLQELLL 515
Query: 249 GYNKLSG-SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291
N+L + L + L L L NSL L +
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.9 bits (204), Expect = 2e-16
Identities = 61/320 (19%), Positives = 106/320 (33%), Gaps = 11/320 (3%)
Query: 357 LGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDL 416
+ ++ S L + + LS+ + G S L +L L
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGE 476
D + + S L ++ L L + + E
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSE 367
Query: 477 IGNLRSISNLALNNNKLSGSI---PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSM 533
+ + + + L N +I ++L L Y ++L P L L
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427
Query: 534 LSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGS 593
N + + VL L+ + + L +L + L L+ N+L L P L +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 594 LAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSH 652
L LE L S N L ++ NL +L L L NN+ + I+ L L L+L
Sbjct: 485 LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 653 NFLREAIPSQICIMQSLENL 672
N L + Q + + L ++
Sbjct: 543 NSLCQEEGIQERLAEMLPSV 562
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.3 bits (192), Expect = 6e-15
Identities = 44/236 (18%), Positives = 77/236 (32%), Gaps = 24/236 (10%)
Query: 426 PSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISN 485
+ L L K + + L + L L + +I I +R++
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397
Query: 486 LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI-----PSELGNLRSLSMLSFAYNK 540
L L Q L + + S + +L A+
Sbjct: 398 LLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 541 LSGSIPH-----SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLA 595
L+ + H + LDLS N + +P L L L L + N L + + +L
Sbjct: 453 LT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLP 508
Query: 596 QLEHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650
+L+ L L +NRL + + + +L LNL N + I+ L +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 28/129 (21%), Positives = 43/129 (33%), Gaps = 29/129 (22%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+ +LDL HN+L +PP + L L+ LQ
Sbjct: 458 HLEQLLLVTHLDLSHNRL-------------------------RALPPALAALRCLEVLQ 492
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSLSDSIP 186
+N L ++ + L L L L +N L+ L + L L+L NSL
Sbjct: 493 ASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EE 549
Query: 187 SEFGNLRSL 195
L +
Sbjct: 550 GIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 32/209 (15%), Positives = 63/209 (30%), Gaps = 19/209 (9%)
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG--SIPHSLGVLDLSSNHIV 560
+L + F I + + + +L + L +LS
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 561 GEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620
+ +EL L +L + + +L L + + S L
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST--------LKA 413
Query: 621 LHYLNLSNNQFSR-----GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLS 675
+ + + R + E + L L+H L + + + +L+LS
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLS 471
Query: 676 HNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
HN L +P + L + S N L+
Sbjct: 472 HNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 34/134 (25%), Positives = 62/134 (46%), Gaps = 6/134 (4%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
+ + L N++ P + L + L N++S + + L +L +L LY N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 276 SLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI- 333
++ +P F L SL +L L NK+N + + +L NL L +++N L +I
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148
Query: 334 GNLRSLSNLGLSGN 347
LR++ + L+ N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 34/129 (26%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGS 448
+ L N + P + L +DL +N +S + + F LRSL++L L NK++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 449 IPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSLGNLSN 506
+P SL L +L L L N ++ + +L +++ L+L +NKL + L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 507 LVILYLYNN 515
+ ++L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 6/129 (4%)
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGI 304
+ L N + P + L + L N +S + + F LRSL+ L L NK+ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 305 IPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPP-SLGYLSN 362
L +L L ++ N ++ + + +L +L+ L L NKL +I + L
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRA 153
Query: 363 LATLYLYSN 371
+ T++L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 38/130 (29%), Positives = 65/130 (50%), Gaps = 8/130 (6%)
Query: 294 LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGS 352
+ L N + I P + L + + NN +S + + LRSL++L L GNK++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 353 IPPSL-GYLSNLATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLT 409
+P SL L +L L L +N + + + + +L +L++LSL NKL +I + L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152
Query: 410 NLATLDLYDN 419
+ T+ L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH-SLGNLTNLDALYLYDN 467
+ + L N++ P F + L + L N++S + + L +L++L LY N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 468 SLSGSIPGEI-GNLRSISNLALNNNKLSGSIP-QSLGNLSNLVILYLYNNSLFDSIPSE- 524
++ +P + L S+ L LN NK++ + + +L NL +L LY+N L +I
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGT 147
Query: 525 LGNLRSLSML 534
LR++ +
Sbjct: 148 FSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 35/131 (26%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
++L +N + P L + L +N + +L P + L +L++L LY N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 184 SIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNNSLFDSIPSE-LGNL 240
+P F L SL +L L NK + + + +L NL L L++N L +I L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPL 151
Query: 241 RSLSMLSLGYN 251
R++ + L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 6/119 (5%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
+ +FS + L +DL +NQ+ + P + L L L N +P + L
Sbjct: 47 IPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK-ITELPKSLFEGLF 104
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L+ L L N++N + + L +LN L+LY N L+ + + L + T+HL N
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 4/112 (3%)
Query: 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHN 653
+ + L N + P +F KL ++LSNNQ S + + L L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 654 FLREAIPSQI-CIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+ +P + + SL+ L L+ N + L F+ +H L + + N+LQ
Sbjct: 91 KI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 32/151 (21%), Positives = 57/151 (37%), Gaps = 20/151 (13%)
Query: 482 SISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL-GNLRSLSMLSFAYNK 540
+I+ + L N + P + L + L NN + + + LRSL+ L NK
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNK 91
Query: 541 LSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHL 600
++ +P + + L L L+L N+++ L L L
Sbjct: 92 IT-ELPK--SLFE---------------GLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133
Query: 601 DLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
L N+L +F L + ++L+ N F
Sbjct: 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 575 KLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR 633
++ L QN + + P +L +DLS+N++S P +F L L+ L L N+ +
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 634 GIPIKL-EELIHLSELDLSHNFLREAIPSQI-CIMQSLENLNLSHNSLVGLIPSCFEKMH 691
+P L E L L L L+ N + + + +L L+L N L + F +
Sbjct: 95 -LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 692 GLLRIDISYN 701
+ + ++ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 27/151 (17%), Positives = 58/151 (38%), Gaps = 22/151 (14%)
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIP 564
+ + L N++ P + L + + N++S +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQ----------- 77
Query: 565 TELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLH 622
L L L+L N+++ +L L L L+ L L++N+++ + +F +L L+
Sbjct: 78 ----GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131
Query: 623 YLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
L+L +N+ L + + L+ N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 55/218 (25%)
Query: 814 TNDFDD-----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKA 867
D + +G G G V + +G+ A+K + + EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDH 74
Query: 868 LTEI-RHRNIVKFYGFC---SHVRHSLAMIL--------------------SNNAAAKDL 903
+ +IV H + L +I+ + AA+
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE-- 132
Query: 904 GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKFLK 960
+++ I A+ ++H+ I HRD+ +N+L + +A + +DFG AK
Sbjct: 133 -------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998
++ T YVAPE+ K + CD++S GV+
Sbjct: 183 QNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 63/289 (21%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 874
+G G G VY+ ++ S VAVK LP + Q +FL E +++ H+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 875 NIVKFYGFCSHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDA 918
NIV+ G +++ + L ++V + I+
Sbjct: 94 NIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 975
Y+ + F +HRDI+++N LL V DFG+A+ + +++ G
Sbjct: 153 CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAM 206
Query: 976 V-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDE 1028
+ PE T K D +SFGVL E+ G P S S N + E
Sbjct: 207 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLE 256
Query: 1029 MLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ R+ P C + I+ C PE RP + + ++
Sbjct: 257 FVTSGGRMDPPKNC--PGPVYRIMT---QCWQHQPEDRPNFAIILERIE 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 64/297 (21%), Positives = 116/297 (39%), Gaps = 75/297 (25%)
Query: 823 IGKGGQGSVYKAELASGE------IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G+G G V+ AE + +VAVK + +Q+F E + LT ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---EASESARQDFQREAELLTMLQHQHI 105
Query: 877 VKFYGFCS-----------------------HVRHSLAMILSNNAAAKDLGWTRRMNVIK 913
V+F+G C+ H + + + A LG + + V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 914 GISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL------KPDSSN-- 965
++ + Y+ F VHRD++++N L+ + DFG+++ + +
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 966 ---WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSL 1020
W PE + Y K T + DV+SFGV+ E+ GK P +S
Sbjct: 223 PIRWM---------PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP---WYQLS---- 265
Query: 1021 NLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
N + + L P C ++ +I+ C P+ R ++ V L+
Sbjct: 266 --NTEAIDCITQGRELERPRAC--PPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 30/135 (22%), Positives = 57/135 (42%), Gaps = 7/135 (5%)
Query: 217 TNLATLYLHNNSLFDSIPSE--LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE 274
A L L+NN + + L L ++ NK++ + + + + L
Sbjct: 32 QYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 275 NSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333
N L ++ + F L SL L L N++ + S L+++ L +++N ++ ++
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 334 -GNLRSLSNLGLSGN 347
L SLS L L N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 313 TNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYS 370
A L ++NN + + I L L + S NK++ I + S + + L S
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 371 NSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLDLYDNSLSGSIPSE 428
N L +++ ++ L SL L L N+++ + + S L+++ L LYDN ++ ++
Sbjct: 91 NRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 429 -FGNLRSLSTLSLGYN 443
F L SLSTL+L N
Sbjct: 148 AFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 26/130 (20%), Positives = 56/130 (43%), Gaps = 7/130 (5%)
Query: 390 LSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGS 448
L L N+ + + L L ++ +N ++ F ++ + L N+L +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95
Query: 449 IPHSL-GNLTNLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNKLSGSIPQ-SLGNLS 505
+ H + L +L L L N ++ + + L S+ L+L +N+++ ++ + L
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 506 NLVILYLYNN 515
+L L L N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 9/144 (6%)
Query: 112 TIPPEIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSN 170
IP I Y L+L N+ I +L L + +N + D+ + S
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 171 LDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNNS 228
++ + L N L ++ + F L SL L L N+ + + + S L+++ L L++N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 229 LFDSIPSE-LGNLRSLSMLSLGYN 251
+ ++ L SLS L+L N
Sbjct: 141 I-TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 5/136 (3%)
Query: 545 IPHSLGVLDLSSNHIVGEIPT-ELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDL 602
IP L L++N T KL L K+ + N+++ + + + + L
Sbjct: 30 IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILL 88
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPS 661
+SNRL N K F L L L L +N+ + + L + L L N + P
Sbjct: 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPG 147
Query: 662 QICIMQSLENLNLSHN 677
+ SL LNL N
Sbjct: 148 AFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 29/178 (16%), Positives = 58/178 (32%), Gaps = 47/178 (26%)
Query: 457 TNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515
L L +N + G L + + +NNK++ + S + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 516 SLFDSIPSEL-GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
L +++ ++ L SL L N+++ + +
Sbjct: 92 RL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGN--DSFI--------------------- 126
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQF 631
L+ + L L N+++ ++ +F L L LNL N F
Sbjct: 127 ------------------GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 30/139 (21%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTL 126
F P L ++ +N++ I S + +
Sbjct: 52 IFKKLPQLRKINFSNNKI-------------------------TDIEEGAFEGASGVNEI 86
Query: 127 QLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSI 185
L N+L ++ +++ L SL L L SN + + S LS++ L LYDN ++ ++
Sbjct: 87 LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144
Query: 186 PSE-FGNLRSLSMLSLGYN 203
F L SLS L+L N
Sbjct: 145 APGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 24/113 (21%), Positives = 49/113 (43%), Gaps = 5/113 (4%)
Query: 595 AQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSH 652
L L++N + F L +L +N SNN+ + I E ++E+ L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTS 90
Query: 653 NFLREAIPSQICI-MQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
N L E + ++ ++SL+ L L N + + F + + + + N++
Sbjct: 91 NRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 64/292 (21%), Positives = 105/292 (35%), Gaps = 65/292 (22%)
Query: 820 EHCIGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+G+G GSV + L + VAVK + +EFL+E + + H N
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPN 97
Query: 876 IVKFYGFCSH---VRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGIS 916
+++ G C M++ K + + + I+
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-----------N 965
+ Y+ N F +HRD++++N +L D V+DFG++K +
Sbjct: 158 LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNI 1024
W A E T K DV++FGV E+ +G P + N
Sbjct: 215 WI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ---------NH 256
Query: 1025 ALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ + L RL P C D+L I+ SC +P RPT + L
Sbjct: 257 EMYDYLLHGHRLKQPEDC--LDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/294 (19%), Positives = 109/294 (37%), Gaps = 73/294 (24%)
Query: 823 IGKGGQGSVYKAELASGE------IVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 874
+G+G G VY+ VA+K + + ++ EFLNE + E
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEASVMKEFNCH 88
Query: 875 NIVKFYGFCSHVRHSLAMIL-------------------SNNAAAKDLGWTRRMNVIKGI 915
++V+ G S +I+ +NN ++ + + I
Sbjct: 89 HVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL------KPDSSN---- 965
+D ++Y++ + F VHRD++++N ++ D + DFG+ + + +
Sbjct: 148 ADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 966 -WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLN 1023
W +PE T DV+SFGV+ E+ + P +S N
Sbjct: 205 RWM---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLS------N 246
Query: 1024 IALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + L P C D L ++ C NP+ RP+ ++ +K
Sbjct: 247 EQVLRFVMEGGLLDKPDNC--PDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 63/289 (21%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 874
+G G G VY+ ++ S VAVK LP + Q +FL E +++ H+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 875 NIVKFYGFCSHVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDA 918
NIV+ G ++L + L ++V + I+
Sbjct: 135 NIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV---SDFGIAKFLKPDSSNWTELAGTYGY 975
Y+ + F +HRDI+++N LL V DFG+A+ + + + G
Sbjct: 194 CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAM 247
Query: 976 V-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDE 1028
+ PE T K D +SFGVL E+ G P S S N + E
Sbjct: 248 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP---YPSKS------NQEVLE 297
Query: 1029 MLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ R+ P C + I+ C PE RP + + ++
Sbjct: 298 FVTSGGRMDPPKNC--PGPVYRIMT---QCWQHQPEDRPNFAIILERIE 341
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 80/300 (26%)
Query: 823 IGKGGQGSVYKAELASGE------IVAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+G+G G V+ AE + +VAVK K + +++F E + LT ++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNLQHE 77
Query: 875 NIVKFYGFCSH------------------------VRHSLAMILSNNAAAKDLGWTRRMN 910
+IVKFYG C + + A +LG ++ ++
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL------KPDSS 964
+ I+ + Y+ + F VHRD++++N L+ + + DFG+++ + +
Sbjct: 138 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 965 N-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSS 1017
W PE + Y K T + DV+SFGV+ E+ GK P +S
Sbjct: 195 TMLPIRWM---------PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP---WFQLS- 240
Query: 1018 SSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
N + E + L P C ++ ++ C P+ R + ++ ++L
Sbjct: 241 -----NTEVIECITQGRVLERPRVC--PKEVYDVML---GCWQREPQQRLNIKEIYKILH 290
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 66/291 (22%)
Query: 823 IGKGGQGSVYKAELASGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
+GKG GSV +A+L + VAVK + + +EFL E + E H ++ K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89
Query: 879 FYGFCS----HVRHSLAMIL----------------SNNAAAKDLGWTRRMNVIKGISDA 918
G R + M++ +L + + I+
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-----------NWT 967
+ Y+ + F +HRD++++N +L D V+DFG+++ + W
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIAL 1026
A E T DV++FGV E++ +G+ P I N +
Sbjct: 207 ---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE---------NAEI 248
Query: 1027 DEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L RL P C +++ ++ C +P+ RP+ + L+
Sbjct: 249 YNYLIGGNRLKQPPEC--MEEVYDLMY---QCWSADPKQRPSFTCLRMELE 294
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 48/229 (20%), Positives = 83/229 (36%), Gaps = 64/229 (27%)
Query: 814 TNDFDD-----EHCIGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNE 864
+ F+D E +G+G V L + + AVK K P E
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIR----SRVFRE 60
Query: 865 VKALTEIR-HRNIVKFYG-FCSHVRHSLAMIL----------------SNNAAAKDLGWT 906
V+ L + + HRN+++ F R L + A+
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV----- 115
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVS-----DFGIAKFLKP 961
V++ ++ AL ++HN I HRD+ +N+L ++ VS DF + +K
Sbjct: 116 ----VVQDVASALDFLHN---KGIAHRDLKPENIL--CEHPNQVSPVKICDFDLGSGIKL 166
Query: 962 DSS-------NWTELAGTYGYVAPE-----LAYTMKVTEKCDVYSFGVL 998
+ G+ Y+APE ++CD++S GV+
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 52/272 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
+G G G V+ A + V VK K E + E+ L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAKDL-------GWTRRMN------VIKGISDALSYMH 923
+K + +++ + + DL R++ + + + A+ Y+
Sbjct: 92 IKVLDIFE-NQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR 147
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 980
I+HRDI +N+++ D + DFG A +L+ +T GT Y APE+
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMG 203
Query: 981 -AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
Y + +++S GV ++ ++P + ++++ P L +
Sbjct: 204 NPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP---------PYLVSKEL 251
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
+ L+S L PE R T+ K+
Sbjct: 252 M---SLVS------GLLQPVPERRTTLEKLVT 274
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 47/142 (33%), Positives = 68/142 (47%), Gaps = 7/142 (4%)
Query: 352 SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTN 410
S+P G +N LYL+ N + P +L +L L LG N+L ++P + +LT
Sbjct: 33 SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 411 LATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469
L LDL N L+ +PS F L L L + NKL+ +P + LT+L L L N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 470 SGSIPGEIGNLRSISNLALNNN 491
G L S+++ L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 46/140 (32%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNN 227
+N L+L+DN ++ P F +L +L L LG N+ ++P + +LT L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 228 SL-------FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
L FD L L L + NKL+ +P + LT+L L L +N L S
Sbjct: 99 QLTVLPSAVFDR-------LVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-S 149
Query: 281 IPSE-FGNLRSLSMLNLGYN 299
IP F L SL+ L N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 48/134 (35%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLYLYEN 275
TN LYLH+N + P +L +L L LG N+L ++P + +LT L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 276 SLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI- 333
L+ +PS F L L L + NKL + P + LT+L L + N L SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 334 GNLRSLSNLGLSGN 347
L SL++ L GN
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 45/140 (32%), Positives = 63/140 (45%), Gaps = 19/140 (13%)
Query: 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSN 371
TN LY+H+N ++ P +L +L L L N+L ++P + L+ L L L +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 372 SL-------FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS 424
L FD L L L + NKL+ +P + LT+L L L N L S
Sbjct: 99 QLTVLPSAVFDR-------LVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-S 149
Query: 425 IPSE-FGNLRSLSTLSLGYN 443
IP F L SL+ L N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 40/134 (29%), Positives = 62/134 (46%), Gaps = 17/134 (12%)
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL-------FDSIPSELGNLRSLSMLSLGY 250
L L N+ + P +L NL LYL +N L FDS L L++L LG
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS-------LTQLTVLDLGT 97
Query: 251 NKLSGSIPHSL-GNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309
N+L+ +P ++ L +L L++ N L+ +P L L+ L L N+L I +
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 310 GNLTNLATLYIHNN 323
L++L Y+ N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 44/154 (28%), Positives = 61/154 (39%), Gaps = 29/154 (18%)
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
+ L L +NQ+ P L +L L L SN L L +L+ L L L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 184 SIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRS 242
+PS F L L L + NK + +P + LT+L L L N L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL------------- 147
Query: 243 LSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
SIPH + L++L YL+ N
Sbjct: 148 ------------KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 40/130 (30%), Positives = 56/130 (43%), Gaps = 5/130 (3%)
Query: 100 KYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLE 158
+ L L N P L LK L L NQL ++P + L+ L L L +N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH-SLGNLT 217
L L +L L + N L+ +P L L+ L+L N+ SIPH + L+
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 218 NLATLYLHNN 227
+L YL N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 43/134 (32%), Positives = 59/134 (44%), Gaps = 3/134 (2%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLS 603
IP + +L L N I P L L +L L NQL L + SL QL LDL
Sbjct: 38 IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLG 96
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQI 663
+N+L+ F LV L L + N+ + +P +E L HL+ L L N L+
Sbjct: 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAF 155
Query: 664 CIMQSLENLNLSHN 677
+ SL + L N
Sbjct: 156 DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 43/130 (33%), Positives = 58/130 (44%), Gaps = 7/130 (5%)
Query: 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNG 135
L L NQ+ P ++ LK L L SN G +P + L+ L L L NQL
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 136 SIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLR 193
+P + RL L L + N L + +P + L++L L L N L SIP F L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 194 SLSMLSLGYN 203
SL+ L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 38/128 (29%), Positives = 58/128 (45%), Gaps = 11/128 (8%)
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
L L N+++ P +L NL LYL N L G +L ++ L L N+L+ +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 498 PQSL-GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH-------SL 549
P ++ L +L L++ N L +P + L L+ L+ N+L SIPH SL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSL 161
Query: 550 GVLDLSSN 557
L N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 35/166 (21%)
Query: 472 SIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL-------FDSIPSE 524
S+P I + L L++N+++ P +L NL LYL +N L FDS
Sbjct: 33 SVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS---- 86
Query: 525 LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS 584
L L++L N+L+ +P V D +L L +L + N+L+
Sbjct: 87 ---LTQLTVLDLGTNQLT-VLPS--AVFD---------------RLVHLKELFMCCNKLT 125
Query: 585 GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
L + L L HL L N+L + +F L L + L N
Sbjct: 126 E-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 5/118 (4%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLS 121
L F S +L L L NQL G +P + ++++L LDL +N +P + L
Sbjct: 55 LEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLV 112
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
+LK L + N+L +P I RL+ L +LAL N L+ + + LS+L +L+ N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 23/110 (20%), Positives = 40/110 (36%), Gaps = 30/110 (27%)
Query: 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR---GIPIKLEELIHLSELDLSHNF 654
+ L L N+++ P F +L+ L L L +NQ G+ L +L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL------------ 90
Query: 655 LREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L+L N L L + F+++ L + + N+L
Sbjct: 91 ---------------TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT 125
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 48/220 (21%), Positives = 80/220 (36%), Gaps = 53/220 (24%)
Query: 811 IRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEV 865
I+ DD +G G G V + + E A+K + EV
Sbjct: 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 105
Query: 866 KALTEI-RHRNIVKFYGFC---SHVRHSLAMIL--------------------SNNAAAK 901
+ + +IV+ R L +++ + A+
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS- 164
Query: 902 DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-DFDNEAHV--SDFGIAKF 958
++K I +A+ Y+H+ I HRD+ +N+L A + +DFG AK
Sbjct: 165 --------EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998
+S T T YVAPE+ K + CD++S GV+
Sbjct: 214 TTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI 449
L L N+ + +P L N +L +DL +N +S F N+ L TL L YN+L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 450 PHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
P L +L L L+ N +S +P G +L ++S+LA+ N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 366 LYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI 425
LYL N +P EL N + L+++ L N++S S N+T L TL L N L I
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 426 PSE-FGNLRSLSTLSLGYNKLSGSIPH-SLGNLTNLDALYLYDN 467
P F L+SL LSL N +S +P + +L+ L L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 5/109 (4%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
++ L L N + +P E N + L+ + L N++S S N+T L L L N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 469 LSGSIP-GEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
L IP L+S+ L+L+ N +S +P+ + +LS L L + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233
L+L N + +P E N + L+++ L N+ S S N+T L TL L N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 234 PSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
P L+SL +LSL N +S +P + +L+ L+ L + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
++ LYL N +P EL N + L+++ L N++S S N+T L TL L N
Sbjct: 31 RDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 277 LSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPH-SLGNLTNLATLYIHNN 323
L IP F L+SL +L+L N ++ +P + +L+ L+ L I N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 3/103 (2%)
Query: 246 LSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGII 305
L L N+ + +P L N +L + L N +S F N+ L L L YN+L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 306 PHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGN 347
P + L +L L +H N +S +P +L +LS+L + N
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
L L NQ +P E+ L + L +N + L S N++ L TL L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 184 SIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
IP F L+SL +LSL N S +P + +L+ L+ L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 29/133 (21%)
Query: 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNS 372
++ LY+ N + +P E+ N + L+ + LS N++S ++
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN----------------Q 72
Query: 373 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FG 430
F N+ L L L YN+L IP L +L L L+ N +S +P F
Sbjct: 73 SFS-------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN 123
Query: 431 NLRSLSTLSLGYN 443
+L +LS L++G N
Sbjct: 124 DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 35/168 (20%), Positives = 57/168 (33%), Gaps = 61/168 (36%)
Query: 472 SIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL-------FDSIPSE 524
+P I R ++ L L+ N+ + +P+ L N +L ++ L NN + F
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFS----- 75
Query: 525 LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS 584
N+ L L +YN+L IP D
Sbjct: 76 --NMTQLLTLILSYNRLR-CIPP--RTFD------------------------------- 99
Query: 585 GQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLNLSNNQF 631
L L L L N +S +P+ +F +L L +L + N
Sbjct: 100 --------GLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTL 126
S++ HL +DL +N++ + Q N+++L L LS N IPP L L+ L
Sbjct: 50 LSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNR-LRCIPPRTFDGLKSLRLL 107
Query: 127 QLFENQLNGSIPYEI-GRLSSLNYLALYSN 155
L N ++ +P LS+L++LA+ +N
Sbjct: 108 SLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 5/104 (4%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNGS 136
L L NQ +P ++ N L +DLS+N T+ + +++ L TL L N+L
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNR-ISTLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 137 IPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
IP L SL L+L+ N + + + +LS L L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLH 622
IP ++ +L L NQ + + +L + L +DLS+NR+S +SF N+ +L
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 623 YLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLR 656
L LS N+ R IP + + L L L L N +
Sbjct: 82 TLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 29/109 (26%)
Query: 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELI--HLSELDLSHNFL 655
L L N+ + +PK N L ++LSNN+ S L ++++L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-----TLSNQSFSNMTQLL------ 81
Query: 656 REAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L LS+N L + P F+ + L + + N++
Sbjct: 82 ---------------TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 56/275 (20%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK-------KFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+GKGG G+V+ L VA+K SPL +T E K H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 875 NIVKFYGFCSHVRHSLAMILSNNAAAKDL-------GWTRRM------NVIKGISDALSY 921
+++ + + ++L A+DL G + + A+ +
Sbjct: 99 GVIRLLDWFET-QEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQH 154
Query: 922 MHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
H+ +VHRDI +N+L+D A + DFG L +T+ GT Y PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEW 209
Query: 981 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036
Y V+S G+L +++ G P + + + L+ P +
Sbjct: 210 ISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAELHF---------PAHVS 257
Query: 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
P C LI CL P SRP++ ++
Sbjct: 258 PDCC---ALIR------RCLAPKPSSRPSLEEILL 283
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 65/316 (20%), Positives = 115/316 (36%), Gaps = 86/316 (27%)
Query: 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGE---IVAVKKFHSPLPGEMTFQQ--E 860
+Y + F D IG+G G V KA + A+K+ + + +
Sbjct: 18 IYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRD 71
Query: 861 FLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMIL------------------------- 894
F E++ L ++ H NI+ G C H R L + +
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 895 SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954
N+ A L + ++ ++ + Y+ F +HRD++++N+L+ + A ++DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFG 187
Query: 955 IAKFLKPDSSN------------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALE 1001
+++ W A E L Y+ T DV+S+GVL E
Sbjct: 188 LSR----GQEVYVKKTMGRLPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWE 233
Query: 1002 VI-KGKHPRDFISSMSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLD 1057
++ G P ++ L E L RL P C + ++ C
Sbjct: 234 IVSLGGTPYCGMT---------CAELYEKLPQGYRLEKPLNC-----DDEVYDLMRQCWR 279
Query: 1058 ENPESRPTMPKVSQLL 1073
E P RP+ ++ L
Sbjct: 280 EKPYERPSFAQILVSL 295
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 48/321 (14%), Positives = 99/321 (30%), Gaps = 52/321 (16%)
Query: 405 LGNLTNLATLDLYDNSLSG----SIPSEFGNLRSLSTLSLGYNKLSG----SIPHSLGNL 456
+ + + L ++++ S+ + S+ + L N + + ++ +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 457 TNLDALYLYDNSLS----------GSIPGEIGNLRSISNLALNNNKLSG----SIPQSLG 502
+L+ D + + + + L++N + L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 503 NLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHI--- 559
+ L LYL+NN L +++ L L + N +
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIA-----RALQELAVNKKAKNAPPLRSIICGRNRLENG 174
Query: 560 -VGEIPTELGKLNFLIKLILAQNQLSGQ-----LSPKLGSLAQLEHLDLSSNRLSN---- 609
+ E L + + QN + + L L +L+ LDL N ++
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234
Query: 610 SIPKSFGNLVKLHYLNLSNNQFS-RGIP-----IKLEELIHLSELDLSHNFLREAIPSQI 663
++ + + L L L++ S RG E I L L L +N + +
Sbjct: 235 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294
Query: 664 C-----IMQSLENLNLSHNSL 679
M L L L+ N
Sbjct: 295 KTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 50/365 (13%), Positives = 100/365 (27%), Gaps = 73/365 (20%)
Query: 337 RSLSNLGLSGNKLSG----SIPPSLGYLSNLATLYLYSNSLFD----SIPSELGNLRSLS 388
S+ L + ++ S+ L ++ + L N++ + + + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 389 MLSLGYNKLS----------GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL----RS 434
+ + +L L T+ L DN+ + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494
L L L N L + ++ + N + ++ N+L
Sbjct: 124 LEHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
Query: 495 G----SIPQSLGNLSNLVILYLYNNSLFDS-IPSELGNLRSLSMLSFAYNKLSGSIPHSL 549
++ + L + + N + I L AY + L
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG-------LAYCQ-------EL 218
Query: 550 GVLDLSSNHI----VGEIPTELGKLNFLIKLILAQNQLSGQ------LSPKLGSLAQLEH 599
VLDL N + L L +L L LS + + L+
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 600 LDLSSNRLSNSIPKSFG-----NLVKLHYLNLSNNQFS-RGIPIK-----LEELIHLSEL 648
L L N + ++ + L +L L+ N+FS +
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 338
Query: 649 DLSHN 653
+L
Sbjct: 339 ELDDM 343
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 52/329 (15%), Positives = 96/329 (29%), Gaps = 71/329 (21%)
Query: 75 LAYLDLWHNQLYG----NIPPQIGNISRLKYLDLSSNLFFGTIPPE--------IGHLSY 122
+ L + + ++ + +K + LS N TI E I
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGN----TIGTEAARWLSENIASKKD 61
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS 182
L+ + + GR+ AL + +L L T+ L DN+
Sbjct: 62 LEIAEFSDIF--------TGRVKDEIPEALRL------LLQALLKCPKLHTVRLSDNAFG 107
Query: 183 DSIPSEFGNL----RSLSMLSLGYNKFS-------------GSIPHSLGNLTNLATLYLH 225
+ + L L L N ++ N L ++
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 226 NNSLFD----SIPSELGNLRSLSMLSLGYNKL-----SGSIPHSLGNLTNLATLYLYENS 276
N L + + R L + + N + + L L L L +N+
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 277 LSG----SIPSEFGNLRSLSMLNLGYNKLNG----IIPHSLGNLTN--LATLYIHNNSLS 326
+ ++ + +L L L L+ + + L N L TL + N +
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 327 GSIPSEIG-----NLRSLSNLGLSGNKLS 350
+ + L L L+GN+ S
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 49/304 (16%), Positives = 96/304 (31%), Gaps = 63/304 (20%)
Query: 70 SSFPHLAYLDLWHNQLYGN-----IPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLK 124
+ + L N + G + I + L+ + S F G + EI
Sbjct: 29 LEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEAL--- 83
Query: 125 TLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED----LIPPSLGNLSNLDTLHLYDNS 180
+ + + L+ + L N + L + L+ L+L++N
Sbjct: 84 ----------RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 133
Query: 181 LSD-------------SIPSEFGNLRSLSMLSLGYNKFSG----SIPHSLGNLTNLATLY 223
L ++ + N L + G N+ + + L T+
Sbjct: 134 LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK 193
Query: 224 LHNNSLFDS-----IPSELGNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLYLYE 274
+ N + + L + L +L L N + ++ +L + NL L L +
Sbjct: 194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253
Query: 275 NSLS-------GSIPSEFGNLRSLSMLNLGYNKLNG----IIPHSLG-NLTNLATLYIHN 322
LS S+ N L L L YN++ + + + +L L ++
Sbjct: 254 CLLSARGAAAVVDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312
Query: 323 NSLS 326
N S
Sbjct: 313 NRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 35/257 (13%), Positives = 72/257 (28%), Gaps = 66/257 (25%)
Query: 481 RSISNLALNNNKLSG----SIPQSLGNLSNLVILYLYNNSLFD----SIPSELGNLRSLS 532
SI +L + ++ S+ L ++ + L N++ + + + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 533 MLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
+ F+ D+ + + EIP L L L
Sbjct: 64 IAEFS---------------DIFTGRVKDEIPEALR-----------------LLLQALL 91
Query: 593 SLAQLEHLDLSSNRLSNSIPKSFGNLVK----LHYLNLSNNQFS-------------RGI 635
+L + LS N + + + + L +L L NN +
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 636 PIKLEELIHLSELDLSHNFLR----EAIPSQICIMQSLENLNLSHNSL-----VGLIPSC 686
K + L + N L + + L + + N + L+
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 687 FEKMHGLLRIDISYNEL 703
L +D+ N
Sbjct: 212 LAYCQELKVLDLQDNTF 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 58/287 (20%), Positives = 97/287 (33%), Gaps = 69/287 (24%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + IG G QG V A + VA+KK P T + E+ + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 82
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNAAAK-------------DLGWTRRMNVIK-GISD- 917
H+NI+ L + + + +L VI+ +
Sbjct: 83 HKNIIGL----------LNVFTPQKSLEEFQDVYIVMELMDANLC-----QVIQMELDHE 127
Query: 918 -----------ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966
+ ++H+ I+HRD+ N+++ D + DFG+A+
Sbjct: 128 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMM 183
Query: 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK---HPRDFISSMSSSSLNLN 1023
T T Y APE+ M E D++S G + E+IKG D I N
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-----DQWNKV 238
Query: 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVS 1070
I L TP + + + + + E+RP S
Sbjct: 239 IEQ-------LGTPC---PEFMKKLQPTVRTYV----ENRPKYAGYS 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 24/153 (15%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
AL Y+ N I+HRD+ N+LLD H++DF IA L ++ T +AGT Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182
Query: 978 PEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030
PE+ Y+ V D +S GV A E+++G+ P SS SS + +
Sbjct: 183 PEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238
Query: 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESR 1063
P + + L+ L+ NP+ R
Sbjct: 239 YPSAWSQEMV---SLLK------KLLEPNPDQR 262
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 78/300 (26%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RH 873
+G+G G V +A+ A+ VAVK L T + ++E+K L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 90
Query: 874 RNIVKFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKG------- 914
N+V G C+ L +I L + ++ K
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 915 ------ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS---- 964
++ + ++ + +HRD++++N+LL N + DFG+A+ + D
Sbjct: 151 ICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 965 -------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS 1016
W APE + T + DV+SFGVL E+ G P
Sbjct: 208 GDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------- 250
Query: 1017 SSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073
+ ++ L R+ P ++ + C P RPT ++ + L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYT--TPEMYQTML---DCWHGEPSQRPTFSELVEHL 305
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 55/276 (19%), Positives = 104/276 (37%), Gaps = 47/276 (17%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + IG G QG V A + VA+KK P T + E+ + +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 119
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNA--AAKDLGWTRRMNVIK-GISD------------ 917
H+NI+ +V + +L VI+ +
Sbjct: 120 HKNIISLL----NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVA 977
+ ++H+ I+HRD+ N+++ D + DFG+A+ S T T Y A
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRA 231
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGK---HPRDFISSMSSSSLNLNIALDEMLDPRL 1034
PE+ M E D++S G + E+++ K RD+I +++++ +L
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-----------WNKVIE-QL 279
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVS 1070
TP + + + + + E+RP ++
Sbjct: 280 GTPC---PEFMKKLQPTVRNYV----ENRPKYAGLT 308
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 60/273 (21%), Positives = 101/273 (36%), Gaps = 54/273 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHR--NI 876
+G GG GSVY ++ VA+K K GE+ EV L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 877 VKFYGFCSHVRHSLAMILSNNAAAKDL-------GWTRRMN------VIKGISDALSYMH 923
++ + S +IL +DL G + + +A+ + H
Sbjct: 111 IRLLDWFE-RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 166
Query: 924 NDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 980
N ++HRDI +N+L+D + E + DFG LK + +T+ GT Y PE
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 221
Query: 981 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
Y + V+S G+L +++ G P + + + + +
Sbjct: 222 YHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---------RQRVSSE 269
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
C LI CL P RPT ++
Sbjct: 270 CQ---HLIR------WCLALRPSDRPTFEEIQN 293
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 8/143 (5%)
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
S+P+ G + L L N L LT+L L L N L F L SL
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 436 STLSLGYNKLSGSIPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKL 493
+ L+L N+L S+P+ + LT L L L N L S+P G L + +L L N+L
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
Query: 494 SGSIPQ-SLGNLSNLVILYLYNN 515
S+P L++L ++L++N
Sbjct: 137 K-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 53/167 (31%), Positives = 73/167 (43%), Gaps = 32/167 (19%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN-LRS 338
S+P+ G + L+L N L + LT+L LY+ N L S+P+ + N L S
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 339 LSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
L+ L LS N+L S+P +FD L L L+L N+L
Sbjct: 78 LTYLNLSTNQLQ-SLPN----------------GVFDK-------LTQLKELALNTNQLQ 113
Query: 399 GSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYN 443
S+P + LT L L LY N L S+P F L SL + L N
Sbjct: 114 -SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 44/142 (30%), Positives = 63/142 (44%), Gaps = 6/142 (4%)
Query: 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291
S+P+ G + L L N L LT+L LYL N L F L SL
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 292 SMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLS 350
+ LNL N+L + LT L L ++ N L S+P + L L +L L N+L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 351 GSIPP-SLGYLSNLATLYLYSN 371
S+P L++L ++L+ N
Sbjct: 138 -SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 42/155 (27%), Positives = 60/155 (38%), Gaps = 30/155 (19%)
Query: 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183
L L N L L+SL L L N L+ L L++L L+L N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 184 SIPSE-FGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELGNLR 241
S+P+ F L L L+L N+ S+P + LT L L L+ N L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL------------ 136
Query: 242 SLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
S+P LT+L ++L++N
Sbjct: 137 -------------KSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 46/134 (34%), Positives = 60/134 (44%), Gaps = 6/134 (4%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN-LTNLATLYLYEN 275
L L NSL L SL+ L LG NKL S+P+ + N LT+L L L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 276 SLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI- 333
L S+P+ F L L L L N+L + LT L L ++ N L S+P +
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF 144
Query: 334 GNLRSLSNLGLSGN 347
L SL + L N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 44/131 (33%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 100 KYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLE 158
YLDL +N L+ L L L N+L S+P + +L+SL YL L +N L+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNL 216
L L+ L L L N L S+P F L L L L N+ S+P L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147
Query: 217 TNLATLYLHNN 227
T+L ++LH+N
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 48/129 (37%), Positives = 60/129 (46%), Gaps = 6/129 (4%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN-LTNLDALYLYDN 467
LDL NSL F L SL+ L LG NKL S+P+ + N LT+L L L N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL-GNLSNLVILYLYNNSLFDSIPSE-L 525
L G L + LALN N+L S+P + L+ L L LY N L S+P
Sbjct: 87 QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVF 144
Query: 526 GNLRSLSML 534
L SL +
Sbjct: 145 DRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 43/130 (33%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNG 135
YLDL N L ++ L L L N ++P + L+ L L L NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 136 SIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLR 193
S+P + +L+ L LAL +N L+ L L+ L L LY N L S+P F L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 194 SLSMLSLGYN 203
SL + L N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 4/114 (3%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLS 603
IP LDL +N + +L L +L L N+L L + L L +L+LS
Sbjct: 26 IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS 84
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLR 656
+N+L + F L +L L L+ NQ +P + ++L L +L L N L+
Sbjct: 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 43/143 (30%), Positives = 59/143 (41%), Gaps = 14/143 (9%)
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
S+P+ G + L L N L LT+L LYL N L G L S+
Sbjct: 21 SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 484 SNLALNNNKLSGSIPQSL-GNLSNLVILYLYNNSLFDSIPSEL-GNLRSLSMLSFAYNKL 541
+ L L+ N+L S+P + L+ L L L N L S+P + L L L N+L
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 542 SGSIPH-------SLGVLDLSSN 557
S+P SL + L N
Sbjct: 137 K-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 6/119 (5%)
Query: 64 LHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGN-ISRLKYLDLSSNLFFGTIPPEI-GHLS 121
L + F L L L N+L ++P + N ++ L YL+LS+N ++P + L+
Sbjct: 43 LPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQ-LQSLPNGVFDKLT 100
Query: 122 YLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
LK L L NQL S+P + +L+ L L LY N L+ + L++L + L+DN
Sbjct: 101 QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 2/111 (1%)
Query: 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNF 654
AQ +LDL +N L + F L L L L N+ +L L+ L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 655 LREAIPSQIC-IMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L +++P+ + + L+ L L+ N L L F+K+ L + + N+L+
Sbjct: 88 L-QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 33/106 (31%), Positives = 46/106 (43%), Gaps = 2/106 (1%)
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
L L N L + L L L L N+L + F L L YLNLS NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSL 679
++L L EL L+ N L +++P + + L++L L N L
Sbjct: 92 PNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 69/357 (19%), Positives = 135/357 (37%), Gaps = 87/357 (24%)
Query: 770 GLFFKF-QRRNNDLQTQ--QSSPGNTRGLLSVLTFEGKIVYE---EIIRATNDFDDEHCI 823
G+ +K+ Q+ ++ + +S GN+ + ++ Y E R F +
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFID----PTQLPYNEKWEFPRNNLQFGKT--L 54
Query: 824 GKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RHR 874
G G G V +A + VAVK L + ++E+K ++ + +H
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKM----LKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 875 NIVKFYGFCSH----------------------VRHSLAMILSNNAAAKDLGWTRRMNVI 912
NIV G C+H L + A ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-----SN-- 965
++ ++++ + +HRD++++NVLL + A + DFG+A+ + DS N
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 966 ----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSL 1020
W APE + T + DV+S+G+L E+ G +P + +
Sbjct: 228 LPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPGILV---- 272
Query: 1021 NLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
N +++ ++ P+ + SI++ +C P RPT ++ L+
Sbjct: 273 --NSKFYKLVKDGYQMAQPAFA--PKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 65/303 (21%), Positives = 108/303 (35%), Gaps = 79/303 (26%)
Query: 820 EHCIGKGGQGSVYKAELASGE------IVAVKKFHSPLPGEMTFQQ--EFLNEVKALTEI 871
+G+ G VYK L VA+K L + EF +E +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT----LKDKAEGPLREEFRHEAMLRARL 69
Query: 872 RHRNIVKFYGFCSHVRHSLAMI------------LSNNAAAKDLGWTRRMNVIKG----- 914
+H N+V G + L+MI L + D+G T +K
Sbjct: 70 QHPNVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 915 --------ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL------K 960
I+ + Y+ + VH+D++++NVL+ +SD G+ + + K
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 961 PDSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISS 1014
++ W APE K + D++S+GV+ EV G P
Sbjct: 186 LLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCG 233
Query: 1015 MSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
S N + EM+ LP P C + +++ I C +E P RP +
Sbjct: 234 YS------NQDVVEMIRNRQVLPCPDDC--PAWVYALM---IECWNEFPSRRPRFKDIHS 282
Query: 1072 LLK 1074
L+
Sbjct: 283 RLR 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
N F +GKGG G V ++ A+G++ A KK + + LNE + L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 874 RNIVK-FYGFCSHVRHSLAMILSN---------NAAAKDLGWTRRMNVIKGISDALSYMH 923
R +V Y + + L + L N + R + I L +H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 980
+ IV+RD+ +N+LLD +SD G+A + + GT GY+APE+
Sbjct: 304 RER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKN 359
Query: 981 -AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
YT D ++ G L E+I G+ P
Sbjct: 360 ERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 7e-14
Identities = 24/100 (24%), Positives = 36/100 (36%), Gaps = 2/100 (2%)
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSL 309
+ H L NL LY+ + L L L + + L + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 310 GNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL 349
L+ L + N+L S+ + SL L LSGN L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 21/100 (21%), Positives = 34/100 (34%), Gaps = 2/100 (2%)
Query: 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGSIPHSL 453
+ H L NL L + + + L L L++ + L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 454 GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
L L L N+L S+ + S+ L L+ N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 25/96 (26%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
H L NL LY+ N + L L L L++ + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 267 LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302
L+ L L N+L L SL L L N L+
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 23/100 (23%), Positives = 34/100 (34%), Gaps = 2/100 (2%)
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSIPHSL 405
+ L NL LY+ + + L L L L++ + L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 406 GNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445
L+ L+L N+L L SL L L N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 4/95 (4%)
Query: 305 IPHSLGNLTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGLSGNKLSGSIPP-SLGYLSN 362
H L NL LYI N + + L L NL + + L + P + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 363 LATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397
L+ L L N+L +S+ + SL L L N L
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 21/102 (20%), Positives = 37/102 (36%), Gaps = 4/102 (3%)
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLYLYENSLSGSIPSE 284
L +L+ L + + + L L L L + ++ L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 285 -FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL 325
F LS LNL +N L + ++ L +L L + N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 29/131 (22%), Positives = 46/131 (35%), Gaps = 7/131 (5%)
Query: 562 EIPTELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620
+ L L +L + Q L + L L +L +L + + L P +F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 621 LHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLV 680
L LNLS N + K + + L EL LS N L + C ++ L+ V
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCS-----CALRWLQRWEEEGLGGV 135
Query: 681 GLIPSCFEKMH 691
Sbjct: 136 PEQKLQCHGQG 146
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 4/102 (3%)
Query: 322 NNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSE 380
+ + +L+ L + + + L L L L + + L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPD 74
Query: 381 -LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
LS L+L +N L S+ +L L L N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 21/101 (20%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 131 NQLNGSIPYEIGRLSSLNYLALYSN-YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE- 188
+ + +L L + + +L+ L L L L L + + L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL 229
F LS L+L +N S+ +L L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 22/100 (22%), Positives = 37/100 (37%), Gaps = 2/100 (2%)
Query: 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSL 501
+ H L NL LY+ + + ++ L + NL + + L P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 502 GNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKL 541
L L L N+L +S+ + SL L + N L
Sbjct: 77 HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 10/102 (9%)
Query: 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNKLSGSIP-- 546
+ L NL LY+ N + L L L L+ + L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 547 -----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQL 583
L L+LS N + + + + L +L+L+ N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 16/112 (14%)
Query: 37 CAW-VGIHCNRGGRVNSI-------NLTSIGLKGM-----LHDFSFSSFPHLAYLDLWHN 83
G+ C R G ++S+ NLT + ++ L L L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 84 QLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLN 134
L + P RL L+LS N ++ + L+ L L N L+
Sbjct: 67 GL-RFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQ-ICIMQSLENLNLSHNSLVGLIPSCFEKMHGL 693
L +L+EL + + + + + + + L NL + + L + P F L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 694 LRIDISYNELQGPIPNSIAFRDAPIE--ALQGNKGLC 728
R+++S+N L+ + ++ L GN C
Sbjct: 83 SRLNLSFNALESLSWK--TVQGLSLQELVLSGNPLHC 117
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 66/273 (24%), Positives = 102/273 (37%), Gaps = 55/273 (20%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IGKG V A + +G VA+K + Q+ F EV+ + + H NIVK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLF- 80
Query: 882 FCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKG------ISDALSYMHN 924
V + + + + A RM + I A+ Y H
Sbjct: 81 ---EVIETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQ 132
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 980
IVHRD+ ++N+LLD D ++DFG + G Y APEL
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQGK 188
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
Y + DV+S GV+ ++ G P D NL + +L + P +
Sbjct: 189 KYDGP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIPFYM 237
Query: 1041 VQD--KLISIVEVAISCLDENPESRPTMPKVSQ 1071
D L+ L NP R T+ ++ +
Sbjct: 238 STDCENLLK------RFLVLNPIKRGTLEQIMK 264
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-14
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQE----FLNEVKALT 869
+ F D +G+GG G V+ ++ A+G++ A KK L + +++ + E K L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240
Query: 870 EIRHRNIVKFYGFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKG--IS 916
++ R IV + + L ++++ N + G+ + I
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
L ++H I++RD+ +NVLLD D +SD G+A LK + AGT G++
Sbjct: 300 SGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 977 APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
APEL Y V D ++ GV E+I + P
Sbjct: 357 APELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 390 LSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSG 447
L L N+L L G L +L L+L N L+ I F + L LG NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 448 SIPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
I + + L L L LYDN +S + G +L S+++L L +N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 39/134 (29%), Positives = 56/134 (41%), Gaps = 24/134 (17%)
Query: 321 HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPS--LGYLSNLATLYLYSNSL----- 373
L IP +I + L L+ N+L I G L +L L L N L
Sbjct: 16 TGRGLK-EIPRDI--PLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEP 71
Query: 374 --FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-F 429
F+ + L LG NK+ I + + L L TL+LYDN +S + F
Sbjct: 72 NAFEG-------ASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSF 122
Query: 430 GNLRSLSTLSLGYN 443
+L SL++L+L N
Sbjct: 123 EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 34/112 (30%), Positives = 46/112 (41%), Gaps = 19/112 (16%)
Query: 198 LSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSL-------FDSIPSELGNLRSLSMLSLG 249
L L N+ L G L +L L L N L F+ + L LG
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG-------ASHIQELQLG 86
Query: 250 YNKLSGSIPHSL-GNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYN 299
NK+ I + + L L TL LY+N +S + F +L SL+ LNL N
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 5/105 (4%)
Query: 246 LSLGYNKLSGSIPHSL-GNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNG 303
L L N+L L G L +L L L N L+ I F + L LG NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE 92
Query: 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGN 347
I L L TL +++N +S + +L SL++L L+ N
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 9/112 (8%)
Query: 409 TNLATLDLYDNSLSGSIPSE--FGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLY 465
+ L L DN L I S+ FG L L L L N+L+ I + +++ L L
Sbjct: 29 LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86
Query: 466 DNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
+N + I L + L L +N++S + S +L++L L L +N
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 113 IPPEIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSNYLEDLIPPSLGNLSNL 171
IP +I + L L +N+L + GRL L L L N L + P + S++
Sbjct: 23 IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 172 DTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
L L +N + I ++ F L L L+L N+ S + S +L +L +L L +N
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 36/122 (29%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSL-GNLSNLDTLHLYDNSLSDSIPSE-FGNLR 193
IP +I L L N L + L G L +L L L N L+ I F
Sbjct: 22 EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 194 SLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELG---NLRSLSMLSLG 249
+ L LG NK I + + L L TL L++N + + G +L SL+ L+L
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMP--GSFEHLNSLTSLNLA 134
Query: 250 YN 251
N
Sbjct: 135 SN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 32/108 (29%), Positives = 44/108 (40%), Gaps = 11/108 (10%)
Query: 294 LNLGYNKLNGIIPHSL-GNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSG 351
L L N+L I L G L +L L + N L+ I + L L NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 352 SIPPSL-GYLSNLATLYLYSNSLFDSIPSELG---NLRSLSMLSLGYN 395
I + L L TL LY N + + G +L SL+ L+L N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQI-SCVMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 25/127 (19%)
Query: 509 ILYLYNNSLFDSIPSE--LGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE 566
L L +N L I S+ G L L L N+L+ I +
Sbjct: 33 ELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLT-GIEP--NAFE------------- 75
Query: 567 LGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYL 624
+ + +L L +N++ ++S K+ L QL+ L+L N++S + SF +L L L
Sbjct: 76 --GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSL 131
Query: 625 NLSNNQF 631
NL++N F
Sbjct: 132 NLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 31/102 (30%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 438 LSLGYNKLSGSIPHSL-GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS 496
L L N+L L G L +L L L N L+G P I L L NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 497 IPQSL-GNLSNLVILYLYNNSLFDSIPSELG---NLRSLSML 534
I + L L L LY+N + + G +L SL+ L
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQI-SCVMP--GSFEHLNSLTSL 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 19/113 (16%)
Query: 575 KLILAQNQLSGQLSPK--LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS 632
+L+L N+L ++S G L L L+L N+L+ P +F + L L N+
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 633 RGIPIKL-EELIHLSELDLSHNFLREAIPSQICIM-------QSLENLNLSHN 677
I K+ L L L+L N + C+M SL +LNL+ N
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQIS-------CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 35/110 (31%), Positives = 48/110 (43%), Gaps = 11/110 (10%)
Query: 49 RVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSN 107
+N L I G+ F PHL L+L NQL I P S ++ L L N
Sbjct: 35 LLNDNELGRISSDGL-----FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGEN 88
Query: 108 LFFGTIPPEI-GHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSN 155
I ++ L LKTL L++NQ++ + L+SL L L SN
Sbjct: 89 K-IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 45/237 (18%)
Query: 800 TFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQ 858
E + + F E G+G G+V E ++G VA+KK + F+
Sbjct: 8 LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ----DPRFR 63
Query: 859 QEFLNEVKALTEIRHRNIVK-FYGFCSHVRHS-------LAM----------ILSNNAAA 900
L ++ L + H NIV+ F + + M +
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 901 KDLGWTRRMNVIKG----ISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGI 955
+IK + ++ +H + HRDI NVL++ + + DFG
Sbjct: 124 VAP----PPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 956 AKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 1006
AK L P N + Y Y APEL YT V D++S G + A E++ G+
Sbjct: 179 AKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 49/225 (21%), Positives = 92/225 (40%), Gaps = 44/225 (19%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKK--FHSPLPGEMTFQQEFLNEVKALTE 870
+ + D +G GG G V+ A + + VA+KK P + L E+K +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRR 64
Query: 871 IRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDL-GWTRRM-----NVIKG--ISD----- 917
+ H NIVK + L + + + M NV++ + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 918 -------ALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSN---W 966
L Y+H+ ++HRD+ N+ ++ ++ + DFG+A+ + P S+
Sbjct: 125 FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 967 TELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
+E T Y +P L YT + D+++ G + E++ GK
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 82/302 (27%)
Query: 823 IGKGGQGSVYKAEL--------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI- 871
+G+G G V AE VAVK L + T + + ++E++ + I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 98
Query: 872 RHRNIVKFYGFCSHVRHSLAMIL-------------------------SNNAAAKDLGWT 906
+H+NI+ G C+ L +I+ N + + +
Sbjct: 99 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD---- 962
++ ++ + Y+ + +HRD++++NVL+ +N ++DFG+A+ +
Sbjct: 158 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 963 -SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISS 1014
++N W APE + T + DV+SFGVL E+ G P I
Sbjct: 215 KTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 264
Query: 1015 MSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
L ++L R+ P+ C ++L ++ C P RPT ++ +
Sbjct: 265 --------VEELFKLLKEGHRMDKPANC--TNELYMMMR---DCWHAVPSQRPTFKQLVE 311
Query: 1072 LL 1073
L
Sbjct: 312 DL 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 38/215 (17%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ +G G GSV A + SGE VA+KK P F + E+ L ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ 81
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNA-------AAKDLGWTRRMNVIK-GISD------- 917
H N++ V + + + DL ++ S+
Sbjct: 82 HENVIGLL----DVFTPASSLRNFYDFYLVMPFMQTDLQ-----KIMGLKFSEEKIQYLV 132
Query: 918 -----ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972
L Y+H+ +VHRD+ N+ ++ D E + DFG+A + + T T
Sbjct: 133 YQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVT 186
Query: 973 YGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 1006
Y APE+ + M + D++S G + E++ GK
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 63/302 (20%), Positives = 119/302 (39%), Gaps = 82/302 (27%)
Query: 823 IGKGGQGSVYKAELASGE--------IVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI- 871
+G+G G V AE + VAVK L + T + + ++E++ + I
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 144
Query: 872 RHRNIVKFYGFCSHVRHSLAMIL-------------------------SNNAAAKDLGWT 906
+H+NI+ G C+ L +I+ N + + +
Sbjct: 145 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD---- 962
++ ++ + Y+ + +HRD++++NVL+ +N ++DFG+A+ +
Sbjct: 204 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 963 -SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISS 1014
++N W APE + T + DV+SFGVL E+ G P I
Sbjct: 261 KTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 310
Query: 1015 MSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
L ++L R+ P+ C ++L ++ C P RPT ++ +
Sbjct: 311 --------VEELFKLLKEGHRMDKPANC--TNELYMMMR---DCWHAVPSQRPTFKQLVE 357
Query: 1072 LL 1073
L
Sbjct: 358 DL 359
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 59/300 (19%), Positives = 114/300 (38%), Gaps = 75/300 (25%)
Query: 823 IGKGGQGSVYKAE---LASGE---IVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRN 875
+G G G V +A L + VAVK ++ ++E+K L+ + H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMN 88
Query: 876 IVKFYGFCS----------------------HVRHSLAMILSNNAAAKDLGWTRRMNVI- 912
IV G C+ R S ++ A +D + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 913 ---KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-----SS 964
++ ++++ + +HRD++++N+LL + DFG+A+ +K D
Sbjct: 149 SFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 965 N------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSS 1017
N W APE + T + DV+S+G+ E+ G P +
Sbjct: 206 NARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253
Query: 1018 SSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ +M+ R+ +P + + ++ +C D +P RPT ++ QL++
Sbjct: 254 -----DSKFYKMIKEGFRMLSPEHAPAE-----MYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 36/205 (17%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 876
+G+G G V K +G IVA+KKF + + + E+K L ++RH N+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 877 VKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
V C V H++ L D + + I + + + H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCHSHN 144
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 981
I+HRDI +N+L+ + DFG A+ L + + T Y APEL
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGK 1006
Y V DV++ G L E+ G+
Sbjct: 202 YGKAV----DVWAIGCLVTEMFMGE 222
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 20/208 (9%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
DF +G+G +V A ELA+ A+K + E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG---------ISDALSYMH- 923
VK Y F L LS + L + R++ I AL Y+H
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---WTELAGTYGYVAPEL 980
I+HRD+ +N+LL+ D ++DFG AK L P+S + GT YV+PEL
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPEL 203
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ D+++ G + +++ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 47/228 (20%), Positives = 82/228 (35%), Gaps = 69/228 (30%)
Query: 823 IGKGGQGSVYKAELASGE------IVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHR 874
+G+G G V KA + VAVK L + ++ L+E L ++ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LKENASPSELRDLLSEFNVLKQVNHP 86
Query: 875 NIVKFYGFC-------------------SHVRHSLAMILSNNAAAKDLGWTRRMNVIKG- 914
+++K YG C +R S + + + + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 915 ------------ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962
IS + Y+ VHRD++++N+L+ + +SDFG+++ + +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 963 -----SSN------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVL 998
S W A E L T + DV+SFGVL
Sbjct: 204 DSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVL 241
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 61/302 (20%), Positives = 113/302 (37%), Gaps = 80/302 (26%)
Query: 823 IGKGGQGSVYKAEL--------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI- 871
+G+G G V AE VAVK L + T + + ++E++ + I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132
Query: 872 RHRNIVKFYGFCSHV--------------------RHSLAMILSNNAAAKDLGWTRRMNV 911
+H+NI+ G C+ + + + +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 912 IKG----ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD----- 962
+ ++ + Y+ + +HRD++++NVL+ DN ++DFG+A+ +
Sbjct: 193 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 963 SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSM 1015
++N W APE + T + DV+SFGVL E+ G P +
Sbjct: 250 TTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298
Query: 1016 SSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072
L ++L R+ PS C ++L ++ C P RPT ++ +
Sbjct: 299 -------VEELFKLLKEGHRMDKPSNC--TNELYMMMR---DCWHAVPSQRPTFKQLVED 346
Query: 1073 LK 1074
L
Sbjct: 347 LD 348
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 36/205 (17%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 876
IG+G G V+K +G+IVA+KKF + + E++ L +++H N+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 877 VKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
V H++ L + ++ A+++ H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCHKHN 122
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 981
+HRD+ +N+L+ + + DFG A+ L S + + T Y +PEL
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGK 1006
Y V DV++ G + E++ G
Sbjct: 180 YGPPV----DVWAIGCVFAELLSGV 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 39/216 (18%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + +G G GSV A + +G VAVKK P + + E++ L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK 86
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNA-------AAKDLGWTRRMNVIKG--ISD------ 917
H N++ V + N DL N++K ++D
Sbjct: 87 HENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN-----NIVKCQKLTDDHVQFL 137
Query: 918 ------ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
L Y+H+ I+HRD+ N+ ++ D E + DFG+A + + T
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVA 191
Query: 972 TYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 1006
T Y APE+ M + D++S G + E++ G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 57/307 (18%), Positives = 116/307 (37%), Gaps = 85/307 (27%)
Query: 823 IGKGGQGSVYKAELASGE------IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 876
IG+G G V++A +VAVK +M Q +F E + E + NI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112
Query: 877 VKFYGFCSHVRHSLAMIL---------------------------------SNNAAAKDL 903
VK G C+ + ++ ++ L
Sbjct: 113 VKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 904 GWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL---- 959
++ + + ++ ++Y+ F VHRD++++N L+ + ++DFG+++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 960 --KPDSSN-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRD 1010
K D ++ W PE + Y + T + DV+++GV+ E+ G P
Sbjct: 229 YYKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP-- 276
Query: 1011 FISSMSSSSLNLNIALDEMLDP--RLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMP 1067
M+ + + + L P C +L +++ C + P RP+
Sbjct: 277 -YYGMA------HEEVIYYVRDGNILACPENC--PLELYNLMR---LCWSKLPADRPSFC 324
Query: 1068 KVSQLLK 1074
+ ++L+
Sbjct: 325 SIHRILQ 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 40/230 (17%)
Query: 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMT---FQQEF- 861
+ E+ + + + I G G+V + G VA+K+ + + T F
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 862 ----LNEVKALTEIRHRNIVKFYG-FCSHVRHSLAMI-LSNNAAAKDLGWTRRMNVIKGI 915
L E++ L H NI+ F ++ + L DL VI
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQ 127
Query: 916 SDALS----------------YMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957
+S +H +VHRD+ N+LL +N+ + DF +A+
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 958 FLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 1006
D +N T Y APEL T+ D++S G + E+ K
Sbjct: 183 EDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 69/358 (19%), Positives = 124/358 (34%), Gaps = 85/358 (23%)
Query: 772 FFKFQRRNNDLQTQQSSPGNTRGLLSVLTFEGKIVYE-EIIRATNDFDDEHCIGKGGQGS 830
+ K R + LQ Q + + V E + + E R +F +G G G
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKV--LGSGAFGK 60
Query: 831 VYKAEL------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RHRNIVKFYG 881
V A VAVK L + + ++E+K +T++ H NIV G
Sbjct: 61 VMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 882 FCS----------------------HVRHSLAMILSNNAAAKDLGWTRRMNVIKG----- 914
C+ R + K L +NV+
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 915 ----ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-----SSN 965
++ + ++ VHRD++++NVL+ + DFG+A+ + D N
Sbjct: 177 FAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233
Query: 966 ------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSS 1018
W APE + T K DV+S+G+L E+ G +P
Sbjct: 234 ARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------YP 276
Query: 1019 SLNLNIALDEMLDP--RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ +++ ++ P ++ I + SC + RP+ P ++ L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTSFLG 330
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ D +G G G+V A + +G VA+KK + P F + E++ L +R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR 82
Query: 873 HRNIVK----------------FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS 916
H N++ FY + L ++ + LG R ++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQML 138
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
L Y+H I+HRD+ N+ ++ D E + DFG+A + S T T Y
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYR 192
Query: 977 APELAYT-MKVTEKCDVYSFGVLALEVIKGK 1006
APE+ M+ T+ D++S G + E+I GK
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 93/574 (16%), Positives = 166/574 (28%), Gaps = 65/574 (11%)
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
T+ L + D + F NLRSL + IP + G + N
Sbjct: 56 TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISN------ 109
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSL--GNLTNLATLYLYENSL--SGSIPSEFGNL 288
NLR L + +S L +L TL L + S + + S +
Sbjct: 110 ------NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHC 163
Query: 289 RSLSMLNLGYNKLNGIIPHSLG----NLTNLATLYIHNNSLSG----SIPSEIGNLRSLS 340
R + L + + + L + T+L L + + + + N RSL
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223
Query: 341 NLGLSGNKLS--GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS 398
++ + ++ + L L + L R L L L Y +
Sbjct: 224 SVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283
Query: 399 GSIPHSLGNLTNLATLDLYDNSLSG-SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT 457
+P + LDL L + +L L +
Sbjct: 284 E-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCK 342
Query: 458 NLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517
L L + + + E G + +AL L + +Y + +
Sbjct: 343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ------------GCQELEYMAVYVSDI 390
Query: 518 FD----SIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFL 573
+ SI + L NL ++ + + DL ++ V + KL
Sbjct: 391 TNESLESIGTYLKNLCDFRLV---------LLDREERITDLPLDNGVRSLLIGCKKLRRF 441
Query: 574 IKLILAQNQLSGQLSPKLGSLA-QLEHLDLSSNRLS-NSIPKSFGNLVKLHYLNLSNNQF 631
L Q L+ +G + + + L S + + L L + F
Sbjct: 442 -AFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500
Query: 632 S-RGIPIKLEELIHLSELDLSHNFLR---EAIPSQICIMQSLENLNLSHNSLVGLIPSCF 687
S R I + +L L L + + + ++E + V
Sbjct: 501 SERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQ-QGEI 559
Query: 688 EKMHGLLRIDISYNELQGP---IPNSIAFRDAPI 718
+M I Y L G P ++ PI
Sbjct: 560 REMEHPAHILA-YYSLAGQRTDCPTTVRVLKEPI 592
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 69/493 (13%), Positives = 142/493 (28%), Gaps = 84/493 (17%)
Query: 167 NLSNLDTLHLYDNSLSDS-----IPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221
NL L ++H +SD + +L +L L + + + + + T
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK-LDKCSGFTTDGLLSIVTHCRKIKT 168
Query: 222 LYLHNNSLFDSIPSELG----NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277
L + +S + L + SL +L+ ++ + N
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT--------EFAKISPKDLETIARNCR 220
Query: 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337
+L S+ + + +L G + NL ++ + + R
Sbjct: 221 ---------SLVSVKVGDFEILELVGFF-KAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270
Query: 338 SLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF-DSIPSELGNLRSLSMLSLGYNK 396
L LGLS + +P + + + L L L + + + +L +L
Sbjct: 271 KLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVI 329
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG------------NLRSLSTLSLGYNK 444
+ L L + + + E G + L +++ +
Sbjct: 330 GDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSD 389
Query: 445 LS----GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS 500
++ SI L NL + + L +P + G S+
Sbjct: 390 ITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG---------------VRSLLIG 434
Query: 501 LGNLSNLVILYLYNNSLFDSIPSELG-NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHI 559
L YL L D S +G ++ + Y S G+++ S
Sbjct: 435 CKKLRRFA-FYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE-----GLMEFSRG-- 486
Query: 560 VGEIPTELGKLNFLIKLILAQNQLSGQ-LSPKLGSLAQLEHLDLSSNRLSNSIPKSFG-- 616
L KL + S + ++ + L L +L + R S +
Sbjct: 487 ----------CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMA 536
Query: 617 -NLVKLHYLNLSN 628
+ +
Sbjct: 537 RPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 45/312 (14%), Positives = 92/312 (29%), Gaps = 31/312 (9%)
Query: 69 FSSFPHLAYLDLWHNQL--YGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
+ L + + ++ N+ L+ ++ + L L
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLAL-YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSI 185
L N +P + + L L Y+ + + NL+ L + +
Sbjct: 276 GLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
Query: 186 PSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLT------------NLATLYLHNNSLFD-- 231
+ L L + + G ++ L + ++ + + +
Sbjct: 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394
Query: 232 --SIPSELGNLRSLSMLSLGYNK------LSGSIPHSLGNLTNLATLYLYENS--LSGSI 281
SI + L NL ++ L + L + L L Y L+
Sbjct: 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454
Query: 282 PSEFG-NLRSLSMLNLGYNKLNGI-IPHSLGNLTNLATLYIHNNSLS-GSIPSEIGNLRS 338
S G ++ + LGY + + NL L + S +I + + L S
Sbjct: 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPS 514
Query: 339 LSNLGLSGNKLS 350
L L + G + S
Sbjct: 515 LRYLWVQGYRAS 526
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 32/214 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 871
NDF IG+GG G VY +G++ A+K + LNE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 872 -RHRNIVK-FYGFCSHVRHSLAMILSNNAAAKDLGW-TRRMNVIKG---------ISDAL 919
IV Y F + + S + L N DL + + V I L
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
+MHN +V+RD+ N+LLD +SD G+A + GT+GY+APE
Sbjct: 306 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASVGTHGYMAPE 360
Query: 980 L-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+ AY D +S G + ++++G P
Sbjct: 361 VLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 7/127 (5%)
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257
L + +L L L L N++ + I S L + +L +LSLG N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 258 PHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP-HSLGNLTNLA 316
+ L L++ N ++ S+ S L +L +L + NK+ L L L
Sbjct: 86 ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143
Query: 317 TLYIHNN 323
L + N
Sbjct: 144 DLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 31/131 (23%), Positives = 54/131 (41%), Gaps = 9/131 (6%)
Query: 552 LDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI 611
L I ++ L L L L+ N + ++S L + L L L N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 612 PKSFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLSELDLSHNFLREAIP-SQICIMQSL 669
L L +S NQ + + +E+L++L L +S+N + ++ + L
Sbjct: 86 ENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 670 ENLNLSHNSLV 680
E+L L+ N L
Sbjct: 143 EDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 30/131 (22%), Positives = 51/131 (38%), Gaps = 15/131 (11%)
Query: 294 LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSN---LGLSGNKLS 350
L+ + + +L L L + N++ +I +L + N L L N +
Sbjct: 30 LHGMIPPIEKM-DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK 83
Query: 351 GSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLS--GSIPHSLGNL 408
I L L++ N + S+ S + L +L +L + NK++ G I L L
Sbjct: 84 -KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKITNWGEIDK-LAAL 139
Query: 409 TNLATLDLYDN 419
L L L N
Sbjct: 140 DKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 33/151 (21%), Positives = 59/151 (39%), Gaps = 9/151 (5%)
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLE-DLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
++ + + + + L+ + + +L L L L N++ I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI- 63
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
S + +L +LSLG N I + L L++ N + S+ S + L +L +L
Sbjct: 64 SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVL 120
Query: 247 SLGYNKLS--GSIPHSLGNLTNLATLYLYEN 275
+ NK++ G I L L L L L N
Sbjct: 121 YMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 28/135 (20%), Positives = 56/135 (41%), Gaps = 10/135 (7%)
Query: 573 LIKLILAQNQLSGQLSPKLGSLAQLEHLDL--SSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
+ K ++ + K + E ++L + + + L +L LS N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59
Query: 631 FSRGIPIK-LEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEK 689
+ I L + +L L L N +++ I + + +LE L +S+N + L S EK
Sbjct: 60 IEK---ISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEK 113
Query: 690 MHGLLRIDISYNELQ 704
+ L + +S N++
Sbjct: 114 LVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 25/149 (16%)
Query: 486 LALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSI 545
L + + +L L L L N++ ++ +L + L
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLR---------- 73
Query: 546 PHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSN 605
+L L N I +I + L +L ++ NQ++ LS + L L L +S+N
Sbjct: 74 -----ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNN 125
Query: 606 RLSN-SIPKSFGNLVKLHYLNLSNNQFSR 633
+++N L KL L L+ N
Sbjct: 126 KITNWGEIDKLAALDKLEDLLLAGNPLYN 154
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 12/145 (8%)
Query: 116 EIGHLSYLKTLQLFENQLNGS----IPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNL 171
E + E + + L + +LAL +N +E + L + NL
Sbjct: 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGMENL 72
Query: 172 DTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL-- 229
L L N + I + +L L + YN+ + S+ + L NL LY+ NN +
Sbjct: 73 RILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN 129
Query: 230 FDSIPSELGNLRSLSMLSLGYNKLS 254
+ I +L L L L L N L
Sbjct: 130 WGEI-DKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 37/176 (21%), Positives = 61/176 (34%), Gaps = 37/176 (21%)
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
L + + +L L L L N++ I + + ++ L+L N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 498 PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN 557
L L++ N + + L + L +L VL +S+N
Sbjct: 86 ENLDAVADTLEELWISYNQI-----ASLSGIEKL---------------VNLRVLYMSNN 125
Query: 558 HI--VGEIPTELGKLNFLIKLILAQNQLSGQLSPK----------LGSLAQLEHLD 601
I GEI +L L+ L L+LA N L + L L+ LD
Sbjct: 126 KITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/142 (21%), Positives = 50/142 (35%), Gaps = 32/142 (22%)
Query: 88 NIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSL 147
+ + + K+L LS+N +I LS ++ L+
Sbjct: 39 KMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLR-------------------- 73
Query: 148 NYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS- 206
L+L N ++ I L+ L + N ++ S L +L +L + NK +
Sbjct: 74 -ILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMSNNKITN 129
Query: 207 -GSIPHSLGNLTNLATLYLHNN 227
G I L L L L L N
Sbjct: 130 WGEIDK-LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 12/127 (9%)
Query: 66 DFSFSSFPHLAYLDLWHNQLYGNIPPQIGNIS---RLKYLDLSSNLFFGTIPPEIGHLSY 122
D + S+ +L L N + +I ++S L+ L L NL I
Sbjct: 41 DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLI-KKIENLDAVADT 94
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSL 181
L+ L + NQ+ S+ I +L +L L + +N + + L L L+ L L N L
Sbjct: 95 LEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 182 SDSIPSE 188
+
Sbjct: 153 YNDYKEN 159
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 31/217 (14%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTE 870
+DF+ IG+G V ++ +G++ A+K K+ GE++ F E L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVN 117
Query: 871 IRHRNIVK-FYGFCSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDAL 919
R I + + F L M +LS R + I A+
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMAI 175
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAP 978
+H VHRDI N+LLD ++DFG L+ D + + +A GT Y++P
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 979 ELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP 1008
E+ + CD ++ GV A E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 51/224 (22%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKK---FHSPLPGEMTFQQEFLNEVKALT 869
+ + IG+G G V A + + VA+KK F T+ Q L E+K L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILL 80
Query: 870 EIRHRNIVKFYG-FCSHVRHSLAMI-LSNNAAAKDLGWTRRMNVIKG--ISD-------- 917
RH NI+ + + + + + DL ++K +S+
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-----KLLKTQHLSNDHICYFLY 135
Query: 918 ----ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---WTE 968
L Y+H N ++HRD+ N+LL+ + + DFG+A+ PD + TE
Sbjct: 136 QILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 969 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 1006
T Y APE+ YT + D++S G +LA E++ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 6e-12
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 39/206 (18%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIV-- 877
IG+G G VYKA+ GE A+KK E T + E+ L E++H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST----TIREISILKELKHSNIVKL 65
Query: 878 --------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHND 925
+ H+ L +L + K + ++Y H+
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE------SVTAKSFLLQLLNGIAYCHDR 119
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 980
++HRD+ +N+L++ + E ++DFG+A+ +T T Y AP++
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGK 1006
Y+ + D++S G + E++ G
Sbjct: 177 KYSTTI----DIWSVGCIFAEMVNGT 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 63/272 (23%), Positives = 97/272 (35%), Gaps = 52/272 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G G V A + E VAVK + + E+ + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 882 FCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKG------ISDALSYMHN 924
R + L + M + + Y+H
Sbjct: 73 ----HRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL- 980
I HRDI +N+LLD + +SDFG+A + ++ L GT YVAPEL
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179
Query: 981 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
+ E DV+S G++ ++ G+ P + S + +
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
L I L ENP +R T+P +
Sbjct: 235 DSAPLALLHKI-------LVENPSARITIPDI 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 57/289 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK-------------------KFHSPLPGEMTFQQEFL 862
IGKG G V A A+K + P PG + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 863 N----EVKALTEIRHRNIVKFYGFCSHV-----RHSLAMI--------LSNNAAAKDLGW 905
E+ L ++ H N+VK V L M+ + K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 906 TRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965
+ + + + Y+H I+HRDI N+L+ D ++DFG++ K +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 966 WTELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022
+ GT ++APE + + DV++ GV + G+ P F+ L+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP--FMDE-RIMCLHS 250
Query: 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
I + P P + ++D + + LD+NPESR +P++
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRM-------LDKNPESRIVVPEIKL 292
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 37/105 (35%), Positives = 47/105 (44%), Gaps = 6/105 (5%)
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSGS 448
L L NKL LT L L L N + S+P F L L+ L L NKL S
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 449 IPHSL-GNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
+P+ + LT L L L N L S+P G L S+ + L+ N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 6/110 (5%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDN 467
++ L+L N L F L L+ LSL N++ S+P + LT L LYL++N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 468 SLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
L S+P G L + LAL+ N+L S+P L++L ++L+ N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 23/133 (17%)
Query: 321 HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSL------ 373
++ L+ S+P+ I + S + L L NKL S+P + L+ L L L N +
Sbjct: 15 NSKGLT-SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70
Query: 374 -FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSE-FG 430
FD L L++L L NKL S+P+ + LT L L L N L S+P F
Sbjct: 71 VFDK-------LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFD 121
Query: 431 NLRSLSTLSLGYN 443
L SL + L N
Sbjct: 122 RLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 36/111 (32%), Positives = 44/111 (39%), Gaps = 18/111 (16%)
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL-------FDSIPSELGNLRSLSMLSLGY 250
L L NK LT L L L N + FD L L++L L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK-------LTKLTILYLHE 85
Query: 251 NKLSGSIPHSL-GNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYN 299
NKL S+P+ + LT L L L N L S+P F L SL + L N
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 4/109 (3%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLYLYEN 275
++ L L +N L L L+ LSL N++ S+P + LT L LYL+EN
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 276 SLSGSIPSE-FGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
L S+P+ F L L L L N+L + LT+L +++H N
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 41/143 (28%), Positives = 56/143 (39%), Gaps = 32/143 (22%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
S+P I SS L L SN L+ L L+ L L L N + S+P F L
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 195 LSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL 253
L++L L NK S+P+ + LT L L L N L
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL------------------------ 112
Query: 254 SGSIPH-SLGNLTNLATLYLYEN 275
S+P LT+L ++L+ N
Sbjct: 113 -KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 36/128 (28%), Positives = 50/128 (39%), Gaps = 28/128 (21%)
Query: 294 LNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSGS 352
L L NKL + LT L L + N + S+P + L L+ L L NKL S
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNL 411
+P +FD L L L+L N+L S+P LT+L
Sbjct: 91 LPN----------------GVFD-------KLTQLKELALDTNQLK-SVPDGIFDRLTSL 126
Query: 412 ATLDLYDN 419
+ L+ N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 31/99 (31%), Positives = 40/99 (40%), Gaps = 4/99 (4%)
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
L L NKL LT L L L N + G L ++ L L+ NKL S+
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SL 91
Query: 498 PQSL-GNLSNLVILYLYNNSLFDSIPSE-LGNLRSLSML 534
P + L+ L L L N L S+P L SL +
Sbjct: 92 PNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 33/117 (28%), Positives = 49/117 (41%), Gaps = 10/117 (8%)
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
IP+ +L L N+L L + L QL L LS N++ + F L KL
Sbjct: 26 IPSSATRLE------LESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 622 HYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHN 677
L L N+ +P + ++L L EL L N L+ + SL+ + L N
Sbjct: 79 TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 35/128 (27%), Positives = 46/128 (35%), Gaps = 32/128 (25%)
Query: 485 NLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL-------FDSIPSELGNLRSLSMLSFA 537
L L +NKL L+ L L L N + FD L L++L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDK-------LTKLTILYLH 84
Query: 538 YNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQL 597
NKL S+P+ GV D KL L +L L NQL L L
Sbjct: 85 ENKLQ-SLPN--GVFD---------------KLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 598 EHLDLSSN 605
+ + L +N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 37/125 (29%), Positives = 50/125 (40%), Gaps = 24/125 (19%)
Query: 509 ILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELG 568
L L +N L L L+ LS + N++ S+P GV D
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFD--------------- 73
Query: 569 KLNFLIKLILAQNQLSGQLSPK--LGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLN 625
KL L L L +N+L Q P L QL+ L L +N+L S+P F L L +
Sbjct: 74 KLTKLTILYLHENKL--QSLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIW 130
Query: 626 LSNNQ 630
L N
Sbjct: 131 LHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWHNQLYGNIPPQI-GNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTL 126
F L L L NQ+ ++P + +++L L L N ++P + L+ LK L
Sbjct: 48 FDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENK-LQSLPNGVFDKLTQLKEL 105
Query: 127 QLFENQLNGSIPYEI-GRLSSLNYLALYSN 155
L NQL S+P I RL+SL + L++N
Sbjct: 106 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 51/220 (23%)
Query: 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLN-EVKALTEIRHR 874
+ D IG G G VY+A+L SGE+VA+KK + + F N E++ + ++ H
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 107
Query: 875 NIVK-FYGFCSHVRHS------LAM----------ILSNNAAAKDLGWTRRMNVIKGIS- 916
NIV+ Y F S L + + A + L + +K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMY 163
Query: 917 ---DALSYMHNDCFPPIVHRDISSKNVLLDFDNEA-HVSDFGIAKFLKPDSSNWTELAGT 972
+L+Y+H+ I HRDI +N+LLD D + DFG AK L N + +
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 973 YGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 1006
Y Y APEL YT + DV+S G VLA E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 62/252 (24%), Positives = 106/252 (42%), Gaps = 54/252 (21%)
Query: 784 TQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVA 843
+ + + ++ VL +GK + I + + IG G G V++A+L + VA
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLVESDEVA 68
Query: 844 VKKFHSPLPGEMTFQQEFLN-EVKALTEIRHRNIVK-FYGFCSHVRHS------LAM--- 892
+KK + F N E++ + ++H N+V F S+ L +
Sbjct: 69 IKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 893 -------ILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHNDCFPPIVHRDISSKNVL 941
+ + M +IK +L+Y+H+ I HRDI +N+L
Sbjct: 121 PETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLL 173
Query: 942 LDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSF 995
LD + + DFG AK L N + + Y Y APEL YT + D++S
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YRAPELIFGATNYTTNI----DIWST 228
Query: 996 G-VLALEVIKGK 1006
G V+A E+++G+
Sbjct: 229 GCVMA-ELMQGQ 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 45/209 (21%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFY 880
+G+G V++A + + E V VK +++ E+K L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLA 97
Query: 881 G-FCSHVRHSLAMILS--NNAAAKDLGWTRRMNVIKGISD------------ALSYMHND 925
V + A++ NN D + + ++D AL Y H+
Sbjct: 98 DIVKDPVSRTPALVFEHVNNT---DFK-----QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 926 CFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 980
I+HRD+ NV++D ++ + + D+G+A+F P + + + PEL
Sbjct: 150 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 981 -AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y + D++S G + +I K P
Sbjct: 206 QMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 41/209 (19%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEF----LNEVKALTEIRHRNIV 877
+G+G +VYKA + + +IVA+KK L + L E+K L E+ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 878 KFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMH 923
H + L +I+ +N+ + IK L Y+H
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLT------PSHIKAYMLMTLQGLEYLH 129
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 980
I+HRD+ N+LLD + ++DFG+AK + +T T Y APEL
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 186
Query: 981 --AYTMKVTEKCDVYSFG-VLALEVIKGK 1006
Y + V D+++ G +LA E++
Sbjct: 187 ARMYGVGV----DMWAVGCILA-ELLLRV 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 39/206 (18%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIV-- 877
+G+G G VYKA+ + G IVA+K+ E T + E+ L E+ H NIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST----AIREISLLKELHHPNIVSL 84
Query: 878 --------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHND 925
+ L +L N + IK +++ H
Sbjct: 85 IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ------DSQIKIYLYQLLRGVAHCHQH 138
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 980
I+HRD+ +N+L++ D ++DFG+A+ ++T T Y AP++
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGK 1006
Y+ V D++S G + E+I GK
Sbjct: 196 KYSTSV----DIWSIGCIFAEMITGK 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 58/233 (24%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEF-------LN 863
+ ++ IG+G G V+KA +G+ VA+KK + E L
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALR 65
Query: 864 EVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAA---------KDL-GWTRRMNV-- 911
E+K L ++H N+V + + A + + DL G + V
Sbjct: 66 EIKILQLLKHENVVNLIE----ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 121
Query: 912 ----IKGIS----DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF----L 959
IK + + L Y+H + I+HRD+ + NVL+ D ++DFG+A+
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 960 KPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 1006
+ +T T Y PEL Y + D++ G ++A E+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 76/240 (31%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKK---FHSPLPGEMTFQQEFLNEVKALT 869
++DF + +G+G G V A +GEIVA+KK F P F L E+K L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64
Query: 870 EIRHRNIVKFYGFCSHVRHSLAMILSNNAAA------------KDLGWTRRMNVIKG--I 915
+H NI+ + ++ DL VI +
Sbjct: 65 HFKHENIITI----------FNIQRPDSFENFNEVYIIQELMQTDLH-----RVISTQML 109
Query: 916 SD------------ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961
SD A+ +H N ++HRD+ N+L++ + + V DFG+A+ +
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 962 DSSNWTELAGTYG----YV------APEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
+++ +E G +V APE+ Y+ + DV+S G + E+ +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 45/207 (21%)
Query: 823 IGKGGQGSVYKA---ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+G+G G VYKA + + A+K+ E+ L E++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-----GTGISMSACREIALLRELKHPNVISL 83
Query: 880 YG-FCSHVR-----------HSLAMILSNNAAAKDLGWTRRMN--VIKGIS----DALSY 921
F SH H L I+ + A+K ++ ++K + D + Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAH----VSDFGIAKFLKPDSSNWTELAG---TYG 974
+H + ++HRD+ N+L+ + ++D G A+ +L T+
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 975 YVAPEL-----AYTMKVTEKCDVYSFG 996
Y APEL YT + D+++ G
Sbjct: 201 YRAPELLLGARHYTKAI----DIWAIG 223
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-11
Identities = 29/130 (22%), Positives = 55/130 (42%), Gaps = 10/130 (7%)
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
++ L++ I E + +L L ++ + +L Q + +D S N +
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 611 IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICI---MQ 667
+ F L +L L ++NN+ R + L L+EL L++N L E + ++
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLK 113
Query: 668 SLENLNLSHN 677
SL L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSML 294
++ N L L K+ I + L + +N + + F LR L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 295 NLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG---LSGN 347
+ N++ I L +L L + NNSL ++ L SL +L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 27/129 (20%), Positives = 45/129 (34%), Gaps = 8/129 (6%)
Query: 245 MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304
M+ L + + N L L + I + L ++ N++ +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 305 IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS--GSIPPSLGYLSN 362
L L TL ++NN + L L+ L L+ N L G + P L L +
Sbjct: 58 --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKS 114
Query: 363 LATLYLYSN 371
L L + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 427 SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNL 486
+++ N L L K+ I + L DA+ DN + + G LR + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 487 ALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFD-SIPSELGNLRSLSMLSFAYN 539
+NNN++ L +L L L NNSL + L +L+SL+ L N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 28/137 (20%), Positives = 45/137 (32%), Gaps = 26/137 (18%)
Query: 379 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTL 438
++ N L L K+ I + L +D DN + + F LR L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 439 SLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIP 498
+ N++ L +L L L +N + L + LA
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNN--------SLVELGDLDPLA----------- 110
Query: 499 QSLGNLSNLVILYLYNN 515
+L +L L + N
Sbjct: 111 ----SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 23/114 (20%), Positives = 35/114 (30%), Gaps = 4/114 (3%)
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222
N L L + I + L + N+ + L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYEN 275
++NN + L L+ L L N L L +L +L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 21/114 (18%), Positives = 34/114 (29%), Gaps = 4/114 (3%)
Query: 355 PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414
L L + I + L + N++ + L L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 415 DLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTNLDALYLYDN 467
+ +N + L L+ L L N L L +L +L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 17/93 (18%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 588 SPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIK-LEELIHLS 646
+ + + + LDL ++ I L + ++ S+N+ + + L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK---LDGFPLLRRLK 67
Query: 647 ELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
L +++N + + L L L++NSL
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 17/105 (16%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 600 LDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAI 659
+ L++ + + + N V+ L+L + I L +D S N +R+
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL- 57
Query: 660 PSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
+++ L+ L +++N + + + + L + ++ N L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/142 (19%), Positives = 53/142 (37%), Gaps = 7/142 (4%)
Query: 283 SEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNL 342
+++ N L+L K+ +I + L + +N + + LR L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 343 GLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD-SIPSELGNLRSLSMLSLGYN---KLS 398
++ N++ L +L L L +NSL + L +L+SL+ L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
Query: 399 GSIPHSLGNLTNLATLDLYDNS 420
+ + + + LD
Sbjct: 130 HYRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 29/117 (24%), Positives = 43/117 (36%), Gaps = 8/117 (6%)
Query: 499 QSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS--GSIPH--SLGVLDL 554
N L L + I + L + F+ N++ P L L +
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 71
Query: 555 SSNHIVGEIPTELGKLNFLIKLILAQNQLS--GQLSPKLGSLAQLEHLDLSSNRLSN 609
++N I L L +LIL N L G L P L SL L +L + N ++N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVTN 127
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 16/91 (17%), Positives = 26/91 (28%), Gaps = 3/91 (3%)
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILY 511
N L L + I L + ++N++ + L L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 512 LYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542
+ NN + L L+ L N L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/119 (23%), Positives = 43/119 (36%), Gaps = 16/119 (13%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISR----LKYLDLSSNLFFGTIPP--EIGHLS 121
+++ LDL ++ P I N+ +D S N I L
Sbjct: 14 QYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNE----IRKLDGFPLLR 64
Query: 122 YLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDN 179
LKTL + N++ L L L L +N L +L L +L +L L + N
Sbjct: 65 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 24/194 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 880
+G+G G V + + AVK L + E++ L +RH+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 881 G-FCSHVRHSLAMI----------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPP 929
+ + + M+ + ++ K + + D L Y+H+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--- 129
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELAYTMK 985
IVH+DI N+LL +S G+A+ L P +++ + G+ + PE+A +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAFQPPEIANGLD 187
Query: 986 VTE--KCDVYSFGV 997
K D++S GV
Sbjct: 188 TFSGFKVDIWSAGV 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 7e-11
Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 44/211 (20%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 876
IG+G G+V+KA + EIVA+K+ + E + E+ L E++H+NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63
Query: 877 V----------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYM 922
V K L + D ++K L +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD------PEIVKSFLFQLLKGLGFC 117
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 980
H+ ++HRD+ +N+L++ + E +++FG+A+ ++ T Y P++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 981 ---AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+ + D++S G + E+ P
Sbjct: 175 GAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTE 870
DF+ IG+G G V +L + ++ A+K K+ E F E L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130
Query: 871 IRHRNIVK-FYGFCSHVRHSLAM----------ILSNNAAAKDLGWTRRMNVIKGISDAL 919
+ I Y F L M +LS R + + A+
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAI 188
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELA-GTYGYV 976
+H VHRDI N+L+ D H+ +DFG L D + + +A GT Y+
Sbjct: 189 DSVHQLH---YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 977 APELAYTMKVTEK-----CDVYSFGVLALEVIKGKHP 1008
+PE+ M+ + CD +S GV E++ G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 45/204 (22%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G +VYK +G VA+K+ L E + E+ + E++H NIV+ Y
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 882 FCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHNDCF 927
+ + L + + + +N++K L++ H +
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTV-GNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AY 982
I+HRD+ +N+L++ + + DFG+A+ + ++ T Y AP++ Y
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 983 TMKVTEKCDVYSFGVLALEVIKGK 1006
+ + D++S G + E+I GK
Sbjct: 187 STSI----DIWSCGCILAEMITGK 206
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 50/306 (16%), Positives = 97/306 (31%), Gaps = 57/306 (18%)
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLG-----NLTNLDALYLYDNSLSGSIPGEIG-----NL 480
+++L L N L L ++ +L L NSL E+
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 481 RSISNLALNNNKLSGSIPQSLGNL-----SNLVILYLYNNSLFDSIPSELGNL-----RS 530
++++L L+ N LS L + +L L N SE S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 531 LSMLSFAYNKLSG-----------SIPHSLGVLDLSSNHI----VGEIPTELGKLNF-LI 574
++ L+ N L +IP ++ L+L N++ E+ L + +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 575 KLILAQNQLSGQLSPKLGSL-----AQLEHLDLSSNRLSNSIPKSFGNLVK----LHYLN 625
L L+ N L + +L + + L+L N L ++ L L +
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 626 LSNNQFSRGIPIKLEELI-------HLSELDLSHNFLREAIPSQIC-----IMQSLENLN 673
L + + + L + +D + + + I + + +
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 674 LSHNSL 679
L + L
Sbjct: 320 LLNQCL 325
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 55/337 (16%), Positives = 106/337 (31%), Gaps = 56/337 (16%)
Query: 165 LGNLSNLDTLHLYDNSLSDSIPSEFG-----NLRSLSMLSLGYNKFSGSIPHSLG----- 214
+ +L L N+L E S++ L+L N L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 215 NLTNLATLYLHNNSLFDSIPSELGNL-----RSLSMLSLGYNKLSGSIPHSLGNL----- 264
N+ +L L N L EL ++++L LG+N S
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 265 TNLATLYLYENSLSGSIPSEFGNL-----RSLSMLNLGYNKLN----GIIPHSLGNL-TN 314
++ +L L N L E + +++ LNL N L + L ++ +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 315 LATLYIHNNSLSGSIPSEIG-----NLRSLSNLGLSGNKLSGS----IPPSLGYLSNLAT 365
+ +L + N L +E+ + +L L N L G + L +L T
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 366 LYLYSNSLFD-------SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL-----TNLAT 413
+YL + + + ++ + N++ + ++ ++ S + NL
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 414 LDLYDNSLS-----GSIPSEFGNLRSLSTLSLGYNKL 445
L + L + + L L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 62/337 (18%), Positives = 108/337 (32%), Gaps = 62/337 (18%)
Query: 381 LGNLRSLSMLSLGYNKLSGSIPHSLG-----NLTNLATLDLYDNSLSGSIPSEFG----- 430
++ L L N L L ++ +L+L NSL E
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLGNL-----TNLDALYLYDNSLSGSIPGEIGNL----- 480
++++L+L N LS L + L L N S E
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 481 RSISNLALNNNKLSGSIPQSLGNL-----SNLVILYLYNNSLFDSIPSELGNL-----RS 530
SI++L L N L L + +N+ L L N+L +EL S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 531 LSMLSFAYNKLS-----------GSIPHSLGVLDLSSNHI----VGEIPTELGKLNFLIK 575
++ L + N L SIP+ + L+L N + + + L L
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 576 LILAQNQLSGQ-------LSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK-----LHY 623
+ L + + L ++ ++ +D + + S NL++
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317
Query: 624 LNLSNN--QFSRGIPIKLEEL---IHLSELDLSHNFL 655
+L N F++ +E+L L E + L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 61/369 (16%), Positives = 110/369 (29%), Gaps = 80/369 (21%)
Query: 73 PHLAYLDLWHNQLYGNIPPQIG-----NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+ LDL N LY ++ + + L+LS N +G + + +Q
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN--------SLGFKNSDELVQ 73
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLED-----LIPPSLGNLSNLDTLHLYDNSLS 182
+ +++ L L N+L L+ + L L N S
Sbjct: 74 ILAAI-----------PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 183 DSIPSEFGNL-----RSLSMLSLGYNKFSGSIPHSLGNL-----TNLATLYLHNNSLFDS 232
SEF S++ L+L N L + N+ +L L N+L
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182
Query: 233 IPSELGNL-----RSLSMLSLGYNKLSGSIPHSLG-----NLTNLATLYLYENSLSGS-- 280
+EL S++ L L N L L ++ +L L N L G
Sbjct: 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242
Query: 281 --IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS 338
+ +L+ L + L Y+ + + L + N++
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG-----------------AAFPNIQK 285
Query: 339 LSNLGLSGNKLSGSIPPSLGYL-----SNLATLYLYSNSLFD-----SIPSELGNLRSLS 388
+ + +G ++ S + L L + L + +L L
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345
Query: 389 MLSLGYNKL 397
L
Sbjct: 346 ESIQTCKPL 354
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 63/272 (23%), Positives = 97/272 (35%), Gaps = 52/272 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G G V A + E VAVK + + E+ + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 882 FCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKG------ISDALSYMHN 924
R + L + M + + Y+H
Sbjct: 73 ----HRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL- 980
I HRDI +N+LLD + +SDFG+A + ++ L GT YVAPEL
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179
Query: 981 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
+ E DV+S G++ ++ G+ P + S + +
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
L I L ENP +R T+P +
Sbjct: 235 DSAPLALLHKI-------LVENPSARITIPDI 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 60/271 (22%), Positives = 97/271 (35%), Gaps = 50/271 (18%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G G V E +G VAVK + + + E++ L RH +I+K Y
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77
Query: 882 FCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMN------VIKGISDALSYMHN 924
V + L + R+ + + I A+ Y H
Sbjct: 78 ---QVISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHR 129
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 980
+VHRD+ +NVLLD A ++DFG++ + T G+ Y APE+
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 185
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
Y + D++S GV+ ++ G P D +L I P S
Sbjct: 186 LYA---GPEVDIWSCGVILYALLCGTLPFD---DEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
L+ L +P R T+ + +
Sbjct: 240 ---TLLM------HMLQVDPLKRATIKDIRE 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 52/250 (20%), Positives = 84/250 (33%), Gaps = 73/250 (29%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + +G G G V + ++ SG+ A+KK + + E+ + +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLD 58
Query: 873 HRNIVK----FYGFCSHVRHSLAMILSNNAAAKDLGWTRRM------------------- 909
H NI+K FY +N
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 910 -------NVIKGISD-------------------ALSYMHNDCFPPIVHRDISSKNVLLD 943
V+K A+ ++H+ I HRDI +N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 944 -FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG- 996
DN + DFG AK L P + + + Y APEL YT + D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGC 230
Query: 997 VLALEVIKGK 1006
V E+I GK
Sbjct: 231 VFG-ELILGK 239
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 9e-11
Identities = 67/505 (13%), Positives = 154/505 (30%), Gaps = 63/505 (12%)
Query: 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232
+ ++ F +RS+ + + +P G ++
Sbjct: 49 FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVY---------PWIEA 99
Query: 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLG-NLTNLATLYLYENSL--SGSIPSEFGNLR 289
+ S L + L ++ + + N L L + + + R
Sbjct: 100 MSSSYTWLEEIR---LKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCR 156
Query: 290 SLSMLNLGYNKLNGIIPHSLG----NLTNLATLYIHNNSLS---GSIPSEIGNLRSLSNL 342
+L L+L + ++ + H L T+L +L I + ++ + +L +L
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216
Query: 343 GLSGNKLSGSIPPSLGYLSNLATLYLYS------NSLFDSIPSELGNLRSLSMLSLGYNK 396
L+ + L L L ++ + L + L LS ++
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDA 276
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLSG-SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455
+ +P + L TL+L ++ + L L + +
Sbjct: 277 VPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAST 336
Query: 456 LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515
+L L + S P + +++ L S+ L +++ +
Sbjct: 337 CKDLREL-----RVFPSEPFVMEPNVALTEQGL------VSVSMGCPKLESVL---YFCR 382
Query: 516 SLFDSIPSELG-NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
+ ++ + N +++ + +L LD+ IV L +L+
Sbjct: 383 QMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD-LRRLS--- 438
Query: 575 KLILAQNQLSGQLSPK-LGSLAQ----LEHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSN 628
LSG L+ K + +E L ++ S+ + L L + +
Sbjct: 439 --------LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
Query: 629 NQFS-RGIPIKLEELIHLSELDLSH 652
F + + +L + L +S
Sbjct: 491 CPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 57/381 (14%), Positives = 112/381 (29%), Gaps = 52/381 (13%)
Query: 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFF 110
+L S+ + + + SFS+ L LK L L+ +
Sbjct: 182 TYTSLVSLNISCLASEVSFSALERLVT-----------------RCPNLKSLKLNRAVPL 224
Query: 111 GTIPPEIGHLSYLKTLQLF------ENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPS 164
+ + L+ L + + + L L+ + + + +P
Sbjct: 225 EKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAV 284
Query: 165 LGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLY 223
S L TL+L ++ + L L + + +L L
Sbjct: 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELR 344
Query: 224 LHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283
+ + F P+ + L +S+G KL S+ + +TN A + + N
Sbjct: 345 VFPSEPFVMEPNVALTEQGLVSVSMGCPKLE-SVLYFCRQMTNAALITIARN-------- 395
Query: 284 EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLG 343
N+ L + A Y+ L + + + + L L
Sbjct: 396 -RPNMTRF----------------RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS 438
Query: 344 LSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD-SIPSELGNLRSLSMLSLGYNKLSG-SI 401
LSG Y + L + D + L SL L + ++
Sbjct: 439 LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL 498
Query: 402 PHSLGNLTNLATLDLYDNSLS 422
+ L + +L + S+S
Sbjct: 499 LANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 52/357 (14%), Positives = 109/357 (30%), Gaps = 47/357 (13%)
Query: 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLT------------NLA 412
+ ++ +RS+ + + +P G L
Sbjct: 49 FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108
Query: 413 TLDLYDNSLS----GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
+ L ++ I F N + L LS + + NL L L ++
Sbjct: 109 EIRLKRMVVTDDCLELIAKSFKNFKVLV-LSSCEGFSTDGLAAIAATCRNLKELDLRES- 166
Query: 469 LSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNL 528
++ +S L++ P + +L +L I L + F ++ +
Sbjct: 167 ----------DVDDVSGHWLSH------FPDTYTSLVSLNISCLASEVSFSALERLVTRC 210
Query: 529 RSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLS 588
+L L KL+ ++P + L +L +L + + LS
Sbjct: 211 PNLKSL-----KLNRAVPLE-KLATLLQRA------PQLEELGTGGYTAEVRPDVYSGLS 258
Query: 589 PKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFS-RGIPIKLEELIHLSE 647
L +L L + + +P + +L LNLS + L + L
Sbjct: 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQR 318
Query: 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L + + + L L + + + P+ GL+ + + +L+
Sbjct: 319 LWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 9e-04
Identities = 48/297 (16%), Positives = 90/297 (30%), Gaps = 48/297 (16%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
+ + Y S ++ F +RS+ L G + NL +
Sbjct: 46 RKVFIGNCYAVSP-ATVIRRFPKVRSVE--------LKGKPHFADFNLVPDG----WGGY 92
Query: 469 LSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLG-NLSNLVILYLYNNSLF--DSIPSEL 525
+ I + + + L ++ + + + N +L L + F D + +
Sbjct: 93 VYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIA 152
Query: 526 GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG 585
R+L L + + H L + T L LN + L+
Sbjct: 153 ATCRNLKELDLRESDVDDVSGHWLSHF--------PDTYTSLVSLNI--------SCLAS 196
Query: 586 QLSPK-LGSLAQ----LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLS------NNQFSRG 634
++S L L L+ L L+ + +L L G
Sbjct: 197 EVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG 256
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSH-----NSLVGLIPSC 686
+ + L L L + + +P+ + L LNLS+ LV L+ C
Sbjct: 257 LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 26/212 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE---FLNEVKALTE 870
D++ IG+G G V ++ ++ A+K EM + + F E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAF 125
Query: 871 IRHRNIVK-FYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNV--------IKGISDALSY 921
+V+ FY F L M++ + +V + AL
Sbjct: 126 ANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA-GTYGYVAPEL 980
+H+ +HRD+ N+LLD ++DFG + + + A GT Y++PE+
Sbjct: 184 IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 981 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
+CD +S GV E++ G P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 42/204 (20%), Positives = 83/204 (40%), Gaps = 35/204 (17%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G +VYK + +VA+K+ L E + EV L +++H NIV +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 882 FCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYMHNDCF 927
+ L L + + M+ +K L+Y H
Sbjct: 68 IIHTEKSLTLVFEYLDKDLKQYLDDCGNIIN------MHNVKLFLFQLLRGLAYCHRQK- 120
Query: 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AY 982
++HRD+ +N+L++ E ++DFG+A+ + + T Y P++ Y
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 983 TMKVTEKCDVYSFGVLALEVIKGK 1006
+ ++ D++ G + E+ G+
Sbjct: 179 STQI----DMWGVGCIFYEMATGR 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 53/222 (23%), Positives = 82/222 (36%), Gaps = 53/222 (23%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+ FD +G G G V + SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 874 RNIVKFYG-------------FC------SHVRHSLAMILSNNAA----AKDLGWTRRMN 910
+VK + SH+R S A A+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ--------- 149
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELA 970
I Y+H+ +++RD+ +N+L+D V+DFG AK + WT L
Sbjct: 150 ----IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT-LC 199
Query: 971 GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
GT +APE+ Y V D ++ GVL E+ G P
Sbjct: 200 GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 50/214 (23%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 876
+G+G G VYKA + + E VA+K+ + ++E + EV L E++HRNI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 877 V----------KFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSYM 922
+ + + + + L + N D+ M VIK + +++
Sbjct: 96 IELKSVIHHNHRLHLIFEYAENDLKKYMDKN---PDVS----MRVIKSFLYQLINGVNFC 148
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAH-----VSDFGIAKFLKPDSSNWTELAGTYGYVA 977
H+ +HRD+ +N+LL + + + DFG+A+ +T T Y
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 978 PEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
PE+ Y+ V D++S + E++
Sbjct: 206 PEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 51/196 (26%), Positives = 73/196 (37%), Gaps = 38/196 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG G G + E+VAVK + + E+ +RH NIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKY----IERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 882 FCSHVRHSLAMI--------LSNNAAAKDLGWTRRMNVIKG------ISDALSYMHNDCF 927
H LA+I L R + + + +SY H+
Sbjct: 84 VILTPTH-LAIIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 928 PPIVHRDISSKNVLLDFDNEAH--VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----A 981
I HRD+ +N LLD + DFG +K S + + GT Y+APE+
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQE 193
Query: 982 YTMKVTEKCDVYSFGV 997
Y K DV+S GV
Sbjct: 194 YDGK---IADVWSCGV 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 49/270 (18%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G G V A + + VA+K L + E+ L +RH +I+K Y
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY- 75
Query: 882 FCSHVRHSLAMI----------LSNNAAAKDLGWTRRMNVIKG------ISDALSYMHND 925
V + I L + K +RM +G I A+ Y H
Sbjct: 76 ---DVITTPTDIVMVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----A 981
IVHRD+ +N+LLD + ++DFG++ + + T G+ Y APE+
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
Y + DV+S G++ ++ G+ P D +L + + P +P
Sbjct: 184 YA---GPEVDVWSCGIVLYVMLVGRLPFD---DEFIPNLFKKVNSCVYVMPDFLSPGAQ- 236
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
LI + +P R T+ ++ +
Sbjct: 237 --SLIR------RMIVADPMQRITIQEIRR 258
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 5e-10
Identities = 77/491 (15%), Positives = 132/491 (26%), Gaps = 163/491 (33%)
Query: 608 SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQ 667
S + K+ +LNL N + L++L++ + N+ + S I
Sbjct: 173 SYKVQCKMDF--KIFWLNLKNCNSPETVLEMLQKLLY----QIDPNWTSRSDHSS-NIKL 225
Query: 668 SLENLNLSHNSLVGLIPSCFEKMH--GLLRIDISYNELQGPIPNSI-AF----------R 714
+ ++ L+ K + LL + N + AF R
Sbjct: 226 RIHSIQAELRRLL------KSKPYENCLLVLLNVQN------AKAWNAFNLSCKILLTTR 273
Query: 715 DAPI-EALQGNKG----LCGDVKGLPSCKTLKSNKQALRKIWVVVVFPLL-----GIVAL 764
+ + L L L T K L K ++ L
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTL----TPDEVKSLLLK-YLDCRPQDLPREVLTTNPR 328
Query: 765 LISLIGLFFK--------FQRRNND--LQTQQSS-----PGNTRGL---LSVL------- 799
+S+I + ++ N D +SS P R + LSV
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388
Query: 800 --TFE---GKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGE 854
++ +++ N + K + S S
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI-------------SIPS----- 430
Query: 855 MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKG 914
E +++ + HR+IV Y N ++I
Sbjct: 431 --IYLELKVKLENEYAL-HRSIVDHY----------------NIPKTFDSD----DLIPP 467
Query: 915 ISDALSYMHNDCFPPIVH---------RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965
D Y H I H R + V LDF F K ++ DS+
Sbjct: 468 YLDQYFYSH------IGHHLKNIEHPERMTLFRMVFLDF-------RFLEQK-IRHDSTA 513
Query: 966 WTELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021
W G + L Y + + Y V A+ DF+ + + +
Sbjct: 514 W----NASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL--------DFLPKIEENLIC 561
Query: 1022 ------LNIAL 1026
L IAL
Sbjct: 562 SKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 1e-09
Identities = 64/498 (12%), Positives = 142/498 (28%), Gaps = 153/498 (30%)
Query: 622 HYLNLSNNQFSRG----IPIKLEELIHLSELDLSH--NFLREAIPSQIC--IMQSLENLN 673
H+++ + + + + + D + + + + I+ S + ++
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFV--DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 674 LSHNSLVGLIPSCFEK-----MHGLLRIDISY------NELQGPIPNSIAFRDAPIEALQ 722
+ L + S E+ + +LRI+ + E + P + + + Q
Sbjct: 63 GTL-RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE------Q 115
Query: 723 GNKGLCGDVKGLPSCKTLKSNKQALRKIWVVVVFPLLGIVALLISLIGLFFKFQRRNNDL 782
++ L D + K N L+ + R L
Sbjct: 116 RDR-LYNDNQVFA-----KYNVSRLQPYL------------------------KLRQA-L 144
Query: 783 QTQQSSPGNTRGLLSVLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIV 842
+ + V ++ G G G K +A ++
Sbjct: 145 LELRPAKN-------V------LID----------------GVLGSG---KTWVAL-DVC 171
Query: 843 AVKKFHSPLPGE---MTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHVRHSLAMILSN 896
K + + + + N + + E+ I + S HS + L
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNC--NSPETVLEMLQKLLYQIDP--NWTSRSDHSSNIKLRI 227
Query: 897 NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV----SD 952
++ +L RR+ K + L +V ++ + F+ +
Sbjct: 228 HSIQAEL---RRLLKSKPYENCL----------LVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 953 FGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 1011
+ FL ++ L + E + K L EV+ +P
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDLPREVLTT-NP--R 328
Query: 1012 ISSMSSSSLNLNIA--LDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDEN-------- 1059
S+ IA + + L +C DKL +I+E +++ L+
Sbjct: 329 RLSI--------IAESIRDGLATWDNWKHVNC---DKLTTIIESSLNVLEPAEYRKMFDR 377
Query: 1060 ----PESRPTMPKVSQLL 1073
P S + L+
Sbjct: 378 LSVFPPSAHIPTILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-08
Identities = 108/633 (17%), Positives = 190/633 (30%), Gaps = 169/633 (26%)
Query: 66 DFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLF----FGTI---PPEIG 118
DF Y D+ L + N D+ ++ I +
Sbjct: 8 DFETGEH-QYQYKDI----LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 119 HLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGN---LSNLDTLH 175
L ++ + + + +NY L S + PS+ + D L+
Sbjct: 63 GTLRL--FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 176 LYDNSLSD----SIPSEFGNLRSLSMLSLGYNKF------SGSIPHSLGNLTNLATLYLH 225
DN + S + LR ++L L K GS G T +A
Sbjct: 121 -NDNQVFAKYNVSRLQPYLKLRQ-ALLELRPAKNVLIDGVLGS-----GK-TWVALDVCL 172
Query: 226 NNSLFDSIPSE-----LGNLRS----LSMLSLGYNKL----------SGSIPHSLGN--- 263
+ + + + L N S L ML ++ S +I + +
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 264 -LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L L YEN L + N ++ + NL L LT T +
Sbjct: 233 ELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKIL----------LT---TRFKQV 277
Query: 323 -NSLSGSIPSEIGNLRSLSNL--GLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS 379
+ LS + + I SL + L+ ++ L Y + +P
Sbjct: 278 TDFLSAATTTHI----SLDHHSMTLTPDE-------VKSLLLK------YLDCRPQDLPR 320
Query: 380 E--LGNLRSLSMLS---------------LGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422
E N R LS+++ + +KL+ I SL L ++D LS
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-RLS 379
Query: 423 -----GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN------LTNLDA----LYLYDN 467
IP+ LSL + + S + N L + +
Sbjct: 380 VFPPSAHIPTI--------LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ---SLGNLSNLVILYLYNNS---LFDSI 521
L + E N ++ +++ + + L Y Y++ L +
Sbjct: 432 YLELKVKLE--NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ----YFYSHIGHHLKNIE 485
Query: 522 PSELGNLRSLSMLSFAY--NKL---------SGSIPHSLGVLDLSSNHIVGEIPTELGKL 570
E L + L F + K+ SGSI ++L L +I P +
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 571 NFLIKLILAQNQLSGQLSPKLGS-LAQLEHLDL 602
N ++ + PK+ L ++ DL
Sbjct: 546 NAILDFL-----------PKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-07
Identities = 71/511 (13%), Positives = 148/511 (28%), Gaps = 154/511 (30%)
Query: 2 EEAHALLRWKTSLQNHNN---------G-SLLSSWTLNN--VTKTSPCA--WVGIHCNRG 47
+ L + L+ N G + ++ + V W+ +
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL----- 189
Query: 48 GRVNSINLTSIGLKGMLH--DFSFSSFPHLAY-------------LDLWHNQLYGN---I 89
NS L+ +L+ D +++S + L ++ Y N +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 90 PPQIGNISRLKYLDLSSNLFFGT--------------IPPEIGH----LSYLKTLQLFEN 131
+ N +LS + T + H L+ + L
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 132 QLN---GSIPYEIGRLSSL----------NYLALYSNY-------LEDLIPPSLGNLSNL 171
L+ +P E+ + + LA + N+ L +I SL L
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 172 DTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD 231
+ ++D LS+ + IP L L+ ++ + +
Sbjct: 370 EYRKMFD---------------RLSVFPPSAH-----IPTIL-----LSLIW--FDVIKS 402
Query: 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291
+ + L S++ + + SIP +YL L + N +L
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPS----------IYL---ELKVKLE----NEYAL 445
Query: 292 --SMLNLGYNKL-----NGIIPHSLGNLTNLATLYI------HNNSLSGSIPSEIGNL-- 336
S+++ YN + +IP L Y H L E L
Sbjct: 446 HRSIVD-HYNIPKTFDSDDLIPPYLDQ-------YFYSHIGHH---LKNIEHPERMTLFR 494
Query: 337 RSLSNLGLSGNKL--SGSIPPSLGYLSN-LATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393
+ K+ + + G + N L L Y + D+ P + ++
Sbjct: 495 MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK 554
Query: 394 YNKLSGSIPHSLGNLTNLATLD----LYDNS 420
+ ++ +L +A + +++ +
Sbjct: 555 IEENLICSKYT--DLLRIALMAEDEAIFEEA 583
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 44/225 (19%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKK--FHSPLPGEMTFQQEFLNEVKAL 868
AT+ ++ IG G G+VYKA + SG VA+K + G + EV L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 869 TEIR---HRNIVKFYGFCS---------------HVRHSLAMILSNNAAAKDLGWTRRMN 910
+ H N+V+ C+ HV L L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-----LPAE 120
Query: 911 VIKGIS----DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSN 965
IK + L ++H +C IVHRD+ +N+L+ ++DFG+A+ +
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MA 175
Query: 966 WTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
T + T Y APE+ Y V D++S G + E+ + K
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 39/220 (17%), Positives = 70/220 (31%), Gaps = 74/220 (33%)
Query: 811 IRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEV 865
I+ DD +G G G V + + E A+K + EV
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 61
Query: 866 KALTEI-RHRNIVKFYGFC---SHVRHSLAMIL--------------------SNNAAAK 901
+ + +IV+ R L +++ + A+
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS- 120
Query: 902 DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKF 958
++K I +A+ Y+H+ I HRD+ +N+L + ++DFG AK
Sbjct: 121 --------EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
Query: 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 998
Y + CD++S GV+
Sbjct: 170 T---------TGEKYD-------------KSCDMWSLGVI 187
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 119 HLSYLKTLQLFENQLN-GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177
S +K L L ++ N G + L +L+ + L + +L L+ L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSG-SIPHSLGNLTNLATLYLHNN 227
DN +S + +L+ L+L NK S L L NL +L L N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 31/119 (26%), Positives = 62/119 (52%), Gaps = 6/119 (5%)
Query: 563 IPTELGKLNF--LIKLILAQNQLS-GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLV 619
I EL + +L+L ++ + G+L +LE L + L+ SI + L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLN 64
Query: 620 KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE-AIPSQICIMQSLENLNLSHN 677
KL L LS+N+ S G+ + E+ +L+ L+LS N +++ + + +++L++L+L +
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 30/110 (27%), Positives = 48/110 (43%), Gaps = 4/110 (3%)
Query: 360 LSNLATLYLYSNSLFD-SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
S++ L L ++ + + L LS L+ SI + L L L L+L D
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTNLDALYLYDN 467
N +SG + +L+ L+L NK+ S L L NL +L L++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 5/110 (4%)
Query: 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
+++ L + + N+ G + L L L+ SI + L L L L
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSG-SIPSEIGNLRSLSNLGLSGN 347
N+++G + NL L + N + S + L +L +L L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 167 NLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
S++ L L ++ ++ + L LS + SI + L L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYEN 275
+N + + +L+ L+L NK+ S L L NL +L L+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 311 NLTNLATLYIHNNSLS-GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369
+++ L + N+ + G + L L L+ SI +L L+ L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLDLYDN 419
N + + +L+ L+L NK+ S L L NL +LDL++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 263 NLTNLATLYLYENSLS-GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH 321
+++ L L + + G + L L+ L I +L L L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 322 NNSLSGSIPSEIGNLRSLSNLGLSGNKLSG-SIPPSLGYLSNLATLYLYSN 371
+N +SG + +L++L LSGNK+ S L L NL +L L++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 4/111 (3%)
Query: 431 NLRSLSTLSLGYNKLS-GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489
+ L L ++ + G + L+ L + L+ SI + L + L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFD-SIPSELGNLRSLSMLSFAYN 539
+N++SG + NL L L N + D S L L +L L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 30/133 (22%), Positives = 47/133 (35%), Gaps = 27/133 (20%)
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
+++ L + + N+ G + L L + L+ SI + L L L L
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLG 502
N++SG + NL L L N +I +L +I L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN--------KIKDLSTIEPLK--------------- 110
Query: 503 NLSNLVILYLYNN 515
L NL L L+N
Sbjct: 111 KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 27/110 (24%), Positives = 41/110 (37%), Gaps = 5/110 (4%)
Query: 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
+++ L + + N+ G + L L N L SI + L L L L L
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELSD 73
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSG-SIPSEFGNLRSLSMLNLGYN 299
N++SG + NL L L N + S L +L L+L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 25/113 (22%), Positives = 50/113 (44%), Gaps = 4/113 (3%)
Query: 593 SLAQLEHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLS 651
+ + ++ L L ++R + + +L +L+ N + I L +L L +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELS 72
Query: 652 HNFLREAIPSQICIMQSLENLNLSHNSLVGL-IPSCFEKMHGLLRIDISYNEL 703
N + + +L +LNLS N + L +K+ L +D+ E+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 30/134 (22%), Positives = 50/134 (37%), Gaps = 24/134 (17%)
Query: 479 NLRSISNLALNNNKLS-GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFA 537
+ L L+N++ + G + L L N L + + NL L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLK-- 67
Query: 538 YNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS--GQLSPKLGSLA 595
L+LS N + G + K L L L+ N++ + P L L
Sbjct: 68 -------------KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLE 113
Query: 596 QLEHLDLSSNRLSN 609
L+ LDL + ++N
Sbjct: 114 NLKSLDLFNCEVTN 127
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 26/117 (22%), Positives = 53/117 (45%), Gaps = 8/117 (6%)
Query: 71 SFPHLAYLDLWHNQLYGNIPPQIGNISR---LKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+ + L L +++ N G L++L + T + L+ LK L+
Sbjct: 15 TPSDVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLE 70
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSLSD 183
L +N+++G + + +L +L L N ++DL L L NL +L L++ +++
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 38/198 (19%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G G V + +G VAVK + + + E++ L RH +I+K Y
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY- 82
Query: 882 FCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMN------VIKGISDALSYMHN 924
V + + I L + R++ + + I + Y H
Sbjct: 83 ---QVISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHR 134
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 980
+VHRD+ +NVLLD A ++DFG++ + T G+ Y APE+
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 190
Query: 981 AYTMKVTEKCDVYSFGVL 998
Y + D++S GV+
Sbjct: 191 LYA---GPEVDIWSSGVI 205
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
S+P I + L L +N + L P +L NL L+ N L+ +IP+ F L
Sbjct: 26 SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 195 LSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
L+ L L N SIP + NL +L +YL+NN
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
++ + L+ S+P+ G L L N+++ P +L NL LY N L+ +
Sbjct: 16 LVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-A 71
Query: 473 IP-GEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
IP G L ++ L LN+N L SIP+ + NL +L +YLYNN
Sbjct: 72 IPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTN 458
S+P G T+ L L +N ++ P F +L +L L NKL+ +IP + LT
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 459 LDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
L L L DN L SIP G NL+S++++ L NN
Sbjct: 83 LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFD 375
+ N L+ S+P+ I L L+ N+++ + P + +L NL LY SN L
Sbjct: 16 LVNCQNIRLA-SVPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKL-T 70
Query: 376 SIPSELG---NLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLDLYDN 419
+IP+ G L L+ L L N L SIP + NL +L + LY+N
Sbjct: 71 AIPT--GVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
S+P G T+ L+L N ++ P F +L +L L NKL I LT L
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83
Query: 316 ATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGN 347
L +++N L SIP NL+SL+++ L N
Sbjct: 84 TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 20/101 (19%)
Query: 208 SIPHSLGNLTNLATLYLHNNSL-------FDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 260
S+P G T+ L+L+NN + FD L +L L NKL+ +IP
Sbjct: 26 SVPA--GIPTDKQRLWLNNNQITKLEPGVFDH-------LVNLQQLYFNSNKLT-AIPTG 75
Query: 261 L-GNLTNLATLYLYENSLSGSIPS-EFGNLRSLSMLNLGYN 299
+ LT L L L +N L SIP F NL+SL+ + L N
Sbjct: 76 VFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 2/86 (2%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSS 604
IP L L++N I P L L +L N+L+ + L QL LDL+
Sbjct: 31 IPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90
Query: 605 NRLSNSIPK-SFGNLVKLHYLNLSNN 629
N L SIP+ +F NL L ++ L NN
Sbjct: 91 NHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 28/109 (25%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNN 227
++ L L +N ++ P F +L +L L NK + +IP + LT L L L++N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
L SIP + NL +L +YLY N
Sbjct: 92 HL-------------------------KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 10/121 (8%)
Query: 563 IPTELGKLNF--LIKLILAQNQLS-GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLV 619
I EL + +L+L + + G++ LE L L + L S+ + L
Sbjct: 14 IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLP 71
Query: 620 KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICI---MQSLENLNLSH 676
KL L LS N+ G+ + E+L +L+ L+LS N L++ S + ++ L++L+L +
Sbjct: 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFN 129
Query: 677 N 677
Sbjct: 130 C 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 28/111 (25%), Positives = 39/111 (35%), Gaps = 4/111 (3%)
Query: 239 NLRSLSMLSLGYNKLS-GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLG 297
++ L L K + G I NL L L L S+ + L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 298 YNKLNGIIPHSLGNLTNLATLYIHNNSLSG-SIPSEIGNLRSLSNLGLSGN 347
N++ G + L NL L + N L S + L L +L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 30/114 (26%), Positives = 47/114 (41%), Gaps = 4/114 (3%)
Query: 359 YLSNLATLYL-YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLY 417
+ + L L S I +L LSL L S+ +L L L L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 418 DNSLSGSIPSEFGNLRSLSTLSLGYNKLSG-SIPHSLGNLTNLDALYLYDNSLS 470
+N + G + L +L+ L+L NKL S L L L +L L++ ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 29/105 (27%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 431 NLRSLSTLSLGYNKLS-GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489
++ L L K + G I NL+ L L + L S+ + L + L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSML 534
N++ G + L NL L L N L D S L L+ L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECL 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 4/110 (3%)
Query: 120 LSYLKTLQLFENQLN-GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178
+ ++ L L + N G I +L +L+L + L + +L L L L L +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSG-SIPHSLGNLTNLATLYLHNN 227
N + + L +L+ L+L NK S L L L +L L N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/118 (25%), Positives = 45/118 (38%), Gaps = 4/118 (3%)
Query: 307 HSLGNLTNLATLYIHNNSLS-GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLAT 365
+ L + N + G I +L L L L S+ L L L
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKK 75
Query: 366 LYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLDLYDNSLS 422
L L N +F + L +L+ L+L NKL S L L L +LDL++ ++
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 4/115 (3%)
Query: 403 HSLGNLTNLATLDLYDNSLS-GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDA 461
+ L L + + G I +L LSL L S+ +L L L
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKK 75
Query: 462 LYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG-SIPQSLGNLSNLVILYLYNN 515
L L +N + G + L ++++L L+ NKL S + L L L L L+N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 29/114 (25%), Positives = 45/114 (39%), Gaps = 4/114 (3%)
Query: 167 NLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
+ + L L + +D I +L LSL S+ +L L L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYENSLS 278
N +F + L +L+ L+L NKL S L L L +L L+ ++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 29/116 (25%), Positives = 46/116 (39%), Gaps = 6/116 (5%)
Query: 259 HSLGNLTNLATLYLYENSLS-GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLAT 317
+ L L + G I +L L+L L + +L L L
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75
Query: 318 LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS--GSIPPSLGYLSNLATLYLYSN 371
L + N + G + L +L++L LSGNKL ++ P L L L +L L++
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 38/134 (28%), Positives = 51/134 (38%), Gaps = 24/134 (17%)
Query: 479 NLRSISNLALNNNKLS-GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFA 537
++ L L+N K + G I NL L L N L + NL L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLK-- 74
Query: 538 YNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS--GQLSPKLGSLA 595
L+LS N I G + KL L L L+ N+L L P L L
Sbjct: 75 -------------KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLE 120
Query: 596 QLEHLDLSSNRLSN 609
L+ LDL + ++N
Sbjct: 121 CLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 593 SLAQLEHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLS 651
+ A + L L + + ++ I V L +L+L N + L +L L +L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELS 79
Query: 652 HNFLREAIPSQICIMQSLENLNLSHNSL 679
N + + + +L +LNLS N L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 4/108 (3%)
Query: 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGS 136
LD + G I L++L L + ++ + L LK L+L EN++ G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSENRIFGG 86
Query: 137 IPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSLSD 183
+ +L +L +L L N L+D+ L L L +L L++ +++
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 31/170 (18%), Positives = 63/170 (37%), Gaps = 35/170 (20%)
Query: 823 IGKGGQGSVYKAE---------LASGEIVAVK--KFHSPLPGEMTFQQ-----EFLNEVK 866
+ QG +Y+A + ++K L E F Q +N+ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 867 ALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGIS---------- 916
L I GF H ++L + + L ++ +S
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLP--SLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 917 --DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPD 962
DAL ++H + + VH +++++N+ +D ++++ V + +G A P
Sbjct: 168 LLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
N+F+ +GKG G V + A+G A+K + L E + L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 874 RNIVK-FYGFCSHVRHSLAMILSNNAAAKDLGW----TRRMNVIKG------ISDALSYM 922
+ Y F +H R M +N +L + R + + I AL Y+
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTYGYVAPEL- 980
H++ +V+RD+ +N++LD D ++DFG+ K +K ++ T GT Y+APE+
Sbjct: 265 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 321
Query: 981 ---AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y V D + GV+ E++ G+ P
Sbjct: 322 EDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 46/244 (18%), Positives = 87/244 (35%), Gaps = 72/244 (29%)
Query: 817 FDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
+ +H IG+G G VY A + + + VA+KK + ++ + L E+ L ++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDY 86
Query: 876 IVKFYGFCSHVRHSLAMILSNNAAAKDL-GWTRRM-----NVIK---GISD--------- 917
I++ Y + +I + +L + K +++
Sbjct: 87 IIRLY----DL-----IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 918 ---ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972
+++H I+HRD+ N LL+ D V DFG+A+ + +
Sbjct: 138 LLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 973 Y----------------GYV------APEL-----AYTMKVTEKCDVYSFG-VLALEVIK 1004
+V APEL YT + D++S G + A E++
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELLN 247
Query: 1005 GKHP 1008
Sbjct: 248 MLQS 251
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 27/155 (17%)
Query: 930 IVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV-----APELAYTM 984
+HRD++++N+LL N + DFG+A+ + D + + APE +
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDR 270
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS---SLNLNIALDEMLDP--RLPTPSC 1039
T + DV+SFGVL E I S+ +S + ++ L R+ P
Sbjct: 271 VYTIQSDVWSFGVLLWE----------IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320
Query: 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + + + C P RPT ++ + L
Sbjct: 321 TTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 29/148 (19%), Positives = 53/148 (35%), Gaps = 15/148 (10%)
Query: 823 IGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RH 873
+G+G G V +A+ A+ VAVK L T + ++E+K L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 85
Query: 874 RNIVKFYGFCSHVRHSLAMILS--NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931
N+V G C+ L +I+ ++R + + + + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFL 959
D+ + + + S F K L
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRS 194
S+P I ++ L LY N + L P L+ L L L +N L+ +P+ F L
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 195 LSMLSLGYNKFSGSIPH-SLGNLTNLATLYLHNN 227
L+ LSL N+ SIP + NL +L ++L NN
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTN 458
S+P G T L LYDN ++ P F L L+ L L N+L+ +P + LT
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 459 LDALYLYDNSLSGSIP-GEIGNLRSISNLALNNN 491
L L L DN L SIP G NL+S++++ L NN
Sbjct: 80 LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 7e-08
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
T+D SL+ S+P+ G + L L N+++ P LT L L L +N L+
Sbjct: 13 TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-V 68
Query: 473 IP-GEIGNLRSISNLALNNNKLSGSIPQ-SLGNLSNLVILYLYNN 515
+P G L ++ L+LN+N+L SIP+ + NL +L ++L NN
Sbjct: 69 LPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
S+P G T LYLY+N ++ P F L L+ L+L N+L + LT L
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL 80
Query: 316 ATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGN 347
L +++N L SIP NL+SL+++ L N
Sbjct: 81 TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 9/106 (8%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFD 375
T+ SL+ S+P+ I + L L N+++ + P + L+ L L L +N L
Sbjct: 13 TVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQL-T 67
Query: 376 SIPSEL-GNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLDLYDN 419
+P+ + L L+ LSL N+L SIP + NL +L + L +N
Sbjct: 68 VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 208 SIPHSLGNLTNLATLYLHNNSL-------FDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 260
S+P G T LYL++N + FD L L+ L L N+L+ +P
Sbjct: 23 SVPT--GIPTTTQVLYLYDNQITKLEPGVFDR-------LTQLTRLDLDNNQLT-VLPAG 72
Query: 261 L-GNLTNLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYN 299
+ LT L L L +N L SIP F NL+SL+ + L N
Sbjct: 73 VFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 28/109 (25%)
Query: 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNN 227
+ L+LYDN ++ P F L L+ L L N+ + +P + LT L L L++N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-SLGNLTNLATLYLYEN 275
L SIP + NL +L ++L N
Sbjct: 89 QL-------------------------KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 2/86 (2%)
Query: 545 IPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSS 604
IP + VL L N I P +L L +L L NQL+ + L QL L L+
Sbjct: 28 IPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87
Query: 605 NRLSNSIPK-SFGNLVKLHYLNLSNN 629
N+L SIP+ +F NL L ++ L NN
Sbjct: 88 NQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 50/221 (22%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 872
+G G +V+ A+ + + VA+K + + + +E+K L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 873 --HRNIVKFY-------GFCSHV-------RHSLAMILSNNAAAKDLGWTRRMNVIKGIS 916
+I+K HV +L ++ + G + +K IS
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY---EHRGIP--LIYVKQIS 137
Query: 917 ----DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH------VSDFGIAKFLKPDSSNW 966
L YMH C I+H DI +NVL++ + ++D G A + ++
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHY 192
Query: 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 1007
T T Y +PE+ D++S L E+I G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 47/179 (26%)
Query: 823 IGKGGQGSVYKAELASGEIVAVK---------KFHSPLPGEMTF-----QQEFLNEVKAL 868
IG+GG G +Y A++ S E V + PL E+ F + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 869 TEIRHRNIVKFYGFCSHVRH--------------SLAMILSNNAAAKDLGWTRRM----- 909
++++ + K++G H ++ L I NA +R
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--------KRFSRKTV 154
Query: 910 -NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSN 965
+ I D L Y+H + VH DI + N+LL++ N V D+G+A P+ +
Sbjct: 155 LQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 56/256 (21%), Positives = 93/256 (36%), Gaps = 80/256 (31%)
Query: 803 GKIVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEF 861
G++ ++ +GKG G V+K+ + +GE+VAVKK T Q
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRT 55
Query: 862 LNEVKALTEIR-HRNIVKFYGFCSHVRHS-------LAMILSNNAAAKDLGWTRRMNVIK 913
E+ LTE+ H NIV +V + L DL VI+
Sbjct: 56 FREIMILTELSGHENIVNLL----NVLRADNDRDVYLVFDY----METDLH-----AVIR 102
Query: 914 G--ISD------------ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957
+ + Y+H ++HRD+ N+LL+ + V+DFG+++
Sbjct: 103 ANILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 958 FLKPDSSNWTELAGTY---------------GYV------APEL-----AYTMKVTEKCD 991
+ + YV APE+ YT + D
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----D 213
Query: 992 VYSFG-VLALEVIKGK 1006
++S G +L E++ GK
Sbjct: 214 MWSLGCILG-EILCGK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA--ELASGEIVAVKKFHSPLPGE---MTFQQEFLNEVK 866
RA ++ IG+G G V+KA G VA+K+ E ++ + EV
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS----TIREVA 63
Query: 867 ALTEIR---HRNIVK----FYGFCSHVRHSLAMI----------LSNNAAAKDLGWTRRM 909
L + H N+V+ + L ++ + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP----T 119
Query: 910 NVIKGIS----DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSS 964
IK + L ++H+ +VHRD+ +N+L+ + ++DFG+A+ +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--M 174
Query: 965 NWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 1006
T + T Y APE+ +Y V D++S G + E+ + K
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I+ L ++ + I++RD+ NV+LD + ++DFG+ K + + T GT
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTP 506
Query: 974 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 45/245 (18%), Positives = 84/245 (34%), Gaps = 87/245 (35%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ ++ H IG G G V +A + +VA+KK ++ + L E+ L +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN 110
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNAAA------------KDLGWTRRMNVIK---GISD 917
H ++VK +++ + D + + +++
Sbjct: 111 HDHVVKVL----------DIVIPKDVEKFDELYVVLEIADSDFK-----KLFRTPVYLTE 155
Query: 918 ------------ALSYMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963
+ Y+H I+HRD+ N L++ D V DFG+A+ +
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 964 SNWTELAGTY---------------------GYV------APEL-----AYTMKVTEKCD 991
+ ++L + G+V APEL YT + D
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----D 266
Query: 992 VYSFG 996
V+S G
Sbjct: 267 VWSIG 271
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 30/161 (18%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
IS AL+Y+H I++RD+ NVLLD + ++D+G+ K L+P + T GT
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 174
Query: 974 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
Y+APE+ Y V D ++ GVL E++ G+ P F SS + + N D +
Sbjct: 175 NYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN-TEDYL 227
Query: 1030 LDPRLPTPSCIVQDKL---ISIVEVAISC----LDENPESR 1063
I++ ++ S+ A S L+++P+ R
Sbjct: 228 FQ-------VILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 2e-07
Identities = 21/125 (16%), Positives = 41/125 (32%), Gaps = 18/125 (14%)
Query: 573 LIKLILAQNQLSGQLSPKLGS--LAQLEHLDL---SSNRLSNSIPKSF------GNLVKL 621
L L + L + + L LE L L + + F L
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNL 254
Query: 622 HYLNLSNNQFSRGIPIKLEE---LIHLSELDLSHNFLR----EAIPSQICIMQSLENLNL 674
+L + + + + E L L +D+S L + + ++ L+ +N+
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINM 314
Query: 675 SHNSL 679
+N L
Sbjct: 315 KYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 31/199 (15%), Positives = 70/199 (35%), Gaps = 36/199 (18%)
Query: 495 GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK-----LSGSIPHSL 549
+ L + L L + + NL+SL ++S + GS +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 550 GVLDL---SSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNR 606
L L ++ L S P L + L +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPL------------FSKDRFPNL------KWLGIVDAE 263
Query: 607 LSNSIPKSFGN---LVKLHYLNLSNNQFS----RGIPIKLEELIHLSELDLSHNFLREAI 659
N + + F L +L +++S + R + ++++ HL +++ +N+L + +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323
Query: 660 PSQICIMQSLE-NLNLSHN 677
++ +SL +++S +
Sbjct: 324 KKELQ--KSLPMKIDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 31/193 (16%), Positives = 68/193 (35%), Gaps = 22/193 (11%)
Query: 447 GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLG--NL 504
+ L + L+ L + + NL+S L + + L S+ + + +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS---LEIISGGLPDSVVEDILGSDL 218
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIP 564
NL L LY ++ R L S +L L + +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPL---------FSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 565 TELGK---LNFLIKLILAQNQLSG----QLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGN 617
+ L L + ++ L+ L + + L+ +++ N LS+ + K
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
Query: 618 LVKLHYLNLSNNQ 630
+ + +++S++Q
Sbjct: 330 SLPMK-IDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 32/194 (16%), Positives = 66/194 (34%), Gaps = 19/194 (9%)
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY--NKLNGIIPHSLGNL 312
+ L + L L + + NL+SL +++ G + + I+ L NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 313 TNLATLYIHNNSLSGSIPSEI------GNLRSLSNLGLSGNKLSGSIPPSLG---YLSNL 363
L + + +L LG+ + + L L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 364 ATLYLYSNSLFDS----IPSELGNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLD 415
T+ + + L D + + ++ L +++ YN LS + SL +++
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
Query: 416 LYDNSLSGSIPSEF 429
YD+ S + +E
Sbjct: 342 EYDDDYSYPMITEL 355
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 27/198 (13%), Positives = 56/198 (28%), Gaps = 24/198 (12%)
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN------LRSLSMLNLGYNKLN 302
+ ++ I + + L+ + S L ++ +LN K
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 303 GIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG-----NLRSLSNLGLSGNKLSGSIPPSL 357
+ NL +L I + L S+ +I NL L +
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242
Query: 358 ------GYLSNLATLYLYSNSLFDSIPSELGN---LRSLSMLSLGYNKLSGS----IPHS 404
NL L + + + L L + + L+ +
Sbjct: 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH 302
Query: 405 LGNLTNLATLDLYDNSLS 422
+ + +L +++ N LS
Sbjct: 303 VDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 32/188 (17%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 120 LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLG--NLSNLDTLHLY 177
L + L + + ++ +L L + S L D + + +L NL+ L LY
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 178 ---DNSLSDSIPSEF------GNLRSLSMLSLGYNKFSGSIPHSLGN---LTNLATLYLH 225
++ D + F +L L + + + L L T+ +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 226 NNSLFDS----IPSELGNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLYLYENSL 277
L D + + ++ L +++ YN LS + SL +++ Y++
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDDDY 347
Query: 278 SGSIPSEF 285
S + +E
Sbjct: 348 SYPMITEL 355
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 5e-06
Identities = 36/220 (16%), Positives = 71/220 (32%), Gaps = 33/220 (15%)
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR-------SL 339
+ L ++ + + S +L+ + L+ NL +L
Sbjct: 140 HFEGLFWGDIDFEEQ----EISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL 195
Query: 340 SNLGLSGNKLSGSIPPSLG--YLSNLATLYLY---SNSLFDSIPSEL------GNLRSLS 388
+L + L S+ + L NL L LY + FD + +L
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 389 MLSLGYNKLSGSIPHSLGN---LTNLATLDLYDNSLSGS----IPSEFGNLRSLSTLSLG 441
L + + + L L T+D+ L+ + ++ L +++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 442 YNKLSG----SIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477
YN LS + SL ++ YD+ S + E+
Sbjct: 316 YNYLSDEMKKELQKSLPMKIDVSDSQEYDDDYSYPMITEL 355
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 29/169 (17%), Positives = 54/169 (31%), Gaps = 21/169 (12%)
Query: 87 GNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIG--RL 144
++ P + + L L + LK+L++ L S+ +I L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKK---PRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 145 SSLNYLALY---SNYLEDLIPPSL------GNLSNLDTLHLYDNSLSDSIPS---EFGNL 192
+L L LY +Y D NL L + D + + E L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 193 RSLSMLSLGYNKFSGS----IPHSLGNLTNLATLYLHNNSLFDSIPSEL 237
L + + + + + + +L + + N L D + EL
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 24/150 (16%), Positives = 50/150 (33%), Gaps = 19/150 (12%)
Query: 54 NLTSIGLK-GMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIG--NISRLKYLDL---SSN 107
L ++ +K P+L L++ L ++ I ++ L+ L L +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 108 LFFGTIPPEI------GHLSYLKTLQLFENQLNGSIPYEIGR---LSSLNYLALYSNYLE 158
F LK L + + + + L L + + + L
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 159 D----LIPPSLGNLSNLDTLHLYDNSLSDS 184
D L+ + + +L +++ N LSD
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I AL Y+H+ +V+RDI +N++LD D ++DFG+ K + ++ T GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 974 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 30/161 (18%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
IS AL+Y+H I++RD+ NVLLD + ++D+G+ K L+P + T GT
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217
Query: 974 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
Y+APE+ Y V D ++ GVL E++ G+ P F SS + + N D +
Sbjct: 218 NYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVGSSDNPDQN-TEDYL 270
Query: 1030 LDPRLPTPSCIVQDKL---ISIVEVAISC----LDENPESR 1063
I++ ++ S+ A S L+++P+ R
Sbjct: 271 FQ-------VILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 35/177 (19%), Positives = 64/177 (36%), Gaps = 46/177 (25%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK------KFHSPLPGEMTF-----QQEFLNEVKALTE 870
IG GG G +Y A E A + + PL E+ F +++ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 871 IRHRNIVKFYGFCSHVR--------------HSLAMILSNNAAAKDLGWTRRMN------ 910
+ + I FYG L I N
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN---------GTFKKSTVLQ 155
Query: 911 VIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE--AHVSDFGIAKFLKPDSSN 965
+ + D L Y+H + + VH DI + N+LL + N +++D+G++ P+ ++
Sbjct: 156 LGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 16/96 (16%)
Query: 918 ALSYMH-NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
AL Y+H D I++RD+ +N+LLD + ++DFG AK +T L GT Y+
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYT-LCGTPDYI 170
Query: 977 APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
APE+ Y + D +SFG+L E++ G P
Sbjct: 171 APEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 17/101 (16%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAK-FLKPDSSNWTELAG 971
I+ AL Y+H+ IV+RD+ +N+LL D++ H+ +DFG+ K ++ +S+ T G
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTST-FCG 201
Query: 972 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
T Y+APE+ Y V D + G + E++ G P
Sbjct: 202 TPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-07
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAK-FLKPDSSNWTELAG 971
I L ++H+ IV+RD+ N+LLD + H+ +DFG+ K + D+ T G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNT-FCG 180
Query: 972 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
T Y+APE+ Y V D +SFGVL E++ G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAK-FLKPDSSNWTELAGTYG 974
AL ++H+ I++RD+ +N+LLD E H+ +DFG++K + + ++ GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS-FCGTVE 191
Query: 975 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ T+ D +SFGVL E++ G P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-07
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK-FLKPDSSNWTELAGTY 973
I AL ++H+ I++RD+ NVLLD + ++DFG+ K + + T GT
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188
Query: 974 GYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+APE+ Y V D ++ GVL E++ G P
Sbjct: 189 DYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-07
Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 17/101 (16%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAK-FLKPDSSNWTELAG 971
I+ L ++ + I++RD+ NV+L D+E H+ +DFG+ K + + T G
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKT-FCG 183
Query: 972 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
T Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 184 TPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 915 ISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAK-FLKPDSSNWTELAG 971
IS AL ++H I++RD+ +N++L +++ HV +DFG+ K + + T G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGTVTHT-FCG 183
Query: 972 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
T Y+APE+ D +S G L +++ G P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 18/100 (18%)
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTE-LAGTYG 974
AL ++H I++RDI +N+LL D+ HV +DFG++K D + GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 975 YVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHP 1008
Y+AP++ + V D +S GVL E++ G P
Sbjct: 226 YMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 46/211 (21%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR------N 875
IGKG G V KA + VA+K + E F ++ E++ L +R + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 876 IVKFYG---FCSHV-------RHSLAMILSNNAAAKDLGWTRRMNVIKGIS----DALSY 921
++ F +H+ +L ++ N K G++ + +++ + L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKN---KFQGFS--LPLVRKFAHSILQCLDA 215
Query: 922 MHNDCFPPIVHRDISSKNVLL--DFDNEAHVSDFGIAKFLKPDSSNWTELAGTY----GY 975
+H I+H D+ +N+LL + V DFG + + + TY Y
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-------HQRVYTYIQSRFY 265
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006
APE+ + D++S G + E++ G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 32/254 (12%), Positives = 61/254 (24%), Gaps = 65/254 (25%)
Query: 811 IRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFH-----SPLPGEMTFQQEFLNEV 865
T IG+G G V++ A VA+K +E L E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 866 KALTEI---------RHRNIVKFYGFC-------------------------------SH 885
E+ R +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 886 VRHSLAMILSN------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939
+ + + K +++ ++ +L+ HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192
Query: 940 VLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK--CDVYSFGV 997
VLL + + K + G + YT+ E+ V+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 998 LALEVIKGKHPRDF 1011
+ ++ G F
Sbjct: 244 MDEDLFTGDGDYQF 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 48/214 (22%), Positives = 74/214 (34%), Gaps = 50/214 (23%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVK------KFHSPLPGEMTFQQEFLNEVKALTEIRHR- 874
IGKG G V KA E VA+K F Q EV+ L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA-QIEVRLLELMNKHD 111
Query: 875 -----NIVKFYGFCSHVRH------SLAMIL-----SNNAAAKDLGWTRRMNVIKGISDA 918
IV H L+ L + N L TR+ + + A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTA 169
Query: 919 LSYMHNDCFPPIVHRDISSKNVLL--DFDNEAHVSDFGIAKFLKPDSSNWTELAGTY--- 973
L ++ I+H D+ +N+LL + + DFG + L + Y
Sbjct: 170 LLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQS 221
Query: 974 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 1006
Y +PE+ M D++S G + +E+ G+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 53/321 (16%), Positives = 98/321 (30%), Gaps = 41/321 (12%)
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
KL + L L L+ H + +E+ L SL L L+G +++ +
Sbjct: 36 KKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV--LSSLRQLNLAGVRMTPVKCTVVA 93
Query: 359 YL-----SNLATLYLYSNSLFDSIPSELGN-LRSLSMLSLGYNKLSGSIPHSLG-----N 407
+ L + L S L + L L L N L L +
Sbjct: 94 AVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHD 153
Query: 408 LTNLATLDLYDNSLSGS----IPSEFGNLRSLSTLSLGYNKLS----GSIPHSLGNLTNL 459
+ TL L +N L+ + + S++ LSL + L + L L
Sbjct: 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL 213
Query: 460 DALYLYDNSLSGSIPGEIGNL----RSISNLALNNNKLS-------GSIPQSLGNLSNLV 508
L + N + + S+ L L N+LS + + + +V
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273
Query: 509 ILYLYNNSLFDSIPSELGN-LRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTEL 567
+ ++ + L R+L+ ++ L + DL + P
Sbjct: 274 VSLTEGTAVSEYWSVILSEVQRNLNSW----DRARVQRHLELLLRDLEDSRGATLNPWRK 329
Query: 568 GKL----NFLIKLILAQNQLS 584
+L + L+
Sbjct: 330 AQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 51/340 (15%), Positives = 103/340 (30%), Gaps = 45/340 (13%)
Query: 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176
I +L L+ Q + +L + L+ + ++ S LS+L L+L
Sbjct: 22 IKNLDALENAQAIKKKLGKLGRQVLPPSELLD-HLFFHYEFQNQRF-SAEVLSSLRQLNL 79
Query: 177 YDNSLSDSIPSEFG-----NLRSLSMLSLGYNKFSGSIPHSLGN-LTNLATLYLHNNSLF 230
++ + +L ++L + + +L L L NSL
Sbjct: 80 AGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139
Query: 231 DS----IPSEL-GNLRSLSMLSLGYNKLSGS----IPHSLGNLTNLATLYLYENSLS--- 278
+ L + ++ L L N L+ + + L T++ L L L
Sbjct: 140 PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEG 199
Query: 279 -GSIPSEFGNLRSLSMLNLGYNKLNG----IIPHSLGNLTNLATLYIHNNSLS------- 326
+ ++ R L LN+ YN + + +L L+++ N LS
Sbjct: 200 LELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259
Query: 327 GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRS 386
+ + G + S + L+ + NS + +
Sbjct: 260 RDLGGAAEGGARVVVSLTEGTAV------SEYWSVILSEVQRNLNSW---DRARVQRHLE 310
Query: 387 LSMLSLGYNKLS----GSIPHSLGNLTNLATLDLYDNSLS 422
L + L ++ + L + L S
Sbjct: 311 LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 50/273 (18%), Positives = 93/273 (34%), Gaps = 32/273 (11%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
TLDL +L + + ++ + + + +
Sbjct: 51 TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 109
Query: 473 IPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF--DSIPSELGNLRS 530
+ G + + NL+L +LS I +L SNLV L L S F ++ + L +
Sbjct: 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169
Query: 531 LSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590
L L+ ++ + V + + +LN + L
Sbjct: 170 LDELNLSWCF---------DFTEKHVQVAVAHVSETITQLNL--------SGYRKNLQKS 212
Query: 591 -LGSLA----QLEHLDLSS-NRLSNSIPKSFGNLVKLHYLNLSNNQF--SRGIPIKLEEL 642
L +L L HLDLS L N + F L L +L+LS + ++L E+
Sbjct: 213 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL-LELGEI 271
Query: 643 IHLSELDLSHNFLREAIPSQICIMQSLENLNLS 675
L L + + + ++L +L ++
Sbjct: 272 PTLKTLQVFGIVPDGTLQL---LKEALPHLQIN 301
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/263 (18%), Positives = 85/263 (32%), Gaps = 15/263 (5%)
Query: 160 LIPPSLGNLSNLDTLHLY--DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLT 217
L P G L + + + + + F R M ++ L +
Sbjct: 59 LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 118
Query: 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY-NKLS-GSIPHSLGNLTNLATLYLY-- 273
L L L L D I + L +L L+L + S ++ L + + L L L
Sbjct: 119 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178
Query: 274 ----ENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN-NSLSGS 328
E + ++ + L++ N + + NL L + + L
Sbjct: 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238
Query: 329 IPSEIGNLRSLSNLGLSG-NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
E L L +L LS + LG + L TL + + D L +L
Sbjct: 239 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV-FGIVPDGTLQLL--KEAL 295
Query: 388 SMLSLGYNKLSGSIPHSLGNLTN 410
L + + + ++GN N
Sbjct: 296 PHLQINCSHFTTIARPTIGNKKN 318
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 26/148 (17%), Positives = 48/148 (32%), Gaps = 22/148 (14%)
Query: 822 CIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQE----------FLNEVKALTEI 871
+G+G + +V+ VK G +F++ F
Sbjct: 97 LMGEGKESAVFNCYSEKFGECVVKFHK---VGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 872 RHRNIVKFYGFC-----SHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
R + K G + +++ M L + + R N + + L +
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---RVENPDEVLDMILEEVAKFY 210
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFG 954
IVH D+S NVL+ + + DF
Sbjct: 211 HRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 44/259 (16%), Positives = 85/259 (32%), Gaps = 84/259 (32%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------H 873
+G G +V+ + + + VA+K S + + L+E++ L +R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 874 RNIVKFYG-FC------SHV-------RHSL-AMILSNNAAAKDLGWTRRMNVIKGISDA 918
+V+ F +H+ H L I+ +N L +++ I+ +
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI--IQQVLQG 158
Query: 919 LSYMHNDCFPPIVHRDISSKNVLLDFDN-------------------------------- 946
L Y+H C I+H DI +N+LL +
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 947 -----------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 989
+ ++D G A ++ TE T Y + E+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGYNTP 273
Query: 990 CDVYSFGVLALEVIKGKHP 1008
D++S +A E+ G +
Sbjct: 274 ADIWSTACMAFELATGDYL 292
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1075 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.39 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.22 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.16 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.82 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.64 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.48 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.47 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.57 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.85 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.4 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.71 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.9 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.75 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.95 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.0 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.68 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-93 Score=896.06 Aligned_cols=721 Identities=32% Similarity=0.456 Sum_probs=648.1
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCccceEEeCCCCceeEEEecccccccc---cCCcccCCCCCccEE
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGM---LHDFSFSSFPHLAYL 78 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~---~~~~~~~~l~~L~~L 78 (1075)
+|++|||+||+++.|+ . .+++|+. ++++|.|.||+|+ .+||++++|++.++.|. ++++ +.+|++|+.+
T Consensus 12 ~~~~all~~k~~~~~~-~--~l~~W~~----~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~-l~~L~~L~~l 82 (768)
T 3rgz_A 12 REIHQLISFKDVLPDK-N--LLPDWSS----NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSS-LLSLTGLESL 82 (768)
T ss_dssp HHHHHHHHHHTTCSCT-T--SSTTCCT----TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHH-TTTCTTCCEE
T ss_pred HHHHHHHHHHhhCCCc-c--cccCCCC----CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChh-HhccCccccc
Confidence 5899999999999854 3 7999972 3345999999999 79999999999999998 7765 8999999999
Q ss_pred EccCCCccCCCCccccccCCCceeecccCcccccCCC--CCCCCCCCcEEEccCcccCCCCCccc-cccCCcceeecccc
Q 042958 79 DLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPP--EIGHLSYLKTLQLFENQLNGSIPYEI-GRLSSLNYLALYSN 155 (1075)
Q Consensus 79 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L~~n 155 (1075)
+++.+.+. .+|..++.+++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+ ..+++|++|++++|
T Consensus 83 ~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 83 FLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp ECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred CCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 99999876 4778999999999999999999999998 99999999999999999999988876 88999999999999
Q ss_pred cccCCCCCC---CCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 156 YLEDLIPPS---LGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 156 ~l~~~~~~~---l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
.+++..+.. +.++++|++|++++|.+++..+ +..+++|++|+|++|++++.+|. ++++++|++|++++|.+++.
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 999988877 8999999999999999998766 48899999999999999987877 99999999999999999999
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCC-ccCcEEEccCCCCCCCcCCCCCc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL-RSLSMLNLGYNKLNGIIPHSLGN 311 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~ 311 (1075)
+|..+..+++|++|++++|++++.+|.. .+++|++|++++|.+++.+|..+... ++|++|++++|.+++..|..|++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~ 316 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGG
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhc
Confidence 9999999999999999999999877765 88999999999999999899888775 99999999999999999999999
Q ss_pred cccccceecccccccCCCCcc-cccccccccccccCCcccccCCCcCCCCC-CcceeeccccccCCCCccccCC--Cccc
Q 042958 312 LTNLATLYIHNNSLSGSIPSE-IGNLRSLSNLGLSGNKLSGSIPPSLGYLS-NLATLYLYSNSLFDSIPSELGN--LRSL 387 (1075)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L 387 (1075)
+++|++|++++|.+++.+|.. +..+++|++|++++|++++.+|..+..++ +|++|++++|.+.+.+|..+.. +++|
T Consensus 317 l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 999999999999999777765 99999999999999999999999999887 9999999999999888888877 8899
Q ss_pred ceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCC
Q 042958 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467 (1075)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 467 (1075)
++|++++|++++.+|..+..+++|++|++++|++++.+|..|+++++|++|++++|++++.+|..+..+++|++|++++|
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 476 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCC
Q 042958 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH 547 (1075)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~ 547 (1075)
++++.+|..++.+++|++|++++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|++++|+++|.+|.
T Consensus 477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~ 556 (768)
T 3rgz_A 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998887
Q ss_pred cccc------cccCC-CccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCccccccccccc
Q 042958 548 SLGV------LDLSS-NHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK 620 (1075)
Q Consensus 548 ~l~~------L~Ls~-N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 620 (1075)
.+.. +++.. +.+............. ..-.--.+.+..+..+..++.++.++++.|.++|.+|..|+.+++
T Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~ 633 (768)
T 3rgz_A 557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECH---GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633 (768)
T ss_dssp GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCC---SSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred HHhcccchhhhhcccccccccccccccccccc---ccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence 5432 22211 1111000000000000 000001244566677788889999999999999999999999999
Q ss_pred ceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccccccEEeecC
Q 042958 621 LHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISY 700 (1075)
Q Consensus 621 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~ 700 (1075)
|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.||||+|+++|.+|..+..++.|+.||+|+
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccCCccccCCCCCCCccccccc
Q 042958 701 NELQGPIPNSIAFRDAPIEALQGNKGLCGDVKGLPSCKTLKS 742 (1075)
Q Consensus 701 N~~~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~l~~c~~~~~ 742 (1075)
|+++|.+|...+|.+++..+|.||+++||.+. ++|.....
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C~~~~~ 753 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--PRCDPSNA 753 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTTS--CCCCSCC-
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCCC--cCCCCCcc
Confidence 99999999999999999999999999999764 47875443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-77 Score=749.56 Aligned_cols=643 Identities=32% Similarity=0.448 Sum_probs=579.7
Q ss_pred EecccccccccC-CcccCCCCCccEEEccCCCccCCCCc--cccccCCCceeecccCcccccCCCCC-CCCCCCcEEEcc
Q 042958 54 NLTSIGLKGMLH-DFSFSSFPHLAYLDLWHNQLYGNIPP--QIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLF 129 (1075)
Q Consensus 54 ~l~~~~l~g~~~-~~~~~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~Ls 129 (1075)
++.++...|..+ +..++.+++|++|||++|.++|.+|. .++++++|++|+|++|.+.+.+|..+ .++++|++|||+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 333333444433 23499999999999999999999999 99999999999999999999998876 899999999999
Q ss_pred CcccCCCCCcc---ccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccc
Q 042958 130 ENQLNGSIPYE---IGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 130 ~n~l~~~~p~~---~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
+|++++..|.. +.++++|++|++++|.+.+..+ +..+++|++|+|++|++++.+|. |+++++|++|+|++|+++
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 236 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence 99999888877 8899999999999999998766 48999999999999999998887 999999999999999999
Q ss_pred cccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccc-ccccccccccccCcCCCCccc
Q 042958 207 GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL-TNLATLYLYENSLSGSIPSEF 285 (1075)
Q Consensus 207 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~ 285 (1075)
+.+|..+.++++|++|++++|.+++.+|.. .+++|++|++++|++++.+|..+... ++|++|++++|.+++.+|..|
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 999999999999999999999999877765 89999999999999999999988875 999999999999999999999
Q ss_pred CCCccCcEEEccCCCCCCCcCCC-CCccccccceecccccccCCCCccccccc-ccccccccCCcccccCCCcCCC--CC
Q 042958 286 GNLRSLSMLNLGYNKLNGIIPHS-LGNLTNLATLYIHNNSLSGSIPSEIGNLR-SLSNLGLSGNKLSGSIPPSLGY--LS 361 (1075)
Q Consensus 286 ~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~l~~--l~ 361 (1075)
+.+++|++|++++|.+.+.+|.. |..+++|++|++++|.+++.+|..+..++ +|+.|++++|++++.+|..+.. ++
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 394 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence 99999999999999998777755 99999999999999999999999999998 9999999999999999988887 88
Q ss_pred CcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccc
Q 042958 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441 (1075)
Q Consensus 362 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 441 (1075)
+|++|++++|.+.+.+|..+.++++|++|++++|++++.+|..++.+++|++|++++|.+++.+|..|..+++|++|+++
T Consensus 395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCC
Q 042958 442 YNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521 (1075)
Q Consensus 442 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 521 (1075)
+|++++.+|..|+++++|++|+|++|++++.+|.+++.+++|+.|+|++|++++.+|..++++++|+.|++++|++++.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCccccccccccccccccccCC-ccc-ccccCC--CccccccchhhhhhhHhHHHhhcccccccccccccCccccc
Q 042958 522 PSELGNLRSLSMLSFAYNKLSGSIPH-SLG-VLDLSS--NHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQL 597 (1075)
Q Consensus 522 ~~~l~~l~~L~~L~l~~N~l~~~~p~-~l~-~L~Ls~--N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L 597 (1075)
|..+.....+..+++..+.-...+.. ... ...... -.+.+..+..+..+..+..++++.|.++|..|..+..++.|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 99998887777666554221000000 000 000000 13455677788888888888999999999999999999999
Q ss_pred ceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCC
Q 042958 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHN 677 (1075)
Q Consensus 598 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N 677 (1075)
+.||||+|+++|.+|.+|+.+++|++|+|++|+++|.+|..++.+++|++||||+|+++|.+|..+..+++|+.||+|+|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCChhhhcccccccEEeecCCc
Q 042958 678 SLVGLIPSCFEKMHGLLRIDISYNE 702 (1075)
Q Consensus 678 ~l~~~~p~~~~~~~~l~~l~~s~N~ 702 (1075)
+|+|.+|.. ..+.++....+.+|+
T Consensus 715 ~l~g~iP~~-~~~~~~~~~~~~gN~ 738 (768)
T 3rgz_A 715 NLSGPIPEM-GQFETFPPAKFLNNP 738 (768)
T ss_dssp EEEEECCSS-SSGGGSCGGGGCSCT
T ss_pred cccccCCCc-hhhccCCHHHhcCCc
Confidence 999999975 233444455666776
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-64 Score=631.35 Aligned_cols=576 Identities=27% Similarity=0.292 Sum_probs=301.9
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
+++++|||++|++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+.+++|++|++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 56777777777777665566777777777777777777666666777777777777777776444445666666666666
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCc--CCCCcCceeccccCCC
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG--NLTNLATLYLHNNSLF 230 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~L~~N~l~ 230 (1075)
++|.+.++.+..|+++++|++|++++|.+++..+..|+++++|++|++++|++++..+..+. .+++|++|++++|.++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 66666665555666666666666666666655555555666666666666665544444332 3355555555555555
Q ss_pred CCCcccccCCCCCCeEeccCCCCCCccCCCCc---ccccccccccccccCcCCCCcccCCCcc--CcEEEccCCCCCCCc
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG---NLTNLATLYLYENSLSGSIPSEFGNLRS--LSMLNLGYNKLNGII 305 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~ 305 (1075)
+..|..+..+++|+.|++++|.+.......+. ..++|+.|++++|.+++..|..|..++. |+.|++++|+++++.
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 55555555555555555555554421111000 1134445555555554444444444433 555555555444444
Q ss_pred CCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCcc----cc
Q 042958 306 PHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS----EL 381 (1075)
Q Consensus 306 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~----~~ 381 (1075)
|..|+.+++|++|++++|.+.+..|..|.++++|+.|++++|...+.++. ..+|. .|
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~-------------------~~lp~i~~~~~ 325 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL-------------------ASLPKIDDFSF 325 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------------------------CCEECTTTT
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc-------------------ccccccChhhc
Confidence 44444444455555554444444444444444444444444332211000 01111 34
Q ss_pred CCCcccceeeeccccccccCChhhccCCCCCeEEeeccccc--cccccccccc--cccceecccccccccCCCCCCcccc
Q 042958 382 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS--GSIPSEFGNL--RSLSTLSLGYNKLSGSIPHSLGNLT 457 (1075)
Q Consensus 382 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~ 457 (1075)
..+++|++|++++|++.+..+..|.++++|++|++++|.+. ......|..+ ++|+.|++++|++++..|.+|..++
T Consensus 326 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~ 405 (680)
T 1ziw_A 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405 (680)
T ss_dssp TTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCT
T ss_pred ccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCC
Confidence 44444555555555554444444444555555555544422 1112222222 2444444444444444444444444
Q ss_pred ccccccccCCccccCCC-ccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCC--CCCCccccCccccccc
Q 042958 458 NLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF--DSIPSELGNLRSLSML 534 (1075)
Q Consensus 458 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L 534 (1075)
+|++|+|++|++++.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.+. +..|..+..+++|+.|
T Consensus 406 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L 485 (680)
T 1ziw_A 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485 (680)
T ss_dssp TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEE
T ss_pred CCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEE
Confidence 44444444444443333 34444444444444444444444444444444444444444443 2233333333333322
Q ss_pred cccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcc---
Q 042958 535 SFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSI--- 611 (1075)
Q Consensus 535 ~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--- 611 (1075)
+++ +|++++..+..|..+++|++|+|++|++++..
T Consensus 486 ~Ls------------------------------------------~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 523 (680)
T 1ziw_A 486 DLS------------------------------------------NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA 523 (680)
T ss_dssp ECC------------------------------------------SSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTT
T ss_pred ECC------------------------------------------CCCCCcCChhhhccccccCEEeCCCCCccccchhh
Confidence 222 22222233333444455555555555554321
Q ss_pred -----cccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhh
Q 042958 612 -----PKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSC 686 (1075)
Q Consensus 612 -----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~ 686 (1075)
+..|..+++|++|+|++|+++...+..|..+++|++|||++|+|++..+..+..+++|+.|++++|+|++..|..
T Consensus 524 ~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 603 (680)
T 1ziw_A 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603 (680)
T ss_dssp STTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHH
T ss_pred ccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhH
Confidence 122555666666666666666444445666666666666666666655555666677777777777777777766
Q ss_pred hc-ccccccEEeecCCccCCCCCC
Q 042958 687 FE-KMHGLLRIDISYNELQGPIPN 709 (1075)
Q Consensus 687 ~~-~~~~l~~l~~s~N~~~~~~p~ 709 (1075)
|. .+++|+.+++++|++.|.++.
T Consensus 604 ~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 604 FGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hcccccccCEEEccCCCcccCCcc
Confidence 66 667777777777777777664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-64 Score=629.20 Aligned_cols=591 Identities=24% Similarity=0.262 Sum_probs=447.1
Q ss_pred CccceEEeCC----------CCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeeccc
Q 042958 37 CAWVGIHCNR----------GGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSS 106 (1075)
Q Consensus 37 c~w~gv~C~~----------~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 106 (1075)
|.|.-|.|+. ..+++.++++++++.+..+. .|+++++|++|||++|.+++..|..++++++|++|+|++
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAA-NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGG-GGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHH-HHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 5566666653 14799999999999886544 499999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCC
Q 042958 107 NLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186 (1075)
Q Consensus 107 n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 186 (1075)
|.+++..+..|+++++|++|+|++|++++..|..|+.+++|++|++++|.+.+..+..++++++|++|++++|.+++..+
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 99996555679999999999999999998777899999999999999999999999999999999999999999998888
Q ss_pred cccc--CccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCccccc---CCCCCCeEeccCCCCCCccCCCC
Q 042958 187 SEFG--NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG---NLRSLSMLSLGYNKLSGSIPHSL 261 (1075)
Q Consensus 187 ~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~~~~~ 261 (1075)
..+. .+++|++|++++|++++..|..+..+++|+.|++++|.+.......+. ..++|+.|++++|.+++..|..|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 7665 558999999999999999999999999999999999987533222211 35899999999999999999999
Q ss_pred ccccc--ccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCC-----C----
Q 042958 262 GNLTN--LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSI-----P---- 330 (1075)
Q Consensus 262 ~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~---- 330 (1075)
.+++. |++|++++|.+++..|..|..+++|+.|++++|.+.+..|.+|.++++|++|++++|...+.+ |
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~ 322 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence 98876 999999999999888899999999999999999999999999999999999999987655322 1
Q ss_pred cccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccC--
Q 042958 331 SEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL-- 408 (1075)
Q Consensus 331 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-- 408 (1075)
..|..+++|++|++++|.+++..+..|..+++|++|++++|.+... ......|..+
T Consensus 323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~----------------------~l~~~~f~~~~~ 380 (680)
T 1ziw_A 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR----------------------TLTNETFVSLAH 380 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCC----------------------EECTTTTGGGTT
T ss_pred hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhh----------------------hcchhhhccccc
Confidence 1444455555555555555544444455555555555555443211 1111222222
Q ss_pred CCCCeEEeeccccccccccccccccccceecccccccccCCC-CCCccccccccccccCCccccCCCccccCcCCCCEEe
Q 042958 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIP-HSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLA 487 (1075)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 487 (1075)
++|+.|++++|+++++.|..|..+++|++|++++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|+
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 355666666666655555556666666666666666654433 4555666666666666666655566666666666666
Q ss_pred CCCCccc--CCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccch
Q 042958 488 LNNNKLS--GSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPT 565 (1075)
Q Consensus 488 L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~ 565 (1075)
+++|.++ +..|..|.++++|+.|+|++|++++..+..+..+++|+.|++++|++++. .+.
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~------------------~~~ 522 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL------------------WKH 522 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGG------------------GST
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcccc------------------chh
Confidence 6666654 34566666666666666666666665555666666666666555555421 000
Q ss_pred hhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhccccccc
Q 042958 566 ELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHL 645 (1075)
Q Consensus 566 ~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 645 (1075)
. +.+.....|..+++|++|+|++|+|+...+..|..+++|++|+|++|++++..+..|..+++|
T Consensus 523 ~----------------~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 586 (680)
T 1ziw_A 523 A----------------NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586 (680)
T ss_dssp T----------------STTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred h----------------ccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCC
Confidence 0 011122347788899999999999985444578999999999999999998777778899999
Q ss_pred ceeeeccccccCchhhhhc-cccccceeecCCCccccCCh
Q 042958 646 SELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSLVGLIP 684 (1075)
Q Consensus 646 ~~L~ls~N~l~~~~~~~~~-~~~~L~~L~ls~N~l~~~~p 684 (1075)
+.|+|++|+|++..|..+. .+++|+.|++++|++....+
T Consensus 587 ~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 9999999999998888777 78899999999999986544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=564.19 Aligned_cols=541 Identities=22% Similarity=0.222 Sum_probs=299.2
Q ss_pred EEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCc
Q 042958 52 SINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131 (1075)
Q Consensus 52 ~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 131 (1075)
.++|.+.++...+.. + -+++++|||++|.+++..|..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|
T Consensus 16 ~~~c~~~~l~~iP~~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 16 TYNCENLGLNEIPGT--L--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp EEECTTSCCSSCCTT--S--CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEECCCCCcccCcCC--C--CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 345555555533221 1 135677777777777666667777777777777777776666666777777777777777
Q ss_pred ccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCC
Q 042958 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH 211 (1075)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 211 (1075)
++++..|..|+.+++|++|++++|.++++.+..++++++|++|++++|++++. .+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~------------------------~~~ 147 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI------------------------KLP 147 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCC------------------------CCC
T ss_pred cccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccccc------------------------Ccc
Confidence 66655555555555555555555555544444444444444444444444443 222
Q ss_pred CCcCCCCcCceeccccCCCCCCcccccCCCCCC--eEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCc
Q 042958 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLS--MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLR 289 (1075)
Q Consensus 212 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 289 (1075)
.+..+++|++|++++|.+++..|..|+.+++|+ .|++++|.+++..|..+.. .+|++|++++|.. .+..+..+.
T Consensus 148 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~ 223 (606)
T 3t6q_A 148 KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLK 223 (606)
T ss_dssp TTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTT
T ss_pred cccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhcc
Confidence 233355555555555555544445555555555 5555555555444444333 3555555555541 222333333
Q ss_pred cCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccc--ccccccccCCcccccCCCcCCCCCCcceee
Q 042958 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR--SLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367 (1075)
Q Consensus 290 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~ 367 (1075)
++....+..+.+.+ +....+. +..+..+. +|+.|++++|.+++..+..|..+++|++|+
T Consensus 224 ~~~l~~l~~~~~~~-----------~~~~~i~--------~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 284 (606)
T 3t6q_A 224 NSTIQSLWLGTFED-----------MDDEDIS--------PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284 (606)
T ss_dssp TCEEEEEECCCCTT-----------SCCCCCC--------GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEE
T ss_pred ccchhheechhhcc-----------ccccccC--------hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEe
Confidence 33333322221111 1111111 11111111 345555555555544444455555555555
Q ss_pred ccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccc-cccccccccceecccccccc
Q 042958 368 LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIP-SEFGNLRSLSTLSLGYNKLS 446 (1075)
Q Consensus 368 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 446 (1075)
+++|.+. .+|..+.++++|++|++++|++.+..|..+..+++|++|++++|.+.+.+| ..|..+++|++|++++|.++
T Consensus 285 l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 363 (606)
T 3t6q_A 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363 (606)
T ss_dssp CTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCC
T ss_pred ccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccc
Confidence 5555553 444455555555555555555555555555555566666666665553332 33556666666666666665
Q ss_pred cCC--CCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCccc-ccCCCccceeeccCCCCCCCCCc
Q 042958 447 GSI--PHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS-LGNLSNLVILYLYNNSLFDSIPS 523 (1075)
Q Consensus 447 ~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~ 523 (1075)
+.. |..+.++++|++|++++|++++..|..|..+++|+.|++++|++++..+.. +.++++|+.|++++|.+++..|.
T Consensus 364 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 443 (606)
T 3t6q_A 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443 (606)
T ss_dssp EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT
T ss_pred cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH
Confidence 443 555666666666666666666666666666666666666666666554433 66677777777777766665565
Q ss_pred cccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecC
Q 042958 524 ELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603 (1075)
Q Consensus 524 ~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 603 (1075)
.++.+++|+.|++++|++++. .+ ..+..+..+++|++|+|+
T Consensus 444 ~~~~l~~L~~L~L~~n~l~~~-----------------~~----------------------~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 444 LFDGLPALQHLNLQGNHFPKG-----------------NI----------------------QKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp TTTTCTTCCEEECTTCBCGGG-----------------EE----------------------CSSCGGGGCTTCCEEECT
T ss_pred HHhCCCCCCEEECCCCCCCcc-----------------cc----------------------ccchhhccCCCccEEECC
Confidence 555555555555555444310 00 011235556677777777
Q ss_pred CCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCC
Q 042958 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLI 683 (1075)
Q Consensus 604 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 683 (1075)
+|++++..|..|+.+++|++|+|++|++++..|..+..+..| .|+|++|++++.+|..+..+++|+.|++++|++....
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 777776666677777777777777777766666666666666 6666666666666666666666666666666665543
Q ss_pred h
Q 042958 684 P 684 (1075)
Q Consensus 684 p 684 (1075)
+
T Consensus 564 ~ 564 (606)
T 3t6q_A 564 S 564 (606)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=568.12 Aligned_cols=533 Identities=22% Similarity=0.257 Sum_probs=366.6
Q ss_pred cceEEeCCC----------CceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCc
Q 042958 39 WVGIHCNRG----------GRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNL 108 (1075)
Q Consensus 39 w~gv~C~~~----------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 108 (1075)
+.-|.|... ..++.++++++.+.+..+. .|+++++|++|||++|.+++..|..|+++++|++|+|++|.
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 566788652 3789999999999876554 59999999999999999998899999999999999999999
Q ss_pred ccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCcc
Q 042958 109 FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188 (1075)
Q Consensus 109 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 188 (1075)
+++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|.+.++..+.+..+++|++|++++|.+++..+..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99899999999999999999999999877888999999999999999999987666777999999999999999988999
Q ss_pred ccCccccc--eEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccc
Q 042958 189 FGNLRSLS--MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266 (1075)
Q Consensus 189 ~~~l~~L~--~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 266 (1075)
|+.+++|+ .|++++|.+++..|..+.. .+|++|++++|. ..+..+..+.++....+..+.+.+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~----------- 237 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFED----------- 237 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTT-----------
T ss_pred hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhcc-----------
Confidence 99999999 8999999999877776654 689999999886 345556666665555554333321
Q ss_pred ccccccccccCcCCCCcccCCCc--cCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccc
Q 042958 267 LATLYLYENSLSGSIPSEFGNLR--SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGL 344 (1075)
Q Consensus 267 L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (1075)
+....+..+ .|..+. +|+.|++++|.++++.+..|..+++|++|++++|.++ .+|..+..+++|++|++
T Consensus 238 ~~~~~i~~~--------~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l 308 (606)
T 3t6q_A 238 MDDEDISPA--------VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308 (606)
T ss_dssp SCCCCCCGG--------GGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEEC
T ss_pred ccccccChh--------HhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEEC
Confidence 111122211 222222 5666777777776666666666666666666666666 45555666666666666
Q ss_pred cCCcccccCCCcCCCCCCcceeeccccccCCCCcc-ccCCCcccceeeeccccccccC--ChhhccCCCCCeEEeecccc
Q 042958 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS-ELGNLRSLSMLSLGYNKLSGSI--PHSLGNLTNLATLDLYDNSL 421 (1075)
Q Consensus 345 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l 421 (1075)
++|++++..|..+..+++|++|++++|.+.+.+|. .+..+++|++|++++|++.+.. +..+..+++|++|++++|++
T Consensus 309 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 388 (606)
T 3t6q_A 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388 (606)
T ss_dssp TTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSC
T ss_pred ccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcC
Confidence 66666655555555556666666666555433332 3555555555555555555433 44455555555555555555
Q ss_pred ccccccccccccccceecccccccccCCCC-CCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCccc
Q 042958 422 SGSIPSEFGNLRSLSTLSLGYNKLSGSIPH-SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS 500 (1075)
Q Consensus 422 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 500 (1075)
++..|..|..+++|++|++++|++++..|. .|.++++|++|++++|.+++..|..++.+++|++|++++|++++...
T Consensus 389 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-- 466 (606)
T 3t6q_A 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI-- 466 (606)
T ss_dssp EEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEE--
T ss_pred CcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccc--
Confidence 555555555555555555555555443332 24444555555555555444444444444444444444444433110
Q ss_pred ccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcc
Q 042958 501 LGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQ 580 (1075)
Q Consensus 501 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~ 580 (1075)
..+..+..+++|+.|++++|++
T Consensus 467 -------------------~~~~~~~~l~~L~~L~Ls~n~l--------------------------------------- 488 (606)
T 3t6q_A 467 -------------------QKTNSLQTLGRLEILVLSFCDL--------------------------------------- 488 (606)
T ss_dssp -------------------CSSCGGGGCTTCCEEECTTSCC---------------------------------------
T ss_pred -------------------ccchhhccCCCccEEECCCCcc---------------------------------------
Confidence 1112333333333333333322
Q ss_pred cccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchh
Q 042958 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP 660 (1075)
Q Consensus 581 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 660 (1075)
++..|..|..+++|++|||++|++++..|..|..+++| +|+|++|++++..|..+..+++|+.|++++|.+.+..+
T Consensus 489 ---~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 489 ---SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ---CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ---CccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 22334456677788888888888888888888888888 88999998888888888888899999999999887554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=572.47 Aligned_cols=531 Identities=25% Similarity=0.281 Sum_probs=391.2
Q ss_pred eeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecccccccc-CCCCcCCCCcCceecccc
Q 042958 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSI-PHSLGNLTNLATLYLHNN 227 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N 227 (1075)
..+.+++.++.++. -.++|++|+|++|.|++..+..|.++++|++|+|++|.+.+.+ |.+|.++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~vP~----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSCCCS----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCCCCC----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 56777778877654 3477888888888888888888888888888888888655444 778888888888888888
Q ss_pred CCCCCCcccccCCCCCCeEeccCCCCCCccCCC--CcccccccccccccccCcCCCC-cccCCCccCcEEEccCCCCCCC
Q 042958 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS--LGNLTNLATLYLYENSLSGSIP-SEFGNLRSLSMLNLGYNKLNGI 304 (1075)
Q Consensus 228 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~ 304 (1075)
.+++..|..|+.+++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 888777888888888888888888888755554 7888888888888888876654 5678888888888888888877
Q ss_pred cCCCCCcc--ccccceecccccccCCCCcccccccc------cccccccCCcccccCCCcCCCC---CCcceeecccccc
Q 042958 305 IPHSLGNL--TNLATLYIHNNSLSGSIPSEIGNLRS------LSNLGLSGNKLSGSIPPSLGYL---SNLATLYLYSNSL 373 (1075)
Q Consensus 305 ~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~l~~N~l~~~~~~~l~~l---~~L~~L~L~~N~l 373 (1075)
.+..|..+ ++|+.|++++|.+.+..|..++.+.+ |+.|++++|.+++..+..+... .+++.|.++.+.+
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 77777777 78888888888888777776666555 7778888777776666655432 4566666653332
Q ss_pred CCCCccccCCCcccceeeeccccccccCChhhccC--CCCCeEEeeccccccccccccccccccceecccccccccCCCC
Q 042958 374 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL--TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451 (1075)
Q Consensus 374 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (1075)
.. +++.|.+.+..+..|.++ ++|+.|++++|.+++..+..|..+++|+.|+|++|++++..|.
T Consensus 244 ~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 308 (844)
T 3j0a_A 244 GA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308 (844)
T ss_dssp BC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT
T ss_pred cc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH
Confidence 11 011223333333334443 4566666666666655566666666666666666666655566
Q ss_pred CCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccc
Q 042958 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531 (1075)
Q Consensus 452 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 531 (1075)
.|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|.++++|+.|+|++|.+++. ..+++|
T Consensus 309 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L 383 (844)
T 3j0a_A 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSI 383 (844)
T ss_dssp TTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSC
T ss_pred HhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCc
Confidence 666666666666666666655566666666666666666666655555566666666666666666432 225566
Q ss_pred ccccccccccccccC---CcccccccCCCccccc-cchhhhhhhHhHHHhhccccccccccc-ccCcccccceeecCCCc
Q 042958 532 SMLSFAYNKLSGSIP---HSLGVLDLSSNHIVGE-IPTELGKLNFLIKLILAQNQLSGQLSP-KLGSLAQLEHLDLSSNR 606 (1075)
Q Consensus 532 ~~L~l~~N~l~~~~p---~~l~~L~Ls~N~l~~~-~p~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~ 606 (1075)
+.|++++|+++ .+| ..++.|++++|++++. .+..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.
T Consensus 384 ~~L~l~~N~l~-~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~ 462 (844)
T 3j0a_A 384 PDIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462 (844)
T ss_dssp SEEEEESCCCC-CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCC
T ss_pred chhccCCCCcc-cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCc
Confidence 66666666665 233 3567788888888763 234466788999999999999976544 36678999999999999
Q ss_pred cc-----CcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCcccc
Q 042958 607 LS-----NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681 (1075)
Q Consensus 607 l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~ 681 (1075)
++ +..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+. ++|+.|++++|+|++
T Consensus 463 l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~ 540 (844)
T 3j0a_A 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLA 540 (844)
T ss_dssp CSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCC
T ss_pred cccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCC
Confidence 97 45567799999999999999999999999999999999999999999997777665 899999999999999
Q ss_pred CChhhhcccccccEEeecCCccCCCCCC
Q 042958 682 LIPSCFEKMHGLLRIDISYNELQGPIPN 709 (1075)
Q Consensus 682 ~~p~~~~~~~~l~~l~~s~N~~~~~~p~ 709 (1075)
.+|..|. .|+.+++++|++.|.++.
T Consensus 541 ~~~~~~~---~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 541 PNPDVFV---SLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCSCCCS---SCCEEEEEEECCCCSSSC
T ss_pred CChhHhC---CcCEEEecCCCccccccc
Confidence 9998765 688999999999998874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=566.43 Aligned_cols=539 Identities=23% Similarity=0.226 Sum_probs=343.8
Q ss_pred EEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccC-CCCCCCCCCCcEEEccCc
Q 042958 53 INLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTI-PPEIGHLSYLKTLQLFEN 131 (1075)
Q Consensus 53 l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n 131 (1075)
++++++++...+. -.++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |.+|.++++|++|+|++|
T Consensus 9 ~dcs~~~L~~vP~-----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 9 AFYRFCNLTQVPQ-----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEESCCCSSCCCS-----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEccCCCCCCCCC-----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4677777776543 2477888888888888778888888888888888888665566 677888888888888888
Q ss_pred ccCCCCCccccccCCcceeecccccccCCCCCC--CCCCCCCCEEEcCCCCCCCCCC-ccccCccccceEeeeccccccc
Q 042958 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPS--LGNLSNLDTLHLYDNSLSDSIP-SEFGNLRSLSMLSLGYNKFSGS 208 (1075)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~ 208 (1075)
.+++..|..|+++++|++|+|++|.+.+..+.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 888777778777777777777777777654443 7777777777777777766544 4567777777777777777766
Q ss_pred cCCCCcCC--CCcCceeccccCCCCCCcccccCCCC------CCeEeccCCCCCCccCCCCcccccccccccccccCcCC
Q 042958 209 IPHSLGNL--TNLATLYLHNNSLFDSIPSELGNLRS------LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280 (1075)
Q Consensus 209 ~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 280 (1075)
.+..+..+ ++|+.|++++|.+.+..|..++.+++ |+.|++++|.+++..+..+...
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~---------------- 227 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA---------------- 227 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGT----------------
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhh----------------
Confidence 66666665 66777777777766655555554443 5555555555554444433321
Q ss_pred CCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccc--cccccccccCCcccccCCCcCC
Q 042958 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL--RSLSNLGLSGNKLSGSIPPSLG 358 (1075)
Q Consensus 281 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~l~ 358 (1075)
....+++.|.++.+.+... ...+.+....+..|.++ ++|+.|++++|.+.+..+..|.
T Consensus 228 -----l~~~~l~~L~l~~~~~~~~---------------~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 287 (844)
T 3j0a_A 228 -----ISKSQAFSLILAHHIMGAG---------------FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287 (844)
T ss_dssp -----SCSCCBSEEECCSSCCBCS---------------SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred -----cCcccccceeccccccccc---------------ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence 0113445555543322110 11122222222233332 4556666666666555555566
Q ss_pred CCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccccccccccccccccee
Q 042958 359 YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTL 438 (1075)
Q Consensus 359 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 438 (1075)
.+++|+.|+|++|.+.+..|..|.++++|++|+|++|++++..|..|..+++|+.|++++|+++++.+..|.++++|++|
T Consensus 288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 367 (844)
T 3j0a_A 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367 (844)
T ss_dssp SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence 66666666666666655555566666666666666666665556666666666666666666666555666666666666
Q ss_pred cccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCC-cccccCCCccceeeccCCCC
Q 042958 439 SLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI-PQSLGNLSNLVILYLYNNSL 517 (1075)
Q Consensus 439 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l 517 (1075)
+|++|.+++ ++ .+++|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+.++++|+.|+|++|++
T Consensus 368 ~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l 438 (844)
T 3j0a_A 368 DLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438 (844)
T ss_dssp EEETCCSCC-CS----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCC
T ss_pred ECCCCCCCc-cc----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcc
Confidence 666666652 22 2566677777777776 34433 345777777777776532 23355777888888888887
Q ss_pred CCCCCc-cccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccc
Q 042958 518 FDSIPS-ELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQ 596 (1075)
Q Consensus 518 ~~~~~~-~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~ 596 (1075)
++..+. .+..+++|+.|++++|.+++ ..+ .+..+..|..+++
T Consensus 439 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~------------------~~~-------------------~~~~~~~~~~l~~ 481 (844)
T 3j0a_A 439 SSCSGDQTPSENPSLEQLFLGENMLQL------------------AWE-------------------TELCWDVFEGLSH 481 (844)
T ss_dssp CCCCSSSSSCSCTTCCBCEEESCCCSS------------------SCC-------------------SCCCSSCSSCBCC
T ss_pred cccccccccccCCccccccCCCCcccc------------------ccc-------------------cccchhhhcCccc
Confidence 654333 23345555555555554431 111 0123345666777
Q ss_pred cceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCC
Q 042958 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSH 676 (1075)
Q Consensus 597 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~ 676 (1075)
|+.|||++|+|++..|..|..+++|++|+|++|+|++..|..+. ++|+.|||++|+|++.+|..+ .+|+.|++++
T Consensus 482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~ 556 (844)
T 3j0a_A 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITH 556 (844)
T ss_dssp EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEE
T ss_pred ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecC
Confidence 77777777777777777777777777777777777776666555 677778888888777777654 3677778888
Q ss_pred CccccCC
Q 042958 677 NSLVGLI 683 (1075)
Q Consensus 677 N~l~~~~ 683 (1075)
|++....
T Consensus 557 Np~~C~c 563 (844)
T 3j0a_A 557 NKFICEC 563 (844)
T ss_dssp ECCCCSS
T ss_pred CCccccc
Confidence 8776543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=548.69 Aligned_cols=536 Identities=23% Similarity=0.217 Sum_probs=291.9
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.+|.++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 57888888887 7777665 78889999999888777778888888888888888888766777677777777777777
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecccccc-ccCCCCcCCCCcCceeccccCCCCCCc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSG-SIPHSLGNLTNLATLYLHNNSLFDSIP 234 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (1075)
.++++.|..|+++++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~ 170 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence 7666666666666666666666666666555566666666666666666654 345556666666666666666655555
Q ss_pred ccccCCCCCC----eEeccCCCCCCccCCCCcccccccccccccccCc-CCCCcccCCCccCcEEEccCCCCCCCcCCCC
Q 042958 235 SELGNLRSLS----MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS-GSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309 (1075)
Q Consensus 235 ~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 309 (1075)
..++.+++|+ +|++++|.+++..+..+... +|++|++++|.++ +..|..+.+++.|+.+++..+.+.+..
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~---- 245 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER---- 245 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC----
T ss_pred hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC----
Confidence 5555444433 45555555554333333332 5555555555554 233444555555555555443332110
Q ss_pred CccccccceecccccccCCCCccccccc--ccccccc-cCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcc
Q 042958 310 GNLTNLATLYIHNNSLSGSIPSEIGNLR--SLSNLGL-SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRS 386 (1075)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l-~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 386 (1075)
.+. ...+..+..+. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++
T Consensus 246 ----~l~----------~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~ 308 (606)
T 3vq2_A 246 ----NLE----------IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFK 308 (606)
T ss_dssp ----CCS----------CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCC
T ss_pred ----ccc----------ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hcccccc
Confidence 000 00111111111 2333333 33444444433 444445555555555442 223 4444444
Q ss_pred cceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccC--CCCCCccccccccccc
Q 042958 387 LSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGS--IPHSLGNLTNLDALYL 464 (1075)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L 464 (1075)
|++|++++|++ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++. .|..+..+++|++|++
T Consensus 309 L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L 383 (606)
T 3vq2_A 309 WQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383 (606)
T ss_dssp CSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEEC
T ss_pred CCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeEC
Confidence 55555555544 2334 22 4444555555444332211 334444444444444444432 1334444444444444
Q ss_pred cCCccccCCCccccCcCCCCEEeCCCCcccCCCc-ccccCCCccceeeccCCCCCCCCCccccCcccccccccccccccc
Q 042958 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIP-QSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543 (1075)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 543 (1075)
++|.+++ +|..+..+++|+.|++++|++++..| ..+.++++|+.|++++|.+++..
T Consensus 384 ~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------------------- 440 (606)
T 3vq2_A 384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF---------------------- 440 (606)
T ss_dssp CSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECC----------------------
T ss_pred CCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccc----------------------
Confidence 4444442 33444444444444444444443333 23344444444444444333322
Q ss_pred ccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccC-cccccccccccce
Q 042958 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN-SIPKSFGNLVKLH 622 (1075)
Q Consensus 544 ~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~ 622 (1075)
|..+..+++|++|+|++|++++ .+|..|+.+++|+
T Consensus 441 --------------------------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 476 (606)
T 3vq2_A 441 --------------------------------------------DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476 (606)
T ss_dssp --------------------------------------------TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred --------------------------------------------hhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCC
Confidence 2334444555555555555554 2455556666666
Q ss_pred EEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccc-cccEEeecCC
Q 042958 623 YLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMH-GLLRIDISYN 701 (1075)
Q Consensus 623 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~-~l~~l~~s~N 701 (1075)
+|+|++|++++..|..+..+++|++|+|++|++++.+|..+..+++|+.|++++|+|+ .+|..+..++ .|+.+++++|
T Consensus 477 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N 555 (606)
T 3vq2_A 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNN 555 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSC
T ss_pred EEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCC
Confidence 6666666666555556666666666666666666666666666666666666666666 3444466665 3777777777
Q ss_pred ccCCCCCC
Q 042958 702 ELQGPIPN 709 (1075)
Q Consensus 702 ~~~~~~p~ 709 (1075)
++.|.++.
T Consensus 556 ~~~c~c~~ 563 (606)
T 3vq2_A 556 SVACICEH 563 (606)
T ss_dssp CCCCSSTT
T ss_pred CcccCCcc
Confidence 77766653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=561.20 Aligned_cols=477 Identities=21% Similarity=0.325 Sum_probs=273.6
Q ss_pred hhHHHHHHHHHhccCCCCC------CCcCCCCcCCCCCCCCCcc---ceEEeCCCCceeEEEecccccccccCCcccCCC
Q 042958 2 EEAHALLRWKTSLQNHNNG------SLLSSWTLNNVTKTSPCAW---VGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSF 72 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~------~~l~sw~~~~~~~~~~c~w---~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l 72 (1075)
.|++||.+||+++..+.+. ....+|+. ++.+|.| .||+|+..|||++|+|+++++.|.++++ +++|
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~----~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~-l~~L 104 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF----NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA-IGQL 104 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCC----SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGG-GGGC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC----CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChH-HhcC
Confidence 5899999999999765331 13447872 3334999 9999998899999999999999999976 9999
Q ss_pred CCccEEEccCCCc------cC------CCCccccccCCCceeecccCcccccCCCCCCCC-CCCcEEEcc----------
Q 042958 73 PHLAYLDLWHNQL------YG------NIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHL-SYLKTLQLF---------- 129 (1075)
Q Consensus 73 ~~L~~L~L~~n~l------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l-~~L~~L~Ls---------- 129 (1075)
++|++|||++|.+ .| .+|... +.+|+ ++++.|.+.+.+|..+..+ ..+..+++.
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 9999999999976 33 455544 66777 8888888888877776632 222233333
Q ss_pred ----------CcccCCCCCccccccCCcceeecccccccCC-----------------CCCCCC--CCCCCCEEEcCCCC
Q 042958 130 ----------ENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-----------------IPPSLG--NLSNLDTLHLYDNS 180 (1075)
Q Consensus 130 ----------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~~~~l~--~l~~L~~L~L~~n~ 180 (1075)
+|+++| +|..++.+++|++|+|++|.+++. +|..++ ++++|++|+|++|+
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred chhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence 344544 455555555555555555555543 444444 55555555555555
Q ss_pred CCCCCCccccCccccceEeeeccc-ccc-ccCCCCcCC------CCcCceeccccCCCCCCcc--cccCCCCCCeEeccC
Q 042958 181 LSDSIPSEFGNLRSLSMLSLGYNK-FSG-SIPHSLGNL------TNLATLYLHNNSLFDSIPS--ELGNLRSLSMLSLGY 250 (1075)
Q Consensus 181 l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~ 250 (1075)
+.+.+|..|+++++|++|+|++|+ +++ .+|..++.+ ++|++|++++|+++ .+|. .++.+++|++|++++
T Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~ 339 (636)
T 4eco_A 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLY 339 (636)
T ss_dssp TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCS
T ss_pred CCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcC
Confidence 555555555555555555555554 444 444444443 44555555555554 3444 444555555555555
Q ss_pred CCCCCccCCCCcccccccccccccccCcCCCCcccCCCcc-CcEEEccCCCCCCCcCCCCCccccccceecccccccCCC
Q 042958 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRS-LSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSI 329 (1075)
Q Consensus 251 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 329 (1075)
|+++|.+| .+..+++|++|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++
T Consensus 340 N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~---------------- 400 (636)
T 4eco_A 340 NQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS---------------- 400 (636)
T ss_dssp CCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTC----------------
T ss_pred CcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcc----------------
Confidence 55544444 4444455555555555544 34444444444 555555555444 3344443332
Q ss_pred CcccccccccccccccCCcccccCCCcCC-------CCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCC
Q 042958 330 PSEIGNLRSLSNLGLSGNKLSGSIPPSLG-------YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP 402 (1075)
Q Consensus 330 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 402 (1075)
+++|+.|++++|++++.+|..+. .+++|++|+|++|.+.+..+..+..+++|++|+|++|+++...+
T Consensus 401 ------l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~ 474 (636)
T 4eco_A 401 ------VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474 (636)
T ss_dssp ------SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred ------cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence 11444444444444444444444 44455555555555543222233345555555555555552222
Q ss_pred hhhccC-------CCCCeEEeeccccccccccccc--cccccceecccccccccCCCCCCccccccccccc------cCC
Q 042958 403 HSLGNL-------TNLATLDLYDNSLSGSIPSEFG--NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL------YDN 467 (1075)
Q Consensus 403 ~~~~~l-------~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L------~~N 467 (1075)
..+... ++|++|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+.++++|+.|+| ++|
T Consensus 475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N 552 (636)
T 4eco_A 475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552 (636)
T ss_dssp SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCC
T ss_pred HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccC
Confidence 222222 25666666666665 3444443 55666666666666654 5555556666666666 456
Q ss_pred ccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCC
Q 042958 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF 518 (1075)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 518 (1075)
++.+.+|..++.+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++.
T Consensus 553 ~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 553 RTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred cccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 66666777777777777777777777 45565554 56777777777664
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=547.71 Aligned_cols=536 Identities=24% Similarity=0.228 Sum_probs=383.1
Q ss_pred EEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCc
Q 042958 52 SINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131 (1075)
Q Consensus 52 ~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 131 (1075)
.++|++.++...+... .+++++|||++|.+++..+..++++++|++|+|++|.+++..|.+|+++++|++|+|++|
T Consensus 15 ~~~c~~~~l~~ip~~~----~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 15 TYQCMDQKLSKVPDDI----PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp EEECTTSCCSSCCTTS----CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEccCCCcccCCCCC----CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 4677777777554322 278999999999999888889999999999999999999888999999999999999999
Q ss_pred ccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCC-CCCccccCccccceEeeeccccccccC
Q 042958 132 QLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSIP 210 (1075)
Q Consensus 132 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 210 (1075)
++++..|..|+++++|++|++++|.+.++.+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~ 170 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred cccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence 9999889999999999999999999999998999999999999999999986 569999999999999999999999889
Q ss_pred CCCcCCCCcC----ceeccccCCCCCCcccccCCCCCCeEeccCCCCC-CccCCCCcccccccccccccccCcCCCCccc
Q 042958 211 HSLGNLTNLA----TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS-GSIPHSLGNLTNLATLYLYENSLSGSIPSEF 285 (1075)
Q Consensus 211 ~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 285 (1075)
..++.+++|+ +|++++|.+++..+..+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+..
T Consensus 171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~---- 245 (606)
T 3vq2_A 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER---- 245 (606)
T ss_dssp TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC----
T ss_pred hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC----
Confidence 8898887776 79999999987666666555 8999999999997 356778889999999998877665321
Q ss_pred CCCccCcEEEccCCCCCCCcCCCCCccccccceec-ccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcc
Q 042958 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYI-HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLA 364 (1075)
Q Consensus 286 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~ 364 (1075)
.+.. +....+..+..+ .++.+++ ..|.+.+..|. +..+++|+.|++++|.+. .+| .+..+++|+
T Consensus 246 ----~l~~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~ 310 (606)
T 3vq2_A 246 ----NLEI-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQ 310 (606)
T ss_dssp ----CCSC-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCS
T ss_pred ----cccc-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCC
Confidence 0100 000111111222 3444444 45555555554 666666666666666665 334 566666667
Q ss_pred eeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccccc--ccccccccccceecccc
Q 042958 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI--PSEFGNLRSLSTLSLGY 442 (1075)
Q Consensus 365 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~ 442 (1075)
+|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|++++.. |..+..+++|++|++++
T Consensus 311 ~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~ 385 (606)
T 3vq2_A 311 SLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385 (606)
T ss_dssp EEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCS
T ss_pred EEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCC
Confidence 777777666 5555 33 6667777777777543322 4556777777777777776552 56677777777777777
Q ss_pred cccccCCCCCCccccccccccccCCccccCCC-ccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCC
Q 042958 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI 521 (1075)
Q Consensus 443 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 521 (1075)
|.+++ +|..|..+++|+.|++++|++++..| ..+..+++|+.|++++|++++..|..++++++|+.|++++|++++.
T Consensus 386 n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~- 463 (606)
T 3vq2_A 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN- 463 (606)
T ss_dssp CSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG-
T ss_pred Ccccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCc-
Confidence 77763 55677777777777777777776666 5677777888888888887777777777777777777777665431
Q ss_pred CccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceee
Q 042958 522 PSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLD 601 (1075)
Q Consensus 522 ~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 601 (1075)
.+|..+..+++|++|+
T Consensus 464 ----------------------------------------------------------------~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 464 ----------------------------------------------------------------TLSNVFANTTNLTFLD 479 (606)
T ss_dssp ----------------------------------------------------------------EECSCCTTCTTCCEEE
T ss_pred ----------------------------------------------------------------chHHhhccCCCCCEEE
Confidence 1122334444555555
Q ss_pred cCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhcccc-ccceeecCCCccc
Q 042958 602 LSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQ-SLENLNLSHNSLV 680 (1075)
Q Consensus 602 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~-~L~~L~ls~N~l~ 680 (1075)
|++|++++..|..|+.+++|++|+|++|++++.+|..+..+++|++|||++|+|+. +|..+..++ +|+.|++++|++.
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcc
Confidence 55555555555555555555555555555555555555555555555555555552 444455554 3666666666665
Q ss_pred cCC
Q 042958 681 GLI 683 (1075)
Q Consensus 681 ~~~ 683 (1075)
...
T Consensus 559 c~c 561 (606)
T 3vq2_A 559 CIC 561 (606)
T ss_dssp CSS
T ss_pred cCC
Confidence 443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=548.80 Aligned_cols=494 Identities=21% Similarity=0.309 Sum_probs=327.5
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCC-CCCCCC--Ccc------------ceEEeCCCCceeEEEecccccccccCC
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNN-VTKTSP--CAW------------VGIHCNRGGRVNSINLTSIGLKGMLHD 66 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~-~~~~~~--c~w------------~gv~C~~~~~v~~l~l~~~~l~g~~~~ 66 (1075)
+|++||++||+++.++ +|+... +....+ |.| .||+|+..+||++|+|+++++.|.+++
T Consensus 269 ~d~~ALl~~k~~l~~~-------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 269 KDYKALKAIWEALDGK-------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHTTGG-------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred HHHHHHHHHHHHcCCC-------CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 5899999999999653 686321 001234 999 999999889999999999999999997
Q ss_pred cccCCCCCccEEEc-cCCCccCCCCcccccc-------------------------------------------------
Q 042958 67 FSFSSFPHLAYLDL-WHNQLYGNIPPQIGNI------------------------------------------------- 96 (1075)
Q Consensus 67 ~~~~~l~~L~~L~L-~~n~l~~~~p~~l~~l------------------------------------------------- 96 (1075)
+ +++|++|++||| ++|.++|..|......
T Consensus 342 ~-l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 A-IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp G-GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred H-HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 6 999999999999 8898888755321111
Q ss_pred --CCCceeeccc--CcccccCCCCCCCCCCCcEEEccCcccCCC-CCccccccCCcceeecccccccCCCCCCCC--CCC
Q 042958 97 --SRLKYLDLSS--NLFFGTIPPEIGHLSYLKTLQLFENQLNGS-IPYEIGRLSSLNYLALYSNYLEDLIPPSLG--NLS 169 (1075)
Q Consensus 97 --~~L~~L~Ls~--n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~--~l~ 169 (1075)
..++.+.+.. |.+++ +|..|+++++|++|+|++|++++. +|..+ +..+.|...+.+|..++ +++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~--------~~~s~n~~~g~iP~~l~f~~L~ 491 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW--------EDANSDYAKQYENEELSWSNLK 491 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC--------SCTTSHHHHHHTTSCCCGGGCT
T ss_pred cccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccc--------cccccccccccCChhhhhccCC
Confidence 1122222222 44444 455555555555555555555541 11000 00001111113566665 777
Q ss_pred CCCEEEcCCCCCCCCCCccccCccccceEeeeccc-ccc-ccCCCCcCCC-------CcCceeccccCCCCCCcc--ccc
Q 042958 170 NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNK-FSG-SIPHSLGNLT-------NLATLYLHNNSLFDSIPS--ELG 238 (1075)
Q Consensus 170 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l~~~~~~--~~~ 238 (1075)
+|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++ +|++|+|++|+++ .+|. .++
T Consensus 492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~ 570 (876)
T 4ecn_A 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ 570 (876)
T ss_dssp TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT
T ss_pred CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh
Confidence 77777777777777777777777777777777776 666 5665444443 7777777777776 5666 677
Q ss_pred CCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCcc-CcEEEccCCCCCCCcCCCCCcccc--c
Q 042958 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRS-LSMLNLGYNKLNGIIPHSLGNLTN--L 315 (1075)
Q Consensus 239 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~--L 315 (1075)
.+++|++|+|++|+++ .+| .|+.+++|++|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |
T Consensus 571 ~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L 646 (876)
T 4ecn_A 571 KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646 (876)
T ss_dssp TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCE
T ss_pred cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCC
Confidence 7777777777777777 566 6777777777777777777 56666777777 777777777777 55666665543 7
Q ss_pred cceecccccccCCCCccc---c--cccccccccccCCcccccCCCc-CCCCCCcceeeccccccCCCCccccC-------
Q 042958 316 ATLYIHNNSLSGSIPSEI---G--NLRSLSNLGLSGNKLSGSIPPS-LGYLSNLATLYLYSNSLFDSIPSELG------- 382 (1075)
Q Consensus 316 ~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~------- 382 (1075)
+.|+|++|.+.+.+|... . .+.+|+.|++++|+++ .+|.. +..+++|+.|+|++|.+. .+|..+.
T Consensus 647 ~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l 724 (876)
T 4ecn_A 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNY 724 (876)
T ss_dssp EEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCC
T ss_pred CEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccc
Confidence 777777777776554322 2 2346777777777777 34443 346777778888877775 4444332
Q ss_pred -CCcccceeeeccccccccCChhhc--cCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccccc
Q 042958 383 -NLRSLSMLSLGYNKLSGSIPHSLG--NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459 (1075)
Q Consensus 383 -~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (1075)
++++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+.++++|+.|+|++|+
T Consensus 725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~--------------- 787 (876)
T 4ecn_A 725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR--------------- 787 (876)
T ss_dssp TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB---------------
T ss_pred cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC---------------
Confidence 2348888888888887 6777776 88888888888888886 67778888888888888765
Q ss_pred ccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccccccccccc
Q 042958 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYN 539 (1075)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N 539 (1075)
++++|++.+.+|..|..+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++....+..+.....+..+.+.+|
T Consensus 788 ---~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n 861 (876)
T 4ecn_A 788 ---DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861 (876)
T ss_dssp ---CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECC
T ss_pred ---CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCC
Confidence 4556666666666666666666666666666 45555544 46666666666666555555555555566666666
Q ss_pred ccc
Q 042958 540 KLS 542 (1075)
Q Consensus 540 ~l~ 542 (1075)
++.
T Consensus 862 ~~~ 864 (876)
T 4ecn_A 862 KTQ 864 (876)
T ss_dssp TTS
T ss_pred Ccc
Confidence 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=496.36 Aligned_cols=516 Identities=22% Similarity=0.226 Sum_probs=320.8
Q ss_pred ceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecccc
Q 042958 148 NYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227 (1075)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 227 (1075)
...+.++..++.++. .+. +++++|+|++|++++..+.+|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~~~c~~~~l~~ip~-~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 86 (570)
T 2z63_A 10 ITYQCMELNFYKIPD-NLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (570)
T ss_dssp TEEECCSSCCSSCCS-SSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred cEEEeCCCCccccCC-Ccc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence 345555555555432 222 45777777777777666666777777777777777776666666777777777777777
Q ss_pred CCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCC-CCcccCCCccCcEEEccCCCCCCCcC
Q 042958 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS-IPSEFGNLRSLSMLNLGYNKLNGIIP 306 (1075)
Q Consensus 228 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~ 306 (1075)
.+++..|..|+.+++|++|++++|++++..+..++++++|++|++++|.+++. +|..|+++++|++|++++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred cCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 76665566666777777777777776654444566666666666666666652 46666666666666666666666555
Q ss_pred CCCCccccc----cceecccccccCCCCcccccccccccccccCCcccc-cCCCcCCCCCCcceeeccccccCCCCcccc
Q 042958 307 HSLGNLTNL----ATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG-SIPPSLGYLSNLATLYLYSNSLFDSIPSEL 381 (1075)
Q Consensus 307 ~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 381 (1075)
..|+.+++| +.|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+.-+.+...
T Consensus 167 ~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~----- 240 (570)
T 2z63_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE----- 240 (570)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC-----
T ss_pred HHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc-----
Confidence 666666666 566666666665555555544 56666666553221 1223334444444433322211100
Q ss_pred CCCcccceeeeccccccccCChhhccCC--CCCeEEeecc-ccccccccccccccccceecccccccccCCCCCCccccc
Q 042958 382 GNLRSLSMLSLGYNKLSGSIPHSLGNLT--NLATLDLYDN-SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTN 458 (1075)
Q Consensus 382 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 458 (1075)
+.+.......+..++ .++.+++++| .+.+..|..|..+++|++|++++|.++ .+|..+..+ +
T Consensus 241 -------------~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~ 305 (570)
T 2z63_A 241 -------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-G 305 (570)
T ss_dssp -------------SSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-C
T ss_pred -------------hhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-C
Confidence 000001111122221 1334444444 444444444555555555555555544 344444444 5
Q ss_pred cccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCC--CccccCccccccccc
Q 042958 459 LDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSI--PSELGNLRSLSMLSF 536 (1075)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~l 536 (1075)
|+.|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++|.+++.. |..+..+++|+.|++
T Consensus 306 L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l 380 (570)
T 2z63_A 306 WQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380 (570)
T ss_dssp CSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEEC
T ss_pred ccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEEC
Confidence 555555555554 3332 2444455555555554433332 44455555555555544322 333344444333333
Q ss_pred cccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccc-cccCcccccceeecCCCcccCcccccc
Q 042958 537 AYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLS-PKLGSLAQLEHLDLSSNRLSNSIPKSF 615 (1075)
Q Consensus 537 ~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 615 (1075)
++|. +.+..+. +..+++|+.|++++|++++..+ ..+..+++|++|++++|++++..|..|
T Consensus 381 ~~n~------------------l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 441 (570)
T 2z63_A 381 SFNG------------------VITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441 (570)
T ss_dssp CSCS------------------EEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred CCCc------------------ccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhh
Confidence 3333 3322222 5555566666666666665544 457889999999999999998899999
Q ss_pred cccccceEEEccccccc-cccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhccccccc
Q 042958 616 GNLVKLHYLNLSNNQFS-RGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLL 694 (1075)
Q Consensus 616 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~ 694 (1075)
..+++|++|+|++|+++ +.+|..+..+++|++|+|++|++++..|..+..+++|+.|++++|++++.+|..|.+++.|+
T Consensus 442 ~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 521 (570)
T 2z63_A 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521 (570)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCc
Confidence 99999999999999997 57899999999999999999999998899999999999999999999999999999999999
Q ss_pred EEeecCCccCCCCCCCc
Q 042958 695 RIDISYNELQGPIPNSI 711 (1075)
Q Consensus 695 ~l~~s~N~~~~~~p~~~ 711 (1075)
.|++++|+++|.+|...
T Consensus 522 ~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 522 KIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EEECCSSCBCCCTTTTH
T ss_pred EEEecCCcccCCCcchH
Confidence 99999999999998743
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=495.61 Aligned_cols=499 Identities=24% Similarity=0.203 Sum_probs=295.7
Q ss_pred EEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcc
Q 042958 53 INLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQ 132 (1075)
Q Consensus 53 l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 132 (1075)
++|++.++...+.. + .+++++|||++|++++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 12 ~~c~~~~l~~ip~~--l--~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 87 (570)
T 2z63_A 12 YQCMELNFYKIPDN--L--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (570)
T ss_dssp EECCSSCCSSCCSS--S--CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEeCCCCccccCCC--c--cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCc
Confidence 45555566543322 1 2468888888888887777788888888888888888887777778888888888888888
Q ss_pred cCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCC-CCccccCccccceEeeeccccccccCC
Q 042958 133 LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDS-IPSEFGNLRSLSMLSLGYNKFSGSIPH 211 (1075)
Q Consensus 133 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 211 (1075)
+++..|..|+++++|++|++++|.++++.+..++++++|++|++++|.+++. +|..|+++++|++|++++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred CCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 8876677888888888888888888887776788888888888888888763 577888888888888888888877777
Q ss_pred CCcCCCCc----CceeccccCCCCCCcccccCCCCCCeEeccCCCCCC-ccCCCCcccccccccccccccCc------CC
Q 042958 212 SLGNLTNL----ATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLYLYENSLS------GS 280 (1075)
Q Consensus 212 ~l~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~------~~ 280 (1075)
.++.+++| ++|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+....+. ..
T Consensus 168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~ 246 (570)
T 2z63_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246 (570)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence 77777777 778888888877767666655 68888888774432 12223333333333333222111 11
Q ss_pred CCcccCCCcc--CcEEEccCC-CCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcC
Q 042958 281 IPSEFGNLRS--LSMLNLGYN-KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL 357 (1075)
Q Consensus 281 ~~~~~~~l~~--L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l 357 (1075)
....|..+++ ++.+++++| .+.+..+..|..+++|++|++++|.+. .+|..+..+ +|++|++++|.+. .+|.
T Consensus 247 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~-- 321 (570)
T 2z63_A 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT-- 321 (570)
T ss_dssp CTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--
T ss_pred chhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--
Confidence 1122222221 334444444 444444555555555555555555555 344444444 5555555555554 2332
Q ss_pred CCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccC--ChhhccCCCCCeEEeecccccccccccccccccc
Q 042958 358 GYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI--PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435 (1075)
Q Consensus 358 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 435 (1075)
..+++|++|++++|.+.+..+. ..+++|++|++++|++++.. +..+..+++|++|++++|.+++..+. |..+++|
T Consensus 322 ~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L 398 (570)
T 2z63_A 322 LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQL 398 (570)
T ss_dssp CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTC
T ss_pred ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCC
Confidence 2444555555555554433332 44455555555555554332 44455555555555555555543332 5555555
Q ss_pred ceecccccccccCCC-CCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc-CCCcccccCCCccceeecc
Q 042958 436 STLSLGYNKLSGSIP-HSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS-GSIPQSLGNLSNLVILYLY 513 (1075)
Q Consensus 436 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 513 (1075)
++|++++|.+++..| ..+.++++|++|++++|++++..|..+..+++|+.|++++|+++ +.+|..+..+++|+.|+++
T Consensus 399 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~ 478 (570)
T 2z63_A 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478 (570)
T ss_dssp CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECC
Confidence 555555555554333 34455555555555555555555555555555555555555554 3445555555555555555
Q ss_pred CCCCCCCCCccccCccccccccccccccccccC------CcccccccCCCccccccc
Q 042958 514 NNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP------HSLGVLDLSSNHIVGEIP 564 (1075)
Q Consensus 514 ~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p------~~l~~L~Ls~N~l~~~~p 564 (1075)
+|++++..|..+..+++|+.|++++|++++..| ++++.|++++|.+++..|
T Consensus 479 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 555555445555555555555555555544322 134555555555555443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=490.55 Aligned_cols=482 Identities=22% Similarity=0.237 Sum_probs=382.3
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.|| |+.. ++++.. +|+. + .++|++|||++|++++..|..++++++|++|+|++|.+++..|.+
T Consensus 4 C~~~~~-c~~~---------~~~l~~-ip~~-~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~ 69 (549)
T 2z81_A 4 CDASGV-CDGR---------SRSFTS-IPSG-L--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69 (549)
T ss_dssp ECTTSE-EECT---------TSCCSS-CCSC-C--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT
T ss_pred CCCCce-EECC---------CCcccc-cccc-C--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh
Confidence 999999 9643 344443 3332 2 378999999999999888999999999999999999999888899
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCC-CCCCCCCCCCCCEEEcCCCCC-CCCCCccccCccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYDNSL-SDSIPSEFGNLRS 194 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l-~~~~~~~~~~l~~ 194 (1075)
|+++++|++|+|++|++++..|..|+.+++|++|++++|.++++ .|..++++++|++|++++|.+ ....+..|.++++
T Consensus 70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 99999999999999999987777899999999999999999985 467899999999999999984 4444578999999
Q ss_pred cceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCccc-ccCCCCCCeEeccCCCCCCcc--C-CCCccccccccc
Q 042958 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE-LGNLRSLSMLSLGYNKLSGSI--P-HSLGNLTNLATL 270 (1075)
Q Consensus 195 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~--~-~~~~~l~~L~~L 270 (1075)
|++|++++|++++..|..+..+++|++|++++|.+.. +|.. +..+++|++|++++|++++.. | .....+++|+.|
T Consensus 150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L 228 (549)
T 2z81_A 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228 (549)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred cCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence 9999999999999999999999999999999999864 4444 467999999999999999742 2 233457889999
Q ss_pred ccccccCcCCCC----cccCCCccCcEEEccCCCCCCCc------CCCCCccccccceecccccccCC-----CCccccc
Q 042958 271 YLYENSLSGSIP----SEFGNLRSLSMLNLGYNKLNGII------PHSLGNLTNLATLYIHNNSLSGS-----IPSEIGN 335 (1075)
Q Consensus 271 ~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~ 335 (1075)
++++|.+++..+ ..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+... .+..+..
T Consensus 229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~ 308 (549)
T 2z81_A 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308 (549)
T ss_dssp EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHH
T ss_pred eccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhh
Confidence 999999886433 34566789999999999887542 23456778888898888876532 1222334
Q ss_pred ccccccccccCCcccccCCCcC-CCCCCcceeeccccccCCCCc---cccCCCcccceeeeccccccccCC--hhhccCC
Q 042958 336 LRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFDSIP---SELGNLRSLSMLSLGYNKLSGSIP--HSLGNLT 409 (1075)
Q Consensus 336 l~~L~~L~l~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~ 409 (1075)
..+|+.|++++|++. .+|..+ ..+++|++|++++|++.+..| ..++.+++|++|++++|++++..+ ..+..++
T Consensus 309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 567888888888887 556555 568888888888888876654 336778888888888888875432 4577888
Q ss_pred CCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCC
Q 042958 410 NLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489 (1075)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 489 (1075)
+|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+. ++|++|+|++|++++.+ ..+++|++|+|+
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 8888888888887 46777888888888888888887 3444432 57888888888888642 467788888888
Q ss_pred CCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccc
Q 042958 490 NNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGS 544 (1075)
Q Consensus 490 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 544 (1075)
+|+|+ .+|. .+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 88887 4555 46788888888888888887777788888777777777776543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=501.05 Aligned_cols=451 Identities=20% Similarity=0.300 Sum_probs=372.9
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcc------cc------cCCCCCCCCCCCcEEEccCcccCCCCCcc
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLF------FG------TIPPEIGHLSYLKTLQLFENQLNGSIPYE 140 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 140 (1075)
.+++.|||+++++.|.+|+++++|++|++|+|++|.+ .+ .+|... +..|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4789999999999999999999999999999999987 33 344333 56677 889999998888877
Q ss_pred ccc-cCCcceeecccccccCCCCCCCCCCCCCCEEEcC--CCCCCCCCCccccCccccceEeeeccccccc---------
Q 042958 141 IGR-LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY--DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGS--------- 208 (1075)
Q Consensus 141 ~~~-l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--------- 208 (1075)
+.. +..+..+++....+.. .....++.+.+. .|++++ +|..|+++++|++|+|++|++++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 664 3444455554433322 112233333333 578888 888899999999999999999975
Q ss_pred --------cCCCCc--CCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCC-CCC-ccCCCCccc------cccccc
Q 042958 209 --------IPHSLG--NLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK-LSG-SIPHSLGNL------TNLATL 270 (1075)
Q Consensus 209 --------~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L 270 (1075)
+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|++++|+ +++ .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 899998 99999999999999999999999999999999999998 888 788888776 899999
Q ss_pred ccccccCcCCCCc--ccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccc-cccccccCC
Q 042958 271 YLYENSLSGSIPS--EFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRS-LSNLGLSGN 347 (1075)
Q Consensus 271 ~L~~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~N 347 (1075)
++++|+++ .+|. .|+.+++|++|++++|+++|.+| .|+.+++|++|++++|.++ .+|..+..+++ |++|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 99999999 7888 89999999999999999997888 8999999999999999999 78888999999 999999999
Q ss_pred cccccCCCcCCCCC--CcceeeccccccCCCCccccC-------CCcccceeeeccccccccCChhhccCCCCCeEEeec
Q 042958 348 KLSGSIPPSLGYLS--NLATLYLYSNSLFDSIPSELG-------NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418 (1075)
Q Consensus 348 ~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 418 (1075)
+++ .+|..+..++ +|++|++++|.+.+..|..+. .+.+|++|+|++|+++...+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 999 7888887765 899999999999998888888 788999999999999865555667799999999999
Q ss_pred cccccccccccccc-------cccceecccccccccCCCCCCc--cccccccccccCCccccCCCccccCcCCCCEEeC-
Q 042958 419 NSLSGSIPSEFGNL-------RSLSTLSLGYNKLSGSIPHSLG--NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL- 488 (1075)
Q Consensus 419 N~l~~~~~~~~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L- 488 (1075)
|+++.+.+..+... ++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 467 N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls 544 (636)
T 4eco_A 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544 (636)
T ss_dssp SCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECC
T ss_pred CCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECC
Confidence 99995544455443 38999999999998 6777776 89999999999999997 8888999999999999
Q ss_pred -----CCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccc
Q 042958 489 -----NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS 542 (1075)
Q Consensus 489 -----~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~ 542 (1075)
++|++.+.+|..++++++|+.|+|++|++ +.+|..+. ++|+.|++++|++.
T Consensus 545 ~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp SCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred CCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 45777778888888888888888888888 56666554 56666666666543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=478.09 Aligned_cols=484 Identities=21% Similarity=0.213 Sum_probs=254.4
Q ss_pred cEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecc
Q 042958 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203 (1075)
Q Consensus 124 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (1075)
.+.|.++|.++ .+|..+. ++|++|++++|.++++.|..|.++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus 8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 34566677776 4555432 45666666666665555555555555555555555555555555555555555555555
Q ss_pred ccccccCCCCcCCCCcCceeccccCCCCC-CcccccCCCCCCeEeccCCCCCCccC-CCCcccccccccccccccCcCCC
Q 042958 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLYLYENSLSGSI 281 (1075)
Q Consensus 204 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~ 281 (1075)
++++..|..|+++++|++|++++|.+++. .|..++.+++|++|++++|.+.+.+| ..|.++++|++|++++|.+++..
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 55544444455555555555555555432 33445555555555555555322232 34555555555555555555545
Q ss_pred CcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCC
Q 042958 282 PSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLS 361 (1075)
Q Consensus 282 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~ 361 (1075)
|..+..+++|+.|++++|.+.......+..+++|++|++++|.+++.... .......++
T Consensus 165 ~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------------~~~~~~~~~ 223 (549)
T 2z81_A 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS---------------------PLPVDEVSS 223 (549)
T ss_dssp TTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCC---------------------CCSSCCCCC
T ss_pred hhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccccc---------------------ccchhhhhh
Confidence 55555555555555555554422222223344555555555554432100 011122344
Q ss_pred CcceeeccccccCCCCc----cccCCCcccceeeeccccccccC------ChhhccCCCCCeEEeecccccccc-----c
Q 042958 362 NLATLYLYSNSLFDSIP----SELGNLRSLSMLSLGYNKLSGSI------PHSLGNLTNLATLDLYDNSLSGSI-----P 426 (1075)
Q Consensus 362 ~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~-----~ 426 (1075)
+|+.|++++|.+.+..+ ..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+.... +
T Consensus 224 ~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~ 303 (549)
T 2z81_A 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303 (549)
T ss_dssp CCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCC
T ss_pred cccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccch
Confidence 45555555554433222 22234455555555555554321 122345556666666666554211 1
Q ss_pred cccccccccceecccccccccCCCCCC-ccccccccccccCCccccCCC---ccccCcCCCCEEeCCCCcccCCCc--cc
Q 042958 427 SEFGNLRSLSTLSLGYNKLSGSIPHSL-GNLTNLDALYLYDNSLSGSIP---GEIGNLRSISNLALNNNKLSGSIP--QS 500 (1075)
Q Consensus 427 ~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~ 500 (1075)
..+....+|+.|++++|+++ .+|..+ .++++|++|+|++|++++.+| ..++.+++|+.|++++|++++..+ ..
T Consensus 304 ~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 382 (549)
T 2z81_A 304 TVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382 (549)
T ss_dssp HHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHH
T ss_pred hhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhh
Confidence 12233456666666666665 445444 356666777777776665543 235666677777777777764332 34
Q ss_pred ccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcc
Q 042958 501 LGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQ 580 (1075)
Q Consensus 501 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~ 580 (1075)
++.+++|+.|++++|+++ .+|..+..+++|+.|++++|++++ +|.
T Consensus 383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-------------------l~~--------------- 427 (549)
T 2z81_A 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-------------------VKT--------------- 427 (549)
T ss_dssp GGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-------------------CCT---------------
T ss_pred hhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-------------------ccc---------------
Confidence 666777777777777765 456666666666655555555431 110
Q ss_pred cccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchh
Q 042958 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP 660 (1075)
Q Consensus 581 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~ 660 (1075)
.. .++|++|||++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|
T Consensus 428 -----~~------~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~ 490 (549)
T 2z81_A 428 -----CI------PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPD 490 (549)
T ss_dssp -----TS------CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCT
T ss_pred -----hh------cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCH
Confidence 00 024555555555555421 34555555555555555 3343 3445566666666666666555
Q ss_pred hhhccccccceeecCCCccccCCh
Q 042958 661 SQICIMQSLENLNLSHNSLVGLIP 684 (1075)
Q Consensus 661 ~~~~~~~~L~~L~ls~N~l~~~~p 684 (1075)
..+..+++|+.|++++|++.+..|
T Consensus 491 ~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 491 GIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp TGGGGCTTCCEEECCSSCBCCCHH
T ss_pred HHHhcCcccCEEEecCCCccCCCc
Confidence 556666666666666666665555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=481.91 Aligned_cols=458 Identities=22% Similarity=0.264 Sum_probs=375.0
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeec-ccCcccccCCCCCCCC----CCCc--EEEc----------cCcccC-
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDL-SSNLFFGTIPPEIGHL----SYLK--TLQL----------FENQLN- 134 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-s~n~l~~~~p~~l~~l----~~L~--~L~L----------s~n~l~- 134 (1075)
.+++.|+|++|++.|.+|+.|++|++|++|+| ++|.++|..|-..... ..++ .+.. ....+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 47899999999999999999999999999999 8999988755332111 0000 0000 000000
Q ss_pred ----------CCCCccccccCCcceeeccc--ccccCCCCCCCCCCCCCCEEEcCCCCCCC-----------------CC
Q 042958 135 ----------GSIPYEIGRLSSLNYLALYS--NYLEDLIPPSLGNLSNLDTLHLYDNSLSD-----------------SI 185 (1075)
Q Consensus 135 ----------~~~p~~~~~l~~L~~L~L~~--n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-----------------~~ 185 (1075)
...+........++.+.+.. |.+++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 00111112233455555544 88888 68889999999999999999998 38
Q ss_pred Ccccc--CccccceEeeeccccccccCCCCcCCCCcCceeccccC-CCC-CCcccccCCC-------CCCeEeccCCCCC
Q 042958 186 PSEFG--NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS-LFD-SIPSELGNLR-------SLSMLSLGYNKLS 254 (1075)
Q Consensus 186 ~~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~Ls~N~l~ 254 (1075)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++ +|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 88877 99999999999999999999999999999999999998 887 7887766655 9999999999999
Q ss_pred CccCC--CCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcccc-ccceecccccccCCCCc
Q 042958 255 GSIPH--SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN-LATLYIHNNSLSGSIPS 331 (1075)
Q Consensus 255 ~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~ 331 (1075)
.+|. .++++++|++|+|++|.++ .+| .|..+++|+.|+|++|++. .+|..+..+++ |++|+|++|.++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 8888 8999999999999999999 778 8999999999999999999 78888999999 999999999999 7888
Q ss_pred ccccccc--cccccccCCcccccCCCcC---C--CCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChh
Q 042958 332 EIGNLRS--LSNLGLSGNKLSGSIPPSL---G--YLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404 (1075)
Q Consensus 332 ~~~~l~~--L~~L~l~~N~l~~~~~~~l---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 404 (1075)
.+..++. |+.|++++|++++.+|... . .+++|+.|+|++|.+....+..+..+++|+.|+|++|+++ .+|..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 715 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence 8887765 9999999999998665432 2 3458999999999997444344558999999999999998 55554
Q ss_pred hcc--------CCCCCeEEeeccccccccccccc--cccccceecccccccccCCCCCCccccccccccccCCccccCCC
Q 042958 405 LGN--------LTNLATLDLYDNSLSGSIPSEFG--NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP 474 (1075)
Q Consensus 405 ~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 474 (1075)
+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++|+
T Consensus 716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------ 787 (876)
T 4ecn_A 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------ 787 (876)
T ss_dssp SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------
T ss_pred HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------
Confidence 433 239999999999999 6777776 99999999999999996 78899999999999999998
Q ss_pred ccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCC------c
Q 042958 475 GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH------S 548 (1075)
Q Consensus 475 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~------~ 548 (1075)
++++|++.+.+|..+.++++|+.|+|++|++ +.+|..+. ++|+.|++++|++...-+. .
T Consensus 788 ------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~ 852 (876)
T 4ecn_A 788 ------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIE 852 (876)
T ss_dssp ------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHH
T ss_pred ------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHcccccc
Confidence 6789999999999999999999999999999 78888876 6999999999998642222 2
Q ss_pred ccccccCCCccc
Q 042958 549 LGVLDLSSNHIV 560 (1075)
Q Consensus 549 l~~L~Ls~N~l~ 560 (1075)
...+.|+.|.+.
T Consensus 853 ~~~~~L~~n~~~ 864 (876)
T 4ecn_A 853 AGMYVLLYDKTQ 864 (876)
T ss_dssp TTCCEEECCTTS
T ss_pred chheeecCCCcc
Confidence 345666666654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=469.41 Aligned_cols=557 Identities=23% Similarity=0.189 Sum_probs=292.6
Q ss_pred CcCCCCcCCCCCCCCCccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCce
Q 042958 22 LLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKY 101 (1075)
Q Consensus 22 ~l~sw~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 101 (1075)
.+++|. .+.|..|+...|...+ +.++|++.+|...+..- -+++++|||++|+|++..|..|+++++|++
T Consensus 12 ~~~~~~-----~~~p~~~~~c~~~~~~--~~~~c~~~~l~~vP~~l----p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~ 80 (635)
T 4g8a_A 12 KLAAAN-----SSIPESWEPCVEVVPN--ITYQCMELNFYKIPDNL----PFSTKNLDLSFNPLRHLGSYSFFSFPELQV 80 (635)
T ss_dssp ------------------CCSEEEETT--TEEECTTSCCSSCCSSS----CTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred hhhccc-----CCCCCCCCCccccCCC--CEEECCCCCcCccCCCC----CcCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence 577886 4445557665554333 23578888887654322 136788888888888666667888888888
Q ss_pred eecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCC
Q 042958 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSL 181 (1075)
Q Consensus 102 L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 181 (1075)
|||++|.|++..|.+|.++++|++|+|++|+|++..+..|.++++|++|++++|.++++.+..|+++++|++|+|++|++
T Consensus 81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence 88888888766667778888888888888877755555666666666666666666666665666666666666666666
Q ss_pred CCC-CCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCC
Q 042958 182 SDS-IPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 260 (1075)
Q Consensus 182 ~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 260 (1075)
++. .|..++.+++|++|+|++|++++..+..|..+.+++. ....++++.|.+....+..
T Consensus 161 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~--------------------~~~~~~ls~n~l~~i~~~~ 220 (635)
T 4g8a_A 161 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--------------------LNLSLDLSLNPMNFIQPGA 220 (635)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTT--------------------CCCEEECTTCCCCEECTTT
T ss_pred ccCCCchhhccchhhhhhcccCccccccccccccchhhhhh--------------------hhhhhhcccCcccccCccc
Confidence 542 3455555666666666666665554444444333221 1123455555555333322
Q ss_pred CcccccccccccccccCcCC-CCcccCCCccCcEEEccCCCC------CCCcCCCCCccccccceecccccccCCCCccc
Q 042958 261 LGNLTNLATLYLYENSLSGS-IPSEFGNLRSLSMLNLGYNKL------NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333 (1075)
Q Consensus 261 ~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 333 (1075)
+. ...++.+++.+|..+.. .+..+..+..++...+..+.. .......+..+..+....+..+......
T Consensus 221 ~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~---- 295 (635)
T 4g8a_A 221 FK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL---- 295 (635)
T ss_dssp TT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCE----
T ss_pred cc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccc----
Confidence 22 23345555555543321 223344455555544433222 2222233444444444444433322110
Q ss_pred ccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCe
Q 042958 334 GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLAT 413 (1075)
Q Consensus 334 ~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 413 (1075)
...+..+....+++.+.+.+|.+... ..+....+|+.|++++|.+.+..+. .+..|+.
T Consensus 296 -----------------~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~ 353 (635)
T 4g8a_A 296 -----------------DGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKR 353 (635)
T ss_dssp -----------------EECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCE
T ss_pred -----------------cchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhh
Confidence 01122233334444444444444222 1223334455555555555433221 2344555
Q ss_pred EEeeccccccccccccccccccceeccccccccc--CCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCC
Q 042958 414 LDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG--SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNN 491 (1075)
Q Consensus 414 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 491 (1075)
+++++|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|+.+++..|.+.. .+..+..+++|+.++++.|
T Consensus 354 l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~ 430 (635)
T 4g8a_A 354 LTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 430 (635)
T ss_dssp EEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTS
T ss_pred cccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhc
Confidence 55555555422 223345556666666665532 233444455666666666666653 4445666666666766666
Q ss_pred cccCCC-cccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhhhh
Q 042958 492 KLSGSI-PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKL 570 (1075)
Q Consensus 492 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~ 570 (1075)
.+.... +..+.++++++.+++++|.+.+..+..+..+++|+.|++++|.+.
T Consensus 431 ~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~---------------------------- 482 (635)
T 4g8a_A 431 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ---------------------------- 482 (635)
T ss_dssp EEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG----------------------------
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccc----------------------------
Confidence 554433 334666777777777777665555555554444444444443321
Q ss_pred hHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeee
Q 042958 571 NFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650 (1075)
Q Consensus 571 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 650 (1075)
.+..|..|..+++|++|||++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|||
T Consensus 483 -------------~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 549 (635)
T 4g8a_A 483 -------------ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 549 (635)
T ss_dssp -------------GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEEC
T ss_pred -------------cccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEEC
Confidence 1123344555566666666666666555666666666666666666666555555555555555555
Q ss_pred ccccccCchhhhhccc-cccceeecCCCccc
Q 042958 651 SHNFLREAIPSQICIM-QSLENLNLSHNSLV 680 (1075)
Q Consensus 651 s~N~l~~~~~~~~~~~-~~L~~L~ls~N~l~ 680 (1075)
++|+|++..|..+..+ ++|+.|++++|++.
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 5555555555555444 34555555555544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=463.18 Aligned_cols=457 Identities=21% Similarity=0.270 Sum_probs=299.1
Q ss_pred CEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCC
Q 042958 172 DTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYN 251 (1075)
Q Consensus 172 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 251 (1075)
++|++++|+++. +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 467777777774 444444 67777777777777655566777777777777777776666666777777777777777
Q ss_pred CCCCccCCCCcccccccccccccccCcC-CCCcccCCCccCcEEEccCCCCCCCcCCCCCccccc--cceecccccc--c
Q 042958 252 KLSGSIPHSLGNLTNLATLYLYENSLSG-SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL--ATLYIHNNSL--S 326 (1075)
Q Consensus 252 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 326 (1075)
+++ .+|.. .+++|++|++++|.+++ .+|..|+++++|++|++++|.+++ ..|..+++| ++|++++|.+ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 776 34444 56666666666666665 245666666666666666666653 234455555 6666666665 4
Q ss_pred CCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCcc-ccCCCcccceeeecccc-------cc
Q 042958 327 GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS-ELGNLRSLSMLSLGYNK-------LS 398 (1075)
Q Consensus 327 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~ 398 (1075)
+..|..+..+.. ....+++++|.+.+.++. .+.++++|+.|++++|. +.
T Consensus 154 ~~~~~~l~~l~~-----------------------~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 210 (520)
T 2z7x_B 154 KEDPEGLQDFNT-----------------------ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210 (520)
T ss_dssp SCCTTTTTTCCE-----------------------EEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred cccccccccccc-----------------------ceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence 444544444331 122334444444443332 34556666666666665 44
Q ss_pred ccCChhhccCCCCCeEEeeccccccccccccc---cccccceecccccccccCCCCCC-----ccccccccccccCCccc
Q 042958 399 GSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG---NLRSLSTLSLGYNKLSGSIPHSL-----GNLTNLDALYLYDNSLS 470 (1075)
Q Consensus 399 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~ 470 (1075)
+.+| .++.+++|+.|++++|.+++..+..+. ..++|++|++++|++++.+|..+ +++++|+.+++++|.+
T Consensus 211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~- 288 (520)
T 2z7x_B 211 SILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF- 288 (520)
T ss_dssp HHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred cchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-
Confidence 4444 566777777777777766643322211 13477777777777777777777 7777888888888877
Q ss_pred cCCC-ccccCc---CCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccC
Q 042958 471 GSIP-GEIGNL---RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP 546 (1075)
Q Consensus 471 ~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p 546 (1075)
.+| ..+..+ .+|+.|++++|.+.... .+..+++|+.|++++|++++..|..++.+++|+.|++++|++++
T Consensus 289 -~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--- 362 (520)
T 2z7x_B 289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE--- 362 (520)
T ss_dssp -CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCB---
T ss_pred -ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCc---
Confidence 344 445444 56888888888775432 12577788888888888877777777777777666666665541
Q ss_pred CcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccc-cccccccceEEE
Q 042958 547 HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK-SFGNLVKLHYLN 625 (1075)
Q Consensus 547 ~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ 625 (1075)
++ .+|..+..+++|++|||++|++++.+|. .|..+++|++|+
T Consensus 363 ----------------l~---------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 363 ----------------LS---------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp ----------------HH---------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ----------------cc---------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 00 1234456677788888888888764554 377778888888
Q ss_pred ccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccccccEEeecCCccCC
Q 042958 626 LSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQG 705 (1075)
Q Consensus 626 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~~~ 705 (1075)
+++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|++++|+|++..+..|..++.|+.|++++|+++|
T Consensus 406 Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 406 MSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp CCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence 888888776666654 67888888888887 577777788888888888888885444447888888888888888887
Q ss_pred CCC
Q 042958 706 PIP 708 (1075)
Q Consensus 706 ~~p 708 (1075)
.++
T Consensus 483 ~c~ 485 (520)
T 2z7x_B 483 SCP 485 (520)
T ss_dssp CHH
T ss_pred cCC
Confidence 765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=466.81 Aligned_cols=450 Identities=22% Similarity=0.208 Sum_probs=310.2
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
++||+++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45666777666 5666555 66777777777776555566677777777777777776666666777777777777777
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCC-CCCccccCccccceEeeeccccccccCCCCcCCCCc--CceeccccCC--C
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL--ATLYLHNNSL--F 230 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~~L~L~~N~l--~ 230 (1075)
.++.+++. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ .
T Consensus 80 ~l~~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLVKISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCCEEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred ceeecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 77654332 67777777777777776 356777777777777777777764 345566666 7777777777 6
Q ss_pred CCCcccccCCC-CCCeEeccCCCCCCccC-CCCccccccccccccccc-------CcCCCCcccCCCccCcEEEccCCCC
Q 042958 231 DSIPSELGNLR-SLSMLSLGYNKLSGSIP-HSLGNLTNLATLYLYENS-------LSGSIPSEFGNLRSLSMLNLGYNKL 301 (1075)
Q Consensus 231 ~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~l 301 (1075)
+..|..+..+. +...+++++|.+.+.++ ..+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 66666666554 33456677777766444 356677777888877776 555444 667777778887777776
Q ss_pred CCCcCCCCC---ccccccceecccccccCCCCccc-----ccccccccccccCCcccccCC-CcCCCC---CCcceeecc
Q 042958 302 NGIIPHSLG---NLTNLATLYIHNNSLSGSIPSEI-----GNLRSLSNLGLSGNKLSGSIP-PSLGYL---SNLATLYLY 369 (1075)
Q Consensus 302 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~-~~l~~l---~~L~~L~L~ 369 (1075)
.+..+..+. .+++|++|++++|.+++.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~ 310 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence 643221111 13477778888888777777777 7777778888877777 344 334333 567788888
Q ss_pred ccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccc--ccccccccccccceeccccccccc
Q 042958 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSG--SIPSEFGNLRSLSTLSLGYNKLSG 447 (1075)
Q Consensus 370 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~ 447 (1075)
+|.+.... .+..+++|++|++++|++++..|..++.+++|++|++++|++++ ..|..|+.+++|++|++++|++++
T Consensus 311 ~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 388 (520)
T 2z7x_B 311 GTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388 (520)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred CCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence 88774332 12567778888888888877777778888888888888888875 345667788888888888888876
Q ss_pred CCCC-CCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCc-cc
Q 042958 448 SIPH-SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS-EL 525 (1075)
Q Consensus 448 ~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l 525 (1075)
.+|. .+..+++|++|++++|++++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|+|++|++++ +|. .+
T Consensus 389 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~ 464 (520)
T 2z7x_B 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIF 464 (520)
T ss_dssp CGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTT
T ss_pred ccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHh
Confidence 4444 477778888888888888776666554 67888888888887 667766788888888888888874 444 37
Q ss_pred cCcccccccccccccccc
Q 042958 526 GNLRSLSMLSFAYNKLSG 543 (1075)
Q Consensus 526 ~~l~~L~~L~l~~N~l~~ 543 (1075)
..+++|+.|++++|.+++
T Consensus 465 ~~l~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 465 DRLTSLQKIWLHTNPWDC 482 (520)
T ss_dssp TTCTTCCEEECCSSCBCC
T ss_pred ccCCcccEEECcCCCCcc
Confidence 777777777777766653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=460.13 Aligned_cols=538 Identities=22% Similarity=0.198 Sum_probs=344.4
Q ss_pred ceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCC
Q 042958 100 KYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179 (1075)
Q Consensus 100 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 179 (1075)
++.+.++-+++ .+|..+. +++++|||++|+|++..|.+|.++++|++|+|++|.|+++.+.+|.++++|++|+|++|
T Consensus 34 ~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N 110 (635)
T 4g8a_A 34 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 110 (635)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC
Confidence 34566666776 6776553 47888888888888666677888888888888888888877777888888888888888
Q ss_pred CCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC-CcccccCCCCCCeEeccCCCCCCccC
Q 042958 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIP 258 (1075)
Q Consensus 180 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~ 258 (1075)
+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++. .|..++.+++|++|++++|++++..+
T Consensus 111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 88777777788888888888888888766666777788888888888877653 46667777778888888777776666
Q ss_pred CCCccccccc----ccccccccCcCCCCcccCCCccCcEEEccCCCCCC-CcCCCCCccccccceecccccccCCCCccc
Q 042958 259 HSLGNLTNLA----TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG-IIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333 (1075)
Q Consensus 259 ~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 333 (1075)
..|..+.+++ .++++.|.++...+..+. ...++.+++.+|.... ..+..+..+..++...+..+....
T Consensus 191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~------ 263 (635)
T 4g8a_A 191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN------ 263 (635)
T ss_dssp GGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT------
T ss_pred ccccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhcccccccccchhhcCCccccccccccccccc------
Confidence 6666555443 344555555543333332 2334455555544331 111223333333333322221110
Q ss_pred ccccccccccccCCcccccCCCcCCCCCCcceeeccccccCC---CCccccCCCcccceeeeccccccccCChhhccCCC
Q 042958 334 GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD---SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 410 (1075)
Q Consensus 334 ~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 410 (1075)
...+.......+..+..+....+..+.... ..+..+..+.+++.+++.+|.+.... .+....+
T Consensus 264 ------------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~ 329 (635)
T 4g8a_A 264 ------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFG 329 (635)
T ss_dssp ------------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCC
T ss_pred ------------ccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchh
Confidence 001111122223333334333333332211 12223344455566666666554322 2344455
Q ss_pred CCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCcccc--CCCccccCcCCCCEEeC
Q 042958 411 LATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSG--SIPGEIGNLRSISNLAL 488 (1075)
Q Consensus 411 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L 488 (1075)
|+.|++++|.+....+ ..+..|+.+++.+|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|+.+++
T Consensus 330 L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~ 404 (635)
T 4g8a_A 330 WQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDL 404 (635)
T ss_dssp CSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEEC
T ss_pred hhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhc
Confidence 6666666665554332 2334555555555555422 223345555555555555532 23334444555555555
Q ss_pred CCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhh
Q 042958 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELG 568 (1075)
Q Consensus 489 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~ 568 (1075)
+.|.+.. .+..+..+++|+.+++++|......+ +..+.
T Consensus 405 ~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~-----------------------------------------~~~~~ 442 (635)
T 4g8a_A 405 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE-----------------------------------------FSVFL 442 (635)
T ss_dssp CSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTS-----------------------------------------SCTTT
T ss_pred ccccccc-ccccccccccccchhhhhcccccccc-----------------------------------------ccccc
Confidence 5555442 33344445555555554444332221 12233
Q ss_pred hhhHhHHHhhcccccccccccccCcccccceeecCCCcc-cCcccccccccccceEEEccccccccccchhcccccccce
Q 042958 569 KLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL-SNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSE 647 (1075)
Q Consensus 569 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 647 (1075)
.+..++.++++.|++++..+..+..++.|+.|+|++|.+ .+.+|..|..+++|++|+|++|+|++..|..|..+++|++
T Consensus 443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 443 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 344445555555666666667788889999999999975 4467889999999999999999999999999999999999
Q ss_pred eeeccccccCchhhhhccccccceeecCCCccccCChhhhccc-ccccEEeecCCccCCCCC
Q 042958 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKM-HGLLRIDISYNELQGPIP 708 (1075)
Q Consensus 648 L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~-~~l~~l~~s~N~~~~~~p 708 (1075)
|+|++|+|++..|..+..+++|+.|||++|+|++.+|..|..+ ++|+.|++++|+|+|.+.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999999999999999999999998 579999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=408.62 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=190.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.++||+|+||+||+|+++ ..||||+++.... .....++|.+|++++++++|||||+++|+|.+....+++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEE
Confidence 467788899999999999999875 3699999875433 3445678999999999999999999999997655444443
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC--
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-- 963 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-- 963 (1075)
+...+ ....++|.++.+|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 33221 235689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeccccccCccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 964 SNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||......... ..........+..+ ..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~---~~ 262 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI---IFMVGRGYASPDLS---KL 262 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHTTCCCCCST---TS
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH---HHHHhcCCCCCCcc---cc
Confidence 23445689999999999864 35899999999999999999999999754321111 11111122222222 22
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+++.++.+++.+||+.||++||||+||++.|+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 3345567999999999999999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=409.03 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=190.5
Q ss_pred CCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
++++.+.||+|+||+||+|.+. +++.||||+++.... ....++|.+|+.++++++|||||+++|+|.+.+..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 4556688999999999999763 468899999975432 23357899999999999999999999999875543
Q ss_pred hh-heecCc-----------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 890 LA-MILSNN-----------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 890 l~-~~~~~~-----------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
+. +.+... .....++|.++.+|+.|||+||+|||+. +||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 22 111111 0124589999999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1075)
+.+||+|||+|+....... ......||++|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------- 254 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------- 254 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 9999999999987654322 2345679999999999999999999999999999999998 89999754321
Q ss_pred hhhhhhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+.... .+.+ .+++..+.+++.+||+.||++||||+||++.|+
T Consensus 255 -~~~~~i~~~~~~~~p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 255 -DVVEMIRNRQVLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp -HHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1122222222 2222 234556999999999999999999999999885
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=407.59 Aligned_cols=242 Identities=23% Similarity=0.416 Sum_probs=190.2
Q ss_pred cCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56778899999999999999764 4788999999753 33456789999999999999999999999987654
Q ss_pred chh-heecCc--------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 889 SLA-MILSNN--------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 889 ~l~-~~~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
.+. +.+... .....++|.++++|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 322 222111 1124689999999999999999999999 9999999999999999999
Q ss_pred ceEeccccccccCCCCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhh
Q 042958 948 AHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1075)
+||+|||+|+......... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------- 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------- 238 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence 9999999998765433222 23468999999999999999999999999999999998 999997543211
Q ss_pred hhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+... ..+.| ..++.++.+++.+||+.||++||||+||.+.|+
T Consensus 239 ~~~~i~~~~~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 239 VIECITQGRVLQRP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp HHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11222222 22222 233456999999999999999999999998875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=407.46 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=184.9
Q ss_pred cCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
++|...++||+|+||+||+|+++ +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45667789999999999999764 4789999999753 34456789999999999999999999999987654
Q ss_pred chhh-eecCcc----------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 889 SLAM-ILSNNA----------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 889 ~l~~-~~~~~~----------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
.+.+ .+...+ ....++|.++++|+.|||+||+|||+. +||||||||+|||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 3222 211111 124589999999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 1022 (1075)
+.+||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~------ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE------ 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH------
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999987654332 2334679999999999999999999999999999999999 999997543211
Q ss_pred hhhhhhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+.. .+++.|. .++.++.+++.+||+.||++||||+||++.|+
T Consensus 269 --~~~~i~~g~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 269 --AIDCITQGRELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp --HHHHHHHTCCCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 1111111 2233322 33456999999999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=439.43 Aligned_cols=454 Identities=22% Similarity=0.212 Sum_probs=246.5
Q ss_pred eEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccC
Q 042958 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFE 130 (1075)
Q Consensus 51 ~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~ 130 (1075)
..++|+++++++. |.. + .++|++|||++|.+++..|..++.+++|++|+|++|.+++..|..|+++++|++|||++
T Consensus 34 ~~l~ls~~~L~~i-p~~-~--~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 34 SMVDYSNRNLTHV-PKD-L--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CEEECTTSCCCSC-CTT-S--CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred cEEEcCCCCCccC-CCC-C--CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 5667777777653 322 2 26677777777777766666777777777777777777766667777777777777777
Q ss_pred cccCCCCCccccccCCcceeecccccccCCC-CCCCCCCCCCCEEEcCCCCCCCCCCccccCcccc--ceEeeecccc--
Q 042958 131 NQLNGSIPYEIGRLSSLNYLALYSNYLEDLI-PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL--SMLSLGYNKF-- 205 (1075)
Q Consensus 131 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~Ls~N~l-- 205 (1075)
|+++ .+|.. .+++|++|++++|.++++. |..|+++++|++|++++|++++. .|..+++| ++|++++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 7776 45544 5666666666666666543 45566666666666666666542 23333444 6666666665
Q ss_pred ccccCCCCcCCC-CcCceeccccCCCCCCcc-cccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCc
Q 042958 206 SGSIPHSLGNLT-NLATLYLHNNSLFDSIPS-ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPS 283 (1075)
Q Consensus 206 ~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 283 (1075)
++..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|+.... .+.+ ...
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-------------------~l~~-~~~ 243 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-------------------RLMT-FLS 243 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-------------------HHHH-HHH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-------------------hHHH-HHH
Confidence 555555555443 111345555555443332 234455555555555531100 0111 111
Q ss_pred ccCCCccCcEEEccCCCCCCCc----CCCCCccccccceecccccccCCCCccc-----ccccccccccccCCcccccCC
Q 042958 284 EFGNLRSLSMLNLGYNKLNGII----PHSLGNLTNLATLYIHNNSLSGSIPSEI-----GNLRSLSNLGLSGNKLSGSIP 354 (1075)
Q Consensus 284 ~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~~~~ 354 (1075)
.|..+++|+.|+++++.+.+.. +..+ ..++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+|
T Consensus 244 ~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p 320 (562)
T 3a79_B 244 ELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFS 320 (562)
T ss_dssp HHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSC
T ss_pred HHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecC
Confidence 2333444444444444333210 0000 11245555555555554444444 3444444444444443 122
Q ss_pred -CcCCC---CCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccc--cccc
Q 042958 355 -PSLGY---LSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS--IPSE 428 (1075)
Q Consensus 355 -~~l~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~ 428 (1075)
..+.. ..+|++|++++|.+.... ....+++|++|++++|++++..|..++.+++|++|++++|++++. .|..
T Consensus 321 ~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 398 (562)
T 3a79_B 321 KEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398 (562)
T ss_dssp HHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT
T ss_pred hhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh
Confidence 11111 134566666666553221 114556666666666666665666666666666666666666642 2345
Q ss_pred cccccccceecccccccccCCC-CCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCcc
Q 042958 429 FGNLRSLSTLSLGYNKLSGSIP-HSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507 (1075)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 507 (1075)
|.++++|++|++++|++++.+| ..+..+++|++|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|
T Consensus 399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L 475 (562)
T 3a79_B 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL 475 (562)
T ss_dssp TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence 6666666666666666665333 3466666666666666666655554443 56667777777666 455555566777
Q ss_pred ceeeccCCCCCCCCCcc-ccCcccccccccccccccc
Q 042958 508 VILYLYNNSLFDSIPSE-LGNLRSLSMLSFAYNKLSG 543 (1075)
Q Consensus 508 ~~L~L~~N~l~~~~~~~-l~~l~~L~~L~l~~N~l~~ 543 (1075)
+.|+|++|++++ +|.. +..+++|+.|++++|.+++
T Consensus 476 ~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 476 QELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp SEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCC
T ss_pred CEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCC
Confidence 777777777663 3333 6666666666666665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=399.99 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=195.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..+.||+|+||+||+|..+ +|+.||||++....... .+.+.+|++++++++|||||+++++|.+.+.. +++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~-~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL-WVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE-EEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE-EEE
Confidence 56888899999999999999664 79999999986543222 35688999999999999999999999876543 333
Q ss_pred ecCccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNAA--------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+++..+ ...+++.+...++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+......
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 332221 35689999999999999999999999 9999999999999999999999999999988766666
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....+.....+.++ .....+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~~~~~~~~----~~~~~s 297 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDNLPPRLK----NLHKVS 297 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSSCCCCS----CGGGSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHcCCCCCCC----ccccCC
Confidence 677899999999999999999999999999999999999999997432211 11111222222222 223445
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++.+++.+||++||++|||++|+++
T Consensus 298 ~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 298 PSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 67999999999999999999999976
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=406.51 Aligned_cols=241 Identities=21% Similarity=0.303 Sum_probs=188.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.+..+ ++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y-iV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY-IV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE-EE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE-EE
Confidence 6899999999999999999965 57999999999765433 334678999999999999999999999998765432 22
Q ss_pred ecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++.. ....+++.+.+.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 32221 123468889999999999999999999 9999999999999999999999999999976543
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.....+.. ..
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~---~~ 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPV---SL 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC---CT
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCC---Cc
Confidence 3334556899999999999999999999999999999999999999974322 112222222232221 12
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||++||++|||++|+++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33456999999999999999999999975
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=436.74 Aligned_cols=436 Identities=21% Similarity=0.215 Sum_probs=309.3
Q ss_pred CceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEE
Q 042958 48 GRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127 (1075)
Q Consensus 48 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 127 (1075)
.+++.++++++.+.+..+. .|+++++|++|+|++|.+++..|..++.+++|++|+|++|.++ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMP-DISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGG-GTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChh-hhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 4789999999999876544 4999999999999999999888999999999999999999998 67777 899999999
Q ss_pred ccCcccCC-CCCccccccCCcceeecccccccCCCCCCCCCCCCC--CEEEcCCCCC--CCCCCccccCcc-ccceEeee
Q 042958 128 LFENQLNG-SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNL--DTLHLYDNSL--SDSIPSEFGNLR-SLSMLSLG 201 (1075)
Q Consensus 128 Ls~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~Ls 201 (1075)
|++|++++ .+|..|+.+++|++|++++|.+.+. .+..+++| ++|++++|.+ ++..|..|..+. ..-.++++
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 204 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence 99999996 4578999999999999999999874 35555555 9999999999 888888888765 22266889
Q ss_pred ccccccccCC-CCcCCCCcCceeccccCCC----CCCcccccCCCCCCeEeccCCCCCCcc----CCCCccccccccccc
Q 042958 202 YNKFSGSIPH-SLGNLTNLATLYLHNNSLF----DSIPSELGNLRSLSMLSLGYNKLSGSI----PHSLGNLTNLATLYL 272 (1075)
Q Consensus 202 ~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L 272 (1075)
.|.+.+.++. .+..+++|+.|++++|+.. ......+..+++|+.|+++++.+.+.. +..+ ..++|++|++
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l 283 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNI 283 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEE
Confidence 9998875553 4667899999999998621 012235677888888888877665321 1111 1125666666
Q ss_pred ccccCcCCCCccc-----CCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccc---cccccccc
Q 042958 273 YENSLSGSIPSEF-----GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL---RSLSNLGL 344 (1075)
Q Consensus 273 ~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l 344 (1075)
++|.+++.+|..+ ..++.|+.++++.|.+ .+| ...+..+ .+|+.|++
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p-----------------------~~~~~~~~~~~~L~~L~l 338 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFS-----------------------KEALYSVFAEMNIKMLSI 338 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSC-----------------------HHHHHHHHHTCCCSEEEE
T ss_pred eccEeeccccchhhhcccccchheehhhccccee--ecC-----------------------hhhhhhhhccCcceEEEc
Confidence 6666665555544 3444444444444443 111 1111111 34555556
Q ss_pred cCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeecccccccc--CChhhccCCCCCeEEeeccccc
Q 042958 345 SGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGS--IPHSLGNLTNLATLDLYDNSLS 422 (1075)
Q Consensus 345 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~ 422 (1075)
++|.+.... ....+++|++|++++|.+.+..|..+.++++|++|++++|++++. .|..+..+++|++|++++|+++
T Consensus 339 ~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~ 416 (562)
T 3a79_B 339 SDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416 (562)
T ss_dssp ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred cCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence 655554211 124556666677777766666666666777777777777777652 2355677777777777777777
Q ss_pred c-ccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccc
Q 042958 423 G-SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL 501 (1075)
Q Consensus 423 ~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 501 (1075)
+ ..+..|..+++|++|++++|++++..|..+. ++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+
T Consensus 417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~ 493 (562)
T 3a79_B 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVF 493 (562)
T ss_dssp SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTST
T ss_pred CccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHH
Confidence 6 3344577777777777777777766665554 57788888888887 566666678888888888888874333337
Q ss_pred cCCCccceeeccCCCCCCCC
Q 042958 502 GNLSNLVILYLYNNSLFDSI 521 (1075)
Q Consensus 502 ~~l~~L~~L~L~~N~l~~~~ 521 (1075)
..+++|+.|++++|++.+..
T Consensus 494 ~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 494 DRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp TTCTTCCCEECCSCCBCCCH
T ss_pred hcCCCCCEEEecCCCcCCCc
Confidence 88888888888888876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=387.56 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=178.4
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.........+.+.+|++++++++|||||++++++.+.+..+ ++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~-iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII-MV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE-EE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE-EE
Confidence 6899999999999999999965 479999999997655444445678999999999999999999999998765533 33
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
++..+ ....+++.+...++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..... ..
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~ 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NF 167 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC-Cc
Confidence 32221 245689999999999999999999999 9999999999999999999999999999876543 33
Q ss_pred eeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
....+||+.|||||++.+..+ +.++||||+||++|||++|+.||..... ......+.....+.+. ..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~~~p~----~~ 235 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVYTLPK----FL 235 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCT----TS
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CC
Confidence 455789999999999998886 5799999999999999999999974321 1112222222322222 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.++.+++.+|+++||++|||++|+++
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 346899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.72 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=193.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++.+.........+.+.+|++++++++|||||++++++.+.+.. +++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL-YFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE-EEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE-EEE
Confidence 5799999999999999999965 57999999998643222223357899999999999999999999999876543 333
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS- 963 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 963 (1075)
+++.. ....+++.+...++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 33322 235689999999999999999999999 99999999999999999999999999999876443
Q ss_pred -CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 -SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+..+.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~p~---- 255 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLEYDFPE---- 255 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCT----
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc----
Confidence 234567899999999999999999999999999999999999999974322 1122223323332222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVS 1070 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl 1070 (1075)
..+.++.+++.+|+++||++|||++|+.
T Consensus 256 ~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2334689999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=400.43 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=196.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..+.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.+|++++|||||+++++|.+.+.. +++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~-~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL-WVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEE-EEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEE-EEE
Confidence 5699999999999999999966 479999999997643332 35688999999999999999999999876543 333
Q ss_pred ecCccc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNAA--------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+++..+ ...+++.+...|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+......
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 333221 34689999999999999999999999 9999999999999999999999999999988766666
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....+.....+.+..+ ...+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~~~~~~~~~~----~~~s 374 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDNLPPRLKNL----HKVS 374 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCSCT----TSSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHcCCCCCCccc----ccCC
Confidence 677899999999999999999999999999999999999999997433211 1111222222222222 2334
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++.+++.+||++||++|||++|+++
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 56899999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=386.39 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=184.2
Q ss_pred CCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc---ccchhhe
Q 042958 818 DDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV---RHSLAMI 893 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l~~~ 893 (1075)
+..++||+|+||+||+|.. .+++.||||++...... ....+.|.+|++++++++|||||+++++|... +..++++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4557899999999999965 47899999998754332 33467899999999999999999999998652 2223333
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccccccccCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++..+..|+.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 33322 2356899999999999999999999981 13999999999999984 78999999999986432
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......+||+.|||||++.+ +|+.++|||||||++|||+||+.||....... .....+.....+ ......
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~--~~~~~~ 254 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP--ASFDKV 254 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC--GGGGGC
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCC--CCCCcc
Confidence 33456789999999998865 69999999999999999999999996432211 111122221111 111222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++++.+++.+||++||++|||++|+++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3456899999999999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=412.17 Aligned_cols=425 Identities=25% Similarity=0.285 Sum_probs=242.5
Q ss_pred CCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 71 SFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
..++|++|++++|++ |.+|++++++++|++|++++|.+.|.+|.+++++++|+.++++.|.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 468899999999999 79999999999999999999999999999999999886666655532 346666
Q ss_pred ecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC
Q 042958 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 151 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (1075)
++++|.+++++. -.++|++|++++|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|+++
T Consensus 77 ~l~~~~l~~lp~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSSLPE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSCCCS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred EecCCccccCCC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 666666666432 13567777777777776 4432 3667777777777763 2221 157777777777776
Q ss_pred CCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 310 (1075)
+ +| .|+.+++|++|++++|++++ +|..+ .+|++|++++|.+++ +| .|+.+++|+.|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 5 55 47777777777777777774 45433 367777777777775 45 57777778888888777775 33322
Q ss_pred ccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccccee
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 390 (1075)
++|++|++++|.++ .+| .++.+++|++|++++|++++ +|.. .++|++|++++|++.+ +|.. +++|++|
T Consensus 215 --~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 47777788888777 455 37777788888888887774 4432 3678888888888754 4443 3678888
Q ss_pred eeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccc
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLS 470 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 470 (1075)
++++|++++. |.. .++|++|++++|++++. +.. .++|++|++++|++++ +|.. +++|++|++++|+++
T Consensus 283 ~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 283 DVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA 350 (454)
T ss_dssp ECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred ECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc
Confidence 8888888752 211 15788888888888752 211 2478888888888885 5544 477888888888888
Q ss_pred cCCCccccCcCCCCEEeCCCCcccC--CCcccccCCCccceeeccCCCCCCCCCccccCcccccccccccccccc--ccC
Q 042958 471 GSIPGEIGNLRSISNLALNNNKLSG--SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG--SIP 546 (1075)
Q Consensus 471 ~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~--~~p 546 (1075)
.+|. .+++|+.|++++|++++ .+|..++. |+.|.+.+.+|.. +++|+.|++++|.+++ .+|
T Consensus 351 -~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 -EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp -CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred -cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 4565 46788888888888887 56665543 2346666666663 4778888889998887 788
Q ss_pred CcccccccCCCccccccchhhh
Q 042958 547 HSLGVLDLSSNHIVGEIPTELG 568 (1075)
Q Consensus 547 ~~l~~L~Ls~N~l~~~~p~~~~ 568 (1075)
.+++.|.+.+|.+.+.++.+..
T Consensus 416 ~sl~~L~~~~~~~~~~~~~~~~ 437 (454)
T 1jl5_A 416 ESVEDLRMNSERVVDPYEFAHE 437 (454)
T ss_dssp ----------------------
T ss_pred hhHhheeCcCcccCCccccCHH
Confidence 8888888888888776655543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=399.83 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc-CceeeEE
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFY 880 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~ 880 (1075)
.+++...++|++.+.||+|+||+||+|.+. +++.||||++.... .....++|.+|++++++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 455556788999999999999999999754 23689999997543 23345789999999999965 8999999
Q ss_pred EEeeccccchhheecCccc-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 042958 881 GFCSHVRHSLAMILSNNAA-------------------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDI 935 (1075)
Q Consensus 881 ~~~~~~~~~l~~~~~~~~~-------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 935 (1075)
|+|......+.+++++... ...++|.++..++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 9997655433333322111 23489999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcc
Q 042958 936 SSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 1012 (1075)
Q Consensus 936 k~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~ 1012 (1075)
||+|||+++++.+||+|||+|+.+..+... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999977654332 334678999999999999999999999999999999998 99999754
Q ss_pred CccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1013 SSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..... ....+.. ..+++.|. .++.++.+++.+||+.||++||||+||++.|+
T Consensus 292 ~~~~~----~~~~i~~--g~~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 292 KIDEE----FCRRLKE--GTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp CCSHH----HHHHHHH--TCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH----HHHHHHc--CCCCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 32211 1111111 12223222 23446999999999999999999999998874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=390.48 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=185.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---chh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---SLA 891 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~l~ 891 (1075)
++|...+.||+|+||+||+|+++ |+.||||++... ......++.|+..+.+++|||||+++|+|.+... .++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35677789999999999999885 999999998642 2222334556777788999999999999986542 122
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDC-----FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+++++.. ....++|.++.+++.|+++||+|||+++ .++||||||||+|||++.++++||+|||+|+.
T Consensus 78 lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 2222221 1356899999999999999999999862 35899999999999999999999999999987
Q ss_pred cCCCCCc----eeccccccCccCccccccC------CCCcccchHhHHHHHHHHHhCCCCCCccCccccc-------hhh
Q 042958 959 LKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-------SLN 1021 (1075)
Q Consensus 959 ~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-------~~~ 1021 (1075)
....... ....+||+.|||||++.+. .++.++|||||||++|||+||+.||......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7654332 2345799999999998764 4678999999999999999998887543221110 001
Q ss_pred hhhhhhhcc----CCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEML----DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......+. .+.++.. ....+.+..+.+++.+||+.||++||||+||++.|+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 111111222 2222221 122345668999999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=391.52 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=184.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..++||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+.+.. +++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~-~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWV-NIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEE-EEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEE-EEE
Confidence 5677788999999999999966 4799999999975321 24699999999999999999999876543 222
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 963 (1075)
+++.. ....+++.+...++.||+.||+|||++ +||||||||+|||++.++ ++||+|||+|+.+..+.
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 32221 235689999999999999999999999 999999999999999998 69999999999876543
Q ss_pred Cc-----eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 964 SN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 964 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.. ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......... ..+.....+ ..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------~~i~~~~~~-~~ 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--------LKIASEPPP-IR 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--------HHHHHSCCG-GG
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--------HHHHcCCCC-ch
Confidence 21 23357999999999999999999999999999999999999999754332211 111111110 01
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
......+..+.+++.+||++||++|||++|+++.|
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l 311 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 11223445699999999999999999999998765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=386.52 Aligned_cols=240 Identities=22% Similarity=0.257 Sum_probs=183.6
Q ss_pred cCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||+||+|+.. +++.||||++........ ...++.+|++++++++|||||++++++.+.+..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~- 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL- 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE-
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE-
Confidence 57999999999999999999652 578999999875432221 134688999999999999999999999876543
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+++++... ....+++.+...++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 33333222 235689999999999999999999999 999999999999999999999999999997665
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||...... .....+.....+.+.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~p~--- 247 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILKAKLGMPQ--- 247 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT---
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHcCCCCCCC---
Confidence 555556778999999999999999999999999999999999999999743321 122222223333332
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTM-----PKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1071 (1075)
..+.++.+++.+||++||++|||+ +|+++
T Consensus 248 -~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 -FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 234468999999999999999985 57664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=402.87 Aligned_cols=374 Identities=25% Similarity=0.254 Sum_probs=211.0
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccC-CCCCCCCCCCcEEEccCcccCCCCCccccccCCcceee
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTI-PPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLA 151 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (1075)
++|++|||++|.+++..|..++++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 56778888888777767777777777777777777776554 45577777777777777777766666666666666666
Q ss_pred cccccccCCCCC--CCCCCCCCCEEEcCCCCCCCCCCcc-ccCccccceEeeeccccccccCCCCcCC--CCcCceeccc
Q 042958 152 LYSNYLEDLIPP--SLGNLSNLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSGSIPHSLGNL--TNLATLYLHN 226 (1075)
Q Consensus 152 L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~L~~ 226 (1075)
+++|.+++..+. .|..+++|++|+|++|++++..|.. |.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 666666553322 2555555555555555555554443 4555555555555555554444444433 3344444444
Q ss_pred cCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCC---ccCcEEEccCCCCCC
Q 042958 227 NSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL---RSLSMLNLGYNKLNG 303 (1075)
Q Consensus 227 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~ 303 (1075)
|.+.+..+..++. .....+..+++|++|++++|.+++..|..+... ++|+.|++++|.+.+
T Consensus 190 n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~ 253 (455)
T 3v47_A 190 ITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253 (455)
T ss_dssp CBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred Ccccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence 4433222111100 000111222334444444444333333222211 344444444443322
Q ss_pred CcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCC
Q 042958 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383 (1075)
Q Consensus 304 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 383 (1075)
.. +..+.+....+..+..+ ..++|++|++++|.+.+..|..+..
T Consensus 254 ~~--------------~~~~~~~~~~~~~~~~~----------------------~~~~L~~L~l~~n~l~~~~~~~~~~ 297 (455)
T 3v47_A 254 SS--------------FGHTNFKDPDNFTFKGL----------------------EASGVKTCDLSKSKIFALLKSVFSH 297 (455)
T ss_dssp CC--------------TTCCSSCCCCTTTTGGG----------------------TTSCCCEEECCSSCCCEECTTTTTT
T ss_pred cc--------------cchhhhccCcccccccc----------------------cccCceEEEecCccccccchhhccc
Confidence 10 00111111111111111 1245666666666666656666666
Q ss_pred CcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccccccccc
Q 042958 384 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALY 463 (1075)
Q Consensus 384 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 463 (1075)
+++|++|++++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 66666666666666666666666677777777777777666666677777777777777777766677777777777777
Q ss_pred ccCCccccCCCccccCcCCCCEEeCCCCcccCCCc
Q 042958 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIP 498 (1075)
Q Consensus 464 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 498 (1075)
|++|++++..+..+..+++|+.|++++|++++..|
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 77777776555566777777777777777776544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=401.32 Aligned_cols=391 Identities=22% Similarity=0.220 Sum_probs=271.8
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.++.++++++ .+|. +. ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.++.
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~---------------- 72 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN---------------- 72 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT----------------
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc----------------
Confidence 46777777776 6665 33 6788888888888877788888888888888888887655432
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCC--CCcCCCCcCceeccccCCCCCC
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH--SLGNLTNLATLYLHNNSLFDSI 233 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~~~~ 233 (1075)
..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+. .|..+++|++|+|++|.+++..
T Consensus 73 -------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 145 (455)
T 3v47_A 73 -------NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145 (455)
T ss_dssp -------TTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCC
T ss_pred -------ccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccC
Confidence 2344555555555555555555555555555555555555555543322 2556666666666666665554
Q ss_pred ccc-ccCCCCCCeEeccCCCCCCccCCCCccc--ccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC
Q 042958 234 PSE-LGNLRSLSMLSLGYNKLSGSIPHSLGNL--TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310 (1075)
Q Consensus 234 ~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 310 (1075)
|.. +..+++|++|++++|++++..+..+..+ .+|+.|++++|.+++..+..+.. .....+.
T Consensus 146 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~ 209 (455)
T 3v47_A 146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPF 209 (455)
T ss_dssp CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTT
T ss_pred cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc----------------ccccccc
Confidence 544 5666666666666666666555555544 45555666665555433222110 0001122
Q ss_pred ccccccceecccccccCCCCcccccc---cccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCC--Cc
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNL---RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN--LR 385 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--l~ 385 (1075)
.+++|++|++++|.+++..|..+... ++|+.|++++|.+.+.. +..+.+.+..+..+.. .+
T Consensus 210 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~ 275 (455)
T 3v47_A 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEAS 275 (455)
T ss_dssp TTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTS
T ss_pred ccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCccccccccccc
Confidence 33445555555555544444444332 55666666666544321 1111222222222332 36
Q ss_pred ccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccccccccccc
Q 042958 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465 (1075)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 465 (1075)
+|++|++++|++.+..|..++.+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 355 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence 89999999999999999999999999999999999999999999999999999999999998889999999999999999
Q ss_pred CCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCc
Q 042958 466 DNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523 (1075)
Q Consensus 466 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 523 (1075)
+|++++..|..|..+++|++|++++|++++..+..+..+++|+.|++++|++++..|.
T Consensus 356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 9999999999999999999999999999987778889999999999999999987763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=404.25 Aligned_cols=420 Identities=26% Similarity=0.318 Sum_probs=181.3
Q ss_pred cccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccccccc
Q 042958 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYL 272 (1075)
Q Consensus 193 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 272 (1075)
++|++|++++|.+ +.+|.+++++++|++|++++|.+.+.+|..++.+++|+.++++.|.. .++++|++
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l 78 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL 78 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence 5566666666666 45666666666666666666666555666565555555555544331 23555555
Q ss_pred ccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCccccc
Q 042958 273 YENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS 352 (1075)
Q Consensus 273 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 352 (1075)
++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|.+++ +|.. .++|++|++++|++++
T Consensus 79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~- 145 (454)
T 1jl5_A 79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK- 145 (454)
T ss_dssp TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-
T ss_pred cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-
Confidence 5555553 2221 2455555555555554 3322 2455555555555553 1111 1345555555555553
Q ss_pred CCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccc
Q 042958 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL 432 (1075)
Q Consensus 353 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 432 (1075)
+| .|+.+++|++|++++|++.+ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|++++
T Consensus 146 lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~--------- 209 (454)
T 1jl5_A 146 LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK--------- 209 (454)
T ss_dssp CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS---------
T ss_pred Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc---------
Confidence 33 35555555555555555532 33221 244445555554443 23 34444444555554444443
Q ss_pred cccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeec
Q 042958 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYL 512 (1075)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 512 (1075)
+|... ++|++|++++|+++ .+| .++.+++|+.|++++|++++ +|.. +++|+.|++
T Consensus 210 ----------------l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l 264 (454)
T 1jl5_A 210 ----------------LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNV 264 (454)
T ss_dssp ----------------CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEEC
T ss_pred ----------------CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEEC
Confidence 22221 24455555555554 334 24455555555555555543 2221 244555555
Q ss_pred cCCCCCCCCCccccCcccccccccccccccc--ccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccc
Q 042958 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSG--SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPK 590 (1075)
Q Consensus 513 ~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~--~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~ 590 (1075)
++|++++ +|.. .++|+.|++++|++++ .+|+++++|++++|++++. +.. ...|+.|++++|++++ +|..
T Consensus 265 ~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~ 335 (454)
T 1jl5_A 265 RDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL 335 (454)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC
T ss_pred CCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc
Confidence 5555543 2322 2445555555555554 4555666666666666541 110 1355666666666664 3333
Q ss_pred cCcccccceeecCCCcccCcccccccccccceEEEcccccccc--ccchhcccccccceeeeccccccCchhhhhccccc
Q 042958 591 LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSR--GIPIKLEELIHLSELDLSHNFLREAIPSQICIMQS 668 (1075)
Q Consensus 591 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~ 668 (1075)
+++|++|++++|+++ .+|. .+++|++|++++|++++ .+|..+.. |+.|.+.+.+|.. +++
T Consensus 336 ---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~ 397 (454)
T 1jl5_A 336 ---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQN 397 (454)
T ss_dssp ---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------
T ss_pred ---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCc
Confidence 477888888888887 4666 46788888888888887 56665543 3457777777763 478
Q ss_pred cceeecCCCcccc--CChhhhcccccccEEeecCCccCCCCCCCc
Q 042958 669 LENLNLSHNSLVG--LIPSCFEKMHGLLRIDISYNELQGPIPNSI 711 (1075)
Q Consensus 669 L~~L~ls~N~l~~--~~p~~~~~~~~l~~l~~s~N~~~~~~p~~~ 711 (1075)
|+.|++++|++++ .+|.+ ++.|.+.+|.+.+++|...
T Consensus 398 L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~~ 436 (454)
T 1jl5_A 398 LKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFAH 436 (454)
T ss_dssp ---------------------------------------------
T ss_pred CCEEECCCCcCCccccchhh------HhheeCcCcccCCccccCH
Confidence 9999999999997 66654 4566788888888776543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=377.78 Aligned_cols=239 Identities=22% Similarity=0.423 Sum_probs=176.2
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-----
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----- 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 888 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 4588899999999999999965 479999999987543 33446789999999999999999999999865432
Q ss_pred ------chhheecCccc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 889 ------SLAMILSNNAA------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 889 ------~l~~~~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
.++++++...+ .....+...+.++.||++||+|||++ +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 12233332211 12345667889999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCc------------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc
Q 042958 951 SDFGIAKFLKPDSSN------------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS 1018 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 1018 (1075)
+|||+|+.+...... .+..+||+.|||||++.+..|+.++||||+||++|||++ ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----- 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----- 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----
Confidence 999999877643221 234579999999999999999999999999999999996 764211
Q ss_pred hhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1019 SLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........+.....+. ......+...+++.+||++||++|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 --ERVRTLTDVRNLKFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --HHHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHhcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111222333333322 23344556788999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=375.35 Aligned_cols=288 Identities=31% Similarity=0.533 Sum_probs=196.5
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCc--cceEEeCCC---CceeEEEeccccccc--ccCCcccCCCCC
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCA--WVGIHCNRG---GRVNSINLTSIGLKG--MLHDFSFSSFPH 74 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~--w~gv~C~~~---~~v~~l~l~~~~l~g--~~~~~~~~~l~~ 74 (1075)
+|++||++||+++.++ . .+++|.. ++.+|. |.||+|+.. ++|+.++++++++.| .+++. ++++++
T Consensus 6 ~~~~aL~~~k~~~~~~-~--~l~~W~~----~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~-l~~l~~ 77 (313)
T 1ogq_A 6 QDKQALLQIKKDLGNP-T--TLSSWLP----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LANLPY 77 (313)
T ss_dssp HHHHHHHHHHHHTTCC-G--GGTTCCT----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-GGGCTT
T ss_pred HHHHHHHHHHHhcCCc-c--cccCCCC----CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChh-HhCCCC
Confidence 5899999999999654 2 6899972 233487 999999864 678888777777776 55554 667777
Q ss_pred ccEEEccC-CCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 75 LAYLDLWH-NQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 75 L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
|++|+|++ |.+.+.+|..++++++|++|+|++|.+++.+|..|+++++|++|+|++|++++.+|..+..+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------- 148 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL--------- 148 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC---------
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcC---------
Confidence 77777774 67777777777777777777777777776677777777777777777777766666655554
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCcc-ccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLR-SLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
++|++|++++|++++.+|..|..++ +|++|++++|++++.+|..+..++ |++|++++|.+++.
T Consensus 149 ---------------~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~ 212 (313)
T 1ogq_A 149 ---------------PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212 (313)
T ss_dssp ---------------TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEEC
T ss_pred ---------------CCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCc
Confidence 4555555555555545555555555 556666666666555565565554 66666666666655
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL 312 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 312 (1075)
.|..|..+++|++|+|++|++++.+|. +..+++|++|++++|.+++.+|..|..+++|++|+|++|++++.+|.. ..+
T Consensus 213 ~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l 290 (313)
T 1ogq_A 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNL 290 (313)
T ss_dssp CGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTG
T ss_pred CCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccc
Confidence 666666666666666666666654443 566667777777777777667777777777777777777777666655 677
Q ss_pred ccccceeccccc
Q 042958 313 TNLATLYIHNNS 324 (1075)
Q Consensus 313 ~~L~~L~L~~N~ 324 (1075)
++|+.|++++|+
T Consensus 291 ~~L~~l~l~~N~ 302 (313)
T 1ogq_A 291 QRFDVSAYANNK 302 (313)
T ss_dssp GGSCGGGTCSSS
T ss_pred cccChHHhcCCC
Confidence 777777777776
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=377.09 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=188.0
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----c
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-----H 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 888 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|+++|++++|||||++++++.... .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 5799999999999999999965 57999999999765432 334577889999999999999999999876432 2
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++.. .....+++.+...++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 223333222 1245789999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC----CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh------------
Q 042958 961 PDS----SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN------------ 1023 (1075)
Q Consensus 961 ~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~------------ 1023 (1075)
... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||..............
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 432 234567899999999998875 468999999999999999999999975432111000000
Q ss_pred ---hhh---hhccCCCCCCCC-cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ---IAL---DEMLDPRLPTPS-CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ---~~~---~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... ........+.+. ......+.++.+++.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000001111100 001122356889999999999999999999976
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=373.05 Aligned_cols=358 Identities=20% Similarity=0.216 Sum_probs=278.7
Q ss_pred ccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCc
Q 042958 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSL 147 (1075)
Q Consensus 68 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 147 (1075)
+++++++|++|||++|.+++. | .++.+++|++|+|++|.+++. | ++.+++|++|+|++|++++. | ++.+++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 477889999999999999864 5 689999999999999999864 4 88999999999999999874 3 8889999
Q ss_pred ceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecccc
Q 042958 148 NYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227 (1075)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 227 (1075)
++|++++|.++++ + ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|++|++++|
T Consensus 109 ~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 109 TYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 9999999999886 3 88899999999999999874 2 788899999999999655455 4778889999999999
Q ss_pred CCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCC
Q 042958 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307 (1075)
Q Consensus 228 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 307 (1075)
++++ +| ++.+++|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++++|++++..
T Consensus 181 ~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~-- 249 (457)
T 3bz5_A 181 KITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD-- 249 (457)
T ss_dssp CCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--
T ss_pred ccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC--
Confidence 9886 44 78888999999999998864 37888889999999999887 45 778888999999999888764
Q ss_pred CCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccc
Q 042958 308 SLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387 (1075)
Q Consensus 308 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 387 (1075)
++.+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. ...+|
T Consensus 250 -~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L 309 (457)
T 3bz5_A 250 -VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGI 309 (457)
T ss_dssp -CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCC
T ss_pred -HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcc
Confidence 445667777777665 35667778887766665 46677888888888877666663 33455
Q ss_pred ceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCC
Q 042958 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467 (1075)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 467 (1075)
+.|++++| ++|++|++++|++++. .++++++|+.|++++|++++ ++.|..|++++|
T Consensus 310 ~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n 365 (457)
T 3bz5_A 310 TELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNN 365 (457)
T ss_dssp SCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGT
T ss_pred eEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCC
Confidence 55555544 5677888888888764 27777888888888887774 245666777778
Q ss_pred ccccCCCccccCcCCCCEEeCCCCcccCCCcccc
Q 042958 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL 501 (1075)
Q Consensus 468 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 501 (1075)
.++|. +.+..|..+++++|+++|.+|..+
T Consensus 366 ~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 366 NFEAE-----GQTITMPKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp SEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred cEEec-----ceeeecCccccccCcEEEEcChhH
Confidence 77764 345566777788888877777654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=372.32 Aligned_cols=345 Identities=35% Similarity=0.496 Sum_probs=191.8
Q ss_pred cCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEE
Q 042958 96 ISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLH 175 (1075)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (1075)
+++|+.|++++|.+. .+| .+..+++|++|+|++|.+++..| +..+++|++|++++|.+.+..+ ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 344444444444443 222 24444444555555444443222 4444455555555555444433 55566666666
Q ss_pred cCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC
Q 042958 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
+++|.+++..+ +..+++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+.. .+..+++|++|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC
Confidence 66666655432 5666666666666666653 22 35666666666664 3343322 25666666666666666653
Q ss_pred ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccc
Q 042958 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335 (1075)
Q Consensus 256 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 335 (1075)
. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..+ +..
T Consensus 192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 263 (466)
T 1o6v_A 192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 263 (466)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence 2 235556666666666666664433 45556666666666666543 245556666666666666654433 555
Q ss_pred ccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEE
Q 042958 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLD 415 (1075)
Q Consensus 336 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 415 (1075)
+++|+.|++++|.+++..+ +..+++|++|++++|++.+..+ +..+++|++|++++|++++..| +..+++|++|+
T Consensus 264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 337 (466)
T 1o6v_A 264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence 6666666666666654322 5556666666666666644332 5556666666666666655444 55666666666
Q ss_pred eeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCcccc
Q 042958 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSG 471 (1075)
Q Consensus 416 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 471 (1075)
+++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 338 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 338 FYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 666666543 345566666666666666665554 5566666666666666664
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=367.62 Aligned_cols=354 Identities=19% Similarity=0.213 Sum_probs=307.6
Q ss_pred CceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEE
Q 042958 48 GRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127 (1075)
Q Consensus 48 ~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 127 (1075)
.+++.++++++++.+. + .++.+++|++|+|++|++++. | ++.+++|++|+|++|.+++. | ++++++|++|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp TTCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred CCCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 5789999999999985 3 388999999999999999974 4 99999999999999999964 4 99999999999
Q ss_pred ccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecccccc
Q 042958 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSG 207 (1075)
Q Consensus 128 Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 207 (1075)
+++|++++ +| ++.+++|++|++++|.++++ .++.+++|++|++++|+..+.+ .+..+++|++|++++|++++
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence 99999997 44 89999999999999999996 3889999999999999665555 48899999999999999996
Q ss_pred ccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCC
Q 042958 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN 287 (1075)
Q Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 287 (1075)
+| +..+++|++|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|++++|++++.. +..
T Consensus 185 -l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~ 252 (457)
T 3bz5_A 185 -LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VST 252 (457)
T ss_dssp -CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTT
T ss_pred -ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHH
Confidence 45 88999999999999999875 48899999999999999997 55 889999999999999999754 456
Q ss_pred CccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceee
Q 042958 288 LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLY 367 (1075)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~ 367 (1075)
+++|+.|++++| +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. ..++|+.|+
T Consensus 253 l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~ 313 (457)
T 3bz5_A 253 LSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELD 313 (457)
T ss_dssp CTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCC
T ss_pred CCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEec
Confidence 788999998876 46678899999887776 57889999999999998777764 345677776
Q ss_pred ccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccccccccc
Q 042958 368 LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447 (1075)
Q Consensus 368 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 447 (1075)
+++| ++|++|++++|++++. + ++.+++|+.|++++|++++ ++.|..|++++|.+.|
T Consensus 314 l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g 369 (457)
T 3bz5_A 314 LSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEA 369 (457)
T ss_dssp CTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEE
T ss_pred hhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEe
Confidence 6655 6799999999999974 3 8999999999999999985 3568888999999987
Q ss_pred CCCCCCccccccccccccCCccccCCCcccc
Q 042958 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478 (1075)
Q Consensus 448 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 478 (1075)
. +++..|..+++++|+++|.+|..+.
T Consensus 370 ~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 370 E-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp E-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred c-----ceeeecCccccccCcEEEEcChhHh
Confidence 5 4677899999999999999997654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=370.75 Aligned_cols=346 Identities=32% Similarity=0.460 Sum_probs=286.6
Q ss_pred CCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 71 SFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
.+++++.|+++++.+. .+| .+..+++|++|+|++|.+++..| ++++++|++|++++|++++..| +..+++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 3567888888888887 455 47888888888888888875443 8888888999998888886544 8888888999
Q ss_pred ecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC
Q 042958 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 151 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (1075)
++++|.+.++.+ +.++++|++|++++|.+++. + .+..+++|++|+++ |.+.+.. .+.++++|++|++++|.++
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~ 190 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS 190 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence 998888888755 88889999999999988864 2 48888899999986 5555333 3888889999999999887
Q ss_pred CCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 310 (1075)
+. ..+..+++|++|++++|.+.+..| ++.+++|++|++++|.+++. ..+..+++|+.|++++|.+.+..+ +.
T Consensus 191 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 191 DI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred CC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 54 347888999999999999887655 77788999999999998853 467888999999999999987655 88
Q ss_pred ccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccccee
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 390 (1075)
.+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++.+..| +..+++|++|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 88999999999999986544 8889999999999999986544 7888999999999999977665 7788999999
Q ss_pred eeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceeccccccccc
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 447 (1075)
++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 9999999865 478899999999999999998776 8899999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=361.25 Aligned_cols=194 Identities=25% Similarity=0.316 Sum_probs=156.7
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
++....++|++.+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++.+ +|||||++++++
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 33445688999999999999999999643 57889999986532 135688999999998 799999999998
Q ss_pred eccccchhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEeccccc
Q 042958 884 SHVRHSLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIA 956 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla 956 (1075)
.+.+..+ ++++...+ -..+++.+...++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 90 ~~~~~~~-lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 90 RKNDHVV-IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EETTEEE-EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EECCEEE-EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 8765533 33332221 24589999999999999999999999 99999999999999877 79999999999
Q ss_pred cccCCCCC----------------------------ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCC
Q 042958 957 KFLKPDSS----------------------------NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKH 1007 (1075)
Q Consensus 957 ~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~ 1007 (1075)
+....... .....+||+.|||||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86543211 12345799999999998875 48999999999999999999999
Q ss_pred CCCc
Q 042958 1008 PRDF 1011 (1075)
Q Consensus 1008 p~~~ 1011 (1075)
||..
T Consensus 246 Pf~~ 249 (361)
T 4f9c_A 246 PFYK 249 (361)
T ss_dssp SSSC
T ss_pred CCCC
Confidence 9953
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=377.52 Aligned_cols=241 Identities=20% Similarity=0.301 Sum_probs=193.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+++|+.++|||||++++++.+....+ ++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~-iv 232 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV-MI 232 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE-EE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE-EE
Confidence 6899999999999999999965 57999999998753 2334577899999999999999999999998765443 33
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC--CCceEeccccccccCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD--NEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~~ 961 (1075)
++... ....+++.+...++.||+.||+|||++ +|+||||||+||+++.+ +.+||+|||+|+.+..
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 32221 234578999999999999999999999 99999999999999864 7999999999998764
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 310 ~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp T-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCCCCSGGG
T ss_pred C-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCCCCcccc
Confidence 4 344567899999999999999999999999999999999999999974332 1122233333322222223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.++.+|+.+||+.||++|||++|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 334557899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=374.06 Aligned_cols=243 Identities=21% Similarity=0.228 Sum_probs=185.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCC---CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLP---GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.++||+|+||+||+|+.+ +|+.||||++.+... .......+...++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999654 799999999864211 1111222334456777888999999999999876553
Q ss_pred hhheecCccc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNAA---------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++++..+ ...+++.+...++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 268 -ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 -SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp -EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred -EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 333333222 35689999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCceeccccccCccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 961 PDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
... ..+.+||+.|||||++. +..|+.++||||+||++|||++|+.||........ ......+.......+.
T Consensus 344 ~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~~~~~p~- 415 (689)
T 3v5w_A 344 KKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELPD- 415 (689)
T ss_dssp SCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHCCCCCCT-
T ss_pred CCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCCCCCCCc-
Confidence 432 34568999999999996 45799999999999999999999999974332111 1111222222222222
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
..+.++.+++.+|+++||++|++ ++||++
T Consensus 416 ---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 416 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 23446899999999999999998 677764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.94 Aligned_cols=268 Identities=32% Similarity=0.598 Sum_probs=209.3
Q ss_pred ccccHHHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEE
Q 042958 803 GKIVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882 (1075)
Q Consensus 803 ~~~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 882 (1075)
..+++.++..+.++|+..+.||+|+||.||+|+..+|+.||||++........ ...+.+|+++++.++||||++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEE
Confidence 35678899999999999999999999999999888899999999876432221 2368899999999999999999999
Q ss_pred eeccccchhheec-Cc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 883 CSHVRHSLAMILS-NN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 883 ~~~~~~~l~~~~~-~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
+......+.++.. .. .....+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9776544322211 11 12334899999999999999999999987779999999999999999999999
Q ss_pred eccccccccCCCCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-------
Q 042958 951 SDFGIAKFLKPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------- 1022 (1075)
Q Consensus 951 ~DfGla~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------- 1022 (1075)
+|||+++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||+............
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999877544332 344569999999999998889999999999999999999999996322111110000
Q ss_pred --hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 --NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........+.... .....+.+..+.+++.+||+.||++|||++||++.|+
T Consensus 256 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 256 LKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1111222222222 2345677889999999999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=364.02 Aligned_cols=302 Identities=23% Similarity=0.216 Sum_probs=172.3
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
+++++|||++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------------- 97 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL-------------- 97 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCT--------------
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCc--------------
Confidence 456677777777766666666666666666666666666666666666666666666666664333
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|++++|.+++.
T Consensus 98 ----------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 98 ----------GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp ----------TSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred ----------ccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 3345555555555555555555555555555555555555555555555555556666666666655554
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL 312 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 312 (1075)
.+..|..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|..+....+|+.|++++|+++.+.+..|..+
T Consensus 168 ~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 247 (477)
T 2id5_A 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL 247 (477)
T ss_dssp CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTC
T ss_pred ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCc
Confidence 44455566666666666666655545555555555555555555544444444444455555555555554443455555
Q ss_pred ccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeee
Q 042958 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSL 392 (1075)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 392 (1075)
++|++|+|++|.+++..+..|..+++|+.|++++|++++..|..|..+++|++|+|++|.+.+..+..|..+++|++|+|
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 55555555555555544455555555555555555555555555555555555555555554444444555555555555
Q ss_pred cccccc
Q 042958 393 GYNKLS 398 (1075)
Q Consensus 393 s~N~l~ 398 (1075)
++|++.
T Consensus 328 ~~N~l~ 333 (477)
T 2id5_A 328 DSNPLA 333 (477)
T ss_dssp CSSCEE
T ss_pred cCCCcc
Confidence 555553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=366.63 Aligned_cols=312 Identities=24% Similarity=0.232 Sum_probs=245.6
Q ss_pred ccceEEeCCC----------CceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccC
Q 042958 38 AWVGIHCNRG----------GRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSN 107 (1075)
Q Consensus 38 ~w~gv~C~~~----------~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 107 (1075)
.|..|.|... ..++.|+++++.+.+..+. .|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 5889999752 3688999999999886554 4999999999999999999888999999999999999999
Q ss_pred cccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCc
Q 042958 108 LFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS 187 (1075)
Q Consensus 108 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~ 187 (1075)
.+++..+..|.++++|++|+|++|++++..|..|..+++|++|++++|.+.++.+..|..+++|++|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99966667789999999999999999988888888899999999999998888888888888888888888888887777
Q ss_pred cccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccc
Q 042958 188 EFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267 (1075)
Q Consensus 188 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 267 (1075)
.|..+++|+.|+|++|.+.+..+..|..+++|++|++++|...+.+|.......+|++|++++|+++...+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 78888888888888888887777778888888888888877766666655555677777777777774433456666666
Q ss_pred cccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCC
Q 042958 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGN 347 (1075)
Q Consensus 268 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 347 (1075)
++|+|++|.+++..+..|..+++|+.|+|++|+++++.|.+|.++++|++|+|++|.+++..+..|..+++|+.|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 66666666666655566666666666666666666666666666666666666666666555555666666666666666
Q ss_pred ccc
Q 042958 348 KLS 350 (1075)
Q Consensus 348 ~l~ 350 (1075)
.+.
T Consensus 331 ~l~ 333 (477)
T 2id5_A 331 PLA 333 (477)
T ss_dssp CEE
T ss_pred Ccc
Confidence 654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=344.27 Aligned_cols=259 Identities=32% Similarity=0.505 Sum_probs=202.6
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++..++++|+..+.||+|+||.||+|..++|+.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34455778999999999999999999998889999999987542 233578999999999999999999999987655
Q ss_pred cchhhee-cCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 888 HSLAMIL-SNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 888 ~~l~~~~-~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
..+.++. ... .....++|.++++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 4322211 110 1123589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-------hhhhh
Q 042958 956 AKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-------LNIAL 1026 (1075)
Q Consensus 956 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------~~~~~ 1026 (1075)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 987543222 223456899999999999889999999999999999999999999754332211110 01111
Q ss_pred hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....++.... ....+.+..+.+++.+||+.||++|||++||++.|+
T Consensus 266 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 266 EQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2223333222 245677889999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.78 Aligned_cols=242 Identities=24% Similarity=0.388 Sum_probs=193.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..+.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l- 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV- 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE-
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE-
Confidence 46899999999999999999964 57999999998654322 24678899999999999999999999887654322
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 222211 134588999999999999999999999 999999999999999999999999999988776655
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ .........+.... ....
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~----~~~~ 242 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGTPELQN----PEKL 242 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHCSCCCSC----GGGS
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCCCCCCC----cccc
Confidence 55667899999999999999999999999999999999999999964332111 11111111122222 2234
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 243 SAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 456899999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=341.70 Aligned_cols=251 Identities=28% Similarity=0.415 Sum_probs=185.3
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++....++|++.+.||+|+||.||+|+.. |+.||||++..... .....+++.+|++++++++||||+++++++....
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334445678999999999999999999774 89999999876543 3344578999999999999999999999997765
Q ss_pred cchhheecCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeeeCCCCCceEecc
Q 042958 888 HSLAMILSNNA------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP--IVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 888 ~~l~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
..+. +++... ....+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~l-v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSI-VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEE-EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEE-EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 4322 222111 112388999999999999999999999 7 999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|+++.............||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ... .......
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-----~~~-~~~~~~~ 257 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAA-VGFKCKR 257 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHH-HHHSCCC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHH-HHhcCCC
Confidence 9998765544444556899999999999999999999999999999999999999974332110 000 1111122
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+ ...+.++.+++.+||+.||++|||++|+++.|+
T Consensus 258 ~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 258 LEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2222 223346999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=336.28 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=199.1
Q ss_pred ccccHHHHHHHhcC----------CCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC
Q 042958 803 GKIVYEEIIRATND----------FDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871 (1075)
Q Consensus 803 ~~~~~~e~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l 871 (1075)
+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence 45677787777764 666779999999999999765 7999999998754322 246788999999999
Q ss_pred CcCceeeEEEEeeccccchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 872 RHRNIVKFYGFCSHVRHSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 872 ~h~niv~l~~~~~~~~~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
+||||+++++++...+..+. +++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++
T Consensus 100 ~h~niv~~~~~~~~~~~~~l-v~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWV-LMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEE-EECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CCCCcceEEEEEEECCEEEE-EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999977554322 222211 134689999999999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 1023 (1075)
.++.+||+|||+++.............||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-----~~ 250 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AM 250 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 9999999999999887655445556789999999999999999999999999999999999999997432211 11
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........+.... ....+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112222222221 2233456899999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.05 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=190.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|+..+.||+|+||.||+|... +++.||+|++.. ......+.+.+|++++++++||||+++++++.+.+..+.+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 467888899999999999999664 699999998854 2345567899999999999999999999999876543322
Q ss_pred eecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 -~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 86 -TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp -EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred -EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 22211 145689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCce--------------eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccc-hhhhhhhhh
Q 042958 963 SSNW--------------TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-SLNLNIALD 1027 (1075)
Q Consensus 963 ~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~ 1027 (1075)
.... ....||+.|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 1457999999999999999999999999999999999999998643322111 111111112
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+..+ ..+.+++.+||+.||++|||++|+++.|+
T Consensus 242 ~~~~~~~~----------~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 242 RYCPPNCP----------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HTCCTTCC----------TTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCCCCC----------HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22122222 24889999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.47 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=192.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++...+..+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l- 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL- 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE-
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE-
Confidence 46799999999999999999976 5899999999875432 23345778999999999999999999999977554332
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.+...++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 222211 235688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......+||+.|+|||++.+..+. .++||||+||++|||++|+.||+.... ......+.......+..
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~--- 236 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGKYRIPFY--- 236 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT---
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC---
Confidence 334556899999999999888775 789999999999999999999974332 11122222233332222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+.++.+++.+||+.||.+|||++|+++
T Consensus 237 -~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 -MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2345889999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=335.52 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=188.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++||||+++++++......+. +
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l-v 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL-V 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE-E
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE-E
Confidence 477899999999999999999888899999999875432 23345778899999999999999999999976554322 2
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 2211 1234589999999999999999999999 999999999999999999999999999998765555
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------------hhhhhcc
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------------IALDEML 1030 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------------~~~~~~~ 1030 (1075)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............. .......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 5566788999999999876 5689999999999999999999999975433221100000 0000000
Q ss_pred CCCCCCCC-----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPS-----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........ ......+.++.+++.+|++.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 001122346889999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=338.74 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=191.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+++++.++||||+++++++...+..+ +
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~-l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC-F 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE-E
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE-E
Confidence 367888999999999999999665 79999999986432112223567889999999999999999999998765432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 222221 234688999999999999999999999 99999999999999999999999999998755554
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......+||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......+. .
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~----~ 227 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPR----T 227 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT----T
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCC----C
Confidence 5556678999999999999999999999999999999999999999643221 111222222222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
.+.++.+++.+||+.||++|| +++||++
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 334689999999999999999 8999875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.98 Aligned_cols=332 Identities=26% Similarity=0.310 Sum_probs=223.3
Q ss_pred cccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccc
Q 042958 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464 (1075)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 464 (1075)
.+++.|++++|.+....+..|..+++|++|++++|.++++.+..|..+++|++|+|++|++++..|..|+++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 44555555555555443444555555555555555555555555555555555555555555555555555555555555
Q ss_pred cCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccccccccccccccc-
Q 042958 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG- 543 (1075)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~- 543 (1075)
++|+++...+..|+.+++|++|++++|++++..|..++.+++|+.|++++|++++. .+..+++|+.|++++|.+++
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 55555533333345555556666665555555555555556666666666655443 23445556666666666654
Q ss_pred ccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceE
Q 042958 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY 623 (1075)
Q Consensus 544 ~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 623 (1075)
..|..++.|++++|.+... |... ...|+.|++++|++++. +.+..+++|++|+|++|.+++..|..|..+++|++
T Consensus 202 ~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 276 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276 (390)
T ss_dssp ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCE
Confidence 4556677777777777644 2222 35677888888888754 56888999999999999999888999999999999
Q ss_pred EEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccccccEEeecCCcc
Q 042958 624 LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL 703 (1075)
Q Consensus 624 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~ 703 (1075)
|+|++|++++ +|..+..+++|++|+|++|++++ +|..+..+++|+.|++++|++++.. +..++.|+.|++++|++
T Consensus 277 L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~ 351 (390)
T 3o6n_A 277 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDW 351 (390)
T ss_dssp EECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCE
T ss_pred EECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCc
Confidence 9999999976 67777889999999999999985 6777888999999999999998763 67788999999999999
Q ss_pred CCCCCCCccccccccccccCCccccCC
Q 042958 704 QGPIPNSIAFRDAPIEALQGNKGLCGD 730 (1075)
Q Consensus 704 ~~~~p~~~~~~~~~~~~~~~n~~lcg~ 730 (1075)
++...... ++..+...+.+++..|+.
T Consensus 352 ~~~~~~~~-~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 352 DCNSLRAL-FRNVARPAVDDADQHCKI 377 (390)
T ss_dssp EHHHHHHH-TTTCCTTTBCCCCSCCCT
T ss_pred cchhHHHH-HHHHHhhcccccCceecc
Confidence 87542211 233333445666666764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.59 Aligned_cols=264 Identities=30% Similarity=0.497 Sum_probs=207.0
Q ss_pred ccccHHHHHHHhcCCCCC------ceecccCceEEEEEEECCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcCCcCc
Q 042958 803 GKIVYEEIIRATNDFDDE------HCIGKGGQGSVYKAELASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRHRN 875 (1075)
Q Consensus 803 ~~~~~~e~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~n 875 (1075)
..+++.++..++.+|... +.||+|+||.||+|.. +++.||||++..... ......+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457889999999999887 8999999999999986 589999999875432 23345678999999999999999
Q ss_pred eeeEEEEeeccccchhheec-----------CccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 876 IVKFYGFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 876 iv~l~~~~~~~~~~l~~~~~-----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
|+++++++......+.++.. .......+++..+++++.|+++||+|||+. +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 99999999765543222211 112234689999999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-
Q 042958 945 DNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN- 1021 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~- 1021 (1075)
++.+||+|||+++........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||+...........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543322 234578999999998875 4889999999999999999999999754332211110
Q ss_pred -----hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 -----LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.........++.+.. .....+..+.+++.+||+.||++|||++||++.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 011123333443332 34567778999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=349.52 Aligned_cols=247 Identities=21% Similarity=0.247 Sum_probs=194.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3457899999999999999999955 5799999999876543 2334567899999999999999999999998765543
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC---CCCCceEeccccccc
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD---FDNEAHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~ 958 (1075)
.+ ++... ....+++.+...++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 87 lv-~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 87 LI-FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EE-ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EE-EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 22 22211 235689999999999999999999999 999999999999998 467899999999988
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
............||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .....+.......+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAGAYDFPS 234 (444)
T ss_dssp CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCCT
T ss_pred ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhCCCCCCc
Confidence 776555556678999999999999999999999999999999999999999643221 111222222222222
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122334456999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=331.51 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=190.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|... +|+.||||++..... .....+.+.+|+.++++++||||+++++++...+..+. +
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l-v 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL-V 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE-E
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE-E
Confidence 57888999999999999999664 689999999976543 33345788899999999999999999999987654332 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 22211 145689999999999999999999999 999999999999999999999999999998765555
Q ss_pred ceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhh-----------hhhccC-
Q 042958 965 NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA-----------LDEMLD- 1031 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~- 1031 (1075)
......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||................ .....+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 556678999999999988766 7999999999999999999888863222111000000000 000000
Q ss_pred ---CC---CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 ---PR---LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ---~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+. ...........+..+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00000111233456899999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=342.11 Aligned_cols=243 Identities=22% Similarity=0.377 Sum_probs=190.3
Q ss_pred hcCCCCCceecccCceEEEEEEE--------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL--------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
.++|++.+.||+|+||.||+|+. .++..||||+++.. ......+++.+|+++++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 46788899999999999999965 24567999999754 2334467899999999999 8999999999997
Q ss_pred ccccchhheecCccc-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNAA-------------------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~~-------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
..+..+.+ ++.... ...+++.+++.++.||++||+|||+. +|+||||||+|
T Consensus 158 ~~~~~~lv-~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 158 QDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp SSSSCEEE-EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCEEEE-EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 75543222 221111 13478999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
|+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999987654332 2233457789999999999999999999999999999999 999997543211
Q ss_pred cchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+... ....+ ..++..+.+++.+||+.||++|||++|+++.|+
T Consensus 314 --------~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 314 --------LFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp --------HHHHHHTTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --------HHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 11111 223446999999999999999999999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=367.44 Aligned_cols=334 Identities=26% Similarity=0.294 Sum_probs=222.4
Q ss_pred cccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccc
Q 042958 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYL 464 (1075)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 464 (1075)
.+++.+++++|.+....+..|..+++|++|+|++|.++++.|..|+.+++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 34455555555554444444455555555555555555544455555555555555555555544555555555555555
Q ss_pred cCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCcccccccccccccccc-
Q 042958 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG- 543 (1075)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~- 543 (1075)
++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++|+.|+|++|.+++. .++.+++|+.|++++|.+++
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc
Confidence 55555544344445555555555555555555555555555555555555555443 13344555555555555554
Q ss_pred ccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceE
Q 042958 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY 623 (1075)
Q Consensus 544 ~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 623 (1075)
..|.+++.|++++|.+....+... ..|+.|+|++|.+++. ..+..+++|+.|+|++|.|++..|..|+.+++|++
T Consensus 208 ~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 282 (597)
T 3oja_B 208 AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282 (597)
T ss_dssp ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCE
T ss_pred cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCE
Confidence 455566777777776664333221 4567777777777753 56888999999999999999888999999999999
Q ss_pred EEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChhhhcccccccEEeecCCcc
Q 042958 624 LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNEL 703 (1075)
Q Consensus 624 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~ 703 (1075)
|+|++|++++ +|..+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|+|++.. +..++.|+.|++++|++
T Consensus 283 L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~ 357 (597)
T 3oja_B 283 LYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDW 357 (597)
T ss_dssp EECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCE
T ss_pred EECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCC
Confidence 9999999986 67777889999999999999985 7777888999999999999998763 66778999999999999
Q ss_pred CCCCCCCccccccccccccCCccccCCCC
Q 042958 704 QGPIPNSIAFRDAPIEALQGNKGLCGDVK 732 (1075)
Q Consensus 704 ~~~~p~~~~~~~~~~~~~~~n~~lcg~~~ 732 (1075)
+|.++.. -+.......+.++...|+...
T Consensus 358 ~~~~~~~-~~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 358 DCNSLRA-LFRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp EHHHHHH-HTTTCCTTTBCCCCCCCCTTC
T ss_pred CChhHHH-HHHHHhhhccccccccCCcch
Confidence 8765332 244445556778888898643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.60 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=190.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++||||+++++++...+..+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46789999999999999999965 47999999998766555666678899999999999999999999999776543322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 -~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 -MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp -EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred -EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 22211 234689999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC-CcCc
Q 042958 964 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP-SCIV 1041 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1041 (1075)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ..... ....+.. ....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~-~~~~~~~~~~~~ 237 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHI-QDSVPNVTTDVR 237 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHH-SSCCCCHHHHSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHh-hccCCCcchhcc
Confidence 2 23345799999999999999999999999999999999999999974332110 11111 1111110 1112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-CHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRP-TMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~ 1074 (1075)
.+.+..+.+++.+|+++||++|| +++++.+.|+
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 23345699999999999999999 8888888764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.96 Aligned_cols=241 Identities=20% Similarity=0.291 Sum_probs=188.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|+.+++.++||||+++++++......+.
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l- 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM- 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE-
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE-
Confidence 36788999999999999999976 5799999999864221111223578899999999999999999999987654332
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++... ....+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 87 v~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~ 162 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-N 162 (336)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-B
T ss_pred EEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC-c
Confidence 222221 235689999999999999999999999 9999999999999999999999999999876543 2
Q ss_pred ceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.....+||+.|+|||++.+..+ ++++||||+|+++|||++|+.||+...... ....+.......+ ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~p----~~ 230 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------LFKKVNSCVYVMP----DF 230 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------CBCCCCSSCCCCC----TT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCCCCCc----cc
Confidence 3345679999999999988776 789999999999999999999997432211 1111111122222 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+.+++.+||+.||.+|||++|+++
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3346899999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=338.88 Aligned_cols=245 Identities=20% Similarity=0.257 Sum_probs=193.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc---hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.+.|++.+.||+|+||.||+|... +|+.||+|++....... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999665 79999999987643221 11357899999999999999999999999876543
Q ss_pred hhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC----CceEeccccc
Q 042958 890 LAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla 956 (1075)
+.+ ++.. .....+++.++..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv-~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLI-LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEE-EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEE-EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 222 2221 1235689999999999999999999999 999999999999998877 7999999999
Q ss_pred cccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 167 HEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVSYDF 237 (361)
T ss_dssp EECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCCC
T ss_pred eEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCCCC
Confidence 876643 234456799999999999998999999999999999999999999974322 11222232222222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.......+..+.+++.+||++||++|||++|+++
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 21112233456899999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=330.09 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=184.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+.+|++++++++||||+++++++...+..+.+ +
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv-~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV-F 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE-E
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE-E
Confidence 57888999999999999999888899999999865432 222246788999999999999999999999876543222 2
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 895 SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 895 ~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+.. .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 211 1135688999999999999999999999 9999999999999999999999999999877654444
Q ss_pred eeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh----------hhh--hccCC
Q 042958 966 WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI----------ALD--EMLDP 1032 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~----------~~~--~~~~~ 1032 (1075)
.....||+.|+|||++.+. .++.++||||+|+++|||++|+.||............... ... ...++
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 4556789999999998764 5899999999999999999999999754321100000000 000 00011
Q ss_pred CCCCC-----CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTP-----SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+... .......+.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11000 0011123456899999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.40 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=188.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.++||+|+||.||+|+.+ +++.||||++++.........+.+..|..++.++ +||||+++++++......+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~- 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF- 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE-
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE-
Confidence 467899999999999999999765 6889999999765433333345688999999887 8999999999998765433
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++++... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 2222221 235689999999999999999999999 9999999999999999999999999999875544
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-hhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-NLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... ........+.......+..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-- 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-- 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT--
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc--
Confidence 4555667899999999999999999999999999999999999999974432211111 1111222233333333322
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
.+.++.+++.+||++||++||++
T Consensus 285 --~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 --LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --CCHHHHHHHHHHhcCCHhHcCCC
Confidence 33458999999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=330.86 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=184.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhc--CCcCceeeEEEEeeccc---c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE--IRHRNIVKFYGFCSHVR---H 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---~ 888 (1075)
.++|++.+.||+|+||.||+|+. +|+.||||++... ..+.+..|.+++.. ++||||+++++++.... .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 46899999999999999999987 5999999998532 13455566666665 79999999999875432 1
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMH--------NDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
.+.++++... ....+++..+++++.|+++||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred eeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 1222222221 2346899999999999999999999 77 999999999999999999999999
Q ss_pred cccccccCCCCCc----eeccccccCccCccccccC------CCCcccchHhHHHHHHHHHhC----------CCCCCcc
Q 042958 953 FGIAKFLKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KHPRDFI 1012 (1075)
Q Consensus 953 fGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~~p~~~~ 1012 (1075)
||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999876554332 2234799999999999876 455799999999999999999 7777543
Q ss_pred Cccccchhhhhhhh-hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1013 SSMSSSSLNLNIAL-DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1013 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.............. .....+..+. .......+..+.+++.+||+.||++|||++||++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 22211111111100 1111111111 1123456778999999999999999999999999885
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.38 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=190.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---h
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS---L 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---l 890 (1075)
.++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++++++||||+++++++...... +
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 468889999999999999999876 899999998642 22345667799999999999999999999765431 2
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDC-------FPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
.++++... ....+++..++.++.|+++||+|||+.. .++|+||||||+||+++.++.+||+|||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 22222221 1345899999999999999999999861 23899999999999999999999999999
Q ss_pred ccccCCCCCc--eeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh--------
Q 042958 956 AKFLKPDSSN--WTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-------- 1020 (1075)
Q Consensus 956 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-------- 1020 (1075)
++.+...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9876644322 334579999999999886 3566789999999999999999999975432211000
Q ss_pred hhhhhhhhccCCCCCC-CC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1021 NLNIALDEMLDPRLPT-PS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
................ .. ......+..+.+++.+||+.||++|||++||++.|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0111111111111111 11 112345667999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=330.98 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=185.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCc-----------------------hhHHHHHHHHHHHHh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGE-----------------------MTFQQEFLNEVKALT 869 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 869 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999965 478999999986543111 112356889999999
Q ss_pred cCCcCceeeEEEEeeccc-cchhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 042958 870 EIRHRNIVKFYGFCSHVR-HSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNV 940 (1075)
Q Consensus 870 ~l~h~niv~l~~~~~~~~-~~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 940 (1075)
+++||||+++++++.... ..+.++++.. .....+++.++..++.|+++||+|||+. +|+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999999997632 2222222221 1234689999999999999999999999 999999999999
Q ss_pred eeCCCCCceEeccccccccCCCCCceeccccccCccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 941 LLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 941 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
+++.++.+||+|||+++.............||+.|+|||.+.+.. ++.++||||+|+++|||++|+.||.......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~- 247 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC- 247 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH-
Confidence 999999999999999988765554555678999999999988765 3788999999999999999999996432211
Q ss_pred chhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1018 SSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.......+. ....+..+.+++.+||+.||++|||++|+++
T Consensus 248 -------~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 -------LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -------HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11111111111110 1123346899999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=340.71 Aligned_cols=311 Identities=19% Similarity=0.159 Sum_probs=205.0
Q ss_pred CCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 71 SFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
.++++++|++++|.++..-+..++.+++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 45778888888888773333346778888888888888876666778888888888888888877666666666666666
Q ss_pred ecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC
Q 042958 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 151 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (1075)
++++|.++.+++..|.++++|++|++++|.+++..+..|..+++|++|++++|++++. .+..+++|++|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 6666666665555556666666666666666655555566666666666666665532 1334445555555555443
Q ss_pred CCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 310 (1075)
+ +...++ |++|++++|.++.. |.. ..++|+.|++++|.+++. ..+.
T Consensus 200 ~-----~~~~~~------------------------L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 200 T-----LAIPIA------------------------VEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp E-----EECCSS------------------------CSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGG
T ss_pred c-----cCCCCc------------------------ceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHc
Confidence 2 122234 45555555555432 211 124566666666666643 3566
Q ss_pred ccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccccee
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 390 (1075)
.+++|++|++++|.+++..|..|..+++|+.|++++|++++ +|..+..+++|++|++++|++. .+|..+..+++|++|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 66777777777777766666677777777777777777764 4555667778888888888774 456667778888888
Q ss_pred eeccccccccCChhhccCCCCCeEEeecccccc
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSG 423 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 423 (1075)
++++|+++.. + +..+++|+.|++++|.++.
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 8888888644 2 6677888888888888875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=338.88 Aligned_cols=245 Identities=21% Similarity=0.275 Sum_probs=193.0
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+....+.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3567999999999999999999664 7999999999765433 3345779999999999999999999999987654432
Q ss_pred heecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEecccccccc
Q 042958 892 MILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDFGIAKFL 959 (1075)
Q Consensus 892 ~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~ 959 (1075)
+ ++.. .....+++.++..++.||++||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 106 v-~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 V-FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp E-ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred E-EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 2 2211 1234578999999999999999999999 999999999999998654 5999999999876
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+..
T Consensus 182 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 182 NDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAYDYPSP 252 (362)
T ss_dssp TTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCTT
T ss_pred cCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCcc
Confidence 643 3334568999999999999989999999999999999999999999643221 1112222222222222
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23344567999999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.21 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=190.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|+.+++++ +||||+++++++......+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~- 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF- 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE-
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE-
Confidence 357888999999999999999765 6899999999765444555567789999999988 8999999999997755432
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++++... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 2222221 135688999999999999999999999 9999999999999999999999999999875544
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccch-hhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS-LNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .........+.......+.
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--- 240 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 240 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT---
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC---
Confidence 445566789999999999999999999999999999999999999997432211110 0111112222222222222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
..+..+.+++.+||+.||++||++
T Consensus 241 -~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 241 -SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 233468999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.89 Aligned_cols=243 Identities=23% Similarity=0.423 Sum_probs=187.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 356788899999999999999764 34569999997542 344467899999999999999999999999775543
Q ss_pred hhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 890 LAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 890 l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+. +++.. .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 126 ~l-v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 126 MI-VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EE-EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EE-EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 22 22211 1234689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCC
Q 042958 960 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRL 1034 (1075)
Q Consensus 960 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1034 (1075)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+.. ...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~ 273 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEGYRL 273 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCCC
Confidence 654322 122345778999999998899999999999999999999 999986433211 1111111 122
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+ ...+..+.+++.+||+.||++|||++||++.|+
T Consensus 274 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 274 PAP----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222 223446999999999999999999999999885
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=340.94 Aligned_cols=243 Identities=21% Similarity=0.315 Sum_probs=186.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|+.+ +|+.||||++...........+.+..|.++++.+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999665 6899999998653222223356788999999988 7999999999998765432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 101 -lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 -FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp -EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred -EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 2222221 235689999999999999999999999 999999999999999999999999999987555
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-- 246 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPTW-- 246 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT--
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence 44555667899999999999999999999999999999999999999974322 11222333333333322
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH------HHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTM------PKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1071 (1075)
.+..+.+++.+|+++||++||++ +|+++
T Consensus 247 --~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 --LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 23458999999999999999998 66664
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=334.40 Aligned_cols=241 Identities=21% Similarity=0.275 Sum_probs=190.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l- 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM- 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE-
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE-
Confidence 467889999999999999999664 6899999998643 2235678899999999999999999999977554322
Q ss_pred eecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC--CCCceEeccccccccC
Q 042958 893 ILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF--DNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~ 960 (1075)
+++.. .....+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++.+.
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 22211 1124689999999999999999999999 9999999999999997 7899999999998876
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+...
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHHH
T ss_pred CC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCCCChhh
Confidence 43 334556799999999999988899999999999999999999999974322 112222222222222111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.++.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2233457999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=344.08 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=195.7
Q ss_pred cHHHHHHHhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceee
Q 042958 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVK 878 (1075)
Q Consensus 806 ~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 878 (1075)
...++....++|++.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|+++++++ +||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455566678999999999999999999963 346899999997542 333457899999999999 8999999
Q ss_pred EEEEeeccccchhheecCccc-----------------------------------------------------------
Q 042958 879 FYGFCSHVRHSLAMILSNNAA----------------------------------------------------------- 899 (1075)
Q Consensus 879 l~~~~~~~~~~l~~~~~~~~~----------------------------------------------------------- 899 (1075)
++++|...+..+.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765533333222111
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 900 ----------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 900 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998765433
Q ss_pred C--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 964 S--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 964 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
. ......||+.|+|||++.+..++.++||||||+++|||++ |+.||........ ......... ....+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~-- 319 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGT--RMRAPD-- 319 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHHTC--CCCCCT--
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHHHHHcCC--CCCCCC--
Confidence 2 2334568899999999999999999999999999999998 9999975432211 111111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++|||++||++.|+
T Consensus 320 --~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 320 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 22346899999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=321.03 Aligned_cols=241 Identities=26% Similarity=0.417 Sum_probs=190.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|+.+++..||||++...... .+++.+|++++++++||||+++++++......+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV- 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE-
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE-
Confidence 4678889999999999999999988889999999754322 46789999999999999999999999765543222
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 22211 134589999999999999999999999 99999999999999999999999999998765443
Q ss_pred Cc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcC
Q 042958 964 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCI 1040 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1075)
.. .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+...... ........ ....+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-- 228 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHRLYRPH-- 228 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCCT--
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCCCCCCC--
Confidence 22 223446678999999998889999999999999999999 999997433211 11111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 229 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 229 --LASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp --TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred --cChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 12345899999999999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=335.24 Aligned_cols=245 Identities=24% Similarity=0.419 Sum_probs=184.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCE----EEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEI----VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|+..+.||+|+||.||+|... +++. ||+|++.... .....+++.+|+.++++++||||++++++|.....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 367888999999999999999754 4543 6888876432 22335789999999999999999999999987664
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+..... .....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 433332221 1235689999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||+....... ....... ...+.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~ 241 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKG--ERLPQP 241 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTT--CCCCCC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-----HHHHHcC--CCCCCC
Confidence 54332 223456889999999999999999999999999999999 9999975432211 1111111 112222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ..+..+.+++.+||+.||++|||++||++.|+
T Consensus 242 ~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 242 P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp T----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 2 23346899999999999999999999998774
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=329.66 Aligned_cols=253 Identities=19% Similarity=0.295 Sum_probs=193.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~ 891 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++..... ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 357888999999999999999665 699999999875322 2225678899999999999999999999876543 222
Q ss_pred heecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee----CCCCCceEecccc
Q 042958 892 MILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL----DFDNEAHVSDFGI 955 (1075)
Q Consensus 892 ~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGl 955 (1075)
++++.. .....+++.+++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 222221 1122389999999999999999999999 99999999999999 7788899999999
Q ss_pred ccccCCCCCceeccccccCccCccccc--------cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAY--------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
++...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||..................
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98776543 334567999999999886 567899999999999999999999999744332211111111111
Q ss_pred hc-----------------cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1028 EM-----------------LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1028 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
.. ....++............+.+++.+||+.||++|||++|+++-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 10 0112233334556778889999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.78 Aligned_cols=245 Identities=23% Similarity=0.383 Sum_probs=190.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|... +++.||||+++.. ......++|.+|++++++++||||++++++|...+..+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~- 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY- 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE-
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE-
Confidence 3467888999999999999999776 7999999998754 23334567899999999999999999999997655432
Q ss_pred heecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 2222211 134588999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCce--eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... ..+.+.+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----~~~~~~~--~~~~~~~~ 338 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVEK--GGRLPCPE 338 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----HHHHHHT--TCCCCCCT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc--CCCCCCCC
Confidence 21111 12235778999999998889999999999999999998 999987543211 1111111 11222222
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++||++.|+
T Consensus 339 ----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 339 ----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 23346899999999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=340.24 Aligned_cols=245 Identities=20% Similarity=0.216 Sum_probs=189.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCC--CCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPL--PGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35789999999999999999965 479999999985321 011112467999999999999999999999998755432
Q ss_pred hheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC---ceEeccc
Q 042958 891 AMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE---AHVSDFG 954 (1075)
Q Consensus 891 ~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfG 954 (1075)
++++... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 103 -lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 -MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp -EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred -EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 2222211 123478999999999999999999999 9999999999999987654 9999999
Q ss_pred cccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
+++.............||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....+.....
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKY 249 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCC
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCC
Confidence 998876654445567899999999999999999999999999999999999999974211 11122222222
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2211111223456899999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.96 Aligned_cols=246 Identities=20% Similarity=0.259 Sum_probs=190.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc---hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.+.|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999665 69999999987643221 11357899999999999999999999999875543
Q ss_pred hhheecC-c-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC----CceEecccccc
Q 042958 890 LAMILSN-N-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIAK 957 (1075)
Q Consensus 890 l~~~~~~-~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla~ 957 (1075)
+.++... . .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 3222111 1 1235689999999999999999999999 999999999999999887 89999999998
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......+
T Consensus 167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 167 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVNYEFE 237 (326)
T ss_dssp ECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHTCCCCC
T ss_pred ECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHhcCCCcC
Confidence 77543 2334567999999999999899999999999999999999999999643221 11111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111223456899999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=336.88 Aligned_cols=244 Identities=22% Similarity=0.434 Sum_probs=179.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
..+|++.+.||+|+||.||+|+.. ++..||||+++... .....++|.+|+.++++++||||+++++++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 367999999999999999999764 57789999997542 334467899999999999999999999999875543
Q ss_pred hhhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+.++ +... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 2222 1111 1234689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCC
Q 042958 961 PDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLP 1035 (1075)
Q Consensus 961 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1035 (1075)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+... +.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~~~ 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRLP 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEECC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence 44322 122335678999999999999999999999999999998 999986432211 11111111 112
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ ...+..+.+++.+||+.||++||+++||++.|+
T Consensus 271 ~~----~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 271 PP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CC----TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC----ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 22 123446999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.19 Aligned_cols=238 Identities=22% Similarity=0.263 Sum_probs=180.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~ 892 (1075)
++|+..++||+|+||+||+|... +|+.||||++......... ..++..|+..+.++ +||||++++++|.+.+..+.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 57999999999999999999765 7999999998765443333 34555666665555 999999999999876554322
Q ss_pred eecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+.... .....++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~ 211 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G 211 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence 21111 1134689999999999999999999999 9999999999999999999999999999876543 2
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+.....+. ......
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~--~~~~~~ 277 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPP--EFTAGL 277 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCH--HHHTTS
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCc--ccccCC
Confidence 3344579999999999876 789999999999999999999776542111 11111111111 111223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+..+.+++.+||+.||++|||++|+++
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 456999999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=335.90 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=188.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+++++.++|||||++++++.+....+.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367889999999999999999654 6899999998643212222356788999999999999999999999876543322
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.. .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 94 -~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 94 -VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp -ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred -EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 2221 1234689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeccccccCccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 964 SNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... .....+.......+.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~p~-- 241 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFETTVVTYPS-- 241 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHHHCCCCCCT--
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHhhcccCCCC--
Confidence 33456789999999999874 45899999999999999999999999743322111 111111112222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-HHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPT-MPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1071 (1075)
..+..+.+++.+||+.||++||+ +++|.+
T Consensus 242 --~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 --AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22346899999999999999998 777764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.55 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=174.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|++++++++||||+++++++...+..+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999654 6999999998754322 2236788999999999999999999999876543222
Q ss_pred eecCcc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 893 ILSNNA--------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 893 ~~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
++... ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 -~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 -FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp -EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred -EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 22111 113588999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh----------hhh
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI----------ALD 1027 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~----------~~~ 1027 (1075)
............||+.|+|||++.+. .++.++||||+||++|||++|+.||............... ...
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 76554445566899999999998764 6899999999999999999999999754321100000000 000
Q ss_pred hc--cCCCCCCC-Cc---------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EM--LDPRLPTP-SC---------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~--~~~~~~~~-~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. ..+..... .. .....+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00000000 00 00112346899999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=320.34 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=189.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHH----HHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQ----QEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++........... +.+.+|++++++++||||+++++++.+...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 46788899999999999999966 4799999999876543322211 678999999999999999999999876553
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeeeCCCCC-----ceEecc
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPP--IVHRDISSKNVLLDFDNE-----AHVSDF 953 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl~Df 953 (1075)
+.+.+... .....+++..++.++.|++.|++|||+. + |+||||||+||+++.++. +||+||
T Consensus 98 -lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 98 -MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 22222111 1244689999999999999999999999 7 999999999999988876 999999
Q ss_pred ccccccCCCCCceeccccccCccCccccc--cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
|+++.... ......||+.|+|||++. ...++.++||||+|+++|||++|+.||.......... ..........
T Consensus 174 g~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLR 248 (287)
T ss_dssp TTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCC
T ss_pred Cccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCC
Confidence 99985432 344567999999999984 4557899999999999999999999997543221100 0111111111
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.. ....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 249 ~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 249 PTI------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 111 1233456999999999999999999999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=354.24 Aligned_cols=312 Identities=20% Similarity=0.162 Sum_probs=211.2
Q ss_pred CCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 71 SFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
.+++++.|++++|.+.+..+..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 35678888888888875444456778888888888888887777788888888888888888877666666666666666
Q ss_pred ecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC
Q 042958 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 151 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (1075)
+|++|.++++++..|+.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.. +..+++|+
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~---------- 195 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLF---------- 195 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCS----------
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhh----------
Confidence 66666666555555556666666666666665555555555555555555555555321 33344444
Q ss_pred CCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 310 (1075)
.|++++|.+++. ...++|+.|++++|.++...+.. .++|+.|+|++|.+++ +..+.
T Consensus 196 --------------~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 196 --------------HANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp --------------EEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGG
T ss_pred --------------hhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhc
Confidence 444444444421 12234555555555555322211 1467777777777764 35677
Q ss_pred ccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCccccee
Q 042958 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390 (1075)
Q Consensus 311 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 390 (1075)
.+++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|++|+|++|.+. .+|..+..+++|++|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 77777777777777777777777777788888888887775 4666677888888888888885 567778888899999
Q ss_pred eeccccccccCChhhccCCCCCeEEeeccccccc
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGS 424 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 424 (1075)
+|++|++++.. +..+++|+.|++++|.+++.
T Consensus 330 ~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 330 YLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp ECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred ECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence 99999987542 66788999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=331.53 Aligned_cols=240 Identities=22% Similarity=0.409 Sum_probs=184.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||++++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467888999999999999999775 79999999997543 23346789999999999999999999998865432
Q ss_pred ----------------------------------------------------chhheecCc------------cccCCCC
Q 042958 889 ----------------------------------------------------SLAMILSNN------------AAAKDLG 904 (1075)
Q Consensus 889 ----------------------------------------------------~l~~~~~~~------------~~~~~l~ 904 (1075)
.+.++++.. .......
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 011222221 1123346
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC------------ceeccccc
Q 042958 905 WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS------------NWTELAGT 972 (1075)
Q Consensus 905 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~------------~~~~~~gt 972 (1075)
+..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 677899999999999999999 999999999999999999999999999988765421 22345799
Q ss_pred cCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHH
Q 042958 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVA 1052 (1075)
Q Consensus 973 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1052 (1075)
+.|+|||++.+..++.++||||+|+++|||++|..|+.. .............+. ........+.+++
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~~~li 306 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLKFPL---LFTQKYPQEHMMV 306 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTCCCH---HHHHHCHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccCCCc---ccccCChhHHHHH
Confidence 999999999999999999999999999999999877531 111122222222221 2334456789999
Q ss_pred HHccCCCCCCCCCHHHHHh
Q 042958 1053 ISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1053 ~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+||+.||++|||++|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=335.71 Aligned_cols=245 Identities=21% Similarity=0.280 Sum_probs=189.9
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 888 (1075)
....++|++.+.||+|+||.||+|+.+ +|+.||||+++..........+.+..|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999765 6899999998643211112246678899999877 99999999999987654
Q ss_pred chhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 SLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.+ ++++... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~-lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LF-FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EE-EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EE-EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 32 2222221 135689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~- 239 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYPR- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT-
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCCc-
Confidence 54444456678999999999999999999999999999999999999999743221 111222222222221
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMP-KVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1071 (1075)
..+.++.+++.+||+.||++||++. ||++
T Consensus 240 ---~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 240 ---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 2234689999999999999999997 6653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=343.62 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=185.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+++.+|+.+++.++||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 46899999999999999999955 479999999997542 233446788999999999999999999999865432
Q ss_pred -chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 -SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 -~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.++++++.... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 12222222211 23488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh--------------hhhhhh
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------------LNIALD 1027 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------------~~~~~~ 1027 (1075)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||............ ......
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred C-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 3 2345568999999999999999999999999999999999999999754321100000 000001
Q ss_pred hccCCCC----------------CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRL----------------PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..... +...........++.+++.+|++.||++|||++|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111100 0000111123567999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.30 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46788899999999999999974 36899999998743 34446789999999999999999999999865432
Q ss_pred -chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 889 -SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 889 -~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
.+.++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 1222222211 123489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcc--------ccchhhhhhhh
Q 042958 958 FLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM--------SSSSLNLNIAL 1026 (1075)
Q Consensus 958 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~--------~~~~~~~~~~~ 1026 (1075)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76544321 22345778899999999999999999999999999999999998632211 00000000111
Q ss_pred hhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1027 DEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1027 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..... .+.+.+ ...+.++.+++.+||+.||++|||++|+++.|+
T Consensus 243 ~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 243 ELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHhccCcCCCC----cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11111 122222 233456999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=329.64 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=186.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++......+.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 368899999999999999999665 7999999998654322 2246788999999999999999999999876553322
Q ss_pred e-ecC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-
Q 042958 893 I-LSN-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS- 963 (1075)
Q Consensus 893 ~-~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 963 (1075)
+ +.. ......+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 2 111 11234589999999999999999999999 99999999999999999999999999998664332
Q ss_pred -CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 964 -SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 964 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||......... ...........+ ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~~--~~ 231 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLN--PW 231 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------HHHHHTTCTTST--TG
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcccccCC--cc
Confidence 22345679999999999987775 77899999999999999999999754322110 111111111111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 234456889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=346.00 Aligned_cols=245 Identities=22% Similarity=0.382 Sum_probs=191.7
Q ss_pred HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++......+.
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv 260 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII 260 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence 3456788889999999999999999889999999997532 125789999999999999999999999875433332
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+.+.... ....+++.++.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 2222111 123578889999999999999999999 9999999999999999999999999999876532
Q ss_pred CC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 963 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 963 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....... ..+.+.+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~~--~~~~~~~~-- 408 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALER--GYRMPRPE-- 408 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHH--TCCCCCCT--
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc--CCCCCCCC--
Confidence 21 1123346788999999998899999999999999999999 999997433211 1111111 11222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++..+.+++.+||+.||++|||+++|++.|+
T Consensus 409 --~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 409 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 23446999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.36 Aligned_cols=242 Identities=23% Similarity=0.404 Sum_probs=190.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|+..+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+....+.++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 4678888999999999999999888999999999754322 367899999999999999999999998755432221
Q ss_pred -ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 -LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 -~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+... .....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 1111 1234589999999999999999999999 999999999999999999999999999987654321
Q ss_pred -ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCc
Q 042958 965 -NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIV 1041 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1041 (1075)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+... ....+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--- 230 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPR--- 230 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCCT---
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCccCCCCC---
Confidence 1223456778999999998999999999999999999999 99998743221 111111111 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 231 -~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 231 -LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 22346899999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=327.10 Aligned_cols=239 Identities=22% Similarity=0.331 Sum_probs=188.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....+ +
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~-l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF-M 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE-E
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE-E
Confidence 367888999999999999999665 79999999986432112223467889999999999999999999998765432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 222221 235688999999999999999999999 9999999999999999999999999999875432
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....+||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~---- 225 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPF---- 225 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTT----
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC----
Confidence 3346799999999999999999999999999999999999999964322 11122222222222222
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
.+.++.+++.+|++.||++|| +++|+++
T Consensus 226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 234589999999999999999 8888875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.35 Aligned_cols=240 Identities=27% Similarity=0.395 Sum_probs=187.7
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..+.||+|+||.||+|.. .+|+.||||++...........+++.+|++++++++||||+++++++......+.++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999965 579999999997654444455678999999999999999999999997755432222
Q ss_pred -ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 -LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 -~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+... .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 1111 1245689999999999999999999999 9999999999999999999999999999876432
Q ss_pred eeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 966 WTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
....||+.|+|||++. +..++.++||||||+++|||++|+.||........ .........+... ..
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~-----~~ 276 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNESPALQ-----SG 276 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCC-----CT
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCCCCC-----CC
Confidence 3457999999999884 56789999999999999999999999864332110 0011111111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..+.+++.+||+.||++|||++|+++
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 22345899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=323.06 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=168.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|+.++++++||||+++++++......+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788999999999999999966 57999999998643211222346789999999999999999999999876543222
Q ss_pred eecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++.. .....+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 90 -~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 -LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp -EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred -EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 2211 1135689999999999999999999999 9999999999999999999999999999877644
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
........||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ............+.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---- 233 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TLNKVVLADYEMPS---- 233 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCT----
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HHHHHhhcccCCcc----
Confidence 444445678999999999999889999999999999999999999997433211 11111112222221
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 22346899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=327.40 Aligned_cols=242 Identities=23% Similarity=0.293 Sum_probs=179.1
Q ss_pred hcCCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCCC-chhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLPG-EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...... .......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999976 47999999999764321 12234568899999999999999999999987554
Q ss_pred chhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 889 SLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 889 ~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.+. +++... ....+++.+...++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~l-v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYL-ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEE-EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEE-EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 332 222221 134578899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
...........||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~p~- 242 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKCKLNLPP- 242 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCCT-
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCC-
Confidence 54444445668999999999999999999999999999999999999999743221 112222222222222
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
..+..+.+++.+||+.||++|| +++|+++
T Consensus 243 ---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 243 ---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 2234589999999999999999 7778765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.79 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=179.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCc-hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGE-MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|+..+.||+|+||.||+|... |+.||||++....... ....+.+.+|+++++.++||||+++++++...+..+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l- 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL- 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE-
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE-
Confidence 367888999999999999999876 8999999987543222 2234678999999999999999999999987654322
Q ss_pred eecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC--------CCCceEeccccc
Q 042958 893 ILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF--------DNEAHVSDFGIA 956 (1075)
Q Consensus 893 ~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--------~~~~kl~DfGla 956 (1075)
+++.. .....+++..++.++.|+++|++|||+....+|+||||||+||+++. ++.+||+|||.+
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 22221 12456899999999999999999999993223999999999999986 678999999999
Q ss_pred cccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
+...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ............
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 233 (271)
T 3dtc_A 164 REWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMNKLAL 233 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHTSCCCC
T ss_pred ccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHhhhcCCCCC
Confidence 8765432 234578999999999999999999999999999999999999997433211 111111111111
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+ .....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 234 P--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 1 11223346999999999999999999999999885
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=332.93 Aligned_cols=243 Identities=23% Similarity=0.371 Sum_probs=183.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc--CceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|+.++++++| |||+++++++......+.
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467889999999999999999888899999999876542 33445789999999999976 999999999987654332
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++.+....
T Consensus 87 -v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 -VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 222211 235689999999999999999999999 999999999999997 6789999999998775443
Q ss_pred C--ceeccccccCccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc
Q 042958 964 S--NWTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 964 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~ 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHAII 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHH
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-------HHHHHHHh
Confidence 2 2335679999999999865 67889999999999999999999999643211 11122222
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++..... ........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 235 DPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 2221111 11112235899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=322.25 Aligned_cols=242 Identities=22% Similarity=0.327 Sum_probs=194.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l- 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV- 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE-
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE-
Confidence 467888999999999999999665 688999999876544445556789999999999999999999999987654322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 222211 134689999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+.......+. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----~ 237 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNEYSIPK----H 237 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCT----T
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhccCCCcc----c
Confidence 4455567999999999999988999999999999999999999999743221 111222222222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 2345899999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=336.96 Aligned_cols=246 Identities=15% Similarity=0.211 Sum_probs=189.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++......+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 46788999999999999999965 5799999999865432 24578999999999 99999999999887554322
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC-----ceEecccccc
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE-----AHVSDFGIAK 957 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGla~ 957 (1075)
+ ++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 83 v-~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 83 V-LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp E-EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred E-EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 2 22211 135789999999999999999999999 9999999999999998887 9999999998
Q ss_pred ccCCCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc
Q 042958 958 FLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 958 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
.+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~-----~~~i~ 233 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER-----YQKIG 233 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH-----HHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH-----HHHHH
Confidence 76544321 2456799999999999999999999999999999999999999975432221111 11111
Q ss_pred CCCCCCCCcC-cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1031 DPRLPTPSCI-VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1031 ~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+.+... ....+ ++.+++..||+.||.+||++++|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 0000000000 00122 6999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=340.28 Aligned_cols=238 Identities=27% Similarity=0.418 Sum_probs=187.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|... |+.||||+++... ..+.|.+|++++++++||||+++++++......+.++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 467888899999999999999886 8899999997542 2468999999999999999999999987765433333
Q ss_pred ecCccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNAA-----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++.... ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 332211 22378999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..... ..+.+.+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----~~i~~--~~~~~~p---- 408 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----PRVEK--GYKMDAP---- 408 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-----HHHHT--TCCCCCC----
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHc--CCCCCCC----
Confidence 223367889999999999999999999999999999998 99999754332111 11111 1122222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 233456999999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.01 Aligned_cols=245 Identities=23% Similarity=0.392 Sum_probs=180.2
Q ss_pred HhcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
..++|++.+.||+|+||.||+|... .+..||+|++... ......+.+.+|+.++++++||||+++++++.+...
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 90 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence 3467888999999999999999664 2457999998754 234456789999999999999999999999865443
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+.+.... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 3333222211 133589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCC
Q 042958 961 PDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTP 1037 (1075)
Q Consensus 961 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1037 (1075)
.... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ....+... ..+.+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLPMP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCCCC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCCCCCC
Confidence 4322 2233456789999999998899999999999999999996 999997543211 11111111 11111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 240 ----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 223446999999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=333.35 Aligned_cols=247 Identities=20% Similarity=0.367 Sum_probs=191.8
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEee
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS 884 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 884 (1075)
....++|++.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344678999999999999999999764 35889999997543 3344678999999999999999999999997
Q ss_pred ccccchhheecCcc---------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 042958 885 HVRHSLAMILSNNA---------------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~---------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 931 (1075)
..+..+.+ ++... ....+++.+++.++.||++||+|||+. +|+
T Consensus 121 ~~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 121 VGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp SSSSCEEE-EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred cCCceEEE-EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 65543222 21111 015689999999999999999999999 999
Q ss_pred EecCCCCCeeeCCCCCceEeccccccccCCCC--CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCC
Q 042958 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1008 (1075)
Q Consensus 932 H~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p 1008 (1075)
||||||+||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999998664332 12234567899999999998899999999999999999999 9999
Q ss_pred CCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1009 RDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
|...... .....+........ ....+..+.+++.+||+.||++|||+.||++.|+
T Consensus 277 ~~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 277 YYGMAHE--------EVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTTSCHH--------HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCChH--------HHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 8743221 11122222222111 1223346999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.46 Aligned_cols=250 Identities=25% Similarity=0.456 Sum_probs=181.4
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|... ..||||+++.... .....+.+.+|++++++++||||+++++++......+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence 3578999999999999999999764 4599999876543 344467899999999999999999999987655443333
Q ss_pred eecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-
Q 042958 893 ILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS- 963 (1075)
Q Consensus 893 ~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 963 (1075)
.+... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 22211 1245689999999999999999999999 99999999999999999999999999998655322
Q ss_pred -CceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 964 -SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 964 -~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
.......||+.|+|||.+. +..++.++||||+|+++|||++|+.||........ ...........+... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~---~ 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLS---K 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCCCTT---S
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCcchh---h
Confidence 2234467999999999986 56688899999999999999999999975332111 011111111111111 1
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....++..+.+++.+||+.||++|||++|+++.|+
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 22234457999999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=333.50 Aligned_cols=243 Identities=19% Similarity=0.269 Sum_probs=189.3
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+....+.+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 467899999999999999999664 79999999987532 22346789999999999999999999999875543222
Q ss_pred ee-cCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC--CCCceEeccccccccCC
Q 042958 893 IL-SNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF--DNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~-~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~ 961 (1075)
+. ... .....+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 21 111 1123689999999999999999999999 9999999999999974 46799999999988764
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.......+....
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~ 274 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDAF 274 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSSTT
T ss_pred Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCcccc
Confidence 32 3344579999999999999999999999999999999999999997433211 11111111111111122
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.++.+++.+||+.||++|||++|+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 234456999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=332.51 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=190.5
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|+.+ +|+.||||++...........+.+..|..+++.+ +||+|+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999765 5889999998653211222346788999999988 8999999999988755432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 -lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 -FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp -EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred -EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 2222221 135689999999999999999999999 999999999999999999999999999987554
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~--- 242 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK--- 242 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT---
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCC---
Confidence 44455667899999999999999999999999999999999999999974322 1122222223332222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
..+.++.+++.+||++||++||+ ++|+++
T Consensus 243 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 -SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 23346899999999999999995 467654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.81 Aligned_cols=244 Identities=21% Similarity=0.284 Sum_probs=190.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+.++++++||||+++++++......+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 478899999999999999999654 689999999875433 233457789999999999999999999999776543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC---ceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE---AHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~~~~ 960 (1075)
++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+....
T Consensus 84 -~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 -FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp -ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred -EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 22211 134588999999999999999999999 9999999999999987665 9999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ....+.......+...
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~ 230 (284)
T 3kk8_A 160 DS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYPSPE 230 (284)
T ss_dssp SS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTT
T ss_pred cC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHHHHHhccccCCchh
Confidence 43 23345679999999999999999999999999999999999999996432211 1111111111111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2233456999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.19 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=184.3
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+.+|++++++++||||+++++++...+..+.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv- 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV- 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE-
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE-
Confidence 57889999999999999999765 69999999986653 3334467788999999999999999999999876543322
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++.. .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 2211 1245689999999999999999999999 999999999999999999999999999988765555
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------------hhhhhcc
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------------IALDEML 1030 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------------~~~~~~~ 1030 (1075)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 5556689999999999876 5679999999999999999999999975432211100000 0000001
Q ss_pred CCCCCCCCcC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPSCI------VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.+... ....+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111110 0123456899999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.17 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=184.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++.............+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46789999999999999999965 57999999999876555556667899999999999999999999998765432
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
..++++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 122222221 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC---ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ............+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~~ 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDPIPP 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCCCCH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCCCCCc
Confidence 4322 2234568999999999999999999999999999999999999997433211 0111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.++.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1111123456999999999999999998777664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=330.81 Aligned_cols=238 Identities=20% Similarity=0.281 Sum_probs=188.8
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch-----hHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
..++|++.+.||+|+||.||+|.. .+++.||||++........ ...+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999965 5789999999876532211 1234677899999999999999999999876
Q ss_pred ccchhheecC-c--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 887 RHSLAMILSN-N--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 887 ~~~l~~~~~~-~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
+..+.++... . .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 5543322211 1 1234689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
...... ......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||..... ........
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~~~~ 243 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAAIHP 243 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTCCCC
T ss_pred ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhccCC
Confidence 776443 2344679999999999988877 7899999999999999999999963211 11112222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+.. .+.++.+++.+||++||++|||++|+++-
T Consensus 244 ~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 244 PYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 221 23358999999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=320.53 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=187.8
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|+..++..||||++...... .+++.+|++++++++||||+++++++......+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 35678889999999999999999998889999999754322 36789999999999999999999999775543222
Q ss_pred eecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++.. .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++.....
T Consensus 98 -~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 98 -TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp -ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred -EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 2211 1135689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 963 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 963 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ......... ....+.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~~--~~~~~~-- 244 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIAQGL--RLYRPH-- 244 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTC--CCCCCT--
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHhccc--CCCCCC--
Confidence 21 1223456788999999998899999999999999999998 999997433211 111111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 245 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 245 --LASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 12345899999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=324.96 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=181.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++...........+++.+|+.++++++||||+++++++...+..+.+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45789999999999999999965 57999999999765444555677899999999999999999999998775543222
Q ss_pred e-ecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 893 I-LSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~-~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+ +... .....+++..+++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 2 1111 1234588999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......+.....+.. .
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--~ 259 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPL--P 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCC--C
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCC--c
Confidence 5444444567899999999999999999999999999999999999998643211 0111111111121111 0
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+..+.+++.+||+.||++|||++||++.|+
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1223446999999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=330.50 Aligned_cols=239 Identities=21% Similarity=0.250 Sum_probs=189.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|+.. +|+.||||++...........+.+.+|+++++.++||||+++++++.+....+ +
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~-l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY-M 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE-E
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE-E
Confidence 367888999999999999999765 79999999986432112223567889999999999999999999998755432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 222221 134688999999999999999999999 9999999999999999999999999999876532
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. .
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~ 260 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPS----H 260 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT----T
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----C
Confidence 2346799999999999999999999999999999999999999974322 1112222222332222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
.+..+.+++.+||+.||++||+ ++||++
T Consensus 261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2346899999999999999998 888865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=340.63 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=191.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|.+.+.||+|+||.||+|... +|+.||||++...........+.+.+|+.+++.++||||+++++++......+.
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l- 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM- 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE-
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE-
Confidence 367888999999999999999765 799999999864321122235678999999999999999999999987654322
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++.. .....+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 22221 1245689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ......+.+.....+..
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~--- 238 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGIFYTPQY--- 238 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTCCCCCTT---
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCcCCCcc---
Confidence 33445689999999999988765 6899999999999999999999974322 11222333333333322
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+.+++.+||+.||++|||++|+++
T Consensus 239 -~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 -LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 2345899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=331.49 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=174.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++......+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3567889999999999999999765 68899999987532 23578899999999999999999999987654322
Q ss_pred heecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEecccccccc
Q 042958 892 MILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDFGIAKFL 959 (1075)
Q Consensus 892 ~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~ 959 (1075)
+++.. .....+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 126 -v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 126 -VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp -EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred -EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 22221 1234589999999999999999999999 9999999999999975 889999999999876
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.......+..
T Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 202 EHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEYYFISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCCCCCTT
T ss_pred Ccc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCCccCCc
Confidence 533 22345679999999999999999999999999999999999999986432211 1122222222222111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22334456999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=327.21 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=168.7
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhheecCc
Q 042958 820 EHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....+.+ ++..
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv-~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV-MELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE-ECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE-EEcc
Confidence 478999999999999664 7999999998532 2467889999999996 99999999999876544322 2221
Q ss_pred ---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEeccccccccCCCCCc
Q 042958 898 ---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 898 ---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~ 965 (1075)
.....+++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++........
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 89 NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 1235689999999999999999999999 999999999999998766 7999999999877665555
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ..........+.......+.......+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCcccccCCC
Confidence 5667889999999999999999999999999999999999999975432111 111122333444444433332333455
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 67999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=334.43 Aligned_cols=239 Identities=22% Similarity=0.256 Sum_probs=179.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHH-HhcCCcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|+.+ +++.||||++...........+.+..|..+ ++.++||||+++++++...+..+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~- 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY- 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE-
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE-
Confidence 467899999999999999999765 689999999976543333334567778777 57789999999999998765433
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++++... ....+++.+.+.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 2222221 134578889999999999999999999 9999999999999999999999999999875544
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~---- 260 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKP---- 260 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSCCCCCS----
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcccCCCC----
Confidence 4455667899999999999999999999999999999999999999964322 1112222222222222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPK 1068 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~e 1068 (1075)
..+..+.+++.+||++||++||++.+
T Consensus 261 ~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 261 NITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 22345899999999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=334.43 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=188.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......++.+|+.++++++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 467888999999999999999743 4678999998653 23344567899999999999999999999997755
Q ss_pred cchhhe-ecCc--------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---Cce
Q 042958 888 HSLAMI-LSNN--------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAH 949 (1075)
Q Consensus 888 ~~l~~~-~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k 949 (1075)
..+.++ +... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 432221 1111 1124589999999999999999999999 999999999999999655 599
Q ss_pred EeccccccccCCCC--CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhh
Q 042958 950 VSDFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIAL 1026 (1075)
Q Consensus 950 l~DfGla~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1026 (1075)
|+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence 99999998653221 22334567899999999999999999999999999999998 99999743321 111
Q ss_pred hhccCCC-CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1027 DEMLDPR-LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1027 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.... ...+ ...+..+.+++.+||+.||++|||++||++.|+
T Consensus 297 ~~i~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 297 EFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCCC----ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1222211 1111 123346899999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.77 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=175.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEECC-CC---EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELAS-GE---IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
...++|++.+.||+|+||.||+|.... ++ .||||++....... ...+++.+|++++++++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345789999999999999999996553 32 79999997643332 34678999999999999999999999987654
Q ss_pred cc-----hhheecCcc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 888 HS-----LAMILSNNA---------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 888 ~~-----l~~~~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
.. ...+++... ....+++.++++++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 32 011221111 112589999999999999999999999 9999999999999999999
Q ss_pred ceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhh
Q 042958 948 AHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1024 (1075)
+||+|||+++....... ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------- 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------
Confidence 99999999987654332 1223456789999999999999999999999999999999 999997543321
Q ss_pred hhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+... ....+ ...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 248 ~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 248 IYNYLIGGNRLKQP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCCC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111 12222 223346999999999999999999999998875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=345.84 Aligned_cols=242 Identities=21% Similarity=0.270 Sum_probs=181.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.............+.+|+++++.++||||++++++|...+..+ +
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~-l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC-F 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE-E
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE-E
Confidence 46799999999999999999965 479999999986432222233467889999999999999999999998765432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++... ....+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 222221 13568899999999999999999998 7 9999999999999999999999999999876555
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~---- 370 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPR---- 370 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT----
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCCCCc----
Confidence 55556678999999999999999999999999999999999999999643221 111222222222222
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
..+.++.+++.+||+.||++|| +++|+++
T Consensus 371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2234689999999999999999 9999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=328.18 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=183.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCE----EEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEI----VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|... +++. ||+|.+..... ....+++.+|+.++++++||||++++++|.....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCc
Confidence 467889999999999999999654 4553 57787754322 2235789999999999999999999999987664
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+...... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4333222211 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+....... ...... ....+.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~~~~--~~~~~~~ 241 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEK--GERLPQP 241 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHT--TCCCCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHc--CCCCCCC
Confidence 44322 223456789999999999999999999999999999999 9999975433211 111111 1122222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 242 ~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 242 P----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp T----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2 23346899999999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=327.57 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=193.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|.+.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..+ +
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF-V 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE-E
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE-E
Confidence 467888999999999999999665 68899999987654444556778999999999999999999999998765432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 222211 135689999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.......+. .
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~----~ 263 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIPK----H 263 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCCT----T
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCCCCCCc----c
Confidence 44556779999999999999899999999999999999999999997432111 11111111222221 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345889999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.99 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=184.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCE----EEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEI----VAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|... +++. ||+|++...... ...+.+.+|+.++++++||||++++++|.....
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcc
Confidence 357888899999999999999654 4554 888887543221 223567789999999999999999999976544
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+.+.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 3333222211 134688899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.... ......|++.|+|||++.+..++.++||||+|+++|||++ |+.||......... ...... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~ 239 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-----DLLEKG--ERLAQP 239 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-----HHHHTT--CBCCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-----HHHHcC--CCCCCC
Confidence 5432 2344567889999999999999999999999999999999 99999754322111 111111 111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. .+..+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 240 QI----CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp TT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred Cc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 2234889999999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=333.54 Aligned_cols=242 Identities=23% Similarity=0.371 Sum_probs=184.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC--cCceeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--HRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~l~~ 892 (1075)
.+|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++......+ +
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~-l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY-M 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE-E
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE-E
Confidence 56899999999999999999888899999999876433 3445678999999999996 599999999988765532 2
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++... ....+++.++..++.||++||+|||+. +|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus 134 v~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 222211 234678889999999999999999999 999999999999996 68999999999987754432
Q ss_pred --ceeccccccCccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 965 --NWTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+.+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~~~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHAIID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHHHHhC
Confidence 2345679999999999865 36889999999999999999999999643211 112222333
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+...... ....+..+.+++.+||+.||++|||++|+++
T Consensus 283 ~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 283 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 2221110 0111345899999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=334.10 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=190.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
.++|.+.+.||+|+||.||+|... ++..||||++... ......+++.+|+++++++ +||||++++++|.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 467888999999999999999652 2357999999764 2334457899999999999 9999999999997
Q ss_pred ccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
..+..+.++ +... ....+++.++++++.||++||+|||+. +|+||||||+|
T Consensus 146 ~~~~~~lv~-e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 146 QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp SSSSCEEEE-ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCceEEEE-EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 755432222 1111 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
|+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987654332 2334467889999999999999999999999999999999 99998743321
Q ss_pred cchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+... ....+ ...+.++.+++.+||+.||++|||++||++.|+
T Consensus 301 -------~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 301 -------ELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp -------HHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111 11111 123346999999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=341.42 Aligned_cols=188 Identities=26% Similarity=0.365 Sum_probs=142.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----H 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+++.+|++++++++|||||++++++.... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 36799999999999999999955 479999999987543 33444678999999999999999999999985432 1
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 2223222221 234689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC---------------------------ceeccccccCccCcccc-ccCCCCcccchHhHHHHHHHHHhC
Q 042958 961 PDSS---------------------------NWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKG 1005 (1075)
Q Consensus 961 ~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg 1005 (1075)
.... .....+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 23445789999999976 566799999999999999999994
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.09 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=190.5
Q ss_pred HHHhcCCCCCceecccCceEEEEEEEC-CC-----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELA-SG-----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
....++|+..+.||+|+||.||+|... ++ ..||+|++.... .....+.+.+|+++++++ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344678999999999999999999764 23 479999987543 334467899999999999 899999999999
Q ss_pred eccccchhheecCcc-----------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 042958 884 SHVRHSLAMILSNNA-----------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNV 940 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~~-----------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 940 (1075)
...+..+.+ ++... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 120 ~~~~~~~lv-~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THGGPVLVI-TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp CSSSSCEEE-EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred ecCCceEEE-EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 775543222 22111 123578999999999999999999999 999999999999
Q ss_pred eeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCcccc
Q 042958 941 LLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSS 1017 (1075)
Q Consensus 941 ll~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 1017 (1075)
+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999999876543322 223457889999999998899999999999999999998 9999874332111
Q ss_pred chhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1018 SSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........... ..+. ..+..+.+++.+||+.||.+|||++||++.|+
T Consensus 276 ----~~~~~~~~~~~--~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 276 ----FYKLVKDGYQM--AQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp ----HHHHHHHTCCC--CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHhcCCCC--CCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 11111111111 1111 12346899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=340.73 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=186.4
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|+..+.||+|+||.||+|.+.++..||||+++.... ..++|.+|++++++++||||+++++++......+.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEe
Confidence 3467888899999999999999998888899999975432 246899999999999999999999999764433322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
.+.... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 222111 124588999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcC
Q 042958 964 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCI 1040 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1040 (1075)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.. .+.+.+.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~~-- 404 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPCPP-- 404 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT--
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCC--
Confidence 2 2233456789999999998999999999999999999999 999987433211 1111111 1222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++..+.+++.+||+.||++|||+++|++.|+
T Consensus 405 --~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 405 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 33446999999999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=324.80 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=183.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|... +++.||||++......+....+.+.+|+.++++++||||+++++++...+..+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999764 789999999976544445556789999999999999999999999977554332
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+ ++... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 112 v-~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 D-MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp E-EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred E-EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 2 22211 234689999999999999999999999 9999999999999999999999999999876543
Q ss_pred C-CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 S-SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..........+.+....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---------VMGAHINQAIPRPSTVR 258 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---------HHHHHHHSCCCCGGGTS
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---------HHHHHhccCCCCccccC
Confidence 2 2233457899999999999999999999999999999999999999743221 11111111111111112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-CHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRP-TMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|| +++|+++.|+
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 23344699999999999999999 9999998874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=322.65 Aligned_cols=249 Identities=16% Similarity=0.201 Sum_probs=189.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.+ +|+|++++++++......+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46789999999999999999965 5799999999865422 24577899999999 89999999999876554332
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC-----ceEeccccccc
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE-----AHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~DfGla~~ 958 (1075)
++..... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 84 v~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 2211111 134589999999999999999999999 9999999999999988776 99999999987
Q ss_pred cCCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 959 LKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 959 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH-HHhhccC
Confidence 765432 12445799999999999999999999999999999999999999976433221111100 0000000
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... .......+..+.+++.+||+.||++|||++||++.|+
T Consensus 240 ~~~---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 240 TPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp SCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccH---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 000 0001122346999999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.80 Aligned_cols=241 Identities=28% Similarity=0.432 Sum_probs=185.1
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
+.++|++.+.||+|+||.||+|... +++.||||++.............+.+|+.++++++||||+++++++.+....+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567889999999999999999654 678999999854322222235678999999999999999999999987654322
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 -v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 -ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp -EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred -EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 222211 235588999999999999999999999 9999999999999999999999999998654432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+.......+.
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---- 228 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEFTFPD---- 228 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCT----
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCCCCCCC----
Confidence 234467899999999999999999999999999999999999999743221 111111112222221
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 12345899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=331.64 Aligned_cols=243 Identities=25% Similarity=0.369 Sum_probs=177.1
Q ss_pred CCCCCceecccCceEEEEEEEC--CC--CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA--SG--EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.|+..+.||+|+||.||+|... ++ ..||||.+... ......++|.+|+.++++++||||++++++|...+....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4566789999999999999653 22 36899998753 233446789999999999999999999999865544333
Q ss_pred heecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 3333221 234578999999999999999999999 999999999999999999999999999987644
Q ss_pred CCC----ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 962 DSS----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 962 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......... .... ......
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-----~~~~--~~~~~~ 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----YLLQ--GRRLLQ 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-----HHHT--TCCCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-----HHHc--CCCCCC
Confidence 321 1233457789999999999999999999999999999999 677776433221111 1111 111222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 318 p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 318 PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 21 22346999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=343.66 Aligned_cols=252 Identities=18% Similarity=0.243 Sum_probs=190.8
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
.++....++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.+++.++|||||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455789999999999999999999765 6899999998642111111123578999999999999999999999876
Q ss_pred ccchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 887 RHSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 887 ~~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
...+ ++++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 142 ~~~~-lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 142 RYLY-MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp SEEE-EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEE-EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 5432 2222221 134588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ceeccccccCccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 959 LKPDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 959 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
+..... .....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||........ ............
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~~ 293 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----YSKIMNHKNSLT 293 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTHHHHCC
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH----HHHHHhcccccc
Confidence 664432 234578999999999998765 78899999999999999999999974332111 011111111112
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1071 (1075)
++... ..+.++.+++.+|++.+|++ ||+++||++
T Consensus 294 ~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 294 FPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 22211 22345899999999999998 999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=326.47 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=183.8
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC--chhHHHHHHHHHHHHhcCC---cCceeeEEEEeecc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG--EMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSHV 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 886 (1075)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... .......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999965 57999999998643211 1111245667777777664 99999999998765
Q ss_pred cc----chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 887 RH----SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 887 ~~----~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
.. .+.++++... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 42 1222222211 122389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh-----
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD----- 1027 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----- 1027 (1075)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.............. ...
T Consensus 164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 241 (308)
T 3g33_A 164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD-LIGLPPED 241 (308)
T ss_dssp CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH-HHCCCCTT
T ss_pred CccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCChh
Confidence 9999876543 233456889999999999999999999999999999999999999974332211000000 000
Q ss_pred ----------hccCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 ----------EMLDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ----------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+ .....+.+..+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 0001123456899999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=331.61 Aligned_cols=236 Identities=23% Similarity=0.282 Sum_probs=180.9
Q ss_pred CceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCcc
Q 042958 820 EHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.+.||+|+||.||+|.. .+|+.||+|++... .....+++.+|++++++++||||+++++++...+..+.+ ++...
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv-~E~~~ 169 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV-MEYVD 169 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE-EECCT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE-EeCCC
Confidence 56899999999999965 57999999998753 223457899999999999999999999999876543222 22211
Q ss_pred ----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee--CCCCCceEeccccccccCCCCCce
Q 042958 899 ----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL--DFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 899 ----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
....+++.++..++.||++||+|||+. +|+||||||+||++ +.++.+||+|||+++.+.... ..
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 123588999999999999999999999 99999999999999 667899999999998876443 33
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+.......+.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCCCChhhhccCCH
Confidence 4457999999999999889999999999999999999999999743321 11222222222222112223445
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++.+++.+|++.||++|||++|+++
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.27 Aligned_cols=242 Identities=26% Similarity=0.454 Sum_probs=179.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++.+. ..+.+.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP-VCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-TEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-cEEEEE
Confidence 356888899999999999999876 889999998632 2357899999999999999999999988743 222221
Q ss_pred ecC----------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC-ceEeccccccccCCC
Q 042958 894 LSN----------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE-AHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~DfGla~~~~~~ 962 (1075)
+.. ......+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 111 111234788999999999999999999932229999999999999998887 799999999865432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+....... . ..........+. ...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~---~~~~~~~~~~~~---~~~ 227 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---R---IMWAVHNGTRPP---LIK 227 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---H---HHHHHHTTCCCC---CBT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---H---HHHHHhcCCCCC---ccc
Confidence 2335689999999999999999999999999999999999999974332110 0 011111111111 112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 23446899999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=324.91 Aligned_cols=245 Identities=24% Similarity=0.391 Sum_probs=190.1
Q ss_pred HhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 356788899999999999999965 345889999997542 344467899999999999999999999998765
Q ss_pred ccchhheecCcc---------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 042958 887 RHSLAMILSNNA---------------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHR 933 (1075)
Q Consensus 887 ~~~l~~~~~~~~---------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 933 (1075)
...+.+ ++... ....+++.++++++.|+++||+|||+. +|+||
T Consensus 99 ~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 99 GPLLLI-VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp SSCEEE-EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CceEEE-EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 543222 21111 112378899999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 042958 934 DISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRD 1010 (1075)
Q Consensus 934 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~ 1010 (1075)
||||+||+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 223456788999999998889999999999999999999 999997
Q ss_pred ccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1011 FISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....... ........ ....+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 255 ~~~~~~~-----~~~~~~~~--~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 255 GIPPERL-----FNLLKTGH--RMERP----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp TCCGGGH-----HHHHHTTC--CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH-----HHHhhcCC--cCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 5432111 11111111 11111 223446999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=323.65 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=184.7
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC--CcCceeeEEEEeeccc
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI--RHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~ 887 (1075)
.....++|++.+.||+|+||.||+|+.. |+.||||++... . ...+..|.+++... +||||+++++++....
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----E--EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344578999999999999999999876 999999998532 1 24445566665554 9999999999987653
Q ss_pred c---chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCeeeCCCCCceEe
Q 042958 888 H---SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDC-----FPPIVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 888 ~---~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
. .+.++++... ....+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 2 2223332221 1345889999999999999999999762 2489999999999999999999999
Q ss_pred ccccccccCCCCCc----eeccccccCccCccccccCCCCcc------cchHhHHHHHHHHHhC----------CCCCCc
Q 042958 952 DFGIAKFLKPDSSN----WTELAGTYGYVAPELAYTMKVTEK------CDVYSFGVLALEVIKG----------KHPRDF 1011 (1075)
Q Consensus 952 DfGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~vl~elltg----------~~p~~~ 1011 (1075)
|||+++.+...... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999876544322 124579999999999987766655 9999999999999999 555543
Q ss_pred cCccccchhhhhhhh-hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1012 ISSMSSSSLNLNIAL-DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1012 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
............... .....+..+. ......++.++.+++.+||+.||++|||++||++.|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccc-cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 222111111111100 1111111111 1112366778999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.58 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=189.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+++.+|+.+++.++|++++..++++........+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999975 6799999999865432 24688999999999998887777776554444333
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC---CCCCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD---FDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~ 960 (1075)
+++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++...
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 333221 234689999999999999999999999 999999999999994 78899999999998766
Q ss_pred CCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 961 PDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 961 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......................+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 54321 24467999999999999999999999999999999999999999854332211111110001110000
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......+..+.+++.+||+.||++|||++||++.|+
T Consensus 240 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 240 ----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp ----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred ----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 0000122346999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=344.21 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=191.6
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
+.++....++|++.++||+|+||+||+|+.+ +++.||||++...........+.+.+|+.+++.++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3455556789999999999999999999765 588999999864211111112348899999999999999999999987
Q ss_pred cccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 886 VRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 886 ~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
.+..+. +++... ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 146 ~~~~~l-V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYL-VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp SSEEEE-EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEE-EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhh
Confidence 655332 222211 135689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhc
Q 042958 956 AKFLKPDSSN-WTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 956 a~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
|+........ ....+||+.|+|||++. ...++.++||||+||++|||++|+.||......+.. .......
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~ 297 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHK 297 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTHH
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH----Hhhhhcc
Confidence 9876554332 33468999999999987 456899999999999999999999999743321111 1111100
Q ss_pred cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHh
Q 042958 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPES--RPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1071 (1075)
....++.. ....+.++.+++.+|+..+|++ ||+++|+++
T Consensus 298 ~~~~~p~~---~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ERFQFPTQ---VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHCCCCSS---CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCcc---cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 01112211 1123346899999999988888 999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=322.19 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=186.6
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++|++++..++++........
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 457899999999999999999965 5799999998754322 2357889999999999888888777755444433
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEecccccccc
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 959 (1075)
++++... ....+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 3333221 135689999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 960 KPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 960 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
..... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 65432 12346789999999999999999999999999999999999999975443322111111111111000
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. .......+..+.+++.+||+.||++|||++||++.|+
T Consensus 239 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (296)
T 4hgt_A 239 I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp H----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred h----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence 0 0000112346999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=327.62 Aligned_cols=251 Identities=16% Similarity=0.223 Sum_probs=178.4
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++...+..+. +
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l-v 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL-V 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE-E
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE-E
Confidence 57888999999999999999765 7999999998654221 112245679999999999999999999977654332 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 22211 134588999999999999999999999 999999999999999999999999999987665545
Q ss_pred ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh----------------hhhhhh
Q 042958 965 NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN----------------LNIALD 1027 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------------~~~~~~ 1027 (1075)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||............ ......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 5556688999999999876 56899999999999999999999999753321100000 000000
Q ss_pred hccCCCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+...... ......+.++.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000 001122356899999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=333.22 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=187.4
Q ss_pred hcCCCCCceeccc--CceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 814 TNDFDDEHCIGKG--GQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
.++|++.+.||+| +||.||+|+.. +|+.||||++..... .....+.+.+|+++++.++|||||++++++...+..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4678999999999 99999999765 799999999976432 2345678889999999999999999999998765433
Q ss_pred hhe-ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMI-LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~-~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++ +... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 222 1111 1125589999999999999999999999 99999999999999999999999999987543
Q ss_pred CCC-------CceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 961 PDS-------SNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 961 ~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....................+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 221 11223478999999999987 678999999999999999999999997543322111100000000000
Q ss_pred CC---------------------------CC-------CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PR---------------------------LP-------TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~---------------------------~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. .+ .........+..+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00 000012233456999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.49 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=190.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCch---hHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEM---TFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++........ ...+++.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999665 699999999876432221 1357899999999999999999999999876543
Q ss_pred hhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC----CceEeccccc
Q 042958 890 LAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla 956 (1075)
+.+ ++.. .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLI-LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEE-ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEE-EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 222 2221 1234578999999999999999999999 999999999999999888 7999999999
Q ss_pred cccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
+...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVSYDF 237 (321)
T ss_dssp EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCCC
T ss_pred eecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhccccc
Confidence 8766432 334567999999999999999999999999999999999999999643221 1112222222211
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.......+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111223456899999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.99 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=188.0
Q ss_pred HhcCCCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
..++|++.+.||+|+||.||+|.... +..||||++.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence 35678889999999999999996542 3469999987542 33446789999999999999999999999876554
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.+..... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++...
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 333322221 1134589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 961 PDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 961 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ....... ...+.+.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~ 237 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----IGVLEKG--DRLPKPD 237 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-----HHHHHHT--CCCCCCT
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-----HHHHhcC--CCCCCCC
Confidence 4332 2233457889999999998899999999999999999998 9999964332211 1111111 1122221
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 238 ----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 238 ----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 22345999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=324.89 Aligned_cols=246 Identities=23% Similarity=0.405 Sum_probs=191.1
Q ss_pred HhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346788899999999999999974 356899999997542 333467899999999999 99999999999977
Q ss_pred cccchhheecCcc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 042958 886 VRHSLAMILSNNA---------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSK 938 (1075)
Q Consensus 886 ~~~~l~~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 938 (1075)
.+..+.+ ++... ....+++.++++++.|+++||+|||+. +|+||||||+
T Consensus 99 ~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 99 GGPTLVI-TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSCEEE-EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred CCCcEEE-EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 5543222 11110 112489999999999999999999999 9999999999
Q ss_pred CeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCcc
Q 042958 939 NVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSM 1015 (1075)
Q Consensus 939 Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 1015 (1075)
||+++.++.+||+|||+++........ .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999877654332 223457889999999999999999999999999999999 99998754321
Q ss_pred ccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ........... ..+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 255 ~~----~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 255 SK----FYKMIKEGFRM--LSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp HH----HHHHHHHTCCC--CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hH----HHHHhccCCCC--CCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11 11111111111 111 123346999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.34 Aligned_cols=243 Identities=21% Similarity=0.379 Sum_probs=190.4
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++......+.+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEE
Confidence 3467888999999999999999988888999999875432 246889999999999999999999998765433332
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
...... ....+++.++.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 222111 122689999999999999999999999 99999999999999999999999999998775433
Q ss_pred Cc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcC
Q 042958 964 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCI 1040 (1075)
Q Consensus 964 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1075)
.. .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ....+... ....+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--- 232 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYRMVRP--- 232 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCC---
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccCCCCc---
Confidence 21 223456789999999988889999999999999999999 999987432211 11111111 11111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 233 -~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 233 -DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 123346999999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=338.49 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=180.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC-----chhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG-----EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
...++|.+.+.||+|+||.||+|.. .+++.||||++...... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3467899999999999999999955 46899999998653211 11222358899999999999999999999876
Q ss_pred cccchhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---CceEecccc
Q 042958 886 VRHSLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAHVSDFGI 955 (1075)
Q Consensus 886 ~~~~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~DfGl 955 (1075)
....+.+.+... .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 554433332211 2245689999999999999999999999 999999999999997544 599999999
Q ss_pred ccccCCCCCceeccccccCccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
++..... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........ ....+...
T Consensus 289 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~i~~~ 360 (419)
T 3i6u_A 289 SKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQITSG 360 (419)
T ss_dssp TTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HHHHHHTT
T ss_pred ceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HHHHHhcC
Confidence 9876543 33445689999999999863 5678899999999999999999999974332111 11111122
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
............+..+.+++.+||+.||++|||++|+++
T Consensus 361 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222111111223457999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=328.24 Aligned_cols=243 Identities=20% Similarity=0.258 Sum_probs=187.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+....+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3567999999999999999999664 789999999975432 234678888887 7999999999998765432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-C---CceEecccccc
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-N---EAHVSDFGIAK 957 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~---~~kl~DfGla~ 957 (1075)
++++... ....+++.++..++.||+.||+|||+. +|+||||||+||++..+ + .+||+|||+++
T Consensus 93 -lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 93 -VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp -EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred -EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 2222211 234589999999999999999999999 99999999999998543 3 49999999999
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
............+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......+.......+
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKFSLS 243 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCCCCC
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCcccC
Confidence 87665555556789999999999988889999999999999999999999997432211 1111222222222222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222334556999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=332.85 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=178.4
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeecccc-c
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRH-S 889 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~ 889 (1075)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++++. ||||+++++++...+. .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 457899999999999999999965 5799999999875432 3334567889999999997 9999999999975442 2
Q ss_pred hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 890 LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 890 l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++++++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 233332222 134688999999999999999999999 9999999999999999999999999999875431
Q ss_pred ---------------------CCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh
Q 042958 963 ---------------------SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 963 ---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 1020 (1075)
.......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112344679999999999876 6789999999999999999999999975432111000
Q ss_pred hhh-------hhh---------------hhccCCCCCCCCcCc-------------HHHHHHHHHHHHHccCCCCCCCCC
Q 042958 1021 NLN-------IAL---------------DEMLDPRLPTPSCIV-------------QDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1021 ~~~-------~~~---------------~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
... ... ............... ...+.++.+++.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 000 000 000000000000000 022346899999999999999999
Q ss_pred HHHHHh
Q 042958 1066 MPKVSQ 1071 (1075)
Q Consensus 1066 ~~evl~ 1071 (1075)
++|+++
T Consensus 323 ~~e~l~ 328 (388)
T 3oz6_A 323 ANDALK 328 (388)
T ss_dssp HHHHTT
T ss_pred HHHHhC
Confidence 999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=327.23 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=183.5
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc--hhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE--MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
...++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|++++++++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999664 69999999987533221 1123468899999999999999999999976554
Q ss_pred chhhee-cCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMIL-SNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~-~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.++. ... .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 322221 111 1234578889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC--------
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-------- 1031 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 1031 (1075)
..........||+.|+|||++.+. .++.++||||+|+++|||++|..||.......... ........
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~----~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT----RIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHHHCCCCTTTSSS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHHHcCCCChhhhhh
Confidence 555555667899999999998764 48899999999999999999999987543211100 00000000
Q ss_pred ----------CCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1032 ----------PRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1032 ----------~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
...+... ......+.++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0012234579999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=326.06 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=186.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++....... .....+.+|+++++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 36789999999999999999976 579999999986654322 224578899999999999999999999876432
Q ss_pred ---chhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 889 ---SLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 889 ---~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
.+.++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 1222222221 234689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC----CceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 957 KFLKPDS----SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 957 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
+.+.... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||............ ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~ 249 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI--SQLCGSIT 249 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCC
Confidence 8765322 22345678999999998876 45799999999999999999999999753321100000 00000000
Q ss_pred C---------------CCCCC-CcCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 P---------------RLPTP-SCIVQD------KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~---------------~~~~~-~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+ ..... .....+ ....+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 00000 000011 1345889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=330.41 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=186.3
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCC--CCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPL--PGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
+....++|++.+.||+|+||.||+|.. .+++.||+|++.... .......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 455678899999999999999999965 578999999985421 01223457899999999999999999999999775
Q ss_pred ccchhheecCccc-------------------------------------------------cCCCCHHHHHHHHHHHHH
Q 042958 887 RHSLAMILSNNAA-------------------------------------------------AKDLGWTRRMNVIKGISD 917 (1075)
Q Consensus 887 ~~~l~~~~~~~~~-------------------------------------------------~~~l~~~~~~~i~~~i~~ 917 (1075)
+..+.+ ++.... ...+++...+.++.|+++
T Consensus 101 ~~~~lv-~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 101 QYICLV-MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SEEEEE-EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CeEEEE-EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 543222 221110 111246667889999999
Q ss_pred HHHHHHhCCCCCeEEecCCCCCeeeCCCC--CceEeccccccccCCCCC----ceeccccccCccCcccccc--CCCCcc
Q 042958 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDN--EAHVSDFGIAKFLKPDSS----NWTELAGTYGYVAPELAYT--MKVTEK 989 (1075)
Q Consensus 918 ~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~DfGla~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~ 989 (1075)
||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998777 899999999986543221 2345679999999999875 678899
Q ss_pred cchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 042958 990 CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069 (1075)
Q Consensus 990 ~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1069 (1075)
+||||||+++|||++|+.||...... .....+.......+.......+..+.+++.+||+.||++|||+.|+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999999999743321 1122222222222222223345579999999999999999999999
Q ss_pred Hh
Q 042958 1070 SQ 1071 (1075)
Q Consensus 1070 l~ 1071 (1075)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=327.42 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=178.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.+++.++||||+++++++......+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l- 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI- 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE-
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE-
Confidence 468999999999999999999665 7999999999754322 2568899999999999999999999987654332
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC--ceEeccccccccCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE--AHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~~~~ 961 (1075)
+++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 222211 235689999999999999999999999 9999999999999987765 99999999985433
Q ss_pred CCCceeccccccCccCccccccCCCCcc-cchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
. .......||+.|+|||++.+..++.+ +||||+|+++|||++|+.||......... ......+.......+.
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----RKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH----HHHHHHHHTTCCCCCT--
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH----HHHHHHHhcCCCCCCC--
Confidence 2 22344679999999999988887655 89999999999999999999754332211 1122222222222211
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1122346899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=326.66 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=195.1
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeE
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKF 879 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 879 (1075)
..+.....++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||||+++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555678999999999999999999964 356899999997543 333456899999999999 79999999
Q ss_pred EEEeeccccchhheecCccc-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 042958 880 YGFCSHVRHSLAMILSNNAA-------------------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRD 934 (1075)
Q Consensus 880 ~~~~~~~~~~l~~~~~~~~~-------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 934 (1075)
++++...+..+.++++.... ...+++.+++.++.|+++||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987765433333322111 11278999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCc
Q 042958 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 1011 (1075)
Q Consensus 935 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~ 1011 (1075)
|||+||+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++||||+|+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876544332 234567889999999999999999999999999999998 9999975
Q ss_pred cCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1012 ISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...... ......... ....+. ..+..+.+++.+||+.||++|||++||++.|+
T Consensus 254 ~~~~~~----~~~~~~~~~--~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 254 VKIDEE----FCRRLKEGT--RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp CCCSHH----HHHHHHHTC--CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cchhHH----HHHHhccCc--cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 432111 111111111 111111 22346899999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=321.41 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=188.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~ 891 (1075)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+.+|++++++++||||+++++++.... ..+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 467888999999999999999664 7999999999765432 344678999999999999999999999885432 2222
Q ss_pred heecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEecCCCCCeeeCCCCCceEecc
Q 042958 892 MILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP-----IVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 892 ~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
++++... ....+++..+++++.|++.||+|||+. + |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 2222221 123489999999999999999999998 6 999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|.++.............|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGK 232 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhcc
Confidence 999876654333345678999999999998899999999999999999999999997443211 111111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+.. ....+.++.+++.+||+.||++|||++||++.+.
T Consensus 233 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FRRI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111 1123346999999999999999999999998754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.25 Aligned_cols=306 Identities=29% Similarity=0.392 Sum_probs=143.5
Q ss_pred ccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCC
Q 042958 93 IGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLD 172 (1075)
Q Consensus 93 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 172 (1075)
+..+++|++|++++|.+. .+| .+..+++|++|++++|++++. |. +..+++|++|++++|.++++
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~------------ 103 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI------------ 103 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC------------
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc------------
Confidence 345566666666666654 233 255555666666666555532 21 44444444444444444432
Q ss_pred EEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCC
Q 042958 173 TLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252 (1075)
Q Consensus 173 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 252 (1075)
..|..+++|++|++++|.+++..+ +..+++|++|++++|.....++ .+..+++|++|++++|.
T Consensus 104 --------------~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~ 166 (347)
T 4fmz_A 104 --------------SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166 (347)
T ss_dssp --------------GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSC
T ss_pred --------------hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCC
Confidence 124444444444444444442211 4444444444444443322222 24445555555555555
Q ss_pred CCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcc
Q 042958 253 LSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSE 332 (1075)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 332 (1075)
+.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 443222 4444444555555444443211 4445555555555555554332 4445555555555555543222
Q ss_pred cccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCC
Q 042958 333 IGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 412 (1075)
Q Consensus 333 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 412 (1075)
+..+++|++|++++|.+++. +.+..+++|++|++++|.+.+. ..+..+++|++|++++|++++..+..+..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 44455555555555554431 2344444555555555544332 2344445555555555555544445555555555
Q ss_pred eEEeeccccccccccccccccccceeccccccc
Q 042958 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKL 445 (1075)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 445 (1075)
+|++++|++++..| +..+++|++|++++|.|
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 55555555554333 44455555555555544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.08 Aligned_cols=241 Identities=20% Similarity=0.287 Sum_probs=188.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||+|++....... .+.+.+|++++++++||||+++++++......+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 467889999999999999999665 57899999987543222 46889999999999999999999999876543322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~ 960 (1075)
++... ....+++.++..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||++..+.
T Consensus 85 -~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 -MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp -EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred -EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 22211 234589999999999999999999999 99999999999999 788899999999998766
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......||+.|+|||.+.+. ++.++||||+|+++|||++|+.||...... .....+.......+...
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~ 230 (277)
T 3f3z_A 161 PG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFTFPEKD 230 (277)
T ss_dssp TT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCHHH
T ss_pred Cc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCchh
Confidence 43 333456799999999988764 899999999999999999999999743221 11122222222222111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123457999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.01 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=187.8
Q ss_pred cCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
+.|++.+.||+|+||.||+|.+ .+++.||||++..... ....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 5578889999999999999974 4689999999875432 22357899999999999999999999999765322
Q ss_pred -hhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 890 -LAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 890 -l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.++++.. .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 22222221 1234589999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcc-------ccchhhhhhhhhh
Q 042958 959 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-------SSSSLNLNIALDE 1028 (1075)
Q Consensus 959 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-------~~~~~~~~~~~~~ 1028 (1075)
....... .....||..|+|||.+.+..++.++||||+|+++|||++|+.|+...... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7655432 23456788899999999989999999999999999999999986422100 0000111111111
Q ss_pred ccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1029 MLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1029 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... ...+.+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 256 ~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 256 LKEGKRLPCP----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HhccCCCCCC----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 111 122222 233456999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=341.53 Aligned_cols=243 Identities=25% Similarity=0.420 Sum_probs=190.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.+. +++.||||+++.... ..++|.+|++++++++||||++++++|......+.+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 466888899999999999999776 488999999975422 257899999999999999999999999775543222
Q ss_pred e-ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 I-LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~-~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+ +... .....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 2 1111 1234588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 963 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 963 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||........ ...... ..+.+.+
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~--~~~~~~~--- 441 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEK--DYRMERP--- 441 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHT--TCCCCCC---
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHc--CCCCCCC---
Confidence 221 223346789999999998899999999999999999999 9999875432111 111111 1122222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..++..+.+++.+||+.||++||||+||++.|+
T Consensus 442 -~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 223446999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.89 Aligned_cols=255 Identities=18% Similarity=0.232 Sum_probs=178.4
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3457899999999999999999965 4799999999976532 2233567889999999999999999999998765433
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-----CCCCceEecccccc
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-----FDNEAHVSDFGIAK 957 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-----~~~~~kl~DfGla~ 957 (1075)
.+ ++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 110 lv-~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LI-FEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EE-EECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EE-EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 22 22211 234589999999999999999999999 999999999999994 44569999999998
Q ss_pred ccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh-------h---h
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI-------A---L 1026 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~-------~---~ 1026 (1075)
.............||+.|+|||++.+. .++.++||||+||++|||++|+.||............... . .
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 876555555566789999999998875 4899999999999999999999999743321110000000 0 0
Q ss_pred hh--ccCCCCCCCCcC------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DE--MLDPRLPTPSCI------VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~--~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. ......+..... ......++.+++.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 000000000000 0112356899999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=331.40 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=185.2
Q ss_pred HhcCCCCCceecccCceEEEEEEECC------CCEEEEEEccCCCCCchh--------HHHHHHHHHHHHhcCCcCceee
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELAS------GEIVAVKKFHSPLPGEMT--------FQQEFLNEVKALTEIRHRNIVK 878 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~ 878 (1075)
..++|++.+.||+|+||.||+|...+ ++.||||++......... ....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999997754 478999998654211000 0112445666778889999999
Q ss_pred EEEEeeccc---cchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC--C
Q 042958 879 FYGFCSHVR---HSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD--F 944 (1075)
Q Consensus 879 l~~~~~~~~---~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~ 944 (1075)
+++++.... ....++++.. .....+++.+++.++.||+.||+|||+. +|+||||||+||+++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 999987642 2222222221 1235689999999999999999999999 999999999999999 8
Q ss_pred CCCceEeccccccccCCCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 945 DNEAHVSDFGIAKFLKPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876543211 1334599999999999999999999999999999999999999974322211
Q ss_pred ch----hhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1018 SS----LNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1018 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. ...........++.++. ...+.++.+++..||+.||++||++++|++.|+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 10 00011112222221111 112346999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.29 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=185.5
Q ss_pred hcCCCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
..+|++.+.||+|+||.||+|...+ +..||+|.+... ......+.+.+|+.++++++||||++++++|...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3567888999999999999997542 236899998753 3344467899999999999999999999997665544
Q ss_pred hhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 890 LAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 890 l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
..++++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 333333221 234578999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC----ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CC
Q 042958 960 KPDSS----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PR 1033 (1075)
Q Consensus 960 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 1033 (1075)
..... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||........ ...... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--------~~~~~~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--------HHHHHTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--------HHHHhcCCC
Confidence 54321 1233567889999999999999999999999999999999 5556543322111 111111 11
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 251 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 251 LLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 12345999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.18 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=188.8
Q ss_pred cCCCCCc-eecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEH-CIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|.+.+ .||+|+||.||+|... +++.||||++... ......+++.+|++++++++||||+++++++......+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence 4455555 8999999999999653 5788999999764 23445678999999999999999999999996544333
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+..... .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 2222211 1235589999999999999999999999 9999999999999999999999999999887644
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCC
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTP 1037 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1037 (1075)
... .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....+... ....+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~~~~~ 235 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMECP 235 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCCCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcCCcCCCC
Confidence 332 123456889999999988889999999999999999998 999997433211 11111111 11111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 236 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 236 ----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 233456999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=317.67 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=185.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCC---EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 816 DFDDEHCIGKGGQGSVYKAELA-SGE---IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~-~g~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.|...+.||+|+||.||+|... +++ .||+|++... ......+.+.+|+.++++++||||+++++++...+....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4555688999999999999653 333 7999998753 334456789999999999999999999999976655423
Q ss_pred heecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++.. .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 332221 1235678999999999999999999999 999999999999999999999999999986644
Q ss_pred CC----CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCC-CccCccccchhhhhhhhhhccCCCCCC
Q 042958 962 DS----SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR-DFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 962 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
.. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.|+ ....... ........ ...+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~~~--~~~~~ 249 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LTHFLAQG--RRLPQ 249 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----HHHHHHTT--CCCCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----HHHHhhcC--CCCCC
Confidence 22 1223456789999999999999999999999999999999966554 3222111 11111111 11122
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+. ..+..+.+++.+||+.||.+|||++|+++.|+
T Consensus 250 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 250 PE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc----cchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 21 22346999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=331.89 Aligned_cols=247 Identities=22% Similarity=0.371 Sum_probs=188.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
...++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457899999999999999999975 246689999997542 222347899999999999 9999999999997
Q ss_pred ccccchhheecCccc--------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 042958 885 HVRHSLAMILSNNAA--------------------------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVH 932 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~~--------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 932 (1075)
..+..+.+ ++.... ...+++..++.++.||++||+|||+. +|+|
T Consensus 120 ~~~~~~lv-~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 120 LSGPIYLI-FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp SSSSCEEE-EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eCCccEEE-EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 75443222 211100 12378999999999999999999999 9999
Q ss_pred ecCCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCC
Q 042958 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPR 1009 (1075)
Q Consensus 933 ~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~ 1009 (1075)
|||||+||+++.++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876544332 233557889999999998899999999999999999998 99999
Q ss_pred CccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1010 DFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ ......... ....+ ...+..+.+++.+||+.||.+|||+.||++.|+
T Consensus 276 ~~~~~~~~----~~~~~~~~~--~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDAN----FYKLIQNGF--KMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TTCCCSHH----HHHHHHTTC--CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCcHHH----HHHHHhcCC--CCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 75432211 111111111 11111 122346999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=325.44 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=181.7
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
+....++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 3345678888999999999999999653 345899999876433 33345789999999999999999999999876
Q ss_pred cccc----hhheecCc---------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC
Q 042958 886 VRHS----LAMILSNN---------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN 946 (1075)
Q Consensus 886 ~~~~----l~~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~ 946 (1075)
.... ..++++.. .....+++.++++++.|+++||.|||+. +|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 5431 11111111 2235689999999999999999999999 999999999999999999
Q ss_pred CceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhh
Q 042958 947 EAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 947 ~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1075)
.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------- 257 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------- 257 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------
Confidence 999999999987654322 2233457889999999999999999999999999999999 889987443211
Q ss_pred hhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
........ .... ....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 258 -~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 258 -MYDYLLHGHRLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp -HHHHHHTTCCCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHcCCCCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 1111 1233446999999999999999999999999875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.39 Aligned_cols=307 Identities=27% Similarity=0.432 Sum_probs=210.8
Q ss_pred cCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcc
Q 042958 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 148 (1075)
+..+++|++|++++|.+. .+| .++.+++|++|++++|.+++. |. +.++++|++|++++|.++. +| .+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 457899999999999997 455 499999999999999999854 44 9999999999999999985 33 688999999
Q ss_pred eeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccC
Q 042958 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS 228 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 228 (1075)
+|++++|.+.++.+ +..+++|++|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 99999999888755 88888888888888865544443 7778888888888887774433 6677777777777777
Q ss_pred CCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCC
Q 042958 229 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308 (1075)
Q Consensus 229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 308 (1075)
+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 764322 6666777777777777664433 5555666666666666654322 55555555555555555532 23
Q ss_pred CCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccc
Q 042958 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLS 388 (1075)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 388 (1075)
+..+++|++|+++ +|++++. +.+..+++|++|++++|.+.+..|..+..+++|+
T Consensus 261 ~~~l~~L~~L~l~------------------------~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 261 VKDLTKLKMLNVG------------------------SNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECC------------------------SSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred HhcCCCcCEEEcc------------------------CCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 4444445555444 4444432 2345555666666666666555556666666666
Q ss_pred eeeeccccccccCChhhccCCCCCeEEeeccccc
Q 042958 389 MLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS 422 (1075)
Q Consensus 389 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 422 (1075)
+|++++|++++..| +..+++|++|++++|.|+
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 66666666665444 666667777777776664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=326.62 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=183.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+++.+|+++++.++||||+++++++......
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 46788999999999999999966 5799999999976532 334467889999999999999999999998765321
Q ss_pred --hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 --LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 --l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++++..+ ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 122222211 134688999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh-----------------
Q 042958 961 PDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL----------------- 1022 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------------- 1022 (1075)
.. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.............
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 345678999999999877 678999999999999999999999997543211100000
Q ss_pred --hhhhhhccCCCCCC--CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 --NIALDEMLDPRLPT--PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 --~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....... +..+. ........+..+.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 257 EAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHS--CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhC--CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000 00000 00111233456899999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=314.96 Aligned_cols=241 Identities=18% Similarity=0.262 Sum_probs=186.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-chhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l~~ 892 (1075)
.++|++.+.||+|+||.||+|..+ |+.||||++..... .....+.+.+|+.++++++||||+++++++..... ...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467888999999999999999886 89999999976533 33445789999999999999999999999977522 2222
Q ss_pred eecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 893 ILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP--IVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 893 ~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+++... ....+++.+++.++.|+++||+|||+. + |+||||||+||+++.++.++++|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 222111 122589999999999999999999998 7 999999999999999999999999987653
Q ss_pred CCCCCceeccccccCccCccccccCCCCc---ccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
.. ....||+.|+|||.+.+..++. ++||||+|+++|||++|+.||........ ..........+..+
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~- 233 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKVALEGLRPTIP- 233 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHHHHHSCCCCCCC-
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHHHHhcCCCCCCC-
Confidence 32 2346899999999998765544 79999999999999999999974332111 01111111111111
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 234 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 234 -----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 223446999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=327.47 Aligned_cols=241 Identities=21% Similarity=0.270 Sum_probs=174.8
Q ss_pred cCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHh-cCCcCceeeEEEEeec---ccc
Q 042958 815 NDFDDE-HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT-EIRHRNIVKFYGFCSH---VRH 888 (1075)
Q Consensus 815 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~---~~~ 888 (1075)
++|.+. +.||+|+||.||+|... +|+.||||++... ..+.+|++++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 456555 68999999999999654 7999999998531 45677888874 4589999999998864 122
Q ss_pred chhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEeccc
Q 042958 889 SLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDFG 954 (1075)
Q Consensus 889 ~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 954 (1075)
.++++++... ....+++.++..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 2333332221 123589999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+.....
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQY 284 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----HHHHHTCC
T ss_pred cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----HHHHcCcc
Confidence 99876533 23345678999999999999999999999999999999999999997543322111111 11111111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.......+.++.+++.+||+.||++|||++|+++
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111112234456999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=343.48 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=193.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++...........+.+.+|+.++++++||||+++++++......+.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999665 7999999998765443334467899999999999999999999999875543322
Q ss_pred ee-cCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEeccccccccCC
Q 042958 893 IL-SNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~-~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~~ 961 (1075)
.. ... .....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+..
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 21 111 1235689999999999999999999999 99999999999999 5678999999999987764
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.......+....
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGKYTFELPQW 251 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCSGGG
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCCccc
Confidence 43 3345679999999999876 6899999999999999999999999743321 112222222222222223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 252 KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 345567999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=326.01 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=192.6
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEE
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 882 (1075)
++....++|++.+.||+|+||.||+|... +++.||||++... .......++.+|+++++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 44456788999999999999999999653 4788999999754 233345679999999999999999999999
Q ss_pred eeccccchhheecCccc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 883 CSHVRHSLAMILSNNAA-------------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
+......+.+ ++.... ...+++.++++++.|++.||+|||+. +|+||||||+||+++
T Consensus 97 ~~~~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 97 VSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp ECSSSSCEEE-EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EccCCccEEE-EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 9775543222 221111 14568899999999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 1020 (1075)
.++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 247 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----- 247 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence 9999999999999866433221 223456889999999999899999999999999999999 89998643221
Q ss_pred hhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1021 NLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+........ ....+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 248 ---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 248 ---QVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp ---HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred ---HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11122222222111 1223346899999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=334.34 Aligned_cols=193 Identities=24% Similarity=0.361 Sum_probs=155.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----H 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|++++++++||||+++++++.... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 46899999999999999999965 468999999997643 33444678999999999999999999999987653 1
Q ss_pred chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++... ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 2222222221 234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC----------------------ceeccccccCccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 961 PDSS----------------------NWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 961 ~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
.... .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 4321 13557899999999986 56679999999999999999998766654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=323.03 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=188.4
Q ss_pred HhcCCCCCceecccCceEEEEEEE--------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEe
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL--------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC 883 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 883 (1075)
..++|++.+.||+|+||.||+|+. .+++.||||++.... .....+.+.+|+++++++ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 357889999999999999999976 357789999997542 334467899999999999 999999999999
Q ss_pred eccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 042958 884 SHVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSK 938 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~ 938 (1075)
...+..+.+ ++... ....+++.+++.++.||++||+|||+. +|+||||||+
T Consensus 111 ~~~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 111 TQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp CSSSCCEEE-EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ccCCceEEE-EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 775543222 21111 012488999999999999999999999 9999999999
Q ss_pred CeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCcc
Q 042958 939 NVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSM 1015 (1075)
Q Consensus 939 Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 1015 (1075)
||+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 999999999999999999876644322 223456789999999998889999999999999999999 99998743321
Q ss_pred ccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ......... ....+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 267 ~-----~~~~~~~~~--~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 267 E-----LFKLLKEGH--RMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp H-----HHHHHHHTC--CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-----HHHHHhcCC--CCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 111111111 11111 123346999999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=331.82 Aligned_cols=255 Identities=18% Similarity=0.289 Sum_probs=193.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc-hh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS-LA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-l~ 891 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++...... ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 357888999999999999999665 699999999875322 22256788999999999999999999998765432 22
Q ss_pred heecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee----CCCCCceEecccc
Q 042958 892 MILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL----DFDNEAHVSDFGI 955 (1075)
Q Consensus 892 ~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~DfGl 955 (1075)
++++.. .....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 222221 1122389999999999999999999999 99999999999999 7777899999999
Q ss_pred ccccCCCCCceeccccccCccCcccccc--------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYT--------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..................
T Consensus 163 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 9876543 23345679999999998865 56788999999999999999999999744332211111111110
Q ss_pred h-----------------ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 E-----------------MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ......+............+.+++.+||+.||++||+++|+++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 0 0011223333345677888999999999999999999999988753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=327.97 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=181.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 36789999999999999999965 4789999999876432 33446778999999999999999999999876542
Q ss_pred -chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 -SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 -~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.+.++++.... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 22222222221 23578999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------------hhhhh
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------NIALD 1027 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------~~~~~ 1027 (1075)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||............. .....
T Consensus 180 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred c-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 3 22344678999999999999999999999999999999999999997543211000000 00000
Q ss_pred hcc--CCCC--------------CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EML--DPRL--------------PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~--~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
... .+.. +...........++.+++.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 0000 1111111233568999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=315.82 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=186.6
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc---hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||.||+|... +|+.||+|++....... ....+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999765 79999999987543221 123578999999999999999999999998765432
Q ss_pred hheecC-c-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC----CceEeccccccc
Q 042958 891 AMILSN-N-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~-~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla~~ 958 (1075)
.++... . .....+++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||.+..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 222111 1 1235689999999999999999999999 999999999999999877 899999999987
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
..... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......+.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAVNYDFDE 232 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhcccCCcc
Confidence 65432 234457899999999999999999999999999999999999999743221 111112122211111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111223456899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.72 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=188.5
Q ss_pred cHHHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-----cCceeeE
Q 042958 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----HRNIVKF 879 (1075)
Q Consensus 806 ~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 879 (1075)
++.+.....++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+..|+.+++.++ ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3344445568999999999999999999966 5789999999863 2334567888999999996 9999999
Q ss_pred EEEeeccccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-----
Q 042958 880 YGFCSHVRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF----- 944 (1075)
Q Consensus 880 ~~~~~~~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~----- 944 (1075)
++++...+..+.+ ++... ....+++.++..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv-~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLI-FEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEE-ECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEE-EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 9998876543222 22111 123488999999999999999999999 9999999999999986
Q ss_pred --------------------CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh
Q 042958 945 --------------------DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 1004 (1075)
Q Consensus 945 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt 1004 (1075)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999875432 234678999999999999999999999999999999999
Q ss_pred CCCCCCccCccccchhhhh-------hh--------hhhccC-----CCCCCCCcCc--------------HHHHHHHHH
Q 042958 1005 GKHPRDFISSMSSSSLNLN-------IA--------LDEMLD-----PRLPTPSCIV--------------QDKLISIVE 1050 (1075)
Q Consensus 1005 g~~p~~~~~~~~~~~~~~~-------~~--------~~~~~~-----~~~~~~~~~~--------------~~~~~~l~~ 1050 (1075)
|+.||.............. .. ...... ..++...... ......+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 9999974332110000000 00 000000 0001000000 001146789
Q ss_pred HHHHccCCCCCCCCCHHHHHh
Q 042958 1051 VAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1051 li~~cl~~dP~~RPs~~evl~ 1071 (1075)
++.+||+.||++|||++|+++
T Consensus 335 li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCChhhCCCHHHHhc
Confidence 999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=340.91 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=190.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|+..+.||+|+||.||+|+.. +|+.||+|++...........+.+..|++++++++||||+++++++......+ +
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~-l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC-L 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE-E
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE-E
Confidence 367888899999999999999765 79999999986432222223467889999999999999999999987765432 2
Q ss_pred eecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 893 ILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 893 ~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 222111 133589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 960 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 960 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ......+.......+.
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~~~~p~- 414 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQAVTYPD- 414 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCCCCCCT-
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcccCCCc-
Confidence 65544445568999999999999999999999999999999999999999754321111 1111222222222222
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHh
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTM-----PKVSQ 1071 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1071 (1075)
..+..+.+++.+||++||++||++ +||++
T Consensus 415 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 ---KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 233468999999999999999975 56653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.91 Aligned_cols=237 Identities=27% Similarity=0.405 Sum_probs=180.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++......+.++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 467889999999999999999876 8999999986532 2467899999999999999999999986655443333
Q ss_pred ecCccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNAA-----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++.... ...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 333221 12278888999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcC
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCI 1040 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1075)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ....+... ....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~---- 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDA---- 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCC----
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCC----
Confidence 223467889999999998899999999999999999998 999987433211 11111111 1111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 1223456999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=318.69 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=189.2
Q ss_pred CCCCceecccCceEEEEEEEC-----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-ch
Q 042958 817 FDDEHCIGKGGQGSVYKAELA-----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-SL 890 (1075)
Q Consensus 817 ~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~l 890 (1075)
|++.+.||+|+||.||++.+. +|+.||||++... ......+.+.+|++++++++||||+++++++...+. .+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 488899999999999988543 6889999999764 233446789999999999999999999999987532 22
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.++++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 22222221 234589999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc-----c-chhhhhhhhhhccCC-
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-----S-SSLNLNIALDEMLDP- 1032 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-----~-~~~~~~~~~~~~~~~- 1032 (1075)
... .....+|+.|+|||++.+..++.++||||+|+++|||++|+.||....... . ..........+....
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 332 233567888999999999889999999999999999999999986422110 0 000000111111111
Q ss_pred -CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1033 -RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1033 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 268 ~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 268 ERLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCC----ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111 233456999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.25 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=187.3
Q ss_pred HhcCCCCCc-eecccCceEEEEEEE---CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 813 ATNDFDDEH-CIGKGGQGSVYKAEL---ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 813 ~~~~~~~~~-~lG~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
...+|++.+ .||+|+||.||+|.. .+++.||||++.... ......+++.+|+++++.++||||+++++++.....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCc
Confidence 346677777 999999999999954 246889999997653 233446789999999999999999999999954433
Q ss_pred chhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 SLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 ~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.+.+.+... .....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 332222211 1234589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCce---eccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 962 DSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 962 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ......... ....+
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~--~~~~~ 242 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGE--RMGCP 242 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTC--CCCCC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--CCCCC
Confidence 44322 22346788999999998889999999999999999999 999997433211 111111111 11111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||++.||++.|+
T Consensus 243 ----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 243 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 223446999999999999999999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=326.21 Aligned_cols=288 Identities=22% Similarity=0.280 Sum_probs=199.3
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCCccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEcc
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLW 81 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~ 81 (1075)
+|++||++||+++..++. +.+++|..........|.|.|++|+.... .+. -...+++++|||+
T Consensus 27 ~~~~aLl~~k~~~~~~~~-~~~~~w~~~~~~~~~~~~~~g~~~~~~~~-------------~l~---~~~~~~l~~L~L~ 89 (328)
T 4fcg_A 27 PYHDVLSQWQRHYNADRN-RWHSAWRQANSNNPQIETRTGRALKATAD-------------LLE---DATQPGRVALELR 89 (328)
T ss_dssp CHHHHHHHHHHHHHHCCT-THHHHHHHHTTTCTTSCCSHHHHHHHHHH-------------HHH---HHTSTTCCEEEEE
T ss_pred hHHHHHHHHHHhccCCch-hhhhhhcccccccccccccCCcchhhhHH-------------HHh---cccccceeEEEcc
Confidence 689999999999976654 57788942222233349999999963210 000 1124567788888
Q ss_pred CCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCC
Q 042958 82 HNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLI 161 (1075)
Q Consensus 82 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 161 (1075)
+|.++ .+|+.++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|++++|.+.+.+
T Consensus 90 ~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~ 166 (328)
T 4fcg_A 90 SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166 (328)
T ss_dssp SSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCC
T ss_pred CCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcccc
Confidence 88887 77777888888888888888887 77888888888888888888887 67777777777777777777766666
Q ss_pred CCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCC
Q 042958 162 PPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLR 241 (1075)
Q Consensus 162 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 241 (1075)
|..+... ..+..|.++++|++|+|++|+++ .+|..+.++++|++|+|++|++++ +|..+..++
T Consensus 167 p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~ 229 (328)
T 4fcg_A 167 PEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP 229 (328)
T ss_dssp CSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCT
T ss_pred ChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCC
Confidence 6554431 11223455666666666666666 566666666677777777776664 444566677
Q ss_pred CCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecc
Q 042958 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH 321 (1075)
Q Consensus 242 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 321 (1075)
+|++|+|++|.+.+.+|..+..+++|++|++++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++++++|+.+++.
T Consensus 230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~ 309 (328)
T 4fcg_A 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309 (328)
T ss_dssp TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECC
T ss_pred CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCC
Confidence 77777777777766667777777777777777777666677677777777777777777777777777777777777776
Q ss_pred ccccc
Q 042958 322 NNSLS 326 (1075)
Q Consensus 322 ~N~l~ 326 (1075)
.+.+.
T Consensus 310 ~~~~~ 314 (328)
T 4fcg_A 310 PHLQA 314 (328)
T ss_dssp GGGSC
T ss_pred HHHHH
Confidence 66554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.00 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=185.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+.+|+.++++++||||+++++++...+..+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 467888999999999999999665 69999999986543 3344466788999999999999999999999876543322
Q ss_pred eecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 103 -~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 -FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp -EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred -EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 2211 1235689999999999999999999999 99999999999999999999999999998776555
Q ss_pred CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh----------------hhhh
Q 042958 964 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL----------------NIAL 1026 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------------~~~~ 1026 (1075)
.......||+.|+|||++.+. .++.++||||+|+++|||++|+.||............. ....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 555567899999999998875 68999999999999999999999997543221100000 0000
Q ss_pred hhccCCCCCCCCc---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 DEMLDPRLPTPSC---IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+....... .....+..+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0011111111000 01123457999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.59 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=191.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.+.|+..+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.+++.++||||+++++++......+.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l- 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI- 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE-
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE-
Confidence 46688899999999999999965 47999999998765322 235789999999999999999999999876554322
Q ss_pred eecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 893 ILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 893 ~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 222211 235689999999999999999999999 999999999999999999999999999988765544
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..........+..+ ...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~------~~~ 243 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIPKNNPPTLE------GNY 243 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCC------SSC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhhcCCCCCCc------ccc
Confidence 4455679999999999999999999999999999999999999987433211 11111111111111 122
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
+..+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3458999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=321.47 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=192.3
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|... +++.||+|++... ....+++.+|++++++++||||+++++++......+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34678888999999999999999765 5889999998643 223578999999999999999999999997765432
Q ss_pred hheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 2221111 1234589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 961 PDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 961 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
..... .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||........ ........ ....+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~- 234 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDY--RMERP- 234 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTC--CCCCC-
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHhccC--CCCCC-
Confidence 44332 233456889999999998999999999999999999999 9999874432111 11111111 11111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+|++.||++|||++|+++.|+
T Consensus 235 ---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 235 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 223346999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.60 Aligned_cols=241 Identities=23% Similarity=0.399 Sum_probs=189.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++......+ ++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC-LV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE-EE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE-EE
Confidence 3678888999999999999999888999999999754322 367899999999999999999999997754432 22
Q ss_pred ecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 22211 124588999999999999999999999 99999999999999999999999999998764321
Q ss_pred C-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcC
Q 042958 964 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCI 1040 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1075)
. ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+... ....+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~-- 228 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPR-- 228 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCCT--
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCcCCCCc--
Confidence 1 1223456788999999998899999999999999999999 89998743221 111111111 111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 229 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 229 --LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22346899999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.98 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=181.7
Q ss_pred hcCCCCCceecccCceEEEEEEEC--CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|++. +++ .||||++...........+.+.+|++++++++||||+++++++......
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 467889999999999999999753 333 6899998765444445568899999999999999999999999876533
Q ss_pred hhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.+...... ....+++.++.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 333222111 124588999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC--CCCC
Q 042958 962 DSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD--PRLP 1035 (1075)
Q Consensus 962 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1035 (1075)
.... .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+.. ...+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEGERLP 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSCCCCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHccCCCCC
Confidence 4332 223457888999999998889999999999999999999 99999743321 11111111 1122
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 246 ~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 246 RP----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC----cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 22 223456999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=346.15 Aligned_cols=236 Identities=23% Similarity=0.372 Sum_probs=181.5
Q ss_pred eecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc-
Q 042958 822 CIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN- 897 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~- 897 (1075)
.||+|+||.||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++++|......+.+.+...
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCC
Confidence 7999999999999653 46679999997643 22335789999999999999999999999986543333322221
Q ss_pred -------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce---e
Q 042958 898 -------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---T 967 (1075)
Q Consensus 898 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~---~ 967 (1075)
.....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.+....... .
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 1234589999999999999999999999 99999999999999999999999999998765433221 2
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcCcHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCIVQDKL 1045 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1045 (1075)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+.. .+.+.+ ..++
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~p----~~~~ 565 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMECP----PECP 565 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCCCCCC----TTCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCCCC----CcCC
Confidence 2345689999999999999999999999999999998 999997543321 1111111 122222 2334
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++.+++.+||+.||++||+++||++.|+
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 56999999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=314.52 Aligned_cols=240 Identities=24% Similarity=0.388 Sum_probs=188.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+.+|++++++++||||+++++++......+ +
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY-L 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE-E
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE-E
Confidence 367888999999999999999665 68899999985422111223467899999999999999999999998755432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 222211 134588999999999999999999999 9999999999999999999999999999765432
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.......+. .
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~----~ 234 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNVDLKFPP----F 234 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCT----T
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhccccCCCC----c
Confidence 234467899999999999999999999999999999999999999743221 111222222222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 2345899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=325.92 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=192.4
Q ss_pred cHHHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc-----hhHHHHHHHHHHHHhcC-CcCceee
Q 042958 806 VYEEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE-----MTFQQEFLNEVKALTEI-RHRNIVK 878 (1075)
Q Consensus 806 ~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~ 878 (1075)
.........++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 33444555678999999999999999999775 79999999986543211 12345788999999999 8999999
Q ss_pred EEEEeeccccchhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCce
Q 042958 879 FYGFCSHVRHSLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH 949 (1075)
Q Consensus 879 l~~~~~~~~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k 949 (1075)
+++++......+. +++... ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+|
T Consensus 165 ~~~~~~~~~~~~l-v~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 165 LIDSYESSSFMFL-VFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEEBSSEEEE-EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEeeCCEEEE-EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999876554322 222211 134689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCceeccccccCccCcccccc------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh
Q 042958 950 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 950 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 1023 (1075)
|+|||++..+... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 241 l~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------- 311 (365)
T 2y7j_A 241 LSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------- 311 (365)
T ss_dssp ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred EEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------
Confidence 9999999877643 23345689999999998863 35788999999999999999999999643211
Q ss_pred hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 312 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111112211111011123446899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=336.40 Aligned_cols=235 Identities=14% Similarity=0.130 Sum_probs=176.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHH---HHHhcCCcCceeeEE-------EE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVKFY-------GF 882 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 882 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999975 57999999999765444444568899999 556666899999998 55
Q ss_pred eecccc----------------chhheecCccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 042958 883 CSHVRH----------------SLAMILSNNAA---------------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931 (1075)
Q Consensus 883 ~~~~~~----------------~l~~~~~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 931 (1075)
+...+. ..+++++...+ ...+++..++.|+.||++||+|||+. +|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 544321 01111211110 11223577888999999999999999 999
Q ss_pred EecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCccccccC-----------CCCcccchHhHHHHHH
Q 042958 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-----------KVTEKCDVYSFGVLAL 1000 (1075)
Q Consensus 932 H~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~vl~ 1000 (1075)
||||||+||+++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++|||||||++|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999998643 23445677 999999999887 8999999999999999
Q ss_pred HHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1001 EVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1001 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
||++|+.||........ ...+.. .. . ..+..+.+++.+||+.||++|||+.|+++
T Consensus 305 elltg~~Pf~~~~~~~~--------~~~~~~-~~---~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGG--------SEWIFR-SC---K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CC--------SGGGGS-SC---C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccc--------hhhhhh-hc---c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999964332111 111111 00 1 12235899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=327.92 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=172.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++.....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 47899999999999999999964 579999999997643 233446788899999999999999999999865421
Q ss_pred -chhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 -SLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 -~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++++.. .....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 112221111 1234689999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh---------------h
Q 042958 961 PDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN---------------I 1024 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---------------~ 1024 (1075)
.. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.............. .
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 344678999999999877 6789999999999999999999999975432211000000 0
Q ss_pred hhhhccC--CCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALDEMLD--PRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.. +..+... .........+.+++.+|++.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 0001000 001122356899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=311.82 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=180.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|++++++++||||+++++++......+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 35788899999999999999966 46899999998764322 2257889999999999999999999999875543222
Q ss_pred eecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEeccccc
Q 042958 893 ILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIA 956 (1075)
Q Consensus 893 ~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla 956 (1075)
++... ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 99 -~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 99 -METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp -ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred -EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 22111 135689999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
+..... .......||+.|+|||.+. ..++.++||||+|+++|||++|+.||........ .. ......+....
T Consensus 175 ~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~-~~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQ-KATYKEPNYAV 246 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HH-HHHHCCCCCCC
T ss_pred eecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----Hh-hhccCCccccc
Confidence 876543 2234567899999999876 4689999999999999999999999974332110 00 01111111111
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. ....+.++.+++.+||+.||++|||++|+++
T Consensus 247 ~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 E---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 0112346889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=326.44 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=187.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----H 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 888 (1075)
..+|++.+.||+|+||.||+|... +++.||||++... ......+.+.+|++++++++||||+++++++.... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999654 7889999998743 23344578999999999999999999999986543 1
Q ss_pred chhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 SLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 ~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
...++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 104 DVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 1222222211 234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc---eeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh---------------
Q 042958 962 DSSN---WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------- 1022 (1075)
Q Consensus 962 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------- 1022 (1075)
.... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 3221 244579999999998654 458999999999999999999999997543321110000
Q ss_pred ----hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 ----NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......................+.++.+++.+|++.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000001122456899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.99 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=185.9
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
..++|++.+.||+|+||.||+|... +|+.||||++..... .+++.+|+.++++++||||+++++++......+.
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999665 699999999875321 3678899999999999999999999876554322
Q ss_pred heecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+++... ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 102 -v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 102 -VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp -EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred -EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 222211 245689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.........|++.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..........+.... .
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~----~ 248 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNPPPTFRK----P 248 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCSS----G
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCcccCC----c
Confidence 5444455679999999999999999999999999999999999999997433211 011111111112211 2
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 223456999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=318.22 Aligned_cols=242 Identities=26% Similarity=0.448 Sum_probs=181.3
Q ss_pred cCCCCCceecccCceEEEEEEECC-----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELAS-----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.+|+..+.||+|+||.||+|.... +..||||++.... .......+.+|++++++++||||+++++++......
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 466677899999999999996542 2469999987542 334456899999999999999999999999765443
Q ss_pred hhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 890 LAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 890 l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+.+ ++.. .....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 122 MII-TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEE-EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEE-EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 222 2211 1235689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CC
Q 042958 960 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RL 1034 (1075)
Q Consensus 960 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1034 (1075)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+... +.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~~ 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGFRL 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCCcC
Confidence 543221 122346788999999998899999999999999999999 99998643221 111122221 22
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+. ..+..+.+++.+||+.||++||+++|+++.|+
T Consensus 270 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 270 PTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2222 23446899999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.31 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=190.5
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhc--CCcCceeeEEEEeecc
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE--IRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 886 (1075)
......++|++.+.||+|+||.||+|+.. |+.||||++... ..+.+.+|++++.. ++||||+++++++...
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 33455678999999999999999999875 999999998532 24567788888887 7999999999999776
Q ss_pred cc---chhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCeeeCCCCC
Q 042958 887 RH---SLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMH--------NDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 887 ~~---~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
.. .+.++++... ....+++.++++++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 52 2223322221 1345889999999999999999999 67 9999999999999999999
Q ss_pred ceEeccccccccCCCCCc----eeccccccCccCccccccC------CCCcccchHhHHHHHHHHHhC----------CC
Q 042958 948 AHVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KH 1007 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~~ 1007 (1075)
+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876654332 2345799999999998765 234689999999999999999 67
Q ss_pred CCCccCccccchhhhh-hhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1008 PRDFISSMSSSSLNLN-IALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1008 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
||.............. ........+.++.. ....+....+.+++.+||+.||++|||++||++.|+
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 7754322111111111 11111112222211 112356678999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=326.15 Aligned_cols=254 Identities=18% Similarity=0.236 Sum_probs=181.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchh--------HHHHHHHHHHHHhcCCcCceeeEEE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMT--------FQQEFLNEVKALTEIRHRNIVKFYG 881 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~ 881 (1075)
.++|++.+.||+|+||.||+|... ++..||||+.......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999765 5788999998754321100 1124678889999999999999999
Q ss_pred Eeecc---ccchhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC--Cc
Q 042958 882 FCSHV---RHSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN--EA 948 (1075)
Q Consensus 882 ~~~~~---~~~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~ 948 (1075)
++... .....++++.. .....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 98762 22222222221 1123689999999999999999999999 999999999999999887 99
Q ss_pred eEeccccccccCCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh
Q 042958 949 HVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN 1021 (1075)
Q Consensus 949 kl~DfGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 1021 (1075)
||+|||+++.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999987643221 123457999999999999999999999999999999999999999642211111100
Q ss_pred hhhhhhhccCCCCCCCC---cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEMLDPRLPTPS---CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...... ...+... ......+.++.+++.+||+.||++|||++||++.|+
T Consensus 273 ~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 273 AKTNLL----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHHH----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHhhc----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 000000 0111000 000023346999999999999999999999999886
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=342.60 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=191.0
Q ss_pred HhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..++|++.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|++++++++||||+++++++.+....+++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence 4567888899999999999999998888899999975432 246899999999999999999999999764433332
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
.+.... ....+++.++++|+.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 222111 124588999999999999999999999 99999999999999999999999999998765321
Q ss_pred C-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcC
Q 042958 964 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCI 1040 (1075)
Q Consensus 964 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1040 (1075)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+.. .+.+.+.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~~~-- 487 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPCPP-- 487 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT--
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCC--
Confidence 1 1123456789999999998899999999999999999999 999987433211 1111111 1222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++..+.+++.+||+.||++|||++||++.|+
T Consensus 488 --~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 488 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 23446899999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=339.40 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=189.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|+..+.||+|+||.||+|... +|+.||||++...........+.+.+|+++++.++|||||++++++.+.+..+ +
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~-l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC-L 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE-E
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE-E
Confidence 467888899999999999999764 79999999986432111223467889999999999999999999987755432 2
Q ss_pred eecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 893 ILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+++... ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 222211 123489999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .....+.......+
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~----~i~~~i~~~~~~~p---- 409 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEVPEEYS---- 409 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH----HHHHHHHHCCCCCC----
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH----HHHHHhhcccccCC----
Confidence 32 3445689999999999999899999999999999999999999997543211111 11111111111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
...+.++.+++.+||++||++|| +++||++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 22344699999999999999999 7888875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=333.00 Aligned_cols=253 Identities=21% Similarity=0.218 Sum_probs=189.5
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 807 YEEIIRATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 807 ~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
+.+.....++|++.+.||+|+||.||+|+.+ +|+.||||++.+.........+.+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3445556789999999999999999999764 799999999864211111223458899999999999999999999987
Q ss_pred cccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccc
Q 042958 886 VRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955 (1075)
Q Consensus 886 ~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGl 955 (1075)
.+..+ ++++... .+..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 133 ~~~~~-lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLY-LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEE-EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEE-EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 65432 2222211 134689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeccccccCccCccccc-------cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 956 AKFLKPDSSN-WTELAGTYGYVAPELAY-------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 956 a~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
++........ ....+||+.|+|||++. +..++.++||||+||++|||++|+.||......... .....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~ 284 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY----GKIVH 284 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHT
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH----HHHHh
Confidence 9877654332 23468999999999987 356899999999999999999999999743321110 01111
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHh
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESR---PTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 1071 (1075)
......++. .....+.++.+++.+|+. +|++| |+++|+++
T Consensus 285 ~~~~~~~p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKEHLSLPL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cccCcCCCc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000011111 011233468999999999 99998 58999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=321.88 Aligned_cols=250 Identities=19% Similarity=0.271 Sum_probs=187.4
Q ss_pred HHHHHhcCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeec
Q 042958 809 EIIRATNDFDDE-HCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 885 (1075)
Q Consensus 809 e~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 885 (1075)
......+.|.+. +.||+|+||.||+|... +|+.||||++....... ....++.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 344555677776 88999999999999665 69999999987643322 2357889999999999 56999999999987
Q ss_pred cccchhhee-cCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEec
Q 042958 886 VRHSLAMIL-SNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSD 952 (1075)
Q Consensus 886 ~~~~l~~~~-~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~D 952 (1075)
....+.++. ... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 654322221 111 1235689999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ....+...
T Consensus 178 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~ 248 (327)
T 3lm5_A 178 FGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------TYLNISQV 248 (327)
T ss_dssp GGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred CccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHHHHHhc
Confidence 99998765432 2344679999999999999999999999999999999999999996433211 11111111
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.......+..+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111122234456899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=320.72 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=191.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 46788899999999999999974 46889999998753 33445779999999999999999999998864332
Q ss_pred -chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 889 -SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 889 -~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
.+.++++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 2223322221 124589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc-------chhhhhhhhh
Q 042958 958 FLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS-------SSLNLNIALD 1027 (1075)
Q Consensus 958 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 1027 (1075)
........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 77654332 2234578889999999998899999999999999999999999863221100 0000011111
Q ss_pred hccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 EMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..... ..+. ....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 256 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 256 LLEEGQRLPA----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhhcccCCCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 1111 2233456999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=339.51 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=187.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|++++++++||||+++++++......+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999664 79999999985432111 1246789999999999999999999999876554322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC---CCCCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD---FDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~ 960 (1075)
+ +... ....+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.+||+|||+++.+.
T Consensus 100 ~-e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 G-ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp E-CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred E-EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 2 2111 135689999999999999999999999 999999999999995 45679999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.......+...
T Consensus 176 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 176 QN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYAFDLPQ 245 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSCSGG
T ss_pred CC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCcc
Confidence 43 33445679999999999876 5999999999999999999999999643221 11222222222222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3344567999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.53 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=188.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+....+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 467889999999999999999765 799999999865422 23457899999999999999999999998775543222
Q ss_pred e-ecC-------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC-
Q 042958 893 I-LSN-------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS- 963 (1075)
Q Consensus 893 ~-~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~- 963 (1075)
+ ... ......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 1 111 11234588999999999999999999999 99999999999999999999999999998654332
Q ss_pred -CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 964 -SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 964 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+........ ...........+ ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~--~~ 231 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------YSDWKEKKTYLN--PW 231 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-------HHHHHTTCTTST--TG
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHhhhcccccC--ch
Confidence 12344678999999999987765 77899999999999999999999754321110 111111111100 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 233456899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=347.63 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=183.0
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 821 HCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
+.||+|+||.||+|.+. +++.||||+++... ......+++.+|++++++++|||||+++++|......+.+.+...
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCC
Confidence 47999999999999553 46789999987543 223346789999999999999999999999976554333332221
Q ss_pred -------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc---ee
Q 042958 898 -------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---WT 967 (1075)
Q Consensus 898 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~---~~ 967 (1075)
.....+++.++..|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 1245689999999999999999999999 9999999999999999999999999999877654322 22
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... ........ .....+ ..++.
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~~~--~~~~~p----~~~~~ 599 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKG--ERMGCP----AGCPR 599 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTT--CCCCCC----TTCCH
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcC--CCCCCC----CCCCH
Confidence 3456789999999999999999999999999999998 999997433211 11111111 112222 22345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
++.+++.+||+.||++||++++|++.|+
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 6999999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=324.29 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=185.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 46888899999999999999965 4799999999976543 334467889999999999999999999999765542
Q ss_pred --hhheecCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 --LAMILSNNA------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 --l~~~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.++++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 122222111 134589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh------------------
Q 042958 962 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------------------ 1022 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------------------ 1022 (1075)
. .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 2 344678999999999887 678999999999999999999999997543211100000
Q ss_pred -hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 -NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......................+..+.+++.+|++.||++|||++|+++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000000000011123457999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=331.89 Aligned_cols=190 Identities=20% Similarity=0.336 Sum_probs=140.8
Q ss_pred cCCCC-CceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cc
Q 042958 815 NDFDD-EHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HS 889 (1075)
Q Consensus 815 ~~~~~-~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 889 (1075)
+.|++ .++||+|+||.||+|... +++.||||++..... ...+.+|+.++++++||||+++++++.... ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44555 458999999999999765 578999999975422 246789999999999999999999985422 22
Q ss_pred hhheecCcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee----CCCCCc
Q 042958 890 LAMILSNNA-----------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL----DFDNEA 948 (1075)
Q Consensus 890 l~~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~ 948 (1075)
++++++... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 222222211 112488999999999999999999999 99999999999999 677899
Q ss_pred eEeccccccccCCCC---CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcc
Q 042958 949 HVSDFGIAKFLKPDS---SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFI 1012 (1075)
Q Consensus 949 kl~DfGla~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~ 1012 (1075)
||+|||+|+.+.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999998765432 223456789999999998874 5899999999999999999999999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=326.07 Aligned_cols=250 Identities=22% Similarity=0.253 Sum_probs=181.6
Q ss_pred HHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH- 888 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 888 (1075)
....++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 34567899999999999999999965 5799999999865422 22379999999999999999999854321
Q ss_pred ------------------------------------chhheecCcc------------ccCCCCHHHHHHHHHHHHHHHH
Q 042958 889 ------------------------------------SLAMILSNNA------------AAKDLGWTRRMNVIKGISDALS 920 (1075)
Q Consensus 889 ------------------------------------~l~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~L~ 920 (1075)
.+.++++... ....+++..+..++.||++||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 1222222221 2356899999999999999999
Q ss_pred HHHhCCCCCeEEecCCCCCeeeC-CCCCceEeccccccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHH
Q 042958 921 YMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVL 998 (1075)
Q Consensus 921 ~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~v 998 (1075)
|||+. +|+||||||+||+++ .++.+||+|||+|+.+.... ......||+.|+|||.+.+. .++.++||||+||+
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 999999999999998 68899999999998765443 33456789999999988765 48999999999999
Q ss_pred HHHHHhCCCCCCccCccccchhhhh-------hhhh----hccCCCCCCCCc------CcHHHHHHHHHHHHHccCCCCC
Q 042958 999 ALEVIKGKHPRDFISSMSSSSLNLN-------IALD----EMLDPRLPTPSC------IVQDKLISIVEVAISCLDENPE 1061 (1075)
Q Consensus 999 l~elltg~~p~~~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~ 1061 (1075)
+|||++|+.||......+....... .... ......++.... .....+..+.+++.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999975432211000000 0000 000011111000 1112345689999999999999
Q ss_pred CCCCHHHHHh
Q 042958 1062 SRPTMPKVSQ 1071 (1075)
Q Consensus 1062 ~RPs~~evl~ 1071 (1075)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.11 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=180.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|.....||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..+.+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv- 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF- 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE-
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE-
Confidence 3455566999999999999965 578999999987542 23357799999999999999999999999765543222
Q ss_pred ecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-CCCceEeccccccccC
Q 042958 894 LSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-DNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 894 ~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~DfGla~~~~ 960 (1075)
++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 2211 1123467888999999999999999999 9999999999999987 8999999999998776
Q ss_pred CCCCceeccccccCccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
..........|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ ...........+..+
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~--- 248 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFKVHPEIP--- 248 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHCCCCCCC---
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcccccccccc---
Confidence 5444445567999999999987643 78999999999999999999999964322110 000000111111221
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.++.+++.+||+.||++|||++|+++
T Consensus 249 ---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ---ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 223346899999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=313.55 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=186.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC-chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cch
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG-EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l 890 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++...... .....+.+.+|++++++++||||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999966 47899999998643111 1123578999999999999999999999985432 222
Q ss_pred hheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 22222211 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC--CceeccccccCccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 961 PDS--SNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 961 ~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
... .......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...... .....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~~~~~ 232 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKGSYAI 232 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCCCCC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcCCCCC
Confidence 432 2234567899999999987654 378999999999999999999999743211 1111121222222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+. ..+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 233 PG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 22345899999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=321.01 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=181.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHH--HhcCCcCceeeEEEEeecc----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKA--LTEIRHRNIVKFYGFCSHV----R 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~----~ 887 (1075)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++... .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46888999999999999999977 5899999998632 12344444444 5568999999999865321 1
Q ss_pred cchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 888 HSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDC------FPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 888 ~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
..+.++++... .....++..+.+++.||++||+|||+.+ .++|+||||||+||+++.++.+||+||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 22223333221 1234588999999999999999999873 238999999999999999999999999
Q ss_pred ccccccCCCC--------CceeccccccCccCcccccc-------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccc
Q 042958 954 GIAKFLKPDS--------SNWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS 1018 (1075)
Q Consensus 954 Gla~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 1018 (1075)
|+++.+.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998765322 11234579999999999886 45678899999999999999998776432221111
Q ss_pred hhhh--------------hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1019 SLNL--------------NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1019 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.... .........+.++.........+..+.+++.+||+.||++|||++||++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 0000 0001111122333332333456778999999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=315.82 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=185.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|.+.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++......+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 467888999999999999999664 799999999875422 2245788999999999999999999999776543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~~ 960 (1075)
++... ....+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 -~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 85 -MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp -ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred -EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 22211 134578999999999999999999999 99999999999999 788899999999997644
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+.......+...
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 161 NG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYEFESPF 230 (304)
T ss_dssp CB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCCCCTTT
T ss_pred CC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCCccc
Confidence 32 233456899999999999999999999999999999999999998643221 11111111111111112
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2234456999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=333.32 Aligned_cols=248 Identities=18% Similarity=0.275 Sum_probs=184.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc-eeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~l~ 891 (1075)
.++|++.++||+|+||.||+|.. .+++.||||++...... +++..|+++++.++|++ +..+..++..... .+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~-~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDY-NV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE-EE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE-EE
Confidence 46899999999999999999965 57999999987654322 35788999999998755 4444444443333 22
Q ss_pred heecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee---CCCCCceEecccccccc
Q 042958 892 MILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL---DFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 892 ~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~DfGla~~~ 959 (1075)
++++... ....+++.+++.|+.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 2222221 145689999999999999999999999 99999999999999 58899999999999877
Q ss_pred CCCCCc-------eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 960 KPDSSN-------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 960 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-SEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-HHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-hhccccc
Confidence 654321 22567999999999999999999999999999999999999999864432211111110 0000000
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
... ......+.++.+++..||+.||++||++++|++.|+
T Consensus 236 ~~~---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 236 SIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp CHH---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cHH---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 000 000112346999999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=314.27 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=173.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.++...++.++||||+++++++...+..+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46788999999999999999966 5799999999875432 223334455666668889999999999999876543322
Q ss_pred e-ecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 893 I-LSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 893 ~-~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+ +... .....+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 2 1111 12356899999999999999999999852 899999999999999999999999999987654
Q ss_pred CCCceeccccccCccCcccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 962 DSSNWTELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.. ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||+...... ...........+..
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 163 DV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPSPQL 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSCCCCC
T ss_pred cc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccCCCCc
Confidence 32 23345799999999996 56678999999999999999999999997422210 01111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 --PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11123446899999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=328.63 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=187.7
Q ss_pred ccHHHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCC--------chhHHHHHHHHHHHHhcCCcCce
Q 042958 805 IVYEEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG--------EMTFQQEFLNEVKALTEIRHRNI 876 (1075)
Q Consensus 805 ~~~~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~ni 876 (1075)
....++....++|++.+.||+|+||.||+|...+|+.||||++...... .....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456778889999999999999999999998888999999998653322 12234789999999999999999
Q ss_pred eeEEEEeecccc----chhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC
Q 042958 877 VKFYGFCSHVRH----SLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD 943 (1075)
Q Consensus 877 v~l~~~~~~~~~----~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~ 943 (1075)
+++++++..... .+.++++.. .....+++..+..++.||+.||+|||+. +|+||||||+||+++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 999999854321 222222221 1234689999999999999999999999 999999999999999
Q ss_pred CCCCceEeccccccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh
Q 042958 944 FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 944 ~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 1022 (1075)
.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999865433 23344678999999998876 678999999999999999999999997533211000000
Q ss_pred ---------------hhhhhhccCCCCCC-CC----cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 ---------------NIALDEMLDPRLPT-PS----CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 ---------------~~~~~~~~~~~~~~-~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.............. +. .........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000111111100 00 011122456899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=317.38 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=184.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc---cc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR---HS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~ 889 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46799999999999999999966 57999999988642 3345678999999999999999999999986321 12
Q ss_pred hhheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 890 LAMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
..++++... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 222222111 245689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCc---------eeccccccCccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh
Q 042958 957 KFLKPDSSN---------WTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI 1024 (1075)
Q Consensus 957 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 1024 (1075)
......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+........ ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhH
Confidence 765421111 12345799999999987554 688999999999999999999998632111100 000
Q ss_pred hhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1025 ALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.... ....+.. ...+..+.+++.+||+.||.+|||++|+++.|+
T Consensus 259 ~~~~--~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 259 AVQN--QLSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HHHC--C--CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Hhhc--cCCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 1111 1112221 123346999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=317.92 Aligned_cols=251 Identities=18% Similarity=0.305 Sum_probs=181.7
Q ss_pred hcCCCCC-ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 814 TNDFDDE-HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 814 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
.+.|++. +.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++...+..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3567764 7899999999999964 4799999999875432 2356789999999985 7999999999998755432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC---ceEeccccccc
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE---AHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~~ 958 (1075)
. +++... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 88 l-v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 88 L-VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp E-EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred E-EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 2 222221 235688999999999999999999999 9999999999999998876 99999999986
Q ss_pred cCCCCC-------ceeccccccCccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCccCccccch-------
Q 042958 959 LKPDSS-------NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS------- 1019 (1075)
Q Consensus 959 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~------- 1019 (1075)
...... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 543211 1223569999999999875 558899999999999999999999997543221000
Q ss_pred hhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1020 LNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.........+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011112222222222221111123456999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=347.33 Aligned_cols=243 Identities=19% Similarity=0.269 Sum_probs=192.9
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999654 6899999998643211122346788899999988 7999999999987755432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 419 -lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 -FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp -EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred -EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 2222221 135689999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
........+||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~--- 563 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK--- 563 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSCCCCCT---
T ss_pred CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCc---
Confidence 55556667899999999999999999999999999999999999999974322 2223334444433332
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH-----HHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTM-----PKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1071 (1075)
..+.++.+++.+||++||++||++ +||++
T Consensus 564 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 564 -SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 234468999999999999999998 67654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=327.30 Aligned_cols=249 Identities=9% Similarity=0.014 Sum_probs=170.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC--CcCceeeEE-------EEe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI--RHRNIVKFY-------GFC 883 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 883 (1075)
..+|+..+.||+|+||.||+|... +|+.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999764 7999999999876554555567788885444444 699988755 333
Q ss_pred ecccc----------------chhheecCccc---------cCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEE
Q 042958 884 SHVRH----------------SLAMILSNNAA---------AKDLGWTRR------MNVIKGISDALSYMHNDCFPPIVH 932 (1075)
Q Consensus 884 ~~~~~----------------~l~~~~~~~~~---------~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ivH 932 (1075)
...+. .++++++.... ...+.+..+ ..++.||++||+|||+. +|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 32211 12222222111 223455555 77889999999999999 9999
Q ss_pred ecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 933 RDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 933 ~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
|||||+||+++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987642 2224567799999999987 679999999999999999999999997
Q ss_pred ccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1011 FISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
............ .............+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 295 ~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGSWKR-PSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTCCCB-CCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccchhh-hhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 543221111000 00011111111111 11233456999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.16 Aligned_cols=249 Identities=15% Similarity=0.209 Sum_probs=185.6
Q ss_pred hcCCCCCceecccCceEEEEEEECC---------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceee------
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS---------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK------ 878 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------ 878 (1075)
.++|++.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3688999999999999999997653 789999998643 36789999999999999988
Q ss_pred ---------EEEEeeccccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 879 ---------FYGFCSHVRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 879 ---------l~~~~~~~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
+++++...+....++++... ....+++.+++.++.||++||+|||+. +|+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 56666653333333332221 125689999999999999999999999 99999999999
Q ss_pred eeeCCCC--CceEeccccccccCCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 940 VLLDFDN--EAHVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 940 ill~~~~--~~kl~DfGla~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
|+++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999987654321 1233579999999999999999999999999999999999999997
Q ss_pred ccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1011 FISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
................... ...+..........+..+.+++.+||+.||++|||++||++.|+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 5432111111000000110 11111111011122356999999999999999999999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.39 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=179.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++...........+.+.+|+.+++.++||||+++++++......+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999999999999765 7999999998643211222356789999999999999999999998776543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 -~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 -MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp -EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred -EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 22211 134578999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||+..... .....+.......+.
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---- 232 (276)
T 2h6d_A 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVFYIPE---- 232 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT----
T ss_pred -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCcccCch----
Confidence 2334578999999999987765 68999999999999999999999743211 111111112222221
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 12345899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=336.85 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=184.5
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +++.||||++........ ....+.+|+.+++.++||||++++++|......+.+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456888999999999999999765 789999999876432222 246789999999999999999999999876544322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~~~ 960 (1075)
++... ....+++..+..++.||++||+|||+. +|+||||||+||+++.. +.+||+|||+++.+.
T Consensus 115 -~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 -MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp -EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred -EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 22211 134688999999999999999999999 99999999999999764 459999999998776
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .....+.......+...
T Consensus 191 ~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~ 260 (494)
T 3lij_A 191 NQ-KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKYTFDSPE 260 (494)
T ss_dssp TT-BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCCSGG
T ss_pred CC-ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCchh
Confidence 43 3344567999999999886 46999999999999999999999999743321 11222222222222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2334556999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=337.58 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=187.4
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc----------hhHHHHHHHHHHHHhcCCcCceeeEEE
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE----------MTFQQEFLNEVKALTEIRHRNIVKFYG 881 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~ 881 (1075)
..++|++.+.||+|+||.||+|... +++.||||++....... ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999664 68999999987543221 123567899999999999999999999
Q ss_pred EeeccccchhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC---Cce
Q 042958 882 FCSHVRHSLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN---EAH 949 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k 949 (1075)
++.+....+.+ ++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv-~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLV-TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEE-EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEE-EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99876544322 22221 135689999999999999999999999 999999999999999876 699
Q ss_pred EeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhc
Q 042958 950 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029 (1075)
Q Consensus 950 l~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1029 (1075)
|+|||+++.+... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+
T Consensus 190 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKKV 259 (504)
T ss_dssp ECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred EEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 9999999877643 33455679999999999874 6899999999999999999999999743321 122222
Q ss_pred cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......+.......+.++.+++.+|++.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222221111233456999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.25 Aligned_cols=241 Identities=21% Similarity=0.327 Sum_probs=184.2
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc---ccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV---RHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l 890 (1075)
..|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+.+|+.++++++||||+++++++... ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3467778899999999999965 4788999999875433 234467899999999999999999999988653 2223
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeeeC-CCCCceEeccccccc
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPP--IVHRDISSKNVLLD-FDNEAHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~DfGla~~ 958 (1075)
.++++... ....+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 33332221 125688999999999999999999999 7 99999999999998 789999999999976
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....... ...........+ .
T Consensus 182 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~--~ 249 (290)
T 1t4h_A 182 KRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP--A 249 (290)
T ss_dssp CCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC--G
T ss_pred cccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHHhccCCc--c
Confidence 5432 3345679999999998864 58999999999999999999999997433211 111111111111 1
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112222346999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=320.94 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=170.1
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeecc-----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHV----- 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~----- 886 (1075)
..+|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+++++. ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 45788999999999999999975 47999999998543 3344678899999999996 99999999998422
Q ss_pred --ccchhheecCc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeeeCCCCCceEe
Q 042958 887 --RHSLAMILSNN-----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPP--IVHRDISSKNVLLDFDNEAHVS 951 (1075)
Q Consensus 887 --~~~l~~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~ 951 (1075)
...+.++++.. .....+++.+++.++.||+.||+|||+. + |+||||||+||+++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 11122222211 1234589999999999999999999999 7 9999999999999999999999
Q ss_pred ccccccccCCCCCc------------eeccccccCccCcccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc
Q 042958 952 DFGIAKFLKPDSSN------------WTELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS 1016 (1075)
Q Consensus 952 DfGla~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 1016 (1075)
|||+++........ .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876543221 1134689999999998 56678899999999999999999999996432211
Q ss_pred cchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ..... ..+.... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 261 ~--------~~~~~--~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 261 I--------VNGKY--SIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------C--CCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred h--------hcCcc--cCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 01100 1111111 1224889999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=319.71 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=183.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCC-----CchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLP-----GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|++.+.||+|+||.||+|... +++.||||++..... ........+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467899999999999999999654 689999999865321 11222346889999999999999999999987765
Q ss_pred cchhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC---ceEecccccc
Q 042958 888 HSLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE---AHVSDFGIAK 957 (1075)
Q Consensus 888 ~~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~DfGla~ 957 (1075)
..+.+.+... .....+++.....++.||++||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 4333322211 1235688999999999999999999999 9999999999999987664 9999999998
Q ss_pred ccCCCCCceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
..... .......||+.|+|||++. ...++.++||||+|+++|||++|+.||......... . ..+.....
T Consensus 166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~---~~~~~~~~ 237 (322)
T 2ycf_A 166 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL----K---DQITSGKY 237 (322)
T ss_dssp ECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH----H---HHHHHTCC
T ss_pred ecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH----H---HHHHhCcc
Confidence 76532 2233457899999999864 567889999999999999999999999743321111 0 11111111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..........+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111111123456899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=319.29 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=184.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 36788889999999999999965 479999999997643 2334467889999999999999999999998765432
Q ss_pred --hhheecCcc------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 --LAMILSNNA------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 --l~~~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.++++... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 122222111 123589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh------------------
Q 042958 962 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL------------------ 1022 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------------------ 1022 (1075)
. .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.............
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 334578999999998877 678999999999999999999999997543211000000
Q ss_pred -hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 -NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......................+..+.+++.+|++.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000001112234557999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=323.94 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=183.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 888 (1075)
..+|+..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 356888999999999999999887777799998864322 12369999999999999999999865332
Q ss_pred chhheecCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEecccc
Q 042958 889 SLAMILSNNA------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGI 955 (1075)
Q Consensus 889 ~l~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGl 955 (1075)
.+.++++... ....+++..+..++.||++||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 1222222221 245689999999999999999999999 999999999999999 789999999999
Q ss_pred ccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-----------hh
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-----------LN 1023 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-----------~~ 1023 (1075)
|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||............ ..
T Consensus 189 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98765433 23456789999999998765 5899999999999999999999999754322110000 00
Q ss_pred hhhhhccCCCCCCCCc------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLDPRLPTPSC------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..........++.... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0001111111111100 11123457999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=313.76 Aligned_cols=237 Identities=19% Similarity=0.370 Sum_probs=180.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CC-------CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeec
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SG-------EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 885 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 885 (1075)
.++|++.+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 467888899999999999999554 34 47999998643 23345789999999999999999999999987
Q ss_pred cccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC--------
Q 042958 886 VRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE-------- 947 (1075)
Q Consensus 886 ~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------- 947 (1075)
.+..+. +++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 84 ~~~~~l-v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 84 GDENIL-VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TTCCEE-EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCCEE-EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 554332 222211 123388999999999999999999999 9999999999999998887
Q ss_pred ceEeccccccccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCC-CCccCccccchhhhhhh
Q 042958 948 AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHP-RDFISSMSSSSLNLNIA 1025 (1075)
Q Consensus 948 ~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~ 1025 (1075)
+||+|||.+...... ....||+.|+|||++.+ ..++.++||||+|+++|||++|..| |....... ....
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~~~~ 230 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----KLQF 230 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHH
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----HHHH
Confidence 999999999765322 33568899999999987 6789999999999999999996554 43221110 0000
Q ss_pred hhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1026 LDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.. .....+.. . +.++.+++.+||+.||++|||++|+++.|+
T Consensus 231 ~~--~~~~~~~~--~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 231 YE--DRHQLPAP--K----AAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HH--TTCCCCCC--S----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hh--ccCCCCCC--C----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 01 11111111 1 224889999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=326.90 Aligned_cols=249 Identities=19% Similarity=0.280 Sum_probs=187.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC--------cCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------HRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~ 884 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 36799999999999999999965 57899999998642 334578899999999995 788999999886
Q ss_pred cc---ccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-----
Q 042958 885 HV---RHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----- 946 (1075)
Q Consensus 885 ~~---~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----- 946 (1075)
.. ...++++++... ....+++..++.++.||+.||+|||+++ +|+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 32 222222222221 1245899999999999999999999964 899999999999999775
Q ss_pred --------------------------------------------CceEeccccccccCCCCCceeccccccCccCccccc
Q 042958 947 --------------------------------------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982 (1075)
Q Consensus 947 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~ 982 (1075)
.+||+|||.++..... .....||+.|+|||++.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhc
Confidence 8999999999876533 34457899999999999
Q ss_pred cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-hhhhhhh------------------ccCC-----CCCC--
Q 042958 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-LNIALDE------------------MLDP-----RLPT-- 1036 (1075)
Q Consensus 983 ~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~------------------~~~~-----~~~~-- 1036 (1075)
+..++.++|||||||++|||++|+.||............ ......+ +... ....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999754432211000 0000000 0000 0000
Q ss_pred ----------CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 ----------PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...........+.+++.+||+.||++|||++|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00123566778999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.02 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=188.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-----CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 888 (1075)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 45688889999999999999974 36899999998753 23446789999999999999999999999876442
Q ss_pred -chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 889 -SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 889 -~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
.+.++++... ....+++.++++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 2222222221 124589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce---eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcc-------ccchhhhhhhhh
Q 042958 958 FLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-------SSSSLNLNIALD 1027 (1075)
Q Consensus 958 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-------~~~~~~~~~~~~ 1027 (1075)
......... ....++..|+|||.+.+..++.++||||+|+++|||++|+.|+...... ............
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 876543321 2345677899999999888999999999999999999999997632100 000000000111
Q ss_pred hcc-C-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 EML-D-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~~~-~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+ . .+.+.+ ...+.++.+++.+||+.||++|||++||++.|+
T Consensus 274 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 274 ELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcCCCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 1 122222 223456999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.48 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=185.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----H 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 888 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|++++++++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 468889999999999999999765 7999999998643 33344567889999999999999999999886532 2
Q ss_pred chhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 889 SLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 889 ~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
...++++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 2222222211 134689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc----------eeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh---------
Q 042958 962 DSSN----------WTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------- 1021 (1075)
Q Consensus 962 ~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------- 1021 (1075)
.... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 3211 223578999999998754 67899999999999999999999999754321100000
Q ss_pred -------hhhhhhhccC--CCCCCC--CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 -------LNIALDEMLD--PRLPTP--SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 -------~~~~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+... +..+.. .......+.++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000000 0001123456899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.68 Aligned_cols=242 Identities=23% Similarity=0.370 Sum_probs=182.2
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..+.+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 477899999999999999999765 689999999865432 2357889999999999999999999999875543222
Q ss_pred eecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++... ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 95 -~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 -IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp -EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred -EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 22211 135689999999999999999999999 9999999999999999999999999998643222
Q ss_pred CCceeccccccCccCcccc-----ccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 963 SSNWTELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
........||+.|+|||++ .+..++.++||||+|+++|||++|+.||........ .........+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~-- 243 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSDPPTLL-- 243 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCS--
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhccCCcccC--
Confidence 2222345789999999988 466788999999999999999999999874332110 0111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 244 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 --TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12233456999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=318.91 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=169.4
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|.. .+++.||||++..... ....+++.+|+.++++++||||+++++++...+..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4467899999999999999999964 4789999999865422 223567889999999999999999999997765432
Q ss_pred hheecCcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 891 AMILSNNA-----------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 891 ~~~~~~~~-----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
.+ ++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 90 lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 90 LV-MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EE-EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EE-ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence 22 21111 134589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC-----ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 954 GIAKFLKPDSS-----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 954 Gla~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
|.+........ ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 99987654321 1234578999999999876 56899999999999999999999999754332111100000000
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. ...... .......+..+.+++.+||+.||++|||++|+++
T Consensus 246 ~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SL-ETGVQD-KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CT-TC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-cccccc-chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 000000 0011123346899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=324.94 Aligned_cols=246 Identities=26% Similarity=0.321 Sum_probs=181.1
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc-----
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH----- 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 888 (1075)
.+|+..+.||+|+||.||+|... +|+.||||++.... ..+.+|+++++.++|||||+++++|.....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 46888899999999999999775 69999999986532 123479999999999999999998854221
Q ss_pred chhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEecccc
Q 042958 889 SLAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGI 955 (1075)
Q Consensus 889 ~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGl 955 (1075)
.+.++++.. .....+++..++.++.||++||+|||+. +|+||||||+||+++.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 122222221 1245689999999999999999999999 99999999999999966 5689999999
Q ss_pred ccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-------hhhh
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-------IALD 1027 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-------~~~~ 1027 (1075)
++.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....... ..+.
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98765433 23446789999999998765 789999999999999999999999975432211000000 0000
Q ss_pred hc----cCCCCCCCCc------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EM----LDPRLPTPSC------IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~----~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.+ ....++.... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 0111111000 01123457999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=317.18 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=180.0
Q ss_pred HHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccc-
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVR- 887 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 887 (1075)
....++|++.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34567899999999999999999976 4799999999865422 236788999999999 8999999999987632
Q ss_pred ----cchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 888 ----HSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 888 ----~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
..+.++++... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 22222222221 135688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
||++..............|++.|+|||++. +..++.++||||||+++|||++|+.||........ .....
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP 247 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHH
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHHhh
Confidence 999987654433444567999999999987 56788999999999999999999999964332110 01111
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+... ....+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 1122346999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=318.70 Aligned_cols=237 Identities=16% Similarity=0.146 Sum_probs=182.4
Q ss_pred HhcCCCCCceecccCceEEEEE------EECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC---cCceeeEEEEe
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKA------ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFC 883 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~------~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 883 (1075)
..++|++.+.||+|+||.||+| ...+++.||||++.... ..++..|+++++.++ |+||+++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 4577889999999999999999 34578999999986431 356778888888886 99999999999
Q ss_pred eccccchhhe-ecCcc------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC------
Q 042958 884 SHVRHSLAMI-LSNNA------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF------ 944 (1075)
Q Consensus 884 ~~~~~~l~~~-~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~------ 944 (1075)
...+..+.++ +...+ ....+++..++.|+.||++||+|||+. +|+||||||+||+++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 7765443222 11110 245689999999999999999999999 9999999999999998
Q ss_pred -----CCCceEeccccccccCC--CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 945 -----DNEAHVSDFGIAKFLKP--DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 945 -----~~~~kl~DfGla~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
++.+||+|||+|+.+.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 89999999999976542 23344567899999999999999999999999999999999999999853222110
Q ss_pred chhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHhhhc
Q 042958 1018 SSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESR-PTMPKVSQLLK 1074 (1075)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~ 1074 (1075)
.....+... . ....+.+++..|++.+|.+| |+++++.+.|+
T Consensus 294 -----------~~~~~~~~~--~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 294 -----------KPEGLFRRL--P---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp -----------EECSCCTTC--S---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred -----------eechhcccc--C---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 011111111 1 13358899999999999999 57777776653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=327.56 Aligned_cols=190 Identities=21% Similarity=0.282 Sum_probs=156.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC------CcCceeeEEEEeecc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI------RHRNIVKFYGFCSHV 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~ 886 (1075)
..+|++.+.||+|+||.||+|.. .+++.||||++.. .....+++.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 45789999999999999999955 4689999999864 233456778888888887 577999999998765
Q ss_pred ccchhhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC--ceEecccc
Q 042958 887 RHSLAMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE--AHVSDFGI 955 (1075)
Q Consensus 887 ~~~l~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~DfGl 955 (1075)
...+.++ +... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 172 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 5432222 1111 1123489999999999999999999999 9999999999999999987 99999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 1013 (1075)
|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 249 a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9865432 334678999999999999999999999999999999999999997543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=308.32 Aligned_cols=237 Identities=21% Similarity=0.294 Sum_probs=183.1
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccch
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l 890 (1075)
..++|++.+.||+|+||.||+|... +++.||||++....... ....++.+|+..+..+ +||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 3567899999999999999999765 79999999987654333 3357788999999999 9999999999997755433
Q ss_pred hheecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC------------
Q 042958 891 AMILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD------------ 945 (1075)
Q Consensus 891 ~~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~------------ 945 (1075)
.+ ++... ....+++.+++.++.||++||+|||+. +|+||||||+||+++.+
T Consensus 88 lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQ-NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EE-EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EE-EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 22 22211 125589999999999999999999999 99999999999999844
Q ss_pred -------CCceEeccccccccCCCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 946 -------NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 946 -------~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||+|+++|||++|+.|+....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998765432 24689999999998766 56689999999999999999998764211
Q ss_pred chhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhh
Q 042958 1018 SSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQL 1072 (1075)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1072 (1075)
....+.....+.. ....+..+.+++.+||+.||++|||++|+++-
T Consensus 236 -------~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -------QWHEIRQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHHHTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHHHcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111222222211 11223469999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.64 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=189.8
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCc------hhHHHHHHHHHHHHhcCC-cCceeeEEEEe
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGE------MTFQQEFLNEVKALTEIR-HRNIVKFYGFC 883 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 883 (1075)
...++|++.+.||+|+||.||+|... +|+.||||++....... ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999764 68999999987543211 123467889999999995 99999999999
Q ss_pred eccccchhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccc
Q 042958 884 SHVRHSLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFG 954 (1075)
Q Consensus 884 ~~~~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfG 954 (1075)
......+.+ ++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLV-FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEE-EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ccCCeEEEE-EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 775543222 22211 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeccccccCccCccccc------cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
.+....... ......|++.|+|||++. ...++.++||||+|+++|||++|+.||...... .....
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~ 240 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLRM 240 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HHHHH
Confidence 998765432 334567899999999875 456789999999999999999999998643221 11111
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111221111122344567999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=318.41 Aligned_cols=245 Identities=20% Similarity=0.315 Sum_probs=188.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCch--------------hHHHHHHHHHHHHhcCCcCceeeE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM--------------TFQQEFLNEVKALTEIRHRNIVKF 879 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 879 (1075)
.++|++.+.||+|+||.||+|.. +|+.||||++........ ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999987 899999999864321111 112789999999999999999999
Q ss_pred EEEeeccccchhheec-C-------------ccc--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeee
Q 042958 880 YGFCSHVRHSLAMILS-N-------------NAA--AKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLL 942 (1075)
Q Consensus 880 ~~~~~~~~~~l~~~~~-~-------------~~~--~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill 942 (1075)
++++...+..+.++.. . ... ...+++..++.++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999876543222111 0 111 4568999999999999999999999 8 99999999999999
Q ss_pred CCCCCceEeccccccccCCCCCceeccccccCccCccccccC-CCCc-ccchHhHHHHHHHHHhCCCCCCccCccccchh
Q 042958 943 DFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTE-KCDVYSFGVLALEVIKGKHPRDFISSMSSSSL 1020 (1075)
Q Consensus 943 ~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 1020 (1075)
+.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||+|+++|||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH----
T ss_pred cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence 99999999999999876543 34456799999999999877 5666 9999999999999999999997543211
Q ss_pred hhhhhhhhccCCCCCCCC---------------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1021 NLNIALDEMLDPRLPTPS---------------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.......+. ......+..+.+++.+||+.||.+|||++|+++
T Consensus 260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111111110 001233457999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=315.67 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=183.9
Q ss_pred hcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......++.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 57899999999999999999963 35789999999643 23344578999999999999999999999998755
Q ss_pred cchhhe-ecCc--------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCce
Q 042958 888 HSLAMI-LSNN--------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAH 949 (1075)
Q Consensus 888 ~~l~~~-~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~k 949 (1075)
..+.++ +... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ ..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 432221 1111 0113488999999999999999999999 99999999999999954 4699
Q ss_pred EeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhh
Q 042958 950 VSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIAL 1026 (1075)
Q Consensus 950 l~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1026 (1075)
|+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HHH
Confidence 999999986543322 2234567899999999998899999999999999999998 99998643221 111
Q ss_pred hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+........ ....+..+.+++.+||+.||++|||++||++.|+
T Consensus 256 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 256 EFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11111111111 1123346899999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=315.48 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=165.0
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHH-HHhcCCcCceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
.++|+..+.||+|+||.||+|... +|+.||||++.... ......++..|+. +++.++||||+++++++...+..+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 468889999999999999999764 79999999997643 2233455566665 7788899999999999987654322
Q ss_pred heecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 892 MILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+ ++... ....+++..+.+++.|+++|+.|||+.. +|+||||||+||+++.++.+||+|||+++.
T Consensus 99 v-~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 C-MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp E-ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred E-EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 2 21111 1456899999999999999999999952 799999999999999999999999999987
Q ss_pred cCCCCCceeccccccCccCcccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ...........
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~ 247 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHhcCCC
Confidence 65432 22334789999999998 45678999999999999999999999997432210 11111111111
Q ss_pred CC-CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PT-PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+. +.......+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 11111223456999999999999999999999976
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=305.81 Aligned_cols=272 Identities=25% Similarity=0.345 Sum_probs=149.6
Q ss_pred CcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecc
Q 042958 146 SLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225 (1075)
Q Consensus 146 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 225 (1075)
+|++|++++|.+.++.+..|.++++|++|++++|++++..|..|+++++|++|+|++|+++ .+|..+. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 3444444444444444445556666666666666666555666666666666666666665 3444333 566666666
Q ss_pred ccCCCCCCcccccCCCCCCeEeccCCCCCC--ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCC
Q 042958 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSG--SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303 (1075)
Q Consensus 226 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 303 (1075)
+|++++..+..|..+++|++|++++|.++. ..+..+..+ +|++|++++|.+++ +|..+. ++|++|++++|.+++
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~ 207 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA 207 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence 666665555556666777777777776642 445556555 66666666666664 343332 456666666666665
Q ss_pred CcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCC
Q 042958 304 IIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383 (1075)
Q Consensus 304 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 383 (1075)
..+..|..+++|++|++++|.+++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++.+..+..|..
T Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 286 (332)
T 2ft3_A 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286 (332)
T ss_dssp CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence 55555666666666666666666555555555555555555555555 44444555555555555555554443333332
Q ss_pred CcccceeeeccccccccCChhhccCCCCCeEEeeccccc--cccccccccccccceeccccc
Q 042958 384 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS--GSIPSEFGNLRSLSTLSLGYN 443 (1075)
Q Consensus 384 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N 443 (1075)
... -....+|+.|++++|.+. ++.|..|..+++|+.|++++|
T Consensus 287 ~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 287 VGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ccc------------------ccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 100 000234555555555554 344555555566666665555
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=312.39 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=183.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC--cCceeeEEEEeeccccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--HRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 889 (1075)
...++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34578999999999999999999888899999999875432 3344678999999999997 49999999999876543
Q ss_pred hhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+. +++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++.+..
T Consensus 104 ~l-v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YM-VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EE-EECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred EE-EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 22 222211 235688999999999999999999999 999999999999996 48999999999987654
Q ss_pred CCCc--eeccccccCccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhh
Q 042958 962 DSSN--WTELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDE 1028 (1075)
Q Consensus 962 ~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1028 (1075)
.... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~~~ 251 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHA 251 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHHHH
Confidence 4321 234578999999999875 46888999999999999999999999643211 111122
Q ss_pred ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..++..... .....+..+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 IIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 222221111 01111345899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.43 Aligned_cols=235 Identities=23% Similarity=0.376 Sum_probs=186.0
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc-----
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV----- 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 886 (1075)
...+|++.+.||+|+||.||+|... +|+.||+|++.... +.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467889999999999999999775 79999999986532 3567899999999999999999987541
Q ss_pred ----------ccchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 887 ----------RHSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 887 ----------~~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
...+.++++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 111222222211 235689999999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA 1025 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 1025 (1075)
+.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+.... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------KF 227 (284)
T ss_dssp TEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------HH
T ss_pred CCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------HH
Confidence 999999999998776443 2344578999999999999999999999999999999999999864211 11
Q ss_pred hhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1026 LDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.........+. ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 228 ~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 228 FTDLRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp HHHHHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11222222221 12235889999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.36 Aligned_cols=245 Identities=22% Similarity=0.313 Sum_probs=188.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|++++++++||||+++++++......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 44578999999999999999999765 79999999986543222 23578899999999999999999999997755432
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEeccccccc
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDFGIAKF 958 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~DfGla~~ 958 (1075)
.+ ++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++..
T Consensus 98 lv-~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IV-GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EE-ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EE-EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 22 22111 134689999999999999999999999 99999999999999764 4699999999987
Q ss_pred cCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
..... ......|++.|+|||.+.+. ++.++||||+|+++|+|++|+.||....... ....+.......+.
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 174 FQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFDL 243 (287)
T ss_dssp BCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCS
T ss_pred ecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCc
Confidence 65432 23345689999999988764 8999999999999999999999997432211 11111112221111
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111233456999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=321.08 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++...+..+.
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l- 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI- 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE-
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE-
Confidence 367888999999999999999665 79999999987642 34456789999999999999999999999987654322
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 222211 1346889999999999999999999832 7999999999999999999999999999765322
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-----------------------
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL----------------------- 1020 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~----------------------- 1020 (1075)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||...........
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 22345789999999999999999999999999999999999999974322110000
Q ss_pred -----------hhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1021 -----------NLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1021 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..............+.. .....+.++.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000011111111100 11123446999999999999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-32 Score=306.39 Aligned_cols=272 Identities=25% Similarity=0.304 Sum_probs=119.6
Q ss_pred CcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEcc
Q 042958 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLG 297 (1075)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 297 (1075)
+|++|++++|.+++..|..|..+++|++|++++|++++..|..|.++++|++|++++|.++. +|..+. ++|++|+++
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS-CCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc-cCcccc--ccCCEEECC
Confidence 34444444444433333334444444444444444443333344444444444444444442 222222 344444444
Q ss_pred CCCCCCCcCCCCCccccccceeccccccc--CCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCC
Q 042958 298 YNKLNGIIPHSLGNLTNLATLYIHNNSLS--GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD 375 (1075)
Q Consensus 298 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 375 (1075)
+|+++++.+..|.++++|++|++++|.++ +..+..+..+ +|+.|++++|++++ +|..+. ++|++|++++|.+.+
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~ 207 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA 207 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence 44444444444444445555555554443 2334444444 45555555555442 232222 344444555554444
Q ss_pred CCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcc
Q 042958 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455 (1075)
Q Consensus 376 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 455 (1075)
..+..+..+++|++|++++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|..
T Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 286 (332)
T 2ft3_A 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286 (332)
T ss_dssp CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence 44444444445555555555554444444444455555555555444 33444444444555555544444433333332
Q ss_pred ccccccccccCCccccCCCccccCcCCCCEEeCCCCccc--CCCcccccCCCccceeeccCC
Q 042958 456 LTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS--GSIPQSLGNLSNLVILYLYNN 515 (1075)
Q Consensus 456 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N 515 (1075)
... -.....|+.|++++|++. +..|..|..+++|+.+++++|
T Consensus 287 ~~~------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 287 VGF------------------GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SSC------------------CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ccc------------------ccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 100 000234455555555554 344455555555555555555
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=314.09 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=184.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeecccc-ch
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRH-SL 890 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~l 890 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++..... ..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 36788999999999999999965 57999999998642 1467899999999997 9999999999986432 22
Q ss_pred hheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCCC
Q 042958 891 AMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 891 ~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 963 (1075)
.++++.... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++......
T Consensus 109 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 222222211 23478899999999999999999999 999999999999999777 89999999998765443
Q ss_pred CceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh---------hhhhhh-------
Q 042958 964 SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL---------NLNIAL------- 1026 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~---------~~~~~~------- 1026 (1075)
......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||........... ......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 3345678999999999877 6689999999999999999999999853221100000 000000
Q ss_pred ----hhccCCCCCC------CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1027 ----DEMLDPRLPT------PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1027 ----~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.......... ........+.++.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 00011223557999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=319.81 Aligned_cols=256 Identities=21% Similarity=0.216 Sum_probs=178.1
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV 886 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 886 (1075)
.+.....++|++.+.||+|+||.||+|.. .+|+.||||++...... ...+.+|++.++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 45567789999999999999999999976 47999999988653222 24566788888999999999999998653
Q ss_pred cc------chhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEecCCCCCeeeCC-C
Q 042958 887 RH------SLAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMH--NDCFPPIVHRDISSKNVLLDF-D 945 (1075)
Q Consensus 887 ~~------~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlk~~Nill~~-~ 945 (1075)
.. .+.++++.. .....+++..+..++.|++.|+.||| +. +|+||||||+||+++. +
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 22 122222221 13456788899999999999999999 77 9999999999999997 8
Q ss_pred CCceEeccccccccCCCCCceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-
Q 042958 946 NEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN- 1023 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~- 1023 (1075)
+.+||+|||+++.+.... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..............
T Consensus 169 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999998766433 334567899999999986654 89999999999999999999999975432211000000
Q ss_pred ------hhhhhccC----------CCCCC---CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ------IALDEMLD----------PRLPT---PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ------~~~~~~~~----------~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........ ...+. ........+.++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 00000 00011123567999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=313.84 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=184.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEE--CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeec-
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL--ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSH- 885 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~- 885 (1075)
.+.++|++.+.||+|+||.||+|.. .+|+.||||++........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 4567899999999999999999976 4688999999864322111 123455677776666 89999999999862
Q ss_pred ---cccchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 886 ---VRHSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 886 ---~~~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
....+.++++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 2222222222211 123488999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhh-------h
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI-------A 1025 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~-------~ 1025 (1075)
||+++..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||............... .
T Consensus 164 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999875432 2234467899999999999999999999999999999999999999754321110000000 0
Q ss_pred h-------hhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 L-------DEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 ~-------~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. ..... .............+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 0000001111233456899999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=314.60 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=182.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEE--EEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIV--AVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|.. .+|..+ |||++.... .....+.+.+|+++++++ +||||+++++++...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 36788999999999999999965 456654 999887532 223356789999999999 999999999999775543
Q ss_pred hhheecCc-------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 890 LAMILSNN-------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 890 l~~~~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
+.+ ++.. .....+++.+++.++.|+++||+|||+. +|+||||||+||+++.
T Consensus 102 ~lv-~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 102 YLA-IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 177 (327)
T ss_dssp EEE-ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred EEE-EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcC
Confidence 222 2211 1123689999999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1023 (1075)
++.+||+|||+++..... .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.......
T Consensus 178 ~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------- 249 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------- 249 (327)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred CCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------
Confidence 999999999999753321 12233456889999999988889999999999999999998 999997433211
Q ss_pred hhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+... ....+ ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 250 -~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 250 -LYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp -HHHHGGGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHhhcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111 11111 123346999999999999999999999998774
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=308.79 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=177.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----- 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 887 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46788999999999999999976 4799999999853 2344578999999999999999999999886532
Q ss_pred -------cchhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceE
Q 042958 888 -------HSLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950 (1075)
Q Consensus 888 -------~~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl 950 (1075)
..+.++++... ....+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 12222222221 123467888899999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCC--------------CceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCcc
Q 042958 951 SDFGIAKFLKPDS--------------SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSM 1015 (1075)
Q Consensus 951 ~DfGla~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 1015 (1075)
+|||.++...... .......||+.|+|||++.+. .++.++||||+|+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998765321 122345689999999998765 68999999999999999998 543111
Q ss_pred ccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........+.......+.......+..+.+++.+||+.||++|||++|+++
T Consensus 233 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -----ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 011111222222222222233344556899999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=312.97 Aligned_cols=252 Identities=31% Similarity=0.492 Sum_probs=222.0
Q ss_pred CCccEEEccCCCccC--CCCccccccCCCceeeccc-CcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcce
Q 042958 73 PHLAYLDLWHNQLYG--NIPPQIGNISRLKYLDLSS-NLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNY 149 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 149 (1075)
.+++.|||++|.++| .+|+.++++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~--------- 120 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF--------- 120 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG---------
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH---------
Confidence 467888888888887 7788888888888888874 7777777777777777777777777776655554
Q ss_pred eecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCC-CcCceeccccC
Q 042958 150 LALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLT-NLATLYLHNNS 228 (1075)
Q Consensus 150 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~L~~N~ 228 (1075)
|.++++|++|+|++|.+++.+|..|..+++|++|++++|++++.+|..+..++ +|++|++++|+
T Consensus 121 ---------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 121 ---------------LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp ---------------GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred ---------------HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence 66677777888888888878889999999999999999999999999999998 99999999999
Q ss_pred CCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCC
Q 042958 229 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308 (1075)
Q Consensus 229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 308 (1075)
+++.+|..+..++ |++|++++|++++..|..|..+++|++|++++|.+++.+|. +..+++|++|++++|++++..|..
T Consensus 186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 263 (313)
T 1ogq_A 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence 9989999999997 99999999999999999999999999999999999976665 888999999999999999999999
Q ss_pred CCccccccceecccccccCCCCcccccccccccccccCCc-ccc
Q 042958 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNK-LSG 351 (1075)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~ 351 (1075)
|..+++|++|+|++|++++.+|.. ..+++|+.|++++|. +.|
T Consensus 264 l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 264 LTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred HhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 999999999999999999988886 889999999999998 554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=313.73 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=178.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR----- 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 887 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 467888999999999999999765 5899999998643 3445678999999999999999999999885432
Q ss_pred --------cchhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEe
Q 042958 888 --------HSLAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVS 951 (1075)
Q Consensus 888 --------~~l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~ 951 (1075)
....++++... ....+++..++.++.|+++||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 11222222211 234688999999999999999999999 999999999999997 56799999
Q ss_pred ccccccccCCCCC---ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh----
Q 042958 952 DFGIAKFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN---- 1023 (1075)
Q Consensus 952 DfGla~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---- 1023 (1075)
|||.++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987653321 2334567899999998765 6789999999999999999999999975432211000000
Q ss_pred ---hhhhh------------ccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ---IALDE------------MLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ---~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+ ...+..+ ........+.++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKP-LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCC-HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhcCcccccccccCCCCC-hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 0000000 00001123456999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=313.33 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=181.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchh
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~ 891 (1075)
...++|++.+.||+|+||.||+|.... .||+|++....... ...+.+.+|+.++++++||||+++++++......+.
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 446789999999999999999998763 49999987643222 223567889999999999999999999987654322
Q ss_pred heecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 892 MILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 892 ~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+ ++.. .....+++.+++.++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 107 v-~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 107 I-TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp E-CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred E-eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 2 2111 1133589999999999999999999999 999999999999998 78999999999876532
Q ss_pred CC-----CceeccccccCccCcccccc---------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhh
Q 042958 962 DS-----SNWTELAGTYGYVAPELAYT---------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD 1027 (1075)
Q Consensus 962 ~~-----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1027 (1075)
.. .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~ 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQMG 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----HHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhc
Confidence 21 22234568999999998874 357889999999999999999999997433211 111111
Q ss_pred hccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1028 EMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+.... ...+..+.+++.+||+.||++|||++|+++.|+
T Consensus 257 ~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 257 TGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp TTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred cCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 111111111 112234899999999999999999999999885
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.39 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=185.0
Q ss_pred hcCCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 887 (1075)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.... ......+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999976 4789999999864321 1112235677899999999 6999999999987655
Q ss_pred cchhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 888 HSLAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 888 ~~l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
..+ ++++... ....+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 133 ~~~-lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLH-LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEE-EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEE-EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 432 2222211 234688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ceeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCC
Q 042958 959 LKPDSS-NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035 (1075)
Q Consensus 959 ~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1075)
+..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ...........+
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~~~~~~~~ 284 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRILKSEPP 284 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHHHCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH----HHHHHHhccCCC
Confidence 643322 2334679999999999885 347899999999999999999999997433221111 111111111222
Q ss_pred CCCcCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHhh
Q 042958 1036 TPSCIVQDKLISIVEVAISCLDENPESRP-----TMPKVSQL 1072 (1075)
Q Consensus 1036 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1072 (1075)
.+ ...+..+.+++.+||+.||++|| +++|+++.
T Consensus 285 ~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 285 YP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 22 22334689999999999999999 99999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=336.58 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=187.6
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC----CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR 887 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 887 (1075)
...++|++.+.||+|+||.||+|... .+..||||++... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCc
Confidence 34567888899999999999999764 2467999998754 23344678999999999999999999999986544
Q ss_pred cchhheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 888 HSLAMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 888 ~~l~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
..+.+.+...+ ....+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 33333222211 133588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 960 KPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 960 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ........ ...+.+
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~~~--~~~~~~ 614 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENG--ERLPMP 614 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHHT--CCCCCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHcC--CCCCCC
Confidence 54322 2233456789999999998899999999999999999997 999987433211 11111111 112222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++|||++||++.|+
T Consensus 615 ----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 615 ----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 223446999999999999999999999999874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=302.17 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=121.2
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
.++++++++++.++ .+|..+. ++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..++.+++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45667777766665 4555443 46666666666666555556666666666666666666555555555555555555
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
++|.++.+....+ ++|++|++++|++++..+..|.++++|++|++++|.++. .+.
T Consensus 108 s~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~ 162 (330)
T 1xku_A 108 SKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGI 162 (330)
T ss_dssp CSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGB
T ss_pred CCCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc----------------------cCc
Confidence 5555554322211 345555555555544444444444444444444444431 012
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL 312 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 312 (1075)
.+..+..+++|++|++++|.++. +|..+. ++|++|++++|.+++..|..|..+++|+.|++++|++++..+..|..+
T Consensus 163 ~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 239 (330)
T 1xku_A 163 ENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239 (330)
T ss_dssp CTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred ChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence 23333444444444444444442 222221 344444444444444444444444444444444444444444444444
Q ss_pred ccccceecccccccCCCCcccccccccccccccCCcccc
Q 042958 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351 (1075)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 351 (1075)
++|++|++++|.++ .+|..+..+++|++|++++|++++
T Consensus 240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 44444444444444 334444444444444444444443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=309.53 Aligned_cols=248 Identities=18% Similarity=0.262 Sum_probs=185.2
Q ss_pred hcCCCCCceecccCceEEEEEEE--CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc------eeeEEEEeec
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL--ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN------IVKFYGFCSH 885 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~ 885 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++|++ ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46889999999999999999965 36889999998642 334577889999999997765 9999999877
Q ss_pred cccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC------------
Q 042958 886 VRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF------------ 944 (1075)
Q Consensus 886 ~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~------------ 944 (1075)
.+..+.++.... .....+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 654322221111 1123578999999999999999999999 9999999999999987
Q ss_pred -------CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 945 -------DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 945 -------~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
++.+||+|||.++..... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 3346789999999999999999999999999999999999999975432110
Q ss_pred chhhhh-------hhhhhc-------------------------cCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC
Q 042958 1018 SSLNLN-------IALDEM-------------------------LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1018 ~~~~~~-------~~~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
...... ...... ...............+..+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 000000 000000 000000001112345678999999999999999999
Q ss_pred HHHHHh
Q 042958 1066 MPKVSQ 1071 (1075)
Q Consensus 1066 ~~evl~ 1071 (1075)
++|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=301.79 Aligned_cols=296 Identities=24% Similarity=0.332 Sum_probs=186.9
Q ss_pred CCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEc
Q 042958 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176 (1075)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (1075)
.++++++++++.++ .+|..+. +.|++|+|++|+++ ++.+..|+++++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~------------------------~~~~~~~~~l~~L~~L~L 83 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT------------------------EIKDGDFKNLKNLHTLIL 83 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC------------------------CBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC------------------------EeChhhhccCCCCCEEEC
Confidence 35666666666655 4444332 34555555555554 444445677777777777
Q ss_pred CCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC-
Q 042958 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG- 255 (1075)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~- 255 (1075)
++|++++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..|..+++|++|++++|.+..
T Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 160 (330)
T 1xku_A 84 INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160 (330)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred CCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCcc
Confidence 777777776777777777777777777777 4555444 678888888888887777778888888888888888863
Q ss_pred -ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccc
Q 042958 256 -SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334 (1075)
Q Consensus 256 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 334 (1075)
..+..+.++++|++|++++|.++. +|..+. ++|++|++++|++++..+..|..+++|++|++++|.+++..+..+.
T Consensus 161 ~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 161 GIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp GBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred CcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 556667777777777777777774 444332 5677777777777666666666666666666666666655555666
Q ss_pred cccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeE
Q 042958 335 NLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414 (1075)
Q Consensus 335 ~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 414 (1075)
.+++|++|++++|+++ .+|..+..+++|++|++++|++.+..+..|.... .....+.|+.|
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l 298 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGV 298 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEE
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccce
Confidence 6666666666666665 4555555555666666666655444444333210 00012456666
Q ss_pred Eeecccccc--ccccccccccccceecccccc
Q 042958 415 DLYDNSLSG--SIPSEFGNLRSLSTLSLGYNK 444 (1075)
Q Consensus 415 ~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 444 (1075)
++++|.+.. +.|..|..+.+|+.++|++|+
T Consensus 299 ~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp ECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred EeecCcccccccCccccccccceeEEEecccC
Confidence 666666542 455667777777777777664
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=314.65 Aligned_cols=237 Identities=20% Similarity=0.311 Sum_probs=184.4
Q ss_pred HHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch---hHHHHHHHHHHHHhcCC--cCceeeEEEEeec
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM---TFQQEFLNEVKALTEIR--HRNIVKFYGFCSH 885 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 885 (1075)
...++|++.+.||+|+||.||+|.. .+++.||||++........ ...+.+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999965 5789999999865432211 11245678999999996 5999999999987
Q ss_pred cccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEecccc
Q 042958 886 VRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGI 955 (1075)
Q Consensus 886 ~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGl 955 (1075)
.+..+.++.... .....+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 655433322221 1235688999999999999999999999 999999999999999 778999999999
Q ss_pred ccccCCCCCceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 956 AKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 956 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ......
T Consensus 197 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~~~~~~ 260 (320)
T 3a99_A 197 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQV 260 (320)
T ss_dssp CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCC
T ss_pred ccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------hhcccc
Confidence 9876533 2344679999999999887766 6889999999999999999999863211 001111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+. ..+.++.+++.+||+.||++|||++||++
T Consensus 261 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 12345899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=305.55 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=168.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|+..+.||+|+||.||+|... +|+.||||++..... .....+.+.++..+++.++||||+++++++...+..+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 467888899999999999999765 799999999976432 222334455566678888999999999999876543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
++... ....+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 103 -~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 -MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp -ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred -EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 22211 13568999999999999999999998 5 8999999999999999999999999999876543
Q ss_pred CCceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 963 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
. ......|++.|+|||++. +..++.++||||||+++|||++|+.||....... ...........+..+..
T Consensus 179 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 179 K-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHHSCCCCCCSS
T ss_pred c-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhccCCCCCCcc
Confidence 2 233457899999999984 4568899999999999999999999997432210 00011111111122211
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. ..+..+.+++.+||+.||.+|||++|+++
T Consensus 254 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 254 M----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 22346899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=315.95 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=183.2
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-----------cCceeeEEE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----------HRNIVKFYG 881 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~ 881 (1075)
.++|++.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 46799999999999999999965 5799999999863 2334577889999999886 899999999
Q ss_pred Eeecccc---chhheecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-----
Q 042958 882 FCSHVRH---SLAMILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD----- 943 (1075)
Q Consensus 882 ~~~~~~~---~l~~~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~----- 943 (1075)
++..... .+.++++... ....+++..+..++.||+.||+|||+.+ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 9875431 2222222211 1345899999999999999999999953 899999999999994
Q ss_pred -CCCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-h
Q 042958 944 -FDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-N 1021 (1075)
Q Consensus 944 -~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-~ 1021 (1075)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........... .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4447999999999876532 3345789999999999999999999999999999999999999975432111000 0
Q ss_pred hhhhhhh------------------ccCC-----CCC------------CCCcCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1022 LNIALDE------------------MLDP-----RLP------------TPSCIVQDKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1022 ~~~~~~~------------------~~~~-----~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
....... +... ... .........+.++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 0000000 0000 000 0011235667789999999999999999999
Q ss_pred HHHHh
Q 042958 1067 PKVSQ 1071 (1075)
Q Consensus 1067 ~evl~ 1071 (1075)
+|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=307.72 Aligned_cols=239 Identities=21% Similarity=0.313 Sum_probs=177.5
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch---hHHHHHHHHHHHHhcC----CcCceeeEEE
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM---TFQQEFLNEVKALTEI----RHRNIVKFYG 881 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~ 881 (1075)
.....++|++.+.||+|+||.||+|.. .+++.||||++........ .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999965 4789999999975432211 1223466789999888 8999999999
Q ss_pred EeeccccchhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEe
Q 042958 882 FCSHVRHSLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVS 951 (1075)
Q Consensus 882 ~~~~~~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~ 951 (1075)
++...+..+.++.... .....+++..++.++.|+++||+|||+. +|+||||||+||+++ .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 9876554433322211 1234589999999999999999999999 999999999999999 88999999
Q ss_pred ccccccccCCCCCceeccccccCccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhcc
Q 042958 952 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030 (1075)
Q Consensus 952 DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1030 (1075)
|||+++..... ......|++.|+|||++.+..+. .++||||+|+++|||++|+.||..... ..
T Consensus 183 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------~~ 246 (312)
T 2iwi_A 183 DFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------------IL 246 (312)
T ss_dssp CCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HH
T ss_pred EcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------Hh
Confidence 99999876543 23456789999999998877664 589999999999999999999863211 01
Q ss_pred CCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+. ..+..+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTCCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111 22345899999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=311.77 Aligned_cols=192 Identities=21% Similarity=0.262 Sum_probs=154.6
Q ss_pred HhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cC-----ceeeEEEEeec
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HR-----NIVKFYGFCSH 885 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 885 (1075)
..++|++.+.||+|+||.||+|... +++.||||++.. ......++..|+++++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3578999999999999999999654 788999999863 2334567788999888884 44 49999998876
Q ss_pred cccchhhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC--CCCCceEeccc
Q 042958 886 VRHSLAMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD--FDNEAHVSDFG 954 (1075)
Q Consensus 886 ~~~~l~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfG 954 (1075)
....+.++ +... .....+++..+..++.|++.||.|||.+ ..+|+||||||+||+++ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 55432222 1111 1124589999999999999999999953 12899999999999995 47789999999
Q ss_pred cccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 1012 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 1012 (1075)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99876532 33467899999999999999999999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=308.70 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=183.9
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CC-CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc------eeeEEEEeec
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SG-EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN------IVKFYGFCSH 885 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~ 885 (1075)
.++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 468999999999999999999664 44 68999998642 334577889999999998766 8999998876
Q ss_pred cccchhhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeee--------------
Q 042958 886 VRHSLAMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLL-------------- 942 (1075)
Q Consensus 886 ~~~~l~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill-------------- 942 (1075)
....+.++ +... .....+++.+++.++.||++||+|||+. +|+||||||+||++
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 55432222 1111 1124689999999999999999999999 99999999999999
Q ss_pred -----CCCCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCcccc
Q 042958 943 -----DFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSS 1017 (1075)
Q Consensus 943 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 1017 (1075)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||........
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999875432 3446799999999999999999999999999999999999999975332110
Q ss_pred chhhhh-------hhhhh------ccC-------------------CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCC
Q 042958 1018 SSLNLN-------IALDE------MLD-------------------PRLPTPSCIVQDKLISIVEVAISCLDENPESRPT 1065 (1075)
Q Consensus 1018 ~~~~~~-------~~~~~------~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1065 (1075)
...... ..... ... ............+..++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 000000 00000 000 0000000112234567999999999999999999
Q ss_pred HHHHHh
Q 042958 1066 MPKVSQ 1071 (1075)
Q Consensus 1066 ~~evl~ 1071 (1075)
++|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=316.55 Aligned_cols=239 Identities=22% Similarity=0.295 Sum_probs=171.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~ 892 (1075)
..+|+..+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.+....+.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 456888899999999997766667799999999865321 2356899999999 899999999998775543222
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-----CCceEeccccccc
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-----NEAHVSDFGIAKF 958 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~DfGla~~ 958 (1075)
++... ......+.++..++.||++||+|||+. +|+||||||+||+++.+ ..+||+|||+|+.
T Consensus 97 -~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 -IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp -EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred -EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 21111 112244455678999999999999999 99999999999999532 3578999999987
Q ss_pred cCCCC---CceeccccccCccCccccc---cCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC
Q 042958 959 LKPDS---SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 959 ~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
..... .......||+.|+|||++. ...++.++||||+||++|||++ |+.||...... .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~~~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANILLG 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHHTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHHhc
Confidence 65432 2234467999999999987 4567889999999999999999 99998532110 0111111
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
................+.+++.+||+.||++|||++||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111112344556889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=305.67 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=156.3
Q ss_pred HhcCCCCCc-eecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc---c
Q 042958 813 ATNDFDDEH-CIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV---R 887 (1075)
Q Consensus 813 ~~~~~~~~~-~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~ 887 (1075)
..++|.+.+ .||+|+||.||+|... +|+.||||++... .. ...+....++.++||||+++++++... .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 356788854 6999999999999665 7999999998642 11 122223345667999999999998652 2
Q ss_pred cchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC---CCceEecc
Q 042958 888 HSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD---NEAHVSDF 953 (1075)
Q Consensus 888 ~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df 953 (1075)
..+.++++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 22222222211 124689999999999999999999999 99999999999999864 45999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|+++..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........... ....+....
T Consensus 176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~ 249 (336)
T 3fhr_A 176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLGQ 249 (336)
T ss_dssp TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhccc
Confidence 999876532 23445789999999999888899999999999999999999999964432211100 011111111
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.......+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111112234456999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=316.67 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=170.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchhhee
Q 042958 816 DFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++......+ +++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~-lv~ 88 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY-IAL 88 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE-EEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE-EEE
Confidence 34456789999999998887778999999998532 235678999999886 8999999999987655432 222
Q ss_pred cCccc--------cC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-------------C
Q 042958 895 SNNAA--------AK-------DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-------------N 946 (1075)
Q Consensus 895 ~~~~~--------~~-------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-------------~ 946 (1075)
+...+ .. ...+..++.++.||+.||+|||+. +|+||||||+||+++.+ +
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence 21111 00 012234567999999999999999 99999999999999754 4
Q ss_pred CceEeccccccccCCCCCc----eeccccccCccCcccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCccCc
Q 042958 947 EAHVSDFGIAKFLKPDSSN----WTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 1014 (1075)
Q Consensus 947 ~~kl~DfGla~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 1014 (1075)
.+||+|||+++.+...... .....||+.|+|||++.+ ..++.++||||+||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 7999999999987654322 234579999999999875 568999999999999999999 9999863221
Q ss_pred cccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. ............ .........+.++.+++.+||+.||++|||+.||++
T Consensus 246 ~~------~~i~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE------SNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH------HHHHHTCCCCCC-CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH------HHHhcCCCCccc-ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 10 111111111110 011123456678999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=319.63 Aligned_cols=235 Identities=14% Similarity=0.125 Sum_probs=168.7
Q ss_pred hcCCCCCceecccCceEEEEEE-ECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc-Cceee---------EEEE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVK---------FYGF 882 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~---------l~~~ 882 (1075)
...|...+.||+|+||.||+|. ..+|+.||||++...........+.+.+|+.+++.++| ++... ..+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3456777899999999999996 45799999999875443333335779999999999977 22111 1111
Q ss_pred ------------eeccc---c-chhheecC---------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 042958 883 ------------CSHVR---H-SLAMILSN---------------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIV 931 (1075)
Q Consensus 883 ------------~~~~~---~-~l~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 931 (1075)
+.... . .+.+++.. ......+++..++.++.|+++||+|||+. +|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11101 0 00000000 11133467888999999999999999999 999
Q ss_pred EecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCcccc----------ccCCCCcccchHhHHHHHHH
Q 042958 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA----------YTMKVTEKCDVYSFGVLALE 1001 (1075)
Q Consensus 932 H~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~vl~e 1001 (1075)
||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999875432 445577 999999998 55668899999999999999
Q ss_pred HHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1002 VIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1002 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
|++|+.||........ ......... ..+..+.+++.+||+.||++||++.|+++
T Consensus 310 lltg~~Pf~~~~~~~~--------~~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALGG--------SEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGSC--------SGGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhhh--------HHHHHhhcc--------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999974332111 111111111 11245999999999999999999988865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=325.60 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=183.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc-----c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV-----R 887 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 887 (1075)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 47899999999999999999965 579999999987542 334467899999999999999999999987541 1
Q ss_pred cchhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC---ceEec
Q 042958 888 HSLAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE---AHVSD 952 (1075)
Q Consensus 888 ~~l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~D 952 (1075)
....++++.. .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 2222222221 1223588899999999999999999999 9999999999999997765 89999
Q ss_pred cccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccc-cch-----hhhhhhh
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS-SSS-----LNLNIAL 1026 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-~~~-----~~~~~~~ 1026 (1075)
||.++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... +.. .......
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 99998765432 3345689999999999999999999999999999999999999996421110 000 0000000
Q ss_pred ------hhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 042958 1027 ------DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVS 1070 (1075)
Q Consensus 1027 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1070 (1075)
........+.+.......+..+.+++.+||+.||++|||++|++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00111222333334455677899999999999999999998754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-34 Score=342.16 Aligned_cols=378 Identities=22% Similarity=0.169 Sum_probs=214.0
Q ss_pred ccCcEEEccCCCCCCCcCCC-CCccccccceecccccccCC----CCcccccccccccccccCCcccccCCCcC-CCCC-
Q 042958 289 RSLSMLNLGYNKLNGIIPHS-LGNLTNLATLYIHNNSLSGS----IPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLS- 361 (1075)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~l-~~l~- 361 (1075)
++|++|+|++|+++...... +..+++|++|++++|.++.. ++..+..+++|++|++++|.+.+..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56778888888877543332 66777888888888877632 34556666777777777777764322222 1233
Q ss_pred ---CcceeeccccccCC----CCccccCCCcccceeeeccccccccCChhhcc-----CCCCCeEEeecccccccc----
Q 042958 362 ---NLATLYLYSNSLFD----SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN-----LTNLATLDLYDNSLSGSI---- 425 (1075)
Q Consensus 362 ---~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~---- 425 (1075)
+|++|++++|.+.. .++..+..+++|++|++++|++++..+..+.. .++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 56777777776653 34556666666666666666665443333322 345666666666666432
Q ss_pred ccccccccccceecccccccccCCCCCCcc-----ccccccccccCCccccC----CCccccCcCCCCEEeCCCCcccCC
Q 042958 426 PSEFGNLRSLSTLSLGYNKLSGSIPHSLGN-----LTNLDALYLYDNSLSGS----IPGEIGNLRSISNLALNNNKLSGS 496 (1075)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ 496 (1075)
+..+..+++|++|++++|.+++..+..+.. .++|++|++++|.+++. ++..+..+++|++|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 334455566666666666655433322221 33555555555555532 234444455555555555554432
Q ss_pred C-----cccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhh
Q 042958 497 I-----PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLN 571 (1075)
Q Consensus 497 ~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~ 571 (1075)
. +..+..+++|+.|++++|.+++.... .++..+.+++
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--------------------------------------~l~~~l~~~~ 284 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------------------------DLCRVLRAKE 284 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------------------------HHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--------------------------------------HHHHHHhhCC
Confidence 1 11122344455555555444322000 0222233333
Q ss_pred HhHHHhhcccccccccccccC-----cccccceeecCCCcccCc----ccccccccccceEEEccccccccccchhccc-
Q 042958 572 FLIKLILAQNQLSGQLSPKLG-----SLAQLEHLDLSSNRLSNS----IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEE- 641 (1075)
Q Consensus 572 ~l~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~- 641 (1075)
.|+.|++++|.+++..+..+. ..++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+..+..
T Consensus 285 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 364 (461)
T 1z7x_W 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364 (461)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred CcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH
Confidence 333333333333322222221 225788888888888764 4566667788888888888887665555543
Q ss_pred ----ccccceeeeccccccC----chhhhhccccccceeecCCCccccCChhhhc-----ccccccEEeecCCccC
Q 042958 642 ----LIHLSELDLSHNFLRE----AIPSQICIMQSLENLNLSHNSLVGLIPSCFE-----KMHGLLRIDISYNELQ 704 (1075)
Q Consensus 642 ----l~~L~~L~ls~N~l~~----~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~-----~~~~l~~l~~s~N~~~ 704 (1075)
.++|++|+|++|++++ .+|..+..+++|+.|++++|++++.....+. ....|+.|++.++.+.
T Consensus 365 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 5678888888888876 6777777788888888888888755333332 1234666766666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-35 Score=344.90 Aligned_cols=390 Identities=22% Similarity=0.155 Sum_probs=289.7
Q ss_pred ccccccccccccCcCCCCc-ccCCCccCcEEEccCCCCCCC----cCCCCCccccccceecccccccCCCCcccc-ccc-
Q 042958 265 TNLATLYLYENSLSGSIPS-EFGNLRSLSMLNLGYNKLNGI----IPHSLGNLTNLATLYIHNNSLSGSIPSEIG-NLR- 337 (1075)
Q Consensus 265 ~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~- 337 (1075)
++|++|++++|+++..... .+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+....+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 5799999999999854433 377899999999999999853 456777889999999999999865444443 344
Q ss_pred ---ccccccccCCcccc----cCCCcCCCCCCcceeeccccccCCCCccccC-----CCcccceeeeccccccccC----
Q 042958 338 ---SLSNLGLSGNKLSG----SIPPSLGYLSNLATLYLYSNSLFDSIPSELG-----NLRSLSMLSLGYNKLSGSI---- 401 (1075)
Q Consensus 338 ---~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~---- 401 (1075)
+|++|++++|+++. .++..+..+++|++|++++|.+.+..+..+. ..++|++|++++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 69999999999984 4588899999999999999998655444333 3567999999999998744
Q ss_pred ChhhccCCCCCeEEeecccccccccccccc-----ccccceecccccccccC----CCCCCccccccccccccCCccccC
Q 042958 402 PHSLGNLTNLATLDLYDNSLSGSIPSEFGN-----LRSLSTLSLGYNKLSGS----IPHSLGNLTNLDALYLYDNSLSGS 472 (1075)
Q Consensus 402 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~ 472 (1075)
+..+..+++|++|++++|.+++..+..+.. .++|++|++++|.+++. ++..+..+++|++|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 667778899999999999998765555543 56999999999999864 577788899999999999999864
Q ss_pred C-----CccccCcCCCCEEeCCCCcccCC----CcccccCCCccceeeccCCCCCCCCCccccCcccccccccccccccc
Q 042958 473 I-----PGEIGNLRSISNLALNNNKLSGS----IPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543 (1075)
Q Consensus 473 ~-----p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~ 543 (1075)
. +..+..+++|++|++++|.++.. ++..+..+++|+.|++++|.+++..+..+...- .
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l-------------~ 309 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL-------------L 309 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHH-------------T
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHh-------------c
Confidence 3 33344689999999999999864 577788899999999999988654433332210 0
Q ss_pred ccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccc-----c
Q 042958 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGN-----L 618 (1075)
Q Consensus 544 ~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l 618 (1075)
.-++++++|++++|.+++..... ++..+..+++|++|||++|+|++..+..+.. .
T Consensus 310 ~~~~~L~~L~L~~n~l~~~~~~~--------------------l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 369 (461)
T 1z7x_W 310 EPGCQLESLWVKSCSFTAACCSH--------------------FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHH--------------------HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred cCCccceeeEcCCCCCchHHHHH--------------------HHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCC
Confidence 01235666666666665432211 2334556678888888888887655554443 5
Q ss_pred ccceEEEcccccccc----ccchhcccccccceeeeccccccCchhhhhcc-----ccccceeecCCCccccCChhhh
Q 042958 619 VKLHYLNLSNNQFSR----GIPIKLEELIHLSELDLSHNFLREAIPSQICI-----MQSLENLNLSHNSLVGLIPSCF 687 (1075)
Q Consensus 619 ~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----~~~L~~L~ls~N~l~~~~p~~~ 687 (1075)
++|++|+|++|++++ .+|..+..+++|++|||++|++++.....+.. ..+|+.|++.++.+....+..+
T Consensus 370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l 447 (461)
T 1z7x_W 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred CceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence 688888888888875 67778888888888888888887653333321 2357777777776665544443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=287.95 Aligned_cols=223 Identities=12% Similarity=0.064 Sum_probs=168.3
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|... +|+.||||++...........+.+.+|+..+++++||||+++++++...+..+ ++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~-lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL-VV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE-EE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE-EE
Confidence 67999999999999999999665 58999999998765555556688999999999999999999999998765432 22
Q ss_pred ecCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 894 LSNNAA-------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 894 ~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
++...+ .......+..+++.|+++||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 222111 11235567888999999999999999 99999999999999999999998543
Q ss_pred eccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHH
Q 042958 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLI 1046 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1075)
|++ .++.++||||||+++|||++|+.||............ ........+.+.......+.
T Consensus 175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----ERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----CBCTTSCBCCHHHHCTTSCH
T ss_pred --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----HHHhccCCCChhhcccCCCH
Confidence 333 3688999999999999999999999754332111000 00111111111111122345
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1047 SIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1047 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.+.+++.+||+.||++| |++|+++.|+
T Consensus 235 ~l~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp HHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred HHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence 69999999999999999 9999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=322.25 Aligned_cols=230 Identities=24% Similarity=0.331 Sum_probs=179.8
Q ss_pred hcCCCCCceecccCceEEEEEEEC--CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA--SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH--- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 888 (1075)
.++|++.+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 368999999999999999999765 6899999998653 334456788999999999999999999999986554
Q ss_pred ---chhheecCcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 ---SLAMILSNNA-----AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ---~l~~~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++.+.... ....+++.+++.++.||++||+|||+. +|+||||||+||+++.+ .+||+|||+++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 2222221111 123689999999999999999999999 99999999999999985 99999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. ....||+.|+|||++.+. ++.++|||||||++|||++|..||...... ..+. ...
T Consensus 233 ~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~~~-~~~ 289 (681)
T 2pzi_A 233 SF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GLPE-DDP 289 (681)
T ss_dssp CC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SCCT-TCH
T ss_pred cC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------cccc-ccc
Confidence 43 345799999999998765 488999999999999999999887531110 0010 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-HHHHHhh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPT-MPKVSQL 1072 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1072 (1075)
.......+.+++.+||++||++||+ ++++...
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 1223457899999999999999996 4445443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=296.03 Aligned_cols=277 Identities=21% Similarity=0.234 Sum_probs=212.9
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.|+ |+. +++++... |.. + .++|++|||++|++++..+..++.+++|++|+|++|.+++..|..
T Consensus 30 C~~~~~-c~~---------~~~~l~~i-P~~-~--~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 95 (353)
T 2z80_A 30 CDRNGI-CKG---------SSGSLNSI-PSG-L--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS 95 (353)
T ss_dssp ECTTSE-EEC---------CSTTCSSC-CTT-C--CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT
T ss_pred CCCCeE-eeC---------CCCCcccc-ccc-c--cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhh
Confidence 999998 754 34444433 322 2 358999999999999766668999999999999999999888888
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCC-CCCCCCCCCCEEEcCCC-CCCCCCCccccCccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIP-PSLGNLSNLDTLHLYDN-SLSDSIPSEFGNLRS 194 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~ 194 (1075)
|+++++|++|+|++|++++..+..++.+++|++|++++|.++++.+ ..+..+++|++|++++| .++...+..|.++++
T Consensus 96 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 175 (353)
T 2z80_A 96 FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175 (353)
T ss_dssp TTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred cCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCC
Confidence 9999999999999999996555558899999999999999998766 67889999999999998 577777788999999
Q ss_pred cceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCc---ccccccccc
Q 042958 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG---NLTNLATLY 271 (1075)
Q Consensus 195 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~ 271 (1075)
|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+. ....++.++
T Consensus 176 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~ 255 (353)
T 2z80_A 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255 (353)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEE
T ss_pred CCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccc
Confidence 99999999999988888999999999999999998654334455688999999999998875544332 234455555
Q ss_pred cccccCcC----CCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 272 LYENSLSG----SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 272 L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
++++.+++ .+|..+..+++|+.|++++|+++.+.+..|..+++|++|++++|.+.+
T Consensus 256 L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp EESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 55555543 245566667777777777777775444445667777777777776664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=284.17 Aligned_cols=250 Identities=24% Similarity=0.242 Sum_probs=164.1
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccc--cCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFG--TIP 114 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~--~~p 114 (1075)
|.|.+|.|+.. ++.. +|.. -.++|++|+|++|+++...+..++.+++|++|+|++|.++. .+|
T Consensus 7 C~~~~l~c~~~-----------~l~~-ip~~---~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNSK-----------GLTS-VPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCSS-----------CCSS-CCSC---CCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCCC-----------Cccc-CCCC---CCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 89999999753 2222 2221 23678999999999884434457889999999999998873 336
Q ss_pred CCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCC-CCCCCCCCCCEEEcCCCCCCCCCCccccCcc
Q 042958 115 PEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLR 193 (1075)
Q Consensus 115 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 193 (1075)
..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..+..|..++
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 150 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCT
T ss_pred cccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCc
Confidence 66777888999999888887 466667777888888888877777655 5677777777777777777766666666777
Q ss_pred ccceEeeecccccc-ccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccccccc
Q 042958 194 SLSMLSLGYNKFSG-SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYL 272 (1075)
Q Consensus 194 ~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 272 (1075)
+|++|++++|.+++ ..|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++
T Consensus 151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 230 (306)
T 2z66_A 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230 (306)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence 77777777776664 45566666666666666666665555555555666666666666555444444445555555555
Q ss_pred ccccCcCCCCcccCCCc-cCcEEEccCCCCC
Q 042958 273 YENSLSGSIPSEFGNLR-SLSMLNLGYNKLN 302 (1075)
Q Consensus 273 ~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 302 (1075)
++|.+++..|..+..++ +|++|+|++|.+.
T Consensus 231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp TTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred CCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 55555544444444442 4555555555444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=283.40 Aligned_cols=220 Identities=20% Similarity=0.278 Sum_probs=161.1
Q ss_pred cCCCCC-ceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHH-hcCCcCceeeEEEEeec---ccc
Q 042958 815 NDFDDE-HCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIRHRNIVKFYGFCSH---VRH 888 (1075)
Q Consensus 815 ~~~~~~-~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~---~~~ 888 (1075)
++|.+. +.||+|+||.||+|.. .+++.||||++.. ...+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 556666 7799999999999965 5799999999853 14567888887 55699999999998865 122
Q ss_pred chhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEeccc
Q 042958 889 SLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDFG 954 (1075)
Q Consensus 889 ~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfG 954 (1075)
.+.++++... ....+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 2222222221 123589999999999999999999999 9999999999999998 7889999999
Q ss_pred cccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 955 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 955 la~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
++.... +..++.++||||+|+++|||++|+.||........... ..........
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----~~~~~~~~~~ 219 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQY 219 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----SCCSSCTTCC
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----HHHHHhhccc
Confidence 987543 23467899999999999999999999964332111000 0011111111
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.......+.++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111223457999999999999999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-33 Score=338.70 Aligned_cols=448 Identities=17% Similarity=0.158 Sum_probs=208.5
Q ss_pred C-ccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCc---cCCCCcccc------------ccCCCc
Q 042958 37 C-AWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQL---YGNIPPQIG------------NISRLK 100 (1075)
Q Consensus 37 c-~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L~ 100 (1075)
| +|+++.+....++ .+.+. ... .++..+..+++|++|+|+++.. .+.+|...+ .+++|+
T Consensus 41 ck~W~~~~~~~~~~l---~~~~~-~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSETREHV---TMALC-YTA-TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHHCCEE---EESCG-GGS-CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhccccEE---EEeec-ccc-ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 6 7999965432222 22211 111 2222355677888888877532 234554444 455555
Q ss_pred eeecccCcccccCCCCCCCC--CCCcEEEccCcc-cCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 101 YLDLSSNLFFGTIPPEIGHL--SYLKTLQLFENQ-LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 101 ~L~Ls~n~l~~~~p~~l~~l--~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
+|+|++|.+++..+..++.. ++|++|+|++|. ++ +..+ +.....+++|++|+|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~---~~~l--------------------~~~~~~~~~L~~L~L~ 172 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT---TDGL--------------------LSIVTHCRKIKTLLME 172 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE---HHHH--------------------HHHHHHCTTCSEEECT
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC---HHHH--------------------HHHHhhCCCCCEEECc
Confidence 55555555554444444332 235555555543 11 0000 1111234455555555
Q ss_pred CCCCCCC----CCccccCccccceEeeeccccc----cccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEecc
Q 042958 178 DNSLSDS----IPSEFGNLRSLSMLSLGYNKFS----GSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLG 249 (1075)
Q Consensus 178 ~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 249 (1075)
+|.+++. ++..+..+++|++|++++|.++ +.++..+.++++|++|++++|.+.+ +|..+..+++|++|+++
T Consensus 173 ~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 173 ESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp TCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred cccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 5544433 2222334455555555555554 1222333445555555555555543 44455555555555555
Q ss_pred CCCCC---CccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcC-CCCCccccccceecccccc
Q 042958 250 YNKLS---GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP-HSLGNLTNLATLYIHNNSL 325 (1075)
Q Consensus 250 ~N~l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l 325 (1075)
..... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++-.
T Consensus 252 ~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~ 330 (592)
T 3ogk_B 252 SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIG 330 (592)
T ss_dssp BCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGH
T ss_pred ccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccC
Confidence 32211 122234444555555555543222 344455555566666666655443222 2234555666666652222
Q ss_pred cCCCCcccccccccccccccC-----------Cccccc-CCCcCCCCCCcceeeccccccCCCCccccCC-Ccccceeee
Q 042958 326 SGSIPSEIGNLRSLSNLGLSG-----------NKLSGS-IPPSLGYLSNLATLYLYSNSLFDSIPSELGN-LRSLSMLSL 392 (1075)
Q Consensus 326 ~~~~~~~~~~l~~L~~L~l~~-----------N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L 392 (1075)
.+..+..+..+++|++|++++ |.+++. ++..+..+++|++|+++.|.+++..+..+.. +++|+.|++
T Consensus 331 ~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l 410 (592)
T 3ogk_B 331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL 410 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred HHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence 222222234455566666652 333321 1111233555666666555554444444433 555666666
Q ss_pred c----ccccccc-----CChhhccCCCCCeEEeecc--ccccccccccc-cccccceeccccccccc-CCCCCCcccccc
Q 042958 393 G----YNKLSGS-----IPHSLGNLTNLATLDLYDN--SLSGSIPSEFG-NLRSLSTLSLGYNKLSG-SIPHSLGNLTNL 459 (1075)
Q Consensus 393 s----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L 459 (1075)
+ .|++++. ++..+.++++|++|++++| .+++..+..+. .+++|++|+|++|++++ .++..+.++++|
T Consensus 411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L 490 (592)
T 3ogk_B 411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL 490 (592)
T ss_dssp EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence 4 4455432 2233445566666666532 24433333332 25556666666666553 223334455566
Q ss_pred ccccccCCccccC-CCccccCcCCCCEEeCCCCcccCCCcccc-cCCCccceeeccC
Q 042958 460 DALYLYDNSLSGS-IPGEIGNLRSISNLALNNNKLSGSIPQSL-GNLSNLVILYLYN 514 (1075)
Q Consensus 460 ~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~ 514 (1075)
++|+|++|.+++. ++..+..+++|+.|++++|++++...+.+ ..++.+....+..
T Consensus 491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 6666666655433 22223445566666666666554332222 2344444444443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=294.05 Aligned_cols=238 Identities=15% Similarity=0.142 Sum_probs=172.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCC-----chhHHHHHHHHHHHHhcCC---------cCceeeE
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG-----EMTFQQEFLNEVKALTEIR---------HRNIVKF 879 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~l 879 (1075)
.++|++.+.||+|+||.||+|+. +|+.||||++...... .....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999987 6899999999765321 2223467889999988885 7777777
Q ss_pred EEEee-----------------c------------cccchhheecC--cc------ccCCCCHHHHHHHHHHHHHHHHHH
Q 042958 880 YGFCS-----------------H------------VRHSLAMILSN--NA------AAKDLGWTRRMNVIKGISDALSYM 922 (1075)
Q Consensus 880 ~~~~~-----------------~------------~~~~l~~~~~~--~~------~~~~l~~~~~~~i~~~i~~~L~~L 922 (1075)
.+++. . ....++++++. .+ ....+++.+++.++.||+.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 76542 1 02222222221 11 124578999999999999999999
Q ss_pred H-hCCCCCeEEecCCCCCeeeCCCC--------------------CceEeccccccccCCCCCceeccccccCccCcccc
Q 042958 923 H-NDCFPPIVHRDISSKNVLLDFDN--------------------EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981 (1075)
Q Consensus 923 H-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~ 981 (1075)
| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++
T Consensus 178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence 9 88 999999999999999887 8999999999876532 34799999999999
Q ss_pred ccCCCCcccchHhHHHH-HHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCC
Q 042958 982 YTMKVTEKCDVYSFGVL-ALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENP 1060 (1075)
Q Consensus 982 ~~~~~~~~~Dv~s~G~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1060 (1075)
.+.. +.++||||+|++ .+++++|..||..... ............ ..............+.++.+++.+||++|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 8776 889999998777 7778889999742100 000011111111 11111122234567788999999999976
Q ss_pred CCCCCHHHHH
Q 042958 1061 ESRPTMPKVS 1070 (1075)
Q Consensus 1061 ~~RPs~~evl 1070 (1075)
|++|++
T Consensus 324 ----sa~e~l 329 (336)
T 2vuw_A 324 ----SATDLL 329 (336)
T ss_dssp ----SHHHHH
T ss_pred ----CHHHHH
Confidence 999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=287.17 Aligned_cols=275 Identities=20% Similarity=0.175 Sum_probs=160.6
Q ss_pred CCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccc
Q 042958 243 LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322 (1075)
Q Consensus 243 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 322 (1075)
....++++|.++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|+++++.+.+|.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 334455555555 3344333 2455555555555544444555556666666666666555555566666666666666
Q ss_pred ccccCCCCcccccccccccccccCCcccccCC-CcCCCCCCcceeecccc-ccCCCCccccCCCcccceeeecccccccc
Q 042958 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIP-PSLGYLSNLATLYLYSN-SLFDSIPSELGNLRSLSMLSLGYNKLSGS 400 (1075)
Q Consensus 323 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 400 (1075)
|.+++..+..|.++++|++|++++|++++..+ ..+..+++|++|++++| .+.+..+..|.++++|++|++++|++++.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 66654444445566666666666666653322 35566666666666666 34444455666666666666666666666
Q ss_pred CChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCc---cccccccccccCCcccc----CC
Q 042958 401 IPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG---NLTNLDALYLYDNSLSG----SI 473 (1075)
Q Consensus 401 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~----~~ 473 (1075)
.|..+..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+. ....++.++|++|.+++ .+
T Consensus 190 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l 269 (353)
T 2z80_A 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV 269 (353)
T ss_dssp CTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHH
T ss_pred CHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhh
Confidence 666666666666666666666544433444566666677776666654433332 23445555555555543 35
Q ss_pred CccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCC
Q 042958 474 PGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520 (1075)
Q Consensus 474 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 520 (1075)
|..+..+++|+.|++++|+++...+..|+++++|+.|+|++|++.+.
T Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 270 MKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp HHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred HHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 66677777777777777777743333357777777777777777543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=278.76 Aligned_cols=231 Identities=25% Similarity=0.253 Sum_probs=144.8
Q ss_pred ccCcEEEccCCCCCCCcCCCCCccccccceecccccccCC--CCcccccccccccccccCCcccccCCCcCCCCCCccee
Q 042958 289 RSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS--IPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366 (1075)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 366 (1075)
++|++|++++|.++.+.+..|.++++|++|++++|.++.. .+..+..+++|++|++++|.++ .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 3455555555555544444455555555555555555422 1344445555666666666555 244445556666666
Q ss_pred eccccccCCCCc-cccCCCcccceeeeccccccccCChhhccCCCCCeEEeecccccc-ccccccccccccceecccccc
Q 042958 367 YLYSNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSG-SIPSEFGNLRSLSTLSLGYNK 444 (1075)
Q Consensus 367 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~ 444 (1075)
++++|.+.+..+ ..+..+++|++|++++|++.+..+..+..+++|++|++++|.+++ ..|..|..+++|++|++++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 666666644433 456666666666666666666666666666777777777776665 456667777777777777777
Q ss_pred cccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCC-CccceeeccCCCCCCC
Q 042958 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL-SNLVILYLYNNSLFDS 520 (1075)
Q Consensus 445 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~ 520 (1075)
+++..|..|.++++|++|+|++|++++..+..+..+++|+.|++++|++++..|..+..+ ++|+.|+|++|++++.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 776666677777777777777777776656567777777777777777777667777766 3777777777777543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=285.21 Aligned_cols=228 Identities=27% Similarity=0.312 Sum_probs=139.0
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
+++++|||++|++++..|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+++
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~------------------ 136 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT------------------ 136 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS------------------
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC------------------
Confidence 34555555555555444555555555555555555555444455555555555555555554
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeec-cccccccCCCCcCCCCcCceeccccCCCC
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY-NKFSGSIPHSLGNLTNLATLYLHNNSLFD 231 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (1075)
.+.+..|..+++|++|+|++|+++...+..|.++++|++|++++ |.+....+..|.++++|++|+|++|++++
T Consensus 137 ------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 137 ------VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp ------BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred ------ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 44444455555555555555555555555555556666666655 33333333456666666666666666654
Q ss_pred CCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCc
Q 042958 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN 311 (1075)
Q Consensus 232 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 311 (1075)
. | .+..+++|++|+|++|++++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|+++++.+..|..
T Consensus 211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 288 (452)
T 3zyi_A 211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP 288 (452)
T ss_dssp C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence 3 2 3566667777777777777666666777777777777777777666677777777777777777777666667777
Q ss_pred cccccceeccccccc
Q 042958 312 LTNLATLYIHNNSLS 326 (1075)
Q Consensus 312 l~~L~~L~L~~N~l~ 326 (1075)
+++|+.|+|++|.+.
T Consensus 289 l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 289 LRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTCCEEECCSSCEE
T ss_pred ccCCCEEEccCCCcC
Confidence 777777777777765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=268.12 Aligned_cols=255 Identities=25% Similarity=0.273 Sum_probs=143.3
Q ss_pred eEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccC
Q 042958 51 NSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFE 130 (1075)
Q Consensus 51 ~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~ 130 (1075)
+.+++++.++..... .-.++|++|+|++|.+++..+..++.+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~~ip~----~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPV----GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSSCCT----TCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcccCCc----CCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 445666666654321 1235666666666666655555566666666666666666655566666666666666666
Q ss_pred cc-cCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecccccccc
Q 042958 131 NQ-LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSI 209 (1075)
Q Consensus 131 n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 209 (1075)
|. ++...|. .|..+++|++|++++|.+++..+..|.++++|++|++++|++++..
T Consensus 90 n~~l~~~~~~------------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 90 NAQLRSVDPA------------------------TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp CTTCCCCCTT------------------------TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCCccccCHH------------------------HhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC
Confidence 65 4433344 4555555555555555555555555555555555555555555444
Q ss_pred CCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCc
Q 042958 210 PHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLR 289 (1075)
Q Consensus 210 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 289 (1075)
+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..|..|..+++|++|++++|.+++..+..|..++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 44455555555555555555544444455566666666666666655566666666666666666666654445566666
Q ss_pred cCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccc
Q 042958 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334 (1075)
Q Consensus 290 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 334 (1075)
+|+.|++++|.+....+. ..-...++.+..+.+.+....|..+.
T Consensus 226 ~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp TCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhC
Confidence 666666666666532211 11123344555555555555555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-31 Score=321.56 Aligned_cols=422 Identities=16% Similarity=0.103 Sum_probs=200.9
Q ss_pred CCCCcccccccccccccccCc---CCCCcccC------------CCccCcEEEccCCCCCCCcCCCCCcc-c-cccceec
Q 042958 258 PHSLGNLTNLATLYLYENSLS---GSIPSEFG------------NLRSLSMLNLGYNKLNGIIPHSLGNL-T-NLATLYI 320 (1075)
Q Consensus 258 ~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~Ls~N~l~~~~~~~~~~l-~-~L~~L~L 320 (1075)
+..+..+++|++|+++++... +.+|..++ .+++|++|+|++|.+++..+..+... + +|++|+|
T Consensus 66 ~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L 145 (592)
T 3ogk_B 66 DRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKL 145 (592)
T ss_dssp HHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEE
T ss_pred HHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEEC
Confidence 334456667777777664321 22332222 45666666666666654444444442 2 3666666
Q ss_pred cccc-ccC-CCCcccccccccccccccCCccccc----CCCcCCCCCCcceeeccccccCC----CCccccCCCccccee
Q 042958 321 HNNS-LSG-SIPSEIGNLRSLSNLGLSGNKLSGS----IPPSLGYLSNLATLYLYSNSLFD----SIPSELGNLRSLSML 390 (1075)
Q Consensus 321 ~~N~-l~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L 390 (1075)
++|. ++. ..+.....+++|++|+|++|.+++. ++..+..+++|++|++++|.+.+ .++..+.++++|+.|
T Consensus 146 ~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L 225 (592)
T 3ogk_B 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225 (592)
T ss_dssp ESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEE
T ss_pred cCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEE
Confidence 6654 110 0111223455666666666665443 11223345556666666555542 122333445555555
Q ss_pred eeccccccccCChhhccCCCCCeEEeeccccc---cccccccccccccceecccccccccCCCCCCccccccccccccCC
Q 042958 391 SLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS---GSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDN 467 (1075)
Q Consensus 391 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 467 (1075)
++++|.+.+ ++..+..+++|++|+++++... ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|
T Consensus 226 ~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~ 303 (592)
T 3ogk_B 226 KVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYA 303 (592)
T ss_dssp ECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTC
T ss_pred eccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCC
Confidence 555555543 4455555555555555542221 112234444555555555554222 34444555555555555555
Q ss_pred ccccCCC-ccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccC-----------CCCCCCCCc-cccCccccccc
Q 042958 468 SLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN-----------NSLFDSIPS-ELGNLRSLSML 534 (1075)
Q Consensus 468 ~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~~~-~l~~l~~L~~L 534 (1075)
.+++... ..+..+++|+.|+++++-..+.++..+..+++|+.|++++ |.+++.... ....+++
T Consensus 304 ~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~---- 379 (592)
T 3ogk_B 304 LLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE---- 379 (592)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTT----
T ss_pred cCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCcc----
Confidence 5443222 2234455555555552211111222233445555555552 233221111 1122333
Q ss_pred cccccccccccCCcccccccCCCccccccchhhhh-hhHhHHHhhc----ccccccc-----cccccCcccccceeecCC
Q 042958 535 SFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGK-LNFLIKLILA----QNQLSGQ-----LSPKLGSLAQLEHLDLSS 604 (1075)
Q Consensus 535 ~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~-~~~l~~L~l~----~n~l~~~-----~~~~~~~l~~L~~L~Ls~ 604 (1075)
|++|++++|.+++..+..++. +++|+.|+++ .|++++. ++..+..+++|+.|+|++
T Consensus 380 --------------L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~ 445 (592)
T 3ogk_B 380 --------------LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445 (592)
T ss_dssp --------------CSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEEC
T ss_pred --------------CeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEec
Confidence 344444444444444444433 4445555553 4444432 222344566666666653
Q ss_pred C--cccCcccccccc-cccceEEEcccccccc-ccchhcccccccceeeeccccccCc-hhhhhccccccceeecCCCcc
Q 042958 605 N--RLSNSIPKSFGN-LVKLHYLNLSNNQFSR-GIPIKLEELIHLSELDLSHNFLREA-IPSQICIMQSLENLNLSHNSL 679 (1075)
Q Consensus 605 N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~~~~L~~L~ls~N~l 679 (1075)
+ .+++..+..+.. +++|++|+|++|++++ .++..+..+++|++|+|++|.+++. ++.....+++|+.|++++|++
T Consensus 446 ~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp CGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred CCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 2 355444444433 5666666666666654 3344445566666666666666543 233334566666666666666
Q ss_pred ccCChhhh-cccccccEEeec
Q 042958 680 VGLIPSCF-EKMHGLLRIDIS 699 (1075)
Q Consensus 680 ~~~~p~~~-~~~~~l~~l~~s 699 (1075)
+......+ ..+|.+....+.
T Consensus 526 t~~~~~~l~~~~p~l~~~~~~ 546 (592)
T 3ogk_B 526 SMTGQDLMQMARPYWNIELIP 546 (592)
T ss_dssp CTTCTTGGGGCCTTEEEEEEC
T ss_pred CHHHHHHHHHhCCCcEEEEec
Confidence 54433333 234544444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=281.97 Aligned_cols=248 Identities=24% Similarity=0.257 Sum_probs=207.7
Q ss_pred CceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCC
Q 042958 99 LKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYD 178 (1075)
Q Consensus 99 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 178 (1075)
...++.+++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|.+.++.+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 344555555554 4444433 4556666666666655555566666666666666666666677799999999999999
Q ss_pred CCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecccc-CCCCCCcccccCCCCCCeEeccCCCCCCcc
Q 042958 179 NSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN-SLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257 (1075)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 257 (1075)
|+++...+..|..+++|++|+|++|+++...+..|.++++|++|++++| .+....+..|..+++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 9999888888999999999999999999877889999999999999995 55544455799999999999999999954
Q ss_pred CCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccc
Q 042958 258 PHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337 (1075)
Q Consensus 258 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 337 (1075)
| .+..+++|++|+|++|.+++..|..|.++++|+.|+|++|+++++.+..|.++++|++|+|++|++++..+..|..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 4 588999999999999999998899999999999999999999999999999999999999999999988888899999
Q ss_pred ccccccccCCcccc
Q 042958 338 SLSNLGLSGNKLSG 351 (1075)
Q Consensus 338 ~L~~L~l~~N~l~~ 351 (1075)
+|+.|++++|.+..
T Consensus 291 ~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 291 YLVELHLHHNPWNC 304 (452)
T ss_dssp TCCEEECCSSCEEC
T ss_pred CCCEEEccCCCcCC
Confidence 99999999999863
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-29 Score=283.31 Aligned_cols=247 Identities=23% Similarity=0.233 Sum_probs=138.5
Q ss_pred CCCCCccEEEccCCCccCCCCccccccCCCceeecccCcc-cccCCCCCC-------CCCCCcEEEccCcccCCCCCccc
Q 042958 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLF-FGTIPPEIG-------HLSYLKTLQLFENQLNGSIPYEI 141 (1075)
Q Consensus 70 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~Ls~n~l~~~~p~~~ 141 (1075)
+..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3455677777777777 677666655 77777777777 345565554 67777777777777777676654
Q ss_pred --cccCCcceeecccccccCCCCCCCCCC-----CCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccc--cCCC
Q 042958 142 --GRLSSLNYLALYSNYLEDLIPPSLGNL-----SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGS--IPHS 212 (1075)
Q Consensus 142 --~~l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~ 212 (1075)
..+++|++|++++|.+++. |..++.+ ++|++|+|++|++++..+..|+.+++|++|+|++|++.+. .+..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 5666666666666666655 4444444 5666666666666655555566666666666666655433 1222
Q ss_pred C--cCCCCcCceeccccCCCCC--Cc-ccccCCCCCCeEeccCCCCCCccC-CCCcccccccccccccccCcCCCCcccC
Q 042958 213 L--GNLTNLATLYLHNNSLFDS--IP-SELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLYLYENSLSGSIPSEFG 286 (1075)
Q Consensus 213 l--~~l~~L~~L~L~~N~l~~~--~~-~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 286 (1075)
+ .++++|++|+|++|++++. ++ ..+..+++|++|+|++|++++..| ..+..+++|++|+|++|.++ .+|..+.
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~ 273 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence 2 4555555555555555421 11 223345555555555555554442 23334455555555555555 3343333
Q ss_pred CCccCcEEEccCCCCCCCcCCCCCccccccceeccccccc
Q 042958 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326 (1075)
Q Consensus 287 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 326 (1075)
++|++|+|++|+|++. |. +..+++|++|++++|+++
T Consensus 274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 4455555555555443 22 444455555555555444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=264.83 Aligned_cols=236 Identities=25% Similarity=0.290 Sum_probs=110.3
Q ss_pred CcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccccccccccc-CcCCCCcccCCCccCcEEEc
Q 042958 218 NLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS-LSGSIPSEFGNLRSLSMLNL 296 (1075)
Q Consensus 218 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L 296 (1075)
+|++|++++|.+++..+..|..+++|++|++++|.+++..|..|..+++|++|++++|. ++...|..|..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 33333333333333333333334444444444444443333344444444444444443 33333344444444444444
Q ss_pred cCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCC
Q 042958 297 GYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376 (1075)
Q Consensus 297 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 376 (1075)
++|.+++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+.+.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 44444444444444444444444444444444444444445555555555555444444455555555555555555444
Q ss_pred CccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCc
Q 042958 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLG 454 (1075)
Q Consensus 377 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 454 (1075)
.|..|..+++|++|++++|++++..+..+..+++|++|++++|.+....+. ..-...++.+..+.+.+....|..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhC
Confidence 455555555555555555555554445555566666666666655532111 11123344445555555555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=278.70 Aligned_cols=227 Identities=28% Similarity=0.324 Sum_probs=128.1
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
++++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.++.+.+..|..+++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 34444444444443334444444444444444444443333444444444444444444444444445555556666666
Q ss_pred CCCCCCCCCccccCccccceEeeecc-ccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCc
Q 042958 178 DNSLSDSIPSEFGNLRSLSMLSLGYN-KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256 (1075)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 256 (1075)
+|.++...+..|..+++|++|+|++| .+....+..|.++++|++|+|++|+++. +| .+..+++|++|+|++|++++.
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCcc
Confidence 66555555555556666666666653 3333333456666666666666666653 33 356666666666666666665
Q ss_pred cCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccccccc
Q 042958 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326 (1075)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 326 (1075)
.|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|.+.
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 5666666666666666666666666666666666666666666666666666666666666666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=278.92 Aligned_cols=247 Identities=24% Similarity=0.242 Sum_probs=223.5
Q ss_pred eeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEcc
Q 042958 50 VNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLF 129 (1075)
Q Consensus 50 v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls 129 (1075)
...+++.+.++...+... .+++++|+|++|++++..+..|+++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGI----STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCSSCCSCC----CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcCcCCCCC----CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 345667777776543322 3789999999999998888999999999999999999998888899999999999999
Q ss_pred CcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCC-CCCCCCCccccCccccceEeeeccccccc
Q 042958 130 ENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN-SLSDSIPSEFGNLRSLSMLSLGYNKFSGS 208 (1075)
Q Consensus 130 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 208 (1075)
+|+++...+..|..+++|++|+|++|.+..+.+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 99999776778999999999999999999999999999999999999995 555556668999999999999999998 5
Q ss_pred cCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCC
Q 042958 209 IPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNL 288 (1075)
Q Consensus 209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 288 (1075)
+| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 55 48899999999999999999889999999999999999999999889999999999999999999998888899999
Q ss_pred ccCcEEEccCCCCC
Q 042958 289 RSLSMLNLGYNKLN 302 (1075)
Q Consensus 289 ~~L~~L~Ls~N~l~ 302 (1075)
++|+.|+|++|.+.
T Consensus 279 ~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 279 HHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEcCCCCcc
Confidence 99999999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=268.25 Aligned_cols=235 Identities=22% Similarity=0.257 Sum_probs=193.2
Q ss_pred cCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEE
Q 042958 96 ISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLH 175 (1075)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (1075)
.+++++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|++++|.++ .+|..++++++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 478888999999887 78888888888888888888888 77777666666666666666665 3344555555555555
Q ss_pred cCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC
Q 042958 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
+++|++.+.+|..+... ..+..|.++++|++|+|++|+++ .+|..+..+++|++|+|++|++++
T Consensus 157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 55555544444433320 11233556999999999999998 788899999999999999999995
Q ss_pred ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccc
Q 042958 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335 (1075)
Q Consensus 256 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 335 (1075)
+|..+..+++|++|++++|.+.+.+|..|..+++|+.|++++|.+.+.+|..+.++++|++|+|++|.+.+.+|..+++
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 6668999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCccc
Q 042958 336 LRSLSNLGLSGNKLS 350 (1075)
Q Consensus 336 l~~L~~L~l~~N~l~ 350 (1075)
+++|+.+++..+.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 999999999988765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=274.12 Aligned_cols=249 Identities=24% Similarity=0.274 Sum_probs=175.8
Q ss_pred cccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccC-CCCCcccc-------ccCCcceeecccccccCCCCC
Q 042958 92 QIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLN-GSIPYEIG-------RLSSLNYLALYSNYLEDLIPP 163 (1075)
Q Consensus 92 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~-~~~p~~~~-------~l~~L~~L~L~~n~l~~~~~~ 163 (1075)
.++..++|++|++++|.+ .+|..+... |++|+|++|+++ +.+|..+. .+++|++|++++|.+++..|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 456788999999999999 778777655 999999999994 56676665 688899999999999887777
Q ss_pred CC--CCCCCCCEEEcCCCCCCCCCCccccCc-----cccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC--Cc
Q 042958 164 SL--GNLSNLDTLHLYDNSLSDSIPSEFGNL-----RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS--IP 234 (1075)
Q Consensus 164 ~l--~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~~ 234 (1075)
.+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 66 8888888888888888877 7777777 7888888888888877778888888888888888887654 23
Q ss_pred ccc--cCCCCCCeEeccCCCCCCc--cC-CCCcccccccccccccccCcCCCC-cccCCCccCcEEEccCCCCCCCcCCC
Q 042958 235 SEL--GNLRSLSMLSLGYNKLSGS--IP-HSLGNLTNLATLYLYENSLSGSIP-SEFGNLRSLSMLNLGYNKLNGIIPHS 308 (1075)
Q Consensus 235 ~~~--~~l~~L~~L~Ls~N~l~~~--~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~ 308 (1075)
..+ ..+++|++|+|++|++++. ++ ..+..+++|++|++++|.+++..| ..+..+++|++|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 333 6777888888888877731 11 223455666666666666665543 34445566666666666666 34444
Q ss_pred CCccccccceecccccccCCCCcccccccccccccccCCccc
Q 042958 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLS 350 (1075)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 350 (1075)
+. ++|++|+|++|+|++. |. +..+++|++|++++|.++
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 43 5566666666666543 33 555555555555555554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=274.39 Aligned_cols=263 Identities=22% Similarity=0.206 Sum_probs=167.2
Q ss_pred ccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccC
Q 042958 267 LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346 (1075)
Q Consensus 267 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 346 (1075)
++.++++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+ +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3344444444443333344445556666666666665555556666666666666666654333 55666666666666
Q ss_pred CcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccc
Q 042958 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIP 426 (1075)
Q Consensus 347 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 426 (1075)
|++++.. ..++|++|++++|.+.+..+.. +++|++|++++|++++..+..+..+++|++|+|++|.+++..+
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 6665322 2256666666666665443332 4557777777777776666667777777777777777776666
Q ss_pred ccc-ccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCC
Q 042958 427 SEF-GNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS 505 (1075)
Q Consensus 427 ~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 505 (1075)
..+ ..+++|++|+|++|++++. |. ...+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 555 3567777777777777644 22 2346777777777777774 4445777777888888888777 4566777778
Q ss_pred ccceeeccCCCCC-CCCCccccCcccccccccccc-cccc
Q 042958 506 NLVILYLYNNSLF-DSIPSELGNLRSLSMLSFAYN-KLSG 543 (1075)
Q Consensus 506 ~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~l~~N-~l~~ 543 (1075)
+|+.|++++|++. +.+|..+..+++|+.+++.++ .++|
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHS
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccC
Confidence 8888888888877 566777777788888777743 3443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-28 Score=274.15 Aligned_cols=256 Identities=23% Similarity=0.231 Sum_probs=136.2
Q ss_pred ceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecccc
Q 042958 148 NYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227 (1075)
Q Consensus 148 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 227 (1075)
+.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344444555444444444444455555555555555444455555555555555555543322 444444444444444
Q ss_pred CCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCC
Q 042958 228 SLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307 (1075)
Q Consensus 228 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 307 (1075)
++ ++.. ..++|++|++++|.+++..+.. +++|+.|++++|++++..+.
T Consensus 91 ~l------------------------~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 91 YV------------------------QELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp EE------------------------EEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB
T ss_pred cc------------------------cccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch
Confidence 44 3211 1134444444444444332222 34566666666666655555
Q ss_pred CCCccccccceecccccccCCCCcccc-cccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcc
Q 042958 308 SLGNLTNLATLYIHNNSLSGSIPSEIG-NLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRS 386 (1075)
Q Consensus 308 ~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 386 (1075)
.|..+++|++|++++|.+++..+..+. .+++|++|++++|.+++. + ....+++|++|+|++|.+.+ +|..+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCc
Confidence 666666666666666666655555443 456666666666666543 1 22235566666666666643 3333556666
Q ss_pred cceeeeccccccccCChhhccCCCCCeEEeeccccc-cccccccccccccceeccc
Q 042958 387 LSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS-GSIPSEFGNLRSLSTLSLG 441 (1075)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 441 (1075)
|++|++++|+++ .+|..+..+++|+.|++++|.++ +..+..+..+++|+.|+++
T Consensus 216 L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred ccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 666666666665 34555666666666666666665 4555556666666666666
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-26 Score=248.03 Aligned_cols=215 Identities=27% Similarity=0.262 Sum_probs=149.9
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.|+.|.+.+.++.++++++++... |.. + .+++++|+|++|++++..+..++.+++|++|+|++|.++...+..
T Consensus 5 C~~~~~~C~c~~~~~~l~~~~~~l~~i-p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~ 80 (270)
T 2o6q_A 5 CKKDGGVCSCNNNKNSVDCSSKKLTAI-PSN-I--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80 (270)
T ss_dssp BGGGTCSBEEETTTTEEECTTSCCSSC-CSC-C--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT
T ss_pred CCCCCCCCEeCCCCCEEEccCCCCCcc-CCC-C--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh
Confidence 999999998777777788888888753 322 1 256788888888887666667778888888888888877544555
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 196 (1075)
|.++++|++|+|++|++++..+..+..+++|++|++++|.++++.+..|..+++|++|+|++|.+++..+..|..+++|+
T Consensus 81 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 160 (270)
T 2o6q_A 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160 (270)
T ss_dssp TSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccc
Confidence 67778888888888877765555666677777777777777776666666777777777777777666555666666666
Q ss_pred eEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC
Q 042958 197 MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 197 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
+|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 161 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred eeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 66666666665555556666666666666666665555556666666666666666553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=271.19 Aligned_cols=268 Identities=28% Similarity=0.344 Sum_probs=146.8
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
.++.|++++|.++ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4788999999988 7787776 78888888888887 5665 56778888888887773 443 34455555555
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 233 (1075)
+|.++++.+ .+++|+.|++++|+++. +|.. +++|++|+|++|++++ +
T Consensus 110 ~N~l~~l~~----~l~~L~~L~L~~N~l~~-------------------------lp~~---l~~L~~L~Ls~N~l~~-l 156 (622)
T 3g06_A 110 SNPLTHLPA----LPSGLCKLWIFGNQLTS-------------------------LPVL---PPGLQELSVSDNQLAS-L 156 (622)
T ss_dssp SCCCCCCCC----CCTTCCEEECCSSCCSC-------------------------CCCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCCCCC----CCCCcCEEECCCCCCCc-------------------------CCCC---CCCCCEEECcCCcCCC-c
Confidence 555444322 23344444444444432 2221 1334444444444432 1
Q ss_pred cccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccc
Q 042958 234 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLT 313 (1075)
Q Consensus 234 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 313 (1075)
|. .+++|+.|++++|++++ +| ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++.
T Consensus 157 ~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~---------- 215 (622)
T 3g06_A 157 PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS---------- 215 (622)
T ss_dssp CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS----------
T ss_pred CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc----------
Confidence 21 12334444444444442 22 122333444444444432 1211 1334444444444442
Q ss_pred cccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeec
Q 042958 314 NLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393 (1075)
Q Consensus 314 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 393 (1075)
+|.. +++|+.|++++|++++ +| ..+++|++|++++|.+. .+|. .+++|+.|+|+
T Consensus 216 ---------------l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 216 ---------------LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVY 269 (622)
T ss_dssp ---------------CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECC
T ss_pred ---------------cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCC
Confidence 2211 2345555555555543 33 23355666666666664 3333 45677778888
Q ss_pred cccccccCChhhccCCCCCeEEeecccccccccccccccc
Q 042958 394 YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLR 433 (1075)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 433 (1075)
+|+|+ .+|..+.++++|+.|+|++|.+++..|..+..++
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 88877 5677788888888888888888877776666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-25 Score=270.29 Aligned_cols=269 Identities=28% Similarity=0.353 Sum_probs=184.9
Q ss_pred CCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEc
Q 042958 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176 (1075)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (1075)
.++++|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---------------------------~l~~L~~L~L 88 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---------------------------LPPELRTLEV 88 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---------------------------CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---------------------------cCCCCCEEEc
Confidence 35788888888887 7777665 67777777777776 2332 2345666666
Q ss_pred CCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCc
Q 042958 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256 (1075)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 256 (1075)
++|++++ +|. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|+++
T Consensus 89 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~-- 154 (622)
T 3g06_A 89 SGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-- 154 (622)
T ss_dssp CSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--
T ss_pred CCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCC--
Confidence 6666653 222 45666666666666663 332 34556666666666653 3322 245555555555554
Q ss_pred cCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccc
Q 042958 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336 (1075)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (1075)
+ +|. .+++|+.|++++|.++++ | ..+++|+.|++++|.+++ +|.. +
T Consensus 155 ----------------------~-l~~---~~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~ 200 (622)
T 3g06_A 155 ----------------------S-LPA---LPSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---P 200 (622)
T ss_dssp ----------------------C-CCC---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred ----------------------C-cCC---ccCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---c
Confidence 2 222 124566666666666643 3 334667777777777764 3332 3
Q ss_pred cccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEe
Q 042958 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDL 416 (1075)
Q Consensus 337 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 416 (1075)
++|+.|++++|.++ .+|.. +++|++|++++|.+.+ +| ..+++|++|+|++|+|+ .+|. .+++|+.|+|
T Consensus 201 ~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~L 268 (622)
T 3g06_A 201 SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSV 268 (622)
T ss_dssp TTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEEC
T ss_pred chhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeC
Confidence 68899999999998 45543 4789999999999965 55 45688999999999998 4555 6789999999
Q ss_pred eccccccccccccccccccceecccccccccCCCCCCcccc
Q 042958 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT 457 (1075)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 457 (1075)
++|+|+ .+|..|.++++|+.|+|++|.+++..|..+..++
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 999999 5688899999999999999999988887776655
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=279.30 Aligned_cols=235 Identities=25% Similarity=0.258 Sum_probs=155.4
Q ss_pred CCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeC
Q 042958 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488 (1075)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 488 (1075)
++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|+.|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 367777777777777666777777777777777777765554 6677777777777777764322 256666666
Q ss_pred CCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhh
Q 042958 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELG 568 (1075)
Q Consensus 489 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~ 568 (1075)
++|.+++..+. .+++|+.|+|++|.+++..|..++.+++|+.
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~----------------------------------- 148 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY----------------------------------- 148 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEE-----------------------------------
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCE-----------------------------------
Confidence 66666654443 2355666666666665555544444444433
Q ss_pred hhhHhHHHhhcccccccccccccC-cccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccce
Q 042958 569 KLNFLIKLILAQNQLSGQLSPKLG-SLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSE 647 (1075)
Q Consensus 569 ~~~~l~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 647 (1075)
|+|++|.+++..|..+. .+++|+.|+|++|.|++. |. +..+++|++|+|++|+|++..| .+..+++|+.
T Consensus 149 -------L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~ 218 (487)
T 3oja_A 149 -------LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTW 218 (487)
T ss_dssp -------EECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSE
T ss_pred -------EECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccE
Confidence 33333444444444443 567788888888888754 32 3347778888888888876433 4777888888
Q ss_pred eeeccccccCchhhhhccccccceeecCCCccc-cCChhhhcccccccEEeec
Q 042958 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLV-GLIPSCFEKMHGLLRIDIS 699 (1075)
Q Consensus 648 L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~-~~~p~~~~~~~~l~~l~~s 699 (1075)
|+|++|.|++ +|..+..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 219 L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp EECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred EEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 8888888875 6666777788888888888887 6777777777777777765
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-27 Score=275.70 Aligned_cols=237 Identities=22% Similarity=0.198 Sum_probs=173.0
Q ss_pred CCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCccee
Q 042958 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATL 366 (1075)
Q Consensus 287 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L 366 (1075)
.+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|++++|.+++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34466777777777766666666777777777777777665444 6667777777777777764322 2677777
Q ss_pred eccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccc-cccccceeccccccc
Q 042958 367 YLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFG-NLRSLSTLSLGYNKL 445 (1075)
Q Consensus 367 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l 445 (1075)
++++|.+.+..+. .+++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..|. .+++|++|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 7777777655443 346677888888888777777788888888888888888877777765 678888888888888
Q ss_pred ccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCC-CCCCcc
Q 042958 446 SGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLF-DSIPSE 524 (1075)
Q Consensus 446 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~ 524 (1075)
++..+ +..+++|+.|+|++|.+++. |..+..+++|+.|+|++|.|++ +|..++.+++|+.|++++|.+. +.+|..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 75532 33578888888888888864 4458888888888888888874 6777888888888888888887 566777
Q ss_pred ccCcccccccccc
Q 042958 525 LGNLRSLSMLSFA 537 (1075)
Q Consensus 525 l~~l~~L~~L~l~ 537 (1075)
+..++.|+.++++
T Consensus 258 ~~~l~~L~~l~~~ 270 (487)
T 3oja_A 258 FSKNQRVQTVAKQ 270 (487)
T ss_dssp HTTCHHHHHHHHH
T ss_pred HHhCCCCcEEecc
Confidence 7788888777775
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-29 Score=310.53 Aligned_cols=182 Identities=15% Similarity=0.137 Sum_probs=95.9
Q ss_pred ccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccC---CCCcc------------ccccCCCcee
Q 042958 38 AWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYG---NIPPQ------------IGNISRLKYL 102 (1075)
Q Consensus 38 ~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~---~~p~~------------l~~l~~L~~L 102 (1075)
+|+++... ....+++.... +..+...+..+++|++|+|+++.... ..|.. ...+++|++|
T Consensus 36 ~W~~~~~~---~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L 110 (594)
T 2p1m_B 36 SWYEIERW---CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI 110 (594)
T ss_dssp HHHHHHHH---HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEE
T ss_pred HHHHhhhh---hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeE
Confidence 79988321 23344444322 22223345667889999998875321 22221 2356677777
Q ss_pred ecccCcccccCCCCCC-CCCCCcEEEccCc-ccCCC-CCccccccCCcceeecccccccCCCCCCCC----CCCCCCEEE
Q 042958 103 DLSSNLFFGTIPPEIG-HLSYLKTLQLFEN-QLNGS-IPYEIGRLSSLNYLALYSNYLEDLIPPSLG----NLSNLDTLH 175 (1075)
Q Consensus 103 ~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~----~l~~L~~L~ 175 (1075)
+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|++++|.+++..+..+. .+++|++|+
T Consensus 111 ~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~ 190 (594)
T 2p1m_B 111 RLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190 (594)
T ss_dssp EEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEE
T ss_pred EeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEE
Confidence 7777777665555554 5677777777776 44422 233334566666777666666554433322 445666666
Q ss_pred cCCCC--CCCC-CCccccCccccceEeeecc-ccccccCCCCcCCCCcCceecc
Q 042958 176 LYDNS--LSDS-IPSEFGNLRSLSMLSLGYN-KFSGSIPHSLGNLTNLATLYLH 225 (1075)
Q Consensus 176 L~~n~--l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~ 225 (1075)
+++|. ++.. ++..+..+++|++|++++| .+. .++..+..+++|++|+++
T Consensus 191 l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~ 243 (594)
T 2p1m_B 191 ISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTG 243 (594)
T ss_dssp CTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECS
T ss_pred ecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccc
Confidence 66664 1100 1111123455555555555 222 244444455555555543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-28 Score=298.84 Aligned_cols=432 Identities=13% Similarity=0.098 Sum_probs=214.2
Q ss_pred ccccCCCCCCeEeccCCCCCC---ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCC-
Q 042958 235 SELGNLRSLSMLSLGYNKLSG---SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG- 310 (1075)
Q Consensus 235 ~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~- 310 (1075)
..+..+++|+.|+++++.... ..|..++. .....++..+..+++|++|+|++|.+++..+..+.
T Consensus 60 ~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~------------~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~ 127 (594)
T 2p1m_B 60 TVIRRFPKVRSVELKGKPHFADFNLVPDGWGG------------YVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAK 127 (594)
T ss_dssp HHHHHCTTCCEEEEECSCGGGGGTCSCTTSCC------------BCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHH
T ss_pred HHHhhCCCceEEeccCCCchhhcccccccccc------------hhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHH
Confidence 345667888888888875321 11211100 00000011122345566666666655544444443
Q ss_pred ccccccceecccc-cccCC-CCcccccccccccccccCCcccccCCCcC----CCCCCcceeeccccc--cCCC-Ccccc
Q 042958 311 NLTNLATLYIHNN-SLSGS-IPSEIGNLRSLSNLGLSGNKLSGSIPPSL----GYLSNLATLYLYSNS--LFDS-IPSEL 381 (1075)
Q Consensus 311 ~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~l----~~l~~L~~L~L~~N~--l~~~-~p~~~ 381 (1075)
.+++|++|+|++| .++.. ++..+.++++|++|++++|.+++..+..+ ..+++|++|++++|. +... ++..+
T Consensus 128 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~ 207 (594)
T 2p1m_B 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207 (594)
T ss_dssp HCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHH
T ss_pred hCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHH
Confidence 4556666666665 33321 22233355666666666666554333222 244566666666664 1100 11112
Q ss_pred CCCcccceeeeccc-cccccCChhhccCCCCCeEEee-------cccccccccccccccccccee-cccccccccCCCCC
Q 042958 382 GNLRSLSMLSLGYN-KLSGSIPHSLGNLTNLATLDLY-------DNSLSGSIPSEFGNLRSLSTL-SLGYNKLSGSIPHS 452 (1075)
Q Consensus 382 ~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~-------~N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~ 452 (1075)
..+++|++|++++| .+. .++..+..+++|+.|+++ .|.+.+ ++..+.++++|+.| .+.+... +.++..
T Consensus 208 ~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~ 284 (594)
T 2p1m_B 208 TRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAV 284 (594)
T ss_dssp HHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGG
T ss_pred HhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHH
Confidence 33466666666666 333 255556666666666633 333333 22345556666665 3332222 123333
Q ss_pred CccccccccccccCCccccCCC-ccccCcCCCCEEeCCCCcccCC-CcccccCCCccceeeccC---------CCCCCCC
Q 042958 453 LGNLTNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGS-IPQSLGNLSNLVILYLYN---------NSLFDSI 521 (1075)
Q Consensus 453 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~~~ 521 (1075)
+..+++|++|+|++|.+++... ..+..+++|+.|++++| ++.. ++.....+++|+.|++++ +.+++..
T Consensus 285 ~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred HHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 3445566666666665543221 12345566666666655 3211 111222355666666532 2222111
Q ss_pred Ccccc-CccccccccccccccccccCCcccccccCCCccccccchhhh-hhhHhHHHhhc--c----ccccc-----ccc
Q 042958 522 PSELG-NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELG-KLNFLIKLILA--Q----NQLSG-----QLS 588 (1075)
Q Consensus 522 ~~~l~-~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~-~~~~l~~L~l~--~----n~l~~-----~~~ 588 (1075)
...+. .+++| +.|++++|.+++..+..+. .+++|+.|+++ + |.+++ .++
T Consensus 364 l~~l~~~~~~L------------------~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~ 425 (594)
T 2p1m_B 364 LVSVSMGCPKL------------------ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFG 425 (594)
T ss_dssp HHHHHHHCTTC------------------CEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHH
T ss_pred HHHHHHhchhH------------------HHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHH
Confidence 11111 13333 3333333333333333332 24444444444 2 33331 111
Q ss_pred cccCcccccceeecCCCcccCcccccccc-cccceEEEccccccccccchhc-ccccccceeeeccccccCchhh-hhcc
Q 042958 589 PKLGSLAQLEHLDLSSNRLSNSIPKSFGN-LVKLHYLNLSNNQFSRGIPIKL-EELIHLSELDLSHNFLREAIPS-QICI 665 (1075)
Q Consensus 589 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~-~~~~ 665 (1075)
..+..+++|+.|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++.... ....
T Consensus 426 ~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~ 504 (594)
T 2p1m_B 426 AIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASK 504 (594)
T ss_dssp HHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGG
T ss_pred HHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHh
Confidence 2245567788888876 666555555554 6778888888888766555444 5677888888888887654443 3344
Q ss_pred ccccceeecCCCccccCChhhh-cccccccEEeecCC
Q 042958 666 MQSLENLNLSHNSLVGLIPSCF-EKMHGLLRIDISYN 701 (1075)
Q Consensus 666 ~~~L~~L~ls~N~l~~~~p~~~-~~~~~l~~l~~s~N 701 (1075)
+++|+.|++++|+++......+ ..+|.|+...+..+
T Consensus 505 l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~ 541 (594)
T 2p1m_B 505 LETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541 (594)
T ss_dssp GGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSS
T ss_pred CCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCC
Confidence 7788888888887754433444 45566655555544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=236.74 Aligned_cols=204 Identities=26% Similarity=0.245 Sum_probs=103.3
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
+|++|||++|++++..+..++++++|++|+|++|.+++..+..+.++++|++|+|++|++++.
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------- 91 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL----------------- 91 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE-----------------
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc-----------------
Confidence 455555555555544444555555555555555555544444455555555555555555433
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccc-cCCCCcCCCCcCceeccccCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGS-IPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
.+..|.++++|++|++++|.+++..+..|+.+++|++|++++|++++. +|..+.++++|++|++++|++++.
T Consensus 92 -------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 92 -------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp -------CTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred -------ChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 333444455555555555555544444455555555555555555432 344445555555555555555444
Q ss_pred CcccccCCCCCC----eEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCC
Q 042958 233 IPSELGNLRSLS----MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302 (1075)
Q Consensus 233 ~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 302 (1075)
.+..+..+++|+ .|++++|.+++..+..+.. .+|++|++++|.+++..+..|..+++|+.|++++|.+.
T Consensus 165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred CHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 444444444444 5566666665433333322 35555555555555444444555555555555555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=237.27 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=141.6
Q ss_pred CcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeec
Q 042958 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY 202 (1075)
Q Consensus 123 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 202 (1075)
|++|+|++|++++..+..+..+++|++|++++|.+.++.+..|.++++|++|++++|++++..+..|.++++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 44444444444433333344444444444444444444455678888888888888988888888888888999999999
Q ss_pred cccccccCCCCcCCCCcCceeccccCCCCC-CcccccCCCCCCeEeccCCCCCCccCCCCccccccc----ccccccccC
Q 042958 203 NKFSGSIPHSLGNLTNLATLYLHNNSLFDS-IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA----TLYLYENSL 277 (1075)
Q Consensus 203 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~n~l 277 (1075)
|++++..+..+.++++|++|++++|.+++. +|..+..+++|++|++++|++++..+..+..+++|+ +|++++|.+
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 888877666788888888888888888764 577888888888888888888876667777777776 666777777
Q ss_pred cCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 278 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
++..+..+.. .+|+.|++++|++++..+..|..+++|++|++++|.+.+
T Consensus 190 ~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 190 NFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred cccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7544444433 367777777777776655566666677777777766664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-23 Score=227.33 Aligned_cols=203 Identities=30% Similarity=0.304 Sum_probs=125.3
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
..+.+|+++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|+++...+..
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~------------- 80 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI------------- 80 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT-------------
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh-------------
Confidence 3567777777776 4665554 56777777777776555556667777777777776666433333
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 233 (1075)
|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..
T Consensus 81 -----------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 81 -----------FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp -----------TSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred -----------hcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 444555555555555555544445555555555555555555555555555666666666666665544
Q ss_pred cccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCC
Q 042958 234 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303 (1075)
Q Consensus 234 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 303 (1075)
+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+..
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 4455666666666666666665555556666667777777777765555567777777777777777653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=234.15 Aligned_cols=225 Identities=27% Similarity=0.315 Sum_probs=133.1
Q ss_pred ccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeee
Q 042958 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSL 392 (1075)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 392 (1075)
.++..+++.++.+... ..+..+++|+.|++++|.++. + ..+..+++|++|++++|.+.+. ..+..+++|++|++
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence 3444445555444422 223445555555665555542 1 2355556666666666665432 24556666666666
Q ss_pred ccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccC
Q 042958 393 GYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472 (1075)
Q Consensus 393 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 472 (1075)
++|++++..+..|..+++|++|++++|++++..+..|+.+++|++|++++|++++..+..|+++++|++|++++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 66666655555566666666666666666665555566666666666666666655555566666666666666666655
Q ss_pred CCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCccc
Q 042958 473 IPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550 (1075)
Q Consensus 473 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~ 550 (1075)
.+..++.+++|+.|++++|++++..+..++.+++|+.|++++|++.+. +++|+.+++..|+++|.+|.++.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence 555566666666666666666666665666666666666666665432 33455556666666555555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=233.76 Aligned_cols=209 Identities=28% Similarity=0.328 Sum_probs=112.8
Q ss_pred CCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccce
Q 042958 118 GHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM 197 (1075)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 197 (1075)
..+++|++|++++|.++. + ..+..+++|++|++++|.+.++ +.+..+++|++|++++|.+++..+..|..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 38 NELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 344444444444444431 1 1233344444444444444332 23555555566666666555555555555556666
Q ss_pred EeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccC
Q 042958 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277 (1075)
Q Consensus 198 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 277 (1075)
|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.+
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 66666665554455555555666666666655554444555566666666666666655455555556666666666666
Q ss_pred cCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccc
Q 042958 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLR 337 (1075)
Q Consensus 278 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 337 (1075)
++..+..|..+++|+.|++++|.+.+. +++|+.|++..|.++|.+|..++.+.
T Consensus 194 ~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 194 KSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred CccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 655555556666666666666655432 33555666666666665555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-23 Score=225.86 Aligned_cols=203 Identities=30% Similarity=0.314 Sum_probs=115.9
Q ss_pred cCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcc
Q 042958 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 148 (1075)
++++++++.+++++++++ .+|..+. +++++|+|++|.+++..|..|.++++|++|+|++|++++. +
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~---------- 71 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q---------- 71 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E----------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-c----------
Confidence 445566666666666665 4554443 4666666666666655555666666666666666665532 1
Q ss_pred eeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccC
Q 042958 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS 228 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 228 (1075)
+ .+.+++|++|++++|+++ .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 72 -------------~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 135 (290)
T 1p9a_G 72 -------------V--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135 (290)
T ss_dssp -------------C--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred -------------C--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCC
Confidence 1 134444555555555554 234445555555555555555554444555555555566666655
Q ss_pred CCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCC
Q 042958 229 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302 (1075)
Q Consensus 229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 302 (1075)
+++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|.+.
T Consensus 136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 55544455555666666666666666444445555666666666666666 34555555566667777766664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-23 Score=221.60 Aligned_cols=190 Identities=27% Similarity=0.274 Sum_probs=104.4
Q ss_pred CCccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCC
Q 042958 36 PCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPP 115 (1075)
Q Consensus 36 ~c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~ 115 (1075)
||.|.|++|... ...++++++++.. +|..+. ++|++|+|++|.+++..|.
T Consensus 4 Cp~~~gC~C~~~--~~~l~~~~~~l~~--------------------------~p~~~~--~~l~~L~L~~n~l~~~~~~ 53 (251)
T 3m19_A 4 CETVTGCTCNEG--KKEVDCQGKSLDS--------------------------VPSGIP--ADTEKLDLQSTGLATLSDA 53 (251)
T ss_dssp CHHHHSSEEEGG--GTEEECTTCCCSS--------------------------CCSCCC--TTCCEEECTTSCCCCCCTT
T ss_pred CCCCCceEcCCC--CeEEecCCCCccc--------------------------cCCCCC--CCCCEEEccCCCcCccCHh
Confidence 358999999532 2234555555443 333332 3444555555555444444
Q ss_pred CCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCcccc
Q 042958 116 EIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195 (1075)
Q Consensus 116 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 195 (1075)
.|.++++|++|+|++|++++..|..+..+++|++|++++|.++++.+..|..+++|++|+|++|++++..+..|..+++|
T Consensus 54 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 133 (251)
T 3m19_A 54 TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcc
Confidence 45555555555555555554444444444444444444444444444455556666666666666665555555666666
Q ss_pred ceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC
Q 042958 196 SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 196 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+
T Consensus 134 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 134 KELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 666666666665444556666666666666666665555556666666666666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=225.46 Aligned_cols=203 Identities=24% Similarity=0.226 Sum_probs=168.9
Q ss_pred CCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccce
Q 042958 118 GHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM 197 (1075)
Q Consensus 118 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 197 (1075)
+++++|+++++++|+++ .+|..+. +++++|++++|.+.++.+..|..+++|++|+|++|.+++..+ .+.+++|++
T Consensus 7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 81 (290)
T 1p9a_G 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGT 81 (290)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCE
T ss_pred cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCE
Confidence 34445555555555554 3343332 455566666666666666678889999999999999987544 378999999
Q ss_pred EeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccC
Q 042958 198 LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSL 277 (1075)
Q Consensus 198 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 277 (1075)
|+|++|+++ .+|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++
T Consensus 82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 999999998 7888999999999999999999988888999999999999999999988788899999999999999999
Q ss_pred cCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 278 SGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 278 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|.+..
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 9877778899999999999999999 567777788899999999999874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=232.85 Aligned_cols=201 Identities=20% Similarity=0.175 Sum_probs=141.9
Q ss_pred CCCcEEEccCcccCCCCCccc--cccCCcceeecccccccCCCC----CCCCCCCCCCEEEcCCCCCCCCCCccccCccc
Q 042958 121 SYLKTLQLFENQLNGSIPYEI--GRLSSLNYLALYSNYLEDLIP----PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRS 194 (1075)
Q Consensus 121 ~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 194 (1075)
++|++|+|++|.+++..|..+ ..+++|++|++++|.+.+..+ ..+..+++|++|+|++|++++..+..|+.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 445555555555555555555 555555555555555554333 23456777888888888887777777778888
Q ss_pred cceEeeeccccccc--c--CCCCcCCCCcCceeccccCCCCCCcc----cccCCCCCCeEeccCCCCCCccCCCCccc--
Q 042958 195 LSMLSLGYNKFSGS--I--PHSLGNLTNLATLYLHNNSLFDSIPS----ELGNLRSLSMLSLGYNKLSGSIPHSLGNL-- 264 (1075)
Q Consensus 195 L~~L~Ls~N~l~~~--~--~~~l~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-- 264 (1075)
|++|+|++|++.+. + +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 88888888876542 1 2334677888888888888863 233 24677888888888888887767777666
Q ss_pred -ccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 265 -TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 265 -~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
++|++|+|++|+++ .+|..+. ++|+.|+|++|++++. |. +..+++|++|+|++|+++.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 58888888888888 5566654 7888899999988865 33 6778888999999988873
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-25 Score=250.10 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=131.4
Q ss_pred eeeccccccccCChhhccCCCCCeEEeeccccccccc----ccccccc-ccceecccccccccCCCCCCccc-----ccc
Q 042958 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIP----SEFGNLR-SLSTLSLGYNKLSGSIPHSLGNL-----TNL 459 (1075)
Q Consensus 390 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L 459 (1075)
+++++|.+++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|++++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3455555555555444444445555555555554444 4444454 55555555555554444444443 555
Q ss_pred ccccccCCccccCCCccccC----c-CCCCEEeCCCCcccCCCcccccC-----CCccceeeccCCCCCCCCCccccCcc
Q 042958 460 DALYLYDNSLSGSIPGEIGN----L-RSISNLALNNNKLSGSIPQSLGN-----LSNLVILYLYNNSLFDSIPSELGNLR 529 (1075)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~l~~l~ 529 (1075)
++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .++|+.|+|++|.+++..+..+...
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~- 161 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI- 161 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH-
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH-
Confidence 55555555555444443322 2 56666666666665544433322 2466666666666654332222110
Q ss_pred ccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccccccCcc-cccceeecCCCccc
Q 042958 530 SLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSL-AQLEHLDLSSNRLS 608 (1075)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~ 608 (1075)
+ ...|.++++|+|++|++++..+..++.. +..+ ++|++|||++|+|+
T Consensus 162 -----------l-~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~i~ 209 (362)
T 3goz_A 162 -----------L-AAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPASVTSLDLSANLLG 209 (362)
T ss_dssp -----------H-HTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECTTSCGG
T ss_pred -----------H-hcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCCCCCEEECCCCCCC
Confidence 0 0122345555555665555444443321 2223 36667777777766
Q ss_pred Cc----cccccccc-ccceEEEccccccccccch----hcccccccceeeeccccccCchhh-------hhcccccccee
Q 042958 609 NS----IPKSFGNL-VKLHYLNLSNNQFSRGIPI----KLEELIHLSELDLSHNFLREAIPS-------QICIMQSLENL 672 (1075)
Q Consensus 609 ~~----~p~~~~~l-~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~~~~~-------~~~~~~~L~~L 672 (1075)
+. ++..+..+ ++|++|+|++|++++..+. .+..+++|++|+|++|.+.+..+. .+..+++|+.|
T Consensus 210 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~L 289 (362)
T 3goz_A 210 LKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILV 289 (362)
T ss_dssp GSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEE
T ss_pred hhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEE
Confidence 42 44444442 3677777777776654432 234556666677766664443322 33344455555
Q ss_pred ecCCCccccC
Q 042958 673 NLSHNSLVGL 682 (1075)
Q Consensus 673 ~ls~N~l~~~ 682 (1075)
|+++|++...
T Consensus 290 dL~~N~l~~~ 299 (362)
T 3goz_A 290 DKNGKEIHPS 299 (362)
T ss_dssp CTTSCBCCGG
T ss_pred ecCCCcCCCc
Confidence 5555555444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-25 Score=249.18 Aligned_cols=233 Identities=18% Similarity=0.180 Sum_probs=112.9
Q ss_pred CCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCC-CCccccccCCcceeecccccccCCCCCCCCCCCCCCEEE
Q 042958 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGS-IPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLH 175 (1075)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (1075)
+++++|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|++++|.+++..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4444444444444433332 33445555555555544433 333444444444444444444444444455555666666
Q ss_pred cCCC-CCCCC-CCccccCccccceEeeecc-ccccc-cCCCCcCCC-CcCceecccc--CCC-CCCcccccCCCCCCeEe
Q 042958 176 LYDN-SLSDS-IPSEFGNLRSLSMLSLGYN-KFSGS-IPHSLGNLT-NLATLYLHNN--SLF-DSIPSELGNLRSLSMLS 247 (1075)
Q Consensus 176 L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~ 247 (1075)
+++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|++++| .++ +.++..+..+++|++|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 6665 45432 3444555566666666666 55532 344455555 6666666665 333 23344455556666666
Q ss_pred ccCCC-CCCccCCCCccccccccccccccc-CcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcc-ccccceeccccc
Q 042958 248 LGYNK-LSGSIPHSLGNLTNLATLYLYENS-LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL-TNLATLYIHNNS 324 (1075)
Q Consensus 248 Ls~N~-l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~ 324 (1075)
+++|. +++..+..+..+++|++|++++|. ++......+..+++|+.|++++| +. ...+..+ .+++.|++++|.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEeccc
Confidence 66665 444444455555555555555553 21111123445555566666555 22 1223333 224445555555
Q ss_pred ccCCCCcccc
Q 042958 325 LSGSIPSEIG 334 (1075)
Q Consensus 325 l~~~~~~~~~ 334 (1075)
+++..|..++
T Consensus 305 l~~~~~~~~~ 314 (336)
T 2ast_B 305 FTTIARPTIG 314 (336)
T ss_dssp SCCTTCSSCS
T ss_pred CccccCCccc
Confidence 5544444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-24 Score=244.35 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=190.8
Q ss_pred eEEeeccccccccccccccccccceecccccccccCCC----CCCcccc-ccccccccCCccccCCCccccCc-----CC
Q 042958 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIP----HSLGNLT-NLDALYLYDNSLSGSIPGEIGNL-----RS 482 (1075)
Q Consensus 413 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 482 (1075)
.++++.|.+++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788888888887777777778888888888886665 6677777 78888888888887777777665 78
Q ss_pred CCEEeCCCCcccCCCcccccCC-----CccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCC
Q 042958 483 ISNLALNNNKLSGSIPQSLGNL-----SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN 557 (1075)
Q Consensus 483 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N 557 (1075)
|++|+|++|++++..+..++.. ++|+.|+|++|++++..+..+... + ...|.++++|+|++|
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~------------l-~~~~~~L~~L~Ls~N 148 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA------------F-SNLPASITSLNLRGN 148 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH------------H-TTSCTTCCEEECTTS
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH------------H-HhCCCceeEEEccCC
Confidence 8888888888876666644433 778888888887765554443221 0 011345666666666
Q ss_pred ccccccchhhhhhhHhHHHhhcccccccccccccCccc-ccceeecCCCcccCcccccccc----c-ccceEEEcccccc
Q 042958 558 HIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLA-QLEHLDLSSNRLSNSIPKSFGN----L-VKLHYLNLSNNQF 631 (1075)
Q Consensus 558 ~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l 631 (1075)
.++...+..+. ..+..++ +|++|+|++|+|++..+..+.. + ++|++|+|++|+|
T Consensus 149 ~l~~~~~~~l~--------------------~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i 208 (362)
T 3goz_A 149 DLGIKSSDELI--------------------QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208 (362)
T ss_dssp CGGGSCHHHHH--------------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred cCCHHHHHHHH--------------------HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCC
Confidence 66543333322 2233344 8999999999999877765544 4 6999999999999
Q ss_pred ccc----cchhcccc-cccceeeeccccccCchhhh----hccccccceeecCCCccccCChh-------hhcccccccE
Q 042958 632 SRG----IPIKLEEL-IHLSELDLSHNFLREAIPSQ----ICIMQSLENLNLSHNSLVGLIPS-------CFEKMHGLLR 695 (1075)
Q Consensus 632 ~~~----~p~~~~~l-~~L~~L~ls~N~l~~~~~~~----~~~~~~L~~L~ls~N~l~~~~p~-------~~~~~~~l~~ 695 (1075)
++. ++..+..+ ++|++|||++|++++..+.. +..+++|+.|++++|.+.+..+. .+..+++|+.
T Consensus 209 ~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~ 288 (362)
T 3goz_A 209 GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288 (362)
T ss_dssp GGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEE
T ss_pred ChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEE
Confidence 873 45566654 59999999999999866533 45678999999999997665544 5678889999
Q ss_pred EeecCCccCCCC
Q 042958 696 IDISYNELQGPI 707 (1075)
Q Consensus 696 l~~s~N~~~~~~ 707 (1075)
||+++|++....
T Consensus 289 LdL~~N~l~~~~ 300 (362)
T 3goz_A 289 VDKNGKEIHPSH 300 (362)
T ss_dssp ECTTSCBCCGGG
T ss_pred EecCCCcCCCcc
Confidence 999999987653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=217.71 Aligned_cols=178 Identities=23% Similarity=0.305 Sum_probs=90.9
Q ss_pred cCcEEEccCCCCCCCcCCCCCccccccceeccccc-ccCCCCcccccccccccccccC-CcccccCCCcCCCCCCcceee
Q 042958 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS-LSGSIPSEIGNLRSLSNLGLSG-NKLSGSIPPSLGYLSNLATLY 367 (1075)
Q Consensus 290 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~l~~l~~L~~L~ 367 (1075)
+|++|++++|+++++.+..|.++++|++|++++|. ++...+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666665555566666666666666664 5544445555566666666655 555544444555555555555
Q ss_pred ccccccCCCCccccCCCcccc---eeeeccc-cccccCChhhccCCCCC-eEEeeccccccccccccccccccceecccc
Q 042958 368 LYSNSLFDSIPSELGNLRSLS---MLSLGYN-KLSGSIPHSLGNLTNLA-TLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442 (1075)
Q Consensus 368 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 442 (1075)
+++|.+.+ +|. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++.+.+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555533 333 44444444 5555555 44444444444444554 5555555444333333333 4444444444
Q ss_pred cc-cccCCCCCCccc-cccccccccCCccc
Q 042958 443 NK-LSGSIPHSLGNL-TNLDALYLYDNSLS 470 (1075)
Q Consensus 443 N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~ 470 (1075)
|+ +++..+..|.++ ++|+.|++++|+++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 42 443333444444 44444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-25 Score=251.17 Aligned_cols=95 Identities=22% Similarity=0.218 Sum_probs=57.2
Q ss_pred ccCcccccceeecCCCccc----CcccccccccccceEEEccccccccc----cchhccc--ccccceeeeccccccC--
Q 042958 590 KLGSLAQLEHLDLSSNRLS----NSIPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEE--LIHLSELDLSHNFLRE-- 657 (1075)
Q Consensus 590 ~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~ls~N~l~~-- 657 (1075)
.+..+++|++|+|++|.|+ +.+|..+..+++|++|+|++|+|++. +|..+.. +++|+.|+|++|.+++
T Consensus 211 ~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g 290 (386)
T 2ca6_A 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290 (386)
T ss_dssp TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHH
T ss_pred HhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHH
Confidence 4555666666666666664 45566666666666666666666554 3444422 6666666666666665
Q ss_pred --chhhhh-ccccccceeecCCCccccCCh
Q 042958 658 --AIPSQI-CIMQSLENLNLSHNSLVGLIP 684 (1075)
Q Consensus 658 --~~~~~~-~~~~~L~~L~ls~N~l~~~~p 684 (1075)
.+|..+ ..+++|+.|++++|++++..|
T Consensus 291 ~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 291 VRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 355555 445666666666666665553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=216.93 Aligned_cols=177 Identities=22% Similarity=0.280 Sum_probs=76.7
Q ss_pred cceeecccccccCCCCCCCCCCCCCCEEEcCCCC-CCCCCCccccCccccceEeeec-cccccccCCCCcCCCCcCceec
Q 042958 147 LNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS-LSDSIPSEFGNLRSLSMLSLGY-NKFSGSIPHSLGNLTNLATLYL 224 (1075)
Q Consensus 147 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~L 224 (1075)
|++|++++|.++++.+..|.++++|++|++++|+ ++.+.+..|.++++|++|++++ |++++..+..|.++++|++|++
T Consensus 33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l 112 (239)
T 2xwt_C 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112 (239)
T ss_dssp CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence 3333333333333333344444455555555553 4444444445555555555554 4554444444444455555555
Q ss_pred cccCCCCCCcccccCCCCCC---eEeccCC-CCCCccCCCCccccccc-ccccccccCcCCCCcccCCCccCcEEEccCC
Q 042958 225 HNNSLFDSIPSELGNLRSLS---MLSLGYN-KLSGSIPHSLGNLTNLA-TLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299 (1075)
Q Consensus 225 ~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 299 (1075)
++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|++++|.++...+..|.. ++|+.|++++|
T Consensus 113 ~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 113 FNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 5554443 232 44444444 4444444 44433333344444444 4444444444222222222 34444444444
Q ss_pred C-CCCCcCCCCCcc-ccccceeccccccc
Q 042958 300 K-LNGIIPHSLGNL-TNLATLYIHNNSLS 326 (1075)
Q Consensus 300 ~-l~~~~~~~~~~l-~~L~~L~L~~N~l~ 326 (1075)
+ ++++.+..|.++ ++|++|++++|+++
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccc
Confidence 2 443333344444 44444444444444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5e-24 Score=255.03 Aligned_cols=180 Identities=18% Similarity=0.114 Sum_probs=117.7
Q ss_pred eecccCceEEEEE-EECCCCEEEEEEccCCCCC-------chhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccchh-
Q 042958 822 CIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPG-------EMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHSLA- 891 (1075)
Q Consensus 822 ~lG~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~l~- 891 (1075)
..+.|++|.++.+ +...|+.||||++.+.... .....++|.+|+++|+++ .|+||+++++|+++.+..+.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3567777777776 4456999999999764221 122346799999999999 79999999999987655432
Q ss_pred heecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 892 MILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 892 ~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
|.+... .....++.. +|+.||++||+|+|++ +||||||||+|||++.++.+||+|||+|+....+..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 222221 123445543 5899999999999999 999999999999999999999999999998776655
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 1008 (1075)
.....+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 56677899999999998764 67789999999998887665444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-24 Score=245.70 Aligned_cols=269 Identities=18% Similarity=0.230 Sum_probs=189.1
Q ss_pred CeEEeeccccccccccccccccccceecccccccccCC----CCCCccccccccccccCC---ccccCCCccc-------
Q 042958 412 ATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI----PHSLGNLTNLDALYLYDN---SLSGSIPGEI------- 477 (1075)
Q Consensus 412 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N---~l~~~~p~~~------- 477 (1075)
+...++...+. .++..+..+++|++|+|++|.+++.. +..|..+++|++|+|++| ++++.+|..+
T Consensus 12 ~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l 90 (386)
T 2ca6_A 12 KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 90 (386)
T ss_dssp EESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHH
T ss_pred ccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHH
Confidence 33333444443 45566777888888888888887653 344667888888888885 4444555544
Q ss_pred cCcCCCCEEeCCCCcccC----CCcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccc
Q 042958 478 GNLRSISNLALNNNKLSG----SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLD 553 (1075)
Q Consensus 478 ~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~ 553 (1075)
..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++..+..+... |. .+..|++++.. ++|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~--~l~~~~~~~~~-~~L~~L~ 165 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQ--ELAVNKKAKNA-PPLRSII 165 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HH--HHHHHHHHHTC-CCCCEEE
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HH--HHhhhhhcccC-CCCcEEE
Confidence 567778888888887776 356667777777777777777754333333221 00 01122222211 3455556
Q ss_pred cCCCcccc-ccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccC-----cccccccccccceEEEcc
Q 042958 554 LSSNHIVG-EIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN-----SIPKSFGNLVKLHYLNLS 627 (1075)
Q Consensus 554 Ls~N~l~~-~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls 627 (1075)
|++|+++. .+|. +...+..+++|++|+|++|+|+. .+|..+..+++|++|+|+
T Consensus 166 L~~n~l~~~~~~~---------------------l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls 224 (386)
T 2ca6_A 166 CGRNRLENGSMKE---------------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224 (386)
T ss_dssp CCSSCCTGGGHHH---------------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECC
T ss_pred CCCCCCCcHHHHH---------------------HHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECc
Confidence 66655541 1111 11345667899999999999973 455588999999999999
Q ss_pred ccccc----cccchhcccccccceeeeccccccCc----hhhhhc--cccccceeecCCCcccc----CChhhh-ccccc
Q 042958 628 NNQFS----RGIPIKLEELIHLSELDLSHNFLREA----IPSQIC--IMQSLENLNLSHNSLVG----LIPSCF-EKMHG 692 (1075)
Q Consensus 628 ~N~l~----~~~p~~~~~l~~L~~L~ls~N~l~~~----~~~~~~--~~~~L~~L~ls~N~l~~----~~p~~~-~~~~~ 692 (1075)
+|+++ +.+|..+..+++|+.|+|++|+|++. ++..+. .+++|+.|+|++|.+++ .+|..+ .++++
T Consensus 225 ~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~ 304 (386)
T 2ca6_A 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304 (386)
T ss_dssp SSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred CCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCC
Confidence 99996 67888999999999999999999986 566663 38999999999999998 578877 67899
Q ss_pred ccEEeecCCccCCCC
Q 042958 693 LLRIDISYNELQGPI 707 (1075)
Q Consensus 693 l~~l~~s~N~~~~~~ 707 (1075)
|+.|++++|++++..
T Consensus 305 L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 305 LLFLELNGNRFSEED 319 (386)
T ss_dssp CCEEECTTSBSCTTS
T ss_pred ceEEEccCCcCCcch
Confidence 999999999988654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=225.18 Aligned_cols=226 Identities=20% Similarity=0.164 Sum_probs=190.1
Q ss_pred CCCccEEEccCCCccCC-CCc--cccccCCCceeecccCcccccCCCCC--CCCCCCcEEEccCcccCCCCC----cccc
Q 042958 72 FPHLAYLDLWHNQLYGN-IPP--QIGNISRLKYLDLSSNLFFGTIPPEI--GHLSYLKTLQLFENQLNGSIP----YEIG 142 (1075)
Q Consensus 72 l~~L~~L~L~~n~l~~~-~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p----~~~~ 142 (1075)
-..++.|++.++.++.. +.. ....+++|++|+|++|.+++.+|..+ ..+++|++|+|++|++++..| ..+.
T Consensus 63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 34578899998887532 111 12345779999999999999999998 999999999999999998666 3456
Q ss_pred ccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCC---C-CccccCccccceEeeeccccccccCC----CCc
Q 042958 143 RLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDS---I-PSEFGNLRSLSMLSLGYNKFSGSIPH----SLG 214 (1075)
Q Consensus 143 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~---~-~~~~~~l~~L~~L~Ls~N~l~~~~~~----~l~ 214 (1075)
.+++|++|++++|.+.+..+..|+.+++|++|+|++|++.+. . +..++.+++|++|+|++|+++. ++. .+.
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 221 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAA 221 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHh
Confidence 799999999999999999999999999999999999998752 2 2335789999999999999973 332 357
Q ss_pred CCCCcCceeccccCCCCCCcccccCC---CCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccC
Q 042958 215 NLTNLATLYLHNNSLFDSIPSELGNL---RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291 (1075)
Q Consensus 215 ~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 291 (1075)
.+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L 296 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV 296 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence 88999999999999998878877776 69999999999999 6777775 7999999999999964 43 7888999
Q ss_pred cEEEccCCCCCC
Q 042958 292 SMLNLGYNKLNG 303 (1075)
Q Consensus 292 ~~L~Ls~N~l~~ 303 (1075)
+.|+|++|+++.
T Consensus 297 ~~L~L~~N~l~~ 308 (310)
T 4glp_A 297 DNLTLDGNPFLV 308 (310)
T ss_dssp SCEECSSTTTSC
T ss_pred cEEECcCCCCCC
Confidence 999999999974
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=220.91 Aligned_cols=170 Identities=30% Similarity=0.428 Sum_probs=75.0
Q ss_pred CCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 71 SFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
.+++|++|++++|.++ .+| .+..+++|++|+|++|.+++. +. +.++++|++|+|++|++++. | .+..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEE
Confidence 3455555555555554 233 355555555555555555432 22 55555555555555555431 1 34444444444
Q ss_pred ecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCC
Q 042958 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 151 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (1075)
++++|.++++.+ +..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|+++
T Consensus 113 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 444444444322 4444444444444444443322 3444444444444444432211 334444444444444443
Q ss_pred CCCcccccCCCCCCeEeccCCCCC
Q 042958 231 DSIPSELGNLRSLSMLSLGYNKLS 254 (1075)
Q Consensus 231 ~~~~~~~~~l~~L~~L~Ls~N~l~ 254 (1075)
+..+ +..+++|++|++++|+++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCC
T ss_pred cChh--hcCCCCCCEEEccCCccC
Confidence 2211 333444444444444443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-21 Score=202.13 Aligned_cols=183 Identities=24% Similarity=0.260 Sum_probs=123.3
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.+|.|+..+ +.. ++ ..-.++|++|+|++|++++..+..++.+++|++|+|++|.+++..+..
T Consensus 7 C~~~~v~c~~~~-----------l~~-~p---~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (208)
T 2o6s_A 7 CSGTTVECYSQG-----------RTS-VP---TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV 71 (208)
T ss_dssp EETTEEECCSSC-----------CSS-CC---SCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred ECCCEEEecCCC-----------ccC-CC---CCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh
Confidence 899999997532 211 12 122467888888888888666666788888888888888888655566
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 196 (1075)
|.++++|++|+|++|++++..+..+..+++|++|++++|.++++.+..|..+++|++|++++|++++..+..|..+++|+
T Consensus 72 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 151 (208)
T 2o6s_A 72 FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ 151 (208)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCcc
Confidence 78888888888888888865555566666777777776666666666666666666666666666665555566666666
Q ss_pred eEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCC
Q 042958 197 MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLR 241 (1075)
Q Consensus 197 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 241 (1075)
+|++++|.+.+ .+++|++|+++.|++++.+|..++.++
T Consensus 152 ~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 152 YIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp EEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred EEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 66666665542 234556666666666655555555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.5e-21 Score=206.98 Aligned_cols=180 Identities=26% Similarity=0.273 Sum_probs=108.4
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
..++++++++.++ .+|..+. +.|++|+|++|++++..|.. |.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~------------------------~~~l~~L~~L~L~ 67 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDAT------------------------FRGLTKLTWLNLD 67 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTT------------------------TTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhH------------------------hcCcccCCEEECC
Confidence 3455666666665 4554443 45566666666655544444 5555555555555
Q ss_pred CCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCcc
Q 042958 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257 (1075)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 257 (1075)
+|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 68 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 147 (251)
T 3m19_A 68 YNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP 147 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence 55555555555555555555555555555444555555666666666666665554555566666666666666666555
Q ss_pred CCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCC
Q 042958 258 PHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304 (1075)
Q Consensus 258 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 304 (1075)
+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus 148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 55666666677777777777665566677777777777777777643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=219.40 Aligned_cols=240 Identities=18% Similarity=0.146 Sum_probs=112.9
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.++.++++++ .||..+ .+++++|+|++|.|+...+.+|.++++|++|+|++|++.+.+|.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~---------------- 72 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA---------------- 72 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT----------------
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh----------------
Confidence 34555555555 455444 23555555555555533333455555555555555555433332
Q ss_pred cccCCCCCCCCCCCCCCE-EEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccc-cCCCCCC
Q 042958 156 YLEDLIPPSLGNLSNLDT-LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHN-NSLFDSI 233 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~ 233 (1075)
..|.+++++++ +.++.|+++.+.|..|..+++|++|++++|+++...+..+....++..|++.+ +++....
T Consensus 73 -------~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 73 -------DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp -------TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred -------hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 22344444332 33334444444444455555555555555555443333444444444444433 3343333
Q ss_pred cccccCCC-CCCeEeccCCCCCCccCCCCccccccccccccc-ccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCc
Q 042958 234 PSELGNLR-SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE-NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN 311 (1075)
Q Consensus 234 ~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 311 (1075)
+..|..+. .++.|+|++|+++. ++.......+|++|++.+ |.++.+.+.+|.++++|++|+|++|+|+.+.+..|.+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred ccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 33344332 45555666666653 333333334555555543 4444333345555666666666666665544444544
Q ss_pred cccccceecccccccCCCCcccccccccccccccC
Q 042958 312 LTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346 (1075)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 346 (1075)
+++|+.+++. .+. .+| .+..+++|+.+++++
T Consensus 225 L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 225 LKKLRARSTY--NLK-KLP-TLEKLVALMEASLTY 255 (350)
T ss_dssp CCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSC
T ss_pred chHhhhccCC--CcC-cCC-CchhCcChhhCcCCC
Confidence 4444444332 222 233 244455555555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=218.09 Aligned_cols=238 Identities=19% Similarity=0.205 Sum_probs=141.9
Q ss_pred cEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCC-CccccCccccce-Eeee
Q 042958 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSI-PSEFGNLRSLSM-LSLG 201 (1075)
Q Consensus 124 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~Ls 201 (1075)
++++.++++++ .+|..+ .+++++|+|++|.|+.+.+.+|.++++|++|+|++|++.+.+ +.+|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555555555 455443 245666666666666666666778888888888888876544 356777777664 5566
Q ss_pred ccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccC-CCCCCccCCCCcccc-cccccccccccCcC
Q 042958 202 YNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY-NKLSGSIPHSLGNLT-NLATLYLYENSLSG 279 (1075)
Q Consensus 202 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~ 279 (1075)
.|+++...|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|++++|+++.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 6777766677777788888888888877766555566666677777754 455544444555543 46666666666664
Q ss_pred CCCcccCCCccCcEEEccC-CCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCC
Q 042958 280 SIPSEFGNLRSLSMLNLGY-NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358 (1075)
Q Consensus 280 ~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~ 358 (1075)
+.+..| ...+|+.|++++ |.++.+.+.+|.++++|++|+|++|+|+...+..|.++++|+.+++. .++ .+| .+.
T Consensus 169 i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l~ 243 (350)
T 4ay9_X 169 IHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TLE 243 (350)
T ss_dssp ECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CTT
T ss_pred CChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-Cch
Confidence 333333 345566666653 55555545566666666666666666665444445444444444332 222 233 244
Q ss_pred CCCCcceeecc
Q 042958 359 YLSNLATLYLY 369 (1075)
Q Consensus 359 ~l~~L~~L~L~ 369 (1075)
.+++|+.+++.
T Consensus 244 ~l~~L~~l~l~ 254 (350)
T 4ay9_X 244 KLVALMEASLT 254 (350)
T ss_dssp TCCSCCEEECS
T ss_pred hCcChhhCcCC
Confidence 44455555444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=217.22 Aligned_cols=212 Identities=26% Similarity=0.368 Sum_probs=182.7
Q ss_pred ccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccc
Q 042958 75 LAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS 154 (1075)
Q Consensus 75 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (1075)
+..+.+..+.+++.++ +.++++|++|++++|.+. .+| .+..+++|++|+|++|++++..+ +..+++|++|++++
T Consensus 21 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence 3344556666664433 568999999999999998 455 68999999999999999996544 99999999999999
Q ss_pred ccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCc
Q 042958 155 NYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP 234 (1075)
Q Consensus 155 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (1075)
|.+.++ +.+..+++|++|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++..+
T Consensus 95 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 95 NPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp CCCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred CcCCCc--hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence 999986 369999999999999999997543 9999999999999999986544 8899999999999999986443
Q ss_pred ccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCC
Q 042958 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304 (1075)
Q Consensus 235 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 304 (1075)
+..+++|++|++++|++++..+ +..+++|++|++++|++++.. .+..+++|+.|++++|++++.
T Consensus 169 --l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 169 --LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp --GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred --hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 8999999999999999996544 889999999999999999755 489999999999999999854
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-23 Score=232.82 Aligned_cols=249 Identities=19% Similarity=0.210 Sum_probs=130.0
Q ss_pred CcEEEccCCCCCCCcCCCCCcc--ccccceecccccccCCCCcccccccccccccccCCccccc-CCCcCCCCCCcceee
Q 042958 291 LSMLNLGYNKLNGIIPHSLGNL--TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS-IPPSLGYLSNLATLY 367 (1075)
Q Consensus 291 L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~ 367 (1075)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 445555555443 2333334 4555555555555543333 33455555555555555433 444455555555556
Q ss_pred ccccccCCCCccccCCCcccceeeeccc-cccc-cCChhhccCCCCCeEEeecc-ccccc-ccccccccc-ccceecccc
Q 042958 368 LYSNSLFDSIPSELGNLRSLSMLSLGYN-KLSG-SIPHSLGNLTNLATLDLYDN-SLSGS-IPSEFGNLR-SLSTLSLGY 442 (1075)
Q Consensus 368 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~ 442 (1075)
+++|.+.+..+..+..+++|++|++++| .+++ .++..+..+++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 5555555455555555666666666666 4443 24444555666666666666 55543 344555566 666666666
Q ss_pred c--ccc-cCCCCCCccccccccccccCCc-cccCCCccccCcCCCCEEeCCCCc-ccCCCcccccCCCccceeeccCCCC
Q 042958 443 N--KLS-GSIPHSLGNLTNLDALYLYDNS-LSGSIPGEIGNLRSISNLALNNNK-LSGSIPQSLGNLSNLVILYLYNNSL 517 (1075)
Q Consensus 443 N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l 517 (1075)
| .++ +.+|..+.++++|++|++++|. +++..+..+..+++|+.|++++|. +.......++++++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 6 333 2344455556666666666666 554555566666666666666664 22111224556666666666666 3
Q ss_pred CCCCCccccCc-cccccccccccccccccCC
Q 042958 518 FDSIPSELGNL-RSLSMLSFAYNKLSGSIPH 547 (1075)
Q Consensus 518 ~~~~~~~l~~l-~~L~~L~l~~N~l~~~~p~ 547 (1075)
+. +.+..+ .++..|++++|++++..|+
T Consensus 284 ~~---~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 284 PD---GTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp CT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred CH---HHHHHHHhhCcceEEecccCccccCC
Confidence 22 122222 2244444555555544443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-21 Score=228.31 Aligned_cols=198 Identities=26% Similarity=0.361 Sum_probs=107.6
Q ss_pred ccceE-EeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 38 AWVGI-HCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 38 ~w~gv-~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
.|.|+ .|.. ++++.|+|+++++.+ ++.. + +++|++|+|++|+|+ .+| +.+++|++|+|++|.|++ +|.
T Consensus 49 ~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~- 117 (571)
T 3cvr_A 49 AVSLLKECLI-NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE- 117 (571)
T ss_dssp HHHHHHHHHH-TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-
T ss_pred hhhhcccccc-CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-
Confidence 79999 6753 456666666666665 3332 2 255666666666665 455 335566666666666654 554
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 196 (1075)
+.+ +|++|+|++|+|++ +|. .+++|++|++++|.++++++ .+++|++|+|++|++++
T Consensus 118 l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~------------- 174 (571)
T 3cvr_A 118 LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF------------- 174 (571)
T ss_dssp CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-------------
T ss_pred hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-------------
Confidence 443 56666666666654 443 34455555555555544222 33444444444444444
Q ss_pred eEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCC-------CeEeccCCCCCCccCCCCcccccccc
Q 042958 197 MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSL-------SMLSLGYNKLSGSIPHSLGNLTNLAT 269 (1075)
Q Consensus 197 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~ 269 (1075)
+|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+++ .+|..+..+++|+.
T Consensus 175 ------------lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 175 ------------LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp ------------CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred ------------cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 333 33 44555555555554 2333 322 34 66666666666 45555656666666
Q ss_pred cccccccCcCCCCcccCCCc
Q 042958 270 LYLYENSLSGSIPSEFGNLR 289 (1075)
Q Consensus 270 L~L~~n~l~~~~~~~~~~l~ 289 (1075)
|+|++|.+++.+|..|..++
T Consensus 235 L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp EECCSSSCCHHHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHHhh
Confidence 66666666666665555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-20 Score=191.53 Aligned_cols=181 Identities=23% Similarity=0.243 Sum_probs=101.9
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.++.+++.++ .+|..+ .++|++|++++|.+++..+..++++++|++|+|++|++++..+..
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~--------------- 71 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV--------------- 71 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT---------------
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh---------------
Confidence 45667776665 455443 346677777777766554555666666666666666666433333
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (1075)
|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|++++..+.
T Consensus 72 ---------~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 72 ---------FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp ---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ---------cCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 44455555555555555544444455555555555555555544444455555555555555555544444
Q ss_pred cccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCcc
Q 042958 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRS 290 (1075)
Q Consensus 236 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 290 (1075)
.+..+++|++|++++|.+.+ .+++|++|+++.|.++|.+|..++.++.
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 45556666666666665543 2335666666666666666665554443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-21 Score=228.94 Aligned_cols=184 Identities=15% Similarity=0.176 Sum_probs=131.1
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEccCCCCCch-----hHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
...+.||+|+||.||+|... ++.+|+|+......... ...+++.+|++++++++||||+++..++...+.. ++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~-~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK-RI 416 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT-EE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc-EE
Confidence 34578999999999999544 88899998654332221 1245689999999999999999554444433322 23
Q ss_pred eecCccccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc----
Q 042958 893 ILSNNAAAK---DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN---- 965 (1075)
Q Consensus 893 ~~~~~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~---- 965 (1075)
+++....+. .+.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+|+........
T Consensus 417 VmE~~~ggsL~~~l~~--~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp EEECCCSEEHHHHSTT--CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred EEECCCCCCHHHHHHH--HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 333222111 1111 568999999999999999 9999999999999998 9999999999987643221
Q ss_pred ---eeccccccCccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCC
Q 042958 966 ---WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRD 1010 (1075)
Q Consensus 966 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~ 1010 (1075)
.....||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 135679999999999987 568888999999999999888887763
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=218.35 Aligned_cols=189 Identities=28% Similarity=0.355 Sum_probs=131.0
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
+|++|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|++++|.++++ |. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~i-p~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTL-PE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCC-CC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCc-ch-hhc--CCCEEECC
Confidence 34444444444432 333331 34444444444444 333 2244455555555555442 22 443 78888888
Q ss_pred CCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCcc
Q 042958 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 257 (1075)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 257 (1075)
+|++++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|++++ +|. |. ++|++|+|++|+++ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 888876 444 57888999999999885 555 57899999999999987 666 66 99999999999999 66
Q ss_pred CCCCcccccc-------cccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcccc
Q 042958 258 PHSLGNLTNL-------ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314 (1075)
Q Consensus 258 ~~~~~~l~~L-------~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 314 (1075)
|. |.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|.+++..|..|..++.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 76 665 77 99999999999 57888888999999999999999988887766544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-20 Score=231.85 Aligned_cols=204 Identities=24% Similarity=0.198 Sum_probs=75.8
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCC-CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEc
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSP-CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDL 80 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~-c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L 80 (1075)
.+++||+++..+...... ..-..|.. .+++ +.|.+++++. ++|++++|.++++.+.. ...++.++|
T Consensus 132 ~~~~~l~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~-------~~~l~~l~L 198 (727)
T 4b8c_D 132 CTKQALMEMADTLTDSKT-AKKQQPTG----DSTPSGTATNSAVST-PLTPKIELFANGKDEAN-------QALLQHKKL 198 (727)
T ss_dssp CCCHHHHHHHHHHHHHHT-TC-----------------------------------------------------------
T ss_pred cchhhhhhhhhhcccccC-cccCCCcC----CCCccccCCCceecC-CccceEEeeCCCCCcch-------hhHhhcCcc
Confidence 468899999998854322 23445641 2233 7899998875 67888888777766531 133566666
Q ss_pred cCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCC
Q 042958 81 WHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL 160 (1075)
Q Consensus 81 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 160 (1075)
+.|.|. .++++.|.+. ..|..+..++.|++|+|++|.+. .+|..+..+++|++|+|++|.++ .
T Consensus 199 s~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~ 261 (727)
T 4b8c_D 199 SQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-E 261 (727)
T ss_dssp --------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-C
T ss_pred Cccccc--------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-c
Confidence 666654 2344455555 55667777777777777777777 56665555555555555555555 3
Q ss_pred CCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccc
Q 042958 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSEL 237 (1075)
Q Consensus 161 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (1075)
+|..|+++++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..|+++++|++|+|++|.+++.+|..+
T Consensus 262 lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 262 LPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp CCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred cChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 3444455555555555555555 33444555555555555555544 344444444444444444444444444433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-18 Score=183.84 Aligned_cols=83 Identities=24% Similarity=0.182 Sum_probs=43.2
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.+|.|+..+ +. .+|.. -.++|++|+|++|.+++..|..++.+++|++|+|++|.|++..+..
T Consensus 19 Cs~~~v~c~~~~-----------l~-~ip~~---~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 83 (229)
T 3e6j_A 19 CSGTTVDCRSKR-----------HA-SVPAG---IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83 (229)
T ss_dssp EETTEEECTTSC-----------CS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred EeCCEeEccCCC-----------cC-ccCCC---CCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh
Confidence 999999997421 11 12211 1245555555555555555555555555555555555554333333
Q ss_pred CCCCCCCcEEEccCcccC
Q 042958 117 IGHLSYLKTLQLFENQLN 134 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~ 134 (1075)
|.++++|++|+|++|+|+
T Consensus 84 ~~~l~~L~~L~Ls~N~l~ 101 (229)
T 3e6j_A 84 FDSLTQLTVLDLGTNQLT 101 (229)
T ss_dssp TTTCTTCCEEECCSSCCC
T ss_pred cccCCCcCEEECCCCcCC
Confidence 445555555555555444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-21 Score=232.06 Aligned_cols=216 Identities=23% Similarity=0.164 Sum_probs=105.8
Q ss_pred ccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccce
Q 042958 430 GNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVI 509 (1075)
Q Consensus 430 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 509 (1075)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|......|..+ ..+.+.+..|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhccc
Confidence 45667777777777776 567777777777777775554211111100 011122334444444444444
Q ss_pred ee-ccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhhhhhhHhHHHhhcccccccccc
Q 042958 510 LY-LYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLS 588 (1075)
Q Consensus 510 L~-L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~ 588 (1075)
|+ ++.|.+ .+|+.+.+++|.++...+..+ +.|+|++|+|++ +|
T Consensus 414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~~L------------------------~~L~Ls~n~l~~-lp 457 (567)
T 1dce_A 414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYADV------------------------RVLHLAHKDLTV-LC 457 (567)
T ss_dssp HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHTTC------------------------SEEECTTSCCSS-CC
T ss_pred Ccchhhccc-----------chhhhhhhhcccccccCccCc------------------------eEEEecCCCCCC-Cc
Confidence 44 333321 223333333333332111222 233333333332 22
Q ss_pred cccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCch-hhhhcccc
Q 042958 589 PKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAI-PSQICIMQ 667 (1075)
Q Consensus 589 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~~~ 667 (1075)
. ++.+++|+.|+|++|+|+ .+|..|+.+++|++|+|++|+|++ +| .+..+++|+.|+|++|+|++.+ |..+..++
T Consensus 458 ~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~ 533 (567)
T 1dce_A 458 H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533 (567)
T ss_dssp C-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCT
T ss_pred C-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCC
Confidence 2 445555555555555555 455555555555555555555554 34 5555555555555555555544 55555555
Q ss_pred ccceeecCCCccccCChh---hhcccccccEEe
Q 042958 668 SLENLNLSHNSLVGLIPS---CFEKMHGLLRID 697 (1075)
Q Consensus 668 ~L~~L~ls~N~l~~~~p~---~~~~~~~l~~l~ 697 (1075)
+|+.|+|++|+|++.+|. .+..++.|+.||
T Consensus 534 ~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 534 RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp TCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 555555555555555432 123345555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=197.89 Aligned_cols=167 Identities=16% Similarity=0.113 Sum_probs=120.4
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCch---------------hHHHHHHHHHHHHhcCC
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEM---------------TFQQEFLNEVKALTEIR 872 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~ 872 (1075)
..+......|++.+.||+|+||.||+|...+|+.||||+++....... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344555667777899999999999999878899999999864321110 13567899999999998
Q ss_pred cCceeeEEEEeeccccchhheecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEec
Q 042958 873 HRNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSD 952 (1075)
Q Consensus 873 h~niv~l~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D 952 (1075)
| +++.+++......+.+.+.....-..+.......++.|+++|++|||+. +|+||||||+||+++ ++.+||+|
T Consensus 163 ~---~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 163 G---LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp T---SSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred C---CCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 4 5555555443333333332222222244455668999999999999999 999999999999999 99999999
Q ss_pred cccccccCCCCCceeccccccCccCcccccc----------CCCCcccchHh
Q 042958 953 FGIAKFLKPDSSNWTELAGTYGYVAPELAYT----------MKVTEKCDVYS 994 (1075)
Q Consensus 953 fGla~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~s 994 (1075)
||+|+.. ..|+|||++.. .++..++|+|.
T Consensus 236 FG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 236 FPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999743 34788998753 34555566664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.1e-19 Score=214.67 Aligned_cols=190 Identities=28% Similarity=0.366 Sum_probs=103.7
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
..+..++|+.+.+.+.++ +..|++|++|++++|.+.. +| .+..+++|++|+|++|++++..| +..+++|++|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 334455566666654433 4567777777777777753 33 46677777777777777765433 566666666666
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
++|.+.++ +.+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+.+.
T Consensus 95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 66666553 2466666666666666666542 2355555555555555555532 3444455555555555555443
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS 278 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 278 (1075)
.| +..+++|+.|+|++|++++. ..+..+++|+.|+|++|.++
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 33 44444455555544444422 12333444444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.3e-19 Score=194.81 Aligned_cols=149 Identities=32% Similarity=0.414 Sum_probs=72.4
Q ss_pred cccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCE
Q 042958 94 GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDT 173 (1075)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (1075)
..+++|++|++++|.+.. +| .+..+++|++|+|++|++++..+ +..+++|++|++++|.++++. .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS--SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG--GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh--hhccCCCCCE
Confidence 455555566665555542 22 35555555555555555554322 444555555555555544431 2555555555
Q ss_pred EEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCC
Q 042958 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKL 253 (1075)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 253 (1075)
|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|++++|++++..+ +..+++|++|++++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence 55555555542 2344455555555555555432 334444444444444444443222 44444444444444444
Q ss_pred C
Q 042958 254 S 254 (1075)
Q Consensus 254 ~ 254 (1075)
+
T Consensus 191 ~ 191 (291)
T 1h6t_A 191 S 191 (291)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.2e-19 Score=214.54 Aligned_cols=189 Identities=30% Similarity=0.416 Sum_probs=93.5
Q ss_pred cCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeecc
Q 042958 290 SLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLY 369 (1075)
Q Consensus 290 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~ 369 (1075)
.+..++++.+.+....+ +..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|++++..+ +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34445555555553322 3455566666666666553 22 35555555666666555554332 5555555555555
Q ss_pred ccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCC
Q 042958 370 SNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI 449 (1075)
Q Consensus 370 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 449 (1075)
+|.+.+ +| .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|+|++. ..|..+++|+.|+|++|+|++..
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 555533 22 445555555555555555432 2344555555555555555433 34444555555555555554433
Q ss_pred CCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc
Q 042958 450 PHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 450 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+++
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 3 44444555555555544432 23444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=197.22 Aligned_cols=192 Identities=28% Similarity=0.372 Sum_probs=106.5
Q ss_pred cCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEE
Q 042958 96 ISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLH 175 (1075)
Q Consensus 96 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (1075)
+.++..+.+..+.+++.. .+..+++|++|++++|.++.. + .+..+++|++|++++|.++++.+ +..+++|++|+
T Consensus 23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~ 96 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96 (291)
T ss_dssp HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence 444555566666665432 244667777777777776632 2 35555555555555555555443 55555555555
Q ss_pred cCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC
Q 042958 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
+++|++++. ..+. .+++|++|++++|++++. ..+..+++|++|++++|++++
T Consensus 97 l~~n~l~~~--~~l~------------------------~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~ 148 (291)
T 1h6t_A 97 LDENKVKDL--SSLK------------------------DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD 148 (291)
T ss_dssp CCSSCCCCG--GGGT------------------------TCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCcCCCC--hhhc------------------------cCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc
Confidence 555555432 1244 444555555555554432 234555555555555555553
Q ss_pred ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccC
Q 042958 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327 (1075)
Q Consensus 256 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 327 (1075)
. ..+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++. + .+..+++|+.|++++|.++.
T Consensus 149 ~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 149 I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred c--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 3 345555566666666666654333 56666666666666666643 2 36666677777777776664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-18 Score=180.18 Aligned_cols=131 Identities=27% Similarity=0.337 Sum_probs=62.3
Q ss_pred CCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
++|+.|+|++|.+++..+..++.+++|++|+|++|.+++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45666666666665444445555666666666666665555555555555555555555555332233333444444444
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecc
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (1075)
++|.++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 444444333333333333333333333333333333333333333333333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=197.60 Aligned_cols=156 Identities=27% Similarity=0.237 Sum_probs=76.7
Q ss_pred ccEEEccCCCccCCCCcccc-ccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 75 LAYLDLWHNQLYGNIPPQIG-NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 75 L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
+++|||++|+|++..+..+. .+++|++|+|++|.|++..|..|.++++|++|+|++|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~------------------- 101 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH------------------- 101 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-------------------
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-------------------
Confidence 45555555555544444444 4555555555555554444444445555555555554444
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCC---cCCCCcCceeccccCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL---GNLTNLATLYLHNNSLF 230 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l---~~l~~L~~L~L~~N~l~ 230 (1075)
.+.+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+++
T Consensus 102 -----~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 102 -----TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp -----EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred -----cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 3333444555555555555555554444555555555555555555553222222 34555555555555555
Q ss_pred CCCcccccCCCC--CCeEeccCCCCC
Q 042958 231 DSIPSELGNLRS--LSMLSLGYNKLS 254 (1075)
Q Consensus 231 ~~~~~~~~~l~~--L~~L~Ls~N~l~ 254 (1075)
+..+..+..++. ++.|+|++|.+.
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ccCHHHhhhccHhhcceEEecCCCcc
Confidence 444444444444 255555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=179.47 Aligned_cols=133 Identities=27% Similarity=0.260 Sum_probs=67.6
Q ss_pred CccEEEccCCCccCCCC-ccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeec
Q 042958 74 HLAYLDLWHNQLYGNIP-PQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLAL 152 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 152 (1075)
.+++|+|++|++++..| ..++.+++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 34566666666654433 23555666666666666665554555555555666666555555444444444444444444
Q ss_pred ccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccc
Q 042958 153 YSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 153 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
++|.++++.|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+.
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 444444444444444444444444444444444444444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=179.83 Aligned_cols=132 Identities=24% Similarity=0.317 Sum_probs=70.1
Q ss_pred ccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccccccccccc
Q 042958 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465 (1075)
Q Consensus 386 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 465 (1075)
+|+.|++++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 45555555555554444455555555555555555555445555555555555555555554444444555555555555
Q ss_pred CCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCC
Q 042958 466 DNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517 (1075)
Q Consensus 466 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 517 (1075)
+|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 5555555555555555555555555555554444555555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=196.68 Aligned_cols=175 Identities=25% Similarity=0.261 Sum_probs=105.4
Q ss_pred ceeeccccccCCCCccccCCCcccceeeeccccccccCChhhc-cCCCCCeEEeeccccccccccccccccccceecccc
Q 042958 364 ATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG-NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442 (1075)
Q Consensus 364 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 442 (1075)
+.+++++|.+. .+|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 34555555552 2343332 2355666666666655555555 666666666666666666556666666666666666
Q ss_pred cccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccc---cCCCccceeeccCCCCCC
Q 042958 443 NKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSL---GNLSNLVILYLYNNSLFD 519 (1075)
Q Consensus 443 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 519 (1075)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555566666667777777777666666667777777777777777765444444 457777777777777765
Q ss_pred CCCccccCcccc--cccccccccc
Q 042958 520 SIPSELGNLRSL--SMLSFAYNKL 541 (1075)
Q Consensus 520 ~~~~~l~~l~~L--~~L~l~~N~l 541 (1075)
..+..+..++.+ +.|++++|.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCE
T ss_pred cCHHHhhhccHhhcceEEecCCCc
Confidence 554555555542 4444444443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-18 Score=178.11 Aligned_cols=153 Identities=24% Similarity=0.249 Sum_probs=90.8
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCC-CCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIP-PEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS 154 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 154 (1075)
+.+|+++|.++ .+|..+. ..+++|+|++|.|++..| ..|.++++|++|+|++|+|++..+..
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~-------------- 76 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA-------------- 76 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTT--------------
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHH--------------
Confidence 47788888876 4676554 345677777777775544 33566666777777666666544444
Q ss_pred ccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCc
Q 042958 155 NYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP 234 (1075)
Q Consensus 155 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (1075)
|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|
T Consensus 77 ----------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 77 ----------FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp ----------TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred ----------hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 4555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccCCCCCCeEeccCCCCCC
Q 042958 235 SELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 235 ~~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
..|..+++|++|+|++|.+.+
T Consensus 147 ~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 147 GAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp TTTTTCTTCCEEECCSCCEEC
T ss_pred HHhcCCCCCCEEEecCcCCcC
Confidence 555555566666666665553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9.1e-20 Score=218.07 Aligned_cols=128 Identities=22% Similarity=0.220 Sum_probs=112.5
Q ss_pred HhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeec
Q 042958 572 FLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLS 651 (1075)
Q Consensus 572 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 651 (1075)
.|..+.+++|.++...+ ..|+.|+|++|+|++ +|. |+.+++|++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 424 ~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls 494 (567)
T 1dce_A 424 DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494 (567)
T ss_dssp HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECC
T ss_pred hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECC
Confidence 45555666666664322 258999999999996 676 999999999999999998 789999999999999999
Q ss_pred cccccCchhhhhccccccceeecCCCccccCC-hhhhcccccccEEeecCCccCCCCCCC
Q 042958 652 HNFLREAIPSQICIMQSLENLNLSHNSLVGLI-PSCFEKMHGLLRIDISYNELQGPIPNS 710 (1075)
Q Consensus 652 ~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~-p~~~~~~~~l~~l~~s~N~~~~~~p~~ 710 (1075)
+|+|++ +| .+..+++|+.|+|++|.|++.+ |..|..+++|+.|++++|++++.+|..
T Consensus 495 ~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 495 DNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp SSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999998 67 8999999999999999999998 999999999999999999999877643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-17 Score=175.31 Aligned_cols=152 Identities=26% Similarity=0.243 Sum_probs=90.7
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.++.+++.++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+..
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~--------------- 83 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV--------------- 83 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT---------------
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh---------------
Confidence 56777777776 6665544 67777777777777666666777777777777777665433333
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (1075)
|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+.
T Consensus 84 ---------~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 84 ---------FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp ---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred ---------cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 445555555555555555544445555555555555555555 4455555555555555555555544444
Q ss_pred cccCCCCCCeEeccCCCCCC
Q 042958 236 ELGNLRSLSMLSLGYNKLSG 255 (1075)
Q Consensus 236 ~~~~l~~L~~L~Ls~N~l~~ 255 (1075)
.|..+++|+.|+|++|.+.+
T Consensus 154 ~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 154 AFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp TTTTCTTCCEEECTTSCBCT
T ss_pred HHhCCCCCCEEEeeCCCccC
Confidence 55555666666666665553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-19 Score=196.09 Aligned_cols=261 Identities=14% Similarity=0.123 Sum_probs=135.0
Q ss_pred CCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcc--------cccccccccccccCcCCCCcccCC
Q 042958 216 LTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN--------LTNLATLYLYENSLSGSIPSEFGN 287 (1075)
Q Consensus 216 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--------l~~L~~L~L~~n~l~~~~~~~~~~ 287 (1075)
+++|+.|+|++|++.. ....-+.++.+..+.+..|.+ .+.+|.+ +++|+.|+|.+ .++.+.+.+|.+
T Consensus 48 l~~L~~LdLs~n~i~~-~~~~~~~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~ 122 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKM-YSGKAGTYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG 122 (329)
T ss_dssp CTTCCEEEEEEEEECC-EEESSSSSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred hccCeEEecCcceeEE-ecCcccccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence 4556666666666541 000111122234444444422 2345555 77777777776 666555667777
Q ss_pred CccCcEEEccCCCCCCCcCCCCCccccccceecccccc----cCCCCcccccccccc-cccccCCcccccCCCcCCCCCC
Q 042958 288 LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSL----SGSIPSEIGNLRSLS-NLGLSGNKLSGSIPPSLGYLSN 362 (1075)
Q Consensus 288 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~l~~l~~ 362 (1075)
+++|+.|++++|.+..+.+.+|.++.++..+.+..+.. .......|.++..|+ .+.+....
T Consensus 123 ~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~-------------- 188 (329)
T 3sb4_A 123 CDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG-------------- 188 (329)
T ss_dssp CTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC--------------
T ss_pred CcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC--------------
Confidence 77777777777777666667777766666665554221 222233344444443 22222111
Q ss_pred cceeeccccccCCCCccc----cCCCcccceeeeccccccccCChhh-ccCCCCCeEEeeccccccccccccccccccce
Q 042958 363 LATLYLYSNSLFDSIPSE----LGNLRSLSMLSLGYNKLSGSIPHSL-GNLTNLATLDLYDNSLSGSIPSEFGNLRSLST 437 (1075)
Q Consensus 363 L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 437 (1075)
.++.. -....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.+|.++++|+.
T Consensus 189 -------------~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~ 254 (329)
T 3sb4_A 189 -------------KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK 254 (329)
T ss_dssp -------------CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred -------------cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence 11111 012233444444433211 111111 12556666666666666555556666666666
Q ss_pred ecccccccccCCCCCCccccccc-cccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccceee
Q 042958 438 LSLGYNKLSGSIPHSLGNLTNLD-ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILY 511 (1075)
Q Consensus 438 L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 511 (1075)
|+|.+| ++.+.+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.+++++|.++...+..|.++++|+.++
T Consensus 255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 666665 5545555566666666 666655 55545556666666666666666666655555666666666655
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=185.68 Aligned_cols=169 Identities=24% Similarity=0.354 Sum_probs=79.6
Q ss_pred ccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeee
Q 042958 313 TNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSL 392 (1075)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 392 (1075)
.++..+++++|.+++. + .+..+++|+.|++++|.++. ++ .+..+++|++|++++|++.+..+ +..+++|++|++
T Consensus 19 ~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 3444444444444421 1 33444444444444444442 22 34444444455555444433222 444555555555
Q ss_pred ccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccC
Q 042958 393 GYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472 (1075)
Q Consensus 393 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 472 (1075)
++|++++. |. +.. ++|++|+|++|++++. ..+..+++|+.|++++|+|++. + .+..+++|+.|+|++|++++.
T Consensus 93 ~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 55555432 21 111 4555555555555532 2355555555555555555532 2 355555555555555555543
Q ss_pred CCccccCcCCCCEEeCCCCcccCC
Q 042958 473 IPGEIGNLRSISNLALNNNKLSGS 496 (1075)
Q Consensus 473 ~p~~~~~l~~L~~L~L~~N~l~~~ 496 (1075)
..+..+++|+.|++++|++++.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECC
T ss_pred --HHhccCCCCCEEeCCCCcccCC
Confidence 4455555555555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.4e-19 Score=197.00 Aligned_cols=123 Identities=15% Similarity=0.182 Sum_probs=62.8
Q ss_pred CCCccEEEccCCCccCCCCccccc-cCCCceeecccCccc--ccCCCCCCCCCCCcEEEccCcccCCCCCccccc-----
Q 042958 72 FPHLAYLDLWHNQLYGNIPPQIGN-ISRLKYLDLSSNLFF--GTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGR----- 143 (1075)
Q Consensus 72 l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~--~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~----- 143 (1075)
+.+++.|.++++ +.+.--..+.. +++|++|||++|.+. ...+.. ++.++.+.+..|.|. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I~---~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFVP---AYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccccC---HHHhccccccc
Confidence 455667776653 11110112222 556777777777665 222222 222444555544332 233444
Q ss_pred ---cCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeec
Q 042958 144 ---LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGY 202 (1075)
Q Consensus 144 ---l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 202 (1075)
+++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 66666666666 56655556666666666666666666555555565555555554443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.8e-18 Score=185.18 Aligned_cols=170 Identities=24% Similarity=0.268 Sum_probs=87.3
Q ss_pred ccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEE
Q 042958 95 NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTL 174 (1075)
Q Consensus 95 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 174 (1075)
.+.+++.++++.|.+++. + .+..+++|++|++++|+++. +| .+..+++|++|++++|.++++.+ +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 344455555555555422 2 34555555555555555542 33 34444555555555555544433 5555555555
Q ss_pred EcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCC
Q 042958 175 HLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254 (1075)
Q Consensus 175 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 254 (1075)
+|++|++++..+ +.. ++|++|+|++|++++. ..+..+++|++|++++|++++. + .+..+++|++|++++|+++
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 555555554322 122 5555555555555532 2355555555555555555543 2 4555556666666666655
Q ss_pred CccCCCCcccccccccccccccCcC
Q 042958 255 GSIPHSLGNLTNLATLYLYENSLSG 279 (1075)
Q Consensus 255 ~~~~~~~~~l~~L~~L~L~~n~l~~ 279 (1075)
+. ..+..+++|+.|++++|.+++
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred ch--HHhccCCCCCEEeCCCCcccC
Confidence 43 445555555555555555553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-18 Score=213.72 Aligned_cols=232 Identities=22% Similarity=0.211 Sum_probs=123.3
Q ss_pred cccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEe
Q 042958 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDL 416 (1075)
Q Consensus 337 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 416 (1075)
+.++.|+|.+|.+.. .+. ..|+.++|+.|.+ ..++++.|.+. ..+..+..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i--------------~~~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSI--------------DEDDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chh-----hHhhcCccCcccc--------------cCcccccccee-cChhhhccCCCCcEEEC
Confidence 345666666666653 222 2234445555544 23355566665 67788888999999999
Q ss_pred eccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCC
Q 042958 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS 496 (1075)
Q Consensus 417 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 496 (1075)
++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .
T Consensus 232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~ 307 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T 307 (727)
T ss_dssp TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence 999998 55666668999999999999998 78888999999999999999999 77999999999999999999997 6
Q ss_pred CcccccCCCccceeeccCCCCCCCCCccccCccc-cccccccccccccccCCcccccccCCCccccccchhhhhhhHhHH
Q 042958 497 IPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRS-LSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIK 575 (1075)
Q Consensus 497 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~~~~~~l~~ 575 (1075)
+|..|+++++|+.|+|++|.|++.+|..+..+.. +..+++++|.+++.+|..+..|+++.|... -..++
T Consensus 308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~l~~n~~~---~~~~~------- 377 (727)
T 4b8c_D 308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIEINTDGEP---QREYD------- 377 (727)
T ss_dssp CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------
T ss_pred cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeEeeccccc---ccccC-------
Confidence 7888999999999999999999888888866533 245789999999999999999999888211 11111
Q ss_pred HhhcccccccccccccCcccccceeecCCCcccC
Q 042958 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSN 609 (1075)
Q Consensus 576 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 609 (1075)
.|.+..+..+..+..++...+++|.+.+
T Consensus 378 ------~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 378 ------SLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ------------------------------CCCG
T ss_pred ------Cccccccchhhcccccceeeeecccccc
Confidence 2233333445566677778888888764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=170.47 Aligned_cols=152 Identities=20% Similarity=0.283 Sum_probs=71.5
Q ss_pred cccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCE
Q 042958 94 GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDT 173 (1075)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 173 (1075)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555555555555 344 4555555555555555443 1224444444444444444444444444455555555
Q ss_pred EEcCCCCCCCCCCccccCccccceEeeeccc-cccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCC
Q 042958 174 LHLYDNSLSDSIPSEFGNLRSLSMLSLGYNK-FSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252 (1075)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 252 (1075)
|++++|++++..+..|+.+++|++|++++|+ ++ .+| .+..+++|++|++++|.+++. + .+..+++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 5555555544444444444555555555544 32 222 344444444444444444331 1 34444444444444444
Q ss_pred C
Q 042958 253 L 253 (1075)
Q Consensus 253 l 253 (1075)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=170.57 Aligned_cols=155 Identities=18% Similarity=0.277 Sum_probs=132.5
Q ss_pred cCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcc
Q 042958 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 148 (1075)
.+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 456788999999999998 667 6999999999999999765 345789999999999999999987888899999999
Q ss_pred eeecccccccCCCCCCCCCCCCCCEEEcCCCC-CCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceecccc
Q 042958 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNS-LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNN 227 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 227 (1075)
+|++++|.+++..+..++.+++|++|++++|. ++. ++ .+..+++|++|++++|++++ ++ .+..+++|++|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 99999999998888889999999999999998 665 44 58999999999999999985 44 7889999999999999
Q ss_pred CCCC
Q 042958 228 SLFD 231 (1075)
Q Consensus 228 ~l~~ 231 (1075)
++.+
T Consensus 192 ~i~~ 195 (197)
T 4ezg_A 192 TIGG 195 (197)
T ss_dssp ----
T ss_pred ccCC
Confidence 9854
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=2.5e-17 Score=168.63 Aligned_cols=131 Identities=25% Similarity=0.347 Sum_probs=64.5
Q ss_pred cccccCCCccccccchhhhhhhHhHHHhhccccccccccc-ccCcccccceeecCCCcccCcccccccccccceEEEccc
Q 042958 550 GVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSP-KLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628 (1075)
Q Consensus 550 ~~L~Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 628 (1075)
+.+++++|+++ .+|..+.. .++.|++++|++++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46677777775 34443322 444455555555443332 244455555555555555444444455555555555555
Q ss_pred cccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCC
Q 042958 629 NQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLI 683 (1075)
Q Consensus 629 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~ 683 (1075)
|+|++..|..|..+++|++|+|++|+|++.+|..+..+++|+.|++++|++.+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 5554444444444455555555555554444444444444444555554444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-15 Score=175.83 Aligned_cols=314 Identities=12% Similarity=0.044 Sum_probs=126.4
Q ss_pred cCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccc
Q 042958 158 EDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSEL 237 (1075)
Q Consensus 158 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (1075)
+.+...+|.++++|+.+.+.. .++.+...+|.++++|+.+++..+ ++.....+|.++.+|+.+.+..+ +......+|
T Consensus 60 tsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF 136 (394)
T 4fs7_A 60 VSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAF 136 (394)
T ss_dssp EEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred eEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceee
Confidence 334445555666666666643 244444555666666666666533 43344455555555555554432 222223334
Q ss_pred cCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccc
Q 042958 238 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLAT 317 (1075)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 317 (1075)
..+..+....... +......+|.++++|+.+.+..+. ..+...+|.++.+|+.+++..| ++.+...+|.++..|+.
T Consensus 137 ~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~ 212 (394)
T 4fs7_A 137 KGCDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLEN 212 (394)
T ss_dssp TTCCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCB
T ss_pred ecccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccce
Confidence 3333222211111 111122334444444444443322 1123334444444444444433 22233344444444444
Q ss_pred eecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccc
Q 042958 318 LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397 (1075)
Q Consensus 318 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 397 (1075)
+.+.++... +.+.+....+|+.+.+..+ ++......|..+..|+.+.+..+.. ......|.++..++.+....+.+
T Consensus 213 i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i 288 (394)
T 4fs7_A 213 MEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIV 288 (394)
T ss_dssp CCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEE
T ss_pred eecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceee
Confidence 444333222 1111222233444433322 1112233344444444444443322 22333344444444444433322
Q ss_pred cccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccc
Q 042958 398 SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477 (1075)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 477 (1075)
....|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.....+|.++++|+.+.+..| ++.+...+|
T Consensus 289 ---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF 362 (394)
T 4fs7_A 289 ---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAF 362 (394)
T ss_dssp ---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTB
T ss_pred ---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHh
Confidence 1223444444444444332 33333344444444444444322 33233344444444444444333 333333344
Q ss_pred cCcCCCCEEeC
Q 042958 478 GNLRSISNLAL 488 (1075)
Q Consensus 478 ~~l~~L~~L~L 488 (1075)
.++.+|+.+++
T Consensus 363 ~~C~~L~~i~l 373 (394)
T 4fs7_A 363 QGCINLKKVEL 373 (394)
T ss_dssp TTCTTCCEEEE
T ss_pred hCCCCCCEEEE
Confidence 44444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-15 Score=174.22 Aligned_cols=270 Identities=13% Similarity=0.101 Sum_probs=131.5
Q ss_pred CCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceec
Q 042958 145 SSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYL 224 (1075)
Q Consensus 145 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 224 (1075)
..++.+.+.+ .++.+...+|.+. +|+.+.+..+ ++.+...+|.++ +|+.+.+.. .++...+.+|.+|++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 3344444332 2334444445443 4555555444 444444445442 355555543 344344445555555555555
Q ss_pred cccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCC
Q 042958 225 HNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304 (1075)
Q Consensus 225 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 304 (1075)
.+|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence 55554433333333 344555555422 33333444444444554444432 33233344444 34444444 2333333
Q ss_pred cCCCCCccccccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCC
Q 042958 305 IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNL 384 (1075)
Q Consensus 305 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 384 (1075)
...+|.++++|+.+++.+|.+.. +.+..+.+.+|..+++|+.+.+.+ .+......+|.++
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c 322 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGN 322 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTC
T ss_pred ChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCC
Confidence 34444444444444444443320 000124445566666666666653 3544445566666
Q ss_pred cccceeeeccccccccCChhhccCCCCCeEEeecccccccccccccccc-ccceecccccccc
Q 042958 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLR-SLSTLSLGYNKLS 446 (1075)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 446 (1075)
.+|+.++|..| ++.+...+|.++ +|+.+++++|.+..+.+..|.+++ +++.|++..+.+.
T Consensus 323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 66666666443 544555666666 677777766666655556666663 5666666666543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=161.98 Aligned_cols=110 Identities=27% Similarity=0.352 Sum_probs=52.4
Q ss_pred CCCeEEeecccccccccc-ccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeC
Q 042958 410 NLATLDLYDNSLSGSIPS-EFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488 (1075)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 488 (1075)
+|++|++++|+|+++.+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 444444444444433332 2444444444444444444444444444444444444444444444444444555555555
Q ss_pred CCCcccCCCcccccCCCccceeeccCCCCCC
Q 042958 489 NNNKLSGSIPQSLGNLSNLVILYLYNNSLFD 519 (1075)
Q Consensus 489 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 519 (1075)
++|+|++..|..|..+++|+.|+|++|++.+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 5555544444455555555555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=8.7e-16 Score=175.52 Aligned_cols=265 Identities=14% Similarity=0.122 Sum_probs=168.3
Q ss_pred CCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEec
Q 042958 169 SNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSL 248 (1075)
Q Consensus 169 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 248 (1075)
..++.+.+.+ .++.+...+|.++ +|+.+.+..+ ++.+...+|.++ +|+++.+.. .++.+.+.+|..+++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555543 3444445556554 5666666544 444444555553 455555553 344334445555555555555
Q ss_pred cCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCC
Q 042958 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328 (1075)
Q Consensus 249 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 328 (1075)
+.|+++ .+...+|. ..+|+.+.+..+ ++.+...+|.++++|+.+++.+| ++.+
T Consensus 188 ~~n~l~------------------------~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I 240 (401)
T 4fdw_A 188 SKTKIT------------------------KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTI 240 (401)
T ss_dssp TTSCCS------------------------EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEE
T ss_pred CCCcce------------------------EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCc
Confidence 555554 33333333 244455555422 44344445555555555555443 3334
Q ss_pred CCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccC-----CCCccccCCCcccceeeeccccccccCCh
Q 042958 329 IPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF-----DSIPSELGNLRSLSMLSLGYNKLSGSIPH 403 (1075)
Q Consensus 329 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 403 (1075)
...+|.+ .+|+.+.+ .+.++.+...+|..+++|+.+.+.+|.+. ...+..|.++++|+.++|. +.+..+...
T Consensus 241 ~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 4445554 45555555 23344455566666777777777666553 3566789999999999999 558778888
Q ss_pred hhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccc-ccccccccCCccc
Q 042958 404 SLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLT-NLDALYLYDNSLS 470 (1075)
Q Consensus 404 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~ 470 (1075)
.|.++++|+.++|..| ++.+...+|.++ +|+.+++++|.+....+..|.+++ ++..|++..+.+.
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 9999999999999665 777888999999 999999999999877788898884 7889999888765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.2e-16 Score=156.85 Aligned_cols=134 Identities=24% Similarity=0.267 Sum_probs=104.3
Q ss_pred CCCCccEEEccCCCcc-CCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcce
Q 042958 71 SFPHLAYLDLWHNQLY-GNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNY 149 (1075)
Q Consensus 71 ~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 149 (1075)
..++|++|+|++|.++ +.+|..++.+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3477999999999997 78888889999999999999998865 78889999999999999998777777777778888
Q ss_pred eecccccccCCCC-CCCCCCCCCCEEEcCCCCCCCCCC---ccccCccccceEeeeccccc
Q 042958 150 LALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSLSDSIP---SEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 150 L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
|++++|.++++.. ..+..+++|++|++++|.+++..+ ..|..+++|++|++++|.+.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 8777777777543 566777777777777777765544 35666677777777776665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-15 Score=174.25 Aligned_cols=317 Identities=12% Similarity=0.022 Sum_probs=147.9
Q ss_pred ccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCcc
Q 042958 109 FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSE 188 (1075)
Q Consensus 109 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~ 188 (1075)
++..-..+|.++++|+.+.|..+ ++.....+|.++++|+.+++..+ ++.+...+|.++++|+.+.+..+ +..+...+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 44444566777777777777643 44333345555555555555433 44444445555555555444332 22233334
Q ss_pred ccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccc
Q 042958 189 FGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 268 (1075)
Q Consensus 189 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 268 (1075)
|.++..++..... .+......+|.++++|+.+.+.+ +... ....+|.++.+|+
T Consensus 136 F~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~------------------------~~~~-I~~~~F~~c~~L~ 188 (394)
T 4fs7_A 136 FKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPD------------------------SMET-LHNGLFSGCGKLK 188 (394)
T ss_dssp TTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCT------------------------TCCE-ECTTTTTTCTTCC
T ss_pred eecccccccccCc--cccccchhhhcccCCCcEEecCC------------------------ccce-eccccccCCCCce
Confidence 4444322222111 11112233444444555544443 3221 3333444444444
Q ss_pred ccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccccCCc
Q 042958 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNK 348 (1075)
Q Consensus 269 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 348 (1075)
.+.+..+ ++.+...+|.++..|+.+.+..+... +...+....+|+.+.+..+ ++.+....|.++..|+.+.+..+.
T Consensus 189 ~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~ 264 (394)
T 4fs7_A 189 SIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK 264 (394)
T ss_dssp BCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT
T ss_pred EEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc
Confidence 4444433 33233344444444444444433222 1122222344444444332 222333444455555555554443
Q ss_pred ccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccc
Q 042958 349 LSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428 (1075)
Q Consensus 349 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 428 (1075)
.. .....|..+..++.+....+.+ ....|..+.+|+.+.+..+ +..+...+|.++++|+.+++.++ ++.+...+
T Consensus 265 ~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 338 (394)
T 4fs7_A 265 LR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS 338 (394)
T ss_dssp CE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence 32 3444455555555555444332 1234455555555555433 44344455556666666666433 44455556
Q ss_pred cccccccceecccccccccCCCCCCccccccccccccC
Q 042958 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466 (1075)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 466 (1075)
|.++.+|+.+++..| ++.....+|.++++|+.+++..
T Consensus 339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 666666666666554 4434455566666666666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=152.42 Aligned_cols=132 Identities=23% Similarity=0.211 Sum_probs=73.7
Q ss_pred CCCcEEEccCcccC-CCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEe
Q 042958 121 SYLKTLQLFENQLN-GSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLS 199 (1075)
Q Consensus 121 ~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 199 (1075)
++|++|++++|+++ +.+|..+..+++|++|++++|.++++ ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 44444444444555555555544444 4456666666666666666665555555566666666
Q ss_pred eecccccccc-CCCCcCCCCcCceeccccCCCCCCc---ccccCCCCCCeEeccCCCCC
Q 042958 200 LGYNKFSGSI-PHSLGNLTNLATLYLHNNSLFDSIP---SELGNLRSLSMLSLGYNKLS 254 (1075)
Q Consensus 200 Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~ 254 (1075)
|++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666665421 1455556666666666666654333 34555666666666666555
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=156.00 Aligned_cols=128 Identities=25% Similarity=0.286 Sum_probs=107.2
Q ss_pred hhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeecccccc
Q 042958 577 ILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLR 656 (1075)
Q Consensus 577 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 656 (1075)
++++|+++ .+|..+ .++|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 16 ~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~ 91 (193)
T 2wfh_A 16 RCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91 (193)
T ss_dssp ECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence 34444444 333333 257899999999997 78888999999999999999999888888999999999999999999
Q ss_pred CchhhhhccccccceeecCCCccccCChhhhcccccccEEeecCCccCCCCC
Q 042958 657 EAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIP 708 (1075)
Q Consensus 657 ~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~~~~~p 708 (1075)
+..|..+..+++|+.|+|++|.|++..+..|..++.|+.|++++|++++.+.
T Consensus 92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 8888889999999999999999998888889999999999999999987664
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-16 Score=151.26 Aligned_cols=128 Identities=22% Similarity=0.271 Sum_probs=90.2
Q ss_pred CCCccEEEccCCCcc-CCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCccee
Q 042958 72 FPHLAYLDLWHNQLY-GNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150 (1075)
Q Consensus 72 l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 150 (1075)
.++|++|++++|.++ +.+|..++.+++|++|++++|.+++. ..++++++|++|+|++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467888888888887 78888888888888888888888755 678888888888888888887677666666666666
Q ss_pred ecccccccCCC-CCCCCCCCCCCEEEcCCCCCCCCCC---ccccCccccceEeee
Q 042958 151 ALYSNYLEDLI-PPSLGNLSNLDTLHLYDNSLSDSIP---SEFGNLRSLSMLSLG 201 (1075)
Q Consensus 151 ~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~Ls 201 (1075)
++++|.++++. +..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 66666666542 3455556666666666666554443 345555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=149.80 Aligned_cols=127 Identities=24% Similarity=0.312 Sum_probs=103.1
Q ss_pred HhHHHhhcccccc-cccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeee
Q 042958 572 FLIKLILAQNQLS-GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDL 650 (1075)
Q Consensus 572 ~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 650 (1075)
.++.|++++|+++ +.+|..+..+++|++|+|++|.|++. ..++.+++|++|+|++|++++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3445555555555 45666677888899999999999865 77888899999999999998878888888999999999
Q ss_pred ccccccCc-hhhhhccccccceeecCCCccccCCh---hhhcccccccEEeecC
Q 042958 651 SHNFLREA-IPSQICIMQSLENLNLSHNSLVGLIP---SCFEKMHGLLRIDISY 700 (1075)
Q Consensus 651 s~N~l~~~-~~~~~~~~~~L~~L~ls~N~l~~~~p---~~~~~~~~l~~l~~s~ 700 (1075)
++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999874 45788889999999999999988877 6788899999998863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=7e-15 Score=148.40 Aligned_cols=132 Identities=25% Similarity=0.274 Sum_probs=88.8
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|++|.|+.. ++.. ++. .-.++|++|++++|++++..+..++.+++|++|+|++|.+++..+..
T Consensus 7 C~~~~l~~~~~-----------~l~~-~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 7 CSGTEIRCNSK-----------GLTS-VPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EETTEEECCSS-----------CCSS-CCT---TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred eCCCEEEecCC-----------CCcc-CCC---CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 89999999753 2221 221 12367888888888888666666788888888888888887655666
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCC
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD 183 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 183 (1075)
++.+++|++|+|++|++++..+..+..+++|++|++++|.++++.+..+..+++|++|++++|.+++
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 7788888888888888876555555666666666666666665555555555666666666665553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.9e-15 Score=150.87 Aligned_cols=62 Identities=27% Similarity=0.273 Sum_probs=30.1
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCC
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGS 136 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 136 (1075)
+|++|+|++|.++ .+|..++.+++|++|+|++|.|++..+..|.++++|++|+|++|+|++.
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i 93 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEe
Confidence 4555555555554 4444455555555555555555444444444444444444444444433
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-15 Score=163.78 Aligned_cols=139 Identities=17% Similarity=0.193 Sum_probs=98.0
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCE--EEEEEccCCCCC---------------------chhHHHHHHHHHHHHh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEI--VAVKKFHSPLPG---------------------EMTFQQEFLNEVKALT 869 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~ 869 (1075)
..-|++.+.||+|+||.||+|.. .+|+. ||||+++..... .......+.+|+.+++
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 33466788999999999999977 67999 999987543211 0112246889999999
Q ss_pred cCCcCce--eeEEEEeeccccchhheecCccc--cCC-------CCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCC
Q 042958 870 EIRHRNI--VKFYGFCSHVRHSLAMILSNNAA--AKD-------LGWTRRMNVIKGISDALSYMH-NDCFPPIVHRDISS 937 (1075)
Q Consensus 870 ~l~h~ni--v~l~~~~~~~~~~l~~~~~~~~~--~~~-------l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlk~ 937 (1075)
+++|+++ +.++++ ....+.+.+....+ ... .++.....++.|++.|+.||| +. +|+||||||
T Consensus 126 ~l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp HHHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred HHHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 9988753 444432 12222222221000 001 123356789999999999999 88 999999999
Q ss_pred CCeeeCCCCCceEeccccccccC
Q 042958 938 KNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 938 ~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+||+++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999998 99999999998653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.9e-14 Score=145.16 Aligned_cols=128 Identities=26% Similarity=0.256 Sum_probs=78.0
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
+.+++++++++ .+|..+. ++|++|++++|.+++..+..++++++|++|+|++|++++..+..+..+++|++|++++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 56777777776 4554443 57777777777777555556677777777777777777544444555555555555555
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
.++++.+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 555555555555555555555555555444444455555555555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=4.7e-16 Score=160.16 Aligned_cols=135 Identities=23% Similarity=0.289 Sum_probs=108.9
Q ss_pred cchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceEEEccccccccccchhcccc
Q 042958 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEEL 642 (1075)
Q Consensus 563 ~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 642 (1075)
+|..+..++.|+.|++++|++++ +| .+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++ +| .+..+
T Consensus 40 l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l 114 (198)
T 1ds9_A 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHH
T ss_pred hhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccC
Confidence 34488888888888888888886 45 7888889999999999988 678888888889999999998876 45 68888
Q ss_pred cccceeeeccccccCchh-hhhccccccceeecCCCccccCChhh----------hcccccccEEeecCCccC
Q 042958 643 IHLSELDLSHNFLREAIP-SQICIMQSLENLNLSHNSLVGLIPSC----------FEKMHGLLRIDISYNELQ 704 (1075)
Q Consensus 643 ~~L~~L~ls~N~l~~~~~-~~~~~~~~L~~L~ls~N~l~~~~p~~----------~~~~~~l~~l~~s~N~~~ 704 (1075)
++|+.|+|++|++++..+ ..+..+++|+.|++++|++.+.+|.. +..++.|+.|| +|.++
T Consensus 115 ~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 889999999999887443 57788888999999999988776653 78888888887 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=9.4e-16 Score=157.89 Aligned_cols=132 Identities=25% Similarity=0.355 Sum_probs=61.5
Q ss_pred ccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCcccccc
Q 042958 380 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459 (1075)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (1075)
.+..+++|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 34444444444444444443 33 4444444444444444444 233344444445555555554443 22 34444455
Q ss_pred ccccccCCccccCCC-ccccCcCCCCEEeCCCCcccCCCcc----------cccCCCccceeeccCCCCC
Q 042958 460 DALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLSGSIPQ----------SLGNLSNLVILYLYNNSLF 518 (1075)
Q Consensus 460 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~----------~~~~l~~L~~L~L~~N~l~ 518 (1075)
++|++++|++++..+ ..+..+++|++|++++|++++..|. .+..+++|+.|| +|.++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 555555555442211 2445555555555555555443333 255566666655 44443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.47 E-value=9.8e-13 Score=151.02 Aligned_cols=334 Identities=11% Similarity=0.113 Sum_probs=180.1
Q ss_pred CCCCCCCCCCC-CCCEEEcCCCCCCCCCCccccCccccceEeeeccc---cccccCCCCcCCCCcCceeccccCCCCCCc
Q 042958 159 DLIPPSLGNLS-NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNK---FSGSIPHSLGNLTNLATLYLHNNSLFDSIP 234 (1075)
Q Consensus 159 ~~~~~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 234 (1075)
.+...+|.+.. .|+.+.+-.+ ++.+...+|.++++|+.+.+..|. ++.....+|.++.+|+.+.+..+ ++....
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~ 130 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS 130 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence 33445566653 4677766543 555566667777777777776653 55455567777777777766554 444445
Q ss_pred ccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcccc
Q 042958 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314 (1075)
Q Consensus 235 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 314 (1075)
.+|..+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. +...+|.++.+
T Consensus 131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~ 206 (394)
T 4gt6_A 131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFA 206 (394)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred hhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccc
Confidence 56777777777777543 33244556777777777777544 44344455544 46777777654332 55566777777
Q ss_pred ccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeecc
Q 042958 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394 (1075)
Q Consensus 315 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 394 (1075)
++......+.... ....+..........+ ..+.....+..+.+.+ .+......+|.++..|+.+.+..
T Consensus 207 l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~ 274 (394)
T 4gt6_A 207 LSTITSDSESYPA-IDNVLYEKSANGDYAL----------IRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPD 274 (394)
T ss_dssp CCEEEECCSSSCB-SSSCEEEECTTSCEEE----------EECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCT
T ss_pred cceeccccccccc-ccceeecccccccccc----------cccccccccceEEcCC-cceEcccceeeecccccEEeccc
Confidence 7766655544432 1111111000000000 0011111222222221 12223334566666666666654
Q ss_pred ccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCC
Q 042958 395 NKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIP 474 (1075)
Q Consensus 395 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 474 (1075)
+.. .+....|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++++|+.+.+..+ ++.+-.
T Consensus 275 ~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~ 350 (394)
T 4gt6_A 275 SVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPE 350 (394)
T ss_dssp TCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCG
T ss_pred ccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhH
Confidence 433 2455566666667776664 3455455566777777777777654 44445566777777777777543 554555
Q ss_pred ccccCcCCCCEEeCCCCcccCCCcccccCCCccceeeccCCCC
Q 042958 475 GEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSL 517 (1075)
Q Consensus 475 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 517 (1075)
.+|.++++|+.+++.+|... -..+...++|+.+.+..|.+
T Consensus 351 ~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 351 SAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp GGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred hHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence 66777777777777776543 13456667777777766544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=3.4e-14 Score=143.10 Aligned_cols=132 Identities=21% Similarity=0.175 Sum_probs=82.5
Q ss_pred cCCCCCccEEEccCCCccCCCCccccccC-CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCc
Q 042958 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNIS-RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSL 147 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 147 (1075)
+.++++|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..++.+++|++|+|++|++++..|..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 556778888888888887 4554 55554 888888888888754 577888888888888888875433334566666
Q ss_pred ceeecccccccCCCC-CCCCCCCCCCEEEcCCCCCCCCCCc----cccCccccceEeeecccc
Q 042958 148 NYLALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSLSDSIPS----EFGNLRSLSMLSLGYNKF 205 (1075)
Q Consensus 148 ~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l 205 (1075)
++|++++|.+..+.+ ..+..+++|++|++++|.++. +|. .+..+++|++|+++.|.+
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 666666666644332 244555555555555555542 222 244455555555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-14 Score=143.86 Aligned_cols=58 Identities=29% Similarity=0.342 Sum_probs=22.3
Q ss_pred CCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCcc
Q 042958 410 NLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469 (1075)
Q Consensus 410 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 469 (1075)
+|++|++++|.|++. ..|..+++|++|++++|+|++..+..|..+++|++|+|++|++
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i 100 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC
Confidence 444444444444332 2333344444444444444322222223333444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-13 Score=138.40 Aligned_cols=110 Identities=24% Similarity=0.308 Sum_probs=82.6
Q ss_pred cceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCC
Q 042958 597 LEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSH 676 (1075)
Q Consensus 597 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~ 676 (1075)
.+.+|+++|.|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 467777777776 4665553 6777777887777777777777777788888888887776666677777788888888
Q ss_pred CccccCChhhhcccccccEEeecCCccCCCCCC
Q 042958 677 NSLVGLIPSCFEKMHGLLRIDISYNELQGPIPN 709 (1075)
Q Consensus 677 N~l~~~~p~~~~~~~~l~~l~~s~N~~~~~~p~ 709 (1075)
|+|++..+..|..+++|+.|++++|++++.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 888777777777788888888888888776653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.8e-13 Score=135.76 Aligned_cols=108 Identities=22% Similarity=0.296 Sum_probs=76.7
Q ss_pred ceeecCCCcccCcccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhhhhccccccceeecCCC
Q 042958 598 EHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHN 677 (1075)
Q Consensus 598 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N 677 (1075)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56777777775 5666554 66777777777777766777777777777777777777655555667777777777777
Q ss_pred ccccCChhhhcccccccEEeecCCccCCCCC
Q 042958 678 SLVGLIPSCFEKMHGLLRIDISYNELQGPIP 708 (1075)
Q Consensus 678 ~l~~~~p~~~~~~~~l~~l~~s~N~~~~~~p 708 (1075)
+|++..+..|..++.|+.|++++|++++.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 7777666667777777777777777776554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.39 E-value=5.6e-12 Score=144.70 Aligned_cols=332 Identities=12% Similarity=0.106 Sum_probs=169.0
Q ss_pred CCCccccCcc-ccceEeeeccccccccCCCCcCCCCcCceeccccC---CCCCCcccccCCCCCCeEeccCCCCCCccCC
Q 042958 184 SIPSEFGNLR-SLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNS---LFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 259 (1075)
Q Consensus 184 ~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 259 (1075)
+...+|.++. .|+.+.+..+ ++.+...+|.++++|+.+.+..|. ++.+-..+|..+.+|+.+.+..+ ++.....
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3444565553 4666666543 444555566666666666665543 33333344555555555444332 2223334
Q ss_pred CCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccccc
Q 042958 260 SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339 (1075)
Q Consensus 260 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 339 (1075)
+|..+.+|+.+.+..+ +..+...+|..+.+|+.+.+..+ +..+...+|.+ .+|+.+.+..+-.. ....+|.++.++
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l 207 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFAL 207 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccc
Confidence 4445555555554422 22233344444555555554433 22233334432 33444444333222 333344444444
Q ss_pred ccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeecc
Q 042958 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN 419 (1075)
Q Consensus 340 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 419 (1075)
+......+.... ....+. ..+.........+.....+..+.+. +.+..+....|.++.+|+.+.+.++
T Consensus 208 ~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~ 275 (394)
T 4gt6_A 208 STITSDSESYPA-IDNVLY----------EKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDS 275 (394)
T ss_dssp CEEEECCSSSCB-SSSCEE----------EECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTT
T ss_pred ceeccccccccc-ccceee----------cccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccc
Confidence 433333222210 100000 0000000000011122333444443 3344455667888888888888766
Q ss_pred ccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcc
Q 042958 420 SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ 499 (1075)
Q Consensus 420 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 499 (1075)
..+ +...+|.++++|+.+.+. +.++.....+|.++++|+.+.+.++ ++.+...+|.++.+|+.+.+..+ ++.....
T Consensus 276 ~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~ 351 (394)
T 4gt6_A 276 VVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPES 351 (394)
T ss_dssp CCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGG
T ss_pred cce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHh
Confidence 543 667788888888888886 4455556677888888888888654 66566778888888888888654 5545567
Q ss_pred cccCCCccceeeccCCCCCCCCCccccCccccccccccccc
Q 042958 500 SLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK 540 (1075)
Q Consensus 500 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~ 540 (1075)
.|.++++|+.+++.+|... -..+....+|+.+.+..|.
T Consensus 352 aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 352 AFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp GGTTCTTCCEEEESSCHHH---HHTCBCCCCC---------
T ss_pred HhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCC
Confidence 7888888888888876532 1344555566666555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.39 E-value=2.8e-13 Score=150.49 Aligned_cols=146 Identities=10% Similarity=0.117 Sum_probs=96.9
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCC------------c---hh----HHHHHHHHHHHHhc
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG------------E---MT----FQQEFLNEVKALTE 870 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------~---~~----~~~~~~~E~~~l~~ 870 (1075)
+.....-|++.+.||+|+||.||+|...+|+.||||+++..... . .. .+.....|...+.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 33444458889999999999999998889999999987532110 0 00 01112456777777
Q ss_pred CCcCcee--eEEEEeeccccchhheecCccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCC
Q 042958 871 IRHRNIV--KFYGFCSHVRHSLAMILSNNAA-AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNE 947 (1075)
Q Consensus 871 l~h~niv--~l~~~~~~~~~~l~~~~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~ 947 (1075)
+.+.++. ..+++ .++.+.|.+..... ...........++.|++.|+.|||+. +||||||||.|||+++++.
T Consensus 170 L~~~gv~vp~p~~~---~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ---SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp HHHTTCSCCCEEEE---ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred HHhcCCCCCeeeec---cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence 7554432 22222 12333333222111 11122334567889999999999999 9999999999999988773
Q ss_pred ----------ceEeccccccccCC
Q 042958 948 ----------AHVSDFGIAKFLKP 961 (1075)
Q Consensus 948 ----------~kl~DfGla~~~~~ 961 (1075)
+.|+||+-+.....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccccceEEEEeCCcccCCC
Confidence 89999998876543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=129.48 Aligned_cols=102 Identities=25% Similarity=0.284 Sum_probs=56.3
Q ss_pred EEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccc
Q 042958 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYL 157 (1075)
Q Consensus 78 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 157 (1075)
+|+++|.++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+
T Consensus 14 l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 444445454 3454442 5566666666666655566666666666666666666644444444444444444444444
Q ss_pred cCCCCCCCCCCCCCCEEEcCCCCCC
Q 042958 158 EDLIPPSLGNLSNLDTLHLYDNSLS 182 (1075)
Q Consensus 158 ~~~~~~~l~~l~~L~~L~L~~n~l~ 182 (1075)
+++.+..|..+++|++|+|++|.++
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 4444444555555666666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-12 Score=128.39 Aligned_cols=103 Identities=24% Similarity=0.300 Sum_probs=61.9
Q ss_pred EEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccccc
Q 042958 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156 (1075)
Q Consensus 77 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 156 (1075)
.+|+++|.++ .+|..+. ++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|.
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4555566654 5565554 666777777777766666667777777777777777765433344555555555555555
Q ss_pred ccCCCCCCCCCCCCCCEEEcCCCCCC
Q 042958 157 LEDLIPPSLGNLSNLDTLHLYDNSLS 182 (1075)
Q Consensus 157 l~~~~~~~l~~l~~L~~L~L~~n~l~ 182 (1075)
++++.+..|..+++|++|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 55554445556666666666666555
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.3e-13 Score=150.93 Aligned_cols=160 Identities=22% Similarity=0.201 Sum_probs=108.5
Q ss_pred cCCcccccccCCCccccccchhhhhh-----hHhHHHhhccccccccccccc-CcccccceeecCCCcccCcccccc---
Q 042958 545 IPHSLGVLDLSSNHIVGEIPTELGKL-----NFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSNSIPKSF--- 615 (1075)
Q Consensus 545 ~p~~l~~L~Ls~N~l~~~~p~~~~~~-----~~l~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~--- 615 (1075)
+++.++.|+|++|.++......+... ..|+.|+|++|.++......+ ..+++|+.|||++|.|+......+
T Consensus 70 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~ 149 (372)
T 3un9_A 70 VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL 149 (372)
T ss_dssp HHTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHH
T ss_pred HHhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHH
Confidence 34556667777777665544444444 467777777777764433333 245678888888888875444444
Q ss_pred --cccccceEEEcccccccc----ccchhcccccccceeeeccccccCch----hhhhccccccceeecCCCccccC---
Q 042958 616 --GNLVKLHYLNLSNNQFSR----GIPIKLEELIHLSELDLSHNFLREAI----PSQICIMQSLENLNLSHNSLVGL--- 682 (1075)
Q Consensus 616 --~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~----~~~~~~~~~L~~L~ls~N~l~~~--- 682 (1075)
...++|++|+|++|.|+. .++..+..+++|++|||++|+|+... +..+...++|+.|+|++|.|+..
T Consensus 150 L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 150 LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229 (372)
T ss_dssp HHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred HHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence 235778888888888864 23444567788888888888887633 55566677888888888888753
Q ss_pred -ChhhhcccccccEEeecCCccC
Q 042958 683 -IPSCFEKMHGLLRIDISYNELQ 704 (1075)
Q Consensus 683 -~p~~~~~~~~l~~l~~s~N~~~ 704 (1075)
++..+...+.|+.||+++|.++
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCC
T ss_pred HHHHHHHhCCCCCEEeccCCCCC
Confidence 3344556688888898888775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=6.5e-13 Score=150.17 Aligned_cols=173 Identities=20% Similarity=0.165 Sum_probs=113.9
Q ss_pred cCCCCEEeCCCCcccCCCcccccCC-----CccceeeccCCCCCCCCCcccc-CccccccccccccccccccCCcccccc
Q 042958 480 LRSISNLALNNNKLSGSIPQSLGNL-----SNLVILYLYNNSLFDSIPSELG-NLRSLSMLSFAYNKLSGSIPHSLGVLD 553 (1075)
Q Consensus 480 l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~l~~N~l~~~~p~~l~~L~ 553 (1075)
++.|+.|+|++|.++......+... ++|+.|+|++|.+++.....+. .+++ ++.||
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~------------------L~~L~ 132 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR------------------ARKLG 132 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHT------------------EEEEE
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHh------------------ccHhh
Confidence 3568888888888875433333332 6777888888776543222221 2222 34455
Q ss_pred cCCCccccccchhhhhhhHhHHHhhccccccccccccc-CcccccceeecCCCcccC----cccccccccccceEEEccc
Q 042958 554 LSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKL-GSLAQLEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSN 628 (1075)
Q Consensus 554 Ls~N~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~ 628 (1075)
|++|.|+......++. .+ ...+.|++|+|++|.|+. .++..+..+++|++|+|++
T Consensus 133 Ls~n~l~~~~~~~L~~--------------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~ 192 (372)
T 3un9_A 133 LQLNSLGPEACKDLRD--------------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLH 192 (372)
T ss_dssp CCSSCCCHHHHHHHHH--------------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTT
T ss_pred cCCCCCCHHHHHHHHH--------------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCC
Confidence 5555554322222211 11 234679999999999875 3445557788999999999
Q ss_pred cccccc----cchhcccccccceeeeccccccCc----hhhhhccccccceeecCCCccccCChhhhccc
Q 042958 629 NQFSRG----IPIKLEELIHLSELDLSHNFLREA----IPSQICIMQSLENLNLSHNSLVGLIPSCFEKM 690 (1075)
Q Consensus 629 N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~ 690 (1075)
|+|+.. ++..+...++|++|||++|.|+.. +...+...++|+.|||++|+|+......+..+
T Consensus 193 N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 193 TGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp SSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred CCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 998753 356677788999999999999864 34445567899999999999987766666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.9e-10 Score=128.61 Aligned_cols=122 Identities=14% Similarity=0.072 Sum_probs=56.1
Q ss_pred CcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccc
Q 042958 355 PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRS 434 (1075)
Q Consensus 355 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 434 (1075)
..|..+..|+.+.+..+ +.......|.++.+|+.+.+..+ +..+....|.++++|+.+.+.++.++.+...+|.++.+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 34444444444444433 22333334444445555544322 33333344555555555555555554444455555555
Q ss_pred cceecccccccccCCCCCCccccccccccccCCccccCCCccccCc
Q 042958 435 LSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480 (1075)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 480 (1075)
|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.+-..+|.+.
T Consensus 312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 555555433 33333445555555555555433 333334444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.6e-10 Score=130.08 Aligned_cols=148 Identities=14% Similarity=0.142 Sum_probs=83.6
Q ss_pred CCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccc
Q 042958 353 IPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNL 432 (1075)
Q Consensus 353 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 432 (1075)
....+..+.+|+.+.+..+ +.......|.++..|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+...+|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 3444555556666655443 22334445566666666666554 44455556666666666666543 444455566666
Q ss_pred cccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCC
Q 042958 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLS 505 (1075)
Q Consensus 433 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 505 (1075)
.+|+.+.+.++.++.....+|.++++|+.+.|..+ ++.+-..+|.++++|+.+.+..+ ++......|.++.
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 66666666666665455566666666666666543 55444556666666666666543 3333344455543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=138.52 Aligned_cols=103 Identities=23% Similarity=0.217 Sum_probs=62.1
Q ss_pred Hhhccc-ccccccccccCcccccceeecCC-CcccCcccccccccccceEEEccccccccccchhcccccccceeeeccc
Q 042958 576 LILAQN-QLSGQLSPKLGSLAQLEHLDLSS-NRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653 (1075)
Q Consensus 576 L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 653 (1075)
++++++ +|+. +|. +..+++|++|+|++ |+|++..|..|+.+++|++|+|++|+|++..|..|..|++|+.|||++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 345555 5653 444 66666666666664 6666555566666666666666666666666666666666666666666
Q ss_pred cccCchhhhhccccccceeecCCCcccc
Q 042958 654 FLREAIPSQICIMQSLENLNLSHNSLVG 681 (1075)
Q Consensus 654 ~l~~~~~~~~~~~~~L~~L~ls~N~l~~ 681 (1075)
+|++..+..+..++ |+.|+|++|++..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 66654444444443 6666666666653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=4.6e-11 Score=134.59 Aligned_cols=103 Identities=23% Similarity=0.223 Sum_probs=66.3
Q ss_pred eeeeccc-cccccCChhhccCCCCCeEEeec-cccccccccccccccccceecccccccccCCCCCCccccccccccccC
Q 042958 389 MLSLGYN-KLSGSIPHSLGNLTNLATLDLYD-NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466 (1075)
Q Consensus 389 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 466 (1075)
.++++++ +++ .+|. +..+++|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 665 3555 66677777777764 777666666666677777777777776666666666666666666666
Q ss_pred CccccCCCccccCcCCCCEEeCCCCccc
Q 042958 467 NSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
|+|++..+..|..++ |+.|+|++|+|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666654444454444 666666666655
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.86 E-value=2.3e-10 Score=128.00 Aligned_cols=103 Identities=20% Similarity=0.245 Sum_probs=58.2
Q ss_pred CceeEEEeccccccc-cc----C--CcccCCCCCccEEEccCCCcc---------CCCCccccccCCCceeecccCcccc
Q 042958 48 GRVNSINLTSIGLKG-ML----H--DFSFSSFPHLAYLDLWHNQLY---------GNIPPQIGNISRLKYLDLSSNLFFG 111 (1075)
Q Consensus 48 ~~v~~l~l~~~~l~g-~~----~--~~~~~~l~~L~~L~L~~n~l~---------~~~p~~l~~l~~L~~L~Ls~n~l~~ 111 (1075)
.+|++|.+...++.| .+ . ..+...+++|+.|.+.++... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 468888877666543 11 0 012445778888888654321 124444566677777777776311
Q ss_pred cCCCCCCCCCCCcEEEccCcccCCCCCcccc--ccCCcceeecc
Q 042958 112 TIPPEIGHLSYLKTLQLFENQLNGSIPYEIG--RLSSLNYLALY 153 (1075)
Q Consensus 112 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~--~l~~L~~L~L~ 153 (1075)
.++. + .+++|++|+|..+.++......+. .+++|++|+|+
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 2333 3 367777777777666533323333 46666666664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=2.6e-10 Score=127.54 Aligned_cols=58 Identities=22% Similarity=0.265 Sum_probs=29.3
Q ss_pred ccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCcccc--CccccceEeee
Q 042958 141 IGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFG--NLRSLSMLSLG 201 (1075)
Q Consensus 141 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls 201 (1075)
+..+++|+.|.|++|.-..+ +. + .+++|++|+|..|.++......+. .+++|++|+|+
T Consensus 168 l~~~P~L~~L~L~g~~~l~l-~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLSI-GK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHTCTTCCEEEEECCBTCBC-CS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred HhcCCCCcEEEEeCCCCcee-cc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 34455566666655421111 11 2 256667777666666533322332 56666666664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.3e-11 Score=127.60 Aligned_cols=143 Identities=20% Similarity=0.137 Sum_probs=73.0
Q ss_pred CccceEEeCCCC-ceeEEEecc---cccccccCCcccCCCCCccEEEccCCCccCCCC-ccccccCCCce--eecccCcc
Q 042958 37 CAWVGIHCNRGG-RVNSINLTS---IGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIP-PQIGNISRLKY--LDLSSNLF 109 (1075)
Q Consensus 37 c~w~gv~C~~~~-~v~~l~l~~---~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~--L~Ls~n~l 109 (1075)
|.|.|+.|+..+ +|+.+...+ .++.|.+.+..+..++. .|....|.-++.++ ..+...+.|+. ++++.|..
T Consensus 78 ~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 78 KAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred HhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence 899999999764 666555544 34444444332222221 11111122121111 12444555665 66677633
Q ss_pred ---cccCCCCCCCCCCCcEEEccCcccCC--CCCccccccCCcceeecccccccCCCCCCCCCCC--CCCEEEcCCCCCC
Q 042958 110 ---FGTIPPEIGHLSYLKTLQLFENQLNG--SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLS--NLDTLHLYDNSLS 182 (1075)
Q Consensus 110 ---~~~~p~~l~~l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~n~l~ 182 (1075)
.+.++....++++|++|+|++|+|++ .+|..+..+++|+.|+|++|.+.+. ..+..++ +|++|+|++|.++
T Consensus 156 ~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 156 SCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp HHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence 22222222467778888888888876 3345555566666666666665554 1122222 5555555555554
Q ss_pred C
Q 042958 183 D 183 (1075)
Q Consensus 183 ~ 183 (1075)
+
T Consensus 234 ~ 234 (267)
T 3rw6_A 234 D 234 (267)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.2e-08 Score=107.89 Aligned_cols=120 Identities=30% Similarity=0.310 Sum_probs=82.2
Q ss_pred Hhhcccccccccccc-cCcccccce--eecCCCcccCcccc----cccccccceEEEcccccccc--ccchhcccccccc
Q 042958 576 LILAQNQLSGQLSPK-LGSLAQLEH--LDLSSNRLSNSIPK----SFGNLVKLHYLNLSNNQFSR--GIPIKLEELIHLS 646 (1075)
Q Consensus 576 L~l~~n~l~~~~~~~-~~~l~~L~~--L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~ 646 (1075)
+....|.-++.++-. |...+.|.. ++++.|+.. .++. ....+++|+.|+|++|+|++ .+|..+..+++|+
T Consensus 121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~ 199 (267)
T 3rw6_A 121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 199 (267)
T ss_dssp HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred HHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence 334444444443333 555666666 777888543 3332 23557888888888888887 4556777888888
Q ss_pred eeeeccccccCchhhhhcccc--ccceeecCCCccccCCh-------hhhcccccccEEee
Q 042958 647 ELDLSHNFLREAIPSQICIMQ--SLENLNLSHNSLVGLIP-------SCFEKMHGLLRIDI 698 (1075)
Q Consensus 647 ~L~ls~N~l~~~~~~~~~~~~--~L~~L~ls~N~l~~~~p-------~~~~~~~~l~~l~~ 698 (1075)
.|+|++|+|++. ..+..+. +|+.|+|++|++.+.+| ..+..+|+|+.||-
T Consensus 200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred EEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence 888888888874 3344444 88999999999987665 34778888888874
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.49 E-value=3.9e-08 Score=99.18 Aligned_cols=115 Identities=15% Similarity=0.202 Sum_probs=76.8
Q ss_pred ccCcccccceeecCCC-cccC----cccccccccccceEEEccccccccc----cchhcccccccceeeeccccccCc--
Q 042958 590 KLGSLAQLEHLDLSSN-RLSN----SIPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEELIHLSELDLSHNFLREA-- 658 (1075)
Q Consensus 590 ~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~-- 658 (1075)
.+...+.|++|+|++| .|+. .+...+...++|++|+|++|+|... +...+.....|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3555667777888877 7754 2334455567788888888877542 233445557788888888888763
Q ss_pred --hhhhhccccccceeec--CCCccccC----ChhhhcccccccEEeecCCccC
Q 042958 659 --IPSQICIMQSLENLNL--SHNSLVGL----IPSCFEKMHGLLRIDISYNELQ 704 (1075)
Q Consensus 659 --~~~~~~~~~~L~~L~l--s~N~l~~~----~p~~~~~~~~l~~l~~s~N~~~ 704 (1075)
+...+...++|+.|+| ++|.|... +...+...++|+.|++++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3455566677888888 77888644 3344555678888888888664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.48 E-value=4.6e-08 Score=104.97 Aligned_cols=136 Identities=14% Similarity=0.121 Sum_probs=90.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc--eeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN--IVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~l~~ 892 (1075)
..|......+.|..+.||++...+|+.+++|+..... ...+..|+++++.+.+.+ +.+++++....+.. .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~-~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD-WL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE-EE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC-EE
Confidence 3444333334666799999987778889999975431 135678899988885444 55688877654332 22
Q ss_pred eecCccccCCCC--HHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 042958 893 ILSNNAAAKDLG--WTRRMNVIKGISDALSYMHNDC-------------------------------------------- 926 (1075)
Q Consensus 893 ~~~~~~~~~~l~--~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------- 926 (1075)
+++...+ ..+. ......++.++++++..||+..
T Consensus 93 v~e~i~G-~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 93 LLGEVPG-QDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EEECCSS-EETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEEecCC-cccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 2222211 1111 1123468889999999999752
Q ss_pred -----------CCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 927 -----------FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 927 -----------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
.+.++|+|++|.||+++.++.+.|+|||.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998766667999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.7e-07 Score=100.52 Aligned_cols=141 Identities=14% Similarity=0.106 Sum_probs=98.7
Q ss_pred HHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccc
Q 042958 811 IRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 811 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 889 (1075)
......|+.....+.|+.+.||++... ++.+++|+........ ...+.+|+++++.+. +..+.++++++...+..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 344567888888899999999999755 7899999986421111 235788999999884 67788899888764332
Q ss_pred hhheecCccccCCC-----CHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 042958 890 LAMILSNNAAAKDL-----GWTRRMNVIKGISDALSYMHNDC-------------------------------------- 926 (1075)
Q Consensus 890 l~~~~~~~~~~~~l-----~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 926 (1075)
+ ++++...+ ..+ +......++.++++++..||+..
T Consensus 86 ~-lv~e~i~G-~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 86 N-LLMSEADG-VLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp E-EEEECCSS-EEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred E-EEEEecCC-eehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 2 22222211 111 12234578899999999999821
Q ss_pred ------------------CCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 927 ------------------FPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 927 ------------------~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
.+.++|+|+++.||+++.+..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999875556799998775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.39 E-value=4.5e-08 Score=98.67 Aligned_cols=92 Identities=14% Similarity=0.153 Sum_probs=71.3
Q ss_pred cccCcccccceeecCCCcccC----cccccccccccceEEEccccccccc----cchhcccccccceeee--ccccccCc
Q 042958 589 PKLGSLAQLEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEELIHLSELDL--SHNFLREA 658 (1075)
Q Consensus 589 ~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l--s~N~l~~~ 658 (1075)
..+...+.|++|||++|.|+. .+...+...++|++|+|++|.|+.. +...+.....|++|+| ++|.|...
T Consensus 59 ~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 59 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 345556789999999999975 2345556668899999999999753 4566777888999999 88999875
Q ss_pred h----hhhhccccccceeecCCCccc
Q 042958 659 I----PSQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 659 ~----~~~~~~~~~L~~L~ls~N~l~ 680 (1075)
. ...+...++|+.|+|++|.+.
T Consensus 139 g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 139 VEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4 344455588999999999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.36 E-value=8.8e-07 Score=99.82 Aligned_cols=136 Identities=13% Similarity=0.225 Sum_probs=94.9
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcc--CCCCCchhHHHHHHHHHHHHhcCC--cCceeeEEEEeecccc--chhhe
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFH--SPLPGEMTFQQEFLNEVKALTEIR--HRNIVKFYGFCSHVRH--SLAMI 893 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~--~l~~~ 893 (1075)
.+.++.|.++.||+.+.. +..+++|+.. ... .......+.+|+++++.+. +..+.++++++.+... ...++
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 467899999999999776 5678889875 221 1112356788999999986 4568889998876532 11122
Q ss_pred ecCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 042958 894 LSNNAA-------AKDLGWTRRMNVIKGISDALSYMHNDC---------------------------------------- 926 (1075)
Q Consensus 894 ~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 926 (1075)
++...+ ...++..++..++.+++++|..||+..
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 222211 123567888999999999999999731
Q ss_pred ---------------CCCeEEecCCCCCeeeCCCCC--ceEeccccccc
Q 042958 927 ---------------FPPIVHRDISSKNVLLDFDNE--AHVSDFGIAKF 958 (1075)
Q Consensus 927 ---------------~~~ivH~Dlk~~Nill~~~~~--~kl~DfGla~~ 958 (1075)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999998764 58999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.20 E-value=8.9e-07 Score=97.19 Aligned_cols=178 Identities=20% Similarity=0.212 Sum_probs=111.1
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCc--eeeEEEEeeccccchh-h-ee
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRN--IVKFYGFCSHVRHSLA-M-IL 894 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~~~l~-~-~~ 894 (1075)
.+.++.|....||+.. +.+++|+... ......+.+|.++++.+ .+.. +.+++.+......... + ++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4569999999999873 5688998542 13356788999999888 3332 4455555433322111 1 12
Q ss_pred cCccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 042958 895 SNNAA-------AKDLGWTRRMNVIKGISDALSYMHNDC----------------------------------------- 926 (1075)
Q Consensus 895 ~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 926 (1075)
....+ ...++..++..++.++++.+..||+..
T Consensus 96 ~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 96 TKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp ECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 11111 123455667889999999999999621
Q ss_pred --------------CCCeEEecCCCCCeeeCC--CCCceEeccccccccCCCCCceeccc---------------cccCc
Q 042958 927 --------------FPPIVHRDISSKNVLLDF--DNEAHVSDFGIAKFLKPDSSNWTELA---------------GTYGY 975 (1075)
Q Consensus 927 --------------~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~---------------gt~~y 975 (1075)
.+.++|+|++|.||+++. ...+.|+||+.+....+... ..... ...++
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999998 45678999999876432111 00000 00011
Q ss_pred cC-ccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 042958 976 VA-PELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 1009 (1075)
Q Consensus 976 ~a-PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 1009 (1075)
.. |+.... .....+.|++|.++|++.+|+.+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 112258999999999999999885
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.64 E-value=2e-05 Score=76.99 Aligned_cols=82 Identities=10% Similarity=0.129 Sum_probs=34.8
Q ss_pred CcceeeccccccCCCCccccCCCcccceeeecccc-ccccCChhhccC----CCCCeEEeecc-cccccccccccccccc
Q 042958 362 NLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK-LSGSIPHSLGNL----TNLATLDLYDN-SLSGSIPSEFGNLRSL 435 (1075)
Q Consensus 362 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~L 435 (1075)
+|++|+++++.++..--..+.++++|+.|+|++|. |+...-..+..+ ++|++|+|++| +||+..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444433333334444445555555442 333222333332 23455555544 2443322334444444
Q ss_pred ceeccccc
Q 042958 436 STLSLGYN 443 (1075)
Q Consensus 436 ~~L~L~~N 443 (1075)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=1.6e-05 Score=77.69 Aligned_cols=83 Identities=12% Similarity=0.122 Sum_probs=53.6
Q ss_pred cccceeeeccccccccCChhhccCCCCCeEEeeccc-cccccccccccc----cccceecccccc-cccCCCCCCccccc
Q 042958 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS-LSGSIPSEFGNL----RSLSTLSLGYNK-LSGSIPHSLGNLTN 458 (1075)
Q Consensus 385 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 458 (1075)
..|+.||++++.|+...-..+.++++|++|+|++|. |++..-..++.+ ++|++|+|++|. |++.--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888877666677788888888888874 665443444443 367777777763 55433333445555
Q ss_pred cccccccCC
Q 042958 459 LDALYLYDN 467 (1075)
Q Consensus 459 L~~L~L~~N 467 (1075)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.48 E-value=6.4e-05 Score=74.94 Aligned_cols=109 Identities=22% Similarity=0.318 Sum_probs=73.9
Q ss_pred cccccceeecCCC-cccC----cccccccccccceEEEcccccccc----ccchhcccccccceeeeccccccCchhh--
Q 042958 593 SLAQLEHLDLSSN-RLSN----SIPKSFGNLVKLHYLNLSNNQFSR----GIPIKLEELIHLSELDLSHNFLREAIPS-- 661 (1075)
Q Consensus 593 ~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~~~-- 661 (1075)
.-+.|++|+|++| +|.. .+.+.+..-+.|+.|+|++|+|.. .+...+..-+.|++|+|++|+|....-.
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3456888888885 7753 344556667788888888888864 3344556677888889988888864433
Q ss_pred --hhccccccceeecCCC---cccc----CChhhhcccccccEEeecCC
Q 042958 662 --QICIMQSLENLNLSHN---SLVG----LIPSCFEKMHGLLRIDISYN 701 (1075)
Q Consensus 662 --~~~~~~~L~~L~ls~N---~l~~----~~p~~~~~~~~l~~l~~s~N 701 (1075)
.+..-..|+.|+|++| .+.. .+...+..-++|..|++++|
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~ 167 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 167 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCC
Confidence 3333456888888865 3332 24455666778888887655
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0011 Score=72.25 Aligned_cols=131 Identities=13% Similarity=0.098 Sum_probs=86.2
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcC---ceeeEEEEeeccccchhheecC
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR---NIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
.+.++.|....||+. |+.+++|+.. .......+..|.++++.+.+. .|.+++.++........+++..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456889999999998 5678888842 123356789999999999652 3566776664222211122222
Q ss_pred ccc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 042958 897 NAA-------AKDLGWTRRMNVIKGISDALSYMHNDC------------------------------------------- 926 (1075)
Q Consensus 897 ~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------- 926 (1075)
..+ ...++..++..++.++++.+..||+..
T Consensus 95 i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 95 VQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred cCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 211 112344556667777777777777532
Q ss_pred --------------CCCeEEecCCCCCeeeCC---CCCc-eEecccccccc
Q 042958 927 --------------FPPIVHRDISSKNVLLDF---DNEA-HVSDFGIAKFL 959 (1075)
Q Consensus 927 --------------~~~ivH~Dlk~~Nill~~---~~~~-kl~DfGla~~~ 959 (1075)
.+.++|+|+++.||+++. ++.+ .|+||+.+...
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 235699999999999997 4564 79999988753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00021 Score=71.18 Aligned_cols=91 Identities=15% Similarity=0.163 Sum_probs=63.2
Q ss_pred ccCcccccceeecCCCcccC----cccccccccccceEEEccccccccc----cchhcccccccceeeeccc---cccCc
Q 042958 590 KLGSLAQLEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEELIHLSELDLSHN---FLREA 658 (1075)
Q Consensus 590 ~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N---~l~~~ 658 (1075)
.+..-+.|+.|+|++|+|.. .+.+.+..-+.|++|+|++|+|+.. +-..+..-..|++|+|++| .+...
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~ 144 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ 144 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHH
Confidence 34455678889999999875 3344455667899999999998753 3344556677999999865 44432
Q ss_pred ----hhhhhccccccceeecCCCccc
Q 042958 659 ----IPSQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 659 ----~~~~~~~~~~L~~L~ls~N~l~ 680 (1075)
+...+..-++|+.|+++.|.+.
T Consensus 145 g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 145 VEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3444555578999999888764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0007 Score=75.79 Aligned_cols=66 Identities=2% Similarity=-0.109 Sum_probs=41.6
Q ss_pred cee-cccCceEEEEEEEC-------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-c--CceeeEEEEeecc
Q 042958 821 HCI-GKGGQGSVYKAELA-------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-H--RNIVKFYGFCSHV 886 (1075)
Q Consensus 821 ~~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~ 886 (1075)
+.| +.|....+|+.+.. +++.+++|+..............+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 557 88999999998654 26788999864321000000134667888888774 3 3567788777554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00098 Score=71.30 Aligned_cols=130 Identities=14% Similarity=0.133 Sum_probs=83.6
Q ss_pred ceecccCce-EEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchhheecCc
Q 042958 821 HCIGKGGQG-SVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 821 ~~lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...++.+. +--|.++++++.+.+..+.+ ++..
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv-me~l 102 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL-TTAI 102 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE-EECC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE-EEee
Confidence 345566665 69988654 466789998542 12457888999998883 33467788888765443222 2211
Q ss_pred cccCC------CCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------------------
Q 042958 898 AAAKD------LGWTRRMNVIKGISDALSYMHNDCF-------------------------------------------- 927 (1075)
Q Consensus 898 ~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~-------------------------------------------- 927 (1075)
.+ .. .....+..++.++++.+..||+...
T Consensus 103 ~G-~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 103 PG-KTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp CS-EEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred CC-ccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 11 11 0112334566777777777775321
Q ss_pred -----------CCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 928 -----------PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 928 -----------~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1379999999999999877677999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0022 Score=69.25 Aligned_cols=65 Identities=20% Similarity=0.262 Sum_probs=46.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc---CceeeEEEE
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH---RNIVKFYGF 882 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~ 882 (1075)
.+....+.+|.|..+.||+.+..||+.|+||+........ ...|..|.+.|+.+.. -.+.+++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~ 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec
Confidence 3445567899999999999999999999999865432221 2467889988888732 234555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0026 Score=59.12 Aligned_cols=58 Identities=28% Similarity=0.291 Sum_probs=39.3
Q ss_pred ceeecCCCccc-CcccccccccccceEEEccccccccccchhcccccccceeeeccccccC
Q 042958 598 EHLDLSSNRLS-NSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLRE 657 (1075)
Q Consensus 598 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 657 (1075)
..+|.+++.++ ..+|..+. ++|++|+|++|+|+...+..|..+.+|+.|+|++|.+..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 36777777775 24554433 357777777777777666667777777777777777754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0048 Score=70.04 Aligned_cols=64 Identities=16% Similarity=0.050 Sum_probs=38.2
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEccCCCC--Cc--hhHHHHHHHHHHHHhcCCc--C-ceeeEEEEe
Q 042958 820 EHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLP--GE--MTFQQEFLNEVKALTEIRH--R-NIVKFYGFC 883 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~ 883 (1075)
.+.+|.|..+.||++... +++.|+||....... .. ....+.+..|.++++.+.. + .+.+++.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d 106 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD 106 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc
Confidence 357999999999999654 478899998643211 00 0112456678888887632 3 345566543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0035 Score=58.31 Aligned_cols=38 Identities=21% Similarity=0.288 Sum_probs=19.8
Q ss_pred cceeecCCCccccCChhhhcccccccEEeecCCccCCC
Q 042958 669 LENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGP 706 (1075)
Q Consensus 669 L~~L~ls~N~l~~~~p~~~~~~~~l~~l~~s~N~~~~~ 706 (1075)
|+.|+|++|.|+.+.+..|..++.|+.|++++|+|.+.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 44555555555544445555555555555555555443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.012 Score=63.92 Aligned_cols=127 Identities=13% Similarity=0.041 Sum_probs=75.6
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce-eeEEEEeeccccchhheecCcc
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI-VKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.+.++.|....+|+. +.+++|+........ .....|+.+++.+....+ .++++++.+.+..+..++ .
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i---~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYI---A 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECC---T
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeec---C
Confidence 678999999999999 558888875421111 112457777766632222 456655443232222222 1
Q ss_pred ccCCCCHHHH---HHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 042958 899 AAKDLGWTRR---MNVIKGISDALSYMHNDC------------------------------------------------- 926 (1075)
Q Consensus 899 ~~~~l~~~~~---~~i~~~i~~~L~~LH~~~------------------------------------------------- 926 (1075)
.+..+..... ..++.++++.|+-+|+..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 2333333222 225566666666676532
Q ss_pred -CCCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 927 -FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 927 -~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.+.++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 123799999999999 56778899999988653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.045 Score=62.39 Aligned_cols=77 Identities=13% Similarity=0.121 Sum_probs=47.8
Q ss_pred CCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceecccc--ccCccCccccccC---CCCcccchHhHHHHHHHH
Q 042958 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG--TYGYVAPELAYTM---KVTEKCDVYSFGVLALEV 1002 (1075)
Q Consensus 928 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~el 1002 (1075)
+.++|+|+++.||+++.++ ++++||+.+....+... ...... ...|.+|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999776 99999998875332111 011111 1346666654311 112234556777788877
Q ss_pred HhCC
Q 042958 1003 IKGK 1006 (1075)
Q Consensus 1003 ltg~ 1006 (1075)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.036 Score=60.06 Aligned_cols=59 Identities=17% Similarity=0.211 Sum_probs=43.6
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC---cCceeeEEEEeec
Q 042958 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSH 885 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 885 (1075)
.+.|+.|....+|+.+.. +..+++|+.... ....+..|.+.++.+. ...|.++++++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~ 102 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS 102 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec
Confidence 467999999999999764 778899986421 2467889999888883 2557777776543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.031 Score=61.66 Aligned_cols=44 Identities=20% Similarity=0.255 Sum_probs=34.4
Q ss_pred HHHHHHHHHh----------CCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 915 ISDALSYMHN----------DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 915 i~~~L~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.+++++|+. ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4456677763 0234899999999999998888999999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.78 E-value=0.098 Score=52.23 Aligned_cols=93 Identities=17% Similarity=0.142 Sum_probs=60.0
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCceeccccccCccCcc
Q 042958 900 AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979 (1075)
Q Consensus 900 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE 979 (1075)
+.++++++.|.++.|.+.+|.-.-.... + ..+=+.|..|++..+|.+...+ +.+. .....+.|||
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~~~~~pe 107 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEPPPVAGK 107 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------------------C
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------ccccCCCChh
Confidence 5679999999999999999877622111 1 1223456889999999988764 1111 1123466888
Q ss_pred ccccCCCCcccchHhHHHHHHHHHhCCCC
Q 042958 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 1008 (1075)
Q Consensus 980 ~~~~~~~~~~~Dv~s~G~vl~elltg~~p 1008 (1075)
... ...+.+.=|||+|+++|.-+--..|
T Consensus 108 ~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 108 LGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp CSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred hcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 763 3456788999999999999875555
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.73 E-value=0.072 Score=60.73 Aligned_cols=58 Identities=19% Similarity=0.332 Sum_probs=38.9
Q ss_pred ceecccCceEEEEEEECC--------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCc-eeeEEEEe
Q 042958 821 HCIGKGGQGSVYKAELAS--------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFYGFC 883 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~ 883 (1075)
+.|+.|....||++...+ ++.|++|+.... .. .+.+..|..+++.+...+ ..++++.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 568889999999998753 578999987432 11 134557888888874333 35566654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.075 Score=58.37 Aligned_cols=33 Identities=33% Similarity=0.344 Sum_probs=28.2
Q ss_pred CCeEEecCCCCCeeeCCC----CCceEeccccccccC
Q 042958 928 PPIVHRDISSKNVLLDFD----NEAHVSDFGIAKFLK 960 (1075)
Q Consensus 928 ~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~~~ 960 (1075)
+.++|||+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 479999999999999875 678999999887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.98 E-value=0.18 Score=57.64 Aligned_cols=59 Identities=19% Similarity=0.149 Sum_probs=36.1
Q ss_pred ceecccCceEEEEEEECC-CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCce-eeEEEEe
Q 042958 821 HCIGKGGQGSVYKAELAS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI-VKFYGFC 883 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~ 883 (1075)
+.|+.|....+|+....+ +..+++|+.......-. .-..|..+++.+...++ .++++++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i----dR~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII----NREREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS----CHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc----CHHHHHHHHHHHHhcCCCCCEEEEe
Confidence 568889999999998764 47888998743211111 11478888887754333 4566655
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.90 E-value=0.16 Score=55.47 Aligned_cols=63 Identities=13% Similarity=0.083 Sum_probs=39.3
Q ss_pred ccHHHHHHHhcCCCC-----CceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC
Q 042958 805 IVYEEIIRATNDFDD-----EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872 (1075)
Q Consensus 805 ~~~~e~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 872 (1075)
.+.+++....+.|.. ...++ |....||+....+|+.+++|+...... . ...+..|..+++.+.
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-T---ADQILEEHQFALQLV 78 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHH
Confidence 344444444444432 24566 888899998777787899999863211 1 345666777777663
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.75 E-value=0.21 Score=54.39 Aligned_cols=44 Identities=23% Similarity=0.277 Sum_probs=32.4
Q ss_pred HHHHHHHHHhC----CCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 915 ISDALSYMHND----CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 915 i~~~L~~LH~~----~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.+.++++++. ..++++|+|+.+.||+++.+..+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 44556666532 124799999999999998775568999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.58 E-value=0.12 Score=57.42 Aligned_cols=132 Identities=15% Similarity=0.202 Sum_probs=71.3
Q ss_pred ceecccCceEEEEEEEC--------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeeccccchh
Q 042958 821 HCIGKGGQGSVYKAELA--------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~l~ 891 (1075)
+.+..|....+|+.... +++.|++|+..... . ....+.+|.++++.+. +.-..++++++... .+.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEE
Confidence 56778888999999764 25789999863211 1 1345668988888773 32235566655331 111
Q ss_pred hee--------------------------cCc--cccCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 042958 892 MIL--------------------------SNN--AAAKDLG--WTRRMNVIKGISD-------------------ALSYM 922 (1075)
Q Consensus 892 ~~~--------------------------~~~--~~~~~l~--~~~~~~i~~~i~~-------------------~L~~L 922 (1075)
.++ +.. ..+.... |.+..++..++.. .+++|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 110 000 0011122 3444444433321 22333
Q ss_pred ----HhC-CCCCeEEecCCCCCeeeCCC----CCceEeccccccc
Q 042958 923 ----HND-CFPPIVHRDISSKNVLLDFD----NEAHVSDFGIAKF 958 (1075)
Q Consensus 923 ----H~~-~~~~ivH~Dlk~~Nill~~~----~~~kl~DfGla~~ 958 (1075)
... ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 22368999999999999876 6899999988764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.62 E-value=0.16 Score=55.83 Aligned_cols=32 Identities=22% Similarity=0.311 Sum_probs=28.3
Q ss_pred CCeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 928 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
+.++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998889999999887653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.51 E-value=0.14 Score=57.04 Aligned_cols=30 Identities=20% Similarity=0.340 Sum_probs=24.8
Q ss_pred CCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 928 PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 928 ~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.++|+|+++.||+++.+. +.++||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3689999999999998654 89999987763
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.00 E-value=0.43 Score=33.96 Aligned_cols=23 Identities=22% Similarity=0.390 Sum_probs=10.2
Q ss_pred HHHHHHHHHHHHHHHhhhheecc
Q 042958 758 LLGIVALLISLIGLFFKFQRRNN 780 (1075)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~r~~~ 780 (1075)
+.++++++++++.+++++|||++
T Consensus 18 VgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 18 VGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHHHHHHHHHHHhhhhHh
Confidence 33344444444444445554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.68 E-value=0.4 Score=33.99 Aligned_cols=21 Identities=19% Similarity=0.312 Sum_probs=9.0
Q ss_pred HHHHHHHHHHHHHhhhheecc
Q 042958 760 GIVALLISLIGLFFKFQRRNN 780 (1075)
Q Consensus 760 ~~~~~~~~~~~~~~~~~r~~~ 780 (1075)
++++++++++..++++|||++
T Consensus 19 Gv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 19 GLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHhhhhhh
Confidence 344434444444444444433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1075 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-28 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-12 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-09 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-55
Identities = 63/279 (22%), Positives = 117/279 (41%), Gaps = 27/279 (9%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
EI IG G G+VYK + VAVK + P Q F NEV L
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTP-QQLQAFKNEVGVL 58
Query: 869 TEIRHRNIVKFYGFCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALS 920
+ RH NI+ F G+ + + ++ + +++ + + +
Sbjct: 59 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAP 978
Y+H I+HRD+ S N+ L D + DFG+A S + + +L+G+ ++AP
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 979 ELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLP 1035
E+ + + DVY+FG++ E++ G+ P S++++ + + L P L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLS 232
Query: 1036 TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ CL + + RP P++ ++
Sbjct: 233 KVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 49/270 (18%), Positives = 101/270 (37%), Gaps = 27/270 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+G G G V+ VAVK FL E + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQHQ 68
Query: 875 NIVKFYGFCSHVRHSLAM---------ILSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
+V+ Y + + + L + +++ I++ ++++
Sbjct: 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW-TELAGTYGYVAPELAYTM 984
+HRD+ + N+L+ ++DFG+A+ ++ + + APE
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 985 KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
T K DV+SFG+L E++ M++ + N+ R+ P ++
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNL----ERGYRMVRPDNCPEE- 238
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ C E PE RPT + +L+
Sbjct: 239 ---LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 32/276 (11%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
D++ + IG G G K + G+I+ K+ E +Q ++EV L E++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 875 NIVKFYGFCSHVRH-------------SLAMILSNNAAAKD-LGWTRRMNVIKGISDALS 920
NIV++Y + LA +++ + L + V+ ++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 921 YMH--NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAP 978
H +D ++HRD+ NV LD + DFG+A+ L D+S GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
E M EK D++S G L E+ P S ++ + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIP 235
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
D+L I+ L+ RP++ ++L+
Sbjct: 236 YRYSDELNEIIT---RMLNLKDYHRPSV---EEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-50
Identities = 57/276 (20%), Positives = 107/276 (38%), Gaps = 29/276 (10%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
EI R E +G+G G V+ VA+K + FL E + +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVM 66
Query: 869 TEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKDL---------GWTRRMNVIKGISDAL 919
++RH +V+ Y S + + + D + +++ I+ +
Sbjct: 67 KKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD-SSNWTELAGTYGYVAP 978
+Y+ VHRD+ + N+L+ + V+DFG+A+ ++ + + + AP
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 979 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
E A + T K DV+SFG+L E+ M + + + R+P P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQV----ERGYRMPCPP 237
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + ++ C + PE RPT + L+
Sbjct: 238 ECPES----LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-50
Identities = 55/273 (20%), Positives = 109/273 (39%), Gaps = 33/273 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
++ IG G G V+ + + VA+K +++F+ E + + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSHP 60
Query: 875 NIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
+V+ YG C L+ L + + + + ++Y+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE-LAGTYGYVAPELAY 982
++HRD++++N L+ + VSDFG+ +F+ D + + +PE+
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALD-EMLDPRLPTPSCIV 1041
+ + K DV+SFGVL EV + S+S + +I+ + PRL +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGFRLYKPRLASTHVY- 232
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ C E PE RP ++ + L
Sbjct: 233 --------QIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
DF+ +GKG G+VY A S I+A+K + + + EV+ + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
NI++ YG+ ++ L R I +++ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+ ++HRDI +N+LL E ++DFG + SS T L GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
EK D++S GVL E + GK P + + + P + +
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDFVTE 229
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ L NP RP + ++L+
Sbjct: 230 G----ARDLISRLLKHNPSQRPML---REVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 29/270 (10%)
Query: 819 DEHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
++ +G G G+V K + VAVK + + + E L E + ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPY 69
Query: 876 IVKFYGFCSHVRHSLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFP 928
IV+ G C L M ++ + + + ++ +S + Y+
Sbjct: 70 IVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ES 126
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVAPELAYTMK 985
VHRD++++NVLL + A +SDFG++K L+ D + + T + APE K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 986 VTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044
+ K DV+SFGVL E G+ P M S + + E R+ P+ ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEKGE----RMGCPAGCPRE- 238
Query: 1045 LISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ C + E+RP V L+
Sbjct: 239 ---MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 63/271 (23%), Positives = 104/271 (38%), Gaps = 33/271 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ IGKG G V + G VAVK + Q FL E +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 875 NIVKFYGFCSHVRHSLAMILS-----------NNAAAKDLGWTRRMNVIKGISDALSYMH 923
N+V+ G + L ++ + LG + + +A+ Y+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 983
VHRD++++NVL+ DN A VSDFG+ K SS + APE
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALRE 174
Query: 984 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
K + K DV+SFG+L E+ + + + ++ P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRV----EKGYKMDAPDGCPPA 228
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ EV +C + RP+ ++ + L+
Sbjct: 229 ----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-48
Identities = 63/306 (20%), Positives = 110/306 (35%), Gaps = 56/306 (18%)
Query: 813 ATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
+DF+ +G G G V+K SG ++A K H L + + + + E++ L E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHEC 61
Query: 872 RHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALS 920
IV FYG SL +L + V + L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLT 118
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+ I+HRD+ N+L++ E + DFG++ L + GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHP------------------------------RD 1010
+ + D++S G+ +E+ G++P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 1011 FISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS--IVEVAISCLDENPESRPTMPK 1068
S +A+ E+LD + P + + S + CL +NP R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL-- 292
Query: 1069 VSQLLK 1074
QL+
Sbjct: 293 -KQLMV 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 4e-48
Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 48/298 (16%)
Query: 807 YEEIIRATNDFDDE---------HCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPG 853
+E+ A +F E IG G G V L VA+K S
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 854 EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKD 902
+ +++FL+E + + H N++ G + SL L N
Sbjct: 69 KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 903 LGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962
+ + +++GI+ + Y+ + VHRD++++N+L++ + VSDFG+++FL+ D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 963 SSNWTELA-----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMS 1016
+S+ T + + APE K T DV+S+G++ EV+ G+ P M+
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMT 238
Query: 1017 SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + I D RLP P + ++ + C ++ RP ++ L
Sbjct: 239 NQDVINAI----EQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 58/275 (21%), Positives = 106/275 (38%), Gaps = 34/275 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
D +G G G V + VA+K + EF+ E K + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHE 59
Query: 875 NIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
+V+ YG C+ R L L + + + K + +A+ Y+
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAY 982
+HRD++++N L++ VSDFG+++++ D + PE+
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 983 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
K + K D+++FGVL E+ GK P + ++ ++ RL P
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------GLRLYRPHLAS 227
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKV-SQLLKI 1075
+ + + SC E + RPT + S +L +
Sbjct: 228 EK----VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (425), Expect = 5e-47
Identities = 61/278 (21%), Positives = 113/278 (40%), Gaps = 31/278 (11%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKA 867
E+ R D +H +G G G VY+ VAVK + +EFL E
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAV 66
Query: 868 LTEIRHRNIVKFYGFCSH----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISD 917
+ EI+H N+V+ G C+ + + + +++ + + IS
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN-WTELAGTYGYV 976
A+ Y+ +HRD++++N L+ ++ V+DFG+++ + D+ +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036
APE K + K DV++FGVL E+ + S + + D R+
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELL----EKDYRMER 237
Query: 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P + + E+ +C NP RP+ ++ Q +
Sbjct: 238 PEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-47
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 43/292 (14%)
Query: 820 EHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 879
+ IGKG G V++ + GE VAVK F S E ++ +E E+ +RH NI+ F
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 62
Query: 880 YGFCSHVRHSLAMI-----------LSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCF- 927
+ + + L + + + + + L+++H +
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 928 ----PPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW----TELAGTYGYVAPE 979
P I HRD+ SKN+L+ + ++D G+A + GT Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 980 LAYTM------KVTEKCDVYSFGVLALEVIKGKHP-----------RDFISSMSSSSLNL 1022
+ + ++ D+Y+ G++ E+ + D + S S
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ L P +P + L + ++ C N +R T ++ + L
Sbjct: 243 KVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 59/283 (20%), Positives = 111/283 (39%), Gaps = 32/283 (11%)
Query: 808 EEIIRATNDFD-DEHCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLN 863
+++ ++ + +G G GSV + VA+K E +E +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58
Query: 864 EVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGI 915
E + + ++ + IV+ G C L M ++ +++ + ++ +
Sbjct: 59 EAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE---LAGT 972
S + Y+ VHRD++++NVLL + A +SDFG++K L D S +T
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLD 1031
+ APE K + + DV+S+GV E + G+ P M + I +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMAFIEQGK--- 229
Query: 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
R+ P + + + C E RP V Q ++
Sbjct: 230 -RMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 29/276 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
D +G G G V + E VAVK + + +F+ EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 871 IRHRNIVKFYGFCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYM 922
+ HRN+++ YG + L+ +++ + Y+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVAPE 979
+ +HRD++++N+LL + + DFG+ + L + ++ + + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 980 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
T + D + FGV E+ G+ P ++ S + I + RLP P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKE---GERLPRPE 238
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
QD I V + C PE RPT + L
Sbjct: 239 DCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 40/288 (13%)
Query: 807 YEEIIRATN---DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFL 862
YE + R N ++ +G G G VYKA+ + + A K + E+ ++++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNV 911
E+ L H NIVK + + ++ ++ + L ++ V
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVV 115
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAG 971
K DAL+Y+H+ I+HRD+ + N+L D + ++DFG++ G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 972 TYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026
T ++APE+ K DV+S G+ +E+ + + P ++ M + L IA
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK 229
Query: 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
E P L PS + ++ CL++N ++R T SQLL+
Sbjct: 230 SE--PPTLAQPSRWSSN-FKDFLK---KCLEKNVDARWTT---SQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 2e-46
Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 34/271 (12%)
Query: 817 FDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
F D IG G G+VY A + + E+VA+KK Q+ + EV+ L ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 876 IVKFYGFCSHVRHSLAMIL---------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDC 926
+++ G H+ +++ K L V G L+Y+H+
Sbjct: 77 TIQYRGCYLR-EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 927 FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-- 984
++HRD+ + N+LL + DFG A + P +S GT ++APE+ M
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDE 188
Query: 985 -KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043
+ K DV+S G+ +E+ + K P +++MS + S +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPALQSGHWSE 241
Query: 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ V+ SCL + P+ RPT LLK
Sbjct: 242 YFRNFVD---SCLQKIPQDRPTS---EVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-46
Identities = 64/269 (23%), Positives = 123/269 (45%), Gaps = 26/269 (9%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ IG+G G+VY A ++A+G+ VA+++ + + ++ +NE+ + E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 873 HRNIVKFYGFCSHVRHS-LAMILSNNAAAKDLGWTRRMN------VIKGISDALSYMHND 925
+ NIV + + M + D+ M+ V + AL ++H++
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
++HRDI S N+LL D ++DFG + P+ S + + GT ++APE+
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 986 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045
K D++S G++A+E+I+G+ P +++ +L L P L P +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGT---PELQNPEKLSAI-F 246
Query: 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ CLD + E R + +LL+
Sbjct: 247 RDFLN---RCLDMDVEKRGSA---KELLQ 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-46
Identities = 58/272 (21%), Positives = 113/272 (41%), Gaps = 33/272 (12%)
Query: 817 FDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 875
FD E IG+G +VYK + VA + + + +Q F E + L ++H N
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 876 IVKFYGFCSHV---RHSLAMIL---------SNNAAAKDLGWTRRMNVIKGISDALSYMH 923
IV+FY + + ++ + K + + + I L ++H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 924 NDCFPPIVHRDISSKNVLL-DFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
PPI+HRD+ N+ + + D G+A + + + GT ++APE+ Y
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-Y 185
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
K E DVY+FG+ LE+ ++P + +++ + + + + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFDKVAI 239
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ I+E C+ +N + R ++ LL
Sbjct: 240 PEVKEIIE---GCIRQNKDERYSI---KDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-45
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 34/278 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGE-----IVAVKKFHSPLPGEMTFQQEFLNEVKALT 869
+ + IG G G VYK L + VA+K + + + +FL E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64
Query: 870 EIRHRNIVKFYGFCSHVRHS-LAMILSNNAAAKD--------LGWTRRMNVIKGISDALS 920
+ H NI++ G S + + N A + + +++GI+ +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVA 977
Y+ N VHRD++++N+L++ + VSDFG+++ L+ D + + A
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP-RLPT 1036
PE K T DV+SFG++ EV+ + L+ + + + D RLPT
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFRLPT 234
Query: 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P I ++ + C + RP + +L
Sbjct: 235 PMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 27/267 (10%)
Query: 823 IGKGGQGSVYKAELA----SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 878
IG+G G VY L AVK + ++ +FL E + + H N++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 879 FYGFCSHVRHSLAMILS--NNAAAKDLGWTRR-----MNVIKGISDALSYMHNDCFPPIV 931
G C S ++L + ++ ++I M V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 932 HRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS----SNWTELAGTYGYVAPELAYTMKVT 987
HRD++++N +LD V+DFG+A+ + N T ++A E T K T
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 988 EKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLIS 1047
K DV+SFGVL E++ P +++ + + + + RL P
Sbjct: 213 TKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYL----LQGRRLLQPEYCPDP---- 262
Query: 1048 IVEVAISCLDENPESRPTMPKVSQLLK 1074
+ EV + C E RP+ ++ +
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAE-LASGE----IVAVKKFHSPLPGEMTFQQEFLN 863
I++ T +F +G G G+VYK + GE VA+K+ + +E L+
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 864 EVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN--------AAAKDLGWTRRMNVIKGI 915
E + + + ++ + G C L L ++G +N I
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTY 973
+ ++Y+ +VHRD++++NVL+ ++DFG+AK L + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 974 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033
++A E T + DV+S+GV E++ + +S ++ + E R
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGE----R 231
Query: 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
LP P D + + + C + +SRP ++
Sbjct: 232 LPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-44
Identities = 63/267 (23%), Positives = 105/267 (39%), Gaps = 26/267 (9%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
D+D +G+G G V A + E VAVK + + + E+ + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 874 RNIVKFYGFCSHVRHS-LAMILSNNAAAKD-------LGWTRRMNVIKGISDALSYMHND 925
N+VKFYG L + + D + + + Y+H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYT 983
I HRDI +N+LLD + +SDFG+A + ++ ++ GT YVAPEL
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 984 MKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
+ E DV+S G++ ++ G+ P D S + + + + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKV 1069
L+ L ENP +R T+P +
Sbjct: 238 -ALLH------KILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-44
Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 32/280 (11%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNE 864
EI R + CIG+G G V++ S VA+K + + +++FL E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQE 58
Query: 865 VKALTEIRHRNIVKFYGFCSHVRHSLAMILSNNAAAKD--------LGWTRRMNVIKGIS 916
+ + H +IVK G + + M L + L + +S
Sbjct: 59 ALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS-NWTELAGTYGY 975
AL+Y+ + VHRDI+++NVL+ ++ + DFG++++++ + ++ +
Sbjct: 119 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 976 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
+APE + T DV+ FGV E++ G P + + N RL
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERL 228
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P P + + C +P RP ++ L
Sbjct: 229 PMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 3e-43
Identities = 51/300 (17%), Positives = 110/300 (36%), Gaps = 55/300 (18%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKAL 868
N+ + IG+G G V++A +VAVK +M Q +F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 869 TEIRHRNIVKFYGFCSHVRH-----------SLAMILSNN-------------------- 897
E + NIVK G C+ + L L +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 898 -AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956
L ++ + + ++ ++Y+ VHRD++++N L+ + ++DFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 957 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 1014
+ + A ++ PE + + T + DV+++GV+ E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY--- 244
Query: 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + + D + +L +++ C + P RP+ + ++L+
Sbjct: 245 ----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-42
Identities = 56/307 (18%), Positives = 110/307 (35%), Gaps = 58/307 (18%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKA------ELASGEIVAVKKFHSPLPGEMTFQQEFL 862
E R + + +G G G V A + VAVK + + ++ +
Sbjct: 33 EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALM 88
Query: 863 NEVKALTEI-RHRNIVKFYGFC-------------------------------SHVRHSL 890
+E+K +T++ H NIV G C + +
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 891 AMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHV 950
L L + + ++ + ++ VHRD++++NVL+ +
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 205
Query: 951 SDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKH 1007
DFG+A+ + DS+ ++APE + T K DV+S+G+L E+ G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 1008 PRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMP 1067
P + + + + ++ P ++ I + SC + RP+ P
Sbjct: 266 PYP---GIPVDANFYKLIQN---GFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFP 315
Query: 1068 KVSQLLK 1074
++ L
Sbjct: 316 NLTSFLG 322
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 54/273 (19%), Positives = 97/273 (35%), Gaps = 22/273 (8%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTE 870
+ DF +G+G +V A ELA+ A+K + E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 871 IRHRNIVKFYGFCSHVRHSLAMIL---SNNAAAKDLGWTRRMN---VIKGISDALSYMHN 924
+ H VK Y L L N K + + ++ +S +
Sbjct: 65 LDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 925 DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAY 982
I+HRD+ +N+LL+ D ++DFG AK L P+S GT YV+PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042
+ D+++ G + +++ G P + N + +++ P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLKI 1075
+VE L + R ++ +
Sbjct: 236 K-ARDLVE---KLLVLDATKRLGCEEMEGYGPL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 155 bits (393), Expect = 5e-42
Identities = 56/285 (19%), Positives = 112/285 (39%), Gaps = 37/285 (12%)
Query: 804 KIVYEEIIRATNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFL 862
+I ++ ++ + +D +G G G V++ E A+G A K +P + ++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVR 71
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNV 911
E++ ++ +RH +V + L +++ + +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEY 129
Query: 912 IKGISDALSYMHNDCFPPIVHRDISSKNVLL--DFDNEAHVSDFGIAKFLKPDSSNWTEL 969
++ + L +MH + VH D+ +N++ NE + DFG+ L P S
Sbjct: 130 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 185
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEM 1029
GT + APE+A V D++S GVL+ ++ G P F +L + D
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWN 243
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+D + + + + L +P +R T+ Q L+
Sbjct: 244 MDDSAFSG---ISEDGKDFIR---KLLLADPNTRMTI---HQALE 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 56/288 (19%), Positives = 109/288 (37%), Gaps = 44/288 (15%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI 871
ND + IG+G G V KA + A+K+ + ++F E++ L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67
Query: 872 -RHRNIVKFYGFCSHVRH-----------SLAMILSN-------------NAAAKDLGWT 906
H NI+ G C H + +L L N+ A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 907 RRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966
+ ++ ++ + Y+ +HRD++++N+L+ + A ++DFG+++ +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 967 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIAL 1026
++A E T DV+S+GVL E++ M+ + L +
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKL-- 239
Query: 1027 DEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
RL P + + ++ C E P RP+ ++ L
Sbjct: 240 --PQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-41
Identities = 58/303 (19%), Positives = 115/303 (37%), Gaps = 55/303 (18%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFL 862
E R N +G G G V +A + VAVK +T ++ +
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALM 74
Query: 863 NEVKALTEI-RHRNIVKFYGFCSHVRH-----------SLAMILSNN------------- 897
+E+K L+ + H NIV G C+ L L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 898 --AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGI 955
L ++ ++ ++++ + +HRD++++N+LL + DFG+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 956 AKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 1013
A+ +K DS+ ++APE + T + DV+S+G+ E+
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-- 249
Query: 1014 SMSSSSLNLNIALDEMLD--PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071
+ ++ +M+ R+ +P + + ++ +C D +P RPT ++ Q
Sbjct: 250 -----GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 1072 LLK 1074
L++
Sbjct: 301 LIE 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (382), Expect = 5e-41
Identities = 49/268 (18%), Positives = 99/268 (36%), Gaps = 23/268 (8%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
DF +G G G V+ +G A+K + + + +E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 874 RNIVKFYGFCSHVRHSLAMI-LSNNAAAKDLGWTRR----MNVIKGISDALSYMHNDCFP 928
I++ +G + ++ L + ++ +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
I++RD+ +N+LLD + ++DFG AK++ L GT Y+APE+ T +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 989 KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048
D +SFG+L E++ G P ++M +++L+ L P +D + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPFFNED-VKDL 231
Query: 1049 VEVAISCLDENPESRPTM--PKVSQLLK 1074
+ + + R +
Sbjct: 232 LS---RLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 6e-41
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 27/268 (10%)
Query: 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
++ ++ +G GG V+ A L VAVK + L + +F F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 873 HRNIVKFYGFCSHVRHS-----LAMILSNN-------AAAKDLGWTRRMNVIKGISDALS 920
H IV Y + + M + + R + VI AL+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTE---LAGTYGYVA 977
+ H I+HRD+ N+++ N V DFGIA+ + ++ T+ + GT Y++
Sbjct: 126 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 978 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037
PE A V + DVYS G + EV+ G+ P + S S+ ++ + P
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 1038 SCIVQDKLISIVEVAISCLDENPESRPT 1065
+ L ++V L +NPE+R
Sbjct: 240 G--LSADLDAVVL---KALAKNPENRYQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 57/273 (20%), Positives = 95/273 (34%), Gaps = 33/273 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT-EIR 872
DF +GKG G V+ AE + + A+K + + + E + L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 873 HRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
H + + + L + + +R I L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H+ IV+RD+ N+LLD D ++DFG+ K + GT Y+APE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
K D +SFGVL E++ G+ P L +I +D PR
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMDNPFYPRWLEKEAK- 231
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L+ PE R + + +
Sbjct: 232 --DLLV------KLFVREPEKRLGVR--GDIRQ 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 3e-40
Identities = 48/284 (16%), Positives = 96/284 (33%), Gaps = 32/284 (11%)
Query: 811 IRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT 869
+R N + IG G G +Y +A+GE VA+K T + E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 870 EIRHRNIVKFYGFCSHVRHSLAMI---------LSNNAAAKDLGWTRRMNVIKGISDALS 920
++ + +C M+ N ++ + + + +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 921 YMHNDCFPPIVHRDISSKNVL---LDFDNEAHVSDFGIAKFLKPDSSN-------WTELA 970
Y+H+ +HRD+ N L N ++ DFG+AK + ++ L
Sbjct: 118 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 971 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030
GT Y + ++ + + D+ S G + + G P + + + I+ +M
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P + + + C + +P + QL +
Sbjct: 235 TPIEVLCKGYPSE-FATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (379), Expect = 4e-40
Identities = 51/274 (18%), Positives = 101/274 (36%), Gaps = 34/274 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+ +D +G G G V++ E A+G + K ++P P + + NE+ + ++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHH 85
Query: 874 RNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
++ + L ++ + +N ++ + L +M
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHM 143
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
H IVH DI +N++ + + V DFG+A L PD T + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEI 199
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
V D+++ GVL ++ G P + N+ + S +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLETLQNV-KRCDWEFDEDAFSSV 255
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++ + L + P R T+ L+
Sbjct: 256 SPE-AKDFIK---NLLQKEPRKRLTV---HDALE 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 53/273 (19%), Positives = 104/273 (38%), Gaps = 25/273 (9%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVK---KFHSPLPGEMTFQQEFLNEVKALTE 870
+ +D +G G V K E ++G A K K + +++ EV L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 871 IRHRNIVKFYGFCSHVRHS-LAMILSNNAAAKDLGWTRRM----NVIKGISDALSYMHND 925
I+H N++ + + L + L D + + + L+ ++
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 926 CFPPIVHRDISSKNVLLDFDNEA----HVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
I H D+ +N++L N + DFG+A + + + + GT +VAPE+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIV 188
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
+ + D++S GV+ ++ G P + + + + E D S +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFEDEYFSNTSALA 247
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+D I L ++P+ R T+ L+
Sbjct: 248 KD-FIR------RLLVKDPKKRMTI---QDSLQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 35/266 (13%)
Query: 823 IGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G+G G V++ E +S + K + T Q E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 882 FCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
+ + ++ +A +L ++ + + +AL ++H+ I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 931 VHRDISSKNVLLDFDNEAHV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
H DI +N++ + + +FG A+ LKP + L Y APE+ V+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVST 182
Query: 989 KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048
D++S G L ++ G +P + ++ + NI E + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINP---FLAETNQQIIENIMNAEYTFDEEAFKE--ISIEAMDF 237
Query: 1049 VEVAISCLDENPESRPTMPKVSQLLK 1074
V+ L + +SR T S+ L+
Sbjct: 238 VD---RLLVKERKSRMTA---SEALQ 257
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 5e-38
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 39/289 (13%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ IG+G G VYKA+ GE A+KK E + E+ L E++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 875 NIVKFYGFCSH-----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMH 923
NIVK Y + ++ L + + + + ++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH 117
Query: 924 NDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 982
+ ++HRD+ +N+L++ + E ++DFG+A+ +T T Y AP+ L
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMS------------SSSLNLNIALDEML 1030
+ K + D++S G + E++ G +S +S N+
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1031 DPRLPTPSCIVQDKLISIV-EVAI----SCLDENPESRPTMPKVSQLLK 1074
DP + + + + E I L +P R T Q L+
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA---KQALE 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-38
Identities = 57/292 (19%), Positives = 107/292 (36%), Gaps = 43/292 (14%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFL 862
E+ R +G+G G VY+ VA+K + M + EFL
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 71
Query: 863 NEVKALTEIRHRNIVKFYGFCSHVRH-----------SLAMIL-------SNNAAAKDLG 904
NE + E ++V+ G S + L L +NN
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 905 WTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964
++ + + I+D ++Y++ VHRD++++N ++ D + DFG+ + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 965 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL 1022
+ +++PE T DV+SFGV+ E+ L+
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSN 241
Query: 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L +++ L D L ++ C NP+ RP+ ++ +K
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 7e-38
Identities = 61/273 (22%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ +D +G G V AE + ++VA+K + NE+ L +I+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KKALEGKEGSMENEIAVLHKIK 65
Query: 873 HRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
H NIV H L + +I + DA+ Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKY 122
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 981
+H+ + + LD D++ +SDFG++K P S T GT GYVAPE+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 181
Query: 982 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041
++ D +S GV+A ++ G P + + L I L + P I
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQI-LKAEYEFDSPYWDDIS 237
Query: 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ ++++PE R T Q L+
Sbjct: 238 DS-AKDFIR---HLMEKDPEKRFTC---EQALQ 263
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-37
Identities = 51/268 (19%), Positives = 97/268 (36%), Gaps = 20/268 (7%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
NDFD +GKG G V A+G A+K + + E + L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 874 RNIVKFYGFCSHVRHSLAMILSNNAAAKDLGWTRRMN-----VIKGISDALSYMHNDCFP 928
+ ++ N +R ++ +S +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 988
+V+RDI +N++LD D ++DFG+ K D + GT Y+APE+
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 989 KCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISI 1048
D + GV+ E++ G+ P + + + +L + P + + S+
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIRFPRTLSPE-AKSL 235
Query: 1049 VEVAISCLDENPESRPTM--PKVSQLLK 1074
+ L ++P+ R ++++
Sbjct: 236 LA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-36
Identities = 56/295 (18%), Positives = 107/295 (36%), Gaps = 50/295 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKAEL--------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVK 866
+ +G+G G V AE VAVK S + + ++E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 867 ALTEI-RHRNIVKFYGFCSHVRH-----------SLAMIL-------------SNNAAAK 901
+ I +H+NI+ G C+ +L L ++ +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 902 DLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961
L ++ ++ + Y+ + +HRD++++NVL+ DN ++DFG+A+ +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 962 DSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSS 1019
++APE + T + DV+SFGVL E+ +
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEE 245
Query: 1020 LNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
L + R+ PS + + + C P RPT ++ + L
Sbjct: 246 LFKLL----KEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 60/280 (21%), Positives = 102/280 (36%), Gaps = 34/280 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEM--TFQQEFLNEVKALTEIRHRNIVKF 879
+G+G +VYKA + +IVA+KK E + L E+K L E+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 880 YGFCSHVRH-SLAMILSNNAAAKDLGWTRRMN----VIKGISDALSYMHNDCFPPIVHRD 934
H + SL + + + + L + I+HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVY 993
+ N+LLD + ++DFG+AK + +T T Y APEL + ++ D++
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185
Query: 994 SFGVLALEVIKGKHPRDFISSM-------------------SSSSLNLNIALDEMLDPRL 1034
+ G + E++ S + SL + L
Sbjct: 186 AVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
D L+ +++ NP +R T +Q LK
Sbjct: 246 HHIFSAAGDDLLDLIQ---GLFLFNPCARITA---TQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (348), Expect = 5e-36
Identities = 57/278 (20%), Positives = 95/278 (34%), Gaps = 35/278 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEV---KALTE 870
NDF IG+GG G VY +G++ A+K + LNE ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 871 IRHRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGISDAL 919
IV L LS + I L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 920 SYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
+MHN +V+RD+ N+LLD +SD G+A + + GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 980 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038
L + D +S G + ++++G P + ++ L + P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELPD 230
Query: 1039 CIVQDKLISIVEVAISCLDENPESRPTMPK--VSQLLK 1074
+ L S++E L + R ++ +
Sbjct: 231 SFSPE-LRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 50/300 (16%)
Query: 809 EIIRATNDFDDEHCIGKGGQGSVYKA------ELASGEIVAVKKFHSPLPGEMTFQQEFL 862
E R + +G+G G V +A + A+ VAVK + +
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALM 64
Query: 863 NEVKALTEIRHR-NIVKFYGFCSHVRHSLAMIL-------------------------SN 896
+E+K L I H N+V G C+ L +I+
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 897 NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956
+ L + ++ + ++ + +HRD++++N+LL N + DFG+A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 957 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 1014
+ + D + ++APE + T + DV+SFGVL E+
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 1015 MSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ R+ P + + + + C P RPT ++ + L
Sbjct: 238 -PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (339), Expect = 2e-35
Identities = 36/274 (13%), Positives = 90/274 (32%), Gaps = 34/274 (12%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
IG+G G +++ L + + VA+K + + +E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 882 FCSHVRHSLAMIL---------SNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVH 932
+ +++ + + K + + +H +V+
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 933 RDISSKNVLLD-----FDNEAHVSDFGIAKFLKPDSSN-------WTELAGTYGYVAPEL 980
RDI N L+ N +V DFG+ KF + + L+GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040
+ + + D+ + G + + ++G P + + ++ I + P +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
++ + + ++ P + L
Sbjct: 245 -PEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (335), Expect = 4e-35
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 43/284 (15%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMT------FQQEFLNEVKAL 868
+++ + +G+G V + + + AVK G + ++ L EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 869 TEIR-HRNIVKFYGFCSHVRH-----------SLAMILSNNAAAKDLGWTRRMNVIKGIS 916
++ H NI++ L L+ L +++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYV 976
+ + +H IVHRD+ +N+LLD D ++DFG + L P E+ GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176
Query: 977 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEML 1030
APE+ ++ D++S GV+ ++ G P M + ++ +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-QFG 235
Query: 1031 DPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
P S V+D L+S L P+ R T + L
Sbjct: 236 SPEWDDYSDTVKD-LVS------RFLVVQPQKRYTA---EEALA 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 53/285 (18%), Positives = 107/285 (37%), Gaps = 29/285 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
++ IG+G G+V+KA+ + EIVA+K+ E L E+ L E++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 874 RNIVKFYGFC-SHVRHSLAMILSNNAAAKDLGWTRRMN----VIKGISDALSYMHNDCFP 928
+NIV+ + S + +L + K V + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-T 987
++HRD+ +N+L++ + E +++FG+A+ ++ T Y P++ + K+ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 988 EKCDVYSFGVLALEVIKGKHP------------------RDFISSMSSSSLNLNIALDEM 1029
D++S G + E+ P S L
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 1030 LDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ P + +V + ++ + L NP R + + L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA---EEALQ 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 35/287 (12%)
Query: 816 DFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+F IG+G G VYKA +GE+VA+KK E + E+ L E+ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 875 NIVKFYGFCSHVRHSLAMI---------LSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
NIVK + + +A + + + + L++ H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTM 984
++HRD+ +N+L++ + ++DFG+A+ +T T Y APE L
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 985 KVTEKCDVYSFGVLALEVIKGKHP----------RDFISSMSSSSLNLNIALDEMLDPRL 1034
+ D++S G + E++ + ++ + + + M D +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 1035 PTPSCIVQD---KLISIVEVAIS----CLDENPESRPTMPKVSQLLK 1074
P QD + + E S L +P R + L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA---KAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-34
Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 49/299 (16%)
Query: 814 TNDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + IG+G G V A + + VA+KK T+ Q L E+K L R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFR 64
Query: 873 HRNIVKFYGFCSH-----------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSY 921
H NI+ V H + L + L + I L Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 922 MHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---TELAGTYGYVAP 978
+H+ ++HRD+ N+LL+ + + DFG+A+ PD + TE T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 979 ELAYT-MKVTEKCDVYSFGVLALEVIKGKHP----------------------RDFISSM 1015
E+ T+ D++S G + E++ + D +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 1016 SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
+ + N ++L K + +++ L NP R + Q L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEV---EQALA 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 56/297 (18%), Positives = 102/297 (34%), Gaps = 42/297 (14%)
Query: 812 RATNDFDDEHCIGKGGQGSVYKAE--LASGEIVAVKKFHSPLPGEMTFQQEFLNEV---K 866
RA ++ IG+G G V+KA G VA+K+ GE + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 867 ALTEIRHRNIVKFYGFCSHVR--------------HSLAMILSNNAAAKDLGWTRRMNVI 912
L H N+V+ + C+ R + + +++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 913 KGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGT 972
+ L ++H+ +VHRD+ +N+L+ + ++DFG+A+ + + + T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------------RDFISSMSSSS 1019
Y APE+ D++S G + E+ + K D I
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 1020 LNLNIALDEMLDPRLPTPSCIVQDKLIS--IVEVAISCLDENPESRPTMPKVSQLLK 1074
++AL I ++ + CL NP R + L
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA---YSALS 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 3e-34
Identities = 50/271 (18%), Positives = 94/271 (34%), Gaps = 29/271 (10%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+ FD +G G G V + SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 874 RNIVKFYGFCS--------HVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHND 925
+VK + + S+ I Y+H+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 926 CFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 985
+++RD+ +N+L+D V+DFG AK L GT +APE+ +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIILSKG 214
Query: 986 VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045
+ D ++ GVL E+ G P + ++++ ++ PS D
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFSSD-- 264
Query: 1046 ISIVEVAISCLDENPESRPTM--PKVSQLLK 1074
+ ++ + L + R V+ +
Sbjct: 265 --LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 53/275 (19%), Positives = 101/275 (36%), Gaps = 46/275 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPL---PGEMTFQQEFLNEVKALTE 870
+ + +G GG GSVY ++ VA+K GE+ EV L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 871 IR--HRNIVKFYGFCSHVRH------------SLAMILSNNAAAKDLGWTRRMNVIKGIS 916
+ +++ + L ++ L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVL 120
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGY 975
+A+ + HN ++HRDI +N+L+D + E + DFG LK + +T+ GT Y
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVY 175
Query: 976 VAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
PE + Y V+S G+L +++ G P + +E++ ++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQV 221
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKV 1069
+ + ++ CL P RPT ++
Sbjct: 222 FFRQRV-SSECQHLIR---WCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-33
Identities = 59/295 (20%), Positives = 101/295 (34%), Gaps = 49/295 (16%)
Query: 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 874
+ D IG G G VY+A+L SGE+VA+KK ++ E++ + ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73
Query: 875 NIVKFYGFCSHVRHS-----------------LAMILSNNAAAKDLGWTRRMNVIKGISD 917
NIV+ F + + A + L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAH-VSDFGIAKFLKPDSSNWTELAGTYGYV 976
+L+Y+H+ I HRDI +N+LLD D + DFG AK L N + + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 977 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036
+ T DV+S G + E++ G+ S + + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 1037 PSCIVQDKLISIVEVAIS-----------------CLDENPESRPTMPKVSQLLK 1074
+ K I + L+ P +R T +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-33
Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 42/276 (15%)
Query: 820 EHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIV 877
+G G G V + + E A+K + EV+ + +IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68
Query: 878 KFYGFCSHVRH---------------SLAMILSNNAAAKDLGWTRRMNVIKGISDALSYM 922
+ ++ L + + + ++K I +A+ Y+
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYL 127
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNE---AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 979
H+ I HRD+ +N+L ++DFG AK +S T T YVAPE
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE 183
Query: 980 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039
+ K + CD++S GV+ ++ G P F S+ + M P P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 1040 I-VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074
V +++ ++ + L P R T+ ++ +
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTI---TEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 52/306 (16%), Positives = 106/306 (34%), Gaps = 49/306 (16%)
Query: 811 IRATNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT 869
+ ++ IG+G G V+KA +G+ VA+KK E F L E+K L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQ 64
Query: 870 EIRHRNIVKFYGFC-------SHVRHSLAMIL------SNNAAAKDLGWTRRMNVIKGIS 916
++H N+V C + + S+ ++ + L + + +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 917 DALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS----NWTELAGT 972
L+ ++ I+HRD+ + NVL+ D ++DFG+A+ + +T T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 973 YGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP---------------------RD 1010
Y PEL + D++ G + E+ +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 1011 FISSMSSSSLNLNIALDEMLDPRLPT--PSCIVQDKLISIVEVAISCLDENPESRPTMPK 1068
++ + L + L + ++ + + + +++ L +P R
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDS-- 299
Query: 1069 VSQLLK 1074
L
Sbjct: 300 -DDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-31
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 36/282 (12%)
Query: 815 NDFDDEHCIGKGGQGSVYKAELA----SGEIVAVKKFH-SPLPGEMTFQQEFLNEVKALT 869
+F+ +G G G V+ +G++ A+K + + + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 870 EIRHR-NIVKFYGFCS-----------HVRHSLAMILSNNAAAKDLGWTRRMNVIKGISD 917
IR +V + L LS + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 918 ALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT-ELAGTYGYV 976
AL ++H I++RDI +N+LLD + ++DFG++K D + + GT Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 977 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034
AP++ + D +S GVL E++ G P F +S +P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255
Query: 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTM--PKVSQLLK 1074
P + +++ L ++P+ R ++ +
Sbjct: 256 PQE---MSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 6e-31
Identities = 59/307 (19%), Positives = 107/307 (34%), Gaps = 51/307 (16%)
Query: 807 YEEIIRATNDFDD----EHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEF 861
+E+ + + +G G G+V A + +G VA+KK + P E+ F +
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRA 64
Query: 862 LNEVKALTEIRHRNIVKFYGFCSHVRHS-------LAMILSNNAAAK-----DLGWTRRM 909
E++ L +RH N++ + L M K LG R
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 910 NVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTEL 969
++ + L Y+H HRD+ N+ ++ D E + DFG+A+ DS +
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYV 179
Query: 970 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSM-------------- 1015
+ + M+ T+ D++S G + E+I GK +
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 1016 --------SSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMP 1067
S + N L E+ + ++++E L + E R T
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTA- 295
Query: 1068 KVSQLLK 1074
+ L
Sbjct: 296 --GEALA 300
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-29
Identities = 55/293 (18%), Positives = 101/293 (34%), Gaps = 41/293 (13%)
Query: 814 TNDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872
+ + +G G GSV A +G VAVKK P + + E++ L ++
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMK 75
Query: 873 HRNIVKFYGFCSH------------VRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALS 920
H N++ + V H + L+N + L +I I L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 921 YMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 980
Y+H+ HRD+ N+ ++ D E + DFG+A+ D +A + +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIM 190
Query: 981 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNI---------------A 1025
M + D++S G + E++ G+ + L L + +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 1026 LDEMLDPRLPTPSCIVQDKLISIVEVAI----SCLDENPESRPTMPKVSQLLK 1074
+ P + I +A+ L + + R T +Q L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA---AQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-28
Identities = 53/302 (17%), Positives = 101/302 (33%), Gaps = 50/302 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKA-ELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 873
+ + IG G QG V A + VA+KK P + T + E+ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 874 RNIVKFYGFCSHVRHS-------LAMILSNNAAAKDL----GWTRRMNVIKGISDALSYM 922
+NI+ + + L M L + + + R ++ + + ++
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 923 HNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 982
H+ +HRD+ N+++ D + DFG+A+ S T T Y APE+
Sbjct: 136 HSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 983 TMKVTEKCDVYSFGVLALEVIKGKHP---------------------RDFISSMSSSSLN 1021
M E D++S G + E+++ K +F+ + + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 1022 LNIALDEMLDPRLPTPSCIVQDKLISIVEVAIS---------CLDENPESRPTMPKVSQL 1072
+ P S + L +P R ++
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV---DDA 308
Query: 1073 LK 1074
L+
Sbjct: 309 LQ 310
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (285), Expect = 3e-28
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 15/288 (5%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
+P L + L L +N +++ +F NL++L L L NK S P + L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
LYL N L + L+ L + K+ S+ + L + + L SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLS 340
F ++ LS + + + I G +L L++ N ++ + + L +L+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 341 NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG- 399
LGLS N +S SL +L L+ +N+ +P L + + + ++ L N +S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 400 -----SIPHSLGNLTNLATLDLYDNSLSGS--IPSEFGNLRSLSTLSL 440
P + + + L+ N + PS F + + + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 2e-25
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 15/288 (5%)
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
+P L + A L L N ++ +F NL++L L L NK++ I P + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 316 ATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFD 375
LY+ N L L+ L K+ S+ L + + L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
++ LS + + ++ +IP L +L L L N ++ + L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 436 STLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
+ L L +N +S SL N +L L+L +N L +PG + + + I + L+NN +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 496 ------SIPQSLGNLSNLVILYLYNNSL--FDSIPSELGNLRSLSMLS 535
P ++ + L++N + ++ PS + + +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (259), Expect = 7e-25
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 15/289 (5%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
+P L + A L L NN + + + NL++L L L NK+S P + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG 327
LYL +N L L+ L + K+ + + L + + L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSG 140
Query: 328 SIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
++ LS + ++ ++ +IP L +L L+L N + + L L +L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447
+ L L +N +S SL N +L L L +N L +P + + + + L N +S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 448 ------SIPHSLGNLTNLDALYLYDNSLSGS--IPGEIGNLRSISNLAL 488
P + + L+ N + P + + + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 103 bits (258), Expect = 9e-25
Identities = 71/288 (24%), Positives = 111/288 (38%), Gaps = 15/288 (5%)
Query: 89 IPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148
+P + LDL +N + +L L TL L N+++ P L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGS 208
L L N L++L L L + S+ + + + L K SG
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 209 IPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 268
+ + L+ + + + ++ +IP G SL+ L L NK++ SL L NLA
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG- 327
L L NS+S N L L+L NKL +P L + + +Y+HNN++S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 328 -----SIPSEIGNLRSLSNLGLSGNKLS-GSIPPS-LGYLSNLATLYL 368
P S S + L N + I PS + A + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (248), Expect = 2e-23
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 13/280 (4%)
Query: 73 PHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQ 132
P A LDL +N++ N+ L L L +N P L L+ L L +NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 133 LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNL 192
L L L + + L + ++ L S F +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252
+ LS + + + +IP L +L L+L N + + L L +L+ L L +N
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 253 LSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI------IP 306
+S SL N +L L+L N L +P + + + ++ L N ++ I P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 307 HSLGNLTNLATLYIHNNSLSGS--IPSEIGNLRSLSNLGL 344
+ + + + +N + PS + + + L
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 9e-22
Identities = 60/311 (19%), Positives = 107/311 (34%), Gaps = 32/311 (10%)
Query: 410 NLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469
+L + D L +P + + L L NK++ NL NL L L +N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 470 SGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLR 529
S PG L + L L+ N+L + L L + + S+ + L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 530 SLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSP 589
+ + + G + L + +A ++ +
Sbjct: 128 VVELGTN-------------------PLKSSGIENGAFQGMKKLSYIRIADTNIT---TI 165
Query: 590 KLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELD 649
G L L L N+++ S L L L LS N S L HL EL
Sbjct: 166 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 650 LSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCF------EKMHGLLRIDISYNEL 703
L++N L + +P + + ++ + L +N++ + + F K + + N +
Sbjct: 226 LNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
Query: 704 QGPIPNSIAFR 714
Q FR
Sbjct: 285 QYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.0 bits (162), Expect = 2e-12
Identities = 50/280 (17%), Positives = 90/280 (32%), Gaps = 34/280 (12%)
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
+P +LDL +N I + L L LIL N++S L +LE L LS
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 604 SNRLSNSIPKSFGNLVKLHYLNL-----------------------SNNQFSRGIPIKLE 640
N+L K L +L + + S +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 641 ELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISY 700
+ LS + ++ + + SL L+L N + + + + ++ L ++ +S+
Sbjct: 148 GMKKLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 701 NELQGPIPNSIAFRDAPIEALQGNKGLCGDVKG---LPSCKTLKSNKQALRKIWVVVVFP 757
N + S+A E N L G + + + + I F
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG-SNDFC 263
Query: 758 LLGIVALLISLIGLFFKFQRRNNDLQTQQSSPGNTRGLLS 797
G S G+ +N +Q + P R +
Sbjct: 264 PPGYNTKKASYSGVSL----FSNPVQYWEIQPSTFRCVYV 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (286), Expect = 3e-28
Identities = 51/297 (17%), Positives = 105/297 (35%), Gaps = 50/297 (16%)
Query: 815 NDFDDEHCIGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR- 872
+D+ +G+G V++A + + E V VK +++ E+K L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88
Query: 873 HRNIVKFYGFCSHVRHSLAMILSNNAAAKDL-------GWTRRMNVIKGISDALSYMHND 925
NI+ ++ + D + I AL Y H+
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 148
Query: 926 CFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 984
I+HRD+ NV++D ++ + + D+G+A+F P + + + PEL
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 204
Query: 985 K-VTEKCDVYSFGVLALEVIKGKHP--------------------RDFISSMSSSSLNLN 1023
+ D++S G + +I K P D + ++ L+
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 1024 IALDEMLD--PRLPTPSCIVQDKLISIVEVAI----SCLDENPESRPTMPKVSQLLK 1074
+++L R + + + A+ L + +SR T + ++
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA---REAME 318
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 112 bits (281), Expect = 3e-27
Identities = 95/387 (24%), Positives = 159/387 (41%), Gaps = 43/387 (11%)
Query: 263 NLTNLATLYLYENSLSGSIP-SEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH 321
L L + +++ ++ ++ + +L LG ++G+ L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-----EYLNNLTQINFS 74
Query: 322 NNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIP--- 378
NN L+ P + NL L ++ ++ N+++ P + TL+ + D +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 379 ------------SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIP 426
S++ L L+ L + L NLT L LD+ N S
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDI 190
Query: 427 SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNL 486
S L +L +L N++S P LTNLD L L N L G + +L ++++L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 487 ALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP 546
L NN++S P L L+ L L L N + + P L L +L+ L N+L P
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 302
Query: 547 HS----LGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
S L L L N+I P + L L +L A N++S L +L + L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNN 629
N++S+ P NL ++ L L++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (276), Expect = 1e-26
Identities = 96/387 (24%), Positives = 161/387 (41%), Gaps = 61/387 (15%)
Query: 167 NLSNLDTLHLYDNSLSDSIP-SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L+ L +++D++ ++ + +L LG G + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH-------------------------- 259
NN L D P L NL L + + N+++ P
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 260 ----------SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN-GIIPHS 308
++ +++ L+ L + G+ ++ L +L+ L N
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYL 368
L LTNL +L NN +S P I +L L L+GN+L +L L+NL L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 369 YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428
+N + + P L L L+ L LG N++S P L LT L L+L +N S
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISP 302
Query: 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLAL 488
NL++L+ L+L +N +S P + +LT L L+ +N +S + NL +I+ L+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 489 NNNKLSGSIPQSLGNLSNLVILYLYNN 515
+N++S P L NL+ + L L +
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 109 bits (273), Expect = 3e-26
Identities = 100/386 (25%), Positives = 164/386 (42%), Gaps = 35/386 (9%)
Query: 95 NISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYS 154
++ L T+ L + TLQ + SI + L++L + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 155 NYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH--- 211
N L D+ P L NL+ L + + +N ++D P + L + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 212 ---------SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSL- 261
++ +++ L+ L F + ++L L +L+ L + S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 262 GNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIH 321
LTNL +L N +S P +L L+L N+L I +L +LTNL L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDLA 249
Query: 322 NNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSEL 381
NN +S P + L L+ L L N++S P L L+ L L L N L D P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS- 304
Query: 382 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLG 441
NL++L+ L+L +N +S P + +LT L L +N +S S NL +++ LS G
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 442 YNKLSGSIPHSLGNLTNLDALYLYDN 467
+N++S P L NLT + L L D
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (269), Expect = 1e-25
Identities = 92/365 (25%), Positives = 151/365 (41%), Gaps = 33/365 (9%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
S + + L + +I + ++ L ++ S+N P + +L+ L +
Sbjct: 39 SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPP------------SLGNLSNLDTLH 175
+ NQ+ P + L D + ++ ++S L L
Sbjct: 95 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154
Query: 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSL-GNLTNLATLYLHNNSLFDSIP 234
+ ++ L +L+ L + S+ LTNL +L NN + D P
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 214
Query: 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSML 294
+ +L LSL N+L +L +LTNL L L N +S P L L+ L
Sbjct: 215 LGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268
Query: 295 NLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIP 354
LG N+++ I P L LT L L ++ N S I NL++L+ L L N +S P
Sbjct: 269 KLGANQISNISP--LAGLTALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP 324
Query: 355 PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATL 414
+ L+ L L+ +N + S S L NL +++ LS G+N++S P L NLT + L
Sbjct: 325 --VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 415 DLYDN 419
L D
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (265), Expect = 4e-25
Identities = 87/382 (22%), Positives = 158/382 (41%), Gaps = 33/382 (8%)
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
L LG + + + +L + TL + SI + L +L+ + S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSL---------SMLSLGYNKL 397
N+L+ P L L+ L + + +N + D P + + L
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 398 SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLS----LGYNKLSGSIPHSL 453
+ S +++++ L + S ++ +L+ L+ L+ L + S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 454 GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLY 513
LTNL++L +N +S P I ++ L+LN N+L +L +L+NL L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 514 NNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP--HSLGVLDLSSNHIVGEIPTELGKLN 571
NN + + P L L L+ L N++S P + +L N E + + L
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 572 FLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
L L L N +S + SL +L+ L ++N++S+ S NL +++L+ +NQ
Sbjct: 308 NLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 632 SRGIPIKLEELIHLSELDLSHN 653
S P L L +++L L+
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 9e-23
Identities = 80/384 (20%), Positives = 140/384 (36%), Gaps = 37/384 (9%)
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYS 370
L + +++ ++ +L ++ L + SI + YL+NL + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 371 NSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF 429
N L D P L L + M + ++ + L + D ++ +
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 430 GNLRSLSTL------------SLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477
S +T+ + L NLT L+ L + N S +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDISVL 193
Query: 478 GNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFA 537
L ++ +L NN++S P L+NL L L N L D L +L +L+ L A
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 538 YNKLSGSIP----HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGS 593
N++S P L L L +N I P L N+ + + +
Sbjct: 250 NNQISNLAPLSGLTKLTELKLGANQISNISPLA----GLTALTNLELNENQLEDISPISN 305
Query: 594 LAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
L L +L L N +S+ P +L KL L +NN+ S L L +++ L HN
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSAGHN 361
Query: 654 FLREAIPSQICIMQSLENLNLSHN 677
+ + P + + + L L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.9 bits (245), Expect = 2e-22
Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 16/266 (6%)
Query: 10 WKTSLQNHNNGSLLSSWTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSF 69
+ N S +S+ + + + ++ I +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 70 SSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLF 129
+ +L L +NQ+ P I ++ L L L+ N + L+ L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 130 ENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEF 189
NQ++ P + L+ L L L +N + ++ P L L+ L L L +N S
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPI 303
Query: 190 GNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLG 249
NL++L+ L+L +N S P + +LT L L+ NN + S S L NL +++ LS G
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG 359
Query: 250 YNKLSGSIPHSLGNLTNLATLYLYEN 275
+N++S P L NLT + L L +
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.8 bits (242), Expect = 3e-22
Identities = 80/380 (21%), Positives = 139/380 (36%), Gaps = 55/380 (14%)
Query: 360 LSNLATLYLYSNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L+ L ++ D++ ++L + +L LG + G + L NL ++ +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPG--- 475
N L+ P NL L + + N+++ P + L+ + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 476 ---------EIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNS-LFDSIPSEL 525
I ++ ++S L G+ L L+NL L + S S S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 526 GNLRSLSMLSFAYNKLSGSIPH----SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQN 581
L +L L N++S P +L L L+ N + L L L L LA N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 582 QLSGQLSPKLGSLAQLEHLDLSSNRLSNSIP--------------------KSFGNLVKL 621
Q+S L L +L L L +N++SN P NL L
Sbjct: 252 QISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681
YL L N S P+ L L L ++N + + S + + ++ L+ HN +
Sbjct: 310 TYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 682 LIPSCFEKMHGLLRIDISYN 701
L P + + ++ ++
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 3e-13
Identities = 62/340 (18%), Positives = 120/340 (35%), Gaps = 55/340 (16%)
Query: 407 NLTNLATLDLYDNSLSGSIP-SEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLY 465
L L +++ ++ ++ + +L LG + G + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 466 DNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL------------------ 507
+N L+ P + NL + ++ +NNN+++ P +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 508 -VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTE 566
+ +++ I + G + + + + L + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 567 LGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNL 626
L KL L LI NQ+S + + L+ L L+ N+L + + +L L L+L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 627 SNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP--------------------SQICIM 666
+NNQ S P L L L+EL L N + P S I +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 667 QSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGP 706
++L L L N++ + P + L R+ + N++
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 8e-08
Identities = 49/273 (17%), Positives = 95/273 (34%), Gaps = 31/273 (11%)
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L L +++ ++ +L ++ L + + SI + L+NL + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN------------HIVGE 562
N L D P L NL L + N+++ P + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 563 IPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS-------F 615
+ N + + S Q + L+ L + I +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 616 GNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLS 675
L L L +NNQ S P+ + +L EL L+ N L++ + + +L +L+L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 676 HNSLVGLIPSCFEKMHGLLRIDISYNELQGPIP 708
+N + L P + L + + N++ P
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (273), Expect = 1e-26
Identities = 82/335 (24%), Positives = 129/335 (38%), Gaps = 38/335 (11%)
Query: 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPC--AWVGIHCNRGGRVNSINLTSIG 59
++ ALL+ K L N LSSW T C W+G+ C+ +
Sbjct: 6 QDKQALLQIKKDLGNPTT---LSSWLPT----TDCCNRTWLGVLCDTDTQT--------- 49
Query: 60 LKGMLHDFSFSSFPHLAYLDLWHNQLYGN--IPPQIGNISRLKYLDLSSNLFF-GTIPPE 116
+ LDL L IP + N+ L +L + G IPP
Sbjct: 50 -------------YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176
I L+ L L + ++G+IP + ++ +L L N L +PPS+ +L NL +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 177 YDNSLSDSIPSEFGNLRSLSM-LSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235
N +S +IP +G+ L +++ N+ +G IP + NL + ++ + S
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDAS 214
Query: 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLN 295
L + +G NL L L N + G++P L+ L LN
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 296 LGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIP 330
+ +N L G IP GNL NN P
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.5 bits (228), Expect = 7e-21
Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 7/265 (2%)
Query: 214 GNLTNLATLYLHNNSL--FDSIPSELGNLRSLSMLSL-GYNKLSGSIPHSLGNLTNLATL 270
+ L L +L IPS L NL L+ L + G N L G IP ++ LT L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 271 YLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIP 330
Y+ ++SG+IP +++L L+ YN L+G +P S+ +L NL + N +SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 331 SEIGNLRSLSN-LGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSM 389
G+ L + +S N+L+G IPP+ L+ S ++ + S L +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 390 LSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI 449
+G NL LDL +N + G++P L+ L +L++ +N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 450 PHSLGNLTNLDALYLYDNSLSGSIP 474
P GNL D +N P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.8 bits (221), Expect = 6e-20
Identities = 70/265 (26%), Positives = 109/265 (41%), Gaps = 7/265 (2%)
Query: 190 GNLRSLSMLSLGYNKFSG--SIPHSLGNLTNLATLYLHNN-SLFDSIPSELGNLRSLSML 246
++ L L IP SL NL L LY+ +L IP + L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIP 306
+ + +SG+IP L + L TL N+LSG++P +L +L + N+++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 307 HSLGNLTNLAT-LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLAT 365
S G+ + L T + I N L+G IP NL + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 366 LYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSI 425
++ FD L + L N++ G++P L L L +L++ N+L G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 426 PSEFGNLRSLSTLSLGYNKLSGSIP 450
P + GNL+ + NK P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.4 bits (194), Expect = 2e-16
Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 14/270 (5%)
Query: 478 GNLRSISNLALNNNKLSG--SIPQSLGNLSNLVILYLYNN-SLFDSIPSELGNLRSLSML 534
++NL L+ L IP SL NL L LY+ +L IP + L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 535 SFAYNKLSGSI------PHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLS 588
+ +SG+I +L LD S N + G +P + L L+ + N++SG +
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 589 PKLGSLAQLEH-LDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSE 647
GS ++L + +S NRL+ IP +F NL + G L ++
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQ 224
Query: 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPI 707
++ + ++L L+L +N + G +P ++ L +++S+N L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 708 PNSIAFRDAPIEALQGNKGLCGDVKGLPSC 737
P + + A NK LCG LP+C
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 4e-16
Identities = 72/263 (27%), Positives = 110/263 (41%), Gaps = 27/263 (10%)
Query: 286 GNLRSLSMLNLGYNKLNGI--IPHSLGNLTNLATLYIHNN-SLSGSIPSEIGNLRSLSNL 342
++ L+L L IP SL NL L LYI +L G IP I L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 343 GLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP 402
++ +SG+IP L + L TL N+L ++P + +L +L ++ N++SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 403 HSLGNLTNLAT-LDLYDNSLSGSIPSEFGNLRSLSTLSL--------------------- 440
S G+ + L T + + N L+G IP F NL
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 441 -GYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQ 499
+G NL+ L L +N + G++P + L+ + +L ++ N L G IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 500 SLGNLSNLVILYLYNNSLFDSIP 522
GNL + NN P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 4e-15
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 29/288 (10%)
Query: 331 SEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSML 390
++NL LSG L P IPS L NL L+ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFL 81
Query: 391 SL-GYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSI 449
+ G N L G IP ++ LT L L + ++SG+IP +++L TL YN LSG++
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 450 PHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRS-ISNLALNNNKLSGSIPQSLGNLSNLV 508
P S+ +L NL + N +SG+IP G+ +++ ++ N+L+G IP + NL+
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201
Query: 509 ILYLYNNSLFDSIPSELGN----LRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIP 564
+ N D+ + L+ S A++ + +L LDL +N I G +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 565 TELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIP 612
L +L FL L ++ N L G++ P+ G+L + + ++N+ P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 1e-24
Identities = 71/265 (26%), Positives = 108/265 (40%), Gaps = 7/265 (2%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
++P I ++ + L+ N + + S NL L L+ N L+ + F L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 196 SMLSLGYNKFSGSI-PHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254
L L N S+ P + L L TL+L L + P L +L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 255 GSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTN 314
+ +L NL L+L+ N +S F L SL L L N++ + PH+ +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 315 LATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF 374
L TLY+ N+LS + LR+L L L+ N + + L S+ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVP 261
Query: 375 DSIPSELGNLRSLSMLSLGYNKLSG 399
S+P L + L N L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (242), Expect = 7e-23
Identities = 68/276 (24%), Positives = 101/276 (36%), Gaps = 8/276 (2%)
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
T L ++P + + + L N++S S NL L+L+ N L+
Sbjct: 15 TTSCPQQGL-QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGII-PHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
+ F L L L+L N + P + L L TL++ L P L +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG 399
L L N L + L NL L+L+ N + L SL L L N+++
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 400 SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNL 459
PH+ +L L TL L+ N+LS LR+L L L N + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWL 250
Query: 460 DALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
+ + S+P L L N L G
Sbjct: 251 QKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (237), Expect = 3e-22
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 8/276 (2%)
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328
T + L ++P + + L N+++ + S NL L++H+N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 329 IPSEIGNLRSLSNLGLSGNKLSGSIPP-SLGYLSNLATLYLYSNSLFDSIPSELGNLRSL 387
+ L L L LS N S+ P + L L TL+L L + P L +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG 447
L L N L + +L NL L L+ N +S F L SL L L N+++
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 448 SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
PH+ +L L LYL+ N+LS + LR++ L LN+N + + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL 250
Query: 508 VILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG 543
++ + S+P L + A N L G
Sbjct: 251 QKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (226), Expect = 9e-21
Identities = 73/275 (26%), Positives = 105/275 (38%), Gaps = 12/275 (4%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
T L ++P I + + L GN++S S NL L+L+SN L
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSI-PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
+ L L L L N S+ P + L L TL L L P F L +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 436 STLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
L L N L + +L NL L+L+ N +S L S+ L L+ N+++
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 496 SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIP-----HSLG 550
P + +L L+ LYL+ N+L L LR+L L N L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG 585
SS+ + +P L + LA N L G
Sbjct: 252 KFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (214), Expect = 3e-19
Identities = 61/257 (23%), Positives = 91/257 (35%), Gaps = 5/257 (1%)
Query: 72 FPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131
+ L N++ L L L SN+ L+ L+ L L +N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 132 QLNGSI-PYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFG 190
S+ P L L+ L L L++L P L+ L L+L DN+L F
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
+L +L+ L L N+ S + L +L L LH N + P +L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310
N LS +L L L L L +N + L +++ +P L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 311 NLTNLATLYIHNNSLSG 327
+ N L G
Sbjct: 270 GRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (193), Expect = 2e-16
Identities = 47/217 (21%), Positives = 72/217 (33%), Gaps = 4/217 (1%)
Query: 63 MLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSY 122
+ + QL P + RL L L P L+
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS 182
L+ L L +N L L +L +L L+ N + + + L +LD L L+ N ++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 183 DSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRS 242
P F +L L L L N S +L L L L L++N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP-WVCDCRARPLWAW 249
Query: 243 LSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
L +++ S+P L L N L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 62/262 (23%), Positives = 96/262 (36%), Gaps = 13/262 (4%)
Query: 472 SIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531
++P I + + L+ N++S S NL IL+L++N L + L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 532 SMLSFAYNKLSGSIP-------HSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLS 584
L + N S+ L L L + P L L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 585 GQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIH 644
L L HL L NR+S+ ++F L L L L N+ + P +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 645 LSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
L L L N L + +++L+ L L+ N V + L + S +E+
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261
Query: 705 GPIPNSIA---FRDAPIEALQG 723
+P +A + LQG
Sbjct: 262 CSLPQRLAGRDLKRLAANDLQG 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.6 bits (244), Expect = 1e-22
Identities = 48/245 (19%), Positives = 90/245 (36%), Gaps = 38/245 (15%)
Query: 823 IGKGGQGSVYKAE-LASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 881
+G G +V+ A+ + + VA+K + G+ + + +E+K L + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 882 FCS--------------------------HVRHSLAMILSNNAAAKDLGWTRRMNVIKGI 915
+ + LA+I L + +++ K +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 134
Query: 916 SDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSS--NWTELAGT 972
L YMH C I+H DI +NVL++ + ++ IA ++T T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 973 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032
Y +PE+ D++S L E+I G + S + + +IA L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 1033 RLPTP 1037
LP+
Sbjct: 253 ELPSY 257
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 7e-22
Identities = 28/177 (15%), Positives = 55/177 (31%), Gaps = 26/177 (14%)
Query: 823 IGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQ-------EFLNEVKALTEIRHRN 875
+G+G + +V+ VK ++ F R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 876 IVKFYGFC-----SHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930
+ K G + +++ M L + + V+ I + ++ ++ I
Sbjct: 68 LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---I 124
Query: 931 VHRDISSKNVLLDFDNEAHVSDFGIAK---------FLKPDSSNWTE-LAGTYGYVA 977
VH D+S NVL+ + + DF + L+ D N + TY
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEK 180
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 50/210 (23%), Positives = 78/210 (37%), Gaps = 7/210 (3%)
Query: 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLY 271
+ + + + +L ++P +L + ++L L N L +L T L L
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPS 331
L + + G L L L+L +N+L + L L L + N L+
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 332 EIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLS 391
+ L L L L GN+L P L L L L +N+L + L L +L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 392 LGYNKLSGSIPHSLGNLTNLATLDLYDNSL 421
L N L +IP L L+ N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 1e-11
Identities = 54/211 (25%), Positives = 68/211 (32%), Gaps = 8/211 (3%)
Query: 43 HCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYL 102
++ +N L + D L L N LY + +RL L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP----KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 103 DLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIP 162
+L G L L TL L NQL +L L + N L L
Sbjct: 61 NLDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPL 117
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222
+L L L L+L N L P L LSL N + L L NL TL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKL 253
L NSL+ +IP L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 46/212 (21%), Positives = 77/212 (36%), Gaps = 11/212 (5%)
Query: 260 SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLY 319
+ + + + + +L+ ++P + + ++L+L N L +L T L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 320 IHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS--IPPSLGYLSNLATLYLYSNSLFDSI 377
L + +++ +L LG + +P L L L + N L
Sbjct: 62 -----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 378 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLST 437
L L L L L N+L P L L L L +N+L+ L +L T
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 438 LSLGYNKLSGSIPHSLGNLTNLDALYLYDNSL 469
L L N L +IP L +L+ N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 53/211 (25%), Positives = 72/211 (34%), Gaps = 7/211 (3%)
Query: 92 QIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLA 151
++ ++ ++ +PP++ L L EN L + + L L
Sbjct: 5 EVSKVASHLEVNCDKR-NLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 152 LYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH 211
L L L L L TL L N L + + +N+ +
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 212 SLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLY 271
+L L L LYL N L P L L LSL N L+ L L NL TL
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302
L ENSL +IP F L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 41/205 (20%), Positives = 67/205 (32%), Gaps = 7/205 (3%)
Query: 452 SLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILY 511
+ + + + +L+ ++P ++ + + L L+ N L +L + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 512 LYNNSLFDSIP-SELGNLRSLSMLSFAYNKLSGSIPHSLGVLD--LSSNHIVGEIPTELG 568
L L L L +L + L + +S N + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 569 KLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628
L L +L L N+L L +LE L L++N L+ L L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 629 NQFSRGIPIKLEELIHLSELDLSHN 653
N IP L L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 46/209 (22%), Positives = 70/209 (33%), Gaps = 11/209 (5%)
Query: 428 EFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLA 487
E + S ++ L+ ++P L + L+L +N L + ++ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 488 LNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS----- 542
L+ +L+ L L L L +N L + S
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 543 GSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
L L L N + P L L KL LA N L+ + L L L+ L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQF 631
N L +IPK F L + L N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 41/207 (19%), Positives = 62/207 (29%), Gaps = 49/207 (23%)
Query: 380 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLS 439
E+ + S ++ L+ ++P L + L L +N L + L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 440 LGYNK---------------------------------------------LSGSIPHSLG 454
L + L+ +L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L L LYL N L PG + + L+L NN L+ L L NL L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKL 541
NSL+ +IP L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 50/229 (21%), Positives = 82/229 (35%), Gaps = 25/229 (10%)
Query: 476 EIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLS 535
E+ + S + + L+ ++P L + IL+L N L+ + L L+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 536 FAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLA 595
++ L L L + L +L
Sbjct: 62 LDRA-----------------ELTKLQVDGTLPVLGTLDL----SHNQLQSLPLLGQTLP 100
Query: 596 QLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFL 655
L LD+S NRL++ + L +L L L N+ P L L +L L++N L
Sbjct: 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
Query: 656 REAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQ 704
E + +++L+ L L NSL IP F H L + N
Sbjct: 161 TELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 9e-11
Identities = 42/274 (15%), Positives = 83/274 (30%), Gaps = 16/274 (5%)
Query: 102 LDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED-L 160
LDL+ + + + + + ++ + E + ++ L ++ +E
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
+ L S L L L LSD I + +L L+L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG---------SIPHSLGNLTNLATLY 271
L+ + FD + + ++ LSG +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 272 LYENSLSGSIPSEFGNLRSLSMLNLGY-NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIP 330
L EF L L L+L + LG + L TL + G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 331 SEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLA 364
+L +L ++ + + P++G N
Sbjct: 243 LLK---EALPHLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 45/270 (16%), Positives = 81/270 (30%), Gaps = 18/270 (6%)
Query: 198 LSLGYNKFSGSIPHSLGNLTNLATLYLH-NNSLFDSIPSELGNLRSLSMLSLGYNKLSG- 255
L L P G L + + S D +E + + + L + +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS-----LG 310
++ L + L L L LS I + +L LNL
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG----NKLSGSIPPSLGYLSNLATL 366
L L + + + + +++ L LSG + S + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 367 YLYSNSLFDSIPSELGNLRSLSMLSLGY-NKLSGSIPHSLGNLTNLATLDLYDNSLSGSI 425
S L + E L L LSL + LG + L TL ++ G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 426 PSEFGNLRSLSTLSLGYNKLSGSIPHSLGN 455
+L L + + + ++GN
Sbjct: 242 QLL---KEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 1e-07
Identities = 40/273 (14%), Positives = 80/273 (29%), Gaps = 21/273 (7%)
Query: 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSN-LFFGTIPPEIGHLSYLKTLQLFENQ 132
+ + + + + R++++DLS++ + T+ + S L+ L L +
Sbjct: 24 GVIAFRCPRSFM-DQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 133 LNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNL 192
L+ I + + S+L L L S L + D
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNK 252
+ ++ SG + + + N D S
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS---------------VM 187
Query: 253 LSGSIPHSLGNLTNLATLYLYE-NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN 311
L L L L L + E G + +L L + +G +
Sbjct: 188 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA 247
Query: 312 LTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGL 344
L +L I+ + + IGN ++ G+
Sbjct: 248 LPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 45/268 (16%), Positives = 87/268 (32%), Gaps = 22/268 (8%)
Query: 437 TLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG- 495
TL L L + L + + A + + + R + ++ L+N+ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 496 SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLS 555
++ L S L L L L D I + L +L L+ + + S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 556 S--------------NHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLD 601
H+ + + L +N LS + L HLD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 602 LSSNRL-SNSIPKSFGNLVKLHYLNLSN-NQFSRGIPIKLEELIHLSELDLSHNFLREAI 659
LS + + N + F L L +L+LS ++L E+ L L + +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 660 PSQICIMQSLENLNLSHNSLVGLIPSCF 687
+ ++L +L ++ + +
Sbjct: 242 QL---LKEALPHLQINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 25/147 (17%), Positives = 48/147 (32%), Gaps = 4/147 (2%)
Query: 26 WTLNNVTKTSPCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQL 85
+ T+ V ++N K L + L
Sbjct: 129 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 188
Query: 86 YGNIPPQIGNISRLKYLDLSS-NLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRL 144
+ + ++ L++L LS E+G + LKTLQ+F +G++ L
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL 248
Query: 145 SSLNYLALYSNYLEDLIPPSLGNLSNL 171
L + ++ + P++GN N
Sbjct: 249 PHLQ---INCSHFTTIARPTIGNKKNQ 272
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 55.2 bits (131), Expect = 4e-09
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 7/167 (4%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSEL-GNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
IP + + L L++N L L G L L L L N+L+G P++ ++
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 267 LATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS 326
+ L L EN + F L L LNL N+++ ++P S +L +L +L + +N +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 327 GSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSL 373
+ L L+G P + ++ L +
Sbjct: 140 CNCHL-AWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 53.3 bits (126), Expect = 2e-08
Identities = 46/186 (24%), Positives = 71/186 (38%), Gaps = 8/186 (4%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNGS 136
+D L IP I L L+ N + G L +L L+L NQL G
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 137 IPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196
P S + L L N ++++ L L TL+LYDN +S +P F +L SL
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL- 128
Query: 197 MLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256
+ H L L+ + PS+ +R + + L +++ S
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS 185
Query: 257 IPHSLG 262
+S G
Sbjct: 186 SENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 50.2 bits (118), Expect = 2e-07
Identities = 47/187 (25%), Positives = 71/187 (37%), Gaps = 8/187 (4%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSL-GYLSNLATLYLYSNSLFD 375
T+ L IP +I + L L+ N+L L G L +L L L N L
Sbjct: 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
P+ + L LG NK+ L L TL+LYDN +S +P F +L SL
Sbjct: 69 IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128
Query: 436 STLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
++L+ + H L L + P + +R + L +++
Sbjct: 129 TSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC 184
Query: 496 SIPQSLG 502
S S G
Sbjct: 185 SSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 5e-06
Identities = 38/177 (21%), Positives = 64/177 (36%), Gaps = 8/177 (4%)
Query: 386 SLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEF-GNLRSLSTLSLGYNK 444
+ + L IP + + L L DN L G L L L L N+
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNL 504
L+G P++ +++ L L +N + L + L L +N++S +P S +L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 505 SNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG---VLDLSSNH 558
++L L L +N F+ L S P + + DL +
Sbjct: 126 NSLTSLNLASNP-FNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 9e-06
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 5/168 (2%)
Query: 544 SIPHSLGVLDLSSNHIVGEIPTEL-GKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDL 602
IP L L+ N + L G+L L+KL L +NQL+G + ++ L L
Sbjct: 26 DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 603 SSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQ 662
N++ K F L +L LNL +NQ S +P E L L+ L+ +
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHL 144
Query: 663 ICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNS 710
+ L +L+ + PS K+ + D+ ++E + NS
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENS 189
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 4e-09
Identities = 37/222 (16%), Positives = 83/222 (37%), Gaps = 12/222 (5%)
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
L + ++ G + ++ ++ + +L + L + ++ +I G + L ++ L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 491 NKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550
N+++ P + L +I L+S+ L +++ P +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIA----GLQSIKTLDLTSTQITDVTPLAGL 128
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
+ +I L+ L +L++L L N++S+
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 611 IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSH 652
P +L L ++L NNQ S P L +L + L++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 6e-09
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 12/222 (5%)
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L N + ++++ ++ +L ++TLS ++ +I + L NL L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
N ++ P + + L+ N K +I + + + + S L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 527 NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ 586
L + L+G S + T L L+ L L N++S
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKADDNKISD- 187
Query: 587 LSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSN 628
L SL L + L +N++S+ P N L + L+N
Sbjct: 188 -ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 9e-09
Identities = 39/228 (17%), Positives = 74/228 (32%), Gaps = 18/228 (7%)
Query: 191 NLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGY 250
L + ++ G + + ++ + +L + TL + + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 251 NKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG 310
N+++ P L +I + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 311 NLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYS 370
L + + L+G + ++ + S L LS L TL
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQV----------SDLTPLANLSKLTTLKADD 182
Query: 371 NSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
N + D P L +L +L + L N++S P L N +NL + L +
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 46/222 (20%), Positives = 83/222 (37%), Gaps = 12/222 (5%)
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L N + ++++ ++ +L I+ L+ ++ + + L+NL+ L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
N + D P + + LS K +I + L T L L+ L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
L L NQ++ LS S NL KL L +N+ S
Sbjct: 133 VLYLDLNQITNISPLA----GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 635 IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSH 676
P L L +L E+ L +N + + P + +L + L++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 41/228 (17%), Positives = 76/228 (33%), Gaps = 18/228 (7%)
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
L + + G + + + + +L + TL ++ + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
N+++ P L +I + + + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L + L+G ++ + S L NL+ L L D
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
N +S P + +L ++ + L NN++S P L N SNL I+ L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 47/227 (20%), Positives = 79/227 (34%), Gaps = 20/227 (8%)
Query: 215 NLTNLATLYLHNNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLY 273
L N + +++ D++ ++L + +LS G + G + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 274 ENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333
+N ++ P + + L+ K I T T + + S +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 334 GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393
L N I YL + S + L NL L+ L
Sbjct: 132 QVLYLDLN----------QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 394 YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSL 440
NK+S P L +L NL + L +N +S P N +L ++L
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 45/217 (20%), Positives = 77/217 (35%), Gaps = 24/217 (11%)
Query: 167 NLSNLDTLHLYDNSLSDSIP-SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L+N + ++++D++ ++ + +LS G G + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEF 285
+N + D P + + LS K +I T T + + S
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 286 GNLRSLSMLNLGYNKLNGIIPH--------------SLGNLTNLATLYIHNNSLSGSIPS 331
L + L G+ L NL+ L TL +N +S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 332 EIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYL 368
+ +L +L + L N++S P L SNL + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 45/226 (19%), Positives = 82/226 (36%), Gaps = 18/226 (7%)
Query: 120 LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L+ + ++ + ++ L + L+ + + + + L+NL L L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
++D P + + LS K +I T T + + S L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
L + L+G YL + S + NL L+ L N
Sbjct: 134 LYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 300 KLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS 345
K++ I P L +L NL +++ NN +S P + N +L + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 41/218 (18%), Positives = 78/218 (35%), Gaps = 22/218 (10%)
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L N + +++++ ++ +L ++ L+ + I + L NL L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N ++ P + + L + K +I + T ++ + S L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 383 NLRSLSMLSLGYNKL--------------SGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428
L + L S L NL+ L TL DN +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
+L +L + L N++S P L N +NL + L +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 32/221 (14%), Positives = 71/221 (32%), Gaps = 12/221 (5%)
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
L + +A + ++ ++ Q+ +L + L + + + L +L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 539 NKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLE 598
N+++ P + L L L+ L+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
L L N+++N P + + LS L L L+ L N + +
Sbjct: 133 VLYLDLNQITNISPLAGLT----NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 659 IPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDIS 699
P + + +L ++L +N + + P L + ++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 20/236 (8%)
Query: 301 LNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYL 360
+N I P L N + ++++ ++ +L ++ L G ++ + YL
Sbjct: 9 INVIFPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYL 62
Query: 361 SNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420
+NL L L N + D P + + LS K +I T T +
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNL 480
+ S L + L+G YL + S + NL
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANL 172
Query: 481 RSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSF 536
++ L ++NK+S P L +L NL+ ++L NN + D P L N +L +++
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 43/215 (20%), Positives = 77/215 (35%), Gaps = 26/215 (12%)
Query: 360 LSNLATLYLYSNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L+N + +++ D++ ++L + +LS G + G + L NL L+L D
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELKD 72
Query: 419 NSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIG 478
N ++ P + + LS K +I T + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 479 NLRSISNLALNNNKL--------------SGSIPQSLGNLSNLVILYLYNNSLFDSIPSE 524
L N N + L S L NLS L L +N + D P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 525 LGNLRSLSMLSFAYNKLSGSIP----HSLGVLDLS 555
L +L +L + N++S P +L ++ L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 24/67 (35%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 160 LIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL 219
L NLS L TL DN +SD P +L +L + L N+ S P L N +NL
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 220 ATLYLHN 226
+ L N
Sbjct: 220 FIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 34/205 (16%), Positives = 65/205 (31%), Gaps = 16/205 (7%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+ + + L + + I + ++ L L+L N P + L
Sbjct: 36 TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPS 187
+ +I + ++ +L L + L+
Sbjct: 94 GNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNL 153
Query: 188 EFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLS 247
++ + S L NL+ L TL +N + D P L +L +L +
Sbjct: 154 QYLS----------IGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201
Query: 248 LGYNKLSGSIPHSLGNLTNLATLYL 272
L N++S P L N +NL + L
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 39/230 (16%), Positives = 73/230 (31%), Gaps = 18/230 (7%)
Query: 67 FSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTL 126
F + + + + + + ++ + L T + +L+ L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGL 68
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
+L +NQ+ P + + L+ I + T + +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
S L + +G YL + S + L NL L+ L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANLSKLTTL 178
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNL 296
NK+S P L +L NL ++L N +S P N +L ++ L
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 19/67 (28%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 112 TIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNL 171
+ + +LS L TL+ +N+++ P + L +L + L +N + D+ P L N SNL
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 172 DTLHLYD 178
+ L +
Sbjct: 220 FIVTLTN 226
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 1e-08
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 175 HLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIP 234
Y N+ S+ I S SL L++ NK +P L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVP 320
Query: 235 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
NL+ L + YN L P ++ +L
Sbjct: 321 ELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 1e-08
Identities = 24/92 (26%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPG 475
Y N+ S I S SL L++ NKL +P L L N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 476 EIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
NL+ L + N L P ++ +L
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 10/95 (10%)
Query: 293 MLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGS 352
N + I +L L + NN L +P+ L L S N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-E 318
Query: 353 IPPSLGYLSNLATLYLYSNSL--FDSIPSELGNLR 385
+P NL L++ N L F IP + +LR
Sbjct: 319 VPELPQ---NLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 12/97 (12%)
Query: 394 YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL 453
N S I +L L++ +N L +P+ L L +N L+ +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELP 323
Query: 454 GNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
NL L + N L P ++ +L +N+
Sbjct: 324 QNLKQLH---VEYNPLR-EFPDIPESVE---DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 25/93 (26%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 271 YLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIP 330
Y N+ S I S SL LN+ NKL +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVP 320
Query: 331 SEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
NL+ L + N L P + +L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 5e-08
Identities = 25/93 (26%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 319 YIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIP 378
+ N+ S I S SL L +S NKL +P L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVP 320
Query: 379 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 411
NL+ L + YN L P ++ +L
Sbjct: 321 ELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 20/90 (22%), Positives = 30/90 (33%), Gaps = 9/90 (10%)
Query: 250 YNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309
N S I +L L + N L +P+ L L +N L +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLAE-VPELP 323
Query: 310 GNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
NL L++ N L P ++ L
Sbjct: 324 QNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 3e-07
Identities = 26/95 (27%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
N SN I L LN+SNN+ +P L L S N L E
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLAE- 318
Query: 659 IPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGL 693
+P + Q+L+ L++ +N L P E + L
Sbjct: 319 VPE---LPQNLKQLHVEYNPLREF-PDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 127 QLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIP 186
+ N + I SL L + +N L + +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVP 320
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL 219
NL+ L + YN P ++ +L
Sbjct: 321 ELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 27/96 (28%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 463 YLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIP 522
Y N+ S I S+ L ++NNKL +P L L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP 320
Query: 523 SELGNLRSLSMLSFAYNKLSG--SIPHSLGVLDLSS 556
NL+ L + YN L IP S+ L ++S
Sbjct: 321 ELPQNLKQLHV---EYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 23/136 (16%), Positives = 43/136 (31%), Gaps = 9/136 (6%)
Query: 36 PCAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGN 95
P + ++ + L + + FS L + N I
Sbjct: 223 PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 282
Query: 96 ISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155
L+ L++S+N +P L+ L N L +P L L+ + N
Sbjct: 283 PPSLEELNVSNN-KLIELPALPPR---LERLIASFNHLA-EVPELPQNLKQLH---VEYN 334
Query: 156 YLEDLIPPSLGNLSNL 171
L + P ++ +L
Sbjct: 335 PLREF-PDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 8e-06
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 8/89 (8%)
Query: 488 LNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG--SI 545
N S I +L L + NN L +P+ L L ++N L+ +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERLIA---SFNHLAEVPEL 322
Query: 546 PHSLGVLDLSSNHI--VGEIPTELGKLNF 572
P +L L + N + +IP + L
Sbjct: 323 PQNLKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 7e-05
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 554 LSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPK 613
N EI + L +L ++ N+L + +LE L S N L+ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLA-EVPE 321
Query: 614 SFGNLVKLHYLNLSNNQFSRGIPIKLEELIHL 645
N L L++ N P E + L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 2e-04
Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 9/90 (10%)
Query: 622 HYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVG 681
N S I + L EL++S+N L E +P+ LE L S N L
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE 318
Query: 682 LIPSCFEKMHGLLRIDISYNELQGPIPNSI 711
+ L ++ + YN L+ P+
Sbjct: 319 VPEL----PQNLKQLHVEYNPLRE-FPDIP 343
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 21/67 (31%), Positives = 30/67 (44%), Gaps = 8/67 (11%)
Query: 620 KLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
+ H L L+N S +P E HL L S N L E +P SL++L + +N+L
Sbjct: 39 QAHELELNNLGLSS-LP---ELPPHLESLVASCNSLTE-LPELPQ---SLKSLLVDNNNL 90
Query: 680 VGLIPSC 686
L
Sbjct: 91 KALSDLP 97
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 17/66 (25%), Positives = 26/66 (39%), Gaps = 5/66 (7%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
L+L + LS S+P +L S L N L+ +P +L +L +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 469 LSGSIP 474
LS P
Sbjct: 93 LSDLPP 98
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 1e-08
Identities = 39/194 (20%), Positives = 62/194 (31%), Gaps = 26/194 (13%)
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L S++ ++ L SI + NN+ + + L N+ L+L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
N L D P L K S+ + LS H L L L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 575 KLILAQNQLSGQLS--------------------PKLGSLAQLEHLDLSSNRLSNSIPKS 614
L L N+++ L L +L++L LS N +S+ ++
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195
Query: 615 FGNLVKLHYLNLSN 628
L L L L +
Sbjct: 196 LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 41/204 (20%), Positives = 69/204 (33%), Gaps = 16/204 (7%)
Query: 167 NLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHN 226
+ +L S++D++ L S+ + + + L N+ L+L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 227 NSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFG 286
N L + L NL++ L + L SL + S+
Sbjct: 78 NKL--TDIKPLANLKN-------LGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 287 NLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
L L L Y N I ++ + ++ I + L L NL LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSK 187
Query: 347 NKLSGSIPPSLGYLSNLATLYLYS 370
N +S +L L NL L L+S
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 39/198 (19%), Positives = 69/198 (34%), Gaps = 10/198 (5%)
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
+L S++ ++ L S+ + + + + L N+ L+L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
N L+ P + NL+++ L L+ NK+ + L S + +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 527 NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ 586
+ + S L L L N I +P L L L L L++N +S
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD- 192
Query: 587 LSPKLGSLAQLEHLDLSS 604
L L L+ L+L S
Sbjct: 193 -LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 42/203 (20%), Positives = 69/203 (33%), Gaps = 16/203 (7%)
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L + S++ ++ L S+ + + + + + L N+ L+++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N L+ P L+NL G + + I G
Sbjct: 78 NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
+ + SL + L LT L TL L DN +S +P L L L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 443 NKLSGSIPHSLGNLTNLDALYLY 465
N +S +L L NLD L L+
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 40/203 (19%), Positives = 68/203 (33%), Gaps = 16/203 (7%)
Query: 215 NLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE 274
L S+ D++ L S+ + + + + L N+ L+L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 275 NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIG 334
N L+ P NL++L L L NK+ + + + SL + S+I
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLK-------KLKSLSLEHNGISDIN 128
Query: 335 NLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGY 394
L L L + ++ ++ I L L L L L
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSK 187
Query: 395 NKLSGSIPHSLGNLTNLATLDLY 417
N +S +L L NL L+L+
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 3e-05
Identities = 31/210 (14%), Positives = 68/210 (32%), Gaps = 16/210 (7%)
Query: 472 SIPGEIG------NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSEL 525
++P I L ++ ++ Q+ L+++ + N+ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 526 GNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSG 585
L +++ L NKL+ P + +L + + ++ L+ L L ++
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLA----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE 120
Query: 586 QLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHL 645
+ S +N I LS + L L L
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL 180
Query: 646 SELDLSHNFLREAIPSQICIMQSLENLNLS 675
L LS N + + + +++L+ L L
Sbjct: 181 QNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 35/192 (18%), Positives = 62/192 (32%), Gaps = 24/192 (12%)
Query: 360 LSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN 419
+ L S+ D++ L S+ + + + + L N+ L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 420 SLSGSIPSEFGNLRSLSTLS----------------LGYNKLSGSIPHSLGNLTNLDALY 463
L+ P L + I G +
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 464 LYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPS 523
LY + + + L + L+L +N++S +P L L+ L LYL N + S
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLR 194
Query: 524 ELGNLRSLSMLS 535
L L++L +L
Sbjct: 195 ALAGLKNLDVLE 206
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 4e-08
Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 597 LEHLDLSSNRLSNS-IPKSFGNLVKLHYLNLSNNQFS----RGIPIKLEELIHLSELDLS 651
++ LD+ LS++ + L + + L + + + I L L+EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 652 HNFLREAIPSQICIM-----QSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYN 701
N L + + ++ L+L + L G L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 2e-07
Identities = 17/95 (17%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 170 NLDTLHLYDNSLSDSIPSE-FGNLRSLSMLSLGYNKFSG----SIPHSLGNLTNLATLYL 224
++ +L + LSD+ +E L+ ++ L + I +L LA L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 225 HNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 259
+N L D + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 16/91 (17%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 410 NLATLDLYDNSLSGSIPSE-FGNLRSLSTLSLGYNKLSG----SIPHSLGNLTNLDALYL 464
++ +LD+ LS + +E L+ + L L+ I +L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSG 495
N L + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 17/95 (17%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 362 NLATLYLYSNSLFDSIPSEL-GNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLDL 416
++ +L + L D+ +EL L+ ++ L L+ I +L LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPH 451
N L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 21/81 (25%), Positives = 34/81 (41%), Gaps = 9/81 (11%)
Query: 571 NFLIKLILAQNQLSGQ----LSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVK-----L 621
+ L L LA +S L+ L + L LDLS+N L ++ V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 622 HYLNLSNNQFSRGIPIKLEEL 642
L L + +S + +L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 2e-06
Identities = 19/95 (20%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 314 NLATLYIHNNSLSGSIPSEI-GNLRSLSNLGLSGNKLSG----SIPPSLGYLSNLATLYL 368
++ +L I LS + +E+ L+ + L L+ I +L LA L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 369 YSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPH 403
SN L D + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 17/95 (17%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 218 NLATLYLHNNSLFDSIPSEL-GNLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLYL 272
++ +L + L D+ +EL L+ ++ L L+ I +L LA L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 273 YENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPH 307
N L + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 19/94 (20%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 548 SLGVLDLSSNHIVGEIPTEL-GKLNFLIKLILAQNQLSGQ----LSPKLGSLAQLEHLDL 602
+ LD+ + EL L + L L+ +S L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 603 SSNRLSNSIPKSFG-----NLVKLHYLNLSNNQF 631
SN L + K+ L+L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 3e-06
Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 386 SLSMLSLGYNKLSGS-IPHSLGNLTNLATLDLYDNSLSG----SIPSEFGNLRSLSTLSL 440
+ L + +LS + L L + L D L+ I S +L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 441 GYNKLSGSIPHSLGNLTNLDALYLYDNSLSG 471
N+L H + + + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 15/93 (16%)
Query: 596 QLEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELI-----HLS 646
L L L+ +S+ S+ + L L+LSNN ++L E + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 647 ELDLSHNFLREAIPSQICIMQSLENLNLSHNSL 679
+L L + E + L+ L SL
Sbjct: 430 QLVLYDIYWSEEME------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 194 SLSMLSLGYNKFSGS-IPHSLGNLTNLATLYLHNNSLFD----SIPSELGNLRSLSMLSL 248
+ L + + S + L L + L + L + I S L +L+ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 249 GYNKLSGSIPHSLGNLTNLATLYLYENSLSG 279
N+L H + + + + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 266 NLATLYLYENSLSGSIPSE-FGNLRSLSMLNLGYNKLNGI----IPHSLGNLTNLATLYI 320
++ +L + LS + +E L+ ++ L L I +L LA L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 321 HNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG 351
+N L + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 24/92 (26%), Positives = 31/92 (33%), Gaps = 13/92 (14%)
Query: 361 SNLATLYLYSNSLFD----SIPSELGNLRSLSMLSLGYNKLSGSIPHSLG-----NLTNL 411
S L L+L + D S+ + L SL L L N L + L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 412 ATLDLYDNSLSGSIPSEFGNLR----SLSTLS 439
L LYD S + L SL +S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 22/94 (23%), Positives = 32/94 (34%), Gaps = 13/94 (13%)
Query: 167 NLSNLDTLHLYDNSLSD----SIPSEFGNLRSLSMLSLGYNKFSGSIPHSLG-----NLT 217
S L L L D +SD S+ + SL L L N + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 218 NLATLYLHNNSLFDSIPSELGNLR----SLSMLS 247
L L L++ + + L L SL ++S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 18/83 (21%), Positives = 27/83 (32%), Gaps = 9/83 (10%)
Query: 383 NLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLDLYDNSLSGSIPSEFG-----NLR 433
L +L L +S S+ +L +L LDL +N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 434 SLSTLSLGYNKLSGSIPHSLGNL 456
L L L S + L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 5e-05
Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 5/95 (5%)
Query: 458 NLDALYLYDNSLSGSIPGEI-GNLRSISNLALNNNKLSG----SIPQSLGNLSNLVILYL 512
++ +L + LS + E+ L+ + L++ L+ I +L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 513 YNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPH 547
+N L D + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 9/84 (10%)
Query: 263 NLTNLATLYLYENSLSG----SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLG-----NLT 313
+ L L+L + +S S+ + SL L+L N L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 314 NLATLYIHNNSLSGSIPSEIGNLR 337
L L +++ S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 13/75 (17%), Positives = 29/75 (38%), Gaps = 5/75 (6%)
Query: 643 IHLSELDLSHNFLREAIPSQIC-IMQSLENLNLSHNSL----VGLIPSCFEKMHGLLRID 697
+ + LD+ L +A +++ ++Q + + L L I S L ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 698 ISYNELQGPIPNSIA 712
+ NEL + +
Sbjct: 62 LRSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 22/99 (22%), Positives = 31/99 (31%), Gaps = 9/99 (9%)
Query: 175 HLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSG----SIPHSLGNLTNLATLYLHNNSLF 230
L D + + L +L L S S+ +L +L L L NN L
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 231 DSIPSELG-----NLRSLSMLSLGYNKLSGSIPHSLGNL 264
D+ +L L L L S + L L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 15/88 (17%), Positives = 26/88 (29%), Gaps = 9/88 (10%)
Query: 282 PSEFGNLRSLSMLNLGYNKLNGI----IPHSLGNLTNLATLYIHNNSLSGSIPSEIG--- 334
L +L L ++ + +L +L L + NN L + ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 335 --NLRSLSNLGLSGNKLSGSIPPSLGYL 360
L L L S + L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 13/107 (12%)
Query: 417 YDNSLSGSIPSEFGNLRSLSTLSLGYNKLSG----SIPHSLGNLTNLDALYLYDNSLSGS 472
D + L L L +S S+ +L +L L L +N L +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 473 IPGEIG-----NLRSISNLALNNNKLSGSIPQSLGNLS----NLVIL 510
++ + L L + S + L L +L ++
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/74 (21%), Positives = 26/74 (35%), Gaps = 5/74 (6%)
Query: 619 VKLHYLNLSNNQFS-RGIPIKLEELIHLSELDLSHNFLRE----AIPSQICIMQSLENLN 673
+ + L++ + S L L + L L E I S + + +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 674 LSHNSLVGLIPSCF 687
L N L + C
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/83 (19%), Positives = 25/83 (30%), Gaps = 9/83 (10%)
Query: 239 NLRSLSMLSLGYNKLSG----SIPHSLGNLTNLATLYLYENSLSGSIPSEFG-----NLR 289
L +L L +S S+ +L +L L L N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 290 SLSMLNLGYNKLNGIIPHSLGNL 312
L L L + + L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 2e-04
Identities = 19/95 (20%), Positives = 29/95 (30%), Gaps = 9/95 (9%)
Query: 537 AYNKLSGSIPHSLGVLDLSSNHIVGE----IPTELGKLNFLIKLILAQNQLSGQLSPKLG 592
+ G L VL L+ + + L + L +L L+ N L +L
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 593 SLAQ-----LEHLDLSSNRLSNSIPKSFGNLVKLH 622
+ LE L L S + L K
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 19/85 (22%), Positives = 28/85 (32%), Gaps = 9/85 (10%)
Query: 615 FGNLVKLHYLNLSNNQFS----RGIPIKLEELIHLSELDLSHNFLREAIPSQIC-----I 665
L L L++ S + L L ELDLS+N L +A Q+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 666 MQSLENLNLSHNSLVGLIPSCFEKM 690
LE L L + + +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 20/104 (19%), Positives = 32/104 (30%), Gaps = 9/104 (8%)
Query: 465 YDNSLSGSIPGEIGNLRSISNLALNNNKLSG----SIPQSLGNLSNLVILYLYNNSLFDS 520
D + G + L L + +S S+ +L +L L L NN L D+
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 521 IPSELG-----NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHI 559
+L L L S + L L+ +
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 13/92 (14%)
Query: 121 SYLKTLQLFENQLNG----SIPYEIGRLSSLNYLALYSNYLEDLIPPSLG-----NLSNL 171
S L+ L L + ++ S+ + SL L L +N L D L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 172 DTLHLYDNSLSDSIPSEFGNLR----SLSMLS 199
+ L LYD S+ + L SL ++S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.002
Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 9/81 (11%)
Query: 145 SSLNYLALYSNYLEDL----IPPSLGNLSNLDTLHLYDNSLSDSIPSEFG-----NLRSL 195
S L L L + D + +L +L L L +N L D+ + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 196 SMLSLGYNKFSGSIPHSLGNL 216
L L +S + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 9/93 (9%)
Query: 65 HDFSFSSFPHLAYLDLWHNQL----YGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIG-- 118
L L L + ++ + L+ LDLS+N ++
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 119 ---HLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148
L+ L L++ + + + L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 13/94 (13%), Positives = 26/94 (27%), Gaps = 5/94 (5%)
Query: 123 LKTLQLFENQLNGS-IPYEIGRLSSLNYLALYSNYLED----LIPPSLGNLSNLDTLHLY 177
+++L + +L+ + + L + L L + I +L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPH 211
N L D +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 33/228 (14%), Positives = 70/228 (30%), Gaps = 13/228 (5%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
++ ++ IPS+ R+ L KL + +L+ + + N +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 473 IPGEI----------GNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIP 522
I ++ ++ + L +N +SN I +L + S+
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 523 SELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQ 582
L +++ + + +L L+ N I + N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 583 LSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQ 630
L + + LD+S R+ + NL KL + N +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 3e-07
Identities = 30/244 (12%), Positives = 67/244 (27%), Gaps = 17/244 (6%)
Query: 221 TLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGS 280
+ + IPS+L R+ L KL + +L + + +N +
Sbjct: 12 VFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS----GSIPSEIGNL 336
I ++ + N + + Y+ ++ +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK 396
+ L ++ + N + +G L+L N + + + + N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 397 LSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNL 456
L + LD+ + NL+ L S ++L L
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST----------YNLKKL 238
Query: 457 TNLD 460
L+
Sbjct: 239 PTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 37/231 (16%), Positives = 64/231 (27%), Gaps = 7/231 (3%)
Query: 242 SLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301
S + +K++ IP L N L L F L + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 302 NGIIPHSLGNLTNLAT--LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGY 359
+I + + N+L P NL +L L +S + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 360 LSNLATLYLYS--NSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLY 417
L + N S +G +L L N + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 418 DNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNS 468
+N+L F L + ++ + L NL L A Y+
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 33/251 (13%), Positives = 61/251 (24%), Gaps = 22/251 (8%)
Query: 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNI 96
C+ C +T I + L +L
Sbjct: 8 CSNRVFLCQES------KVTEI---------PSDLPRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156
L+ +++S N I ++ E N + N L +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 157 LEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSM----LSLGYNKFSGSIPHS 212
P + + +L + L + E + LS L L N +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 213 LGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYL 272
NN+L + +L + ++ + L NL L
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 273 YENSLSGSIPS 283
Y +P+
Sbjct: 233 YNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 7e-05
Identities = 31/223 (13%), Positives = 53/223 (23%), Gaps = 9/223 (4%)
Query: 161 IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLA 220
IP L N L L F L + + N I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 221 TLYL----HNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENS 276
+N + + ++S K + L + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 277 LSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336
+ S G +L L N + I + NN+L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPS 379
L +S ++ L L L Y+ +P+
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 25/224 (11%), Positives = 59/224 (26%), Gaps = 9/224 (4%)
Query: 136 SIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
IP ++ + L L + + +L+ + + N + + I ++ +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 196 SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLF----DSIPSELGNLRSLSMLSLGYN 251
+ + YL ++ + + L + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 252 KLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGN 311
+ +G L+L +N + F + + N L +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 312 LTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPP 355
+ L I + + NL+ L K +P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 29/228 (12%), Positives = 62/228 (27%), Gaps = 7/228 (3%)
Query: 269 TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGS 328
E+ ++ IPS+ R+ L KL I + +L + I N +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 329 IPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF----DSIPSELGNL 384
I +++ + + + + + YL ++ +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNK 444
+ L + N + +G L L N + F + N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 445 LSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
L + L + + + NL+ + + N K
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 28/224 (12%), Positives = 59/224 (26%), Gaps = 9/224 (4%)
Query: 208 SIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNL 267
IP L N L L L + + N + I + +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 268 ATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK--LNGIIPHSLGNLTNLATLYIHN--N 323
E + + + ++ L + + + + L I + N
Sbjct: 80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139
Query: 324 SLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGN 383
+ S +G L L+ N + + +N+L +
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199
Query: 384 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPS 427
+L + ++ + L NL L Y+ +P+
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 9e-04
Identities = 29/230 (12%), Positives = 59/230 (25%), Gaps = 13/230 (5%)
Query: 434 SLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
S +K++ IP L N L L G + + ++ N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 494 SGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLS----------G 543
I + + + + + ++ +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 544 SIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLS 603
S+ L + + N E + +G + L L +N + + E
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 604 SNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHN 653
+N L F L++S + LE L L +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 21/216 (9%), Positives = 52/216 (24%), Gaps = 6/216 (2%)
Query: 89 IPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148
IP + L L+ +++ +N + I ++
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS----DSIPSEFGNLRSLSMLSLGYNK 204
+ L + + +L ++ + + L + N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 205 FSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL 264
+ +G L+L+ N + + + + N L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNK 300
+ L + + NL+ L + K
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 26/231 (11%), Positives = 59/231 (25%), Gaps = 7/231 (3%)
Query: 170 NLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSL 229
+ ++ ++ IPS+ R+ L K + +L + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 230 FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLS----GSIPSEF 285
+ I +++ + + + YL ++ +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS 345
+ L + N +G L+++ N + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 346 GNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNK 396
N L S L + + L NL+ L S K
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 30/228 (13%), Positives = 62/228 (27%), Gaps = 7/228 (3%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
+ ++ IPS++ R+ L KL + +L + + N + +
Sbjct: 12 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLS----GSIPSEFGNL 432
I +++ + + + L ++ +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 433 RSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNK 492
+ L + N + +G L+L N + + +NN
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 493 LSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNK 540
L S VIL + + L NL+ L S K
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 27/120 (22%), Positives = 42/120 (35%), Gaps = 7/120 (5%)
Query: 245 MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGI 304
+L L + L+ + L L + L L N L P+ LR L +L N L +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 305 IPHSLGNLTNLATLYIHNNSL-SGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
+ L + NN L + + + L L L GN L L+ +
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 317 TLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDS 376
L++ + L+ + + L +++L LS N+L +PP+L L L L N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDN--ALE 56
Query: 377 IPSELGNLRSLSMLSLGYNKL-SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
+ NL L L L N+L + L + L L+L NSL L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 5e-07
Identities = 29/119 (24%), Positives = 42/119 (35%), Gaps = 5/119 (4%)
Query: 413 TLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGS 472
L L L+ + L ++ L L +N+L P +L L L+ L DN+L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 473 IPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSL 531
L NN + Q L + LV+L L NSL L +
Sbjct: 59 DGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 30/120 (25%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGS 136
L L H L + + + + +LDLS N +PP + L L+ LQ +N L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 137 IPYEIGRLSSLNYLALYSNYLEDLIPP-SLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL 195
L L L +N L+ L + L L+L NSL L +
Sbjct: 59 DGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 34/108 (31%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 576 LILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGI 635
L LA L+ L L + HLDLS NRL P + L L L S+N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 636 PIKLEELIHLSELDLSHNFLRE-AIPSQICIMQSLENLNLSHNSLVGL 682
+ L EL L +N L++ A + L LNL NSL
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 31/128 (24%), Positives = 47/128 (36%), Gaps = 12/128 (9%)
Query: 149 YLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGS 208
L L L L L L + L L N L P+ LR L +L + +
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALE 56
Query: 209 IPHSLGNLTNLATLYLHNNSLFD-SIPSELGNLRSLSMLSLGYNKLSG------SIPHSL 261
+ NL L L L NN L + L + L +L+L N L + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 262 GNLTNLAT 269
+++++ T
Sbjct: 117 PSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 26/106 (24%)
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQL------------- 597
VL L+ + + L +L + L L+ N+L P L +L L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENV 58
Query: 598 ---------EHLDLSSNRLSN-SIPKSFGNLVKLHYLNLSNNQFSR 633
+ L L +NRL + + + +L LNL N +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 24/117 (20%), Positives = 49/117 (41%), Gaps = 7/117 (5%)
Query: 509 ILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSG---SIPHSLGVLDLSSNHIVGEIPT 565
+L+L + L ++ L L ++ L ++N+L ++ + L ++ E
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 566 ELGKLNFLIKLILAQNQLSGQLSPK-LGSLAQLEHLDLSSNRLSNSIPKSFGNLVKL 621
+ L L +L+L N+L + + L S +L L+L N L L ++
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 26/108 (24%), Positives = 39/108 (36%), Gaps = 6/108 (5%)
Query: 437 TLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGS 496
L L + L+ + L L + L L N L P + LR + L + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALE 56
Query: 497 IPQSLGNLSNLVILYLYNNSLFD-SIPSELGNLRSLSMLSFAYNKLSG 543
+ NL L L L NN L + L + L +L+ N L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 45/337 (13%), Positives = 108/337 (32%), Gaps = 25/337 (7%)
Query: 338 SLSNLGLSGNKLSG----SIPPSLGYLSNLATLYLYSNSLFD----SIPSELGNLRSLSM 389
S+ L + ++ S+ L ++ + L N++ + + + + L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 390 LSLGYN---KLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLS 446
++ IP +L L +++ S + + L +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 447 GSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS-GSIPQSLGNLS 505
+ L + ++ + N + ++ N+L GS+ +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 506 NLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPT 565
+ +L+ P + +L + K+ ++ L S+ I +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 566 ELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKS-----FGNLVK 620
L +L L+ A+ + + L+ L L N + ++ +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 621 LHYLNLSNNQFSR--GIPIKLEELI------HLSELD 649
L +L L+ N+FS + ++ E+ L ELD
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 4e-05
Identities = 47/327 (14%), Positives = 95/327 (29%), Gaps = 34/327 (10%)
Query: 193 RSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFD----SIPSELGNLRSLSMLSL 248
+SL + ++ S+ L ++ + L N++ + + + + L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 249 GYNKL----------SGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGY 298
+ +L L T+ L +N+ + + S
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 299 NKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLG 358
N + G A + N + + P + + L K S
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 359 YLSNLATLY------LYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLA 412
L + + + L + + + + S ++ +L + NL
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 413 TLDLYDNSLSGSIPSEFGN------LRSLSTLSLGYNKLSGSIPHSL-----GNLTNLDA 461
L L D LS + + L TL L YN++ +L + +L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 462 LYLYDNSLS--GSIPGEIGNLRSISNL 486
L L N S + EI + S
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 5e-05
Identities = 44/347 (12%), Positives = 96/347 (27%), Gaps = 30/347 (8%)
Query: 289 RSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSG----SIPSEIGNLRSLSNLGL 344
+SL + + + L ++ + + N++ + I + + L
Sbjct: 8 KSLKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 345 SGN---KLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSI 401
S ++ IP +L L +++ S + + + L + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 402 PHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLS-GSIPHSLGNLTNLD 460
L A + ++ + N L ++ G N+L GS+ +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 461 ALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDS 520
L+ +G P I +L K+ + +L + + +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 521 IPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQ 580
L S + + S L L L N I + L +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID-------- 298
Query: 581 NQLSGQLSPKLGSLAQLEHLDLSSNRLS--NSIPKSFGNLVKLHYLN 625
+ L L+L+ NR S + + +
Sbjct: 299 -----------EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 44/328 (13%), Positives = 97/328 (29%), Gaps = 34/328 (10%)
Query: 241 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG----SIPSEFGNLRSLSMLNL 296
+SL + ++ S+ L ++ + L N++ + + + L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 297 GYNKLNGI----------IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346
+ + +L L T+ + +N+ + + + S
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 347 NKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLG 406
+ + P G A L N + P + + L G K S
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 407 NLTNL------ATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLD 460
L + + ++ L + + + S ++ +L + NL
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 461 ALYLYDNSLSGSIPGEIGN------LRSISNLALNNNKLSGSIPQSL-----GNLSNLVI 509
L L D LS + + + L L N++ ++L + +L+
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 510 LYLYNNSL--FDSIPSELGNLRSLSMLS 535
L L N D + E+ + S
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 46/331 (13%), Positives = 91/331 (27%), Gaps = 38/331 (11%)
Query: 142 GRLS----SLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD----SIPSEFGNLR 193
R S SL A+ + + + L ++ + L N++ + + +
Sbjct: 1 ARFSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 194 SLSMLSLGYN----------KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSL 243
L + + + +L L T+ L +N+ + L + S
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 244 SMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303
+ + G A L N + + P + + L G K
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179
Query: 304 IIPHSLGNLTNLATLYIHNNSLSGS------IPSEIGNLRSLSNLGLSGNKLSGSIPPSL 357
S L + + + + S ++ +L
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 358 GYLSNLATLYLYSNSLFDSIPSELGN------LRSLSMLSLGYNKLSGSIPHSL-----G 406
NL L L L + + + L L L YN++ +L
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 299
Query: 407 NLTNLATLDLYDNSLS--GSIPSEFGNLRSL 435
+ +L L+L N S + E + S
Sbjct: 300 KMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 40/323 (12%), Positives = 85/323 (26%), Gaps = 15/323 (4%)
Query: 385 RSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSG----SIPSEFGNLRSLSTLSL 440
+SL + ++ S+ L ++ + L N++ + + + L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 441 GYN---KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSI 497
++ IP +L L +++ S + L+ + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 498 PQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSN 557
L + ++ + N L + N+L S
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 558 HIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGN 617
+ + G I+ +L + Q L SS
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 618 LVKLHYLNLSNNQFSR-GIPIKLEELIHLSELDLSHNFLREAIPSQICI-----MQSLEN 671
+ L+ LS + E I L L L +N + + M L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 672 LNLSHNSLVGLIPSCFEKMHGLL 694
L L+ N +++ +
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 15/98 (15%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 39 WVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQI----- 93
R +N L++ G ++ FS L L L +N++ + +
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 94 GNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFEN 131
+ L +L+L+ N F + + + + +
Sbjct: 299 EKMPDLLFLELNGN-RFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 14/103 (13%), Positives = 27/103 (26%), Gaps = 8/103 (7%)
Query: 597 LEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSNNQFS----RGIPIKLEELIHLSEL 648
+E L + ++ S+ + + LS N R + + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 649 DLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMH 691
+ S F ++ L L L + S
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 43/326 (13%), Positives = 88/326 (26%), Gaps = 34/326 (10%)
Query: 99 LKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNG----SIPYEIGRLSSLNYLALYS 154
LK +++ ++ + +K + L N + + I L
Sbjct: 10 LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 155 NYLEDL----------IPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNK 204
+ + + +L L T+ L DN+ + + S
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 205 FSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNL 264
+ + G A L N + P + + L G K S L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 265 TNLATLYLYENSLSGS------IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATL 318
+ + + N + + + +L + NL L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 319 YIHNNSLSGSIPSEIGN------LRSLSNLGLSGNKLSGSIPPSL-----GYLSNLATLY 367
+++ LS + + + L L L N++ +L + +L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 368 LYSNSL--FDSIPSELGNLRSLSMLS 391
L N D + E+ + S
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 44/323 (13%), Positives = 90/323 (27%), Gaps = 35/323 (10%)
Query: 54 NLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGN----IPPQIGNISRLKYLDLSSNL- 108
+T+ K + + + L N + + I + L+ + S
Sbjct: 14 AITTEDEKSVFA--VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 109 ---------FFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED 159
+ + L T++L +N + + S + + +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 160 LIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL 219
+ P G L N + + P + + L G K S L +
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191
Query: 220 ATLYLHNNSLFDS------IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLY 273
+ + + + S ++ +L + NL L L
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251
Query: 274 ENSLSGSIPSEFGN------LRSLSMLNLGYNKLNGIIPHSL-----GNLTNLATLYIHN 322
+ LS + + L L L YN++ +L + +L L ++
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 323 NSLS--GSIPSEIGNLRSLSNLG 343
N S + EI + S G
Sbjct: 312 NRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 42/330 (12%), Positives = 93/330 (28%), Gaps = 34/330 (10%)
Query: 123 LKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLED----LIPPSLGNLSNLDTLHLYD 178
LK + S+ + S+ + L N + + ++ + +L+ D
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 179 NS---LSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235
+ D IP L + + S +L ++ + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGN-------- 287
L + + ++ N L ++ N L E+
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 288 -LRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLS----GSIPSEIGNLRSLSNL 342
+ + + ++ L L L + +N+ + ++ + + +L L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 343 GLSGNKLSGSIPPSLG------YLSNLATLYLYSNSLFDSIPSEL-----GNLRSLSMLS 391
GL+ LS ++ L TL L N + L + L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 392 LGYNKLS--GSIPHSLGNLTNLATLDLYDN 419
L N+ S + + + + D
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRGELDE 338
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (111), Expect = 2e-06
Identities = 20/128 (15%), Positives = 42/128 (32%), Gaps = 3/128 (2%)
Query: 586 QLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHL 645
+ + + + + LDL ++ I L + ++ S+N+ + L L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRL 65
Query: 646 SELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQG 705
L +++N + + L L L++NSLV L L
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 706 PIPNSIAF 713
+ +
Sbjct: 126 NKKHYRLY 133
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 4e-05
Identities = 23/135 (17%), Positives = 42/135 (31%), Gaps = 7/135 (5%)
Query: 260 SLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLY 319
N L L + I + L ++ N++ + L L TL
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 69
Query: 320 IHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSG-SIPPSLGYLSNLATLYLYS---NSLFD 375
++NN + L L+ L L+ N L L L +L L + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 376 SIPSELGNLRSLSML 390
+ + + +L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 1e-04
Identities = 25/133 (18%), Positives = 45/133 (33%), Gaps = 4/133 (3%)
Query: 187 SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSML 246
+++ N L L K I + L + +N + LR L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68
Query: 247 SLGYNKLSGSIPHSLGNLTNLATLYLYENSLSG-SIPSEFGNLRSLSMLNLGYNKLNGII 305
+ N++ L +L L L NSL +L+SL+ L + N +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 306 PHSLGNLTNLATL 318
+ L + + +
Sbjct: 129 HYRLYVIYKVPQV 141
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 28/136 (20%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 379 SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTL 438
++ N L L K+ I + L +D DN + F LR L TL
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 439 SLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSG-SIPGEIGNLRSISNLALNNNK---LS 494
+ N++ L +L L L +NSL + +L+S++ L + N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 495 GSIPQSLGNLSNLVIL 510
+ + + +L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 4e-04
Identities = 25/135 (18%), Positives = 45/135 (33%), Gaps = 7/135 (5%)
Query: 68 SFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQ 127
+++ LDL ++ I + + +D S N L LKTL
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 128 LFENQLNGSIPYEIGRLSSLNYLALYSNYLEDL-IPPSLGNLSNLDTLHLYD---NSLSD 183
+ N++ L L L L +N L +L L +L +L L + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 184 SIPSEFGNLRSLSML 198
+ + +L
Sbjct: 130 YRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 9e-04
Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 4/133 (3%)
Query: 91 PQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYL 150
Q N R + LDL I L + +N++ + L L L
Sbjct: 12 AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 151 ALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSD-SIPSEFGNLRSLSMLSLGYNKFSGSI 209
+ +N + + L +L L L +NSL + +L+SL+ L + N +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 210 PHSLGNLTNLATL 222
+ L + + +
Sbjct: 129 HYRLYVIYKVPQV 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 2e-06
Identities = 23/135 (17%), Positives = 46/135 (34%), Gaps = 7/135 (5%)
Query: 208 SIPHSLGNLTNLATLYLHNNSL-FDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTN 266
+ + + + L L D L+ + ++ ++ N+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR----SSMAATLRIIEENIPE 66
Query: 267 LATLYLYENSLSG--SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324
L +L L N L + S +L +LNL N+L L L++ NS
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 325 LSGSIPSEIGNLRSL 339
LS + + + ++
Sbjct: 127 LSDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 28/129 (21%), Positives = 45/129 (34%), Gaps = 7/129 (5%)
Query: 595 AQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNF 654
+ LDL R LN ++ + + I E + L L+LS+N
Sbjct: 22 GSQQALDLKGLR----SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNR 76
Query: 655 LR--EAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMHGLLRIDISYNELQGPIPNSIA 712
L + + S + +L+ LNLS N L K L + + N L +
Sbjct: 77 LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
Query: 713 FRDAPIEAL 721
+ A E
Sbjct: 137 YISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 27/134 (20%), Positives = 45/134 (33%), Gaps = 5/134 (3%)
Query: 232 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSL 291
+ + S +L L L L +S++ ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 292 SMLNLGYNKLNGI--IPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKL 349
LNL N+L + + + NL L + N L + L L L GN L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 350 SGSIPPSLGYLSNL 363
S + Y+S +
Sbjct: 128 SDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 24/135 (17%), Positives = 45/135 (33%), Gaps = 5/135 (3%)
Query: 376 SIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSL 435
+ + S +L L L L+ +S++ ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 436 STLSLGYNKLSG--SIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKL 493
+L+L N+L + + NL L L N L + + L L+ N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 494 SGSIPQSLGNLSNLV 508
S + +S +
Sbjct: 128 SDTFRDQSTYISAIR 142
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 548 SLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRL 607
S LDL +L N + L ++ ++ L ++ +L L+LS+NRL
Sbjct: 23 SQQALDLKGLRS----DPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 608 SN--SIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPSQ 662
+ L LNLS N+ + + + L EL L N L + Q
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 9e-04
Identities = 27/145 (18%), Positives = 40/145 (27%), Gaps = 12/145 (8%)
Query: 280 SIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSL 339
+ S L L L L ++ + ++ N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 340 SNLGLSGNKLSG--SIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397
+L LS N+L + + NL L L N L + L L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 398 SGSIPHS-------LGNLTNLATLD 415
S + L LD
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.002
Identities = 24/126 (19%), Positives = 40/126 (31%), Gaps = 5/126 (3%)
Query: 424 SIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSI 483
+ S +L L L L +S++ ++ N+ +
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67
Query: 484 SNLALNNNKLSG--SIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKL 541
+L L+NN+L + + NL IL L N L + L L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 542 SGSIPH 547
S +
Sbjct: 128 SDTFRD 133
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 41/201 (20%), Positives = 72/201 (35%), Gaps = 18/201 (8%)
Query: 167 NLSNLDTLHLYDNSLSDSIP-SEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLH 225
L+ L +++D++ ++ + +L LG G + L NL +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 226 NNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEF 285
NN L D P L L+ + L + + T + I
Sbjct: 71 NNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 286 GNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS 345
++ L + +L LT+L L +N ++ P + NL +L L +S
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 346 GNKLSGSIPPSLGYLSNLATL 366
NK+S L L+NL +L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 40/200 (20%), Positives = 71/200 (35%), Gaps = 16/200 (8%)
Query: 263 NLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322
L L + +++ ++ +L ++ L + I + L NL + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 323 NSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELG 382
N L+ P L NL + L + + T + I
Sbjct: 72 NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGY 442
++ L + + S +L LT+L L+ N ++ P NL +L L +
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 443 NKLSGSIPHSLGNLTNLDAL 462
NK+S L LTNL++L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 43/201 (21%), Positives = 69/201 (34%), Gaps = 18/201 (8%)
Query: 215 NLTNLATLYLHNNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLY 273
L L ++ D++ ++L + +L LG + G + L NL +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 274 ENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEI 333
N L+ P L L + L + T + I
Sbjct: 71 NNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 334 GNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393
+ L + + S +L L++L L SN + D P L NL +L L +
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 394 YNKLSGSIPHSLGNLTNLATL 414
NK+S L LTNL +L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 42/194 (21%), Positives = 80/194 (41%), Gaps = 10/194 (5%)
Query: 455 NLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYN 514
L L +++ ++ +L ++ L + + SI + L+NL + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 515 NSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLI 574
N L D P + +++ + + + L+ + L L L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 575 KLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRG 634
+L L+ N +S L L L+ L+ SSN++++ P NL L L++S+N+ S
Sbjct: 132 RLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS-D 186
Query: 635 IPIKLEELIHLSEL 648
I + L +L +L L
Sbjct: 187 ISV-LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 34/194 (17%), Positives = 66/194 (34%), Gaps = 10/194 (5%)
Query: 431 NLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNN 490
L LG ++ ++ + +L + L + SI G + L +++ + +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 491 NKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLG 550
N+L+ P +++ + + + + + +L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 551 VLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS 610
L+LSSN I L + L +L LE LD+SSN++S+
Sbjct: 132 RLELSSNTISDISALS----GLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD- 186
Query: 611 IPKSFGNLVKLHYL 624
L L L
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 36/199 (18%), Positives = 66/199 (33%), Gaps = 16/199 (8%)
Query: 144 LSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203
L+ L + D + S +L + TL + L +L+ ++ N
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGN 263
+ + P + + + + + + + +L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN- 131
Query: 264 LTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNN 323
L +S + S S L SL LN N++ + P L NLT L L I +N
Sbjct: 132 -------RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 324 SLSGSIPSEIGNLRSLSNL 342
+S S + L +L +L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 36/192 (18%), Positives = 68/192 (35%), Gaps = 26/192 (13%)
Query: 360 LSNLATLYLYSNSLFDSIP-SELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418
L+ L ++ D++ ++L + +L LG + G + L NL ++ +
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71
Query: 419 NSLSGSI----------------PSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDAL 462
N L+ + T G + I +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 463 YLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIP 522
L +S + S + L S+ L ++N+++ P L NL+ L L + +N + S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV--SDI 187
Query: 523 SELGNLRSLSML 534
S L L +L L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 30/199 (15%), Positives = 63/199 (31%), Gaps = 16/199 (8%)
Query: 120 LSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDN 179
L+ L + + ++ L + L ++ + + L+NL ++ +N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 180 SLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGN 239
L+D P + +++ + + + + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 240 LRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYN 299
L S +I + L +S + NL +L L++ N
Sbjct: 133 LELSSN----------TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSN 182
Query: 300 KLNGIIPHSLGNLTNLATL 318
K++ I L LTNL +L
Sbjct: 183 KVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 38/194 (19%), Positives = 72/194 (37%), Gaps = 10/194 (5%)
Query: 479 NLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAY 538
L L ++ ++ Q+ +L + L + + L +L+ ++F+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 539 NKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLE 598
N+L+ P + +I N L L +L L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 599 HLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREA 658
L+LSSN +S+ S ++ + +NQ + P L L L LD+S N + +
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFS--SNQVTDLKP--LANLTTLERLDISSNKVSD- 186
Query: 659 IPSQICIMQSLENL 672
S + + +LE+L
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 37/194 (19%), Positives = 67/194 (34%), Gaps = 10/194 (5%)
Query: 407 NLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466
L L +++ ++ +L ++TL + SI + L NL + +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 467 NSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELG 526
N L+ P + + L NN I + + N L
Sbjct: 72 NQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 527 NLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTELGKLNFLIKLILAQNQLSGQ 586
NL L + S + +S + S++ V ++ L L L +L ++ N++S
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVSD- 186
Query: 587 LSPKLGSLAQLEHL 600
L L LE L
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 25/148 (16%), Positives = 45/148 (30%), Gaps = 2/148 (1%)
Query: 217 TNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLATLYLYEN 275
+ L + L +L+ L + + + L L L L + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 276 SLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335
L P F LS LNL +N L + ++ L+ + N +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNL 363
G+ KL L ++ N
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 7e-05
Identities = 29/149 (19%), Positives = 42/149 (28%), Gaps = 4/149 (2%)
Query: 265 TNLATLYLYENSLSGSIPSEFGNLRSLSMLNL-GYNKLNGIIPHSLGNLTNLATLYIHNN 323
+ L + +L+ L + L + L L L L I +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 324 SLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLF-DSIPSELG 382
L P LS L LS N L S+ +L L L N L L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 383 NLRSLSMLSLGYNKLSGSIPHSLGNLTNL 411
+ + KL L ++ N
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 20/143 (13%), Positives = 40/143 (27%), Gaps = 2/143 (1%)
Query: 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEI-GHLSYLKTLQLFENQLNGS 136
L + + + L L + + + L L+ L + ++ L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 137 IPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLS 196
P L+ L L N LE L ++ LS + + +
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 197 MLSLGYNKFSGSIPHSLGNLTNL 219
+ + K L ++ N
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 20/104 (19%), Positives = 32/104 (30%), Gaps = 2/104 (1%)
Query: 589 PKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHYLNLSNNQFSRGIPIKLEE-LIHLSE 647
P L + + L L + N Q + + ++ L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 648 LDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPSCFEKMH 691
L + + LR P L LNLS N+L L + +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 21/142 (14%), Positives = 38/142 (26%), Gaps = 2/142 (1%)
Query: 409 TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIP-HSLGNLTNLDALYLYDN 467
+ L + +L+ L + + + L L L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 468 SLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLVILYLYNNSLFDSIPSELGN 527
L P +S L L+ N L +++ LS ++ N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 528 LRSLSMLSFAYNKLSGSIPHSL 549
+ KL L
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 29/155 (18%), Positives = 46/155 (29%), Gaps = 4/155 (2%)
Query: 355 PSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIP-HSLGNLTNLAT 413
P + L + L +L+ L + + + L L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 414 LDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSI 473
L + + L P F LS L+L +N L S+ +L L L N L S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 474 -PGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNL 507
+ + KL L ++ N
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 27/155 (17%), Positives = 43/155 (27%), Gaps = 4/155 (2%)
Query: 163 PSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIP-HSLGNLTNLAT 221
P L + +L+ L + + + L L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 222 LYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSI 281
L + + L P LS L+L +N L S+ +L L L N L S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 282 -PSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315
+ + KL L ++ N
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1075 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.03 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.36 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=388.91 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=189.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||+||+|+++ ..||||+++..... ....++|.+|++++++++|||||+++|++.+....+.+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence 468999999999999999999765 36999999765433 334678999999999999999999999987655443333
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
+... .....+++.++.+++.||++||+|||+. +||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 2221 1235689999999999999999999999 999999999999999999999999999987654322
Q ss_pred -ceeccccccCccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 965 -NWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
......||+.|||||++.+. .++.++|||||||++|||+||+.||......... ..........+.. ...
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~~~~~p~~---~~~ 234 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGRGYLSPDL---SKV 234 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHHTSCCCCG---GGS
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH---HHHHhcCCCCCcc---hhc
Confidence 33456899999999998643 4789999999999999999999999754322111 1111111122221 112
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
....+.++.+++.+||+.||++||||+||++.|+
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2334457999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=387.47 Aligned_cols=243 Identities=20% Similarity=0.334 Sum_probs=191.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||+||+|.+++++.||||+++.... ..++|.+|++++++++|||||+++|++.+....+.+.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEE
Confidence 467888899999999999999998889999999975432 2467999999999999999999999987655444333
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+...+ ....++|.++++|+.||++||+|||+. +|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 22221 123589999999999999999999999 999999999999999999999999999998765432
Q ss_pred -ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC-CCCCCCcCcH
Q 042958 965 -NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPSCIVQ 1042 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1042 (1075)
......||+.|+|||++.+..++.++|||||||++|||+||..|+...... ......+... +.+.+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~~~~p~---- 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVRPD---- 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCT----
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCcc----
Confidence 233457899999999999999999999999999999999966654322111 1111122221 222222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++||||+||++.|+
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 23346899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=385.18 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=181.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-cchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-HSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~l~~ 892 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|++++++++|||||++++++.+.. ..+.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 6799999999999999999965 57999999999765433 334678999999999999999999999987543 22333
Q ss_pred eecCcc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCeeeCCCCCceEecccccc
Q 042958 893 ILSNNA-------------AAKDLGWTRRMNVIKGISDALSYMHNDC--FPPIVHRDISSKNVLLDFDNEAHVSDFGIAK 957 (1075)
Q Consensus 893 ~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~ 957 (1075)
+++... ....+++..++.++.||+.||+|||+.. ..+|+||||||+||+++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 333221 2356899999999999999999999862 1249999999999999999999999999999
Q ss_pred ccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 958 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 958 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.+...........||+.|||||++.+..++.++|||||||++|||+||+.||...... .....+.....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFRRI 234 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence 8776555556678999999999999999999999999999999999999999743321 11122222222211
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223446999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=380.41 Aligned_cols=239 Identities=28% Similarity=0.438 Sum_probs=192.7
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|+.+ +|+.||+|++......+....+.+.+|++++++++|||||++++++.+.+..+ ++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~-iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY-LI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE-EE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE-EE
Confidence 57888999999999999999764 79999999986432222333577899999999999999999999998765543 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 22221 235689999999999999999999999 9999999999999999999999999999876533
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~~ 227 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFPD----FV 227 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCT----TS
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCc----cC
Confidence 33456899999999999999999999999999999999999999974322 1122233333333322 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.++.+++.+||++||++|||++|+++
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 346899999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=381.04 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=194.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+.+..+ ++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~-iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW-VV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE-EE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE-EE
Confidence 4799999999999999999965 57999999998754322 2467999999999999999999999998766543 23
Q ss_pred ecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
++... ....+++.+...++.||+.||+|||++ +|+||||||+||+++.++++||+|||+|+.+......
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 32221 134688999999999999999999999 9999999999999999999999999999987766555
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .........+.++. ....+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~----~~~~s 243 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGTPELQN----PEKLS 243 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHCSCCCSS----GGGSC
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-----HHHHHhCCCCCCCC----cccCC
Confidence 6677899999999999999999999999999999999999999964332110 00111111112221 23345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.+++.+||++||++|||++|+++
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 56999999999999999999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=381.91 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=180.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe-
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI- 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~- 893 (1075)
++|+..+.||+|+||+||+|.+.+++.||||++..... ..++|.+|++++++++|||||+++|+|...+..+.++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 56888899999999999999998899999999875322 2468999999999999999999999998765433222
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+... .....++|..+.+++.|||+||+|||+. +|+||||||+||++++++.+||+|||+|+........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 1111 1235688999999999999999999999 9999999999999999999999999999877654332
Q ss_pred -eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhC-CCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 966 -WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 966 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.....||+.|+|||++.+..++.++|||||||++|||+|+ +.||...... ......... .+...+. .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~--~~~~~p~----~ 226 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG--FRLYKPR----L 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHHHHT--CCCCCCT----T
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHhc--CCCCCcc----c
Confidence 2345789999999999999999999999999999999995 5554422111 111111111 1222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
++.++.+++.+||+.||++||||+||++.|+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 2346899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-43 Score=382.96 Aligned_cols=243 Identities=25% Similarity=0.450 Sum_probs=178.9
Q ss_pred cCCCCCceecccCceEEEEEEEC-CC---CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SG---EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||+||+|.++ +| ..||||++.... .....++|.+|++++++++|||||+++|+|...+..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 44566789999999999999764 33 368999986542 3344678999999999999999999999997765433
Q ss_pred hhe-ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMI-LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~-~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
.++ +... .....++|.++.+++.||++||+|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 222 1111 1234689999999999999999999999 999999999999999999999999999997765
Q ss_pred CCCc-----eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhcc-CCCC
Q 042958 962 DSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEML-DPRL 1034 (1075)
Q Consensus 962 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1034 (1075)
.... .....||+.|||||++.+..++.++|||||||++|||+| |+.||...... .....+. ..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDYRL 252 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence 4322 122457899999999999999999999999999999998 89998743321 1111121 2223
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+.+. +.+..+.+++.+||+.||++||||+||++.|+
T Consensus 253 ~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 253 PPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 3322 33456999999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=371.43 Aligned_cols=241 Identities=23% Similarity=0.402 Sum_probs=193.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe-
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI- 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~- 893 (1075)
++|+..++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++|||||+++|+|.+....+.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 689999999999999999999998889999999764322 468999999999999999999999998765432222
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC-
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS- 964 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~- 964 (1075)
+... .....+++..+++++.|+++||+|||+. +|+||||||+||++++++.+||+|||+|+.......
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 1111 2345689999999999999999999999 999999999999999999999999999987655433
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ....+... .+.+.+. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i~~~--~~~~~p~----~ 225 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIAQG--LRLYRPH----L 225 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHHTT--CCCCCCT----T
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHHHhC--CCCCCcc----c
Confidence 2334678999999999999999999999999999999998 899997543211 11111111 1222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHhhh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQLL 1073 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1073 (1075)
.+.++.+++.+||+.||++||||+||++.|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 334699999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-44 Score=388.42 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=192.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
...++|++.+.||+|+||+||+|.+. +|+.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34567888899999999999999765 689999999875432 2467999999999999999999999998765443
Q ss_pred hhe-ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 891 AMI-LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 891 ~~~-~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.++ +... .....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 222 2211 1235689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCc-eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCc
Q 042958 961 PDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSC 1039 (1075)
Q Consensus 961 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1075)
..... .....|++.|+|||++.+..++.++|||||||++|||++|+.|+....... ........ ..+.+.+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----~~~~~i~~--~~~~~~~-- 238 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK--DYRMERP-- 238 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT--TCCCCCC--
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----HHHHHHhc--CCCCCCC--
Confidence 54332 333468899999999999999999999999999999999777754222111 01111111 1122222
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1040 IVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1040 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.++.+++.+||+.||++||||+||++.|+
T Consensus 239 --~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 239 --EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 223446999999999999999999999998774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=378.67 Aligned_cols=243 Identities=25% Similarity=0.349 Sum_probs=187.2
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh-
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM- 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~- 892 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+++.+|++++++++|||||++++++.+.+..+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 5789999999999999999976 47999999998754322 2346789999999999999999999999876544222
Q ss_pred eecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC--
Q 042958 893 ILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS-- 963 (1075)
Q Consensus 893 ~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~-- 963 (1075)
.+... .....+++.+++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 11111 2244689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
......+||+.|||||++.+..+ +.++||||+||++|||++|+.||........ ............ ....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~~~~~~~~~~--~~~~ 230 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYL--NPWK 230 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HHHHHHTTCTTS--TTGG
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCCCC--Cccc
Confidence 22345689999999999988876 5789999999999999999999974332111 011111111111 1122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||++||++|||++|+++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33456889999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=380.72 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=182.2
Q ss_pred cCCCCCceecccCceEEEEEEECCC-----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASG-----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
..|+..++||+|+||+||+|.+++. ..||||++.... ......+|.+|++++++++|||||+++|+|.+....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4677889999999999999976532 379999986543 233456799999999999999999999999876554
Q ss_pred hhheec-Cc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILS-NN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~-~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
+.++.. .. .....++|.++.+++.||+.|++|||+. +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 332211 11 1235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC-CCCC
Q 042958 961 PDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP-RLPT 1036 (1075)
Q Consensus 961 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1036 (1075)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..|+...... ......+.+. +.+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLPT 234 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCCCC
Confidence 44322 22356899999999999999999999999999999999976665422111 1112222222 2222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+ .+.+..+.+++.+||+.||++||||+||++.|+
T Consensus 235 ~----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 235 P----MDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp C----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred c----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 2 233456999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=380.45 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=191.4
Q ss_pred cCCCCCc-eecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEH-CIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. ......++|.+|++++++++|||||+++|+|......+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence 4555556 4999999999999654 3557999999754 23445678999999999999999999999997655443
Q ss_pred hheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+.+... .....+++.++.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 3333221 1235689999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCC
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTP 1037 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1037 (1075)
... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+... +.+.+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~p 234 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRMECP 234 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCCCC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence 332 234568999999999999999999999999999999998 999997543211 11112221 22222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.++.+++.+||+.||++||||.+|++.|+
T Consensus 235 ----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 235 ----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 233456999999999999999999999998874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=375.60 Aligned_cols=238 Identities=25% Similarity=0.405 Sum_probs=185.2
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecCc
Q 042958 821 HCIGKGGQGSVYKAELA---SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSNN 897 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~~ 897 (1075)
++||+|+||+||+|.++ +++.||||+++.... +....++|.+|++++++++|||||+++|+|......+.+.+...
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCC
Confidence 46999999999999764 356899999975432 33446789999999999999999999999976554433333222
Q ss_pred -------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce---e
Q 042958 898 -------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW---T 967 (1075)
Q Consensus 898 -------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~---~ 967 (1075)
.....+++.++.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+.+....... .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 1245689999999999999999999999 99999999999999999999999999999876543322 2
Q ss_pred ccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcCcHHHH
Q 042958 968 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCIVQDKL 1045 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1045 (1075)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+.. .+.+.+. ..+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~~~p~----~~~ 236 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPA----GCP 236 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCCCCCT----TCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCc----ccC
Confidence 3568999999999999999999999999999999998 899997433211 1111111 2222222 234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1046 ISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.++.+++.+||+.||++||||+||++.|+
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 56999999999999999999999988764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=378.48 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=189.3
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..+. +
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l-v 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI-L 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE-E
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE-E
Confidence 5688899999999999999966 4799999999875422 234678999999999999999999999987655432 2
Q ss_pred ecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 894 LSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
++.. .....+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 2221 1235689999999999999999999999 99999999999999999999999999998654433
Q ss_pred CceeccccccCccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 964 SNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.......||+.|+|||++. +..|+.++||||+||++|||++|+.||......+ ....+.....+. .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~-~ 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPT-L 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCC-C
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCC-C
Confidence 3344568999999999884 4568899999999999999999999997543221 111111111111 1
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
......+.++.+++.+||++||++|||++|+++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112334557999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-43 Score=382.62 Aligned_cols=240 Identities=27% Similarity=0.386 Sum_probs=189.6
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
+.|+..+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++|||||++++++.+.+..+.++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3488889999999999999965 578999999997665455555678999999999999999999999998765433222
Q ss_pred -ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 -LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 -~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
+... .....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 2111 1245689999999999999999999999 999999999999999999999999999987543
Q ss_pred eeccccccCccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 966 WTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... .....+.....+.. ...
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~--~~~ 237 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPAL--QSG 237 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCC--SCT
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCC--CCC
Confidence 234679999999999864 45899999999999999999999998643221 11111111111111 112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||++||++|||++|+++
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 23456999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=376.25 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=186.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
.++|++.+.||+|+||+||+|.+++++.||||++..... ..++|.+|+.++++++|||||+++|+|.+.+..+.+.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence 367999999999999999999998888999999975432 2467999999999999999999999997655443333
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
+...+ ....++|.++++++.||++||+|||+. +|+||||||+||++|.++++||+|||+|+.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 22221 134589999999999999999999999 999999999999999999999999999987654332
Q ss_pred -ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcCcH
Q 042958 965 -NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCIVQ 1042 (1075)
Q Consensus 965 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 1042 (1075)
......||+.|+|||++.+..++.++||||||+++|||++|..|+...... ......+.. .+.+.+ .
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~----~ 237 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCP----P 237 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCC----T
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCC----c
Confidence 334467899999999999999999999999999999999976665422211 111111111 122222 2
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++||||+||+++|+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 33456999999999999999999999998874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=379.01 Aligned_cols=241 Identities=22% Similarity=0.288 Sum_probs=189.0
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+.+|++++++++|||||++++++.+.+..+ ++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~-iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY-FG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE-EE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE-EE
Confidence 5799999999999999999966 579999999986432222233567999999999999999999999998765432 22
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.+.+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 22221 245689999999999999999999999 999999999999999999999999999998764432
Q ss_pred --ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 965 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 965 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~---- 231 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEYDFPE---- 231 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCCCCT----
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCCCCCCc----
Confidence 23456899999999999999999999999999999999999999974322 1122223333332222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||++||++|||++|+++
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 23346899999999999999999998643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=375.81 Aligned_cols=245 Identities=24% Similarity=0.418 Sum_probs=183.0
Q ss_pred cCCCCCceecccCceEEEEEEEC--CC--CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA--SG--EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||.||+|++. ++ ..||||++...........++|.+|++++++++|||||+++|+|.+....+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 56888999999999999999653 23 378999987665555556688999999999999999999999997754433
Q ss_pred hheecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 891 AMILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 891 ~~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+.+.... ....+++..+.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 33222211 134589999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCc---eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC--CCCC
Q 042958 963 SSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP--RLPT 1036 (1075)
Q Consensus 963 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1036 (1075)
... .....|+..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... +.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEGERLPR 236 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSCCCCCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhCCCCCCC
Confidence 432 223467889999999999999999999999999999998 89998643321 111222221 2222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+ ...+..+.+++.+||+.||++||||+||.+.|+
T Consensus 237 ~----~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 237 P----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2 223446999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-42 Score=368.49 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=183.5
Q ss_pred CCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecc---ccchhhe
Q 042958 818 DDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHV---RHSLAMI 893 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~l~~~ 893 (1075)
+..++||+|+||+||+|... +++.||+|++...... ....+.|.+|++++++++|||||++++++... +..+.++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 45568999999999999664 7899999998764332 33467899999999999999999999998652 2223333
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC-CCCCceEeccccccccCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD-FDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~DfGla~~~~~~~ 963 (1075)
++... ....+++.+++.++.||++||+|||++. ++|+||||||+||+++ +++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 33221 2356899999999999999999999981 1399999999999996 578999999999986443
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......+||+.|||||++.+ .++.++||||+||++|||++|+.||....... .....+.....+ ......
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~--~~~~~~ 237 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP--ASFDKV 237 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC--GGGGGC
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCC--cccCcc
Confidence 33456789999999998865 59999999999999999999999996432211 111122211111 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.++++.+++.+||++||++|||++|+++
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 3456899999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=380.63 Aligned_cols=244 Identities=24% Similarity=0.425 Sum_probs=188.2
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCC----EEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGE----IVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
++|++.+.||+|+||+||+|.+. +|+ +||||+++... .....++|.+|++++++++|||||+++|+|.+....
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCee
Confidence 46899999999999999999664 454 68999886542 223357899999999999999999999999887655
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.+..... .....+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 44433222 1245689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCC
Q 042958 962 DSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPS 1038 (1075)
Q Consensus 962 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1075)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+....... ...... ..+.+.+.
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----~~~i~~--~~~~~~p~ 236 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEK--GERLPQPP 236 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----HHHHHH--TCCCCCCT
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHc--CCCCCCCc
Confidence 4432 233568999999999999999999999999999999998 8889875432211 111111 12223322
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+.++.+++.+||+.||++||||+||++.|+
T Consensus 237 ----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 237 ----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp ----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 23446899999999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=381.91 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=188.9
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++... .....+++.+|+.++++++|||||+++++|.+....+.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i- 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI- 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE-
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE-
Confidence 57899999999999999999965 479999999987643 23345789999999999999999999999987665432
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++... ....+++..++.++.|+++||.|||+ + +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 222211 23468999999999999999999996 5 8999999999999999999999999999876432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh---------------------
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN--------------------- 1021 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~--------------------- 1021 (1075)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||............
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234568999999999999999999999999999999999999999643321100000
Q ss_pred -------------hhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 -------------LNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.............+. ......+.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCcc--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000000000 011112356899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-42 Score=376.02 Aligned_cols=243 Identities=26% Similarity=0.324 Sum_probs=176.4
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.+.|++.+.||+|+||+||+|+.+ +|+.||||++....... ..+.+.+|++++++++|||||++++++.+.+..+ +
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~-l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY-L 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE-E
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE-E
Confidence 467899999999999999999664 79999999987643322 2467889999999999999999999998765432 2
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC---CCCCceEeccccccccC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD---FDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~DfGla~~~~ 960 (1075)
+++... ....+++.+...++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||+|+...
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 332221 234689999999999999999999999 999999999999995 57899999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.......+...
T Consensus 162 ~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 162 PG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEFDSPY 232 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCCCTTT
T ss_pred CC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCCCCcc
Confidence 43 2334568999999999999999999999999999999999999999743221 11222222222222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.++.+++.+||++||++|||++|+++
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3344557999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-42 Score=378.40 Aligned_cols=250 Identities=19% Similarity=0.343 Sum_probs=192.7
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEE
Q 042958 809 EIIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 882 (1075)
Q Consensus 809 e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 882 (1075)
+++...++|++.+.||+|+||+||+|+++ +++.||||++.... .....++|.+|++++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34445678999999999999999999764 45789999987542 34456789999999999999999999999
Q ss_pred eeccccchhheecC--------------------------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 042958 883 CSHVRHSLAMILSN--------------------------------NAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPI 930 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~--------------------------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 930 (1075)
|......+..+... ......+++.++.+|+.|++.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 97654332221110 11233488999999999999999999999 99
Q ss_pred EEecCCCCCeeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCC-C
Q 042958 931 VHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-H 1007 (1075)
Q Consensus 931 vH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~ 1007 (1075)
|||||||+||++|.++.+||+|||+|+.+..... ......|++.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999987654322 233467889999999999999999999999999999999986 5
Q ss_pred CCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1008 PRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1008 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
||...... .....+.+...+.. +...+.++.+++.+||+.||++||||.||+++|+
T Consensus 242 p~~~~~~~--------e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 242 PYYGMAHE--------EVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TTTTSCHH--------HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHH--------HHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 66543221 12222333332221 1233456999999999999999999999999885
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=380.29 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=187.6
Q ss_pred hcCCCCCceecccCceEEEEEEECC-C-----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS-G-----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 886 (1075)
.++|++.+.||+|+||+||+|+... + ..||||++..... ......+.+|+.+++++ +|||||+++++|.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3678889999999999999996542 2 3699999865432 22346789999999998 899999999999876
Q ss_pred ccchhheecCcc--------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 042958 887 RHSLAMILSNNA--------------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRD 934 (1075)
Q Consensus 887 ~~~l~~~~~~~~--------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 934 (1075)
+..+.+ ++... ....+++..++.++.||++||+|||++ +|||||
T Consensus 114 ~~~~lv-~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 114 GPIYLI-FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSCEEE-EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CeEEEE-EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 553222 21111 123589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCc
Q 042958 935 ISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 1011 (1075)
Q Consensus 935 lk~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~ 1011 (1075)
|||+||+++.++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876654432 234568999999999999999999999999999999998 8999975
Q ss_pred cCccccchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1012 ISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...... ........ .+++.+. ..+.++.+++.+||+.||++||||+||++.|+
T Consensus 270 ~~~~~~----~~~~~~~~--~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDAN----FYKLIQNG--FKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHH----HHHHHHTT--CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHH----HHHHHhcC--CCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433211 11111111 1222222 23346999999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=364.15 Aligned_cols=238 Identities=27% Similarity=0.408 Sum_probs=181.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
-++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+....+.++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 356778899999999999999886 8899999996532 2467999999999999999999999997654444444
Q ss_pred ecCccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 894 LSNNAA-----------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 ~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
+++... ...++|..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 333221 23479999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
.....+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ...+..- .+.+.+
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-----~~~i~~~--~~~~~~---- 222 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKG--YKMDAP---- 222 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----HHHHTTT--CCCCCC----
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcC--CCCCCC----
Confidence 234568899999999999999999999999999999998 7888764332211 1111111 122222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+.++.+++.+||+.||++||||.||++.|+
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 223356899999999999999999999999885
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=374.45 Aligned_cols=242 Identities=22% Similarity=0.267 Sum_probs=194.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||.||+|+. .+|+.||||++.+.........+++.+|+.++++++|||||++++++.+.+..+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35789999999999999999965 57999999998653222223357789999999999999999999999886654332
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++.. ....+++...+.++.||+.||+|||++ +|+||||||+||+++++|.+||+|||+|+......
T Consensus 84 -~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 -MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp -EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred -eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 22221 235688889999999999999999999 99999999999999999999999999999876655
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .....+.......+. .
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~~~~~~p~----~ 227 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPR----T 227 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT----T
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhcCCCCCCc----c
Confidence 5666788999999999999999999999999999999999999999743321 112222222333332 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
.+.++.+++.+||++||++||+ ++|+++
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 3346899999999999999995 788865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-41 Score=377.25 Aligned_cols=241 Identities=20% Similarity=0.292 Sum_probs=192.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..+. +
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i-v 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM-I 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE-E
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE-E
Confidence 5799999999999999999965 57999999998753 23345789999999999999999999999987655432 2
Q ss_pred ecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC--CCCceEeccccccccCC
Q 042958 894 LSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF--DNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 ~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~DfGla~~~~~ 961 (1075)
++.. .....+++.++..++.||+.||+|||+. +||||||||+||+++. ++.+||+|||+|+.+..
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 2221 1234589999999999999999999999 9999999999999964 57899999999998764
Q ss_pred CCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCc
Q 042958 962 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIV 1041 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1075)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 179 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp T-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSCCGGG
T ss_pred c-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcccc
Confidence 4 334557899999999999999999999999999999999999999964322 1122222222222222223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1042 QDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1042 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.++.+++.+||++||++|||++|+++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 344557999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=368.20 Aligned_cols=244 Identities=23% Similarity=0.395 Sum_probs=181.8
Q ss_pred hcCCCCCceecccCceEEEEEEECC----CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS----GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||.||+|.+.. +..||||+++.. ......+.|.+|++++++++|||||+++|+|.+....
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEE
Confidence 4678889999999999999997642 356899998654 3344567899999999999999999999999765443
Q ss_pred hhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 LAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
+.+.+... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 33332221 1234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccccchhhhhhhhhhccCC-CCCCCC
Q 042958 962 DSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMSSSSLNLNIALDEMLDP-RLPTPS 1038 (1075)
Q Consensus 962 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1038 (1075)
... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+... +.+.+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~~~~- 231 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLPMP- 231 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCCCC-
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCC-
Confidence 432 2344568999999999999999999999999999999998 899987543321 11122222 22222
Q ss_pred cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1039 CIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1039 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
...+..+.+++.+||+.||++||||+||++.|+
T Consensus 232 ---~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 232 ---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 233456999999999999999999999998774
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-41 Score=375.44 Aligned_cols=242 Identities=19% Similarity=0.278 Sum_probs=192.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..+.++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999965 579999999987542 233567889999999999999999999998765543222
Q ss_pred -ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeC--CCCCceEeccccccccCCC
Q 042958 894 -LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLD--FDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 894 -~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~DfGla~~~~~~ 962 (1075)
+... .....+++.+.+.|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 1111 1234589999999999999999999999 999999999999998 5789999999999987654
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQ 1042 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1075)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+.....
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~ 253 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFDEDAFS 253 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCCSSTTT
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCccccc
Confidence 3345568999999999999999999999999999999999999999743321 1122222222222222233
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1043 DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1043 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+.++.+++.+||++||++|||++|+++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 44557899999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=368.91 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=193.4
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCC---chhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPG---EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... .....+.+.+|++++++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999976 57999999998654322 222357899999999999999999999999876654
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC----CceEeccccc
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN----EAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~DfGla 956 (1075)
+.+ ++... ....+++.+.+.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv-~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILI-LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEE-EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEE-EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 322 22211 235689999999999999999999999 999999999999999877 4999999999
Q ss_pred cccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCC
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPT 1036 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1075)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......
T Consensus 165 ~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 165 HKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVNYEF 235 (293)
T ss_dssp EECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTTCCCC
T ss_pred hhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCC
Confidence 887543 2334567999999999999999999999999999999999999999743221 1122222222222
Q ss_pred CCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1037 PSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1037 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
+.......+..+.+++.+||++||++|||++|+++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21122233456899999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-41 Score=366.10 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=189.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---c
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---S 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~ 889 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.....+....+.|.+|+++++.++|||||++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999965 5799999999987665566667789999999999999999999999876442 1
Q ss_pred hhheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 LAMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 l~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++++... ....+++.+.+.++.||+.||+|||+. +|+||||||+||+++.++..+++|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 222332221 245689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCC---ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ............+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDPIPP 234 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCCCCG
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcCCCCC
Confidence 4322 2345679999999999999999999999999999999999999997433211 1111111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHhhh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRP-TMPKVSQLL 1073 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L 1073 (1075)
.......+.++.+++.+|+++||++|| |++|+++.|
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 112223445699999999999999999 899988765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-41 Score=369.78 Aligned_cols=238 Identities=22% Similarity=0.336 Sum_probs=189.9
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.++++++|||||++++++.+.+..+. +
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i-v 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM-I 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE-E
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee-E
Confidence 5688999999999999999976 5799999999864322222335789999999999999999999999987655433 2
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
++... ....+++.....++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 22221 234578888889999999999999999 9999999999999999999999999999886533
Q ss_pred ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHH
Q 042958 965 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDK 1044 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1075)
....+||+.|||||++.+..++.++||||+||++|||++|+.||...... .....+.......+.. .
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~----~ 224 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAELRFPPF----F 224 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCCCCCTT----S
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCCCCCCCC----C
Confidence 34568999999999999999999999999999999999999999743221 1122222223322222 2
Q ss_pred HHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1045 LISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1045 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
+.++.+++.+|+++||.+|| |++|+++
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 34589999999999999996 8999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-41 Score=374.05 Aligned_cols=239 Identities=20% Similarity=0.233 Sum_probs=190.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|+++++.++|||||++++++......+.++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999966 479999999986432222233567899999999999999999999998766543332
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.... .....+++.+.+.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 2211 1235689999999999999999999999 9999999999999999999999999999987533
Q ss_pred eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHHHH
Q 042958 966 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQDKL 1045 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1075)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ..+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~----~~s 262 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPS----HFS 262 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT----TCC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCCCCc----cCC
Confidence 3456899999999999999999999999999999999999999974322 1112222222332222 233
Q ss_pred HHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1046 ISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1046 ~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
.++.+++.+||++||++|+ |++|+++
T Consensus 263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 4589999999999999994 8999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=364.09 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=184.4
Q ss_pred CceecccCceEEEEEEECCC----CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheec
Q 042958 820 EHCIGKGGQGSVYKAELASG----EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILS 895 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~ 895 (1075)
.++||+|+||+||+|.+.++ ..||||+++.. ......++|.+|++++++++|||||+++|+|...+..+.++++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 46899999999999976432 36999998653 3444568899999999999999999999998765544333333
Q ss_pred Ccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 896 NNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 896 ~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
... .....++.++.+++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 221 234467889999999999999999999 9999999999999999999999999999876544322
Q ss_pred ----eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC-CCCCCCCcC
Q 042958 966 ----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD-PRLPTPSCI 1040 (1075)
Q Consensus 966 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1040 (1075)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||........ ....+.. .+...+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------~~~~i~~g~~~~~p~-- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQPE-- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCT--
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCCCcc--
Confidence 2235689999999999999999999999999999999998888753222111 1111111 1222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
..+..+.+++.+||+.||++||||.||++.|+
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 22346999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=367.12 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=181.7
Q ss_pred HHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 812 RATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 812 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
...++|++.+.||+|+||.||+|... +++.||||+++... .....+++..|...+.++ +|+|||.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 34578999999999999999999653 34689999987543 233456788888888887 7899999999987
Q ss_pred ccccchhheecCcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNNA-------------------------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
..+..+.++++... ....+++.++..++.||++||+|||++ +|+||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 66554433332211 123478999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCC-CCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~ 1016 (1075)
|+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876544332 33467999999999999999999999999999999999865 5675433211
Q ss_pred cchhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
. ......... +.+.+ ...+.++.+++.+||+.||++||||+||++.|+
T Consensus 245 ~----~~~~~~~~~--~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 245 E----FCRRLKEGT--RMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp H----HHHHHHHTC--CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHHhcCC--CCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1 111111111 12222 123346899999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-40 Score=360.61 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=188.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhee
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMIL 894 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~ 894 (1075)
++|++.+.||+|+||+||+|+.++|+.||||++..... .....+.+.+|+.++++++|||||++++++...+..+.++.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57889999999999999999989999999999976532 22335789999999999999999999999988766544432
Q ss_pred cCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCce
Q 042958 895 SNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNW 966 (1075)
Q Consensus 895 ~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 966 (1075)
... .....+++.++..++.||+.||+|||+. +||||||||+||+++.++.+|++|||.|..........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 221 2346689999999999999999999999 99999999999999999999999999998876655555
Q ss_pred eccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-----------h--hhhhhhc---
Q 042958 967 TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN-----------L--NIALDEM--- 1029 (1075)
Q Consensus 967 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-----------~--~~~~~~~--- 1029 (1075)
....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+..... . .......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 566789999999988754 4689999999999999999999999743321100000 0 0000000
Q ss_pred cCCCCCCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1030 LDPRLPTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1030 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.....+.+ .......+..+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0111223456899999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-40 Score=354.55 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=192.0
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCc------hhHHHHHHHHHHHHhcCC-cCceeeEEEEeecc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGE------MTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHV 886 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 886 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.+.+|+.++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999966 579999999987654332 123456889999999996 99999999999876
Q ss_pred ccchhhe-ecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 887 RHSLAMI-LSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 887 ~~~l~~~-~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+..+.++ +... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 5532222 1111 1245689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCceeccccccCccCcccccc------CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDP 1032 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1075)
..... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~~~~~i~~~ 230 (277)
T d1phka_ 160 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLRMIMSG 230 (277)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred ccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------HHHHHHHhC
Confidence 76543 3455789999999998863 34688999999999999999999999743321 111222222
Q ss_pred CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.......+.++.+++.+||++||++|||++||++
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222222223345567999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=362.86 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=189.4
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....+++.+|++++++++|||||++++++.+....+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 6899999999999999999965 57999999999654322 223468899999999999999999999998765543322
Q ss_pred ecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCC
Q 042958 894 LSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 894 ~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 964 (1075)
.... .....+++.+++.++.||+.||+|||+. +||||||||+||+++.++.+||+|||.|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 1111 1245689999999999999999999999 999999999999999999999999999998776655
Q ss_pred ceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhh----------hhhhhhhccC--
Q 042958 965 NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN----------LNIALDEMLD-- 1031 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~-- 1031 (1075)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||............ .........+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 566678999999999877665 478999999999999999999999754321100000 0000000000
Q ss_pred CCCCCCCc-----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1032 PRLPTPSC-----IVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1032 ~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.... .....+.++.+++.+|+++||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000000 01122356899999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=365.26 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=193.2
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEEC------CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEe
Q 042958 810 IIRATNDFDDEHCIGKGGQGSVYKAELA------SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC 883 (1075)
Q Consensus 810 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 883 (1075)
++...++|+..+.||+|+||+||+|.+. +++.||||+++.. ........|.+|++++++++|||||+++|+|
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 3344578889999999999999999653 3578999999754 2334456799999999999999999999999
Q ss_pred eccccchhheecC-c-----------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC
Q 042958 884 SHVRHSLAMILSN-N-----------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD 945 (1075)
Q Consensus 884 ~~~~~~l~~~~~~-~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~ 945 (1075)
......+.++... . .....+++.++.+++.|+|+||.|||++ +|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 7655443222111 1 1123468899999999999999999999 99999999999999999
Q ss_pred CCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCC-CCCCccCccccchhhh
Q 042958 946 NEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSMSSSSLNL 1022 (1075)
Q Consensus 946 ~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~ 1022 (1075)
+++||+|||+|+........ .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||.....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------- 241 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 241 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------
Confidence 99999999999876544332 23346899999999999999999999999999999999985 66653222
Q ss_pred hhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1023 NIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
......+.+...+.. ....+..+.+++.+||+.||++||||+||++.|+
T Consensus 242 ~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 242 EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 122233333332221 1223456999999999999999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.2e-40 Score=363.96 Aligned_cols=288 Identities=31% Similarity=0.520 Sum_probs=189.1
Q ss_pred hhHHHHHHHHHhccCCCCCCCcCCCCcCCCCCCCCC--ccceEEeCCC---CceeEEEecccccccc--cCCcccCCCCC
Q 042958 2 EEAHALLRWKTSLQNHNNGSLLSSWTLNNVTKTSPC--AWVGIHCNRG---GRVNSINLTSIGLKGM--LHDFSFSSFPH 74 (1075)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sw~~~~~~~~~~c--~w~gv~C~~~---~~v~~l~l~~~~l~g~--~~~~~~~~l~~ 74 (1075)
+|++||++||++++++ ..+++|.. ++++| .|+||+|+.. +||++|+|+++++.|. +|++ +++|++
T Consensus 6 ~e~~aLl~~k~~~~~~---~~l~sW~~----~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~-l~~L~~ 77 (313)
T d1ogqa_ 6 QDKQALLQIKKDLGNP---TTLSSWLP----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS-LANLPY 77 (313)
T ss_dssp HHHHHHHHHHHHTTCC---GGGTTCCT----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG-GGGCTT
T ss_pred HHHHHHHHHHHHCCCC---CcCCCCCC----CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChH-HhcCcc
Confidence 6999999999999876 36899972 33347 5999999865 3788888888777774 3333 666777
Q ss_pred ccEEEccC-CCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 75 LAYLDLWH-NQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 75 L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
|++|||++ |+++|.+|+.|++|++|++|+|++|.+.+..|..+..+..|+++++++|.+.+.+|..++.
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~---------- 147 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS---------- 147 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG----------
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc----------
Confidence 77777765 5666666666666666666666666666666666666666666666666666666655544
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCcccc-ceEeeeccccccccCCCCcCCCCcCceeccccCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSL-SMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDS 232 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 232 (1075)
+++|+++++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++.++...+.
T Consensus 148 --------------l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~ 212 (313)
T d1ogqa_ 148 --------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD 212 (313)
T ss_dssp --------------CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEEC
T ss_pred --------------Ccccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccc
Confidence 4555555555555555555555555443 555566666665555555554333 466666666556
Q ss_pred CcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCcc
Q 042958 233 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNL 312 (1075)
Q Consensus 233 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 312 (1075)
+|..+..+++++.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+| .++++
T Consensus 213 ~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L 290 (313)
T d1ogqa_ 213 ASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290 (313)
T ss_dssp CGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTG
T ss_pred cccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-CcccC
Confidence 66666666666666666666665433 45566666666666666666666667777777777777777766555 35667
Q ss_pred ccccceeccccc
Q 042958 313 TNLATLYIHNNS 324 (1075)
Q Consensus 313 ~~L~~L~L~~N~ 324 (1075)
++|+.+++++|+
T Consensus 291 ~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 291 QRFDVSAYANNK 302 (313)
T ss_dssp GGSCGGGTCSSS
T ss_pred CCCCHHHhCCCc
Confidence 777777777776
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=358.64 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=183.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc---chh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---SLA 891 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~l~ 891 (1075)
++|...+.||+|+||.||+|+++ |+.||||++... .......+.|+..+..++|||||+++|+|.+.+. .+.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45667789999999999999875 899999998632 2222233455666677899999999999976542 222
Q ss_pred heecCcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 892 MILSNNA--------AAKDLGWTRRMNVIKGISDALSYMHNDC-----FPPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
++++... ....++|.++++++.|+|.|++|+|+.. .++|+||||||+||+++.++.+||+|||+++.
T Consensus 78 lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 2332221 1346899999999999999999999741 24999999999999999999999999999988
Q ss_pred cCCCCC----ceeccccccCccCccccccCC------CCcccchHhHHHHHHHHHhCCCCCCccCccccc-------hhh
Q 042958 959 LKPDSS----NWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSS-------SLN 1021 (1075)
Q Consensus 959 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-------~~~ 1021 (1075)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 765432 233467999999999987643 567899999999999999999887543222111 011
Q ss_pred hhhhhhhccCCCCCC--C-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1022 LNIALDEMLDPRLPT--P-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1022 ~~~~~~~~~~~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.........+..... + .....+....+.+++.+||+.||++||||.||++.|+
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 111122222222211 1 1112345567999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=361.84 Aligned_cols=248 Identities=23% Similarity=0.255 Sum_probs=182.3
Q ss_pred CceecccCceEEEEEEE-CCCCEEEEEEccCCCCCc--hhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhheecC
Q 042958 820 EHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGE--MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMILSN 896 (1075)
Q Consensus 820 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~~~~ 896 (1075)
.++||+|+||+||+|.. .+|+.||||+++...... ....+.+.+|+.++++++|||||++++++...+..+.+ ++.
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv-mE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV-FDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE-EEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeeh-hhh
Confidence 47899999999999965 479999999987543221 11235688999999999999999999999876654332 222
Q ss_pred c---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCcee
Q 042958 897 N---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSNWT 967 (1075)
Q Consensus 897 ~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 967 (1075)
. .....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 2 1245688899999999999999999999 999999999999999999999999999988776655556
Q ss_pred ccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh-----------hh--h-hhccCC
Q 042958 968 ELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN-----------IA--L-DEMLDP 1032 (1075)
Q Consensus 968 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-----------~~--~-~~~~~~ 1032 (1075)
..+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....... .. . ......
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 67899999999988654 579999999999999999999999974332111000000 00 0 000000
Q ss_pred CCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1033 RLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1033 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..+... ......+.++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 001122356899999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=364.14 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=189.3
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHh-cCCcCceeeEEEEeeccccchhh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALT-EIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++++.........+.+..|..++. .++|||||++++++.+.+..+ +
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y-i 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF-F 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE-E
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee-E
Confidence 5789999999999999999966 479999999986432111222456667777765 689999999999998866543 3
Q ss_pred eecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCC
Q 042958 893 ILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDS 963 (1075)
Q Consensus 893 ~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~ 963 (1075)
+++... ....+++.+.+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 332221 235688999999999999999999999 99999999999999999999999999999876665
Q ss_pred CceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcCcHH
Q 042958 964 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCIVQD 1043 (1075)
Q Consensus 964 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1075)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~p~----~ 225 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYPR----W 225 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCT----T
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCc----c
Confidence 6666778999999999999999999999999999999999999999743321 111112222222222 2
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHH-HHHh
Q 042958 1044 KLISIVEVAISCLDENPESRPTMP-KVSQ 1071 (1075)
Q Consensus 1044 ~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1071 (1075)
.+.++.+++.+||++||++|||+. |+++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 334689999999999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-39 Score=365.59 Aligned_cols=242 Identities=21% Similarity=0.214 Sum_probs=184.0
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHH---HHHHHHHhcCCcCceeeEEEEeeccccch
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEF---LNEVKALTEIRHRNIVKFYGFCSHVRHSL 890 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~l 890 (1075)
++|++.+.||+|+||.||+|+.. +|+.||||++.............+ ..|+++++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999664 799999999853221111112223 34577888889999999999998765533
Q ss_pred hheecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 891 AMILSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 891 ~~~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 -ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 -FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp -EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred -EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 2232222 234578889999999999999999999 999999999999999999999999999997654
Q ss_pred CCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 962 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 962 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
. ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||........ ..............+.
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~-- 230 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELPD-- 230 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHSSSCCCCCCS--
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcccCCCCCCC--
Confidence 3 2345689999999999864 5689999999999999999999999975332211 1112222222222222
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPT-----MPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1071 (1075)
..+.++.+++.+||++||++||| ++|+++
T Consensus 231 --~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 23446899999999999999999 688864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=360.59 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=190.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAM 892 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~ 892 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+++++.++|||||++++++.+.+..+ +
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~-l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV-M 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE-E
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE-E
Confidence 36789999999999999999966 478999999997532 22456889999999999999999999998765432 2
Q ss_pred eecCcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC--CCceEeccccccccC
Q 042958 893 ILSNNA----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD--NEAHVSDFGIAKFLK 960 (1075)
Q Consensus 893 ~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~DfGla~~~~ 960 (1075)
+++... ....+++.+.+.++.||++||+|||+. +|+||||||+||+++.+ ..+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 222211 233689999999999999999999999 99999999999999854 489999999998765
Q ss_pred CCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCCCcC
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTPSCI 1040 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1075)
.. .......+|+.|+|||...+..++.++||||+||++|||++|+.||..... ......+.......+...
T Consensus 156 ~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~ 226 (321)
T d1tkia_ 156 PG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp TT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHHH
T ss_pred cC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCChhh
Confidence 43 334556889999999999999999999999999999999999999974322 112223333333222111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1041 VQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1041 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....+.++.+++.+|+++||++|||++|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233456899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=357.13 Aligned_cols=234 Identities=21% Similarity=0.331 Sum_probs=183.2
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCch---hHHHHHHHHHHHHhcCC--cCceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEM---TFQQEFLNEVKALTEIR--HRNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 888 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||++......+. ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999965 5799999999865332211 11234678999999986 8999999999987665
Q ss_pred chhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCC-CCceEeccccccc
Q 042958 889 SLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFD-NEAHVSDFGIAKF 958 (1075)
Q Consensus 889 ~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~DfGla~~ 958 (1075)
.+.++.... .....+++.+++.++.||++||+|||+. +|+||||||+||+++.+ +.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 443332221 1245689999999999999999999999 99999999999999865 7899999999987
Q ss_pred cCCCCCceeccccccCccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 959 LKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 959 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +.......+
T Consensus 161 ~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~~~~~ 224 (273)
T d1xwsa_ 161 LKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQVFFR 224 (273)
T ss_dssp CCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCCCCS
T ss_pred ccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------HhhcccCCC
Confidence 543 33456789999999999987765 5778999999999999999999963211 111111111
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. ..+.++.+++.+||++||++|||++|+++
T Consensus 225 ~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 225 Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 12346899999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=358.04 Aligned_cols=246 Identities=23% Similarity=0.404 Sum_probs=189.2
Q ss_pred hcCCCCCceecccCceEEEEEEE------CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL------ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV 886 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 886 (1075)
.++|++.+.||+|+||.||+|++ .+++.||||+++... ......+|.+|+.+++++ +|||||+++|+|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 46788899999999999999975 346789999997543 334467899999999999 699999999999876
Q ss_pred ccchhhe-ecCc-------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 042958 887 RHSLAMI-LSNN-------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNV 940 (1075)
Q Consensus 887 ~~~l~~~-~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Ni 940 (1075)
+..+.++ +... .....+++..+.+++.||++|++|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 5432221 1111 1123588999999999999999999999 999999999999
Q ss_pred eeCCCCCceEeccccccccCCCCCc--eeccccccCccCccccccCCCCcccchHhHHHHHHHHHhC-CCCCCccCcccc
Q 042958 941 LLDFDNEAHVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSMSS 1017 (1075)
Q Consensus 941 ll~~~~~~kl~DfGla~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~ 1017 (1075)
+++.++.+|++|||.++........ .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999987654332 2346789999999999999999999999999999999995 555543222111
Q ss_pred chhhhhhhhhhccCCCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1018 SSLNLNIALDEMLDPRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1018 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......-. +...+ ...+..+.+++.+||++||++||||+||+++|+
T Consensus 257 ----~~~~i~~~~--~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 257 ----FYKMIKEGF--RMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp ----HHHHHHHTC--CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHhcCC--CCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111111111 11111 123346999999999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=357.45 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=185.0
Q ss_pred hcCCCCCceecccCceEEEEEEECC--------CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEee
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELAS--------GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 884 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 884 (1075)
.++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4678888999999999999996532 2479999997643 333457889999999888 8999999999998
Q ss_pred ccccchhheecCc-------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 042958 885 HVRHSLAMILSNN-------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKN 939 (1075)
Q Consensus 885 ~~~~~l~~~~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N 939 (1075)
+....+ ++++.. .....+++.++++++.||+.||+|||+. +||||||||+|
T Consensus 90 ~~~~~~-~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 90 QDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp SSSSCE-EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred cCCeEE-EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 755432 222111 1124589999999999999999999999 99999999999
Q ss_pred eeeCCCCCceEeccccccccCCCCC--ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccCccc
Q 042958 940 VLLDFDNEAHVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSMS 1016 (1075)
Q Consensus 940 ill~~~~~~kl~DfGla~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 1016 (1075)
||++.++.+||+|||+++....... ......||+.|+|||.+.++.++.++||||||+++|||++ |+.||......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 9999999999999999987754432 2344678999999999999999999999999999999998 78888643321
Q ss_pred cchhhhhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1017 SSSLNLNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1017 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+... +.+.+. ..+..+.+++.+||++||++||||+||++.|+
T Consensus 245 -------~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 245 -------ELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp -------HHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHHHHHHcCCCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 111222221 222222 23346999999999999999999999999885
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=358.17 Aligned_cols=242 Identities=21% Similarity=0.277 Sum_probs=184.5
Q ss_pred hcCCCCCc-eecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeecc---c
Q 042958 814 TNDFDDEH-CIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHV---R 887 (1075)
Q Consensus 814 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---~ 887 (1075)
.++|.+.. .||+|+||+||+|.. .+|+.||||+++. .+.+.+|+.++.++ +|||||++++++.+. +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 35787764 699999999999965 5799999999863 14577899887655 899999999988642 2
Q ss_pred cchhheecCcc-----------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEecc
Q 042958 888 HSLAMILSNNA-----------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDF 953 (1075)
Q Consensus 888 ~~l~~~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Df 953 (1075)
..+++++++.. ....+++.+.+.++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 32333332221 124689999999999999999999999 9999999999999986 457999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCC
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPR 1033 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1075)
|+|+...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.......... .....+....
T Consensus 159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~ 233 (335)
T d2ozaa1 159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQ 233 (335)
T ss_dssp TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS
T ss_pred ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCC
Confidence 9998776543 3455689999999999999999999999999999999999999997443221110 1111222222
Q ss_pred CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1034 LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1034 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
...+.......+.++.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22222223345567999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=357.79 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=183.6
Q ss_pred HhcCCCCCceecccCceEEEEEEE-CC-CCEEEEEEccCCCCCchhHHHHHHHHHHHHhcC---CcCceeeEEEEeecc-
Q 042958 813 ATNDFDDEHCIGKGGQGSVYKAEL-AS-GEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHV- 886 (1075)
Q Consensus 813 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~- 886 (1075)
..++|++.+.||+|+||+||+|.. ++ ++.||||+++.....+. ....+.+|+.+++.+ +||||++++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 357899999999999999999976 44 66799999865322211 123455677766655 899999999998532
Q ss_pred ---ccchhheecCc----------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEecc
Q 042958 887 ---RHSLAMILSNN----------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDF 953 (1075)
Q Consensus 887 ---~~~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df 953 (1075)
...+.++++.. .....+++...+.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 12222222221 1245578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhh----------
Q 042958 954 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLN---------- 1023 (1075)
Q Consensus 954 Gla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---------- 1023 (1075)
|.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.......
T Consensus 161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 999865432 334567899999999999999999999999999999999999999975432110000000
Q ss_pred ---hh-hhhccCCCCC-CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 ---IA-LDEMLDPRLP-TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ---~~-~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.. .......... .........+..+.+++.+||++||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000000 001111223456889999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=358.10 Aligned_cols=242 Identities=22% Similarity=0.354 Sum_probs=183.1
Q ss_pred hcCCCCCceecccCceEEEEEEEC-CCC--EEEEEEccCCCCCchhHHHHHHHHHHHHhcC-CcCceeeEEEEeeccccc
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAELA-SGE--IVAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHVRHS 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 889 (1075)
.++|++.++||+|+||+||+|.++ +|. .||||++..... ....++|.+|+++++++ +|||||+++|+|.+.+..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 367888899999999999999665 454 578888754322 22356799999999999 799999999999876543
Q ss_pred hhheecCc-------------------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC
Q 042958 890 LAMILSNN-------------------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF 944 (1075)
Q Consensus 890 l~~~~~~~-------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~ 944 (1075)
+. +++.. .....++|.++++++.||++|+.|+|+. +|+||||||+|||++.
T Consensus 87 ~i-V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 87 YL-AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 162 (309)
T ss_dssp EE-EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred EE-EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC
Confidence 22 22111 1245689999999999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCC-CCCccCccccchhhhh
Q 042958 945 DNEAHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH-PRDFISSMSSSSLNLN 1023 (1075)
Q Consensus 945 ~~~~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~~~~~~~~ 1023 (1075)
++.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------- 233 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 233 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--------
Confidence 9999999999998654322 2234568999999999999999999999999999999999764 66532211
Q ss_pred hhhhhccC-CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1024 IALDEMLD-PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1024 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.....+.. .+.+.+ ...+.++.+++.+||+.||++||||+||++.|+
T Consensus 234 ~~~~~i~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 234 ELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHHHGGGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11122221 122222 223446999999999999999999999998774
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-38 Score=347.96 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=182.7
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .+++..|+++++.++|++++..++++........++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999965 5799999999875432 235778999999998887666665554433333332
Q ss_pred ecCcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC---CCCceEeccccccccCC
Q 042958 894 LSNNA---------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF---DNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 894 ~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~DfGla~~~~~ 961 (1075)
++..+ ....+++..+..++.|++.||+|||+. +|+||||||+||+++. +..+|++|||+|+.+..
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 22211 245689999999999999999999999 9999999999998864 45799999999998764
Q ss_pred CCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCC
Q 042958 962 DSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRL 1034 (1075)
Q Consensus 962 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1075)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 332 223467999999999999999999999999999999999999999754432221111111111110000
Q ss_pred CCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1035 PTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1035 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
.......+.++.+++..||+.||++||+++++.+.|+
T Consensus 238 ---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 238 ---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp ---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred ---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 0001123346899999999999999999999887764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=341.92 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=192.8
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccchhhe
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHSLAMI 893 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l~~~ 893 (1075)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+++.+|+.+++.++||||++++++|.+......++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5789999999999999999965 5799999999976543 3345688999999999999999999999998876654433
Q ss_pred ecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCCCCc
Q 042958 894 LSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPDSSN 965 (1075)
Q Consensus 894 ~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 965 (1075)
.... .....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 2211 2345678999999999999999999999 9999999999999999999999999999987766555
Q ss_pred eeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------------hhhhhhcc
Q 042958 966 WTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------NIALDEML 1030 (1075)
Q Consensus 966 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------~~~~~~~~ 1030 (1075)
.....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||............. ........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 56667889999999887665 6899999999999999999999974222111000000 00000000
Q ss_pred C----CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1031 D----PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1031 ~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
. ................+.+++.+|++.||++||||+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000111112233456889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-38 Score=351.09 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=183.7
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|++++++++|||||+++++|...+..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46788999999999999999965 5799999999976543 334467899999999999999999999999765431
Q ss_pred --hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 890 --LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 890 --l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
++++++..+ ....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+|+...
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 222222221 245689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchh------------------h
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL------------------N 1021 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~------------------~ 1021 (1075)
. ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||........... .
T Consensus 173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred C---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 3 33456899999999998764 568999999999999999999999975432110000 0
Q ss_pred hhhhhhhccCC-CCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1022 LNIALDEMLDP-RLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1022 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
........... ...............+.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 000001111223456889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=350.93 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=183.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccccc---
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRHS--- 889 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 889 (1075)
+++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+++.+|++++++++||||+++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 35788999999999999999954 589999999987542 344467889999999999999999999998654321
Q ss_pred -hhheecCcc-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCC
Q 042958 890 -LAMILSNNA-------AAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKP 961 (1075)
Q Consensus 890 -l~~~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~ 961 (1075)
++++++..+ ....+++..++.++.|++.||+|||+. +||||||||+||+++.++.+||+|||+|+....
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 111111111 235689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC---ceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh---------------
Q 042958 962 DSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------- 1022 (1075)
Q Consensus 962 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------- 1022 (1075)
... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 322 2344679999999998854 467899999999999999999999997443211000000
Q ss_pred --hhhhhhccCCCC-CCC-CcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1023 --NIALDEMLDPRL-PTP-SCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1023 --~~~~~~~~~~~~-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.........+.. ..+ .......+.++.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000 0001112346889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-37 Score=342.44 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=182.3
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||++......+ ...+++.+|++++++++||||+++++++.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 47899999999999999999965 589999999986653332 234678899999999999999999998865322
Q ss_pred ---chhheecCc---------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccc
Q 042958 889 ---SLAMILSNN---------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIA 956 (1075)
Q Consensus 889 ---~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla 956 (1075)
.+.++++.. .....++..+.+.++.||++||+|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 122222211 2245678899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhh------
Q 042958 957 KFLKPDSS----NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIA------ 1025 (1075)
Q Consensus 957 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~------ 1025 (1075)
+....... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||+...............
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 87654322 22345799999999998765 68999999999999999999999997433211100000000
Q ss_pred -hhhcc----C---CCCCCCCcCcH------HHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1026 -LDEML----D---PRLPTPSCIVQ------DKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1026 -~~~~~----~---~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..... . ........... .....+.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000 0 00000000011 11345778999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=343.62 Aligned_cols=245 Identities=26% Similarity=0.304 Sum_probs=181.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----cc
Q 042958 816 DFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-----HS 889 (1075)
Q Consensus 816 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 889 (1075)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++||||++++++|.... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 578889999999999999976 4799999999875421 2247999999999999999999985432 12
Q ss_pred hhheecCc------------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccc
Q 042958 890 LAMILSNN------------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIA 956 (1075)
Q Consensus 890 l~~~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla 956 (1075)
++++++.. .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 22222222 1244689999999999999999999999 999999999999999875 8999999999
Q ss_pred cccCCCCCceeccccccCccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh-----------hhhh
Q 042958 957 KFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL-----------NLNI 1024 (1075)
Q Consensus 957 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-----------~~~~ 1024 (1075)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... ....
T Consensus 171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 8775443 3345689999999998765 5689999999999999999999999974432111000 0000
Q ss_pred hhhhccCCCCCCCC------cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALDEMLDPRLPTPS------CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
.........++... ......+.++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111111100 011223456899999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.8e-37 Score=332.76 Aligned_cols=249 Identities=16% Similarity=0.207 Sum_probs=185.8
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc-CceeeEEEEeeccccchh
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFYGFCSHVRHSLA 891 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~l~ 891 (1075)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... +.+.+|++.++.++| +|++.+++++......+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 36789999999999999999965 47999999988654221 346678888888865 899999998877655433
Q ss_pred heecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCC-----CCCceEeccccccc
Q 042958 892 MILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDF-----DNEAHVSDFGIAKF 958 (1075)
Q Consensus 892 ~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~DfGla~~ 958 (1075)
++.... .....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|+.
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 322111 1235689999999999999999999999 9999999999999975 56899999999987
Q ss_pred cCCCCC-------ceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccC
Q 042958 959 LKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLD 1031 (1075)
Q Consensus 959 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1075)
+..... .....+||+.|||||++.+..++.++||||+|+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 654321 2334679999999999999999999999999999999999999997544322111100000000000
Q ss_pred CCCCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHhhhc
Q 042958 1032 PRLPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQLLK 1074 (1075)
Q Consensus 1032 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1074 (1075)
+ ........+.++.+++..|++.+|++||+++.+.+.|+
T Consensus 236 ~----~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 236 P----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp C----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred C----hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 0 00001122346899999999999999999998887653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=340.76 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=181.4
Q ss_pred cCCCCCceecccCceEEEEEEEC-CCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeeccc-----c
Q 042958 815 NDFDDEHCIGKGGQGSVYKAELA-SGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVR-----H 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 888 (1075)
++|++.++||+|+||+||+|... +|+.||||++..... .....+++.+|+.++++++|||||+++++|...+ .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 57999999999999999999654 799999999976543 3444678999999999999999999999986432 2
Q ss_pred chhheecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 889 SLAMILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 889 ~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.+++.++.... ...+++.+.+.++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc
Confidence 22233322211 34589999999999999999999999 9999999999999999999999999998865543
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchh--------------hhhhhhhh
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSL--------------NLNIALDE 1028 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~--------------~~~~~~~~ 1028 (1075)
.......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+....... ........
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred -cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 334556799999999999999999999999999999999999999964332110000 00000000
Q ss_pred ccCCC----------------CCCCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1029 MLDPR----------------LPTPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1029 ~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
..... .+.........+.++.+++.+|++.||++||||+|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 11111122345678999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-36 Score=336.29 Aligned_cols=247 Identities=20% Similarity=0.268 Sum_probs=184.5
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeecccc-chh
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHVRH-SLA 891 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~l~ 891 (1075)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|++++++++ ||||+++++++..... .+.
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 5799999999999999999966 579999999986421 467889999999995 9999999999875432 233
Q ss_pred heecCccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCC-CceEeccccccccCCCCC
Q 042958 892 MILSNNAA------AKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDN-EAHVSDFGIAKFLKPDSS 964 (1075)
Q Consensus 892 ~~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~DfGla~~~~~~~~ 964 (1075)
++++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 33332221 34689999999999999999999999 999999999999998765 58999999998766443
Q ss_pred ceeccccccCccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh--------------------h
Q 042958 965 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL--------------------N 1023 (1075)
Q Consensus 965 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------------------~ 1023 (1075)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||............. .
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 34556789999999998765 47999999999999999999999986433211000000 0
Q ss_pred hhhhhccCCCCC------CCCcCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1024 IALDEMLDPRLP------TPSCIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1024 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
............ .........+.++.+++.+|++.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000111233456899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=334.83 Aligned_cols=246 Identities=21% Similarity=0.287 Sum_probs=184.9
Q ss_pred cCCCCCceecccCceEEEEEEE----CCCCEEEEEEccCCCC-CchhHHHHHHHHHHHHhcCCc-CceeeEEEEeecccc
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL----ASGEIVAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRH-RNIVKFYGFCSHVRH 888 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 888 (1075)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .+....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999964 2589999999865321 112224568899999999966 899999999887665
Q ss_pred chhheecCc--------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 SLAMILSNN--------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 ~l~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+..+.... .....+.......++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 433222111 1234567788889999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ceeccccccCccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCccCccccchhhhhhhhhhccCCCCCCC
Q 042958 961 PDSS-NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNLNIALDEMLDPRLPTP 1037 (1075)
Q Consensus 961 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1075)
.... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........... ..........+.+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~----i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE----ISRRILKSEPPYP 256 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH----HHHHHHHCCCCCC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhcccCCCCCc
Confidence 4322 34456799999999998754 468899999999999999999999975443221111 1111122222222
Q ss_pred CcCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHh
Q 042958 1038 SCIVQDKLISIVEVAISCLDENPESRP-----TMPKVSQ 1071 (1075)
Q Consensus 1038 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1071 (1075)
. ..+.++.+++.+||++||++|| |++|+++
T Consensus 257 ~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred c----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2 3345699999999999999999 4788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=338.72 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=182.5
Q ss_pred hcCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCcCceeeEEEEeecccc----
Q 042958 814 TNDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHVRH---- 888 (1075)
Q Consensus 814 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 888 (1075)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+++.+|++++++++|||||++++++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46799999999999999999965 5799999999986543 33345678999999999999999999998854321
Q ss_pred -chhheecCc-------cccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccC
Q 042958 889 -SLAMILSNN-------AAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLK 960 (1075)
Q Consensus 889 -~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~ 960 (1075)
.+.++++.. .....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+|++|||.|....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 122221111 1235689999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCceeccccccCccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCccCccccchhhh---------------hh
Q 042958 961 PDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLNL---------------NI 1024 (1075)
Q Consensus 961 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------------~~ 1024 (1075)
.......|++.|+|||...+.. ++.++||||+||++|||++|+.||...+......... ..
T Consensus 173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 2334567899999999877654 6889999999999999999999997433211000000 00
Q ss_pred hhhhccC--CCCCCCC--cCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHh
Q 042958 1025 ALDEMLD--PRLPTPS--CIVQDKLISIVEVAISCLDENPESRPTMPKVSQ 1071 (1075)
Q Consensus 1025 ~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1071 (1075)
....... ...+... ......+.++.+++.+|++.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000 0111000 001123456889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-33 Score=319.39 Aligned_cols=247 Identities=19% Similarity=0.251 Sum_probs=180.1
Q ss_pred cCCCCCceecccCceEEEEEEE-CCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-----------cCceeeEEEE
Q 042958 815 NDFDDEHCIGKGGQGSVYKAEL-ASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----------HRNIVKFYGF 882 (1075)
Q Consensus 815 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 882 (1075)
.+|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3589999999999999999965 57999999999743 233467788999888875 5789999988
Q ss_pred eeccccc---hhheecC----------ccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeeeCCCCC-
Q 042958 883 CSHVRHS---LAMILSN----------NAAAKDLGWTRRMNVIKGISDALSYMHN-DCFPPIVHRDISSKNVLLDFDNE- 947 (1075)
Q Consensus 883 ~~~~~~~---l~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~Nill~~~~~- 947 (1075)
+...... ..+.... ......+++..+..++.||+.|++|||+ . +|+||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence 8654321 1111111 1234567888999999999999999998 5 8999999999999987654
Q ss_pred -----ceEeccccccccCCCCCceeccccccCccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccCccccchhh-
Q 042958 948 -----AHVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSMSSSSLN- 1021 (1075)
Q Consensus 948 -----~kl~DfGla~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~- 1021 (1075)
++++|||.|..... .....+||+.|+|||++.+..++.++||||+||+++||++|+.||............
T Consensus 166 ~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999986543 234567999999999999999999999999999999999999999744322110000
Q ss_pred hh------------------hhhhhccCC-----CCCC------------CCcCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 042958 1022 LN------------------IALDEMLDP-----RLPT------------PSCIVQDKLISIVEVAISCLDENPESRPTM 1066 (1075)
Q Consensus 1022 ~~------------------~~~~~~~~~-----~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1066 (1075)
.. .......+. .... ........+.++.+++.+|++.||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00 000000000 0000 111234567789999999999999999999
Q ss_pred HHHHh
Q 042958 1067 PKVSQ 1071 (1075)
Q Consensus 1067 ~evl~ 1071 (1075)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=9.1e-29 Score=282.18 Aligned_cols=357 Identities=31% Similarity=0.395 Sum_probs=188.4
Q ss_pred EEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccc
Q 042958 78 LDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYL 157 (1075)
Q Consensus 78 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 157 (1075)
.+++.+++++.++ ...+.+|++|++++|.|+. + +.+..+++|++|+|++|+|++. | .++++++|++|++++|.+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccc
Confidence 3555566665554 3466777788888777763 3 4577778888888888877753 3 267777777777777777
Q ss_pred cCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccc
Q 042958 158 EDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSEL 237 (1075)
Q Consensus 158 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (1075)
.++.+ ++++++|+.|++++|.+++..+ ......+..+....|.+....+................ .....+
T Consensus 101 ~~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 171 (384)
T d2omza2 101 ADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKPL 171 (384)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGGG
T ss_pred ccccc--cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc-----chhhhh
Confidence 76643 7777888888888877775443 34445667777777766533222221111111111111 111233
Q ss_pred cCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccc
Q 042958 238 GNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLAT 317 (1075)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 317 (1075)
...+.........|... ....+..+++++.+++++|.+++..| +...++|+.|++++|+++.. ..+..+++|+.
T Consensus 172 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 245 (384)
T d2omza2 172 ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTD 245 (384)
T ss_dssp TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccch
Confidence 33444444444444433 12334445555555555555554322 23344555555555555432 23444555555
Q ss_pred eecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccc
Q 042958 318 LYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKL 397 (1075)
Q Consensus 318 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 397 (1075)
|++++|.+++..+ +..+++|+.|++++|+++ +.. .+..+..++.++++.|++
T Consensus 246 L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~------------------------~~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 246 LDLANNQISNLAP--LSGLTKLTELKLGANQIS------------------------NIS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCC------------------------CCG--GGTTCTTCSEEECCSSCC
T ss_pred hccccCccCCCCc--ccccccCCEeeccCcccC------------------------CCC--cccccccccccccccccc
Confidence 5555555543221 344444444444444444 221 234444455555555555
Q ss_pred cccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccc
Q 042958 398 SGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEI 477 (1075)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 477 (1075)
++ ...+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .|.++++|++|++++|++++..| +
T Consensus 298 ~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l 369 (384)
T d2omza2 298 ED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--L 369 (384)
T ss_dssp SC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred cc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--h
Confidence 42 123445555555555555555432 24555555555555555552 22 35555555555555555554332 5
Q ss_pred cCcCCCCEEeCCCC
Q 042958 478 GNLRSISNLALNNN 491 (1075)
Q Consensus 478 ~~l~~L~~L~L~~N 491 (1075)
.++++|+.|+|++|
T Consensus 370 ~~l~~L~~L~L~~N 383 (384)
T d2omza2 370 ANLTRITQLGLNDQ 383 (384)
T ss_dssp TTCTTCSEEECCCE
T ss_pred ccCCCCCEeeCCCC
Confidence 55556666666555
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=3e-30 Score=285.38 Aligned_cols=253 Identities=31% Similarity=0.486 Sum_probs=220.3
Q ss_pred CCccEEEccCCCccC--CCCccccccCCCceeeccc-CcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcce
Q 042958 73 PHLAYLDLWHNQLYG--NIPPQIGNISRLKYLDLSS-NLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNY 149 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 149 (1075)
.+++.|||++|+++| .+|+.+++|++|++|+|++ |.++|.+|++|++|++|++|+|++|++.+..|..
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~--------- 120 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF--------- 120 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG---------
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccccc---------
Confidence 478889999998887 4788888888888888876 6787778877877777777777777777655444
Q ss_pred eecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCc-CceeccccC
Q 042958 150 LALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNL-ATLYLHNNS 228 (1075)
Q Consensus 150 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~~L~L~~N~ 228 (1075)
+..+.+|+.+++++|.+.+.+|..|++++.|+++++++|.+++.+|..+..+..+ +.+++++|+
T Consensus 121 ---------------~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~ 185 (313)
T d1ogqa_ 121 ---------------LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp ---------------GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred ---------------ccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccc
Confidence 5667778888888888888889999999999999999999999999999988876 889999999
Q ss_pred CCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCC
Q 042958 229 LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHS 308 (1075)
Q Consensus 229 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 308 (1075)
+++..|..+..+..+ .++++.+...+.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|+|++|++++.+|..
T Consensus 186 l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 186 LTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH
Confidence 999889888887655 79999999999999999999999999999999997654 6888999999999999999999999
Q ss_pred CCccccccceecccccccCCCCcccccccccccccccCCc-cccc
Q 042958 309 LGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNK-LSGS 352 (1075)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~ 352 (1075)
|+++++|++|+|++|+++|.+|. ++++++|+.+++++|+ +.|.
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred HhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 99999999999999999998884 6889999999999998 5553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.4e-28 Score=280.71 Aligned_cols=322 Identities=33% Similarity=0.437 Sum_probs=179.8
Q ss_pred CCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCC
Q 042958 165 LGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLS 244 (1075)
Q Consensus 165 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 244 (1075)
+..+++|++|+|++|+|++..+ |+++++|++|++++|++++.. .++++++|+.|++++|.+++..+ ......+.
T Consensus 62 l~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~ 135 (384)
T d2omza2 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLN 135 (384)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCS
T ss_pred cccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccc
Confidence 3344444444444444443322 444555555555555544321 14445555555555555443221 22334444
Q ss_pred eEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccccc
Q 042958 245 MLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNS 324 (1075)
Q Consensus 245 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 324 (1075)
.+....|.+....+................ .....+.............|... ....+..+++++.+++++|.
T Consensus 136 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~ 208 (384)
T d2omza2 136 RLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQ 208 (384)
T ss_dssp EEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccccccc-----chhhhhccccccccccccccccc--cccccccccccceeeccCCc
Confidence 555554444422221111111111111111 11223344445555555555544 23445666777777777777
Q ss_pred ccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChh
Q 042958 325 LSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHS 404 (1075)
Q Consensus 325 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 404 (1075)
+++..| +...++|+.|++++|.++. .+.+..+++|+.|++++|.+.+.. .+..+++|+.|++++|++++.. .
T Consensus 209 i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~ 280 (384)
T d2omza2 209 ISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--P 280 (384)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--G
T ss_pred cCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--c
Confidence 765433 3455677777777777663 235666777777777777775433 2666777777777777776433 3
Q ss_pred hccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCC
Q 042958 405 LGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSIS 484 (1075)
Q Consensus 405 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 484 (1075)
+..++.++.+++++|.+++. ..+..+++++.|++++|++++.. .+..+++|++|++++|+|++ ++ .++.+++|+
T Consensus 281 ~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~ 354 (384)
T d2omza2 281 LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNIN 354 (384)
T ss_dssp GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCC
T ss_pred cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCC
Confidence 66677777777777777642 34666777777777777777543 26667777777777777763 33 466777777
Q ss_pred EEeCCCCcccCCCcccccCCCccceeeccCC
Q 042958 485 NLALNNNKLSGSIPQSLGNLSNLVILYLYNN 515 (1075)
Q Consensus 485 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 515 (1075)
+|++++|++++..| +.++++|+.|+|++|
T Consensus 355 ~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred EEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 77777777765443 666777777777666
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.8e-25 Score=245.74 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=171.7
Q ss_pred CccceEEeCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCC
Q 042958 37 CAWVGIHCNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPE 116 (1075)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 116 (1075)
|.|.+|.|++ .+|+. +|+. + .+.+++|||++|+|+...+..|.++++|++|++++|.+....|..
T Consensus 10 c~~~~~~C~~-----------~~L~~-lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSD-----------LGLEK-VPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTT-----------SCCCS-CCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecC-----------CCCCc-cCCC-C--CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 7888888874 23332 2332 2 257889999999988444457888999999999999988777888
Q ss_pred CCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCC--CCCCccccCccc
Q 042958 117 IGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLS--DSIPSEFGNLRS 194 (1075)
Q Consensus 117 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~ 194 (1075)
|.++++|++|++++|+++ .+|.. ....|..|++..|.+..+.+..+.....++.++...|... ...+..|..+++
T Consensus 75 f~~l~~L~~L~l~~n~l~-~l~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~ 151 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLK-ELPEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151 (305)
T ss_dssp TTTCTTCCEEECCSSCCS-BCCSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred hhCCCccCEecccCCccC-cCccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccc
Confidence 889999999999999888 45543 2346777777777777776666666777777777766543 233445666677
Q ss_pred cceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCccccccccccccc
Q 042958 195 LSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYE 274 (1075)
Q Consensus 195 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 274 (1075)
|+++++++|.++ .+|..+ +++|++|++++|..++..+..|..++.+++|++++|.+++..+..+.++++|++|+|++
T Consensus 152 L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~ 228 (305)
T d1xkua_ 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228 (305)
T ss_dssp CCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS
T ss_pred cCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccc
Confidence 777777777766 344332 45667777777776666666666677777777777777666566666666677777776
Q ss_pred ccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCC
Q 042958 275 NSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSL 309 (1075)
Q Consensus 275 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 309 (1075)
|.++ .+|.+|..+++|++|+|++|+|+.+....|
T Consensus 229 N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f 262 (305)
T d1xkua_ 229 NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262 (305)
T ss_dssp SCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred cccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence 6666 345566666666666666666665443333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=3.7e-25 Score=243.16 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=113.5
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcC
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLY 177 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 177 (1075)
.++.+|-++++++ .+|..+. +++++|+|++|+|+ .+.+.+|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~------------------------~l~~~~f~~l~~L~~L~l~ 63 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT------------------------EIKDGDFKNLKNLHTLILI 63 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC------------------------CBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC------------------------CcChhHhhccccccccccc
Confidence 4455555555555 4454442 34555555555555 3333345555555555555
Q ss_pred CCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCC--
Q 042958 178 DNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSG-- 255 (1075)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-- 255 (1075)
+|.+....|..|.++++|++|++++|+++ .+|..+ ...++.|++.+|.+.+..+..+.....+..++...|....
T Consensus 64 ~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~ 140 (305)
T d1xkua_ 64 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140 (305)
T ss_dssp SSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred cccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC
Confidence 55555555555555555555555555555 233222 2345555555555554444445555555555555554331
Q ss_pred ccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccc
Q 042958 256 SIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGN 335 (1075)
Q Consensus 256 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 335 (1075)
..+..+..+++|+.+++++|.++. +|..+ +++|+.|++++|.+....+.+|.+++.+++|++++|.+.+..+..+.+
T Consensus 141 ~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~ 217 (305)
T d1xkua_ 141 IENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217 (305)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred CCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccc
Confidence 122334444444444444444442 22211 234444444444444444444444444444444444444444444444
Q ss_pred ccccccccccCCcccccCCCcCCCCCCcceeecccccc
Q 042958 336 LRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSL 373 (1075)
Q Consensus 336 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 373 (1075)
+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|
T Consensus 218 l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred cccceeeeccccccc-ccccccccccCCCEEECCCCcc
Confidence 444444444444443 2333444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.6e-25 Score=238.84 Aligned_cols=223 Identities=26% Similarity=0.286 Sum_probs=119.8
Q ss_pred cccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCccccccccccccccc-CCc
Q 042958 270 LYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLS-GNK 348 (1075)
Q Consensus 270 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~-~N~ 348 (1075)
++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..+..+..++.+... .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344455555 3443332 345666666666665555556666666666666655555555555555555544332 333
Q ss_pred ccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccc
Q 042958 349 LSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSE 428 (1075)
Q Consensus 349 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 428 (1075)
++... +..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+..
T Consensus 93 ~~~l~------------------------~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~ 148 (284)
T d1ozna_ 93 LRSVD------------------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148 (284)
T ss_dssp CCCCC------------------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred ccccc------------------------chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH
Confidence 33333 444445555555555555554444444555555555555555555444455
Q ss_pred cccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCcccccCCCccc
Q 042958 429 FGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQSLGNLSNLV 508 (1075)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 508 (1075)
|..+++|++|++++|++++..+.+|.++++|+++++++|++++..|..|..+++|++|++++|++.+..+..|+++++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 55555555555555555555555555555555555555555555555555555566666666666555555555666666
Q ss_pred eeeccCCCCCC
Q 042958 509 ILYLYNNSLFD 519 (1075)
Q Consensus 509 ~L~L~~N~l~~ 519 (1075)
.|+|++|++..
T Consensus 229 ~L~l~~N~l~C 239 (284)
T d1ozna_ 229 YLRLNDNPWVC 239 (284)
T ss_dssp EEECCSSCEEC
T ss_pred EEEecCCCCCC
Confidence 66666665543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.7e-25 Score=237.31 Aligned_cols=206 Identities=28% Similarity=0.316 Sum_probs=121.1
Q ss_pred CCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc-cccccCCCCCCCCCCCCCCEEEc
Q 042958 98 RLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY-SNYLEDLIPPSLGNLSNLDTLHL 176 (1075)
Q Consensus 98 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~-~n~l~~~~~~~l~~l~~L~~L~L 176 (1075)
.+++|+|++|.|+...+.+|.++++|++|++++|++.+..+..+..+..++++... .+.+..+.+..|+++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34555555555553333445555555555555555554444444444444444332 33444444555666666666666
Q ss_pred CCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCc
Q 042958 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256 (1075)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 256 (1075)
++|.+....+..+..+++|+.+++++|++++..+.+|..+++|++|++++|++++..+..|..+++|+++++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 66666655555566666666666666666655555566666666666666666655555666666666666666666655
Q ss_pred cCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCC
Q 042958 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNG 303 (1075)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 303 (1075)
.|..|.++++|++|++++|.+++..+.+|..+++|++|++++|.+..
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 56666666666666666666665555566666666666666666553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=9.6e-22 Score=210.56 Aligned_cols=203 Identities=28% Similarity=0.265 Sum_probs=147.3
Q ss_pred eCCCCceeEEEecccccccccCCcccCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCC
Q 042958 44 CNRGGRVNSINLTSIGLKGMLHDFSFSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYL 123 (1075)
Q Consensus 44 C~~~~~v~~l~l~~~~l~g~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L 123 (1075)
|........++|++++|+. +|+. +. +++++|||++|.|++..+..|.++++|++|+|++|.|+ .+| .++.+++|
T Consensus 6 ~~~~~~~~~v~C~~~~L~~-iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L 79 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLTA-LPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79 (266)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTC
T ss_pred EcccCCCeEEEccCCCCCe-eCcC-cC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccc
Confidence 5554445566888888875 3432 21 56888888888888655567888888888888888887 444 35778888
Q ss_pred cEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecc
Q 042958 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203 (1075)
Q Consensus 124 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (1075)
++|+|++|++++ .+..+..+++|++|++++|.+..+.+..+..+.++++|++++|.++...+..+..+++|++|++++|
T Consensus 80 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred cccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence 888888888874 4666777777777777777777777777777777777777777777766666777777777777777
Q ss_pred ccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCC
Q 042958 204 KFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLS 254 (1075)
Q Consensus 204 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 254 (1075)
++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 777666666777777777777777776 45666666777777777777665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=8.3e-22 Score=211.04 Aligned_cols=197 Identities=29% Similarity=0.330 Sum_probs=91.3
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
.+...|.++++++ .+|+.+. ++|++|+|++|.|++..+.+|.++++|++|+|++|+|+. +|
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~--------------- 71 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ--------------- 71 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE---------------
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc---------------
Confidence 3444455555555 3454443 345555555555554334445555555555555555441 11
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 233 (1075)
.++.+++|++|+|++|+++. .+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...
T Consensus 72 ----------~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 72 ----------VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140 (266)
T ss_dssp ----------CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred ----------cccccccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceec
Confidence 12334444444554444443 2333444444444444444444444444444444444444444444433
Q ss_pred cccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCC
Q 042958 234 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301 (1075)
Q Consensus 234 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 301 (1075)
+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 444444444444444444444444444444444444444444444 3343344444444444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=5.2e-21 Score=193.43 Aligned_cols=172 Identities=16% Similarity=0.132 Sum_probs=119.6
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEccCCCCC---------------chhHHHHHHHHHHHHhcCCcCceeeEEEE
Q 042958 818 DDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPG---------------EMTFQQEFLNEVKALTEIRHRNIVKFYGF 882 (1075)
Q Consensus 818 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 882 (1075)
.+.++||+|+||.||+|...+|+.||||+++..... ..........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999998888999999987532111 01122345678999999999999998876
Q ss_pred eeccccchhheecCccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeeeCCCCCceEeccccccccCCC
Q 042958 883 CSHVRHSLAMILSNNAAAKDLGWTRRMNVIKGISDALSYMHNDCFPPIVHRDISSKNVLLDFDNEAHVSDFGIAKFLKPD 962 (1075)
Q Consensus 883 ~~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~~~~ 962 (1075)
.. ..+.+.+........++.....+++.|+++|++|||+. +|+||||||+||+++++ .++++|||.|+....+
T Consensus 83 ~~---~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~ 155 (191)
T d1zara2 83 EG---NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEE 155 (191)
T ss_dssp ET---TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTST
T ss_pred cC---CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCCC
Confidence 42 23444444444444566677788999999999999999 99999999999999965 5999999999876533
Q ss_pred CCceeccccccCccCccccccCCCCcccchHhHHHHH
Q 042958 963 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 999 (1075)
Q Consensus 963 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl 999 (1075)
....- ....... -.|. ..++|+.++|+||..--+
T Consensus 156 ~~~~~-l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 156 GWREI-LERDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp THHHH-HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CcHHH-HHHHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 22100 0000000 0111 135678899999976544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1.7e-18 Score=193.51 Aligned_cols=305 Identities=28% Similarity=0.301 Sum_probs=150.5
Q ss_pred CccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecc
Q 042958 74 HLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALY 153 (1075)
Q Consensus 74 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 153 (1075)
++++|||++++++ .+|+. +++|++|+|++|.|+ .+|+.+ .+|++|++++|+++. ++.. .++|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 4678888888887 57753 457888888888887 667553 467777888887762 2211 1235555555
Q ss_pred cccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCC
Q 042958 154 SNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSI 233 (1075)
Q Consensus 154 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 233 (1075)
+|.+..+. .++.+++|++|++++|.+..... ....+..+.+..+... .
T Consensus 107 ~n~l~~lp--~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--------------------------~ 154 (353)
T d1jl5a_ 107 NNQLEKLP--ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--------------------------E 154 (353)
T ss_dssp SSCCSSCC--CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--------------------------S
T ss_pred cccccccc--chhhhccceeecccccccccccc----ccccccchhhcccccc--------------------------c
Confidence 55555442 13445555555555555442211 1223333433333322 1
Q ss_pred cccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccc
Q 042958 234 PSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLT 313 (1075)
Q Consensus 234 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 313 (1075)
...+..++.++.|++++|.... .+.... ..+.+....+.+. .++ .+..++.|+.+++++|.... .+.. ..
T Consensus 155 ~~~l~~l~~l~~L~l~~n~~~~-~~~~~~---~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~---~~ 224 (353)
T d1jl5a_ 155 LPELQNLPFLTAIYADNNSLKK-LPDLPL---SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PP 224 (353)
T ss_dssp CCCCTTCTTCCEEECCSSCCSS-CCCCCT---TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CT
T ss_pred cccccccccceecccccccccc-cccccc---ccccccccccccc-ccc-cccccccccccccccccccc-cccc---cc
Confidence 2233444444445554444442 111111 1223333333333 122 23445555555555555442 2221 23
Q ss_pred cccceecccccccCCCCcccccccccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeec
Q 042958 314 NLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLG 393 (1075)
Q Consensus 314 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 393 (1075)
++..+.+.++.+.. .+.. ...+...++..+.+.+. +. -.......++..+.+.+ ....+++|++|+|+
T Consensus 225 ~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l-~~---l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 225 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRS----LCDLPPSLEELNVS 292 (353)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSE----ECCCCTTCCEEECC
T ss_pred cccccccccccccc-cccc---ccccccccccccccccc-cc---ccchhcccccccCcccc----ccccCCCCCEEECC
Confidence 44445555555442 2211 12333334433333321 00 01123344444444422 12234567777777
Q ss_pred cccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCC
Q 042958 394 YNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSL 453 (1075)
Q Consensus 394 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 453 (1075)
+|+++ .+|. .+++|+.|+|++|+|+. +|.. +++|++|++++|+|+ .+|+..
T Consensus 293 ~N~l~-~lp~---~~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~-~lp~~~ 343 (353)
T d1jl5a_ 293 NNKLI-ELPA---LPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 343 (353)
T ss_dssp SSCCS-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred CCccC-cccc---ccCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCC-CCCccc
Confidence 77776 4443 24677777777777774 4432 456778888888877 556543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1.3e-18 Score=194.49 Aligned_cols=314 Identities=27% Similarity=0.332 Sum_probs=212.2
Q ss_pred CCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEc
Q 042958 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHL 176 (1075)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 176 (1075)
.++++|||++|.++ .+|+. .++|++|+|++|+|+ .+|.. +.+|+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---------------------------~~~L~~L~l 85 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---------------------------PQSLKSLLV 85 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---------------------------CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---------------------------hhhhhhhhh
Confidence 35777777777776 56653 356777777777776 44533 235566666
Q ss_pred CCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcccccCCCCCCeEeccCCCCCCc
Q 042958 177 YDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGS 256 (1075)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 256 (1075)
++|+++.. ++ + .+.|++|++++|.+. .+|. ++.+++|++|++++|.+... +. ....+..+.+..+...
T Consensus 86 ~~n~l~~l-~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~-- 153 (353)
T d1jl5a_ 86 DNNNLKAL-SD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE-- 153 (353)
T ss_dssp CSSCCSCC-CS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--
T ss_pred hhcccchh-hh-h--ccccccccccccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--
Confidence 66665532 11 1 135778888888877 4453 56778888888888877643 22 2456777888776665
Q ss_pred cCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccc
Q 042958 257 IPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNL 336 (1075)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (1075)
....+..++.++.|++++|..... +.. ....+.+..+++.+.. . ..+..++.|+.+++++|.... .+.. .
T Consensus 154 ~~~~l~~l~~l~~L~l~~n~~~~~-~~~---~~~~~~l~~~~~~~~~-~-~~~~~l~~L~~l~l~~n~~~~-~~~~---~ 223 (353)
T d1jl5a_ 154 ELPELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGNNILEE-L-PELQNLPFLTTIYADNNLLKT-LPDL---P 223 (353)
T ss_dssp SCCCCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSS-C-CCCTTCTTCCEEECCSSCCSS-CCSC---C
T ss_pred ccccccccccceeccccccccccc-ccc---cccccccccccccccc-c-ccccccccccccccccccccc-cccc---c
Confidence 345677888999999999998843 322 2345677777777763 3 346789999999999998873 4433 4
Q ss_pred cccccccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCC-cccceeeeccccccccCChhhccCCCCCeEE
Q 042958 337 RSLSNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNL-RSLSMLSLGYNKLSGSIPHSLGNLTNLATLD 415 (1075)
Q Consensus 337 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 415 (1075)
.++..+.+.++.+.. .+. ....+...++..+.+.+. ..+ ......++..|.+.+. ...+++|++|+
T Consensus 224 ~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~ 290 (353)
T d1jl5a_ 224 PSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----CDLPPSLEELN 290 (353)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEE
T ss_pred ccccccccccccccc-ccc---cccccccccccccccccc-----ccccchhcccccccCccccc----cccCCCCCEEE
Confidence 567788888888763 332 234566677766655321 222 3445677777777632 23467999999
Q ss_pred eeccccccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCC
Q 042958 416 LYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALN 489 (1075)
Q Consensus 416 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 489 (1075)
|++|+|+. +|.. +++|+.|+|++|+|+ .+|.. +++|++|++++|+|+ .+|... .+|+.|.++
T Consensus 291 Ls~N~l~~-lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 291 VSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CCCCccCc-cccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeECc
Confidence 99999984 5543 578999999999998 56654 467999999999998 577543 357777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=5.2e-19 Score=184.26 Aligned_cols=204 Identities=25% Similarity=0.379 Sum_probs=103.9
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
..++++.+.+++.+ .+..+.+|++|++++|.|+. + +.+.++++|++|++++|++++..| +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 44455556665443 34556666666666666653 3 346666666666666666664322 455555555555555
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCcc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS 235 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 235 (1075)
.++.+ +.++++++|+.+++++|...+..+ +...+.++.+ .++.+.+... .
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l------------------------~~~~~~~~~~--~ 145 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL------------------------YLDLNQITNI--S 145 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEE------------------------ECCSSCCCCC--G
T ss_pred ccccc--ccccccccccccccccccccccch--hccccchhhh------------------------hchhhhhchh--h
Confidence 55443 224455555555555554443221 3333444444 4444444321 1
Q ss_pred cccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccc
Q 042958 236 ELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNL 315 (1075)
Q Consensus 236 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 315 (1075)
.+..+++|++|++++|.+.+.. .++++++|++|++++|++++. + .|+++++|++|+|++|+++++.| ++++++|
T Consensus 146 ~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L 219 (227)
T d1h6ua2 146 PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNL 219 (227)
T ss_dssp GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTC
T ss_pred hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCC
Confidence 2344445555555555544221 244455555555555555532 1 24555566666666666554322 5556666
Q ss_pred cceecc
Q 042958 316 ATLYIH 321 (1075)
Q Consensus 316 ~~L~L~ 321 (1075)
++|+++
T Consensus 220 ~~L~ls 225 (227)
T d1h6ua2 220 FIVTLT 225 (227)
T ss_dssp CEEEEE
T ss_pred CEEEee
Confidence 666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4e-18 Score=179.53 Aligned_cols=202 Identities=16% Similarity=0.126 Sum_probs=107.6
Q ss_pred CCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCC-ccccccCCcceeecccccccCCCCCCCCCCCCCCEEE
Q 042958 97 SRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIP-YEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLH 175 (1075)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 175 (1075)
+++++|+|++|.|+...+.+|.++++|++|+|++|.+...+| ..|..++++++|.+..
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~--------------------- 87 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK--------------------- 87 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC---------------------
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc---------------------
Confidence 356666666666654334456667777777777776654333 2333444444443322
Q ss_pred cCCCCCCCCCCccccCccccceEeeeccccccccC-CCCcCCCCcCceeccccCCCCCCcccccCCC-CCCeEeccCCCC
Q 042958 176 LYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIP-HSLGNLTNLATLYLHNNSLFDSIPSELGNLR-SLSMLSLGYNKL 253 (1075)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l 253 (1075)
.|++....+..|.++++|++|++++|++....+ ..+..+..+..+...++.+....+..|..++ .++.|++++|++
T Consensus 88 --~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 88 --ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp --CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred --cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence 123333333344444444444444444432111 1122233333334444444443344444433 566677777777
Q ss_pred CCccCCCCccccccc-ccccccccCcCCCCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceeccc
Q 042958 254 SGSIPHSLGNLTNLA-TLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHN 322 (1075)
Q Consensus 254 ~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 322 (1075)
+...+..+ ..++++ .+++++|+++...+..|.++++|++|++++|+|+.+.+..|.++++|+.+++.+
T Consensus 166 ~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 166 QEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 74333333 333433 345666777755555677778888888888887766666777777777776643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=4.1e-18 Score=179.45 Aligned_cols=217 Identities=15% Similarity=0.174 Sum_probs=107.8
Q ss_pred EEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCC-CCccccCccccceEeeec-
Q 042958 125 TLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDS-IPSEFGNLRSLSMLSLGY- 202 (1075)
Q Consensus 125 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~- 202 (1075)
+++.+++.++ .+|..+. +++++|++++|.++.+.+..|.++++|++|++++|.+... .+..|.++++++++.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4444444444 3443321 2445555555555554455566667777777777766543 344566677777776653
Q ss_pred cccccccCCCCcCCCCcCceeccccCCCCCCcc-cccCCCCCCeEeccCCCCCCccCCCCcccc-cccccccccccCcCC
Q 042958 203 NKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPS-ELGNLRSLSMLSLGYNKLSGSIPHSLGNLT-NLATLYLYENSLSGS 280 (1075)
Q Consensus 203 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~ 280 (1075)
|++....+..|.++++|++|++++|++....+. .+..++.+..+..+++.+....+..|.+++ .++.|++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 456555666666666777777776666533221 223344444444455555533344444432 445555555555533
Q ss_pred CCcccCCCccCcEEEccCCCCCCCcCCCCCccccccceecccccccCCCCcccccccccccccc
Q 042958 281 IPSEFGNLRSLSMLNLGYNKLNGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGL 344 (1075)
Q Consensus 281 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 344 (1075)
.+..|.....++.+++++|+++.+.+..|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 169 ~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 3333322222222234444454443444455555555555555554333334444444444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.8e-18 Score=180.06 Aligned_cols=189 Identities=27% Similarity=0.395 Sum_probs=146.0
Q ss_pred cccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCc
Q 042958 142 GRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLAT 221 (1075)
Q Consensus 142 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 221 (1075)
..+.+|++|++.+|.++++ +.+..+++|++|++++|++++..| +..+++|+++++++|.++. + ..+.++++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-ccccccccccc
Confidence 3445555555555555544 236677777777777777776543 7777888888888887763 3 35778888888
Q ss_pred eeccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCC
Q 042958 222 LYLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKL 301 (1075)
Q Consensus 222 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 301 (1075)
++++++...+. ..+...+.++.+.++.+.+.... .+..+++|++|++++|.++.. ..+.++++|+.|+|++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 88888887643 34677889999999999987543 477888999999999999853 3488999999999999999
Q ss_pred CCCcCCCCCccccccceecccccccCCCCcccccccccccccccC
Q 042958 302 NGIIPHSLGNLTNLATLYIHNNSLSGSIPSEIGNLRSLSNLGLSG 346 (1075)
Q Consensus 302 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 346 (1075)
+++. .|+++++|++|+|++|+++... .++++++|+.|++++
T Consensus 186 ~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 186 SDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred CCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 9753 3889999999999999999654 388999999999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.2e-20 Score=219.63 Aligned_cols=104 Identities=27% Similarity=0.207 Sum_probs=68.1
Q ss_pred cccccceeecCCCcccCc----cccccc-ccccceEEEccccccccc----cchhcccccccceeeeccccccCchhhhh
Q 042958 593 SLAQLEHLDLSSNRLSNS----IPKSFG-NLVKLHYLNLSNNQFSRG----IPIKLEELIHLSELDLSHNFLREAIPSQI 663 (1075)
Q Consensus 593 ~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~~ 663 (1075)
....|++|||++|.|++. ++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|||++|+|+......+
T Consensus 338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l 417 (460)
T d1z7xw1 338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417 (460)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred cccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHH
Confidence 345688888888888642 333332 356688888888888642 34456667888888888888876544443
Q ss_pred c-----cccccceeecCCCccccCChhhh----cccccccEE
Q 042958 664 C-----IMQSLENLNLSHNSLVGLIPSCF----EKMHGLLRI 696 (1075)
Q Consensus 664 ~-----~~~~L~~L~ls~N~l~~~~p~~~----~~~~~l~~l 696 (1075)
. +-..|+.|++++|.+....+..+ ...|.|+.+
T Consensus 418 ~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp HHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred HHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 2 22358888888888876555544 344455443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=3.7e-20 Score=215.34 Aligned_cols=375 Identities=22% Similarity=0.158 Sum_probs=198.6
Q ss_pred ccccceecccccccCCC-CcccccccccccccccCCcccc----cCCCcCCCCCCcceeeccccccCCC----CccccC-
Q 042958 313 TNLATLYIHNNSLSGSI-PSEIGNLRSLSNLGLSGNKLSG----SIPPSLGYLSNLATLYLYSNSLFDS----IPSELG- 382 (1075)
Q Consensus 313 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~- 382 (1075)
.+|++|+++.|+++... ...+..+++++.|+|++|.++. .+...+..+++|++|+|++|.+... +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36788888888887432 3345567777788888887663 2234456677777777777776422 112222
Q ss_pred CCcccceeeecccccccc----CChhhccCCCCCeEEeecccccccccccccc-----ccccceecccccccccC----C
Q 042958 383 NLRSLSMLSLGYNKLSGS----IPHSLGNLTNLATLDLYDNSLSGSIPSEFGN-----LRSLSTLSLGYNKLSGS----I 449 (1075)
Q Consensus 383 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~ 449 (1075)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+.. ......+......+... .
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 123577777777776543 2345556677777777777765432222211 01111111111111100 0
Q ss_pred CCCCccccccccccccCCccccCCC----ccc-cCcCCCCEEeCCCCcccCCC----cccccCCCccceeeccCCCCCCC
Q 042958 450 PHSLGNLTNLDALYLYDNSLSGSIP----GEI-GNLRSISNLALNNNKLSGSI----PQSLGNLSNLVILYLYNNSLFDS 520 (1075)
Q Consensus 450 p~~~~~l~~L~~L~L~~N~l~~~~p----~~~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~ 520 (1075)
-..+.....++.++++++......- ..+ ..-.....+++.++.+.... ...+...+.++.+++++|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 0011122334444444443321100 000 11122334444444433110 11122334444555544443211
Q ss_pred -----CCccccCccccccccccccccccccCCcccccccCCCcccccc----chhhhhhhHhHHHhhccccccccccccc
Q 042958 521 -----IPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEI----PTELGKLNFLIKLILAQNQLSGQLSPKL 591 (1075)
Q Consensus 521 -----~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~----p~~~~~~~~l~~L~l~~n~l~~~~~~~~ 591 (1075)
.+.... ....++.+++++|.+.... ...+...+.+..+++++|.+++.....+
T Consensus 242 ~~~~~~~~~~~------------------~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l 303 (460)
T d1z7xw1 242 GMAELCPGLLH------------------PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303 (460)
T ss_dssp HHHHHHHHHTS------------------TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred ccchhhccccc------------------ccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence 001111 1234556666666654322 2223344455566666666653222211
Q ss_pred -----CcccccceeecCCCcccCcccc----cccccccceEEEccccccccc----cchhcc-cccccceeeeccccccC
Q 042958 592 -----GSLAQLEHLDLSSNRLSNSIPK----SFGNLVKLHYLNLSNNQFSRG----IPIKLE-ELIHLSELDLSHNFLRE 657 (1075)
Q Consensus 592 -----~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~ 657 (1075)
.....|+.+++++|.++..... .+...++|++|+|++|+|+.. ++..+. ....|++|+|++|.|+.
T Consensus 304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred hccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 2345789999999998764333 334556899999999998653 233333 35669999999999985
Q ss_pred c----hhhhhccccccceeecCCCccccCChhhh----c-ccccccEEeecCCccCC
Q 042958 658 A----IPSQICIMQSLENLNLSHNSLVGLIPSCF----E-KMHGLLRIDISYNELQG 705 (1075)
Q Consensus 658 ~----~~~~~~~~~~L~~L~ls~N~l~~~~p~~~----~-~~~~l~~l~~s~N~~~~ 705 (1075)
. ++..+..+++|+.||+++|+|+......+ . +...|+.|++++|.+..
T Consensus 384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 3 45556677899999999999975444333 2 23368999999888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=6.7e-18 Score=170.40 Aligned_cols=107 Identities=29% Similarity=0.313 Sum_probs=48.2
Q ss_pred CCccEEEccCCCccCCC-CccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceee
Q 042958 73 PHLAYLDLWHNQLYGNI-PPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLA 151 (1075)
Q Consensus 73 ~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 151 (1075)
+++++|+|++|.|++.+ +..|+.+++|++|+|++|.+.+..+..+..+++|++|+|++|+|+...|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 34555555555555433 23344555555555555555544444555555555555555555433333333333333333
Q ss_pred cccccccCCCCCCCCCCCCCCEEEcCCC
Q 042958 152 LYSNYLEDLIPPSLGNLSNLDTLHLYDN 179 (1075)
Q Consensus 152 L~~n~l~~~~~~~l~~l~~L~~L~L~~n 179 (1075)
|++|.|+.+.+..|..+++|++|+|++|
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred cCCccccccCHHHhcCCccccccccccc
Confidence 3333333333333333333333333333
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=1.2e-17 Score=168.51 Aligned_cols=127 Identities=31% Similarity=0.439 Sum_probs=64.8
Q ss_pred eeeccccccCCCCccccCCCcccceeeeccccccc-cCChhhccCCCCCeEEeeccccccccccccccccccceeccccc
Q 042958 365 TLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSG-SIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYN 443 (1075)
Q Consensus 365 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 443 (1075)
+++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|+++.+.+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3444444442 2333322 345555555555543 22344455555555555555555555555555555555555555
Q ss_pred ccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCccc
Q 042958 444 KLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
+|+...|.+|.++++|++|+|++|+|++..|+.|..+++|++|+|++|++.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 555444555555555555555555555555555555555555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.1e-17 Score=164.85 Aligned_cols=177 Identities=29% Similarity=0.394 Sum_probs=96.5
Q ss_pred EEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccccc
Q 042958 77 YLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNY 156 (1075)
Q Consensus 77 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 156 (1075)
.++++.+++++.++ ...+.++++|++++|.++. + +.+..+++|++|++++|++++..| ++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34555566654433 2456666777777776653 2 245666677777777776664322 5556666666666665
Q ss_pred ccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCccc
Q 042958 157 LEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSE 236 (1075)
Q Consensus 157 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 236 (1075)
+..+. .++++++|+.|++++|.+.... .+..+++|+.|++++|++.. + ..+..+++|++|++.+|++++. + .
T Consensus 96 ~~~~~--~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 96 IADIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred ccccc--cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-c
Confidence 55543 2556666666666666555422 25555566666666665542 2 2355555555555555555532 1 2
Q ss_pred ccCCCCCCeEeccCCCCCCccCCCCcccccccc
Q 042958 237 LGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLAT 269 (1075)
Q Consensus 237 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 269 (1075)
++++++|++|++++|++++ ++ .++.+++|++
T Consensus 168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 5555555555555555553 22 2444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4.6e-17 Score=166.71 Aligned_cols=179 Identities=31% Similarity=0.425 Sum_probs=87.3
Q ss_pred EccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeeccccccc
Q 042958 79 DLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLE 158 (1075)
Q Consensus 79 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~ 158 (1075)
++..+.+++.++. ..+..|++|++++|.++.. + .+..+++|++|+|++|+|++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~----------------------- 82 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD----------------------- 82 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-----------------------
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-----------------------
Confidence 4444444444332 2345555555555555422 1 24555555555555555553
Q ss_pred CCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCceeccccCCCCCCccccc
Q 042958 159 DLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATLYLHNNSLFDSIPSELG 238 (1075)
Q Consensus 159 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 238 (1075)
+.+ ++.+++|++|++++|++++. + .+.++++|+.|++++|.+.. + ..+..+++++.+++++|.+++ +..+.
T Consensus 83 -l~~--~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~ 153 (210)
T d1h6ta2 83 -IKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLS 153 (210)
T ss_dssp -CGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGG
T ss_pred -ccc--cccCcccccccccccccccc-c-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccc
Confidence 221 33444444444444444432 1 24444555555555554431 1 234445555555555555542 22344
Q ss_pred CCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEcc
Q 042958 239 NLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLG 297 (1075)
Q Consensus 239 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 297 (1075)
.+++|+++++++|++++.. .+.++++|++|++++|+++. ++ .|.++++|++|+|+
T Consensus 154 ~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 5555555555555555322 25555556666666665553 22 35556666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=4.2e-17 Score=166.98 Aligned_cols=166 Identities=31% Similarity=0.431 Sum_probs=110.2
Q ss_pred ccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeeccccccccCCCCcCCCCcCce
Q 042958 143 RLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYNKFSGSIPHSLGNLTNLATL 222 (1075)
Q Consensus 143 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 222 (1075)
.+.+|++|++++|.+.++. .+..+++|++|++++|++++..+ ++.+++|++|++++|++++ ++ .+.++++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-cc-ccccccccccc
Confidence 3445555555555555442 26677888888888888876443 6778888888888888874 33 46777788888
Q ss_pred eccccCCCCCCcccccCCCCCCeEeccCCCCCCccCCCCcccccccccccccccCcCCCCcccCCCccCcEEEccCCCCC
Q 042958 223 YLHNNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLYLYENSLSGSIPSEFGNLRSLSMLNLGYNKLN 302 (1075)
Q Consensus 223 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 302 (1075)
++++|.+.. ...+..+++++.+++++|.+++. ..+..+++|+++++++|++++. + .+.++++|+.|+|++|+|+
T Consensus 118 ~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCC
Confidence 888777653 23567777777777777777632 2455666777777777777643 2 3666777777777777776
Q ss_pred CCcCCCCCccccccceeccc
Q 042958 303 GIIPHSLGNLTNLATLYIHN 322 (1075)
Q Consensus 303 ~~~~~~~~~l~~L~~L~L~~ 322 (1075)
.+ + .|.++++|++|+|++
T Consensus 192 ~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 DL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp BC-G-GGTTCTTCSEEEEEE
T ss_pred CC-h-hhcCCCCCCEEEccC
Confidence 43 2 466667777776653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=2.4e-17 Score=167.32 Aligned_cols=178 Identities=27% Similarity=0.377 Sum_probs=101.4
Q ss_pred cccccCCcccccCCCcCCCCCCcceeeccccccCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccc
Q 042958 341 NLGLSGNKLSGSIPPSLGYLSNLATLYLYSNSLFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNS 420 (1075)
Q Consensus 341 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 420 (1075)
.+.++.+.+++.++ ...+.++++|++++|.+... +.+..+++|++|++++|++++..+ ++++++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34444444443221 22344555555555555332 234556666666666666654322 5666666666666666
Q ss_pred cccccccccccccccceecccccccccCCCCCCccccccccccccCCccccCCCccccCcCCCCEEeCCCCcccCCCccc
Q 042958 421 LSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYDNSLSGSIPGEIGNLRSISNLALNNNKLSGSIPQS 500 (1075)
Q Consensus 421 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 500 (1075)
+.... .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.. .
T Consensus 96 ~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~ 167 (199)
T d2omxa2 96 IADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--P 167 (199)
T ss_dssp CCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--G
T ss_pred ccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--c
Confidence 65332 356666666666666666532 235566667777777776652 2 24666677777777777766432 3
Q ss_pred ccCCCccceeeccCCCCCCCCCccccCccccccc
Q 042958 501 LGNLSNLVILYLYNNSLFDSIPSELGNLRSLSML 534 (1075)
Q Consensus 501 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 534 (1075)
++++++|+.|++++|++++ ++ .++.+++|+.|
T Consensus 168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 6677777777777777654 22 45566665543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=6.1e-16 Score=166.16 Aligned_cols=222 Identities=18% Similarity=0.170 Sum_probs=106.8
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCC-CccccccCCcceeeccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSI-PYEIGRLSSLNYLALYS 154 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~ 154 (1075)
++|||+++.+.......+-. ..+..+.++...+...+ .......+|++|||+++.++... +..+..+++|++|++++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 35677766654221111111 12445555555554222 22334557777777777766332 23345566666666666
Q ss_pred ccccCCCCCCCCCCCCCCEEEcCCC-CCCCC-CCccccCccccceEeeecc-ccccc-cCCCCcC-CCCcCceecccc--
Q 042958 155 NYLEDLIPPSLGNLSNLDTLHLYDN-SLSDS-IPSEFGNLRSLSMLSLGYN-KFSGS-IPHSLGN-LTNLATLYLHNN-- 227 (1075)
Q Consensus 155 n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~l~~-l~~L~~L~L~~N-- 227 (1075)
+.+.+..+..++.+++|++|++++| .+++. +...+.++++|++|+++++ .++.. +...+.. .++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 6666555555666667777777664 44421 1112345566666666664 23211 1111222 245666666543
Q ss_pred CCCCC-CcccccCCCCCCeEeccCC-CCCCccCCCCcccccccccccccc-cCcCCCCcccCCCccCcEEEccCC
Q 042958 228 SLFDS-IPSELGNLRSLSMLSLGYN-KLSGSIPHSLGNLTNLATLYLYEN-SLSGSIPSEFGNLRSLSMLNLGYN 299 (1075)
Q Consensus 228 ~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N 299 (1075)
.+++. +...+..+++|++|++++| .+++.....+..+++|++|++++| .++......++++++|+.|+++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 22211 1112234555666666553 244333444444455555555542 343333333444444555554443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=5.5e-14 Score=129.36 Aligned_cols=102 Identities=28% Similarity=0.382 Sum_probs=61.1
Q ss_pred cEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcceeecccc
Q 042958 76 AYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSN 155 (1075)
Q Consensus 76 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 155 (1075)
|+|||++|+++ .++ .++.+++|++|++++|.|+ .+|+.++.+++|++|++++|+|+. +| .
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~--------------- 60 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-G--------------- 60 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-G---------------
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-c---------------
Confidence 46777777776 444 3677777777777777776 556666677777777777777663 22 2
Q ss_pred cccCCCCCCCCCCCCCCEEEcCCCCCCCCC-CccccCccccceEeeeccccc
Q 042958 156 YLEDLIPPSLGNLSNLDTLHLYDNSLSDSI-PSEFGNLRSLSMLSLGYNKFS 206 (1075)
Q Consensus 156 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 206 (1075)
++.+++|++|++++|+|+... ...+..+++|++|++++|.++
T Consensus 61 ---------~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 61 ---------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp ---------GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ---------cccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 444555555555555554332 234555555666666666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2.5e-14 Score=138.70 Aligned_cols=110 Identities=23% Similarity=0.179 Sum_probs=65.6
Q ss_pred cCCCCCccEEEccCCCccCCCCccccccCCCceeecccCcccccCCCCCCCCCCCcEEEccCcccCCCCCccccccCCcc
Q 042958 69 FSSFPHLAYLDLWHNQLYGNIPPQIGNISRLKYLDLSSNLFFGTIPPEIGHLSYLKTLQLFENQLNGSIPYEIGRLSSLN 148 (1075)
Q Consensus 69 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 148 (1075)
+.+...+++|||++|+|+ .+|..+..+++|++|+|++|.|+ .+ +.+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 556667777888888776 45655566777777777777776 33 3467777777777777777643333334455555
Q ss_pred eeecccccccCCCC-CCCCCCCCCCEEEcCCCCC
Q 042958 149 YLALYSNYLEDLIP-PSLGNLSNLDTLHLYDNSL 181 (1075)
Q Consensus 149 ~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l 181 (1075)
+|++++|.+.++.. ..+..+++|++|++++|.+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cceeccccccccccccccccccccchhhcCCCcc
Confidence 55555555544321 2334444444444444444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3e-14 Score=138.09 Aligned_cols=126 Identities=17% Similarity=0.140 Sum_probs=59.6
Q ss_pred CCCCCcEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceE
Q 042958 119 HLSYLKTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSML 198 (1075)
Q Consensus 119 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 198 (1075)
+..+|++|||++|+|+ .+|..+..+++|++|+|++|.|+.+ +.|..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 4444455555555544 2233333344444444444444433 225555556666666666555444444555555566
Q ss_pred eeeccccccccC-CCCcCCCCcCceeccccCCCCCC---cccccCCCCCCeEe
Q 042958 199 SLGYNKFSGSIP-HSLGNLTNLATLYLHNNSLFDSI---PSELGNLRSLSMLS 247 (1075)
Q Consensus 199 ~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 247 (1075)
++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 665555542211 23444555555555555553221 11244455555544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=3.4e-14 Score=152.29 Aligned_cols=99 Identities=18% Similarity=0.212 Sum_probs=45.5
Q ss_pred ceeeeccccccccCChhhccC--CCCCeEEeeccccccccccccccccccceecccccccccC-CCCCCccccccccccc
Q 042958 388 SMLSLGYNKLSGSIPHSLGNL--TNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGS-IPHSLGNLTNLDALYL 464 (1075)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L 464 (1075)
+.+|++++.+. |+.++.+ ..+..+.++...+.... .......+|++||++++.++.. ++..+.++++|++|+|
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 35677766653 2222222 12334444444433211 1222334556666665555422 2233444555555555
Q ss_pred cCCccccCCCccccCcCCCCEEeCCC
Q 042958 465 YDNSLSGSIPGEIGNLRSISNLALNN 490 (1075)
Q Consensus 465 ~~N~l~~~~p~~~~~l~~L~~L~L~~ 490 (1075)
++|.+++..+..++.+++|++|++++
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred cccCCCcHHHHHHhcCCCCcCccccc
Confidence 55555544444455555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=6.7e-15 Score=163.21 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=145.7
Q ss_pred ccccccccccceecccccccccC----CCCCCccccccccccccCCccccC---CC-------ccccCcCCCCEEeCCCC
Q 042958 426 PSEFGNLRSLSTLSLGYNKLSGS----IPHSLGNLTNLDALYLYDNSLSGS---IP-------GEIGNLRSISNLALNNN 491 (1075)
Q Consensus 426 ~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---~p-------~~~~~l~~L~~L~L~~N 491 (1075)
...+....+|+.|+|++|.|... +-..+...++|+.|+++++..... .| ..+...++|+.|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 34566778899999999988642 334566678888888887765421 11 22345677888888888
Q ss_pred cccCC----CcccccCCCccceeeccCCCCCCCCCccccCccccccccccccccccccCCcccccccCCCccccccchhh
Q 042958 492 KLSGS----IPQSLGNLSNLVILYLYNNSLFDSIPSELGNLRSLSMLSFAYNKLSGSIPHSLGVLDLSSNHIVGEIPTEL 567 (1075)
Q Consensus 492 ~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~L~Ls~N~l~~~~p~~~ 567 (1075)
.+... +...+...++|+.|++++|.+.......+. ..+..+....+. .....++.+++++|++....-..
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~~~---~~~~~L~~l~l~~n~i~~~~~~~- 177 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNKKA---KNAPPLRSIICGRNRLENGSMKE- 177 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHHHH---HTCCCCCEEECCSSCCTGGGHHH-
T ss_pred ccccccccchhhhhcccccchheeccccccccccccccc--cccccccccccc---ccCcccceeeccccccccccccc-
Confidence 77654 233344567777777777766321111111 111111111100 11234666677777665321111
Q ss_pred hhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCc-----ccccccccccceEEEccccccccc----cchh
Q 042958 568 GKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNS-----IPKSFGNLVKLHYLNLSNNQFSRG----IPIK 638 (1075)
Q Consensus 568 ~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 638 (1075)
+...+...+.|+.|+|++|.|+.. +...+..+++|+.|+|++|.++.. +...
T Consensus 178 -------------------l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 178 -------------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp -------------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred -------------------ccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 112233445677777777776531 334456667777777777776432 3344
Q ss_pred cccccccceeeeccccccCchhhhhc------cccccceeecCCCccccCC----hhhhc-ccccccEEeecCCccCC
Q 042958 639 LEELIHLSELDLSHNFLREAIPSQIC------IMQSLENLNLSHNSLVGLI----PSCFE-KMHGLLRIDISYNELQG 705 (1075)
Q Consensus 639 ~~~l~~L~~L~ls~N~l~~~~~~~~~------~~~~L~~L~ls~N~l~~~~----p~~~~-~~~~l~~l~~s~N~~~~ 705 (1075)
+...++|++|+|++|.|++.....++ ..+.|+.|++++|.|+... ...+. +.+.|+.|++++|++..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 56677777777777777654333332 2345777888887776432 23332 46678888888887753
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.2e-13 Score=127.09 Aligned_cols=118 Identities=30% Similarity=0.347 Sum_probs=83.8
Q ss_pred cEEEccCcccCCCCCccccccCCcceeecccccccCCCCCCCCCCCCCCEEEcCCCCCCCCCCccccCccccceEeeecc
Q 042958 124 KTLQLFENQLNGSIPYEIGRLSSLNYLALYSNYLEDLIPPSLGNLSNLDTLHLYDNSLSDSIPSEFGNLRSLSMLSLGYN 203 (1075)
Q Consensus 124 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (1075)
|+|||++|+++ .++ .+..+++|++|++++|.++++ |+.|+.+++|++|++++|+|++. | .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~l-p~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCC-CGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcc-hhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 34555555555 222 255555555555555555544 34578888999999999999864 3 4899999999999999
Q ss_pred cccccc-CCCCcCCCCcCceeccccCCCCC---CcccccCCCCCCeE
Q 042958 204 KFSGSI-PHSLGNLTNLATLYLHNNSLFDS---IPSELGNLRSLSML 246 (1075)
Q Consensus 204 ~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L 246 (1075)
+|+... ...+..+++|++|++++|.+++. ....+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 998543 25788999999999999999743 22334557787765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=3.8e-15 Score=165.29 Aligned_cols=86 Identities=22% Similarity=0.263 Sum_probs=36.4
Q ss_pred cccceeeecccccccc----CChhhccCCCCCeEEeeccccccc-----cccccccccccceecccccccccC----CCC
Q 042958 385 RSLSMLSLGYNKLSGS----IPHSLGNLTNLATLDLYDNSLSGS-----IPSEFGNLRSLSTLSLGYNKLSGS----IPH 451 (1075)
Q Consensus 385 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~p~ 451 (1075)
+.|+.+++++|++... +...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 3444555555544321 112233344555555555554421 122334444455555555544321 122
Q ss_pred CCccccccccccccCCccc
Q 042958 452 SLGNLTNLDALYLYDNSLS 470 (1075)
Q Consensus 452 ~~~~l~~L~~L~L~~N~l~ 470 (1075)
.+..+++|++|+|++|.|+
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HGGGCTTCCEEECTTCCCC
T ss_pred cccccccchhhhhhcCccC
Confidence 3334444445555555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=3.2e-14 Score=143.04 Aligned_cols=146 Identities=23% Similarity=0.256 Sum_probs=111.2
Q ss_pred CCcccccccCCC--ccccccchhhhhhhHhHHHhhcccccccccccccCcccccceeecCCCcccCcccccccccccceE
Q 042958 546 PHSLGVLDLSSN--HIVGEIPTELGKLNFLIKLILAQNQLSGQLSPKLGSLAQLEHLDLSSNRLSNSIPKSFGNLVKLHY 623 (1075)
Q Consensus 546 p~~l~~L~Ls~N--~l~~~~p~~~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 623 (1075)
+...+.++++++ .+. .+|..+..+.+|+.|+|++|+|+.. + .+..+++|+.|+|++|+|+ .+|..+..+++|++
T Consensus 22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~ 97 (198)
T d1m9la_ 22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCE
T ss_pred ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccc
Confidence 334445555543 233 5667888888899999999998843 3 5888899999999999997 56776777788999
Q ss_pred EEccccccccccchhcccccccceeeeccccccCchh-hhhccccccceeecCCCccccCChhh----------hccccc
Q 042958 624 LNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIP-SQICIMQSLENLNLSHNSLVGLIPSC----------FEKMHG 692 (1075)
Q Consensus 624 L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~~~~L~~L~ls~N~l~~~~p~~----------~~~~~~ 692 (1075)
|++++|+|+.. ..+..+++|+.|+|++|+|+.... ..+..+++|+.|++++|++....+.. +..+|.
T Consensus 98 L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~ 175 (198)
T d1m9la_ 98 LWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175 (198)
T ss_dssp EECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSS
T ss_pred ccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCC
Confidence 99999998753 347888899999999999987433 56788899999999999987554432 567888
Q ss_pred ccEEe
Q 042958 693 LLRID 697 (1075)
Q Consensus 693 l~~l~ 697 (1075)
|+.||
T Consensus 176 L~~LD 180 (198)
T d1m9la_ 176 LKKLD 180 (198)
T ss_dssp CCEES
T ss_pred cCEeC
Confidence 88887
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=6e-14 Score=141.05 Aligned_cols=113 Identities=26% Similarity=0.397 Sum_probs=63.8
Q ss_pred CccccCCCcccceeeeccccccccCChhhccCCCCCeEEeeccccccccccccccccccceecccccccccCCCCCCccc
Q 042958 377 IPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYDNSLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNL 456 (1075)
Q Consensus 377 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 456 (1075)
++..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+. +|..+..+++|++|++++|+|+. + ..+.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc-ccccccccccccccccccccccc-c-cccccc
Confidence 44556666666666666666653 22 36666666666666666653 34444445566666666666653 2 235556
Q ss_pred cccccccccCCccccCCC-ccccCcCCCCEEeCCCCccc
Q 042958 457 TNLDALYLYDNSLSGSIP-GEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 494 (1075)
++|+.|++++|+++.... ..+..+++|+.|++++|++.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 666666666666653211 24555556666666666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=4.2e-12 Score=121.86 Aligned_cols=105 Identities=23% Similarity=0.182 Sum_probs=58.0
Q ss_pred ceeeeccccccccCChhhccCCCCCeEEeecc-ccccccccccccccccceecccccccccCCCCCCccccccccccccC
Q 042958 388 SMLSLGYNKLSGSIPHSLGNLTNLATLDLYDN-SLSGSIPSEFGNLRSLSTLSLGYNKLSGSIPHSLGNLTNLDALYLYD 466 (1075)
Q Consensus 388 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 466 (1075)
+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555555554 34445555556666666544 35555555566666666666666666655555566666666666666
Q ss_pred CccccCCCccccCcCCCCEEeCCCCccc
Q 042958 467 NSLSGSIPGEIGNLRSISNLALNNNKLS 494 (1075)
Q Consensus 467 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 494 (1075)
|+|+...+..|..+ +|+.|+|++|++.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCcccChhhhccc-cccccccCCCccc
Confidence 66663333333332 4666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=1.2e-11 Score=118.48 Aligned_cols=104 Identities=25% Similarity=0.185 Sum_probs=54.6
Q ss_pred ccccccCCcccccCCCcCCCCCCcceeeccccc-cCCCCccccCCCcccceeeeccccccccCChhhccCCCCCeEEeec
Q 042958 340 SNLGLSGNKLSGSIPPSLGYLSNLATLYLYSNS-LFDSIPSELGNLRSLSMLSLGYNKLSGSIPHSLGNLTNLATLDLYD 418 (1075)
Q Consensus 340 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 418 (1075)
+.++++++.+. ..|..+..+++|++|++++|+ +....+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34455555544 334445555555555554442 4444444555555555555555555555555555555555555555
Q ss_pred cccccccccccccccccceeccccccc
Q 042958 419 NSLSGSIPSEFGNLRSLSTLSLGYNKL 445 (1075)
Q Consensus 419 N~l~~~~~~~~~~l~~L~~L~L~~N~l 445 (1075)
|+|+.+.++.|..+ +|+.|+|++|.+
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~ 115 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPL 115 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred CCCcccChhhhccc-cccccccCCCcc
Confidence 55554444444333 455555555555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=1.4e-09 Score=104.73 Aligned_cols=86 Identities=31% Similarity=0.266 Sum_probs=49.4
Q ss_pred cccccccccceEEEccccccccc--cchhcccccccceeeeccccccCchhhhhccccccceeecCCCccccCChh----
Q 042958 612 PKSFGNLVKLHYLNLSNNQFSRG--IPIKLEELIHLSELDLSHNFLREAIPSQICIMQSLENLNLSHNSLVGLIPS---- 685 (1075)
Q Consensus 612 p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~---- 685 (1075)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|||++|+|+...+-.......|+.|++++|++......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 33334455555555555555542 234455566666666666666654433333445577777777777655432
Q ss_pred ---hhcccccccEEe
Q 042958 686 ---CFEKMHGLLRID 697 (1075)
Q Consensus 686 ---~~~~~~~l~~l~ 697 (1075)
-+..+|.|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 256677888777
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=3.3e-09 Score=102.02 Aligned_cols=90 Identities=24% Similarity=0.231 Sum_probs=69.9
Q ss_pred ccccCcccccceeecCCCcccCc--ccccccccccceEEEccccccccccchhcccccccceeeeccccccCchhh----
Q 042958 588 SPKLGSLAQLEHLDLSSNRLSNS--IPKSFGNLVKLHYLNLSNNQFSRGIPIKLEELIHLSELDLSHNFLREAIPS---- 661 (1075)
Q Consensus 588 ~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~---- 661 (1075)
+..+..+++|++||||+|+|+.. ++..+..+++|++|+|++|+|+...+..+.....|++|+|++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 33445688999999999999864 345678899999999999999876665666667899999999999875432
Q ss_pred ---hhccccccceeecCCCcc
Q 042958 662 ---QICIMQSLENLNLSHNSL 679 (1075)
Q Consensus 662 ---~~~~~~~L~~L~ls~N~l 679 (1075)
.+..+|+|+.|| ++.+
T Consensus 138 ~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 138 ISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHHCCCCCEEC--cCCC
Confidence 356689999886 5554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=6.8e-06 Score=78.57 Aligned_cols=109 Identities=21% Similarity=0.313 Sum_probs=75.7
Q ss_pred cccccceeecCCC-cccCc----ccccccccccceEEEcccccccc----ccchhcccccccceeeeccccccCchh---
Q 042958 593 SLAQLEHLDLSSN-RLSNS----IPKSFGNLVKLHYLNLSNNQFSR----GIPIKLEELIHLSELDLSHNFLREAIP--- 660 (1075)
Q Consensus 593 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~~--- 660 (1075)
..+.|++|+|+++ .++.. +...+...++|++|+|++|.+.. .+...+...+.|++|+|++|.|+...-
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3467888999874 56532 33456667788999999988864 233445567788999999998886433
Q ss_pred -hhhccccccceeecCCCccccC-------ChhhhcccccccEEeecCC
Q 042958 661 -SQICIMQSLENLNLSHNSLVGL-------IPSCFEKMHGLLRIDISYN 701 (1075)
Q Consensus 661 -~~~~~~~~L~~L~ls~N~l~~~-------~p~~~~~~~~l~~l~~s~N 701 (1075)
..+...++|+.|++++|.+... +...+...++|..|+++++
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 3445557799999998876543 3455666778888887665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=4.8e-05 Score=72.43 Aligned_cols=90 Identities=14% Similarity=0.122 Sum_probs=61.6
Q ss_pred cCcccccceeecCCCcccC----cccccccccccceEEEcccccccccc----chhcccccccceeeeccccccCc----
Q 042958 591 LGSLAQLEHLDLSSNRLSN----SIPKSFGNLVKLHYLNLSNNQFSRGI----PIKLEELIHLSELDLSHNFLREA---- 658 (1075)
Q Consensus 591 ~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~ls~N~l~~~---- 658 (1075)
+...+.|++|+|++|.++. .+...+...+.|++|+|++|.|+... -..+...+.|++|+|++|++...
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 4455678888888888864 23344555678888888888886532 23456667788999988876532
Q ss_pred ---hhhhhccccccceeecCCCccc
Q 042958 659 ---IPSQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 659 ---~~~~~~~~~~L~~L~ls~N~l~ 680 (1075)
+...+..-++|+.|+++.+...
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHhCCCccEeeCcCCCch
Confidence 3444555678999998877553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.32 E-value=0.00015 Score=74.69 Aligned_cols=146 Identities=14% Similarity=0.117 Sum_probs=88.3
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEeecc
Q 042958 808 EEIIRATNDFDDEHCIGKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHV 886 (1075)
Q Consensus 808 ~e~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 886 (1075)
.|+...-+.|+..+..+.++.+.||+.... ++.++||+........ ...+.+|...+..+. +--+.++++++...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 455566677776665555556789998654 6677888875432222 234667888777663 33356777776554
Q ss_pred ccchhheecCcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCC-----------------------------------
Q 042958 887 RHSLAMILSNNAAA----KDLGWTRRMNVIKGISDALSYMHNDCF----------------------------------- 927 (1075)
Q Consensus 887 ~~~l~~~~~~~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~----------------------------------- 927 (1075)
+..+. ++....+. ...+.....+++.++++.+..||+...
T Consensus 83 ~~~~l-v~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 83 GWSNL-LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp TEEEE-EEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred CceEE-EEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 33222 22221110 011112234456677777777775421
Q ss_pred ---------------------CCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 928 ---------------------PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 928 ---------------------~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.++|+|+.|.||++++++.+.|.||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1378999999999999776667999987753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.24 E-value=7.9e-05 Score=70.85 Aligned_cols=111 Identities=14% Similarity=0.187 Sum_probs=72.5
Q ss_pred cccccceeecCC-CcccC----cccccccccccceEEEccccccccc----cchhcccccccceeeeccccccCch----
Q 042958 593 SLAQLEHLDLSS-NRLSN----SIPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEELIHLSELDLSHNFLREAI---- 659 (1075)
Q Consensus 593 ~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~---- 659 (1075)
..+.|++|+|++ |.|+. .+-..+...++|++|+|++|.++.. +-..+.....++.+++++|.+....
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 456778888876 45653 2334455677788888888877542 2234556777888888888886533
Q ss_pred hhhhccccccce--eecCCCcccc----CChhhhcccccccEEeecCCcc
Q 042958 660 PSQICIMQSLEN--LNLSHNSLVG----LIPSCFEKMHGLLRIDISYNEL 703 (1075)
Q Consensus 660 ~~~~~~~~~L~~--L~ls~N~l~~----~~p~~~~~~~~l~~l~~s~N~~ 703 (1075)
-..+...++|+. |++++|.+.. .+...+.+.++|+.|++++++.
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 344556677776 4556777753 3455567788888888876643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.03 E-value=0.00038 Score=71.11 Aligned_cols=130 Identities=13% Similarity=0.090 Sum_probs=76.1
Q ss_pred eecccCc-eEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCCc--CceeeEEEEeeccccchhheecCcc
Q 042958 822 CIGKGGQ-GSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHVRHSLAMILSNNA 898 (1075)
Q Consensus 822 ~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~l~~~~~~~~ 898 (1075)
.+..|.. +.||+.+.+++..+++|....... ..+..|+..++.+.. -.+.++++++.+.+..+.+ +....
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v-~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL-LGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE-EECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE-EEeee
Confidence 3455553 689999888888899998654322 245667777766632 3356677776654433222 11111
Q ss_pred c-cCCCCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------------------------
Q 042958 899 A-AKDLGWTRRMNVIKGISDALSYMHNDCF-------------------------------------------------- 927 (1075)
Q Consensus 899 ~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~-------------------------------------------------- 927 (1075)
+ ...-.+......+.++++.+.-||+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 1 0000011122333455555555554211
Q ss_pred -----CCeEEecCCCCCeeeCCCCCceEeccccccc
Q 042958 928 -----PPIVHRDISSKNVLLDFDNEAHVSDFGIAKF 958 (1075)
Q Consensus 928 -----~~ivH~Dlk~~Nill~~~~~~kl~DfGla~~ 958 (1075)
+.++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2379999999999999876678999987753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.87 E-value=7.1e-05 Score=71.18 Aligned_cols=92 Identities=16% Similarity=0.152 Sum_probs=66.0
Q ss_pred cccCcccccceeecCCCcccCc----ccccccccccceEEEccccccccc----cchhccccccccee--eeccccccC-
Q 042958 589 PKLGSLAQLEHLDLSSNRLSNS----IPKSFGNLVKLHYLNLSNNQFSRG----IPIKLEELIHLSEL--DLSHNFLRE- 657 (1075)
Q Consensus 589 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L--~ls~N~l~~- 657 (1075)
..+...++|++|+|++|.++.. +...+...++++.+++++|.++.. +-..+...+.|+.+ ++++|.+..
T Consensus 40 ~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~ 119 (166)
T d1io0a_ 40 EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 119 (166)
T ss_dssp HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred HHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHH
Confidence 3455678899999999988753 334456678899999999988642 33556777888864 456788865
Q ss_pred ---chhhhhccccccceeecCCCccc
Q 042958 658 ---AIPSQICIMQSLENLNLSHNSLV 680 (1075)
Q Consensus 658 ---~~~~~~~~~~~L~~L~ls~N~l~ 680 (1075)
.+...+...+.|+.|+++.|...
T Consensus 120 ~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 120 VEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 34455667788999999887664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.54 E-value=0.013 Score=63.39 Aligned_cols=30 Identities=20% Similarity=0.310 Sum_probs=25.9
Q ss_pred CeEEecCCCCCeeeCCCCCceEecccccccc
Q 042958 929 PIVHRDISSKNVLLDFDNEAHVSDFGIAKFL 959 (1075)
Q Consensus 929 ~ivH~Dlk~~Nill~~~~~~kl~DfGla~~~ 959 (1075)
.++|||+.+.||+++++ .++|+||..|..-
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 68999999999999865 4899999888653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.07 E-value=0.03 Score=58.45 Aligned_cols=63 Identities=8% Similarity=0.150 Sum_probs=39.0
Q ss_pred cccHHHHHHHhcCCCCCcee-----cccCceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC
Q 042958 804 KIVYEEIIRATNDFDDEHCI-----GKGGQGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872 (1075)
Q Consensus 804 ~~~~~e~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 872 (1075)
..+.+|+.....+|..++.. ..|---+.|+.+..+|+ +++|++..... .+++..|++++..+.
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-----~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-----KNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC-----HHHHHHHHHHHHhhh
Confidence 35567888888889876543 45666888999877665 88998754321 134455666666663
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.03 E-value=0.017 Score=60.76 Aligned_cols=41 Identities=15% Similarity=0.135 Sum_probs=31.0
Q ss_pred ceEEEEEEECCCCEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC
Q 042958 828 QGSVYKAELASGEIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 872 (1075)
Q Consensus 828 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 872 (1075)
--.||+++..+|+.|++|+.+.... ..+++..|...+..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLV 75 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHH
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHH
Confidence 4589999999999999999764321 2466778888887774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.36 E-value=0.16 Score=54.51 Aligned_cols=59 Identities=19% Similarity=0.283 Sum_probs=38.7
Q ss_pred ceecccCceEEEEEEECCC--------CEEEEEEccCCCCCchhHHHHHHHHHHHHhcCC-cCceeeEEEEee
Q 042958 821 HCIGKGGQGSVYKAELASG--------EIVAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCS 884 (1075)
Q Consensus 821 ~~lG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 884 (1075)
+.|+.|-.-.+|++...++ +.|.+++.... .. .....+|..+++.+. +.-..++++++.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 5688899999999977543 45777765421 11 234457888888884 433457777764
|